Citrus Sinensis ID: 048517

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450---
Protein Sequence
MTFQHYVKRISYDECTISVADVNLANGSCTNLFPHAFTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNRSVDNPSYEDLRKLLDSGFDFTWFEECSSYHPITNWIPIDVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHISGRETESASLTE
Secondary Structure (PSIPRED)
ccEEEEEEEEEccccEEEEEcccccccccccccccccccccccccccccEEEEEccccccccccccccccEEEEEEEEccccccccccHHHHHHHHcccccccccccccccccccEEEcEEEHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHcccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHcccccccEEEEEEEcccccccccccccccccccccccHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccccccccccccccccccEEEEEcccccccccccHHccccccccccccccHHHHHHHHHHHccccccccccccccccccHHHHHHHHHccccEEEEcccHHHHHHHHHHHHHEEccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEEEccccHHHHHHHHcccccccccccHHccccccccccccEEEEEcccccccccccccccccEEEEEcccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHcHHHcccccccccEEccEcccccEEEEEEEccccccHHHHHHHHHccccccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEEcccHcHEEEcccccccHcHccHHHEcccccccccccEEEEEcccccHHHHHcccccEEEcccHHHHHEEEEEEHcccccccccccccccccHHHHHHHHHHcccccEEcccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccEEccccccccccccccccc
Coil and Loop (DISEMBL)
mtfqhyvkrisydectisvadvnlangsctnlfphaftkvpclsdnksnVYVYLGsadtndaisdlpescvfiskvpvvlnrsvdnpsyEDLRKLLDSGfdftwfeecssyhpitnwipidVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNILLPEIIAVTNhfthklgqggfgsvykgqlHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYeympngsldrhifskenkgqtfglekpheiALGTARGIEylhngcdvcilhfdikphnilldhnfipkvsdfglakfhpkendfvsisdtrgtigylapelisrnfgtvscksdvYGFGMVLLEMaggrrnsnmnatrsskayfpswvydqlnkggdlelrnVTEIESMIARKLCMIGLWCiqvkaadrpsMTKVLEMLEGsiddlqmppkpffsssrhisgretesaslte
Flexible Loop (DISEMBL)
MTFQHYVKRISYDECTISVADVNLANGSCTNLFPHAFTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNRSVDNPSYEDLRKLLDSGFDFTWFEECSSYHPITNWIPIDVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLApelisrnfgtvSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSiddlqmppkpffsssrhisgretesaslte
Low Complexity Region (SEG)
MTFQHYVKRISYDECTISVADVNLANGSCTNLFPHAFTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNRSVDNPSYEDLRKLLDSGFDFTWFEECSSYHPITNWIPIDVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHISGRETESASLTE
Disordered region (IsUnstruct)
***QHYVKRISYDECTISVADVNLANGSCTNLFPHAFTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNRSVDNPSYEDLRKLLDSGFDFTWFEECSSYHPITNWIPIDVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG*************KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAAD********************************************
Disordered Region (DISOPRED)
MTFQHYVKRISYDECTISVADVNLANGSCTNLFPHAFTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNRSVDNPSYEDLRKLLDSGFDFTWFEECSSYHPITNWIPIDVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENS*FSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS*****RSS*AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPK*********************
Disordered Region (DISEMBL)
MTFQHYVKRISYDECTISVADVNLANGSCTNLFPHAFTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNRSVDNPSYEDLRKLLDSGFDFTWFEECSSYHPITNWIPIDVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFS*****************
Disordered Region (DISPRO)
*TFQHYVKRISYDECTISVADVNLANGSCTNLFPHAFTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNRSVDNPSYEDLRKLLDSGFDFTWFEECSSYHPITNWIPIDVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSS***************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTFQHYVKRISYDECTISVADVNLANGSCTNLFPHAFTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNRSVDNPSYEDLRKLLDSGFDFTWFEECSSYHPITNWIPIDVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHISGRETESASLTE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	453	2.2.26 [Sep-21-2011]
Q9FID5	806	Probable receptor-like pr	yes	no	0.642	0.361	0.496	1e-78
Q9FID6	813	Probable receptor-like pr	no	no	0.724	0.403	0.431	7e-78
Q3ECH2	892	Probable receptor-like pr	no	no	0.701	0.356	0.434	1e-75
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.677	0.352	0.402	3e-61
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.646	0.356	0.417	4e-59
O64477	828	G-type lectin S-receptor-	no	no	0.591	0.323	0.428	1e-57
Q9XID3	829	G-type lectin S-receptor-	no	no	0.633	0.346	0.399	3e-54
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.677	0.297	0.379	5e-51
Q39203	797	G-type lectin S-receptor-	no	no	0.653	0.371	0.383	7e-51
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.682	0.299	0.373	1e-50

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  294 bits (752), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 157/316 (49%), Positives = 206/316 (65%), Gaps = 25/316 (7%)

Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           E+  +T  F++ +G+GGFG+VY G L  GR +AVK++++ K SAE+FINE          
Sbjct: 492 ELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQTSHV 551

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               LLG C EG KRA+VYE++ NGSLD+  F   NK  T  +   + IALG ARG+EYL
Sbjct: 552 NIVSLLGFCFEGSKRAIVYEFLENGSLDQ--FMSRNKSLTQDVTTLYGIALGIARGLEYL 609

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
           H GC   I+HFDIKP NILLD N  PKVSDFGLAK   K    +S+ DTRGTIGY+APE+
Sbjct: 610 HYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEV 669

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS--SKAYFPSWVYDQLNKGGDLE 380
            SR +G VS KSDVY FGM++++M G R    +    S  S  YFP W+Y  L  G    
Sbjct: 670 FSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTW 729

Query: 381 L--RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSS 438
           +    +T+ E  IA+K+ ++GLWCIQ   +DRPSM +V+EM+EGS+D L++PPKP    S
Sbjct: 730 IFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP----S 785

Query: 439 RHISGRE-TESASLTE 453
            HIS    TES+SL++
Sbjct: 786 MHISTEVITESSSLSD 801

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  291 bits (745), Expect = 7e-78,   Method: Compositional matrix adjust.
 Identities = 157/364 (43%), Positives = 224/364 (61%), Gaps = 36/364 (9%)

Query: 120 IDVLIIGRFI-LAP-IVFLVFLIHKYRTTMQTVDNILL-----------PEIIAVTNHFT 166
           I ++++G  I LA  IV ++ LI + +      +N ++            E+  +T  F+
Sbjct: 440 IILIVVGSVIGLATFIVIIMLLIRQMKRKKNKKENSVIMFKLLLKQYIYAELKKITKSFS 499

Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCS 212
           H +G+GGFG+VY+G L  GR +AVK++++ K + ++FINE              LLG C 
Sbjct: 500 HTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFCY 559

Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILH 272
           EG KRA++ E++ +GSLD+  F   NK  T  +   + IALG ARG+EYLH GC   I+H
Sbjct: 560 EGSKRAIISEFLEHGSLDQ--FISRNKSLTPNVTTLYGIALGIARGLEYLHYGCKTRIVH 617

Query: 273 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSC 332
           FDIKP NILLD NF PKV+DFGLAK   K    +S+ DTRGTIGY+APE++SR +G +S 
Sbjct: 618 FDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGGISH 677

Query: 333 KSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL--RNVTEIESM 390
           KSDVY +GM++L+M G R          S AYFP W+Y  L  G    +    + E ++ 
Sbjct: 678 KSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEEDNK 737

Query: 391 IARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHISGRET-ESA 449
           I +K+ ++ LWCI+   +DRP M KV+EM+EGS+D L++PPKP    SRHIS     ES+
Sbjct: 738 IVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKP----SRHISTELVLESS 793

Query: 450 SLTE 453
           SL++
Sbjct: 794 SLSD 797

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  283 bits (725), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 159/366 (43%), Positives = 217/366 (59%), Gaps = 48/366 (13%)

Query: 114 ITNWIPIDVLIIGRFILAPIVFLVFLIHKYRTTM----QTVDNI-------LLP------ 156
           I   +    + +G      IVFLV L   +R  +    +T D +       L+P      
Sbjct: 489 IATLVRYTFIALGALTGVVIVFLVLLCPCFRVQIFRKRKTSDEVRLQKLKALIPLKHYTY 548

Query: 157 -EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS-AEEFINE-------- 206
            E+  +T  FT  +G+GGFG VY G L    ++AVK++++SK +  E+FINE        
Sbjct: 549 AEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTS 608

Query: 207 ------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                 LLG C EG +RA++YE++ NGSLD+ I  K +      L+  + IALG ARG+E
Sbjct: 609 HVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSS--VNLDLKTLYGIALGVARGLE 666

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH GC   I+HFDIKP N+LLD N  PKVSDFGLAK   K+   +S+ DTRGTIGY+AP
Sbjct: 667 YLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAP 726

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA-TRS--SKAYFPSWVYDQLNKG- 376
           E+ISR +G+VS KSDVY +GM++LEM G R+    +  +RS  S  YFP W+Y  L K  
Sbjct: 727 EMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSIYFPEWIYKDLEKAN 786

Query: 377 ---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL 427
                    G L    ++  E  IARK+ ++GLWCIQ   +DRP M KV+EM+EGS+D L
Sbjct: 787 IKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDAL 846

Query: 428 QMPPKP 433
           ++PP+P
Sbjct: 847 EVPPRP 852

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  236 bits (602), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 140/348 (40%), Positives = 196/348 (56%), Gaps = 41/348 (11%)

Query: 118 IPIDVLIIGRFILAPIV--FLVFLIHKYRTTMQTVDNILL----------PEIIAVTNHF 165
           IPI   ++G  +L  ++   L + + + RT  +   N L+           ++   TN+F
Sbjct: 476 IPI---VVGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNF 532

Query: 166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAE-EFINE--------------LLGL 210
           +  LG GGFG+VYKG +    L+AVK ++ +    E EFI E              L G 
Sbjct: 533 SQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGY 592

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           CSE   R LVYEYM NGSLD+ IFS E            EIA+ TA+GI Y H  C   I
Sbjct: 593 CSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRI 652

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DIKP NILLD NF PKVSDFGLAK   +E+  V ++  RGT GYLAPE +S     +
Sbjct: 653 IHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV-VTMIRGTRGYLAPEWVSNR--PI 709

Query: 331 SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE-----LRNVT 385
           + K+DVY +GM+LLE+ GGRRN +M +  +   ++P W Y +L  G  L+     L+ V 
Sbjct: 710 TVKADVYSYGMLLLEIVGGRRNLDM-SYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVA 768

Query: 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKP 433
           E E ++  K   +  WCIQ + + RPSM +V+++LEG+ D++ +PP P
Sbjct: 769 EEEEVV--KALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMP 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  229 bits (583), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 140/335 (41%), Positives = 191/335 (57%), Gaps = 42/335 (12%)

Query: 133 IVFLVFLIHKYRTTMQTV-------DNIL-----LP------EIIAVTNHFTHKLGQGGF 174
           ++F+ F IHK +  +          DN L     +P      ++ + TN+F+ KLGQGGF
Sbjct: 445 LIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGF 504

Query: 175 GSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALV 220
           GSVY+G L  G  +AVK +E      +EF  E              L G C+EG  R L 
Sbjct: 505 GSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLA 564

Query: 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNI 280
           YE++  GSL+R IF K++       +    IALGTA+G+ YLH  CD  I+H DIKP NI
Sbjct: 565 YEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENI 624

Query: 281 LLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFG 340
           LLD NF  KVSDFGLAK   +E   V  +  RGT GYLAPE I+ N+  +S KSDVY +G
Sbjct: 625 LLDDNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYLAPEWIT-NY-AISEKSDVYSYG 681

Query: 341 MVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-----DLELRNVTEIESMIARKL 395
           MVLLE+ GGR+N + + T S K +FPS+ + ++ +G      D +++NV   +  + R +
Sbjct: 682 MVLLELIGGRKNYDPSET-SEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAM 740

Query: 396 CMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMP 430
               LWCIQ     RPSM+KV++MLEG    +Q P
Sbjct: 741 -KTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPP 774

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  224 bits (570), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 129/301 (42%), Positives = 176/301 (58%), Gaps = 33/301 (10%)

Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           E+   T +F+ KLG GGFGSV+KG L     IAVK +E      ++F  E          
Sbjct: 487 ELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHV 546

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQ-TFGLEKPHEIALGTARGIEY 261
               L G CSEG K+ LVY+YMPNGSLD H+F  + + +   G +   +IALGTARG+ Y
Sbjct: 547 NLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAY 606

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           LH+ C  CI+H DIKP NILLD  F PKV+DFGLAK   +  DF  +  T RGT GYLAP
Sbjct: 607 LHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGR--DFSRVLTTMRGTRGYLAP 664

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           E IS     ++ K+DVY +GM+L E+  GRRN+  +     + +FPSW    L K GD+ 
Sbjct: 665 EWISGV--AITAKADVYSYGMMLFELVSGRRNTEQSENEKVR-FFPSWAATILTKDGDIR 721

Query: 381 L-------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKP 433
                    +  +IE +   + C +  WCIQ + + RP+M++V+++LEG    L++ P P
Sbjct: 722 SLVDPRLEGDAVDIEEVT--RACKVACWCIQDEESHRPAMSQVVQILEGV---LEVNPPP 776

Query: 434 F 434
           F
Sbjct: 777 F 777

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  213 bits (542), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 125/313 (39%), Positives = 178/313 (56%), Gaps = 26/313 (8%)

Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           E+   T  F  KLG GGFG+VY+G L    ++AVK +E  +   ++F  E          
Sbjct: 478 ELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 537

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               L+G CS+G  R LVYE+M NGSLD  +F+ ++  +    E    IALGTA+GI YL
Sbjct: 538 NLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDS-AKFLTWEYRFNIALGTAKGITYL 596

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPE 321
           H  C  CI+H DIKP NIL+D NF  KVSDFGLAK  +PK+N + ++S  RGT GYLAPE
Sbjct: 597 HEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY-NMSSVRGTRGYLAPE 655

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG---- 377
            ++     ++ KSDVY +GMVLLE+  G+RN ++ + +++   F  W Y++  KG     
Sbjct: 656 WLANL--PITSKSDVYSYGMVLLELVSGKRNFDV-SEKTNHKKFSIWAYEEFEKGNTKAI 712

Query: 378 -DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFS 436
            D  L     ++     ++     WCIQ +   RP+M KV++MLEG I +++ P  P   
Sbjct: 713 LDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG-ITEIKNPLCPKTI 771

Query: 437 SSRHISGRETESA 449
           S    SG    ++
Sbjct: 772 SEVSFSGNSMSTS 784

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  202 bits (514), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 130/343 (37%), Positives = 185/343 (53%), Gaps = 36/343 (10%)

Query: 123 LIIGRFILAPIVFLVFLIHKYRTTMQTVDNILLP-----------EIIAVTNHF--THKL 169
           +I+G  +L+ I  +V  I + R    T D  +L            E+ + T  F  ++KL
Sbjct: 640 VIVGVGLLSIISGVVIFIIRKRRKRYTDDEEILSMDVKPYTFTYSELKSATQDFDPSNKL 699

Query: 170 GQGGFGSVYKGQLHTGRLIAVKMME-NSKFSAEEFINE--------------LLGLCSEG 214
           G+GGFG VYKG+L+ GR +AVK++   S+    +F+ E              L G C EG
Sbjct: 700 GEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEG 759

Query: 215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFD 274
             R LVYEY+PNGSLD+ +F +  K         +EI LG ARG+ YLH    + I+H D
Sbjct: 760 EHRLLVYEYLPNGSLDQALFGE--KTLHLDWSTRYEICLGVARGLVYLHEEARLRIVHRD 817

Query: 275 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           +K  NILLD   +PKVSDFGLAK +  +   +S +   GTIGYLAPE   R  G ++ K+
Sbjct: 818 VKASNILLDSKLVPKVSDFGLAKLYDDKKTHIS-TRVAGTIGYLAPEYAMR--GHLTEKT 874

Query: 335 DVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL--RNVTEIESMIA 392
           DVY FG+V LE+  GR NS+ N     K Y   W ++   KG ++EL    +TE      
Sbjct: 875 DVYAFGVVALELVSGRPNSDEN-LEDEKRYLLEWAWNLHEKGREVELIDHQLTEFNMEEG 933

Query: 393 RKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFF 435
           +++  I L C Q   A RP M++V+ ML G ++   +  KP +
Sbjct: 934 KRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKPGY 976

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  201 bits (512), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 128/334 (38%), Positives = 181/334 (54%), Gaps = 38/334 (11%)

Query: 122 VLIIGRFILAPIVFLVFLIHKYRTTMQTVDNILL--------PEIIAVTNHFTHKLGQGG 173
           + ++G  +L P++ L     + +T  Q  D   +         E+ + TN F+ K+G GG
Sbjct: 412 ISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSATNGFSDKVGHGG 471

Query: 174 FGSVYKGQL-HTGRLIAVKMMEN-----SKFSAE-------EFIN--ELLGLCSEGFKRA 218
           FG+V+KG L  +   +AVK +E      S+F AE       + +N   L G CSE   R 
Sbjct: 472 FGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRL 531

Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           LVY+YMP GSL  ++     K      E    IALGTA+GI YLH GC  CI+H DIKP 
Sbjct: 532 LVYDYMPQGSLSSYLSRTSPK--LLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPE 589

Query: 279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYG 338
           NILLD ++  KVSDFGLAK   ++   V ++  RGT GY+APE IS     ++ K+DVY 
Sbjct: 590 NILLDSDYNAKVSDFGLAKLLGRDFSRV-LATMRGTWGYVAPEWISGL--PITTKADVYS 646

Query: 339 FGMVLLEMAGGRRNSNMNA-------TRSSKAYFPSWVYDQLNKG---GDLELRNVTEIE 388
           FGM LLE+ GGRRN  +N+       T   K +FP W   ++ +G     ++ R   E  
Sbjct: 647 FGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYN 706

Query: 389 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422
           +    ++  + +WCIQ     RP+M  V++MLEG
Sbjct: 707 TEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  201 bits (511), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 129/345 (37%), Positives = 185/345 (53%), Gaps = 36/345 (10%)

Query: 123 LIIGRFILAPIVFLVFLIHKYRTTMQTVDNILL-----------PEIIAVTNHF--THKL 169
           +I+G  +L+ +  +V    + R    T D  LL            E+ + T  F  ++KL
Sbjct: 641 VIVGVGLLSILAGVVMFTIRKRRKRYTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKL 700

Query: 170 GQGGFGSVYKGQLHTGRLIAVKMME-NSKFSAEEFINE--------------LLGLCSEG 214
           G+GGFG VYKG L+ GR++AVK++   S+    +F+ E              L G C EG
Sbjct: 701 GEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEG 760

Query: 215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFD 274
             R LVYEY+PNGSLD+ +F   +K         +EI LG ARG+ YLH    V I+H D
Sbjct: 761 EHRMLVYEYLPNGSLDQALFG--DKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRD 818

Query: 275 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           +K  NILLD   +P++SDFGLAK +  +   +S +   GTIGYLAPE   R  G ++ K+
Sbjct: 819 VKASNILLDSRLVPQISDFGLAKLYDDKKTHIS-TRVAGTIGYLAPEYAMR--GHLTEKT 875

Query: 335 DVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL--RNVTEIESMIA 392
           DVY FG+V LE+  GR NS+ N     K Y   W ++   K  D+EL    +T+     A
Sbjct: 876 DVYAFGVVALELVSGRPNSDEN-LEEEKKYLLEWAWNLHEKSRDIELIDDKLTDFNMEEA 934

Query: 393 RKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSS 437
           +++  I L C Q   A RP M++V+ ML G ++   +  KP + S
Sbjct: 935 KRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTSKPGYVS 979

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	453
255570697	631	kinase, putative [Ricinus communis] gi|2	0.980	0.703	0.492	1e-134
224108395	348	predicted protein [Populus trichocarpa]	0.651	0.847	0.639	1e-109
224101781	348	predicted protein [Populus trichocarpa]	0.651	0.847	0.643	1e-108
326512250	662	predicted protein [Hordeum vulgare subsp	0.880	0.602	0.443	1e-105
115434146	630	Os01g0114600 [Oryza sativa Japonica Grou	0.883	0.634	0.466	1e-104
326516936	691	predicted protein [Hordeum vulgare subsp	0.885	0.580	0.424	1e-104
8575484	650	receptor-like kinase [Oryza sativa Japon	0.883	0.615	0.448	1e-104
357135051	680	PREDICTED: probable receptor-like protei	0.880	0.586	0.430	1e-104
115434136	659	Os01g0114100 [Oryza sativa Japonica Grou	0.883	0.606	0.444	1e-103
357130561	663	PREDICTED: probable receptor-like protei	0.710	0.485	0.535	1e-103

>gi|255570697|ref|XP_002526303.1| kinase, putative [Ricinus communis] gi|223534384|gb|EEF36092.1| kinase, putative [Ricinus communis]

 Score =  484 bits (1247), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 269/546 (49%), Positives = 341/546 (62%), Gaps = 102/546 (18%)

Query: 4   QHYVKRISYDECTISVADVNLANGSC--------------------------TNLF---- 33
           ++YV +ISYD+  I + DVNLANGSC                          T+ F    
Sbjct: 81  KYYVNQISYDKHIIRLVDVNLANGSCNLPYISVSVDEVRGDSRYRGLVSSTFTSFFRCSS 140

Query: 34  ---PHAFTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNRSVDNPSYE 90
                A+  VPC S N S+VYV    + +   ISDL  SC FIS+VP +  ++V  PSY+
Sbjct: 141 EINDQAYRDVPCFSGNGSHVYV----SYSTYVISDLQGSCSFISRVPTIY-QNVLYPSYQ 195

Query: 91  DLRKLLDSGFDFTWFEECSS--------------------------YHPITN-------W 117
            + +L+  GFD  W  EC                            Y P          W
Sbjct: 196 SILQLMALGFDLEWSVECRDCIADGGICSLSSVGTPNVYECYYSGIYIPAAVSLIFAAIW 255

Query: 118 -IPIDVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNI--LLP-------------EIIAV 161
            I + + +I RF++APIV + FLIHKYRT  +T ++   LLP             +IIA+
Sbjct: 256 DILLAINLIARFVVAPIVIVGFLIHKYRTQKKTEESKENLLPNEPSMMPRRYSYSDIIAI 315

Query: 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------L 207
           TN+F  K+G+GGFG+VYKGQL  G L+AVKM+ +SKFS ++FI+E              L
Sbjct: 316 TNNFKDKIGKGGFGTVYKGQLPDGFLVAVKMLGDSKFSDKDFIDEVSTIGKIHHANVVQL 375

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           +G CSEG   AL++EY+  GSLD+HIFS+E + Q F  EK  +IA+GTARGIE+LH GCD
Sbjct: 376 VGFCSEGSYHALLFEYIARGSLDKHIFSREAEFQPFSWEKRLQIAIGTARGIEHLHVGCD 435

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
           VCILHFDIKPHN+LL HNFIPKVSDFGLAKF+PKENDFVS+S  RGTIGY+APELIS+N 
Sbjct: 436 VCILHFDIKPHNVLLHHNFIPKVSDFGLAKFYPKENDFVSVSTARGTIGYIAPELISKNL 495

Query: 328 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387
           G+VSCKSDVY +G++LLEM GGRRN N N   S K +F SWVYD LN+GGDLEL +V E 
Sbjct: 496 GSVSCKSDVYSYGILLLEMVGGRRNINPNGNSSGKVHFASWVYDHLNEGGDLELESVNEA 555

Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHISGRETE 447
           E+ IA+KLC++GLWCI   ++DRPSMTKV+EMLEG IDDLQ+PP P  S   H++    +
Sbjct: 556 EAAIAKKLCIVGLWCINKNSSDRPSMTKVVEMLEGKIDDLQLPPSP-LSFPDHVAAEGPQ 614

Query: 448 SASLTE 453
           S S TE
Sbjct: 615 SDSSTE 620

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108395|ref|XP_002314832.1| predicted protein [Populus trichocarpa] gi|222863872|gb|EEF01003.1| predicted protein [Populus trichocarpa]

 Score =  400 bits (1029), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 199/311 (63%), Positives = 240/311 (77%), Gaps = 16/311 (5%)

Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           +IIA+TN+F +KLGQGGFG+VYKGQL  G  +AVKM++N K + E+FINE          
Sbjct: 29  DIIAITNNFENKLGQGGFGTVYKGQLRDGFSVAVKMLDNPKCNDEDFINEVSIIGRIHQV 88

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               L+G CSEG  RALV+EYM NGSLD+ +FS+E +    G EK  +IALGTARGIE+L
Sbjct: 89  NIVWLMGFCSEGCHRALVFEYMANGSLDKLLFSREAERHLVGWEKLLQIALGTARGIEHL 148

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
           H GC+VCILH DIKP N+LLD+NFIPKVSDFGL+KF+P+E DFVSIS TRGTIGY+APE+
Sbjct: 149 HGGCNVCILHSDIKPQNVLLDNNFIPKVSDFGLSKFYPEEKDFVSISTTRGTIGYIAPEM 208

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382
           ISRN G VSCKSDVY FGM+LLEMAG RRNSN     SS+ YFPSWVYD L +  DL+L 
Sbjct: 209 ISRNLGAVSCKSDVYSFGMLLLEMAGRRRNSNSKGNCSSEVYFPSWVYDHLIERADLQLE 268

Query: 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHIS 442
           NVTEIE+ I RKLC++GLWCIQ  A+DRPSMTKV+EMLE ++DDLQ+PP    S  + IS
Sbjct: 269 NVTEIEAGIPRKLCLVGLWCIQKAASDRPSMTKVVEMLEANVDDLQLPPNA-LSFPQSIS 327

Query: 443 GRETESASLTE 453
            +E +S S TE
Sbjct: 328 -KEPQSDSSTE 337

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224101781|ref|XP_002312418.1| predicted protein [Populus trichocarpa] gi|222852238|gb|EEE89785.1| predicted protein [Populus trichocarpa]

 Score =  397 bits (1021), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 200/311 (64%), Positives = 234/311 (75%), Gaps = 16/311 (5%)

Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           +IIA+TN+F  KLGQGGFG+VYKGQL    L+AVKM+ N+K + E+FINE          
Sbjct: 29  DIIAITNNFKDKLGQGGFGNVYKGQLRDAFLVAVKMLGNAKCNDEDFINEVSIIGRIHHV 88

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               L+G CSEG  RALV+EYM NGSLD+ +FS+E +      EK  +IA+GTARGIE+L
Sbjct: 89  NIVRLVGFCSEGSYRALVFEYMANGSLDKLLFSRETELLLVSWEKLLQIAVGTARGIEHL 148

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
           H GC VCILH DIKPHN+LLD NFIPKVSDFGLAKF+P E DFVSIS TRGTIGY APE+
Sbjct: 149 HGGCSVCILHLDIKPHNVLLDSNFIPKVSDFGLAKFYPSEKDFVSISTTRGTIGYFAPEM 208

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382
           ISRN G VSCKSDVY FGM+LLEMAG RR SN     SS  YFPSWVYD L++GGDLEL 
Sbjct: 209 ISRNLGAVSCKSDVYSFGMLLLEMAGRRRKSNSKGNCSSDVYFPSWVYDHLSEGGDLELE 268

Query: 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHIS 442
           NVTEIE+ IARKLC+ GLWCIQ  A+DRP+MTKV+EML  +IDDLQ+P     S  + IS
Sbjct: 269 NVTEIEAAIARKLCIAGLWCIQKAASDRPTMTKVVEMLGANIDDLQLPSNA-LSFPQSIS 327

Query: 443 GRETESASLTE 453
            +E +S S TE
Sbjct: 328 -KEPQSDSSTE 337

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326512250|dbj|BAJ96106.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  387 bits (994), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 218/491 (44%), Positives = 303/491 (61%), Gaps = 92/491 (18%)

Query: 37  FTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVP-----VVLNRSVDNPSYED 91
           +  V CLS + S  +VY+ ++  +D++ +L  SC F++  P     +     ++N SY D
Sbjct: 158 YMPVACLSTSHS--FVYVLTSLRSDSMKNLEPSCGFLAMTPLDGQDIRSTVPLENVSYAD 215

Query: 92  LRKLLDSGFDFTW---------FEEC-------SSYHPITNWIPIDVLIIG--------- 126
           + K +  GF+  +         F+EC       S    I + + +DV+ +G         
Sbjct: 216 VVKFMKYGFNVGFPSKHRGHGNFKECVMDLMPASPQDWILSILMVDVIFLGCAAEALPLP 275

Query: 127 ----------------------RFILAPIVFLVFLIHKY---RTTMQTVDNILL------ 155
                                 RF+LAP+V L+FL +KY   R T+  V+  LL      
Sbjct: 276 IGMCLYIIQVASPFFKLFAALCRFVLAPLVVLIFLAYKYWKTRITIDAVEKFLLMRQMIS 335

Query: 156 ------PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMME-NSKFSAEEFINE-- 206
                  +I+AVT+HF +KLGQGG+GSVY+G L     +AVKM+E NS  + E+FINE  
Sbjct: 336 PSRYAYTDIVAVTSHFRNKLGQGGYGSVYEGVLPGDVHVAVKMLEGNSNCNGEDFINEVS 395

Query: 207 ------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG 254
                       L+G CSE  +RALVYEYMP GSLD++IFS E+K +TF  +K +EIALG
Sbjct: 396 TIGRIHHVNVVRLVGFCSEEMRRALVYEYMPGGSLDKYIFSPESK-KTFSWDKLNEIALG 454

Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            ARGI YLH GC++ I+HFDIKPHNILLD NF+PKV+DFGLAK +P++  FV     RGT
Sbjct: 455 IARGINYLHQGCEMQIIHFDIKPHNILLDRNFVPKVADFGLAKLYPRDESFVPSRALRGT 514

Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNATRSSKAYFPSWVYDQ 372
           IGY+APE+ISR+FG +S KSDVY FGM+LLEMAGGRRN+  N+NA  SS++Y+PSWVY +
Sbjct: 515 IGYIAPEMISRSFGLISSKSDVYSFGMLLLEMAGGRRNADPNLNAANSSQSYYPSWVYGR 574

Query: 373 LNKGGDLELRNVTEIESM--IARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMP 430
           L    + E+R ++  + M  + +KLC++GLWCIQ+++ DRP+M +V+EMLEG +D LQMP
Sbjct: 575 L---AEQEVRGISPADDMHELEKKLCIVGLWCIQMRSKDRPTMGEVIEMLEGGVDGLQMP 631

Query: 431 PKPFFSSSRHI 441
            +PFF    HI
Sbjct: 632 SRPFFCDEGHI 642

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434146|ref|NP_001041831.1| Os01g0114600 [Oryza sativa Japonica Group] gi|8575476|gb|AAF78015.1|AF238471_1 receptor-like kinase [Oryza sativa Japonica Group] gi|113531362|dbj|BAF03745.1| Os01g0114600 [Oryza sativa Japonica Group] gi|125568772|gb|EAZ10287.1| hypothetical protein OsJ_00123 [Oryza sativa Japonica Group]

 Score =  385 bits (990), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 208/446 (46%), Positives = 282/446 (63%), Gaps = 46/446 (10%)

Query: 37  FTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPV-----VLNRSVDNPSYED 91
           +  V CLS + S VYV  GS      +  L  SC ++   P+      +N S+   SY D
Sbjct: 170 YKPVACLSTSHSFVYVLTGSESETVYVESLEPSCGYLGMTPLDDRGASINASL---SYAD 226

Query: 92  LRKLLDSGFDFTWFEECSSYHPITNWIPIDVLIIGRFILAPIVFLVFLIHKY---RTTMQ 148
           + K +  GF         +YH        + +   RF+LAP+V L FL HKY   R T+ 
Sbjct: 227 VLKYMRKGFAIGISSSSGTYHFDFRACLAESV---RFLLAPLVVLTFLSHKYWKARITID 283

Query: 149 TVDNIL------------LPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL-IAVKMME- 194
            V+  L              +IIA+T+HF  +LGQG +G+VYKG L  G + +AVKM+  
Sbjct: 284 AVEKFLRMQEMLSPMRYGYTDIIAITSHFRDRLGQGSYGTVYKGVLLPGNIHVAVKMLNG 343

Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
           NS  + EEFI+E              L+G CSE  +RALVYEYMP GSLD++IFS +   
Sbjct: 344 NSNCNGEEFISEVSTIGRIHHVNVVRLVGFCSEEMRRALVYEYMPRGSLDKYIFSSD--- 400

Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           ++F  +K +EIALG ARGI YLH GCD+ ILHFDIKPHNILLD NF+PKV+DFGLA+ +P
Sbjct: 401 KSFSRDKLNEIALGIARGINYLHQGCDLQILHFDIKPHNILLDKNFVPKVADFGLARLYP 460

Query: 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS 360
           ++  FV +S  RGT+GY+APE+ISR+FG +S KSDVY FGM+LLEMAGGRRN++ NA  S
Sbjct: 461 RDKSFVPVSAARGTVGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRNADPNAENS 520

Query: 361 SKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420
           S+AY+PS VY QL +    E+    ++  +  +KLC++GLWCIQ+++ DRP M++V+EML
Sbjct: 521 SQAYYPSRVYRQLTRQETGEITAAADMHEL-EKKLCIVGLWCIQMRSCDRPMMSEVIEML 579

Query: 421 EGSIDDLQMPPKPFFSSSRHISGRET 446
           EG +D LQ+PP+PFF    +I   E+
Sbjct: 580 EGGVDCLQIPPRPFFCDDDYIPAMES 605

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326516936|dbj|BAJ96460.1| predicted protein [Hordeum vulgare subsp. vulgare] gi|326526275|dbj|BAJ97154.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  385 bits (990), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 216/509 (42%), Positives = 295/509 (57%), Gaps = 108/509 (21%)

Query: 36  AFTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNRSVD-----NPSYE 90
           A+  V CLS N S+VYV++  +D    + DL   C +++K+ +    S D     N SY 
Sbjct: 159 AYKPVACLSANNSHVYVWV--SDYECMVEDLEPYCGYLAKILLGNEYSTDSLQLHNASYA 216

Query: 91  DLRKLLDSGF---------------------------DFTWFEECSSYHPITNW------ 117
           D+ +++  GF                             ++F+E SS   I NW      
Sbjct: 217 DIIQVISRGFTVKFPVDTTRPSPSVKLRKNINLCLNNSISYFKEQSSGAGIMNWAHVFFW 276

Query: 118 ----------------------------------IPIDVLIIGRFILAPIVFLVFLIHKY 143
                                             IP  + ++ RF+LAP+   +FL +KY
Sbjct: 277 SEVHFLECVTQLSSDHYYTTQFVLVVVTIVSAIAIPKFLFVLCRFLLAPLAVWIFLAYKY 336

Query: 144 RTTMQTVDNI---------------LLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL- 187
             T   +D +                  +IIA+T HF  KLGQGG+G+VYKG L  G + 
Sbjct: 337 WKTRIIIDAVEKFLRIQQLIGPTRYAYTDIIAITRHFRDKLGQGGYGTVYKGVLLPGDVH 396

Query: 188 IAVKMME-NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRH 232
           +AVKM+E NS  + E+FI+E              L+G CSE  +RALVYEYMPNGSLD++
Sbjct: 397 VAVKMLEGNSNCNGEDFISEVSTIGRIHHVNVVRLMGFCSEELRRALVYEYMPNGSLDKY 456

Query: 233 IFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD 292
           IFS E   ++F  +K +EIALG ARGI YLH GCD+ ILHFDIKPHNILLD+NF+PKV+D
Sbjct: 457 IFSTE---KSFSWDKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDNNFVPKVAD 513

Query: 293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN 352
           FGLAK +P+ + FV +S  RGT+GY+APE+ISR+FG +S KSDVY FGM+LLEMAGGRRN
Sbjct: 514 FGLAKLYPRGDSFVPLSAMRGTVGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRN 573

Query: 353 SNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS 412
           ++ N   SS+AY+PSWVYDQL +    E+  V      + +KLC++GLWCIQ+++ DRP+
Sbjct: 574 ADPNMGSSSQAYYPSWVYDQLTREEAGEISPVAVDMHELEKKLCVVGLWCIQMRSRDRPT 633

Query: 413 MTKVLEMLEGSIDDLQMPPKPFFSSSRHI 441
           M++V+E+LE  +D LQMP +PFF    HI
Sbjct: 634 MSEVIEILEAGVDGLQMPSRPFFCDEGHI 662

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|8575484|gb|AAF78019.1|AF238475_1 receptor-like kinase [Oryza sativa Japonica Group]

 Score =  384 bits (987), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 218/486 (44%), Positives = 299/486 (61%), Gaps = 86/486 (17%)

Query: 37  FTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNR-----SVDNPSYED 91
           +  V CLS ++S VYV+ G       I +L  SC +++  P+  ++     ++ N SY+D
Sbjct: 151 YMPVACLSTSRSFVYVFTGQQSA--YIQNLEPSCGYLATTPLGGSKLNSTSALQNVSYQD 208

Query: 92  LRKLLDSGF----DFT---W-FEEC--------------------------SSYHPITNW 117
           + KL+ +GF     FT   W F+EC                          S  + I  +
Sbjct: 209 VVKLMMTGFAVRFPFTVSGWNFKECLALSIRIANIAIIDFYFWSCFLLGDRSHNNLIYTY 268

Query: 118 IPIDVL--------IIGRFILAPIVFLVFLIHKYRTTMQTVDNI---------LLP---- 156
           + +D          ++ RF+LAP+   +FL HKY     T+D +         L P    
Sbjct: 269 MVVDTALLILKWTAVLCRFVLAPLAVFIFLAHKYWRNKITIDAVEKFLQMQLTLGPTRYA 328

Query: 157 --EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE-------- 206
             ++ A+T HF  KLGQGG+GSVYKG L     +AVK++EN+  + EEFI+E        
Sbjct: 329 YTDLTAITGHFGEKLGQGGYGSVYKGVLPGYVNVAVKVLENANCNGEEFISEVSTIGRIH 388

Query: 207 ------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                 L+G CSE  +RALVYEYMP GSLD++IFS +   ++F  +K +EIALG ARGI 
Sbjct: 389 HVNVVRLVGFCSEELRRALVYEYMPRGSLDKYIFSSK---RSFSWDKLNEIALGIARGIN 445

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH GCD+ ILHFDIKPHNILLD NF+PKV+DFGLAK +P++N FV ++  RGTIGY+AP
Sbjct: 446 YLHQGCDMQILHFDIKPHNILLDDNFVPKVADFGLAKLYPRDNSFVPLNALRGTIGYIAP 505

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG---- 376
           E+ISR+FG +S KSDVY FGM+LLEMAGGRRNS+M+A  SS+AY+PSWVYD+L +     
Sbjct: 506 EMISRSFGVISSKSDVYSFGMLLLEMAGGRRNSDMHAGNSSQAYYPSWVYDRLIEQQVGV 565

Query: 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFS 436
           G++    V  +  +  RKLC+IGL CIQ+K+ DRP+M++V+EMLEG +  LQMPP+PFF 
Sbjct: 566 GEISAATVANMHEL-ERKLCIIGLHCIQMKSHDRPTMSEVIEMLEGGVVGLQMPPRPFFC 624

Query: 437 SSRHIS 442
               +S
Sbjct: 625 DDESMS 630

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357135051|ref|XP_003569125.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Brachypodium distachyon]

 Score =  383 bits (984), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 219/509 (43%), Positives = 296/509 (58%), Gaps = 110/509 (21%)

Query: 37  FTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVL--NRSVD-----NPSY 89
           +  V CLS N S+VYV +  ++   ++ +L   C +++  P+    N S D     N SY
Sbjct: 156 YKPVDCLSANNSHVYVLV--SELGCSVHELEPYCGYLAMSPLSFGDNHSSDWLQPQNTSY 213

Query: 90  EDLRKLLDSGF---------------------------DFTWFEECSSYHPITNW----- 117
           ED+ +L+  GF                             ++F+E +S   I NW     
Sbjct: 214 EDITQLIRKGFVVGFPGETTTRPWRRGVCVTINRCLNNSISYFKEQTSGGSIMNWTHAFF 273

Query: 118 ----------------------------------IPIDVLIIGRFILAPIVFLVFLIHKY 143
                                             I   + ++ RF+LAP+V  +FL +KY
Sbjct: 274 WSEIHFLECVITSSNNYYTTRSLLVVTTIVSSIAILKFIFVLCRFVLAPMVVWIFLAYKY 333

Query: 144 RTTMQTVDNI---------------LLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL- 187
             T  T+D +                  +I A+T HF  KLGQGG+GSVYKG L  G + 
Sbjct: 334 WKTRITIDVVEKFLRIQQMIGPTRYAYTDITAITGHFRDKLGQGGYGSVYKGVLLPGDVH 393

Query: 188 IAVKMME-NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRH 232
           +AVKM+E NS  + E+FI+E              L+G CSE  KRALVYEYMP+GSLD++
Sbjct: 394 VAVKMLEGNSSCNGEDFISEVSTIGRIHHVNVVRLVGFCSEEMKRALVYEYMPHGSLDKY 453

Query: 233 IFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD 292
           IFS E   ++F  +K +EIALG ARGI YLH GCD+ ILHFDIKPHNILLD NF+PKV+D
Sbjct: 454 IFSAE---KSFSWDKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDSNFVPKVAD 510

Query: 293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN 352
           FGLAK +P++N FV +S  RGTIGY+APE+ISR+FG +S KSDVY FGM+LLEMAGGRRN
Sbjct: 511 FGLAKLYPRDNSFVPLSALRGTIGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRN 570

Query: 353 SNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS 412
           ++ NA RSS+AY+PSWVYDQL +    E+    ++  +  +KLC++GLWCIQ+K+ DRP+
Sbjct: 571 ADPNAARSSQAYYPSWVYDQLTQQEAGEISPAADMHEL-EKKLCVVGLWCIQMKSHDRPT 629

Query: 413 MTKVLEMLEGSIDDLQMPPKPFFSSSRHI 441
           M++V+E+LE     LQMP +PFF    HI
Sbjct: 630 MSEVIEVLEAGAHGLQMPSRPFFCDEEHI 658

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434136|ref|NP_001041826.1| Os01g0114100 [Oryza sativa Japonica Group] gi|52076330|dbj|BAD45151.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group] gi|113531357|dbj|BAF03740.1| Os01g0114100 [Oryza sativa Japonica Group] gi|215687145|dbj|BAG90915.1| unnamed protein product [Oryza sativa Japonica Group]

 Score =  382 bits (982), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 220/495 (44%), Positives = 297/495 (60%), Gaps = 95/495 (19%)

Query: 37  FTKVPCLSDNKSNVYVYLGSADTNDAISDLPESCVFISKVPVVLNR-----SVDNPSYED 91
           +  V CLS ++S VYV+ G       I +L  SC +++  P+  ++     ++ N SY+D
Sbjct: 151 YMPVACLSTSRSFVYVFTGQQSA--YIQNLEPSCGYLATTPLGGSKLNSTSALQNVSYQD 208

Query: 92  LRKLLDSGF----DFT---W-FEEC----------SSYHPITNWIPID------------ 121
           + KL+ +GF     FT   W F+EC           S   I N   ID            
Sbjct: 209 VVKLMMTGFAVRFPFTVSGWNFKECLALSIRQTGTGSKERIANIAIIDFYFWSCFLLGDR 268

Query: 122 ---------------------VLIIGRFILAPIVFLVFLIHKYRTTMQTVDNI------- 153
                                  ++ RF+LAP+   +FL HKY     T+D +       
Sbjct: 269 SHNNLIYTYMVVDTALLILKWTAVLCRFVLAPLAVFIFLAHKYWRNKITIDAVEKFLQMQ 328

Query: 154 --LLP------EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFIN 205
             L P      ++ A+T HF  KLGQGG+GSVYKG L     +AVK++EN+  + EEFI+
Sbjct: 329 LTLGPTRYAYTDLTAITGHFGEKLGQGGYGSVYKGVLPGYVNVAVKVLENANCNGEEFIS 388

Query: 206 E--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI 251
           E              L+G CSE  +RALVYEYMP GSLD++IFS +   ++F  +K +EI
Sbjct: 389 EVSTIGRIHHVNVVRLVGFCSEELRRALVYEYMPRGSLDKYIFSSK---RSFSWDKLNEI 445

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           ALG ARGI YLH GCD+ ILHFDIKPHNILLD NF+PKV+DFGLAK +P++N FV ++  
Sbjct: 446 ALGIARGINYLHQGCDMQILHFDIKPHNILLDDNFVPKVADFGLAKLYPRDNSFVPLNAL 505

Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 371
           RGTIGY+APE+ISR+FG +S KSDVY FGM+LLEMAGGRRNS+M+A  SS+AY+PSWVYD
Sbjct: 506 RGTIGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRNSDMHAGNSSQAYYPSWVYD 565

Query: 372 QLNKG----GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL 427
           +L +     G++    V  +  +  RKLC+IGL CIQ+K+ DRP+M++V+EMLEG +  L
Sbjct: 566 RLIEQQVGVGEISAATVANMHEL-ERKLCIIGLHCIQMKSHDRPTMSEVIEMLEGGVVGL 624

Query: 428 QMPPKPFFSSSRHIS 442
           QMPP+PFF     +S
Sbjct: 625 QMPPRPFFCDDESMS 639

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357130561|ref|XP_003566916.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Brachypodium distachyon]

 Score =  382 bits (981), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 191/357 (53%), Positives = 256/357 (71%), Gaps = 35/357 (9%)

Query: 117 WIPIDVLIIGRFILAPIVFLVFLIHKYRTTMQTVDNI---------------LLPEIIAV 161
           WI   + ++ RF+LAP++ L+FL HKY  T  T+D +                  +I+AV
Sbjct: 289 WIVKWIAVLCRFVLAPLMVLLFLAHKYWKTRITIDAVEKFLRMQQMIGPTRYTYTDIVAV 348

Query: 162 TNHFTHKLGQGGFGSVYKGQLHTGRL-IAVKMMEN-SKFSAEEFINE------------- 206
           T+HF  KLGQGG+GSV+KG LH G + +AVKM+++ S  + E+FI+E             
Sbjct: 349 TSHFRDKLGQGGYGSVFKGVLHPGDVHVAVKMLDSKSNCNGEDFISEVSTIGRIHHVNVV 408

Query: 207 -LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            L+G CSE  +RALVYEYMP+GSLD++IFS E   ++F  +K +EIALG ARGI YLH G
Sbjct: 409 CLIGFCSEEMRRALVYEYMPHGSLDKYIFSAE---KSFSWDKLNEIALGIARGINYLHQG 465

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
           C++ I+HFDIKPHNILLD NF+PKV+DFGLAK +P++N FV +S  RGTIGY+APE+ISR
Sbjct: 466 CEMQIVHFDIKPHNILLDSNFVPKVADFGLAKLYPRDNSFVPLSALRGTIGYIAPEMISR 525

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
           +FG +S KSDVY FGM+LLEMAGGRRN + NA  SS++Y+PSWVYDQL +  +L   +V+
Sbjct: 526 SFGAISSKSDVYSFGMLLLEMAGGRRNVDANAVNSSQSYYPSWVYDQLTRQEELGEISVS 585

Query: 386 EIE-SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHI 441
             E   + RKLC++GLWCIQ+++ DRP+M++V+EMLEGS+  LQMP +PFF    HI
Sbjct: 586 VAEMHELERKLCIVGLWCIQMRSQDRPTMSEVIEMLEGSVGGLQMPSRPFFCDEGHI 642

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	453
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.646	0.434	0.477	2.2e-76
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.607	0.431	0.477	2.9e-74
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.604	0.411	0.483	5.9e-74
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.607	0.308	0.481	8.8e-74
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.642	0.361	0.496	9.6e-73
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.642	0.357	0.468	2.3e-71
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.604	0.321	0.481	1.8e-69
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.607	0.413	0.479	2.4e-69
TAIR|locus:2176697	588	AT5G38240 [Arabidopsis thalian	0.646	0.498	0.462	2.4e-67
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.604	0.342	0.479	2e-65

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 725 (260.3 bits), Expect = 2.2e-76, Sum P(2) = 2.2e-76
 Identities = 152/318 (47%), Positives = 206/318 (64%)

Query:   157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS-AEEFINE--------- 206
             ++  +T  F   +G+GGFG VY+G L  GR++AVK+++ SK + +E+FINE         
Sbjct:   340 QVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFINEVSSMSQTSH 399

Query:   207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                  LLG CSEG +RA++YE++ NGSLD+  F  E       L   + IALG ARG+EY
Sbjct:   400 VNIVSLLGFCSEGSRRAIIYEFLENGSLDK--FISEKTSVILDLTALYGIALGVARGLEY 457

Query:   262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
             LH GC   I+HFDIKP N+LLD N  PKVSDFGLAK   K+   +S+ DTRGTIGY+APE
Sbjct:   458 LHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTIGYIAPE 517

Query:   322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM--NATRSSKAYFPSWVYDQLNKG--G 377
             +ISR +G+VS KSDVY +GM++ EM G R+      N+   S  YFP W+Y  L K   G
Sbjct:   518 MISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKDLEKADNG 577

Query:   378 DLE-LR-NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFF 435
             DLE +   ++  E  IA+K+ ++GLWCIQ   +DRP M KV+EM+EGS+D L++PP+P  
Sbjct:   578 DLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRPVL 637

Query:   436 SSSRHISGRETESASLTE 453
                 H+ G   ES+ +TE
Sbjct:   638 QQI-HV-GPLLESSWITE 653

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 701 (251.8 bits), Expect = 2.9e-74, Sum P(2) = 2.9e-74
 Identities = 141/295 (47%), Positives = 190/295 (64%)

Query:   157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
             E+  +T  F+H LG+GGFG+VY G L  GR +AVK++++ K + E+FINE          
Sbjct:   315 EVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKILKDFKSNGEDFINEVASMSQTSHV 374

Query:   207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
                 LLG C EG KRA+VYE++ NGSLD+  F  E K     +   + IALG ARG++YL
Sbjct:   375 NIVSLLGFCYEGSKRAIVYEFLENGSLDQ--FLSEKKSLNLDVSTLYRIALGVARGLDYL 432

Query:   263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
             H+GC   I+HFDIKP NILLD  F PKVSDFGLAK   K    +S+ D RGTIGY+APE+
Sbjct:   433 HHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIGYIAPEV 492

Query:   323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNATRSSKAYFPSWVYDQLNKGGDLE 380
              S  +G VS KSDVY +GM++LEM G +        A+ SS AYFP W+Y  L  G D  
Sbjct:   493 FSGMYGRVSHKSDVYSYGMLVLEMIGAKNKEIEETAASNSSSAYFPDWIYKNLENGEDTW 552

Query:   381 L--RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKP 433
                  ++  +  +A+K+ ++GLWCIQ    +RP M +++EM+EGS+D L++PPKP
Sbjct:   553 KFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSLDVLEVPPKP 607

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 726 (260.6 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
 Identities = 143/296 (48%), Positives = 202/296 (68%)

Query:   157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
             ++ ++T  F   +G+GGFG+VY+G L+ GR +AVK+++ S+ + E+FINE          
Sbjct:   342 QVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGNGEDFINEVASMSQTSHV 401

Query:   207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
                 LLG CSEG+KRA++YE+M NGSLD+ I SK  K  T    + + IALG ARG+EYL
Sbjct:   402 NIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSK--KSSTMDWRELYGIALGVARGLEYL 459

Query:   263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
             H+GC   I+HFDIKP N+LLD N  PKVSDFGLAK   ++   +S+ DTRGTIGY+APE+
Sbjct:   460 HHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILSLMDTRGTIGYIAPEV 519

Query:   323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--YFPSWVYDQLNK---GG 377
              SR +G VS KSDVY +GM++L++ G R  ++   T SS +  YFP W+Y  L K   G 
Sbjct:   520 FSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPEWIYRDLEKAHNGK 579

Query:   378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKP 433
              +E   ++  E  IA+K+ ++GLWCIQ    DRP+M +V+EM+EG++D L++PP+P
Sbjct:   580 SIETA-ISNEEDEIAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEGNLDALEVPPRP 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 696 (250.1 bits), Expect = 8.8e-74, Sum P(3) = 8.8e-74
 Identities = 147/305 (48%), Positives = 199/305 (65%)

Query:   157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS-AEEFINE--------- 206
             E+  +T  FT  +G+GGFG VY G L    ++AVK++++SK +  E+FINE         
Sbjct:   550 EVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSH 609

Query:   207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                  LLG C EG +RA++YE++ NGSLD+ I  K +      L+  + IALG ARG+EY
Sbjct:   610 VNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSSVN--LDLKTLYGIALGVARGLEY 667

Query:   262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
             LH GC   I+HFDIKP N+LLD N  PKVSDFGLAK   K+   +S+ DTRGTIGY+APE
Sbjct:   668 LHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPE 727

Query:   322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA-TRS--SKAYFPSWVYDQLNKGG- 377
             +ISR +G+VS KSDVY +GM++LEM G R+    +  +RS  S  YFP W+Y  L K   
Sbjct:   728 MISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSIYFPEWIYKDLEKANI 787

Query:   378 -DLE-------LRN-VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ 428
              D+E       + N ++  E  IARK+ ++GLWCIQ   +DRP M KV+EM+EGS+D L+
Sbjct:   788 KDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALE 847

Query:   429 MPPKP 433
             +PP+P
Sbjct:   848 VPPRP 852

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 735 (263.8 bits), Expect = 9.6e-73, P = 9.6e-73
 Identities = 157/316 (49%), Positives = 206/316 (65%)

Query:   157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
             E+  +T  F++ +G+GGFG+VY G L  GR +AVK++++ K SAE+FINE          
Sbjct:   492 ELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQTSHV 551

Query:   207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
                 LLG C EG KRA+VYE++ NGSLD+  F   NK  T  +   + IALG ARG+EYL
Sbjct:   552 NIVSLLGFCFEGSKRAIVYEFLENGSLDQ--FMSRNKSLTQDVTTLYGIALGIARGLEYL 609

Query:   263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
             H GC   I+HFDIKP NILLD N  PKVSDFGLAK   K    +S+ DTRGTIGY+APE+
Sbjct:   610 HYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEV 669

Query:   323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS--SKAYFPSWVYDQLNKGGDLE 380
              SR +G VS KSDVY FGM++++M G R    +    S  S  YFP W+Y  L  G    
Sbjct:   670 FSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTW 729

Query:   381 L--RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSS 438
             +    +T+ E  IA+K+ ++GLWCIQ   +DRPSM +V+EM+EGS+D L++PPKP    S
Sbjct:   730 IFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP----S 785

Query:   439 RHISGRE-TESASLTE 453
              HIS    TES+SL++
Sbjct:   786 MHISTEVITESSSLSD 801

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 722 (259.2 bits), Expect = 2.3e-71, P = 2.3e-71
 Identities = 147/314 (46%), Positives = 203/314 (64%)

Query:   157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
             E+  +T  F+H +G+GGFG+VY+G L  GR +AVK++++ K + ++FINE          
Sbjct:   490 ELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHV 549

Query:   207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
                 LLG C EG KRA++ E++ +GSLD+  F   NK  T  +   + IALG ARG+EYL
Sbjct:   550 NIVSLLGFCYEGSKRAIISEFLEHGSLDQ--FISRNKSLTPNVTTLYGIALGIARGLEYL 607

Query:   263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
             H GC   I+HFDIKP NILLD NF PKV+DFGLAK   K    +S+ DTRGTIGY+APE+
Sbjct:   608 HYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEV 667

Query:   323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL- 381
             +SR +G +S KSDVY +GM++L+M G R          S AYFP W+Y  L  G    + 
Sbjct:   668 VSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWII 727

Query:   382 -RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRH 440
                + E ++ I +K+ ++ LWCI+   +DRP M KV+EM+EGS+D L++PPKP    SRH
Sbjct:   728 GDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKP----SRH 783

Query:   441 ISGRET-ESASLTE 453
             IS     ES+SL++
Sbjct:   784 ISTELVLESSSLSD 797

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 704 (252.9 bits), Expect = 1.8e-69, P = 1.8e-69
 Identities = 144/299 (48%), Positives = 196/299 (65%)

Query:   161 VTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSAEEFINELL---------- 208
             +TN F H +G+GGFG+VYKG+L   +GR IA+K+++ SK + EEFINEL+          
Sbjct:   517 MTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKESKGNGEEFINELVSMSRASHVNI 576

Query:   209 ----GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
                 G C EG +RA++YE+MPNGSLD+  F  EN       +  + IA+G ARG+EYLHN
Sbjct:   577 VSLFGFCYEGSQRAIIYEFMPNGSLDK--FISENMSTKIEWKTLYNIAVGVARGLEYLHN 634

Query:   265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
              C   I+HFDIKP NIL+D +  PK+SDFGLAK   K+   +S+ D RGT+GY+APE+ S
Sbjct:   635 SCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDARGTVGYIAPEMFS 694

Query:   325 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM--NATRSSKAYFPSWVYDQLNKGGDLELR 382
             +N+G VS KSDVY +GMV+LEM G  +   +  +AT  S  YFP WVY+ L +   + L 
Sbjct:   695 KNYGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSSMYFPDWVYEDLERKETMRLL 754

Query:   383 N----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS-IDDLQMPPKPFFS 436
                    E E  I +++ ++GLWCIQ   +DRP M KV+EMLEGS ++ LQ+PPKP  +
Sbjct:   755 EDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGSRLEALQVPPKPLLN 813

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 2.4e-69, P = 2.4e-69
 Identities = 142/296 (47%), Positives = 195/296 (65%)

Query:   161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE------------- 206
             +TN F H LG+GGFG+VYKG+L  +GR +AVK+++ S+ + EEFINE             
Sbjct:   329 MTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEEFINEVASMSRTSHVNIV 388

Query:   207 -LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
              LLG C E  KRA++YE+MPNGSLD++I +  N       E+ +++A+G +RG+EYLHN 
Sbjct:   389 SLLGFCYEKNKRAIIYEFMPNGSLDKYISA--NMSTKMEWERLYDVAVGISRGLEYLHNR 446

Query:   266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
             C   I+HFDIKP NIL+D N  PK+SDFGLAK    +   +S+   RGT GY+APE+ S+
Sbjct:   447 CVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSK 506

Query:   326 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--YFPSWVYDQLNKGGDLEL-- 381
             NFG VS KSDVY +GMV+LEM G +    +  + S+    YFP WVY    KG    +  
Sbjct:   507 NFGAVSHKSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIFG 566

Query:   382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSS 437
              ++T+ E  IA+KL ++ LWCIQ+  +DRP M KV+EMLEG+++ LQ+PP P   S
Sbjct:   567 DSITDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQVPPNPLLFS 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)]

 Score = 684 (245.8 bits), Expect = 2.4e-67, P = 2.4e-67
 Identities = 150/324 (46%), Positives = 200/324 (61%)

Query:   150 VDNILLPEIIAVTNHFTHKLGQ-----GGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFI 204
             +  +++ EII  T      +GQ     GGFG+VYKG L  GR +AVK++++S  + E+FI
Sbjct:   263 ISPLIVAEIIPNTRSILITIGQEVVGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFI 322

Query:   205 NE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE 250
             NE              LLG C E  KRA+VYE++ NGSLD+   S  +    +G      
Sbjct:   323 NEVASISQTSHVNIVSLLGFCFEKSKRAIVYEFLENGSLDQS--SNLDVSTLYG------ 374

Query:   251 IALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310
             IALG ARGIEYLH GC   I+HFDIKP N+LLD N  PKV+DFGLAK   K+   +S+ D
Sbjct:   375 IALGVARGIEYLHFGCKKRIVHFDIKPQNVLLDENLKPKVADFGLAKLCEKQESILSLLD 434

Query:   311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM-NA-TRSSKAYFPSW 368
             TRGTIGY+APEL SR +G VS KSDVY +GM++LEM G R    + NA + +S AYFP W
Sbjct:   435 TRGTIGYIAPELFSRVYGNVSHKSDVYSYGMLVLEMTGARNKERVQNADSNNSSAYFPDW 494

Query:   369 VYDQLNKGGDLELR--NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
             ++  L  G  ++L    +T  E  IA+K+ ++GLWCIQ + +DRPSM KV+ M+EG++D 
Sbjct:   495 IFKDLENGDYVKLLADGLTREEEDIAKKMILVGLWCIQFRPSDRPSMNKVVGMMEGNLDS 554

Query:   427 LQMPPKPFFSSSRHISGRETESAS 450
             L  PPKP        +  E+   S
Sbjct:   555 LDPPPKPLLHMPMQNNNAESSQPS 578

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
 Identities = 143/298 (47%), Positives = 191/298 (64%)

Query:   157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTG-RLIAVKMMENSKFSAEEFINE--------- 206
             ++  +T  F + LG+GGFG+VYKG+L  G R +AVK+++ S    E+FINE         
Sbjct:   453 QVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEIASMSRTSH 512

Query:   207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                  LLG C EG K+A++YE MPNGSLD+ I SK N       +  + IA+G + G+EY
Sbjct:   513 ANIVSLLGFCYEGRKKAIIYELMPNGSLDKFI-SK-NMSAKMEWKTLYNIAVGVSHGLEY 570

Query:   262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
             LH+ C   I+HFDIKP NIL+D +  PK+SDFGLAK        +S+   RGTIGY+APE
Sbjct:   571 LHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARGTIGYIAPE 630

Query:   322 LISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNATRSSKAYFPSWVYDQLNKGGD 378
             + S+NFG VS KSDVY +GMV+LEM G R   R  N  ++ +S  YFP W+Y  L KG  
Sbjct:   631 VFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQNAGSSNTSM-YFPDWIYKDLEKGEI 689

Query:   379 LELR--NVTEIES-MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKP 433
             +      +TE E   I +K+ ++GLWCIQ    DRP M+KV+EMLEGS++ LQ+PPKP
Sbjct:   690 MSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEGSLEALQIPPKP 747

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	453
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-40
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-37
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-35
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-24
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-20
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-19
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-17
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-13
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-10
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-09
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-06
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-05
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.002
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.002
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.003
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.004
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  144 bits (366), Expect = 3e-40
 Identities = 81/281 (28%), Positives = 126/281 (44%), Gaps = 50/281 (17%)

Query: 165 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKFSA--EEFINE----------- 206
              KLG+G FG VYKG L          +AVK ++        EEF+ E           
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
              LLG+C+E     +V EYMP G L  ++  ++N+ +   L      AL  ARG+EYL 
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
                  +H D+   N L+  N + K+SDFGL++    ++D+  +   +  I ++APE  
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPE-- 174

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
           S   G  + KSDV+ FG++L E+   G      M+            V + L KG  L  
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---------VLEYLKKGYRLPK 225

Query: 382 RNV--TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420
                 E+  ++        L C      DRP+ ++++E+L
Sbjct: 226 PPNCPPELYKLM--------LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  143 bits (363), Expect = 7e-40
 Identities = 79/279 (28%), Positives = 122/279 (43%), Gaps = 47/279 (16%)

Query: 165 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKFSA--EEFINE----------- 206
              KLG+G FG VYKG+L          +AVK ++        EEF+ E           
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
              LLG+C+E     +V EYM  G L  ++  ++N+     L      AL  ARG+EYL 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRP-KLSLSDLLSFALQIARGMEYLE 119

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
                  +H D+   N L+  N + K+SDFGL++    + D+      +  I ++APE  
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPE-- 173

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
           S   G  + KSDV+ FG++L E+   G +    M+            V + L  G  L  
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLEYLKNGYRL-- 222

Query: 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420
                       +L  + L C      DRP+ ++++E+L
Sbjct: 223 ----PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  139 bits (352), Expect = 7e-39
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 27/196 (13%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMM--ENSKFSAEEFINE--------------LLGLC 211
           LG+GGFG+VY  +   TG+ +A+K++  E+S    EE + E              L G+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
            +     LV EY   GSL   +   +        ++   I L    G+EYLH+     I+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHS---NGII 114

Query: 272 HFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           H D+KP NILLD  N   K++DFGL+K    +   +      GT  Y+APE++    G  
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVLLGK-GYY 171

Query: 331 SCKSDVYGFGMVLLEM 346
           S KSD++  G++L E+
Sbjct: 172 SEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  137 bits (348), Expect = 1e-37
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 48/279 (17%)

Query: 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFIN----------------- 205
               KLG G FG+VYK +   TG+++AVK+++     +++                    
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61

Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-N 264
            L+    +     LV EY   G L  ++     +G     ++  +IAL   RG+EYLH N
Sbjct: 62  RLIDAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELI 323
           G    I+H D+KP NILLD N + K++DFGLAK   K +   S   T  GT  Y+APE++
Sbjct: 118 G----IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS---SSLTTFVGTPWYMAPEVL 170

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
               G    K DV+  G++L E+  G+      N+             +  +   G  LE
Sbjct: 171 LGGNG-YGPKVDVWSLGVILYELLTGKPPFSGENILD--------QLQLIRR-ILGPPLE 220

Query: 381 LRNVTEIESMI-ARKLCMIGLWCIQVKAADRPSMTKVLE 418
                       A+ L      C+    + RP+  ++L+
Sbjct: 221 FDEPKWSSGSEEAKDLI---KKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  136 bits (345), Expect = 3e-37
 Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 52/283 (18%)

Query: 164 HFTHKLGQGGFGSVYKGQLH-----TGRLIAVKMMENSKFSA--EEFINE---------- 206
               KLG+G FG VYKG L      T   +AVK ++        EEF+ E          
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               LLG+C++G    +V EYMP G L   +      G+   L+   ++AL  A+G+EYL
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
                   +H D+   N L+  N + K+SDFGL++   +++ +      +  I ++APE 
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           +    G  + KSDV+ FG++L E+   G +    M+            V + L  G  L 
Sbjct: 176 L--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLELLEDGYRLP 224

Query: 381 LRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420
            R      E+  ++ +        C      DRP+ ++++E L
Sbjct: 225 -RPENCPDELYELMLQ--------CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  131 bits (332), Expect = 2e-35
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 29/200 (14%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS--AEEFINE--------------LLGL 210
           KLG+G FG VY  +   TG+L+A+K+++  K     E  + E              L  +
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             +  K  LV EY   G L   +     K      ++           +EYLH      I
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLH---SKGI 118

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+KP NILLD +   K++DFGLA+     +    ++   GT  Y+APE++       
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLGK--GY 173

Query: 331 SCKSDVYGFGMVLLEMAGGR 350
               D++  G++L E+  G+
Sbjct: 174 GKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  130 bits (329), Expect = 5e-35
 Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 51/283 (18%)

Query: 168 KLGQGGFGSVYKGQLHTG----RLIAVKMMENSKFSAE--EFINE--------------L 207
           KLG+G FG VYKG+L         +AVK ++      E  +F+ E              L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHI-----FSKENKGQTFGLEKPHEIALGTARGIEYL 262
           LG+C+E     LV EYM  G L  ++          +  T  L+     A+  A+G+EYL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
            +      +H D+   N L+  + + K+SDFGL++    ++ +   +  +  I ++APE 
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           +    G  + KSDV+ FG++L E+   G      ++            V + L KG  L 
Sbjct: 179 L--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---------VLEYLRKGYRLP 227

Query: 381 L-RNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                  E+  ++        L C Q+   DRP+ ++++E LE
Sbjct: 228 KPEYCPDELYELM--------LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  126 bits (318), Expect = 2e-33
 Identities = 64/209 (30%), Positives = 91/209 (43%), Gaps = 37/209 (17%)

Query: 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMME---NSKFSAEEFINELLGLCS---------- 212
             LG+G FGSVY      TG L+AVK +E   +S+   E    E+  L S          
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 213 -----EGFKRALVY-EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA---RGIEYLH 263
                E      ++ EY+  GSL   +       + FG      I   T     G+ YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL-------KKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 264 -NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
            NG    I+H DIK  NIL+D + + K++DFG AK              RGT  ++APE+
Sbjct: 119 SNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
           I          +D++  G  ++EMA G+ 
Sbjct: 175 IRG--EEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  102 bits (256), Expect = 7e-25
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 29/201 (14%)

Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMM-ENSKFSAEEFINE--LLGLCSEGF------- 215
            K+G+GGFG VYK     TG+ +A+K++   SK   E+ INE  +L  C           
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 216 -----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDVC 269
                +  +V E+   GSL   +   ++  QT    +   +     +G+EYLH NG    
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSNG---- 118

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I+H DIK  NILL  +   K+ DFGL+          ++    GT  ++APE+I+     
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING--KP 173

Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K+D++  G+  +E+A G+
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  100 bits (251), Expect = 3e-24
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 46/275 (16%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
              ++G G FG V+ G     R +A+K +     S E+FI E              L G+
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C+E     LV+E+M +G L  ++ ++  K   F  E    + L    G+ YL +     +
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESS---NV 121

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFS--FSKY 178

Query: 331 SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-----GDLELRNVT 385
           S KSDV+ FG+++ E+    +    N + S        V + +N G       L  ++V 
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGFRLYKPRLASQSVY 231

Query: 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420
           E+              C + +  DRPS + +L  L
Sbjct: 232 ELMQ-----------HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 97.2 bits (243), Expect = 7e-23
 Identities = 72/283 (25%), Positives = 118/283 (41%), Gaps = 65/283 (22%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE---FINE--LLGLCS--------E 213
           ++G+G FG VY  +    G+L  +K ++ S  S +E    +NE  +L   +        E
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 214 GFKR----ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI-------ALGTARGIEYL 262
            F+      +V EY   G L + I  ++ +G+ F      +I        L     ++YL
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF---PEEQILDWFVQLCLA----LKYL 119

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
           H      ILH DIKP NI L  N + K+ DFG++K     +         GT  YL+PEL
Sbjct: 120 H---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPEL 174

Query: 323 ISR---NFGTVSCKSDVYGFGMVLLEMAGGRR---NSNMNATRSSKAYFPSWVYDQLNKG 376
                 N+     KSD++  G VL E+   +      N+             +  ++ KG
Sbjct: 175 CQNKPYNY-----KSDIWSLGCVLYELCTLKHPFEGENLLE-----------LALKILKG 218

Query: 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419
                     I S  + +L  +    +Q    +RPS+ ++L+ 
Sbjct: 219 ------QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 96.7 bits (241), Expect = 9e-23
 Identities = 78/264 (29%), Positives = 116/264 (43%), Gaps = 45/264 (17%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMME-NSKFSAEEFINE--------------LLGLCS 212
           KLG G FG V++G       +A+K+++ +     ++F  E              L  +CS
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILH 272
            G    ++ E M  GSL    F +  +GQ   +    ++A   A G+ YL    +   +H
Sbjct: 73  VGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127

Query: 273 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSC 332
            D+   NIL+  + + KV+DFGLA+   KE D    SD +    + APE  S   GT S 
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARL-IKE-DVYLSSDKKIPYKWTAPEAASH--GTFST 183

Query: 333 KSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL--ELRNVTEIE 388
           KSDV+ FG++L EM   G      MN            VYDQ+  G  +    +   EI 
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPYPGMNNHE---------VYDQITAGYRMPCPAKCPQEIY 234

Query: 389 SMIARKLCMIGLWCIQVKAADRPS 412
            +      M+  W  +    DRPS
Sbjct: 235 KI------MLECWAAE--PEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 3e-22
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 23/196 (11%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  +LG G FG V+ G+      +A+KM+     S ++FI E              L G+
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     +V EYM NG L    + +E KG+  G E   ++       +EYL +      
Sbjct: 68  CTKQRPIFIVTEYMANGCLLN--YLRERKGK-LGTEWLLDMCSDVCEAMEYLESN---GF 121

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+  + + KVSDFGLA++   ++ + S   T+  + +  PE+   ++   
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARY-VLDDQYTSSQGTKFPVKWAPPEVF--DYSRF 178

Query: 331 SCKSDVYGFGMVLLEM 346
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 61/193 (31%), Positives = 97/193 (50%), Gaps = 22/193 (11%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLG G FG V+ G  +    +AVK ++    S E F+ E              L  +CSE
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K  +G+   L +  ++A   A G+ YL +      +H 
Sbjct: 73  EEPIYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127

Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D+   NIL+  N + K++DFGLA+   +++++ +    +  I + APE    N+G  + K
Sbjct: 128 DLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTAPEAA--NYGRFTIK 184

Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 185 SDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 57/280 (20%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENS-------KFSAEEF---------INELLGLC 211
           K+G+G FG VYKG L     +AVK   ++       KF  E           I +L+G+C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
            +     +V E +P GSL   +  K+N+     ++K  +++L  A G+EYL +    CI 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKN--CI- 115

Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISDTRGTI--GYLAPELISRNFG 328
           H D+   N L+  N + K+SDFG+++   +E   + ++SD    I   + APE +  N+G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEAL--NYG 170

Query: 329 TVSCKSDVYGFGMVLLEM--AGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386
             + +SDV+ +G++L E    G      M+  ++          +++  G          
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---------ERIESGY--------- 212

Query: 387 IESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 421
              M A +LC      + L C      +RPS +++   L+
Sbjct: 213 --RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 92.1 bits (229), Expect = 6e-21
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 34/207 (16%)

Query: 165 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSK-------FSAE---------EF 203
           F  +LG+G FG V   +      +TG  +AVK + +S        F  E         E 
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 204 INELLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
           I +  G+C +   R+  L+ EY+P+GSL    + + ++ Q   L++    +    +G++Y
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLR--DYLQRHRDQ-INLKRLLLFSSQICKGMDY 124

Query: 262 LHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLA 319
           L +       +H D+   NIL++   + K+SDFGLAK  P++ D+  + +   + I + A
Sbjct: 125 LGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEM 346
           PE +  +    S  SDV+ FG+ L E+
Sbjct: 181 PECLRTS--KFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 91.6 bits (228), Expect = 6e-21
 Identities = 68/216 (31%), Positives = 97/216 (44%), Gaps = 48/216 (22%)

Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMM---ENSKFSAEEFINELLGLCSEGFK------ 216
           +K+G G FG VY    L TG L+AVK +   +N   + +E  +E+  L  E  K      
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVL--ELLKHPNLVK 63

Query: 217 -------RALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA---RGIEYLH 263
                  R  VY   EY   G+L+     +  +     +   H I + T     G+ YLH
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEE--LLEHGR-----ILDEHVIRVYTLQLLEGLAYLH 116

Query: 264 -NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISDTRGTIGYLAP 320
            +G    I+H DIKP NI LDHN + K+ DFG A    +        +    GT  Y+AP
Sbjct: 117 SHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Query: 321 ELISRN-----FGTVSCKSDVYGFGMVLLEMAGGRR 351
           E+I+               D++  G V+LEMA G+R
Sbjct: 173 EVITGGKGKGHGRAA----DIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 93.3 bits (230), Expect = 9e-21
 Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 31/209 (14%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF-------------------INELL 208
           KLG+G FG VY  +    +L+A+K++     S  +                    I +L 
Sbjct: 7   KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
               +     LV EY+  GSL   +  K  +       +   I       +EYLH     
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK 120

Query: 269 CILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSI----SDTRGTIGYLAPELI 323
            I+H DIKP NILLD +  + K+ DFGLAK  P      SI    S + GT GY+APE++
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 324 SR-NFGTVSCKSDVYGFGMVLLEMAGGRR 351
              +    S  SD++  G+ L E+  G  
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 79/272 (29%), Positives = 118/272 (43%), Gaps = 49/272 (18%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---EEFINELLGLCS----------E 213
           KLG+G +GSVYK + L   +  A+K ++    S    E+ +NE+  L S          E
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 214 GF----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            F    K  +V EY P G L + I  ++ K +    ++   I +   RG++ LH   +  
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQK 123

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ILH D+K  NILL  N + K+ D G++K   K      I    GT  Y+APE+       
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGR--P 177

Query: 330 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR----NVT 385
            S KSD++  G +L EMA         A RS +               DL  +       
Sbjct: 178 YSYKSDIWSLGCLLYEMATFA--PPFEA-RSMQ---------------DLRYKVQRGKYP 219

Query: 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
            I  + ++ L       +QVK   RP+  K+L
Sbjct: 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 51/213 (23%)

Query: 167 HKLGQGGFGSVYKGQLH--TGRLIAVK---MMENSKFSAEEFINELLGL----------C 211
             LGQG  G VYK + H  TG++ A+K   +  + +F  ++ + EL  L          C
Sbjct: 7   KVLGQGSSGVVYKVR-HKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVVKC 64

Query: 212 SEGFKR----ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA-----RGIEYL 262
              F +    ++V EYM  GSL   +  K+            E  L        +G++YL
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIP-------EPVLAYIARQILKGLDYL 115

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP----KENDFVSISDTRGTIGYL 318
           H      I+H DIKP N+L++     K++DFG++K       + N FV      GT+ Y+
Sbjct: 116 HT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYM 167

Query: 319 APELI-SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           +PE I   ++      +D++  G+ LLE A G+
Sbjct: 168 SPERIQGESYSY---AADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 26/206 (12%)

Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           EI   +     KLG G FG V++G  +    +AVK ++      ++F+ E          
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               L  +C+      +V E M  GSL  ++  +   G+   L +  ++A   A G+ YL
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 263 --HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
              N      +H D+   N+L+  N I KV+DFGLA+   KE+ + +    +  I + AP
Sbjct: 120 EAQN-----YIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAP 173

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E     +   S KSDV+ FG++L E+
Sbjct: 174 EAA--LYNRFSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 27/197 (13%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
                +G+G FG V  G  + G+ +AVK +++   +A+ F+ E              LLG
Sbjct: 9   KLGATIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +  +G    +V EYM  GSL  ++ S+        L +    AL    G+EYL       
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN--- 122

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
            +H D+   N+L+  + + KVSDFGLAK   +  D       +  + + APE +      
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALRE--KK 175

Query: 330 VSCKSDVYGFGMVLLEM 346
            S KSDV+ FG++L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 86.1 bits (214), Expect = 7e-19
 Identities = 67/211 (31%), Positives = 94/211 (44%), Gaps = 47/211 (22%)

Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINELLGL--CS--------E 213
              K+G+G  G VYK     TG+ +A+K M   K + E  INE+L +  C         +
Sbjct: 23  NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 214 GFKRA----LVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIA---LGTARGIEYLH 263
            +       +V EYM  GSL       F + N+ Q         IA       +G+EYLH
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ---------IAYVCREVLQGLEYLH 133

Query: 264 -NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYL 318
                   +H DIK  NILL  +   K++DFG A    K   K N  V      GT  ++
Sbjct: 134 SQNV----IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV------GTPYWM 183

Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           APE+I R       K D++  G++ +EMA G
Sbjct: 184 APEVIKRK--DYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 77/279 (27%), Positives = 118/279 (42%), Gaps = 61/279 (21%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVK--MMENSKFSAEEFINEL------------------ 207
           LG G FGSVY+G  L  G   AVK   + +   + +E + +L                  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR---GIEYLHN 264
           LG   E     +  E +P GSL           + +G      I L T +   G+EYLH+
Sbjct: 68  LGTEREEDNLYIFLELVPGGSL-------AKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
                 +H DIK  NIL+D N + K++DFG+AK    E  F      +G+  ++APE+I+
Sbjct: 121 RN---TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSF--AKSFKGSPYWMAPEVIA 174

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-----VYDQLNKGGDL 379
           +  G     +D++  G  +LEMA G+               P W     V      G   
Sbjct: 175 QQ-GGYGLAADIWSLGCTVLEMATGK---------------PPWSQLEGVAAVFKIGRSK 218

Query: 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
           EL  + +  S  A+   +    C+Q   + RP+  ++LE
Sbjct: 219 ELPPIPDHLSDEAKDFILK---CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 67/259 (25%), Positives = 106/259 (40%), Gaps = 48/259 (18%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINELLGLCSE-------------- 213
           +G+G +G VY    + TG ++AVK +E     A    +    +                 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 214 ------GFKRALVY-----EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR---GI 259
                 GF+    Y     EY+P GS+   +       +T+G  +   +   T +   G+
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-------RTYGRFEEQLVRFFTEQVLEGL 121

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
            YLH+     ILH D+K  N+L+D + I K+SDFG++K      D       +G++ ++A
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNA--------TRSSKAYFPSWVY 370
           PE+I       S K D++  G V+LEM  GRR  S+  A         + S    P  V 
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238

Query: 371 DQLNKGGDLELRNVTEIES 389
             L+      L     I  
Sbjct: 239 MNLSPVALDFLNACFTINP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 35/207 (16%)

Query: 169 LGQGGFGSVYKGQLH-TGR---LIAVKMMENSKFSAE--EFINE--------------LL 208
           +G G FG V +G+L   G+    +A+K ++      +  +F+ E              L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+ ++     ++ EYM NGSLD+  F +EN G+ F + +   +  G A G++YL    ++
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDK--FLRENDGK-FTVGQLVGMLRGIASGMKYL---SEM 125

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG---TIGYLAPELISR 325
             +H D+   NIL++ N + KVSDFGL++      D  +   T+G    I + APE I+ 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRR---LEDSEATYTTKGGKIPIRWTAPEAIA- 181

Query: 326 NFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            +   +  SDV+ FG+V+ E M+ G R
Sbjct: 182 -YRKFTSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 23/193 (11%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---LLGLCSEGFKRA------ 218
           KLG G FG V+ G  +    +A+K ++    S E F+ E   +  L      R       
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 219 ----LVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
               ++ EYM NGSL D   F K  +G    + K  ++A   A G+ ++        +H 
Sbjct: 73  EPIYIITEYMENGSLVD---FLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHR 126

Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I  N+GT + K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIK 183

Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 184 SDVWSFGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 74/274 (27%), Positives = 118/274 (43%), Gaps = 44/274 (16%)

Query: 167 HKLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G        +AVK ++      EEF+ E              LLG+C
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 72  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++     + + + +  +  I + APE  S  +   S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE--SLAYNKFS 183

Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----SWVYDQLNKGGDLELRNVTEI 387
            KSDV+ FG++L E+          AT     Y P    S VY+ L KG  +E       
Sbjct: 184 IKSDVWAFGVLLWEI----------ATYGMSPY-PGIDLSQVYELLEKGYRMER------ 226

Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                 K+  +   C Q   +DRPS  ++ +  E
Sbjct: 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 39/216 (18%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKMMENS-------KFSAE--------- 201
               +LG+G FG V+ G+ +         L+AVK ++ +        F  E         
Sbjct: 8   VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 202 EFINELLGLCSEGFKRALVYEYMPNGSLDRHI--------FSKENKGQTF--GLEKPHEI 251
           E I +  G+C+EG    +V+EYM +G L++ +        F K          L +  +I
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A+  A G+ YL +   V   H D+   N L+ ++ + K+ DFG+++      D+  +   
Sbjct: 128 AVQIASGMVYLASQHFV---HRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDYYRVGGH 183

Query: 312 RG-TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
               I ++ PE I   +   + +SDV+ FG+VL E+
Sbjct: 184 TMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 41/215 (19%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINE--LLGLC---------SEGF 215
           KLG+G +GSVYK     TG+++A+K++   +   +E I E  +L  C            F
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPV-EEDLQEIIKEISILKQCDSPYIVKYYGSYF 68

Query: 216 KRA---LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILH 272
           K     +V EY   GS+   I    NK  T   E+   I   T +G+EYLH+      +H
Sbjct: 69  KNTDLWIVMEYCGAGSV-SDIMKITNK--TLTEEEIAAILYQTLKGLEYLHS---NKKIH 122

Query: 273 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT---RGT-IG---YLAPELISR 325
            DIK  NILL+     K++DFG++           ++DT   R T IG   ++APE+I  
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSG---------QLTDTMAKRNTVIGTPFWMAPEVIQE 173

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATR 359
                + K+D++  G+  +EMA G+   S+++  R
Sbjct: 174 I--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 73/291 (25%), Positives = 120/291 (41%), Gaps = 65/291 (22%)

Query: 169 LGQGGFGSVYKGQLH----TGRLIAVKMMENSKFSA---EEFINE--------------L 207
           LG+G FGSV +GQL     +   +AVK M+    +    EEF++E              L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 208 LGLCSEGFKRA------LVYEYMPNGSLDRHIFSK--ENKGQTFGLEKPHEIALGTARGI 259
           +G+C E           ++  +M +G L   +         +   L+   +  +  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           EYL N      +H D+   N +L  +    V+DFGL+K     + +      +  + ++A
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----SWVYDQLNK 375
            E ++    T   KSDV+ FG+ + E+          ATR    Y P      +YD L  
Sbjct: 184 IESLADRVYTS--KSDVWAFGVTMWEI----------ATRGQTPY-PGVENHEIYDYLRH 230

Query: 376 GGDLELRNVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 421
           G  L+             + C+  L+     C +    DRP+ TK+ E+LE
Sbjct: 231 GNRLK-----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 34/203 (16%)

Query: 168 KLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSAE--EFINEL--LGLCSE----GFKR 217
           +LG G  G V K   H  TG+++AVK +      A   + + EL  L  C+     GF  
Sbjct: 8   ELGAGNSGVVSKVL-HRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 218 ALVY--------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           A           EYM  GSLD+    KE +G+        +IA+   +G+ YLH      
Sbjct: 67  AFYNNGDISICMEYMDGGSLDK--ILKEVQGR-IPERILGKIAVAVLKGLTYLHE--KHK 121

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNF 327
           I+H D+KP NIL++     K+ DFG++    +     FV      GT  Y+APE I  N 
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------GTSSYMAPERIQGND 175

Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
            +V  KSD++  G+ L+E+A GR
Sbjct: 176 YSV--KSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 23/193 (11%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLG G FG V+ G  +    +AVK ++    S E F+ E              L  + SE
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K+ +G+   L    ++A   A G+ Y+     +  +H 
Sbjct: 73  E-PIYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126

Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+    + K++DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 184 SDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 38/206 (18%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN-----------------ELLG 209
           +LG G FGSVY  +   TG L+A+K M+   +S EE +N                 +L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDV 268
           +  E  +   V+EYM  G+L  +   K+ KG+ F       I     +G+ ++H +G   
Sbjct: 66  VFRENDELYFVFEYM-EGNL--YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--- 119

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN----DFVSISDTRGTIGYLAPELIS 324
              H D+KP N+L+    + K++DFGLA+   +      D+VS   TR    Y APE++ 
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYTDYVS---TR---WYRAPEILL 171

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGR 350
           R+  + S   D++  G ++ E+   R
Sbjct: 172 RS-TSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 47/206 (22%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINELLG---LCS----------E 213
            +G+G FG VYKG  L TG  +A+K +   K   EE +  ++    L             
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 214 GFKR-----ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA---RGIEYLHN- 264
           G         ++ EY  NGSL + I       + FG      +A+      +G+ YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQII-------KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAP 320
           G    ++H DIK  NIL   + + K++DFG+A         +   V      GT  ++AP
Sbjct: 119 G----VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV------GTPYWMAP 168

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E+I       S  SD++  G  ++E+
Sbjct: 169 EVI--EMSGASTASDIWSLGCTVIEL 192

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 60/286 (20%)

Query: 169 LGQGGFGSVYKGQLHTG--RLIAVK--MMENSKF-----SAEEFINELLGLCS------- 212
           LG G FG VYK +       L+A+K   + N  F       ++ I +++   +       
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 213 ------------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                       E  +  +V + +    L  H  S + K Q F  E+   I +     + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH   +  I+H D+ P+NI+L  +    ++DFGLAK    E+   S+    GTI Y  P
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTILYSCP 182

Query: 321 ELI-SRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNM--NATRSSKAYFPSWVYDQLN 374
           E++ +  +G    K+DV+ FG +L +M   +    ++NM   AT+  +A     VY+ L 
Sbjct: 183 EIVKNEPYGE---KADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA-----VYEPLP 234

Query: 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420
                        E M +  +  +   C+   A  RP + +V  M+
Sbjct: 235 -------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 59/193 (30%), Positives = 98/193 (50%), Gaps = 22/193 (11%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE-----------LLGLCSEGFK 216
           KLG G FG V+ G  +    +AVK ++    S + F+ E           L+ L +   K
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 217 RALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
              +Y   EYM  GSL    F K ++G    L K  + +   A G+ Y+        +H 
Sbjct: 73  EEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127

Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ + K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIK 184

Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 185 SDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 80.6 bits (200), Expect = 3e-17
 Identities = 68/231 (29%), Positives = 103/231 (44%), Gaps = 45/231 (19%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA----EEFINE--LLGLCSEGF------ 215
           LG+G FG V   +   TG+L A+K+++  K       E  + E  +L   +  F      
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARGIEYLHNG 265
                 K  LV EY P G L  H+ SKE +   F  E+      EI L     +EYLH+ 
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHL-SKEGR---FSEERARFYAAEIVLA----LEYLHS- 111

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
             + I++ D+KP NILLD +   K++DFGLAK     ++    +   GT  YLAPE++  
Sbjct: 112 --LGIIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLG 167

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 369
                +   D +  G++L EM  G+      +              FP ++
Sbjct: 168 KGYGKAV--DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL 216

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 80.5 bits (198), Expect = 4e-17
 Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 23/194 (11%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 73  E-PIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 334 SDVYGFGMVLLEMA 347
           SDV+ FG++L E+ 
Sbjct: 184 SDVWSFGILLTELT 197

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.8 bits (198), Expect = 1e-16
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 38/206 (18%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF------------------INELL 208
           KLG+G +G VYK +   TG ++A+K +       E                    I +LL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            +     K  LV+EY     L +++   + +           I     RG+ Y H     
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCH---SH 117

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI--SR 325
            ILH D+KP NIL++ + + K++DFGLA+ F      +   +    T+ Y APE++  S+
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY---THEVVTLWYRAPEILLGSK 174

Query: 326 NFGT-VSCKSDVYGFGMVLLEMAGGR 350
           ++ T V    D++  G +  EM  G+
Sbjct: 175 HYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 42/197 (21%)

Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFS-AEEFIN------------------- 205
            KLG+G +  VYK     TGR++A+K ++  +   A++ IN                   
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            LL +        LV+E+M    L++ I   ++K             L T RG+EYLH+ 
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVI---KDKSIVLTPADIKSYMLMTLRGLEYLHSN 121

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELI 323
               ILH D+KP+N+L+  + + K++DFGLA+    P       ++    T  Y APEL+
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK----MTHQVVTRWYRAPELL 174

Query: 324 SRNFGTVSCKSDVYGFG 340
              FG    +   YG G
Sbjct: 175 ---FG---ARH--YGVG 183

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 78.2 bits (192), Expect = 3e-16
 Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 23/193 (11%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++      E F+ E              L  + SE
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V E+M  GSL    F KE  G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 73  E-PIYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126

Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + K++DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 184 SDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 68/206 (33%), Positives = 97/206 (47%), Gaps = 36/206 (17%)

Query: 168 KLGQGGFGSVYKGQL-HTGRLIAVKM----------------MENSKFSAEEFINELLGL 210
           +LG+G  GSV K +L +TG + A+K                 +E +K     +I +  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 211 CSEGFKR--ALVYEYMPNGSLDRHIFSK-ENKGQTFGLEKP-HEIALGTARGIEYLHNGC 266
             +       +  EY   GSLD  I+ K + +G   G EK   +IA    +G+ YLH   
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIG-EKVLGKIAESVLKGLSYLH--- 122

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISDT-RGTIGYLAPELIS 324
              I+H DIKP NILL      K+ DFG++       + V S++ T  GT  Y+APE I 
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVS------GELVNSLAGTFTGTSFYMAPERIQ 176

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGR 350
                 S  SDV+  G+ LLE+A  R
Sbjct: 177 G--KPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 41/208 (19%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMME--NSKFSA---EEF----------INELLGLCS 212
           LG+G +G VY  + L T   IA+K +   +S++     EE           I + LG  S
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG-----TARGIEYLHNGCD 267
           E     +  E +P GSL   + SK      +G  K +E  +         G++YLH   D
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSK------WGPLKDNEQTIIFYTKQILEGLKYLH---D 126

Query: 268 VCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPEL 322
             I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+APE+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------TGTLQYMAPEV 180

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           I +        +D++  G  ++EMA G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 61/208 (29%), Positives = 109/208 (52%), Gaps = 34/208 (16%)

Query: 169 LGQGGFGSVYKGQL-HTGR---LIAVKMMEN--SKFSAEEFINE--------------LL 208
           +G G FG V +G+L   G+    +A+K +++  ++    +F++E              L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+ ++     ++ E+M NG+LD   F ++N GQ F + +   +  G A G++YL    ++
Sbjct: 72  GVVTKSRPVMIITEFMENGALDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---SEM 125

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISDTRGTIGYLAPELIS- 324
             +H D+   NIL++ N + KVSDFGL++F      +  + S    +  I + APE I+ 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 325 RNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
           R F   +  SDV+ +G+V+ E M+ G R
Sbjct: 186 RKF---TSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.2 bits (190), Expect = 5e-16
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  +LG G FG V+ G+      +A+K +     S E+FI E              L G+
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     +V E+M NG L    + ++ +G+    +    +      G+EYL        
Sbjct: 68  CTQQKPLYIVTEFMENGCLLN--YLRQRQGK-LSKDMLLSMCQDVCEGMEYLERN---SF 121

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+    + KVSDFG+ ++   ++++ S S  +  + +  PE+   NF   
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVF--NFSKY 178

Query: 331 SCKSDVYGFGMVLLEM 346
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 48/214 (22%)

Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMME---NSKFSAEEFINEL------------------ 207
           LG+G +G+VY G  + G+LIAVK +E   ++  +AE+   +L                  
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR----GIEYLH 263
           LG C +    ++  E++P GS+   +         FG   P  +     +    G+ YLH
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSIL-------NRFG-PLPEPVFCKYTKQILDGVAYLH 119

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK------FHPKENDFVSISDTRGTIGY 317
           N    C++H DIK +N++L  N I K+ DFG A+       H   ++   +    GT  +
Sbjct: 120 NN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM--LKSMHGTPYW 174

Query: 318 LAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 350
           +APE+I+ + +G    KSD++  G  + EMA G+
Sbjct: 175 MAPEVINESGYGR---KSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 77.6 bits (192), Expect = 6e-16
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 55/217 (25%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVK--MMENSKFSAEEF------------------IN 205
            ++G+G +G VYK +   TG L+A+K   MEN K   E F                  I 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK---EGFPITAIREIKLLQKLRHPNIV 61

Query: 206 ELLGLCSEGFKRA--LVYEYMP---NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
            L  + +   K +  +V+EYM     G LD       +    F   +          G++
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTGLLD-------SPEVKFTESQIKCYMKQLLEGLQ 114

Query: 261 YLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVS--ISDTRGTI 315
           YLH NG    ILH DIK  NIL++++ + K++DFGLA+ + K N  D+ +  I     T+
Sbjct: 115 YLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-----TL 165

Query: 316 GYLAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y  PEL+  +  +G    + D++  G +L E+  G+
Sbjct: 166 WYRPPELLLGATRYGP---EVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 33/202 (16%)

Query: 167 HKLGQGGFGSVYKG--QLHTGRLI--AVKMMENSKFSA--EEFINE-------------- 206
            +LG G FGSV KG   + +G+ +  AVK ++    +A  +EF+ E              
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 207 LLGLC-SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           L+G+C  E     LV E  P G L    + K+   +   +    E+A   A G+ YL   
Sbjct: 61  LIGVCKGEPL--MLVMELAPLGPL--LKYLKKR--REIPVSDLKELAHQVAMGMAYLE-- 112

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELIS 324
                +H D+   N+LL +    K+SDFG+++      + + + +  R  + + APE I 
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI- 170

Query: 325 RNFGTVSCKSDVYGFGMVLLEM 346
            N+G  S KSDV+ +G+ L E 
Sbjct: 171 -NYGKFSSKSDVWSYGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 21/192 (10%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---LLGLCSEGFKRA------ 218
           KLG G FG V+    +    +AVK M+    S E F+ E   +  L  +   +       
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 219 ----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFD 274
               ++ E+M  GSL    F K ++G    L K  + +   A G+ ++        +H D
Sbjct: 73  EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD 127

Query: 275 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           ++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ + KS
Sbjct: 128 LRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKS 184

Query: 335 DVYGFGMVLLEM 346
           DV+ FG++L+E+
Sbjct: 185 DVWSFGILLMEI 196

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 63/267 (23%), Positives = 115/267 (43%), Gaps = 47/267 (17%)

Query: 169 LGQGGFGSVYKG----QLHTGRL-IAVKMMEN--SKFSAEEFINE--------------L 207
           LG G FG+VYKG    +    ++ +A+K++    S  + +E ++E              L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           LG+C    +  L+ + MP G L  ++  + +K    G +      +  A+G+ YL    +
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYV--RNHKD-NIGSQYLLNWCVQIAKGMSYLE---E 127

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             ++H D+   N+L+      K++DFGLAK    +         +  I ++A E I    
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI--LH 185

Query: 328 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
              + KSDV+ +G+ + E+   G +    + A           + D L KG  L    + 
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---------IPDLLEKGERLPQPPIC 236

Query: 386 EIESMIARKLCMIGLWCIQVKAADRPS 412
            I+      + M+ + C  + A  RP+
Sbjct: 237 TID------VYMVLVKCWMIDAESRPT 257

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 76.5 bits (188), Expect = 8e-16
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 23/196 (11%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  +LG G FG V  G+      +A+KM++    S +EFI E              L G+
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     +V EYM NG L  ++     + Q   L    E+      G+ YL +      
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESK---QF 121

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+D     KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVL--LYSKF 178

Query: 331 SCKSDVYGFGMVLLEM 346
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 33/207 (15%)

Query: 169 LGQGGFGSVYKGQLHT------GRLIAVKMMENSKFSAE--EFINE-------------- 206
           LGQG FG VY+G             +A+K +  +    E  EF+NE              
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSK------ENKGQTFGLEKPHEIALGTARGIE 260
           LLG+ S G    +V E M  G L  ++ S+              L+K  ++A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YL        +H D+   N ++  +   K+ DFG+ +   + + +         + ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMA 347
           E  S   G  + KSDV+ FG+VL EMA
Sbjct: 191 E--SLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 31/205 (15%)

Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENSK------FSAE---------EFI 204
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E         + I
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 205 NELLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
            +  G+C    +R   LV EY+P GSL R    K ++ +     K    A    +G+EYL
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSL-RDYLQK-HRERLDH-RKLLLYASQICKGMEYL 124

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPE 321
             G    + H D+   NIL++     K+ DFGL K  P++ ++  + +     I + APE
Sbjct: 125 --GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEM 346
            ++ +    S  SDV+ FG+VL E+
Sbjct: 182 SLTES--KFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 58/215 (26%), Positives = 85/215 (39%), Gaps = 33/215 (15%)

Query: 170 GQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE-----------LLGLCSE 213
           G+G FG V   Q   T ++ A+K M   K     S    +NE           L+ L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 214 ---GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
                   LV + +  G L  H+    ++   F  E+           +EYLH+     I
Sbjct: 69  FQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLHSKG---I 121

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +H DIKP NILLD      ++DF +A K  P        + T GT GY+APE++ R    
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----TTSTSGTPGYMAPEVLCRQ--G 175

Query: 330 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 364
            S   D +  G+   E   G+R    ++       
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 69/217 (31%), Positives = 115/217 (52%), Gaps = 40/217 (18%)

Query: 163 NHFTHK--LGQGGFGSVYKGQLHT-GR---LIAVKMMEN--SKFSAEEFINE-------- 206
           +H T +  +G G FG V++G L   GR    +A+K ++   ++   ++F++E        
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 207 ------LLGLCSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
                 L G+ ++ FK A+ + EYM NG+LD+  + +++ G+ F   +   +  G A G+
Sbjct: 65  HHNIIRLEGVVTK-FKPAMIITEYMENGALDK--YLRDHDGE-FSSYQLVGMLRGIAAGM 120

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG---TIG 316
           +YL    D+  +H D+   NIL++ N   KVSDFGL++    E+D      T G    I 
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPIR 175

Query: 317 YLAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
           + APE I+ R F +    SDV+ FG+V+ E M+ G R
Sbjct: 176 WTAPEAIAYRKFTSA---SDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 70/239 (29%), Positives = 104/239 (43%), Gaps = 64/239 (26%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLG 209
           LG G FG V   +   +G+  A+K++  +K       E  +NE              L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 210 LCSEGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------EIALGTARGI 259
                F+      LV EY+P G L    FS   K   F    P       ++ L     +
Sbjct: 69  ----SFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPE--PVARFYAAQVVLA----L 114

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           EYLH+  D  I++ D+KP N+LLD +   K++DFG AK   K   + ++    GT  YLA
Sbjct: 115 EYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTY-TLC---GTPEYLA 166

Query: 320 PELI-SRNFGTVSCKS-DVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 369
           PE+I S+ +G    K+ D +  G+++ EM  G     + N           K  FPS+ 
Sbjct: 167 PEIILSKGYG----KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF 221

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 65/225 (28%), Positives = 89/225 (39%), Gaps = 49/225 (21%)

Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVK--MMENSK----FSAEEFINELLGLCSEGFK 216
               KLG+G FG VYK  Q+ TGR++A+K  +M N K     +A   I  L  L      
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVV 70

Query: 217 RAL--VYEYMPNGSLDRHIFSK-------------ENKGQTFGLEKPH--EIALGTARGI 259
             +    E        R                  EN   +  L +       L    GI
Sbjct: 71  PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--PSVKLTESQIKCYMLQLLEGI 128

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH------------PKENDFVS 307
            YLH   +  ILH DIK  NIL+D+  I K++DFGLA+ +                 + +
Sbjct: 129 NYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185

Query: 308 ISDTRGTIGYLAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           +  TR    Y  PEL+   R + T     D++G G V  EM   R
Sbjct: 186 LVVTR---WYRPPELLLGERRYTT---AVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 73/271 (26%), Positives = 114/271 (42%), Gaps = 47/271 (17%)

Query: 168 KLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFSA---EEFINELLGLCS----------- 212
           K+G+G FG V+K       R+ A+K ++ SK +    EE I+E   L             
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 213 ---EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  K  +V EY  NG L  H   K  +G+    ++     +    G+ +LH+     
Sbjct: 67  SFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--- 121

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ILH DIK  N+ LD     K+ D G+AK      +F +     GT  YL+PEL       
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDK--P 177

Query: 330 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE--LRNVTE- 386
            + KSDV+  G+VL E   G+               P   +D  N+G  +   +R V   
Sbjct: 178 YNEKSDVWALGVVLYECCTGK--------------HP---FDANNQGALILKIIRGVFPP 220

Query: 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
           +  M +++L  +   C+      RP   ++L
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 29/201 (14%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE----FINE--LLGLCSEGFKRALVY 221
           LG+GGFG V   Q+  TG++ A K +E  +    +     +NE  +L   +  F   L Y
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 222 EY------------MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            Y            M  G L  HI++  N G  F  E+    A     G+E LH      
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLHREN--- 122

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
            ++ D+KP NILLD     ++SD GLA   P+     SI    GT+GY+APE+++    T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYT 179

Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
           +S   D +G G ++ EM  G+
Sbjct: 180 LS--PDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.2 bits (182), Expect = 8e-15
 Identities = 81/286 (28%), Positives = 136/286 (47%), Gaps = 60/286 (20%)

Query: 169 LGQGGFGSVYKGQLHT-GR---LIAVKMME--NSKFSAEEFINE--------------LL 208
           +G G FG V  G+L   G+    +A+K ++   ++    +F++E              L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+ ++     +V EYM NGSLD   F +++ GQ F + +   +  G A G++YL    D+
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQ-FTVIQLVGMLRGIASGMKYL---SDM 125

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG---TIGYLAPELIS- 324
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + APE I+ 
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 325 RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383
           R F   +  SDV+ +G+V+ E M+ G R              P W  +  N+  D+ ++ 
Sbjct: 184 RKF---TSASDVWSYGIVMWEVMSYGER--------------PYW--EMSNQ--DV-IKA 221

Query: 384 VTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSI 424
           + E   + A   C   L      C Q    +RP   +++ +L+  I
Sbjct: 222 IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 67/201 (33%), Positives = 95/201 (47%), Gaps = 29/201 (14%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENS---KFSAEEF-INE--LLGLCSEGFKRALVY 221
           LG+GGFG V   Q+  TG++ A K +E     K   E   +NE  +L   +  F  +L Y
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 222 EY------------MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            Y            M  G L  HI++  N G  F  E+    A     G+E LH      
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLHRER--- 122

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I++ D+KP NILLD     ++SD GLA     E +  +I    GT+GY+APE++     T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGE--TIRGRVGTVGYMAPEVVKNERYT 179

Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
            S   D +G G ++ EM  G+
Sbjct: 180 FS--PDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 33/203 (16%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE----FINE--LLGLCSEGFKRALVY 221
           LG+GGFG V   Q+  TG++ A K +E  +    +     +NE  +L   +  F  +L Y
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 222 EY------------MPNGSLDRHIFSKENKGQTFGLEKPHEI--ALGTARGIEYLHNGCD 267
            Y            M  G L  HI+   + G+  G E+   +  A     G+E LH    
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIY---HMGEA-GFEEGRAVFYAAEICCGLEDLHQER- 122

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             I++ D+KP NILLD +   ++SD GLA   P+     +I    GT+GY+APE++    
Sbjct: 123 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNER 177

Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
            T S   D +  G +L EM  G+
Sbjct: 178 YTFS--PDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 55/224 (24%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAE---EFIN---ELLGLCSE--GFKRA- 218
           +G+G F +V   +   T +  A+K+++  +   E   +++    E+L   +   G  +  
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68

Query: 219 ----------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR---GIEYLH-N 264
                      V EY PNG L ++I       + +G           A     +EYLH  
Sbjct: 69  YTFQDEENLYFVLEYAPNGELLQYI-------RKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----HPKENDFVSISDTR------- 312
           G    I+H D+KP NILLD +   K++DFG AK       P+ N   + +          
Sbjct: 122 G----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 313 ------GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
                 GT  Y++PEL++         SD++  G ++ +M  G+
Sbjct: 178 RFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 45/215 (20%)

Query: 168 KLGQGGFGSVYKGQLHT------GRLIAVKMMENSKFSAE---------------EFINE 206
           +LG+G FG V+  + H         L+AVK ++ +  SA                + I  
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFS--------KENKGQTFG-LEKPHEIALGT-- 255
             G+C+EG    +V+EYM +G L+R + S           +    G L     +A+ +  
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 256 ARGIEYLHNGCDVCILHF---DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312
           A G+ YL +      LHF   D+   N L+    + K+ DFG+++     + +     T 
Sbjct: 132 ASGMVYLAS------LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 313 GTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
             I ++ PE ++ R F T   +SD++ FG+VL E+
Sbjct: 186 LPIRWMPPESILYRKFTT---ESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 29/195 (14%)

Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMMENS-------KFSAEEF---------INELLGLCS 212
           LG+G FG V+KG L     +AVK  +         KF +E           I +L+G+C+
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILH 272
           +     +V E +P G     +  K+++ +T  L K    AL  A G+ YL +    CI H
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK---FALDAAAGMAYLES--KNCI-H 116

Query: 273 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD--TRGTIGYLAPELISRNFGTV 330
            D+   N L+  N + K+SDFG+++   +E+D +  S    +  I + APE +  N+G  
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEAL--NYGRY 171

Query: 331 SCKSDVYGFGMVLLE 345
           S +SDV+ +G++L E
Sbjct: 172 SSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 44/213 (20%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMM---ENSKFSAEEFINELLGLCSEG---------F 215
           +G+G +G VYK     TG+L+A+K+M   E+ +   +E  N L    +            
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73

Query: 216 KRA---------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL---GTARGIEYLH 263
           K+          LV E    GS+   +     KG+   L++   IA     T RG+ YLH
Sbjct: 74  KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKR--LKEEW-IAYILRETLRGLAYLH 130

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLA 319
                 ++H DIK  NILL  N   K+ DFG    L     + N F+      GT  ++A
Sbjct: 131 ENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------GTPYWMA 181

Query: 320 PELISRNFG---TVSCKSDVYGFGMVLLEMAGG 349
           PE+I+ +     +   +SDV+  G+  +E+A G
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.1 bits (174), Expect = 6e-14
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 31/194 (15%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG-LCS 212
            +G+G FG+V +G+ +TG+ +AVK ++    +A+ F+ E              LLG +  
Sbjct: 13  IIGEGEFGAVLQGE-YTGQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILH 272
            G    +V E M  G+L    F +        + +  + +L  A G+EYL +     ++H
Sbjct: 71  NGLY--IVMELMSKGNLVN--FLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123

Query: 273 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSC 332
            D+   NIL+  + + KVSDFGLA+      D     +++  + + APE +       S 
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHK--KFSS 176

Query: 333 KSDVYGFGMVLLEM 346
           KSDV+ +G++L E+
Sbjct: 177 KSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 46/216 (21%)

Query: 165 FTHKLGQGGFGSVYKGQLH--TGRLIAVK----MMENSKFSAEEFINEL--LGLCSEG-- 214
              +LG+G +GSVYK  LH  TG  +A+K     ++ SKF+  + I EL  L        
Sbjct: 5   VLDELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFN--QIIMELDILHKAVSPYI 61

Query: 215 -------FKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKP--HEIALGTARGIEYL 262
                  F    VY   EYM  GSLD+ +++      T G+ +     I     +G+++L
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDK-LYA--GGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 263 ---HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYL 318
              HN     I+H D+KP N+L++ N   K+ DFG++      N   S++ T  G   Y+
Sbjct: 119 KEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSG-----NLVASLAKTNIGCQSYM 168

Query: 319 APELIS----RNFGTVSCKSDVYGFGMVLLEMAGGR 350
           APE I         T + +SDV+  G+ +LEMA GR
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 70.7 bits (174), Expect = 9e-14
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 28/206 (13%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE---FINEL-----------LGLCS 212
            +G+G FG+V K +    G+++  K ++    + +E    ++E+           +    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 213 EGFKRA-----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
               R+     +V EY   G L + I   + + +    E    I       +   HN  D
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 268 V--CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELIS 324
               +LH D+KP NI LD N   K+ DFGLAK    ++ F     T  GT  Y++PE ++
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK---TYVGTPYYMSPEQLN 183

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGR 350
               +   KSD++  G ++ E+    
Sbjct: 184 HM--SYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 44/217 (20%)

Query: 167 HKLGQGGFGSVYKGQL-----HTGRL-IAVKMMENSKFSAE--EFINE------------ 206
             LG+G FG V K +            +AVKM+++     +  + ++E            
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------ 251
              LLG+C++     +V EY  +G+L   + ++   G+    + P               
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SIS 309
           A   ARG+E+L +    CI H D+   N+L+  + + K++DFGLA+  H    D+    +
Sbjct: 138 AYQVARGMEFLAS--KKCI-HRDLAARNVLVTEDHVMKIADFGLARDIH--HIDYYRKTT 192

Query: 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           + R  + ++APE +     T   +SDV+ FG++L E+
Sbjct: 193 NGRLPVKWMAPEALFDRVYTH--QSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 43/226 (19%)

Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMM--ENSKFSAEEFINE-- 206
           EI      F  +LG+G FG VYKG+L       +   +A+K +         +EF  E  
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 207 ------------LLGLCSEGFKRALVYEYMPNGSLDRHI----------FSKENKGQTFG 244
                       LLG+C++     +++EY+ +G L   +              ++     
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 245 LEKPH--EIALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           L+      IA+  A G+EYL  H+      +H D+   N L+      K+SDFGL++   
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             + +   S +   + ++ PE I   +G  + +SD++ FG+VL E+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 37/203 (18%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKM--MENSKFSAEEFINEL--LGLCS---------- 212
            +G+G FG VYK     T +++A+K+  +E ++   E+   E+  L  C           
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 213 --EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             +G K  ++ EY   GS    +     K           I      G+EYLH    +  
Sbjct: 68  FLKGSKLWIIMEYCGGGSC-LDLL----KPGKLDETYIAFILREVLLGLEYLHEEGKI-- 120

Query: 271 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
            H DIK  NILL      K++DFG    L     K N FV      GT  ++APE+I + 
Sbjct: 121 -HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPFWMAPEVIKQ- 172

Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
                 K+D++  G+  +E+A G
Sbjct: 173 -SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 30/205 (14%)

Query: 165 FTHKLGQGGFGSVYK----GQLHTGRLI--AVKMMENSKFSAE----------------- 201
           F   LG G FG V +    G   +  ++  AVKM++ +  S+E                 
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 202 EFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
           E I  LLG C+ G    ++ EY   G L   +  K     T   E     +   A+G+ +
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL--EDLLSFSYQVAKGMAF 156

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
           L +    CI H D+   N+LL H  I K+ DFGLA+    ++++V   + R  + ++APE
Sbjct: 157 LAS--KNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEM 346
            I     T   +SDV+ +G++L E+
Sbjct: 214 SIFNCVYTF--ESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 29/200 (14%)

Query: 168 KLGQGGFGSVYKGQLHT--GRLI--AVKMMENSKFSA--EEFINE---LLGLCSEGFKR- 217
           KLG G FG V +G+  T  G++I  AVK +++ K S   ++F+ E   +  L  E   R 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 218 ---------ALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
                     +V E  P GSL DR    +++    F +    + A+  A G+ YL +   
Sbjct: 62  YGVVLTHPLMMVTELAPLGSLLDR---LRKDALGHFLISTLCDYAVQIANGMRYLESKR- 117

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISDTRGTIGYLAPELISRN 326
              +H D+   NILL  +   K+ DFGL +  P+  D +V     +    + APE  S  
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--SLR 173

Query: 327 FGTVSCKSDVYGFGMVLLEM 346
             T S  SDV+ FG+ L EM
Sbjct: 174 TRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 29/201 (14%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE----FINE--LLGLCSEGFKRALVY 221
           LG+GGFG V   Q+  TG++ A K +E  +    +     +NE  +L   +  F  +L Y
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 222 EY------------MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            Y            M  G L  HI++  N G  F  ++    A     G+E L       
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQRER--- 122

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I++ D+KP NILLD     ++SD GLA   P+     ++    GT+GY+APE+I+    T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYT 179

Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
            S   D +G G ++ EM  G+
Sbjct: 180 FS--PDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 35/198 (17%)

Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG-LC 211
             +G+G FG V  G  + G  +AVK ++N   +A+ F+ E              LLG + 
Sbjct: 12  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQT-FGLEKPHEIALGTARGIEYLHNGCDVCI 270
            E     +V EYM  GSL  ++ S+   G++  G +   + +L     +EYL        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPE-LISRNFG 328
           +H D+   N+L+  + + KVSDFGL K      +  S  DT +  + + APE L  + F 
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 177

Query: 329 TVSCKSDVYGFGMVLLEM 346
           T   KSDV+ FG++L E+
Sbjct: 178 T---KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 33/203 (16%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE----FINE--LLGLCSEGFKRALVY 221
           LG+GGFG V   Q+  TG++ A K ++  +    +     +NE  +L   S  F  +L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 222 EY------------MPNGSLDRHIFSKENKGQTFGLEKPHEI--ALGTARGIEYLHNGCD 267
            +            M  G L  HI+   N G+  G  +   I  A     G+E+LH    
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIY---NVGEP-GFPEARAIFYAAQIICGLEHLHQ--- 113

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             I++ D+KP N+LLD +   ++SD GLA           I    GT GY+APE++    
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQG-- 168

Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
                  D +  G  L EM  GR
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 51/211 (24%)

Query: 169 LGQGGFGSVYKGQLHTG----RLIAVK-------MMENSKFSAEEFINE---------LL 208
           +G+G FG VY G L          AVK       + E  +F  E  I +         LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 209 GLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT------FGLEKPHEIALGTARGIE 260
           G+C  SEG    +V  YM +G L R+    E    T      FGL+         A+G+E
Sbjct: 63  GICLPSEGSP-LVVLPYMKHGDL-RNFIRSETHNPTVKDLIGFGLQ--------VAKGME 112

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGT---IG 316
           YL +   V   H D+   N +LD +F  KV+DFGLA+  + KE  + S+ +  G    + 
Sbjct: 113 YLASKKFV---HRDLAARNCMLDESFTVKVADFGLARDIYDKE--YYSVHNHTGAKLPVK 167

Query: 317 YLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 168 WMALESLQTQKFTT---KSDVWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 58/237 (24%), Positives = 94/237 (39%), Gaps = 61/237 (25%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENS------------------KFSAEEFINELL 208
           K+G+G +G VYK +   TG ++A+K ++                    + +    I  LL
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIK-LL 64

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH--EIALGTARGIEYLH-NG 265
            +        LV+E+M           K  K +  GL +           +G+ + H +G
Sbjct: 65  DVFRHKGDLYLVFEFM------DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKEN---DFVSISDTRGTIGYLAPE 321
               ILH D+KP N+L++   + K++DFGLA+ F         +V       T  Y APE
Sbjct: 119 ----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV------TRWYRAPE 168

Query: 322 LI--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLNK 375
           L+   + + T     D++  G +  E+   R              FP     DQL K
Sbjct: 169 LLLGDKGYST---PVDIWSVGCIFAELLSRR------------PLFPGKSEIDQLFK 210

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 26/202 (12%)

Query: 169 LGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSAEE--FINEL-----LGLCSEG----- 214
           LG+G +G V K + H  TG ++AVK +  +  S E+   + +L        C        
Sbjct: 9   LGRGAYGVVDKMR-HVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 215 --FKRALVYEYMP--NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             F+   V+  M   + SLD+      +KG T   +   +IA+   + +EYLH+   V  
Sbjct: 68  ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV-- 125

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS--RNFG 328
           +H D+KP N+L++ N   K+ DFG++ +     D V+ +   G   Y+APE I+   N  
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQK 182

Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
               KSDV+  G+ ++E+A GR
Sbjct: 183 GYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 51/214 (23%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMM------ENSKFSA-----------EEFINELL 208
             +G+G +G V K +   TG ++A+K        E+ K +A            E I  L 
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 209 GLCSEGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT---ARGIEY 261
               E F+R     LV+EY+    L+     + + G   GL  P  +        + I Y
Sbjct: 67  ----EAFRRKGRLYLVFEYVERTLLE---LLEASPG---GLP-PDAVRSYIWQLLQAIAY 115

Query: 262 LH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISDTRGTIGYL 318
            H +     I+H DIKP NIL+  + + K+ DFG A+       +       TR    Y 
Sbjct: 116 CHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR---WYR 168

Query: 319 APELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           APEL+    N+G      DV+  G ++ E+  G 
Sbjct: 169 APELLVGDTNYGK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 52/261 (19%)

Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMMEN----SKFSA------------EEFINEL 207
           LG G FG+V+KG  +  G  I    A+K +++      F                +I  L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           LG+C  G    LV +  P GSL  H+  ++++  +   ++     +  A+G+ YL    +
Sbjct: 75  LGICP-GASLQLVTQLSPLGSLLDHV--RQHRD-SLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             ++H ++   NILL  + I +++DFG+A     ++     S+ +  I ++A E I   F
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI--LF 185

Query: 328 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
           G  + +SDV+ +G+ + EM   G    + M          P  V D L KG         
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR---------PHEVPDLLEKG--------- 227

Query: 386 EIESMIARKLCMIGLWCIQVK 406
             E +   ++C I ++ + VK
Sbjct: 228 --ERLAQPQICTIDVYMVMVK 246

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 33/201 (16%)

Query: 169 LGQGGFGSVYK-GQLHTGRLIAVKMME-NSKFSAEEFINELLGLCSE-------GFKRAL 219
           LG G  GSV K   + TG ++A K++   +K S  + I   L +  E        F  A 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 220 VY--------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +         E+M  GSLDR I+    KG    +E   +IA+    G+ YL+N     I+
Sbjct: 73  LNENNICMCMEFMDCGSLDR-IY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIM 126

Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISDT-RGTIGYLAPELISRNFGT 329
           H DIKP NIL++     K+ DFG++       + + SI+DT  GT  Y++PE I    G 
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVS------GELINSIADTFVGTSTYMSPERIQG--GK 178

Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
            + KSDV+  G+ ++E+A G+
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 33/203 (16%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFI---NELLGLCSEGFKRALVY 221
           LG+GGFG V   Q+ +TG++ A K ++  +    S E+      E+L   +  F   L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 222 EY------------MPNGSLDRHIFSKENKGQTFGLEKPHEI--ALGTARGIEYLHNGCD 267
            +            M  G L  HI+   N G+  GLE    I  +     GI +LH    
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIY---NVGER-GLEMERVIHYSAQITCGILHLH---S 113

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
           + I++ D+KP N+LLD     ++SD GLA       D  +I+   GT GY+APE++    
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAPEILKEE- 169

Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
              S   D +  G  + EM  GR
Sbjct: 170 -PYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 42/216 (19%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE----------FINELLGLCSEGF 215
            ++G G FG+VY  + + T  ++A+K M  S   + E          F+ +L    +  +
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 216 KRA--------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIA---LGTARGIEYLHN 264
           K          LV EY    + D  I     K       +  EIA    G  +G+ YLH+
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASD--ILEVHKKPL-----QEVEIAAICHGALQGLAYLHS 133

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI- 323
                 +H DIK  NILL      K++DFG A      N FV      GT  ++APE+I 
Sbjct: 134 ---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVIL 184

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNA 357
           + + G    K DV+  G+  +E+A  R+    NMNA
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNA 219

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 46/212 (21%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKM--MENSK--FS-------------AEEFINELLG 209
           K+GQG FG V+K +   T +++A+K   MEN K  F                E +  L+ 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78

Query: 210 LCS------EGFKRA--LVYEYMPN---GSLDRHIFSKENKGQTFGLEKPHEIALGTARG 258
           +C         +K +  LV+E+  +   G L        NK   F L +  ++      G
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEHDLAGLL-------SNKNVKFTLSEIKKVMKMLLNG 131

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTR-GTIG 316
           + Y+H      ILH D+K  NIL+  + I K++DFGLA+ F   +N   +    R  T+ 
Sbjct: 132 LYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 317 YLAPELI--SRNFGTVSCKSDVYGFGMVLLEM 346
           Y  PEL+   R++G      D++G G ++ EM
Sbjct: 189 YRPPELLLGERDYGP---PIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 34/202 (16%)

Query: 169 LGQGGFGSVY-----KGQLHTGRLIAVKMM--ENSKFSAEEFINEL-------------- 207
           LG+G FG V           TG ++AVK +  E  + +   +  E+              
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 208 LGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            G CSE   +   L+ EY+P GSL R    K        L +    A     G+ YLH+ 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL-RDYLPKHK----LNLAQLLLFAQQICEGMAYLHSQ 126

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS-DTRGTIGYLAPELIS 324
                +H D+   N+LLD++ + K+ DFGLAK  P+ +++  +  D    + + A E + 
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 325 RNFGTVSCKSDVYGFGMVLLEM 346
            N    S  SDV+ FG+ L E+
Sbjct: 184 EN--KFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 39/204 (19%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAE--------------------EFINEL 207
           LGQG FG VY    + TGR +AVK +     S E                    E I + 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
            G   +    ++  EYMP GS+   + +     +T   +   +I      G+EYLH    
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLH---S 122

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISDTRGTIGYLAPELI 323
             I+H DIK  NIL D     K+ DFG +K             S++   GT  +++PE+I
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT---GTPYWMSPEVI 179

Query: 324 S-RNFGTVSCKSDVYGFGMVLLEM 346
           S   +G    K+DV+  G  ++EM
Sbjct: 180 SGEGYGR---KADVWSVGCTVVEM 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 38/203 (18%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NELLGL-------CSEGFKRA 218
           K+G+G  G V       TGR +AVK M+  K    E + NE++ +         E +   
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 219 LV-------YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           LV        E++  G+L   I +     +    E+   + L   + + +LH      ++
Sbjct: 86  LVGDELWVVMEFLEGGALT-DIVTHTRMNE----EQIATVCLAVLKALSFLHAQG---VI 137

Query: 272 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISRN- 326
           H DIK  +ILL  +   K+SDFG    ++K  P+    V      GT  ++APE+ISR  
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVISRLP 191

Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +GT   + D++  G++++EM  G
Sbjct: 192 YGT---EVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 40/217 (18%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMME-NSKFSAEEFINE--LLGLCS--------EGF- 215
           LG G FG VYK Q   TG   A K+++  S+   E+F+ E  +L  C         E + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 216 ---KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG--TARGIEYLHNGCDVCI 270
              K  ++ E+   G+LD  +   E      GL +P    +       + +LH+     +
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSHK---V 124

Query: 271 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELIS-R 325
           +H D+K  NILL  +   K++DFG          K + F+      GT  ++APE+++  
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEVVACE 178

Query: 326 NFGT--VSCKSDVYGFGMVLLEMAGGR-RNSNMNATR 359
            F       K+D++  G+ L+E+A     +  +N  R
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 39/207 (18%)

Query: 168 KLGQGGFGSVYK-GQLHTGRLIAVK--------------MMENSKFSAE---EFINELLG 209
           ++G+G  G V+K     TG  +A+K               +   K        ++ +LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKEN---KGQTFGLEKPHEIALGTARGIEYLH-NG 265
           +   G    LV EYMP   L   +  +E    + Q               +G+ Y+H NG
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSY------MRMLLKGVAYMHANG 119

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-- 323
               I+H D+KP N+L+  + + K++DFGLA+   +E      S    T  Y APEL+  
Sbjct: 120 ----IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYG 174

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           +R +       D++  G +  E+  G 
Sbjct: 175 ARKYDP---GVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.9 bits (160), Expect = 5e-12
 Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 40/210 (19%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRA--------- 218
           +G G +G VYKG+ + TG+L A+K+M+ +    EE   E+  L      R          
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 219 ------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
                       LV E+   GS+   I  K  KG T   E    I     RG+ +LH   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQH- 130

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPEL 322
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 182

Query: 323 ISRNF---GTVSCKSDVYGFGMVLLEMAGG 349
           I+ +     T   KSD++  G+  +EMA G
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 35/201 (17%)

Query: 168 KLGQGGFGSVYKG---QLHTGRLIAVKMMENSKFSA-----------------EEFINEL 207
           +LG G FG+V KG      + + +AVK+++N                        +I  +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL--HNG 265
           +G+C E     LV E    G L++ +   ++  +    E  H++++G    ++YL   N 
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETN- 115

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELIS 324
                +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE + 
Sbjct: 116 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM- 170

Query: 325 RNFGTVSCKSDVYGFGMVLLE 345
            N+   S KSDV+ FG+++ E
Sbjct: 171 -NYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 67/257 (26%), Positives = 103/257 (40%), Gaps = 58/257 (22%)

Query: 171 QGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRA----------- 218
           +G FGSVY  +   TG   A+K+++ S   A+   N++  + +E   RA           
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK---NQVTNVKAE---RAIMMIQGESPYV 59

Query: 219 --------------LVYEYMPNGSLDRHIFSKENKGQTFG---LEKPHEIALGTARGIEY 261
                         LV EY+  G     I       +T G    +   +       G+E 
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLI-------KTLGGLPEDWAKQYIAEVVLGVED 112

Query: 262 LH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           LH  G    I+H DIKP N+L+D     K++DFGL++   +   FV      GT  YLAP
Sbjct: 113 LHQRG----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAP 162

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           E I           D +  G V+ E   G    +     +  A F + +  ++N   +++
Sbjct: 163 ETILGVGDDKMS--DWWSLGCVIFEFLFGYPPFHAE---TPDAVFDNILSRRINWPEEVK 217

Query: 381 LRNVTEIESMIARKLCM 397
                E   +I R LCM
Sbjct: 218 EFCSPEAVDLINRLLCM 234

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 59/187 (31%), Positives = 91/187 (48%), Gaps = 46/187 (24%)

Query: 169 LGQGGFGSVYKGQLHTG----RLIAVKMME------NSKFSAEE-------------FIN 205
           LG+GG+G V++ +  TG    ++ A+K+++      N K +A               FI 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG------QTFGLEKPHEIALGTARGI 259
           +L+     G K  L+ EY+  G L  H+   E +G        F L    EI+L     +
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLS---EISLA----L 113

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYL 318
           E+LH      I++ D+KP NILLD     K++DFGL K    E    +++ T  GTI Y+
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCGTIEYM 167

Query: 319 APELISR 325
           APE++ R
Sbjct: 168 APEILMR 174

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 65/297 (21%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRL---IAVKMMEN--SKFSAEEFINELLGLCSEGFKRAL 219
           F   +G+G FG V K ++    L    A+K M+   SK    +F  EL  LC  G    +
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 220 VY---------------EYMPNGSL------------DRHIFSKENKGQTFGLEKPHEIA 252
           +                EY P+G+L            D       +   T   ++    A
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312
              ARG++YL        +H D+   NIL+  N++ K++DFGL++    +  +V  +  R
Sbjct: 131 ADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 184

Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVY 370
             + ++A E  S N+   +  SDV+ +G++L E+   GG     M             +Y
Sbjct: 185 LPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LY 233

Query: 371 DQLNKGGDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL----EMLE 421
           ++L +G  LE  L    E+  ++ +        C + K  +RPS  ++L     MLE
Sbjct: 234 EKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSFAQILVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 38/201 (18%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKM----------------MENSKFSAEEFINELLGLC 211
           LG G  G+VYK   L T R++AVK+                +E        +I    G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
               + ++  E+M  GSLD +    E      G      IA+   +G+ YL +   + IL
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPE---HVLG-----RIAVAVVKGLTYLWS---LKIL 117

Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISDTR-GTIGYLAPELISRNFGT 329
           H D+KP N+L++     K+ DFG++         V SI+ T  GT  Y+APE IS     
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST------QLVNSIAKTYVGTNAYMAPERISGE--Q 169

Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
               SDV+  G+  +E+A GR
Sbjct: 170 YGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 66/291 (22%)

Query: 169 LGQGGFGSVYKGQLHTGRLI---AVKMME---NSKFSAEEFINE--------------LL 208
           LG+G FGSV +GQL+    I   AVK M+    ++   E+F++E              L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 209 GLC-----SEGFKRALV-YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT--ARGIE 260
           G+C     SEG+   +V   +M +G L   +           L     +   T  A G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YL +      +H D+   N +L+ N    V+DFGL+K     + +      +  + ++A 
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 321 E-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----SWVYDQLNK 375
           E L  R + T   KSDV+ FG+ + E+          ATR    Y P    S +YD L +
Sbjct: 184 ESLADRVYTT---KSDVWSFGVTMWEI----------ATRGQTPY-PGVENSEIYDYLRQ 229

Query: 376 GGDLELRNVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 421
           G  L+               C+ GL+     C  +   DRPS   +   LE
Sbjct: 230 GNRLK-----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 46/209 (22%)

Query: 169 LGQGGFGSVY------KGQLHTGRLIAVKMMENSKFSAEEFINELL-------------- 208
           LG+G FG V       +G  +TG  +AVK ++    S    I +L               
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENI 68

Query: 209 ----GLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               G+C+E       L+ E++P+GSL  ++   +NK     L++  + A+   +G++YL
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYL 125

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPE 321
            +   V   H D+   N+L++     K+ DFGL K    + ++ ++ D   + + + APE
Sbjct: 126 GSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 322 LISRNFGTVSCK----SDVYGFGMVLLEM 346
            +      +  K    SDV+ FG+ L E+
Sbjct: 183 CL------IQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 59/225 (26%)

Query: 169 LGQGGFGSVYKGQ---LHTGR---LIAVKMMEN-------SKFSAE-----EF----INE 206
           +GQG FG V++ +   L       ++AVKM++        + F  E     EF    I +
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 207 LLGLCSEGFKRALVYEYMPNGSLD---RH--------IFSKENKGQTFGLEKPH------ 249
           LLG+C+ G    L++EYM  G L+   RH        +    +  +  GL          
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 250 -EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-------FHPK 301
             IA   A G+ YL    +   +H D+   N L+  N + K++DFGL++       +   
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           END + I        ++ PE I   +   + +SDV+ +G+VL E+
Sbjct: 190 ENDAIPIR-------WMPPESIF--YNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 41/208 (19%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM-----ENSKFSAEEFINELLGLCSEGF------ 215
           KLG+G + +VYKG+   TG ++A+K +     E +  +A   I+ +  L  E        
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 216 -----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY-LHNGCDVC 269
                K  LV+EYM +  L +++ +   +G    L+        T +   Y L  G   C
Sbjct: 67  IHTENKLMLVFEYM-DKDLKKYMDTHGVRG---ALD------PNTVKSFTYQLLKGIAFC 116

Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI- 323
               +LH D+KP N+L++     K++DFGLA+ F    N F   S+   T+ Y AP+++ 
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVVTLWYRAPDVLL 173

Query: 324 -SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            SR   T S   D++  G ++ EM  GR
Sbjct: 174 GSR---TYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 42/214 (19%)

Query: 168 KLGQGGFGSVYKGQLHT------GRLIAVKMMENSKFSAE---------------EFINE 206
           +LG+G FG V+  + +         L+AVK +++   +A                E I +
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFS-------------KENKGQTFGLEKPHEIAL 253
             G+C +G    +V+EYM +G L++ + +             ++ KG+  GL +   IA 
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-LGLSQMLHIAS 130

Query: 254 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
             A G+ YL +      +H D+   N L+  N + K+ DFG+++     + +     T  
Sbjct: 131 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 314 TIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
            I ++ PE ++ R F T   +SDV+ FG++L E+
Sbjct: 188 PIRWMPPESIMYRKFTT---ESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 50/217 (23%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAE------------------------EF 203
           +G G FGSVY G    +G L+AVK +E    SA                         E 
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 204 INELLGLCSEGFKRALVYEYMPNGS----LDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
           I + LG   +     +  EY+P GS    L+ +   +E   + F  +          +G+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ--------ILKGL 119

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT------RG 313
            YLHN     I+H DIK  NIL+D+    K+SDFG++K    E + +S          +G
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQG 174

Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           ++ ++APE++ +   T   K+D++  G +++EM  G+
Sbjct: 175 SVFWMAPEVVKQTSYTR--KADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 73/234 (31%), Positives = 108/234 (46%), Gaps = 54/234 (23%)

Query: 169 LGQGGFGSVYKGQLH--TGRLIAVK--------------MMENS---KFSAEEFINELLG 209
           +G+G FG+V K  LH  +G ++AVK              +M+     + S   +I +  G
Sbjct: 12  IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 210 -LCSEGFKRALV-YEYMPNGSLDRHIFSK---ENKGQTFGLEKPHEIALGTARGIEYLHN 264
            L  EG     +  E M + SLD+  F K   E        E   +IA+ T + + YL  
Sbjct: 71  ALFREG--DCWICMELM-DISLDK--FYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--GTIGYLAPEL 322
             ++ I+H D+KP NILLD N   K+ DFG++     +    SI+ TR  G   Y+APE 
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGISG-QLVD----SIAKTRDAGCRPYMAPER 178

Query: 323 ISRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW--VYDQL 373
           I  +       +SDV+  G+ L E+A G            K  +P W  V+DQL
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATG------------KFPYPKWNSVFDQL 220

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 48/209 (22%)

Query: 169 LGQGGFGSVY---KGQLHTGRLIAVKMMENSKFSAEEFINEL------LGLCSEGF---- 215
           + +G +G V+   K    TG + A+K+++ +    +  ++++      L      +    
Sbjct: 1   ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 216 --------KRALVYEYMPNG---SLDRHI--FSKENKGQTFGLEKPHEIALGTARGIEYL 262
                      LV EY+P G   SL  ++    ++            EI L     +EYL
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA----LEYL 109

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF------HPKENDFVSISDTRGTIG 316
           H+     I+H D+KP NIL+D N   K++DFGL+K           +D        GT  
Sbjct: 110 HS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLE 345
           Y+APE+I    G  S   D +  G +L E
Sbjct: 167 YIAPEVI-LGQGH-SKTVDWWSLGCILYE 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 40/210 (19%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRA--------- 218
           +G G +G VYKG+ + TG+L A+K+M+ ++   EE   E+  L      R          
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 219 ------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
                       LV E+   GS+   +  K  KG     +    I     RG+ +LH   
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGLAHLHAH- 140

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPEL 322
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 192

Query: 323 ISRNF---GTVSCKSDVYGFGMVLLEMAGG 349
           I+ +     T   +SD++  G+  +EMA G
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 33/199 (16%)

Query: 168 KLGQGGFGSVYKGQLHT-GRLIAVKMMENS-------KFSAEEFINE---------LLGL 210
           ++G+G FG V+ G+L      +AVK    +       KF  E  I +         L+G+
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     +V E +  G     +     +G    +++  ++    A G+EYL +    CI
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLESKH--CI 116

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT----IGYLAPELISRN 326
            H D+   N L+    + K+SDFG+++   +E D V  + T G     + + APE +  N
Sbjct: 117 -HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGV-YASTGGMKQIPVKWTAPEAL--N 169

Query: 327 FGTVSCKSDVYGFGMVLLE 345
           +G  S +SDV+ FG++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 70/288 (24%), Positives = 111/288 (38%), Gaps = 73/288 (25%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVK------MMENS---------------------KFS 199
           K+G+G F  VYK   L  GR++A+K      MM+                       K+ 
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 200 AEEFI--NELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR 257
           A  FI  NEL           +V E    G L R I   + + +        +  +    
Sbjct: 69  AS-FIENNELN----------IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
            +E++H+     I+H DIKP N+ +    + K+ D GL +F   +    +     GT  Y
Sbjct: 118 ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYY 172

Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMN----ATRSSKAYFPSWVY 370
           ++PE I  N    + KSD++  G +L EMA  +       MN      +  K  +P    
Sbjct: 173 MSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPA 230

Query: 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
           D  ++    ELR++                 CI      RP ++ VL+
Sbjct: 231 DHYSE----ELRDLVSR--------------CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 47/220 (21%)

Query: 169 LGQGGFGSVYKGQLH--TGR----LIAVKMMENSKFSAE------EF----------INE 206
           LG+G FG V K       GR     +AVKM++ +  S+E      EF          + +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 207 LLGLCSEGFKRALVYEYMPNGSL------DRHI----FSKENKGQTFGLEKPHEIALGT- 255
           L G CS+     L+ EY   GSL       R +       +    +  L+ P E AL   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 256 ---------ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306
                    +RG++YL    ++ ++H D+   N+L+      K+SDFGL++   +E+ +V
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTT--QSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 30/210 (14%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKM--MENSKFSAEEFINEL--LGLCSEGFKRALVYE 222
           ++G+G FG VYKG    T  ++A+K+  +E ++   E+   E+  L  C   +       
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 223 YMPNGSLDRHIFSKENKGQTFGLEKP---HEIALGTA-----RGIEYLHNGCDVCILHFD 274
           Y+    L   I      G    L KP    E  + T      +G++YLH+   +   H D
Sbjct: 71  YLKGTKL-WIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI---HRD 126

Query: 275 IKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           IK  N+LL      K++DFG+A        K N FV      GT  ++APE+I ++    
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIKQS--AY 178

Query: 331 SCKSDVYGFGMVLLEMAGGR-RNSNMNATR 359
             K+D++  G+  +E+A G   NS+++  R
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMR 208

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.4 bits (151), Expect = 9e-11
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 38/214 (17%)

Query: 167 HKLGQGGFGSVY-KGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMP 225
           H++G G FG+VY     HT  ++AVK M  S     E   +++      F + L +   P
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK--FLQQLKH---P 81

Query: 226 NGSLDRHIFSKENK---------GQTFGLEKPHE----------IALGTARGIEYLHNGC 266
           N    +  + KE+          G    L + H+          I  G  +G+ YLH+  
Sbjct: 82  NTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SR 325
              ++H DIK  NILL      K++DFG A      N FV      GT  ++APE+I + 
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAM 192

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNA 357
           + G    K DV+  G+  +E+A  R+    NMNA
Sbjct: 193 DEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNA 225

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 45/209 (21%)

Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA--EEFINELLGL----------CSEG 214
           ++G G  G+VYK     TGRL A+K++  +       +   E+  L          C + 
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 215 FKRA----LVYEYMPNGSLD-RHIFSKENKGQTFGLEKPHEIALG-TAR----GIEYLHN 264
           F       ++ E+M  GSL+  HI                E  L   AR    GI YLH 
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIA--------------DEQFLADVARQILSGIAYLHR 186

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
                I+H DIKP N+L++     K++DFG+++   +  D    + + GTI Y++PE I+
Sbjct: 187 RH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERIN 241

Query: 325 R--NFGTVS-CKSDVYGFGMVLLEMAGGR 350
              N G       D++  G+ +LE   GR
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 31/199 (15%)

Query: 168 KLGQGGFGSVYKG--QLHTGRL-IAVKMM--ENSKFSAEE--------------FINELL 208
           +LG G FG V KG  ++   ++ +A+K++  EN K   +E              +I  ++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGL-EKPHEIALGTARGIEYLHNGCD 267
           G+C E     LV E    G L++ +  K+++     + E  H++++G    ++YL     
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEGKNF 116

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELISRN 326
           V   H D+   N+LL +    K+SDFGL+K     ++ + + S  +  + + APE I  N
Sbjct: 117 V---HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--N 171

Query: 327 FGTVSCKSDVYGFGMVLLE 345
           F   S +SDV+ +G+ + E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 71/245 (28%), Positives = 108/245 (44%), Gaps = 75/245 (30%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMM-----ENSKFSAEEFINE--LLGLCSEGFKRA 218
            KLG+G + +VYKG+   TG+L+A+K +     E + F+A   I E  LL    +  K A
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA---IREASLL----KDLKHA 63

Query: 219 ----------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT---ARGI 259
                           LV+EY+ +  L +++   ++ G   G    H + L      RG+
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYL-DTDLKQYM---DDCG---GGLSMHNVRLFLFQLLRGL 116

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISDTRGT 314
            Y H      +LH D+KP N+L+      K++DFGLA+          N+ V       T
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-------T 166

Query: 315 IGYLAPE--LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP--SWVY 370
           + Y  P+  L S  + T     D++G G +  EMA GR              FP  + V 
Sbjct: 167 LWYRPPDVLLGSTEYST---SLDMWGVGCIFYEMATGR------------PLFPGSTDVE 211

Query: 371 DQLNK 375
           DQL+K
Sbjct: 212 DQLHK 216

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 38/92 (41%), Positives = 55/92 (59%), Gaps = 7/92 (7%)

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           ARG+E+L      CI H D+   NILL  N + K+ DFGLA+   K+ D+V   D R  +
Sbjct: 183 ARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 316 GYLAPELISRNFGTV-SCKSDVYGFGMVLLEM 346
            ++APE I   F  V + +SDV+ FG++L E+
Sbjct: 240 KWMAPESI---FDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 34/203 (16%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENS------------------KFSAEEFINELL 208
            +G+G +G V K +   TG+++A+K    S                  +   E  +N L+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVN-LI 66

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            +     +  LV+E++ +  LD      E         +  +      RGIE+ H+    
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-- 326
            I+H DIKP NIL+  + + K+ DFG A+      +    +D   T  Y APEL+  +  
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTK 177

Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +G      D++  G ++ EM  G
Sbjct: 178 YGR---AVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)

Query: 169 LGQGGFGSVYKGQLH------TGRLIAVKMMENSK-------FSAE---------EFINE 206
           LG+G FG V+  +           L+ VK ++ +K       F  E         + +  
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIF---SKENKGQTFGLEKPHEIALGT--ARGIEY 261
           LLGLC E     ++ EY   G L + +    SK+ K +   L    ++AL T  A G+++
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
           L N      +H D+   N L+      KVS   L+K     +++  + +    + +LAPE
Sbjct: 133 LSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWLAPE 188

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ-LN--KGGD 378
            +  +    S KSDV+ FG+++ E+               +  F     ++ LN  + G 
Sbjct: 189 AVQED--DFSTKSDVWSFGVLMWEV-----------FTQGELPFYGLSDEEVLNRLQAGK 235

Query: 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           LEL     +      +L  +   C  V   DRPS ++++  L 
Sbjct: 236 LELP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 40/214 (18%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRL---IAVKMMEN--SKFSAEEFINELLGLCSEGF---- 215
           F   +G+G FG V +  +    L    A+KM++   S+    +F  EL  LC  G     
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 216 --------KRALVY---EYMPNGSLDRHI-----------FSKEN-KGQTFGLEKPHEIA 252
                    R  +Y   EY P G+L   +           F+KE+    T   ++  + A
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312
              A G++YL    +   +H D+   N+L+  N   K++DFGL++    E  +V  +  R
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179

Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             + ++A E  S N+   + KSDV+ FG++L E+
Sbjct: 180 LPVRWMAIE--SLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 48/214 (22%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELL------GLCS-------- 212
            +G G    VY    L     +A+K ++  K      ++EL         C+        
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPNVVKYY 65

Query: 213 ----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL---GTARGIEYLH-N 264
                G +  LV  Y+  GSL   + S   +G   GL++   IA       +G+EYLH N
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG---GLDEA-IIATVLKEVLKGLEYLHSN 121

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--------HPKENDFVSISDTRGTIG 316
           G     +H DIK  NILL  +   K++DFG++                FV      GT  
Sbjct: 122 G----QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV------GTPC 171

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           ++APE++ +  G    K+D++ FG+  +E+A G 
Sbjct: 172 WMAPEVMEQVHGYDF-KADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 35/209 (16%)

Query: 168 KLGQGGFGSVYKGQLHTGRL-------IAVKMMENSKFSAE--EFINE------------ 206
           +LGQG FG VY+G +  G +       +A+K +  +    E  EF+NE            
Sbjct: 13  ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFS-----KENKGQTF-GLEKPHEIALGTARG 258
             LLG+ S+G    ++ E M  G L  ++ S     + N  Q    L+K  ++A   A G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           + YL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + ++
Sbjct: 132 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEMA 347
           +PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 189 SPE--SLKDGVFTTYSDVWSFGVVLWEIA 215

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 40/204 (19%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NELLGL--------------- 210
           K+GQG  G+VY    + TG+ +A+K M   +   +E I NE+L +               
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 211 --CSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
               E +   +V EY+  GSL D    +  ++GQ   + +    AL      E+LH+   
Sbjct: 86  LVGDELW---VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQAL------EFLHSNQ- 135

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISDTRGTIGYLAPELISRN 326
             ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 136 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK 190

Query: 327 -FGTVSCKSDVYGFGMVLLEMAGG 349
            +G    K D++  G++ +EM  G
Sbjct: 191 AYGP---KVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 45/131 (34%), Positives = 66/131 (50%), Gaps = 16/131 (12%)

Query: 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNIL 281
           E+M  GSLD+ +  K  +     L K   I++   RG+ YL       I+H D+KP NIL
Sbjct: 79  EHMDGGSLDQ-VLKKAGRIPENILGK---ISIAVLRGLTYLREKHK--IMHRDVKPSNIL 132

Query: 282 LDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGF 339
           ++     K+ DFG++        N FV      GT  Y++PE +     TV   SD++  
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYTVQ--SDIWSL 184

Query: 340 GMVLLEMAGGR 350
           G+ L+EMA GR
Sbjct: 185 GLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 34/215 (15%)

Query: 169 LGQGGFGSVYK-GQLHTGRLIAVKMMENSKFSAEE----FINE--LLGLCSEG------- 214
           +G+GGFG VY   +  TG++ A+K ++  +   ++     +NE  +L L S G       
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 215 ----F----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
               F    K + + + M  G L  H+    ++   F   +    A     G+E++HN  
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHNRF 117

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
              +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+APE++ + 
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKG 170

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 361
               S  +D +  G +L ++  G      + T+  
Sbjct: 171 VAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 42/205 (20%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINEL---------------LGL 210
            K+G+G F  V K Q   TG+  A+K M+    S E+ +N L               L L
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRL 63

Query: 211 CSEGFKR-----ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-N 264
               F R     ALV+E M + +L   I   + + +    ++         + ++++H N
Sbjct: 64  IEVLFDRKTGRLALVFELM-DMNLYELI---KGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISDTRGTIGYLAPE 321
           G    I H DIKP NIL+  + + K++DFG  +     P   +++S   TR    Y APE
Sbjct: 120 G----IFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYIS---TR---WYRAPE 168

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEM 346
            +  + G    K D++  G V  E+
Sbjct: 169 CLLTD-GYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 35/203 (17%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMEN-SKFSAEEFINEL--LGLCSEGF-------- 215
           +LG G FG VYK +   TG L A K++E  S+   E+++ E+  L  C+  +        
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 216 ----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
               K  ++ E+ P G++D  +   +      GL +P +I +   + +E L     + I+
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEP-QIQVICRQMLEALQYLHSMKII 132

Query: 272 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELI---S 324
           H D+K  N+LL  +   K++DFG++    K   + + F+      GT  ++APE++   +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCET 186

Query: 325 RNFGTVSCKSDVYGFGMVLLEMA 347
                   K+D++  G+ L+EMA
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 49/231 (21%)

Query: 169 LGQGGFGSVYKGQLHTGR----LIAVKMMENSKFSAEE-----------------FINEL 207
           LGQG FG V+  +  TG     L A+K+++ +     +                 FI +L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 208 -LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEK----PHEIALGTARGIEYL 262
                +EG K  L+ +++  G L    F++ +K   F  E       E+AL     +++L
Sbjct: 64  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALA----LDHL 114

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
           H+   + I++ D+KP NILLD     K++DFGL+K    +++  + S   GT+ Y+APE+
Sbjct: 115 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC-GTVEYMAPEV 169

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFP 366
           ++R   T S  +D + FG+++ EM  G        R   M     +K   P
Sbjct: 170 VNRRGHTQS--ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 38/203 (18%)

Query: 168 KLGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI-NELLGL-------CSEGFKRA 218
           K+G+G  G V    + H+GR +AVKMM+  K    E + NE++ +         E +K  
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 219 LV-------YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           LV        E++  G+L   I S+    +    E+   +     + + YLH+     ++
Sbjct: 88  LVGEELWVLMEFLQGGALT-DIVSQTRLNE----EQIATVCESVLQALCYLHSQG---VI 139

Query: 272 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISRN- 326
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR  
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRTP 193

Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +GT   + D++  G++++EM  G
Sbjct: 194 YGT---EVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 32/206 (15%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIA---VKMMENSKFSAEE--FINE--------------LL 208
           ++G G FG V  G+ H G   A   VK +  S    E+  F+ E               L
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKP---HEIALGTARGIEYLHNG 265
           G C E     LV E+ P G L  ++  + N+G    + +      +A   A G+ +LH  
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS- 324
                +H D+   N  L  +   K+ D+GLA     E+ +++       + +LAPEL+  
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 325 --RNFGTV--SCKSDVYGFGMVLLEM 346
             ++      + KS+++  G+ + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 36/204 (17%)

Query: 169 LGQGGFGSVYK-GQLHTGRLIAVKMMENSKFSAEE----FINE--LLGLCSEG---FKRA 218
           +G+GGFG VY   +  TG++ A+K ++  +   ++     +NE  +L L S G   F   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 219 LVYEY------------MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           + Y +            M  G L  H+    ++   F  ++    A     G+E++HN  
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
              +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+APE++ + 
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQK- 169

Query: 327 FGTV-SCKSDVYGFGMVLLEMAGG 349
            GT     +D +  G +L ++  G
Sbjct: 170 -GTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 48/223 (21%)

Query: 165 FTHKLGQGGFGSVY---------------KGQLHTGRLIAVKMM--ENSKFSAEEFINE- 206
              KLG+G FG V+                       L+AVKM+  + +K +  +F+ E 
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 207 -------------LLGLCSEGFKRALVYEYMPNGSLD-----RHI---FSKENKGQTFGL 245
                        LLG+C       ++ EYM NG L+     R I   F+  N   +  +
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 246 EKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305
                +A+  A G++YL     +  +H D+   N L+ +++  K++DFG+++ +    D+
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-NLYSGDY 184

Query: 306 VSISDTRGT--IGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             I   R    I ++A E I    G  +  SDV+ FG+ L EM
Sbjct: 185 YRIQG-RAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 40/215 (18%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKM--MENSKFSAEEFINEL--LGLCS---------- 212
           ++G+G FG V+KG    T +++A+K+  +E ++   E+   E+  L  C           
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 213 --EGFKRALVYEYMPNGS-LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             +G K  ++ EY+  GS LD       ++ Q   + K  EI     +G++YLH+   + 
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK--EIL----KGLDYLHSEKKI- 123

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELISR 325
             H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I +
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIQQ 175

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATR 359
           +      K+D++  G+  +E+A G   NS+M+  R
Sbjct: 176 S--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 39/216 (18%)

Query: 165 FTHKLGQGGFGSVYKGQLHT-----GRLIAVKMME--NSKFSAEEFINE----------- 206
           F  +LG+  FG +YKG L+       +L+A+K ++  N+     EF  E           
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSK---------ENKGQTFGLEKPH----E 250
              LLG+ ++     +++EY+  G L   +  +          ++  T      H     
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 251 IALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310
           IA+  A G+EYL +      +H D+   NIL+      K+SD GL++     + +     
Sbjct: 129 IAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           +   I ++ PE I   +G  S  SD++ FG+VL E+
Sbjct: 186 SLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 36/91 (39%), Positives = 54/91 (59%), Gaps = 5/91 (5%)

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           A+G+E+L      CI H D+   NILL  N + K+ DFGLA+   K+ D+V   D R  +
Sbjct: 189 AKGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            ++APE I     T+  +SDV+ FG++L E+
Sbjct: 246 KWMAPETIFDRVYTI--QSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 41/209 (19%)

Query: 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFI-NELLGL--CSE------ 213
               ++G G +G VYK + + TG L+A+K+++       E I  E+  L  C        
Sbjct: 6   ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 214 --GFKRA----LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHEIAL---GTARGIEYLH 263
              + R     +V EY   GSL   I+       T G L +  +IA     T +G+ YLH
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQ-DIYQ-----VTRGPLSEL-QIAYVCRETLKGLAYLH 118

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLA 319
                  +H DIK  NILL  +   K++DFG++        K   F+      GT  ++A
Sbjct: 119 E---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYWMA 169

Query: 320 PELISRNF-GTVSCKSDVYGFGMVLLEMA 347
           PE+ +    G    K D++  G+  +E+A
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELA 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 30/204 (14%)

Query: 169 LGQGGFGSVYKG--QLHTGR--LIAVKMMENS-------KFSAE-----EF----INELL 208
           LG G FG + +G  +L + R   +A+  +           F AE     +F    I  L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+ + G    +V EYM NG+LD   F ++++GQ    +    +  G A G++YL    ++
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAGQL-MGMLPGLASGMKYL---SEM 126

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
             +H  +  H +L++ + + K+S F   +    E  + ++S  +  + + APE I   + 
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSG-KSPVLWAAPEAI--QYH 183

Query: 329 TVSCKSDVYGFGMVLLE-MAGGRR 351
             S  SDV+ FG+V+ E M+ G R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 40/204 (19%)

Query: 168 KLGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI-NELLGLCSE------------ 213
           K+G+G  G V    + HTG+ +AVK M+  K    E + NE++ +               
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 214 --GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V E++  G+L D    ++ N+      E+   + L   R + YLHN     +
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIATVCLSVLRALSYLHNQG---V 139

Query: 271 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISR- 325
           +H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR 
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV------GTPYWMAPEVISRL 193

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +GT   + D++  G++++EM  G
Sbjct: 194 PYGT---EVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 29/199 (14%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKM--MENSKFSAEEFINEL--LGLCSEGFKRALVYE 222
           K+G+G FG V+KG    T +++A+K+  +E ++   E+   E+  L  C   +       
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 223 YMPNGSLDRHIFSKENKGQTFGLEKP---HEIALGTA-----RGIEYLHNGCDVCILHFD 274
           Y+ +  L   I      G    L +P    E  + T      +G++YLH+   +   H D
Sbjct: 71  YLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI---HRD 126

Query: 275 IKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           IK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+I ++    
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIKQS--AY 178

Query: 331 SCKSDVYGFGMVLLEMAGG 349
             K+D++  G+  +E+A G
Sbjct: 179 DSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 59.0 bits (142), Expect = 1e-09
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 32/200 (16%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NELLGLCSE------------ 213
           K+GQG  G+VY    + TG+ +A++ M   +   +E I NE+L +               
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 214 --GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V EY+  GSL D    +  ++GQ   + +         + +E+LH+     +
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE------CLQALEFLHSNQ---V 137

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R    
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK--A 192

Query: 330 VSCKSDVYGFGMVLLEMAGG 349
              K D++  G++ +EM  G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 31/203 (15%)

Query: 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNIL 281
           EY   G+L   I     KGQ F  E            + Y+H      ILH DIK  NI 
Sbjct: 79  EYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIF 133

Query: 282 LDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPEL---ISRNFGTVSCKSDVY 337
           L    + K+ DFG++K         S+++T  GT  Y++PEL   +  NF     KSD++
Sbjct: 134 LTKAGLIKLGDFGISK---ILGSEYSMAETVVGTPYYMSPELCQGVKYNF-----KSDIW 185

Query: 338 GFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCM 397
             G VL E+        +   R+  A  P  +  ++ +G      N T + S+ + +L  
Sbjct: 186 ALGCVLYEL--------LTLKRTFDATNPLNLVVKIVQG------NYTPVVSVYSSELIS 231

Query: 398 IGLWCIQVKAADRPSMTKVLEML 420
           +    +Q     RP+  +VL+  
Sbjct: 232 LVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 53/187 (28%), Positives = 81/187 (43%), Gaps = 31/187 (16%)

Query: 236 KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295
           KE KG+     +  E  +  A  ++YLH   +  ILH D+K  N+ L    I KV D G+
Sbjct: 92  KEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGI 148

Query: 296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN- 354
           A+    + D  S     GT  Y++PEL S      + KSDV+  G  + EMA  +   N 
Sbjct: 149 ARVLENQCDMAST--LIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNA 204

Query: 355 --MNAT--RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR 410
             MN+   R  +   P    D   + G+L       I +M+++            +   R
Sbjct: 205 KDMNSLVYRIIEGKLPPMPKDYSPELGEL-------IATMLSK------------RPEKR 245

Query: 411 PSMTKVL 417
           PS+  +L
Sbjct: 246 PSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 59/283 (20%)

Query: 169 LGQGGFGSVYKGQLHTGRL---IAVKMMEN--SKFSAEEFINELLGLCSEGF-------- 215
           +G+G FG V K ++    L    A+K M+   SK    +F  EL  LC  G         
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 216 ----KRALVY---EYMPNGSLDRHI-----------FSKEN-KGQTFGLEKPHEIALGTA 256
                R  +Y   EY P+G+L   +           F+  N    T   ++    A   A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++YL        +H D+   NIL+  N++ K++DFGL++    +  +V  +  R  + 
Sbjct: 123 RGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLN 374
           ++A E  S N+   +  SDV+ +G++L E+   GG     M             +Y++L 
Sbjct: 177 WMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LYEKLP 225

Query: 375 KGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 416
           +G  LE   N  +    + R+       C + K  +RPS  ++
Sbjct: 226 QGYRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 44/216 (20%)

Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMEN-----------SKFSAEEFINE--- 206
           LG+G FG V         K + +    +AVKM+++           S+    + I +   
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEK---PHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   ++ 
Sbjct: 140 AYQVARGMEYL--ASQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 197 RLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 47/215 (21%)

Query: 168 KLGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE----------- 206
           +LGQG FG VY        KG+  T   +AVK +  S    E  EF+NE           
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAET--RVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPH-----EIALGTAR 257
              LLG+ S+G    +V E M +G L  ++ S +       G   P      ++A   A 
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG- 316
           G+ YL+    V   H D+   N ++ H+F  K+ DFG+ +    E D+      +G  G 
Sbjct: 131 GMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYR----KGGKGL 182

Query: 317 ----YLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
               ++APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 183 LPVRWMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 61/247 (24%), Positives = 94/247 (38%), Gaps = 70/247 (28%)

Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE--------------------FINE 206
            LG+G  G V+  +L  TG+L A+K+++  K    +                    F+  
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLD--KKEMIKRNKVKRVLTEQEILATLDHPFLPT 65

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR----GIEYL 262
           L           LV +Y P G L      +   G+        E+A   A      +EYL
Sbjct: 66  LYASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCL----SEEVARFYAAEVLLALEYL 119

Query: 263 H-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---------------------FHP 300
           H  G    I++ D+KP NILL  +    +SDF L+K                      + 
Sbjct: 120 HLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 301 KENDFVS-ISDTR-----GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---R 351
             ++  S     R     GT  Y+APE+IS +    +   D +  G++L EM  G    +
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYGTTPFK 233

Query: 352 NSNMNAT 358
            SN + T
Sbjct: 234 GSNRDET 240

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 32/200 (16%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NELLGLCSE------------ 213
           K+GQG  G+VY    + TG+ +A+K M   +   +E I NE+L +               
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 214 --GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V EY+  GSL D    +  ++GQ   + +         + +++LH+     +
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE------CLQALDFLHSNQ---V 136

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R    
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK--A 191

Query: 330 VSCKSDVYGFGMVLLEMAGG 349
              K D++  G++ +EM  G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 7/92 (7%)

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           ARG+E+L      CI H D+   NILL  N + K+ DFGLA+   K+ D+V     R  +
Sbjct: 184 ARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 316 GYLAPELISRNFGTV-SCKSDVYGFGMVLLEM 346
            ++APE I   F  V + +SDV+ FG++L E+
Sbjct: 241 KWMAPESI---FDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 44/216 (20%)

Query: 169 LGQGGFGSVYKGQLH--------TGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V + + +            +AVKM++++    +  + I+E            
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQ--TFGLEKPHE----------I 251
              LLG+C++     ++ EY   G+L   + ++   G   TF + K  E           
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL +    CI H D+   N+L+  + + K++DFGLA+     + +   S+ 
Sbjct: 140 AYQVARGMEYLES--RRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 197 RLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 37/210 (17%)

Query: 168 KLGQGGFGSVYKGQLHT------GRLIAVKMMENSKFSAE---------------EFINE 206
           +LG+G FG V+  + +         L+AVK ++++  +A                E I +
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRH---------IFSKENKGQTFGLEKPHEIALGTAR 257
             G+C EG    +V+EYM +G L++          + ++ N+       +   IA   A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
           G+ YL +      +H D+   N L+  N + K+ DFG+++     + +     T   I +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 318 LAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           + PE ++ R F T   +SDV+  G+VL E+
Sbjct: 189 MPPESIMYRKFTT---ESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 38/210 (18%)

Query: 169 LGQGGFGSVYKGQLH----TGRLIAVKMMENSKFSA---EEFINELLGLCSEGFKRALVY 221
           LG+G FGSV + QL     + + +AVKM++   FS+   EEF+ E    C + F    V 
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLRE--AACMKEFDHPNVI 64

Query: 222 EYM-------PNGSLDRHI----FSKENKGQTFGL-----EKPHEIALGT--------AR 257
           + +         G L   +    F K     TF L     E+P  + L T        A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
           G+EYL +      +H D+   N +L+ N    V+DFGL+K     + +     ++  + +
Sbjct: 125 GMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           LA E ++ N  T    SDV+ FG+ + E+ 
Sbjct: 182 LALESLADNVYTT--HSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 57.2 bits (139), Expect = 3e-09
 Identities = 64/217 (29%), Positives = 87/217 (40%), Gaps = 63/217 (29%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFI---NELLGLCSEGF------ 215
           LG GGFG V   ++    R  A+K ++         +E I    E+L  C+  F      
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 216 ---KRALVY---EYMPNGSL-----DRHIFSKENKGQTFGLEKPHEIALGTAR------- 257
               +  +Y   EY   G L     DR +F +                  TAR       
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEY-----------------TARFYIACVV 103

Query: 258 -GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISDTRG 313
              EYLHN     I++ D+KP N+LLD N   K+ DFG AK      K   F       G
Sbjct: 104 LAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------G 154

Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           T  Y+APE+I  N G      D +  G++L E+  GR
Sbjct: 155 TPEYVAPEIIL-NKGY-DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)

Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   ++ 
Sbjct: 143 TYQVARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 200 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 50/213 (23%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSK------FSAEEFINELLGLCSEGFKRALVY 221
           LG+GGFG V   Q+  TG+L A K +   +      +        +L      F  +L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 222 EY------------MPNGSLDRHIFS--KENKGQTFGLEKPHEIALGTAR---GIEYLHN 264
            +            M  G L  HI++  +EN G      +P      TA+   G+E+LH 
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG----FPEPRAC-FYTAQIISGLEHLHQ 115

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-------GTIGY 317
                I++ D+KP N+LLD++   ++SD GLA         V + D +       GT G+
Sbjct: 116 RR---IIYRDLKPENVLLDNDGNVRISDLGLA---------VELKDGQSKTKGYAGTPGF 163

Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           +APEL+       S   D +  G+ L EM   R
Sbjct: 164 MAPELLQGEEYDFSV--DYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 42/207 (20%)

Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TG+  A+K+++     A++ +      + +L      F  AL Y
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 222 ------------EYMPNGSLDRH-----IFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
                       EY   G L  H     +FS E++ + +G E            + YLH+
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFS-EDRARFYGAE--------IVSALGYLHS 113

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
            CD  +++ D+K  N++LD +   K++DFGL K    +    ++    GT  YLAPE++ 
Sbjct: 114 -CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLE 168

Query: 325 RN-FGTVSCKSDVYGFGMVLLEMAGGR 350
            N +G      D +G G+V+ EM  GR
Sbjct: 169 DNDYGRA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)

Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA-----EEF--------------INEL 207
            ++G G FG V   +++T   +A  +++  K +A      EF              I + 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENK---GQTFGLEKPHEIALGTARGIEYLHN 264
           LG C E     LV+EY   G L  ++  ++      Q   L++   +A   A G+ ++H 
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHK 117

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI- 323
                 LH D+   N  L  +   KV D+G+     KE+   +  D    + +LAPEL+ 
Sbjct: 118 ---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174

Query: 324 SRNFGTVSCK----SDVYGFGMVLLEM 346
             + G ++ +    S+V+  G+ L E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 78/295 (26%), Positives = 125/295 (42%), Gaps = 83/295 (28%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMM---ENSKFSAEEFINEL----------------- 207
           LG G F S Y+ + + TG L+AVK +    N+    EE +  L                 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 208 -LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA------RGIE 260
            LG   E     L  E+M  GS+  H+ SK      +G     + A+         RG+ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVS-HLLSK------YG---AFKEAVIINYTEQLLRGLS 117

Query: 261 YLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDT-----RGT 314
           YLH   +  I+H D+K  N+L+D      +++DFG A    +     + +        GT
Sbjct: 118 YLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA---RLAAKGTGAGEFQGQLLGT 171

Query: 315 IGYLAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGR------RNSNMNAT--RSSKAYF 365
           I ++APE++    +G  SC  DV+  G V++EMA  +      ++SN  A   + + A  
Sbjct: 172 IAFMAPEVLRGEQYGR-SC--DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228

Query: 366 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420
              + + L+ G    LR+VT              L C++++  DRP      E+L
Sbjct: 229 APSIPEHLSPG----LRDVT--------------LRCLELQPEDRP---PSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 43/207 (20%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMM---ENSKFSAEEFINEL--LGLCSE----GFKRA 218
           +LG G  G V K Q     LI  + +   E       + I EL  L  C+     GF  A
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 219 --------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI----ALGTARGIEYLHNGC 266
                   +  E+M  GSLD+ +  KE K        P EI    ++   RG+ YL    
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVL--KEAK------RIPEEILGKVSIAVLRGLAYLREKH 123

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELIS 324
              I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE + 
Sbjct: 124 Q--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ 175

Query: 325 RNFGT-VSCKSDVYGFGMVLLEMAGGR 350
              GT  S +SD++  G+ L+E+A GR
Sbjct: 176 ---GTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 41/207 (19%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM------ENSKFSA----------EEF----INE 206
           ++G G +G+VYK +  H+G  +A+K +      +    S           E F    I  
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 207 LLGLCS-----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGL--EKPHEIALGTARGI 259
           L+ +C+        K  LV+E+     +D+ + +  +K    GL  E   ++     RG+
Sbjct: 67  LMDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y A
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRA 175

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEM 346
           PE++ ++  T +   D++  G +  EM
Sbjct: 176 PEVLLQS--TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 51/275 (18%)

Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMM-ENSKFSAEE---------------FINEL 207
           LG G FG+VYKG  +  G  +    A+K++ EN+   A +               ++  L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           LG+C     + LV + MP G L  ++  +ENK +  G +      +  A+G+ YL    +
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYV--RENKDR-IGSQDLLNWCVQIAKGMSYLE---E 127

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE-LISRN 326
           V ++H D+   N+L+      K++DFGLA+    +         +  I ++A E ++ R 
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--FPSW-VYDQLNKGGDLELRN 383
           F   + +SDV+ +G+ + E+           T  +K Y   P+  + D L KG  L    
Sbjct: 188 F---THQSDVWSYGVTVWEL----------MTFGAKPYDGIPAREIPDLLEKGERLPQPP 234

Query: 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
           +  I+      + MI + C  + +  RP   ++++
Sbjct: 235 ICTID------VYMIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 31/202 (15%)

Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K+++     A++ +      N +L      F  AL Y
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 222 ------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                       EY   G L  H+    ++ + F  ++           ++YLH+  +V 
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 117

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FG 328
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  YLAPE++  N +G
Sbjct: 118 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG 174

Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
                 D +G G+V+ EM  GR
Sbjct: 175 RA---VDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 56.8 bits (138), Expect = 8e-09
 Identities = 40/131 (30%), Positives = 60/131 (45%), Gaps = 38/131 (29%)

Query: 257 RGIEYLH--NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISD--- 310
           RG++YLH  N     ++H D+KP NIL++ N   K+ DFGLA+   P E++   +++   
Sbjct: 114 RGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168

Query: 311 TRGTIGYLAPELISRNFGTVSCKS-----DVYGFGMVLLEMAGGRRNSNMNATRSSKAYF 365
           TR    Y APEL+      +S        D++  G +  E+               K  F
Sbjct: 169 TR---WYRAPELL------LSSSRYTKAIDIWSVGCIFAELLTR------------KPLF 207

Query: 366 P-SWVYDQLNK 375
           P     DQLN 
Sbjct: 208 PGRDYIDQLNL 218

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 9/96 (9%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++YLH+     ILH DIKP N+L++ N + K+ DFGLA+   + ++   ++    T  
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQY 169

Query: 317 YLAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE++  SR++ +     D++  G +  E+ G R
Sbjct: 170 YRAPEILMGSRHYTS---AVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 71/296 (23%), Positives = 112/296 (37%), Gaps = 76/296 (25%)

Query: 169 LGQGGFGSVYKGQLHTGRLIAVKM--------------------MEN---SKFSAEEFIN 205
           LG G FG VY+G        AV++                    ME    SKF+ +  I 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQN-IV 72

Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            L+G+  E   R ++ E M  G L    F +EN+ +    E+P  + +      + L   
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRP---ERPSSLTM-----KDLLFCA 122

Query: 266 CDV---C-------ILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTR 312
            DV   C        +H DI   N LL       + K++DFG+A+   + + +       
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMNATRSSKAYF 365
             I ++ PE      G  + K+DV+ FG++L E+         GR N             
Sbjct: 183 LPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----------- 229

Query: 366 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
              V + +  GG L+          + R    I   C Q    DRP+   +LE ++
Sbjct: 230 ---VMEFVTGGGRLD--PPKGCPGPVYR----IMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 56.0 bits (135), Expect = 9e-09
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 42/212 (19%)

Query: 169 LGQGGFGSVYKGQL------HTGRL-IAVKMM-------ENSKFSAE---------EFIN 205
           LG G FG VY+G         +G + +AVK +       E  +F  E           I 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFG-----LEKPHEIALGTARGIE 260
           +LLG+C     + ++ E M  G L  ++  ++ + + FG     L++  +I L  A+G  
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 261 YLHNGCDVCILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           YL     +  +H D+   N L+     D + + K+ DFGLA+   K + +    +    +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 316 GYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
            ++APE L+   F T   +SDV+ FG+++ E+
Sbjct: 178 RWMAPESLLDGKFTT---QSDVWSFGVLMWEI 206

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 40/209 (19%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKM--MENSK----FSAEEFINELLGLCSEGFKRA- 218
           +++G+G +G VY+ +   +G ++A+K   M+N +     S+   I  LL L         
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 219 ------------LVYEYMPN--GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
                       LV EY      SL       +N    F   +   + L   RG++YLH 
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQDLASL------LDNMPTPFSESQVKCLMLQLLRGLQYLH- 125

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI 323
             +  I+H D+K  N+LL      K++DFGLA+ +         ++    T+ Y APEL+
Sbjct: 126 --ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTPKVVTLWYRAPELL 180

Query: 324 SRNFG-TVSCKS-DVYGFGMVLLEMAGGR 350
               G T    + D++  G +L E+   +
Sbjct: 181 ---LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 35/205 (17%)

Query: 169 LGQGGFGSVY------KGQLHTGRLIAV-KMMENSKFSAEEFINELLGLCS--------E 213
           +G+G FG V+        +L   + I V +M ++ + +A+     +L L S        E
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQ-VLKLLSHPNIIEYYE 66

Query: 214 GF--KRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            F   +AL  V EY P G+L  +I  + N      L     I     + +  LH+     
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNS-----LLDEDTILHFFVQILLALHHVHTKL 121

Query: 270 ILHFDIKPHNILLD-HNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           ILH D+K  NILLD H  + K+ DFG++K    K   +  +    GT  Y++PEL   + 
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV----GTPCYISPELCEGKP 177

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRR 351
           +     KSD++  G VL E+A  +R
Sbjct: 178 YNQ---KSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 63/231 (27%), Positives = 91/231 (39%), Gaps = 67/231 (29%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVK-----MMEN----SKFSAEEFINELL--------- 208
            +G+GG G VY        R +A+K     + EN     +F  E  I   L         
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 209 GLCSEGFKRALVYEYMP--NG----SLDRHIFSKENKGQTFGLEKPHEI--ALGT----- 255
            +CS+G     VY  MP   G    SL + ++ KE+      L K      ++G      
Sbjct: 69  SICSDG---DPVYYTMPYIEGYTLKSLLKSVWQKES------LSKELAEKTSVGAFLSIF 119

Query: 256 ---ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312
                 IEY+H+     +LH D+KP NILL       + D+G A F   E + +   D  
Sbjct: 120 HKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 313 ----------------GTIGYLAPELISRNFGT-VSCKSDVYGFGMVLLEM 346
                           GT  Y+APE   R  G   S  +D+Y  G++L +M
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 48/210 (22%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE---FI----------------NEL 207
           K+G+G +G V+K +   TG+++A+K     KF   E    I                  L
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 208 LGLCSEGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           + L  E F+R     LV+EY  +  L  +   K  +G    L K  +I   T + + + H
Sbjct: 63  VNLI-EVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIK--KIIWQTLQAVNFCH 117

Query: 264 -NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISDTRGTIGYLAPE 321
            + C    +H D+KP NIL+      K+ DFG A+      +D+     TR    Y APE
Sbjct: 118 KHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---WYRAPE 170

Query: 322 LI--SRNFGTVSCKSDVYGFGMVLLEMAGG 349
           L+     +G      DV+  G V  E+  G
Sbjct: 171 LLVGDTQYGP---PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 5/95 (5%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H   +V  LH D+KP N+LL+ N   K+ DFGLA+    E+D    +++   T 
Sbjct: 117 RGLKYIH-SANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE I  N    +   D++  G +L EM   R
Sbjct: 174 WYRAPE-IMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)

Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMEN--SKFSAEEFINE------------ 206
           LG+G FG V         K + +    +AVKM+++  ++    + I+E            
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------------EI 251
              LLG C++     ++ EY   G+L  ++ ++   G  +                    
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   ++ 
Sbjct: 146 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 203 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 42/210 (20%)

Query: 169 LGQGGFGSVY----KGQLHTGRLIAVKMMENSKF----------SAEEFINELLGLC--- 211
           LG G +G V+     G    G+L A+K+++ +              E  + E +  C   
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 212 -------SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARGIE 260
                      K  L+ +Y+  G L  H++ +E+    F   +      EI L     ++
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH----FTESEVRVYIAEIVLA----LD 119

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLA 319
           +LH    + I++ DIK  NILLD      ++DFGL+K F  +E +        GTI Y+A
Sbjct: 120 HLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE--RAYSFCGTIEYMA 174

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           PE+I    G      D +  G++  E+  G
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 28/204 (13%)

Query: 168 KLGQGGFGSVYKGQLHTG---RLIAVKMMENSKFSAEE--FINEL--------------L 208
           ++G G FG V  G++++G     + VK +  S    E+  F+ E               L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           G C+E     LV E+ P G L  ++ S ++ +  T        +A   A G+ +LH    
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
              +H D+   N LL  +   K+ D+GL+    KE+ +V+       + ++APEL+    
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 328 GTV-----SCKSDVYGFGMVLLEM 346
           G +     + +S+V+  G+ + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 52/226 (23%), Positives = 87/226 (38%), Gaps = 67/226 (29%)

Query: 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMM-------ENSK------------------ 197
               ++G G  G VYK +   TG ++AVK M       EN +                  
Sbjct: 18  ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77

Query: 198 -------FSAEEFI-NELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH 249
                    ++ FI  EL+  C +   +  +   +P       I  K             
Sbjct: 78  KCYGYFITDSDVFICMELMSTCLDKLLK-RIQGPIP-----EDILGK------------- 118

Query: 250 EIALGTARGIEYL---HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306
            + +   + + YL   H      ++H D+KP NILLD +   K+ DFG++       D  
Sbjct: 119 -MTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSK 169

Query: 307 SISDTRGTIGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGR 350
           + + + G   Y+APE I           ++DV+  G+ L+E+A G+
Sbjct: 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 62/203 (30%), Positives = 90/203 (44%), Gaps = 35/203 (17%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMM-------ENSK-FSAEEFINELL-GLCSE----- 213
           LGQG FG VY      TGR +AVK +       E SK  +A E   +LL  L  E     
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 214 -GFKR-------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            G  R       ++  E+MP GS+   + S     +    +   +I      G+ YLH+ 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHSN 125

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELIS 324
               I+H DIK  NIL D     K+ DFG +K           +    GT  +++PE+IS
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 325 -RNFGTVSCKSDVYGFGMVLLEM 346
              +G    K+D++  G  ++EM
Sbjct: 183 GEGYGR---KADIWSVGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 43/230 (18%)

Query: 142 KYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFSA 200
           ++R  +Q V +   P      ++F  K+G+G  G V    + + G+L+AVK M+  K   
Sbjct: 4   QFRAALQMVVDPGDPR--TYLDNFI-KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR 60

Query: 201 EEFI-NELLGL-------CSEGFKRALV-------YEYMPNGSL-DRHIFSKENKGQTFG 244
            E + NE++ +         E +   LV        E++  G+L D    ++ N+     
Sbjct: 61  RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----- 115

Query: 245 LEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHP 300
            E+   + L   + +  LH      ++H DIK  +ILL H+   K+SDFG    ++K  P
Sbjct: 116 -EQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171

Query: 301 KENDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGG 349
           +    V      GT  ++APELISR  +G    + D++  G++++EM  G
Sbjct: 172 RRKSLV------GTPYWMAPELISRLPYGP---EVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 37/205 (18%)

Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVK-------------------MMENSKFSAEEFINEL 207
           KLG+G + +V+KG+   T  L+A+K                   +++N K +    I  L
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN---IVTL 68

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
             +        LV+EY+ +  L +++   +N G    +           RG+ Y H    
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHKRK- 123

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             ILH D+KP N+L++     K++DFGLA+   K     + S+   T+ Y  P+++    
Sbjct: 124 --ILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVL---L 176

Query: 328 GTV--SCKSDVYGFGMVLLEMAGGR 350
           G+   S   D++G G +L EMA GR
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 59/233 (25%)

Query: 165 FTHKLGQGGFGSV---------------YKGQLHTGR--LIAVKMM--ENSKFSAEEFIN 205
           F  KLG+G FG V               +   +  GR  L+AVK++  + +K +  +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 206 E--------------LLGLCSEGFKRALVYEYMPNGSLD-----RHIFSKENKGQTFGLE 246
           E              LLG+C +     ++ EYM NG L+      H+  KE  G    + 
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND-AVP 127

Query: 247 KPH-----------EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295
             H            +AL  A G++YL +   +  +H D+   N L+  N   K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184

Query: 296 AKFHPKENDFVSISDTRGT--IGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           ++ +    D+  I   R    I ++A E I    G  +  SDV+ FG+ L E+
Sbjct: 185 SR-NLYAGDYYRIQG-RAVLPIRWMAWECIL--MGKFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 49/210 (23%)

Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM-----ENSKFSAEEFINELLGLCSEGF------ 215
           KLG+G + +VYKG+    G+L+A+K++     E + F+A    + L GL           
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 216 -----KRALVYEYMPNG---SLDRHIFSKENKGQTFGLEKPHEIAL---GTARGIEYLHN 264
                   LV+EY+       +D+H           G   P  + L      RG+ Y+H 
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHP----------GGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----HPKENDFVSISDTRGTIGYLA 319
                ILH D+KP N+L+      K++DFGLA+      H   N+ V       T+ Y  
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-------TLWYRP 171

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           P+++  +    +C  D++G G + +EM  G
Sbjct: 172 PDVLLGSTEYSTC-LDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 43/226 (19%)

Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFSA--EEFINE-- 206
           EI   T  F  +LG+  FG VYKG L         + +A+K +++       EEF +E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 207 ------------LLGLCSEGFKRALVYEYMPNGSLDRHIF----------SKENKGQTFG 244
                       LLG+ ++    ++++ Y  +  L   +           + ++K     
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 245 LEKPH--EIALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           LE      I    A G+E+L  H+       H D+   N+L+      K+SD GL +   
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             + +  + ++   I +++PE I   +G  S  SD++ +G+VL E+
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           ARG+E+L      C+ H D+   N+LL    I K+ DFGLA+    ++++VS   T   +
Sbjct: 247 ARGMEFL--ASKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            ++APE I  N  T    SDV+ +G++L E+
Sbjct: 304 KWMAPESIFDNLYTT--LSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 22/138 (15%)

Query: 218 ALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           ++  E+M  GSLD+ +  K  +   Q  G     ++++   +G+ YL       I+H D+
Sbjct: 79  SICMEHMDGGSLDQ-VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDV 130

Query: 276 KPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGT-VSC 332
           KP NIL++     K+ DFG++        N FV      GT  Y++PE +    GT  S 
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ---GTHYSV 181

Query: 333 KSDVYGFGMVLLEMAGGR 350
           +SD++  G+ L+EMA GR
Sbjct: 182 QSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 59/191 (30%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE-----------------------FI 204
           +G+G +G+VYK + L+TGR +A+K +   +    E                        I
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 205 NELLGLC-----SEGFKRALVYEYMP---NGSLDRHIFSKENKGQTFGLEKP------HE 250
             LL +C         K  LV+E++       L +            GL          +
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKP--------GLPPETIKDLMRQ 115

Query: 251 IALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310
           +     RG+++LH+     I+H D+KP NIL+  +   K++DFGLA+ +  E    S+  
Sbjct: 116 LL----RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV- 167

Query: 311 TRGTIGYLAPE 321
              T+ Y APE
Sbjct: 168 --VTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 59/236 (25%), Positives = 92/236 (38%), Gaps = 79/236 (33%)

Query: 169 LGQGGFGSVYKGQL----HTGRLIAVKMM---------ENSKFSAE---------EFINE 206
           +G+G FG V    L     TG++ A+K++         + +   AE          +I +
Sbjct: 9   IGRGAFGEV---WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65

Query: 207 LLGLCSEGFKRAL--VYEYMPNGSL-----DRHIFSKENKGQTFGLEKPHEIALGTARGI 259
           L    S   +  L  V EYMP G L      + +F  E   + +  E    + L     +
Sbjct: 66  LY--YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF-PEETARFYIAE----LVLA----L 114

Query: 260 EYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK--------------------- 297
           + +H  G     +H DIKP NIL+D +   K++DFGL K                     
Sbjct: 115 DSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 298 ------FHPKENDFVSISDTRGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
                     +   V  + T GT  Y+APE L    +G    + D +  G++L EM
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG---LECDWWSLGVILYEM 223

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 41/214 (19%)

Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMM------ENSKFSAEEFINELLGL-------CSEG 214
           LG G  G+V    ++  G   AVK++      E  K  A+  +  LL         C E 
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 215 FKR------------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           F +            ALV +Y   G L + I S+    +TF   + HE  L   + +  +
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF---REHEAGLLFIQVLLAV 156

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-----GTIGY 317
           H+     ++H DIK  NILL  N + K+ DFG +K +       ++SD       GT  Y
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA-----TVSDDVGRTFCGTPYY 211

Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
           +APE+  R     S K+D++  G++L E+   +R
Sbjct: 212 VAPEIWRRK--PYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 66/236 (27%), Positives = 100/236 (42%), Gaps = 54/236 (22%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVK----------------MMENSKFS---AEEFINELL 208
           LG+G FG V+  +L  T +  A+K                M+E    S      F+  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 209 GLCSEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
             C+   K  L  V EY+  G L  HI S       F L +    A     G+++LH+  
Sbjct: 63  --CTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-----GTIGYLAPE 321
              I++ D+K  NILLD +   K++DFG+     KEN    + D +     GT  Y+APE
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMC----KEN---MLGDAKTCTFCGTPDYIAPE 166

Query: 322 -LISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSWV 369
            L+ + + T     D + FG++L EM  G+             + R     +P W+
Sbjct: 167 ILLGQKYNT---SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 38/203 (18%)

Query: 168 KLGQGGFGSVYKG--QLHTGRLI--AVKMMEN-------SKFSAEEF---------INEL 207
            +G+G FG VY+G         I  AVK  +N        KF  E +         I +L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI----ALGTARGIEYLH 263
           +G+ +E     +V E  P G L R  + + NK                +   +  + YL 
Sbjct: 73  IGVITEN-PVWIVMELAPLGEL-RS-YLQVNKYSL-----DLASLILYSYQLSTALAYLE 124

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
           +   V   H DI   N+L+      K+ DFGL+++  ++  +   S  +  I ++APE I
Sbjct: 125 SKRFV---HRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESI 180

Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             NF   +  SDV+ FG+ + E+
Sbjct: 181 --NFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 54.5 bits (131), Expect = 8e-08
 Identities = 45/198 (22%), Positives = 86/198 (43%), Gaps = 28/198 (14%)

Query: 169 LGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE-----------LLGLCSEGFK 216
           + +G  G+ YKG+     +   VK + +        I +           L+GLC     
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKG 757

Query: 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
             L++EY+   +L   +       +    E+  +IA+G A+ + +LH  C   ++  ++ 
Sbjct: 758 AYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810

Query: 277 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDV 336
           P  I++D    P +    L      +      S       Y+APE  +R    ++ KSD+
Sbjct: 811 PEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPE--TRETKDITEKSDI 861

Query: 337 YGFGMVLLEMAGGRRNSN 354
           YGFG++L+E+  G+  ++
Sbjct: 862 YGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 38/213 (17%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPN 226
           ++G G FG+VY  + +    ++A+K M  S   + E   +++      F + L +   PN
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR--FLQKLRH---PN 76

Query: 227 GSLDRHIFSKENK---------GQTFGLEKPHE----------IALGTARGIEYLHNGCD 267
               R  + +E+          G    L + H+          +  G  +G+ YLH+   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN- 135

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
             ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + +
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMD 187

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNA 357
            G    K DV+  G+  +E+   R+    NMNA
Sbjct: 188 EGQYDGKVDVWSLGITCIEL-AERKPPLFNMNA 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 37/205 (18%)

Query: 168 KLGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGF------ 215
           KLG+G + +VYKG      QL   ++I++K  E   F+A    + L GL           
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 216 ---KRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL---GTARGIEYLHNGCD 267
              K  L  V+EYM       H    +   Q  G   P+ + L      RG+ Y+H    
Sbjct: 72  IHTKETLTFVFEYM-------HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             ILH D+KP N+L+ +    K++DFGLA+   K     + S    T+ Y  P+++    
Sbjct: 124 --ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVL---L 176

Query: 328 GTV--SCKSDVYGFGMVLLEMAGGR 350
           G    S   D++G G + +EM  G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 58/213 (27%), Positives = 87/213 (40%), Gaps = 60/213 (28%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFI---NELLGLCSEGFKRAL----- 219
           LG+G FG V   +   TG L A+K ++      +  I   +E+  L  E  KR       
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALK------KGDIIARDEVESLMCE--KRIFETANS 58

Query: 220 ---------------------VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARG 258
                                V EY   G L  HI +       F   +    A     G
Sbjct: 59  ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLG 113

Query: 259 IEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISDTRG 313
           ++YLH N     I++ D+K  N+LLD     K++DFGL K    F  + + F       G
Sbjct: 114 LQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC------G 163

Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           T  +LAPE+++    T +   D +G G+++ EM
Sbjct: 164 TPEFLAPEVLTETSYTRAV--DWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 35/203 (17%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAE--------------------EFINEL 207
           LGQG FG VY    + TGR +A K ++    S E                    E I + 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 208 LGLCSEGFKRALV--YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            G   +  ++ L    EYMP GS+   + +     ++   +   +I      G+ YLH+ 
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLHSN 125

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELIS 324
               I+H DIK  NIL D     K+ DFG +K           I    GT  +++PE+IS
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 325 -RNFGTVSCKSDVYGFGMVLLEM 346
              +G    K+DV+  G  ++EM
Sbjct: 183 GEGYGR---KADVWSLGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 37/91 (40%), Positives = 50/91 (54%), Gaps = 12/91 (13%)

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           EYLH+  D  I++ D+KP N+LLD+    KV+DFG AK  P +  F       GT  YLA
Sbjct: 132 EYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTFTLC----GTPEYLA 183

Query: 320 PELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 349
           PE+I S+  G      D +  G++L E   G
Sbjct: 184 PEVIQSKGHGKA---VDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 16/152 (10%)

Query: 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR---GIEYLHNGCDVCILH 272
           K  L+ +Y+  G L  H+  +E         K  E+ + +      +E+LH    + I++
Sbjct: 79  KLHLILDYINGGELFTHLSQRERF-------KEQEVQIYSGEIVLALEHLHK---LGIIY 128

Query: 273 FDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
            DIK  NILLD N    ++DFGL+K FH  E +        GTI Y+AP+++    G   
Sbjct: 129 RDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHD 186

Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA 363
              D +  G+++ E+  G     ++  ++S+A
Sbjct: 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 32/203 (15%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINELLG--------LCSE-----G 214
           +G+G FG VY+ +   T R+ A+K++   +  A++ +   +G        L  E     G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 215 FKRA--------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
            K +        LV +YM  G L  H+  KE +   F  ++           +E+LH   
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGR---FSEDRAKFYIAELVLALEHLHKYD 116

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
              I++ D+KP NILLD      + DFGL+K +  +N   + +   GT  YLAPE++   
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDE 171

Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
            G      D +  G+++ EM  G
Sbjct: 172 KGYTK-HVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 47/271 (17%)

Query: 169 LGQGGFGSVYKG----QLHTGRL-IAVKMME-------NSKFSAEEFIN---------EL 207
           LG G FG+VYKG    +  T ++ +A+K++        N +F  E  I           L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + LV + MP+G L  ++   K+N G    L    +IA    +G+ YL    
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIA----KGMMYLE--- 126

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           +  ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  +
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--H 184

Query: 327 FGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
           +   + +SDV+ +G+ + E M  G +  +   TR         + D L KG  L    + 
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLPQPPIC 236

Query: 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKV 416
            I+      + M+ + C  + A  RP   ++
Sbjct: 237 TID------VYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 13/133 (9%)

Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
            V EY+  G L  H+ S+E   + F  ++           ++YLH+G    I++ D+K  
Sbjct: 72  FVMEYVNGGELFFHL-SRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLE 124

Query: 279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FGTVSCKSDVY 337
           N++LD +   K++DFGL K      D  ++    GT  YLAPE++  N +G      D +
Sbjct: 125 NLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRA---VDWW 179

Query: 338 GFGMVLLEMAGGR 350
           G G+V+ EM  GR
Sbjct: 180 GLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 49/224 (21%)

Query: 165 FTHKLGQGGFGSVY----KGQLHTGR-------------LIAVKMM--ENSKFSAEEFIN 205
           F  KLG+G FG V+    +G                   L+AVKM+  + +K +  +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 206 E--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH-- 249
           E              LL +C       ++ EYM NG L++ +   E +      +     
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 250 -----EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304
                 +A   A G++YL +   +  +H D+   N L+  N+  K++DFG+++ +    D
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSGD 184

Query: 305 FVSISDTRGT--IGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           +  I   R    I +++ E I    G  +  SDV+ FG+ L E+
Sbjct: 185 YYRIQG-RAVLPIRWMSWESIL--LGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 63/214 (29%), Positives = 89/214 (41%), Gaps = 55/214 (25%)

Query: 169 LGQGGFGSV----YKGQLHTGRLIAVK----------------MMENSKFSAEEFINELL 208
           LG+G FG V     KG   T  L AVK                M E    +       L 
Sbjct: 3   LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 209 GL--CSEGFKRA-LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPH------EIALGTARG 258
            L  C +   R   V EY+  G L  HI       Q  G  ++P       EI LG    
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHI-------QRSGRFDEPRARFYAAEIVLG---- 108

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISDTRGTIG 316
           +++LH   +  I++ D+K  N+LLD     K++DFG+     KE     V+ S   GT  
Sbjct: 109 LQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMC----KEGILGGVTTSTFCGTPD 161

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y+APE++S      +   D +  G++L EM  G+
Sbjct: 162 YIAPEILSYQPYGPAV--DWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 8/90 (8%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G+ YLH      I+H D+K  NI ++      + D G A+F      F+ ++   GT+ 
Sbjct: 168 EGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA---GTVE 221

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             APE+++R+    + K+D++  G+VL EM
Sbjct: 222 TNAPEVLARD--KYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE----------FINELLGLCSEGFK 216
           ++G G FG+VY  + + T  ++A+K M  S   + E          F+  +    S  +K
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE------IALGTARGIEYLHNGCDVCI 270
              + E+     ++  + S  +  +    +KP +      I  G  +G+ YLH+     +
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---M 146

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGT 329
           +H DIK  NILL      K++DFG A      N FV      GT  ++APE+I + + G 
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILAMDEGQ 200

Query: 330 VSCKSDVYGFGMVLLEMAGGRRN-SNMNA 357
              K DV+  G+  +E+A  +    NMNA
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPLFNMNA 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 36/100 (36%), Positives = 50/100 (50%), Gaps = 18/100 (18%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR---- 312
           R I+YLH      I+H DIK  NI ++H     + DFG A F       V I+  +    
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP------VDINANKYYGW 243

Query: 313 -GTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 350
            GTI   APEL++R+ +G      D++  G+VL EMA   
Sbjct: 244 AGTIATNAPELLARDPYGPA---VDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 35/204 (17%)

Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVK--MMENSKFSAEEFINELLGLCSEGFKRA------ 218
           KLG+G + +VYKG+   T  L+A+K   +E+ + +    I E+  L  +  K A      
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLL--KDLKHANIVTLH 70

Query: 219 ----------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
                     LV+EY+ +  L +++   ++ G +  +           RG+ Y H     
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCHRRK-- 124

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI--SRN 326
            +LH D+KP N+L++     K++DFGLA+   K     + S+   T+ Y  P+++  S +
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGR 350
           + T   + D++G G +  EM+ GR
Sbjct: 182 YST---QIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 20/103 (19%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI- 315
           R ++Y+H      + H D+KP NIL + +   K+ DFGLA+        V+ +DT   I 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR--------VAFNDTPTAIF 162

Query: 316 --------GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
                    Y APEL    F   +   D++  G +  E+  G+
Sbjct: 163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 30/201 (14%)

Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K++      A++ +      + +L      F  AL Y
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 222 EYMPNGSLDRHIFSKE--NKGQTF-GLEKPHEIALGTAR--------GIEYLHNGCDVCI 270
            +  +   DR  F  E  N G+ F  L +        AR         +EYLH+     +
Sbjct: 63  AFQTH---DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 116

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FGT 329
           ++ DIK  N++LD +   K++DFGL K     +D  ++    GT  YLAPE++  N +G 
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
                D +G G+V+ EM  GR
Sbjct: 175 A---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 47/218 (21%), Positives = 89/218 (40%), Gaps = 43/218 (19%)

Query: 158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMM--ENSKFSAEEFINE--------- 206
            +   +       +    +          L+AVK++  + S  + E+F+ E         
Sbjct: 22  HLCEADGLQDFSEKAFAENDNADA---PVLVAVKVLRPDASDNAREDFLKEVKILSRLSD 78

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH-------EIALG 254
                LLG+C+      ++ EYM NG L++ +     +                  +A  
Sbjct: 79  PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQ 138

Query: 255 TARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312
            A G+ YL   N      +H D+   N L+  N+  K++DFG+++ +   +D+  +   +
Sbjct: 139 IASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSSDYYRV---Q 189

Query: 313 GT----IGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           G     I ++A E +    G  + KSDV+ FG+ L E+
Sbjct: 190 GRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 48/233 (20%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVK---------------MMENSKFSAEEFINELLG--L 210
           LG+G FG V   +L   G   AVK                M   +  A  + N  L    
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 211 CSEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           C+   K  L  V E++  G L  HI   ++KG+ F L +    A     G+++LH+    
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHI---QDKGR-FDLYRATFYAAEIVCGLQFLHSKG-- 116

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-----GTIGYLAPELI 323
            I++ D+K  N++LD +   K++DFG+     KEN F    D R     GT  Y+APE++
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMC----KENVF---GDNRASTFCGTPDYIAPEIL 168

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSWV 369
                T S   D + FG++L EM  G+        +    + R    ++P W+
Sbjct: 169 QGLKYTFSV--DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 35/204 (17%)

Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVK--MMENSKFSAEEFINELLGLCSEGFKRA------ 218
           KLG+G + +V+KG+   T  L+A+K   +E+ + +    I E+  L  +  K A      
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLL--KDLKHANIVTLH 70

Query: 219 ----------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
                     LV+EY+ +  L +++   ++ G    +           RG+ Y H     
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHRRK-- 124

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI--SRN 326
            +LH D+KP N+L++     K++DFGLA+   K     + S+   T+ Y  P+++  S  
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGR 350
           + T   + D++G G +  EMA GR
Sbjct: 182 YST---QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 46/208 (22%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKR-ALVYE-YM 224
           K+G+G +G VYKG+   TG+++A+K     K   E   +E  G+ S   +  +L+ E   
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLE---SEEEGVPSTAIREISLLKELQH 58

Query: 225 PNGSLDRHIFSKENKGQ------TFGLEK-----PHEIALGTARGIEYLH---NGCDVC- 269
           PN    + +  +E++        +  L+K     P    +       YL+    G   C 
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 270 ---ILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISDTRGTIGYLAPE 321
              +LH D+KP N+L+D+  + K++DFGLA+          ++ V       T+ Y APE
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-------TLWYRAPE 171

Query: 322 LISRNFGTV--SCKSDVYGFGMVLLEMA 347
           ++    G+   S   D++  G +  EMA
Sbjct: 172 VL---LGSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 51.1 bits (122), Expect = 5e-07
 Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 33/202 (16%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE-------------------FINELL 208
           LG+G FG V   +L  +GRL AVK+++      ++                   F+ +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 209 GLCSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
             C +   R   V E++  G L  HI     K + F   +    A      + +LH   D
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLH---D 114

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             I++ D+K  N+LLDH    K++DFG+ K         + S   GT  Y+APE++    
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEML 172

Query: 328 GTVSCKSDVYGFGMVLLEMAGG 349
              S   D +  G++L EM  G
Sbjct: 173 YGPSV--DWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 41/212 (19%)

Query: 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE-------------------F 203
           +F   LG+G FG V   +   T  L A+K+++      ++                   F
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 204 INELLGLCSEGFKRA-LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI--ALGTARGIE 260
           + +L   C +   R   V EY+  G L   I       Q    ++PH +  A   A G+ 
Sbjct: 63  LTQLHS-CFQTMDRLYFVMEYVNGGDLMYQI------QQVGRFKEPHAVFYAAEIAIGLF 115

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISDTRGTIGYL 318
           +LH+     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  Y+
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENMWDGVTTKTFCGTPDYI 168

Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           APE+I+  +       D + FG++L EM  G+
Sbjct: 169 APEIIA--YQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 42/134 (31%), Positives = 66/134 (49%), Gaps = 11/134 (8%)

Query: 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           K  L+ EY   G L++ I  +  +   F   + +E+ L   + +  L       ++H D+
Sbjct: 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPF---QEYEVGLLFYQIVLALDEVHSRKMMHRDL 195

Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI---SDTRGTIGYLAPELISRNFGTVSC 332
           K  NI L    I K+ DFG +K   + +D VS+   S   GT  YLAPEL  R     S 
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSK---QYSDSVSLDVASSFCGTPYYLAPELWERK--RYSK 250

Query: 333 KSDVYGFGMVLLEM 346
           K+D++  G++L E+
Sbjct: 251 KADMWSLGVILYEL 264

Length = 478

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 32/204 (15%)

Query: 164 HFTHKLGQGGFGSVY--KGQLHTGRLIAVKMMENSKFSAEE---FINELLGLC------- 211
               K+G+G FG +Y  K +  +   + +K ++ +K   +E      E++ L        
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 212 -------SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
                   E  +  +V EY   G L + I     +G  F  ++     +  + G++++H 
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIH- 118

Query: 265 GCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPEL 322
             D  ILH DIK  NI L  N  + K+ DFG+A+   + ND + ++ T  GT  YL+PE+
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAYTCVGTPYYLSPEI 173

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEM 346
                   + K+D++  G VL E+
Sbjct: 174 CQNR--PYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 7/92 (7%)

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++V   + R  +
Sbjct: 224 AKGMSFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 316 GYLAPELISRNFGTV-SCKSDVYGFGMVLLEM 346
            ++APE I   F  V + +SDV+ +G++L E+
Sbjct: 281 KWMAPESI---FNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 53/216 (24%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKM----MENS--------------KFSAEEFINELL 208
           K+G+G +G VYK +  +TG+L+A+K     M+                  S   +I  LL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 209 GLCSEGFKRA-----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY-L 262
            +     K       LV+EY+ +  L + + S   +G    L         T +   Y L
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSN-GRGPGRPLPAK------TIKSFMYQL 119

Query: 263 HNGCDVC----ILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFV----SISDTRG 313
             G   C    ++H D+KP N+L+D    + K++D GL +       F     S +    
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHEIV 173

Query: 314 TIGYLAPELI--SRNFGTVSCKSDVYGFGMVLLEMA 347
           T+ Y APE++  S ++ T     D++  G +  EM+
Sbjct: 174 TLWYRAPEVLLGSTHYST---PVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 8/97 (8%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISDTRG 313
           RG++Y+H+     ++H D+KP N+L++ +   ++ DFG+A+     P E+ +  +++   
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF-MTEYVA 173

Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           T  Y APEL+  +    +   D++  G +  EM G R
Sbjct: 174 TRWYRAPELL-LSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 11/95 (11%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH-PKENDFVSISDTRGTI 315
           RG++Y+H+     ++H D+KP NIL++ N   K+ DFGLA+   P+   +VS      T 
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS------TR 169

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE I   +     + D++  G +  EM  G+
Sbjct: 170 YYRAPE-IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 61/203 (30%), Positives = 88/203 (43%), Gaps = 35/203 (17%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMM-------ENSK-FSAEEFINELLGL--------- 210
           LG+G FG VY      TGR +AVK +       E SK  +A E   +LL           
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 211 --C---SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
             C    E  K ++  EYMP GS+   + +     +        +I     +G+ YLH+ 
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLHSN 125

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELIS 324
               I+H DIK  NIL D     K+ DFG +K           I    GT  +++PE+IS
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 325 -RNFGTVSCKSDVYGFGMVLLEM 346
              +G    K+DV+     ++EM
Sbjct: 183 GEGYGR---KADVWSVACTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 53/224 (23%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKM------MENSKFSA-------EEF----INELLG 209
           K+G+G +G VYK +   TG ++A+K        E    +A       +E     I +LL 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHSHR--- 120

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISDTRGTIGYLAPELI- 323
           +LH D+KP N+L++     K++DFGLA+          ++ V       T+ Y APE++ 
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYRAPEILL 173

Query: 324 -SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP 366
             + + T     D++  G +  EM           TR  +A FP
Sbjct: 174 GCKYYSTA---VDIWSLGCIFAEM----------VTR--RALFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 32/200 (16%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NELLGLCS------------- 212
           K+GQG  G+V+    + TG+ +A+K +   K   +E I NE+L +               
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 213 -EGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V EY+  GSL D    +  ++ Q   + +         + +E+LH      +
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE------CLQALEFLHANQ---V 136

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +H DIK  N+LL  +   K++DFG  A+  P+++     S   GT  ++APE+++R    
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK--A 191

Query: 330 VSCKSDVYGFGMVLLEMAGG 349
              K D++  G++ +EM  G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 10/96 (10%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     +LH D+KP N+LL+ N   K+ DFGLA+   ++ DF  +++   T  
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRW 173

Query: 317 YLAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APEL+     + T     DV+  G +  E+ G +
Sbjct: 174 YRAPELLLNCSEYTTA---IDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 33/203 (16%)

Query: 167 HKLGQGGFGSVY----KGQLHTGRLIAVKMMENSKFSAEEFIN-----ELLG-------- 209
            +LG+G FG+VY    K  +   RL  +K +   + +  E +      +LL         
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 210 ------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
                 L  + F   ++ EY     LD  +   ++ G+T    +  E  +    G+ Y+H
Sbjct: 66  KFHASFLERDAF--CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
                 ILH D+K  NI L +N + K+ DFG+++      D  +     GT  Y++PE +
Sbjct: 124 ---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEAL 177

Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
                    KSD++  G +L EM
Sbjct: 178 KHQ--GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 19/153 (12%)

Query: 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           K  L+ +Y+  G +  H++ ++N  +        EI L     +E+LH    + I++ DI
Sbjct: 79  KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHLHK---LGIVYRDI 131

Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-----GTIGYLAPELISRNFGTV 330
           K  NILLD      ++DFGL+K      +F+S    R     GTI Y+APE+I R  G  
Sbjct: 132 KLENILLDSEGHVVLTDFGLSK------EFLSEEKERTYSFCGTIEYMAPEII-RGKGGH 184

Query: 331 SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA 363
               D +  G+++ E+  G     +   R++++
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 60/207 (28%), Positives = 88/207 (42%), Gaps = 47/207 (22%)

Query: 169 LGQGGFGSVYKGQLHTGR-LIAVKMM--------------ENSKFSAEE----FINELLG 209
           +G G FG V+  +        A+K+M               N K   +E    FI  L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 210 LCSEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
             +E  +R L  + EY+P G L  ++ +      + GL    EI       +EYLH+   
Sbjct: 68  -WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA----LEYLHS--- 119

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR----GTIGYLAPELI 323
             I++ D+KP NILLD     K++DFG AK          + D      GT  YLAPE+I
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAK---------KLRDRTWTLCGTPEYLAPEVI 170

Query: 324 -SRNFGTVSCKSDVYGFGMVLLEMAGG 349
            S+         D +  G+++ EM  G
Sbjct: 171 QSKGHNKA---VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 49.5 bits (119), Expect = 2e-06
 Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 76/237 (32%)

Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVK------------------MMENSKFSAEEFINEL 207
            KLG+G +G V+K     T  ++A+K                  +M   +      I +L
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72

Query: 208 LGLCSEGFKRA-------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARG 258
           L +      +A       LV+EYM     D H   + N      LE  H+  I     + 
Sbjct: 73  LNVI-----KAENDKDIYLVFEYMET---DLHAVIRANI-----LEDVHKRYIMYQLLKA 119

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG-- 316
           ++Y+H+G    ++H D+KP NILL+ +   K++DFGLA+         S+S+        
Sbjct: 120 LKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR---------SLSELEENPENP 167

Query: 317 ----------YLAPELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRR----NSNMN 356
                     Y APE++  S  +   V    D++  G +L EM  G+      S +N
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGKPLFPGTSTLN 220

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 49/139 (35%), Positives = 74/139 (53%), Gaps = 27/139 (19%)

Query: 220 VYEYMPNGSLDRHIFSKENKGQTFG-LEKPHEI--ALGTARGIEYLHNGCDVCILHFDIK 276
           V EY+  G L  HI       Q  G  ++PH +  A   A G+ +LH+     I++ D+K
Sbjct: 79  VMEYVNGGDLMYHI-------QQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLK 128

Query: 277 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR---GTIGYLAPELIS-RNFGTVSC 332
             N++LD     K++DFG+     KEN F   + TR   GT  Y+APE+I+ + +G    
Sbjct: 129 LDNVMLDAEGHIKIADFGMC----KENIFGGKT-TRTFCGTPDYIAPEIIAYQPYG---- 179

Query: 333 KS-DVYGFGMVLLEMAGGR 350
           KS D + FG++L EM  G+
Sbjct: 180 KSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 37/209 (17%)

Query: 165 FTHKLGQGGFGSVYKGQLH-TGRLIAVK----------------MMENSKFSAEE---FI 204
           F   LG+G FG V   +   T  L A+K                M+E    + ++   F+
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63

Query: 205 NELLGLCSEGFKRA-LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI--ALGTARGIEY 261
            +L   C +   R   V EY+  G L  HI       Q    ++P  +  A   + G+ +
Sbjct: 64  TQLHS-CFQTVDRLYFVMEYVNGGDLMYHI------QQVGKFKEPQAVFYAAEISVGLFF 116

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
           LH      I++ D+K  N++LD     K++DFG+ K H  +   V+     GT  Y+APE
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPE 171

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           +I+  +       D + +G++L EM  G+
Sbjct: 172 IIA--YQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 45/208 (21%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVK-------------------MMENSKFSAEEFINELL 208
           +G+G +G+VY+G  + TGR++A+K                   ++   + S    I +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL---GTARGIEYLHNG 265
           G   +G +  ++ EY   GS+      K        + + + I++        ++Y+H  
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV--RTLMKAGP-----IAEKY-ISVIIREVLVALKYIHK- 119

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR----GTIGYLAPE 321
             V ++H DIK  NIL+ +    K+ DFG+A            S  R    GT  ++APE
Sbjct: 120 --VGVIHRDIKAANILVTNTGNVKLCDFGVAA------LLNQNSSKRSTFVGTPYWMAPE 171

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           +I         K+D++  G+ + EMA G
Sbjct: 172 VI-TEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 52/212 (24%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---AEEFINELLGL----------CSEG 214
           +G+G +G V K +   T  ++A+K  ++S+ +    E  + EL  L            E 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 215 FKRA----LVYEY-----------MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
           F+R     LV+EY           MPNG     +     +   + L K           I
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-----RSYIYQLIK----------AI 113

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
            + H      I+H DIKP N+L+ HN + K+ DFG A+   + ++  + ++   T  Y +
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRS 169

Query: 320 PELISRNFGTVSCKS-DVYGFGMVLLEMAGGR 350
           PEL+    G    K+ D++  G +L E++ G+
Sbjct: 170 PELL---LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 28/162 (17%)

Query: 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDVCILHFDIKPH 278
           V EY+  G L  HI S       F   +    A     G+++LH  G    I++ D+K  
Sbjct: 74  VMEYLNGGDLMFHIQSSGR----FDEARARFYAAEIICGLQFLHKKG----IIYRDLKLD 125

Query: 279 NILLDHNFIPKVSDFGLAKFH----PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           N+LLD +   K++DFG+ K +     K + F       GT  Y+APE++       S   
Sbjct: 126 NVLLDKDGHIKIADFGMCKENMNGEGKASTFC------GTPDYIAPEILKGQKYNESV-- 177

Query: 335 DVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSWV 369
           D + FG++L EM  G+        +   ++  + + +FP W+
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 10/90 (11%)

Query: 270 ILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTR-----GTIGYLAPE 321
           I+H D+KP NI++         KV DFG+    P   D    + TR     GT  Y APE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
            + R    V+  SD+Y +G++ LE   G+R
Sbjct: 160 QL-RG-EPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 15/98 (15%)

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--- 312
           A  + YLH+   + I++ D+KP NILLD      ++DFGL     KE   +  S T    
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLC----KEG--IEHSKTTSTF 156

Query: 313 -GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
            GT  YLAPE++ +     +   D +  G VL EM  G
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTV--DWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 75/280 (26%), Positives = 119/280 (42%), Gaps = 63/280 (22%)

Query: 168 KLGQGGFG-SVYKGQLHTGRLIAVKMMENSKFSA---EEFINELLGLCS----------E 213
           K+G+G FG ++       G+   +K +  SK S    EE   E+  L +          E
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 214 GFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            F+      +V +Y   G L + I ++  +G  F  ++  +  +     ++++H   D  
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVH---DRK 121

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELI-SRNF 327
           ILH DIK  NI L  +   K+ DFG+A+     N  V ++ T  GT  YL+PE+  +R +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICENRPY 178

Query: 328 GTVSCKSDVYGFGMVLLEM--------AGGRRNSNMNATRSSKAYFPS-WVYDQLNKGGD 378
                KSD++  G VL EM        AG  +N  +   R S     S + YD       
Sbjct: 179 NN---KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYD------- 228

Query: 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
             LRN+  +  +  R               DRPS+  +LE
Sbjct: 229 --LRNL--VSQLFKR------------NPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 30/91 (32%), Positives = 53/91 (58%), Gaps = 5/91 (5%)

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           A+G+++L      CI H D+   N+LL    + K+ DFGLA+    ++++V   + R  +
Sbjct: 222 AQGMDFL--ASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            ++APE I     TV  +SDV+ +G++L E+
Sbjct: 279 KWMAPESIFDCVYTV--QSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 51/231 (22%), Positives = 88/231 (38%), Gaps = 65/231 (28%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAE---------------------EFINE 206
           LG+G +G V K     TG+++A+K ++  + S +                     + +NE
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 207 L-----LGL----CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGT 255
           +     +GL        F   LV + M    L + +  K        L +     I L  
Sbjct: 77  IKHENIMGLVDVYVEGDFIN-LVMDIM-ASDLKKVVDRK------IRLTESQVKCILLQI 128

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG-- 313
             G+  LH       +H D+ P NI ++   I K++DFGLA+ +       ++S      
Sbjct: 129 LNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 314 ----------TIGYLAPELISRNFG----TVSCKSDVYGFGMVLLEMAGGR 350
                     T+ Y APEL+    G      +   D++  G +  E+  G+
Sbjct: 186 RREEMTSKVVTLWYRAPELL---MGAEKYHFAV--DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 58/203 (28%), Positives = 84/203 (41%), Gaps = 35/203 (17%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMM---------ENSKFSAEEFINELLGLCSEGFKRA 218
           +G+G FG V   +    G+  AVK++         E     AE   N LL      F   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAER--NVLLKNVKHPFLVG 60

Query: 219 LVYEYMPNGSL--------DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           L Y +     L           +F    + ++F   +    A   A  + YLH+   + I
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INI 117

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR----GTIGYLAPELISRN 326
           ++ D+KP NILLD      ++DFGL K      + ++ SDT     GT  YLAPE+I + 
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK------EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
                   D +  G VL EM  G
Sbjct: 172 --PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.4 bits (117), Expect = 4e-06
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 44/226 (19%)

Query: 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR---GIEYLHNGCD----V 268
           K  ++ E+   G L R+I   +   + FG  + H I   T +    + Y HN  D     
Sbjct: 88  KLYILMEFCDAGDLSRNI---QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE 144

Query: 269 CILHFDIKPHNILLDHNF-----------------IPKVSDFGLAKFHPKENDFVSISDT 311
            +LH D+KP NI L                     I K+ DFGL+K    E+   S    
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV-- 202

Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 371
            GT  Y +PEL+     +   KSD++  G ++ E+  G+       T   KA   S +  
Sbjct: 203 -GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK-------TPFHKANNFSQLIS 254

Query: 372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
           +L +G DL ++  ++  +++ + L       + + A +RPS  + L
Sbjct: 255 ELKRGPDLPIKGKSKELNILIKNL-------LNLSAKERPSALQCL 293

Length = 1021

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 33/202 (16%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMEN-SKFSAEEFINE--LLGLCSE----GFKRAL 219
           +LG G FG VYK Q   TG L A K+++  S+   E+++ E  +L  C          A 
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 220 VY--------EYMPNGSLDRHIFSKENKGQTFGLEKPH--EIALGTARGIEYLHNGCDVC 269
            Y        E+   G++D  +   E       L +P    +   T   + YLH   +  
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERP-----LTEPQIRVVCKQTLEALNYLH---ENK 123

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELI---SR 325
           I+H D+K  NIL   +   K++DFG++    K    +   D+  GT  ++APE++   + 
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 326 NFGTVSCKSDVYGFGMVLLEMA 347
                  K+DV+  G+ L+EMA
Sbjct: 181 KDRPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 34/97 (35%), Positives = 56/97 (57%), Gaps = 8/97 (8%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FH--PKENDFVSISDTRG 313
            G++Y+H+  +V  LH D+KP N+L++ +   K+ DFGLA+ F   P EN    +++   
Sbjct: 116 CGLKYIHSA-NV--LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA-GFMTEYVA 171

Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           T  Y APE I  +F + +   DV+  G +L E+ G +
Sbjct: 172 TRWYRAPE-IMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 61/223 (27%), Positives = 90/223 (40%), Gaps = 71/223 (31%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVK---------------MMENS--KFSAEEFINELLG 209
           K+G+G +G VYK +   TG ++A+K               + E S  K      I  LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 210 LCSEGFKRALVYEYM-----------PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARG 258
           +     K  LV+E++           P   LD  +     K   + L           +G
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI----KSYLYQL----------LQG 111

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-F--------HPKENDFVSIS 309
           I Y H+     +LH D+KP N+L+D     K++DFGLA+ F        H    + V   
Sbjct: 112 IAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH----EVV--- 161

Query: 310 DTRGTIGYLAPE--LISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
               T+ Y APE  L SR + T     D++  G +  EM   R
Sbjct: 162 ----TLWYRAPEILLGSRQYST---PVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 70/268 (26%), Positives = 115/268 (42%), Gaps = 51/268 (19%)

Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIF-SKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 75  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 126

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           +  ++H D+   N+L+      K++DFGLAK    +         +  I ++A E I   
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--FP-SWVYDQLNKGGDLELRN 383
               + +SDV+ +G+ + E+           T  SK Y   P S +   L KG  L    
Sbjct: 187 --IYTHQSDVWSYGVTVWEL----------MTFGSKPYDGIPASEISSILEKGERLPQPP 234

Query: 384 VTEIESMIARKLCMIGLWCIQVKAADRP 411
           +  I+      + MI + C  + A  RP
Sbjct: 235 ICTID------VYMIMVKCWMIDADSRP 256

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 29/157 (18%)

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+ +    + K+ D GL +F   +    +     GT  Y++PE I  N   
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHEN--G 182

Query: 330 VSCKSDVYGFGMVLLEMA-------GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382
            + KSD++  G +L EMA       G + N      +  +  +P    D  ++    ELR
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE----ELR 238

Query: 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419
            +  +              CI      RP +T V ++
Sbjct: 239 QLVNM--------------CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 7/90 (7%)

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
            +E++H+     ++H DIKP N+ +    + K+ D GL +F   +    +     GT  Y
Sbjct: 118 AVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYY 172

Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           ++PE I  N    + KSD++  G +L EMA
Sbjct: 173 MSPERIHEN--GYNFKSDIWSLGCLLYEMA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 9/92 (9%)

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGY 317
           +E LH      +++ D+KP NILLD+     + DFGL K + K++D    ++T  GT  Y
Sbjct: 106 LENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEY 159

Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           LAPEL+    G      D +  G++L EM  G
Sbjct: 160 LAPELLL-GHGYTKA-VDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 44/207 (21%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVK-----------MMENSKFSAEEF----INELLG- 209
            ++G G +G VYK + LHTG L AVK           +++   F  +E     I    G 
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74

Query: 210 -LCSEGFKRALVYEYMPNGSLDR--HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
            L  E  K  +  EY   GSL    H+    ++ Q         +   T +G+ YLH+  
Sbjct: 75  YLSRE--KLWICMEYCGGGSLQDIYHVTGPLSELQI------AYVCRETLQGLAYLHSKG 126

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPEL 322
               +H DIK  NILL  N   K++DFG+A        K   F+      GT  ++APE+
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI------GTPYWMAPEV 177

Query: 323 --ISRNFGTVSCKSDVYGFGMVLLEMA 347
             + +N G  +   D++  G+  +E+A
Sbjct: 178 AAVEKN-GGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 35/205 (17%)

Query: 171 QGGFGSVYKGQLHTGR-----------------LIAVKMM--ENSKFSAEEFINEL--LG 209
           +G FG ++ G L   +                  I V ++  E+         N L  L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 210 LCSEGFKRALV-YEYMPNGSLDRHI----FSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
           +C E  +   V Y YM  G+L   +      + N  Q    ++   +A+  A G+ YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRG-TIGYLAPEL 322
                ++H DI   N ++D     K++D  L++   P   D+  + D     + ++A E 
Sbjct: 136 ---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFP--MDYHCLGDNENRPVKWMALES 190

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMA 347
           +       S  SDV+ FG++L E+ 
Sbjct: 191 LVNKE--YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 43/212 (20%)

Query: 163 NHFT--HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK-FSAEE---FINE---LLGLCS 212
             F    ++GQGG+G V+  +   TG ++A+K M+ S  F   E    + E   L    S
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 213 EGFKRALVY------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
           E   + L+Y            EY+P G   R + +        G+          A   E
Sbjct: 61  EWLVK-LLYAFQDDEYLYLAMEYVPGGDF-RTLLN------NLGVLSEDHARFYMAEMFE 112

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLA 319
            +    ++  +H D+KP N L+D +   K++DFGL+K        V+ +++  G+  Y+A
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYANSVVGSPDYMA 166

Query: 320 PELI-SRNFG-TVSCKSDVYGFGMVLLEMAGG 349
           PE++  + +  TV    D +  G +L E   G
Sbjct: 167 PEVLRGKGYDFTV----DYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 45/209 (21%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE----------------LLGL- 210
           +G+G +  V   +L  T R+ A+K+++    + +E I+                 L+GL 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 211 -CSEGFKRA-LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            C +   R   V E++  G L  H+  +    +        EI+L     + +LH     
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHERG-- 116

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  Y+APE++     
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEIL----- 168

Query: 329 TVSCKSDVYGF-------GMVLLEMAGGR 350
               + + YGF       G+++ EM  GR
Sbjct: 169 ----RGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 34/207 (16%)

Query: 166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMM------ENSKFSAEEFINELLGLCSEGFKRA 218
             K+G+G +G VYK +   T   IA+K +      E    +A   I+ L  +      R 
Sbjct: 7   VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 219 -----------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
                      LV+EY+ +  L +H+ S  +  +   L K +   +   RGI Y H+   
Sbjct: 67  QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQI--LRGIAYCHSHR- 122

Query: 268 VCILHFDIKPHNILLDH-NFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI-- 323
             +LH D+KP N+L+D      K++DFGLA+ F      F   +    T+ Y APE++  
Sbjct: 123 --VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF---THEVVTLWYRAPEILLG 177

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           SR++ T     D++  G +  EM   +
Sbjct: 178 SRHYST---PVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 44/212 (20%)

Query: 169 LGQGGFGSVYKGQL----HTGRLIAVKMMENSKFSAEE------------------FINE 206
           +G+G FG V   Q+     TG + A+K+M+ S   A+E                  +I +
Sbjct: 9   VGRGHFGEV---QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65

Query: 207 LLGLCSEGFKRALVYEYMPNGSL----DRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           L     +     LV EY P G L    +R+    +     F L          A  +  +
Sbjct: 66  LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYL----------AELVLAI 115

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
           H+   +  +H DIKP N+L+D     K++DFG A          S     GT  Y+APE+
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEV 174

Query: 323 ISRNFGTVSCKSDV----YGFGMVLLEMAGGR 350
           ++   G       V    +  G++  EM  GR
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 52/215 (24%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRL--IAVKMMENSK----------FSAEEFIN------ 205
           +F   LG G FG V            +A+K  E SK          FS  + +N      
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92

Query: 206 --ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGI---- 259
              L G   +     LV E++  G      F + NK        P+++    A  I    
Sbjct: 93  CVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRNK------RFPNDVGCFYAAQIVLIF 144

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-----GT 314
           EYL +   + I++ D+KP N+LLD +   K++DFG AK          + DTR     GT
Sbjct: 145 EYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK----------VVDTRTYTLCGT 191

Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
             Y+APE++  N G     +D +  G+ + E+  G
Sbjct: 192 PEYIAPEIL-LNVGHGKA-ADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           A G+E+L      C+ H D+   N+L+    + K+ DFGLA+   ++++++S   T   +
Sbjct: 249 ANGMEFL--ASKNCV-HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            ++APE I  N  T    SDV+ FG++L E+
Sbjct: 306 KWMAPESIFNNLYTTL--SDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 49/208 (23%), Positives = 100/208 (48%), Gaps = 42/208 (20%)

Query: 168 KLGQGGFGSVYKGQ--LHTGRLIAVKMM------ENSKFSA----------EEF----IN 205
           ++G+G +G V+K +   + GR +A+K +      E    S           E F    + 
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 206 ELLGLCS-----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGL--EKPHEIALGTARG 258
            L  +C+        K  LV+E+     +D+ + +  +K    G+  E   ++     RG
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           +++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +   ++++    T+ Y 
Sbjct: 123 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYR 176

Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE++ ++  + +   D++  G +  EM
Sbjct: 177 APEVLLQS--SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 58/243 (23%), Positives = 91/243 (37%), Gaps = 78/243 (32%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---------SAEEFI------NELLGL-C 211
           +G+G FG V   Q   TG + A+K +  S+           AE  I        ++ L  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68

Query: 212 SEGFKRA----LVYEYMPNGSL-----DRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           S  F+      L+ EY+P G +      +  F+ E + + +  E        T   I+ +
Sbjct: 69  S--FQDENYLYLIMEYLPGGDMMTLLMKKDTFT-EEETRFYIAE--------TILAIDSI 117

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK--------------FHPKENDFVSI 308
           H    +  +H DIKP N+LLD     K+SDFGL                 H   ++F+  
Sbjct: 118 HK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 309 S----------------------DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
                                   T GT  Y+APE+  +      C  D +  G+++ EM
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC--DWWSLGVIMYEM 232

Query: 347 AGG 349
             G
Sbjct: 233 LVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 36/133 (27%), Positives = 55/133 (41%), Gaps = 46/133 (34%)

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL---------AKF-----HPKEND 304
           IE +H    +  +H DIKP NIL+D +   K++DFGL         +K+     H +++ 
Sbjct: 114 IESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 305 F------VSISDTR---------------------GTIGYLAPELISRNFGTVSCKSDVY 337
                    I   R                     GT  Y+APE++ R   T  C  D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC--DWW 228

Query: 338 GFGMVLLEMAGGR 350
             G++L EM  G+
Sbjct: 229 SVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 44/199 (22%), Positives = 69/199 (34%), Gaps = 53/199 (26%)

Query: 164 HFTHKLGQGGFGSVYKGQL---HTGRLIAVKMMENSKFSAEEF----INELLGLCSE--- 213
                +G+G +G VYK +      G+  A+K  +  K            E+  L  E   
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREI-ALLRELKH 61

Query: 214 --------------GFKRALVYEYMPNGSLDRHI--FSKENKGQTFGLEKPHEIALGTAR 257
                              L+++Y  +      I  F ++ K           I     +
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKR--------VSIPPSMVK 111

Query: 258 --------GIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLA-KFHPKEND 304
                   G+ YLH+     +LH D+KP NIL+        + K+ D GLA  F+     
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 305 FVSISDTRGTIGYLAPELI 323
              +     TI Y APEL+
Sbjct: 169 LADLDPVVVTIWYRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 45.3 bits (108), Expect = 3e-05
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 18/96 (18%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KF-HPKENDFVSISDTRG- 313
            G+ +LH   D  ILH D+K  N+LL++  I K+ DFGLA ++  P +        T+  
Sbjct: 117 SGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP------YTQLV 167

Query: 314 -TIGYLAPELISRNFGT--VSCKSDVYGFGMVLLEM 346
            T+ Y APEL+    G    S   D++  G +  E+
Sbjct: 168 VTLWYRAPELL---LGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 35/203 (17%)

Query: 169 LGQGGFGSVYKGQLHT-GRLIAVKMM---------ENSKFSAEEFINELLGLCSEGF--- 215
           +G+G FG V   +  + G   AVK++         E +   AE   N LL      F   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAER--NVLLKNLKHPFLVG 60

Query: 216 ---------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
                    K   V +Y+  G L  H+     + + F   +    A   A  I YLH+  
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS-- 114

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
            + I++ D+KP NILLD      ++DFGL K   +  +  + S   GT  YLAPE++ + 
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKE 171

Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
                   D +  G VL EM  G
Sbjct: 172 --PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 45/158 (28%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM------ENSKFSAEEFINELLGLCSEGFKR--- 217
           K+G+G +G+V+K +   T  ++A+K +      E    SA   I  L  L  +   R   
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 218 --------ALVYEYMP----------NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
                    LV+EY            NG +D  I       ++F  +          +G+
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV------KSFMFQ--------LLKGL 112

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
            + H+     +LH D+KP N+L++ N   K++DFGLA+
Sbjct: 113 AFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 35/105 (33%), Positives = 50/105 (47%), Gaps = 20/105 (19%)

Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----------HPKEN 303
           T   +EYLHN     I+H D+KP N+L+      K++DFGL+K               E 
Sbjct: 110 TVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 304 DFVSISDTR--GTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLE 345
           D     D +  GT  Y+APE+I R  +G      D +  G++L E
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 33/203 (16%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE----------------LLGL- 210
           +G+G +  V   +L  T R+ A+K+++    + +E I+                 L+GL 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 211 -CSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            C +   R   V EY+  G L  H+  +    +        EI+L     + YLH   + 
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ER 115

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNF 327
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  Y+APE++   ++
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDY 173

Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
           G      D +  G+++ EM  GR
Sbjct: 174 GF---SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 44.3 bits (104), Expect = 6e-05
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 38/204 (18%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMM-----ENSKFSAEEFI-------NELLGLCSE 213
            ++G G +G VYK + ++TG L A+K++     E+     +E I       + ++     
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74

Query: 214 GFKRALVY---EYMPNGSLDR--HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
             +R  ++   E+   GSL    H+    ++ Q   + +       T +G+ YLH+   +
Sbjct: 75  YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRE------TLQGLYYLHSKGKM 128

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELIS 324
              H DIK  NILL  N   K++DFG    +     K   F+      GT  ++APE+ +
Sbjct: 129 ---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI------GTPYWMAPEVAA 179

Query: 325 -RNFGTVSCKSDVYGFGMVLLEMA 347
               G  +   D++  G+  +E+A
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.9 bits (106), Expect = 7e-05
 Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 30/148 (20%)

Query: 171 QGGFGSVYKGQL-HTGRLIAVKMMENSK------------------FSAEEFINELLGLC 211
           +G FG VY G+  +  +L AVK+++ +                    S   FI  L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 212 SEGFKRALVYEYMPNGSLDR--HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                  LV EY+  G +    HI+   +  +   ++   E+AL     ++YLH      
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFD--EEMAVKYISEVALA----LDYLHRHG--- 124

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAK 297
           I+H D+KP N+L+ +    K++DFGL+K
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 10/94 (10%)

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
           GI++LH+     I+H D+KP NI++  +   K+ DFGLA+          ++    T  Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 183

Query: 318 LAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGR 350
            APE+I    G       D++  G ++ EM  G 
Sbjct: 184 RAPEVI---LGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 18/110 (16%)

Query: 251 IALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN------ 303
           I  G  RG+ YLH NG     +H +IK  +IL+  + +  +S  GL+  +          
Sbjct: 106 ILFGALRGLNYLHQNGY----IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAK 159

Query: 304 ---DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
              DF   S +   + +L+PEL+ ++    + KSD+Y  G+   E+A GR
Sbjct: 160 VVYDFPQFSTS--VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 40/131 (30%), Positives = 63/131 (48%), Gaps = 15/131 (11%)

Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           +V EY   G L + I  K  +G+ F  +   +  +    G++++H   +  +LH DIK  
Sbjct: 75  IVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSK 129

Query: 279 NILLDHNFIPKVSDFGLAKF--HPKENDFVSISDTR-GTIGYLAPELISRNFGTVSCKSD 335
           NI L  N   K+ DFG A+    P      + + T  GT  Y+ PE I  N    + KSD
Sbjct: 130 NIFLTQNGKVKLGDFGSARLLTSP-----GAYACTYVGTPYYVPPE-IWENM-PYNNKSD 182

Query: 336 VYGFGMVLLEM 346
           ++  G +L E+
Sbjct: 183 IWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 48/189 (25%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKM--MENSKFSAEEF----INEL-----------LGL 210
           +G+G +G VYK +   TG L+A+K   ++N K   E F    I E+           + L
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNL 71

Query: 211 C--------SEGFKRA-----LVYEYMPN---GSLDRHIFSKENKGQTFGLEKPHEIALG 254
                    +  FK+      LV+EYM +   G L       E+    F  +        
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-------ESGLVHFSEDHIKSFMKQ 124

Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
              G+ Y H       LH DIK  NILL++    K++DFGLA+ +  E +    ++   T
Sbjct: 125 LLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSE-ESRPYTNKVIT 180

Query: 315 IGYLAPELI 323
           + Y  PEL+
Sbjct: 181 LWYRPPELL 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 41/131 (31%), Positives = 62/131 (47%), Gaps = 11/131 (8%)

Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
            V +Y+  G L  H+     + + F   +    A   A  + YLH+   + I++ D+KP 
Sbjct: 73  FVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPE 125

Query: 279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYG 338
           NILLD      ++DFGL K + + N   + S   GT  YLAPE++ +         D + 
Sbjct: 126 NILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWC 181

Query: 339 FGMVLLEMAGG 349
            G VL EM  G
Sbjct: 182 LGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 182

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 183 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 11/95 (11%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE-NDFVSISDTRGTI 315
           RG++Y+H+     I+H D+KP NI ++ +   K+ DFGLA+    E   +V       T 
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV------ATR 179

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  N+   +   D++  G ++ E+  G+
Sbjct: 180 WYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 59/242 (24%), Positives = 101/242 (41%), Gaps = 48/242 (19%)

Query: 140 IHKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYK-GQLHTGRLIAVKMME---- 194
           +  Y ++M  ++++  P     T      +G+G +G VYK      G L AVK+++    
Sbjct: 4   LFPYNSSMLGLESLGDP---TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60

Query: 195 -NSKFSAEEFINELL----------GL------CSEGFKRALVYEYMPNGSLDRHIFSKE 237
            + +  AE  I + L          G+         G +  LV E    GS+   +    
Sbjct: 61  VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG-QLWLVLELCNGGSVTELVKGLL 119

Query: 238 NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
             GQ         I  G   G+++LHN     I+H D+K +NILL      K+ DFG++ 
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVS- 175

Query: 298 FHPKENDFVSISDTR-------GTIGYLAPELIS---RNFGTVSCKSDVYGFGMVLLEMA 347
                     ++ TR       GT  ++APE+I+   +   +   + DV+  G+  +E+ 
Sbjct: 176 --------AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227

Query: 348 GG 349
            G
Sbjct: 228 DG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 50/215 (23%)

Query: 169 LGQGGFGSVYKG---------QLHTGRLIAVKMMENSK-------FSAEEFINEL----- 207
           LGQG F  ++KG         +LH   ++ +K+++ S        F A   +++L     
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVL-LKVLDKSHRNYSESFFEAASMMSQLSHKHL 61

Query: 208 ---LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
               G+C  G +  +V EY+  GSLD ++  K+NK       K  E+A   A  + +L  
Sbjct: 62  VLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWK-LEVAKQLAWALHFLE- 117

Query: 265 GCDVCILHFDIKPHNILLDHN---------FIPKVSDFGLA-KFHPKENDFVSISDTRGT 314
             D  + H ++   N+LL            FI K+SD G++    PKE     I   R  
Sbjct: 118 --DKGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKE-----ILLER-- 167

Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           I ++ PE I  N   +S  +D + FG  L E+  G
Sbjct: 168 IPWVPPECI-ENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 20/146 (13%)

Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           LV EY+  G L  H+  +    +        EI +     + +LH   +  I++ D+K  
Sbjct: 73  LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLH---ERGIIYRDLKLD 125

Query: 279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKSDVY 337
           N+LLD +   K++D+G+ K      D  + S   GT  Y+APE++    +G      D +
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGF---SVDWW 180

Query: 338 GFGMVLLEMAGGRR-------NSNMN 356
             G+++ EM  GR        N +MN
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDMN 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 37/133 (27%), Positives = 63/133 (47%), Gaps = 11/133 (8%)

Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           +V EYMP G L  ++ S  +  + +      E+ L     ++ +H+   + ++H D+KP 
Sbjct: 120 MVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLA----LDAIHS---MGLIHRDVKPD 171

Query: 279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT--VSCKSDV 336
           N+LLD +   K++DFG       E   V      GT  Y++PE++    G      + D 
Sbjct: 172 NMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 337 YGFGMVLLEMAGG 349
           +  G+ L EM  G
Sbjct: 231 WSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.0 bits (98), Expect = 5e-04
 Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 61/233 (26%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE------------------FINELLG 209
           +G+G FG V   Q   TG + A+K++  +    +E                  ++ ++  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +     L+ E++P G +   +  K+    T   E+       T   I+ +H    + 
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ---LG 121

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLA----KFH------------PKENDFVSISDTR- 312
            +H DIKP N+LLD     K+SDFGL     K H            P +  F +++  R 
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181

Query: 313 ----------------GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
                           GT  Y+APE+  +      C  D +  G+++ EM  G
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 29/201 (14%)

Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFINE------LLGLCSEGFKRALVY 221
           +G G +G+V       TG  +A+K +    F +E F         LL          L+ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIGLLD 81

Query: 222 EYMPNGSLDR-HIF-----------SKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            + P+ SLDR H F            K  K +    ++   +     +G++Y+H      
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG--- 138

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I+H D+KP N+ ++ +   K+ DFGLA+    +++      TR    Y APE+I  N+  
Sbjct: 139 IIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVVTR---WYRAPEVI-LNWMH 192

Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
            +   D++  G ++ EM  G+
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 38/133 (28%), Positives = 63/133 (47%), Gaps = 11/133 (8%)

Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           +V EYMP G L  ++ S  +  + +      E+ L     ++ +H+   +  +H D+KP 
Sbjct: 120 MVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLA----LDAIHS---MGFIHRDVKPD 171

Query: 279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT--VSCKSDV 336
           N+LLD +   K++DFG      KE   V      GT  Y++PE++    G      + D 
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 337 YGFGMVLLEMAGG 349
           +  G+ L EM  G
Sbjct: 231 WSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 41.6 bits (97), Expect = 6e-04
 Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 22/120 (18%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   ++ DFGLA+    E     ++    T  
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRW 180

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLNK 375
           Y APE I  N+   +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLKG------------KALFPGNDYIDQLKR 227

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 41.4 bits (97), Expect = 7e-04
 Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 26/201 (12%)

Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMME---NSKFSAEEFINELLGL----------CS 212
            ++G G +GSV       TG  +A+K +     S+  A+    EL  L            
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 213 EGFKRALVYEYMPNGSLDR-HIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           + F  A+  +   +  L   ++ +   K  G     +K   +      G++Y+H+     
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--- 137

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE+I  N+  
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVI-LNWMH 191

Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
            +   D++  G ++ EM  G+
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 41.3 bits (97), Expect = 8e-04
 Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 10/98 (10%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKF-HPKENDFVSISDTRGT 314
           RG++Y+H+     +LH D+KP N+ ++  + + K+ DFGLA+   P  +    +S+   T
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 315 IGYLAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
             Y +P L+    N+       D++  G +  EM  G+
Sbjct: 182 KWYRSPRLLLSPNNYTKA---IDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 56/233 (24%), Positives = 89/233 (38%), Gaps = 61/233 (26%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINELLG----------------LC 211
           +G+G FG V   Q   TG + A+K++  +    +E +  +                    
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68

Query: 212 SEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           S   KR L  + E++P G +   +  K+    T   E        T   I+ +H    + 
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQ---LG 121

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLA----KFH------------PKENDFVSISDTR- 312
            +H DIKP N+LLD     K+SDFGL     K H            P +  F +++  R 
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 313 ----------------GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
                           GT  Y+APE+  +      C  D +  G+++ EM  G
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 11/133 (8%)

Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           +V EYMP G L  ++ S  +  + +      E+ L     ++ +H+   +  +H D+KP 
Sbjct: 120 MVMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVVLA----LDAIHS---MGFIHRDVKPD 171

Query: 279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI--SRNFGTVSCKSDV 336
           N+LLD +   K++DFG        N  V      GT  Y++PE++      G    + D 
Sbjct: 172 NMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 337 YGFGMVLLEMAGG 349
           +  G+ L EM  G
Sbjct: 231 WSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 37/127 (29%)

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
           GI++LH+     I+H D+KP NI++  +   K+ DFGLA+             T GT   
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------------TAGTSFM 181

Query: 318 LAPELISRNFGTVSC--------KSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV 369
           + P +++R +               D++  G ++ EM  G               FP   
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG------------GVLFPGTD 229

Query: 370 Y-DQLNK 375
           + DQ NK
Sbjct: 230 HIDQWNK 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR---NF 327
           +H DIKP N+LLD N   +++DFG +     ++  V  S   GT  Y++PE++       
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 328 GTVSCKSDVYGFGMVLLEMAGG 349
           G    + D +  G+ + EM  G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 37/206 (17%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVK-MMENSKFSAEEF--------INELL---GLCSEGF 215
           +G G FG VY+   + T   +A+K ++++ ++   E         IN +       +E F
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECF 133

Query: 216 KRA-------LVYEYMPNGSLDRHI--FSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           K+        +V E++P  ++ +++  +++ N      L K +   L   R + Y+H+  
Sbjct: 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYIHSKF 190

Query: 267 DVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-- 323
              I H D+KP N+L+D N    K+ DFG AK        VS   +R    Y APEL+  
Sbjct: 191 ---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR---FYRAPELMLG 244

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGG 349
           + N+ T     D++  G ++ EM  G
Sbjct: 245 ATNYTT---HIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 10/95 (10%)

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISDT--RG 313
           +EY+H   +  I H DIKP NI++D N    + D+G+A     H K  ++        RG
Sbjct: 139 LEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRG 195

Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG 348
           T+ Y    L + N   V+ + D+   G  +L+ AG
Sbjct: 196 TLYYAG--LDAHNGACVTRRGDLESLGYCMLKWAG 228

Length = 294

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR---NF 327
           +H DIKP NIL+D N   +++DFG +     E+  V  S   GT  Y++PE++       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 328 GTVSCKSDVYGFGMVLLEMAGG 349
           G    + D +  G+ + EM  G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	453
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.98
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.98
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG1152	772	consensus Signal transduction serine/threonine kin	99.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.9
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
PRK09188	365	serine/threonine protein kinase; Provisional	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.71
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
smart00090	237	RIO RIO-like kinase.	99.69
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
PRK12274	218	serine/threonine protein kinase; Provisional	99.67
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.62
PRK14879	211	serine/threonine protein kinase; Provisional	99.6
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.57
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.54
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.54
PRK10345	210	hypothetical protein; Provisional	99.51
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.47
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.39
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.35
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.33
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.14
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.06
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.95
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.88
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.81
COG4248	637	Uncharacterized protein with protein kinase and he	98.8
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.7
KOG3087	229	consensus Serine/threonine protein kinase [General	98.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.61
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.61
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.51
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.5
KOG1243	690	consensus Protein kinase [General function predict	98.49
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.44
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.27
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.2
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.1
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.09
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.06
PRK09902	216	hypothetical protein; Provisional	97.93
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.9
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.64
PF01636	239	APH: Phosphotransferase enzyme family This family	97.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.28
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.27
PRK10593	297	hypothetical protein; Provisional	96.93
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.87
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.8
PLN02876	822	acyl-CoA dehydrogenase	96.76
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.75
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.4
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.38
PF14380	94	WAK_assoc: Wall-associated receptor kinase C-termi	96.26
KOG2270	520	consensus Serine/threonine protein kinase involved	96.25
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.25
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.15
COG2334	331	Putative homoserine kinase type II (protein kinase	96.09
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.02
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.91
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	95.9
PRK05231	319	homoserine kinase; Provisional	95.9
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	95.85
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	95.57
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.54
PLN02236	344	choline kinase	95.43
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	94.76
PRK06148	1013	hypothetical protein; Provisional	93.91
PF13947	106	GUB_WAK_bind: Wall-associated receptor kinase gala	93.7
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.61
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	93.35
PRK11768	325	serine/threonine protein kinase; Provisional	93.06
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	92.71
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	92.61
PHA03111	444	Ser/Thr kinase; Provisional	92.41
PLN02756	418	S-methyl-5-thioribose kinase	91.48
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	91.19
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	90.83
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	89.87
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	89.7
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	89.18
PRK10271	188	thiK thiamine kinase; Provisional	88.19
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	88.04
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	87.75

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-53  Score=422.40  Aligned_cols=269  Identities=43%  Similarity=0.750  Sum_probs=226.4

Q ss_pred             ccccchhHHHHHhhhhh--cccCccCceEEEEEEEcCCcEEEEEEecCCCCC-HHHHHHH--------------Hhcccc
Q 048517          150 VDNILLPEIIAVTNHFT--HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCS  212 (453)
Q Consensus       150 ~~~~~~~~~~~~~~~~~--~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~  212 (453)
                      ...+...++..+|++|.  +.||+||||.||+|.+++|+.||||++...... ..+|.+|              |+|||.
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            34577889999999999  689999999999999999999999998876554 5668777              799999


Q ss_pred             cCc-ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517          213 EGF-KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  291 (453)
Q Consensus       213 ~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  291 (453)
                      +.. .++||||||+||+|.++|+.....  .++|.+|++||.++|+||+|||+.|.++|+||||||+|||||+++++||+
T Consensus       142 e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             cCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            998 499999999999999999875543  88999999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCC-CCCceeeccc-CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHH
Q 048517          292 DFGLAKFHPK-ENDFVSISDT-RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV  369 (453)
Q Consensus       292 DFGla~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  369 (453)
                      |||+|+..+. ....   ... .||.||+|||++..  +.++.|+|||||||+|+||+||+++.+..... .+..+..|.
T Consensus       220 DFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~-~~~~l~~w~  293 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSV---STTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-GELSLVEWA  293 (361)
T ss_pred             CccCcccCCccccce---eeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCc-ccccHHHHH
Confidence            9999987765 3221   122 89999999999976  58999999999999999999999998865522 344588898


Q ss_pred             HHHhhhCCCccccchh----hhHH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          370 YDQLNKGGDLELRNVT----EIES-MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       370 ~~~l~~~~~~~~~~~~----~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ...+.++...++.+..    .... ....++..++.+|++.+|++||+|.+|+++|+.....
T Consensus       294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            8887776443333322    1221 4566799999999999999999999999999765443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=355.75  Aligned_cols=244  Identities=32%  Similarity=0.502  Sum_probs=197.3

Q ss_pred             hhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCc-ceEEEEEecCC
Q 048517          165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGF-KRALVYEYMPN  226 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~-~~~lv~E~~~~  226 (453)
                      +.+.||+|+||+||+|.++....||||++......   .++|.+|              ++|.|.+.. ..++|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            44569999999999999995555999999875433   3356555              688888877 78999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc-eeecccCCcceEEcCCC-ceEEEecCCccccCCCCC
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC-ILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~~  304 (453)
                      |+|.++++..  ....+++..++.++.+||+||+|||++   + ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            9999999764  357899999999999999999999998   6 99999999999999997 99999999998765432 


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                       ...+...||+.|||||++.+....++.|+||||||+++|||+||+.||.....       ..-+......+.+..+.  
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~~Rp~~p--  268 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGGLRPPIP--  268 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCC--
Confidence             23355789999999999984223799999999999999999999999976543       11233333444444332  


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                          ......+..++.+||+.||+.||++.+++.+|+.....+.
T Consensus       269 ----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  269 ----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             ----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                2255678999999999999999999999999997665443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=359.30  Aligned_cols=247  Identities=30%  Similarity=0.487  Sum_probs=210.1

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      ++......+.++||+|-||.||.|.++....||||.++......++|+.|              ++|+|..+...+||||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            44555566789999999999999999988899999999887788888766              7899999889999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      ||++|+|.++|..  ..+..+...+.+.++.|||+|++||+++   ++|||||.++|||++++..+||+|||||+.... 
T Consensus       282 ~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-  355 (468)
T KOG0197|consen  282 YMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD-  355 (468)
T ss_pred             ecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC-
Confidence            9999999999954  3457899999999999999999999998   999999999999999999999999999995444 


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      +.+.......-++.|.|||++..  +.+|.||||||||++||||+| |+.|+......        -+.+.+++|.+..-
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------ev~~~le~GyRlp~  425 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------EVLELLERGYRLPR  425 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHH--------HHHHHHhccCcCCC
Confidence            44444455667889999999975  589999999999999999999 77776654432        27788888887654


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      +      ...+..+.+++..||+.+|++|||++.+...|+....
T Consensus       426 P------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  426 P------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             C------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            3      3355779999999999999999999999999986443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=323.36  Aligned_cols=233  Identities=27%  Similarity=0.369  Sum_probs=185.1

Q ss_pred             hcccCccCceEEEEEEEc-CCcEEEEEEecCC--CCCHHHHHHH--------------HhcccccCc-ceEEEEEecCCC
Q 048517          166 THKLGQGGFGSVYKGQLH-TGRLIAVKMMENS--KFSAEEFINE--------------LLGLCSEGF-KRALVYEYMPNG  227 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~~-~~~lv~E~~~~g  227 (453)
                      .+.||+|.-|+|||++++ +++.+|+|.+...  .....+.++|              .+|.|.... ...++||||++|
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG  163 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG  163 (364)
T ss_pred             hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence            467999999999999965 7899999999543  3334455555              456666666 499999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      ||++.+..    .+.+++..+-.|+.++++||.|||+.  ..||||||||+|||++..|.+||+|||.++.....    .
T Consensus       164 SLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~  233 (364)
T KOG0581|consen  164 SLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----I  233 (364)
T ss_pred             CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----h
Confidence            99998842    25689999999999999999999963  39999999999999999999999999999876543    2


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      ..+..||..|||||.+.+.  .|+.++||||||++++|+.+|+-|+.......  ... ...+..+..+....++.    
T Consensus       234 a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~--~~~-~~Ll~~Iv~~ppP~lP~----  304 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY--LDI-FELLCAIVDEPPPRLPE----  304 (364)
T ss_pred             cccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCC--CCH-HHHHHHHhcCCCCCCCc----
Confidence            3567899999999999975  89999999999999999999999987652111  111 11233444333322211    


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       ...+++++.++..||+.||.+|||+.|+++
T Consensus       305 -~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  305 -GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             146788999999999999999999999987

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-42  Score=328.62  Aligned_cols=245  Identities=25%  Similarity=0.346  Sum_probs=196.9

Q ss_pred             chhHHHHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH-------HHH-HHH--------------Hhcc
Q 048517          154 LLPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA-------EEF-INE--------------LLGL  210 (453)
Q Consensus       154 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~-------~~~-i~e--------------l~g~  210 (453)
                      ..|+.....|-+.+.||+|+||.|-+|. .++|+.||||++++.+...       ... .+|              +.++
T Consensus       165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~  244 (475)
T KOG0615|consen  165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF  244 (475)
T ss_pred             CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence            3455566677788999999999999998 5689999999998632211       111 122              6788


Q ss_pred             cccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---Cc
Q 048517          211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FI  287 (453)
Q Consensus       211 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~  287 (453)
                      +......|+|||||+||.|.+.+..    ...+....-..+++|++.|+.|||++   +|+||||||+|||+..+   ..
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~l  317 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCL  317 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceE
Confidence            8888888999999999999998853    35677778899999999999999998   99999999999999765   88


Q ss_pred             eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCC-CccchHHHHHHHHHHHHcCCCCCCCCccccccccch
Q 048517          288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP  366 (453)
Q Consensus       288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  366 (453)
                      +||+|||+|+......   -+.+.+||+.|.|||++.+....+ ..|.|+||+||+||-+++|.+||.......      
T Consensus       318 lKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------  388 (475)
T KOG0615|consen  318 LKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------  388 (475)
T ss_pred             EEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------
Confidence            9999999999876433   356789999999999998753333 348999999999999999999997544322      


Q ss_pred             HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       -..+++.++....-   ......++++...++.|||+.||++|||+.|+++
T Consensus       389 -sl~eQI~~G~y~f~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  389 -SLKEQILKGRYAFG---PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -cHHHHHhcCccccc---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             15566766654322   2356678889999999999999999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-41  Score=336.71  Aligned_cols=232  Identities=24%  Similarity=0.377  Sum_probs=194.5

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecC----CCCCHHHHHHH--------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMEN----SKFSAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~----~~~~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      .+|...+.||+|||..||+++. .+|..||+|++.+    .....+...+|              +++++++....|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4567778899999999999995 8999999999976    22233333333              789999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      |+|++|+|..++.    ....++++++..+..||+.||.|||+.   +|+|||||..|+||+++.++||+|||||.....
T Consensus        98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999998873    347899999999999999999999998   999999999999999999999999999998875


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ++..  ..+.+|||.|+|||++.+.  ..+..+||||+||++|-|+.|++||+...-.        ..++.+....-.  
T Consensus       171 ~~Er--k~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk--------ety~~Ik~~~Y~--  236 (592)
T KOG0575|consen  171 DGER--KKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVK--------ETYNKIKLNEYS--  236 (592)
T ss_pred             cccc--cceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHH--------HHHHHHHhcCcc--
Confidence            5432  2567899999999999865  7899999999999999999999999765422        255555554332  


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           .+..++....+|+..+|+.+|.+|||+++|+.
T Consensus       237 -----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 -----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 23345567788999999999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-41  Score=308.12  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=198.0

Q ss_pred             HHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH---HHHHHH--------------Hhc-ccccCcc-eEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---EEFINE--------------LLG-LCSEGFK-RAL  219 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g-~~~~~~~-~~l  219 (453)
                      ...+.+.++||+|.||+||++. +.+|..||.|.++....+.   .+.+.|              .++ .+.+... .+|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            3456778899999999999998 7799999999887643332   233333              233 2223333 789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc--eeecccCCcceEEcCCCceEEEecCCcc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ||||+..|+|...+......++.++++.+|+++.|+++||..+|++- ++  |+||||||.||+|++++.+||+||||++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence            99999999999999877777889999999999999999999999942 24  9999999999999999999999999999


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ++..+..+  .....|||.||+||.+...  +++.||||||+||++|||+.-++||...+-       .+ ..+.+.++.
T Consensus       177 ~l~s~~tf--A~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-------~~-L~~KI~qgd  244 (375)
T KOG0591|consen  177 FLSSKTTF--AHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNL-------LS-LCKKIEQGD  244 (375)
T ss_pred             HhcchhHH--HHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccH-------HH-HHHHHHcCC
Confidence            98766543  2567899999999999876  899999999999999999999999975421       11 344556654


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ...+     ...-++..+.+++..|+..||+.||+...+++.+...++
T Consensus       245 ~~~~-----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~  287 (375)
T KOG0591|consen  245 YPPL-----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD  287 (375)
T ss_pred             CCCC-----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence            3222     224578899999999999999999997666666665443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=316.00  Aligned_cols=232  Identities=25%  Similarity=0.428  Sum_probs=181.2

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.++||+|+||+||+|++. ++..||||.+.+.+...   +-.+.|              |+.++...+..+||||||
T Consensus        12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC   91 (429)
T KOG0595|consen   12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC   91 (429)
T ss_pred             ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence            456678999999999999954 78999999987754322   211222              677888889999999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC------CceEEEecCCccc
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN------FIPKVSDFGLAKF  298 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~------~~~kl~DFGla~~  298 (453)
                      .+|+|.+||...    ..+++.....++.|+|.||++||++   +||||||||+||||+.+      -.+||+|||+|+.
T Consensus        92 ~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   92 NGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            999999999543    4799999999999999999999998   99999999999999764      5789999999998


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ......   ..+.+|++-|||||++...  +|+.|+|+||+|++||+|++|+.||+.....+        ....++++..
T Consensus       165 L~~~~~---a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e--------L~~~~~k~~~  231 (429)
T KOG0595|consen  165 LQPGSM---AETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPKE--------LLLYIKKGNE  231 (429)
T ss_pred             CCchhH---HHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhcccc
Confidence            875432   3567899999999999754  89999999999999999999999997544221        2224444433


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...    ..+...+..+.++....++.+|.+|-+..+-..
T Consensus       232 ~~~----~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  232 IVP----VLPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             ccC----chhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence            221    133344445567777778888888877766543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.3e-40  Score=325.79  Aligned_cols=249  Identities=26%  Similarity=0.420  Sum_probs=186.5

Q ss_pred             HHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCCC--HHHHHHH---------------Hhccccc-Cc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSE-GF  215 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~-~~  215 (453)
                      ...+.+.++||+|+||.||+|..      .+++.||||++......  ...+..|               +++.|.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            34567789999999999999974      23578999998753321  2234444               3344443 34


Q ss_pred             ceEEEEEecCCCChhhhhhhccCC--------------------------------------------------------
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENK--------------------------------------------------------  239 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  239 (453)
                      ..+++|||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            578999999999999988642210                                                        


Q ss_pred             --CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCc
Q 048517          240 --GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY  317 (453)
Q Consensus       240 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  317 (453)
                        ...+++.++..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...............+|+.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              13588889999999999999999998   9999999999999999999999999999865443332233345567899


Q ss_pred             cChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHH
Q 048517          318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLC  396 (453)
Q Consensus       318 ~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~  396 (453)
                      +|||++.+.  .++.++||||||+++|||++ |+.||......       ......+..+.....      +...+..+.
T Consensus       243 ~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDGTRMRA------PENATPEIY  307 (338)
T ss_pred             cCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcCCCCCC------CCCCCHHHH
Confidence            999998764  78999999999999999997 99998653321       112233333322211      122345688


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          397 MIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       397 ~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      +++.+||+.||++|||+.+++++|+..+.+
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999976553

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.5e-41  Score=347.96  Aligned_cols=246  Identities=28%  Similarity=0.453  Sum_probs=205.0

Q ss_pred             HhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ..-.+.++||+|.||.||+|+..      +...||||.|+....  ...+|.+|              |+|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            33446688999999999999853      345799999998544  35667666              799999999999


Q ss_pred             EEEEecCCCChhhhhhhccCC----------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCce
Q 048517          219 LVYEYMPNGSLDRHIFSKENK----------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP  288 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~  288 (453)
                      +|+|||..|+|.++|......          ...|+..+.+.||.|||.|++||-++   .+|||||..+|+|+.++..+
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence            999999999999999643221          23388899999999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchH
Q 048517          289 KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPS  367 (453)
Q Consensus       289 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  367 (453)
                      ||+||||+|-.-..+.+.......-.++||+||.|..  +.+|.+||||||||+|||+++ |+.|+.....++       
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------  713 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------  713 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence            9999999997766666554445567889999999974  699999999999999999998 888887654432       


Q ss_pred             HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                       +.+.+.+++.+.      -++..+.++..|+..||+.+|++||+++||-..|+...+
T Consensus       714 -VIe~i~~g~lL~------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  714 -VIECIRAGQLLS------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -HHHHHHcCCccc------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence             777788877654      344456789999999999999999999999999987544

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=324.96  Aligned_cols=250  Identities=27%  Similarity=0.491  Sum_probs=193.8

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEE
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      |......+...||+|.||+||+|++..  .||||+++......   +.|-+|              +.|+|..... ++|
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            333344456889999999999999883  59999998855443   445555              5688877665 999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      ..||++.+|+.+|+-.+   ..|...+.+.||.|||+|+.|||.+   +|||||||..||+|.++++|||+||||+....
T Consensus       466 TqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             ehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeee
Confidence            99999999999997654   5688999999999999999999999   99999999999999999999999999997544


Q ss_pred             CCCCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      .-..........|...|||||++.. ...++++.+||||||+|+|||++|..|+.....++  ..|      .+.+|.. 
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--Iif------mVGrG~l-  610 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--IIF------MVGRGYL-  610 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--eEE------Eeccccc-
Confidence            3222223455668899999999863 23488999999999999999999999998443322  111      1112210 


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                       ..+.........+.|.+|+..||..++++||.+.+++.+|+..+..
T Consensus       611 -~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  611 -MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             -CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence             1111223445567899999999999999999999999999876553

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=335.04  Aligned_cols=248  Identities=27%  Similarity=0.430  Sum_probs=199.0

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc-C---CcEEEEEEecCC--CCCHHHHHHH--------------HhcccccCcc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-T---GRLIAVKMMENS--KFSAEEFINE--------------LLGLCSEGFK  216 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~---g~~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~~~  216 (453)
                      ||....-.+.+.||.|.||.|++|+++ .   ...||||.|+..  .....+|+.|              |.|+......
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            333333345577999999999999975 2   347999999873  4456788887              5666677778


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++|.|||+||+|+.+|...   ...|+|.++..++.+||.|+.||-+.   ++|||||..+|||++.|..+||+||||+
T Consensus       705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence            89999999999999999433   35699999999999999999999986   9999999999999999999999999999


Q ss_pred             cccCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhh
Q 048517          297 KFHPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       297 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      |....+... .......-+++|.|||.+.-  ..+|.+|||||||+++||.++ |.+|+......+        +.+.++
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--------VIkaIe  848 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VIKAIE  848 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHH--------HHHHHH
Confidence            977554421 11122223578999999974  489999999999999999886 888886554322        677788


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ++-++..      +.+.+..|.+|+++|||+|..+||++.+++.+|++.+..
T Consensus       849 ~gyRLPp------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  849 QGYRLPP------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             hccCCCC------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            8777653      334557799999999999999999999999999987654

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=345.67  Aligned_cols=251  Identities=27%  Similarity=0.462  Sum_probs=202.0

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc--CCc----EEEEEEecCC--CCCHHHHHHH--------------HhcccccC
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH--TGR----LIAVKMMENS--KFSAEEFINE--------------LLGLCSEG  214 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~--~g~----~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~  214 (453)
                      ++...+-.+.+.||+|.||.||+|...  +|.    .||||.+...  ....++|++|              ++|.|-+.
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            344455556678999999999999854  343    4999999874  3345677777              88999999


Q ss_pred             cceEEEEEecCCCChhhhhhhccC---CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKEN---KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  291 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  291 (453)
                      ...++++|||++|+|..+|...+.   ....|+...++.++.+||+|+.||+++   .+|||||..+|+||++...+||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence            999999999999999999965421   246789999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517          292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  370 (453)
                      |||||+-....+.+.......-...|||||.+..  +.++.|+|||||||+|||++| |..|+...+...        +.
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v~  914 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------VL  914 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------HH
Confidence            9999996555555444334456789999999986  589999999999999999999 778886544322        34


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ....++.+++      .+.....++.+++..||+.+|++||++..+++.++.+...
T Consensus       915 ~~~~~ggRL~------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  915 LDVLEGGRLD------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             HHHHhCCccC------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            4333344443      3344567889999999999999999999999998876554

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=304.70  Aligned_cols=224  Identities=26%  Similarity=0.378  Sum_probs=180.8

Q ss_pred             hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHH----H--------------HHHHHhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAE----E--------------FINELLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~----~--------------~i~el~g~~~~~~~~~lv~E~  223 (453)
                      ..+.+.||+|+||.||..+ .++++.+|+|++++.+....    .              |+..|.-.+++..+++||+||
T Consensus        27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~  106 (357)
T KOG0598|consen   27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY  106 (357)
T ss_pred             eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence            3456889999999999998 55799999999987433221    1              112255567788899999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +.||.|..+|.    ....+++..+.-++.+|+.||.|||+.   +||||||||+|||||.+|+++|+||||++..-..+
T Consensus       107 ~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  107 LNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             cCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            99999999983    346799999999999999999999998   99999999999999999999999999999655443


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  .+...+||+.|||||++.+.  .++..+|.||+|+++|||++|.+||...+..        ..++.+.++.....  
T Consensus       180 ~--~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~--------~~~~~I~~~k~~~~--  245 (357)
T KOG0598|consen  180 D--ATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVK--------KMYDKILKGKLPLP--  245 (357)
T ss_pred             C--ccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHH--------HHHHHHhcCcCCCC--
Confidence            3  23457899999999999875  8999999999999999999999999765432        24455555442222  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCC
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRP  411 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  411 (453)
                          +.-++....+++...|+.+|++|-
T Consensus       246 ----p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  246 ----PGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ----CccCCHHHHHHHHHHhccCHHHhc
Confidence                122345688899999999999995

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=314.68  Aligned_cols=229  Identities=28%  Similarity=0.393  Sum_probs=187.5

Q ss_pred             hcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHH-HHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF-INE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~-i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      -.+||+|+-|.||.+. ..+++.||||++...+...++. ++|              .+.-+..+...++|||||++|+|
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            4689999999999998 6689999999998866655543 233              34444455789999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      .+.+     ....+++.++..|+.++++||+|||.+   +|+|||||.+|||++.++.+||+|||++.........  -.
T Consensus       358 TDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~  427 (550)
T KOG0578|consen  358 TDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RS  427 (550)
T ss_pred             hhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--cc
Confidence            8887     234589999999999999999999998   9999999999999999999999999999887665542  25


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ...||+.|||||++.+.  .|.+|.||||||++++||+-|.+||-.....        -....+......++.    .+.
T Consensus       428 TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--------rAlyLIa~ng~P~lk----~~~  493 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGTPKLK----NPE  493 (550)
T ss_pred             cccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChH--------HHHHHHhhcCCCCcC----Ccc
Confidence            67899999999999886  8999999999999999999999999653221        122233333443332    344


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          390 MIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .++..+.+++.+||+.|+++|||++|+|+
T Consensus       494 klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  494 KLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            56778999999999999999999999987

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-37  Score=314.74  Aligned_cols=246  Identities=26%  Similarity=0.427  Sum_probs=186.2

Q ss_pred             HHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCC--CHHHHHHH---------------HhcccccCcc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKF--SAEEFINE---------------LLGLCSEGFK  216 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~~~~~  216 (453)
                      ...+.+.++||+|+||.||+|+.      .++..||||+++....  ..+.+.+|               +++.|..+..
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            44567789999999999999963      2466899999975332  12233333               5667778888


Q ss_pred             eEEEEEecCCCChhhhhhhccC----------------------------------------------------------
Q 048517          217 RALVYEYMPNGSLDRHIFSKEN----------------------------------------------------------  238 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------  238 (453)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998854221                                                          


Q ss_pred             -------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          239 -------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       239 -------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                                   ....++|..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         112578899999999999999999998   9999999999999999999999999999876544332


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                      .......++..|+|||.+.+.  .++.++||||||+++|||++ |..||......       ....+.+..+.....   
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~---  338 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYKMIKEGYRMLS---  338 (375)
T ss_pred             cccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHHHHHHHhCccCCC---
Confidence            222334567789999999764  78999999999999999998 78887543211       112233333222111   


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                         +...+..+.+++.+||+.||++|||+.+|+++|++.
T Consensus       339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence               111235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1e-37  Score=305.99  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=181.8

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcC-----------------CcEEEEEEecCCCC--CHHHHHHH--------------
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHT-----------------GRLIAVKMMENSKF--SAEEFINE--------------  206 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~-----------------g~~VAVK~l~~~~~--~~~~~i~e--------------  206 (453)
                      +..+.+.++||+|+||.||++..++                 +..||||.+.....  ...++..|              
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4456778999999999999997532                 34799999876422  22344444              


Q ss_pred             HhcccccCcceEEEEEecCCCChhhhhhhcc---------------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCcee
Q 048517          207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKE---------------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL  271 (453)
Q Consensus       207 l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  271 (453)
                      +++++......++||||+++|+|.+++....               .....++|..++.++.|++.||.|||+.   +|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            4566667778899999999999999885421               1123578899999999999999999998   999


Q ss_pred             ecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcC--
Q 048517          272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG--  349 (453)
Q Consensus       272 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg--  349 (453)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++..  +.++.++||||||+++|||+++  
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHHHccC
Confidence            999999999999999999999999986544333222334456889999999875  3789999999999999999874  


Q ss_pred             CCCCCCCccccccccchHHHHHHhhhCC-CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          350 RRNSNMNATRSSKAYFPSWVYDQLNKGG-DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       350 ~~p~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      ..|+......   . ....+...+.... .....    .+...+..+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus       239 ~~p~~~~~~~---~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         239 EQPYGELTDE---Q-VIENAGEFFRDQGRQVYLF----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCcCCHH---H-HHHHHHHHhhhcccccccc----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            4555432211   1 1111111111111 00000    111234568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-38  Score=305.54  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=189.1

Q ss_pred             HHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHH-----------------HHHHhcccccCc-ceEE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF-----------------INELLGLCSEGF-KRAL  219 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~-----------------i~el~g~~~~~~-~~~l  219 (453)
                      ...+|...++||.|.||+||+|+ ..+|..||||.++..-..-++.                 +..|..+..+.. .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            34578888999999999999999 6689999999988754444432                 222555555555 8899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||| ..+|.+.+..+   ...|+...+..|+.||.+||+|+|.+   ++.|||+||+|||+..+..+||+|||+||-.
T Consensus        88 VfE~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            99999 56888877443   57899999999999999999999998   9999999999999999999999999999976


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc----------chHHH
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY----------FPSWV  369 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~----------~~~~~  369 (453)
                      ....   ..+.-..|..|+|||++.+. +.|+.+.|+|++||+++|+.+-++-|...++.. +.+          ...|.
T Consensus       161 ~Skp---PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  161 RSKP---PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             ccCC---CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHHhCCCccccch
Confidence            5544   34667789999999999876 789999999999999999999998887655421 110          00111


Q ss_pred             H-HHhhhCCCcccc--c---hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          370 Y-DQLNKGGDLELR--N---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       370 ~-~~l~~~~~~~~~--~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      . ..+.........  .   ........+.+..+++.+|+++||++|||+++.+++
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1 111110000000  0   011112256788999999999999999999999985

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=299.33  Aligned_cols=255  Identities=25%  Similarity=0.328  Sum_probs=189.0

Q ss_pred             hhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC--------------HHHHHHHHhcccccC----cceEEEEEecC
Q 048517          164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS--------------AEEFINELLGLCSEG----FKRALVYEYMP  225 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~--------------~~~~i~el~g~~~~~----~~~~lv~E~~~  225 (453)
                      ++.+.||+|.||.||||+++ ++.||||++......              .++.|.++++.-..+    ...+||+||.+
T Consensus       213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             hhHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            35678999999999999998 599999999752211              123344455544433    37899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC------CCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG------CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      +|+|.+||.     ...++|....+|+..+++||+|||+.      +.++|+|||||++|||+.+|++..|+|||+|..+
T Consensus       292 kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  292 KGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             CCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            999999993     35789999999999999999999975      3468999999999999999999999999999987


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCC----CCCccchHHHHHHHHHHHHcCCCCCCCCcccccc----------ccc
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFG----TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK----------AYF  365 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~----------~~~  365 (453)
                      .............||.+|||||++.+...    ..-.+.||||+|.|||||+++-..+........+          ..+
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            65544333445789999999999986421    1123789999999999999976554322111111          112


Q ss_pred             hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          366 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       366 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ...-.-.+.+..+..+++.. ........+++.+..||..||+-|.|+.-|-+++.....
T Consensus       447 e~mq~~VV~kK~RP~~p~~W-~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAW-RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             HHHHHHHHhhccCCCChhhh-hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            22222233444454444433 222445678999999999999999999999998876443

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.9e-37  Score=299.33  Aligned_cols=230  Identities=19%  Similarity=0.294  Sum_probs=180.0

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCCH----HHHHHH--------------Hhccccc----CcceEEEEEec
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSE----GFKRALVYEYM  224 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~----~~~~~lv~E~~  224 (453)
                      ..||+|++|.||+|.. +|+.||||.+.......    +.+.+|              ++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4699999999999998 48999999998754433    334344              4565544    34678999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++|+|.+++..    ...++|.....++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999843    24689999999999999999999973  278899999999999999999999999998654322 


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh-hhCCCccccc
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL-NKGGDLELRN  383 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~  383 (453)
                          ....||..|+|||++.+....++.++|||||||++|||++|+.||......       . +...+ ..+.....  
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~-~~~~i~~~~~~~~~--  243 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------E-IYDLIINKNNSLKL--  243 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhcCCCCCC--
Confidence                234588999999999764457899999999999999999999999754321       1 22222 22222221  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                          +...+..+.+++.+||+.||++|||++++++.|+.
T Consensus       244 ----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        244 ----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             ----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence                11234568899999999999999999999999974

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.7e-37  Score=301.88  Aligned_cols=235  Identities=27%  Similarity=0.369  Sum_probs=179.2

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +...+.||+|+||.||++.. .+|+.||||.+.....    ....+.+|              +.+.+......++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            45568899999999999984 5899999999875321    12233333              34455667788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|..++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999998877532  234689999999999999999999998   99999999999999999999999999998754332


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   .....||..|+|||++.+.  .++.++|||||||++|||++|+.||........    ...+...+.... .    
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~-~----  222 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKEDQ-E----  222 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhccc-c----
Confidence            2   2345689999999999764  789999999999999999999999975433211    011111111111 1    


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                        ......+..+.+++.+||+.||++||+     ++++++
T Consensus       223 --~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 --EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              122234567889999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-37  Score=297.05  Aligned_cols=235  Identities=33%  Similarity=0.549  Sum_probs=180.1

Q ss_pred             hhcccCccCceEEEEEEEc-----CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          165 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~-----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.+.||+|.||.||+|.+.     .+..|+||+++.....  .+++++|              ++|+|......++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999976     3678999999663322  4556555              67888877789999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.++|...  ....+++.++..|+.|+++||.|||+.   +++|+||+++||+++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999654  235789999999999999999999998   99999999999999999999999999998774433


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .........+...|+|||.+...  .++.++||||||+++|||++ |+.|+.....        .-+...+.++..... 
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~-  226 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLPI-  226 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETTS-
T ss_pred             ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc--------cccccccccccccee-
Confidence            33333445678899999999764  68999999999999999999 6777654321        113344444433222 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                           +...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       227 -----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 -----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 112345688999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-37  Score=312.88  Aligned_cols=247  Identities=24%  Similarity=0.437  Sum_probs=184.8

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFK  216 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~  216 (453)
                      ...+.+.+.||+|+||.||+|+..      +++.||||++......  .+.+..|               +++.|.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            445667899999999999998732      3458999999764322  2233333               4566777788


Q ss_pred             eEEEEEecCCCChhhhhhhccC----------------------------------------------------------
Q 048517          217 RALVYEYMPNGSLDRHIFSKEN----------------------------------------------------------  238 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------  238 (453)
                      .++||||+++|+|.+++.....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            8999999999999998853210                                                          


Q ss_pred             --------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517          239 --------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD  310 (453)
Q Consensus       239 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  310 (453)
                              ....+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    113578889999999999999999998   999999999999999999999999999986544333222233


Q ss_pred             cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ..++..|+|||++.+.  .++.++||||||+++|||++ |+.||.......       .....+..+.....      +.
T Consensus       274 ~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~~~~~~~------~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKRGYQMSR------PD  338 (374)
T ss_pred             CCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHcccCccC------CC
Confidence            4567789999998753  78999999999999999997 999986533211       11222222211111      11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          390 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      ..+..+.+++.+||+.+|++|||+.+|+++|++++
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            12457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.2e-37  Score=296.70  Aligned_cols=241  Identities=24%  Similarity=0.361  Sum_probs=184.9

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      ...+.+.+.||+|+||.||+|+++    .+..||+|+++.....  .+.++.|              +++++..+...++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            445677899999999999999853    3678999998864322  2344444              4566677788999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||+++|+|.+++...   ...++|.+++.++.|++.||+|||+.   +++||||||+|||++.++.+|++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999988532   24689999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ...... ......++..|+|||.+.+  +.++.++||||||+++||+++ |+.||......        ...+.+.++..
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~  226 (266)
T cd05064         158 KSEAIY-TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGFR  226 (266)
T ss_pred             cccchh-cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCC
Confidence            222111 1122345678999999876  378999999999999999775 99998644321        12333333322


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      ..      .+...+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus       227 ~~------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 LP------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CC------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            21      1223456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.9e-37  Score=293.43  Aligned_cols=240  Identities=27%  Similarity=0.425  Sum_probs=187.6

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ..+.+.++||+|+||.||+|..++++.||+|.+.......+.+..|              +++.+......+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   85 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK   85 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence            3456678999999999999998888899999987655555555544              34566677778999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++...  ....+++.++..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||+++........ 
T Consensus        86 ~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05072          86 GSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-  159 (261)
T ss_pred             CcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence            9999988543  235689999999999999999999998   9999999999999999999999999999876443221 


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      ......++..|+|||++..  +.++.++||||||+++|||++ |+.||......        .....+........    
T Consensus       160 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~----  225 (261)
T cd05072         160 AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRGYRMPR----  225 (261)
T ss_pred             ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCCCC----
Confidence            1223446778999999875  378889999999999999998 88888643211        12222332222111    


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                        ....+..+.+++.+|++.+|++|||++++.++|+.
T Consensus       226 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 --MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              11234568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-37  Score=292.63  Aligned_cols=242  Identities=29%  Similarity=0.406  Sum_probs=188.9

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      ...++++.+.||+|+||.||+|..++++.||||.+.......+++..|              +++++......+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            345667789999999999999998888899999998765555566555              345667777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++....  ...+++..+..++.+++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++.......
T Consensus        84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            9999999885432  35689999999999999999999998   999999999999999999999999999987653221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                       ........+..|+|||++...  .++.++||||||++++||++ |+.|+......        -....+.......   
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~---  224 (261)
T cd05068         159 -EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------EVLQQVDQGYRMP---  224 (261)
T ss_pred             -cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC---
Confidence             111222334689999988753  78999999999999999999 88888643211        1222332222111   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                         .+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         225 ---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               112234678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=311.08  Aligned_cols=244  Identities=28%  Similarity=0.408  Sum_probs=205.0

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      +......+.++||-|-||.||.|.++ -.-.||||.|+.+....++|+.|              |+|+|......|||.|
T Consensus       264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            33333446789999999999999976 46789999999999999999877              8999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      ||.+|+|.+||..  -....++--.++.+|.||+.|++||..+   ++|||||..+|+|+.++-.+||+||||++++..+
T Consensus       344 fM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             cccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            9999999999943  3345677778899999999999999998   9999999999999999999999999999998776


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ... ......-.+.|.|||.+.-  ..++.|+|||+|||+|||+.| |..|+....-        ..++..++++.+.+ 
T Consensus       419 TYT-AHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqVY~LLEkgyRM~-  486 (1157)
T KOG4278|consen  419 TYT-AHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYGLLEKGYRMD-  486 (1157)
T ss_pred             cee-cccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHHHHHHhcccccc-
Confidence            432 2233445778999998864  589999999999999999998 7777754331        23888888887654 


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                           .+..+..++.+|+++||++.|.+||++.|+-+.+|.+
T Consensus       487 -----~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  487 -----GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             -----CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence                 4445668899999999999999999999999888754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=296.38  Aligned_cols=246  Identities=21%  Similarity=0.296  Sum_probs=189.7

Q ss_pred             HhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHH-HHHH-H--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAE-EFIN-E--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~-~~i~-e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..|.+.+.||.|.-++||+|+ .+.+..||||+++.++.+.+ +.+. |              .+..+..++.+++||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            356778899999999999999 66889999999998766554 3333 3              23334567789999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      |.+||+.+.+...-  ...+.+..+..|++++++||.|||++   +.||||||+.||||+.+|.+||+|||.+...-...
T Consensus       106 Ma~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999986532  35589999999999999999999998   99999999999999999999999999876543332


Q ss_pred             Cc-eee-cccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC-cc
Q 048517          304 DF-VSI-SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD-LE  380 (453)
Q Consensus       304 ~~-~~~-~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~-~~  380 (453)
                      .. ... ....||+.|||||++.+....|+.|+||||||++..||.+|..||...-..       +.....+..... ..
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------kvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------KVLLLTLQNDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------HHHHHHhcCCCCCcc
Confidence            22 111 456899999999997776678999999999999999999999999532211       112222222211 01


Q ss_pred             c-cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 L-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      . ....+....+...+.+++..||+.||.+|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0 0112244556678999999999999999999999886

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-36  Score=294.45  Aligned_cols=244  Identities=26%  Similarity=0.424  Sum_probs=187.2

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcce
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKR  217 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~  217 (453)
                      ..++.+.+.||+|+||.||+|+..      +++.||||.+......  .+++.+|              +++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            456778899999999999999863      3578999998764333  2334333              45666777889


Q ss_pred             EEEEEecCCCChhhhhhhcc----------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517          218 ALVYEYMPNGSLDRHIFSKE----------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  287 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~  287 (453)
                      +++|||+++|+|.+++....          .....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999986432          1234588999999999999999999998   9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccch
Q 048517          288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFP  366 (453)
Q Consensus       288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  366 (453)
                      +||+|||+++...............+++.|+|||++...  .++.++||||||+++|||++ |+.||.......      
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------  232 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------  232 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence            999999999865433222222334567889999998763  78999999999999999998 999986433211      


Q ss_pred             HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                        ..+.+..+....      .+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus       233 --~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         233 --VIECITQGRLLQ------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --HHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              222222222211      112244678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.5e-37  Score=291.65  Aligned_cols=236  Identities=25%  Similarity=0.442  Sum_probs=185.2

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      .+.+.++||+|+||.||+++.+++..+|+|.+.......+++..|              +++++......+++|||+++|
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG   84 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence            455678899999999999998888899999987765555666555              456777788899999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.+++....   ..++|..+..++.+++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus        85 ~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05114          85 CLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS  157 (256)
T ss_pred             cHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence            9999885322   3589999999999999999999998   999999999999999999999999999986543222 11


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      .....++..|+|||.+...  .++.++||||||+++|||++ |+.|+......       . ....+.++.....     
T Consensus       158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~-~~~~i~~~~~~~~-----  222 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------E-VVEMISRGFRLYR-----  222 (256)
T ss_pred             cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHHCCCCCCC-----
Confidence            2233456789999998753  68899999999999999999 88888643321       1 2223333222111     


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                       +...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       223 -~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         223 -PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence             111235689999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-37  Score=286.94  Aligned_cols=244  Identities=25%  Similarity=0.332  Sum_probs=182.5

Q ss_pred             hhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH-----------------HHHHHHHhcccccCcceEEEEEecC
Q 048517          164 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA-----------------EEFINELLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~-----------------~~~i~el~g~~~~~~~~~lv~E~~~  225 (453)
                      +-..++|+|+||.||+++. ++|+.||||++..+..+.                 ++.+..|+..|....+.+||+||++
T Consensus         5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d   84 (396)
T KOG0593|consen    5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD   84 (396)
T ss_pred             hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence            3446899999999999995 479999999998754432                 1234448889999999999999997


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      .--|+ .|   +.....++.+.+.+++.|+++|+.|+|++   +++||||||+|||++.++.+||+|||.|+....... 
T Consensus        85 hTvL~-eL---e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   85 HTVLH-EL---ERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             hHHHH-HH---HhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence            65443 33   33446788999999999999999999998   999999999999999999999999999998764332 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH--------HHhhhCC
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY--------DQLNKGG  377 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~l~~~~  377 (453)
                       ..+.-..|..|.|||.+.+. .+|....|||++||++.||++|.+-|...++- .+.+......        +.+....
T Consensus       157 -~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-DQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  157 -NYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-DQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             -hhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchH-HHHHHHHHHHcccCHHHHHHhccCC
Confidence             23566789999999999875 48899999999999999999999877654432 1222111111        1111111


Q ss_pred             ------CccccchhhhHH---HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 ------DLELRNVTEIES---MIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ------~~~~~~~~~~~~---~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                            ..++......+.   .++.-+.+++..||++||++|+|-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                  111111111222   23456889999999999999999998874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=297.74  Aligned_cols=241  Identities=29%  Similarity=0.346  Sum_probs=180.2

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH-HHHHHH--------------HhcccccCc--ceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA-EEFINE--------------LLGLCSEGF--KRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~-~~~i~e--------------l~g~~~~~~--~~~lv~E~  223 (453)
                      .+...+.||+|+||+||++... +|...|||......... +....|              .+|......  ...+.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            3556688999999999999954 59999999887652111 112222              234322222  57899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~  302 (453)
                      +++|+|.+++...  .+ .|+.+.+..+..||++||+|||++   +|+|+||||+|||++. ++.+||+|||+++.....
T Consensus        98 ~~~GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   98 APGGSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             cCCCcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999998432  22 699999999999999999999998   9999999999999999 799999999999866531


Q ss_pred             CC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          303 ND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       303 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      .. .......+||+.|||||++... .....++||||+||++.||+||++|+...      .....+...........  
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P--  242 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLP--  242 (313)
T ss_pred             cccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCC--
Confidence            11 1122456899999999999851 13345999999999999999999998642      11122222222222111  


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                          ..+..++....+++..|++.+|++|||++++++..-
T Consensus       243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence                244456778899999999999999999999998554

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-36  Score=291.40  Aligned_cols=240  Identities=29%  Similarity=0.436  Sum_probs=186.4

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .+.+.++||+|+||.||+|... +++.||+|.+..+....+++..|              +++++......+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            4566789999999999999954 68899999988765544555444              45677777888999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      ++|.+++...  ....+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++....... .
T Consensus        87 ~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~  160 (263)
T cd05052          87 GNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  160 (263)
T ss_pred             CcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence            9999988432  235689999999999999999999998   999999999999999999999999999986644321 1


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      ......++.+|+|||.+...  .++.++||||||+++|||++ |..|+......        -..+.+......+     
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~-----  225 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKGYRME-----  225 (263)
T ss_pred             ccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCC-----
Confidence            11223346789999988754  78899999999999999998 88887643211        1222333221111     


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                       .+...+..+.+++.+||+.+|++|||+.+++++|+..
T Consensus       226 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 -RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             1122346788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.8e-37  Score=295.40  Aligned_cols=242  Identities=25%  Similarity=0.430  Sum_probs=185.7

Q ss_pred             hhhhhcccCccCceEEEEEEEcC-C-----cEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHT-G-----RLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~-g-----~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      .+.+.+.||+|+||.||+|.... +     +.||+|.+.....  ...++.+|              +++++......++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            45677899999999999998542 2     5799999875332  12334333              3456666777899


Q ss_pred             EEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517          220 VYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  287 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~  287 (453)
                      +|||+++|+|.+++.....            ....+++.+++.++.|++.||.|||+.   +++|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence            9999999999999864321            114688899999999999999999998   9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccch
Q 048517          288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFP  366 (453)
Q Consensus       288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  366 (453)
                      +||+|||+++...............+++.|+|||.+...  .++.++|||||||++|||++ |+.||......       
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------  233 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------  233 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence            999999999865443322223344578899999998753  78999999999999999998 99898643321       


Q ss_pred             HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                       -+...+..+....      .+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus       234 -~~~~~i~~~~~~~------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 -EVIEMIRSRQLLP------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHHHcCCcCC------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             1333333332221      223455779999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-38  Score=310.93  Aligned_cols=242  Identities=27%  Similarity=0.418  Sum_probs=193.4

Q ss_pred             ccCccCceEEEEEEEcCCcEEEEEEecCCCCCH--------HHHHHHHhcccccCcceEEEEEecCCCChhhhhhhccCC
Q 048517          168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA--------EEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENK  239 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~--------~~~i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~  239 (453)
                      =||.|+.|.||+|+++ ++.||||+++.-+...        ++.|.++.|+|....-.+||||||..|-|...|.    .
T Consensus       131 WlGSGaQGAVF~Grl~-netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk----a  205 (904)
T KOG4721|consen  131 WLGSGAQGAVFLGRLH-NETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK----A  205 (904)
T ss_pred             hhccCcccceeeeecc-CceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh----c
Confidence            4999999999999998 7899999887644333        3345568899999999999999999999999984    3


Q ss_pred             CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccC
Q 048517          240 GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA  319 (453)
Q Consensus       240 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  319 (453)
                      +..++......+.++||.|+.|||.+   .|||||||.-||||..+..+||+|||-++......+   .....||..|||
T Consensus       206 ~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMSFaGTVaWMA  279 (904)
T KOG4721|consen  206 GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMSFAGTVAWMA  279 (904)
T ss_pred             cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hhhhhhhHhhhC
Confidence            46788888999999999999999998   999999999999999999999999999986655432   245679999999


Q ss_pred             hhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHH
Q 048517          320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIG  399 (453)
Q Consensus       320 PE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~  399 (453)
                      ||++...  +.+.|+||||||||||||+||..|+..-+...           .+.......+.  ...+...++-+..|+
T Consensus       280 PEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------IIwGVGsNsL~--LpvPstcP~GfklL~  344 (904)
T KOG4721|consen  280 PEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------IIWGVGSNSLH--LPVPSTCPDGFKLLL  344 (904)
T ss_pred             HHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchhe-----------eEEeccCCccc--ccCcccCchHHHHHH
Confidence            9999875  89999999999999999999999986443211           11111111111  124455667788899


Q ss_pred             HHhcccCCCCCCCHHHHHHHHhCCCCC-CCCCCCCCC
Q 048517          400 LWCIQVKAADRPSMTKVLEMLEGSIDD-LQMPPKPFF  435 (453)
Q Consensus       400 ~~Cl~~~p~~RPs~~evl~~Le~~~~~-~~~p~~p~~  435 (453)
                      ++||+.+|..|||+.+++..|+-.-.+ +.++.+.+|
T Consensus       345 Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf  381 (904)
T KOG4721|consen  345 KQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYF  381 (904)
T ss_pred             HHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHH
Confidence            999999999999999999999865443 355544433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=305.65  Aligned_cols=233  Identities=26%  Similarity=0.369  Sum_probs=184.4

Q ss_pred             hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---------HH-HHHHH---------HhcccccCcceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---------AE-EFINE---------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---------~~-~~i~e---------l~g~~~~~~~~~lv~E  222 (453)
                      +.|.+.||+|+|++|++|+ ..+++.+|||++.+....         .| +.+..         |+-.+++...+|+|+|
T Consensus        75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe  154 (604)
T KOG0592|consen   75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE  154 (604)
T ss_pred             cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence            4578999999999999999 568999999998763211         11 11222         5566788889999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |.+||+|.++|.    +-+.|+......++.+|+.||+|||+.   +||||||||+|||||.|+++||+|||.|+.+...
T Consensus       155 ~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  155 YAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             ecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            999999999994    336799999999999999999999998   9999999999999999999999999999987543


Q ss_pred             CCc---------ee--ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517          303 NDF---------VS--ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  371 (453)
Q Consensus       303 ~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  371 (453)
                      ...         ..  .....||..|.+||++...  ..+..+|+|+|||+||.|+.|++||...++     |   .+.+
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----y---liFq  297 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANE-----Y---LIFQ  297 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccH-----H---HHHH
Confidence            221         11  1346799999999999864  889999999999999999999999976542     1   1233


Q ss_pred             HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      .+.+-   +.    +.+...++...+|+.+.|..||.+|+|.+++-+.
T Consensus       298 kI~~l---~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  298 KIQAL---DY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHh---cc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            33221   11    1222333667889999999999999999998774

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.8e-37  Score=304.97  Aligned_cols=251  Identities=27%  Similarity=0.377  Sum_probs=205.3

Q ss_pred             hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHH-----------------HHHHHhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE-----------------FINELLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~-----------------~i~el~g~~~~~~~~~lv~E~  223 (453)
                      .|.+.+.||+|+||.||||+ ..+.+.||+|.+.+.....++                 .+.+++..++...+.++|.||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            46677899999999999998 557999999999876554422                 244578888999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +.+ +|..+|.    ....++++.+..|+.++..||.|||+.   +|+|||+||+|||++.++++|++|||+|+.+..+.
T Consensus        83 a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   83 AVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            976 9999883    446799999999999999999999998   99999999999999999999999999999876543


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  ..+...|||-|||||...+  ..++..+|.||+||++||+.+|++||....       +...+. .+...       
T Consensus       155 ~--vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~-~I~~d-------  215 (808)
T KOG0597|consen  155 S--VLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVK-SILKD-------  215 (808)
T ss_pred             e--eeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHH-HHhcC-------
Confidence            3  4467789999999999986  489999999999999999999999996432       111111 22211       


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCCCCCCCCCCCCCCCCCC
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSIDDLQMPPKPFFSSSR  439 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~~~~~~~p~~p~~~~~~  439 (453)
                      ....+.+.+..+..++.-.|+.||..|.|-.+++.  +.++....++.|..+.+.+.-
T Consensus       216 ~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spf  273 (808)
T KOG0597|consen  216 PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPF  273 (808)
T ss_pred             CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCcc
Confidence            11233356678899999999999999999999987  678888888888888776553

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-36  Score=303.37  Aligned_cols=248  Identities=28%  Similarity=0.450  Sum_probs=184.7

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH---------------Hhcccc-cCc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCS-EGF  215 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~-~~~  215 (453)
                      ..++++.+.||+|+||.||+|...      +++.||+|++......  .+.+..|               +++.|. .+.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            346778899999999999999632      3578999998753321  1222222               334343 345


Q ss_pred             ceEEEEEecCCCChhhhhhhccCC--------------------------------------------------------
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENK--------------------------------------------------------  239 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  239 (453)
                      ..++++||+++|+|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            678999999999999988543210                                                        


Q ss_pred             -CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCcc
Q 048517          240 -GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL  318 (453)
Q Consensus       240 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  318 (453)
                       ...++|..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             13689999999999999999999998   99999999999999999999999999998764433322334456678899


Q ss_pred             ChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHH
Q 048517          319 APELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCM  397 (453)
Q Consensus       319 aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~  397 (453)
                      |||++.+.  .++.++|||||||+++||++ |+.||.......       .....+..+....      .+......+.+
T Consensus       243 aPE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------EFCRRLKEGTRMR------APEYATPEIYS  307 (337)
T ss_pred             CcHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------HHHHHHhccCCCC------CCccCCHHHHH
Confidence            99998764  78999999999999999997 998886432111       1222232222211      11223456889


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          398 IGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       398 l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ++.+||+.+|++||++.|++++|+..++
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-36  Score=317.43  Aligned_cols=240  Identities=25%  Similarity=0.316  Sum_probs=182.2

Q ss_pred             HhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH---HHHHHHHh--------------cccccC--------
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---EEFINELL--------------GLCSEG--------  214 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~---~~~i~el~--------------g~~~~~--------  214 (453)
                      ..|.+.+.||+|+||+||+++ ..+|+.||||++.......   ..+..|+.              ..+...        
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            467788999999999999998 5579999999987644332   23333321              111100        


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...++||||+++|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence            125799999999999999866544456789999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      +++...............||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....       .. +.....
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~-~~~~~~  258 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM-------EE-VMHKTL  258 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHh
Confidence            99876433222222345799999999999764  789999999999999999999999964321       11 222222


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      .+....      .+..++..+..++.+||+.+|++||++.++++.
T Consensus       259 ~~~~~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 AGRYDP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             cCCCCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            222111      122344678899999999999999999999864

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-36  Score=298.53  Aligned_cols=244  Identities=25%  Similarity=0.406  Sum_probs=183.4

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCc----EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGR----LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~----~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ...++..+.||+|+||.||+|++. +|+    .||||+++....  ..+++..|              ++|+|... ...
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            344566789999999999999853 444    489999875322  23344443              45555543 467


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +++||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            999999999999988532   24688999999999999999999998   999999999999999999999999999997


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ..............++..|+|||++.+.  .++.++||||||+++|||++ |+.|+......        -....+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~  228 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGE  228 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhCCC
Confidence            7544332222334457789999998764  78999999999999999998 99988643211        1222333332


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      .....      ......+..++.+||+.+|++|||+.++++.|.....+
T Consensus       229 ~~~~~------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         229 RLPQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CCCCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            22111      11234678899999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=290.64  Aligned_cols=241  Identities=27%  Similarity=0.420  Sum_probs=185.1

Q ss_pred             HhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ..+.+.+.||+|+||.||+|+..    +...||||.+......  ..++..|              +++++..+...+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            34567789999999999999864    2457999998764332  2345444              45556677788999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +|+|+||||+|||+++++.+||+|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999998532   24789999999999999999999997   99999999999999999999999999999775


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ............++..|+|||.+...  .++.++||||||++++||++ |+.|+......        ...+.+.+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRL  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            32222222234456789999998764  78899999999999999998 88887543211        122333332221


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      ..      +...+..+.+++.+||+.+|++||++++++++|++.
T Consensus       228 ~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 PP------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11      122345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.8e-36  Score=291.63  Aligned_cols=245  Identities=25%  Similarity=0.394  Sum_probs=183.6

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcc
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFK  216 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~  216 (453)
                      ....+.+.++||+|+||.||+|...      ++..||||.+.....  ...++..|              +++++..+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3455677899999999999999753      356799999865322  22234443              4566777788


Q ss_pred             eEEEEEecCCCChhhhhhhccCC------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517          217 RALVYEYMPNGSLDRHIFSKENK------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  290 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  290 (453)
                      .++||||+++|+|.+++......      ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999988543211      23568889999999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHH
Q 048517          291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  369 (453)
Q Consensus       291 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  369 (453)
                      +|||+++...............+++.|+|||.+.+  +.++.++||||||+++|||++ |..|+......        -.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~  230 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QV  230 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence            99999986544333222223356788999999875  378999999999999999999 67777543211        12


Q ss_pred             HHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      .+..........      +...+..+.+++.+||+.+|++|||+.|++++|++
T Consensus       231 ~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         231 LRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            222222221111      11233568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.5e-36  Score=307.39  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=187.2

Q ss_pred             HhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH---------------HhcccccCcce
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE---------------LLGLCSEGFKR  217 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~~~~~~  217 (453)
                      ..+.+.++||+|+||.||+|+..      .+..||||++.....  ..+.+++|               ++++|......
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            34566789999999999999842      234799999975332  22344444               56677778889


Q ss_pred             EEEEEecCCCChhhhhhhccC-----------------------------------------------------------
Q 048517          218 ALVYEYMPNGSLDRHIFSKEN-----------------------------------------------------------  238 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~-----------------------------------------------------------  238 (453)
                      ++||||+++|+|.+++.....                                                           
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            999999999999998864210                                                           


Q ss_pred             ---------------------------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC
Q 048517          239 ---------------------------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN  285 (453)
Q Consensus       239 ---------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~  285 (453)
                                                       ....+++..+..++.|+++||+|||+.   +|+|+||||+|||++.+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~  273 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence                                             113578889999999999999999998   99999999999999999


Q ss_pred             CceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccccc
Q 048517          286 FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY  364 (453)
Q Consensus       286 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~  364 (453)
                      +.+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+......     
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-----  346 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-----  346 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchh-----
Confidence            99999999999876443332233344577899999998763  78899999999999999997 88888643211     


Q ss_pred             chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          365 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       365 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                        ......+..+....      .+...+..+.+++.+||+.+|++|||+.+|+++|+..++
T Consensus       347 --~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 --STFYNKIKSGYRMA------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             --HHHHHHHhcCCCCC------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence              11222333322211      112345678899999999999999999999999997543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=310.33  Aligned_cols=240  Identities=29%  Similarity=0.454  Sum_probs=190.2

Q ss_pred             hhhcccCccCceEEEEEEEcC--C--cE-EEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQLHT--G--RL-IAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~~--g--~~-VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      .+.++||+|+||.||+|++..  +  .. ||||..+.+.    ....+|++|              ++|++....+.++|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            345899999999999999653  3  23 8999988632    234566666              79999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      ||+|+||+|+++|...   +..++..+++.++.+.|+||+|||++   +++||||..+|+|++.++.+||+||||++...
T Consensus       240 mEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            9999999999999432   23699999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeec-ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh-hhCC
Q 048517          301 KENDFVSIS-DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL-NKGG  377 (453)
Q Consensus       301 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l-~~~~  377 (453)
                      .   +.... ...-+..|+|||.+..  +.++.++|||||||++||+.+ |..|+......        .+...+ ..+.
T Consensus       314 ~---~~~~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~  380 (474)
T KOG0194|consen  314 Q---YVMKKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGY  380 (474)
T ss_pred             c---eeeccccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCc
Confidence            1   11112 2346789999999986  489999999999999999998 77787654322        233344 3343


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      +.....      ..+..+..++.+||+.+|++||||.++.+.|+.......
T Consensus       381 r~~~~~------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  381 RMPIPS------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             cCCCCC------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            333322      234567788889999999999999999999987666544

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.4e-36  Score=285.83  Aligned_cols=242  Identities=26%  Similarity=0.419  Sum_probs=190.1

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHHH--------------hcccccCcceEEEEEe
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINEL--------------LGLCSEGFKRALVYEY  223 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~el--------------~g~~~~~~~~~lv~E~  223 (453)
                      +...++++.++||+|+||.||+|..++++.||+|.+.......+++..|+              ++++ .....++++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~   81 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY   81 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence            45567888999999999999999988899999999987666666766662              2333 24457899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...  .+..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999999988532  345789999999999999999999997   99999999999999999999999999998765322


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      . .......++..|+|||++...  .++.++||||||++++||++ |+.||......        -..+.+.++..... 
T Consensus       157 ~-~~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-  224 (260)
T cd05067         157 Y-TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGYRMPR-  224 (260)
T ss_pred             c-ccccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCCCCCC-
Confidence            2 112334567889999998753  68899999999999999998 99998643321        12223333322221 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                           ....+..+.+++.+||+.+|++|||++++++.|+.
T Consensus       225 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 -----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 11234568999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.8e-36  Score=286.97  Aligned_cols=239  Identities=31%  Similarity=0.471  Sum_probs=188.1

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ..|.+.++||.|+||.||+|...+++.+|+|.+..... ...++..|              +++++......++||||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            44677899999999999999988899999999876543 23333333              5566777788899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++...  .+..+++.++..++.+++.||+|||+.   +|+|+||||+||++++++.+||+|||++........ 
T Consensus        86 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          86 KGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            99999998543  345689999999999999999999998   999999999999999999999999999986643321 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                       ......++..|+|||.+...  .++.++||||||+++++|++ |+.|+......        .....+..+....    
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~----  224 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAGYRMP----  224 (261)
T ss_pred             -cccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhCCcCC----
Confidence             12344567889999998753  78899999999999999998 88888643311        1222232222211    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                        .+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       225 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 --CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence              112334568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=334.98  Aligned_cols=243  Identities=23%  Similarity=0.416  Sum_probs=185.1

Q ss_pred             hhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHH-----------HHHHhcccccCcceEEEEEecCCCChhhh
Q 048517          165 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEF-----------INELLGLCSEGFKRALVYEYMPNGSLDRH  232 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~-----------i~el~g~~~~~~~~~lv~E~~~~gsL~~~  232 (453)
                      ..+.||+|+||.||+|+. .+|+.||||.+.......+++           +.+++++|......++||||+++|+|.++
T Consensus       694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~  773 (968)
T PLN00113        694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV  773 (968)
T ss_pred             cccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHH
Confidence            345799999999999996 589999999987643332222           22378888888889999999999999999


Q ss_pred             hhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccC
Q 048517          233 IFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR  312 (453)
Q Consensus       233 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  312 (453)
                      +.       .++|.++..|+.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||........      ....
T Consensus       774 l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~  839 (968)
T PLN00113        774 LR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCF  839 (968)
T ss_pred             Hh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCcc
Confidence            83       38999999999999999999998777899999999999999999988886 6665433221      2336


Q ss_pred             CCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC-----Cccccchhhh
Q 048517          313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-----DLELRNVTEI  387 (453)
Q Consensus       313 gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~~~~  387 (453)
                      +|++|+|||++.+.  .++.|+|||||||++|||+||+.|++.....  ......|.........     +..+......
T Consensus       840 ~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (968)
T PLN00113        840 ISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSV  915 (968)
T ss_pred             ccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence            88999999998753  7899999999999999999999998643321  2234444433222111     0111111112


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ......++.+++.+||+.+|++||||+||+++|++...
T Consensus       916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            23344568899999999999999999999999997544

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.1e-36  Score=287.71  Aligned_cols=241  Identities=27%  Similarity=0.409  Sum_probs=187.1

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ...+.+.++||+|+||.||+|+.+++..||+|++.......+++..|              +++++ .....++||||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE-CCCCcEEEEEcCC
Confidence            34678889999999999999998777789999998765555666555              23333 2345789999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            99999998532  234679999999999999999999998   9999999999999999999999999999866543321


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                       ......++..|+|||+..+.  .++.++||||||+++|||++ |+.||.....        ....+.+..+....    
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~----  223 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMP----  223 (262)
T ss_pred             -cccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcCCCCC----
Confidence             12234567789999988653  78999999999999999999 7778754321        11223332222111    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                        .....+..+.+++.+|++.+|++||++.+++++|+..
T Consensus       224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              1223456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.1e-36  Score=286.17  Aligned_cols=237  Identities=28%  Similarity=0.464  Sum_probs=186.0

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      .+.+.+.||+|+||.||+|+..++..+|||.+.......+++.+|              +++++......+++|||+++|
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG   84 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence            356778999999999999998777789999988765555666555              467777777889999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.+++...   ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++....... ..
T Consensus        85 ~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05113          85 CLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS  157 (256)
T ss_pred             cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence            999988532   23689999999999999999999998   999999999999999999999999999986544322 11


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      .....++..|+|||.+...  .++.++||||||+++|||++ |+.|+......        -..+.+.++......    
T Consensus       158 ~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----  223 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGLRLYRP----  223 (256)
T ss_pred             cCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCCCCCCC----
Confidence            2233466789999999753  68889999999999999998 88888543221        122333333222111    


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                        ...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              113467899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.5e-36  Score=300.67  Aligned_cols=226  Identities=23%  Similarity=0.329  Sum_probs=174.7

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      +.||+|+||.||+++. .+|+.||||++.....    ...+++.|              +.+.+..+...++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999985 4799999999875321    11223333              345566777889999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.+++..    ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  151 (323)
T cd05571          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence            99888843    35689999999999999999999998   999999999999999999999999999975432221  1


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      .....||+.|+|||.+.+.  .++.++||||+||++|||++|+.||......        .....+.... ..      .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~-~~------~  214 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEE-IR------F  214 (323)
T ss_pred             ccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCC-CC------C
Confidence            2345699999999999764  7889999999999999999999999643211        1122222111 11      1


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                      +..++..+.+++.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            223456788999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-36  Score=287.32  Aligned_cols=236  Identities=28%  Similarity=0.457  Sum_probs=184.2

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      .+.+.+.||+|+||.||+|..++++.+|+|++.......+++..|              +++++......++|+||++++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            356778999999999999998878899999987655555555554              455666777889999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++........ .
T Consensus        85 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~  157 (256)
T cd05059          85 CLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S  157 (256)
T ss_pred             CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence            999988532   23689999999999999999999998   9999999999999999999999999999865432211 1


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      .....++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        ...+.+..+.....     
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-----  222 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVSAGYRLYR-----  222 (256)
T ss_pred             cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHHHcCCcCCC-----
Confidence            1223345689999998764  78899999999999999999 78888643221        12223332222111     


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                       +...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             112456789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4e-36  Score=291.31  Aligned_cols=243  Identities=23%  Similarity=0.373  Sum_probs=184.8

Q ss_pred             HhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ..+.+.++||+|+||.||+|+..      +++.||||.+......  .+.+..|              +++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            45677889999999999999853      2578999999764322  2333333              456666777889


Q ss_pred             EEEEecCCCChhhhhhhcc------------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC
Q 048517          219 LVYEYMPNGSLDRHIFSKE------------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  286 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~  286 (453)
                      +++||+++++|.+++....            .....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence            9999999999999985321            1124588889999999999999999998   999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccc
Q 048517          287 IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYF  365 (453)
Q Consensus       287 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~  365 (453)
                      .+||+|||+++...............+++.|+|||.+..  +.++.++||||||+++|||++ |..|+.....       
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------  232 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------  232 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            999999999886644333222344556789999999865  378899999999999999998 7777753221       


Q ss_pred             hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          366 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       366 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                       .-..+.+.++.....      +...+..+..++.+||+.+|++||++++|++.|+.
T Consensus       233 -~~~~~~i~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 -QDVIEMIRNRQVLPC------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             113333433332221      12244568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=292.87  Aligned_cols=228  Identities=24%  Similarity=0.254  Sum_probs=178.6

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHH--------------HHHHhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEF--------------INELLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~--------------i~el~g~~~~~~~~~lv~E~  223 (453)
                      |.+.+.||+|+||.||+|+.. +|+.||||++.....    ..+.+              +.++++.+.+....++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            556789999999999999955 789999999864321    11222              22356677778889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          83 VPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            999999998843    24689999999999999999999998   99999999999999999999999999998654321


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                           ....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.....        ....+.+..+.. .   
T Consensus       156 -----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~-~---  216 (291)
T cd05612         156 -----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGKL-E---  216 (291)
T ss_pred             -----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCc-C---
Confidence                 234689999999998764  678999999999999999999999865332        112333333221 1   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLEM  419 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~  419 (453)
                         .+......+.+++.+||+.||.+||+     ++++++.
T Consensus       217 ---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         217 ---FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence               11223456889999999999999995     8887764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=301.52  Aligned_cols=233  Identities=28%  Similarity=0.425  Sum_probs=183.2

Q ss_pred             HHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCC----CC-CHHHHHH-H---------------HhcccccCcce
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENS----KF-SAEEFIN-E---------------LLGLCSEGFKR  217 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~----~~-~~~~~i~-e---------------l~g~~~~~~~~  217 (453)
                      ...|.+.+.||+|+||+|+.|+ ..+|+.||||++...    .. ...+.+. |               ++.+.......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            3466778899999999999998 457899999987663    11 1122221 2               33444556668


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLA  296 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla  296 (453)
                      ++||||+.+|+|.+++..    ...+.+..+..++.|++.|++|+|+.   +|+||||||+|||+|.+ +++||+|||++
T Consensus        96 ~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999953    36788899999999999999999998   99999999999999999 99999999999


Q ss_pred             cccC-CCCCceeecccCCCCCccChhhhcccCCCC-CccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          297 KFHP-KENDFVSISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       297 ~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      .... .+.   ......||+.|+|||++.+. +.| ..++||||+||+||.|++|+.||+....       +. .+..+.
T Consensus       169 ~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~-~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~-l~~ki~  236 (370)
T KOG0583|consen  169 AISPGEDG---LLKTFCGSPAYAAPEVLSGK-GTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PN-LYRKIR  236 (370)
T ss_pred             cccCCCCC---cccCCCCCcccCCHHHhCCC-CCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HH-HHHHHh
Confidence            9874 222   34678899999999999975 225 5899999999999999999999986321       11 223333


Q ss_pred             hCCCccccchhhhHHHH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KGGDLELRNVTEIESMI-ARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+...       .+..+ +..+..++.+|++.+|..|+|+.++++
T Consensus       237 ~~~~~-------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  237 KGEFK-------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             cCCcc-------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            33221       22222 677899999999999999999999994

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.8e-36  Score=286.09  Aligned_cols=240  Identities=28%  Similarity=0.428  Sum_probs=186.5

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ...+.+.++||+|+||.||+|..+++..||+|.+.......+++..|              +++++. ....+++|||++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            34567889999999999999998888899999998766666666665              233333 345789999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +++|.+++...  ....+++.++..++.+++.||+|||+.   +|+|+||||+||++++++.+||+|||++.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            99999988542  234689999999999999999999998   9999999999999999999999999999876443221


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                       ......++..|+|||.+...  .++.++||||||++++||++ |+.||......        ...+.+..+....    
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~----  223 (260)
T cd05070         159 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVLEQVERGYRMP----  223 (260)
T ss_pred             -cccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC----
Confidence             11233456789999988653  78899999999999999999 88888543211        1223333222211    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                        .+...+..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       224 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 --CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              122334568999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=274.63  Aligned_cols=252  Identities=27%  Similarity=0.331  Sum_probs=192.5

Q ss_pred             HHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCC-CCHHHHHHH--------------Hhccc-----ccCcceE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSK-FSAEEFINE--------------LLGLC-----SEGFKRA  218 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~-~~~~~~i~e--------------l~g~~-----~~~~~~~  218 (453)
                      ..+|.+.++||+|||+.||.++ +.+++.+|+|++.... ...+..++|              ++..+     ...+..+
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            3467888999999999999999 7789999999987754 333433333              33333     2344589


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      |++.|...|||.+++.....++..+++.+.+.|+.++.+||++||+. .+++.||||||.|||+.+.+.+++.|||.++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            99999999999999977777778899999999999999999999997 34699999999999999999999999999986


Q ss_pred             cCCCCC-------ceeecccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH
Q 048517          299 HPKEND-------FVSISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       299 ~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  370 (453)
                      .+-.-.       .+.......|..|.|||.+.-.. -.++.++|||||||+||+|+.|..||+..-+......+.    
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA----  254 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA----  254 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe----
Confidence            542211       01112345799999999986532 367999999999999999999999997543321111110    


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                        +..++. ..    .....+++.+.+++.+|+|.||.+||++.+++..++..
T Consensus       255 --v~n~q~-s~----P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  255 --VQNAQI-SI----PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --eecccc-cc----CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence              000011 00    11223778999999999999999999999999998864

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=296.55  Aligned_cols=226  Identities=25%  Similarity=0.315  Sum_probs=172.6

Q ss_pred             cCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       169 LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      ||+|+||.||+++.. +++.||+|++....    .....+..|              +++.+......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999954 68899999987521    122233333              44566777888999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      .+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  151 (312)
T cd05585          81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN  151 (312)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence            998843    34689999999999999999999998   999999999999999999999999999986433222  123


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ...||+.|+|||.+.+.  .++.++||||+||++|||++|+.||.....       .. ....+.... ..      .+.
T Consensus       152 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~-~~~~~~~~~-~~------~~~  214 (312)
T cd05585         152 TFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NE-MYRKILQEP-LR------FPD  214 (312)
T ss_pred             cccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCH-------HH-HHHHHHcCC-CC------CCC
Confidence            45699999999999764  789999999999999999999999964321       11 222222211 11      122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          390 MIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                      .++..+.+++.+||+.||++||++..+.+.|
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            3446788999999999999998654443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.4e-36  Score=290.20  Aligned_cols=245  Identities=24%  Similarity=0.401  Sum_probs=186.0

Q ss_pred             hhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      .+.+.+.||+|+||.||++...      ++..+|+|.+..... ..+.+..|              +++++......+++
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   85 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            4456789999999999999742      356799998876432 23334444              45667777889999


Q ss_pred             EEecCCCChhhhhhhcc---------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517          221 YEYMPNGSLDRHIFSKE---------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  291 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  291 (453)
                      |||+++++|.+++....         .....+++.+++.++.|++.||+|||+.   +++||||||+|||++.++.+||+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~  162 (288)
T cd05093          86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG  162 (288)
T ss_pred             EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEec
Confidence            99999999999885432         1224589999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517          292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  370 (453)
                      |||+++...............++..|+|||.+...  .++.++||||||++++||++ |+.|+......        -..
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~~~  232 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EVI  232 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH
Confidence            99999866443322222334567889999998753  78899999999999999998 88887543321        122


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      +.+..+......      ...+..+.+++.+||+.+|.+|||+.++++.|++...
T Consensus       233 ~~i~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         233 ECITQGRVLQRP------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHcCCcCCCC------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            333333222111      1233568999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=300.49  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=196.4

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      |+....-.|.++||+|-||.|.++....+..||||+++....  ...+|..|              |+|.|..++..++|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            333344457789999999999999999889999999987433  23566555              89999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      +|||++|+|..++...+..  .+.-.....|+.|||.|++||.+-   ++|||||.++|+|+|.++++||+|||+++..-
T Consensus       614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            9999999999999654332  245566788999999999999998   99999999999999999999999999999776


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc--CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ....+........+++|||||.+..  +.+|.++|||+||+++||+++  ..+|+.....++.    .+..-..+..+..
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v----ven~~~~~~~~~~  762 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV----VENAGEFFRDQGR  762 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH----HHhhhhhcCCCCc
Confidence            6666665566678899999999875  589999999999999999876  5667754432210    0111111211111


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      ..   ....+......+.+++++||..+.++|||++++...|..
T Consensus       763 ~~---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  763 QV---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             ce---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            11   111334455678899999999999999999999998875

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.1e-36  Score=292.15  Aligned_cols=245  Identities=25%  Similarity=0.429  Sum_probs=187.0

Q ss_pred             hhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      .+.+.+.||+|+||.||+|+..      ++..+|+|.+...... .+.+.+|              +++++......++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            3456689999999999999742      3567999998764332 2233333              45677777888999


Q ss_pred             EEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCce
Q 048517          221 YEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP  288 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~  288 (453)
                      |||+++++|.+++.....            ....++|..++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            999999999999864321            224589999999999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchH
Q 048517          289 KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPS  367 (453)
Q Consensus       289 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  367 (453)
                      ||+|||+++...............++..|+|||.+...  .++.++||||||+++|||++ |+.|+......        
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------  232 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------  232 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            99999999865443322222344568899999998764  78899999999999999998 99988643321        


Q ss_pred             HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ...+.+..+.....      ....+..+.+++.+||+.+|++|||+.+|+++|+....
T Consensus       233 ~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         233 EVIECITQGRVLER------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHHHhCCCCCCC------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            12223333322211      11234568899999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.7e-36  Score=297.91  Aligned_cols=225  Identities=24%  Similarity=0.297  Sum_probs=173.0

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH---------------HhcccccCcceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE---------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e---------------l~g~~~~~~~~~lv~E  222 (453)
                      +++.+.||+|+||.||+|+.. +++.||||++.....    ..+.+..|               +.+++......++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            456788999999999999855 688999999875321    11122222               3455566777899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++..    ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          82 YVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999988743    24689999999999999999999998   9999999999999999999999999999754322


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        -....+......   
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~~~~---  219 (323)
T cd05616         155 GV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNVA---  219 (323)
T ss_pred             CC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC---
Confidence            21  12345699999999999764  7899999999999999999999999654321        122222222111   


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSM  413 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  413 (453)
                          .+...+..+.+++.+|++.+|++|++.
T Consensus       220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 ----YPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                112345678899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.9e-36  Score=287.19  Aligned_cols=240  Identities=27%  Similarity=0.418  Sum_probs=179.1

Q ss_pred             hhcccCccCceEEEEEEEcC-Cc--EEEEEEecCCCCC---HHHHHHH--------------Hhccccc------CcceE
Q 048517          165 FTHKLGQGGFGSVYKGQLHT-GR--LIAVKMMENSKFS---AEEFINE--------------LLGLCSE------GFKRA  218 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~~-g~--~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~------~~~~~  218 (453)
                      +.++||+|+||.||+|+..+ ++  .||||.++.....   .+.+..|              ++++|..      ....+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            56789999999999999654 33  6999988764322   2334433              3343321      12468


Q ss_pred             EEEEecCCCChhhhhhhcc--CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          219 LVYEYMPNGSLDRHIFSKE--NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      +++||+++|+|.+++....  .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence            9999999999998874322  2234589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhh
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      +...............+++.|+|||.+...  .++.++||||||+++|||++ |+.||.....        ....+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~  229 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLRQ  229 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHc
Confidence            876543322222233467789999998764  78999999999999999999 7888754321        123444444


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      +......      ......+.+++.+||+.+|++|||+.++++.|+..
T Consensus       230 ~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNRLKQP------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            4332211      12345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-36  Score=287.84  Aligned_cols=244  Identities=27%  Similarity=0.397  Sum_probs=186.1

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcce
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKR  217 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~  217 (453)
                      ...+.+.+.||+|+||.||+|...      +++.||+|.+......  ..++..|              +++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            445667789999999999999854      2468999998754321  2233333              45666777889


Q ss_pred             EEEEEecCCCChhhhhhhccC------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517          218 ALVYEYMPNGSLDRHIFSKEN------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  291 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  291 (453)
                      ++||||+++|+|.+++.....      ....++|..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            999999999999999865332      123578999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517          292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  370 (453)
                      |||+++...............+|..|+|||.+...  .++.++||||||+++|||++ |+.|+......        -..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~  231 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVL  231 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HHH
Confidence            99999866544332223344578899999998753  78999999999999999998 88888543221        122


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      +.+..+......      ...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       232 ~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         232 KFVIDGGHLDLP------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHhcCCCCCCC------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            333333222211      1225678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.9e-36  Score=295.67  Aligned_cols=221  Identities=24%  Similarity=0.322  Sum_probs=171.1

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHH---------------HHhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFIN---------------ELLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~---------------el~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+++.. +++.||||++....    ...+.++.               .+++++......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999954 68999999987521    11222222               245566677788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--  151 (320)
T cd05590          81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--  151 (320)
T ss_pred             chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence            999988743    24689999999999999999999998   999999999999999999999999999875432221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......        .+.+.+......       
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~-------  214 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDEVV-------  214 (320)
T ss_pred             cccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCCC-------
Confidence            12345699999999999764  7889999999999999999999999754321        122333222211       


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSM  413 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~  413 (453)
                      .+..++..+.+++.+||+.||++||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            112234568899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=299.00  Aligned_cols=231  Identities=25%  Similarity=0.350  Sum_probs=183.2

Q ss_pred             hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH--HH--------------HHHHHhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA--EE--------------FINELLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~--~~--------------~i~el~g~~~~~~~~~lv~E~~~  225 (453)
                      |.-.+.||+|.||.||+|. ..+++.||+|++.......  ++              .+.+.+|.+..+..++++||||.
T Consensus        15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~   94 (467)
T KOG0201|consen   15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG   94 (467)
T ss_pred             cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence            3444789999999999999 4579999999998643322  11              23346777788888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|++.+.+    ..+..+.+..+.-|..++..||.|||++   +.+|||||+.|||+..++.+||+|||.+-........
T Consensus        95 gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   95 GGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             Ccchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999988    3344558888888999999999999998   9999999999999999999999999999877655443


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      .  .+..||+.|||||++.+.  .|+.|+||||+|++.+||.+|.+|+.....-..        .-.+.+..      ..
T Consensus       168 r--~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--------lflIpk~~------PP  229 (467)
T KOG0201|consen  168 R--KTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--------LFLIPKSA------PP  229 (467)
T ss_pred             c--ccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceE--------EEeccCCC------CC
Confidence            2  567899999999999864  899999999999999999999999864332100        00111111      11


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ......++.+.+++..||+.+|++|||+.++++
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            122356678999999999999999999998876

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-35  Score=284.99  Aligned_cols=241  Identities=29%  Similarity=0.452  Sum_probs=181.5

Q ss_pred             hhhcccCccCceEEEEEEEc-C---CcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCc------c
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-T---GRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGF------K  216 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~---g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~------~  216 (453)
                      ++.+.||+|+||.||+|+.. +   +..||||+++.....   .+++..|              +++++....      .
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            45688999999999999864 2   378999998764332   2334444              344443333      3


Q ss_pred             eEEEEEecCCCChhhhhhhcc--CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          217 RALVYEYMPNGSLDRHIFSKE--NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      .++++||+++|+|..++....  .....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence            689999999999999886543  2234689999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      +++...............++..|+|||.+...  .++.++||||||+++|||++ |..|+......        -..+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~~  228 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDYL  228 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH
Confidence            99876544332222233457789999998653  78899999999999999999 88887543211        123333


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      ..+.....      +......+.+++.+||+.||++|||+.|+++.|+..
T Consensus       229 ~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RHGNRLKQ------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HcCCCCCC------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            33322221      123446789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.2e-36  Score=312.30  Aligned_cols=237  Identities=21%  Similarity=0.212  Sum_probs=182.2

Q ss_pred             hhhhcccCccCceEEEEEEE-cC-CcEEEEEEecCCCCCHH-HHHHH--------------HhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HT-GRLIAVKMMENSKFSAE-EFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~-g~~VAVK~l~~~~~~~~-~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      |.+.+.||+|+||.||++.. .+ ++.||+|.+........ .+..|              +++.+..+...++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            66778999999999999984 34 67899997654332222 22223              4666777888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            9999998865433445788999999999999999999998   9999999999999999999999999999876543322


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      .......||++|+|||++.+.  .++.++|||||||++|||++|+.||......        .+...+..+....     
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~~~~-----  290 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYGKYDP-----  290 (478)
T ss_pred             ccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCC-----
Confidence            222445699999999998764  7899999999999999999999998643221        1222222222211     


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       .+..++..+.+++.+||+.+|++|||+.++++
T Consensus       291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             11223456889999999999999999999864

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.5e-36  Score=296.24  Aligned_cols=225  Identities=24%  Similarity=0.302  Sum_probs=172.1

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E  222 (453)
                      +.+.+.||+|+||.||+|+.. +++.||||++....    ...+.++.|               +.+++......++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            456789999999999999955 67899999987532    122223332               3344556677899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          82 YVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999988843    24688999999999999999999998   9999999999999999999999999998753222


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        -....+..... .  
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~-~--  219 (324)
T cd05587         155 GK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNV-S--  219 (324)
T ss_pred             CC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC-C--
Confidence            11  12345699999999999764  6889999999999999999999999644321        12222222211 1  


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSM  413 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  413 (453)
                          .+..++..+.+++.+||+.+|.+||+.
T Consensus       220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 ----YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                112244568899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.8e-36  Score=291.61  Aligned_cols=245  Identities=24%  Similarity=0.409  Sum_probs=185.6

Q ss_pred             HhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCCH--HHHHHH---------------HhcccccCcce
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSA--EEFINE---------------LLGLCSEGFKR  217 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~~--~~~i~e---------------l~g~~~~~~~~  217 (453)
                      ..+.+.+.||+|+||.||++...      ....+|+|.+.......  .++..|               +++++..+...
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            34556789999999999999854      23689999987643221  223333               34556677778


Q ss_pred             EEEEEecCCCChhhhhhhcc------------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC
Q 048517          218 ALVYEYMPNGSLDRHIFSKE------------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN  285 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~  285 (453)
                      +++|||+++|+|.+++....            .....+++..++.++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTED  168 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCC
Confidence            99999999999999985432            2345789999999999999999999998   99999999999999999


Q ss_pred             CceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccccc
Q 048517          286 FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY  364 (453)
Q Consensus       286 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~  364 (453)
                      +.+||+|||+++...............++..|+|||.+...  .++.++||||||+++|||++ |..|+......     
T Consensus       169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  241 (293)
T cd05053         169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----  241 (293)
T ss_pred             CeEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence            99999999999876544333233344567889999988653  78899999999999999997 88887533211     


Q ss_pred             chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          365 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       365 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                         -..+.+..+.....      +......+.+++.+||+.+|++|||+.++++.|+..+
T Consensus       242 ---~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 ---ELFKLLKEGYRMEK------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ---HHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence               12333333322211      1123456889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.9e-36  Score=290.87  Aligned_cols=232  Identities=24%  Similarity=0.329  Sum_probs=175.8

Q ss_pred             cCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       169 LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      ||+|+||+||++.. .+|+.||||.+......    .+.+..|              +.+.+..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999985 47899999998753221    1223333              33445666778999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      ..++.........+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988765444456799999999999999999999998   999999999999999999999999999976544322  123


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ...||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.........    ......+....       ...+.
T Consensus       156 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~-------~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILNDS-------VTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhcccC-------CCCcc
Confidence            45789999999999864  7889999999999999999999999654321110    00111111110       11223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          390 MIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                      .++..+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            3556788999999999999999     6777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6e-36  Score=296.14  Aligned_cols=227  Identities=21%  Similarity=0.289  Sum_probs=174.5

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+|+.. +++.||||++....    ...+.++.|               +++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999955 68899999987532    111222222               45566677788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|..++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  151 (321)
T cd05591          81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--  151 (321)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence            999888743    34689999999999999999999998   999999999999999999999999999875432222  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        ...+.+......       
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~~~~-------  214 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHDDVL-------  214 (321)
T ss_pred             cccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCC-------
Confidence            12345689999999998764  7889999999999999999999999754321        122223222211       


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRP-------SMTKVLEM  419 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RP-------s~~evl~~  419 (453)
                      .+...+..+.+++..||+.+|++||       ++.++++.
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            1112345688999999999999999       78888653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=300.71  Aligned_cols=235  Identities=21%  Similarity=0.286  Sum_probs=180.4

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |.+.++||+|+||.||+|+.. +|+.||||++.....    ..+.+..|              +++.+......++||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            456789999999999999965 689999999875321    12233333              44566677789999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....  
T Consensus        83 ~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          83 VPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999998842    34688999999999999999999998   999999999999999999999999999986543  


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC-Ccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-DLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~  382 (453)
                         ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+.... .....
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~  220 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKETLQRP  220 (333)
T ss_pred             ---ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhccccccCC
Confidence               12345699999999999764  78899999999999999999999996533211        112222111 11110


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ........++..+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0010112345678899999999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.8e-35  Score=281.48  Aligned_cols=231  Identities=25%  Similarity=0.429  Sum_probs=177.2

Q ss_pred             ccCccCceEEEEEEE---cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          168 KLGQGGFGSVYKGQL---HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~~---~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      +||+|+||.||+|.+   .+++.+|+|++......   .+++..|              +++++. ....++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            699999999999974   36789999998754322   2344444              344443 44568999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce-
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-  306 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-  306 (453)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......... 
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99998843    24689999999999999999999998   99999999999999999999999999998765443221 


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      ......++..|+|||.+..  +.++.++||||||+++|||++ |+.||......        -..+.+.++......   
T Consensus       154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~i~~~~~~~~~---  220 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQMIESGERMECP---  220 (257)
T ss_pred             ecCCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCCCCC---
Confidence            1122345678999998865  378889999999999999998 99998643221        123334443332221   


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                         ...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       221 ---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 ---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence               1234568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-36  Score=295.27  Aligned_cols=248  Identities=24%  Similarity=0.331  Sum_probs=182.6

Q ss_pred             hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH--HHH-HHH--------------Hhccccc--CcceEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA--EEF-INE--------------LLGLCSE--GFKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~--~~~-i~e--------------l~g~~~~--~~~~~lv~  221 (453)
                      .++-.++||+|.||.||+++ +.+|+.||+|++..+....  -.+ ++|              |.+...+  ....|||+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            34445789999999999999 7799999999987654221  111 222              4444443  36789999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      |||+. +|...+.   +..-.|+..++..+++|++.||+|+|+.   +|+|||||.+|||||++|.+||+|||||+++..
T Consensus       198 eYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  198 EYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             ecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            99965 5655552   3456799999999999999999999998   999999999999999999999999999998866


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc---------cccchHHHHHH
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS---------KAYFPSWVYDQ  372 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~  372 (453)
                      .... ..+...-|..|.|||.+.+. ..|+.+.|+||.||+|.||+.|++.+....+-+.         ...-..|....
T Consensus       271 ~~~~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  271 SGSA-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCc-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            5533 35677889999999999986 5899999999999999999999988866543210         00001121111


Q ss_pred             hhhCCCccc-----cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          373 LNKGGDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       373 l~~~~~~~~-----~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +..-.....     +...+.-...+....+|+..+|..||.+|.|+.++++
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            110000000     0111222334567788999999999999999999876

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=278.37  Aligned_cols=219  Identities=27%  Similarity=0.367  Sum_probs=178.6

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----------HH--------HHHHHhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----------EE--------FINELLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----------~~--------~i~el~g~~~~~~~~~lv~E~  223 (453)
                      +++.+.||.|+||.|.+.+.+ +|..+|+|++++.+.-.          +.        |+..|.+.+.+....++||||
T Consensus        46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey  125 (355)
T KOG0616|consen   46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY  125 (355)
T ss_pred             hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence            345578999999999999954 78999999998643211          11        122267778899999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      .++|.|..++.    +..+++.+.+.-+|.+|+.||+|||+.   +|++||+||+|||||.+|.+||.|||.|+..... 
T Consensus       126 v~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  126 VPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             cCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999983    346899999999999999999999998   9999999999999999999999999999976553 


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                          +.+.+|||.|+|||.++..  ++..++|.|||||++|||+.|.+||...+.        .-+++.+.+++..    
T Consensus       198 ----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v~----  259 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKVK----  259 (355)
T ss_pred             ----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCccc----
Confidence                3567899999999999875  889999999999999999999999976543        2366666665443    


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCC
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADR  410 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~R  410 (453)
                         .+.-.+..+.+|+...||.|-.+|
T Consensus       260 ---fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 ---FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ---CCcccCHHHHHHHHHHHhhhhHhh
Confidence               233344566777777888887777

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8e-36  Score=288.72  Aligned_cols=248  Identities=21%  Similarity=0.316  Sum_probs=187.3

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEcC-----CcEEEEEEecCCCCC--HHHHHHH--------------Hhccccc-Ccc
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLHT-----GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSE-GFK  216 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~~-----g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~-~~~  216 (453)
                      ...++.+.+.||+|+||.||+|...+     ++.||+|++......  .+.+..|              +++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34566778899999999999999765     788999998753221  2334344              3454444 466


Q ss_pred             eEEEEEecCCCChhhhhhhccCC----CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEe
Q 048517          217 RALVYEYMPNGSLDRHIFSKENK----GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  292 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~D  292 (453)
                      .++++||+++|+|.+++......    ...+++.+++.++.+++.||+|||+.   +++|+||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            78999999999999998553322    25689999999999999999999998   999999999999999999999999


Q ss_pred             cCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHH
Q 048517          293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYD  371 (453)
Q Consensus       293 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  371 (453)
                      ||+++...............++..|+|||++...  .++.++||||||+++||+++ |+.|+.......        ...
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~  230 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--------MAA  230 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--------HHH
Confidence            9999865443322222234567789999998764  68899999999999999999 999986432211        222


Q ss_pred             HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      .+..+.....      ....+..+.+++.+||+.+|++|||+.++++.|+...+
T Consensus       231 ~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         231 YLKDGYRLAQ------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHcCCCCCC------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            2333222111      11234568899999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-35  Score=283.02  Aligned_cols=239  Identities=27%  Similarity=0.414  Sum_probs=184.5

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ..+.+.++||+|+||.||++..+++..||+|.+.......+.+..|              +++++. ....+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            4567788999999999999998877789999987655555555554              233333 3457899999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++...  ....++|..+..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||+++........ 
T Consensus        85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          85 GSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            9999988543  234589999999999999999999998   9999999999999999999999999999866433211 


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      ......++..|+|||...+.  ..+.++||||||+++|||++ |+.|+......        -..+.+.......     
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~-----  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQVERGYRMP-----  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC-----
Confidence            12234567789999988753  78899999999999999999 88888643211        1222232221111     


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                       .+...+..+.+++.+||+.+|++||++++++++|+.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 -CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             122345678899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-35  Score=288.35  Aligned_cols=242  Identities=25%  Similarity=0.407  Sum_probs=183.0

Q ss_pred             hhhhhcccCccCceEEEEEEE-----cCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-----~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ..++.++||+|+||.||+|+.     .+++.||+|.+......  ..++.+|              +++++..+...+++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            456778999999999999984     25678999998753221  1233333              34556667788999


Q ss_pred             EEecCCCChhhhhhhccC-------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517          221 YEYMPNGSLDRHIFSKEN-------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  287 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~  287 (453)
                      |||+++|+|.+++.....             ....+++.+++.++.+++.||+|||+.   +|+|+||||+|||++.++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence            999999999999853221             123578899999999999999999998   9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccch
Q 048517          288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFP  366 (453)
Q Consensus       288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  366 (453)
                      +||+|||+++...............++..|+|||++.+.  .++.++||||||++++||++ |..||.....        
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------  232 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------  232 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence            999999999865443322222344567789999998753  68999999999999999998 8888754321        


Q ss_pred             HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      ..+.+.+........      +...+..+.+++.+||+.+|++||++.++.++|++
T Consensus       233 ~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEVIEMVRKRQLLPC------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            113333333322211      12234568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.3e-36  Score=294.59  Aligned_cols=225  Identities=24%  Similarity=0.330  Sum_probs=171.3

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+|+.. +++.||||.+....    ...+..+.|               +++.+..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999964 68899999987532    111122111               34455667788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--  151 (316)
T cd05592          81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--  151 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence            999988743    24689999999999999999999998   999999999999999999999999999986433221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......        .+...+..... .      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~-~------  214 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILNDRP-H------  214 (316)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC-C------
Confidence            22345699999999999764  6889999999999999999999999754321        12222222111 1      


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL  417 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl  417 (453)
                      .+..++..+.+++.+||+.+|++||++. +++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1122345678899999999999999875 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.5e-35  Score=266.68  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=183.9

Q ss_pred             hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC-----------------HHHHHHHHhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS-----------------AEEFINELLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~-----------------~~~~i~el~g~~~~~~~~~lv~E~  223 (453)
                      +|.-.++||+|.||.||+|+ ..+|+.||||+++..+..                 .++.+.+|+..+.......||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            45566889999999999999 678999999998764322                 123344588888888899999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      |+ -+|+..+.   .+...|+..++..++.++.+||+|||++   .|+||||||.|+|++.++.+||+|||+|+.+....
T Consensus        83 m~-tdLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   83 MP-TDLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             cc-ccHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            95 57887773   3446789999999999999999999998   99999999999999999999999999999987655


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc----
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL----  379 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~----  379 (453)
                      ..  .+...-|..|.|||.+.+. ..|+...|+||.||++.||+-|.+-+...++-+ |   -..+...+......    
T Consensus       156 ~~--~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-Q---L~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  156 RI--QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-Q---LSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             cc--cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-H---HHHHHHHcCCCCcccCcc
Confidence            42  2344789999999999875 588999999999999999998876665443211 0   00111111110000    


Q ss_pred             -------------cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          380 -------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       380 -------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                                   +.......-...+....+++..++.+||.+|+|++|++++
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                         0000000111233466899999999999999999999874

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.2e-36  Score=297.19  Aligned_cols=229  Identities=21%  Similarity=0.319  Sum_probs=172.3

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+++.. +++.||+|++......    .+.+..|               +++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999954 6889999998763211    1112122               45566677788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--  151 (329)
T cd05618          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--  151 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence            999887732    24689999999999999999999998   999999999999999999999999999975432221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccc-ccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS-SKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||....... .......++.+.+..... .     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-----  223 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-----  223 (329)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-----
Confidence            12345689999999999764  78899999999999999999999996432211 111222333333333221 1     


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSM  413 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  413 (453)
                       .+...+..+.+++.+||+.||++||+.
T Consensus       224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 -IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             122234568899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-35  Score=288.96  Aligned_cols=242  Identities=22%  Similarity=0.337  Sum_probs=173.6

Q ss_pred             hhhhhcccCccCceEEEEEEE-c-CCcEEEEEEecCCCC---CHHHHHHH-----------------Hhcccc-----cC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-H-TGRLIAVKMMENSKF---SAEEFINE-----------------LLGLCS-----EG  214 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~-~g~~VAVK~l~~~~~---~~~~~i~e-----------------l~g~~~-----~~  214 (453)
                      +|.+.++||+|+||.||+|+. . +|+.||||.+.....   ....+..|                 ++++|.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            466778999999999999985 3 478899998865321   11122222                 233332     23


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...++|+||+. ++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            45789999996 6898887432  234589999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      +++......   ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||........   + ..+.+...
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~-~~i~~~~~  226 (290)
T cd07862         156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---L-GKILDVIG  226 (290)
T ss_pred             ceEeccCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---H-HHHHHHhC
Confidence            998654332   22345689999999998754  788999999999999999999999975432110   0 00111000


Q ss_pred             hC-------------CCc---cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KG-------------GDL---ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~-------------~~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..             ...   ............+..+.+++.+||+.+|++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00             000   000000111234566789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.4e-35  Score=291.28  Aligned_cols=225  Identities=24%  Similarity=0.325  Sum_probs=172.0

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+|+.. +|+.||||.++...    ...+....|               +++.+......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 68999999987532    111122211               44556677788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05620          81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--  151 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence            999988743    24688999999999999999999998   999999999999999999999999999874322211  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||++.+.  .++.++||||+|+++|||++|+.||......        ...+.+..... .      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~~~-~------  214 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDTP-H------  214 (316)
T ss_pred             ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-C------
Confidence            12345699999999999764  7889999999999999999999999644321        12222222211 1      


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL  417 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl  417 (453)
                      .+...+..+.+++.+||+.||++||++. ++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1112345688899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-35  Score=287.82  Aligned_cols=240  Identities=25%  Similarity=0.420  Sum_probs=180.1

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCc----EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGR----LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~----~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ..++.++||+|+||+||+|+. .+|+    .||+|++.....  ..+++.+|              +++++.. ...+++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~   86 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV   86 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence            445668999999999999984 4555    489999875322  22334343              3344433 346799


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      +||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          87 TQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999988532   24689999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ............++..|+|||.+.+.  .++.++||||||+++|||++ |..|+......        -....+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~  230 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERL  230 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcC
Confidence            43332222233457789999998753  78899999999999999998 88887543211        122233333222


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      ..      +...+..+.+++.+||+.||++||++.++++.|+...
T Consensus       231 ~~------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         231 PQ------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             CC------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            21      1123456889999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-35  Score=286.83  Aligned_cols=241  Identities=25%  Similarity=0.394  Sum_probs=179.9

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCc----EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGR----LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~----~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      .+++.+.||+|+||.||+|+. .+|+    .|++|.+.....  ..+++..+              +++++. +...+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence            345568899999999999985 3454    478887754321  12233332              344443 3456789


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      +||+++|+|.+++...   ...++|..+..++.|++.||+|||+.   +++|+||||+|||+++++.+||+|||+++...
T Consensus        87 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          87 TQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999998532   34689999999999999999999998   99999999999999999999999999998764


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ............++..|+|||.+..  +.++.++||||||+++|||++ |+.|+......        ...+.+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~  230 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------EVPDLLEKGERL  230 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcC
Confidence            4332222234557789999999875  378999999999999999998 99888643221        122333333322


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ....      .....+..++.+||+.+|++|||+.|+++.|+...+
T Consensus       231 ~~~~------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 AQPQ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            2111      122456788999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-36  Score=296.92  Aligned_cols=228  Identities=24%  Similarity=0.339  Sum_probs=178.1

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .+.+.+.||+|+||.||+|+.. +|+.||||++....    ...+.+..|              +++.+..+...++|||
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            4567789999999999999965 68999999987532    122233333              4556677788999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        99 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         99 FVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             CCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999998843    24688899999999999999999998   9999999999999999999999999999866432


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .     ....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.....        ...++.+..+. ... 
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~-~~~-  234 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAGR-LKF-  234 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCC-cCC-
Confidence            2     234689999999999764  678999999999999999999999964321        11223333322 111 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                           +..++..+.+++.+||+.||.+||+     ++++++
T Consensus       235 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        235 -----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             -----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 1123456789999999999999997     677764

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.5e-36  Score=296.35  Aligned_cols=242  Identities=24%  Similarity=0.313  Sum_probs=179.5

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..+...++||+|+||.||+++.. +|..||+|++.....  ..+++..|              +++++..+...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            34566789999999999999955 788999999876422  12334444              45666677788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...+++..+..++.+++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          85 MDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            999999998843    24588999999999999999999975  269999999999999999999999999997653321


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch-----------------
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-----------------  366 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~-----------------  366 (453)
                          .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...........+.                 
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence                2345689999999999764  78999999999999999999999996432211000000                 


Q ss_pred             ---------------------HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          367 ---------------------SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       367 ---------------------~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                                           ....+.+........     ....+...+.+++.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL-----PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCC-----CCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                 000000000000000     011245678999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-35  Score=288.62  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=185.0

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcc
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFK  216 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~  216 (453)
                      ...++.+.++||+|+||.||+|...      .+..||+|.+......  ..++.+|              +++.+.....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3456778899999999999999743      2558999988754322  2233333              4666777778


Q ss_pred             eEEEEEecCCCChhhhhhhccC------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517          217 RALVYEYMPNGSLDRHIFSKEN------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  290 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  290 (453)
                      .++||||+++|+|.+++.....      ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            8999999999999999854221      123456778899999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHH
Q 048517          291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  369 (453)
Q Consensus       291 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  369 (453)
                      +|||+++...............++..|+|||.+.+.  .++.++||||||++++||++ |..|+......        -.
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------~~  230 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------QV  230 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence            999999865443322222233457789999998753  78999999999999999998 67777543211        12


Q ss_pred             HHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      .+.+..+.....      +...+..+.+++.+||+.+|++|||+.++++.|++.+.
T Consensus       231 ~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         231 LKFVMDGGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             HHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence            222222222211      11224578999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.3e-36  Score=295.79  Aligned_cols=227  Identities=22%  Similarity=0.342  Sum_probs=174.4

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      +.||+|+||.||+++. .+|+.||||++.....    ...+++.|              +.+.+......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999985 4799999999975321    12233333              345566777889999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|..++..    ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  151 (328)
T cd05593          81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T  151 (328)
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence            99888743    34689999999999999999999998   999999999999999999999999999875432221  1


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       . ..+.+.... ..      .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~-~~~~~~~~~-~~------~  214 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELILMED-IK------F  214 (328)
T ss_pred             cccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHH-------H-HHHHhccCC-cc------C
Confidence            2345699999999999764  6889999999999999999999999643211       0 111221111 11      1


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  419 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~  419 (453)
                      +..++..+.+++.+||+.||++||     ++.++++.
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            223456788999999999999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.5e-36  Score=300.10  Aligned_cols=236  Identities=25%  Similarity=0.332  Sum_probs=175.9

Q ss_pred             hhhhcccCccCceEEEEEEE----cCCcEEEEEEecCCCC-----CHHHHHHH---------------HhcccccCcceE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF-----SAEEFINE---------------LLGLCSEGFKRA  218 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~-----~~~~~i~e---------------l~g~~~~~~~~~  218 (453)
                      |.+.++||+|+||.||+++.    .+|+.||+|++.....     ..+.+..|               +++.+......+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            45678999999999999874    3688999999865211     11222222               234455666788


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        82 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          82 LILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999998853    24689999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ....... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||........    ...+...+.....
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~  228 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRILKCDP  228 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHhcCCC
Confidence            5433221 12345699999999998753 3478899999999999999999999965432211    1112222222111


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                       .      .+..++..+.+++.+||+.||++||     +++++++
T Consensus       229 -~------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         229 -P------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -C------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence             1      1122445688899999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-35  Score=281.27  Aligned_cols=243  Identities=30%  Similarity=0.468  Sum_probs=189.6

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +....+.+.++||+|+||.||++..++++.||||.+.......+++..|              +++++......+++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3345567788999999999999998888999999998766666666555              45566666788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++...  ....+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||+++......
T Consensus        83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999988542  235689999999999999999999998   99999999999999999999999999998764322


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      . .......++..|+|||.+.+.  .++.++||||+|++++||++ |+.||......        ...+.+..+..... 
T Consensus       158 ~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~-  225 (261)
T cd05034         158 Y-TAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYRMPR-  225 (261)
T ss_pred             h-hhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC-
Confidence            1 111233456789999998754  68899999999999999998 89888543211        12222322211111 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                           +...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       226 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 -----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                 11124568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.4e-35  Score=293.96  Aligned_cols=225  Identities=23%  Similarity=0.301  Sum_probs=173.3

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC----CCHHHHHH---------------HHhcccccCcceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK----FSAEEFIN---------------ELLGLCSEGFKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~----~~~~~~i~---------------el~g~~~~~~~~~lv~E  222 (453)
                      +++.+.||+|+||.||+++. .+|+.||||++....    ...+.++.               .+.+++......++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            46778999999999999985 478999999987532    11122222               24455666778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++..    ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 y~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          82 YVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999988843    24689999999999999999999998   9999999999999999999999999998754322


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        .....+..... .  
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~-~--  219 (323)
T cd05615         155 GV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNV-S--  219 (323)
T ss_pred             Cc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-C--
Confidence            21  12345689999999999764  7889999999999999999999999754321        12222222211 1  


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSM  413 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  413 (453)
                          .+...+..+.+++.+||+.+|.+|++.
T Consensus       220 ----~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 ----YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                112234567889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-36  Score=303.19  Aligned_cols=231  Identities=25%  Similarity=0.353  Sum_probs=190.5

Q ss_pred             hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCC-------CCCHHH--HHHH---------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENS-------KFSAEE--FINE---------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~-------~~~~~~--~i~e---------l~g~~~~~~~~~lv~E~  223 (453)
                      +.+.+.||.|+-|.|-.|+ ..+|+.+|||++.+.       ....+.  .|.+         |+.++.++.++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            4567889999999999998 568999999999874       112221  2222         78888999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|-|.+++.    .++.|+..++.+++.||+.|+.|+|+.   +|+|||+||+|+|||.+.++||+|||+|.+...+.
T Consensus        94 v~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   94 VPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             cCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999994    346899999999999999999999998   99999999999999999999999999999876654


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   ..+.+|+|.|.|||++.+. ..-..++||||.||+|+.|+||+.||+..+.+.        ++..+.+|..     
T Consensus       167 l---LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--------LLlKV~~G~f-----  229 (786)
T KOG0588|consen  167 L---LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--------LLLKVQRGVF-----  229 (786)
T ss_pred             c---ccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHH--------HHHHHHcCcc-----
Confidence            2   3567899999999999985 234779999999999999999999998544221        2223333322     


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                        +.+..++.+...|+.+|+..||+.|.|++||++.
T Consensus       230 --~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  230 --EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             --cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence              3456677788999999999999999999999983

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-35  Score=293.21  Aligned_cols=228  Identities=26%  Similarity=0.356  Sum_probs=174.9

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHH-----------------HHHHhcccccCcceEEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEF-----------------INELLGLCSEGFKRALVY  221 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~-----------------i~el~g~~~~~~~~~lv~  221 (453)
                      .+.+.||+|+||.||+|... +|+.||||+++...    ...+.+                 +.++++++..+...++||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            45688999999999999854 78999999987532    111122                 222556667778899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|..++.     ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        82 E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          82 EYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             cCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999988773     24689999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ...  ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......        -....+..+...  
T Consensus       154 ~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~--  219 (324)
T cd05589         154 FGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVNDEVR--  219 (324)
T ss_pred             CCC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC--
Confidence            221  12345699999999999764  7889999999999999999999999654321        122222222211  


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                           .+..++..+.+++.+||+.||.+||     ++.++++
T Consensus       220 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 -----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 1122345678899999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.3e-36  Score=295.48  Aligned_cols=226  Identities=25%  Similarity=0.346  Sum_probs=173.7

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      +.||+|+||.||+++. .+|+.||+|++.....    ....+..|              +++.+......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999995 4799999999875321    12222222              455667777889999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  151 (323)
T cd05595          81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence            99887742    34689999999999999999999998   999999999999999999999999999875322221  1


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ..+.+.... ..      .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~~~~-~~------~  214 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEE-IR------F  214 (323)
T ss_pred             cccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCC-CC------C
Confidence            2345699999999998753  78899999999999999999999986443211        112221111 11      1


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                      +..++..+.+++.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            123456788999999999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-35  Score=288.38  Aligned_cols=246  Identities=22%  Similarity=0.278  Sum_probs=178.0

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.+.||+|+||.||+++.+ +++.||||++.....   ..+.+..|              +++.+......++||||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV   82 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence            566789999999999999965 688999999875322   12223332              566777788899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      +++++....    .....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          83 EKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             CCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            988776543    1234689999999999999999999998   999999999999999999999999999987643221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHHHHHHhhhCC
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVYDQLNKGG  377 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~l~~~~  377 (453)
                      . ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||.........       ..++.-.........
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         156 A-NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             c-cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            1 12345689999999999764  6889999999999999999999999754321100       000000000000000


Q ss_pred             ---Ccccc---ch----hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 ---DLELR---NV----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ---~~~~~---~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         .....   ..    ......++..+.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               00000   00    0011224567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.9e-36  Score=296.24  Aligned_cols=248  Identities=20%  Similarity=0.252  Sum_probs=173.4

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC---CCHHHHHHH--------------Hhccccc-----CcceEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSE-----GFKRAL  219 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~-----~~~~~l  219 (453)
                      |.+.++||+|+||.||+|+. .+|+.||||++....   ....++..|              +++++..     ....++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            56678999999999999995 478999999987521   122334444              2333321     124789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||+. ++|.+.+..    ...+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        82 v~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          82 VFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            999995 688887732    34689999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-------cchHHHHH
Q 048517          300 PKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------YFPSWVYD  371 (453)
Q Consensus       300 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~~  371 (453)
                      ..... ........||+.|+|||++.+....++.++|||||||++|||++|+.||..........       ..+.....
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            33221 11123456899999999987533478899999999999999999999986543211000       00000000


Q ss_pred             Hhhh---------CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          372 QLNK---------GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       372 ~l~~---------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+..         ...................+.+++.+||+.+|++|||++|+++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000         0000000000000113356789999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-35  Score=278.58  Aligned_cols=236  Identities=31%  Similarity=0.506  Sum_probs=186.2

Q ss_pred             cccCccCceEEEEEEEcC----CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLHT----GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~----g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+|....    +..||||.+......  .+++..|              +++++..+...+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999653    889999999875443  2333333              45666777888999999999


Q ss_pred             CChhhhhhhccCC-----CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          227 GSLDRHIFSKENK-----GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       227 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ++|.+++......     ...+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998544211     36799999999999999999999998   999999999999999999999999999988765


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ...........++..|+|||.+...  .++.++||||+|++++||++ |+.|+.....        ....+.+..+....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  227 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRLP  227 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            5433333456688999999998764  78999999999999999999 5888865421        11233333322221


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                            .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  12233567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.2e-36  Score=293.04  Aligned_cols=250  Identities=24%  Similarity=0.395  Sum_probs=186.9

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc--------CCcEEEEEEecCCCC--CHHHHHHH---------------Hhccc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMMENSKF--SAEEFINE---------------LLGLC  211 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~--------~g~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~  211 (453)
                      ++....+.+.++||+|+||.||+++..        +++.+|+|.+.....  ...++..|               +++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            334456778899999999999999742        235799999976422  22233333               34566


Q ss_pred             ccCcceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcc
Q 048517          212 SEGFKRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHN  279 (453)
Q Consensus       212 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N  279 (453)
                      ......++||||+++|+|.+++.....            ....++|.+++.++.|++.||+|||+.   +++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            677788999999999999999965322            123589999999999999999999987   99999999999


Q ss_pred             eEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcc
Q 048517          280 ILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAT  358 (453)
Q Consensus       280 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~  358 (453)
                      |+++.++.+||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.....
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            99999999999999999866433222222223456789999998753  68899999999999999998 7788753321


Q ss_pred             ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                              .-+.+.+......+      .+...+..+.+++.+||+.+|++|||+.+|++.|+.++.
T Consensus       249 --------~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         249 --------EELFKLLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             --------HHHHHHHHcCCCCC------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                    11223333332221      112234578889999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-35  Score=289.19  Aligned_cols=243  Identities=26%  Similarity=0.400  Sum_probs=184.2

Q ss_pred             hhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ++.+.||+|+||.||+|+..      ....+|+|.+......  .+++..|              +++.+......++++
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            45688999999999999843      2357999988754322  2334444              456667777889999


Q ss_pred             EecCCCChhhhhhhccC--------------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceE
Q 048517          222 EYMPNGSLDRHIFSKEN--------------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNIL  281 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIL  281 (453)
                      ||+.+|+|.+++.....                    ....+++..++.++.|++.||+|||+.   +|+||||||+|||
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence            99999999998854221                    123588999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccc
Q 048517          282 LDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRS  360 (453)
Q Consensus       282 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~  360 (453)
                      +++++.+||+|||+++...............++..|+|||.+.+.  .++.++||||||++++||++ |+.|+.....  
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            999999999999999865443332222334567789999998754  68899999999999999998 8888854321  


Q ss_pred             ccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          361 SKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       361 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                            ..+.+.+........      +...+..+.+++.+||+.+|++||++.++++.|++++.
T Consensus       236 ------~~~~~~~~~~~~~~~------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ------ERLFNLLKTGYRMER------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ------HHHHHHHhCCCCCCC------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                  122333333222111      12234578899999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-35  Score=293.68  Aligned_cols=248  Identities=27%  Similarity=0.424  Sum_probs=183.8

Q ss_pred             HHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCCC--HHHHHHH---------------Hhcccc-cCc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCS-EGF  215 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~-~~~  215 (453)
                      ...+.+.+.||+|+||.||+|+.      .+++.||||++......  ...+..|               ++++|. .+.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            44677889999999999999973      35789999999764322  1223233               444443 344


Q ss_pred             ceEEEEEecCCCChhhhhhhccC---------------------------------------------------------
Q 048517          216 KRALVYEYMPNGSLDRHIFSKEN---------------------------------------------------------  238 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  238 (453)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            57899999999999998864321                                                         


Q ss_pred             ------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccC
Q 048517          239 ------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR  312 (453)
Q Consensus       239 ------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  312 (453)
                            ....++|..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  013478889999999999999999998   99999999999999999999999999998654433222223345


Q ss_pred             CCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHH
Q 048517          313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI  391 (453)
Q Consensus       313 gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  391 (453)
                      ++..|+|||.+...  .++.++||||||+++|||++ |..|+......       ......+..+......      ...
T Consensus       243 ~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~------~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAP------DYT  307 (343)
T ss_pred             CCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCCCCCC------CCC
Confidence            67789999998753  78899999999999999996 88887543211       1122233333222211      112


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          392 ARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       392 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      +..+.+++.+||+.+|++|||+.++++.|+..++
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3468899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.7e-35  Score=292.38  Aligned_cols=225  Identities=25%  Similarity=0.341  Sum_probs=172.1

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+|+.. +++.||||++....    ...+....|               +++.+......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 68899999987532    111222211               44556667778999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++..    ...+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05619          81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--  151 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence            999988843    24689999999999999999999998   999999999999999999999999999875322221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        ...+.+......       
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~-------  214 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMDNPC-------  214 (316)
T ss_pred             ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC-------
Confidence            12345689999999999764  6889999999999999999999999653311        122223222111       


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL  417 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl  417 (453)
                      .+...+..+.+++.+||+.+|++||++. ++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            1122345678899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-35  Score=281.99  Aligned_cols=233  Identities=23%  Similarity=0.406  Sum_probs=176.4

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      ++||+|+||.||+|+. .+++.||+|.......  ....+..|              +++++......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4799999999999995 4799999998764321  12334444              45667777888999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      .+++..   ....+++.+++.++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            998843   234689999999999999999999998   99999999999999999999999999987543321111111


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  388 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  388 (453)
                      ....+..|+|||.+..  +.++.++||||||+++|||++ |..|+......        .....+.......      .+
T Consensus       155 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~~~~~~------~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQGVRLP------CP  218 (252)
T ss_pred             CCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCCCC------Cc
Confidence            1223567999999875  368899999999999999997 88877543211        1222332222211      11


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          389 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       389 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      ...+..+.+++.+||+.+|++|||+.++.++|+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            223457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-35  Score=294.05  Aligned_cols=234  Identities=20%  Similarity=0.308  Sum_probs=176.2

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+++.. +++.||||+++......    ..+..|               +++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999954 78999999997632211    112222               45556677788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--  151 (329)
T cd05588          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--  151 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence            999888742    35689999999999999999999998   999999999999999999999999999874322221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccc-ccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS-SKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||+...... .......+..+.+..... .     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----  223 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R-----  223 (329)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C-----
Confidence            12345689999999999764  78899999999999999999999997432211 112222334444433221 1     


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPS------MTKVLE  418 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs------~~evl~  418 (453)
                       .+..++..+.+++.+||+.||.+|||      +.++++
T Consensus       224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence             11223456889999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-35  Score=293.72  Aligned_cols=249  Identities=24%  Similarity=0.406  Sum_probs=185.9

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc--------CCcEEEEEEecCCCC--CHHHHHHH---------------Hhccc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMMENSKF--SAEEFINE---------------LLGLC  211 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~--------~g~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~  211 (453)
                      ++...++.+.++||+|+||.||+++..        .+..||+|.+.....  ..+++..|               +++.|
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            344456788899999999999999732        123799998875322  12233333               45566


Q ss_pred             ccCcceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcc
Q 048517          212 SEGFKRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHN  279 (453)
Q Consensus       212 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N  279 (453)
                      ......++++||+++|+|.+++.....            ....++|.++..++.|++.||+|||+.   +|+||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            677788999999999999999864321            234588999999999999999999998   99999999999


Q ss_pred             eEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcc
Q 048517          280 ILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAT  358 (453)
Q Consensus       280 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~  358 (453)
                      ||++.++.+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+.....
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999866443322222334456789999998764  78889999999999999998 7787753321


Q ss_pred             ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                              .-....+......+.      +......+.+++.+||+.+|++|||+.++++.|+...
T Consensus       243 --------~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 --------EELFKLLKEGHRMDK------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             --------HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                    112223333222111      1123456889999999999999999999999999766

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-35  Score=291.14  Aligned_cols=249  Identities=22%  Similarity=0.394  Sum_probs=187.0

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEE--------cCCcEEEEEEecCCCC--CHHHHHHH---------------Hhcccc
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQL--------HTGRLIAVKMMENSKF--SAEEFINE---------------LLGLCS  212 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~--------~~g~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~  212 (453)
                      +....+.+.+.||+|+||.||+++.        .++..||+|.+.....  ...++..|               +++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            4455666778999999999999973        1345799999875321  12233333               455666


Q ss_pred             cCcceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcce
Q 048517          213 EGFKRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNI  280 (453)
Q Consensus       213 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI  280 (453)
                      .....+++|||+++|+|.+++.....            ....++|.++..++.|++.||+|||+.   +|+||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            77788999999999999999865322            124578899999999999999999998   999999999999


Q ss_pred             EEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccc
Q 048517          281 LLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATR  359 (453)
Q Consensus       281 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~  359 (453)
                      +++.++.+||+|||+++...............+++.|+|||++.+.  .++.++||||||+++|||++ |+.|+....  
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~--  244 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--  244 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCC--
Confidence            9999999999999999876544332223334567889999998753  68899999999999999998 777764322  


Q ss_pred             cccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          360 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       360 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                            .....+.+..+.....      +...+..+..++.+||+.+|++|||+.++++.|++++.
T Consensus       245 ------~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         245 ------VEELFKLLKEGHRMDK------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ------HHHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence                  1113333333322211      11234568889999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5e-36  Score=296.83  Aligned_cols=225  Identities=24%  Similarity=0.340  Sum_probs=173.5

Q ss_pred             hcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHH----------HHHH--------HHhcccccCcceEEEEEecCC
Q 048517          166 THKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAE----------EFIN--------ELLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~----------~~i~--------el~g~~~~~~~~~lv~E~~~~  226 (453)
                      ...||+|+||.||+++. .+|..+|+|+|+++.....          +.+.        +|+-.+++...+||||||++|
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            46799999999999994 5799999999988543221          1122        266677888999999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC-----
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK-----  301 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~-----  301 (453)
                      |++...|.    ....|+...+..++.+++-||+-||+.   ++|||||||+|+|||.+|++||+||||+.-...     
T Consensus       226 GD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  226 GDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             ccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence            99999883    447899999999999999999999998   999999999999999999999999999853211     


Q ss_pred             ----------------CCCce------e------------------ecccCCCCCccChhhhcccCCCCCccchHHHHHH
Q 048517          302 ----------------ENDFV------S------------------ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGM  341 (453)
Q Consensus       302 ----------------~~~~~------~------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gv  341 (453)
                                      .....      .                  .....|||-|||||++.+.  .++..+|.||+||
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSLG~  376 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSLGC  376 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHHHH
Confidence                            00000      0                  0123599999999999986  6899999999999


Q ss_pred             HHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC-CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC
Q 048517          342 VLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS  412 (453)
Q Consensus       342 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  412 (453)
                      ++|||+.|.+||......+        ++..+.... .+..+    .....+.+..+++.+|+. ||++|--
T Consensus       377 ImyEmLvGyPPF~s~tp~~--------T~rkI~nwr~~l~fP----~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQE--------TYRKIVNWRETLKFP----EEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHH--------HHHHHHHHhhhccCC----CcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999997655432        444443322 11111    111223567889999998 9999985

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.7e-35  Score=286.20  Aligned_cols=243  Identities=25%  Similarity=0.395  Sum_probs=181.8

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcce
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKR  217 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~  217 (453)
                      ...+.+.+.||+|+||.||+|...      .+..||+|.+.....  ....+..|              +++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            344566789999999999999864      367899998875332  23345554              45556667778


Q ss_pred             EEEEEecCCCChhhhhhhccC---CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC---ceEEE
Q 048517          218 ALVYEYMPNGSLDRHIFSKEN---KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVS  291 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~---~~kl~  291 (453)
                      +++|||+++|+|.+++.....   ....++|..++.++.||+.||+|||+.   +++|+||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            999999999999999855321   123689999999999999999999998   999999999999998654   69999


Q ss_pred             ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517          292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  370 (453)
                      |||+++................+..|+|||++.+.  .++.++|||||||++|||++ |+.||......        ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~~~  231 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------EVM  231 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence            99999876433222222233345789999999753  78999999999999999997 88888643221        122


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      +.+........      +...+..+.+++.+|++.+|++|||+.+|++.|+
T Consensus       232 ~~~~~~~~~~~------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         232 EFVTGGGRLDP------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            22222222111      1223457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-35  Score=296.03  Aligned_cols=234  Identities=23%  Similarity=0.278  Sum_probs=181.8

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc-C-CcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-T-GRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFK  216 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~-g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~  216 (453)
                      .+....+.+.+.||+|+||.||+|+.. + +..||+|.+....    ...+.+..|              +++++.....
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            444556778899999999999999854 3 3689999986532    122233333              5667777888


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a  178 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFA  178 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCC
Confidence            9999999999999998843    24689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      +......     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ...+..+..+
T Consensus       179 ~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~  243 (340)
T PTZ00426        179 KVVDTRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEG  243 (340)
T ss_pred             eecCCCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcC
Confidence            8654321     345699999999999764  678999999999999999999999975432        1233333332


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  419 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~  419 (453)
                      ...       .+...+..+.+++.+|++.+|++|+     |++++++.
T Consensus       244 ~~~-------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        244 IIY-------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCC-------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            211       1122345678899999999999995     89988764

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.8e-35  Score=280.95  Aligned_cols=244  Identities=21%  Similarity=0.318  Sum_probs=186.3

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .+.+.++||+|+||.||+|+. .+++.||||.+.....    ...++..|              +++++......++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            356778999999999999995 4789999998764221    12234443              4555666677899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++.........+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999988754333345688899999999999999999998   9999999999999999999999999999876443


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......+++.|+|||.+.+.  .++.++|+||||+++|||++|+.|+......     ... ....+.......  
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~-~~~~~~~~~~~~--  227 (267)
T cd08228         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFS-LCQKIEQCDYPP--  227 (267)
T ss_pred             hH--HHhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHH-HHHHHhcCCCCC--
Confidence            22  12345688999999998764  6788999999999999999999998543211     011 122222222111  


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                         ......+..+.+++.+||+.+|++||++++|++.|+..
T Consensus       228 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 ---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence               11233456789999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.9e-35  Score=281.55  Aligned_cols=244  Identities=23%  Similarity=0.336  Sum_probs=187.0

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .+++.+.||+|+||.||+++. .+|+.+|||.+.....    ...++.+|              +++++..+...+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            356778999999999999994 5899999998765322    12233333              4566667778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++++|.+++.........+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999998864333446789999999999999999999998   9999999999999999999999999998866443


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......++..|+|||++.+.  .++.++||||||+++|||++|..|+.......     .. ..+.+........ 
T Consensus       160 ~~--~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~~-  228 (267)
T cd08229         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YS-LCKKIEQCDYPPL-  228 (267)
T ss_pred             Cc--ccccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchH-----HH-HhhhhhcCCCCCC-
Confidence            22  12334688999999998764  68889999999999999999999986432110     00 1112222111111 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                          .....+..+.+++.+||+.+|++||||.+|++++++.
T Consensus       229 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         229 ----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                1123556788999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.3e-35  Score=282.73  Aligned_cols=242  Identities=24%  Similarity=0.378  Sum_probs=174.0

Q ss_pred             cccCccCceEEEEEEEcC---CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQLHT---GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~---g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      ++||+|+||.||+|...+   ...+|+|.+......  ...+++|              +++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            469999999999997543   457889987653322  2334444              456677778899999999999


Q ss_pred             ChhhhhhhccC-CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          228 SLDRHIFSKEN-KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       228 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      +|.+++..... ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865432 223457888899999999999999998   99999999999999999999999999987644333222


Q ss_pred             eecccCCCCCccChhhhccc-----CCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          307 SISDTRGTIGYLAPELISRN-----FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ......++..|+|||++...     ...++.++||||||+++|||++ |+.|+......        .............
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~~~  229 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLKQVVREQDIK  229 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhhccCcc
Confidence            22334567789999987532     1256889999999999999999 67777543211        1111111112111


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      +... ......+..+.+++..|+ .||++|||+++|+++|.
T Consensus       230 ~~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111 122334556777888898 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.4e-35  Score=293.18  Aligned_cols=232  Identities=25%  Similarity=0.387  Sum_probs=172.9

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ++.++||+|+||.||+|+.. +|+.||||++......  .+++.+|              +++++......++||||+++
T Consensus        77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  156 (353)
T PLN00034         77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG  156 (353)
T ss_pred             hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence            45678999999999999954 7899999998653321  2233333              56677778889999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+..        ...+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus       157 ~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        157 GSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             Ccccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            9986532        345677889999999999999998   999999999999999999999999999987643321  


Q ss_pred             eecccCCCCCccChhhhcccC---CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          307 SISDTRGTIGYLAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~---~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      ......||..|+|||.+....   ...+.++|||||||++|||++|+.||.......    +.... ..........   
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~-~~~~~~~~~~---  295 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WASLM-CAICMSQPPE---  295 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHH-HHHhccCCCC---
Confidence            123457999999999885321   134568999999999999999999997332211    11111 1111111111   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                         ........+.+++.+||+.||++|||+.|+++.
T Consensus       296 ---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 ---APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               122345678999999999999999999999883

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=290.34  Aligned_cols=250  Identities=23%  Similarity=0.366  Sum_probs=180.6

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEcC---------------CcEEEEEEecCCCC--CHHHHHHH--------------H
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLHT---------------GRLIAVKMMENSKF--SAEEFINE--------------L  207 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~~---------------g~~VAVK~l~~~~~--~~~~~i~e--------------l  207 (453)
                      ....+.+.++||+|+||.||+++...               ...||||.+.....  ..+++.+|              +
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            34567788999999999999987532               23589999876422  12334444              4


Q ss_pred             hcccccCcceEEEEEecCCCChhhhhhhccC--------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcc
Q 048517          208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKEN--------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHN  279 (453)
Q Consensus       208 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N  279 (453)
                      ++++......++||||+++++|.+++.....        ....++|..++.++.+++.||+|||+.   +++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence            5667777888999999999999998854321        112478899999999999999999998   99999999999


Q ss_pred             eEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc--CCCCCCCCc
Q 048517          280 ILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNA  357 (453)
Q Consensus       280 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt--g~~p~~~~~  357 (453)
                      |+++.++.+||+|||+++...............++..|+|||.+..  +.++.++||||||++++||++  +..|+....
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            9999999999999999986544332222233456778999998875  378999999999999999998  455654332


Q ss_pred             cccccccchHHHHHHhhhC-CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          358 TRSSKAYFPSWVYDQLNKG-GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       358 ~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      ...    ......+..... .....    ..+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       238 ~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         238 DEQ----VIENTGEFFRNQGRQIYL----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             hHH----HHHHHHHhhhhccccccC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            111    000111111111 10000    011123457999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=301.11  Aligned_cols=223  Identities=26%  Similarity=0.399  Sum_probs=182.5

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHH---------------HHHHHhcccccCcceEEEEEe
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEE---------------FINELLGLCSEGFKRALVYEY  223 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~---------------~i~el~g~~~~~~~~~lv~E~  223 (453)
                      .|.+.||+|.||+|+++.++ +++.+|||++++...    ..+.               |+..|+.+++...+.++||||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            35578999999999999965 788999999988432    2222               222378888999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      ..||++..+.     ....|+...+.-++.+|+.||.|||++   +||+||||.+|||||.+|++||+||||++-.-...
T Consensus       451 ~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  451 VAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             cCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCC
Confidence            9999965444     336799999999999999999999998   99999999999999999999999999998654333


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  .+++..|||-|||||++.+.  .|+...|.|||||+||||+.|..||...++.+        +.+.+.....     
T Consensus       523 ~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--------~FdsI~~d~~-----  585 (694)
T KOG0694|consen  523 D--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--------VFDSIVNDEV-----  585 (694)
T ss_pred             C--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHhcCCC-----
Confidence            2  34678999999999999875  89999999999999999999999998766432        3333333221     


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSM  413 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  413 (453)
                        ..+..++.+...++.++|..+|++|--+
T Consensus       586 --~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 --RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --CCCCcccHHHHHHHHHHhccCcccccCC
Confidence              2455567788999999999999999966

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.8e-35  Score=299.63  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=187.1

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH---------------Hhccccc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSE  213 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~  213 (453)
                      ++....+.+.++||+|+||.||+|+..      .++.||||+++.....  .+.++.|               +++.|..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            444445566789999999999999854      3468999999764322  2334444               3456667


Q ss_pred             CcceEEEEEecCCCChhhhhhhccC-------------------------------------------------------
Q 048517          214 GFKRALVYEYMPNGSLDRHIFSKEN-------------------------------------------------------  238 (453)
Q Consensus       214 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------  238 (453)
                      ....++|+||+++|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            7788999999999999999864321                                                       


Q ss_pred             ---------------------------------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcc
Q 048517          239 ---------------------------------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHN  279 (453)
Q Consensus       239 ---------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N  279 (453)
                                                             ....++|..+..++.|++.||+|||+.   +|+||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence                                                   112467888899999999999999997   99999999999


Q ss_pred             eEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcc
Q 048517          280 ILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAT  358 (453)
Q Consensus       280 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~  358 (453)
                      ||++.++.+||+|||+++...............++..|+|||.+...  .++.++||||||+++|||++ |+.|+.....
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            99999999999999999865433322222334578899999998763  68899999999999999998 8888754321


Q ss_pred             ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      .       ......+..+.....      +...+..+.+++.+||+.+|++||+++++++.|+..+
T Consensus       348 ~-------~~~~~~~~~~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 N-------EQFYNAIKRGYRMAK------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             h-------HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1       112223333222211      1123467899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.1e-34  Score=278.13  Aligned_cols=244  Identities=24%  Similarity=0.354  Sum_probs=187.7

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||.||+|... +|+.||+|.++...    ...+++..|              +++.+......+++||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4567789999999999999966 89999999886421    113334443              4555666778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++.........+++.++..++.+++.||.|||+.   +|+|+||||+||+++.++.++|+|||+++.....
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999998865444456689999999999999999999998   9999999999999999999999999998865433


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+......     ... ..+.+..+..... 
T Consensus       160 ~~--~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~~~~~~-  228 (267)
T cd08224         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYS-LCKKIEKCDYPPL-  228 (267)
T ss_pred             Cc--ccceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHH-HHhhhhcCCCCCC-
Confidence            21  12334688999999998754  6889999999999999999999998543211     111 1222222222111 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                          ........+.+++.+||+.+|++|||+.+++++|+++
T Consensus       229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                1123456788999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.3e-36  Score=295.64  Aligned_cols=226  Identities=23%  Similarity=0.341  Sum_probs=172.9

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      +.||+|+||.||+++. .+|+.||+|++.....    ...++..|              +.+.+......++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999985 5799999999876321    12223333              344556677889999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      +|..++..    ...+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--  151 (325)
T cd05594          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--  151 (325)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence            99888742    3468999999999999999999997 5   899999999999999999999999999875433222  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        -....+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~~i~~~~-~~------  214 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEE-IR------  214 (325)
T ss_pred             ccccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHH--------HHHHHHhcCC-CC------
Confidence            12345699999999999764  7889999999999999999999999643221        0111221111 11      


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                      .+..++..+.+++.+||+.||++|+     ++.++++
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            1122345688899999999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-36  Score=297.86  Aligned_cols=236  Identities=25%  Similarity=0.327  Sum_probs=181.1

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.++||+|+||+||+|+.. +|+.||||++....    .....+..|              +++.+.++...++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            3566789999999999999965 79999999987532    112222222              5666777888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          82 YMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999988532    5689999999999999999999997   9999999999999999999999999999865433


Q ss_pred             C---------------------------CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 048517          303 N---------------------------DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  355 (453)
Q Consensus       303 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~  355 (453)
                      .                           .........||+.|+|||.+.+.  .++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCC
Confidence            2                           00112345699999999999864  789999999999999999999999975


Q ss_pred             CccccccccchHHHHHHhhh-CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 048517          356 NATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS-MTKVLEM  419 (453)
Q Consensus       356 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~~  419 (453)
                      ....        .....+.. .........    ..++..+.+++.+|++ +|.+||+ ++++++.
T Consensus       233 ~~~~--------~~~~~i~~~~~~~~~p~~----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         233 DTLQ--------ETYNKIINWKESLRFPPD----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCHH--------HHHHHHhccCCcccCCCC----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            4321        11222222 111111111    1145678889999998 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.3e-35  Score=291.72  Aligned_cols=228  Identities=21%  Similarity=0.316  Sum_probs=172.1

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----HHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----EEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+++. .+++.||||++.......    +.+..|               +++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999995 468899999997642211    112222               34555667788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  151 (327)
T cd05617          81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--  151 (327)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence            999888742    24689999999999999999999998   999999999999999999999999999975322221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||....... ......+....+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~-~~------  221 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILEKP-IR------  221 (327)
T ss_pred             ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHhCC-CC------
Confidence            12345699999999999764  78899999999999999999999996543221 1112223333333221 11      


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSM  413 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~  413 (453)
                      .+...+..+.+++.+||+.||++||++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            112234567889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-35  Score=279.44  Aligned_cols=233  Identities=28%  Similarity=0.464  Sum_probs=178.3

Q ss_pred             cccCccCceEEEEEEEc-C---CcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-T---GRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~---g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ++||+|+||.||+|+.. .   +..+|+|.+.....  ..+++..|              +++++. ....+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999743 2   36899999886544  33445444              234443 4467899999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++...    ..+++..+..++.|++.||+|||..   +++|+||||+|||++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999998532    3689999999999999999999998   99999999999999999999999999998765433221


Q ss_pred             -eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          307 -SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       307 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                       ......++..|+|||.+...  .++.++||||||+++|||++ |+.||......        -....+.......    
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~----  218 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--------EVIAMLESGERLP----  218 (257)
T ss_pred             ccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCCcCC----
Confidence             11223345789999998753  78999999999999999998 99998643321        1223333332221    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                        .+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus       219 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 --RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence              1122346788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-35  Score=290.87  Aligned_cols=244  Identities=23%  Similarity=0.324  Sum_probs=175.0

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .|.+.++||+|+||.||+|+.. +++.||||++.....  ....+.+|              +++++......++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV   85 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence            4667789999999999999965 789999999875322  12223333              456667777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      + ++|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          86 H-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             C-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            5 677777643   235688999999999999999999998   999999999999999999999999999975433221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC--------
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG--------  376 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~--------  376 (453)
                        ......+|+.|+|||.+.+. ..++.++||||+||++|||++|+.||........  .+ ..+...+...        
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QL-ERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             --cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HH-HHHHHHhCCCChhhccch
Confidence              12345689999999998653 3578899999999999999999999975322100  00 0000000000        


Q ss_pred             --------CCccccchhhhHH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 --------GDLELRNVTEIES-----MIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 --------~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                              .............     .....+.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                    0000000000000     12245778999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.9e-35  Score=285.23  Aligned_cols=242  Identities=26%  Similarity=0.419  Sum_probs=181.9

Q ss_pred             hhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ...+.++||+|+||.||++...      ++..+|+|.+...... .+++..|              +++++..+...+++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV   85 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence            3456789999999999999742      4668999988764322 2334333              44566677778999


Q ss_pred             EEecCCCChhhhhhhccC-----------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceE
Q 048517          221 YEYMPNGSLDRHIFSKEN-----------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  289 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~k  289 (453)
                      +||+++|+|.+++.....           ....+++.+++.++.|++.||+|||+.   +++|+||||+|||+++++.+|
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~k  162 (280)
T cd05092          86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVK  162 (280)
T ss_pred             EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEE
Confidence            999999999999864321           113589999999999999999999998   999999999999999999999


Q ss_pred             EEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHH
Q 048517          290 VSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSW  368 (453)
Q Consensus       290 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  368 (453)
                      |+|||+++...............+++.|+|||.+.+.  .++.++|||||||++|||++ |+.||.......        
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------  232 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--------  232 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--------
Confidence            9999999865433322222333457889999998764  78999999999999999998 888875432211        


Q ss_pred             HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          369 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      .......+.....      +...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       233 ~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         233 AIECITQGRELER------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHHcCccCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            1222222222111      11234568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.2e-35  Score=291.70  Aligned_cols=226  Identities=24%  Similarity=0.307  Sum_probs=174.2

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHH---------------HHhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFIN---------------ELLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~---------------el~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||+||+++.. +++.||||++....    ...+.+..               .+++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 68899999987532    11122222               245666777789999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|..++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  151 (318)
T cd05570          81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--  151 (318)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence            999888743    24689999999999999999999998   999999999999999999999999999875322221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .....+......       
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~~~~-------  214 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILEDEVR-------  214 (318)
T ss_pred             cccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCC-------
Confidence            12334689999999999764  7889999999999999999999999644321        122222222111       


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~  418 (453)
                      .+..++..+.+++.+||+.||++|||+     .++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            112244678899999999999999999     88765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-35  Score=286.00  Aligned_cols=236  Identities=28%  Similarity=0.363  Sum_probs=179.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      ||+..+.||+|+||+||++.. .+++.||||++......    ...+.+|              +++.+..+...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            355678899999999999995 47899999998753211    1223333              3455666778999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.++|+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999887532  234689999999999999999999998   9999999999999999999999999999875433


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..   .....||+.|+|||++.+.  .++.++||||+|+++|||++|+.||.......    ....+...+....     
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~-----  221 (285)
T cd05605         156 ET---IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKEDQ-----  221 (285)
T ss_pred             Cc---cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhcc-----
Confidence            22   1344689999999999753  78899999999999999999999997533211    0011111221111     


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                        ...+..++..+.+++.+||+.||++||     ++.++++
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence              112233556788999999999999999     7888855

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.3e-35  Score=291.66  Aligned_cols=187  Identities=26%  Similarity=0.357  Sum_probs=153.1

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      +....|++.++||+|+||.||++... +++.+|+|++.....  ..+++..|              +++++..+...++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            34456778899999999999999965 788999998876422  12334333              56677788889999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++..    ...+++..+..++.+++.||.|||+.  .+|+|+||||+|||++.++.+||+|||++....
T Consensus        82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            999999999998843    24588899999999999999999974  279999999999999999999999999997653


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN  356 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~  356 (453)
                      ...    .....||..|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       156 ~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         156 DSM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhc----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            321    1334689999999999764  6889999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.8e-35  Score=281.07  Aligned_cols=242  Identities=26%  Similarity=0.429  Sum_probs=186.8

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +...++.+.++||+|+||.||++..+++..+|+|.+.......+.+.+|              +.+++.. ...+++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            3455677889999999999999998888889999987655555566555              2233334 567899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...  ....+++.++..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999999998542  345689999999999999999999998   99999999999999999999999999998654332


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      . .......++..|+|||++..  +.++.++|+||||++++|+++ |+.|+......        -....+..+....  
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~--  223 (260)
T cd05073         157 Y-TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRMP--  223 (260)
T ss_pred             c-ccccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCCCCC--
Confidence            2 12223446678999999875  378889999999999999998 88888643211        1122222222211  


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                          .....+..+.+++.+|++.+|++||++.++.++|+.
T Consensus       224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                112334568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.1e-35  Score=280.60  Aligned_cols=242  Identities=24%  Similarity=0.380  Sum_probs=174.0

Q ss_pred             cccCccCceEEEEEEEcC---CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQLHT---GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~---g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      +.||+|+||.||+|...+   +..+|+|.+......  ..++.+|              +++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999998653   467999988764322  2234443              466777777889999999999


Q ss_pred             ChhhhhhhccC-CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          228 SLDRHIFSKEN-KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       228 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      +|.+++..... ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999865332 223567788889999999999999998   99999999999999999999999999997654333222


Q ss_pred             eecccCCCCCccChhhhcccCC-----CCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          307 SISDTRGTIGYLAPELISRNFG-----TVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~-----~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ......++..|+|||++....+     .++.++||||||+++|||++ |+.||.......        ............
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--------VLTYTVREQQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHhhcccCC
Confidence            2233457888999999864211     35789999999999999996 999986433211        111111111111


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      ..... ........+.+++..|+ .+|++|||+++|+..|+
T Consensus       230 ~~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11100 11112345777889998 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-35  Score=293.36  Aligned_cols=222  Identities=27%  Similarity=0.329  Sum_probs=169.9

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||+||+|+.. +|+.||||++.....    ...+++.|               +++.+......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999964 799999999875321    12222222               33445566778999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (323)
T cd05575          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--  151 (323)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence            999988843    34688999999999999999999998   999999999999999999999999999875432221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        ...+.+..... ..     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~-~~-----  215 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--------EMYDNILNKPL-RL-----  215 (323)
T ss_pred             ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCCC-CC-----
Confidence            22345699999999998764  7889999999999999999999999643211        12222222211 11     


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMT  414 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  414 (453)
                       ....+..+.+++.+||+.+|++||++.
T Consensus       216 -~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 -KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             112346688999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3e-35  Score=286.82  Aligned_cols=248  Identities=23%  Similarity=0.358  Sum_probs=182.4

Q ss_pred             HhhhhhcccCccCceEEEEEEEcC-----------------CcEEEEEEecCCCC--CHHHHHHH--------------H
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHT-----------------GRLIAVKMMENSKF--SAEEFINE--------------L  207 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~-----------------g~~VAVK~l~~~~~--~~~~~i~e--------------l  207 (453)
                      ..+.+.++||+|+||.||+++..+                 +..||+|++.....  ..+++..|              +
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            356778999999999999987542                 35689999876432  23344443              4


Q ss_pred             hcccccCcceEEEEEecCCCChhhhhhhccC-------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcce
Q 048517          208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKEN-------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNI  280 (453)
Q Consensus       208 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI  280 (453)
                      ++++..+...++++||+++++|.+++.....       ....+++..++.++.|++.||+|||+.   +|+|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence            5566667788999999999999999854331       123689999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc--CCCCCCCCcc
Q 048517          281 LLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNAT  358 (453)
Q Consensus       281 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt--g~~p~~~~~~  358 (453)
                      +++.++.++|+|||+++...............+|..|+|||.+.+.  .++.++||||||+++|||++  |..|+.....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999999865444333233445578899999998753  78999999999999999998  5566643221


Q ss_pred             ccccccchHHHHHHhhhCC-CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          359 RSSKAYFPSWVYDQLNKGG-DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       359 ~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                              ..+...+.... ..........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       240 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 --------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence                    11222221110 00000000111223457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.5e-35  Score=277.14  Aligned_cols=236  Identities=28%  Similarity=0.495  Sum_probs=183.7

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      .+.+.+.||+|+||.||++...+++.+|+|.+........++..|              +++++......++++||++++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG   84 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence            456678999999999999997778899999988765555566555              345666777889999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.+++...   ...++++.+..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||+++........ .
T Consensus        85 ~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~  157 (256)
T cd05112          85 CLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S  157 (256)
T ss_pred             cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence            999988432   24588999999999999999999998   9999999999999999999999999999865433211 1


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      .....++.+|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        ...+.+.++.....     
T Consensus       158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-----  222 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGFRLYK-----  222 (256)
T ss_pred             cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCCCCCC-----
Confidence            1233456789999998753  78899999999999999998 88888643211        12223332221111     


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                       +...+..+.+++.+||+.+|++|||+.+++++|
T Consensus       223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence             111235688999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.8e-35  Score=286.74  Aligned_cols=243  Identities=23%  Similarity=0.333  Sum_probs=175.4

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .|.+.++||+|+||.||+|+.. +++.||+|++.....  ....+.+|              +++++......++||||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            3566789999999999999854 789999999875321  22233333              455666667788999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      + |+|.+++..   .+..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          86 D-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             C-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            7 588887743   234578899999999999999999998   999999999999999999999999999976533221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh---------
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK---------  375 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~---------  375 (453)
                        ......+|+.|+|||.+.+. ..++.++||||+||++|||++|+.||........   + ..+...+..         
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~-~~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---L-HLIFRLLGTPTEETWPGI  231 (288)
T ss_pred             --cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---H-HHHHHHhCCCChHHhhcc
Confidence              12345689999999998653 3678999999999999999999999865432110   0 000000000         


Q ss_pred             --CC---Ccccc-----chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 --GG---DLELR-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 --~~---~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        ..   .....     .........+....+++.+||+.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              00   00000     000011123456789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.2e-35  Score=277.45  Aligned_cols=232  Identities=26%  Similarity=0.413  Sum_probs=178.8

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCCChh
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLD  230 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~  230 (453)
                      +.||+|+||.||+|...+++.||+|.+......  ...+.+|              +++++......++||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            369999999999999888999999998764322  2234333              456677777889999999999999


Q ss_pred             hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517          231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD  310 (453)
Q Consensus       231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  310 (453)
                      +++...   ...+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~  153 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL  153 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence            988432   24588999999999999999999998   999999999999999999999999999975433221 11122


Q ss_pred             cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ..++..|+|||++..  +.++.++||||||+++||+++ |..||......        .....+..+.....      +.
T Consensus       154 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~------~~  217 (250)
T cd05085         154 KQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYRMSC------PQ  217 (250)
T ss_pred             CCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCCCCC------CC
Confidence            345678999999875  478899999999999999998 88888643221        12223333222211      11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          390 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      ..+..+.+++.+|++.+|++|||+.++++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            23467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.1e-35  Score=285.09  Aligned_cols=242  Identities=26%  Similarity=0.423  Sum_probs=182.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      .+.+.++||+|+||.||+++.+      ++..||+|++.....  ...++..|              +++++..+...++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL   85 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence            4556789999999999999853      467899999875432  12334433              4566777778899


Q ss_pred             EEEecCCCChhhhhhhcc------------------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceE
Q 048517          220 VYEYMPNGSLDRHIFSKE------------------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNIL  281 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIL  281 (453)
                      ++||+++|+|.+++....                  .....+++..++.++.|++.||+|||+.   +++||||||+||+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil  162 (288)
T cd05050          86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL  162 (288)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence            999999999999985321                  1123578889999999999999999998   9999999999999


Q ss_pred             EcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccc
Q 048517          282 LDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRS  360 (453)
Q Consensus       282 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~  360 (453)
                      ++.++.+||+|||+++................+..|+|||.+.+.  .++.++|||||||++|||++ |..|+...... 
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            999999999999998865433222222233456789999998754  78999999999999999997 77777533211 


Q ss_pred             ccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          361 SKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       361 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                             -....+..+.....      +...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 -------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -------EVIYYVRDGNVLSC------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -------HHHHHHhcCCCCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                   12223333322211      11234578899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.9e-35  Score=285.27  Aligned_cols=246  Identities=25%  Similarity=0.405  Sum_probs=185.6

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccC
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEG  214 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~  214 (453)
                      +....+.+.+.||+|+||.||++...      ++..||||++......  .+.+..|               +++.+...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            44455677889999999999999741      3558999998764322  2233333               44566677


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...+++|||+++|+|.+++....  ...+++.++..++.+++.||+|||+.   +|+|+||||+|||++.+..+|++|||
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence            78899999999999999885422  23489999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      +++...............++..|+|||.+...  .++.++||||+|+++|||++ |+.|+......       ....+.+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~~~~~~  257 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SKFYKLI  257 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HHHHHHH
Confidence            99866544332222334567889999998754  68899999999999999998 88887643221       1112222


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      ..+.....      +...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus       258 ~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         258 KEGYRMAQ------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HcCCcCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            22221111      112245688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-35  Score=295.56  Aligned_cols=247  Identities=21%  Similarity=0.215  Sum_probs=176.1

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHH-HHH--------HHhcccccCcceEEEEEecCCCChh
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE-FIN--------ELLGLCSEGFKRALVYEYMPNGSLD  230 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~-~i~--------el~g~~~~~~~~~lv~E~~~~gsL~  230 (453)
                      ..|.+.++||+|+||.||++.. .+++.||+|.........|. .+.        ++++++..+...++|+|++. ++|.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~  170 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY  170 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence            4577788999999999999984 57899999976543222221 111        25666777778899999994 7888


Q ss_pred             hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517          231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD  310 (453)
Q Consensus       231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  310 (453)
                      +++..    ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus       171 ~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~  242 (391)
T PHA03212        171 CYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYG  242 (391)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccccc
Confidence            87733    24689999999999999999999998   999999999999999999999999999975432211 11234


Q ss_pred             cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc---hHHHHH----------------
Q 048517          311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF---PSWVYD----------------  371 (453)
Q Consensus       311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~----------------  371 (453)
                      ..||+.|+|||++.+.  .++.++|||||||++|||++|+.|+............   ...+..                
T Consensus       243 ~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        243 WAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             ccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            5799999999999764  7899999999999999999999886533211100000   000000                


Q ss_pred             ------HhhhCCCccc--cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          372 ------QLNKGGDLEL--RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       372 ------~l~~~~~~~~--~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                            ..........  ..........+..+..++.+||+.||++|||++|+++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  0000000000  0001112234567889999999999999999999986

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.1e-35  Score=281.10  Aligned_cols=240  Identities=28%  Similarity=0.437  Sum_probs=181.1

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCc---EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGR---LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~---~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      .+...+.||+|+||.||+|+.. +++   .+|+|.+.....  ..+++..|              +.+++......++||
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT   85 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence            4456688999999999999964 333   799999875422  22334444              455566677789999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++++|.+++...   ...+++.++..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          86 EYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999988432   25689999999999999999999998   999999999999999999999999999986643


Q ss_pred             CCCcee-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          302 ENDFVS-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       302 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ...... ......+..|+|||++...  .++.++||||||+++|||++ |+.|+......        .....+.++...
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~~~  229 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGFRL  229 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCCCC
Confidence            322111 1122335679999998753  68899999999999999997 99998643321        122333332221


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      ..      .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus       230 ~~------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 PA------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11      112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.4e-35  Score=291.25  Aligned_cols=225  Identities=25%  Similarity=0.293  Sum_probs=170.6

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+++. .+|+.||||++....    ....++..|               +++.+......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 579999999986531    111222222               34555667788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|..++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  151 (325)
T cd05604          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--  151 (325)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence            99988774    235689999999999999999999998   999999999999999999999999999875422221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        ...+.+..... ..     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~~~~-~~-----  215 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILHKPL-VL-----  215 (325)
T ss_pred             CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHcCCc-cC-----
Confidence            12345699999999999764  7889999999999999999999999653311        12222222211 11     


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVL  417 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl  417 (453)
                       ....+..+.+++.+|++.+|.+||++.+.+
T Consensus       216 -~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         216 -RPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             -CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence             111335677899999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.6e-35  Score=284.56  Aligned_cols=248  Identities=24%  Similarity=0.356  Sum_probs=179.1

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-----------------CCcEEEEEEecCCCC--CHHHHHHH--------------H
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-----------------TGRLIAVKMMENSKF--SAEEFINE--------------L  207 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-----------------~g~~VAVK~l~~~~~--~~~~~i~e--------------l  207 (453)
                      ..+.+.++||+|+||.||++...                 ++..||+|++.....  ...++..|              +
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            34677889999999999998532                 245799999875422  22344444              4


Q ss_pred             hcccccCcceEEEEEecCCCChhhhhhhccC-------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcce
Q 048517          208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKEN-------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNI  280 (453)
Q Consensus       208 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI  280 (453)
                      ++++......+++|||+++|+|.+++.....       ....+++.++..++.|++.||+|||+.   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            5566667778999999999999998864321       123578889999999999999999998   999999999999


Q ss_pred             EEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc--CCCCCCCCcc
Q 048517          281 LLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNAT  358 (453)
Q Consensus       281 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt--g~~p~~~~~~  358 (453)
                      |++.++.+||+|||+++...............+++.|+|||....  +.++.++|||||||++|||++  |..|+.....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999999999999999986544332222223345678999998765  478999999999999999998  6667653322


Q ss_pred             ccccccchHHHHHHhhhC-CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          359 RSSKAYFPSWVYDQLNKG-GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       359 ~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      ..   .. .......... ......    .+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       240 ~~---~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 EQ---VI-ENTGEFFRDQGRQVYLP----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HH---HH-HHHHHHHhhccccccCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11   00 0011111111 111110    11123357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-34  Score=278.18  Aligned_cols=239  Identities=26%  Similarity=0.383  Sum_probs=182.9

Q ss_pred             hhhhcccCccCceEEEEEEEcC--CcEEEEEEecCCCC-----------CHHHHHHH---------------HhcccccC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMMENSKF-----------SAEEFINE---------------LLGLCSEG  214 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~~--g~~VAVK~l~~~~~-----------~~~~~i~e---------------l~g~~~~~  214 (453)
                      |.+.+.||+|+||.||+|....  ++.+|||.+.....           ...+++.|               +++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            4567889999999999999654  78899998764211           11223333               44566677


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...+++|||+++++|.+.+.........+++..++.++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence            889999999999999988855434456789999999999999999999963  279999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      ++.......   ......|+..|+|||.+.+  +.++.++||||||+++|||++|+.|+......       . ....+.
T Consensus       160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~-~~~~~~  226 (269)
T cd08528         160 LAKQKQPES---KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNML-------S-LATKIV  226 (269)
T ss_pred             ceeeccccc---ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHH-------H-HHHHHh
Confidence            998765433   2244568999999999975  36899999999999999999999998543211       1 111222


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      +......     .....+..+.+++.+||+.||++||++.|+.++++
T Consensus       227 ~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 EAVYEPL-----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hccCCcC-----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            2211111     11123467889999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.1e-35  Score=291.50  Aligned_cols=226  Identities=26%  Similarity=0.306  Sum_probs=171.2

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+++.. +++.||+|++....    ....++..|               +++.+......++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999955 67899999987532    111222222               34455667788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++..    ...++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--  151 (325)
T cd05602          81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--  151 (325)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence            999988843    34578888899999999999999998   999999999999999999999999999975432221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        ..++.+..... .      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~-~------  214 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKPL-Q------  214 (325)
T ss_pred             CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCCc-C------
Confidence            12345699999999999764  7889999999999999999999999643321        12222222111 1      


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ....++..+.+++.+||+.+|.+||++.+.+.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            11123456888999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-34  Score=285.45  Aligned_cols=247  Identities=24%  Similarity=0.415  Sum_probs=184.9

Q ss_pred             HhhhhhcccCccCceEEEEEEEc--------CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCc
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGF  215 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~--------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~  215 (453)
                      ..+.+.++||+|+||.||+++..        .+..||+|.+......  ..++..|               +++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            45567889999999999999742        3457999998754322  2233333               345566677


Q ss_pred             ceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517          216 KRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD  283 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~  283 (453)
                      ..++++||+++|+|.+++.....            ....++|.++..++.|++.||.|||+.   +|+|+||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            78999999999999999865321            124589999999999999999999998   999999999999999


Q ss_pred             CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccc
Q 048517          284 HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSK  362 (453)
Q Consensus       284 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~  362 (453)
                      .++.+||+|||+++...............++..|+|||.+.+  +.++.++||||||+++|||++ |+.|+.....    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----  242 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----  242 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence            999999999999986644322222222345568999999875  378899999999999999999 8888753321    


Q ss_pred             ccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                          ....+.+..+.....      +...+..+.+++.+||+.+|++|||+.++++.|++....
T Consensus       243 ----~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         243 ----EELFKLLREGHRMDK------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             ----HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                123333333322221      112334678899999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.3e-35  Score=288.28  Aligned_cols=226  Identities=25%  Similarity=0.356  Sum_probs=173.3

Q ss_pred             cccCccCceEEEEEEE----cCCcEEEEEEecCCCC-----CHHHHHH--------------HHhcccccCcceEEEEEe
Q 048517          167 HKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF-----SAEEFIN--------------ELLGLCSEGFKRALVYEY  223 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~-----~~~~~i~--------------el~g~~~~~~~~~lv~E~  223 (453)
                      ++||+|+||.||+++.    .+++.||||++.....     ....+..              ++++.+..+...++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999984    3588999999875211     1111222              245667777889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...+.+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999988843    34678888999999999999999998   99999999999999999999999999987543322


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .....+..+.. .   
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~~~~~-~---  218 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKILKGKL-N---  218 (323)
T ss_pred             C--cccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCC-C---
Confidence            1  12335699999999999764  6788999999999999999999999654321        12222222211 1   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                         .+..++..+.+++.+||+.+|++||     ++.++++
T Consensus       219 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 ---LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               1122345688999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.2e-34  Score=275.64  Aligned_cols=232  Identities=26%  Similarity=0.429  Sum_probs=176.8

Q ss_pred             ccCccCceEEEEEEEc---CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecCCCC
Q 048517          168 KLGQGGFGSVYKGQLH---TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGS  228 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gs  228 (453)
                      .||+|+||.||+|.+.   ++..||+|++.....  ..+++..|              +++++. ....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999754   456799999876432  22344444              345554 346789999999999


Q ss_pred             hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce-e
Q 048517          229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-S  307 (453)
Q Consensus       229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~  307 (453)
                      |.+++...   ...+++..++.++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||+++......... .
T Consensus        81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99988532   35689999999999999999999998   99999999999999999999999999998654433221 1


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      .....++..|+|||.+...  .++.++||||||+++||+++ |+.|+......        -+...+.++......    
T Consensus       155 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----  220 (257)
T cd05115         155 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIEQGKRLDCP----  220 (257)
T ss_pred             cCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCCCCCC----
Confidence            1223346789999998753  68889999999999999996 99998644321        123334443332221    


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                        ......+.+++.+||+.+|++||++.+|.+.|+.
T Consensus       221 --~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         221 --AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence              1234578889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.6e-35  Score=284.75  Aligned_cols=244  Identities=26%  Similarity=0.408  Sum_probs=178.1

Q ss_pred             hhhcccCccCceEEEEEEE-----cCCcEEEEEEecCCCC--CHHHHHHH--------------Hhccccc--CcceEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSE--GFKRALV  220 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~-----~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~--~~~~~lv  220 (453)
                      .+.+.||+|+||+||++..     .+++.||+|.+.....  ..+.+..|              +++++..  ....+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            5678999999999988652     3688999999876432  23444444              3344433  3357899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++..     ..+++.++..++.|++.||.|||+.   +|+|+||||+|||++.++.+||+|||+++...
T Consensus        87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence            999999999998842     3589999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCcee-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHHHHHH
Q 048517          301 KENDFVS-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVYDQ  372 (453)
Q Consensus       301 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~  372 (453)
                      ....... .....++..|+|||.+...  .++.++||||||++++||++|+.|+......-..       ........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            4332111 1223456779999998753  7889999999999999999999987543211000       0000001111


Q ss_pred             hhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       373 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      +.......      .+......+.+++.+||+.+|++|||+++++++|+.+
T Consensus       237 ~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRLP------CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCCC------CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            11111110      1222346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.9e-35  Score=294.60  Aligned_cols=236  Identities=23%  Similarity=0.285  Sum_probs=170.0

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.+.+.||+|+||+||+++. .+++.||||++......    ...+..|              +++.+.+....++||||
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~   82 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF   82 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence            45668899999999999985 46899999999753211    1122222              35556677788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          83 LPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999998843    35689999999999999999999998   99999999999999999999999999987543211


Q ss_pred             Cc---------------------------------eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC
Q 048517          304 DF---------------------------------VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  350 (453)
Q Consensus       304 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~  350 (453)
                      ..                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCC
Confidence            00                                 001234699999999999764  7889999999999999999999


Q ss_pred             CCCCCCccccccccchHHHHHHhhhC-CCccccchhhhHHHHHHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 048517          351 RNSNMNATRSSKAYFPSWVYDQLNKG-GDLELRNVTEIESMIARKLCMIGLWCI--QVKAADRPSMTKVLEM  419 (453)
Q Consensus       351 ~p~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl--~~~p~~RPs~~evl~~  419 (453)
                      .||......        .....+... .........    ..+..+.+++.+++  ..++..||+++|+++.
T Consensus       234 ~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETPQ--------ETYKKVMNWKETLIFPPEV----PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCHH--------HHHHHHHcCcCcccCCCcC----CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999643321        122222221 111111111    12234455555533  3344567999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=276.84  Aligned_cols=235  Identities=29%  Similarity=0.457  Sum_probs=184.7

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ..+++.+.||+|+||.||+|... |+.||||.+.......+++..|              +++++......++||||+++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            34567789999999999999876 8899999998765444455554              45566667788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      ++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++......   
T Consensus        85 ~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          85 GSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            9999988432  224689999999999999999999998   99999999999999999999999999998663322   


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                        .....+..|+|||.+..  +.++.++||||||++++||++ |+.|+.....        ......+..+....     
T Consensus       157 --~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~-----  219 (256)
T cd05039         157 --DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEKGYRME-----  219 (256)
T ss_pred             --ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCC-----
Confidence              23345678999999875  378889999999999999997 8888754321        11223333322211     


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                       .+...+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus       220 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 -APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             -CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence             112234678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=279.59  Aligned_cols=236  Identities=27%  Similarity=0.431  Sum_probs=175.0

Q ss_pred             cccCccCceEEEEEEEc-CCc--EEEEEEecCCCC--CHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGR--LIAVKMMENSKF--SAEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~--~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+|+.. ++.  .+|+|.+.....  ..+.+..|               +++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999965 444  578898875322  22333333               34556666778999999999


Q ss_pred             CChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          227 GSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       227 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      |+|.+++.....            ....+++.++..++.|++.||+|||+.   +++|+||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999854321            223588999999999999999999997   99999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      +++.....   ........+..|+|||++...  .++.++||||||++++||++ |+.||......       . ....+
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~-~~~~~  224 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------E-LYEKL  224 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------H-HHHHH
Confidence            98632211   111223346789999998653  68899999999999999997 99988543211       1 22222


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      ..+...+.      +......+.+++.+||+.+|.+|||+.++++.|+.++
T Consensus       225 ~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 PQGYRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             hCCCCCCC------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            22222111      1123456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.7e-34  Score=277.99  Aligned_cols=238  Identities=27%  Similarity=0.343  Sum_probs=177.3

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH---------------Hhccccc------CcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE---------------LLGLCSE------GFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~------~~~~~  218 (453)
                      ..+.+.+.||+|+||.||+|... +++.||+|.+........++..|               +.+.+..      ....+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            34566788999999999999854 68999999987654444444333               2233322      23578


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ++|||+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||+++.
T Consensus        86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999988532  235689999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      ......  ......|+..|+|||++...   ...++.++|||||||++|||++|+.|+.......        .......
T Consensus       161 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~--------~~~~~~~  230 (272)
T cd06637         161 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPR  230 (272)
T ss_pred             cccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhc
Confidence            543221  22345689999999998632   2357889999999999999999999986432110        1111111


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ......     .....+..+.+++.+||+.+|.+|||+.++++
T Consensus       231 ~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NPAPRL-----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCC-----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            111110     11123456889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.7e-35  Score=288.55  Aligned_cols=222  Identities=26%  Similarity=0.345  Sum_probs=168.6

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+|+.. +|+.||+|++.....    ...+++.|               +++.+......++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 689999999865321    11222222               34555667788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|..++..    ...++...+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (321)
T cd05603          81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--  151 (321)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence            999887732    34688889999999999999999998   999999999999999999999999999875322221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......       . ..+.+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~-~~~~i~~~~-~~------  214 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------Q-MYDNILHKP-LQ------  214 (321)
T ss_pred             ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHH-------H-HHHHHhcCC-CC------
Confidence            12345689999999998764  6889999999999999999999999654211       1 222222221 11      


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMT  414 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  414 (453)
                      .+......+.+++.+||+.+|.+||+..
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1112345688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.8e-35  Score=288.00  Aligned_cols=247  Identities=26%  Similarity=0.409  Sum_probs=181.3

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEc-CCc--EEEEEEecCCC--CCHHHHHHH---------------HhcccccCcce
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGR--LIAVKMMENSK--FSAEEFINE---------------LLGLCSEGFKR  217 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~--~VAVK~l~~~~--~~~~~~i~e---------------l~g~~~~~~~~  217 (453)
                      +.-..+.+.+.||+|+||.||+|... ++.  .+|+|.+....  ...+++..|               +++++..+...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            33445667789999999999999854 454  46888776422  122233333               34566677788


Q ss_pred             EEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC
Q 048517          218 ALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN  285 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~  285 (453)
                      ++++||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+.   +++||||||+|||++.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence            999999999999999864321            224688999999999999999999998   99999999999999999


Q ss_pred             CceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccccc
Q 048517          286 FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY  364 (453)
Q Consensus       286 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~  364 (453)
                      +.+||+|||+++......   ......++..|+|||.+...  .++.++||||||++++||+| |..||.......    
T Consensus       161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----  231 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----  231 (303)
T ss_pred             CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHH----
Confidence            999999999986432111   11222346789999988654  68899999999999999998 999885432211    


Q ss_pred             chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          365 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       365 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                          ..+.+..+.....      +...+..+.+++.+||+.+|++||++.+++++|+.+++.
T Consensus       232 ----~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         232 ----LYEKLPQGYRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             ----HHHHHhcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                1222222211111      112345688999999999999999999999999876554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.4e-34  Score=276.44  Aligned_cols=233  Identities=30%  Similarity=0.446  Sum_probs=179.1

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------Hhccc-ccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLC-SEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~-~~~~~~~lv~E~~~~  226 (453)
                      .+.+.+.||+|+||.||++... |+.||+|.+.... ..+.+..|              +++++ ..+...++++||+++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            4567789999999999999866 7889999987543 23444444              33433 345568999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++...  ....+++..++.++.+++.||+|||++   +++||||||+||+++.++.+||+|||+++......   
T Consensus        85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          85 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999988532  234589999999999999999999998   99999999999999999999999999987543322   


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                        ....++..|+|||++...  .++.++||||||+++|||++ |+.|+.....       . -....+.++....     
T Consensus       157 --~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~-----  219 (256)
T cd05082         157 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------K-DVVPRVEKGYKMD-----  219 (256)
T ss_pred             --CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------H-HHHHHHhcCCCCC-----
Confidence              233456789999998753  78899999999999999997 8888753321       1 1222232222111     


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                       .....+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus       220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence             112234678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.9e-34  Score=274.65  Aligned_cols=233  Identities=28%  Similarity=0.409  Sum_probs=182.5

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      +.+.+.||+|+||.||+|+.. +|+.|++|.+.....   ..+++..|              +++.+......++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            356688999999999999964 789999999865322   23344333              456667777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++...  ....+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          82 ENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            999999988643  235789999999999999999999997   999999999999999999999999999986654332


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                      .  .....|++.|+|||++.+.  .++.++|+||||++++||++|+.|+.....        .........+....    
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~----  220 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGVFPP----  220 (256)
T ss_pred             h--hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCC----
Confidence            1  1334688999999998764  688999999999999999999999864431        11222222222211    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        ....+...+.+++.+||+.+|++||++.++++
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         221 --VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             --CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence              12235567899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.6e-34  Score=278.25  Aligned_cols=242  Identities=22%  Similarity=0.347  Sum_probs=170.4

Q ss_pred             cccCccCceEEEEEEEcCC---cEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQLHTG---RLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g---~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      ++||+|+||.||+|...++   ..+++|.+.....  ..+.+++|              +++.|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999985433   3466777654322  23344443              566777778889999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.+++.........+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999865433334567778889999999999999998   999999999999999999999999999864322221112


Q ss_pred             ecccCCCCCccChhhhccc-----CCCCCccchHHHHHHHHHHHHcC-CCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          308 ISDTRGTIGYLAPELISRN-----FGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      .....++..|+|||++...     ....+.++||||||+++|||+++ ..|+.....       .......+.. .....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~-~~~~~  229 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKD-QQVKL  229 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhh-ccccc
Confidence            2345678899999987532     12457899999999999999974 556643221       1112222222 11111


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      .... ....+...+.+++..|| .+|++||++++|++.|-
T Consensus       230 ~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQ-LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCc-cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1110 11124456778889999 67999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1e-34  Score=279.06  Aligned_cols=236  Identities=26%  Similarity=0.443  Sum_probs=179.2

Q ss_pred             cccCccCceEEEEEEEcC-------CcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          167 HKLGQGGFGSVYKGQLHT-------GRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~-------g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.||+|+||.||+|+..+       ++.+|||.+....  ....++.+|              +++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998542       2579999886533  223444444              45667777788999999


Q ss_pred             cCCCChhhhhhhccC---CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-----ceEEEecCC
Q 048517          224 MPNGSLDRHIFSKEN---KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-----IPKVSDFGL  295 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-----~~kl~DFGl  295 (453)
                      +++|+|.+++.....   ....+++.+++.++.|++.||+|||+.   +++|+||||+||+++.+.     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999864322   224588999999999999999999997   999999999999999877     899999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhh
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      ++...............++..|+|||.+.+  +.++.++||||||+++|||++ |+.|+.......        ....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~  227 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHVT  227 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHHh
Confidence            986544332222233456788999999876  478999999999999999998 998886432111        122222


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      .+....      .....+..+.+++.+||+.+|++||++.++++.|+
T Consensus       228 ~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 AGGRLQ------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cCCccC------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            222111      12234567889999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.4e-35  Score=285.37  Aligned_cols=245  Identities=23%  Similarity=0.387  Sum_probs=181.5

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCc--EEEEEEecCCCC--CHHHHHHH---------------HhcccccCcceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGR--LIAVKMMENSKF--SAEEFINE---------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~--~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~~~~~~~lv~E  222 (453)
                      +.+.+.||+|+||.||+|+.. ++.  .+|+|.++....  ..+++..|               +++++......++++|
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e   83 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE   83 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence            456789999999999999865 343  578988874221  22333333               4555666677899999


Q ss_pred             ecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517          223 YMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  290 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  290 (453)
                      |+++|+|.+++.....            ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence            9999999999854321            123588999999999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHH
Q 048517          291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  369 (453)
Q Consensus       291 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  369 (453)
                      +|||++.......   .......+..|+|||++...  .++.++||||||++++||++ |+.||......       . .
T Consensus       161 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~-~  227 (297)
T cd05089         161 ADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------E-L  227 (297)
T ss_pred             CCcCCCcccccee---ccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H-H
Confidence            9999987432111   11222345679999988753  68899999999999999997 99998543211       1 2


Q ss_pred             HHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCC
Q 048517          370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM  429 (453)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~  429 (453)
                      ...+..+....      .+..++..+.+++.+||+.+|.+|||+.++++.|+.+++..+.
T Consensus       228 ~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         228 YEKLPQGYRME------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             HHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            22232222111      1122345688999999999999999999999999987765543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.7e-35  Score=280.61  Aligned_cols=241  Identities=26%  Similarity=0.427  Sum_probs=180.7

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CC---cEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TG---RLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g---~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ..+++.+.||+|+||.||+|... ++   ..||||.+.....  ...+|..|              +.+++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            34667889999999999999854 33   3699999876322  22344444              45556677788999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++...   ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999988432   34689999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeecccC---CCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhC
Q 048517          301 KENDFVSISDTR---GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       301 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      ............   .+..|+|||.+..  +.++.++||||||+++|||++ |+.|+......        -..+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------~~~~~i~~~  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVINAIEQD  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcC
Confidence            332211111111   2457999999875  378899999999999999886 99888643321        122222222


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      ....      .+.+.+..+.+++.+||+.+|++||++.+++.+|++.
T Consensus       228 ~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 YRLP------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcCC------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111      1122345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1e-35  Score=295.43  Aligned_cols=236  Identities=23%  Similarity=0.275  Sum_probs=178.5

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |.+.++||+|+||+||+++. .+|+.||||+++....    ..+.+..|              +++.+......++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            56678999999999999985 4789999999976322    11222222              34556667788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999988532   24689999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CceeecccCCCCCccChhhhccc----CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-CC
Q 048517          304 DFVSISDTRGTIGYLAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GD  378 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-~~  378 (453)
                      .. ......||+.|+|||++...    ...++.++|||||||++|||++|+.||......       . ....+... ..
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~-~~~~i~~~~~~  227 (330)
T cd05601         157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------K-TYNNIMNFQRF  227 (330)
T ss_pred             ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------H-HHHHHHcCCCc
Confidence            22 22345689999999998631    235788999999999999999999999643321       1 12222221 11


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .....    ...++..+.+++..|++ +|.+|||+.++++
T Consensus       228 ~~~~~----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 LKFPE----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cCCCC----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11111    11234567889999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=293.73  Aligned_cols=226  Identities=25%  Similarity=0.340  Sum_probs=168.9

Q ss_pred             cCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH-----------------HhcccccCcceEEEEEecCC
Q 048517          169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE-----------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       169 LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e-----------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ||+|+||+||+|+. .+|+.||||++......    ....+.|                 ++..+......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999995 46999999998653211    1111111                 22334556778999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++..    ...+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--  151 (330)
T cd05586          81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--  151 (330)
T ss_pred             ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence            999988742    35689999999999999999999998   999999999999999999999999999975433221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||.+.+. ..++.++||||+||++|||++|+.||......        .....+..+.. .+.    
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~-~~~----  217 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFGKV-RFP----  217 (330)
T ss_pred             CccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcCCC-CCC----
Confidence            12345699999999998653 35788999999999999999999998653211        12233332221 111    


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRP----SMTKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RP----s~~evl~  418 (453)
                       ...++..+.+++.+||+.+|++||    ++.++++
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             112345678899999999999999    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5e-35  Score=295.37  Aligned_cols=238  Identities=19%  Similarity=0.258  Sum_probs=179.6

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ..+.+.++||+|+||.||+++.. +++.||+|++....    .....+..|              +++.+..+...++||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            35667789999999999999954 78999999986521    111222222              455667777899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|.+++..     ..++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       123 Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         123 EYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999998742     3477888899999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeecccCCCCCccChhhhccc--CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-CC
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GD  378 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-~~  378 (453)
                      .... ......||+.|+|||.+...  ...++.++|||||||++|||++|+.||......        ..+..+... ..
T Consensus       195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~  265 (370)
T cd05596         195 NGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDHKNS  265 (370)
T ss_pred             CCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCCc
Confidence            3221 12345799999999998653  134789999999999999999999999754321        122233221 11


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  419 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~  419 (453)
                      .....    ...++..+.+++.+||+.+|++  |||+.++++.
T Consensus       266 ~~~~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 LTFPD----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCCC----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            11111    1124567888999999999987  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.7e-35  Score=296.70  Aligned_cols=237  Identities=22%  Similarity=0.240  Sum_probs=172.6

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.+.++||+|+||+||+|+. .+++.||||++......    ...+..|              +++.+.+....++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            44568899999999999984 57899999999753221    1222222              56677778889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          83 IPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999998843    24588889999999999999999998   99999999999999999999999999986432100


Q ss_pred             Cc---------------------------------------------eeecccCCCCCccChhhhcccCCCCCccchHHH
Q 048517          304 DF---------------------------------------------VSISDTRGTIGYLAPELISRNFGTVSCKSDVYG  338 (453)
Q Consensus       304 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S  338 (453)
                      ..                                             .......||+.|+|||.+.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceee
Confidence            00                                             000124699999999999764  6889999999


Q ss_pred             HHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHH--hcccCCCCCCCHHHH
Q 048517          339 FGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLW--CIQVKAADRPSMTKV  416 (453)
Q Consensus       339 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPs~~ev  416 (453)
                      |||++|||++|+.||.......       .....+...........    ..++..+.+++.+  |+..++..||++.++
T Consensus       234 lG~il~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~----~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTE-------TQLKVINWENTLHIPPQ----VKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHH-------HHHHHHccccccCCCCC----CCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999999997543211       01111111111111111    1123456666666  556677779999999


Q ss_pred             HHH
Q 048517          417 LEM  419 (453)
Q Consensus       417 l~~  419 (453)
                      ++.
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-34  Score=299.99  Aligned_cols=248  Identities=19%  Similarity=0.267  Sum_probs=171.4

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHH------HHHHH--------------Hhcccc-cCcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAE------EFINE--------------LLGLCS-EGFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~------~~i~e--------------l~g~~~-~~~~~~  218 (453)
                      ..|.+.++||+|+||+||+|+. .+++.||||+++.......      +++.+              ++.++. .....+
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            4566778999999999999985 4688999999965322111      12222              122232 234678


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC------------
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF------------  286 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~------------  286 (453)
                      +|||++ +++|.+++..    ...+++..+..|+.||+.||+|||++  .+|+||||||+|||++.++            
T Consensus       209 iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             EEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccC
Confidence            999988 7788888743    24689999999999999999999973  2899999999999998665            


Q ss_pred             ----ceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc
Q 048517          287 ----IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK  362 (453)
Q Consensus       287 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~  362 (453)
                          .+||+|||++......     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........
T Consensus       282 ~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             CCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                4999999988643221     2345799999999999864  7899999999999999999999999754321100


Q ss_pred             -------ccch-HHHHH--------HhhhCCCccc-cch----------hhhHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 048517          363 -------AYFP-SWVYD--------QLNKGGDLEL-RNV----------TEIESMIARKLCMIGLWCIQVKAADRPSMTK  415 (453)
Q Consensus       363 -------~~~~-~~~~~--------~l~~~~~~~~-~~~----------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  415 (453)
                             ..++ .|...        .......... ...          ..........+++|+.+||+.||++|||++|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence                   0000 11100        0000000000 000          0000112346789999999999999999999


Q ss_pred             HHH--HHhC
Q 048517          416 VLE--MLEG  422 (453)
Q Consensus       416 vl~--~Le~  422 (453)
                      +++  .+.+
T Consensus       435 ~L~Hp~~~~  443 (467)
T PTZ00284        435 MTTHPYVLK  443 (467)
T ss_pred             HhcCccccc
Confidence            997  4444

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.5e-35  Score=279.08  Aligned_cols=242  Identities=23%  Similarity=0.266  Sum_probs=179.6

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ...|.+.++||+|+||.||+|+. .+++.||+|++...... ...+.+|              +++.+..+...++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            34567789999999999999995 57899999998754322 2222222              44566677788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++......
T Consensus        88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999998842    24688999999999999999999998   99999999999999999999999999998654321


Q ss_pred             CceeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .  ......|+..|+|||.+... ...++.++||||||++++||++|+.|+.........        ..+... .....
T Consensus       161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--------~~~~~~-~~~~~  229 (267)
T cd06646         161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FLMSKS-NFQPP  229 (267)
T ss_pred             c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--------eeeecC-CCCCC
Confidence            1  12334688999999987532 235788999999999999999999998533211100        000010 00000


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                      . .......+..+.+++.+||+.+|++|||++++++.|
T Consensus       230 ~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 K-LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             C-CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0 001123446788999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-34  Score=296.55  Aligned_cols=249  Identities=19%  Similarity=0.211  Sum_probs=177.9

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHH-HHHH--------HHhcccccCcceEEEEEecCCCChhh
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAE-EFIN--------ELLGLCSEGFKRALVYEYMPNGSLDR  231 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~-~~i~--------el~g~~~~~~~~~lv~E~~~~gsL~~  231 (453)
                      .+.+.++||+|+||.||++... +++.||||.........+ +.+.        ++++++..+...++|||++ .++|.+
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~  248 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYT  248 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHH
Confidence            4566789999999999999965 688999996543221111 1222        2567777788889999999 478888


Q ss_pred             hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeeccc
Q 048517          232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT  311 (453)
Q Consensus       232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  311 (453)
                      ++...   ...++|.+++.|+.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++..............
T Consensus       249 ~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  322 (461)
T PHA03211        249 YLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI  322 (461)
T ss_pred             HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence            77432   24699999999999999999999998   9999999999999999999999999999876443222122345


Q ss_pred             CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc--cccc------
Q 048517          312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL--ELRN------  383 (453)
Q Consensus       312 ~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~~~------  383 (453)
                      .||+.|+|||++.+.  .++.++|||||||++|||++|..++...........+...+.+.+.+....  +...      
T Consensus       323 ~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        323 AGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             CCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            699999999999764  789999999999999999998876543222111112222222222221110  0000      


Q ss_pred             -------------------hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          384 -------------------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       384 -------------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                                         ...........+.+++.+||+.||.+|||+.|+++.
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                               000001223467889999999999999999999873

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=296.00  Aligned_cols=241  Identities=25%  Similarity=0.429  Sum_probs=195.1

Q ss_pred             HhhhhhcccCccCceEEEEEEEc---CCc--EEEEEEecCC--CCCHHHHHHH--------------HhcccccCcceEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH---TGR--LIAVKMMENS--KFSAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~---~g~--~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      ..-.+.++||.|-||.||+|.+.   .|.  .||||.-+.+  ..+.+.|+.|              |+|.|.+. ..++
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            33345678999999999999853   233  4889987763  3345667665              88999765 6899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      |||.++.|.|..||..   .+..|+...+..++.||..||+|||+.   +.|||||..+|||+...-++||+|||++|..
T Consensus       468 vmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             EEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence            9999999999999943   346789999999999999999999998   9999999999999999999999999999988


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ..+..+.. +....++.|||||.+.  +.+++.++|||.|||.+||+++ |.+||..-....        +.-++++|.+
T Consensus       542 ed~~yYka-S~~kLPIKWmaPESIN--fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------VI~~iEnGeR  610 (974)
T KOG4257|consen  542 EDDAYYKA-SRGKLPIKWMAPESIN--FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------VIGHIENGER  610 (974)
T ss_pred             cccchhhc-cccccceeecCccccc--hhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------eEEEecCCCC
Confidence            77766544 3455678999999885  4589999999999999999886 889997543322        3335667776


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      +..      +...+..+..++.+||..+|.+||.+.++.+.|+..+.
T Consensus       611 lP~------P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  611 LPC------PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCC------CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            653      33456778899999999999999999999988865443

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.2e-34  Score=278.89  Aligned_cols=232  Identities=25%  Similarity=0.340  Sum_probs=173.1

Q ss_pred             cCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       169 LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      ||+|+||.||+++. .+|+.||+|.+.....    .......|              +.+.+..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999985 4699999999864211    11111112              34556667788999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      .+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......   ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~  152 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT  152 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence            8887532  234588999999999999999999998   99999999999999999999999999998664432   123


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ...||..|+|||++.+.  .++.++||||+||++|||++|+.|+........    ...+........ ...     ...
T Consensus       153 ~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~-~~~-----~~~  220 (277)
T cd05607         153 QRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTLEDE-VKF-----EHQ  220 (277)
T ss_pred             ccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhhccc-ccc-----ccc
Confidence            45689999999999764  689999999999999999999999864332111    001111111111 000     111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          390 MIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                      .++..+.+++..||+.||++||++.|+++.+
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            2456689999999999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.4e-34  Score=298.36  Aligned_cols=245  Identities=19%  Similarity=0.265  Sum_probs=171.7

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHH---HHHH--------Hhcccc--------cCcceEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE---FINE--------LLGLCS--------EGFKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~---~i~e--------l~g~~~--------~~~~~~lv~  221 (453)
                      .|.+.++||+|+||.||+|.. .+++.||||++........+   .+..        +.+++.        .....++||
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm  146 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM  146 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence            466778999999999999995 47899999988654322221   1111        222221        112356899


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHP  300 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~  300 (453)
                      ||++ ++|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|||+++...
T Consensus       147 E~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        147 EFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             ecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            9997 467776654334456789999999999999999999998   999999999999998664 79999999998664


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC----
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG----  376 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~----  376 (453)
                      ....   .....||+.|+|||++.+. ..++.++|||||||++|||++|++||........   +.. +...+...    
T Consensus       223 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~-i~~~~~~p~~~~  294 (440)
T PTZ00036        223 AGQR---SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ---LVR-IIQVLGTPTEDQ  294 (440)
T ss_pred             CCCC---cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHH-HHHHhCCCCHHH
Confidence            4322   1235689999999998653 3688999999999999999999999965432110   000 00000000    


Q ss_pred             --------CCccccch--h----hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 --------GDLELRNV--T----EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 --------~~~~~~~~--~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                              ........  .    ..+...+..+.+++.+||+.+|.+|||+.|+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                    00000000  0    011123457889999999999999999999985

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-34  Score=279.36  Aligned_cols=248  Identities=22%  Similarity=0.370  Sum_probs=181.4

Q ss_pred             HhhhhhcccCccCceEEEEEEE-----cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccC--cce
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEG--FKR  217 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-----~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~--~~~  217 (453)
                      .++...++||+|+||.||+++.     .+++.||+|.+.....  ..+++..|              +.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3456678899999999999974     3578999999875322  12333333              34444443  457


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||+++++|.+++...   ...++|..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            8999999999999988432   24589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccc--------cccccchHH
Q 048517          298 FHPKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR--------SSKAYFPSW  368 (453)
Q Consensus       298 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~--------~~~~~~~~~  368 (453)
                      ......... ......++..|+|||++.+.  .++.++||||||++++||++++.|.......        ..+... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~-~~  234 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV-TR  234 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH-HH
Confidence            765433221 11234567789999998753  6889999999999999999987664322110        001111 11


Q ss_pred             HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          369 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      ..+.+..+....      .+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       235 ~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVRVLEEGKRLP------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHcCccCC------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            122222222221      1122456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-35  Score=280.24  Aligned_cols=238  Identities=30%  Similarity=0.451  Sum_probs=178.6

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHH---HHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEF---INE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~---i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |++.+.||+|+||+||+++.. +++.+|+|++..........   ..|              +++++......+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999965 57799999998764433322   112              344555677788999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++.    ....+++..+..++.|+++||.+||+.   +|+|+||||+||++++++.++|+|||.+....... 
T Consensus        81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-  152 (260)
T PF00069_consen   81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-  152 (260)
T ss_dssp             TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-
T ss_pred             cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence            9999999985    235689999999999999999999998   99999999999999999999999999998642211 


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                       .......+|..|+|||.+.. ....+.++||||+|+++++|++|+.|+..........    ...+....    .....
T Consensus       153 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~----~~~~~~~~----~~~~~  222 (260)
T PF00069_consen  153 -ENFNPFVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE----IIEKILKR----PLPSS  222 (260)
T ss_dssp             -SEBSSSSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH----HHHHHHHT----HHHHH
T ss_pred             -cccccccccccccccccccc-cccccccccccccccccccccccccccccccchhhhh----hhhhcccc----ccccc
Confidence             23456678999999999872 1478999999999999999999999987541111000    01111110    00000


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..........+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0001111267999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=295.60  Aligned_cols=234  Identities=24%  Similarity=0.300  Sum_probs=174.6

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |.+.+.||+|+||+||+++.. +|+.||||++.....    ....+..|              +++.+..+...++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY   82 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence            456689999999999999954 789999999875321    11122222              55667778889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          83 LPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999998853    24689999999999999999999998   99999999999999999999999999987543211


Q ss_pred             Cce------------------------------------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH
Q 048517          304 DFV------------------------------------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA  347 (453)
Q Consensus       304 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell  347 (453)
                      ...                                    ......||+.|+|||++.+.  .++.++|||||||+++||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhh
Confidence            000                                    00123599999999998764  7899999999999999999


Q ss_pred             cCCCCCCCCccccccccchHHHHHHhhh-CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 048517          348 GGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVLE  418 (453)
Q Consensus       348 tg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~  418 (453)
                      +|+.||.......        ....+.. .........    ..++..+.+++.+|+. +|.+|++   +.++++
T Consensus       234 ~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSDNPQE--------TYRKIINWKETLQFPDE----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCCCHHH--------HHHHHHcCCCccCCCCC----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999996543211        1112211 111111111    1234567788888986 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.9e-34  Score=276.08  Aligned_cols=248  Identities=26%  Similarity=0.443  Sum_probs=183.8

Q ss_pred             hhhhhcccCccCceEEEEEEEc-----CCcEEEEEEecCCCCC--HHHHHHH--------------Hhccccc--CcceE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSE--GFKRA  218 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~--~~~~~  218 (453)
                      .+++.++||+|+||.||++++.     +++.||||.+......  .+++..|              +++++..  +...+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4556789999999999999854     3789999999875543  3445444              3444444  45678


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ++|||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999985332   3589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-------cchHHHH
Q 048517          299 HPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------YFPSWVY  370 (453)
Q Consensus       299 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~  370 (453)
                      ....... .......++..|+|||.+...  .++.++||||||++++||++|+.|+..........       .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            7633322 111223456679999998764  78899999999999999999998875432211000       0011111


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      +.+.......      .+...+..+.+++.+||+.+|++|||+.||+++|+++
T Consensus       237 ~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLP------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCC------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            2222221111      1112335688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.2e-35  Score=289.63  Aligned_cols=223  Identities=24%  Similarity=0.302  Sum_probs=171.7

Q ss_pred             cccCccCceEEEEEEE----cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          167 HKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      +.||+|+||.||+++.    .+|+.||+|++.....   ....+..|              +++.+......++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    3689999999875321   11222222              4566677788899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            9999998843    34689999999999999999999998   999999999999999999999999999986543321 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                       ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......        .....+.+... .     
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~~~-~-----  216 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKAKL-G-----  216 (318)
T ss_pred             -ceecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcCCC-C-----
Confidence             12345689999999999764  6788999999999999999999998643211        12222222211 1     


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTK  415 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  415 (453)
                       .+..++..+.+++.+||+.||++|||+.+
T Consensus       217 -~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 -MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             12224466889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-34  Score=272.10  Aligned_cols=234  Identities=27%  Similarity=0.445  Sum_probs=178.6

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCCChh
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLD  230 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~  230 (453)
                      ++||+|+||.||++..++++.||+|.+......  .+++..|              +++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999777999999988764332  2344444              455667777889999999999999


Q ss_pred             hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517          231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD  310 (453)
Q Consensus       231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  310 (453)
                      +++...   ...+++..+..++.+++.||.|||++   +++||||||+||+++.++.+||+|||+++.............
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            988432   24688999999999999999999998   999999999999999999999999999986543221111122


Q ss_pred             cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ..++..|+|||.+.+  +.++.++|+||||++++||++ |..|+......        .....+.......      .+.
T Consensus       155 ~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~~~~~~~~~------~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRERIESGYRMP------APQ  218 (251)
T ss_pred             CcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHHHhcCCCCC------CCc
Confidence            334667999999875  378899999999999999998 77777543211        1122222221111      112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          390 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      ..+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=297.59  Aligned_cols=240  Identities=27%  Similarity=0.441  Sum_probs=195.4

Q ss_pred             hcccCccCceEEEEEE-EcCCc----EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          166 THKLGQGGFGSVYKGQ-LHTGR----LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~-~~~g~----~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .++||+|+||+||+|. .+.|+    +||||++.....  ...+++.|              |+|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            3679999999999998 55554    689999876432  24444444              888887665 77999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      +.|+|.+|+..   ....+.....+.+..|||+||.|||.+   +++||||..+|||+..-..+|+.|||++++...++.
T Consensus       780 P~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  780 PLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             ccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            99999999954   346788899999999999999999998   999999999999999999999999999999877665


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      ........-.+.|||=|.+...  .++.++|||||||++||++| |.+|++....++        +.+.++++.++.   
T Consensus       854 ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dlle~geRLs---  920 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDLLEKGERLS---  920 (1177)
T ss_pred             cccccccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHHHhccccCC---
Confidence            4444444556789999999864  89999999999999999998 888887654332        666777777643   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                         .+.....++..++.+||..|++.||+++++.+.+.....+.+
T Consensus       921 ---qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  921 ---QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             ---CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence               333455678899999999999999999999998877655543

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2e-34  Score=277.08  Aligned_cols=241  Identities=27%  Similarity=0.433  Sum_probs=182.2

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-C---CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-T---GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~---g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ..+++.+.||+|+||.||+|+.. +   +..+|+|.++.....  .+.+..|              +.+++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            35567789999999999999853 2   347999998754322  2334444              45566677788999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++...   ...+++.++..++.|++.||+|||+.   +++|+||||+|||++.++.+|++|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999998532   24689999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCcee-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          301 KENDFVS-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       301 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ....... .....++..|+|||.+...  .++.++||||||++++|+++ |+.|+.......        ....+.++..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYR  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCc
Confidence            4332111 1122345689999999763  78999999999999999886 999886433211        2222333221


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      ..      .....+..+.+++.+|++.+|++||||.++++.|++.
T Consensus       228 ~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 LP------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CC------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            11      1112345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-34  Score=281.10  Aligned_cols=235  Identities=27%  Similarity=0.365  Sum_probs=176.6

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ++..+.||+|+||.||++.. .+++.||||.+......    ...+..|              +.+.+..+...++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            44567899999999999985 47899999998753221    1223333              33445566778999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999988543  224689999999999999999999997   99999999999999999999999999997654332


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   .....||..|+|||++.+.  .++.++||||+|+++|||++|+.||..........    ...........     
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~----~~~~~~~~~~~-----  222 (285)
T cd05630         157 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EVERLVKEVQE-----  222 (285)
T ss_pred             c---ccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH----HHHhhhhhhhh-----
Confidence            2   1334689999999999764  78899999999999999999999997543211000    01111111000     


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                        .........+.+++.+||+.||++|||     +.|+++
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence              011223456889999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.7e-34  Score=273.28  Aligned_cols=233  Identities=30%  Similarity=0.456  Sum_probs=177.3

Q ss_pred             cccCccCceEEEEEEEcC--C--cEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLHT--G--RLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~--g--~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|++|.||+|...+  +  ..||||.+.....  ..+++..|              +++.+.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3699999987544  23344444              3444445 678899999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++.....  ..++|..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999854322  5689999999999999999999998   99999999999999999999999999998775433221


Q ss_pred             -eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhh-CCCccccc
Q 048517          307 -SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELRN  383 (453)
Q Consensus       307 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~  383 (453)
                       ......++.+|+|||++...  .++.++||||||++++||++ |+.|+......       . ....+.. .....   
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~-~~~~~~~~~~~~~---  221 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------Q-ILKKIDKEGERLE---  221 (257)
T ss_pred             ecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHhcCCcCC---
Confidence             11234578899999998754  78899999999999999998 99998643221       1 1112221 11111   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                         .+...+..+.+++.+|++.+|++|||+.++++.|.
T Consensus       222 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 ---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               11223457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-34  Score=276.89  Aligned_cols=247  Identities=27%  Similarity=0.422  Sum_probs=177.2

Q ss_pred             hhhhcccCccCceEEEEEEEc-----CCcEEEEEEecCCCCC-HHHHHHH--------------Hhccc--ccCcceEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-----TGRLIAVKMMENSKFS-AEEFINE--------------LLGLC--SEGFKRALV  220 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-----~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~--~~~~~~~lv  220 (453)
                      +.+.+.||+|+||.||++...     +++.||||.+...... .+++..|              +.+++  ......++|
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   85 (284)
T cd05081           6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV   85 (284)
T ss_pred             ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence            456688999999999999742     5889999998764322 2334344              23333  223457899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      +||+++|+|.+++...   ...++|..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++...
T Consensus        86 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          86 MEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            9999999999988432   24589999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCceee-cccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc-----c---ccchHHHHH
Q 048517          301 KENDFVSI-SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-----K---AYFPSWVYD  371 (453)
Q Consensus       301 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~-----~---~~~~~~~~~  371 (453)
                      ........ ....++..|+|||++.+.  .++.++||||||++++||++|..+.........     .   ........+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            44332111 122234569999998753  688999999999999999998766432211000     0   000011111


Q ss_pred             HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      .+.......      .....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       238 ~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGRLP------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCcCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            222221111      1112345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.5e-35  Score=293.59  Aligned_cols=238  Identities=20%  Similarity=0.277  Sum_probs=177.3

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---C-CHHHHHHH--------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---F-SAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~-~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ..|.+.+.||+|+||.||+++.. +++.||+|++....   . ....+..|              +++.+..+...++||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            45667789999999999999965 68899999986521   1 11122222              455667778899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       123 Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         123 EYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            99999999998832     3478889999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCceeecccCCCCCccChhhhcccC--CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-CC
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GD  378 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-~~  378 (453)
                      ... .......||+.|+|||++.+..  +.++.++||||+||++|||++|+.||......        .....+... ..
T Consensus       195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~  265 (370)
T cd05621         195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSKIMDHKNS  265 (370)
T ss_pred             CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCcc
Confidence            322 1223567999999999987532  23788999999999999999999999654321        122222221 11


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  419 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~  419 (453)
                      ....    ....++..+..++.+|++.++.+  |||+.|+++.
T Consensus       266 ~~~p----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 LNFP----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCCC----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            2211    11224556778888999755543  8899999885

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.7e-34  Score=274.96  Aligned_cols=236  Identities=27%  Similarity=0.408  Sum_probs=172.4

Q ss_pred             cccCccCceEEEEEEEc----CCcEEEEEEecCCCC--CHHHHHHH--------------Hhcccc-cCcceEEEEEecC
Q 048517          167 HKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCS-EGFKRALVYEYMP  225 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~-~~~~~~lv~E~~~  225 (453)
                      +.||+|+||.||+|...    ++..||||.+.....  ..+.+..|              +++++. .+...++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    245799998864322  22344343              345443 3455789999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999998532   23467888899999999999999998   9999999999999999999999999999865432211


Q ss_pred             e--eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC-CCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          306 V--SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       306 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .  ......++..|+|||.+...  .++.++||||||+++|||++|+ .|+......       . ....+..+..... 
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------~-~~~~~~~~~~~~~-  223 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-------D-ITVYLLQGRRLLQ-  223 (262)
T ss_pred             eecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHhcCCCCCC-
Confidence            1  11233467789999998753  7889999999999999999965 444322111       1 2222333222211 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                           +...+..+.+++.+||+.+|++||++.++++.|+...
T Consensus       224 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         224 -----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                 1122356889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4e-34  Score=280.61  Aligned_cols=241  Identities=26%  Similarity=0.434  Sum_probs=179.3

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCc----EEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGR----LIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~----~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      +...+.||+|+||.||+|+. .+|+    .||+|.+......  ..++.+|              ++++|.. ....+++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~v~   87 (303)
T cd05110           9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLVT   87 (303)
T ss_pred             ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCceeee
Confidence            34457899999999999985 3454    5799988764322  1233333              4555543 3467899


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++....
T Consensus        88 e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          88 QLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             hhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999988532   24688999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ...........++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        ...+.+..+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  231 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPDLLEKGERLP  231 (303)
T ss_pred             cccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCCC
Confidence            3322222334467789999998753  78899999999999999997 88888543211        1222333332222


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ..      ......+..++..||..+|++||++.++++.|+...++
T Consensus       232 ~~------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         232 QP------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            11      11234688899999999999999999999999875443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-34  Score=275.86  Aligned_cols=243  Identities=25%  Similarity=0.406  Sum_probs=183.9

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCc----EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGR----LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~----~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ...+++.+.||+|+||.||+|..+ +|+    .||+|.+.....  ..+++.+|              ++++|.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            345667789999999999999854 343    689998876543  22344444              3445544 5778


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +++||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999998543   24589999999999999999999997   999999999999999999999999999987


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ..............++..|+|||.+..  ..++.++|+||||++++|+++ |+.|+......        -+...+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~  228 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--------EIPDLLEKGE  228 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhCCC
Confidence            654433222222334678999998865  378899999999999999998 99998654321        1223333332


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ......      ..+..+.+++.+||..+|++||++.++++.|+....
T Consensus       229 ~~~~~~------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         229 RLPQPP------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCCC------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            222111      122457889999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.8e-34  Score=277.67  Aligned_cols=241  Identities=22%  Similarity=0.284  Sum_probs=177.4

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------Hhccc-----ccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLC-----SEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~-----~~~~~~~lv  220 (453)
                      ++.+.+.||+|+||.||++.. .+++.+|+|++.......+++..|               +++++     ..+...++|
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   98 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV   98 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence            455668999999999999985 468999999987543322333222               33333     234567999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++++|.+++.........+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            999999999988754333445688999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ....  ......|++.|+|||++...   ...++.++||||+||++|||++|+.|+.......        .........
T Consensus       176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--------~~~~~~~~~  245 (286)
T cd06638         176 STRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--------ALFKIPRNP  245 (286)
T ss_pred             cCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--------HHhhccccC
Confidence            3221  12344689999999988531   1357889999999999999999999986432110        000111111


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      .....    .+......+..++.+||+.+|++|||+.|+++.
T Consensus       246 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         246 PPTLH----QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCccc----CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11110    111234568899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-34  Score=278.10  Aligned_cols=247  Identities=26%  Similarity=0.304  Sum_probs=182.4

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      ...+++.++||+|+||+||++.. .+|+.||+|++.....  ..+++..|              +++.+......++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            34567789999999999999985 4789999998765322  23344443              3456667778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++++|.+++..    ...+++..+..++.+++.||.|||+.  .+++|+||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999888732    24689999999999999999999973  27999999999999999999999999998754322


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .    .....|+..|+|||++.+.  .++.++|||||||+++||++|+.||...............+.+.+.........
T Consensus       158 ~----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd06620         158 I----ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP  231 (284)
T ss_pred             c----cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence            1    1234689999999998753  788999999999999999999999975443211111111111111111000000


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                      .  .........+.+++.+||+.||++|||+.|++++.
T Consensus       232 ~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         232 R--LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             C--CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0  01112456788999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.1e-34  Score=278.08  Aligned_cols=235  Identities=26%  Similarity=0.355  Sum_probs=175.7

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +...+.||+|+||+||+|.. .+++.||+|.+......    ...+..|              +.+.+..+...+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            34557899999999999985 57999999998753221    1223333              23455566778999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999999887543  234699999999999999999999998   99999999999999999999999999997654322


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   .....|+..|+|||++.+.  .++.++|+||||+++|||++|+.||........    ...+...+......    
T Consensus       157 ~---~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~~~----  223 (285)
T cd05632         157 S---IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETEEV----  223 (285)
T ss_pred             c---ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccccc----
Confidence            1   1334689999999999753  788999999999999999999999965432110    01111111111110    


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                         .....+..+.+++..|++.+|++||+     +.++++
T Consensus       224 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         224 ---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ---cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence               11223456788999999999999999     566665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.6e-34  Score=280.10  Aligned_cols=233  Identities=26%  Similarity=0.359  Sum_probs=179.2

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      +|.+.++||+|+||.||+|+. .+++.||+|.+...... .+.+..|              +++.+..+...++||||++
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~  100 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence            455668899999999999984 57899999998764332 2333333              4455666778899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +++|.+++..     ..+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++........ 
T Consensus       101 ~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            9999998732     3578999999999999999999998   999999999999999999999999999886543321 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                       ......+++.|+|||.+.+.  ..+.++|||||||+++||++|+.||.......       ......... ....    
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~~~~~~-~~~~----  236 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNG-TPEL----  236 (296)
T ss_pred             -ccCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHHHhcCC-CCCC----
Confidence             11334688999999998763  67899999999999999999999996443211       111111111 1111    


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..+..+...+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            112334567889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-34  Score=273.90  Aligned_cols=247  Identities=24%  Similarity=0.316  Sum_probs=178.9

Q ss_pred             hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC--------HHH-HHHH---------HhcccccCc------c
Q 048517          162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS--------AEE-FINE---------LLGLCSEGF------K  216 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~--------~~~-~i~e---------l~g~~~~~~------~  216 (453)
                      .+...++||+|+||+||+|+ ..+|+.||+|++..+...        +|. .+++         |.+++....      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            44556789999999999999 568999999998764331        111 1222         444444444      6


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++|+||+ .-+|.+++.........++...+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+|
T Consensus        92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence            78999999 5688888855432224566688999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      +...-...  ..+...+|..|.|||++.+. ..|+...||||+||++.||++++.-|....+...    -.-+.+.+...
T Consensus       168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q----l~~If~~lGtP  240 (323)
T KOG0594|consen  168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ----LFRIFRLLGTP  240 (323)
T ss_pred             HHhcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH----HHHHHHHcCCC
Confidence            97653332  23566789999999999876 3699999999999999999999888866543110    00011111110


Q ss_pred             C-----------Cc--c------ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          377 G-----------DL--E------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       377 ~-----------~~--~------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      .           +.  .      ................+++.+||+.+|.+|.|++.++++
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            0           00  0      000011111122468889999999999999999999885

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-35  Score=295.06  Aligned_cols=235  Identities=24%  Similarity=0.304  Sum_probs=172.9

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |.+.++||+|+||.||+++. .+|+.||||++.....    ...++..|              +++.+.+....++||||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~   82 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF   82 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence            45678999999999999985 5799999999865321    11222222              55667777889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+....
T Consensus        83 ~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          83 LPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999998843    34688899999999999999999998   99999999999999999999999999996432110


Q ss_pred             Cc------------e---------------------------------eecccCCCCCccChhhhcccCCCCCccchHHH
Q 048517          304 DF------------V---------------------------------SISDTRGTIGYLAPELISRNFGTVSCKSDVYG  338 (453)
Q Consensus       304 ~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S  338 (453)
                      ..            .                                 ......||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwS  233 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEe
Confidence            00            0                                 00123599999999999764  7889999999


Q ss_pred             HHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh-CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCC---CCHH
Q 048517          339 FGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR---PSMT  414 (453)
Q Consensus       339 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~  414 (453)
                      |||++|||++|+.||......        .....+.. ........    ...++..+.+++.+|++ +|.+|   ||+.
T Consensus       234 lGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~p~----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSH--------ETYRKIINWRETLYFPD----DIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHH--------HHHHHHHccCCccCCCC----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            999999999999999643321        12222221 11111111    11234567889999997 66665   5999


Q ss_pred             HHHHH
Q 048517          415 KVLEM  419 (453)
Q Consensus       415 evl~~  419 (453)
                      ++++.
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3e-34  Score=289.85  Aligned_cols=246  Identities=23%  Similarity=0.323  Sum_probs=174.5

Q ss_pred             hhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCc-----ceEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGF-----KRALV  220 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~-----~~~lv  220 (453)
                      +..++||+|+||.||++.. .+|+.||||++.....   ...++.+|              +++++....     ..++|
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            3567899999999999995 5799999999865321   22333333              455555444     67999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      +||+. ++|.+.+.    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          83 TELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             eeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            99996 57777663    235689999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc---------ccchH----
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK---------AYFPS----  367 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~----  367 (453)
                      ..... ......+|+.|+|||.+.+. ..++.++||||+||+++||++|+.||.........         .....    
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         155 PDESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cCccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            33221 22344688999999998763 35788999999999999999999999654321100         00000    


Q ss_pred             --HHHHHhhhCCCcc--ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          368 --WVYDQLNKGGDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       368 --~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                        .....+.......  ...........+..+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence              0001111100000  000000111224568899999999999999999999873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.1e-34  Score=270.82  Aligned_cols=226  Identities=23%  Similarity=0.365  Sum_probs=170.0

Q ss_pred             cccCccCceEEEEEEEcC-C----------cEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEE
Q 048517          167 HKLGQGGFGSVYKGQLHT-G----------RLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~-g----------~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      +.||+|+||.||+|...+ +          ..|++|.+.........+..|              +++++.. ...++|+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            469999999999999653 3          258888876644333444333              5666666 6679999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-------ceEEEecC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-------IPKVSDFG  294 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-------~~kl~DFG  294 (453)
                      ||+++|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++       .+||+|||
T Consensus        80 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999885432   2689999999999999999999998   999999999999999887       79999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcC-CCCCCCCccccccccchHHHHHHh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      ++......      ....++..|+|||++......++.++||||||+++|||++| ..|+.......       +. ...
T Consensus       154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------~~-~~~  219 (259)
T cd05037         154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------KE-RFY  219 (259)
T ss_pred             cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------HH-HHH
Confidence            99865431      23346778999999876434688999999999999999994 66664432111       01 111


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      .........  .      ...+.+++.+||+.+|.+|||+.++++.|+
T Consensus       220 ~~~~~~~~~--~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 QDQHRLPMP--D------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hcCCCCCCC--C------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111111110  0      157889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.2e-34  Score=278.47  Aligned_cols=241  Identities=24%  Similarity=0.362  Sum_probs=171.4

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH-----------------Hhccccc-----Ccc
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE-----------------LLGLCSE-----GFK  216 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e-----------------l~g~~~~-----~~~  216 (453)
                      |.+.++||+|+||.||+|+.. +|+.||+|.+.....   .......|                 +++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            556789999999999999854 789999998875221   11111111                 2233221     234


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++++||++ ++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             EEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence            689999997 5888877432  234589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      +.......   .....||..|+|||++.+.  .++.++||||+||+++||++|++||.......   .+.. +...+...
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~-~~~~~~~~  226 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGK-IFDLIGLP  226 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHH-HHHHhCCC
Confidence            86643321   2345689999999999764  78999999999999999999999986443211   0000 11100000


Q ss_pred             -------------CCc---cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 -------------GDL---ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 -------------~~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                   ...   ...........+...+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                         000   000001111234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.2e-34  Score=281.19  Aligned_cols=247  Identities=22%  Similarity=0.336  Sum_probs=176.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      +|.+.++||+|+||.||+|+.. +++.||+|.+.....  ....+.+|              +++++..+...++||||+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            4666789999999999999854 788999999875321  12223333              466677777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++ +|.+++...   +..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          87 DK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            75 787776432   34588999999999999999999998   999999999999999999999999999976533221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------hHHHHHHhhhC-
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNKG-  376 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~l~~~-  376 (453)
                        ......+|+.|+|||.+.+. ..++.++||||+|++++||++|+.||............       ....+..+... 
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             --ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence              12334678999999998653 36788999999999999999999999654321100000       00000000000 


Q ss_pred             --CCcccc-----chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 --GDLELR-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 --~~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        ......     ........++..+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence              000000     000111224556789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.8e-34  Score=276.44  Aligned_cols=242  Identities=24%  Similarity=0.372  Sum_probs=183.3

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcC----CcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCcceEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~----g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      ..++.+.++||+|+||.||+|...+    ...||||......  ...+++.+|              +++++.. ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            4456677899999999999998543    3479999887543  223345444              3445544 45689


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||+++|+|.+++...   ...+++.++..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999998432   24589999999999999999999997   9999999999999999999999999999876


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ...... ......++..|+|||.+...  .++.++||||||++++||++ |+.||.......        ....+..+..
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~  226 (270)
T cd05056         158 EDESYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGER  226 (270)
T ss_pred             ccccce-ecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCc
Confidence            544322 12233456789999988653  68899999999999999986 999986443211        1223333332


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ...      +...+..+.+++.+|+..+|++|||+.++++.|++..+
T Consensus       227 ~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         227 LPM------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            221      12234578889999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.4e-34  Score=273.39  Aligned_cols=234  Identities=24%  Similarity=0.302  Sum_probs=179.7

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      +.+.++||+|+||.||+++.. +++.+|+|.+....  ...+++..|              +.+.+..+...++++||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            456789999999999999854 78999999886432  122333333              3455667778899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++..  .....+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++++|||+++........
T Consensus        82 ~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          82 GGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            9999888743  2335688999999999999999999998   9999999999999999999999999999866443221


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                        .....|++.|+|||++.+.  ..+.++|+||||+++++|++|+.||......       . ....+..+.....    
T Consensus       157 --~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~----  220 (255)
T cd08219         157 --ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWK-------N-LILKVCQGSYKPL----  220 (255)
T ss_pred             --cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHH-------H-HHHHHhcCCCCCC----
Confidence              1335688999999998764  6889999999999999999999998643211       1 1222222222211    


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                        +..++..+.+++.+||+.+|++|||+.+++..
T Consensus       221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              12244568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-33  Score=271.71  Aligned_cols=226  Identities=22%  Similarity=0.368  Sum_probs=167.3

Q ss_pred             cccCccCceEEEEEEEcC-------------CcEEEEEEecCCCCCH-HHHHHH--------------HhcccccCcceE
Q 048517          167 HKLGQGGFGSVYKGQLHT-------------GRLIAVKMMENSKFSA-EEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~-------------g~~VAVK~l~~~~~~~-~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      +.||+|+||.||+|.+.+             ...||+|.+....... ..+..+              +++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358999887643322 122222              567777778889


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc-------eEEE
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-------PKVS  291 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~-------~kl~  291 (453)
                      ++|||+++|+|+.++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.       +|++
T Consensus        81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            999999999998887432   34689999999999999999999998   9999999999999986654       8999


Q ss_pred             ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH-cCCCCCCCCccccccccchHHHH
Q 048517          292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~  370 (453)
                      |||++......      ....++..|+|||.+... ..++.++|||||||++|||+ +|+.|+.......        . 
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~-  218 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------K-  218 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------H-
Confidence            99998754322      234578899999988632 46888999999999999998 5777765322110        0 


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      ..+...... ..  .    .....+.+++.+||+.||++||++.++++.|+
T Consensus       219 ~~~~~~~~~-~~--~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 ERFYEGQCM-LV--T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHHhcCcc-CC--C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            111111111 00  0    11246788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-34  Score=275.76  Aligned_cols=235  Identities=21%  Similarity=0.332  Sum_probs=194.2

Q ss_pred             HHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHHHH------------------HHhcccccCcceEE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN------------------ELLGLCSEGFKRAL  219 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~i~------------------el~g~~~~~~~~~l  219 (453)
                      .+-+|.|.+.||+|.||.|-++. ...|+.||||.+.+++...++-+.                  .++.++...++..|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            34578889999999999999998 568999999999886654433211                  16778889999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||..+|.|.+|+..    ...|+..+...++.||.+|+.|+|.+   +++|||||.+|||||.|+++||+||||+.++
T Consensus       131 vMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  131 VMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence            9999999999999943    36799999999999999999999998   9999999999999999999999999999988


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ..+.-   ..+.+|++-|.+||.+.+. +.-.+..|-||+|++||.|+.|..||+..+..        ....++..+...
T Consensus       204 ~~~kf---LqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk--------~lvrQIs~GaYr  271 (668)
T KOG0611|consen  204 ADKKF---LQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK--------RLVRQISRGAYR  271 (668)
T ss_pred             ccccH---HHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHH--------HHHHHhhccccc
Confidence            76542   3567899999999999875 23367999999999999999999999875432        244556655443


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                      +....        ....-+++|||-.||++|.|+.+|...-
T Consensus       272 EP~~P--------SdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 EPETP--------SDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             CCCCC--------chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            33222        2456799999999999999999998753

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.6e-34  Score=275.56  Aligned_cols=234  Identities=25%  Similarity=0.343  Sum_probs=175.3

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      +++.+.||+|+||.||+|.. .+++.||+|++.....  ...++..|              +++.+......++|+||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            35668899999999999984 5789999999865422  22334444              4556667777899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +++|..+.        .+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+||+|||++.......  
T Consensus        83 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          83 GGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            99996542        467888899999999999999998   99999999999999999999999999998654322  


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                        .....||..|+|||++.+.  .++.++||||||+++|||++|+.||.............. ....+........    
T Consensus       150 --~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~----  220 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ-LLQCIVDEDPPVL----  220 (279)
T ss_pred             --ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHH-HHHHHhccCCCCC----
Confidence              2345789999999999764  688999999999999999999999865332211111111 1111111111110    


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                       .....+..+.+++.+|++.+|++||+++++++.
T Consensus       221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             011234568899999999999999999999873

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-33  Score=273.05  Aligned_cols=233  Identities=24%  Similarity=0.341  Sum_probs=179.7

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..|...+.||+|+||.||+|... +++.||+|.+.....  ..+.+..|              +++.+..+...++|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45566688999999999999854 688999999875332  12223232              66777788889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++.     ...+++..+..++.++++||.|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999998873     24689999999999999999999998   99999999999999999999999999997654322


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  ......++..|+|||++.+.  .++.++||||||++++||++|+.|+.......        ....+.......   
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~---  220 (277)
T cd06642         156 I--KRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSPPT---  220 (277)
T ss_pred             h--hhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCCCCC---
Confidence            1  11234588999999998764  68899999999999999999999986432111        111111111111   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                         .....+..+.+++.+||+.+|++||++.++++.
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 ---LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ---CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence               122344568899999999999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-33  Score=268.85  Aligned_cols=234  Identities=26%  Similarity=0.355  Sum_probs=181.9

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .+.+.++||+|+||.||+|... +++.+|+|.+..... .+++..|              +++.+......++++||+++
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            4567789999999999999966 489999999876432 4444444              45666777888999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      ++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++........  
T Consensus        83 ~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          83 GSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            999998843   235789999999999999999999998   999999999999999999999999999987644321  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+........        ..........    ...
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~----~~~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFMIPNKPPP----TLS  220 (256)
T ss_pred             ccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhhhccCCCC----CCC
Confidence            12334578899999998764  788999999999999999999999875332110        0011110010    011


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+..+...+.+++.+||+.+|++|||++++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            22334567889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1e-34  Score=293.65  Aligned_cols=236  Identities=23%  Similarity=0.278  Sum_probs=171.2

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |.+.++||+|+||.||+++. .+++.||||++.....    ....+..|              +++.+..+...++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            45678999999999999995 4689999999865211    11222222              45566677889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...++...+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+....
T Consensus        83 ~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          83 IPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999843    24678888999999999999999998   99999999999999999999999999975321000


Q ss_pred             C-----------------------------------------ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHH
Q 048517          304 D-----------------------------------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMV  342 (453)
Q Consensus       304 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvv  342 (453)
                      .                                         ........||+.|+|||++.+.  .++.++|||||||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvi  233 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccce
Confidence            0                                         0001124699999999999764  68899999999999


Q ss_pred             HHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 048517          343 LLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP---SMTKVLEM  419 (453)
Q Consensus       343 l~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---s~~evl~~  419 (453)
                      +|||++|+.||.......       ................    ...++..+.+++.+|+ .+|.+|+   |+.++++.
T Consensus       234 lyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         234 LYEMLVGQPPFLADTPAE-------TQLKVINWETTLHIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eeehhhCCCCCCCCCHHH-------HHHHHhccCccccCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999999997543211       1111111111111111    1123345666777765 4999999   88888864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-34  Score=288.85  Aligned_cols=249  Identities=20%  Similarity=0.211  Sum_probs=179.6

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc---CCcEEEEEEecCCCCCHHH--H--------HHHHhcccccCcceEEEEEecCC
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH---TGRLIAVKMMENSKFSAEE--F--------INELLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~~~~~--~--------i~el~g~~~~~~~~~lv~E~~~~  226 (453)
                      ..+|.+.++||+|+||.||++...   .++.||||.+........+  .        +.++++.+......+++||++. 
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  169 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-  169 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence            446778899999999999999743   4678999998764332221  1        2225566667778899999995 


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      ++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       170 ~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        170 CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence            68888772    235789999999999999999999998   99999999999999999999999999998665433322


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh------------
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN------------  374 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~------------  374 (453)
                      ......||+.|+|||++...  .++.++|||||||++|||++|+.||...........+.. +.+.+.            
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             cccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccCCccch
Confidence            23345799999999999764  788999999999999999999999965433221111100 111000            


Q ss_pred             -------h---CCCccccchhh-hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          375 -------K---GGDLELRNVTE-IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       375 -------~---~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                             +   ........... ........+.+++.+||+.||++|||+.|++..
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   0   00000000000 001223467789999999999999999999874

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-34  Score=292.68  Aligned_cols=235  Identities=22%  Similarity=0.252  Sum_probs=169.1

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.+.++||+|+||.||+|+. .+++.||||++......    ...+..|              +++.+..+...++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            44568899999999999985 57899999998753211    1122222              45666777889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          83 IPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999998843    24678889999999999999999998   99999999999999999999999999975321100


Q ss_pred             C---------------------------------------------ceeecccCCCCCccChhhhcccCCCCCccchHHH
Q 048517          304 D---------------------------------------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYG  338 (453)
Q Consensus       304 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S  338 (453)
                      .                                             ........||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEe
Confidence            0                                             0001123689999999999764  7889999999


Q ss_pred             HHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 048517          339 FGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTK  415 (453)
Q Consensus       339 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~e  415 (453)
                      +||++|||++|+.||.......       .....+..........    ...++....+++.+++ .+|++|++   +.+
T Consensus       234 lGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLE-------TQMKVINWQTSLHIPP----QAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHH-------HHHHHHccCCCcCCCC----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            9999999999999997543211       1111111111111111    1122344556666655 49999997   777


Q ss_pred             HHH
Q 048517          416 VLE  418 (453)
Q Consensus       416 vl~  418 (453)
                      +++
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            665

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-33  Score=274.04  Aligned_cols=248  Identities=24%  Similarity=0.297  Sum_probs=176.1

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.++||+|+||.||+|+.. +++.||||.+.....   ..+.+..|              +++++..+...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            455688999999999999964 789999999865321   12233333              566677778899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      + ++|.+++... .....+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++........
T Consensus        82 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          82 S-MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             C-CCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            7 6888877432 2235789999999999999999999998   999999999999999999999999999976533221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc------------cchHHH--H
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA------------YFPSWV--Y  370 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~------------~~~~~~--~  370 (453)
                        ......+++.|+|||.+.+. ..++.++||||||++++||++|+.|+..........            .++.+.  .
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             --cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence              12334678999999988653 357889999999999999999999986433211000            000000  0


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +...................++..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000000000011224567789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-34  Score=285.03  Aligned_cols=180  Identities=21%  Similarity=0.296  Sum_probs=146.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHH---------HHHHHhcccccCcceEEEEEecCCCChhh
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE---------FINELLGLCSEGFKRALVYEYMPNGSLDR  231 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~---------~i~el~g~~~~~~~~~lv~E~~~~gsL~~  231 (453)
                      .|.+.+.||+|+||.||+|+.. +++.||+|+........+.         .+.++++++......++|+|++ .++|.+
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~  145 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYT  145 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHH
Confidence            4667789999999999999965 6789999986543332222         2333778888888899999999 568888


Q ss_pred             hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeeccc
Q 048517          232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT  311 (453)
Q Consensus       232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  311 (453)
                      ++..   ....+++..+..|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......   ....
T Consensus       146 ~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~  216 (357)
T PHA03209        146 YLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGL  216 (357)
T ss_pred             HHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc---cccc
Confidence            7743   235689999999999999999999998   999999999999999999999999999975432221   2345


Q ss_pred             CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCC
Q 048517          312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  353 (453)
Q Consensus       312 ~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~  353 (453)
                      .||+.|+|||++.+.  .++.++|||||||++|||+++..++
T Consensus       217 ~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        217 AGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcc
Confidence            689999999999764  7899999999999999999866554

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3e-34  Score=289.76  Aligned_cols=240  Identities=21%  Similarity=0.276  Sum_probs=177.5

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      ....+.+.+.||+|+||.||+++.. +++.||+|++.....    ....+..|              +++.+..+...++
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3456677789999999999999955 789999999864211    11122222              4555667778899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||+++|+|.+++..     ..++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       121 v~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         121 VMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            9999999999988732     3478888899999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccC--CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-  376 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-  376 (453)
                      ...... ......||+.|+|||++....  +.++.++|||||||++|||++|+.||......        ..+..+... 
T Consensus       193 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~  263 (371)
T cd05622         193 NKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMNHK  263 (371)
T ss_pred             CcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC
Confidence            433221 123457999999999987532  24788999999999999999999999754321        122223221 


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  419 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~  419 (453)
                      ......    ....++..+..++.+|++.++.+  ||++.++++.
T Consensus       264 ~~~~~~----~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         264 NSLTFP----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CcccCC----CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            111111    11234566788999999844433  7799988874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-34  Score=282.24  Aligned_cols=239  Identities=19%  Similarity=0.238  Sum_probs=173.5

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---C-CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---F-SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |.+.+.||+|+||.||+++.. +++.||||++....   . ..+.+..|              +++.+..+...++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            567789999999999999954 68999999986421   1 11222222              45566677889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          83 YVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             CCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999998843   234688999999999999999999998   99999999999999999999999999987654332


Q ss_pred             CceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh-CCCc
Q 048517          304 DFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDL  379 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~  379 (453)
                      .. ......||+.|+|||++...   .+.++.++|||||||++|||++|+.||......       . .+..+.. ....
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~-~~~~i~~~~~~~  227 (331)
T cd05597         157 TV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------E-TYGKIMNHKEHF  227 (331)
T ss_pred             Cc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------H-HHHHHHcCCCcc
Confidence            21 11234699999999998641   235788999999999999999999998643211       1 1112211 1111


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQV--KAADRPSMTKVLEM  419 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~--~p~~RPs~~evl~~  419 (453)
                      .+..   .....+..+.+++.+|+..  ++..||++.++++.
T Consensus       228 ~~~~---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 QFPP---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cCCC---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            1111   1112445677777777654  34448899988875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-33  Score=267.10  Aligned_cols=234  Identities=32%  Similarity=0.524  Sum_probs=179.7

Q ss_pred             hhcccCccCceEEEEEEEcC-----CcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          165 FTHKLGQGGFGSVYKGQLHT-----GRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~~-----g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.+.||+|+||.||+++..+     +..||+|++.....  ..+.+..|              +++.+......+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            56789999999999999653     38899999976543  23344333              45566667788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++.....  ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus        83 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       83 MEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             cCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999998854321  2289999999999999999999998   99999999999999999999999999998765543


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .... ....++..|+|||.+..  ..++.++||||+|++++||++ |+.|+.....        ....+.+........ 
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~-  225 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRLPK-  225 (258)
T ss_pred             cccc-ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCC-
Confidence            3221 13347889999999854  478899999999999999998 7777754221        112223333322221 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                           ....+..+.+++.+|++.+|++|||+.++++.|
T Consensus       226 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 -----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 112456788999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.5e-33  Score=270.84  Aligned_cols=239  Identities=21%  Similarity=0.252  Sum_probs=177.3

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      ..+.+.++||+|+||.||+|+. .+++.||+|.+...... ...+.+|              +++.+......++++||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4567788999999999999985 47899999998764322 2222232              344555677889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++..    ...+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            99999998742    24689999999999999999999998   999999999999999999999999999876543211


Q ss_pred             ceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          305 FVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                        ......|+..|+|||++.. ..+.++.++||||+||++|||++|+.|+.......       ... .......... .
T Consensus       162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-------~~~-~~~~~~~~~~-~  230 (267)
T cd06645         162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-------ALF-LMTKSNFQPP-K  230 (267)
T ss_pred             --ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-------hHH-hhhccCCCCC-c
Confidence              2234568999999998742 12467889999999999999999999985432111       011 1111110000 0


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       ......++..+.+++.+||+.+|++|||++++++
T Consensus       231 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 -LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence             0011123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.4e-34  Score=275.08  Aligned_cols=247  Identities=22%  Similarity=0.324  Sum_probs=178.4

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHH--------------HHhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFIN--------------ELLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~--------------el~g~~~~~~~~~lv~E~  223 (453)
                      +|++.++||+|+||.||+|..+ +++.||+|++......   .+.+..              .+++++..+...++|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            3566789999999999999965 6899999987653221   222322              267778888889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.++..    ....++|.++..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          82 VDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             CCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99999887653    224589999999999999999999998   99999999999999999999999999998654432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHHHHHHhhhC
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVYDQLNKG  376 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~l~~~  376 (453)
                      .  ......++..|+|||++.+. ..++.++||||||++++||++|++|+.........       ..+...........
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             c--ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            2  12334578899999998653 35778999999999999999999888643321000       00000000000000


Q ss_pred             -----C-Cccccc---hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 -----G-DLELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 -----~-~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           . ......   .......++..+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                 0 000000   00011234567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.1e-33  Score=267.83  Aligned_cols=233  Identities=26%  Similarity=0.346  Sum_probs=177.1

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------Hhcccc-cCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCS-EGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~-~~~~~~lv~E~  223 (453)
                      |.+.+.||+|++|.||+++.. +++.||+|.+......   .+.+..|              +.+.+. .....+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            567789999999999999954 6889999998753322   2223333              223332 33457899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++...  ....+++.++..++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999999988532  335689999999999999999999998   99999999999999999999999999998664332


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  ......+++.|+|||.+.+.  .++.++||||+|++++||++|+.|+.....       ..... .+..+....   
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~-~~~~~~~~~---  221 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVY-RIIEGKLPP---  221 (257)
T ss_pred             C--ccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHH-HHHhcCCCC---
Confidence            2  12344688999999998764  788899999999999999999999864321       11112 222222111   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         .+...+..+.+++.+|++.+|++|||+.++++
T Consensus       222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ---CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               12235567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-33  Score=273.40  Aligned_cols=225  Identities=24%  Similarity=0.368  Sum_probs=167.3

Q ss_pred             ccCccCceEEEEEEEcC-------------------------CcEEEEEEecCCCCC-HHHHHHH--------------H
Q 048517          168 KLGQGGFGSVYKGQLHT-------------------------GRLIAVKMMENSKFS-AEEFINE--------------L  207 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~~~~-------------------------g~~VAVK~l~~~~~~-~~~~i~e--------------l  207 (453)
                      .||+|+||.||+|++..                         ...||+|++...... ..++..+              +
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998521                         135899998754322 2233332              5


Q ss_pred             hcccccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-
Q 048517          208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-  286 (453)
Q Consensus       208 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-  286 (453)
                      +++|......++||||+++|+|..++..   ....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            6777778888999999999999888743   234688999999999999999999998   999999999999997543 


Q ss_pred             ------ceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH-cCCCCCCCCccc
Q 048517          287 ------IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNATR  359 (453)
Q Consensus       287 ------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell-tg~~p~~~~~~~  359 (453)
                            .+|++|||++......      ....++..|+|||.+.+. ..++.++||||||+++|||+ +|+.|+......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  228 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPS  228 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence                  4799999998644322      223477889999988653 46889999999999999995 788888643221


Q ss_pred             cccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          360 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       360 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      .        ............        ......+.+++.+||+.+|++|||+.++++.|.
T Consensus       229 ~--------~~~~~~~~~~~~--------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 E--------KERFYEKKHRLP--------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H--------HHHHHHhccCCC--------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1        111111111110        111245888999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.2e-34  Score=307.01  Aligned_cols=247  Identities=24%  Similarity=0.311  Sum_probs=182.0

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.++||+|+||.||+|+.. +|+.||||++......    .+++.+|              +++++.++...+++||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            3566789999999999999954 6899999998753221    2344444              4567777888899999


Q ss_pred             ecCCCChhhhhhhccC-------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          223 YMPNGSLDRHIFSKEN-------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      |+++|+|.+++.....       ....+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence            9999999998854211       123467788899999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCC----------------ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccc
Q 048517          296 AKFHPKEND----------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR  359 (453)
Q Consensus       296 a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~  359 (453)
                      ++.......                ........||+.|+|||.+.+.  .++.++|||||||+++||++|+.||......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            986521110                0001124699999999998764  7899999999999999999999999653221


Q ss_pred             cccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhCCCC
Q 048517          360 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSID  425 (453)
Q Consensus       360 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~Le~~~~  425 (453)
                      ..  .    ....+...  ..    ......++..+.+++.+|++.||++|| +++++.+.|+..+.
T Consensus       238 ki--~----~~~~i~~P--~~----~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        238 KI--S----YRDVILSP--IE----VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hh--h----hhhhccCh--hh----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            10  0    00001000  00    001123456688899999999999996 67778777776543

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-33  Score=271.77  Aligned_cols=239  Identities=25%  Similarity=0.302  Sum_probs=176.8

Q ss_pred             HHhhhhh--cccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEE
Q 048517          160 AVTNHFT--HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       160 ~~~~~~~--~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      .+++++.  ..||+|+||.||+|+. ++++.||+|.+..... ..+.+.+|              +++++..+...++++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            3444443  5799999999999994 4688999998876433 22333333              566777778899999


Q ss_pred             EecCCCChhhhhhhccCCCCCC--CchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccc
Q 048517          222 EYMPNGSLDRHIFSKENKGQTF--GLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKF  298 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~  298 (453)
                      ||+++++|.+++....   ..+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||++..
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          85 EQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             ecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999885432   234  7788889999999999999998   9999999999999986 67999999999876


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ......  ......++..|+|||++.+....++.++||||||+++|||++|+.|+........    ..+  ........
T Consensus       159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~~~--~~~~~~~~  230 (268)
T cd06624         159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----AMF--KVGMFKIH  230 (268)
T ss_pred             cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----hHh--hhhhhccC
Confidence            543222  1223458899999999865433578899999999999999999999864321110    000  00000001


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .      ..+......+..++.+||+.+|++|||+.++++
T Consensus       231 ~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 P------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             C------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            1      122234567889999999999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.5e-33  Score=273.98  Aligned_cols=186  Identities=25%  Similarity=0.333  Sum_probs=140.9

Q ss_pred             hcccCccCceEEEEEEEc---CCcEEEEEEecCCCCCHHHHHHH--------------Hhcccc--cCcceEEEEEecCC
Q 048517          166 THKLGQGGFGSVYKGQLH---TGRLIAVKMMENSKFSAEEFINE--------------LLGLCS--EGFKRALVYEYMPN  226 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~--~~~~~~lv~E~~~~  226 (453)
                      ..+||+|+||.||+|+..   +++.||+|.+...... ....+|              +++.+.  .+...++++||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            468999999999999854   5688999998764322 122222              333332  2345789999985 


Q ss_pred             CChhhhhhhcc-----CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE----cCCCceEEEecCCcc
Q 048517          227 GSLDRHIFSKE-----NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK  297 (453)
Q Consensus       227 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~  297 (453)
                      ++|.+++....     .....+++..+..++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            57777663221     1223588899999999999999999998   99999999999999    456789999999998


Q ss_pred             ccCCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517          298 FHPKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  357 (453)
Q Consensus       298 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~  357 (453)
                      ....... ........||+.|+|||++.+. ..++.++||||+||+++||++|++||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            7643321 1122345789999999998753 357889999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.5e-33  Score=283.34  Aligned_cols=244  Identities=21%  Similarity=0.204  Sum_probs=171.4

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccC------cc
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEG------FK  216 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~------~~  216 (453)
                      ..|.+.+.||+|+||.||+++. .+|+.||||++.....   ...++.+|              +++++...      ..
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            4566778999999999999985 4789999999865321   22333333              33333222      34


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++||||+++ +|.+.+.      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       101 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         101 VYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            6899999965 5555552      2478889999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc--------cccch--
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--------KAYFP--  366 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~--------~~~~~--  366 (453)
                      +......   ......||+.|+|||.+.+.  .++.++||||+||++|||++|+.||........        .....  
T Consensus       171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         171 RTACTNF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             cccccCc---cCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            7643322   12345689999999999764  788999999999999999999999975432100        00000  


Q ss_pred             -----HHHHHHhhhCCCcc---c---------cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          367 -----SWVYDQLNKGGDLE---L---------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       367 -----~~~~~~l~~~~~~~---~---------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                           ..+...........   .         .............+.+++.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                 00000011000000   0         00000111224568899999999999999999999883

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.8e-33  Score=272.63  Aligned_cols=236  Identities=24%  Similarity=0.323  Sum_probs=177.9

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      |++.++||+|+||.||+|... ++..+|+|.+..... ..+.+.+|              +++.+..+...++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            556788999999999999965 588899999865332 23334443              45566677788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|..++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........  
T Consensus        87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  158 (282)
T cd06643          87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  158 (282)
T ss_pred             CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence            9998877432   24689999999999999999999998   999999999999999999999999999876533221  


Q ss_pred             eecccCCCCCccChhhhcc---cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          307 SISDTRGTIGYLAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      ......+|..|+|||++..   ....++.++|||||||++|||++|+.|+......       . .............  
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~--  228 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------R-VLLKIAKSEPPTL--  228 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------H-HHHHHhhcCCCCC--
Confidence            1234568999999999852   1235778999999999999999999998643211       0 1111111111111  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        ..+..++..+.+++.+||+.+|++||++.++++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              112234467889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-33  Score=269.30  Aligned_cols=232  Identities=28%  Similarity=0.457  Sum_probs=177.7

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      .+.+.+.||+|+||.||+|.. +++.||+|++.... ..+.+..|              +++.+.. ...+++|||+++|
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~   83 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKG   83 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCC
Confidence            456778999999999999975 57889999986542 23344444              2334433 3468999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++......    
T Consensus        84 ~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          84 NLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            999998543  234688999999999999999999997   99999999999999999999999999997643221    


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                       .....+..|+|||.+..  +.++.++|+||||++++||++ |+.|+......       . ....+.++.....     
T Consensus       155 -~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~-----  218 (254)
T cd05083         155 -DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------E-VKECVEKGYRMEP-----  218 (254)
T ss_pred             -CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------H-HHHHHhCCCCCCC-----
Confidence             22344678999998865  378899999999999999997 88888643221       1 2223333322211     


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                       ...++..+.+++.+||+.+|++||++.++++.|++
T Consensus       219 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 -PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             12234678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.3e-33  Score=273.72  Aligned_cols=228  Identities=25%  Similarity=0.372  Sum_probs=170.4

Q ss_pred             ccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH-----------------HhcccccCcceEEEEEecC
Q 048517          168 KLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE-----------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e-----------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .||+|+||.||++.. .+|+.+|||.+......    ...+..+                 +.+.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999995 46899999988653221    1111111                 1223345567889999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.+||+|||++.......  
T Consensus        81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            9999988742    24689999999999999999999998   99999999999999999999999999987543322  


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                        .....||..|+|||.+.+. ..++.++||||+|++++||++|+.||........     .... ........      
T Consensus       152 --~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~~~~------  216 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEID-RMTLTVNV------  216 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHH-HHhhcCCc------
Confidence              1234689999999988642 3578899999999999999999999965432110     0011 11111111      


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  419 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~  419 (453)
                      ..+...+..+.+++.+||+.||++||     |++++++.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            12233456788999999999999999     69999884

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-34  Score=279.06  Aligned_cols=241  Identities=23%  Similarity=0.319  Sum_probs=179.7

Q ss_pred             HHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH---------------HHHHHH--------------Hhc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---------------EEFINE--------------LLG  209 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~---------------~~~i~e--------------l~g  209 (453)
                      -.+|.+.+.||+|.||.|-+|+ ..+++.||||++.+.+...               ++...|              |+.
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            3466778899999999999999 5589999999997643221               122222              233


Q ss_pred             ccc--cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517          210 LCS--EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  287 (453)
Q Consensus       210 ~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~  287 (453)
                      +..  .....|||+|||..|.+...    ......|+..++++++.++..||+|||.+   +|+||||||+|+||+++++
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence            332  34568999999999988532    12223399999999999999999999998   9999999999999999999


Q ss_pred             eEEEecCCccccCCCC---CceeecccCCCCCccChhhhcccC--CCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc
Q 048517          288 PKVSDFGLAKFHPKEN---DFVSISDTRGTIGYLAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK  362 (453)
Q Consensus       288 ~kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~  362 (453)
                      +||+|||.+...+...   .........|||.|+|||...+..  ...+.+.||||+||+||.|+.|+.||......   
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---  325 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---  325 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---
Confidence            9999999998663221   111234468999999999987621  23467999999999999999999999754321   


Q ss_pred             ccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                           ..++.+..... .+.    ...++.+.+.+|++++|+.||+.|.+..+|....
T Consensus       326 -----~l~~KIvn~pL-~fP----~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  326 -----ELFDKIVNDPL-EFP----ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             -----HHHHHHhcCcc-cCC----CcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                 13333333221 111    2224567789999999999999999999998755

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=269.72  Aligned_cols=235  Identities=26%  Similarity=0.301  Sum_probs=178.1

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC------HHHHHHH--------------HhcccccCcceEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS------AEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~------~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      +...+.||+|++|.||++.. .+++.||+|.+......      ...+..|              +++++..+...++++
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            45668999999999999985 57899999988653221      1122222              456677778899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++++|.+++..    ...+++..+..++.+++.||.|||+.   +|+|+||||+||++++++.++|+|||+++....
T Consensus        84 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          84 EYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999998843    24588899999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCcee-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          302 ENDFVS-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       302 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ...... .....++..|+|||.+.+.  .++.++||||+|+++|||++|+.||......       ..............
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~  227 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQ  227 (263)
T ss_pred             cccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCCCC
Confidence            221110 1234578899999999864  6889999999999999999999998643211       00111111111111


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                            .+......+.+++.+||+.+|++|||+.++++.
T Consensus       228 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         228 ------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                  222345568889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-33  Score=276.33  Aligned_cols=234  Identities=25%  Similarity=0.360  Sum_probs=180.2

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      ..|.+.++||+|+||.||+|+. .+++.||+|.+...... .+.+..|              +++.+..+...++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            4566778999999999999995 57999999998764333 2333333              456667777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++..     ..+++.++..++.+++.||.|||+.   +++|+||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            99999998732     3578999999999999999999998   999999999999999999999999999876543322


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                        ......+++.|+|||.+.+.  .++.++||||||+++|+|++|+.||........       ... ........    
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-------~~~-~~~~~~~~----  234 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYL-IATNGTPE----  234 (297)
T ss_pred             --CcCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-------eee-eccCCCCC----
Confidence              12334688999999998763  678999999999999999999999965332110       000 01111111    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...+..+...+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1122334566888999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.1e-33  Score=273.51  Aligned_cols=240  Identities=26%  Similarity=0.319  Sum_probs=177.0

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------Hhccccc-----CcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLCSE-----GFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~-----~~~~~lv  220 (453)
                      .+.+.+.||+|+||.||++.. .+++.+|+|.+.......+++..|               +++++..     ....++|
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv  102 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV  102 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence            355668899999999999995 578999999987643333332222               2333332     2357899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      +||+++|+|.+++.........+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++...
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            999999999998854333456789999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeecccCCCCCccChhhhcccC---CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      .....  .....|+..|+|||.+....   ..++.++|||||||++|||++|+.|+.......       .+. .+....
T Consensus       180 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-------~~~-~~~~~~  249 (291)
T cd06639         180 STRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-------TLF-KIPRNP  249 (291)
T ss_pred             ccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-------HHH-HHhcCC
Confidence            32211  13346889999999886421   136889999999999999999999986432211       011 111111


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .....    ........+.+++.+||+.+|++||++.++++
T Consensus       250 ~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         250 PPTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCCC----cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111    11223456889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=269.93  Aligned_cols=241  Identities=27%  Similarity=0.349  Sum_probs=181.6

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH---------------Hhccccc------CcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE---------------LLGLCSE------GFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~------~~~~~  218 (453)
                      ..|.+.+.||+|+||.||+|... +++.+|+|++.......+++..|               +++++..      +...+
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            45667789999999999999964 68899999988755444444443               2333432      33478


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ++|||+++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            99999999999998855443456789999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      ......  ......|+..|+|||.+...   ...++.++||||||++++||++|+.||.......        ....+..
T Consensus       163 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~  232 (275)
T cd06608         163 LDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------ALFKIPR  232 (275)
T ss_pred             cccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------HHHHhhc
Confidence            543221  12345689999999988542   1356789999999999999999999986432110        1111111


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .....    ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         233 NPPPT----LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cCCCC----CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111    1122335567889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-33  Score=276.12  Aligned_cols=232  Identities=25%  Similarity=0.375  Sum_probs=179.3

Q ss_pred             hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      |.+.++||.|+||.||+|. ..+|+.||+|.+...... .+.+.+|              +++.+......++|+||+++
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  100 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG  100 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence            4566889999999999998 457999999998764332 3333333              55667777889999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      ++|.+++..     ..+++.++..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||++......... 
T Consensus       101 ~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655         101 GSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence            999998732     3589999999999999999999998   9999999999999999999999999998865433221 


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                       .....++..|+|||.+.+.  .++.++|||||||++|||++|+.||.......       ... .+........    .
T Consensus       172 -~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------~~~-~~~~~~~~~~----~  236 (296)
T cd06655         172 -RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALY-LIATNGTPEL----Q  236 (296)
T ss_pred             -CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH-HHHhcCCccc----C
Confidence             1334688999999998764  68899999999999999999999986543211       011 1111111111    1


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+..+...+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            12234456888999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-34  Score=255.66  Aligned_cols=230  Identities=23%  Similarity=0.344  Sum_probs=190.1

Q ss_pred             hhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC------------------HHHHHHHHhcccccCcceEEEEEec
Q 048517          164 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS------------------AEEFINELLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~------------------~~~~i~el~g~~~~~~~~~lv~E~~  224 (453)
                      ++.+.||+|.||.||.|+. +++-.||+|++.++...                  .+..|.++++++.+....+|++||.
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya  104 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA  104 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence            4568899999999999995 47889999998764211                  1234556999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      .+|+|.+.|...  ....++......+..|+|.||.|+|..   +++||||||+|+|++.++..|++|||-+...+... 
T Consensus       105 ~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k-  178 (281)
T KOG0580|consen  105 PRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK-  178 (281)
T ss_pred             CCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCC-
Confidence            999999999643  346788899999999999999999998   99999999999999999999999999998665322 


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                         -...+||.-|.+||...+.  ..+.+.|+|++|++.+|++.|.+||......        ..++.+.+....     
T Consensus       179 ---R~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--------etYkrI~k~~~~-----  240 (281)
T KOG0580|consen  179 ---RKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--------ETYKRIRKVDLK-----  240 (281)
T ss_pred             ---ceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhhH--------HHHHHHHHcccc-----
Confidence               2456799999999999875  7889999999999999999999999865522        255566553322     


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                        .+..++....+++.+|+..+|.+|.+..|+++.
T Consensus       241 --~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  241 --FPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             --CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence              223455678889999999999999999999863

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.5e-33  Score=271.41  Aligned_cols=241  Identities=27%  Similarity=0.401  Sum_probs=176.6

Q ss_pred             hhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccC------cc
Q 048517          164 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEG------FK  216 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~------~~  216 (453)
                      .+.+.||+|+||.||+|...    +++.||||++......   .+++..|              +++++...      ..
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            45678999999999999853    4689999998764322   2334344              22322221      12


Q ss_pred             eEEEEEecCCCChhhhhhhccC--CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          217 RALVYEYMPNGSLDRHIFSKEN--KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      .++++||+++|+|.+++.....  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence            3688999999999988754321  223578899999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      +++...............++..|++||.+...  .++.++||||||+++|||++ |+.|+......        .....+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--------~~~~~~  228 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--------EIYNYL  228 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--------HHHHHH
Confidence            99876443322222333456789999998754  67889999999999999999 77877533211        122223


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      ........      .......+.+++.+||+.+|++|||+.++++.|+++
T Consensus       229 ~~~~~~~~------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IKGNRLKQ------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            22222111      112345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.9e-34  Score=271.40  Aligned_cols=226  Identities=23%  Similarity=0.320  Sum_probs=167.3

Q ss_pred             cccCccCceEEEEEEEc-C-------CcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          167 HKLGQGGFGSVYKGQLH-T-------GRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~-------g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.||+|+||.||+|... .       ...||+|.+...... .+++..+              +++.+..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            46999999999999853 2       234888987653322 2233222              56677777788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc--------eEEEecCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--------PKVSDFGL  295 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~--------~kl~DFGl  295 (453)
                      +++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.        +|++|||+
T Consensus        81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999998533   23689999999999999999999998   9999999999999987665        69999998


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC-CCCCCCccccccccchHHHHHHhh
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      +......      ....+++.|+|||++.+. ..++.++||||||+++|||++|+ .|+.......        ......
T Consensus       155 ~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~  219 (258)
T cd05078         155 SITVLPK------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYE  219 (258)
T ss_pred             ccccCCc------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHH
Confidence            8754322      234578899999999753 35788999999999999999995 4443221100        011111


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      .  ...+.      .....++.+++.+||+.+|++|||++++++.|+
T Consensus       220 ~--~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 D--RHQLP------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             c--cccCC------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1  11111      112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.9e-33  Score=269.48  Aligned_cols=239  Identities=26%  Similarity=0.335  Sum_probs=179.7

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .+++.+.||+|+||.||++..+ +|+.||+|.+......  ..++++|              +++.+......++|+||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            3567789999999999999965 7999999988653221  2233333              566777788899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|..++.... ....+++..+..++.+++.||.|||+.  .+|+|+||||+||+++.++.+||+|||++....... 
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999988875321 234789999999999999999999963  289999999999999999999999999997653322 


Q ss_pred             ceeecccCCCCCccChhhhcccC----CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          305 FVSISDTRGTIGYLAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~----~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                         .....++.+|+|||.+.+..    ..++.++|+|||||++|||++|+.||......        .....+.......
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~  226 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--------NIFAQLSAIVDGD  226 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--------hHHHHHHHHhhcC
Confidence               13345888999999885421    23588999999999999999999998643211        1112221111100


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .   ...+..+...+..++.+||+.+|++||++.++++
T Consensus       227 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 P---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             C---CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            0   0122235667889999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-33  Score=269.82  Aligned_cols=240  Identities=26%  Similarity=0.374  Sum_probs=178.2

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---C--------HHHHHHH--------------HhcccccCcc
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---S--------AEEFINE--------------LLGLCSEGFK  216 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~--------~~~~i~e--------------l~g~~~~~~~  216 (453)
                      |...+.||+|+||.||+|.. .+|+.||||.+.....   .        .+.+..|              +++++.....
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            34457899999999999984 4789999998754211   1        0122222              4567777788


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++|+||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            89999999999999988432    4689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      +...............|+..|+|||.+......++.++||||||++++|+++|+.|+......       ....+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKLGNKR  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHhhccc
Confidence            865432222222345688999999998764224789999999999999999999998533211       0011111111


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ......  ......+...+.+++.+||+.+|++|||+.+|++
T Consensus       229 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 SAPPIP--PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCcCC--ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            111111  1122234567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.5e-33  Score=278.01  Aligned_cols=249  Identities=17%  Similarity=0.216  Sum_probs=174.5

Q ss_pred             hhcccCcc--CceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHH-H--------------HhcccccCcceEEEEEec
Q 048517          165 FTHKLGQG--GFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFIN-E--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       165 ~~~~LG~G--~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~-e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      +.++||+|  +||+||+++. ++|+.||||++......  ..+++. |              +++++..+...++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999985 57999999998764322  112222 2              456777788899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++|+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999884322  24589999999999999999999998   999999999999999999999999986543321111


Q ss_pred             ce-----eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-----ccchH------H
Q 048517          305 FV-----SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-----AYFPS------W  368 (453)
Q Consensus       305 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-----~~~~~------~  368 (453)
                      ..     ......++..|+|||++.+....++.++|||||||+++||++|+.||.........     ...+.      .
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            00     01123467789999999764346889999999999999999999999643211100     00000      0


Q ss_pred             HHHHhh-------------hCCC-------ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          369 VYDQLN-------------KGGD-------LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       369 ~~~~l~-------------~~~~-------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..+.+.             .+..       ............++..+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000000             0000       0000000122234567899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-33  Score=306.72  Aligned_cols=244  Identities=25%  Similarity=0.343  Sum_probs=180.8

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------Hhcccc--cCcce
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCS--EGFKR  217 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~--~~~~~  217 (453)
                      .....|.+.++||+|+||+||+++. .+++.||+|.+......   ...++.|              +++++.  .....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            3344677889999999999999995 46889999998754322   2334444              344332  33457


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCC----CceeecccCCcceEEcC---------
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD----VCILHFDIKPHNILLDH---------  284 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dikp~NILl~~---------  284 (453)
                      +|||||+++|+|.++|.........+++..++.|+.||+.||.|||+...    .+|+||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            89999999999999986543334579999999999999999999998521    36999999999999964         


Q ss_pred             --------CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 048517          285 --------NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN  356 (453)
Q Consensus       285 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~  356 (453)
                              ...+||+|||+++.......   .....||+.|+|||++......++.++|||||||+||||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    34589999999986543321   2345699999999998654346889999999999999999999999643


Q ss_pred             ccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          357 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       357 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..      + ..+...+........       ...+..+.+++.+||+.+|.+||++.+++.
T Consensus       247 ~~------~-~qli~~lk~~p~lpi-------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NN------F-SQLISELKRGPDLPI-------KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             Cc------H-HHHHHHHhcCCCCCc-------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            21      1 112223332222111       112456889999999999999999999984

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.2e-33  Score=266.95  Aligned_cols=239  Identities=23%  Similarity=0.328  Sum_probs=182.4

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------Hhcccc--cCcceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCS--EGFKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~--~~~~~~lv~E  222 (453)
                      |++.+.||.|+||.||++.. .+|+.||+|.+..+...   .+++..|              +++.+.  .+...+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            45668899999999999984 57899999998754322   2233333              233332  3445789999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC--CCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |+++++|.+++.........+++..++.++.+++.||.|||..+  +.+++|+||||+||+++.++.+||+|||++....
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~  161 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG  161 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence            99999999998654444567999999999999999999999332  3499999999999999999999999999998765


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      .....  .....++..|+|||.+...  .++.++||||||+++++|++|+.|+.....        ....+.+..+....
T Consensus       162 ~~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~  229 (265)
T cd08217         162 HDSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASKIKEGKFRR  229 (265)
T ss_pred             CCccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHHHhcCCCCC
Confidence            44321  2345689999999998764  688999999999999999999999875431        11222333322211


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                            .+...+..+.+++.+|++.+|++||++.+|+++
T Consensus       230 ------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         230 ------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  223445678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-34  Score=283.32  Aligned_cols=235  Identities=26%  Similarity=0.342  Sum_probs=189.7

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHH---HHHHH--------------HhcccccCcc-eEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAE---EFINE--------------LLGLCSEGFK-RALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~---~~i~e--------------l~g~~~~~~~-~~lv~E  222 (453)
                      .|...+++|+|+||.++..+.+ +++.+++|.+...+....   ..++|              ....+.+++. .+|||+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            4667789999999999999844 788999999887543322   22333              2344445555 899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |++||+|.+.|...  ++..++.+++..++.|++.|+.|||+.   .|+|||||+.||+++.+..+||+|||+|+....+
T Consensus        85 Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             ecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999988543  367899999999999999999999987   9999999999999999999999999999988776


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ...  .....||+.||.||.+.+.  +|..|+||||+||++|||++-+++|...+.       ...+.+.... ..    
T Consensus       160 ~~~--a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ki~~~-~~----  223 (426)
T KOG0589|consen  160 DSL--ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILKINRG-LY----  223 (426)
T ss_pred             hhh--hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccch-------HHHHHHHhhc-cC----
Confidence            533  2457899999999999986  899999999999999999999999975432       2223333222 11    


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                        ...+..++..+..++..|++.+|+.||++.+++.+
T Consensus       224 --~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  224 --SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence              22455677889999999999999999999999875

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-33  Score=280.06  Aligned_cols=244  Identities=20%  Similarity=0.231  Sum_probs=171.0

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------Hhccccc------Ccc
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSE------GFK  216 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~------~~~  216 (453)
                      ..|...+.||+|+||.||+|.. .+++.||||++.....   ..+++.+|              +++++..      ...
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            3566778999999999999984 5788999999875322   12223233              3443322      134


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++++|++ +++|.+.+.     ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             EEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence            68999988 788887662     24689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-------cchHHH
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------YFPSWV  369 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~  369 (453)
                      +.....     .....||+.|+|||++.+. ..++.++||||+||+++||++|+.||........-.       ......
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            865432     1344689999999998753 367889999999999999999999986432110000       000000


Q ss_pred             HHHhhhC---------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          370 YDQLNKG---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       370 ~~~l~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ...+...         ..................+.+++.+|++.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000         0000000000001123457789999999999999999999963

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.6e-34  Score=277.24  Aligned_cols=247  Identities=19%  Similarity=0.219  Sum_probs=166.5

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEcC----CcEEEEEEecCCCCC--HHH----------HHHH--------------
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMMENSKFS--AEE----------FINE--------------  206 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~----g~~VAVK~l~~~~~~--~~~----------~i~e--------------  206 (453)
                      ++....|.+.++||+|+||.||+|+..+    +..+|+|+.......  .+.          .+.+              
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            4445567888999999999999999653    456777764432211  111          1111              


Q ss_pred             HhcccccC----cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE
Q 048517          207 LLGLCSEG----FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL  282 (453)
Q Consensus       207 l~g~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl  282 (453)
                      +++.+...    ...++++|++. .++.+.+..    ....++..+..|+.|++.||+|||+.   +|+||||||+|||+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            11111111    12356666653 345444421    13357888899999999999999998   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517          283 DHNFIPKVSDFGLAKFHPKENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  357 (453)
Q Consensus       283 ~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~  357 (453)
                      +.++.+||+|||+|+........     .......||+.|+|||++.+.  .++.++|||||||+++||++|+.||....
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999876432211     111234699999999998764  78999999999999999999999997553


Q ss_pred             ccccccc-chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          358 TRSSKAY-FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       358 ~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      ....... ...-....+.++.. ..       ....+.+.+++..|++.+|++||++.++++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        238 HNGNLIHAAKCDFIKRLHEGKI-KI-------KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             cchHHHHHhHHHHHHHhhhhhh-cc-------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            2211000 00001122222111 11       112466889999999999999999999998764

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.4e-33  Score=271.54  Aligned_cols=238  Identities=25%  Similarity=0.376  Sum_probs=177.1

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~lv~E~~  224 (453)
                      +.+.+.||+|+||.||+++.. +|+.||||.+......  ..++..|               +++.+..+...+++|||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~   82 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM   82 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence            456688999999999999954 7999999998764322  2223222               445566677889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      + |+|.+++.........+++..++.++.|++.||+|||++  .+++||||||+||+++.++.+||+|||+++...... 
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence            6 788887754333446799999999999999999999974  379999999999999999999999999998654321 


Q ss_pred             ceeecccCCCCCccChhhhccc--CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          305 FVSISDTRGTIGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~--~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                        ......++..|+|||.+.+.  ...++.++|+||||+++|||++|+.|+......     +. .....+ ++..... 
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~-~~~~~~-~~~~~~~-  228 (283)
T cd06617         159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQ-QLKQVV-EEPSPQL-  228 (283)
T ss_pred             --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HH-HHHHHH-hcCCCCC-
Confidence              11234588899999988642  135688999999999999999999998642211     00 011111 1111111 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          ....++..+.+++.+||+.+|++||++.++++
T Consensus       229 ----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         229 ----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                11124567889999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.4e-33  Score=281.23  Aligned_cols=244  Identities=22%  Similarity=0.214  Sum_probs=171.7

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------Hhccccc------Ccc
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSE------GFK  216 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~------~~~  216 (453)
                      ..|.+.+.||+|+||.||++.. ..++.||||++.....   ...++.+|              +++.+..      ...
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            4566778999999999999985 4689999999875322   22233333              2333322      234


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         104 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             EEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            6899999965 6666652      2478899999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc--------cccchHH
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--------KAYFPSW  368 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~--------~~~~~~~  368 (453)
                      +......   ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||........        ....+.+
T Consensus       174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         174 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             cccCCCC---cccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            8654322   12345689999999999764  788999999999999999999999965432110        0000000


Q ss_pred             -------HHHHhhhCCCcc------------ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          369 -------VYDQLNKGGDLE------------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       369 -------~~~~l~~~~~~~------------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                             +...........            ..............+.+++.+||+.||.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                   000000000000            000000111123567899999999999999999999884

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.7e-33  Score=271.77  Aligned_cols=243  Identities=24%  Similarity=0.338  Sum_probs=177.7

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC------HHHHHHH--------------HhcccccCcceEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS------AEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~------~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      |++.+.||+|+||.||+|... +|+.||||.+......      ...+..|              +++++......++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            456678999999999999954 7899999998764322      1122222              567777778889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+ +|+|.+++....   ..+++..+..++.|+++||.|||+.   +|+|+||||+||+++.++.+||+|||+++....
T Consensus        82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            999 999999884321   3699999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh-------
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN-------  374 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~-------  374 (453)
                      ...  ......+++.|+|||.+.+. ..++.++||||||++++||++|.+++.......   .+.. ....+.       
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~  227 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGK-IFEALGTPTEENW  227 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHH-HHHHcCCCchhhh
Confidence            322  12334578889999988643 367889999999999999999977775432210   0000 000000       


Q ss_pred             -------hCCCc---cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          375 -------KGGDL---ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       375 -------~~~~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                             .....   ............+..+.+++.+||+.+|++|||++|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                   00000   0000001112345678999999999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-33  Score=277.89  Aligned_cols=240  Identities=23%  Similarity=0.301  Sum_probs=176.6

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      +++.++||+|+||.||+++. .+|..+|+|.+.....  ..+++..|              +++.+..+...++++||++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            45678899999999999985 4788999998875322  12334343              4566677788999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +++|.+++...    ..+++..+..++.|+++||.|||+.  .+++|+||||+|||++.++.+||+|||++.......  
T Consensus        83 ~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          83 GGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999998432    5688999999999999999999973  289999999999999999999999999987553321  


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHH-----------------
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-----------------  368 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-----------------  368 (453)
                        .....++..|+|||.+.+.  .++.++||||||++++||++|+.|+...........+...                 
T Consensus       155 --~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             --cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence              1345688999999998754  6889999999999999999999998643321100000000                 


Q ss_pred             -----------HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          369 -----------VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       369 -----------~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                                 ..+.+........     ....++..+.+++.+||+.+|++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKL-----PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccC-----cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       0000000000000     001134568899999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-33  Score=280.46  Aligned_cols=239  Identities=19%  Similarity=0.234  Sum_probs=173.6

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---C-CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---F-SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.+.++||+|+||.||+++.+ +++.+|+|++.+..   . ....+..|              +.+.+......++||||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey   82 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY   82 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence            556789999999999999965 57889999986421   1 11112222              34455667788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            9999999998532   24689999999999999999999998   99999999999999999999999999997553332


Q ss_pred             CceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-CCc
Q 048517          304 DFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GDL  379 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-~~~  379 (453)
                      .. ......||+.|+|||++...   .+.++.++|||||||++|||++|+.||......       . ....+... ...
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-------~-~~~~i~~~~~~~  227 (332)
T cd05623         157 TV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------E-TYGKIMNHKERF  227 (332)
T ss_pred             cc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-------H-HHHHHhCCCccc
Confidence            21 22345699999999998631   236788999999999999999999999643211       1 12222221 111


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAA--DRPSMTKVLEM  419 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~--~RPs~~evl~~  419 (453)
                      ....   ....++..+.+++.+|+..+++  .||++.++++.
T Consensus       228 ~~p~---~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QFPA---QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCCC---ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1111   1122345677788887765444  47899988765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.5e-34  Score=289.15  Aligned_cols=234  Identities=23%  Similarity=0.300  Sum_probs=169.9

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +++.+.||+|+||.||+++.. +++.||||++.....    ....+..|              +++.+..+...++||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            445688999999999999854 789999999875211    11222222              34556677788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          83 LPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999998843    34689999999999999999999998   99999999999999999999999999987543211


Q ss_pred             Cc---------------------------------eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC
Q 048517          304 DF---------------------------------VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  350 (453)
Q Consensus       304 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~  350 (453)
                      ..                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCC
Confidence            00                                 001234699999999999764  7889999999999999999999


Q ss_pred             CCCCCCccccccccchHHHHHHhhh-CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 048517          351 RNSNMNATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVLE  418 (453)
Q Consensus       351 ~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~  418 (453)
                      .||......        .....+.. ..........    ..+..+.+++.+++ .+|.+|++   +.++++
T Consensus       234 ~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         234 PPFCSETPQ--------ETYRKVMNWKETLVFPPEV----PISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCCHH--------HHHHHHHcCCCceecCCCC----CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            999654321        12222222 1111111111    13345666777766 49999996   555554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.3e-33  Score=266.51  Aligned_cols=235  Identities=25%  Similarity=0.334  Sum_probs=182.5

Q ss_pred             hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.+.||+|+||.||.++ ..+++.+++|.+.....   ...++.+|              +++++.+....+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            5567899999999999998 45789999998875432   22334343              456667778889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++|+|.+++...  ....+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          82 NGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             CCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            999999988533  235689999999999999999999998   999999999999999999999999999987644332


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                        ......+++.|+|||.+.+.  ..+.++||||||++++||++|+.|+......       . ....+..+....    
T Consensus       157 --~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~-~~~~~~~~~~~~----  220 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPL-------N-LVVKIVQGNYTP----  220 (256)
T ss_pred             --cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHcCCCCC----
Confidence              12345689999999998764  5788999999999999999999998643211       1 122222222111    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                        .....+..+.+++.+||+.+|++|||++++++.+
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence              1133456788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-33  Score=268.78  Aligned_cols=232  Identities=25%  Similarity=0.330  Sum_probs=179.7

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .|++.+.||.|+||.||+|+.. +++.||+|++.....  ....+..|              +.+.+..+...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            3567789999999999999954 789999999876432  12233333              445556677889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++.......
T Consensus        82 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          82 GGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            99999998842     2789999999999999999999998   999999999999999999999999999987654321


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                        ......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+......        .....+.......+.  
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~--  219 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIPKNNPPSLE--  219 (274)
T ss_pred             --ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhhhcCCCCCc--
Confidence              12345688899999999764  5899999999999999999999998643311        111122222111111  


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         ...++..+.+++.+||+.+|++|||++++++
T Consensus       220 ---~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 ---GNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ---ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               0114556889999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.6e-33  Score=269.68  Aligned_cols=244  Identities=27%  Similarity=0.342  Sum_probs=180.3

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------Hhccccc--CcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSE--GFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~--~~~~~lv~E~  223 (453)
                      +.+.++||.|++|.||++... +++.+|+|.+.....  ..+++.+|              +++++..  ....++||||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   82 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY   82 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence            345678999999999999964 689999999875432  23444444              3444432  3457899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999988765444456789999999999999999999998   99999999999999999999999999987543321


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .    ....++..|+|||.+.+.  .++.++||||+|+++|||++|+.|+.......   ..+......+.......+..
T Consensus       160 ~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd06621         160 A----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPNPELKD  230 (287)
T ss_pred             c----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHHHHHHhcCCchhhcc
Confidence            1    234578899999998753  78899999999999999999999997553210   01111122222211111111


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...........+.+++.+||+.+|.+|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            11111224567899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.6e-33  Score=272.12  Aligned_cols=238  Identities=26%  Similarity=0.329  Sum_probs=178.6

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      ..|++.++||+|+||.||+|+.. +++.||+|.+..... ..+++..|              +++.+......++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            35677889999999999999965 589999999876432 22334333              455566677889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|..++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            999998877432   24689999999999999999999998   999999999999999999999999999875432211


Q ss_pred             ceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          305 FVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                        ......+++.|+|||++...   ...++.++|||||||++|||++|+.|+......        .....+.+......
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  235 (292)
T cd06644         166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPTL  235 (292)
T ss_pred             --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCCCccC
Confidence              11334588899999988531   135688999999999999999999998543211        11112222111111


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          ..+..++..+.+++.+||+.+|++||++.++++
T Consensus       236 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 ----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                112234456888999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.3e-33  Score=272.05  Aligned_cols=229  Identities=25%  Similarity=0.345  Sum_probs=175.3

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecCCCChh
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLD  230 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~  230 (453)
                      .+||+|+||.||++.. .+++.||||.+...... .+.+.+|              +++.+..+...++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            5799999999999985 46899999998653322 2233333              566677788899999999999999


Q ss_pred             hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517          231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD  310 (453)
Q Consensus       231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  310 (453)
                      +++..     ..+++.++..++.+++.||+|||+.   +|+||||||+||+++.++.+||+|||++........  ....
T Consensus       108 ~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~  177 (292)
T cd06658         108 DIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKS  177 (292)
T ss_pred             HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCce
Confidence            87732     3588999999999999999999998   999999999999999999999999999876543221  1233


Q ss_pred             cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHH
Q 048517          311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM  390 (453)
Q Consensus       311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (453)
                      ..|+..|+|||.+.+.  .++.++||||||++++||++|+.|+.......        ....+.........    ....
T Consensus       178 ~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~~  243 (292)
T cd06658         178 LVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------AMRRIRDNLPPRVK----DSHK  243 (292)
T ss_pred             eecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCccc----cccc
Confidence            4688999999998754  68889999999999999999999986432110        11112111111111    1122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          391 IARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       391 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      .+..+..++.+|++.+|++|||++++++.
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            34567889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.1e-33  Score=270.87  Aligned_cols=238  Identities=26%  Similarity=0.325  Sum_probs=176.5

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------Hhcccc------cCcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLCS------EGFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~------~~~~~~  218 (453)
                      ..+.+.+.||+|+||.||+|+. .+++.||+|++........++..|               +++++.      .....+
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            4566778999999999999995 578999999987654333333333               222332      235678


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ++|||+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++..
T Consensus        96 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            999999999999988532  234578888999999999999999998   999999999999999999999999999875


Q ss_pred             cCCCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      ......  ......|+..|+|||.+...   ...++.++||||||+++|||++|+.||.......        ....+..
T Consensus       171 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--------~~~~~~~  240 (282)
T cd06636         171 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPR  240 (282)
T ss_pred             hhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--------hhhhHhh
Confidence            532211  12335688999999987531   2357889999999999999999999986432111        1111111


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .....     ......+..+.+++.+||+.+|.+||++.|+++
T Consensus       241 ~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 NPPPK-----LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCCCC-----CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11111     012234567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.5e-33  Score=272.58  Aligned_cols=230  Identities=25%  Similarity=0.352  Sum_probs=176.7

Q ss_pred             hcccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          166 THKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      ..+||+|+||.||++.. .+++.||||.+..... ..+.+.+|              +++++..+...++++||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            34799999999999985 4789999999865332 22333333              56777778889999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      ..++..     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........  ...
T Consensus       106 ~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  175 (297)
T cd06659         106 TDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK  175 (297)
T ss_pred             HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence            887622     4589999999999999999999998   999999999999999999999999999876543321  123


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ...|+..|+|||++.+.  .++.++||||||++++||++|+.||.......        ....+.........    ...
T Consensus       176 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~  241 (297)
T cd06659         176 SLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPPPKLK----NAH  241 (297)
T ss_pred             ceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCCCcc----ccC
Confidence            45689999999999764  67899999999999999999999986432110        11222221111111    112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          390 MIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      .....+.+++.+||+.+|++||+++++++.
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            234568889999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.1e-33  Score=268.42  Aligned_cols=233  Identities=23%  Similarity=0.349  Sum_probs=179.9

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..|...++||+|+||.||+|... +++.||||.+.....  ....+..|              +++.+..+...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34556688999999999999954 689999999875432  12233333              45566677789999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++..     ..+++.++..++.+++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            999999998732     3588899999999999999999998   99999999999999999999999999997664432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  ......++..|+|||++.+.  ..+.++||||||+++|||++|+.|+.......        ....+.....     
T Consensus       156 ~--~~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~-----  218 (277)
T cd06640         156 I--KRNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLIPKNNP-----  218 (277)
T ss_pred             c--ccccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------HhhhhhcCCC-----
Confidence            1  12334678899999998754  68899999999999999999999986433211        1111111111     


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                       .......+..+.+++.+||+.+|++||++.++++.
T Consensus       219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 -PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence             11233455678899999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.8e-33  Score=268.53  Aligned_cols=235  Identities=26%  Similarity=0.380  Sum_probs=177.1

Q ss_pred             hhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH-------HHHHHH--------------HhcccccCcceEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA-------EEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~-------~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      +...+.||+|+||.||+|...+|+.+|||.+.......       ..+.+|              +.+++.+....++++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            34567899999999999998889999999887532211       122222              456667778889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++....
T Consensus        82 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          82 EFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999998843    24578999999999999999999998   999999999999999999999999999876532


Q ss_pred             CCCc----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          302 ENDF----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       302 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ....    .......|+..|+|||++.+.  .++.++||||||++++||++|+.||.......        .........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYIGAHR  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHH--------HHHHhhhcc
Confidence            1110    111234689999999998764  67899999999999999999999996432211        001111111


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...    ...+..+...+..++.+||+.+|++||++.++++
T Consensus       225 ~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 GLM----PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC----CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            100    0112234567889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.9e-33  Score=271.16  Aligned_cols=246  Identities=23%  Similarity=0.288  Sum_probs=176.9

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |++.+.||+|+||.||+|+.. +|+.||+|++.....   ..+.+..|              +++.+......++||||+
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   82 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC   82 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence            566788999999999999965 689999998865321   12233333              456666777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|...+.    ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        83 ~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          83 DHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             CccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            9998877652    234689999999999999999999997   999999999999999999999999999987654332


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc----hHHHH---HHhhhCC
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF----PSWVY---DQLNKGG  377 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~----~~~~~---~~l~~~~  377 (453)
                        ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||............    ..+..   +......
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             --cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence              11234578899999998653 35788999999999999999999998644321100000    00000   0000000


Q ss_pred             ------Cccccc---hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 ------DLELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ------~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                            ......   .......++..+.+++.+||+.+|++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                  000000   00011223567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3e-33  Score=266.76  Aligned_cols=233  Identities=25%  Similarity=0.342  Sum_probs=179.8

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.++||+|+||.||+++. .+|+.||+|.+.....   ...++..|              +.+++......++|+||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            55678999999999999984 5789999999875322   22233333              455667778899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++...  ....+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          82 EGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999988432  234678999999999999999999998   999999999999999999999999999986644322


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                      .  .....|++.|+|||++.+.  ..+.++|+||||++++||++|+.|+.....       ...+... ..+....    
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~-~~~~~~~----  220 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKI-IRGSYPP----  220 (256)
T ss_pred             h--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHH-hcCCCCC----
Confidence            1  1234588899999998764  678899999999999999999999864321       1112222 2222211    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        .+...+..+.+++.+||+.+|++||++.+|++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              12234567899999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.1e-33  Score=270.18  Aligned_cols=244  Identities=20%  Similarity=0.260  Sum_probs=174.4

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.++||+|+||.||+|+.. +|+.||+|.+......   ...+..|              +++++......++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            456788999999999999954 7999999998643211   1112222              566677778899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      + ++|.+++...   ...+++..+..++.||++||.|||+.   +|+|+||||+||+++.++.+||+|||+++.......
T Consensus        82 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          82 D-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            6 5787776432   24689999999999999999999998   999999999999999999999999999986543221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch----------HHHHHHhh
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----------SWVYDQLN  374 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~----------~~~~~~l~  374 (453)
                        ......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+.......  ..+.          ...+..+.
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVS  229 (284)
T ss_pred             --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhh
Confidence              12345678999999998653 356889999999999999999998864332211  0000          00000010


Q ss_pred             hCCC---c-cccch---hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KGGD---L-ELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~~~---~-~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ....   . .....   ......++..+.+++.+||+.||.+|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000   0 00000   0011224567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-32  Score=271.48  Aligned_cols=185  Identities=24%  Similarity=0.335  Sum_probs=140.2

Q ss_pred             cccCccCceEEEEEEEc---CCcEEEEEEecCCCCCHHHHHHH--------------Hhccc--ccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQLH---TGRLIAVKMMENSKFSAEEFINE--------------LLGLC--SEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~--~~~~~~~lv~E~~~~g  227 (453)
                      .+||+|+||.||+|+..   +++.||+|.+...... ..+.+|              +++++  ..+...++++||+++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            58999999999999865   4578999998764322 222222              23333  234567899999864 


Q ss_pred             Chhhhhhhcc-----CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE----cCCCceEEEecCCccc
Q 048517          228 SLDRHIFSKE-----NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKF  298 (453)
Q Consensus       228 sL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~~  298 (453)
                      +|.+++....     .....+++..+..++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            6766663211     1224588899999999999999999998   99999999999999    5667999999999987


Q ss_pred             cCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517          299 HPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  357 (453)
Q Consensus       299 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~  357 (453)
                      ....... .......||+.|+|||.+.+. ..++.++|||||||++|||+||+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            6433211 122345689999999998753 357899999999999999999999996543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-33  Score=280.70  Aligned_cols=239  Identities=19%  Similarity=0.252  Sum_probs=174.1

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---C-HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---S-AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~-~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |.+.++||+|+||.||+++.. +++.||+|++.....   . ...+..|              +.+.+......++||||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            566789999999999999954 788999999865211   1 1112222              34455677788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          83 YVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999998532   24688999999999999999999998   99999999999999999999999999998665433


Q ss_pred             CceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh-CCCc
Q 048517          304 DFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDL  379 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~  379 (453)
                      .. ......||++|+|||++.+.   .+.++.++||||||+++|||++|+.||......       . ....+.. ....
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~-~~~~i~~~~~~~  227 (331)
T cd05624         157 TV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------E-TYGKIMNHEERF  227 (331)
T ss_pred             ce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------H-HHHHHHcCCCcc
Confidence            22 12335699999999998642   135788999999999999999999999643321       1 1222221 1111


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  419 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~  419 (453)
                      ....   ....++..+.+++.+|++.++++  |++++++++.
T Consensus       228 ~~p~---~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 QFPS---HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cCCC---ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            1111   11223456778888888865544  4678888653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.8e-33  Score=274.20  Aligned_cols=252  Identities=21%  Similarity=0.328  Sum_probs=178.5

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .|.+.++||+|+||.||+|+.. +++.||+|.+.....  ....+..|              +++++......++|+||+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~   86 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   86 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence            4566789999999999999854 689999999875322  22223232              556667777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      + ++|.+++...   ...+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++.......
T Consensus        87 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          87 D-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             c-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            7 6888877432   34688999999999999999999998   999999999999999999999999999976433221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------hHHHHHHh-hhC
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQL-NKG  376 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~l-~~~  376 (453)
                        ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.||............       ....+..+ ...
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             --cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence              12334578999999998753 35788999999999999999999998654321100000       00000000 000


Q ss_pred             C--Cccccc-----hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCC
Q 048517          377 G--DLELRN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS  423 (453)
Q Consensus       377 ~--~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~  423 (453)
                      .  ......     .......++..+.+++.+||+.||.+|||++|+++  .++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            0  000000     00011223456789999999999999999999987  44443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.4e-33  Score=267.34  Aligned_cols=233  Identities=27%  Similarity=0.389  Sum_probs=176.4

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----------HHHHHH--------------HhcccccCcce
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----------EEFINE--------------LLGLCSEGFKR  217 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----------~~~i~e--------------l~g~~~~~~~~  217 (453)
                      +.+...||+|+||.||+|.. .+++.||+|.+.......          +.+..|              +++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            45678899999999999985 468999999886532211          112222              45566677788


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++++||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++
T Consensus        82 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             EEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999998843    24688999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCce----eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh
Q 048517          298 FHPKENDFV----SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       298 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      .........    ......|+..|+|||.+.+.  .++.++||||+|+++|||++|+.||.......        ....+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~  224 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--------AIFKI  224 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--------HHHHH
Confidence            765321110    11234588899999998763  67889999999999999999999996532210        11111


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .......      .+...+..+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GENASPE------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hccCCCc------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            1111111      12234567889999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.5e-33  Score=279.34  Aligned_cols=243  Identities=22%  Similarity=0.208  Sum_probs=171.0

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------Hhccccc------Ccce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSE------GFKR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~------~~~~  217 (453)
                      .|.+.+.||+|+||.||++.. ..++.||||++......   ..++..|              +++++..      ....
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            455678899999999999984 47899999998753222   2233333              3343322      2346


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||+++ +|.+.+.      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        98 ~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          98 YLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             EEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            899999965 5656552      2478899999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc--------ccchH--
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK--------AYFPS--  367 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~--  367 (453)
                      ......   ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........        ...+.  
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         168 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cCCCcc---ccCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            654322   12345689999999999764  6889999999999999999999999643311000        00000  


Q ss_pred             -----HHHHHhhhCCC---cccc---------chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          368 -----WVYDQLNKGGD---LELR---------NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       368 -----~~~~~l~~~~~---~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                           .+.........   ....         ............+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                 00001110000   0000         0000112234568899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-34  Score=269.70  Aligned_cols=244  Identities=22%  Similarity=0.274  Sum_probs=177.0

Q ss_pred             hcccCccCceEEEEEE-EcCCcEEEEEEecC---CCCCHHHHHHHH--------------hccc-----ccCcceEEEEE
Q 048517          166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMEN---SKFSAEEFINEL--------------LGLC-----SEGFKRALVYE  222 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~---~~~~~~~~i~el--------------~g~~-----~~~~~~~lv~E  222 (453)
                      .+.||+|+||.|+.+. ..+|+.||||++..   .....++-.+|+              ....     ..-...++|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            4679999999999998 45899999999874   222333434441              1111     23456789999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      +| .-+|...+.    .+..|+.....-+.+|+++||.|+|+.   +|+|||+||+|+|++.+...||+|||+|+.....
T Consensus       107 lM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  107 LM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             HH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence            99 667777773    334599999999999999999999998   9999999999999999999999999999987543


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHH-------
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSW-------  368 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~-------  368 (453)
                      .....++....|..|.|||.+.. ...++.+.||||.||++.||++|++-|...+.-..-       ..-+..       
T Consensus       179 ~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             CcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            22223466778999999999865 468999999999999999999999988765432110       000011       


Q ss_pred             --HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          369 --VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       369 --~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        +...+..-...........-.......++++.+||..||.+|+|++|.++
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence              11112111111111111111234457889999999999999999999987

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.9e-33  Score=266.90  Aligned_cols=241  Identities=26%  Similarity=0.388  Sum_probs=179.6

Q ss_pred             hhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      +....+||+|+||.||+|+.+      +.+.||+|.+......  .+++..|              +++++......++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (275)
T cd05046           7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI   86 (275)
T ss_pred             ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence            345578999999999999853      3567999988764332  2334443              55677777788999


Q ss_pred             EEecCCCChhhhhhhccCC-----CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          221 YEYMPNGSLDRHIFSKENK-----GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      |||+++|+|.+++......     ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++++|||+
T Consensus        87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~  163 (275)
T cd05046          87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSL  163 (275)
T ss_pred             EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccc
Confidence            9999999999998543311     12689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhh
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      ++....... .......++..|+|||.+.+.  ..+.++||||||++++||++ |..||.......        ......
T Consensus       164 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--------~~~~~~  232 (275)
T cd05046         164 SKDVYNSEY-YKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--------VLNRLQ  232 (275)
T ss_pred             ccccCcccc-cccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchHH--------HHHHHH
Confidence            875432221 122334567789999988753  67889999999999999998 777775332111        122222


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      .+.. ...    .....+..+.+++.+||+.+|++|||+.+++++|.+
T Consensus       233 ~~~~-~~~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         233 AGKL-ELP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             cCCc-CCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1111 110    111234578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=284.06  Aligned_cols=231  Identities=28%  Similarity=0.384  Sum_probs=185.0

Q ss_pred             ccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---------------HHHHHHHHhcccccCcceEEEEEecCCCChhh
Q 048517          168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---------------AEEFINELLGLCSEGFKRALVYEYMPNGSLDR  231 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---------------~~~~i~el~g~~~~~~~~~lv~E~~~~gsL~~  231 (453)
                      .||+|.||+||-|+ .++...+|||.+......               .+..|.+.+|.|++++..-+.||-++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            49999999999999 556778999988652211               23456668999999999999999999999999


Q ss_pred             hhhhccCCCCCC--CchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCCCceee
Q 048517          232 HIFSKENKGQTF--GLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSI  308 (453)
Q Consensus       232 ~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~  308 (453)
                      .|.+..   .++  .+.+.--+.+||++||.|||.+   .|||||||-+|+|++. .|.+||+|||-++....-..  .+
T Consensus       662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~T  733 (1226)
T KOG4279|consen  662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CT  733 (1226)
T ss_pred             HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc--cc
Confidence            885443   455  6777888999999999999998   9999999999999975 78999999999987655443  23


Q ss_pred             cccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhH
Q 048517          309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  388 (453)
Q Consensus       309 ~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  388 (453)
                      .+..||.-|||||++......|..++|||||||++.||.|||+||-.....+.         ....-| ...  -..+.+
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------AMFkVG-myK--vHP~iP  801 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------AMFKVG-MYK--VHPPIP  801 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------hhhhhc-cee--cCCCCc
Confidence            45679999999999987656889999999999999999999999964322110         111111 111  123467


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          389 SMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       389 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+++.+...++++|+.++|.+||+++++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            788889999999999999999999999987

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-33  Score=266.77  Aligned_cols=229  Identities=25%  Similarity=0.291  Sum_probs=174.5

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----HHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----EEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.||+|+||.||+|.. .+|+.||||.+.......    ..+..|               +++.+..+...++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4699999999999985 468999999987543211    111111               45566677788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      ++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+++.....    
T Consensus        82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----  150 (260)
T cd05611          82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----  150 (260)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence            999998843    24688999999999999999999998   9999999999999999999999999998754331    


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                        ....++..|+|||.+.+.  .++.++||||||++++||++|..|+......        -....+..+....   ...
T Consensus       151 --~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~---~~~  215 (260)
T cd05611         151 --KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNILSRRINW---PEE  215 (260)
T ss_pred             --ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcccCC---CCc
Confidence              234588899999998764  5789999999999999999999998643221        1222222221110   011


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      ....++..+.+++.+||+.+|++|||+.++.+.|.
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            11234567899999999999999998877766665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-33  Score=296.71  Aligned_cols=244  Identities=26%  Similarity=0.423  Sum_probs=193.7

Q ss_pred             hhhcccCccCceEEEEEEEc----C----CcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceE
Q 048517          164 HFTHKLGQGGFGSVYKGQLH----T----GRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRA  218 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~----~----g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~  218 (453)
                      .+.+.||+|.||.|++|...    .    ...||||+++.....  .+.+..|               ++|.|..+...+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            45669999999999999843    1    457999999874333  3334333               789999989999


Q ss_pred             EEEEecCCCChhhhhhhcc---CC-------C--CCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC
Q 048517          219 LVYEYMPNGSLDRHIFSKE---NK-------G--QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  286 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~  286 (453)
                      +|.||++.|+|.++|...+   ..       .  ..++...++.++.|||.|++||++.   +++||||..+|||+..+.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence            9999999999999997654   00       1  2388899999999999999999998   999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCceeeccc-CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccccc
Q 048517          287 IPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY  364 (453)
Q Consensus       287 ~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~  364 (453)
                      .+||+|||+|+.......+...... .-...|||||.+...  .++.|+||||||++||||+| |..|+....       
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-------  526 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPGIP-------  526 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCCCC-------
Confidence            9999999999977666555422211 245679999999864  89999999999999999998 667775311       


Q ss_pred             chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          365 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       365 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ...-+.+.+.+|.+.+.+.      ....++.++++.||+.+|++||++.++++.|+..+.
T Consensus       527 ~~~~l~~~l~~G~r~~~P~------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  527 PTEELLEFLKEGNRMEQPE------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             cHHHHHHHHhcCCCCCCCC------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            1222466788887765433      234678899999999999999999999999998543

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-33  Score=269.40  Aligned_cols=238  Identities=23%  Similarity=0.314  Sum_probs=180.4

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      ..|.+.++||+|+||.||+|+.. +++.||+|.+..... ..+.+..|              +++.+..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            35677889999999999999964 689999999875432 23344444              455666777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++...   ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999987432   24689999999999999999999998   999999999999999999999999999876533221


Q ss_pred             ceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          305 FVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                        ......+|+.|+|||.+...   ...++.++||||||+++|||++|+.|+.......        ....+..+....+
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  228 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKILKSEPPTL  228 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHhcCCCCCc
Confidence              11334689999999998532   1356789999999999999999999986432110        1112222211111


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          ..+..++..+.+++.+||+.+|++||++.++++
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         229 ----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             ----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence                112234456888999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.7e-33  Score=264.13  Aligned_cols=232  Identities=28%  Similarity=0.360  Sum_probs=178.1

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC------CHHHHHHH--------------HhcccccCcceEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF------SAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~------~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      +...+.||+|+||.||+|... +++.|++|.+.....      ..+.+..|              +.+++..+...++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            455678999999999999965 799999998865321      12233333              456677778889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++++|.+++..    ...+++..+..++.+++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          82 ELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999998842    24588999999999999999999998   999999999999999999999999999886544


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ..   ......++..|+|||.+... ..++.++|+||||+++++|++|+.||......       .............. 
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~-  222 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKELPP-  222 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcccCCC-
Confidence            32   12345688999999998654 13889999999999999999999998643311       11111111111111 


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           .+..+...+.+++.+||+.+|++||++.++++
T Consensus       223 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 -----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                 12234567888999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.4e-32  Score=268.44  Aligned_cols=247  Identities=25%  Similarity=0.345  Sum_probs=186.8

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .++.+.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+..|              +.+.+......++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            4666778999999999999984 4789999999865332 23334433              456666777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++..     ..+++.++..++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            99999998832     3578999999999999999999998   999999999999999999999999999876544332


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                        ......+++.|+|||.+...  .++.++||||||+++||+++|+.||.........       . .+.......    
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~-~~~~~~~~~----  234 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------Y-LIATNGTPE----  234 (293)
T ss_pred             --ccccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------e-ehhcCCCCC----
Confidence              12334688999999998753  6789999999999999999999999754321100       0 011111111    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhCCCCCCCCCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSIDDLQMPP  431 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~~~~~~~~p~  431 (453)
                      ......+...+.+++.+||+.+|++||++.+++.+  ++......++||
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~  283 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP  283 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence            11122344568889999999999999999999984  555554455544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=263.56  Aligned_cols=239  Identities=23%  Similarity=0.273  Sum_probs=180.0

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .+++.+.||+|+||.||++.. .+++.+|+|.+...... .+.+..|              +++.+..+...+++|||++
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~   83 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG   83 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence            456778999999999999995 46889999998764322 2333333              4556667778899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +++|.+++...   ...+++.++..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++........ 
T Consensus        84 ~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          84 GGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            99999987432   24688999999999999999999998   999999999999999999999999999986543221 


Q ss_pred             eeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          306 VSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                       ......++..|+|||.+... .+.++.++||||||+++|||++|+.|+.......        .......... ... .
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--------~~~~~~~~~~-~~~-~  225 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--------ALFLISKSNF-PPP-K  225 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhccC-CCc-c
Confidence             12345688899999998642 1267889999999999999999999986433111        1111111100 000 0


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .......+..+.+++.+||+.+|.+|||+++++.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1123345567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=266.04  Aligned_cols=232  Identities=23%  Similarity=0.350  Sum_probs=176.2

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH-----------------HhcccccCcceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE-----------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e-----------------l~g~~~~~~~~~lv~E  222 (453)
                      |++.+.||+|+||.||+|.. .+++.||||.+.....  ...++..|                 +++.+..+...+++||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            45667899999999999995 5799999999865322  22233222                 3445566777889999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++++|.+++..     ..+++..++.++.+++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          83 YAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             cCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999988732     3689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......|+..|+|||.+.+. ..++.++||||||+++|+|++|+.|+.......       +. ..+.......+ 
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~-~~~~~~~~~~~-  222 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AM-MLIPKSKPPRL-  222 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hh-hccccCCCCCC-
Confidence            32  12344688999999998642 256889999999999999999999986432211       11 11111111111 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          ........+.+++.+||+.+|++||++.++++
T Consensus       223 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 ----EDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ----CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                01114457889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.2e-33  Score=268.37  Aligned_cols=244  Identities=22%  Similarity=0.318  Sum_probs=179.2

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.+.||+|+||.||+|+. .+|+.||||++.....   ..+.+..|              +++.+..+...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            56778999999999999995 4789999999876432   22334443              455566677889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                       +++|.+++...   ...+++.++..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence             99999987532   25689999999999999999999998   999999999999999999999999999987654322


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC--------
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG--------  376 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~--------  376 (453)
                       .......++..|+|||.+.+. ..++.++||||+|++++||++|++++.......    ....+.+.+...        
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChHHHhhc
Confidence             112345689999999988653 356889999999999999999987775432210    000111111000        


Q ss_pred             ------CCccccc-----hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          377 ------GDLELRN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       377 ------~~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                            .......     ......+....+.+++.+||+.+|++|||++++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  0000000     001112335788999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.2e-32  Score=263.61  Aligned_cols=242  Identities=23%  Similarity=0.297  Sum_probs=181.2

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      +++.+.||+|+||+||+|.. .++..+|+|++.....  ....+..|              +++.+......++++|+++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            56778999999999999994 4788999999876433  22333333              3444556777899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +++|.+++..... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.........
T Consensus        83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          83 GGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             CCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            9999998854321 24689999999999999999999998   9999999999999999999999999999876543322


Q ss_pred             e--eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          306 V--SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       306 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  ......|+..|+|||.+... ...+.++|+||||++++||++|+.|+.......       ...+.+.. .......
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~-~~~~~~~  229 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQN-DPPSLET  229 (267)
T ss_pred             cccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcC-CCCCcCC
Confidence            1  11234588999999998753 367899999999999999999999986432211       01111111 1111110


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      . .....++..+.+++.+||+.+|++|||+.++++
T Consensus       230 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         230 G-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             c-cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0 011245567889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=266.93  Aligned_cols=246  Identities=22%  Similarity=0.275  Sum_probs=176.4

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ++.++||.|++|.||+|..+ +|+.||||++.....   ..+.+.+|              +++++..+...+++|||+ 
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-   80 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-   80 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-
Confidence            45678999999999999854 799999999875321   12233333              567777888899999999 


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +++|.+++....  ...+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||+++....... 
T Consensus        81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             CcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            478988874322  24689999999999999999999998   999999999999999999999999999976533221 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc-------chHHHHHHh-----
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQL-----  373 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-------~~~~~~~~l-----  373 (453)
                       ......++..|+|||++.+. ..++.++||||||+++|||++|+.||...........       ...+.+...     
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             -ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence             12334568899999988653 3568899999999999999999999865432110000       000000000     


Q ss_pred             --hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          374 --NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       374 --~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        .................++..+.+++.+|++.+|++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              000000000011112234467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-32  Score=268.42  Aligned_cols=245  Identities=21%  Similarity=0.303  Sum_probs=173.0

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH---------------HhcccccCcc-----eE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE---------------LLGLCSEGFK-----RA  218 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e---------------l~g~~~~~~~-----~~  218 (453)
                      |...+.||+|+||.||+|... +|+.||||.+.....   ....+..|               +++++.....     .+
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            456688999999999999954 799999998765322   12233333               3334443333     78


Q ss_pred             EEEEecCCCChhhhhhhccCC-CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCc
Q 048517          219 LVYEYMPNGSLDRHIFSKENK-GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLA  296 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla  296 (453)
                      ++|||+++ +|.+++...... ...+++..+..++.||+.||.|||+.   +|+||||||+||+++. ++.+||+|||++
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence            99999985 888887543322 35689999999999999999999998   9999999999999998 899999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      +.......  ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.||........   +. -+...+...
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~-~~~~~~~~~  231 (295)
T cd07837         159 RAFSIPVK--SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LL-HIFKLLGTP  231 (295)
T ss_pred             eecCCCcc--ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HH-HHHHHhCCC
Confidence            86533211  11334578899999988653 3578999999999999999999999864322110   00 000000000


Q ss_pred             CC-----------------ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 GD-----------------LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ~~-----------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..                 .............+..+.+++.+||+.+|.+|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00                 0000000111234567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.2e-32  Score=262.27  Aligned_cols=232  Identities=24%  Similarity=0.367  Sum_probs=176.6

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.+.||+|+||.||++.. .+++.+|||.+......   ..++..|              +++.+..+...++|+||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            45678999999999999985 47899999998764322   2233333              344455667789999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCccccCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~~~~  303 (453)
                      ++++|.+++...  ....+++..+..++.+++.||+|||++   +++|+||||+||+++.+ ..+||+|||++.......
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          82 PGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            999999998542  234689999999999999999999998   99999999999999854 568999999998764432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   .....++..|+|||.+.+.  ..+.++||||||+++|+|++|+.|+.....       ........ ......   
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~-~~~~~~---  220 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIM-SGTFAP---  220 (256)
T ss_pred             c---ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHH-hcCCCC---
Confidence            1   1234588899999998753  678899999999999999999999864321       11122221 111111   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         .+...+..+.+++.+||+.+|++|||+.++++
T Consensus       221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               11224567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-32  Score=262.13  Aligned_cols=236  Identities=27%  Similarity=0.370  Sum_probs=179.9

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      +.+.+.||+|+||.||++... +++.||+|.+.....  ..+++.+|              +++.+......++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            456788999999999999965 789999999876432  22334333              4566667788899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      +++|.+++....   ..+++..+..++.+++.||+|||+ .   +++|+||||+||+++.++.+||+|||.+........
T Consensus        83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          83 GGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999885332   568889999999999999999999 6   999999999999999999999999999876533221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                          ....++..|+|||.+.+.  .++.++||||||+++++|++|+.|+.......  ..... ..+..........   
T Consensus       157 ----~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~~---  224 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPP--DGIFE-LLQYIVNEPPPRL---  224 (265)
T ss_pred             ----hcccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccccc--ccHHH-HHHHHhcCCCCCC---
Confidence                125688899999998764  78899999999999999999999986543211  01111 1122222111111   


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        ....++..+.+++.+||+.+|++|||+.+++.
T Consensus       225 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 --PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             --ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence              11125567889999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-33  Score=267.73  Aligned_cols=250  Identities=25%  Similarity=0.349  Sum_probs=179.0

Q ss_pred             hhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH-------------HhcccccC-------cceEEEEEe
Q 048517          164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE-------------LLGLCSEG-------FKRALVYEY  223 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e-------------l~g~~~~~-------~~~~lv~E~  223 (453)
                      .+.+.||+|.||.||+|+++ |..||||++....  +..+.+|             ++||.-.+       .+++||.+|
T Consensus       214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY  290 (513)
T KOG2052|consen  214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY  290 (513)
T ss_pred             EEEEEecCccccceeecccc-CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence            45578999999999999999 8999999997532  2222222             45554211       257899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC-----CCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG-----CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      .++|||.|||..     ..++-+..++++..+|.||++||-.     ..+.|.|||||+.|||+..|+...|+|+|||..
T Consensus       291 He~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~  365 (513)
T KOG2052|consen  291 HEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  365 (513)
T ss_pred             ccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence            999999999942     5789999999999999999999953     457899999999999999999999999999987


Q ss_pred             cCCCCCce--eecccCCCCCccChhhhcccCC--C--CCccchHHHHHHHHHHHHcCC----------CCCCCCcccccc
Q 048517          299 HPKENDFV--SISDTRGTIGYLAPELISRNFG--T--VSCKSDVYGFGMVLLEMAGGR----------RNSNMNATRSSK  362 (453)
Q Consensus       299 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~--~--~s~k~DV~S~Gvvl~elltg~----------~p~~~~~~~~~~  362 (453)
                      ...+.+..  ..+...||.+|||||++.....  .  --..+||||||.++||+.-+-          .||......  +
T Consensus       366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~--D  443 (513)
T KOG2052|consen  366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS--D  443 (513)
T ss_pred             ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC--C
Confidence            76553322  2355689999999999975311  1  112689999999999997421          344322111  1


Q ss_pred             ccchHHHHHHh-hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          363 AYFPSWVYDQL-NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       363 ~~~~~~~~~~l-~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ..+.. ..+.+ .+..+..+++.. ...+....|.++++.||..+|.-|-|+-.+-+.|.+..+
T Consensus       444 Ps~ee-MrkVVCv~~~RP~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  444 PSFEE-MRKVVCVQKLRPNIPNRW-KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCHHH-HhcceeecccCCCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            11111 11111 112222222222 334566789999999999999999999888888876543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3e-33  Score=283.88  Aligned_cols=188  Identities=27%  Similarity=0.338  Sum_probs=156.4

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHHHHH--------------------HhcccccCc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE--------------------LLGLCSEGF  215 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~i~e--------------------l~g~~~~~~  215 (453)
                      +.+..+|.+.+.||+|+||.|-+|. ..+++.||||++++.+.-..+-..|                    +++++....
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            5555678888999999999999999 5679999999999865544333222                    567778888


Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC--CCceEEEec
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDF  293 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~--~~~~kl~DF  293 (453)
                      +.+||+|.+ .-+|.++|.  .++...|+...+..|+.||+.||.+||+.   +|||+||||+||||.+  ...+||+||
T Consensus       262 HlciVfELL-~~NLYellK--~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLK--NNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             ceeeeehhh-hhhHHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEec
Confidence            999999999 678999884  45567799999999999999999999998   9999999999999964  348999999


Q ss_pred             CCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517          294 GLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  357 (453)
Q Consensus       294 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~  357 (453)
                      |.|......-     ..-.-+..|+|||++.+-  +|+.+.|||||||++.||++|.+-|...+
T Consensus       336 GSSc~~~q~v-----ytYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  336 GSSCFESQRV-----YTYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             ccccccCCcc-----eeeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCC
Confidence            9998765432     234567899999999985  89999999999999999999977665443

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.4e-34  Score=259.20  Aligned_cols=232  Identities=26%  Similarity=0.316  Sum_probs=185.1

Q ss_pred             hcccCccCceEEEEEE-EcCCcEEEEEEecCCC-----CCHHHH----HHH---------------HhcccccCcceEEE
Q 048517          166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSK-----FSAEEF----INE---------------LLGLCSEGFKRALV  220 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~-----~~~~~~----i~e---------------l~g~~~~~~~~~lv  220 (453)
                      ++.||+|..++|-++. ..+|+..|+|++....     ....+.    +.|               |..+++.....++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            4679999999999887 4578999999986521     111111    111               55667777788999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      +|.|+.|.|.++|.    ....++++....|+.|+..|++|||..   +||||||||+|||+|+|.++||+|||.|...+
T Consensus       102 Fdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen  102 FDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence            99999999999994    446799999999999999999999998   99999999999999999999999999999887


Q ss_pred             CCCCceeecccCCCCCccChhhhccc----CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      .+..   ....+|||||+|||.+...    .+.|+...|.|+.||++|.|+.|.+||.-..+        ......+.+|
T Consensus       175 ~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------mlMLR~ImeG  243 (411)
T KOG0599|consen  175 PGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------MLMLRMIMEG  243 (411)
T ss_pred             Cchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HHHHHHHHhc
Confidence            6653   4667899999999988642    35788899999999999999999999853221        1123344444


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +-.   ...+...+++....+++.+|||.||.+|.|++|+++
T Consensus       244 kyq---F~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  244 KYQ---FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ccc---cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            321   122345567778899999999999999999999986

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=284.63  Aligned_cols=234  Identities=24%  Similarity=0.414  Sum_probs=190.0

Q ss_pred             hhhcccCccCceEEEEEEEc--CCc--EEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          164 HFTHKLGQGGFGSVYKGQLH--TGR--LIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~--~g~--~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      .+.++||+|.||.|++|.+.  +|+  .||||.+......  ..+|+.|              |+|+..+ ....+|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            35578999999999999864  454  5899999886554  5678887              5666655 567799999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      ++.|||.+.|..  .....|-...+-.++.|||.|+.||.++   ++|||||..+|+||-....+||+||||.+.....+
T Consensus       192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            999999999965  3456788888999999999999999998   99999999999999999999999999999887666


Q ss_pred             Cceeecc-cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          304 DFVSISD-TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       304 ~~~~~~~-~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      .+..+.. ..-...|.|||.+..  ..++.++|||+|||+||||+| |..|+.....        ..+.+.+++++++. 
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~erLp-  335 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAGERLP-  335 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhccccccCC-
Confidence            5544433 345678999999975  489999999999999999998 5567654332        23666666665543 


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                           -+...++.++++++.||..+|++|||+..+.+.
T Consensus       336 -----RPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  336 -----RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             -----CCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                 334467889999999999999999999999743

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.9e-33  Score=267.53  Aligned_cols=243  Identities=21%  Similarity=0.249  Sum_probs=173.9

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccC--cceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEG--FKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~--~~~~lv~E  222 (453)
                      |++.++||+|+||.||+|+. .+++.||+|.+......  ......|               +++++...  ...++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            35678899999999999995 47899999998763221  1111122               44555555  77899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |++ |+|.+.+...   ...++|.++..++.|++.||+|||+.   +++|+||||+||+++. +.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            996 5887777432   24689999999999999999999998   9999999999999999 99999999999866443


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc--------cccchHHHHHHhh
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--------KAYFPSWVYDQLN  374 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~l~  374 (453)
                      ...   ....++..|+|||.+... +.++.++||||+||++|||++|+.||........        ......| .....
T Consensus       153 ~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  227 (282)
T cd07831         153 PPY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFR  227 (282)
T ss_pred             CCc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhc
Confidence            221   234578899999987543 3578899999999999999999999965432110        0000111 11111


Q ss_pred             hCCCccc--cc-----hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KGGDLEL--RN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~~~~~~--~~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .......  ..     ........+..+.+++.+||+.+|++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            1110000  00     00112234678999999999999999999999976

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-32  Score=265.75  Aligned_cols=240  Identities=21%  Similarity=0.297  Sum_probs=175.9

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |+..+.||.|+||.||+|+.. +|+.||||++......   ...+.+|              +++++..+...++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            345678999999999999854 7899999988753221   1233333              677777888899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      . ++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||+++.......
T Consensus        82 ~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          82 H-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             c-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            5 6888887533  235689999999999999999999998   999999999999999999999999999876543221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC-------
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-------  377 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~-------  377 (453)
                        ......++..|+|||.+.+. ..++.++||||||++++||+||+.||.......       ...+......       
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~  225 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-------QLFRIFRTLGTPDEVVW  225 (284)
T ss_pred             --ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHHHhCCCChhhh
Confidence              12334578899999988653 346889999999999999999999986433211       0111000000       


Q ss_pred             --------------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 --------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 --------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                    .............+...+.+++.+||+.||++|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                          00000000111223456788999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2e-32  Score=261.90  Aligned_cols=238  Identities=27%  Similarity=0.404  Sum_probs=179.2

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |+..+.||+|+||.||+|... +++.||+|.+......   ..++..|              +++.+......++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            556789999999999999854 7899999998875443   2233333              455666677889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++..    ...+++..+..++.++++||.|||+.   +|+|+||+|+||++++++.+||+|||++........
T Consensus        82 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          82 SGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999998843    24588999999999999999999998   999999999999999999999999999987654332


Q ss_pred             cee--ecccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          305 FVS--ISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       305 ~~~--~~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ...  .....++..|+|||++.... ...+.++||||||++++||++|+.||.......      .... .+..+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~-~~~~~~~~~~  227 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMF-HVGAGHKPPI  227 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHH-HHhcCCCCCC
Confidence            111  12346789999999987642 237889999999999999999999986432110      0011 1111111111


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .    ........+.+++.+||+.+|++|||+.+++.
T Consensus       228 ~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 P----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             C----cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1    11123556788999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=273.34  Aligned_cols=251  Identities=22%  Similarity=0.246  Sum_probs=176.2

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC--CCCHHHHHHH--------------Hhccccc-----CcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS--KFSAEEFINE--------------LLGLCSE-----GFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~-----~~~~~l  219 (453)
                      .|.+.++||+|+||.||+|+. .+|+.||||.+...  .....++..|              +++++..     ....++
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   85 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI   85 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence            456678999999999999984 57999999998642  1222333333              3333322     235789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ++||+. ++|.+.+.     ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          86 VQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             Eehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999996 47776662     24689999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh---
Q 048517          300 PKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK---  375 (453)
Q Consensus       300 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~---  375 (453)
                      ....... ......||..|+|||.+.+. ..++.++||||+|++++||++|+.||........    ...+.+.+..   
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~----~~~~~~~~~~~~~  231 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ----LNLILGVLGTPSQ  231 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCCH
Confidence            4332211 11234688999999987543 3678899999999999999999999864321100    0000000000   


Q ss_pred             -----------------CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhCCCCC
Q 048517          376 -----------------GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSIDD  426 (453)
Q Consensus       376 -----------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~~~~~  426 (453)
                                       ................+..+.+++.+||+.+|++|||+.++++.  ++...+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                             00000000000111235678899999999999999999999986  6655444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.2e-33  Score=271.88  Aligned_cols=239  Identities=20%  Similarity=0.228  Sum_probs=178.3

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +++.+.||+|+||.||++... +++.||+|.+.....    ....+..|              +++.+..+...++||||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            456788999999999999954 688999999876432    12233333              44556667778999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++..    ...+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||+++......
T Consensus        83 ~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          83 VEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999843    24689999999999999999999998   99999999999999999999999999987421110


Q ss_pred             C-------------ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH
Q 048517          304 D-------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       304 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  370 (453)
                      .             ........++..|+|||.+...  .++.++|+||||+++|||++|+.||.....        ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~  225 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELF  225 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence            0             0011123578899999998753  688999999999999999999999864321        1122


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      .....+......    .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       226 ~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISDDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhcccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            222221111110    111344668899999999999999998888888875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-34  Score=283.39  Aligned_cols=226  Identities=27%  Similarity=0.374  Sum_probs=179.3

Q ss_pred             cccCccCceEEEEEE-EcCCcEEEEEEecCCCC-CHH---HHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF-SAE---EFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~-~~~---~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      +.||.|+||.||.++ ..+...||||++..+.. ..+   +.+.|              .-|++...+..+|||||| -|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence            579999999999999 55788999999876432 332   22333              356777777889999999 55


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      |-.+.+   +...+++....+..|..+.+.||+|||+.   +.||||||..||||++.+.+||+|||.|......     
T Consensus       111 SAsDll---eVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----  179 (948)
T KOG0577|consen  111 SASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----  179 (948)
T ss_pred             cHHHHH---HHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence            666666   23446789999999999999999999998   9999999999999999999999999999876554     


Q ss_pred             ecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          308 ISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                       ....|||.|||||++.. ..|+|+-|+||||+|++..||..+++|....+.-+        ..-++.+.....+     
T Consensus       180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--------ALYHIAQNesPtL-----  245 (948)
T KOG0577|consen  180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPTL-----  245 (948)
T ss_pred             -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--------HHHHHHhcCCCCC-----
Confidence             34569999999999865 34799999999999999999999999976544221        2234444333222     


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...+.+..++.++..||+.-|.+|||..+++.
T Consensus       246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            23456678999999999999999999988765

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=270.31  Aligned_cols=251  Identities=21%  Similarity=0.276  Sum_probs=175.7

Q ss_pred             hhhhcccCccCceEEEEEEEc---CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccC--cceEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH---TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEG--FKRAL  219 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~--~~~~l  219 (453)
                      |.+.++||+|+||.||+|+..   +++.||+|.+....    ...+....|              +++++...  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            456788999999999999954   58999999987632    112222222              55666666  77899


Q ss_pred             EEEecCCCChhhhhhhccC-CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC----CCceEEEecC
Q 048517          220 VYEYMPNGSLDRHIFSKEN-KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSDFG  294 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~----~~~~kl~DFG  294 (453)
                      ||||+++ +|.+.+..... ....++...+..++.|++.||.|||+.   +|+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 66665533222 224788999999999999999999998   9999999999999999    9999999999


Q ss_pred             CccccCCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-cchHH----
Q 048517          295 LAKFHPKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-YFPSW----  368 (453)
Q Consensus       295 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~----  368 (453)
                      +++....... ........+|..|+|||.+.+. ..++.++||||||++++||++|+.|+.......... .+...    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            9987643322 1122344678999999988653 357889999999999999999999997554332000 00000    


Q ss_pred             HHHHhh---------------------hCCCccccc--hhh-hHH--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          369 VYDQLN---------------------KGGDLELRN--VTE-IES--MIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       369 ~~~~l~---------------------~~~~~~~~~--~~~-~~~--~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +...+.                     .........  ... .+.  ..+..+.+++.+||+.+|++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000                     000000000  000 011  33457889999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-32  Score=266.99  Aligned_cols=227  Identities=25%  Similarity=0.356  Sum_probs=170.4

Q ss_pred             ccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH-----------------HhcccccCcceEEEEEecC
Q 048517          168 KLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE-----------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e-----------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .||+|+||.||++.. .+++.||+|.+......    ...+..+                 +.+.+......++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 56899999988653211    1111111                 2333455667889999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++..    ...+++..+..++.|+++||+|||+.   +|+|+||||+||+++.++.+||+|||+++....... 
T Consensus        81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-  152 (278)
T cd05606          81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (278)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence            9999888732    35699999999999999999999998   999999999999999999999999999875533221 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                         ....|+..|+|||.+.+. ..++.++||||+|++++||++|+.||........     ....... ......     
T Consensus       153 ---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~-~~~~~~-----  217 (278)
T cd05606         153 ---HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT-LTMAVE-----  217 (278)
T ss_pred             ---cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HHHHHHh-hccCCC-----
Confidence               234689999999998642 2578899999999999999999999965422110     0011111 111111     


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                       .+...+..+.+++.+|++.+|.+||     ++.++++
T Consensus       218 -~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         218 -LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             1222356788999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.5e-32  Score=264.12  Aligned_cols=233  Identities=24%  Similarity=0.340  Sum_probs=178.9

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..+.+.++||+|+||.||+|.. .+++.||||++......  ..++.+|              +++.+..+...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            3456678899999999999985 47899999998654321  2233333              45556677788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++.     ...+++..+..++.+++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999998873     24589999999999999999999998   99999999999999999999999999987654322


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  ......++..|+|||.+...  ..+.++||||||++++||++|+.|+.....        ......+.......   
T Consensus       156 ~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~---  220 (277)
T cd06641         156 I--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLIPKNNPPT---  220 (277)
T ss_pred             h--hhccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHHhcCCCCC---
Confidence            1  11334688899999998753  678899999999999999999999864321        11122222221111   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                         ....++..+.+++.+||+.+|++||++.++++.
T Consensus       221 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 ---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               122344668889999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-32  Score=268.54  Aligned_cols=236  Identities=25%  Similarity=0.301  Sum_probs=177.4

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +++.+.||+|+||.||++... +++.||+|.+.......    +.+..|              +++.+..+...++||||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   82 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY   82 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence            456688999999999999965 59999999987644332    223232              45666777788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +.+++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          83 CPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             cCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999987432  335789999999999999999999998   99999999999999999999999999987553221


Q ss_pred             Cce---------------------------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 048517          304 DFV---------------------------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN  356 (453)
Q Consensus       304 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~  356 (453)
                      ...                           ......||..|+|||++.+.  .++.++||||||+++|+|++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            100                           01123578899999999764  6789999999999999999999998644


Q ss_pred             ccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 048517          357 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS----MTKVLE  418 (453)
Q Consensus       357 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs----~~evl~  418 (453)
                      ....       ...+.....  ....    ....++..+.+++.+||+.+|++|||    +.++++
T Consensus       236 ~~~~-------~~~~~~~~~--~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRDE-------TFSNILKKE--VTFP----GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chHH-------HHHHHhcCC--ccCC----CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            3211       011111111  1111    11115567999999999999999999    666555

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.3e-32  Score=263.39  Aligned_cols=224  Identities=21%  Similarity=0.287  Sum_probs=171.7

Q ss_pred             cCccCceEEEEEEE-cCCcEEEEEEecCCCCCH-HHHHHH----------HhcccccCcceEEEEEecCCCChhhhhhhc
Q 048517          169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA-EEFINE----------LLGLCSEGFKRALVYEYMPNGSLDRHIFSK  236 (453)
Q Consensus       169 LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~-~~~i~e----------l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~  236 (453)
                      ||+|+||.||+++. .+++.+|+|.+....... +....+          +++.+......++||||+++|+|.+++...
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~  103 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE  103 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc
Confidence            59999999999985 578999999987643322 222222          455566677889999999999999988432


Q ss_pred             cCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccCCCCCceeecccCCCC
Q 048517          237 ENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISDTRGTI  315 (453)
Q Consensus       237 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~  315 (453)
                          ..++|.++..++.|+++||.|||+.   +++|+||||+||+++.++ .++|+|||+++.....      ....++.
T Consensus       104 ----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~  170 (267)
T PHA03390        104 ----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTL  170 (267)
T ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCC
Confidence                3789999999999999999999998   999999999999999988 9999999998765432      2235889


Q ss_pred             CccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHH
Q 048517          316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKL  395 (453)
Q Consensus       316 ~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l  395 (453)
                      .|+|||++.+.  .++.++||||+|++++||++|+.|+.......  .....+....  . ...      ......+..+
T Consensus       171 ~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--~-~~~------~~~~~~~~~~  237 (267)
T PHA03390        171 DYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ--Q-KKL------PFIKNVSKNA  237 (267)
T ss_pred             cccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh--c-ccC------CcccccCHHH
Confidence            99999999764  68899999999999999999999997432211  1111111111  1 111      1122455678


Q ss_pred             HHHHHHhcccCCCCCCC-HHHHHH
Q 048517          396 CMIGLWCIQVKAADRPS-MTKVLE  418 (453)
Q Consensus       396 ~~l~~~Cl~~~p~~RPs-~~evl~  418 (453)
                      .+++.+||+.+|.+||+ ++++++
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhc
Confidence            99999999999999995 688874

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-33  Score=290.40  Aligned_cols=242  Identities=20%  Similarity=0.231  Sum_probs=180.6

Q ss_pred             hhhcccCccCceEEEEEEEcCC-cEEEEEEecCCCC-CHH------HHHHH------Hhcccc---------c-CcceEE
Q 048517          164 HFTHKLGQGGFGSVYKGQLHTG-RLIAVKMMENSKF-SAE------EFINE------LLGLCS---------E-GFKRAL  219 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~~g-~~VAVK~l~~~~~-~~~------~~i~e------l~g~~~---------~-~~~~~l  219 (453)
                      .+.+.|.+|||+.||.++...+ ..+|+|++..... ..+      ++++.      +++|+.         . ....+|
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            4567899999999999996655 9999998765422 222      22333      233443         1 235679


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      .||||++|+|-+++..+..  ..|++.++++|+.++++|+++||.. .++|||||||-+||||+.+++.||||||.|.-.
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             ehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            9999999999999965543  3499999999999999999999984 778999999999999999999999999998743


Q ss_pred             CCCC-Cceee------cccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517          300 PKEN-DFVSI------SDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  371 (453)
Q Consensus       300 ~~~~-~~~~~------~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  371 (453)
                      -..- .....      -...-|+-|+|||++.-.- -.++.|+|||++||+||-|+....||+....-.           
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----------  265 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----------  265 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----------
Confidence            2211 10000      1224689999999986421 278999999999999999999999997542110           


Q ss_pred             HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                       +..+.-.     ......++..|..|+..||+.+|++||++-+|++.+-.+..
T Consensus       266 -Ilng~Y~-----~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  266 -ILNGNYS-----FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             -EEecccc-----CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence             1111110     11224577889999999999999999999999998765543

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.9e-32  Score=258.20  Aligned_cols=233  Identities=26%  Similarity=0.371  Sum_probs=178.5

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      +.+.+.||+|+||.||+|..+ +|+.||+|.+....   ...+.+..|              +++.+......++++||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            456788999999999999965 68999999986532   122223222              667777888899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~  303 (453)
                      ++++|.+++...  ....+++..+..++.+++.||.|||+.   +++|+||||+||++++++ .+||+|||.+.......
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          82 DGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999988532  234689999999999999999999998   999999999999998875 57999999998664432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      ..  .....|++.|+|||.+...  .++.++||||||++++||++|+.|+.....       ..++...... ....   
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~-~~~~---  221 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQG-YFAP---  221 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhcc-cCCC---
Confidence            21  1234689999999988754  688999999999999999999999864321       1222222221 1111   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         .....+..+.+++.+|++.+|++|||+.++++
T Consensus       222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               11123456889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.4e-32  Score=265.81  Aligned_cols=238  Identities=23%  Similarity=0.359  Sum_probs=176.1

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHH---------------HHHHHhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEE---------------FINELLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~---------------~i~el~g~~~~~~~~~lv~E~  223 (453)
                      .+.+.+.||+|+||.||+|..+ +++.||||.+......  ..+               .+.++++++......+++|||
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   95 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL   95 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence            4566789999999999999976 4899999998753221  111               223367788888889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +. +++.+.+...   ...+++..+..++.+++.||+|||+.  .+|+||||+|+||++++++.+||+|||++.......
T Consensus        96 ~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          96 MS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             cC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            85 5676655332   24789999999999999999999973  289999999999999999999999999997654332


Q ss_pred             CceeecccCCCCCccChhhhcccC--CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      .   .....++..|+|||.+.+..  +.++.++||||||+++|||++|+.|+......     + . .............
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~-~-~~~~~~~~~~~~~  239 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----F-E-VLTKILQEEPPSL  239 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----H-H-HHHHHhcCCCCCC
Confidence            2   12345788999999987542  45789999999999999999999998642211     0 0 1111111111111


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      .    ....+...+.+++.+||+.+|++||++.++++.
T Consensus       240 ~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         240 P----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1    111234568999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.3e-32  Score=262.67  Aligned_cols=233  Identities=27%  Similarity=0.329  Sum_probs=169.5

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC------HHHHHHH--------------Hhccccc--CcceEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS------AEEFINE--------------LLGLCSE--GFKRAL  219 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~------~~~~i~e--------------l~g~~~~--~~~~~l  219 (453)
                      +...+.||+|+||.||++.. .+++.||+|.+......      .+.+.+|              +++++..  +...++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            45568899999999999985 46899999988653211      1223223              2343332  345789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ++||+++++|.+++..    ...+++.....++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++..
T Consensus        84 ~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          84 FMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            9999999999998843    24588999999999999999999987   9999999999999999999999999999765


Q ss_pred             CCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ..... ........++.+|+|||.+.+.  .++.++||||||+++|||++|+.||......       ..+.........
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~~~  227 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTN  227 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCCCC
Confidence            32111 0111234588999999998764  6889999999999999999999998643211       111111111111


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .      ..+......+..++ +||..+|++||+++|+++
T Consensus       228 ~------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 P------QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             C------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1      11223344555565 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=266.45  Aligned_cols=248  Identities=21%  Similarity=0.266  Sum_probs=178.2

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      .|++.++||+|+||.||+|..+ +++.||||.++....   ..+.+..|              +++++..+...++++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            3567789999999999999965 688999998865321   22333333              56777777889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      ++++.+.....    ....+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          82 VERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99877765442    234589999999999999999999998   99999999999999999999999999998765443


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-------cchHHHHHHhhhC
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------YFPSWVYDQLNKG  376 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~~~l~~~  376 (453)
                      .. ......++..|+|||++.+. ..++.++||||||+++|||++|+.|+..........       .++..........
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            21 12345678899999998753 367889999999999999999999886432210000       0000000000000


Q ss_pred             ------CCccccchhh----hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 ------GDLELRNVTE----IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ------~~~~~~~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                            ...+......    .+..++..+.+++.+||+.+|++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                  0000000000    11223677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-32  Score=262.86  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=177.4

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHH-----------------HHHHHHhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAE-----------------EFINELLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~-----------------~~i~el~g~~~~~~~~~lv~E~~  224 (453)
                      |++.+.||+|+||+||+|+.. +++.||||.+.......+                 ..+..+++.+..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            356788999999999999965 588999999876432111                 11223566777788899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                       +|+|.+++....  +..+++.++..++.|++.+|.|||+.   +++|+||+|+||+++.++.++|+|||+++.......
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             889988885432  35789999999999999999999998   999999999999999999999999999986544322


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc---------ccchHHHHHH-hh
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK---------AYFPSWVYDQ-LN  374 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~-l~  374 (453)
                         .....++..|+|||.+.+. ..++.++|+||||++++||++|+.|+.........         ..-..|.... +.
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         155 ---YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             ---cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence               1234578899999988653 36789999999999999999999988654321100         0000010000 00


Q ss_pred             hCCCccccc-----hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KGGDLELRN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~~~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .........     ...........+.+++.+||+.+|++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000     00001112467889999999999999999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3e-32  Score=287.73  Aligned_cols=252  Identities=23%  Similarity=0.240  Sum_probs=162.5

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-C----CcEEEEEEecCCCCCHHHHHHH-------------Hhcc-----cccCcce
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-T----GRLIAVKMMENSKFSAEEFINE-------------LLGL-----CSEGFKR  217 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~----g~~VAVK~l~~~~~~~~~~i~e-------------l~g~-----~~~~~~~  217 (453)
                      ..+.+.++||+|+||.||+|++. +    ++.||||++...... +.++.+             +.++     +..+...
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEY  210 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHHHHHhhchhhHHHHHHhhhcccccccCCce
Confidence            34566789999999999999964 5    789999988653221 111111             1111     2455678


Q ss_pred             EEEEEecCCCChhhhhhhccCC----------------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceE
Q 048517          218 ALVYEYMPNGSLDRHIFSKENK----------------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNIL  281 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIL  281 (453)
                      ++|+||+++++|.+++......                ........+..++.|++.||+|||+.   +|+||||||+|||
T Consensus       211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL  287 (566)
T PLN03225        211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII  287 (566)
T ss_pred             EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence            9999999999999888533210                01112334567999999999999998   9999999999999


Q ss_pred             EcC-CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCC--------------------CCCccchHHHHH
Q 048517          282 LDH-NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG--------------------TVSCKSDVYGFG  340 (453)
Q Consensus       282 l~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~s~k~DV~S~G  340 (453)
                      ++. ++.+||+|||+|+......... .....+|+.|+|||.+.....                    .++.++||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            986 6899999999998654332221 234578999999996642111                    234567999999


Q ss_pred             HHHHHHHcCCCCCCCCccc------cccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 048517          341 MVLLEMAGGRRNSNMNATR------SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT  414 (453)
Q Consensus       341 vvl~elltg~~p~~~~~~~------~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  414 (453)
                      |+||||+++..+.+.....      .....+..|... +......+.....+..........+++.+||+.||++|||+.
T Consensus       367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~  445 (566)
T PLN03225        367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK  445 (566)
T ss_pred             HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence            9999999876554321100      000111111110 000000000000000011123455899999999999999999


Q ss_pred             HHHH
Q 048517          415 KVLE  418 (453)
Q Consensus       415 evl~  418 (453)
                      ++++
T Consensus       446 e~L~  449 (566)
T PLN03225        446 AALA  449 (566)
T ss_pred             HHhC
Confidence            9987

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-32  Score=271.68  Aligned_cols=238  Identities=25%  Similarity=0.322  Sum_probs=190.4

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH---------------HhcccccCcc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE---------------LLGLCSEGFK  216 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e---------------l~g~~~~~~~  216 (453)
                      +-....|.+.+.||+|.||.||+++.+ +|+.+|+|.+.+....    .+...+|               +.+.+.....
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            344556778899999999999999965 5999999999874432    1233222               4566777788


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC----CCceEEEe
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSD  292 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~----~~~~kl~D  292 (453)
                      .++|||++.+|.|.+.+...     .++...+..++.|++.++.|||+.   +|+||||||+|+|+..    ++.+|++|
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEee
Confidence            89999999999999999644     399999999999999999999997   9999999999999954    35799999


Q ss_pred             cCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517          293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  372 (453)
Q Consensus       293 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  372 (453)
                      ||++.......   ......||+.|+|||++...  .++..+||||+|+++|.|++|.+||.......        ....
T Consensus       183 FGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------~~~~  249 (382)
T KOG0032|consen  183 FGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------IFLA  249 (382)
T ss_pred             CCCceEccCCc---eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhH--------HHHH
Confidence            99999876632   34678899999999999853  89999999999999999999999998655322        1223


Q ss_pred             hhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       373 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +..+..   ....+....++....+++..|+..||.+|+|+.++++
T Consensus       250 i~~~~~---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  250 ILRGDF---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHcCCC---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            333222   1112234456778899999999999999999999998

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-33  Score=268.97  Aligned_cols=242  Identities=26%  Similarity=0.309  Sum_probs=175.0

Q ss_pred             hhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHH-HHHHH--------Hhccccc---C--cceEEEEEecCCC
Q 048517          165 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAE-EFINE--------LLGLCSE---G--FKRALVYEYMPNG  227 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~-~~i~e--------l~g~~~~---~--~~~~lv~E~~~~g  227 (453)
                      -.+.+|.|+||.||+|++. +++.||||+.-.++.  +.| +++.+        |.-++..   .  -...+|||||+. 
T Consensus        28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-  106 (364)
T KOG0658|consen   28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-  106 (364)
T ss_pred             eeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-
Confidence            3478999999999999955 679999998765433  222 23332        2223221   1  134589999964 


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCccccCCCCCce
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~~~~~~~  306 (453)
                      +|.+.+......+..++...+.-+..||.+||.|||+.   +|+||||||+|+|+|.+ +.+||||||.|+....++.. 
T Consensus       107 tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn-  182 (364)
T KOG0658|consen  107 TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN-  182 (364)
T ss_pred             HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc-
Confidence            88888865444557788888999999999999999997   99999999999999976 99999999999987665533 


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC--------
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD--------  378 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~--------  378 (453)
                        ..-.-|..|+|||.+.+. ..|+.+.||||.||++.||+-|++-|........    -..+.+.+....+        
T Consensus       183 --iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ----L~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  183 --ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ----LVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             --eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH----HHHHHHHhCCCCHHHHhhcCc
Confidence              233568899999999886 5899999999999999999999998876443211    0111111111100        


Q ss_pred             -------ccccchh--h-hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 -------LELRNVT--E-IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 -------~~~~~~~--~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                             ..+....  . .......+..+++.++++.+|.+|.++.|++.
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                   0000000  0 22334567899999999999999999999886

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.6e-32  Score=266.24  Aligned_cols=235  Identities=26%  Similarity=0.325  Sum_probs=177.2

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .+...+.||+|+||.||+++. .+|+.||+|.+.......    .++..|              +++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            355667899999999999995 478999999987543221    233333              4556667778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+. |+|.+.+...   ...++|.++..++.+++.||.|||+.   +|+|+||+|+||+++.++.+||+|||++......
T Consensus       106 ~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            996 5777766432   35689999999999999999999998   9999999999999999999999999998754332


Q ss_pred             CCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                            ....|+..|+|||.+.. ..+.++.++||||||+++|||++|+.|+.......        ....+........
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  244 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPTL  244 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhccCCCC
Confidence                  23468899999999753 22468899999999999999999999986432110        1112222111111


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                           ........+.+++.+||+.+|++||++.++++.+.-
T Consensus       245 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         245 -----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             -----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence                 112244568899999999999999999999986554

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.7e-32  Score=263.63  Aligned_cols=229  Identities=25%  Similarity=0.332  Sum_probs=175.7

Q ss_pred             hcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          166 THKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      .+.||+|++|.||++.. .+++.||+|.+...... .+.+.+|              +++++......++++||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            46899999999999985 57899999988653322 2333333              34455667788999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      .+++..     ..+++.++..++.+++.||+|||+.   +|+||||+|+||+++.++.++|+|||++........  ...
T Consensus       104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~  173 (285)
T cd06648         104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK  173 (285)
T ss_pred             HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence            998843     4589999999999999999999998   999999999999999999999999999876543221  123


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ...|+..|+|||.+.+.  .++.++||||||++++||++|+.|+......        .....+.........    ...
T Consensus       174 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----~~~  239 (285)
T cd06648         174 SLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDNLPPKLK----NLH  239 (285)
T ss_pred             cccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhcCCCCCc----ccc
Confidence            34689999999998764  6889999999999999999999998643211        112222222111111    111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          390 MIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .++..+.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            24467899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.5e-32  Score=257.51  Aligned_cols=233  Identities=30%  Similarity=0.410  Sum_probs=182.3

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      +++.++||+|+||.||+++. .+++.+|+|.+......   ..++..|              +.+.+......++|+||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            45678999999999999984 47889999998764322   2233333              455666677889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++.........+++..+..++.+++.||+|||+.   +++|+||+|+||+++.++.+||+|||+++...... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-  157 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-  157 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence            99999999865444456789999999999999999999998   99999999999999999999999999998765542 


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                         .....++..|+|||.+.+.  .++.++|+||+|++++||++|+.|+......       . .......+....    
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~----  220 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------D-LRYKVQRGKYPP----  220 (256)
T ss_pred             ---cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhcCCCCC----
Confidence               1334588899999998764  6788999999999999999999998643311       0 111222221111    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        .+......+.+++.+|++.+|++|||+.++++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 --IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             --CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              22245567899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2e-32  Score=266.13  Aligned_cols=241  Identities=22%  Similarity=0.286  Sum_probs=178.6

Q ss_pred             hhhhcccCccCceEEEEEEE----cCCcEEEEEEecCCCC-----CHHHHHHH---------------HhcccccCcceE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF-----SAEEFINE---------------LLGLCSEGFKRA  218 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~-----~~~~~i~e---------------l~g~~~~~~~~~  218 (453)
                      +.+.+.||+|+||.||+++.    .+++.||||.+.....     ..+.+..|               +.+.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            45668899999999999974    3578899999875321     11222222               444555667788


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+++|+|.+++..    ...+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||+++.
T Consensus        82 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          82 LILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999998843    24688999999999999999999997   999999999999999999999999999986


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ........ .....|+..|+|||.+.+.....+.++||||||++++||++|+.|+.......   .... ..........
T Consensus       155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~-~~~~~~~~~~  229 (288)
T cd05583         155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSE-ISRRILKSKP  229 (288)
T ss_pred             cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHH-HHHHHHccCC
Confidence            54433211 12345889999999987643347889999999999999999999986432211   0111 1111111111


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                       .      .+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       230 -~------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         230 -P------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -C------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence             1      112234567889999999999999999999888874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.2e-32  Score=266.69  Aligned_cols=233  Identities=27%  Similarity=0.331  Sum_probs=175.8

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC-H---HHHHHH--------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS-A---EEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~-~---~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ..|.+.++||+|+||.||+|+.. +|+.||+|.+...... .   .++.+|              +.++|......++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            34667789999999999999954 7899999988653221 1   234343              455666777889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+. |++.+.+...   ...+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.+||+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9996 6776665322   24689999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      .      ....++..|+|||.+.+ ..+.++.++||||||+++|||++|+.|+.......       ... .+.......
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~-~~~~~~~~~  233 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALY-HIAQNDSPT  233 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHH-HHhcCCCCC
Confidence            2      23457889999998753 12468889999999999999999999986432111       111 111111111


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      .     .....+..+.+++.+||+.+|++||++.+++..
T Consensus       234 ~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         234 L-----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             C-----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            1     122345678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=266.53  Aligned_cols=244  Identities=24%  Similarity=0.361  Sum_probs=173.1

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .|.+.+.||+|+||.||+|+.. +++.||||.+......  ...+.+|              +.+++..+...++||||+
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL   85 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence            3556789999999999999965 7899999998653221  1222222              456777778899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      + ++|.+++...   ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++.......
T Consensus        86 ~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          86 D-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             C-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            7 4898877432   24688999999999999999999998   999999999999999999999999999875432211


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC--------
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG--------  376 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~--------  376 (453)
                        ......++..|+|||.+.+. ..++.++||||+|+++|||++|+.||........+   ...+.+.+...        
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ---LHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             --cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH---HHHHHHhcCCCChhhhhhh
Confidence              11233568899999988653 35788999999999999999999998643311000   00000000000        


Q ss_pred             ------C--Cccc---cchhhhHHHHH--HHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 ------G--DLEL---RNVTEIESMIA--RKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ------~--~~~~---~~~~~~~~~~~--~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                            .  ....   ...........  ..+.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                  0  0000   00000000112  56778999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-32  Score=263.27  Aligned_cols=242  Identities=24%  Similarity=0.290  Sum_probs=175.3

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccC--cceEEEEEe
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEG--FKRALVYEY  223 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~--~~~~lv~E~  223 (453)
                      ++.++||+|+||.||+|+.. +|+.+|+|.+....   .....+..|              +.+++...  ...++|+||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            45678999999999999965 68999999998652   122333333              45566655  788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      ++ ++|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.......
T Consensus        82 ~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          82 MD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            97 4888877432   24789999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-------
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-------  376 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-------  376 (453)
                      . .......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+........   + ..+.+.....       
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~-~~~~~~~~~~~~~~~~~  228 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---L-EKIFELCGSPTDENWPG  228 (287)
T ss_pred             c-ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---H-HHHHHHhCCCchhhccc
Confidence            1 112334578899999987653 3578899999999999999999999865432110   0 0011100000       


Q ss_pred             ---------CCcccc---chhhhHHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 ---------GDLELR---NVTEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ---------~~~~~~---~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                               ......   ...+.... ++..+.+++.+||+.+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                     000000   00001111 2567899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-32  Score=258.31  Aligned_cols=238  Identities=24%  Similarity=0.270  Sum_probs=175.2

Q ss_pred             hcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH------HHHHHHHhcc-------------cccCcceEEEEEecC
Q 048517          166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA------EEFINELLGL-------------CSEGFKRALVYEYMP  225 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~------~~~i~el~g~-------------~~~~~~~~lv~E~~~  225 (453)
                      .++|++|.||.||+|+ .++++.||+|+++.++...      -+-|+-|...             ..+-+..++|||||+
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E  160 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE  160 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence            4689999999999999 5589999999998754211      1112222111             123345899999996


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      . +|...+...   +..++..++.-+..|+++|++|||..   -|+||||||+|+|+...|.+||+|||+||.+....  
T Consensus       161 h-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--  231 (419)
T KOG0663|consen  161 H-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL--  231 (419)
T ss_pred             h-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc--
Confidence            5 677777433   36899999999999999999999998   99999999999999999999999999999886543  


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC--------
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG--------  377 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~--------  377 (453)
                      ...+...-|..|.|||.+.+. ..|+...|+||+||++.||+++++-|....+-..    -..+...+....        
T Consensus       232 k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ----l~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ----LDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH----HHHHHHHhCCCccccCCCcc
Confidence            245667889999999999885 6899999999999999999999988865543210    111111111100        


Q ss_pred             --------------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 --------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 --------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                    ...++..... ..+++.-.+++...+..||.+|.|+++.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~-~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGA-LSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccc-cccchhHHHHHHHHhccCccccccHHHhhc
Confidence                          0000000000 003456678889999999999999999987

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.6e-32  Score=258.32  Aligned_cols=237  Identities=26%  Similarity=0.392  Sum_probs=178.0

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-------HHHHHHH--------------HhcccccCcceEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-------AEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-------~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      |...+.||+|+||.||+|.. .+++.||+|.+......       .+++..|              +++.+.+....++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            34557899999999999984 57899999998753211       1223333              56777788889999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCcccc
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFH  299 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~  299 (453)
                      +||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++ .+||+|||++...
T Consensus        82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          82 VEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999998843    24688999999999999999999998   999999999999998775 6999999999766


Q ss_pred             CCCCCce--eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          300 PKENDFV--SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       300 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      .......  ......+|..|+|||.+.+.  .++.++||||+|++++||++|+.|+.......    .............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~  228 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN----HLALIFKIASATT  228 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcc----hHHHHHHHhccCC
Confidence            4331110  11234578899999998754  67899999999999999999999986432211    0111111111111


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .      ...+......+.+++.+|++.+|++|||+.++++
T Consensus       229 ~------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 A------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             C------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            1      1133345677889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-34  Score=262.52  Aligned_cols=235  Identities=25%  Similarity=0.359  Sum_probs=185.0

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ...+..+||+|+||.||++.+ .+|+.||||.+.... ...+.+.|              .+|.+-....+++|||||..
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            345668999999999999985 479999999987643 33444444              56766777889999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |++.+.+..   ..++|+..++..++...++||+|||.-   .-+|||||..||||+.+|.+||+|||.|-.....  ..
T Consensus       113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA  184 (502)
T KOG0574|consen  113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA  184 (502)
T ss_pred             CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence            999998843   347899999999999999999999986   8899999999999999999999999999765432  11


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ..+...||+.|||||++..-  .|..++||||+|+...||..|++|+.....-  ...|      .+..    .......
T Consensus       185 KRNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--RAIF------MIPT----~PPPTF~  250 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPM--RAIF------MIPT----KPPPTFK  250 (502)
T ss_pred             hhCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCccccccc--ceeE------eccC----CCCCCCC
Confidence            23556799999999999874  7899999999999999999999998643210  0000      0000    0111112


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      -+.+.+..+.++++.||-.+|++|-|+.++++.
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            455667789999999999999999999888763

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.6e-32  Score=258.35  Aligned_cols=231  Identities=23%  Similarity=0.333  Sum_probs=176.3

Q ss_pred             cCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHH--------------HHhcccccCcceEEEEEecCCCCh
Q 048517          169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFIN--------------ELLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       169 LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~--------------el~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      ||.|+||.||+++.. +|+.+|+|.+.....    ..+.+..              ++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            699999999999976 599999999876432    1222222              255666777889999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC-----
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-----  304 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~-----  304 (453)
                      .+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9988532    3689999999999999999999998   999999999999999999999999999886543321     


Q ss_pred             -ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          305 -FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       305 -~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                       ........++..|+|||.....  ..+.++||||||++++||++|+.|+......        -....+..+.. ....
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~-~~~~  222 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILNGKI-EWPE  222 (265)
T ss_pred             ccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCc-CCCc
Confidence             0112334578899999998764  5788999999999999999999998644321        12222222211 1111


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                          ....+..+..++.+||+.+|++|||+.++.+.|+
T Consensus       223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 ----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                1113567889999999999999999977777775

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-31  Score=259.73  Aligned_cols=241  Identities=21%  Similarity=0.266  Sum_probs=178.1

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ...+.||+|++|.||+|..+ +|+.+|+|.+......   ...+..|              +++.+..+...++++||++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD   81 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence            45678999999999999954 7899999998764332   2223222              4566777788999999997


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      + +|.+++...   ...+++..+..++.+++.||.|||+.   +|+|+||||+||+++.++.+||+|||.+........ 
T Consensus        82 ~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          82 T-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             C-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            5 887777432   25789999999999999999999998   999999999999999999999999999987654431 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC---------
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG---------  376 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~---------  376 (453)
                       ......++..|+|||.+.+. ...+.++|+||+|+++++|++|+.||........    ...+.+.+...         
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ----LFKIFRTLGTPDPEVWPKFT  227 (283)
T ss_pred             -cccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCchHhcccch
Confidence             12334578899999998753 3678999999999999999999998865432110    00000000000         


Q ss_pred             ----------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 ----------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ----------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                ...............+..+.+++.+||+.+|.+||++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      000000111223446778999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.3e-32  Score=257.87  Aligned_cols=235  Identities=27%  Similarity=0.373  Sum_probs=182.9

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      +++.+.||+|++|.||+++.. +++.||||++.....  ..+++..|              +++++......++++||++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            356689999999999999965 599999999877543  23445444              3455667778899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      +++|.+++...    ..+++..++.++.|+++||+|||+ .   +++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          83 GGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            99999998432    568999999999999999999999 7   999999999999999999999999999987654332


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                      .  .....++..|+|||.+...  .++.++|+||||+++|||++|+.|+......    .... ....+.......    
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~-~~~~~~~~~~~~----  222 (264)
T cd06623         156 Q--CNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFE-LMQAICDGPPPS----  222 (264)
T ss_pred             c--ccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHH-HHHHHhcCCCCC----
Confidence            1  1234588899999998764  7888999999999999999999998654321    1111 112222211111    


Q ss_pred             hhhHHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          385 TEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       385 ~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                        .... ++..+.+++.+||+.+|++|||+.++++.
T Consensus       223 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 --LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              1122 55679999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.9e-32  Score=262.62  Aligned_cols=235  Identities=29%  Similarity=0.361  Sum_probs=180.9

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .+.+.+.||+|+||.||+|..+ +++.||+|.+.......+++..|              +++.+......++++||+++
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   99 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG   99 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence            3556688999999999999976 78999999998654444455444              34455666788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      ++|.+++....   ..+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.+||+|||++........  
T Consensus       100 ~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  171 (286)
T cd06614         100 GSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--  171 (286)
T ss_pred             CcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence            99999985432   4799999999999999999999997   999999999999999999999999999875543221  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++|+.|+.......        ....+........    .
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~----~  237 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--------ALFLITTKGIPPL----K  237 (286)
T ss_pred             hhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCCC----c
Confidence            11234578899999998754  67899999999999999999999986432110        1111111111111    1


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ....+...+.+++.+||+.+|.+|||+.++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            12224567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.5e-32  Score=254.26  Aligned_cols=233  Identities=28%  Similarity=0.423  Sum_probs=179.2

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      |...+.||+|++|.||++... +++.+++|++..... ...++.+|              +.+.+......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            345678999999999999965 789999999977543 33344444              34555666778999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      ++|.+++...   ...+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+........  
T Consensus        82 ~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          82 GSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            9999987432   25789999999999999999999997   999999999999999999999999999987654431  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                       .....++..|+|||.+...  ..+.++||||||+++++|++|+.|+......       ..... ..........    
T Consensus       154 -~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~-~~~~~~~~~~----  218 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFK-IATNGPPGLR----  218 (253)
T ss_pred             -ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHH-HHhcCCCCcC----
Confidence             2344688899999998764  5788999999999999999999998643211       11111 1111111111    


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ....+...+.+++.+||+.+|++|||+.++++
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11112467899999999999999999999976

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.2e-32  Score=258.93  Aligned_cols=233  Identities=24%  Similarity=0.287  Sum_probs=170.2

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---C---HHHHHHH--------------Hhccccc--CcceEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---S---AEEFINE--------------LLGLCSE--GFKRAL  219 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~---~~~~i~e--------------l~g~~~~--~~~~~l  219 (453)
                      +...+.||+|+||.||+|... +|+.||||.+.....   .   .+.+..|              +.+++.+  ....++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            345688999999999999954 689999998754211   1   1222223              2343433  345779


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ++||+++++|.+++...    ..+++.....++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          84 FMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            99999999999988432    3578889999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ...... .......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+.......       -..+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~  227 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIATQPTN  227 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------HHHHHhcCCCC
Confidence            322111 112234588999999998764  68899999999999999999999986432110       01111111111


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                            ...+......+..++.+|+. +|++||+++++++
T Consensus       228 ------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         228 ------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                  11233455677888889985 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.6e-32  Score=268.58  Aligned_cols=252  Identities=21%  Similarity=0.261  Sum_probs=176.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC---CCCHHHHHHH--------------HhcccccC-----cceE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS---KFSAEEFINE--------------LLGLCSEG-----FKRA  218 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~i~e--------------l~g~~~~~-----~~~~  218 (453)
                      .|...+.||+|+||+||+|+. .+|+.||||.+...   .....++..|              +++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            355667899999999999984 57999999988652   1122233233              34444322     2478


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +++||+. ++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.
T Consensus        86 lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          86 IVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            9999995 68887773    235689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------------
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------------  365 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------------  365 (453)
                      ......  ......++..|+|||.+... ..++.++||||||++++||++|+.||............             
T Consensus       158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         158 TSEKGD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             cCCCcc--cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            644321  12334578899999988653 35889999999999999999999998643211000000             


Q ss_pred             ---hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhCCC
Q 048517          366 ---PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSI  424 (453)
Q Consensus       366 ---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~~~  424 (453)
                         .....+.+..................+..+.+++.+||+.+|++|||++++++.  ++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence               000000110000000000011122345678999999999999999999999986  65543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.1e-32  Score=259.41  Aligned_cols=231  Identities=25%  Similarity=0.329  Sum_probs=179.5

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |++.+.||+|+||.||+++.. +++.||+|.+.....    ..+++..|              +++++..+...++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            456789999999999999965 689999999875321    22333333              56677778889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++...    ..+++..+..++.++++||.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          82 LLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999988432    4788999999999999999999998   99999999999999999999999999998665432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                         ......|+..|+|||.+...  ..+.++|+||||+++++|++|+.|+......     ...+....... ...    
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~----  219 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET-ADV----  219 (258)
T ss_pred             ---cccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc-ccc----
Confidence               12345688899999998764  5889999999999999999999998755432     11112222111 111    


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSM--TKVL  417 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~--~evl  417 (453)
                        ..+...+..+.+++.+||+.+|.+||++  +|++
T Consensus       220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              1222344778899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5e-32  Score=263.20  Aligned_cols=237  Identities=27%  Similarity=0.359  Sum_probs=171.4

Q ss_pred             hhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceEEEEEecC
Q 048517          164 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .+.++||+|+||.||++.. .+|+.||+|.+......  ..++..|               +++++......+++|||+.
T Consensus         7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~   86 (288)
T cd06616           7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD   86 (288)
T ss_pred             HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence            3457899999999999985 46899999998753322  2233333               3455556667889999985


Q ss_pred             CCChhhhhhh-ccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          226 NGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       226 ~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                       +++.+.... .......+++..+..++.+++.||+|||+.  .+++||||||+||+++.++.+||+|||+++.......
T Consensus        87 -~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd06616          87 -ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA  163 (288)
T ss_pred             -CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence             455443211 112235689999999999999999999974  3899999999999999999999999999976543221


Q ss_pred             ceeecccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh---CCCcc
Q 048517          305 FVSISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK---GGDLE  380 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~---~~~~~  380 (453)
                         .....|+..|+|||.+.... ..++.++||||||+++|||++|+.||.....          ..+.+.+   +....
T Consensus       164 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~~~~~  230 (288)
T cd06616         164 ---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------VFDQLTQVVKGDPPI  230 (288)
T ss_pred             ---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------HHHHHhhhcCCCCCc
Confidence               12346889999999987531 2578899999999999999999999864321          1111111   11111


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +.  ......++..+.+++.+||+.+|++|||+.+|++
T Consensus       231 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         231 LS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11  1111235567899999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.98  E-value=6.9e-32  Score=262.88  Aligned_cols=227  Identities=28%  Similarity=0.395  Sum_probs=176.3

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |.+.+.||+|+||.||++... +++.||+|.+.....    ..+.+..|              +++++..+...++||||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            556789999999999999954 689999999875321    12223332              45566677788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+++..... 
T Consensus        83 ~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          83 VPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            9999999988432    5689999999999999999999998   9999999999999999999999999999876443 


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                          .....+++.|+|||.+...  ..+.++||||||++++||++|+.|+.....        ......+..+. ..   
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~-~~---  216 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGK-VR---  216 (290)
T ss_pred             ----CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCC-cc---
Confidence                1334688999999998754  678899999999999999999999864331        11222222221 11   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                         .+...+..+.+++.+||+.+|.+||     +++|+++
T Consensus       217 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 ---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               1122346788999999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=1e-31  Score=255.32  Aligned_cols=235  Identities=29%  Similarity=0.415  Sum_probs=182.2

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.+.||+|+||.||++... +++.||+|.+.....   ...++..|              +.+.+..+...++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            456678999999999999954 789999999876433   22233333              234445567789999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++.........+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            99999998865443457899999999999999999999998   999999999999999999999999999987654431


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                        ......|++.|+|||.+...  .++.++||||+|+++++|++|+.|+......        -+...+.......+   
T Consensus       159 --~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~---  223 (258)
T cd08215         159 --LAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQYPPI---  223 (258)
T ss_pred             --eecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCCCCCC---
Confidence              22344688899999988764  6889999999999999999999998643211        12222222222211   


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         +......+.+++.+||+.+|++|||+.++++
T Consensus       224 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 ---PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               1134467889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.98  E-value=3.4e-32  Score=264.91  Aligned_cols=245  Identities=23%  Similarity=0.289  Sum_probs=170.6

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      |.+.+.||+|+||.||+|.. .+|+.||+|.+......  ...+.+|              +.+++..+...++|+||+.
T Consensus         7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07870           7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH   86 (291)
T ss_pred             eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence            45668899999999999985 47899999998653221  1222232              3455666778899999995


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                       ++|.+++...   ...+.+..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++....... 
T Consensus        87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  158 (291)
T cd07870          87 -TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-  158 (291)
T ss_pred             -CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence             6777766432   24578888999999999999999998   999999999999999999999999999975433221 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHH---------HHHHhhh-
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW---------VYDQLNK-  375 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---------~~~~l~~-  375 (453)
                       ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||....... +.....|         ....+.. 
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             -CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCCChhhhhhhhhc
Confidence             11334578999999998653 357889999999999999999999986443210 0000000         0000000 


Q ss_pred             --CCC----cc-ccchhhhH--HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 --GGD----LE-LRNVTEIE--SMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 --~~~----~~-~~~~~~~~--~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        ...    .. ........  ......+.+++.+|++.||.+|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence              000    00 00000000  011346778999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=2e-31  Score=262.34  Aligned_cols=248  Identities=17%  Similarity=0.169  Sum_probs=172.6

Q ss_pred             hhcccCccCceEEEEEEEcCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      +.+.+|.|+++.||++.. +++.||||++.....   ..+.+..|              +++.+......+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344556666666666655 699999999875422   22233333              566677778899999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc--
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF--  305 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~--  305 (453)
                      +|.+++...  ....+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+|++|||.+.........  
T Consensus        85 ~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          85 SCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            999988543  234588899999999999999999998   9999999999999999999999999988754322110  


Q ss_pred             ---eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-----ccchHHH----HHH-
Q 048517          306 ---VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-----AYFPSWV----YDQ-  372 (453)
Q Consensus       306 ---~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-----~~~~~~~----~~~-  372 (453)
                         .......++..|+|||++......++.++||||||+++|||++|+.||.........     ...+.+.    ... 
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence               011234577899999998764346888999999999999999999999754321100     0000000    000 


Q ss_pred             ---hhh----CCC--ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          373 ---LNK----GGD--LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       373 ---l~~----~~~--~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         ...    ...  ............+...+.+++.+||+.+|++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence               000    000  0000011123345567889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.98  E-value=8.6e-32  Score=260.73  Aligned_cols=248  Identities=22%  Similarity=0.310  Sum_probs=177.3

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      |++.++||+|++|.||+|+.. +|+.||||.+.....  ..+.+..|              +++++......++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            456789999999999999965 689999999876422  22233333              5666777778899999998


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      + +|.+++.... ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||+++....... 
T Consensus        82 ~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          82 K-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             c-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            4 8888774432 234689999999999999999999998   999999999999999999999999999976533221 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------hHHHHHHhhhCCC
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNKGGD  378 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~l~~~~~  378 (453)
                       ......++..|++||++.+. ..++.++||||||+++|||++|+.|+............       ....++.+.....
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             12334578899999998653 35688999999999999999999998654321100000       0000011111000


Q ss_pred             c--ccc-----chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 L--ELR-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 ~--~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .  ...     .........+..+.+++.+|++.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0  000     000111233567889999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=3.6e-32  Score=270.76  Aligned_cols=250  Identities=23%  Similarity=0.273  Sum_probs=175.0

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH---------------Hhccccc--CcceE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE---------------LLGLCSE--GFKRA  218 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e---------------l~g~~~~--~~~~~  218 (453)
                      ...+.+.+.||+|+||.||+|... +|+.||||.+....   .....+..|               +++++..  +...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            345677789999999999999965 68899999885421   111122222               3444433  33578


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||++ ++|..++..     ..++|..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++.
T Consensus        86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999997 588887732     2688999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCc---eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHH
Q 048517          299 HPKENDF---VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSW  368 (453)
Q Consensus       299 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~  368 (453)
                      .......   .......||..|+|||.+.+. ..++.++||||||+++|||++|+.||.........       ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            6543321   122334689999999988653 46788999999999999999999998643221100       000000


Q ss_pred             HHH---------HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          369 VYD---------QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       369 ~~~---------~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ...         .+..................+..+.+++.+||+.+|++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000         000000000000111112245678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.98  E-value=9.8e-32  Score=261.97  Aligned_cols=247  Identities=21%  Similarity=0.260  Sum_probs=174.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccC--cceEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEG--FKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~--~~~~lv~  221 (453)
                      .|.+.+.||+|+||.||+|..+ +++.+|+|.++.....   ...+..|              +.+++...  ...++|+
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            4667789999999999999965 6899999998753221   1122222              34444444  7789999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||++ ++|.+.+...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++....
T Consensus        86 e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          86 EYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             hhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            9997 5888877432   23689999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc---------hHHHH-H
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF---------PSWVY-D  371 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~---------~~~~~-~  371 (453)
                      ...  ......+++.|+|||.+.+. ...+.++|+||+|++++||++|+.||............         ..|.. .
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            321  12344578899999998753 34688999999999999999999998643321100000         00000 0


Q ss_pred             HhhhCC---Ccccc--ch-hhhHHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          372 QLNKGG---DLELR--NV-TEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       372 ~l~~~~---~~~~~--~~-~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+....   .....  .. ...+.. +...+.+++.+||+.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            000000   00000  00 001111 3567889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=2e-31  Score=253.03  Aligned_cols=235  Identities=27%  Similarity=0.346  Sum_probs=180.4

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccC--cceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEG--FKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~--~~~~lv~E  222 (453)
                      +...+.||+|++|.||+|... +++.|++|++.....   ..+.+..|              +++.+...  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            345578999999999999966 799999999876542   23333333              33455555  67899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++++|.+++...    ..+++..++.++.+++.||+|||+.   +++|+||+|+||+++.++.+||+|||.+......
T Consensus        82 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          82 YVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999988432    3789999999999999999999997   9999999999999999999999999999877654


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..........++..|+|||.+...  ..+.++||||||+++++|++|+.|+......      ..............   
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~---  223 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGSSGEPP---  223 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHhccccCCCc---
Confidence            321112345688999999998764  5889999999999999999999998654311      01111111101111   


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         ..+......+.+++.+|++.+|++||++.++++
T Consensus       224 ---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         224 ---EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               122233577999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=4.6e-32  Score=263.92  Aligned_cols=237  Identities=22%  Similarity=0.283  Sum_probs=174.4

Q ss_pred             hhhhcccCccCceEEEEEEE----cCCcEEEEEEecCCCC-----CHHHHHHH---------------HhcccccCcceE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF-----SAEEFINE---------------LLGLCSEGFKRA  218 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~-----~~~~~i~e---------------l~g~~~~~~~~~  218 (453)
                      +++.+.||+|+||.||+++.    .+|+.||+|++.....     ..+++..|               +.+.+..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            45668899999999999985    3789999999875221     11222222               334455666788


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +|+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        82 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          82 LILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999998843    24688999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ....... ......|+..|+|||.+.......+.++||||||+++|||++|+.|+.......   .... ..+.+.....
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~-~~~~~~~~~~  229 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAE-ISRRILKSEP  229 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHH-HHHHhhccCC
Confidence            5433211 122345889999999987543457889999999999999999999986432211   1111 1122221111


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                       .      .+..+...+.+++.+||+.+|++||     ++.++++
T Consensus       230 -~------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 -P------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -C------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence             1      1122445688999999999999997     6666655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=1e-31  Score=261.97  Aligned_cols=240  Identities=22%  Similarity=0.309  Sum_probs=173.5

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      +++.++||+|++|.||+|... +|+.||+|.+.....   ..+.+..|              +++++..+...++||||+
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL   83 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence            556789999999999999954 789999998865322   12233333              456677778899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~  303 (453)
                      + ++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||||+||+++. +..+||+|||+++......
T Consensus        84 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         84 D-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             c-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            5 5787776332  223467888889999999999999998   9999999999999985 5679999999998654322


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh---hC----
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN---KG----  376 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~---~~----  376 (453)
                      .  ......+++.|+|||++.+. ..++.++||||+|+++|||++|+.||........       ....+.   ..    
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-------~~~~~~~~~~~~~~~  227 (294)
T PLN00009        158 R--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-------LFKIFRILGTPNEET  227 (294)
T ss_pred             c--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhCCCChhh
Confidence            1  12334578899999998653 3578899999999999999999999865432110       111000   00    


Q ss_pred             --------------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 --------------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 --------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                    ...............+..+.+++.+|++.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                          000000000111234567889999999999999999999986

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.98  E-value=2.2e-31  Score=254.98  Aligned_cols=226  Identities=26%  Similarity=0.356  Sum_probs=173.0

Q ss_pred             cCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       169 LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      ||.|+||.||+++.. +++.||+|.+......    .+.+..|              +++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999965 5899999998764321    2233333              45566677788999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      .+++...    ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++......   ...
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            9988432    4589999999999999999999998   99999999999999999999999999998765432   113


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh-CCCccccchhhhH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIE  388 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~  388 (453)
                      ...++..|+|||.+...  .++.++|+||+|+++|||++|+.|+.......     .. ....... .....      .+
T Consensus       151 ~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~~------~~  216 (262)
T cd05572         151 TFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----ME-IYNDILKGNGKLE------FP  216 (262)
T ss_pred             cccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HH-HHHHHhccCCCCC------CC
Confidence            34688899999998753  67899999999999999999999986543211     11 1122221 11111      11


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          389 SMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       389 ~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                      ......+..++.+||+.+|++||+     ++|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            122567899999999999999999     566554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=6.7e-32  Score=261.13  Aligned_cols=229  Identities=28%  Similarity=0.362  Sum_probs=171.5

Q ss_pred             cCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       169 LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      ||+|+||+||++.. .+|+.||+|.+.....    ....+..|              +++.+......++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            79999999999984 4789999999865321    12223333              34555666778999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      .+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++........   ..
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~  152 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK  152 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cc
Confidence            99885432  24689999999999999999999998   999999999999999999999999999986543221   23


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ...++..|+|||.+.+.  .++.++||||+|+++++|++|+.||........        .+.+.+....   .....+.
T Consensus       153 ~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~---~~~~~~~  219 (277)
T cd05577         153 GRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--------KEELKRRTLE---MAVEYPD  219 (277)
T ss_pred             cccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--------HHHHHhcccc---ccccCCc
Confidence            34578899999998764  688999999999999999999999865432111        0111111000   0011222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          390 MIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                      ..+..+.+++.+||+.+|++||     ++.++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            3456788999999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=2.8e-32  Score=270.29  Aligned_cols=234  Identities=21%  Similarity=0.266  Sum_probs=177.6

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCC---CCHHHHHHH---------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSK---FSAEEFINE---------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~---~~~~~~i~e---------------l~g~~~~~~~~~lv~E~  223 (453)
                      .|...++||.||-+.||++.-.+.+.+|+|.+....   ....-|.+|               |+.+-..+...|+||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            455668899999999999998888889998765532   223344444               55566667889999998


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      = .-+|.+.|....  .....| .+..+..|++.++.+.|++   +|||.||||.|.|+- .|.+||.|||+|.....+.
T Consensus       442 G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  442 G-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             c-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            5 678888884332  233345 7889999999999999998   999999999999994 5689999999999998887


Q ss_pred             CceeecccCCCCCccChhhhcccCC---------CCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFG---------TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~---------~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      .........||+.||+||++.....         .++.++||||+||+||+|+.|+.||..-..          .+..+.
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----------~~aKl~  583 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----------QIAKLH  583 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------HHHHHH
Confidence            7666677899999999999864311         278899999999999999999999963211          111121


Q ss_pred             hC----CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KG----GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~----~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .-    -.++.+....   .  ..+.++++.||+.||++|||+.|+++
T Consensus       584 aI~~P~~~Iefp~~~~---~--~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  584 AITDPNHEIEFPDIPE---N--DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             hhcCCCccccccCCCC---c--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            11    1122222111   1  12899999999999999999999987

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.98  E-value=1.7e-31  Score=265.75  Aligned_cols=248  Identities=19%  Similarity=0.244  Sum_probs=173.9

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------Hhcccc----cCcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCS----EGFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~----~~~~~~l  219 (453)
                      .+.+.+.||+|+||.||+|.. .+|+.||+|++.....   ....+..|              +.+++.    .....++
T Consensus         6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l   85 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV   85 (334)
T ss_pred             ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence            455668899999999999994 5799999999875321   22233332              233332    2345789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      |+||+. |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          86 VMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            999995 688887732    34589999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCCce--eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc------------cc
Q 048517          300 PKENDFV--SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA------------YF  365 (453)
Q Consensus       300 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~------------~~  365 (453)
                      .......  ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||..........            .+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            4322111  11234688999999998653 357899999999999999999999996432210000            00


Q ss_pred             ----hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          366 ----PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       366 ----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          ...+......................+..+.+++.+||+.+|++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                00000001000000000000111234577999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=2.1e-31  Score=258.08  Aligned_cols=240  Identities=23%  Similarity=0.329  Sum_probs=172.9

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH-----------------HhcccccCcc-----e
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE-----------------LLGLCSEGFK-----R  217 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e-----------------l~g~~~~~~~-----~  217 (453)
                      ++.+.||+|+||.||+|+.+ +++.||+|.+......   ...+..|                 +.+++.....     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            45678999999999999976 5899999998743211   1122122                 3444444444     8


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      +++|||+. ++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.
T Consensus        82 ~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          82 TLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             EEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence            89999996 58888774322  24689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      .......   .....++..|+|||.+.+.  .++.++||||||++++||++|+.|+.......   .+.. +.+......
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~-~~~~~~~~~  226 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDK-IFDVIGLPS  226 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHH-HHHHcCCCC
Confidence            7644322   1233578899999999764  68899999999999999999998886543211   0111 111100000


Q ss_pred             ----------------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 ----------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ----------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                      .................+.+++.+||+.||++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                            00000011122344567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=1.8e-31  Score=260.92  Aligned_cols=246  Identities=24%  Similarity=0.262  Sum_probs=173.3

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccC-------
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEG-------  214 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~-------  214 (453)
                      ...+.+.++||+|+||.||+|..+ +|+.||||.++....   ....+..|              +++++...       
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            345667789999999999999965 689999999865321   11222222              34444332       


Q ss_pred             ---cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517          215 ---FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  291 (453)
Q Consensus       215 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  291 (453)
                         ...++++||+++ ++.+.+..   ....+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+||+
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence               368899999976 66666632   234689999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517          292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  371 (453)
Q Consensus       292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  371 (453)
                      |||++........ .......++..|+|||.+.+. ...+.++||||||++++||++|+.|+........   +.. +.+
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~-~~~  232 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LEL-ISR  232 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHH-HHH
Confidence            9999987654332 111233467889999988643 3568899999999999999999999865432110   000 000


Q ss_pred             HhhhCC-------------------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          372 QLNKGG-------------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       372 ~l~~~~-------------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ......                   .............++..+.+++.+||+.+|.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000                   00000000011123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=2.6e-31  Score=254.23  Aligned_cols=234  Identities=24%  Similarity=0.324  Sum_probs=175.6

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC------CCHHHH--------------HHHHhcccccCcceEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK------FSAEEF--------------INELLGLCSEGFKRALVY  221 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~------~~~~~~--------------i~el~g~~~~~~~~~lv~  221 (453)
                      |.+.++||+|+||.||+++.. .+..+++|+++...      ....++              +.++++.+.+....++++
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            567789999999999999854 45556666655311      111111              223566777777889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++++|.+.+.........+++..++.++.|++.||.|||+.   +++|+||||+||+++. ..+||+|||+++....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999998865444456799999999999999999999998   9999999999999976 4699999999987644


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ...  ......|++.|+|||.+...  .++.++|+||||+++|+|++|+.|+.....       .. .......+.... 
T Consensus       158 ~~~--~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~-~~~~~~~~~~~~-  224 (260)
T cd08222         158 SCD--LATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LS-VVLRIVEGPTPS-  224 (260)
T ss_pred             Ccc--cccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HH-HHHHHHcCCCCC-
Confidence            322  12345688999999988653  678899999999999999999999853221       11 111222221111 


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           .+..++..+.+++.+||+.+|++||++.++++
T Consensus       225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         225 -----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                 22345567889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=2.6e-33  Score=252.77  Aligned_cols=235  Identities=23%  Similarity=0.322  Sum_probs=185.4

Q ss_pred             HhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      ..|.+.+.||+|.|+.||++. .++|+.+|+|+++..+...   ++..+|              |....++.+..++|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            356677899999999999997 5689999999987644332   222222              5555667778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEecCCcccc
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFH  299 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~~~  299 (453)
                      +|.||+|..-|..+    ..+++..+-....||+.+|.|.|.+   +|||||+||+|+||..   .--+||+|||+|...
T Consensus        91 ~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             cccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999998777433    4577888889999999999999998   9999999999999953   456899999999877


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ....   ......|||+|||||++.+.  +++..+|||+.||+|+-|+.|+.||......        -+++++.++...
T Consensus       164 ~~g~---~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------rlye~I~~g~yd  230 (355)
T KOG0033|consen  164 NDGE---AWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYEQIKAGAYD  230 (355)
T ss_pred             CCcc---ccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------HHHHHHhccccC
Confidence            6322   34567899999999999875  8999999999999999999999999764322        266777665432


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      -.   ......+++...+++.+||..||.+|.|+.|.+.
T Consensus       231 ~~---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 YP---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CC---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            11   1133445667888999999999999999988764

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=2.7e-31  Score=259.40  Aligned_cols=228  Identities=25%  Similarity=0.340  Sum_probs=173.5

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCCCChh
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLD  230 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~  230 (453)
                      .+||+|+||.||++.. .+|+.||||.+..... ..+.+..|              +++.+..+...+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999986 5799999998865332 22333333              455666778899999999999998


Q ss_pred             hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517          231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD  310 (453)
Q Consensus       231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  310 (453)
                      +++..     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........  ....
T Consensus       106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            87632     3579999999999999999999998   999999999999999999999999999876543221  1233


Q ss_pred             cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHH
Q 048517          311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM  390 (453)
Q Consensus       311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (453)
                      ..|+.+|+|||.+.+.  .++.++|+||+|++++||++|+.|+.......        ....+.........    ....
T Consensus       176 ~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLPPKLK----NLHK  241 (292)
T ss_pred             cccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhhCCcccC----Cccc
Confidence            4688999999988653  67889999999999999999999986432110        11112111111110    1112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          391 IARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       391 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +...+.+++.+||+.+|.+||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            3456788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=274.24  Aligned_cols=236  Identities=24%  Similarity=0.318  Sum_probs=180.4

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecC-CCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMEN-SKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~-~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +++...||.|+||.||+++.+ ++-..|-|++.. +....++|+.|              |++.+...+.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            455678999999999999965 455567777754 33334455444              56656667788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |-++..+..   -+..|+..++.-++++++.||.|||++   +|||||||..|||++-+|.++|+|||.+......  ..
T Consensus       114 GAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q  185 (1187)
T KOG0579|consen  114 GAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ  185 (1187)
T ss_pred             chHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence            999888753   346899999999999999999999998   9999999999999999999999999998643221  11


Q ss_pred             eecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          307 SISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      ......|||.|||||+....   ..+|..++||||||++|.||..+.+|....+           .+..+.+....+.+-
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----------pMRVllKiaKSePPT  254 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----------PMRVLLKIAKSEPPT  254 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----------hHHHHHHHhhcCCCc
Confidence            22456799999999988642   2478999999999999999999998864322           223332222222111


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       ...+...+..+.+++.+||..||..||++.++++
T Consensus       255 -LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 -LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence             1245556678999999999999999999988875

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=2.7e-31  Score=261.25  Aligned_cols=236  Identities=25%  Similarity=0.323  Sum_probs=175.7

Q ss_pred             HHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      ...++...+.||+|+||.||+|+. .+++.||+|.+.....    ...++..|              +.+++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            334556668899999999999995 4688999998864322    12233333              3455666777899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      |+||+. |+|.+.+...   ...+++.++..++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus        93 v~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          93 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            999996 6887766432   24588999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ...      ....++..|+|||.+.+ ..+.++.++||||||+++|||++|+.|+......       .... .+..+..
T Consensus       166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~-~~~~~~~  231 (308)
T cd06634         166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALY-HIAQNES  231 (308)
T ss_pred             cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHH-HHhhcCC
Confidence            432      23457889999999853 1246788999999999999999999997543211       1111 1111111


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                      ...     .....+..+.+++.+||+.+|++||++.++++..
T Consensus       232 ~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 PAL-----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CCc-----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            111     1223456688999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=4.6e-31  Score=261.94  Aligned_cols=247  Identities=21%  Similarity=0.292  Sum_probs=171.9

Q ss_pred             cccCcc--CceEEEEEEE-cCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQG--GFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G--~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .+||+|  +||+||+++. .+|+.||||++.......   +.+..|              +++++..+...++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456776  9999999995 479999999987643322   222222              45666677788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++||+.+..........
T Consensus        84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            99998875432  24588999999999999999999998   99999999999999999999999998654332211100


Q ss_pred             e-----ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------c-------cchH
Q 048517          307 S-----ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------A-------YFPS  367 (453)
Q Consensus       307 ~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~-------~~~~  367 (453)
                      .     .....++..|+|||++.+....++.++||||||++++||++|+.||.........       .       .++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence            0     0112345679999999765446789999999999999999999998654321100       0       0000


Q ss_pred             HHHH---------------HhhhC---CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          368 WVYD---------------QLNKG---GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       368 ~~~~---------------~l~~~---~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      -...               .....   ..................+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0000               00000   000000001123345678899999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=2.9e-31  Score=266.14  Aligned_cols=244  Identities=21%  Similarity=0.210  Sum_probs=171.5

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------Hhccccc------Ccc
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSE------GFK  216 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~------~~~  216 (453)
                      ..|...+.||+|+||.||+++. .+|+.||||.+.....   ...++..|              +++++..      ...
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            3456668899999999999994 5799999999865321   12233333              2333321      234


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++|+||+. ++|.+.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        96 ~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          96 VYLVMELMD-ANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             EEEEEeccC-CCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            689999995 57877663      1288899999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc--------cccchHH
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--------KAYFPSW  368 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~--------~~~~~~~  368 (453)
                      +.......   .....+|..|+|||.+.+.  .++.++|||||||++++|++|+.||........        ......+
T Consensus       166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         166 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             eeCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            86543321   2334588999999999764  788999999999999999999999864432100        0000000


Q ss_pred             -------HHHHhhhCCCcc---c----------cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          369 -------VYDQLNKGGDLE---L----------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       369 -------~~~~l~~~~~~~---~----------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                             ......+.....   .          .............+.+++.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   000010000000   0          00000012345668899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=3.7e-31  Score=260.08  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=171.8

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccC--cceEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEG--FKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~--~~~~lv~  221 (453)
                      .+++.+.||+|+||.||+|... +|+.||+|.+......   ......|              +++++...  ...++||
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM   87 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence            3556788999999999999964 6999999998643211   1111222              23343322  4578999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||++ ++|.+++...   ...+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++....
T Consensus        88 e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          88 EYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             ecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9996 5787777432   25689999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch-------HHHHHHhh
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-------SWVYDQLN  374 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~-------~~~~~~l~  374 (453)
                      ...  ......++..|+|||.+.+. ..++.++||||+|+++|||++|+.||.............       ......+.
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             ccC--CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            321  12334467889999998653 357889999999999999999999986443211000000       00000000


Q ss_pred             h---CCCccc-----cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 K---GGDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~---~~~~~~-----~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .   ......     ..........++.+.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0   000000     0000011123567789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=3.5e-31  Score=259.52  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=169.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccC--------c
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEG--------F  215 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~--------~  215 (453)
                      .|.+.++||+|+||.||+|... +++.||||.+.....   ....+..|              ++++|...        .
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            4667789999999999999954 799999998864221   11122222              34444322        3


Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      ..++||||+. ++|.+.+..   ....+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        93 ~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          93 SFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             eEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence            4589999996 477777632   224689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCc--eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc-------ch
Q 048517          296 AKFHPKENDF--VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FP  366 (453)
Q Consensus       296 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-------~~  366 (453)
                      +.........  .......++..|+|||.+.+. ..++.++||||||++++||++|+.|+...........       ++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9866432211  112334578899999988653 3468899999999999999999998865432110000       00


Q ss_pred             HHHHHHh---hhCCCccccchh--hhHH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          367 SWVYDQL---NKGGDLELRNVT--EIES-----MIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       367 ~~~~~~l---~~~~~~~~~~~~--~~~~-----~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..+....   ............  ....     .....+.+++.+||+.+|++|||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000000   000000000000  0000     11245678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.1e-31  Score=250.35  Aligned_cols=231  Identities=25%  Similarity=0.362  Sum_probs=178.2

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.+.||+|++|.||+++.. +++.||+|.+.....   ..+++..|              +.+++..+...++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            456789999999999999855 688999999987543   22334333              244555667789999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          82 ENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999988432    5689999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                      .  .....++..|+|||...+.  ..+.++||||+|+++++|++|+.|+......      .  ............    
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~--~~~~~~~~~~~~----  218 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPM------A--ALFRIVQDDHPP----  218 (254)
T ss_pred             c--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHH------H--HHHHHhccCCCC----
Confidence            1  2334688999999998764  5788999999999999999999998643211      0  111111111111    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        .+......+..++.+||+.+|++|||+.+++.
T Consensus       219 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 --LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              12223467889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=266.45  Aligned_cols=227  Identities=27%  Similarity=0.402  Sum_probs=175.4

Q ss_pred             hhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CH------HHHHHH---------HhcccccCcceEEEEEecC
Q 048517          165 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SA------EEFINE---------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~------~~~i~e---------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .-+.||+||||.||-++. .+|+.+|.|.+.+...   ..      +..|.+         |---+.....++||+..|.
T Consensus       189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN  268 (591)
T KOG0986|consen  189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN  268 (591)
T ss_pred             eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence            346899999999999985 4799999998765211   11      112222         1122456778999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      ||+|.-+|+...  ...++...+.-++.+|+-||++||+.   +||.||+||+|||||+.|+++|+|.|||.-++.... 
T Consensus       269 GGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-  342 (591)
T KOG0986|consen  269 GGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-  342 (591)
T ss_pred             CCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc-
Confidence            999999886443  36799999999999999999999998   999999999999999999999999999998877653 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                        .....||.||||||++.+.  .|+...|.||+||+||||+.|+.||....++..      |  +.+.+.   .+....
T Consensus       343 --~~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------~--eEvdrr---~~~~~~  407 (591)
T KOG0986|consen  343 --IRGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------R--EEVDRR---TLEDPE  407 (591)
T ss_pred             --cccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhh------H--HHHHHH---Hhcchh
Confidence              3455899999999999875  699999999999999999999999976544321      1  111111   011122


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPS  412 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs  412 (453)
                      +.++..+++...+....|+.||++|--
T Consensus       408 ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  408 EYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             hcccccCHHHHHHHHHHHccCHHHhcc
Confidence            344556677788888889999999863

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=5.1e-31  Score=254.19  Aligned_cols=232  Identities=22%  Similarity=0.314  Sum_probs=177.1

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHH---------------HHhcccccCcceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFIN---------------ELLGLCSEGFKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~---------------el~g~~~~~~~~~lv~E  222 (453)
                      |.+.+.||+|+||.||+|+.. +|+.||+|++..+...    .+.+..               ++++++..+...+++||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            556788999999999999965 7999999998763221    112222               24556677778999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          83 YAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999998843    24799999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CCc------------------eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc
Q 048517          303 NDF------------------VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY  364 (453)
Q Consensus       303 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~  364 (453)
                      ...                  .......++..|+|||.+...  ..+.++||||||++++++++|+.|+......     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----  228 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----  228 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence            211                  111233578899999988764  6888999999999999999999998754311     


Q ss_pred             chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 048517          365 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSM----TKVLE  418 (453)
Q Consensus       365 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~----~evl~  418 (453)
                         ........... .      .+..++..+.+++.+||+.+|++|||+    +++++
T Consensus       229 ---~~~~~~~~~~~-~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 ---LTFQKILKLEY-S------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HHHHHHHhcCC-C------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               11122211111 1      112235678999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=1.3e-30  Score=257.01  Aligned_cols=228  Identities=28%  Similarity=0.366  Sum_probs=170.6

Q ss_pred             hhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          165 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ..++||+|+||.||+|+. .+|+.||+|.+......    ..++..|              +.+++..+...++||||+.
T Consensus        25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  104 (313)
T cd06633          25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL  104 (313)
T ss_pred             cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence            346799999999999995 47899999998753221    1233333              3456667778899999995


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                       |++.+.+..   ....+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......   
T Consensus       105 -~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---  174 (313)
T cd06633         105 -GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---  174 (313)
T ss_pred             -CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence             577776632   235689999999999999999999998   9999999999999999999999999998643221   


Q ss_pred             eeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          306 VSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                         ....|+..|+|||++.. ..+.++.++||||||+++|||++|+.|+.......       ...... .......   
T Consensus       175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~-~~~~~~~---  240 (313)
T cd06633         175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIA-QNDSPTL---  240 (313)
T ss_pred             ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHH-hcCCCCC---
Confidence               23468899999999853 12468889999999999999999999986543211       111111 1111111   


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        .....+..+.+++.+||+.+|++||++.+++.
T Consensus       241 --~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         241 --QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             --CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              11123356888999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1e-30  Score=251.90  Aligned_cols=240  Identities=25%  Similarity=0.338  Sum_probs=183.7

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH------HH------------HHHHHhcccccCcceEEEEEec
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA------EE------------FINELLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~------~~------------~i~el~g~~~~~~~~~lv~E~~  224 (453)
                      ++.+.||.|.-|+||++++. ++..+|+|++.+.....      -+            |+-.|+..++..+..+|+||||
T Consensus        80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC  159 (459)
T KOG0610|consen   80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC  159 (459)
T ss_pred             HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence            44578999999999999977 46899999998742221      11            2223788888899999999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC-
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN-  303 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~-  303 (453)
                      +||+|...++  ++.+..++...+.-++.+++-||+|||-.   +||.|||||+|||+.++|++-|+||.|+..+...- 
T Consensus       160 pGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  160 PGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             CCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            9999987664  45668899999999999999999999987   99999999999999999999999999975432100 


Q ss_pred             --------------------------------Cc---------------------eeecccCCCCCccChhhhcccCCCC
Q 048517          304 --------------------------------DF---------------------VSISDTRGTIGYLAPELISRNFGTV  330 (453)
Q Consensus       304 --------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~  330 (453)
                                                      ..                     .......||-.|+|||++.+.  .-
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--GH  312 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--GH  312 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--CC
Confidence                                            00                     001123589999999999986  67


Q ss_pred             CccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCC
Q 048517          331 SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR  410 (453)
Q Consensus       331 s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R  410 (453)
                      +.++|+|+||++||||+.|+.||.....+.   .    ....+.+.  ....    .....+..+.+|++..|..||.+|
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~---T----l~NIv~~~--l~Fp----~~~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---T----LRNIVGQP--LKFP----EEPEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchh---h----HHHHhcCC--CcCC----CCCcchhHHHHHHHHHhccChhhh
Confidence            889999999999999999999998765432   1    22222221  1111    111455678899999999999999


Q ss_pred             CC----HHHHHH--HHhCC
Q 048517          411 PS----MTKVLE--MLEGS  423 (453)
Q Consensus       411 Ps----~~evl~--~Le~~  423 (453)
                      .-    +.||-+  +++|.
T Consensus       380 lg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  380 LGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             hccccchHHhhcCccccCC
Confidence            98    777765  45553

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.6e-31  Score=261.14  Aligned_cols=251  Identities=22%  Similarity=0.251  Sum_probs=178.8

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccCc-----ceEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEGF-----KRAL  219 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~~-----~~~l  219 (453)
                      |.+.+.||+|+||.||+|+.. +|+.||||.+....   ...+.+..|              +.+++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            566789999999999999965 58999999887632   122233333              455555543     6899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      +|||++ ++|.+++..    ...+++..+..++.+++.||+|||+.   +|+|+||||+|||++.++.++|+|||++...
T Consensus        82 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          82 VTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             Eecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            999997 578887732    24799999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc---------c-----
Q 048517          300 PKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA---------Y-----  364 (453)
Q Consensus       300 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~---------~-----  364 (453)
                      ..... ........+|..|+|||.+.+. ..++.++|+||+|+++++|++|+.||..........         .     
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             cccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            54321 0112344678899999998764 268899999999999999999999986543211000         0     


Q ss_pred             --chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhC
Q 048517          365 --FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEG  422 (453)
Q Consensus       365 --~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~  422 (453)
                        ......+.+.....................+.+++.+||+.+|++|||+.++++.  +++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence              0000000000000000000001112245678999999999999999999999983  554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-30  Score=252.09  Aligned_cols=245  Identities=24%  Similarity=0.304  Sum_probs=176.4

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .+.++||+|+||.||+|+.. +++.||+|++....   ...+.+..|              +.+++......++|+||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            35578999999999999965 69999999988642   112222222              5677777788999999997


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                       ++|.+++....   ..+++..+..++.+++.||+|||+.   +|+|+||+|+||++++++.+||+|||+++....... 
T Consensus        82 -~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          82 -MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             -cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence             58999885321   4689999999999999999999998   999999999999999999999999999987644322 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc-------chHHHHHHhhhC--
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQLNKG--  376 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-------~~~~~~~~l~~~--  376 (453)
                       ......++..|+|||.+.+. ..++.++||||||++++||++|+.|+...........       .....+......  
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence             12234467789999998653 3678899999999999999999998865432110000       000000000000  


Q ss_pred             --CCcc---ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 --GDLE---LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 --~~~~---~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        ....   ..............+.+++.+||+.+|++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              0000   00000111123567999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=9.6e-31  Score=261.24  Aligned_cols=248  Identities=19%  Similarity=0.234  Sum_probs=169.7

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------Hhccccc-----------
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSE-----------  213 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~-----------  213 (453)
                      .+|.+.+.||.|+||.||+|.. .+|+.||+|.+...... .+.+.+|              +++++..           
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            3456678999999999999985 57899999998664332 2223222              3333222           


Q ss_pred             ---CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-CCCceE
Q 048517          214 ---GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPK  289 (453)
Q Consensus       214 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~-~~~~~k  289 (453)
                         ....++|+||++ ++|.+++.     ...+++..+..++.|++.||.|||+.   +|+||||||+||+++ .+..+|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence               234689999997 58877762     23588999999999999999999998   999999999999997 466789


Q ss_pred             EEecCCccccCCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc----
Q 048517          290 VSDFGLAKFHPKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY----  364 (453)
Q Consensus       290 l~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~----  364 (453)
                      ++|||+++......... ......++..|+|||.+.+. ..++.++|||||||++|||++|+.||...........    
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999997653321111 11223578899999987542 3578899999999999999999999964432110000    


Q ss_pred             -----------chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          365 -----------FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       365 -----------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                 +..........................+..+.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                       000000000000000000000111234467889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.9e-31  Score=279.24  Aligned_cols=253  Identities=18%  Similarity=0.221  Sum_probs=164.0

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc--CCcEEEEE------------------EecCCCCCHHHHHHH-------------
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVK------------------MMENSKFSAEEFINE-------------  206 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~--~g~~VAVK------------------~l~~~~~~~~~~i~e-------------  206 (453)
                      ...|.+.++||+|+||+||++..+  ++..+++|                  .+.........+.+|             
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            346777899999999999998754  22222222                  111111112223333             


Q ss_pred             -HhcccccCcceEEEEEecCCCChhhhhhhccCC-CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC
Q 048517          207 -LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENK-GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  284 (453)
Q Consensus       207 -l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~  284 (453)
                       +++++......++++|++ .++|.+++...... .......++..|+.|++.||+|||+.   +|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence             556666777789999998 45777776432211 12234556778999999999999998   9999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCC-CCCCccccccc
Q 048517          285 NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNATRSSKA  363 (453)
Q Consensus       285 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p-~~~~~~~~~~~  363 (453)
                      ++.+||+|||+++........ ......||..|+|||++.+.  .++.++|||||||++|||++|+.+ +..........
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999876543221 11335699999999999764  789999999999999999998754 33221110000


Q ss_pred             -------------cch---HHHHHHhhhCCCcccc-chhh--hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          364 -------------YFP---SWVYDQLNKGGDLELR-NVTE--IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       364 -------------~~~---~~~~~~l~~~~~~~~~-~~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                                   .++   ....+.+......... ....  ........+.+++.+||+.||++|||+.|+++.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                         000   0111111111000000 0000  001123456778999999999999999999873

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=5.9e-31  Score=261.74  Aligned_cols=241  Identities=21%  Similarity=0.272  Sum_probs=173.0

Q ss_pred             hhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---------------HHHHHH--------------HhcccccC
Q 048517          165 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---------------EEFINE--------------LLGLCSEG  214 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---------------~~~i~e--------------l~g~~~~~  214 (453)
                      +.+.||+|+||.||+|... +++.||||.+.......               ..+..|              +++++..+
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            4467999999999999954 79999999886532211               012232              45666677


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...+++|||+. |+|.+++..    ...+++.....++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcc
Confidence            78899999996 688888732    34689999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCC------------ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc
Q 048517          295 LAKFHPKEND------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK  362 (453)
Q Consensus       295 la~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~  362 (453)
                      +++.......            ........++..|+|||.+.+. ..++.++||||+|++++||++|+.|+........ 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-  242 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-  242 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            9986541110            0111234568899999998653 3578899999999999999999999865432110 


Q ss_pred             ccchHHHHHHhhhCCCc-----------------cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          363 AYFPSWVYDQLNKGGDL-----------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       363 ~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         ...+...+......                 ............+..+.+++.+||+.+|++|||+.+++.
T Consensus       243 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             ---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence               00111111100000                 000000111223467889999999999999999999987

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=248.57  Aligned_cols=222  Identities=25%  Similarity=0.359  Sum_probs=175.6

Q ss_pred             hhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC------------------HHHHHHHHhcccccCcceEEEEEec
Q 048517          164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS------------------AEEFINELLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~------------------~~~~i~el~g~~~~~~~~~lv~E~~  224 (453)
                      .|.+.||+|.||.|.+++ ..+|+.+|+|++++.-.-                  .+.|+..|--.++.+.++++||||.
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya  250 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA  250 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence            467899999999999999 558999999999874221                  1234555666677888999999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      .||.|.-+|.    ....++.....-+-.+|+.||.|||++   +||.||+|.+|.|||.+|++||+||||++-.-....
T Consensus       251 nGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  251 NGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             cCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence            9999998883    346789999999999999999999998   999999999999999999999999999985432222


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                        .+...+|||.|+|||++..+  .|..+.|.|.+||++|||+.|+.||.......        ..+.+.-.   +    
T Consensus       324 --t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------LFeLIl~e---d----  384 (516)
T KOG0690|consen  324 --TTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------LFELILME---D----  384 (516)
T ss_pred             --eeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhH--------HHHHHHhh---h----
Confidence              34677999999999999875  88999999999999999999999997544321        11211111   1    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRP  411 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP  411 (453)
                      ...+..++.+...++.-.|..||.+|-
T Consensus       385 ~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  385 LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            113334445566777888899999997

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1e-30  Score=259.87  Aligned_cols=247  Identities=21%  Similarity=0.232  Sum_probs=168.9

Q ss_pred             hhhhcccCccCceEEEEEEEc-C--CcEEEEEEecCCC---CCHHHHHHH---------------Hhccc----ccCcce
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-T--GRLIAVKMMENSK---FSAEEFINE---------------LLGLC----SEGFKR  217 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~--g~~VAVK~l~~~~---~~~~~~i~e---------------l~g~~----~~~~~~  217 (453)
                      +.+.+.||+|+||.||+++.. +  ++.||||.+....   .....++.|               +++.+    ......
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            456788999999999999954 4  7899999886521   112233333               12211    112346


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++++||+. ++|.+.+.    ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        82 ~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          82 YLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            78888885 68888773    235689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCc--eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc--------ccchH
Q 048517          298 FHPKENDF--VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK--------AYFPS  367 (453)
Q Consensus       298 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~  367 (453)
                      ........  .......||..|+|||.+.+. ..++.++||||+|+++++|++|+.||........-        .....
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            65432211  111234689999999987652 36789999999999999999999998653311000        00000


Q ss_pred             HHHH--------HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          368 WVYD--------QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       368 ~~~~--------~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +...        .......................+.+++.+|++.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000        00000000000000011112457889999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-32  Score=248.26  Aligned_cols=234  Identities=23%  Similarity=0.324  Sum_probs=168.8

Q ss_pred             hhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517          165 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +...||.|..|.|++++.. +|+.+|||.+......  .++.+..               .+|++-.+...++.||.|. 
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence            3467999999999999955 6899999998764322  2233322               3444444444555566652 


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      --+++.+..   ...++++..+-++...+++||.||-.+  .+|+|||+||+|||+|+.|++|++|||++-..-...   
T Consensus       175 ~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---  246 (391)
T KOG0983|consen  175 TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---  246 (391)
T ss_pred             HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence            223333321   235577777788999999999999987  599999999999999999999999999987553322   


Q ss_pred             eecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      ..+...|-+.|||||.+.-+ ...|..++||||||+.|+||.||+.||.....+     |.  +...+.+.....+.   
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe--~ltkvln~ePP~L~---  316 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FE--VLTKVLNEEPPLLP---  316 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HH--HHHHHHhcCCCCCC---
Confidence            12345688899999999754 457888999999999999999999999875432     11  22222222221111   


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       .....+..++++...||+.|+.+||...++++
T Consensus       317 -~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  317 -GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence             22226788999999999999999999998876

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.6e-30  Score=259.82  Aligned_cols=247  Identities=20%  Similarity=0.257  Sum_probs=172.9

Q ss_pred             hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCc------ce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGF------KR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~------~~  217 (453)
                      +|.+.+.||+|+||.||++. ..+|+.||||++......   .+.+..|              +++.+....      ..
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF   95 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence            45667889999999999998 457999999998653221   2233333              233333222      35


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||+ +++|.+++.     ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        96 ~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          96 YLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             EEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence            8999998 778887763     24689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHHHH
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVY  370 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~  370 (453)
                      ......     ....+++.|+|||.+.+. ..++.++|+||+|+++++|++|+.||.........       ...+....
T Consensus       167 ~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         167 QTDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             ccccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            653321     234578899999998753 35788999999999999999999998644321000       00000000


Q ss_pred             HHhhhC---------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCC
Q 048517          371 DQLNKG---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS  423 (453)
Q Consensus       371 ~~l~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~  423 (453)
                      +.+...         ..................+.+++.+|++.||++|||+.++++  .++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            000000         000000000011233456889999999999999999999994  55544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-30  Score=259.89  Aligned_cols=244  Identities=22%  Similarity=0.306  Sum_probs=169.2

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccC------cceE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEG------FKRA  218 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~------~~~~  218 (453)
                      +...+.||+|+||.||+|+. .+|+.||||++....   .....+..|              +++++...      ...+
T Consensus        17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   96 (342)
T cd07879          17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY   96 (342)
T ss_pred             eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence            44457899999999999995 579999999986521   112223333              34444322      3458


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +|+||+.. +|..++      ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        97 lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          97 LVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             EEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            99999964 665543      23589999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc--------ccchHHHH
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK--------AYFPSWVY  370 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~  370 (453)
                      .....     ....+|..|+|||.+.+. ..++.++||||||+++|||++|+.||........-        ..-+.+ .
T Consensus       167 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~  239 (342)
T cd07879         167 ADAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF-V  239 (342)
T ss_pred             CCCCC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH-H
Confidence            53321     234578899999998652 35788999999999999999999999753211000        000000 0


Q ss_pred             HHhhhC---------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCC
Q 048517          371 DQLNKG---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS  423 (453)
Q Consensus       371 ~~l~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~  423 (453)
                      +.+...         ...............+..+.+++.+||+.||++||+++++++  .+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            000000         000000000001123456889999999999999999999995  46654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=1.7e-30  Score=254.79  Aligned_cols=249  Identities=24%  Similarity=0.264  Sum_probs=169.2

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------Hhccccc--------Cc
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSE--------GF  215 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~--------~~  215 (453)
                      .|.+.++||+|+||.||+|+.. +++.||||++......   ...+.+|              +++++..        ..
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   88 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG   88 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence            4566789999999999999954 6899999988542211   1122222              3333322        23


Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      ..++|+||+.+ +|...+..   ....+++.++..++.|+++||+|||+.   +|+|+||||+||+++.++.+||+|||+
T Consensus        89 ~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          89 SVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             eEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence            46899999964 66665532   235699999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCce---------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc--
Q 048517          296 AKFHPKENDFV---------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--  364 (453)
Q Consensus       296 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~--  364 (453)
                      ++.........         ..+...+++.|+|||.+.+. ..++.++||||||++++||++|++||...........  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            98654322111         11233568889999988653 3578899999999999999999999865432110000  


Q ss_pred             -----chHHHHH---HhhhCC--Ccccc---chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          365 -----FPSWVYD---QLNKGG--DLELR---NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       365 -----~~~~~~~---~l~~~~--~~~~~---~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           ...+.+.   .+....  .....   ............+.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                 0000000   000000  00000   000011122356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.9e-30  Score=244.03  Aligned_cols=221  Identities=30%  Similarity=0.389  Sum_probs=171.7

Q ss_pred             cCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       169 LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      ||+|+||.||++... +++.+|+|.+......    .+++..|              +++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999965 6899999998764321    2223222              46667778889999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      .+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~  151 (250)
T cd05123          81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN  151 (250)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence            9988432    3689999999999999999999997   999999999999999999999999999987644321  224


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ...++..|+|||.+.+.  ..+.++|+||||+++|||++|+.|+.....        ......+... ...      .+.
T Consensus       152 ~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~------~~~  214 (250)
T cd05123         152 TFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKD-PLR------FPE  214 (250)
T ss_pred             CCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcC-CCC------CCC
Confidence            45688899999998764  578899999999999999999999864432        1112222221 111      111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHH
Q 048517          390 MIARKLCMIGLWCIQVKAADRPSMTK  415 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RPs~~e  415 (453)
                      ..+..+.+++.+||+.+|++||++.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            22467889999999999999999955

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=8e-31  Score=248.04  Aligned_cols=211  Identities=19%  Similarity=0.140  Sum_probs=162.3

Q ss_pred             cCceEEEEEEE-cCCcEEEEEEecCCCCCHHH----------HHHHHhcccccCcceEEEEEecCCCChhhhhhhccCCC
Q 048517          172 GGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE----------FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG  240 (453)
Q Consensus       172 G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~----------~i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~  240 (453)
                      |.||.||+++. .+|+.+|+|++........+          .+..+++++......+++|||+++|+|.+++...    
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF----   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh----
Confidence            89999999995 57899999999764322211          1222566677778899999999999999988432    


Q ss_pred             CCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccCh
Q 048517          241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP  320 (453)
Q Consensus       241 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  320 (453)
                      ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++|||.+.......     ....++..|+||
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aP  151 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAP  151 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCC
Confidence            3589999999999999999999998   99999999999999999999999999886553321     234467789999


Q ss_pred             hhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHH
Q 048517          321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGL  400 (453)
Q Consensus       321 E~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~  400 (453)
                      |.+...  .++.++||||+|++++||++|+.++......             ........      .+..++..+..++.
T Consensus       152 E~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------~~~~~~~~------~~~~~~~~~~~li~  210 (237)
T cd05576         152 EVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSG-------------INTHTTLN------IPEWVSEEARSLLQ  210 (237)
T ss_pred             cccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------cccccccC------CcccCCHHHHHHHH
Confidence            988653  6788999999999999999999876432110             00000111      12234567889999


Q ss_pred             HhcccCCCCCCCHHH
Q 048517          401 WCIQVKAADRPSMTK  415 (453)
Q Consensus       401 ~Cl~~~p~~RPs~~e  415 (453)
                      +|++.||++||++.+
T Consensus       211 ~~l~~dp~~R~~~~~  225 (237)
T cd05576         211 QLLQFNPTERLGAGV  225 (237)
T ss_pred             HHccCCHHHhcCCCc
Confidence            999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.9e-31  Score=268.77  Aligned_cols=230  Identities=24%  Similarity=0.363  Sum_probs=177.7

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEE---EEEecCCCC--CHHHHHHH--------------Hhccccc--CcceEEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIA---VKMMENSKF--SAEEFINE--------------LLGLCSE--GFKRALVY  221 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VA---VK~l~~~~~--~~~~~i~e--------------l~g~~~~--~~~~~lv~  221 (453)
                      .|...||+|+|=+||+|... +|..||   ||.-+..+.  ..++|..|              ++..+.+  +....+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            35678999999999999854 677776   332222222  23555555              2333322  23366899


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHP  300 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~  300 (453)
                      |.|..|+|..|+..    .+..+...+..++.||++||.|||++ +++|+|||||.+||+++. -|.+||+|+|||.+..
T Consensus       123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            99999999999843    35678889999999999999999996 789999999999999986 4899999999999876


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ....    ....|||.|||||++..   .|....|||||||.++||+|+..|+.       +..-++-+|+.+..|....
T Consensus       198 ~s~a----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYs-------EC~n~AQIYKKV~SGiKP~  263 (632)
T KOG0584|consen  198 KSHA----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYS-------ECTNPAQIYKKVTSGIKPA  263 (632)
T ss_pred             cccc----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChh-------hhCCHHHHHHHHHcCCCHH
Confidence            5432    33679999999999974   68999999999999999999999985       3334556787777665432


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .     ...--...+.+++..||.. ..+|||+.|+++
T Consensus       264 s-----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  264 A-----LSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             H-----hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            1     1222235688999999999 999999999987

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-30  Score=248.30  Aligned_cols=233  Identities=24%  Similarity=0.277  Sum_probs=171.3

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC------CHHHHHHH--------------Hhccccc--CcceEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF------SAEEFINE--------------LLGLCSE--GFKRAL  219 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~------~~~~~i~e--------------l~g~~~~--~~~~~l  219 (453)
                      +.+.+.||+|+||.||+|.. .+|+.||+|.+.....      ....+..|              +++++..  ....++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            55678999999999999985 4699999998754211      11223222              2333333  345789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ++||+++++|.+++...    ..+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||+++..
T Consensus        84 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          84 FVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            99999999999988432    3578999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ..... ........++..|+|||.+.+.  ..+.++|+||||++++||++|+.||......       .-+.+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~  227 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTK  227 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcCCCC
Confidence            32110 0111234588999999998764  6789999999999999999999998643211       111111111111


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .      ..+..+.+.+.+++.+|++ +|..||+..+++.
T Consensus       228 ~------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         228 P------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             C------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1      1233455678999999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.4e-30  Score=258.41  Aligned_cols=242  Identities=20%  Similarity=0.256  Sum_probs=171.2

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCc------ce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGF------KR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~------~~  217 (453)
                      .|.+.+.||+|+||.||+|+.. +++.||||++.....   ..+++..|              +.+++....      ..
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            4556788999999999999965 688999999865321   11222222              333343333      37


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++|+||+ +++|.+++..     ..+++..+..++.|+++||+|||+.   +|+|+||||+||+++.++.+||+|||++.
T Consensus        96 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          96 YLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             EEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence            8999998 6799887732     4689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc--------cchHHH
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--------YFPSWV  369 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~--------~~~~~~  369 (453)
                      .....     .....+|..|+|||.+.+. ...+.++||||||++++||++|+.||..........        ..+.+.
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            65432     1334578899999998653 367889999999999999999999986433210000        000000


Q ss_pred             HH--------HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          370 YD--------QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       370 ~~--------~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..        .+..................+..+.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00        00000000000000111123567899999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=276.74  Aligned_cols=237  Identities=22%  Similarity=0.261  Sum_probs=181.5

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecC---CCCCHH---------------HHHHHHhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMEN---SKFSAE---------------EFINELLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~---~~~~~~---------------~~i~el~g~~~~~~~~~lv~  221 (453)
                      ..+.+.+.||+|+||.|...+. .+++.+|+|++++   .+....               +++..|.--+++...+|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            3455678999999999999995 5789999999987   222222               34444666678889999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      |||+||+|-..+.    +...++.+.+.-++.+|.-||.-||+-   ++|||||||+|||||..|++||+|||.+-.+..
T Consensus       155 dY~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             ecccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            9999999988883    223688999999999999999999997   999999999999999999999999999987776


Q ss_pred             CCCceeecccCCCCCccChhhhccc--C-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-C
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRN--F-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-G  377 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-~  377 (453)
                      ++... .....|||-|++||++...  . |.|...+|.||+||++|||+.|..||...+--        ..|..+... .
T Consensus       228 dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv--------eTY~KIm~hk~  298 (1317)
T KOG0612|consen  228 DGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV--------ETYGKIMNHKE  298 (1317)
T ss_pred             CCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH--------HHHHHHhchhh
Confidence            66543 4678899999999998642  2 57889999999999999999999999643311        123333222 2


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVLE  418 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~  418 (453)
                      .+.++.    ..+++....+++.+.+. +|+.|-.   ++++-.
T Consensus       299 ~l~FP~----~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  299 SLSFPD----ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hcCCCc----ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            222221    12255666677776654 7788877   777654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=252.45  Aligned_cols=229  Identities=24%  Similarity=0.331  Sum_probs=182.1

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-------------------CHHHHHHHHhcccccCcc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-------------------SAEEFINELLGLCSEGFK  216 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-------------------~~~~~i~el~g~~~~~~~  216 (453)
                      .+.....+|...||+|+||.|.++.-+ +.+.+|||+|+++-.                   ....|+..|..+++.-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            444455688899999999999999855 567899999876311                   112466778888888899


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      +++||||+.+|+|--++.    .-..+.++.+.-+|.+||-||-+||++   +|+.||||..|||||.++++||+|||++
T Consensus       425 LyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             eeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence            999999999999988883    335688889999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      +-.--+.  ..+.+..|||.|+|||.+.-  .+|...+|.|||||+||||+.|++||+...+.+        +...+.+.
T Consensus       498 KEni~~~--~TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--------lF~aI~eh  565 (683)
T KOG0696|consen  498 KENIFDG--VTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQAIMEH  565 (683)
T ss_pred             cccccCC--cceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHHc
Confidence            8533222  23456789999999999874  488999999999999999999999998765432        23333332


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP  411 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  411 (453)
                      ..       ..+..++.+...+....|...|.+|-
T Consensus       566 nv-------syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 NV-------SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             cC-------cCcccccHHHHHHHHHHhhcCCcccc
Confidence            22       14444566677778888888888885

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=2.6e-30  Score=256.67  Aligned_cols=242  Identities=21%  Similarity=0.234  Sum_probs=170.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC---CCHHHHHHH--------------Hhcccc-cCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK---FSAEEFINE--------------LLGLCS-EGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~-~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||.||++.. .+|+.||||.+....   ...+.+..|              +.+++. .+...++++|
T Consensus        11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e   90 (328)
T cd07856          11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE   90 (328)
T ss_pred             ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence            455668999999999999984 489999999875421   122333333              334443 3556889999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+ +++|.+++.     ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++.....
T Consensus        91 ~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          91 LL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             hh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            98 568887763     24578888899999999999999998   9999999999999999999999999999754322


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc--------chHHHHHHhh
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--------FPSWVYDQLN  374 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~--------~~~~~~~~l~  374 (453)
                           .....++..|+|||.+.+. ..++.++||||||++++||++|+.||...........        ..++.. .+.
T Consensus       162 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  234 (328)
T cd07856         162 -----MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN-TIC  234 (328)
T ss_pred             -----cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH-hcc
Confidence                 1234578899999987542 3678999999999999999999999865432110000        000000 000


Q ss_pred             hCCC------ccccch---hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          375 KGGD------LELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       375 ~~~~------~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ....      ......   .......+..+.+++.+||+.+|++|||+.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000      000000   00111234678999999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=249.32  Aligned_cols=237  Identities=24%  Similarity=0.309  Sum_probs=179.7

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHH---------------HHHHhcccccCcceEEEEEecCCCC
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEF---------------INELLGLCSEGFKRALVYEYMPNGS  228 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~---------------i~el~g~~~~~~~~~lv~E~~~~gs  228 (453)
                      ..||.|+||+|+|-.. +.|+..|||++.....  ...++               |.+++|.+-.+...++.||.| ..|
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence            4699999999999884 5899999999876433  22333               334788887888899999999 567


Q ss_pred             hhhhhhh-ccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          229 LDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       229 L~~~l~~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      |+.+... .......+++.-+-.|..-+.+||.||-..  ..|+|||+||+|||||..|.+||+|||++-.....   ..
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iA  223 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IA  223 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH---HH
Confidence            7654321 112346788888889999999999999976  58999999999999999999999999998654321   12


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc--hh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN--VT  385 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~  385 (453)
                      .+...|-..|||||.+......+..+|||||+|++|+|+.||+-|+.....          +.+++.+....+.+.  ..
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----------vfeql~~Vv~gdpp~l~~~  293 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----------VFEQLCQVVIGDPPILLFD  293 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------HHHHHHHHHcCCCCeecCc
Confidence            244568889999999987655689999999999999999999999864322          445554432222111  11


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ......+..|..++.-|+..|..+||+..++.++
T Consensus       294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1223467789999999999999999999988763

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-32  Score=289.50  Aligned_cols=234  Identities=29%  Similarity=0.372  Sum_probs=176.7

Q ss_pred             hcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---H-----HHHHHH---------HhcccccCcceEEEEEecCCC
Q 048517          166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---A-----EEFINE---------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---~-----~~~i~e---------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      ..+||.|.||.||-|. .++|...|||.+......   .     +.-+.|         .+|+-.+....+|-||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            3579999999999998 678999999977542111   1     111112         355556677788999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc--
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF--  305 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~--  305 (453)
                      +|.+.+.    .+...++.....+..|++.|++|||++   +||||||||.||+|+.+|.+|++|||.|.........  
T Consensus      1320 sLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             cHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            9999883    334456666677889999999999998   9999999999999999999999999999876544211  


Q ss_pred             eeecccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHH-HHHHhhhCCCccccc
Q 048517          306 VSISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-VYDQLNKGGDLELRN  383 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~l~~~~~~~~~~  383 (453)
                      .......||+.|||||++.+.. ..-..+.||||+|||++||+||++|+...+..        | ++-+...+....   
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--------~aIMy~V~~gh~Pq--- 1461 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--------WAIMYHVAAGHKPQ--- 1461 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------hHHHhHHhccCCCC---
Confidence            1234567999999999998743 23456899999999999999999999654321        2 222333333322   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                         .+..++..-.+++.+||+.||++|.++.|+++.=
T Consensus      1462 ---~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1462 ---IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             ---CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence               3334677788999999999999999998877643

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.1e-30  Score=256.35  Aligned_cols=249  Identities=21%  Similarity=0.238  Sum_probs=170.2

Q ss_pred             hHHHHHh--hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------Hhccccc--
Q 048517          156 PEIIAVT--NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSE--  213 (453)
Q Consensus       156 ~~~~~~~--~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~--  213 (453)
                      +++...+  |...+.||+|+||.||+|.. .+|+.||+|++......   .+.+.+|              +.+++..  
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            3444443  34457899999999999984 57999999998753221   2333333              2222221  


Q ss_pred             ----CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceE
Q 048517          214 ----GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  289 (453)
Q Consensus       214 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~k  289 (453)
                          ....+++++++ +++|.+.+.     ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence                12356778776 788877663     23589999999999999999999998   999999999999999999999


Q ss_pred             EEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc------
Q 048517          290 VSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA------  363 (453)
Q Consensus       290 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~------  363 (453)
                      |+|||+++.....     .....+|..|+|||.+.+. ..++.++||||||++++||++|+.||..........      
T Consensus       161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (345)
T cd07877         161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  234 (345)
T ss_pred             Eeccccccccccc-----ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999864332     1334678999999988652 367889999999999999999999986433211000      


Q ss_pred             -cchHHHHHHhhhC---------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          364 -YFPSWVYDQLNKG---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       364 -~~~~~~~~~l~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                       ..+......+...         ...............+..+.+++.+|++.+|++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence             0000000000000         0000000000000124568899999999999999999999873

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=9.9e-30  Score=262.96  Aligned_cols=246  Identities=20%  Similarity=0.228  Sum_probs=164.7

Q ss_pred             hhhhhcccCccCceEEEEEEE-----------------cCCcEEEEEEecCCCCC-HHHHH-------------------
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-----------------HTGRLIAVKMMENSKFS-AEEFI-------------------  204 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-----------------~~g~~VAVK~l~~~~~~-~~~~i-------------------  204 (453)
                      .+.+.++||+|+||+||+|.+                 .+++.||||.+...... .++|+                   
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            445668999999999999964                 24568999998653221 11221                   


Q ss_pred             --------------HHHhccccc--------CcceEEEEEecCCCChhhhhhhccC--------------------CCCC
Q 048517          205 --------------NELLGLCSE--------GFKRALVYEYMPNGSLDRHIFSKEN--------------------KGQT  242 (453)
Q Consensus       205 --------------~el~g~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~  242 (453)
                                    .+++++|..        ....+|||||+++|+|.++++....                    ....
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence                          123444432        3457899999999999999864321                    1124


Q ss_pred             CCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhh
Q 048517          243 FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL  322 (453)
Q Consensus       243 l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  322 (453)
                      ++|..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||.
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEE  381 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhh
Confidence            56788999999999999999998   9999999999999999999999999999765432221 1122345889999998


Q ss_pred             hcccCC--------------------CCCccchHHHHHHHHHHHHcCCC-CCCCCcccc-----ccccchHHHHHHhhhC
Q 048517          323 ISRNFG--------------------TVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRS-----SKAYFPSWVYDQLNKG  376 (453)
Q Consensus       323 ~~~~~~--------------------~~s~k~DV~S~Gvvl~elltg~~-p~~~~~~~~-----~~~~~~~~~~~~l~~~  376 (453)
                      +.....                    ....+.||||+||+++||++|.. |+.......     .......|..   ...
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~---~~~  458 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM---YKG  458 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh---hcc
Confidence            753210                    11235799999999999999875 553211100     0011111211   111


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKA---ADRPSMTKVLE  418 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPs~~evl~  418 (453)
                      ......    .....+....+++.++|..+|   .+|+|++|+++
T Consensus       459 ~~~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QKYDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cCCCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            111111    122234567888999998765   68999999986

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-30  Score=261.56  Aligned_cols=226  Identities=23%  Similarity=0.290  Sum_probs=181.3

Q ss_pred             hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH------------HHHHHHHhcccccCcceEEEEEecCCCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA------------EEFINELLGLCSEGFKRALVYEYMPNGS  228 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~------------~~~i~el~g~~~~~~~~~lv~E~~~~gs  228 (453)
                      .|.+...+|.|+|+.|-.+. ..+++..+||++.......            ++.+.++.+.+.++...++|||.+.+|-
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e  402 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE  402 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence            35566789999999999988 5678999999998752211            2334457888889999999999999998


Q ss_pred             hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE-cCCCceEEEecCCccccCCCCCcee
Q 048517          229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl-~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +.+.+...    ..+. .++..|+.+|+.++.|||++   ++||||+||+|||+ ++.++++|+|||.++.....     
T Consensus       403 ll~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----  469 (612)
T KOG0603|consen  403 LLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----  469 (612)
T ss_pred             HHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence            88877433    2233 77888999999999999998   99999999999999 58899999999999876554     


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      ....+-|..|.|||+....  .+++++|+||||++||+|++|+.|+......       ..++..+..+.         .
T Consensus       470 ~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~---------~  531 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPK---------F  531 (612)
T ss_pred             hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCc---------c
Confidence            2455788999999999854  8999999999999999999999999754332       11333333321         1


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...++....+|+.+|||.||.+||+|.++..
T Consensus       532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  532 SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            2446677889999999999999999999876

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=4e-30  Score=262.20  Aligned_cols=249  Identities=27%  Similarity=0.382  Sum_probs=178.4

Q ss_pred             hhhcccCccCceEEEEEE-EcCCcEEEEEEecC--CCCCHHHHHHH--------------Hhccccc------CcceEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMEN--SKFSAEEFINE--------------LLGLCSE------GFKRALV  220 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~--~~~~~~~~i~e--------------l~g~~~~------~~~~~lv  220 (453)
                      ...+.||+||||.||+|+ ..+|+.||||.++.  .....+....|              +++.-..      .....++
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            345789999999999999 56899999999877  23344444333              2222222      2345799


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc----CCCceEEEecCCc
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD----HNFIPKVSDFGLA  296 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~----~~~~~kl~DFGla  296 (453)
                      ||||.+|||+..|.+.++ ...|+..+.+.++.+++.||.|||++   +|+||||||.||++-    ..-.-||+|||.|
T Consensus        96 mEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999976654 46799999999999999999999998   999999999999993    3345799999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      +-...+..   .....||..|.+||.+.+. +.++..+|.|||||++||++||..||........   .....+..+.+.
T Consensus       172 rel~d~s~---~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~---~~~~~~~~~tkk  244 (732)
T KOG4250|consen  172 RELDDNSL---FTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGPKN---NKEIMWHIITKK  244 (732)
T ss_pred             ccCCCCCe---eeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCccc---cchhhhhhhccC
Confidence            98876663   4567899999999999852 4789999999999999999999999976443211   111111111111


Q ss_pred             -------------CCcc----ccchhhhHHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHhCC
Q 048517          377 -------------GDLE----LRNVTEIESMIARKLCMIGLWCIQVKAADRP--SMTKVLEMLEGS  423 (453)
Q Consensus       377 -------------~~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP--s~~evl~~Le~~  423 (453)
                                   ....    ++............+......+|..+|++|-  ...+....+.++
T Consensus       245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence                         0111    0111123344555677777778888888887  554444444433

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=3.4e-30  Score=274.89  Aligned_cols=182  Identities=26%  Similarity=0.366  Sum_probs=135.2

Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCC-CchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTF-GLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      +|+=||||+.-++.+++....    .. .....++++.+|+.||.|+|++   +||||||||.||+||++..+||+|||+
T Consensus       671 LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGL  743 (1351)
T KOG1035|consen  671 LYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGL  743 (1351)
T ss_pred             EEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeeccccc
Confidence            467799999988888774321    11 4677899999999999999998   999999999999999999999999999


Q ss_pred             ccccC----------C------CCCceeecccCCCCCccChhhhcccCC-CCCccchHHHHHHHHHHHHcCCCCCCCCcc
Q 048517          296 AKFHP----------K------ENDFVSISDTRGTIGYLAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGRRNSNMNAT  358 (453)
Q Consensus       296 a~~~~----------~------~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~k~DV~S~Gvvl~elltg~~p~~~~~~  358 (453)
                      |....          .      .......+...||.-|+|||++.+... .++.|+|+||+|++++||+.   ||....+
T Consensus       744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME  820 (1351)
T KOG1035|consen  744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME  820 (1351)
T ss_pred             chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH
Confidence            98621          0      011112356679999999999987522 69999999999999999985   3543322


Q ss_pred             ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +       ..+...+.++.....   ..........=..++.|+++.||.+|||+.|++.
T Consensus       821 R-------a~iL~~LR~g~iP~~---~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  821 R-------ASILTNLRKGSIPEP---ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             H-------HHHHHhcccCCCCCC---cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            2       124455554433222   1122233344567999999999999999999875

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.8e-30  Score=250.53  Aligned_cols=235  Identities=19%  Similarity=0.324  Sum_probs=189.4

Q ss_pred             HHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH---HHHHH--------------HHhcccccCcceEEE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---EEFIN--------------ELLGLCSEGFKRALV  220 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~---~~~i~--------------el~g~~~~~~~~~lv  220 (453)
                      ++.-|.+.+.||+|.|..|-+++ .-+|..||||++.+.+...   ...++              .||.+.....++|||
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            34567788999999999999998 5589999999998865432   22233              267777788899999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE-cCCCceEEEecCCcccc
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL-DHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl-~~~~~~kl~DFGla~~~  299 (453)
                      +|.=.+|+|.+||...+   ..+.++...+++.||..|+.|+|+-   -+|||||||+|+.+ ..-|-+||.|||++..+
T Consensus        96 LELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            99999999999996443   5789999999999999999999997   89999999999987 45689999999999877


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ....   ..+..+|+..|-|||.+.+. ..-.++.||||+||+||-|+.|+.||...++.+        ....+.+-.  
T Consensus       170 ~PG~---kL~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------TLTmImDCK--  235 (864)
T KOG4717|consen  170 QPGK---KLTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------TLTMIMDCK--  235 (864)
T ss_pred             CCcc---hhhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchh--------hhhhhhccc--
Confidence            6654   34677899999999999875 233679999999999999999999997554322        111111111  


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           ...+.-++.+..+++..||+.||.+|.|.+||+.
T Consensus       236 -----YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 -----YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -----ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                 1245567788999999999999999999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.8e-31  Score=251.88  Aligned_cols=249  Identities=23%  Similarity=0.305  Sum_probs=185.1

Q ss_pred             hHHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------------HhcccccC
Q 048517          156 PEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------------LLGLCSEG  214 (453)
Q Consensus       156 ~~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------------l~g~~~~~  214 (453)
                      .+....+|...+.+|+|.||.|-++..+ .+..||||+++.-..-.+..+.|                    +..++.-.
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            4666778888899999999999999854 57899999998744333333222                    44556677


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-----------
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD-----------  283 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~-----------  283 (453)
                      ++.++|+|.| |-|+.++|  .++.-.+++...+..|+.|++++++|||+.   +++|-||||+|||+-           
T Consensus       164 ghiCivfell-G~S~~dFl--k~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFL--KENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             CceEEEEecc-ChhHHHHh--ccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence            7889999998 66889988  344557899999999999999999999998   999999999999992           


Q ss_pred             ---------CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 048517          284 ---------HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  354 (453)
Q Consensus       284 ---------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~  354 (453)
                               .+..+||.|||.|+......     +....|..|.|||++.+-  +++.++||||+||+|.|+.+|..-|.
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeeccceecc
Confidence                     24569999999999765544     344578999999999985  89999999999999999999998776


Q ss_pred             CCccccc----c---ccchHHHHHH------hhhCCCcccc-------------------chhhhHHHHHHHHHHHHHHh
Q 048517          355 MNATRSS----K---AYFPSWVYDQ------LNKGGDLELR-------------------NVTEIESMIARKLCMIGLWC  402 (453)
Q Consensus       355 ~~~~~~~----~---~~~~~~~~~~------l~~~~~~~~~-------------------~~~~~~~~~~~~l~~l~~~C  402 (453)
                      .....+.    +   ..+|.-....      ...+ .++-.                   ......+.....+.+|+..|
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            5542210    0   1111111111      1111 11100                   00111233456799999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 048517          403 IQVKAADRPSMTKVLE  418 (453)
Q Consensus       403 l~~~p~~RPs~~evl~  418 (453)
                      |..||.+|+|+.|++.
T Consensus       390 L~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  390 LEFDPARRITLREALS  405 (415)
T ss_pred             HccCccccccHHHHhc
Confidence            9999999999999976

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=1.3e-29  Score=273.77  Aligned_cols=129  Identities=28%  Similarity=0.424  Sum_probs=106.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.++||+|+||.||+|... +++.||||++.......    +.+..|              +++.+......++|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            3556789999999999999965 78999999997643221    223222              3444556677899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      |+.+++|.+++..    ...+++..++.|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        85 y~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999998843    24588899999999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-30  Score=236.95  Aligned_cols=235  Identities=21%  Similarity=0.245  Sum_probs=185.2

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH-----------Hhccc----ccCcceEEEEEecCCCChh
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE-----------LLGLC----SEGFKRALVYEYMPNGSLD  230 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e-----------l~g~~----~~~~~~~lv~E~~~~gsL~  230 (453)
                      ++||-|-.|.|-.+.. .+|+.+|+|+|..+...+.+....           ++.++    ....-+++|||.|+||.|.
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLf  147 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELF  147 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHH
Confidence            5799999999999985 479999999998765444432221           22222    2334467899999999999


Q ss_pred             hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc---CCCceEEEecCCccccCCCCCcee
Q 048517          231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      ..+..+  ....+++.++.+|.+||+.|+.|||+.   +|.||||||+|+|..   .|..+||+|||+|+......   .
T Consensus       148 sriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~  219 (400)
T KOG0604|consen  148 SRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---D  219 (400)
T ss_pred             HHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCc---c
Confidence            988543  346799999999999999999999997   999999999999995   36689999999998654433   3


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      ..+.+-|+.|.|||++...  .+....|+||+||++|-|+.|.+||..+....    ++......+..++-.-   ..+.
T Consensus       220 L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gqy~F---P~pE  290 (400)
T KOG0604|consen  220 LMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQYEF---PEPE  290 (400)
T ss_pred             ccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccCccC---CChh
Confidence            4667899999999999764  68889999999999999999999997665422    2333445555554322   2345


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+.+++...++++..|..+|.+|.|+.++.+
T Consensus       291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            6778888899999999999999999999986

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-29  Score=260.63  Aligned_cols=238  Identities=27%  Similarity=0.338  Sum_probs=185.9

Q ss_pred             hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHHHHH---------------Hhcccc-----cCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE---------------LLGLCS-----EGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~-----~~~~~~lv  220 (453)
                      +..|.+.||.|.+|.||+++ .++|+.+|||++.......++...|               .+|++-     .+++++||
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            45677899999999999999 6789999999998755444443333               333332     35678999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      ||||.+||..+.+....  +..+.|+.+.-|+.++++||.+||.+   .++|||||-.|||++.++.+||.|||++....
T Consensus       100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            99999999999885543  78899999999999999999999998   99999999999999999999999999998664


Q ss_pred             CCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ....  ...+..||+.|||||++...   ...++..+|+||+|++..||.-|.+|+.....           ...+-...
T Consensus       175 sT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------mraLF~Ip  241 (953)
T KOG0587|consen  175 STVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALFLIP  241 (953)
T ss_pred             cccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------hhhhccCC
Confidence            4322  23556799999999999753   23677899999999999999999999854321           11121111


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +.... ....+....+++.+++..||..|.+.||++.++++
T Consensus       242 RNPPP-kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  242 RNPPP-KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCCc-cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            11111 11135566788999999999999999999988875

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.8e-29  Score=231.05  Aligned_cols=259  Identities=22%  Similarity=0.294  Sum_probs=190.2

Q ss_pred             cccCccCceEEEEEE-EcCCcEEEEEEecCCCC-CH---------------HHHHHHHhcccccCcceEEEEEecCCCCh
Q 048517          167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF-SA---------------EEFINELLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~-~~---------------~~~i~el~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      +.||+|+|+.|--++ +.+|+.+|||++.+... .+               +..|.+|+.|+.+..+.|||||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            679999999999998 88999999999987422 12               23356689999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---CceEEEecCCccccCCCCC--
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKEND--  304 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~~~~~~--  304 (453)
                      ..+|..    ...+++.++.++.++|+.||.+||.+   +|.|||+||+|||-...   .-+||+||.|..-......  
T Consensus       164 LshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  164 LSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            999954    35799999999999999999999998   99999999999999643   3589999988764332221  


Q ss_pred             ---ceeecccCCCCCccChhhhcc---cCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHHHHH
Q 048517          305 ---FVSISDTRGTIGYLAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVYD  371 (453)
Q Consensus       305 ---~~~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~  371 (453)
                         .....++.|+..|||||+..-   ...-|..+.|.||+||+||-|++|.+||-......--       ..-.+...+
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence               123345678889999998643   2235678999999999999999999999765432110       011223344


Q ss_pred             HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCCCCCCCCCCCCCC
Q 048517          372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSIDDLQMPPKPFF  435 (453)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~~~~~~~p~~p~~  435 (453)
                      .+.++.-.-   +......++....+++...+..++.+|-++.+++.  ...+...+-.+|..+.+
T Consensus       317 sIQEGkYeF---PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~  379 (463)
T KOG0607|consen  317 SIQEGKYEF---PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVL  379 (463)
T ss_pred             HHhccCCcC---ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCccc
Confidence            455543322   22233445556667777788899999999999887  34444444444444444

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=1.1e-29  Score=236.27  Aligned_cols=254  Identities=22%  Similarity=0.273  Sum_probs=175.6

Q ss_pred             hhhhhcccCccCceEEEEEE-Ec--C--CcEEEEEEecCCCCC----H---H--HHHHH--------Hhccccc-CcceE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQ-LH--T--GRLIAVKMMENSKFS----A---E--EFINE--------LLGLCSE-GFKRA  218 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~-~~--~--g~~VAVK~l~~~~~~----~---~--~~i~e--------l~g~~~~-~~~~~  218 (453)
                      .|+...+||+|.||.||++. .+  +  .+.+|||+++.++..    .   +  ...+|        |..++.. +...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            45667889999999999996 32  3  237899999875321    1   1  11222        3333333 67789


Q ss_pred             EEEEecCCCChhhhhh-hccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC----CceEEEec
Q 048517          219 LVYEYMPNGSLDRHIF-SKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN----FIPKVSDF  293 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~-~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~----~~~kl~DF  293 (453)
                      +++||.+. +|...|+ .+......++...+..|+.||+.|+.|||++   =|+||||||.|||+..+    |.+||+||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999976 5555553 3334456788999999999999999999998   89999999999999877    99999999


Q ss_pred             CCccccCCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-cchHHHH-
Q 048517          294 GLAKFHPKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-YFPSWVY-  370 (453)
Q Consensus       294 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~-  370 (453)
                      |+++++...-... +.....-|..|.|||.+.+. ..||.+.|||+.||++.||+|-.+-|.....+.... .+..--. 
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999986543322 23445679999999999885 589999999999999999999988776544332221 1111111 


Q ss_pred             ---HHhhhCCCc---cccchh-------h----------hH------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          371 ---DQLNKGGDL---ELRNVT-------E----------IE------SMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       371 ---~~l~~~~~~---~~~~~~-------~----------~~------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                         +.+......   .+..-.       .          ..      ..-++....++..+|++||-+|.|+++.++..
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence               111110000   000000       0          00      00112366788999999999999999998743

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=2.1e-28  Score=229.56  Aligned_cols=223  Identities=26%  Similarity=0.353  Sum_probs=172.7

Q ss_pred             CceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCCChhhhhhh
Q 048517          173 GFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFS  235 (453)
Q Consensus       173 ~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~~~l~~  235 (453)
                      +||.||+|+.. +|+.+|+|++......  .+.+..|              +.+++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            68999999976 5899999999764332  2344333              56677777888999999999999998843


Q ss_pred             ccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCC
Q 048517          236 KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI  315 (453)
Q Consensus       236 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~  315 (453)
                      .    ..+++..+..++.++++++.|||+.   +++|+||+|+||+++.++.++++|||.+.......   ......++.
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence            2    2289999999999999999999998   99999999999999999999999999998765542   223456888


Q ss_pred             CccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHH
Q 048517          316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKL  395 (453)
Q Consensus       316 ~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l  395 (453)
                      .|++||.+..  ..++.++||||||+++++|++|+.|+......       .-..+.+.........    ....+...+
T Consensus       151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~----~~~~~~~~~  217 (244)
T smart00220      151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELFKKIGKPKPPFPP----PEWKISPEA  217 (244)
T ss_pred             CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCCcc----ccccCCHHH
Confidence            9999999875  36788999999999999999999998653111       1122333322211100    111144678


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 048517          396 CMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       396 ~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+++.+|++.+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            89999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.7e-30  Score=246.70  Aligned_cols=239  Identities=27%  Similarity=0.370  Sum_probs=176.0

Q ss_pred             hhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHH----------------------HHHHhcccc-cCcceEE
Q 048517          164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF----------------------INELLGLCS-EGFKRAL  219 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~----------------------i~el~g~~~-~~~~~~l  219 (453)
                      -+.+.||+|||+.||++. +..++.||||+-...+.+.++-                      |.+++.+++ +.+..+-
T Consensus       466 LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCT  545 (775)
T KOG1151|consen  466 LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCT  545 (775)
T ss_pred             HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccccee
Confidence            344679999999999998 6779999999865544333211                      112566655 4456789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEecCCc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLA  296 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla  296 (453)
                      |+||++|.+|+-||.    ....++.+++..|+.||+.||.||... .++|||-||||.||||-+   -|.+||.||||+
T Consensus       546 VLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  546 VLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             eeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            999999999999883    346789999999999999999999986 679999999999999943   478999999999


Q ss_pred             cccCCCCCce-----eecccCCCCCccChhhhccc--CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHH
Q 048517          297 KFHPKENDFV-----SISDTRGTIGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV  369 (453)
Q Consensus       297 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  369 (453)
                      +.+..+....     -+....||..|++||.+.-.  .+.++.|.||||.||++|.++.|++||..+....         
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---------  691 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---------  691 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---------
Confidence            9987654331     12345799999999987532  3578999999999999999999999997654322         


Q ss_pred             HHHhhhCCCccccchh-hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517          370 YDQLNKGGDLELRNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKVL  417 (453)
Q Consensus       370 ~~~l~~~~~~~~~~~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl  417 (453)
                       +.+.....+...... +....++.....++++||+..-++|....++.
T Consensus       692 -dILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 -DILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -HHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence             122222111111100 01122334567799999999999997665543

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=4.6e-29  Score=251.26  Aligned_cols=230  Identities=21%  Similarity=0.301  Sum_probs=182.4

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHH---HH--------------HHHHhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAE---EF--------------INELLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~---~~--------------i~el~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.++||+|.|+.|.+|+. .++..||||++.++..+..   .+              +.+|+.+.......++||||.
T Consensus        58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya  137 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA  137 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence            45568899999999999994 4799999999988544332   12              222666677778899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      .+|.+++|+..    ........+..++.|+.+|++|||++   .|+|||||++||||+.+.++||+|||++..+.... 
T Consensus       138 ~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-  209 (596)
T KOG0586|consen  138 SGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-  209 (596)
T ss_pred             cCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc-
Confidence            99999999943    24455588899999999999999998   99999999999999999999999999999887543 


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                        ...+..|++.|.|||++.+. ....+.+|+||+|++||-|+.|..||+...-.+.       -...+....+      
T Consensus       210 --~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------r~rvl~gk~r------  273 (596)
T KOG0586|consen  210 --MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------RPRVLRGKYR------  273 (596)
T ss_pred             --cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccc-------cchheeeeec------
Confidence              23567899999999999886 3568899999999999999999999986543321       1111211111      


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        .+.-++.....+++++|-.+|.+|++++++.+
T Consensus       274 --Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  274 --IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             --ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence              22223445777899999999999999999876

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-29  Score=238.07  Aligned_cols=238  Identities=21%  Similarity=0.309  Sum_probs=181.7

Q ss_pred             hhcccCccCceEEEEEEE------cCCcEEEEEEecCCC--CCHHHHHHH---H-----------hcccc-cCcceEEEE
Q 048517          165 FTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSK--FSAEEFINE---L-----------LGLCS-EGFKRALVY  221 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~--~~~~~~i~e---l-----------~g~~~-~~~~~~lv~  221 (453)
                      +...+-+|.||.||.|.+      ++.+.|-||.++...  .....++.|   +           .+.+. +....+++|
T Consensus       288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y  367 (563)
T KOG1024|consen  288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY  367 (563)
T ss_pred             chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence            345688999999999954      345667788776532  233445555   2           23332 334567899


Q ss_pred             EecCCCChhhhhhh----ccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          222 EYMPNGSLDRHIFS----KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       222 E~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      .++.-|+|..+|..    ..+..+.++-.++..++.|++.|++|||+.   ++||.||..+|++||+...+||+|=.++|
T Consensus       368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR  444 (563)
T KOG1024|consen  368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR  444 (563)
T ss_pred             eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence            99999999999862    122345678888999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeec-ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhh
Q 048517          298 FHPKENDFVSIS-DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       298 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      -.-..+.. ..+ ....+..||+||.+...  .++.++|||||||+||||+| |+.|+...+        |..++..+.+
T Consensus       445 DLFP~DYh-cLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeID--------PfEm~~ylkd  513 (563)
T KOG1024|consen  445 DLFPGDYH-CLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEID--------PFEMEHYLKD  513 (563)
T ss_pred             ccCccccc-ccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccC--------HHHHHHHHhc
Confidence            54332222 222 22356789999999876  89999999999999999998 777875433        2335667777


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      |.++.      .+.+.+.++..++.-||...|++|||+++++.-|.+
T Consensus       514 GyRla------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  514 GYRLA------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             cceec------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            77654      333456779999999999999999999999987764

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.95  E-value=6.4e-29  Score=244.65  Aligned_cols=227  Identities=27%  Similarity=0.352  Sum_probs=176.7

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccCcceEEEEEecCCCC
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGS  228 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gs  228 (453)
                      +.||.|-||+||-|+. ++|+.||||++.+.+   ...++..+|              |...|+...+.++|||-+ +|+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence            5799999999999985 589999999997732   233444444              334566778889999999 556


Q ss_pred             hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---CceEEEecCCccccCCCCCc
Q 048517          229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~~~~~~~  305 (453)
                      +.+.|.+.+  ..+|+.....-+..||+-||.|||.+   +|+|+||||+||||...   ..+||+|||.|+..+...-.
T Consensus       649 MLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            666665543  46788888888999999999999998   99999999999999643   47999999999998765422


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                         ....|||.|+|||++...  .+...-|+||.||++|--++|.-||+...+          +.+++......   -+.
T Consensus       724 ---rsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----------IndQIQNAaFM---yPp  785 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDED----------INDQIQNAAFM---YPP  785 (888)
T ss_pred             ---hhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccc----------hhHHhhccccc---cCC
Confidence               456899999999999875  788999999999999999999999975443          33444432221   122


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL  417 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl  417 (453)
                      ....+++...++++...||.+-.+|-|..+-+
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            34456677788888888998888888887654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=9.3e-29  Score=218.37  Aligned_cols=185  Identities=28%  Similarity=0.417  Sum_probs=148.1

Q ss_pred             cccCccCceEEEEEE-EcCCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceEEEEEecCCCC
Q 048517          167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRALVYEYMPNGS  228 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~gs  228 (453)
                      ..||+|++|.|=+-+ ..+|+..|||.+...-.+  ..+.+.+               ++|-..+....++.||.| .-|
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tS  130 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTS  130 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhh
Confidence            579999999998887 458999999998764322  3344444               455555667789999999 568


Q ss_pred             hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceee
Q 048517          229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  308 (453)
Q Consensus       229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  308 (453)
                      |+.+....-..+..+++..+-+||..+.+||.|||++  ..++|||+||+|||++.+|.+|++|||++-.....-   ..
T Consensus       131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Ak  205 (282)
T KOG0984|consen  131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AK  205 (282)
T ss_pred             HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh---HH
Confidence            8777654445677889999999999999999999997  799999999999999999999999999987553321   22


Q ss_pred             cccCCCCCccChhhhccc--CCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517          309 SDTRGTIGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  357 (453)
Q Consensus       309 ~~~~gt~~y~aPE~~~~~--~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~  357 (453)
                      +...|-..|||||.+...  ...|+-|+||||+|+.+.||.+++.|++...
T Consensus       206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            334577889999998642  2368999999999999999999999987543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-28  Score=227.62  Aligned_cols=229  Identities=20%  Similarity=0.310  Sum_probs=176.3

Q ss_pred             hhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHH---H----------------HHHHhcccccCcceEEEEEec
Q 048517          165 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE---F----------------INELLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~---~----------------i~el~g~~~~~~~~~lv~E~~  224 (453)
                      +...||+|+|..|-.+++ ++.+.+|+|++++.-.+.++   +                +.-|..+++...++++|.||.
T Consensus       254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv  333 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV  333 (593)
T ss_pred             eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence            346799999999999995 47889999998764322211   1                111566778888999999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++|+|--++.    ....|+.+.+.-+..+|.-||.|||+.   +|+.||+|..|+|+|..+++||.|+|+++-.-.+..
T Consensus       334 ~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  334 NGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             cCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            9999977663    335689999999999999999999998   999999999999999999999999999986555444


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                      .  +++..|||.|+|||.+.+.  .|....|.|++||+++||+.|+.||+.-.....+.+-.......+.+.+.-     
T Consensus       407 ~--tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-----  477 (593)
T KOG0695|consen  407 T--TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-----  477 (593)
T ss_pred             c--cccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-----
Confidence            2  3567899999999999886  788899999999999999999999986443333333333344443332221     


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRP  411 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP  411 (453)
                        .+..++-+...+++.-|..||.+|-
T Consensus       478 --iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 --IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             --ccceeehhhHHHHHHhhcCCcHHhc
Confidence              2223344566677888889998885

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=251.46  Aligned_cols=230  Identities=25%  Similarity=0.317  Sum_probs=163.0

Q ss_pred             cccCccCceE-EEEEEEcCCcEEEEEEecCCCCCHH----HHHHH---------HhcccccCcceEEEEEecCCCChhhh
Q 048517          167 HKLGQGGFGS-VYKGQLHTGRLIAVKMMENSKFSAE----EFINE---------LLGLCSEGFKRALVYEYMPNGSLDRH  232 (453)
Q Consensus       167 ~~LG~G~fG~-Vy~g~~~~g~~VAVK~l~~~~~~~~----~~i~e---------l~g~~~~~~~~~lv~E~~~~gsL~~~  232 (453)
                      +.+|.|+-|+ ||+|... |+.||||++-.+....-    +.+.|         .++.-++...+|+..|.| .-+|.++
T Consensus       515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dl  592 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDL  592 (903)
T ss_pred             HHcccCCCCcEEEEEeeC-CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHH
Confidence            5689999875 5999988 88999998865433211    11222         223334556678999999 6799999


Q ss_pred             hhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-----CCceEEEecCCccccCCCC-Cce
Q 048517          233 IFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFHPKEN-DFV  306 (453)
Q Consensus       233 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-----~~~~kl~DFGla~~~~~~~-~~~  306 (453)
                      +...........-...+.+..|+++||++||+-   +||||||||+||||+.     ...++|+|||+++....+. ++.
T Consensus       593 ie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~  669 (903)
T KOG1027|consen  593 IESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS  669 (903)
T ss_pred             HhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh
Confidence            855311111122245678899999999999997   9999999999999965     3579999999999876543 333


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcC-CCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      ......||-||+|||.+...  .-+.++|++|+||++|+.++| ++||...-.++.          .+..+....... .
T Consensus       670 r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----------NIl~~~~~L~~L-~  736 (903)
T KOG1027|consen  670 RLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----------NILTGNYTLVHL-E  736 (903)
T ss_pred             cccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhh----------hhhcCccceeee-c
Confidence            34566799999999999874  456699999999999999986 889976543321          111121111000 0


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL  417 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl  417 (453)
                      ...+.   ...+++.+|++++|..||++.+|+
T Consensus       737 ~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  737 PLPDC---EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             cCchH---HHHHHHHHhcCCCcccCCCHHHHh
Confidence            11111   567899999999999999999986

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.2e-28  Score=236.58  Aligned_cols=221  Identities=24%  Similarity=0.295  Sum_probs=179.8

Q ss_pred             cccCccCceEEEEEEEcCCc-EEEEEEecCCCC----CH--------------HHHHHHHhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQLHTGR-LIAVKMMENSKF----SA--------------EEFINELLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~-~VAVK~l~~~~~----~~--------------~~~i~el~g~~~~~~~~~lv~E~~~~g  227 (453)
                      ..||-||||.|=+.+.+..+ .+|+|++++...    ..              .+||.+|+..+.+....|++||-|-||
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            45999999999998877444 489998876211    11              246667899999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      .|-..|    .....|...+..-++..+..|++|||++   +||.|||||+|.+||.+|-+||.|||.|+......   .
T Consensus       506 ElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---K  575 (732)
T KOG0614|consen  506 ELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---K  575 (732)
T ss_pred             hhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC---c
Confidence            998887    3446788899999999999999999998   99999999999999999999999999999886654   3


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      +.+.+|||.|.|||.+...  ....++|.||+|++++||++|++||...+.        ...+..+.++-+.     .+.
T Consensus       576 TwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dp--------mktYn~ILkGid~-----i~~  640 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDP--------MKTYNLILKGIDK-----IEF  640 (732)
T ss_pred             eeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCch--------HHHHHHHHhhhhh-----hhc
Confidence            4667899999999999875  677899999999999999999999975542        2355555554321     234


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCC
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRPS  412 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RPs  412 (453)
                      +..+.+....++++.-..+|.+|--
T Consensus       641 Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  641 PRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ccccchhHHHHHHHHHhcCcHhhhc
Confidence            5556677788888888899999985

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-27  Score=203.38  Aligned_cols=240  Identities=22%  Similarity=0.290  Sum_probs=171.2

Q ss_pred             hcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---HHHH--------------HHHHhcccccCcceEEEEEecCCC
Q 048517          166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---AEEF--------------INELLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---~~~~--------------i~el~g~~~~~~~~~lv~E~~~~g  227 (453)
                      -++||+|.||+||+|+ .++++.||+|....+...   ....              +.+|+.......+.-+|+||| ..
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence            4689999999999999 557899999988653221   1111              222666667778889999999 56


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.++..+   -+..++.+....++.|+++||.+.|++   +++|||+||+|.|++.|+..|++|||+++-+.-.-.  .
T Consensus        86 dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr--c  157 (292)
T KOG0662|consen   86 DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--C  157 (292)
T ss_pred             HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE--e
Confidence            78777643   346788889999999999999999998   999999999999999999999999999998765432  3


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-----------
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-----------  376 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-----------  376 (453)
                      .+...-|..|.+|.++.+. .-++...|+||-||++.|+....+|....+.-..+.   .-+...+...           
T Consensus       158 ysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddql---krif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL---KRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             eeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH---HHHHHHhCCCccccCCccccC
Confidence            3556789999999999875 578999999999999999998555543332211110   0011111110           


Q ss_pred             ---CCccccchhh----hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 ---GDLELRNVTE----IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ---~~~~~~~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         ....+-.+..    ....+...-.++....+.-+|..|.++++.++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence               0000000111    11222234456777788889999999998765

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4.5e-27  Score=235.93  Aligned_cols=193  Identities=25%  Similarity=0.374  Sum_probs=151.6

Q ss_pred             cccCccCceEEEEEE-EcCCcEEEEEEecCCCC----------CHHHHHHH--------HhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF----------SAEEFINE--------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~----------~~~~~i~e--------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      +.||-|+||.|.++. .++...+|+|.|.+...          .+++.+.|        |+-.+.++..+|+||+|++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            349999999999998 55677899998876321          12233433        777788899999999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC-----
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE-----  302 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~-----  302 (453)
                      ++-..|...    ..|.++.+.-++.++..|+++.|.-   ++|||||||+|||||.+|++||.||||+.-+...     
T Consensus       715 DmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  715 DMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            999988543    4677888888899999999999986   9999999999999999999999999998533211     


Q ss_pred             ---CCce--------------------------------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH
Q 048517          303 ---NDFV--------------------------------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA  347 (453)
Q Consensus       303 ---~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell  347 (453)
                         .+..                                ......||+.|+|||++.+.  .++-.+|.||.||+|+||+
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHHh
Confidence               0000                                00122499999999999875  7888999999999999999


Q ss_pred             cCCCCCCCCccccccccchHH
Q 048517          348 GGRRNSNMNATRSSKAYFPSW  368 (453)
Q Consensus       348 tg~~p~~~~~~~~~~~~~~~~  368 (453)
                      .|+.||........+.-..+|
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeeh
Confidence            999999876655544444444

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.9e-26  Score=207.65  Aligned_cols=166  Identities=21%  Similarity=0.228  Sum_probs=124.8

Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |||.+++...   +..++|.+++.|+.|+++||.|||+.   +      ||+|||++.++.+|+  ||+++.....    
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~----   62 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE----   62 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc----
Confidence            7888888432   35699999999999999999999997   4      999999999999999  9999865432    


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                         ...||+.|||||++.+.  .++.++|||||||++|||++|+.|+......      .......+.......... ..
T Consensus        63 ---~~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~-~~  130 (176)
T smart00750       63 ---QSRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNGMPADDPRD-RS  130 (176)
T ss_pred             ---cCCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHHhccCCccc-cc
Confidence               22589999999999764  7889999999999999999999998643221      111111111111111100 11


Q ss_pred             hHHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          387 IESMIAR--KLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       387 ~~~~~~~--~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      .......  .+.+++.+||+.+|++|||+.++++.+..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            1222333  68999999999999999999999998864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=9.6e-28  Score=217.65  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=169.0

Q ss_pred             hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecC--CCCC-HH--------------HHHHHHhccccc--------Cc
Q 048517          162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMEN--SKFS-AE--------------EFINELLGLCSE--------GF  215 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~--~~~~-~~--------------~~i~el~g~~~~--------~~  215 (453)
                      +|.-..+||+|.||.||+++ .++|+.||+|+.-.  .+.+ ..              +.+..++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            33444689999999999999 55788999986432  2221 11              222225555532        23


Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      ..++|+.+|+. +|...|.   +....++..++..++.++..||.|+|+.   .|+|||+|+.|+||+.++.+||+|||+
T Consensus        98 t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            47899999964 5655552   3346789999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCc--eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH---
Q 048517          296 AKFHPKENDF--VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY---  370 (453)
Q Consensus       296 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~---  370 (453)
                      ++.+......  ...+...-|..|.+||.+.+. ..++++.|||.-||++.||.||.+-+..+.+.. +..+.+...   
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqq-ql~~Is~LcGs~  248 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ-QLHLISQLCGSI  248 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHH-HHHHHHHHhccC
Confidence            9866432221  112344569999999999875 689999999999999999999987776554321 111100000   


Q ss_pred             -----HHhhh---CCCccccchhh----hHHHH------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          371 -----DQLNK---GGDLELRNVTE----IESMI------ARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       371 -----~~l~~---~~~~~~~~~~~----~~~~~------~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           ....+   -+..+++....    ...+.      ....++++..++..||.+||.+.+++.
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                 00000   00000000000    00111      125678999999999999999998875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-26  Score=225.00  Aligned_cols=117  Identities=30%  Similarity=0.493  Sum_probs=94.7

Q ss_pred             HhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHHHHH----------------------Hhcccc----c
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE----------------------LLGLCS----E  213 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~i~e----------------------l~g~~~----~  213 (453)
                      .+|.+.+|||=|.|++||++. ..+.+.||+|+.+....-.+.-+.|                      |+..+.    .
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            678889999999999999998 5678999999998754433333222                      444443    4


Q ss_pred             CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE
Q 048517          214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL  282 (453)
Q Consensus       214 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl  282 (453)
                      +.+.++|+|++ |-+|.+.|....  -+.++...+.+|+.||+.||.|||..|  +|||-||||+|||+
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            56789999999 778888875433  356888999999999999999999987  99999999999997

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.8e-25  Score=204.23  Aligned_cols=196  Identities=36%  Similarity=0.579  Sum_probs=161.1

Q ss_pred             cCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCCChhh
Q 048517          169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDR  231 (453)
Q Consensus       169 LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~~  231 (453)
                      ||+|++|.||++... +|+.+++|++......  .+.+.+|              +++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999965 4899999999876542  3334333              3444555567899999999999999


Q ss_pred             hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCCCceeecc
Q 048517          232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISD  310 (453)
Q Consensus       232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~  310 (453)
                      ++....   ..+++..+..++.++++++.+||+.   +++|+||+|.||+++. +..++|+|||.+........  ....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            884321   4689999999999999999999998   9999999999999999 89999999999987654321  1233


Q ss_pred             cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHH
Q 048517          311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM  390 (453)
Q Consensus       311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (453)
                      ..+...|++||.+... ...+.++|+|++|+++++|                                            
T Consensus       153 ~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            5578899999988653 3678899999999999999                                            


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          391 IARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       391 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                        ..+.+++.+|++.+|++||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              468889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-27  Score=219.15  Aligned_cols=246  Identities=22%  Similarity=0.302  Sum_probs=168.6

Q ss_pred             hcccCccCceEEEEEEE-cCCcEEEEEEecCC---CCCHHHHHHHH--hcccccCc-----------------ceEEEEE
Q 048517          166 THKLGQGGFGSVYKGQL-HTGRLIAVKMMENS---KFSAEEFINEL--LGLCSEGF-----------------KRALVYE  222 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~i~el--~g~~~~~~-----------------~~~lv~E  222 (453)
                      .+-||.|+||.||.... ++|+.||.|++.+-   -....++..|+  +.++..++                 ..|++.|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            36799999999999985 48999999988652   22334455553  22222211                 2356777


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      .| ..+|.+.|.    ....|+-+.+.-+.+||++||.|||+.   +|+||||||.|.|++.|...||+|||+++....+
T Consensus       138 Lm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  138 LM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence            77 456777663    446799999999999999999999998   9999999999999999999999999999987655


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------hHHHHHHhhh
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNK  375 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~l~~  375 (453)
                      +.. .++...-|-.|.|||.+.+. ..|+.+.||||.||++.||+.++--|.....-+.-..+       ....++...+
T Consensus       210 ~~~-hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  210 DRL-NMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhh-hhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            433 23555678899999999885 58999999999999999999888666433221100000       0001111111


Q ss_pred             CCC-------ccccch-----hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          376 GGD-------LELRNV-----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       376 ~~~-------~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                      |..       ....+.     ...+..-...-..+...++..+|+.|.+.++.+..+.
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            100       000000     0001111223445667788999999999999887664

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=8.8e-26  Score=249.10  Aligned_cols=209  Identities=16%  Similarity=0.187  Sum_probs=143.9

Q ss_pred             CcEEEEEEecCCCCCHH-HHHHHHhcccc-------cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHH
Q 048517          185 GRLIAVKMMENSKFSAE-EFINELLGLCS-------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA  256 (453)
Q Consensus       185 g~~VAVK~l~~~~~~~~-~~i~el~g~~~-------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia  256 (453)
                      ...||+--..+.+...+ +++..+++.+.       +....+.++||+ +++|.++|..   ....+++.+++.++.||+
T Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~   90 (793)
T PLN00181         15 TSGVSEFCTDGSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIV   90 (793)
T ss_pred             cccccccCCCccchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHH
Confidence            34466655555444444 68888888772       223567788987 6699999843   235699999999999999


Q ss_pred             HHHHHhHcCCCCceeecccCCcceEEcC-------------------CCceEEEecCCccccCCCCC-------------
Q 048517          257 RGIEYLHNGCDVCILHFDIKPHNILLDH-------------------NFIPKVSDFGLAKFHPKEND-------------  304 (453)
Q Consensus       257 ~gL~yLH~~~~~~ivH~Dikp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~-------------  304 (453)
                      +||.|||++   +|+||||||+||||+.                   ++.+|++|||+++.......             
T Consensus        91 ~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~  167 (793)
T PLN00181         91 EIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQP  167 (793)
T ss_pred             HHHHHHHhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCC
Confidence            999999998   9999999999999954                   45566777777654211000             


Q ss_pred             -ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          305 -FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       305 -~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                       ........||+.|||||++.+.  .++.++|||||||+||||++|..|+.....          ....+..... ..  
T Consensus       168 ~~~~~~~~~gt~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----------~~~~~~~~~~-~~--  232 (793)
T PLN00181        168 FPMKQILAMEMSWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSR----------TMSSLRHRVL-PP--  232 (793)
T ss_pred             CcccccccCCCcceEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHH----------HHHHHHHhhc-Ch--
Confidence             0001123578899999998764  789999999999999999998877542110          1111111100 00  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         ...........++.+||+.+|.+||||.|+++
T Consensus       233 ---~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        233 ---QILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ---hhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence               00011233567888999999999999999986

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8.2e-25  Score=200.59  Aligned_cols=240  Identities=20%  Similarity=0.310  Sum_probs=176.4

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHHH-hc---------------ccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINEL-LG---------------LCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~el-~g---------------~~~~~~~~~lv~E~  223 (453)
                      ..|++.+.||+|.||.+-++.++ +++.+++|.+........+|.+|+ ++               .++..+...+++||
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            35677889999999999999965 678899999998888888998883 22               23344456789999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE-cCC-CceEEEecCCccccCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL-DHN-FIPKVSDFGLAKFHPK  301 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl-~~~-~~~kl~DFGla~~~~~  301 (453)
                      ++.|+|...+     ....+.+.....++.|+++||.|+|++   ++||||||.+|||+ +.| -.+||+|||+++..+.
T Consensus       104 aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  104 APRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             Cccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            9999998766     235677888899999999999999999   99999999999999 444 4799999999875432


Q ss_pred             CCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      .-     .-..-+..|.+||.....   .....+.+|||.||++++.++||+.|+....    ...-+.|-+.+..++..
T Consensus       176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~----~~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS----IMDKPYWEWEQWLKRKN  246 (378)
T ss_pred             ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh----ccCchHHHHHHHhcccC
Confidence            11     222356679999977532   1245778999999999999999999997322    12223344444444333


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                      ..++   ..-...+.++..+.++-+..++++|=.+.++-++-
T Consensus       247 ~~~P---~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 PALP---KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ccCc---hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            2221   12223456677788888999999996666666554

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=2.6e-25  Score=219.19  Aligned_cols=254  Identities=20%  Similarity=0.285  Sum_probs=185.5

Q ss_pred             chhHHHHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC------HHHHHHH--------------Hhcccc
Q 048517          154 LLPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS------AEEFINE--------------LLGLCS  212 (453)
Q Consensus       154 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~------~~~~i~e--------------l~g~~~  212 (453)
                      .+.|+...+|.+....|+|-|++|-.|.. ..|+.||||++.+...-      .-+++.+              |+..+.
T Consensus       425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            45688889999999999999999999984 45889999999874221      1123332              555667


Q ss_pred             cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEE
Q 048517          213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVS  291 (453)
Q Consensus       213 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~  291 (453)
                      ..++++||+|-+ ..+|.+.|... ..+..|....+..++.|+.-||..|-..   +|+|.||||.|||+++. ..+|||
T Consensus       505 hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  505 HKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             hcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence            788999999988 67888887433 3446788999999999999999999997   99999999999999874 578999


Q ss_pred             ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------cc
Q 048517          292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AY  364 (453)
Q Consensus       292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~  364 (453)
                      |||.|......+    .+...-+..|.|||.+.+.  +|+...|+||.||.||||.||+--|........-       .-
T Consensus       580 DfGSA~~~~ene----itPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  580 DFGSASFASENE----ITPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             cCcccccccccc----ccHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence            999998765543    2333456689999999985  8899999999999999999999877654332111       11


Q ss_pred             chHHHH-------HHhhhC--------------CC------ccc-cc----------hhhhHHHHHHHHHHHHHHhcccC
Q 048517          365 FPSWVY-------DQLNKG--------------GD------LEL-RN----------VTEIESMIARKLCMIGLWCIQVK  406 (453)
Q Consensus       365 ~~~~~~-------~~l~~~--------------~~------~~~-~~----------~~~~~~~~~~~l~~l~~~Cl~~~  406 (453)
                      +|.-+.       +++.+.              ..      +.+ .+          ..........++..|+..|+..|
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence            111111       011000              00      000 00          01122334467889999999999


Q ss_pred             CCCCCCHHHHHH
Q 048517          407 AADRPSMTKVLE  418 (453)
Q Consensus       407 p~~RPs~~evl~  418 (453)
                      |++|.|..+.++
T Consensus       734 P~KRit~nqAL~  745 (752)
T KOG0670|consen  734 PEKRITVNQALK  745 (752)
T ss_pred             hhhcCCHHHHhc
Confidence            999999999875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=3.7e-25  Score=198.40  Aligned_cols=244  Identities=18%  Similarity=0.287  Sum_probs=173.0

Q ss_pred             HhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCC-CHHHHHHH------------Hhccccc--CcceEEEEEec
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF-SAEEFINE------------LLGLCSE--GFKRALVYEYM  224 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~-~~~~~i~e------------l~g~~~~--~~~~~lv~E~~  224 (453)
                      ..|++.+++|+|.++.||.|. ..+++.++||+++.-+. ...+.+.-            |+....+  .....||+||.
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v  117 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV  117 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence            356778999999999999998 66788999999987332 22222222            2222222  33457999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~  303 (453)
                      .|.+.....       ..|+-..+...+.+++.||.|+|+.   +|.|||+||+|+++|. .-..+|.|+|+|.++....
T Consensus       118 ~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  118 NNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             ccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            988875544       5678888999999999999999998   9999999999999986 5679999999999887655


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch------HHHHHHhhh--
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP------SWVYDQLNK--  375 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~------~~~~~~l~~--  375 (453)
                      .+   +....+..|--||.+.. +..+...-|+|||||+|.+|+..+.||.-..+...+.--.      ......+.+  
T Consensus       188 eY---nVRVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  188 EY---NVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             ee---eeeeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            43   33446677889998875 3578889999999999999999999997654432221000      001111111  


Q ss_pred             -------------CCCccccc--hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 -------------GGDLELRN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 -------------~~~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                   ..+.....  ..+...-...+..+++...|..|.++|||++|..+
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                         11100000  00111123367888999999999999999999865

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=6.2e-24  Score=197.48  Aligned_cols=184  Identities=33%  Similarity=0.481  Sum_probs=148.7

Q ss_pred             hhhcccCccCceEEEEEEEcC-CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          164 HFTHKLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~~-g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .+.+.||+|++|.||++...+ ++.+|+|.+......  .+.+..|              +++++......++++||+++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            456789999999999999764 899999999875432  3333333              45566666788999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      ++|.+++....   ..+++..+..++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        82 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       82 GDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            99999885322   1188999999999999999999998   9999999999999999999999999999877554200 


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  355 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~  355 (453)
                      ......++..|++||.+. ....++.++|||+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            113345778899999984 224778899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=4.2e-24  Score=206.91  Aligned_cols=183  Identities=25%  Similarity=0.355  Sum_probs=143.6

Q ss_pred             hhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCC-CH-------------HHHHHHHhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKF-SA-------------EEFINELLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~-~~-------------~~~i~el~g~~~~~~~~~lv~E~~  224 (453)
                      +...++||+|.|++||++.+.    .++.||+|.+..... ..             ...+..+.++...++...+|+||+
T Consensus        38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~  117 (418)
T KOG1167|consen   38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF  117 (418)
T ss_pred             hhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence            445689999999999999843    477899998876322 11             122333667777888999999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~  303 (453)
                      +.-...+++       ..++...+..++..+..||.++|++   +||||||||+|+|.+. ...-.|.|||+|.......
T Consensus       118 ~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  118 EHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             CccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            999988877       4577889999999999999999998   9999999999999986 4667899999997211000


Q ss_pred             ---------------------------------Ccee---------ecccCCCCCccChhhhcccCCCCCccchHHHHHH
Q 048517          304 ---------------------------------DFVS---------ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGM  341 (453)
Q Consensus       304 ---------------------------------~~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gv  341 (453)
                                                       .+..         .....||+||.|||++.+. +.-+.++||||.|+
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GV  266 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGV  266 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccc
Confidence                                             0000         0112499999999999874 67899999999999


Q ss_pred             HHHHHHcCCCCCCCC
Q 048517          342 VLLEMAGGRRNSNMN  356 (453)
Q Consensus       342 vl~elltg~~p~~~~  356 (453)
                      +++.+++++.||...
T Consensus       267 I~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  267 ILLSLLSRRYPFFKA  281 (418)
T ss_pred             eeehhhccccccccC
Confidence            999999999998643

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.90  E-value=2.3e-24  Score=214.95  Aligned_cols=177  Identities=24%  Similarity=0.313  Sum_probs=147.9

Q ss_pred             hcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH--------------------------HHHHHHHhcccccCcceE
Q 048517          166 THKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA--------------------------EEFINELLGLCSEGFKRA  218 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~--------------------------~~~i~el~g~~~~~~~~~  218 (453)
                      .+.||+|+||.|+.+.++ +...|+||++.+++...                          ++.|.+++.+++++...+
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            367999999999999965 56789999987643221                          244666999999999999


Q ss_pred             EEEEec-CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          219 LVYEYM-PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       219 lv~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      |++|-. ++.+|.++|    ..+..+++++..-|++|++.|+++||++   +|||||||-+|+.+|.+|.+||.|||.|.
T Consensus       646 l~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             EEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchh
Confidence            999987 566888888    3446799999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  354 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~  354 (453)
                      .....    .....+||.+|.|||++.+. ......-|||++|++||.++....|+.
T Consensus       719 ~~ksg----pfd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  719 YTKSG----PFDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhcCC----CcceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            65433    22456899999999999875 234567899999999999998887763

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.90  E-value=3.4e-24  Score=216.92  Aligned_cols=236  Identities=22%  Similarity=0.252  Sum_probs=177.1

Q ss_pred             hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---------------HHHHHHHHhcccccCcceEEEEEecCC
Q 048517          163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---------------AEEFINELLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---------------~~~~i~el~g~~~~~~~~~lv~E~~~~  226 (453)
                      |.+...+|.|.||.|||++ .++++..|||+++.....               .+..+..++|.+....+.++.|||+.+
T Consensus        17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg   96 (829)
T KOG0576|consen   17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG   96 (829)
T ss_pred             hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence            4566789999999999999 668999999998763211               123344578888888899999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+..+    ....++..++...+++..+||+|||+.   +=+|||||-.|||+++.+.+|++|||.+..+...  ..
T Consensus        97 gslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~  167 (829)
T KOG0576|consen   97 GSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA  167 (829)
T ss_pred             Ccccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence            99988764    236789999999999999999999998   8899999999999999999999999998655321  11


Q ss_pred             eecccCCCCCccChhhhc-ccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~-~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      ......||+.|||||+.. ...+.+..++|||+.|+...|+-.-++|......        .-+.....+... +.. ..
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------mr~l~LmTkS~~-qpp-~l  237 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------MRALFLMTKSGF-QPP-TL  237 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------HHHHHHhhccCC-CCC-cc
Confidence            224567999999999763 3347889999999999999999877766432111        001111111111 110 01


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL  417 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl  417 (453)
                      .......+.+-++++.|+..+|++|||++..+
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            12233456788999999999999999997654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.88  E-value=8.2e-23  Score=191.57  Aligned_cols=231  Identities=24%  Similarity=0.248  Sum_probs=160.0

Q ss_pred             cccCccCceEEEEEE-EcCCcEEEEEEecCCCC---CHHHHHHH--------------Hhccccc------CcceEEEEE
Q 048517          167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSE------GFKRALVYE  222 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~------~~~~~lv~E  222 (453)
                      ..+|.|.- .|-.+. .-.+++||+|++...-.   ..++.-.|              ++.++..      -...++|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            34677766 454444 23588999998754211   11111111              3333322      224578999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      +| .++|...+.      ..++-+++..|..|+..|++|||+.   +|+||||||+||++..+..+||.|||+|+....+
T Consensus       102 ~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen  102 LM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             hh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence            99 667877664      3467788899999999999999998   9999999999999999999999999999865443


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH------------
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY------------  370 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~------------  370 (453)
                         ..++....|..|.|||++.+.  ++..++||||.||++.||++|+--|.....      +..|..            
T Consensus       172 ---~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~------idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  172 ---FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDH------IDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             ---cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchH------HHHHHHHHHHhcCCCHHH
Confidence               245667789999999999986  599999999999999999999987763322      111211            


Q ss_pred             -HHhhh-----------CC---------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          371 -DQLNK-----------GG---------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       371 -~~l~~-----------~~---------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                       +++..           -.         +.......+.+.........++.+||-.+|++|.|+.+++..
T Consensus       241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence             11100           00         000001111122233457789999999999999999999874

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=3.5e-22  Score=183.40  Aligned_cols=237  Identities=20%  Similarity=0.361  Sum_probs=176.3

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCC---CCHHHHHH--------------HHhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSK---FSAEEFIN--------------ELLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~---~~~~~~i~--------------el~g~~~~~~~~~lv~E~~  224 (453)
                      .-++.-+|.+..-|..|+|+++ |..+++|+++...   ...++|-.              .++|-|.......++..||
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            3456678999999999999998 5556668876522   22233333              3788898888899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE--ecCCccccCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS--DFGLAKFHPKE  302 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~--DFGla~~~~~~  302 (453)
                      +.|||...|+..  .+...+-.++.+++.++|+|++|||+- ++-|...-+.++.+++|++.+++|+  |--.+      
T Consensus       270 p~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs------  340 (448)
T KOG0195|consen  270 PFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS------  340 (448)
T ss_pred             cchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee------
Confidence            999999999754  345677889999999999999999996 4456667899999999999998886  21111      


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCC-CccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                        ++ .....-.|.||+||.+++..... -.++|+|||+++||||.|+..||.....-+.       -.+...++-+.. 
T Consensus       341 --fq-e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------gmkialeglrv~-  409 (448)
T KOG0195|consen  341 --FQ-EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------GMKIALEGLRVH-  409 (448)
T ss_pred             --ee-ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------hhhhhhcccccc-
Confidence              11 12334578899999998753322 4589999999999999999999965432110       111222222222 


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                           .+..+++.+.+++.-|+..||.+||.+..|+-.||+..
T Consensus       410 -----ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  410 -----IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -----CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                 44456788999999999999999999999999999753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=5.7e-20  Score=182.09  Aligned_cols=251  Identities=20%  Similarity=0.233  Sum_probs=172.4

Q ss_pred             hhhhhcccCccCceEEEEEEEcC--CcEEEEEEecCCCCCH------H-HHHHHHh------cc------c-ccCcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMMENSKFSA------E-EFINELL------GL------C-SEGFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~--g~~VAVK~l~~~~~~~------~-~~i~el~------g~------~-~~~~~~~l  219 (453)
                      .+.+.++||+|+||.||++....  ...+|+|.........      + ..+..+.      ++      . ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            56778999999999999999654  3579999876532211      1 2222232      22      2 24446789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-----CceEEEecC
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-----FIPKVSDFG  294 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-----~~~kl~DFG  294 (453)
                      ||+.. +-+|.+.....  ....++..+.+.|+.|++.+|++||+.   +++||||||.|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~--~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRN--PPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhC--CCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99987 88998865322  257899999999999999999999998   99999999999999754     468999999


Q ss_pred             Ccc--ccCCCCC---ce--e-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch
Q 048517          295 LAK--FHPKEND---FV--S-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP  366 (453)
Q Consensus       295 la~--~~~~~~~---~~--~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  366 (453)
                      +++  .+.....   ..  . ....+||..|.++++..+.  ..+.+.|+||++.++.|+..|..|+..........   
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~---  247 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS---  247 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchHH---
Confidence            999  3322221   00  1 1235699999999998875  78999999999999999999999885433221100   


Q ss_pred             HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCC
Q 048517          367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMP  430 (453)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p  430 (453)
                        ............  .   ........+.++...+-..+..++|....+.+.|+.........
T Consensus       248 --~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~  304 (322)
T KOG1164|consen  248 --KFEKDPRKLLTD--R---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSK  304 (322)
T ss_pred             --HHHHHhhhhccc--c---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCC
Confidence              001111100000  0   00111234555666666689999999999999987765554333

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=1.2e-20  Score=199.58  Aligned_cols=238  Identities=21%  Similarity=0.246  Sum_probs=168.3

Q ss_pred             hhcccCccCceEEEEEE-EcCCcEEEEEEecC---CCCCHHHHHH----H--------------HhcccccCcceEEEEE
Q 048517          165 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMEN---SKFSAEEFIN----E--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~---~~~~~~~~i~----e--------------l~g~~~~~~~~~lv~E  222 (453)
                      ....+|.|.+|.|+... .......+.|....   .....+++..    |              .+..+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            34679999999887776 33444444443321   1112222211    1              2222223333334599


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++ +|...+-    ....++-.++..+.+|+..|+.|||+.   +|.|||+|++|++++.++.+||+|||.+..+...
T Consensus       402 ~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  402 YCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             cccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            9999 9988773    224688899999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCc--eeecccCCCCCccChhhhcccCCCC-CccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          303 NDF--VSISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       303 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ...  .......|+..|+|||.+.+.  .+ ....||||.|+++..|++|+.||........+.      .+........
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~  545 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRN  545 (601)
T ss_pred             cchhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccc
Confidence            332  445677899999999999875  44 458999999999999999999987654332111      1111111112


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...........++.....++.++|+++|.+|.||++|++
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            222233356677788899999999999999999999986

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=3.8e-20  Score=184.24  Aligned_cols=151  Identities=21%  Similarity=0.187  Sum_probs=109.8

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc--CCcEEEEEEecCCCC------CHHHHHHHH-----------h-cccccCcceEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMMENSKF------SAEEFINEL-----------L-GLCSEGFKRAL  219 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~--~g~~VAVK~l~~~~~------~~~~~i~el-----------~-g~~~~~~~~~l  219 (453)
                      ...|.+.+.||+|+||+||+|+..  +++.||||++.....      ..+.+.+|.           . .+. .....++
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~-~~~~~~L   95 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL-ATGKDGL   95 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE-EcCCcEE
Confidence            345777899999999999999854  578889998753211      123344441           1 111 2235789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeeccc-CCcceEEcCCCceEEEecCCccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI-KPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di-kp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ||||+++++|.. + .  .. .      ...++.+++++|.|||+.   +|+|||| ||+|||++.++.+||+|||+|+.
T Consensus        96 VmE~~~G~~L~~-~-~--~~-~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         96 VRGWTEGVPLHL-A-R--PH-G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             EEEccCCCCHHH-h-C--cc-c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence            999999999962 2 1  00 0      146788999999999998   9999999 99999999999999999999997


Q ss_pred             cCCCCCcee------ecccCCCCCccChhhhcc
Q 048517          299 HPKENDFVS------ISDTRGTIGYLAPELISR  325 (453)
Q Consensus       299 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~  325 (453)
                      .........      .....+++.|+|||++..
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            755432111      134568888999998864

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=7.6e-20  Score=185.55  Aligned_cols=216  Identities=21%  Similarity=0.352  Sum_probs=164.2

Q ss_pred             HHHHHHHHhcccccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCce-eecccCCc
Q 048517          200 AEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI-LHFDIKPH  278 (453)
Q Consensus       200 ~~~~i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vH~Dikp~  278 (453)
                      .++.++.++|.+.++...+.|.+|+..|+|.+.+..   ....++|.....+.++|+.||+|||+.   +| .|+.+++.
T Consensus         5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s~   78 (484)
T KOG1023|consen    5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKSS   78 (484)
T ss_pred             chhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeeccc
Confidence            467788999999999999999999999999999954   346789999999999999999999987   55 99999999


Q ss_pred             ceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhccc--CC---CCCccchHHHHHHHHHHHHcCCCCC
Q 048517          279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN--FG---TVSCKSDVYGFGMVLLEMAGGRRNS  353 (453)
Q Consensus       279 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~---~~s~k~DV~S~Gvvl~elltg~~p~  353 (453)
                      |+++|.++.+|++|||+..+..............-..-|.|||.+...  ..   ..+.+.||||||++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999999876431111111222344569999998763  11   2577899999999999999999999


Q ss_pred             CCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          354 NMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      +........    ..+...+.++.....+.......+....+..++..||..+|++||++.+|-..++....
T Consensus       159 ~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  159 DLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            875543322    22333344422222222222122444578999999999999999999999999887554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.81  E-value=1.3e-18  Score=168.55  Aligned_cols=247  Identities=28%  Similarity=0.349  Sum_probs=173.5

Q ss_pred             hhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC----HHHHHHH---------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS----AEEFINE---------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~----~~~~i~e---------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.....||.|+||.||++...  ..+|+|.+......    ...+..|               +...+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            345678999999999999977  88999998764332    3344433               12223333346899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKE  302 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~  302 (453)
                      +.++++.+.+...... ..+.......+..+++.++.|+|+.   +++|||+||+||+++... .++++|||+++.....
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999998655322111 3688889999999999999999998   899999999999999988 7999999999865544


Q ss_pred             CCce----eecccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          303 NDFV----SISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       303 ~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ....    ......||..|+|||.+.... ...+...|+||+|++++++++|..|+......    .......+.+....
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~  231 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELP  231 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcC
Confidence            3221    235667999999999997631 36888999999999999999999996543321    00111222222221


Q ss_pred             Cc--cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          378 DL--ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       378 ~~--~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ..  ...............+.+++..|+..+|..|.++.+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11  0000000001223467788899999999999999887764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=2.6e-19  Score=163.63  Aligned_cols=126  Identities=17%  Similarity=0.195  Sum_probs=94.9

Q ss_pred             hcccCccCceEEEEEEEcCCcEEEEEEecCCCC---C------------------------------HHHHHHHHhcccc
Q 048517          166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---S------------------------------AEEFINELLGLCS  212 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---~------------------------------~~~~i~el~g~~~  212 (453)
                      ...||+|+||.||+|...+|+.||||+++.+..   .                              +-+.+..+.....
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            367999999999999987899999999875421   1                              0112222322111


Q ss_pred             ------cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHh-HcCCCCceeecccCCcceEEcCC
Q 048517          213 ------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL-HNGCDVCILHFDIKPHNILLDHN  285 (453)
Q Consensus       213 ------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dikp~NILl~~~  285 (453)
                            .....++||||++++++.....    ....+++.+...++.|++.+|.|| |+.   +|+||||||+|||++ +
T Consensus        82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILLKSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEecCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence                  0122379999999887765432    124688999999999999999999 676   999999999999998 4


Q ss_pred             CceEEEecCCcccc
Q 048517          286 FIPKVSDFGLAKFH  299 (453)
Q Consensus       286 ~~~kl~DFGla~~~  299 (453)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999999743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=7.9e-19  Score=165.60  Aligned_cols=249  Identities=18%  Similarity=0.263  Sum_probs=170.4

Q ss_pred             hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCC---CHHHH--HHH---------HhcccccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF---SAEEF--INE---------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~---~~~~~--i~e---------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      -|.+.++||+|.||.++.|+ +-++++||||.-.....   ...++  -+-         ++-|..++.+..||+|.+ +
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            45677999999999999999 66799999997544221   12222  111         344456777888999998 7


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-----CceEEEecCCccccCC
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-----FIPKVSDFGLAKFHPK  301 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-----~~~kl~DFGla~~~~~  301 (453)
                      -||+|...   --+..|+.+++..||+|++.-++|+|++   .+|.|||||+|.||...     -.+.+.|||+|+.+..
T Consensus       108 PSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  108 PSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             cCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            78887662   2357899999999999999999999998   99999999999999643     3578999999998755


Q ss_pred             CCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          302 ENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       302 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      ..+.     .......||.+||+-....+.  .-+.+-|.=|+|-++++.+-|..||.......     -+..++.+.+.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-----nK~kYeKIGe~  254 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-----NKEKYEKIGET  254 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcc-----hHHHHHHhccc
Confidence            4332     222345699999998877765  67889999999999999999999997543221     11133444332


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ....  ...+.-..++.++..-+.-.-..+-.+-|...-+...+...++.
T Consensus       255 Kr~T--~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  255 KRST--PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             cccC--CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence            2211  11122222334444444444445555666655444444443333

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=3.9e-19  Score=160.97  Aligned_cols=260  Identities=20%  Similarity=0.232  Sum_probs=174.8

Q ss_pred             HHHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC----HHHHHHH----------HhcccccCcceEEEEE
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS----AEEFINE----------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~----~~~~i~e----------l~g~~~~~~~~~lv~E  222 (453)
                      +....|.+.++||.|+||.+|.|. ..+|..||||+-......    .+.-+-+          +..+..++....+||+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            344567788999999999999998 778999999986653221    1111111          4455677788899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---CceEEEecCCcccc
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFH  299 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~  299 (453)
                      .+ +-||++...-   -...++..+++-.+-|++.-++|+|..   +++||||||+|.|..-+   ..+.+.|||+|+.+
T Consensus        92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            98 7788876522   235789999999999999999999998   99999999999999654   35789999999977


Q ss_pred             CCCCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          300 PKENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       300 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      ....+.     .......||..|.+-....+.  .-+.+.|+=|+|.+|..+--|..|+......+..     -.++.+.
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-----QKyEkI~  237 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-----QKYEKIS  237 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----HHHHHHH
Confidence            543221     122344699999988877653  5678899999999999999999999764432211     1222222


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCC
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKP  433 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p  433 (453)
                      +......  ....-...+.++...+.-|-+.-=++-|...-+-++++-....+.....-
T Consensus       238 EkK~s~~--ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~  294 (341)
T KOG1163|consen  238 EKKMSTP--IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDY  294 (341)
T ss_pred             HhhcCCC--HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCe
Confidence            2211100  01122223344555666666666666665554444444333333333333

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=1.8e-18  Score=158.24  Aligned_cols=128  Identities=20%  Similarity=0.214  Sum_probs=94.8

Q ss_pred             hcccCccCceEEEEEEEcCCcEEEEEEecCCCCC----------------------HH-----------HHHHHHhcccc
Q 048517          166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS----------------------AE-----------EFINELLGLCS  212 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~----------------------~~-----------~~i~el~g~~~  212 (453)
                      ...||+|+||.||+|+..+|+.||||++......                      ..           +.+.++.....
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3579999999999999778999999998764211                      00           11111211110


Q ss_pred             c------CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCC
Q 048517          213 E------GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHN  285 (453)
Q Consensus       213 ~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~  285 (453)
                      .      ....+|||||++++++.....    ....++......++.+++.++.+||+ .   +|+||||||+|||++ +
T Consensus        82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKKNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecCCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence            0      012379999999886544321    12356778889999999999999999 7   999999999999999 8


Q ss_pred             CceEEEecCCccccCC
Q 048517          286 FIPKVSDFGLAKFHPK  301 (453)
Q Consensus       286 ~~~kl~DFGla~~~~~  301 (453)
                      +.++|+|||+++....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=2.8e-18  Score=164.24  Aligned_cols=218  Identities=22%  Similarity=0.301  Sum_probs=139.9

Q ss_pred             hhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHHHhcc-----------------------------
Q 048517          165 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINELLGL-----------------------------  210 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~el~g~-----------------------------  210 (453)
                      ..+.||.|+++.||.++.. +|+.+|||+......    ..+++.+|-+..                             
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            3467999999999999966 699999998765322    223333331110                             


Q ss_pred             ----cccCc--------ceEEEEEecCCCChhhhh---hhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeeccc
Q 048517          211 ----CSEGF--------KRALVYEYMPNGSLDRHI---FSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI  275 (453)
Q Consensus       211 ----~~~~~--------~~~lv~E~~~~gsL~~~l---~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di  275 (453)
                          ...+.        ..+++|+-+ .++|.+.+   +........+....++.+..|+++.+++||+.   +++|+||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi  171 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI  171 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence                00010        124566666 56776664   33322223455556677889999999999998   9999999


Q ss_pred             CCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhccc------CCCCCccchHHHHHHHHHHHHcC
Q 048517          276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN------FGTVSCKSDVYGFGMVLLEMAGG  349 (453)
Q Consensus       276 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~k~DV~S~Gvvl~elltg  349 (453)
                      ||+|++++.+|.++|+||+.........     .....+..|.+||.....      .-.++.+.|.|++|+++|.|..+
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999999999999998776543311     113456789999977542      12578899999999999999999


Q ss_pred             CCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCC
Q 048517          350 RRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR  410 (453)
Q Consensus       350 ~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R  410 (453)
                      +.|++.........    |           +.   ..-. ++++.+..++..+|+.+|++|
T Consensus       247 ~lPf~~~~~~~~~~----~-----------~f---~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPE----W-----------DF---SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSG----G-----------GG---TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCcccccc----c-----------cc---hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99998765432211    1           11   1112 566788999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=2.7e-17  Score=178.00  Aligned_cols=182  Identities=23%  Similarity=0.254  Sum_probs=142.8

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH----HHHHHH-----------HhcccccCcceEEEE
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA----EEFINE-----------LLGLCSEGFKRALVY  221 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~----~~~i~e-----------l~g~~~~~~~~~lv~  221 (453)
                      ++-...+.+.+.||+|+||+||+|...+|+.||+|+-+......    .+.+.+           +.....-.+.-+||+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            33344556678899999999999997779999999876543221    111111           222222234457999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-------CCCceEEEecC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD-------HNFIPKVSDFG  294 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~-------~~~~~kl~DFG  294 (453)
                      ||.+.|||.+++.    ..+..+|.....++.|+++.++.||..   +|||+||||+|.||.       .+..++|+|||
T Consensus       774 ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  774 EYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            9999999999984    557789999999999999999999998   999999999999993       34578999999


Q ss_pred             Cccc---cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC
Q 048517          295 LAKF---HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  350 (453)
Q Consensus       295 la~~---~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~  350 (453)
                      -+--   ++...   ......+|-++-.+|+..+.  .++..+|-|.++.+++-|+.|+
T Consensus       847 ~siDm~lfp~~~---~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  847 RSIDMKLFPDGT---KFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cceeeeEcCCCc---EEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHH
Confidence            9853   33332   23556788899999999886  8999999999999999999986

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.71  E-value=6.6e-18  Score=179.83  Aligned_cols=237  Identities=23%  Similarity=0.269  Sum_probs=158.6

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCC--CCCHHHHHHHHhccc----------------ccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENS--KFSAEEFINELLGLC----------------SEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~--~~~~~~~i~el~g~~----------------~~~~~~~lv~E~  223 (453)
                      ..++.+.||.+.|=+|.+|+.+.|. |+||++-+.  ....+.|.++|.+.-                ...+..+||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            3456788999999999999998887 999988663  334455544432211                122233466666


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc--CC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PK  301 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~--~~  301 (453)
                      . .-+|.|.|    ....-+..-+..-|+.|++.||.-.|..   +|+|||||.+|||++.=.=+.|+||..-+..  +.
T Consensus       103 v-khnLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 V-KHNLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             H-hhhhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            6 34666666    3334567777888999999999999998   9999999999999988656789999765532  22


Q ss_pred             CC--C--ceeecccCCCCCccChhhhcccC---------CCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchH
Q 048517          302 EN--D--FVSISDTRGTIGYLAPELISRNF---------GTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPS  367 (453)
Q Consensus       302 ~~--~--~~~~~~~~gt~~y~aPE~~~~~~---------~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  367 (453)
                      ++  +  +.- .+.+.-..|+|||.+....         +..+++.||||.||++.||++ |+++|....-         
T Consensus       175 DNPadf~fFF-DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL---------  244 (1431)
T KOG1240|consen  175 DNPADFTFFF-DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL---------  244 (1431)
T ss_pred             CCcccceEEE-ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH---------
Confidence            21  1  111 1222334799999886421         137889999999999999987 5777642210         


Q ss_pred             HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                        ... +.+......  ...+......++.+++.|+|.||..|-|+++.++.-+|
T Consensus       245 --~aY-r~~~~~~~e--~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  245 --LAY-RSGNADDPE--QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             --HhH-hccCccCHH--HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence              000 011111000  00111222368899999999999999999999988554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=3.1e-17  Score=152.62  Aligned_cols=160  Identities=14%  Similarity=0.112  Sum_probs=113.5

Q ss_pred             hhHHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHH----------HHH--------------Hhcc
Q 048517          155 LPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF----------INE--------------LLGL  210 (453)
Q Consensus       155 ~~~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~----------i~e--------------l~g~  210 (453)
                      +.++...+++..+.||.|+||.||.... +++.+|||.+.......+.+          ..|              ...+
T Consensus        25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            4467777888889999999999999665 57789999997643332222          222              1111


Q ss_pred             cc--c------CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE
Q 048517          211 CS--E------GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL  282 (453)
Q Consensus       211 ~~--~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl  282 (453)
                      ..  .      ....+|+|||++|.+|.+..        .++.    ....+++.+|..+|+.   +++|||+||.||++
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili  168 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV  168 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence            11  1      23578999999999997753        1221    3466999999999998   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH
Q 048517          283 DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA  347 (453)
Q Consensus       283 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell  347 (453)
                      +.++ ++|+|||..+....+...              ..+....  .+..++|+||||+.+.-+.
T Consensus       169 ~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler--~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLER--HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             eCCC-EEEEECCCcccccchhhH--------------HHHHHHh--HhcccccccceeEeehHHH
Confidence            9988 999999988754322110              0022222  3457999999999987654

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.8e-16  Score=149.82  Aligned_cols=129  Identities=17%  Similarity=0.137  Sum_probs=95.3

Q ss_pred             hhhhcccCccCceEEEEEE--EcCCcEEEEEEecCCCCC-------------------------------HHHHHHHHhc
Q 048517          163 NHFTHKLGQGGFGSVYKGQ--LHTGRLIAVKMMENSKFS-------------------------------AEEFINELLG  209 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~--~~~g~~VAVK~l~~~~~~-------------------------------~~~~i~el~g  209 (453)
                      +.+.+.||+|+||.||+|.  ..+|+.||||++......                               +.+.+.++..
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            3466889999999999998  568999999998753210                               0011111221


Q ss_pred             --ccc----cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc-eeecccCCcceEE
Q 048517          210 --LCS----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC-ILHFDIKPHNILL  282 (453)
Q Consensus       210 --~~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dikp~NILl  282 (453)
                        ...    .....++||||+++++|.....    ....+...+...++.|++.++.+||+.   + |+|+||||+||++
T Consensus       110 ~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli  182 (237)
T smart00090      110 AGVPVPKPIAWRRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILV  182 (237)
T ss_pred             cCCCCCeeeEecCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEE
Confidence              100    1123579999999988866542    123345556789999999999999998   8 9999999999999


Q ss_pred             cCCCceEEEecCCcccc
Q 048517          283 DHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       283 ~~~~~~kl~DFGla~~~  299 (453)
                      + ++.++|+|||.+...
T Consensus       183 ~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      183 H-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             E-CCCEEEEEChhhhcc
Confidence            9 889999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=2.5e-17  Score=164.67  Aligned_cols=175  Identities=22%  Similarity=0.289  Sum_probs=129.2

Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      ..++.|+++...+|.++|.+++ .....+|...+.++.|++.|++|   +   +.+|+|+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            4678999999999999996443 34567888999999999999999   4   899999999999999999999999999


Q ss_pred             ccccCCCC----CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517          296 AKFHPKEN----DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       296 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  370 (453)
                      ........    .....+...||..||+||.+.+.  .++.|+||||+|++|+|++. -..+++    +       .-..
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~e----r-------~~t~  469 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFE----R-------IATL  469 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHH----H-------HHhh
Confidence            88665544    22334566799999999999976  89999999999999999986 111111    0       0011


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV  416 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev  416 (453)
                      ..+.++...+ .    ...++ +.=..++.|++.+.|.+||++.++
T Consensus       470 ~d~r~g~ip~-~----~~~d~-p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 TDIRDGIIPP-E----FLQDY-PEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhhcCCCCh-H----HhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence            2222222110 0    11111 223568899999999999955443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=4.1e-16  Score=143.55  Aligned_cols=126  Identities=23%  Similarity=0.203  Sum_probs=95.0

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH-----------------------HHHHHH------Hhcc--
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA-----------------------EEFINE------LLGL--  210 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~-----------------------~~~i~e------l~g~--  210 (453)
                      ++.+.+.||+|+||.||++...+|+.||||++.......                       .....|      +.+.  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            366678999999999999998889999999876432100                       001111      2121  


Q ss_pred             ----cccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC
Q 048517          211 ----CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  286 (453)
Q Consensus       211 ----~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~  286 (453)
                          .......+++|||+++++|.+...          ......++.+++.++.++|+.   +|+|+||||.||++++++
T Consensus        96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~  162 (198)
T cd05144          96 PVPKPIDWNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDE  162 (198)
T ss_pred             CCCceeecCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCC
Confidence                011234589999999999865431          134567899999999999997   999999999999999999


Q ss_pred             ceEEEecCCccccC
Q 048517          287 IPKVSDFGLAKFHP  300 (453)
Q Consensus       287 ~~kl~DFGla~~~~  300 (453)
                      .++|+|||++....
T Consensus       163 ~~~liDfg~~~~~~  176 (198)
T cd05144         163 KIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEEECCccccCC
Confidence            99999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=1.8e-16  Score=144.70  Aligned_cols=177  Identities=17%  Similarity=0.091  Sum_probs=123.5

Q ss_pred             hcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHH-----HHHHH------Hhccc-----ccCcceEEEEEecCCCCh
Q 048517          166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAE-----EFINE------LLGLC-----SEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~-----~~i~e------l~g~~-----~~~~~~~lv~E~~~~gsL  229 (453)
                      ...|++|+||+||...- ++++++.+.+..+....+     .+..|      |.+.-     ..-...+++|||+.+.+|
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~L   85 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAAM   85 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCccH
Confidence            45799999999997665 688888888877544222     23333      21100     011345899999999998


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeeccc-CCcceEEcCCCceEEEecCCccccCCCCCc---
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI-KPHNILLDHNFIPKVSDFGLAKFHPKENDF---  305 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di-kp~NILl~~~~~~kl~DFGla~~~~~~~~~---  305 (453)
                      ...+.    .       ....++.+++++|.++|+.   +|+|||| ||.|||++.++.++|+|||++.........   
T Consensus        86 ~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         86 YQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             Hhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            65331    0       1235778999999999998   9999999 799999999999999999999865443310   


Q ss_pred             -e-------eecccCCCCCccChhhhcccCCCCC-ccchHHHHHHHHHHHHcCCCCCCCCcc
Q 048517          306 -V-------SISDTRGTIGYLAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGRRNSNMNAT  358 (453)
Q Consensus       306 -~-------~~~~~~gt~~y~aPE~~~~~~~~~s-~k~DV~S~Gvvl~elltg~~p~~~~~~  358 (453)
                       .       ...-...++.|++|+...-- ...+ ...+.++-|.-+|.++|++.+.....+
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence             0       00112478899999854321 1223 567888999999999999987654443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.67  E-value=1.9e-17  Score=168.43  Aligned_cols=216  Identities=24%  Similarity=0.254  Sum_probs=156.8

Q ss_pred             cCccCceEEEEEE----EcCCcEEEEEEecCCCCC---------HHHHHHH---------HhcccccCcceEEEEEecCC
Q 048517          169 LGQGGFGSVYKGQ----LHTGRLIAVKMMENSKFS---------AEEFINE---------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       169 LG~G~fG~Vy~g~----~~~g~~VAVK~l~~~~~~---------~~~~i~e---------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +|+|.||.|+..+    .+.|+.+|+|.+++....         .+.+..+         +.-.++...+.+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7999999999865    335778898887762211         1111111         22233455667889999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |.|...+    .....++..........++-+++++|+.   +|+|||+|++||+++.+|++|+.|||+++..-...   
T Consensus        82 g~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---  151 (612)
T KOG0603|consen   82 GDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---  151 (612)
T ss_pred             chhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence            9987766    3345677778888888999999999998   99999999999999999999999999998654332   


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                         ..+||.-|||||.+.    .....+|.||||++.+||+||-.||..            .+...+.+.+.       .
T Consensus       152 ---~~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~-------~  205 (612)
T KOG0603|consen  152 ---IACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAEL-------E  205 (612)
T ss_pred             ---hcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhcc-------C
Confidence               227999999999986    356689999999999999999999864            12233322111       2


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSM--TKVLEML  420 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~--~evl~~L  420 (453)
                      .+.+.+.....+...++..+|..|--.  ..+.+.+
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK  241 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence            445555666667777777778887744  3444444

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.2e-15  Score=138.69  Aligned_cols=125  Identities=21%  Similarity=0.203  Sum_probs=89.4

Q ss_pred             hcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---HHHH----------------------HH------Hhccc---
Q 048517          166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFI----------------------NE------LLGLC---  211 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~~~i----------------------~e------l~g~~---  211 (453)
                      .+.||+|+||.||+|...+|+.||||++.......   ...+                      .|      +....   
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999987532211   1111                      11      11110   


Q ss_pred             ---ccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCCCc
Q 048517          212 ---SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFI  287 (453)
Q Consensus       212 ---~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~~~  287 (453)
                         ..-...+++|||++++++........    ... .....++.+++.++.++|+ .   +|+|+||||+||+++ ++.
T Consensus        82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CceEecCCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCc
Confidence               00124589999999965432211110    011 6678999999999999998 6   999999999999999 899


Q ss_pred             eEEEecCCcccc
Q 048517          288 PKVSDFGLAKFH  299 (453)
Q Consensus       288 ~kl~DFGla~~~  299 (453)
                      ++++|||.+...
T Consensus       153 ~~liDfg~a~~~  164 (187)
T cd05119         153 VYIIDVPQAVEI  164 (187)
T ss_pred             EEEEECcccccc
Confidence            999999999744

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=2e-15  Score=145.78  Aligned_cols=185  Identities=19%  Similarity=0.198  Sum_probs=124.9

Q ss_pred             CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE--cCCC--ceE
Q 048517          214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL--DHNF--IPK  289 (453)
Q Consensus       214 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl--~~~~--~~k  289 (453)
                      +..+++||.-. .-+|..++...     ..+.....-|+.|+++|..|||++   +|.|||+|++|||+  |+|.  ...
T Consensus       315 ~~tlylvMkrY-~~tLr~yl~~~-----~~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LV  385 (598)
T KOG4158|consen  315 PKTLYLVMKRY-RQTLREYLWTR-----HRSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLV  385 (598)
T ss_pred             CceEEEehhcc-hhhHHHHHhcC-----CCchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEE
Confidence            34467888776 45888888543     345566778899999999999998   99999999999999  4444  467


Q ss_pred             EEecCCccccCCCCC---ceee-cccCCCCCccChhhhcccCCCC----CccchHHHHHHHHHHHHcCCCCCCCCccccc
Q 048517          290 VSDFGLAKFHPKEND---FVSI-SDTRGTIGYLAPELISRNFGTV----SCKSDVYGFGMVLLEMAGGRRNSNMNATRSS  361 (453)
Q Consensus       290 l~DFGla~~~~~~~~---~~~~-~~~~gt~~y~aPE~~~~~~~~~----s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~  361 (453)
                      |+|||.+--.....-   +.+. -...|.-.-||||+.....|+.    -.|+|.|+.|.+.||+++...||....    
T Consensus       386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG----  461 (598)
T KOG4158|consen  386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG----  461 (598)
T ss_pred             EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc----
Confidence            899998753322111   1111 1234667789999886543321    349999999999999999999986521    


Q ss_pred             cccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517          362 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  420 (453)
Q Consensus       362 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L  420 (453)
                      +..+..-.+   .+.+..      ..++.+...+.+++...|+.||.+|||..=....|
T Consensus       462 em~L~~r~Y---qe~qLP------alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  462 EMLLDTRTY---QESQLP------ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             hheechhhh---hhhhCC------CCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence            111111111   111111      13334456688899999999999999875544444

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.60  E-value=5.8e-15  Score=136.89  Aligned_cols=119  Identities=24%  Similarity=0.334  Sum_probs=92.2

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---------HHHHHH------H--------hcccccCcceEEEEEe
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---------EEFINE------L--------LGLCSEGFKRALVYEY  223 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---------~~~i~e------l--------~g~~~~~~~~~lv~E~  223 (453)
                      +.||+|++|.||+|.. +|..|+||+........         +++..|      +        ..++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4799999999999987 57789999865432111         122222      1        1123344567899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +++++|.+.+...       .+ .+..++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+|||+++.
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999887321       12 7889999999999999998   999999999999999 78899999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.57  E-value=1.5e-14  Score=132.91  Aligned_cols=115  Identities=24%  Similarity=0.337  Sum_probs=86.9

Q ss_pred             ccCccCceEEEEEEEcCCcEEEEEEecCCCCC---------HHHHHHH------Hh--c------ccccCcceEEEEEec
Q 048517          168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---------AEEFINE------LL--G------LCSEGFKRALVYEYM  224 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---------~~~~i~e------l~--g------~~~~~~~~~lv~E~~  224 (453)
                      .||+|+||.||+|.. +|+.|++|........         .+++..|      +.  +      ++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 4788999986542211         1122222      21  1      122344568999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ++++|.+.+....    .       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.+++.|||+++.
T Consensus        80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988763211    0       7899999999999998   999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.54  E-value=4.7e-15  Score=158.20  Aligned_cols=204  Identities=21%  Similarity=0.265  Sum_probs=132.7

Q ss_pred             hcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHHHhcccccCcceEEEEEecCCCChhhhhhhccCCCCCCC
Q 048517          166 THKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFG  244 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~  244 (453)
                      .+.|-.|++|.||..+++ ..+.+|+|+- +.+.-.+.    ++.+- ++  .+.|      |+-...+.    ....++
T Consensus        88 IklisngAygavylvrh~~trqrfa~kiN-kq~lilRn----ilt~a-~n--pfvv------gDc~tllk----~~g~lP  149 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLILRN----ILTFA-GN--PFVV------GDCATLLK----NIGPLP  149 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhccc-ccchhhhc----ccccc-CC--ccee------chhhhhcc----cCCCCc
Confidence            367889999999999865 5678888543 22211110    11111 11  1222      33222221    112233


Q ss_pred             chhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC-------------ceeeccc
Q 048517          245 LEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-------------FVSISDT  311 (453)
Q Consensus       245 ~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~-------------~~~~~~~  311 (453)
                      ..        .+.+++|||+.   +|+|||+||+|.+++.-|++|+.|||+++.......             .......
T Consensus       150 vd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqv  218 (1205)
T KOG0606|consen  150 VD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQV  218 (1205)
T ss_pred             ch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccc
Confidence            22        27889999998   999999999999999999999999999875321100             0111344


Q ss_pred             CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHH
Q 048517          312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI  391 (453)
Q Consensus       312 ~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  391 (453)
                      +||+.|+|||++...  .|...+|+|++|+++||.+.|..||.....+   ..|...+.+.+...+         ....+
T Consensus       219 cgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~visd~i~wpE---------~dea~  284 (1205)
T KOG0606|consen  219 CGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDDIEWPE---------EDEAL  284 (1205)
T ss_pred             cCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhhhhccccc---------cCcCC
Confidence            799999999999875  6888999999999999999999999866432   222222222222111         11223


Q ss_pred             HHHHHHHHHHhcccCCCCCCC
Q 048517          392 ARKLCMIGLWCIQVKAADRPS  412 (453)
Q Consensus       392 ~~~l~~l~~~Cl~~~p~~RPs  412 (453)
                      ..+..+++.+.|+.+|.+|--
T Consensus       285 p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  285 PPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             CHHHHHHHHHHHHhChHhhcc
Confidence            345777888899999999973

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.54  E-value=2.9e-14  Score=150.77  Aligned_cols=118  Identities=20%  Similarity=0.276  Sum_probs=87.2

Q ss_pred             hhcccCccCceEEEEEEEcCCcEEEEEEe-cCC-CC-------CHHHHHHH------H--------hcccccCcceEEEE
Q 048517          165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMM-ENS-KF-------SAEEFINE------L--------LGLCSEGFKRALVY  221 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l-~~~-~~-------~~~~~i~e------l--------~g~~~~~~~~~lv~  221 (453)
                      ..++||+|+||+||+|.+.+.. +++|+. .+. ..       ..+++..|      +        ..++......++||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            3578999999999999876443 444432 221 10       11223333      1        12223344678999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||+++++|.+++.            ....++.+++++|.|||+.   +++||||||+|||+ .++.++|+|||+++..
T Consensus       416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999988773            4578999999999999998   99999999999999 5778999999999753

>PRK10345 hypothetical protein; Provisional

Probab=99.51  E-value=8.9e-14  Score=128.68  Aligned_cols=118  Identities=19%  Similarity=0.273  Sum_probs=82.2

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCC-CHHHHHHH-------------------HhcccccCc---c-eEEEEE
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF-SAEEFINE-------------------LLGLCSEGF---K-RALVYE  222 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~-~~~~~i~e-------------------l~g~~~~~~---~-~~lv~E  222 (453)
                      +.||+|+||.||. ...++.. +||++..... ..+++.+|                   ++|+...+.   . ..+|+|
T Consensus         8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            5799999999996 3334444 6998875322 22333333                   445554442   2 237899


Q ss_pred             e--cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHH-HHhHcCCCCceeecccCCcceEEcC----CCceEEEecCC
Q 048517          223 Y--MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGI-EYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSDFGL  295 (453)
Q Consensus       223 ~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dikp~NILl~~----~~~~kl~DFGl  295 (453)
                      |  +.+|+|.+++..     ..++..  ..++.+++.++ +|||++   +|+||||||+|||++.    +..++|+||+.
T Consensus        86 ~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         86 FDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             CCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            9  558999999932     224444  35677888777 999998   9999999999999974    34899999544


Q ss_pred             c
Q 048517          296 A  296 (453)
Q Consensus       296 a  296 (453)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.47  E-value=4.8e-13  Score=115.91  Aligned_cols=121  Identities=23%  Similarity=0.205  Sum_probs=93.7

Q ss_pred             hcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH------H----------hcccccCcceEEEEEecCCCCh
Q 048517          166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE------L----------LGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e------l----------~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      .+.||+|.++.||++..++ +.++||....... ..++..|      +          +.........++++||++++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            3679999999999999864 7899999876532 2222222      2          2223334567899999988877


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ...           +......++.++++++++||.....+++|+|++|+||+++.++.+++.|||.++..
T Consensus        81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            532           55677889999999999999875557999999999999999899999999998743

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=5.7e-14  Score=148.90  Aligned_cols=242  Identities=22%  Similarity=0.259  Sum_probs=172.0

Q ss_pred             HhhhhhcccCccCceEEEEEEEc--CCcEEEEEEecCCCCCH------------------HHHHHHHhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSA------------------EEFINELLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~--~g~~VAVK~l~~~~~~~------------------~~~i~el~g~~~~~~~~~lv  220 (453)
                      ..+.+.+.||+|+|+.|-.....  ....+|+|.+.......                  +..+..+++........++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            34566778999999999887643  34567777665432111                  11122255555666778899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhH-cCCCCceeecccCCcceEEcCCC-ceEEEecCCccc
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKF  298 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~  298 (453)
                      .+|..++++.+-+.  .......+....-....|+..++.|+| ..   ++.|+||||+|.+++.++ ..|++|||+|..
T Consensus       100 ~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  100 LSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999987663  112225667777889999999999999 76   999999999999999999 999999999998


Q ss_pred             cCC-CCCceeecccCC-CCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          299 HPK-ENDFVSISDTRG-TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       299 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      +.. .+.........| ++.|+|||...+. .......|+||.|+++.-+++|..|++......  ..+..|....    
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~----  247 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK----  247 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccc--ccceeecccc----
Confidence            876 444444556678 9999999998763 345778999999999999999999987654432  2222222221    


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...    ..............+...++..+|..|.+.+++-.
T Consensus       248 ~~~----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 GRF----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ccc----ccCccccCChhhhhcccccccCCchhccccccccc
Confidence            000    00112223345667778888899999999887654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.35  E-value=7.6e-12  Score=128.60  Aligned_cols=125  Identities=21%  Similarity=0.227  Sum_probs=89.7

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCC---------------------------HHH--------------HHH
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---------------------------AEE--------------FIN  205 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---------------------------~~~--------------~i~  205 (453)
                      +.||.|++|.||+|++++|+.||||+.+.....                           ..+              |..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            469999999999999999999999998653110                           000              111


Q ss_pred             H------Hhcccc-------------cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHH-HHHHhHcC
Q 048517          206 E------LLGLCS-------------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR-GIEYLHNG  265 (453)
Q Consensus       206 e------l~g~~~-------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~  265 (453)
                      |      +...+.             .....+|||||++|++|.+......   ...   .+..++..++. .+..+|..
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence            1      111111             1224579999999999988763221   111   34567777666 46788887


Q ss_pred             CCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       266 ~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                         +++|+|+||.||+++.++.+++.|||++....
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               99999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.35  E-value=5.4e-12  Score=119.54  Aligned_cols=119  Identities=18%  Similarity=0.201  Sum_probs=84.5

Q ss_pred             cccC-ccCceEEEEEEEcCCcEEEEEEecCCC--------------CCHHHHHHH------H----------hccccc-C
Q 048517          167 HKLG-QGGFGSVYKGQLHTGRLIAVKMMENSK--------------FSAEEFINE------L----------LGLCSE-G  214 (453)
Q Consensus       167 ~~LG-~G~fG~Vy~g~~~~g~~VAVK~l~~~~--------------~~~~~~i~e------l----------~g~~~~-~  214 (453)
                      ..|| .||.|+||..... +..++||.+....              .....+..|      |          +++... .
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4688 8999999999876 7789999775311              111122222      2          111111 1


Q ss_pred             c---ceEEEEEecCC-CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517          215 F---KRALVYEYMPN-GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  290 (453)
Q Consensus       215 ~---~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  290 (453)
                      .   ..++|+|++++ .+|.+++..     ..++.    ..+.+++.+|.+||+.   +|+|+||||.|||++.++.++|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE-----APLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc-----CCCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            1   23599999997 688877632     22333    2467899999999998   9999999999999999889999


Q ss_pred             EecCCccc
Q 048517          291 SDFGLAKF  298 (453)
Q Consensus       291 ~DFGla~~  298 (453)
                      +|||.++.
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99999874

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=2.2e-12  Score=122.35  Aligned_cols=185  Identities=23%  Similarity=0.281  Sum_probs=122.6

Q ss_pred             CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEec
Q 048517          214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  293 (453)
Q Consensus       214 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF  293 (453)
                      ..+..++.|||..|++..+|.........+......+++.||..||.|||+ |+++|+|+++..+-|++..++-+|+.--
T Consensus       144 ~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~PpiihgnlTc~tifiq~ngLIkig~~  222 (458)
T KOG1266|consen  144 KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSV  222 (458)
T ss_pred             ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccCCcchhheeecCCceEEeccc
Confidence            345678999999999999997766666778888888999999999999999 6899999999999999999998888521


Q ss_pred             CCccccCCCCC--ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517          294 GLAKFHPKEND--FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  371 (453)
Q Consensus       294 Gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  371 (453)
                      .-......-..  ........+-++|.|||+=..  ...+..+|||+||+..+||.-+.--..    .+...+.+.   .
T Consensus       223 ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~t----nseS~~~~e---e  293 (458)
T KOG1266|consen  223 APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQST----NSESKVEVE---E  293 (458)
T ss_pred             CccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccC----CCcceeehh---h
Confidence            11110000000  001122346789999996433  366779999999999999987653211    111111110   0


Q ss_pred             HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+... ...+.+         ..=+.++..|++.+|..||+|.+.+-
T Consensus       294 ~ia~~-i~~len---------~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  294 NIANV-IIGLEN---------GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             hhhhh-eeeccC---------ccccCcCcccccCCCCCCcchhhhhc
Confidence            00000 000000         01134566799999999999988754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.14  E-value=2.8e-10  Score=101.45  Aligned_cols=116  Identities=20%  Similarity=0.156  Sum_probs=82.0

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHH------HHH---------HhcccccCcceEEEEEecCCCChhh
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF------INE---------LLGLCSEGFKRALVYEYMPNGSLDR  231 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~------i~e---------l~g~~~~~~~~~lv~E~~~~gsL~~  231 (453)
                      +.|+.|.++.||+++.. ++.+++|+..........+      +..         ++.+  .....++||||+++.++..
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence            46889999999999876 7789999976543111111      111         1222  2223579999999988754


Q ss_pred             hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC--CCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      .         .   .....++.+++++|+.||+..  ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus        81 ~---------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 E---------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             c---------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            2         0   112346789999999999872  22369999999999999 66899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.13  E-value=1.3e-10  Score=121.36  Aligned_cols=125  Identities=18%  Similarity=0.186  Sum_probs=80.3

Q ss_pred             cccCccCceEEEEEEEcC-CcEEEEEEecCCCC---------------------------CHH----H----------HH
Q 048517          167 HKLGQGGFGSVYKGQLHT-GRLIAVKMMENSKF---------------------------SAE----E----------FI  204 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~-g~~VAVK~l~~~~~---------------------------~~~----~----------~i  204 (453)
                      +.||.|++|.||+|++++ |+.||||++.....                           ...    +          +.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            469999999999999887 99999999875310                           001    1          11


Q ss_pred             HH------Hhccccc-------------CcceEEEEEecCCCChhhhhhhccCC--CCCCCchhHHHHHHHHHHHHHHhH
Q 048517          205 NE------LLGLCSE-------------GFKRALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLH  263 (453)
Q Consensus       205 ~e------l~g~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH  263 (453)
                      .|      +...+.+             .....|||||++|+.+.+.-......  ...+....+..++.|+       +
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            11      2222222             12346999999999997642111100  0112222222233333       3


Q ss_pred             cCCCCceeecccCCcceEEcCCC----ceEEEecCCccccCC
Q 048517          264 NGCDVCILHFDIKPHNILLDHNF----IPKVSDFGLAKFHPK  301 (453)
Q Consensus       264 ~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFGla~~~~~  301 (453)
                      ..   +++|+|+||.||+++.++    .+++.|||+......
T Consensus       278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            34   999999999999999887    999999999876643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=3e-10  Score=116.12  Aligned_cols=236  Identities=22%  Similarity=0.202  Sum_probs=159.2

Q ss_pred             HHHhhhhhcccCc--cCceEEEEEEE---cCCcEEEEEEecC--C-----CCCHHHH-----------HHHHhcccccCc
Q 048517          159 IAVTNHFTHKLGQ--GGFGSVYKGQL---HTGRLIAVKMMEN--S-----KFSAEEF-----------INELLGLCSEGF  215 (453)
Q Consensus       159 ~~~~~~~~~~LG~--G~fG~Vy~g~~---~~g~~VAVK~l~~--~-----~~~~~~~-----------i~el~g~~~~~~  215 (453)
                      ...+..+.+.+|.  |.+|.||.+..   .+++.+|+|.-+.  +     .....++           ..........++
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3344455678999  99999999986   3688999997322  1     1111111           111233445666


Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHH----HHHHhHcCCCCceeecccCCcceEEcCC-CceEE
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR----GIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKV  290 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl  290 (453)
                      ..++-+|.+ +.+|..+.+..   ...+.-..++.+..+..+    ||.++|+.   .++|-|+||.||++..+ ...++
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cceeeeccc-cchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence            778888888 47777766432   234566667777777777    99999998   99999999999999999 88999


Q ss_pred             EecCCccccCCCC---CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchH
Q 048517          291 SDFGLAKFHPKEN---DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS  367 (453)
Q Consensus       291 ~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  367 (453)
                      .|||+........   .........|...|++||...+   .++.+.|+|++|.+.+|-..+-......       +...
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g-------~~~~  334 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVG-------KNSS  334 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCC-------CCCC
Confidence            9999998775443   1111223367788999999874   6888999999999999998876544322       1122


Q ss_pred             HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      |.  ++.++. +.    .+.-......+..+...+++.+|-.|++.+.+..
T Consensus       335 W~--~~r~~~-ip----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 WS--QLRQGY-IP----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc--cccccc-Cc----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            21  122211 10    1111122334555888999999999998877765

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.95  E-value=5.1e-09  Score=95.48  Aligned_cols=125  Identities=14%  Similarity=0.117  Sum_probs=83.2

Q ss_pred             cccCccCceEEEEEEEcC-------CcEEEEEEecCCCC---CH-------------------HHHH-----HH------
Q 048517          167 HKLGQGGFGSVYKGQLHT-------GRLIAVKMMENSKF---SA-------------------EEFI-----NE------  206 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~-------g~~VAVK~l~~~~~---~~-------------------~~~i-----~e------  206 (453)
                      ..||.|-=+.||.|.-.+       +..+|||+.+.+..   ..                   ...+     .|      
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       57999998753210   00                   1011     11      


Q ss_pred             Hh--cccc----cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHh-HcCCCCceeecccCCcc
Q 048517          207 LL--GLCS----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL-HNGCDVCILHFDIKPHN  279 (453)
Q Consensus       207 l~--g~~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dikp~N  279 (453)
                      +.  |.-.    .-...+|||||+.++.+.....    ....++..+...+..+++.+|..| |+.   +|+|+|+++.|
T Consensus        83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N  155 (197)
T cd05146          83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN  155 (197)
T ss_pred             HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            11  1110    1134579999997654422111    112344456678889999999999 776   99999999999


Q ss_pred             eEEcCCCceEEEecCCcccc
Q 048517          280 ILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       280 ILl~~~~~~kl~DFGla~~~  299 (453)
                      ||++ ++.+.|+|||.+...
T Consensus       156 IL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EEEE-CCcEEEEECCCceeC
Confidence            9997 467999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.88  E-value=1.6e-08  Score=93.93  Aligned_cols=127  Identities=21%  Similarity=0.261  Sum_probs=91.4

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCC--CHHHHHHH----------------HhcccccC---cceEEEEEecC
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF--SAEEFINE----------------LLGLCSEG---FKRALVYEYMP  225 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~--~~~~~i~e----------------l~g~~~~~---~~~~lv~E~~~  225 (453)
                      +.||.|..+.||++...+|+.+++|+......  ...++..|                ++.+....   ...++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999987778999999765332  12222222                22333332   24589999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC---------------------------------------
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC---------------------------------------  266 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------  266 (453)
                      +.++.+.+..     ..++..++..++.+++++|.+||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9988765421     24667777888888888888888531                                       


Q ss_pred             --------------CCceeecccCCcceEEcC--CCceEEEecCCccc
Q 048517          267 --------------DVCILHFDIKPHNILLDH--NFIPKVSDFGLAKF  298 (453)
Q Consensus       267 --------------~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~  298 (453)
                                    ...++|+|++|.||+++.  +..+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245899999999999998  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.81  E-value=1.8e-09  Score=110.59  Aligned_cols=227  Identities=19%  Similarity=0.261  Sum_probs=151.2

Q ss_pred             hhhcccCccCceEEEEEEEc--CCcEEEEEEecCCCCCH--------HHHHHHHhccc----------ccCcceEEEEEe
Q 048517          164 HFTHKLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSA--------EEFINELLGLC----------SEGFKRALVYEY  223 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~--~g~~VAVK~l~~~~~~~--------~~~i~el~g~~----------~~~~~~~lv~E~  223 (453)
                      ++..+||.|.|+.|++...+  ++..+++|.+.+.....        +-++...++.+          ......++=-||
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~  347 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF  347 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence            44578999999999998744  68889999876633221        11222222322          233445688899


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCccccCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~~~  302 (453)
                      ++++++...+    .....+....++.+..+++.++.++|+.   .++|+|+||+||++..+ +..+++|||.+....-.
T Consensus       348 ~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  348 CEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             hcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee
Confidence            9999987765    2335678888899999999999999987   99999999999999886 88899999998642211


Q ss_pred             CCceeecccCCCCCcc-ChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          303 NDFVSISDTRGTIGYL-APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~-aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      .     ....++-++. .+|.+... ..+-.+.|++|||.-+.|.+++..-.....         .|.  .+..+.... 
T Consensus       421 ~-----~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---------~~~--~i~~~~~p~-  482 (524)
T KOG0601|consen  421 S-----GVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGV---------QSL--TIRSGDTPN-  482 (524)
T ss_pred             c-----ccccccccccccchhhccc-cccccccccccccccccccccCcccCcccc---------cce--eeecccccC-
Confidence            1     1122333444 25555443 367789999999999999998864322111         010  111111111 


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                           .+. ....+..++.-++..++..||++.+...+.+
T Consensus       483 -----~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  483 -----LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             -----CCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                 111 1145666777888999999999888766544

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.80  E-value=1.9e-07  Score=92.03  Aligned_cols=249  Identities=15%  Similarity=0.121  Sum_probs=149.0

Q ss_pred             hhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC-HHHHHHH--------------------HhcccccCcceEEEEE
Q 048517          165 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS-AEEFINE--------------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~-~~~~i~e--------------------l~g~~~~~~~~~lv~E  222 (453)
                      ....||+|+-+.+|--- ..+  .|| |+...-.-. ..+...+                    |+|- ..+...-++|.
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d--~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGflmP   90 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD--QVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFLMP   90 (637)
T ss_pred             CCccccCCccceeeecchhhc--hhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEecc
Confidence            35679999999999542 322  243 666542211 1121222                    2221 12222456666


Q ss_pred             ecCCCChhhhhhhc---cCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          223 YMPNGSLDRHIFSK---ENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       223 ~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      .+.+..=-..+++.   +..-....|+.++..+..+|.+.+-||..   +.+-+|++++|+|+.+++.+.|.|=..-.+.
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence            66554222222222   22335689999999999999999999998   9999999999999999999999974433333


Q ss_pred             CCCCCceeecccCCCCCccChhhhc-ccC--CCCCccchHHHHHHHHHHHHcC-CCCCCCCccccc-----cccchHHHH
Q 048517          300 PKENDFVSISDTRGTIGYLAPELIS-RNF--GTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSS-----KAYFPSWVY  370 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~s~k~DV~S~Gvvl~elltg-~~p~~~~~~~~~-----~~~~~~~~~  370 (453)
                      ..+..   .....|...|.+||.-. ..+  -.-+...|-|.+|+++++++.| ++||...-..+.     +..+....+
T Consensus       168 ~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         168 ANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             cCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            22222   23467889999999654 111  1446789999999999998876 889865433221     111111111


Q ss_pred             HHhhhCCCccccchhh-hHHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHhCC
Q 048517          371 DQLNKGGDLELRNVTE-IESMIARKLCMIGLWCIQV--KAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~--~p~~RPs~~evl~~Le~~  423 (453)
                      ....+.+........+ --..+...+..+..+|+..  ++.-|||.+..+..|...
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            1111111111111111 1233445666777788865  366899999888776543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.70  E-value=1.9e-07  Score=82.97  Aligned_cols=116  Identities=23%  Similarity=0.282  Sum_probs=83.2

Q ss_pred             ccCccCceEEEEEEEcCCcEEEEEEecCCCCC---------HHHHHHH--------Hhccc------ccCcceEEEEEec
Q 048517          168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---------AEEFINE--------LLGLC------SEGFKRALVYEYM  224 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---------~~~~i~e--------l~g~~------~~~~~~~lv~E~~  224 (453)
                      .+++|+=+.+|.+.+. |.++.+|.-......         .++-.+|        -.|.+      .+.....++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999765 445777743322111         1112222        22333      2444567999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ++-.|.+.+...           ...++..+-.-+.-||..   +|+|+|+.++||++..+. +.+.||||+...
T Consensus        82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999998888322           366788888889999998   999999999999997764 999999999743

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.62  E-value=5.1e-07  Score=80.03  Aligned_cols=127  Identities=24%  Similarity=0.336  Sum_probs=86.4

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCC---------CHHHHHHH--------Hhccc------ccCcceEEEEEe
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---------SAEEFINE--------LLGLC------SEGFKRALVYEY  223 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---------~~~~~i~e--------l~g~~------~~~~~~~lv~E~  223 (453)
                      ..|-||+=+.|+++... |+...||.-.....         ...+-.+|        ..|.+      .+...-.|+|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            45788999999999877 77777774322111         11222222        22333      233345699999


Q ss_pred             cCC-CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC---ceEEEecCCcccc
Q 048517          224 MPN-GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFH  299 (453)
Q Consensus       224 ~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~---~~kl~DFGla~~~  299 (453)
                      +++ -++.+++.+.-.  ....-+.....+..|-+.+.-||.+   .|+|+||..+||+|..++   .+.+.|||++...
T Consensus        92 ~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   92 IDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             ccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            976 478888754322  2222333378899999999999998   999999999999996543   4689999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.61  E-value=3.2e-08  Score=106.79  Aligned_cols=181  Identities=18%  Similarity=0.199  Sum_probs=126.5

Q ss_pred             cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEe
Q 048517          213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  292 (453)
Q Consensus       213 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~D  292 (453)
                      ......|+++|..+++|...|+..    ...+.+-.......+..+++|||+.   .+.|+|++|.|+|...++..+++|
T Consensus       875 ~rsP~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~  947 (1205)
T KOG0606|consen  875 CRSPLPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD  947 (1205)
T ss_pred             CCCCcchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence            455678999999999998877533    2455555566667788899999997   699999999999999999999999


Q ss_pred             cCCccccCC---------------------CCC---c-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHH
Q 048517          293 FGLAKFHPK---------------------END---F-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVL  343 (453)
Q Consensus       293 FGla~~~~~---------------------~~~---~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl  343 (453)
                      ||......-                     ...   .     .......||+.|.+||...+.  .-...+|+|+.|+.+
T Consensus       948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen  948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCL 1025 (1205)
T ss_pred             cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhh
Confidence            984322110                     000   0     011234689999999998875  566789999999999


Q ss_pred             HHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 048517          344 LEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT  414 (453)
Q Consensus       344 ~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  414 (453)
                      +|.++|.+||+......        +.+.+..+.....    ..+.+.+.....++...+..+|.+|-.|.
T Consensus      1026 ~e~l~g~pp~na~tpq~--------~f~ni~~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAETPQQ--------IFENILNRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhcCCCCCCCcchhh--------hhhccccCCCCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999999997654322        2233332222111    12233344566677777778888887765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.61  E-value=4.6e-07  Score=82.32  Aligned_cols=73  Identities=30%  Similarity=0.377  Sum_probs=50.0

Q ss_pred             eEEEEEecC--CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHH-hHcCCCCceeecccCCcceEEcCCCceEEEec
Q 048517          217 RALVYEYMP--NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY-LHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  293 (453)
Q Consensus       217 ~~lv~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF  293 (453)
                      ..|||||++  +..+.. +..     ..++.+....++.+++..+.. +|..   +|+|+|+.+.|||++++ .+.+.||
T Consensus        81 ~~ivME~I~~~G~~~~~-l~~-----~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPR-LKD-----VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             TEEEEE--EETTEEGGC-HHH-----CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred             CEEEEEecCCCccchhh-HHh-----ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence            469999998  544433 311     122256677888888886666 4676   99999999999999988 9999999


Q ss_pred             CCcccc
Q 048517          294 GLAKFH  299 (453)
Q Consensus       294 Gla~~~  299 (453)
                      |.+...
T Consensus       151 ~qav~~  156 (188)
T PF01163_consen  151 GQAVDS  156 (188)
T ss_dssp             TTEEET
T ss_pred             Ccceec
Confidence            988643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.51  E-value=3.3e-08  Score=102.89  Aligned_cols=152  Identities=18%  Similarity=0.241  Sum_probs=101.4

Q ss_pred             HHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee-ec------ccCCCCCccChhhhc
Q 048517          252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-IS------DTRGTIGYLAPELIS  324 (453)
Q Consensus       252 ~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~------~~~gt~~y~aPE~~~  324 (453)
                      +.+++.|+.|+|..  ..+||++|.|++|.+++++..||+.|+.+........+.. ..      -......|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            44566999999987  5899999999999999999999999998765443221110 01      112455799999997


Q ss_pred             ccCCCCCccchHHHHHHHHHHHHcCCCC-CCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhc
Q 048517          325 RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCI  403 (453)
Q Consensus       325 ~~~~~~s~k~DV~S~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl  403 (453)
                      ..  ..+.++|+||+|++++.+..|+++ +.......         ....... ..+... ......+..++.+=+.+.+
T Consensus       183 ~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~---------~~~~~~~-~~~~~~-~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL---------SYSFSRN-LLNAGA-FGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cc--cccccccceeeeeEEEEEecCCcchhhccCCcc---------hhhhhhc-cccccc-ccccccCcHHHHHHHHHHh
Confidence            64  678899999999999999954443 33222110         0001110 001000 0122445567777888899


Q ss_pred             ccCCCCCCCHHHHHH
Q 048517          404 QVKAADRPSMTKVLE  418 (453)
Q Consensus       404 ~~~p~~RPs~~evl~  418 (453)
                      ..++..||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998876654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.50  E-value=1.1e-06  Score=84.41  Aligned_cols=78  Identities=17%  Similarity=0.081  Sum_probs=62.7

Q ss_pred             ceEEEEEecCCC-ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-------CCc
Q 048517          216 KRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-------NFI  287 (453)
Q Consensus       216 ~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-------~~~  287 (453)
                      .-+||+|++++- +|.+++....  ....+......++.+++..+.-||..   +|+|+|++++|||++.       +..
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            467999999876 7888763211  12344566778999999999999998   9999999999999975       468


Q ss_pred             eEEEecCCccc
Q 048517          288 PKVSDFGLAKF  298 (453)
Q Consensus       288 ~kl~DFGla~~  298 (453)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            89999998853

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.49  E-value=7.1e-07  Score=92.81  Aligned_cols=151  Identities=17%  Similarity=0.182  Sum_probs=103.0

Q ss_pred             EcCCcEEEEEEecCCCCC---------------HHHHHHHHhcccccCcceEEEEEecCCCChhhhhhhccCCCCCCCch
Q 048517          182 LHTGRLIAVKMMENSKFS---------------AEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE  246 (453)
Q Consensus       182 ~~~g~~VAVK~l~~~~~~---------------~~~~i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~  246 (453)
                      ..++.+|.|...+.+...               ++..|..++.........|||+|-+.-  |..++.       .++-.
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk-------~l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLK-------ELGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHH-------HhHHH
Confidence            446677777766654331               122333456666677789999998743  444441       23345


Q ss_pred             hHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhccc
Q 048517          247 KPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN  326 (453)
Q Consensus       247 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  326 (453)
                      ...-.+.||+.||.+||..|  +++|++|....|++++.|..||++|.++.....-..  .......--.|..|+.+...
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            55667889999999999764  899999999999999999999999988764432211  01111222346777765432


Q ss_pred             CCCCCccchHHHHHHHHHHHHcC
Q 048517          327 FGTVSCKSDVYGFGMVLLEMAGG  349 (453)
Q Consensus       327 ~~~~s~k~DV~S~Gvvl~elltg  349 (453)
                          ....|.|-||++++|++.|
T Consensus       181 ----~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 ----EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ----ccchhhhhHHHHHHHHhCc
Confidence                1457999999999999998

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.44  E-value=1.3e-06  Score=82.32  Aligned_cols=122  Identities=25%  Similarity=0.235  Sum_probs=83.0

Q ss_pred             hhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC-------CH----------------------HHHHHHHhcc--cc
Q 048517          164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF-------SA----------------------EEFINELLGL--CS  212 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~-------~~----------------------~~~i~el~g~--~~  212 (453)
                      .+..+||-|.=+.||.|..+.|.++|||.=.....       ..                      -+++..|+..  -.
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            45689999999999999999999999995332100       00                      0112223333  11


Q ss_pred             ----cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCce
Q 048517          213 ----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP  288 (453)
Q Consensus       213 ----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~  288 (453)
                          ..++.++||||.++--|.+.         +++.+..-.|+..|+.-+.-+-..   +|||+|+.+-||++++|+.+
T Consensus       174 P~P~~~nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         174 PKPIAWNRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCccccccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCE
Confidence                23456899999988666431         123444445555555555555455   99999999999999999999


Q ss_pred             EEEecCCcc
Q 048517          289 KVSDFGLAK  297 (453)
Q Consensus       289 kl~DFGla~  297 (453)
                      .+.||--+.
T Consensus       242 ~vIDwPQ~v  250 (304)
T COG0478         242 VVIDWPQAV  250 (304)
T ss_pred             EEEeCcccc
Confidence            999996554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=4e-06  Score=87.35  Aligned_cols=135  Identities=20%  Similarity=0.223  Sum_probs=88.3

Q ss_pred             HHHHhhhhh-cccCccCceEEEEEEEcCCcEEEEEEecCCCCC---------------------------HHHHHHH---
Q 048517          158 IIAVTNHFT-HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---------------------------AEEFINE---  206 (453)
Q Consensus       158 ~~~~~~~~~-~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---------------------------~~~~i~e---  206 (453)
                      +.+.-.+|. +-|+.++-|.||+|++++|+.||||+....-..                           ..+.+.|   
T Consensus       121 iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~  200 (517)
T COG0661         121 IEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK  200 (517)
T ss_pred             HHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence            333444555 469999999999999999999999998653111                           0111111   


Q ss_pred             -----------------Hhcc-------------cccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHH
Q 048517          207 -----------------LLGL-------------CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA  256 (453)
Q Consensus       207 -----------------l~g~-------------~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia  256 (453)
                                       +-..             .+-.....|+|||++|-.+.+......   ..++   +..++..++
T Consensus       201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~  274 (517)
T COG0661         201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLV  274 (517)
T ss_pred             HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHH
Confidence                             1001             112345679999999999988753222   2333   333444444


Q ss_pred             HH-HHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          257 RG-IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       257 ~g-L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ++ +..+-..   +++|.|..|.||+++.++...+.|||+......
T Consensus       275 ~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         275 RAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            33 2222223   899999999999999999999999999876543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.20  E-value=0.00013  Score=74.18  Aligned_cols=155  Identities=18%  Similarity=0.276  Sum_probs=109.9

Q ss_pred             eEEEEEE-EcCCcEEEEEEecCCCCC--------HHHHHH----------HHhc-ccccCcceEEEEEecCC-CChhhhh
Q 048517          175 GSVYKGQ-LHTGRLIAVKMMENSKFS--------AEEFIN----------ELLG-LCSEGFKRALVYEYMPN-GSLDRHI  233 (453)
Q Consensus       175 G~Vy~g~-~~~g~~VAVK~l~~~~~~--------~~~~i~----------el~g-~~~~~~~~~lv~E~~~~-gsL~~~l  233 (453)
                      .+.|++. ..||..+..|+++..+..        .+.+.+          +++. .--.....++||+|.++ ++|.+..
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            5779998 458999999999542211        122211          1221 22234567899999986 6777765


Q ss_pred             hhccC-----------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          234 FSKEN-----------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       234 ~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      +....           .+...++..+|.++.|+..||.++|+.   ++.-+-+.+++||++.+..++|+..|...+...+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            53221           123566788999999999999999998   9999999999999999999999999887765443


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCC
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  353 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~  353 (453)
                      .              .+|  +..     --+-|.=.||.+++.|.+|..+.
T Consensus       447 ~--------------~~~--le~-----~Qq~D~~~lG~ll~aLAt~~~ns  476 (655)
T KOG3741|consen  447 P--------------TEP--LES-----QQQNDLRDLGLLLLALATGTENS  476 (655)
T ss_pred             C--------------Ccc--hhH-----HhhhhHHHHHHHHHHHhhccccc
Confidence            2              011  111     11468889999999999997653

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.10  E-value=2.8e-05  Score=80.89  Aligned_cols=130  Identities=18%  Similarity=0.191  Sum_probs=84.1

Q ss_pred             hhhh-cccCccCceEEEEEEEcCCcEEEEEEecCCCCCH--H------------------------------------HH
Q 048517          163 NHFT-HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA--E------------------------------------EF  203 (453)
Q Consensus       163 ~~~~-~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~--~------------------------------------~~  203 (453)
                      ..|. +.||.-+.|.||+|++++|+.||||+.+..-...  .                                    +|
T Consensus       162 ~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF  241 (538)
T KOG1235|consen  162 SEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF  241 (538)
T ss_pred             HhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence            3444 4699999999999999999999999976532111  0                                    01


Q ss_pred             HHH------Hhc----------------ccccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHH
Q 048517          204 INE------LLG----------------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY  261 (453)
Q Consensus       204 i~e------l~g----------------~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y  261 (453)
                      .+|      ...                +.+-...+.|+||||+|..+.+.-.-.+   ..++..   .|+..+.++...
T Consensus       242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~---~i~~~l~~~~~~  315 (538)
T KOG1235|consen  242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK---RGISPH---DILNKLVEAYLE  315 (538)
T ss_pred             HHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH---cCCCHH---HHHHHHHHHHHH
Confidence            111      000                0112235789999999998877643332   234443   344444443222


Q ss_pred             hHcCCCCceeecccCCcceEEc----CCCceEEEecCCccccC
Q 048517          262 LHNGCDVCILHFDIKPHNILLD----HNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       262 LH~~~~~~ivH~Dikp~NILl~----~~~~~kl~DFGla~~~~  300 (453)
                      +=  ...+++|.|-.|.||+++    .++.+.+.|||+.....
T Consensus       316 qI--f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  316 QI--FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HH--HhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            11  123899999999999998    36789999999987553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.09  E-value=8.2e-06  Score=75.49  Aligned_cols=77  Identities=27%  Similarity=0.351  Sum_probs=63.9

Q ss_pred             ceEEEEEecCCC-ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC---ceEEE
Q 048517          216 KRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVS  291 (453)
Q Consensus       216 ~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~---~~kl~  291 (453)
                      .-++|+|++++- +|.+++....    .++......++.++++.+.-||..   +|+|+|++++|||++.+.   .+.+.
T Consensus        91 ~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lI  163 (206)
T PF06293_consen   91 RSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLI  163 (206)
T ss_pred             eEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEE
Confidence            347999999874 7888774321    255667789999999999999998   999999999999998876   89999


Q ss_pred             ecCCcccc
Q 048517          292 DFGLAKFH  299 (453)
Q Consensus       292 DFGla~~~  299 (453)
                      ||+-++..
T Consensus       164 Dld~~~~~  171 (206)
T PF06293_consen  164 DLDRMRFR  171 (206)
T ss_pred             cchhceeC
Confidence            99987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.06  E-value=5.8e-05  Score=70.52  Aligned_cols=126  Identities=21%  Similarity=0.231  Sum_probs=84.0

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHH----------H---------------------HHHHhcccc--c
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE----------F---------------------INELLGLCS--E  213 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~----------~---------------------i~el~g~~~--~  213 (453)
                      ..|.+|.-..||+|.-.++..||||+...+....+.          |                     +..++....  .
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            357888889999999888999999998764332221          1                     001221111  1


Q ss_pred             ----CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceE
Q 048517          214 ----GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  289 (453)
Q Consensus       214 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~k  289 (453)
                          .....|||||+......    ...-+...+.......+..++++.+.-|-..  .++||+||..-|||+. ++.+.
T Consensus       134 ~Pi~~~~nVLvMEfIg~~g~p----AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         134 EPIAFRNNVLVMEFIGDDGLP----APRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CceeecCCeEEEEeccCCCCC----CCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeEE
Confidence                12346999999654210    0111112333335677788888888888873  2999999999999999 88999


Q ss_pred             EEecCCcccc
Q 048517          290 VSDFGLAKFH  299 (453)
Q Consensus       290 l~DFGla~~~  299 (453)
                      ++|||-|...
T Consensus       207 iID~~QaV~~  216 (268)
T COG1718         207 IIDVSQAVTI  216 (268)
T ss_pred             EEECcccccc
Confidence            9999988643

>PRK09902 hypothetical protein; Provisional

Probab=97.93  E-value=0.00017  Score=66.40  Aligned_cols=124  Identities=15%  Similarity=0.121  Sum_probs=87.5

Q ss_pred             cCccCceEEEEEEEcCCcEEEEEEecCC-------CCCHHHHHHHHh---------------ccccc-----CcceEEEE
Q 048517          169 LGQGGFGSVYKGQLHTGRLIAVKMMENS-------KFSAEEFINELL---------------GLCSE-----GFKRALVY  221 (453)
Q Consensus       169 LG~G~fG~Vy~g~~~~g~~VAVK~l~~~-------~~~~~~~i~el~---------------g~~~~-----~~~~~lv~  221 (453)
                      -|+||-+.|+.-.+. |+.+-+|.-.+.       .....-|..|+.               .++..     ..+.+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            467999999997776 457999987631       223344555511               12211     12357899


Q ss_pred             EecCC-CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc--eEEEecCCccc
Q 048517          222 EYMPN-GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--PKVSDFGLAKF  298 (453)
Q Consensus       222 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~--~kl~DFGla~~  298 (453)
                      |-+.+ -+|.+++...  .-...+...+..+..++++.+.-||+.   ++.|+|+.++|||++.++.  +++.||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97753 6787776321  123456667789999999999999998   9999999999999986666  99999987663

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.90  E-value=8.7e-05  Score=68.53  Aligned_cols=124  Identities=17%  Similarity=0.164  Sum_probs=79.3

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH----------------H--hcccc------
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE----------------L--LGLCS------  212 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e----------------l--~g~~~------  212 (453)
                      ++....+...+.+-......|.+-..+ |+...+|.........++++..                +  .|+-.      
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            444444444455655555556555555 6788888876643333333221                0  11111      


Q ss_pred             --------cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC
Q 048517          213 --------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  284 (453)
Q Consensus       213 --------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~  284 (453)
                              -....+++|||++|..|.+..        .++.    .++..+..++.-||+.   +++|+|..|.|++++.
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~  170 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN  170 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence                    112235899999998886543        1121    3556778889999998   9999999999999986


Q ss_pred             CCceEEEecCCcc
Q 048517          285 NFIPKVSDFGLAK  297 (453)
Q Consensus       285 ~~~~kl~DFGla~  297 (453)
                      ++ +++.||+..+
T Consensus       171 ~~-i~iID~~~k~  182 (229)
T PF06176_consen  171 NG-IRIIDTQGKR  182 (229)
T ss_pred             Cc-EEEEECcccc
Confidence            55 8999997665

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.64  E-value=0.00057  Score=64.14  Aligned_cols=30  Identities=20%  Similarity=0.144  Sum_probs=26.3

Q ss_pred             CceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ..++|+|+.|.||++++++ +.|.||+.+..
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            4678999999999999887 99999988753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.34  E-value=0.0012  Score=61.30  Aligned_cols=129  Identities=21%  Similarity=0.168  Sum_probs=69.1

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH----------------Hhccc---ccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE----------------LLGLC---SEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e----------------l~g~~---~~~~~~~lv~E~~~~g  227 (453)
                      +.|+.|..+.||+....+ +.+++|..... ....+...|                ++..+   ......+++|+++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            468889999999999887 68999997654 111111111                12211   1122357899999998


Q ss_pred             Chhh----------------h---hhhccCCCCCCCchh---------HHHH------------HHHHHH-HHHHhHc--
Q 048517          228 SLDR----------------H---IFSKENKGQTFGLEK---------PHEI------------ALGTAR-GIEYLHN--  264 (453)
Q Consensus       228 sL~~----------------~---l~~~~~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~--  264 (453)
                      ++..                .   ++........+.+..         ....            ...+.+ .+..+++  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            8776                1   111111111111110         0000            111222 2333332  


Q ss_pred             --CCCCceeecccCCcceEEc-CCCceEEEecCCcc
Q 048517          265 --GCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAK  297 (453)
Q Consensus       265 --~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~  297 (453)
                        .....++|+|+.|+|||++ +++.+-|.||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              2345799999999999999 56666899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.28  E-value=0.0023  Score=60.52  Aligned_cols=30  Identities=23%  Similarity=0.253  Sum_probs=26.8

Q ss_pred             CceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          268 VCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      +.++|+|+.|.|||++++..+.|.||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            469999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.27  E-value=0.00078  Score=61.31  Aligned_cols=91  Identities=25%  Similarity=0.226  Sum_probs=69.6

Q ss_pred             HHHHhcccccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517          204 INELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD  283 (453)
Q Consensus       204 i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~  283 (453)
                      +.+++|.|-    .+.+.||...+++.... ..-..-..-+|..+.+||.++++.+.+|++.....+.-.|++++|+-++
T Consensus        22 ~pk~lG~CG----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~   96 (188)
T PF12260_consen   22 FPKLLGSCG----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVN   96 (188)
T ss_pred             CCCeeeECC----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEe
Confidence            334677773    47899999887664210 0001113468999999999999999999996555688889999999999


Q ss_pred             CCCceEEEecCCcccc
Q 048517          284 HNFIPKVSDFGLAKFH  299 (453)
Q Consensus       284 ~~~~~kl~DFGla~~~  299 (453)
                      +++.+|+.|...+...
T Consensus        97 ~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   97 DDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCcEEEEechhcchh
Confidence            9999999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=96.93  E-value=0.0098  Score=58.25  Aligned_cols=61  Identities=11%  Similarity=0.077  Sum_probs=39.3

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH-----------------Hhccccc---CcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE-----------------LLGLCSE---GFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e-----------------l~g~~~~---~~~~~lv~E~~~~  226 (453)
                      +.||.|..+.||+-...+++ +.+|..+. ......+..|                 +++.|..   .+..++|||++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            46999999999998876664 66676443 1112222222                 3444432   3557999999998


Q ss_pred             CCh
Q 048517          227 GSL  229 (453)
Q Consensus       227 gsL  229 (453)
                      +++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.87  E-value=0.012  Score=55.31  Aligned_cols=31  Identities=29%  Similarity=0.457  Sum_probs=26.5

Q ss_pred             CceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ..++|+|+.+.||+++++...-|.||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4599999999999999776677999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.80  E-value=0.01  Score=55.59  Aligned_cols=31  Identities=23%  Similarity=0.306  Sum_probs=27.0

Q ss_pred             CCceeecccCCcceEEcC-CCceEEEecCCcc
Q 048517          267 DVCILHFDIKPHNILLDH-NFIPKVSDFGLAK  297 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~  297 (453)
                      +..++|+|+.+.|||++. +..+.+.||..|.
T Consensus       169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            357999999999999998 5789999998775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PLN02876 acyl-CoA dehydrogenase

Probab=96.76  E-value=0.016  Score=64.95  Aligned_cols=44  Identities=18%  Similarity=0.307  Sum_probs=31.3

Q ss_pred             HHHHHHhHcCCC--------CceeecccCCcceEEcC-CC-ceEEEecCCcccc
Q 048517          256 ARGIEYLHNGCD--------VCILHFDIKPHNILLDH-NF-IPKVSDFGLAKFH  299 (453)
Q Consensus       256 a~gL~yLH~~~~--------~~ivH~Dikp~NILl~~-~~-~~kl~DFGla~~~  299 (453)
                      .+.+.+|..+.+        +.++|+|+++.|||++. +. ..-|.||+++..-
T Consensus       205 ~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        205 LELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             HHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            344667754322        35999999999999985 33 3578999988653

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.75  E-value=0.013  Score=52.19  Aligned_cols=119  Identities=20%  Similarity=0.227  Sum_probs=71.8

Q ss_pred             hhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC----HH-HHHHHHhcccccC-----cceEEEEEecCCCChhhhhh
Q 048517          165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS----AE-EFINELLGLCSEG-----FKRALVYEYMPNGSLDRHIF  234 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~----~~-~~i~el~g~~~~~-----~~~~lv~E~~~~gsL~~~l~  234 (453)
                      ..+.||+|.+|.||+|.+. |..+|+|+-..+...    .+ +++..+-+.....     +...+.|||..|-.|.+.-.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~~  104 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLEI  104 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhhh
Confidence            4567999999999999987 668999987653221    11 2222232222211     11235699998878765431


Q ss_pred             hccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCC--cceEEcCCCceEEEecCCcccc
Q 048517          235 SKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKP--HNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       235 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp--~NILl~~~~~~kl~DFGla~~~  299 (453)
                      .       .+-    +-...++..---|-.   .+|-|+.|.-  +||++.. ..+.|.||..|+..
T Consensus       105 ~-------~~r----k~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k  156 (201)
T COG2112         105 G-------GDR----KHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVND-RDVYIIDFDSATFK  156 (201)
T ss_pred             c-------ccH----HHHHHHHHHHHHHHH---hccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence            1       122    223334444333333   3899999974  4666654 48999999988743

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.40  E-value=0.046  Score=55.58  Aligned_cols=32  Identities=25%  Similarity=0.312  Sum_probs=26.9

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ...++|||+.+.||++..+ .+++.||-.+...
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~G  253 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFYG  253 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEeccccccC
Confidence            3479999999999999776 5899999877643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.38  E-value=0.00078  Score=70.38  Aligned_cols=170  Identities=19%  Similarity=0.158  Sum_probs=109.6

Q ss_pred             hcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHHHhcccccC-------------cceEEEEEecCCC-Chhh
Q 048517          166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEG-------------FKRALVYEYMPNG-SLDR  231 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~el~g~~~~~-------------~~~~lv~E~~~~g-sL~~  231 (453)
                      -+..++|++++++|.+--..+...+|.+...  .......||+.-|...             ...++.++++..| +...
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~  324 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL  324 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence            3457889999999987322233335554433  3334455555554433             3345666666555 2111


Q ss_pred             hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeeccc
Q 048517          232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT  311 (453)
Q Consensus       232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  311 (453)
                      -.   ......+...+...+...-.++++|||+.   .=+|+|    ||+..+ ...|.+||+......+..   .....
T Consensus       325 ~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~  390 (829)
T KOG0576|consen  325 EM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTA  390 (829)
T ss_pred             cC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccC
Confidence            10   01112233344456667778899999986   558888    887765 678999999987665543   23456


Q ss_pred             CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCC
Q 048517          312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  353 (453)
Q Consensus       312 ~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~  353 (453)
                      .+|+.|+|||+...+  .+..+.|+|+.|+--.++.-|-+|-
T Consensus       391 ~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCC
Confidence            799999999988764  8889999999998777777776554

>PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal

Probab=96.26  E-value=0.015  Score=46.44  Aligned_cols=47  Identities=28%  Similarity=0.391  Sum_probs=36.1

Q ss_pred             CCCCCCceEEEEEeeecCCCC-CCCCHHHHHHHHhcCcceeee--cccCC
Q 048517           64 SDLPESCVFISKVPVVLNRSV-DNPSYEDLRKLLDSGFDFTWF--EECSS  110 (453)
Q Consensus        64 ~~~~~~c~~~~~~p~~~~~~~-~~~~~~~~~~~~~~g~~~~~~--~~~~~  110 (453)
                      .++...|...+.|||+..... ...+..++.+.|++||+|+|.  ...|.
T Consensus        19 ~~~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~   68 (94)
T PF14380_consen   19 SDLAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCR   68 (94)
T ss_pred             cccCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCc
Confidence            456789999999999774321 234788999999999999999  34554

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.25  E-value=0.015  Score=57.63  Aligned_cols=126  Identities=19%  Similarity=0.326  Sum_probs=85.8

Q ss_pred             hhcccCccCceEEEEEEEcCCcEEEEEEecCCCC---CHHHHHHH----Hhccccc-----------------------C
Q 048517          165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---SAEEFINE----LLGLCSE-----------------------G  214 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---~~~~~i~e----l~g~~~~-----------------------~  214 (453)
                      +...|..|-=..||.+.-.+|..+|||+.+.+-.   .+++++.-    -.|+|..                       +
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            3457899999999999988999999998765321   11111110    0112211                       1


Q ss_pred             ---------cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC
Q 048517          215 ---------FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN  285 (453)
Q Consensus       215 ---------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~  285 (453)
                               ....|||+|+....-   - ...-+...++...+...-.+++.-+.-|.+.|  .+||.||.--|+|+- +
T Consensus       228 IP~PePIlLk~hVLVM~FlGrdgw---~-aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  228 IPCPEPILLKNHVLVMEFLGRDGW---A-APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D  300 (520)
T ss_pred             CCCCCceeeecceEeeeeccCCCC---c-CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence                     113589999953221   1 11123346777788888899999999999886  899999999999995 5


Q ss_pred             CceEEEecCCcc
Q 048517          286 FIPKVSDFGLAK  297 (453)
Q Consensus       286 ~~~kl~DFGla~  297 (453)
                      |.+.++|-+-+.
T Consensus       301 G~lyiIDVSQSV  312 (520)
T KOG2270|consen  301 GKLYIIDVSQSV  312 (520)
T ss_pred             CEEEEEEccccc
Confidence            678899977664

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.25  E-value=0.025  Score=51.83  Aligned_cols=40  Identities=28%  Similarity=0.265  Sum_probs=32.6

Q ss_pred             HHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          249 HEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       249 ~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      ..-+.++.+-|..+|..   +|+-+|+|+.|..     .-||+|||.+
T Consensus       167 ~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  167 IRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             hhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            34556778888899998   9999999999987     3489999864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.15  E-value=0.0058  Score=59.44  Aligned_cols=120  Identities=18%  Similarity=0.179  Sum_probs=79.5

Q ss_pred             hhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC------HH-----------------------HHHHHHhc--cc
Q 048517          163 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS------AE-----------------------EFINELLG--LC  211 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~------~~-----------------------~~i~el~g--~~  211 (453)
                      +.+.++||-|.=+.||.+-..+|++.++|.-......      ..                       .|+..|+.  |-
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            4567899999999999999999999999853211000      00                       12222332  21


Q ss_pred             c----cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517          212 S----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  287 (453)
Q Consensus       212 ~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~  287 (453)
                      .    +..+.++|||++.+-.|...-       ...+.++   +...+..-+.-|-.+   ++||+|..-=||+++++..
T Consensus       174 VPkpiD~~RH~Vvmelv~g~Pl~~v~-------~v~d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  174 VPKPIDHNRHCVVMELVDGYPLRQVR-------HVEDPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCcccccceeeHHHhhcccceeeee-------ecCChHH---HHHHHHHHHHHHHHc---CceecccchheeEEecCCC
Confidence            1    234568999999888775422       1122233   333333444555555   9999999999999999999


Q ss_pred             eEEEecCC
Q 048517          288 PKVSDFGL  295 (453)
Q Consensus       288 ~kl~DFGl  295 (453)
                      ++++||--
T Consensus       241 i~vIDFPQ  248 (465)
T KOG2268|consen  241 IVVIDFPQ  248 (465)
T ss_pred             EEEeechH
Confidence            99999954

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.09  E-value=0.1  Score=51.74  Aligned_cols=126  Identities=24%  Similarity=0.399  Sum_probs=73.5

Q ss_pred             cCccCceEEEEEEEcCCcEEEEEEecCCCCCHH--HH----HHHH------------------hcccccCcceEEEEEec
Q 048517          169 LGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAE--EF----INEL------------------LGLCSEGFKRALVYEYM  224 (453)
Q Consensus       169 LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~--~~----i~el------------------~g~~~~~~~~~lv~E~~  224 (453)
                      |.+ .-..+|+.+..+|+. ++|+.... ....  ++    +..|                  +.......+.+-+++|+
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            444 457889998887877 88988875 3222  22    2221                  11112223678899999


Q ss_pred             CCCChhh-h--------------hhh--------ccCCCCCCCchh-------------HHHHHHHHHHHHHHhHcC---
Q 048517          225 PNGSLDR-H--------------IFS--------KENKGQTFGLEK-------------PHEIALGTARGIEYLHNG---  265 (453)
Q Consensus       225 ~~gsL~~-~--------------l~~--------~~~~~~~l~~~~-------------~~~i~~~ia~gL~yLH~~---  265 (453)
                      +|..+.. -              ++.        .........|..             ......++...+..+.+.   
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9988872 1              111        111122345541             011233334444444432   


Q ss_pred             -CCCc---eeecccCCcceEEcCCCc-eEEEecCCcc
Q 048517          266 -CDVC---ILHFDIKPHNILLDHNFI-PKVSDFGLAK  297 (453)
Q Consensus       266 -~~~~---ivH~Dikp~NILl~~~~~-~kl~DFGla~  297 (453)
                       -...   +||+|+.|.||+++.+.. ..+.||+-+.
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             2223   999999999999998874 8899998764

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.02  E-value=0.058  Score=51.36  Aligned_cols=30  Identities=23%  Similarity=0.321  Sum_probs=26.0

Q ss_pred             CceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ..++|+|+.|.||++++++ +.|.||..+..
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            4689999999999999877 78999988753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.91  E-value=0.058  Score=52.69  Aligned_cols=32  Identities=31%  Similarity=0.297  Sum_probs=27.9

Q ss_pred             CCCceeecccCCcceEEcCC----CceEEEecCCcc
Q 048517          266 CDVCILHFDIKPHNILLDHN----FIPKVSDFGLAK  297 (453)
Q Consensus       266 ~~~~ivH~Dikp~NILl~~~----~~~kl~DFGla~  297 (453)
                      ....++|+|+.+.|||++++    ..+++.||..|.
T Consensus       177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            45679999999999999875    789999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=95.90  E-value=0.066  Score=52.07  Aligned_cols=130  Identities=18%  Similarity=0.172  Sum_probs=72.3

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCC----HHHHHHHHh--ccc--------------ccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS----AEEFINELL--GLC--------------SEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~----~~~~i~el~--g~~--------------~~~~~~~lv~E~~~~  226 (453)
                      +.|..|.-..+|+....+ ..+++|+.......    ..+++..|.  |+-              ...+..+++++|++|
T Consensus        20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G   98 (296)
T cd05153          20 EGISAGIENTNYFVTTDS-GRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAG   98 (296)
T ss_pred             ecccCccccceEEEEeCC-CcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCC
Confidence            357777778999987654 46888987642111    111222221  110              112345789999998


Q ss_pred             CChhh----h----------hhhccC-------CCCCCCchhHH----------HHHHHHHHHHHHhHc----CCCCcee
Q 048517          227 GSLDR----H----------IFSKEN-------KGQTFGLEKPH----------EIALGTARGIEYLHN----GCDVCIL  271 (453)
Q Consensus       227 gsL~~----~----------l~~~~~-------~~~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~~~iv  271 (453)
                      ..+..    .          +|....       ......|....          .....+...+.++.+    .....++
T Consensus        99 ~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~  178 (296)
T cd05153          99 EHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVI  178 (296)
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCC
Confidence            77532    0          111000       00112332211          111223344555553    2234799


Q ss_pred             ecccCCcceEEcCCCceEEEecCCcc
Q 048517          272 HFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       272 H~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      |+|+.|.|||++++..+.|.||+.+.
T Consensus       179 HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         179 HADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             ccCcCcccEEEeCCceEEEeehhhhc
Confidence            99999999999998778899998775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=95.90  E-value=0.08  Score=52.13  Aligned_cols=31  Identities=23%  Similarity=0.340  Sum_probs=26.7

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ..+++|+|+.|.|||++.+...-|.||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4589999999999999977666899998875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=95.85  E-value=0.035  Score=62.23  Aligned_cols=167  Identities=19%  Similarity=0.175  Sum_probs=109.2

Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCc---ceEEcCCCceEEE--ecCC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH---NILLDHNFIPKVS--DFGL  295 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~---NILl~~~~~~kl~--DFGl  295 (453)
                      -|++..-++...+    ......+..+.+.+..+...||.|+|+.   ...|.-+..+   +-..+..+....+  ||+.
T Consensus       265 ~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~s  337 (1351)
T KOG1035|consen  265 QEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDS  337 (1351)
T ss_pred             HhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHHHh---ccceeEEecccccccccCccceeecchhhhcc
Confidence            4555555555544    2335678888889999999999999997   5555555444   4444566677777  8888


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      ++..+.....   ....-+..+.+||....+....+...|+|.+|..+..+..|..+.......          ...+..
T Consensus       338 s~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~----------~~~l~~  404 (1351)
T KOG1035|consen  338 SKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP----------VSLLDV  404 (1351)
T ss_pred             cccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch----------hhhhcc
Confidence            8766543321   223345678889888765445556689999999999998876543221110          000000


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  421 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le  421 (453)
                               .     ....+......|+..++++|++..++++..-
T Consensus       405 ---------~-----~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  405 ---------L-----STSELLDALPKCLDEDSEERLSALELLTHPF  436 (1351)
T ss_pred             ---------c-----cchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence                     0     0013566777899999999999999998653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=95.57  E-value=0.13  Score=47.13  Aligned_cols=112  Identities=20%  Similarity=0.276  Sum_probs=69.7

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCC-----------------CCHHHHHHH--------------------Hhc
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSK-----------------FSAEEFINE--------------------LLG  209 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~-----------------~~~~~~i~e--------------------l~g  209 (453)
                      ..||+|+.=.||.-  ++.....||+.....                 ....++..|                    .+|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            46999999888874  445557888887654                 112333333                    345


Q ss_pred             ccccCcceEEEEEecCC--C----ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517          210 LCSEGFKRALVYEYMPN--G----SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD  283 (453)
Q Consensus       210 ~~~~~~~~~lv~E~~~~--g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~  283 (453)
                      +...+....+|+|.+.+  |    +|.+++.     ...++. ...+   .+-+-..||-+.   .|+.+|++|+||++.
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQ---ALDEFKRYLLDH---HIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHH---HHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence            55555566788888743  3    4566652     123443 3333   333445667666   899999999999995


Q ss_pred             CC--C--ceEEEe
Q 048517          284 HN--F--IPKVSD  292 (453)
Q Consensus       284 ~~--~--~~kl~D  292 (453)
                      .+  +  .+.|.|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            32  2  466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.54  E-value=0.0018  Score=73.74  Aligned_cols=134  Identities=13%  Similarity=0.034  Sum_probs=95.0

Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC--CCceeecccCCcceEEcCCCceEEEec
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDF  293 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DF  293 (453)
                      ..+..++|+..|.+.+.|.....+...+...-+...-.+......-.|+..  ..--+|+++|+-|.+|..+-.+|++++
T Consensus      1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred             HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence            345788899999999988665544445544444443344344445544432  224789999999999999999999999


Q ss_pred             CCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCC
Q 048517          294 GLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  353 (453)
Q Consensus       294 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~  353 (453)
                      |+.+........  .+...+++-|+.|+....-  .++.++|+|..|+.+++..-|..++
T Consensus      1385 gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1385 GLDKIKNPVLSF--FGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             ccccccCchHhh--hhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHHHhcccHHH
Confidence            999943332221  2445678889999987654  6677799999999999998776554

>PLN02236 choline kinase

Probab=95.43  E-value=0.11  Score=51.97  Aligned_cols=32  Identities=22%  Similarity=0.429  Sum_probs=27.2

Q ss_pred             CCceeecccCCcceEEcC-CCceEEEecCCccc
Q 048517          267 DVCILHFDIKPHNILLDH-NFIPKVSDFGLAKF  298 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~  298 (453)
                      +..++|+|+++.|||+++ +..+.+.||..+..
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            457999999999999986 57899999988753

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=94.76  E-value=0.37  Score=47.42  Aligned_cols=43  Identities=26%  Similarity=0.400  Sum_probs=33.9

Q ss_pred             HHHhHcCC-----CCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          259 IEYLHNGC-----DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       259 L~yLH~~~-----~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ..+|+++.     .+.++|+|+.+.|++++.+.-+-|.||+++.+-..
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            45555442     25699999999999999888899999999986543

>PRK06148 hypothetical protein; Provisional

Probab=93.91  E-value=0.54  Score=53.91  Aligned_cols=33  Identities=30%  Similarity=0.318  Sum_probs=26.9

Q ss_pred             CCCceeecccCCcceEEcCCC--ceE-EEecCCccc
Q 048517          266 CDVCILHFDIKPHNILLDHNF--IPK-VSDFGLAKF  298 (453)
Q Consensus       266 ~~~~ivH~Dikp~NILl~~~~--~~k-l~DFGla~~  298 (453)
                      ...++||+|+.+.|||++.+.  .+. |.|||-+..
T Consensus       201 Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        201 LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            345899999999999999875  454 999998753

>PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding

Probab=93.70  E-value=0.14  Score=41.75  Aligned_cols=23  Identities=35%  Similarity=0.257  Sum_probs=21.0

Q ss_pred             cccEEEEEEecCCcEEEEEecCC
Q 048517            2 TFQHYVKRISYDECTISVADVNL   24 (453)
Q Consensus         2 ~~~y~V~~I~Y~~~t~~v~d~~~   24 (453)
                      .++|+|++|+|.+++++|.++..
T Consensus        46 ~~~~~V~~I~~~~~~i~v~~~~~   68 (106)
T PF13947_consen   46 SGNYEVLSISYENGTIRVSDPIS   68 (106)
T ss_pred             CCcEEEEEEecCCCEEEEEeccc
Confidence            47899999999999999999875

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.61  E-value=0.2  Score=50.58  Aligned_cols=60  Identities=20%  Similarity=0.119  Sum_probs=41.2

Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD  283 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~  283 (453)
                      ..|+-+|+.+.++..++...     ..++....+++.--++||.-+---  .+.+|.|+.|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~-----~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK-----SQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhcc-----cChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence            34677888898998888432     233345566666666665544332  2899999999999994

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=93.35  E-value=0.21  Score=49.61  Aligned_cols=55  Identities=18%  Similarity=0.176  Sum_probs=49.2

Q ss_pred             CCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          242 TFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       242 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      .-.|++...|+.+.++.+.-+..+  .+.=|||+.-.||||+ +|++.|.||-++|+-
T Consensus       317 ~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         317 ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeecc
Confidence            457899999999999988888876  5889999999999999 999999999999954

>PRK11768 serine/threonine protein kinase; Provisional

Probab=93.06  E-value=1.6  Score=43.14  Aligned_cols=29  Identities=34%  Similarity=0.421  Sum_probs=24.5

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ..+++|+|+.+.|||++ + .+.|.||+-+.
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            44789999999999995 4 57899999775

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=92.71  E-value=0.8  Score=45.51  Aligned_cols=31  Identities=23%  Similarity=0.330  Sum_probs=26.3

Q ss_pred             CceeecccCCcceEEcC-CCceEEEecCCccc
Q 048517          268 VCILHFDIKPHNILLDH-NFIPKVSDFGLAKF  298 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~  298 (453)
                      .-++|+|+.+.|||+++ ++.+++.||..|..
T Consensus       182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            35899999999999975 57899999988753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=92.61  E-value=0.18  Score=49.39  Aligned_cols=42  Identities=29%  Similarity=0.506  Sum_probs=32.3

Q ss_pred             HHHHHHhHc----CCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          256 ARGIEYLHN----GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       256 a~gL~yLH~----~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      .+.++++..    ....+++|+|+++.||+++.+....|.||+.+.
T Consensus       171 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       171 DKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            344555542    234689999999999999988777899998774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PHA03111 Ser/Thr kinase; Provisional

Probab=92.41  E-value=0.15  Score=50.05  Aligned_cols=37  Identities=35%  Similarity=0.331  Sum_probs=27.0

Q ss_pred             hhHHHHHHHHHHHHHHh-HcCCCCceeecccCCcceEE
Q 048517          246 EKPHEIALGTARGIEYL-HNGCDVCILHFDIKPHNILL  282 (453)
Q Consensus       246 ~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dikp~NILl  282 (453)
                      +-+..+..|||--.-.. .-.|....+|-||||+|||+
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILi  316 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILI  316 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEE
Confidence            34566778887655444 33445689999999999999

>PLN02756 S-methyl-5-thioribose kinase

Probab=91.48  E-value=2.8  Score=42.87  Aligned_cols=31  Identities=16%  Similarity=0.295  Sum_probs=25.5

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      .+.++|+|+.|.||+++.+. +++.|...+..
T Consensus       229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~~  259 (418)
T PLN02756        229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAFY  259 (418)
T ss_pred             ccceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence            36899999999999999875 88888765543

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=91.19  E-value=0.65  Score=45.20  Aligned_cols=60  Identities=18%  Similarity=0.231  Sum_probs=31.6

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---H-HHHHH-----------HhcccccCcceEEEEEecCCC
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---E-EFINE-----------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~-~~i~e-----------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      +.++.|.-..+|+.. .+++.+-||+-.......   | +-++.           .+++.......+|++||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            458888889999987 668889999877432211   1 11111           333333445568999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=90.83  E-value=0.25  Score=48.76  Aligned_cols=51  Identities=29%  Similarity=0.427  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHHHHH--hHc-CCCCceeecccCCcceEEc------------------CCCceEEEecCCccccC
Q 048517          248 PHEIALGTARGIEY--LHN-GCDVCILHFDIKPHNILLD------------------HNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       248 ~~~i~~~ia~gL~y--LH~-~~~~~ivH~Dikp~NILl~------------------~~~~~kl~DFGla~~~~  300 (453)
                      +..+..|+|  |.|  .-+ .|....+|-||||+|||+=                  +.-.++|-||.+++...
T Consensus       277 vkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  277 VKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             HHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence            455666765  344  322 2456899999999999992                  22246777887776543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=89.87  E-value=0.088  Score=44.06  Aligned_cols=34  Identities=24%  Similarity=0.432  Sum_probs=29.0

Q ss_pred             hhhh-cccCccCceEEEEEEEcCCcEEEEEEecCC
Q 048517          163 NHFT-HKLGQGGFGSVYKGQLHTGRLIAVKMMENS  196 (453)
Q Consensus       163 ~~~~-~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~  196 (453)
                      ..|. +-||.|+.|.||+|++++|+.||||+.+..
T Consensus        12 ~~fd~~PlasASiaQVh~a~l~~g~~VaVKV~rP~   46 (119)
T PF03109_consen   12 DEFDPEPLASASIAQVHRARLKDGEEVAVKVQRPG   46 (119)
T ss_pred             HHCCcchhhheehhhheeeeecccchhhhhhcchH
Confidence            3444 469999999999999999999999998763

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=89.70  E-value=0.7  Score=45.12  Aligned_cols=30  Identities=33%  Similarity=0.253  Sum_probs=25.7

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ..+++|+|+.++||+++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            358999999999999987 567899998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=89.18  E-value=0.57  Score=43.57  Aligned_cols=76  Identities=20%  Similarity=0.230  Sum_probs=55.3

Q ss_pred             HHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccch
Q 048517          256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD  335 (453)
Q Consensus       256 a~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~D  335 (453)
                      +++|.-.|+. ....+|+|-.|+||+-|..|.+||.|=+..-              ..+..|.--|     +...+.++.
T Consensus       151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--------------~~~V~~vN~~-----Y~~lT~~aE  210 (308)
T PF07387_consen  151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--------------ENQVNMVNIE-----YESLTQEAE  210 (308)
T ss_pred             HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--------------hheeeEEeee-----ccccChHHH
Confidence            4667888864 4689999999999999999999999965432              1122233322     235678899


Q ss_pred             HHHHHHHHHHHHcCCC
Q 048517          336 VYGFGMVLLEMAGGRR  351 (453)
Q Consensus       336 V~S~Gvvl~elltg~~  351 (453)
                      +-+|=..+++++...+
T Consensus       211 ~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  211 VKVFVKSCLKLVEKQR  226 (308)
T ss_pred             HHHHHHHHHHHHHHHh
Confidence            9999999999886543

The function of this family is unknown.

>PRK10271 thiK thiamine kinase; Provisional

Probab=88.19  E-value=0.42  Score=43.31  Aligned_cols=30  Identities=20%  Similarity=0.282  Sum_probs=26.1

Q ss_pred             CceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ...+|+|+.|.|+++++++ ++|.||+.+..
T Consensus        77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            3579999999999998877 88999998863

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=88.04  E-value=2.6  Score=40.22  Aligned_cols=65  Identities=17%  Similarity=0.109  Sum_probs=40.3

Q ss_pred             ccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHH-----HHHHHhcc------cccCcceEEEEEecC-CCChhhh
Q 048517          168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE-----FINELLGL------CSEGFKRALVYEYMP-NGSLDRH  232 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~-----~i~el~g~------~~~~~~~~lv~E~~~-~gsL~~~  232 (453)
                      .+-.|..+.|+.++..+|.++++|+........++     .+.-.-|.      -.+.....+++|... +-+|.+.
T Consensus         9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~~~L~~w~G~GaVrll~~d~~~~AlLLErl~~g~~L~~~   85 (253)
T PF04655_consen    9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGEAALRWWNGRGAVRLLAADPERGALLLERLDPGRSLASL   85 (253)
T ss_pred             CCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHHhHhheeCCCCceeeeccccccchhhhhhccCCCchhhc
Confidence            45678889999999999999999998764433222     22211111      112234568888884 4455443

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=87.75  E-value=0.57  Score=43.08  Aligned_cols=30  Identities=33%  Similarity=0.490  Sum_probs=21.5

Q ss_pred             CceeecccCCcceEE-cCCCceEEEecCCcc
Q 048517          268 VCILHFDIKPHNILL-DHNFIPKVSDFGLAK  297 (453)
Q Consensus       268 ~~ivH~Dikp~NILl-~~~~~~kl~DFGla~  297 (453)
                      .-+.|+|+.|.|||+ +.++.+++.||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            468999999999999 888999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	453
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-39
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-38
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-34
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-26
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-24
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-06
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-06
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-06
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-06
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-05
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-05
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-05
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-04
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-04
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-04
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-04
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-04
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-04
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-04
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-04
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-04
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-04
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-04
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-04
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-04
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-04
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-04
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-04
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-04
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-04
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-04
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-04
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-04
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-04
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-04
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-04
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-04
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		6e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 152/293 (51%), Gaps = 29/293 (9%)
Query: 155 LPEIIAVTNHFTHK--LGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF--------- 203
           L E+   +++F++K  LG+GGFG VYKG+L  G L+AVK ++  +    E          
Sbjct: 30  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMI 89
Query: 204 -------INELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
                  +  L G C    +R LVY YM NGS+   +  +          K   IALG+A
Sbjct: 90  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 149
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG+ YLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V  +  RGTIG
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRGTIG 208
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM-NATRSSKAYFPSWVYDQLNK 375
           ++APE +S   G  S K+DV+G+G++LLE+  G+R  ++             WV   L +
Sbjct: 209 HIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 266
Query: 376 GG-----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423
                  D++L+   + E +   +L  + L C Q    +RP M++V+ MLEG 
Sbjct: 267 KKLEALVDVDLQGNYKDEEV--EQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 150/292 (51%), Gaps = 29/292 (9%)
Query: 155 LPEIIAVTNHFTHK--LGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF--------- 203
           L E+   +++F +K  LG+GGFG VYKG+L  G L+AVK ++  +    E          
Sbjct: 22  LRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 204 -------INELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
                  +  L G C    +R LVY YM NGS+   +  +          K   IALG+A
Sbjct: 82  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG+ YLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V  +  RG IG
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRGXIG 200
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM-NATRSSKAYFPSWVYDQLNK 375
           ++APE +S   G  S K+DV+G+G++LLE+  G+R  ++             WV   L +
Sbjct: 201 HIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 376 GG-----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422
                  D++L+   + E +   +L  + L C Q    +RP M++V+ MLEG
Sbjct: 259 KKLEALVDVDLQGNYKDEEV--EQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 147/289 (50%), Gaps = 30/289 (10%)
Query: 155 LPEIIAVTNHFTHK--LGQGGFGSVYKGQLHTGRLIAVKMM--ENSK------------- 197
           L ++   TN+F HK  +G G FG VYKG L  G  +A+K    E+S+             
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 198 FSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR 257
           F     +  L+G C E  +  L+Y+YM NG+L RH++  +    +   E+  EI +G AR
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
           G+ YLH      I+H D+K  NILLD NF+PK++DFG++K   + +        +GT+GY
Sbjct: 151 GLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377
           + PE   +  G ++ KSDVY FG+VL E+    R++ + +          W  +  N G 
Sbjct: 208 IDPEYFIK--GRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 378 -----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                D  L +    ES+  RK     + C+ + + DRPSM  VL  LE
Sbjct: 265 LEQIVDPNLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 146/289 (50%), Gaps = 30/289 (10%)
Query: 155 LPEIIAVTNHFTHK--LGQGGFGSVYKGQLHTGRLIAVKMM--ENSK------------- 197
           L ++   TN+F HK  +G G FG VYKG L  G  +A+K    E+S+             
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 198 FSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR 257
           F     +  L+G C E  +  L+Y+YM NG+L RH++  +    +   E+  EI +G AR
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
           G+ YLH      I+H D+K  NILLD NF+PK++DFG++K   +          +GT+GY
Sbjct: 151 GLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377
           + PE   +  G ++ KSDVY FG+VL E+    R++ + +          W  +  N G 
Sbjct: 208 IDPEYFIK--GRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 378 -----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                D  L +    ES+  RK     + C+ + + DRPSM  VL  LE
Sbjct: 265 LEQIVDPNLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 96/299 (32%), Positives = 137/299 (45%), Gaps = 49/299 (16%)
Query: 157 EIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF----- 203
           E+  VTN+F         +K+G+GGFG VYKG ++   +   K+      + EE      
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 78
Query: 204 -------------INELLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPH 249
                        + ELLG  S+G    LVY YMPNGSL DR   S  +           
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSWHMRC 136
Query: 250 EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309
           +IA G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    V  S
Sbjct: 137 KIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXS 193
Query: 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-------RRNSNMNATRSSK 362
              GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G       R    +   +   
Sbjct: 194 RIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250
Query: 363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                 + D ++K   +   + T +E+M +     +   C+  K   RP + KV ++L+
Sbjct: 251 EDEEKTIEDYIDK--KMNDADSTSVEAMYS-----VASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 95/299 (31%), Positives = 136/299 (45%), Gaps = 49/299 (16%)
Query: 157 EIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF----- 203
           E+  VTN+F         +K+G+GGFG VYKG ++   +   K+      + EE      
Sbjct: 13  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 72
Query: 204 -------------INELLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPH 249
                        + ELLG  S+G    LVY YMPNGSL DR   S  +           
Sbjct: 73  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSWHMRC 130
Query: 250 EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309
           +IA G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    V   
Sbjct: 131 KIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXX 187
Query: 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-------RRNSNMNATRSSK 362
              GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G       R    +   +   
Sbjct: 188 RIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 244
Query: 363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                 + D ++K   +   + T +E+M +     +   C+  K   RP + KV ++L+
Sbjct: 245 EDEEKTIEDYIDK--KMNDADSTSVEAMYS-----VASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 95/299 (31%), Positives = 136/299 (45%), Gaps = 49/299 (16%)
Query: 157 EIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF----- 203
           E+  VTN+F         +K+G+GGFG VYKG ++   +   K+      + EE      
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 78
Query: 204 -------------INELLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPH 249
                        + ELLG  S+G    LVY YMPNGSL DR   S  +           
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSWHMRC 136
Query: 250 EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309
           +IA G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    V   
Sbjct: 137 KIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXX 193
Query: 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-------RRNSNMNATRSSK 362
              GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G       R    +   +   
Sbjct: 194 RIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250
Query: 363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                 + D ++K   +   + T +E+M +     +   C+  K   RP + KV ++L+
Sbjct: 251 EDEEKTIEDYIDK--KMNDADSTSVEAMYS-----VASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 128/292 (43%), Gaps = 35/292 (11%)
Query: 157 EIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF----- 203
           E+  VTN+F         +K G+GGFG VYKG ++   +   K+      + EE      
Sbjct: 10  ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 69
Query: 204 -------------INELLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPH 249
                        + ELLG  S+G    LVY Y PNGSL DR   S  +           
Sbjct: 70  QEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDR--LSCLDGTPPLSWHXRC 127
Query: 250 EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309
           +IA G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    V  S
Sbjct: 128 KIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXS 184
Query: 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV 369
              GT  Y APE +    G ++ KSD+Y FG+VLLE+  G    + +            +
Sbjct: 185 RIVGTTAYXAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 241
Query: 370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
            D+     D   +   + +S        +   C+  K   RP + KV ++L+
Sbjct: 242 EDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 138/274 (50%), Gaps = 38/274 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 18  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+ + E K   F ++K  +IA  TARG++YLH      
Sbjct: 76  YSTKP-QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKS--- 128
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387
             S +SDVY FG+VL E M G    SN+N            + + + +G      +++++
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIEMVGRGSLSP--DLSKV 238
Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
            S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 239 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 136/273 (49%), Gaps = 36/273 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINELLGL------------- 210
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+  L             
Sbjct: 30  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
            S   + A+V ++    SL  H+ + E K   F ++K  +IA  TARG++YLH      I
Sbjct: 88  YSTAPQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFGT 329
           +H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++   
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 330 VSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 388
            S +SDVY FG+VL E M G    SN+N            + + + +G      +++++ 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIEMVGRGSLSP--DLSKVR 251
Query: 389 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 138/274 (50%), Gaps = 38/274 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 30  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+ + E K   F ++K  +IA  TARG++YLH      
Sbjct: 88  YSTKP-QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387
             S +SDVY FG+VL E M G    SN+N            + + + +G      +++++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIEMVGRGSLSP--DLSKV 250
Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
            S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 24/201 (11%)
Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAE---EFINEL------------- 207
           +   K+G G FG+V++ + H G  +AVK++    F AE   EF+ E+             
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 208 -LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
            +G  ++    ++V EY+  GSL R +  K    +     +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR- 156
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           +  I+H ++K  N+L+D  +  KV DFGL++   K + F+S     GT  ++APE++   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 327 FGTVSCKSDVYGFGMVLLEMA 347
               + KSDVY FG++L E+A
Sbjct: 215 --PSNEKSDVYSFGVILWELA 233

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 24/201 (11%)
Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAE---EFINEL------------- 207
           +   K+G G FG+V++ + H G  +AVK++    F AE   EF+ E+             
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 208 -LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
            +G  ++    ++V EY+  GSL R +  K    +     +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR- 156
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           +  I+H D+K  N+L+D  +  KV DFGL++   K + F+      GT  ++APE++   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 327 FGTVSCKSDVYGFGMVLLEMA 347
               + KSDVY FG++L E+A
Sbjct: 215 --PSNEKSDVYSFGVILWELA 233

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 109/211 (51%), Gaps = 27/211 (12%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF------------- 203
           EI A     + ++G G FG+VYKG+ H    +AVK+++    + E+F             
Sbjct: 32  EIEASEVMLSTRIGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKT 89
Query: 204 --INELL--GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
             +N LL  G  ++    A+V ++    SL +H+  +E K Q F L    +IA  TA+G+
Sbjct: 90  RHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLI---DIARQTAQGM 145
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           +YLH      I+H D+K +NI L      K+ DFGLA    + +    +    G++ ++A
Sbjct: 146 DYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 320 PELIS-RNFGTVSCKSDVYGFGMVLLEMAGG 349
           PE+I  ++    S +SDVY +G+VL E+  G
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  ++G G FG V+ G       +A+K +     S E+FI E              L G+
Sbjct: 14  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C E     LV+E+M +G L  ++ ++      F  E    + L    G+ YL    + C+
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EACV 127
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 184
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSDV+ FG+++ E+
Sbjct: 185 SSKSDVWSFGVLMWEV 200

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  ++G G FG V+ G       +A+K +     S E+FI E              L G+
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C E     LV+E+M +G L  ++ ++      F  E    + L    G+ YL    + C+
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EACV 124
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 181
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSDV+ FG+++ E+
Sbjct: 182 SSKSDVWSFGVLMWEV 197

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  ++G G FG V+ G       +A+K +     S E+FI E              L G+
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C E     LV+E+M +G L  ++ ++      F  E    + L    G+ YL    + C+
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EACV 122
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 179
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSDV+ FG+++ E+
Sbjct: 180 SSKSDVWSFGVLMWEV 195

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF---------------INELLGLC 211
            ++G G FG+VYKG+ H    +AVKM+  +  + ++                +N LL + 
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 212 -SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
            S   + A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH      I
Sbjct: 72  YSTAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFGT 329
           +H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++   
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 330 VSCKSDVYGFGMVLLE-MAGGRRNSNMN 356
            S +SDVY FG+VL E M G    SN+N
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 28/209 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH      
Sbjct: 72  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 356
             S +SDVY FG+VL E M G    SN+N
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 28/209 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 16  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH      
Sbjct: 74  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 126
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 356
             S +SDVY FG+VL E M G    SN+N
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 28/209 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 19  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH      
Sbjct: 77  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 356
             S +SDVY FG+VL E M G    SN+N
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 28/209 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 19  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH      
Sbjct: 77  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 356
             S +SDVY FG+VL E M G    SN+N
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  ++G G FG V+ G       +A+K +     S E+FI E              L G+
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C E     LV E+M +G L  ++ ++      F  E    + L    G+ YL    + C+
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 182
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSDV+ FG+++ E+
Sbjct: 183 SSKSDVWSFGVLMWEV 198

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 28/209 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 41  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH      
Sbjct: 99  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 151
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 356
             S +SDVY FG+VL E M G    SN+N
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  ++G G FG V+ G       +A+K ++    S ++FI E              L G+
Sbjct: 31  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C E     LV+E+M +G L  ++ ++      F  E    + L    G+ YL    + C+
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EACV 144
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 201
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSDV+ FG+++ E+
Sbjct: 202 SSKSDVWSFGVLMWEV 217

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 28/209 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 42  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH      
Sbjct: 100 YSTKP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 356
             S +SDVY FG+VL E M G    SN+N
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 28/209 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH      
Sbjct: 72  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 356
             S +SDVY FG+VL E M G    SN+N
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 28/209 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 34  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH      
Sbjct: 92  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 144
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 356
             S +SDVY FG+VL E M G    SN+N
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 28/209 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINEL--------------LG 209
            ++G G FG+VYKG+ H    +AVKM+  +  + ++   F NE+              +G
Sbjct: 42  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             ++  + A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH      
Sbjct: 100 YSTKP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS-RNFG 328
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 329 TVSCKSDVYGFGMVLLE-MAGGRRNSNMN 356
             S +SDVY FG+VL E M G    SN+N
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  ++G G FG V+ G       +A+K +     S E+FI E              L G+
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C E     LV+E+M +G L  ++ ++      F  E    + L    G+ YL    +  +
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EASV 124
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 181
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSDV+ FG+++ E+
Sbjct: 182 SSKSDVWSFGVLMWEV 197

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 29/231 (12%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           EI   +     +LG G FG V+ G  +    +AVK ++    S + F+ E          
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 68
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               L  + +      ++ EYM  GSL    F K ++G    L K  + +   A G+ Y+
Sbjct: 69  KLVRLYAVVTREEPIYIITEYMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 126
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
                   +H D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 127 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEA 182
Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMNATRSSKAYFP 366
           I  NFG  + KSDV+ FG++L E+         GR N+++    S     P
Sbjct: 183 I--NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMP 231

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 23/198 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 78  E-PIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 131
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 188
Query: 334 SDVYGFGMVLLEMAGGRR 351
           SDV+ FG++L E+    R
Sbjct: 189 SDVWSFGILLTELTTKGR 206

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 23/198 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 76  E-PIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 129
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 186
Query: 334 SDVYGFGMVLLEMAGGRR 351
           SDV+ FG++L E+    R
Sbjct: 187 SDVWSFGILLTELTTKGR 204

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 23/198 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 251 E-PIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 334 SDVYGFGMVLLEMAGGRR 351
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 23/198 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 251 E-PIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 334 SDVYGFGMVLLEMAGGRR 351
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 23/198 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 74  E-PIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 127
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 184
Query: 334 SDVYGFGMVLLEMAGGRR 351
           SDV+ FG++L E+    R
Sbjct: 185 SDVWSFGILLTELTTKGR 202

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 122/275 (44%), Gaps = 36/275 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      +V EYMP G+L  ++  + N+ +   +   + +A   +  +EYL        +
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYL-RECNREEVTAVVLLY-MATQISSAMEYLEKKN---FI 152
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N  T S
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--TFS 209
Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 391
            KSDV+ FG++L E+A    +       S        VYD L KG  +E           
Sbjct: 210 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYDLLEKGYRMEQ------PEGC 256
Query: 392 ARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
             K+  +   C +   ADRPS  +  +  E    D
Sbjct: 257 PPKVYELMRACWKWSPADRPSFAETHQAFETMFHD 291

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 23/193 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 85  E-PIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 23/193 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 85  E-PIYIVIEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 23/193 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 85  E-PIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 23/198 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 251 E-PIYIVGEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 334 SDVYGFGMVLLEMAGGRR 351
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 23/193 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 85  E-PIYIVCEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 23/198 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 75  E-PIXIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 128
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N+  +    +  I + APE  +  +G  + K
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPE--AALYGRFTIK 185
Query: 334 SDVYGFGMVLLEMAGGRR 351
           SDV+ FG++L E+    R
Sbjct: 186 SDVWSFGILLTELTTKGR 203

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 73
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 74  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 131
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I
Sbjct: 132 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI 187
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 188 --NYGTFTIKSDVWSFGILLTEI 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 75  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 132
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I
Sbjct: 133 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI 188
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 189 --NYGTFTIKSDVWSFGILLTEI 209

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           EI   +     KLG G FG V+    +    +AVK M+    S E F+ E          
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 70
Query: 207 -LLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
            L+ L +   K    ++ E+M  GSL    F K ++G    L K  + +   A G+ ++ 
Sbjct: 71  KLVKLHAVVTKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
                  +H D++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE I
Sbjct: 129 QR---NYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAI 184
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             NFG+ + KSDV+ FG++L+E+
Sbjct: 185 --NFGSFTIKSDVWSFGILLMEI 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI 182
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 183 --NYGTFTIKSDVWSFGILLTEI 203

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 23/193 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 334 E-PIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 444
Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 445 SDVWSFGILLTEL 457

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 23/193 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 85  E-PIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D+   NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 78
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 79  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 136
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I
Sbjct: 137 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI 192
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 193 --NYGTFTIKSDVWSFGILLTEI 213

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 63
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 64  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 121
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I
Sbjct: 122 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI 177
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 178 --NYGTFTIKSDVWSFGILLTEI 198

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 23/198 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  +++   A G+ Y+     +  +H 
Sbjct: 82  E-PIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 192
Query: 334 SDVYGFGMVLLEMAGGRR 351
           SDV+ FG++L E+    R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 23/198 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  +++   A G+ Y+     +  +H 
Sbjct: 82  E-PIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAPE--AALYGRFTIK 192
Query: 334 SDVYGFGMVLLEMAGGRR 351
           SDV+ FG++L E+    R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 29/231 (12%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           EI   +     KLG G FG V+ G  +    +AVK ++    S + F+ E          
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 67
Query: 207 -LLGLCSEGFKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
            L+ L +   K   +Y   E+M  GSL    F K ++G    L K  + +   A G+ Y+
Sbjct: 68  KLVRLYAVVTKEEPIYIITEFMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
                   +H D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 126 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEA 181
Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMNATRSSKAYFP 366
           I  NFG  + KS+V+ FG++L E+         GR N+++ +  S     P
Sbjct: 182 I--NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMP 230

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 23/193 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  G L    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 85  E-PIYIVMEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 23/193 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 85  E-PIYIVIEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N+  +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 23/198 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 252 E-PIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 305
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGL +   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 362
Query: 334 SDVYGFGMVLLEMAGGRR 351
           SDV+ FG++L E+    R
Sbjct: 363 SDVWSFGILLTELTTKGR 380

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           EI   +     KLG G FG V+    +    +AVK M+    S E F+ E          
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 207 -LLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
            L+ L +   K    ++ E+M  GSL    F K ++G    L K  + +   A G+ ++ 
Sbjct: 244 KLVKLHAVVTKEPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
                  +H D++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE I
Sbjct: 302 QR---NYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAI 357
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             NFG+ + KSDV+ FG++L+E+
Sbjct: 358 --NFGSFTIKSDVWSFGILLMEI 378

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 23/193 (11%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  + SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  G L    F K   G+   L +  ++A   A G+ Y+     +  +H 
Sbjct: 85  E-PIYIVTEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 334 SDVYGFGMVLLEM 346
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE I
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAI 182
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 183 --NYGTFTIKSDVWSFGILLTEI 203

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 77
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 78  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 135
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE I
Sbjct: 136 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAI 191
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 192 --NYGTFTIKSDVWSFGILLTEI 212

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 70
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 71  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 128
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE I
Sbjct: 129 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAI 184
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 185 --NYGTFTIKSDVWSFGILLTEI 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 69
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 70  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 127
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE I
Sbjct: 128 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAI 183
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 184 --NYGTFTIKSDVWSFGILLTEI 204

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE I
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAI 182
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 183 --NYGTFTIKSDVWSFGILLTEI 203

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 76
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 77  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 134
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE I
Sbjct: 135 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAI 190
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 191 --NYGTFTIKSDVWSFGILLTEI 211

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  +LG G FG V  G+      +A+KM++    S +EFI E              L G+
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     ++ EYM NG L  ++    ++ QT   ++  E+       +EYL +      
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 126
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSRGSKFPVRWSPPEVLM--YSKF 183
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSD++ FG+++ E+
Sbjct: 184 SSKSDIWAFGVLMWEI 199

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 75  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 132
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE I
Sbjct: 133 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAI 188
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 189 --NYGTFTIKSDVWSFGILLTEI 209

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  +LG G FG V  G+      +A+KM++    S +EFI E              L G+
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     ++ EYM NG L  ++    ++ QT   ++  E+       +EYL +      
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 121
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 178
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSD++ FG+++ E+
Sbjct: 179 SSKSDIWAFGVLMWEI 194

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  +LG G FG V  G+      +A+KM++    S +EFI E              L G+
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     ++ EYM NG L  ++    ++ QT   ++  E+       +EYL +      
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 125
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 182
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSD++ FG+++ E+
Sbjct: 183 SSKSDIWAFGVLMWEI 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  +LG G FG V  G+      +A+KM++    S +EFI E              L G+
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     ++ EYM NG L  ++    ++ QT   ++  E+       +EYL +      
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 126
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 183
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSD++ FG+++ E+
Sbjct: 184 SSKSDIWAFGVLMWEI 199

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           EI   +     +LG G FG V+ G  +    +A+K ++    S E F+ E          
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHD 64
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               L  + SE     +V EYM  GSL    F K+ +G+   L    ++A   A G+ Y+
Sbjct: 65  KLVQLYAVVSEE-PIYIVTEYMNKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYI 121
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
                +  +H D++  NIL+ +  I K++DFGLA+   ++N+  +    +  I + APE 
Sbjct: 122 ER---MNYIHRDLRSANILVGNGLICKIADFGLARLI-EDNEXTARQGAKFPIKWTAPE- 176
Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
            +  +G  + KSDV+ FG++L E+    R
Sbjct: 177 -AALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 117/270 (43%), Gaps = 36/270 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  F + +  +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-FTAHAGAKFPIKWTAPESLAYN--KFS 188
Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 391
            KSDV+ FG++L E+A                  PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMER------PEGC 235
Query: 392 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G FG V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 64
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 65  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 122
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H +++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I
Sbjct: 123 ---ERNYIHRNLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI 178
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 179 --NYGTFTIKSDVWSFGILLTEI 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  +LG G FG V  G+      +A+KM++    S +EFI E              L G+
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     ++ EYM NG L  ++    ++ QT   ++  E+       +EYL +      
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 132
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 189
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSD++ FG+++ E+
Sbjct: 190 SSKSDIWAFGVLMWEI 205

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  +LG G FG V  G+      +A+KM++    S +EFI E              L G+
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     ++ EYM NG L  ++    ++ QT   ++  E+       +EYL +      
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 141
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 198
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSD++ FG+++ E+
Sbjct: 199 SSKSDIWAFGVLMWEI 214

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 63/288 (21%)
Query: 169 LGQGGFGSVYKGQLHTGR-----LIAVKMMENSKFSAE--EFINE--------------L 207
           +G G FG VYKG L T        +A+K ++      +  +F+ E              L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
            G+ S+     ++ EYM NG+LD+  F +E  G+ F + +   +  G A G++YL N   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDK--FLREKDGE-FSVLQLVGMLRGIAAGMKYLAN--- 165
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG---TIGYLAPELIS 324
           +  +H D+   NIL++ N + KVSDFGL++    E+D  +   T G    I + APE IS
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 325 -RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSW------VYDQLNKG 376
            R F   +  SDV+ FG+V+ E M  G R              P W      V   +N G
Sbjct: 224 YRKF---TSASDVWSFGIVMWEVMTYGER--------------PYWELSNHEVMKAINDG 266
Query: 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424
               L    +  S I + +    + C Q + A RP    ++ +L+  I
Sbjct: 267 --FRLPTPMDCPSAIYQLM----MQCWQQERARRPKFADIVSILDKLI 308

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 32/218 (14%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHT-GRL---IAVKMMEN--SKFSAEEFINE---- 206
           EI A   H    +G G  G V  G+L   G+    +A+K ++   ++    +F++E    
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 207 ----------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
                     L G+ + G    +V EYM NGSLD   F + + GQ F + +   +  G  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-- 314
            G+ YL    D+  +H D+   N+L+D N + KVSDFGL++    + D  + + T G   
Sbjct: 162 AGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD-AAXTTTGGKIP 217
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
           I + APE I+  F T S  SDV+ FG+V+ E +A G R
Sbjct: 218 IRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 23/196 (11%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  +LG G FG V  G+      +A+KM++    S +EFI E              L G+
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C++     ++ EYM NG L  ++    ++ QT   ++  E+       +EYL +      
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 141
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           LH D+   N L++   + KVSDFGL+++   + +  S+  ++  + +  PE++   +   
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVG-SKFPVRWSPPEVLM--YSKF 198
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSD++ FG+++ E+
Sbjct: 199 SSKSDIWAFGVLMWEI 214

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 32/218 (14%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHT-GRL---IAVKMMEN--SKFSAEEFINE---- 206
           EI A   H    +G G  G V  G+L   G+    +A+K ++   ++    +F++E    
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 207 ----------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
                     L G+ + G    +V EYM NGSLD   F + + GQ F + +   +  G  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-- 314
            G+ YL    D+  +H D+   N+L+D N + KVSDFGL++    + D  + + T G   
Sbjct: 162 AGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD-AAYTTTGGKIP 217
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
           I + APE I+  F T S  SDV+ FG+V+ E +A G R
Sbjct: 218 IRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 116/270 (42%), Gaps = 36/270 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G FG VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +    + +  +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTX-TAHAGAKFPIKWTAPESLAYN--KFS 188
Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 391
            KSDV+ FG++L E+A                  PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMER------PEGC 235
Query: 392 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 116/270 (42%), Gaps = 36/270 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +    + +  +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTX-TAHAGAKFPIKWTAPESLAYN--KFS 188
Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 391
            KSDV+ FG++L E+A                  PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMER------PEGC 235
Query: 392 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 36/270 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 391
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER------PEGC 242
Query: 392 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 36/270 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 391
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER------PEGC 242
Query: 392 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 27/195 (13%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
           +LG G FG V  G+      +AVKM++    S +EF  E                G+CS+
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH--EIALGTARGIEYLHNGCDVCIL 271
            +   +V EY+ NG L  ++ S        GLE     E+      G+ +L +      +
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESHQ---FI 126
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+D +   KVSDFG+ ++   ++ +VS   T+  + + APE+   ++   S
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVF--HYFKYS 183
Query: 332 CKSDVYGFGMVLLEM 346
            KSDV+ FG+++ E+
Sbjct: 184 SKSDVWAFGILMWEV 198

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 80  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAPAGAKFPIKWTAPESLAYN--KFS 191
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 192 IKSDVWAFGVLLWEIA 207

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 111/229 (48%), Gaps = 34/229 (14%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRL---IAVKMME-- 194
           H Y    Q V      EI A        +G G FG V  G+L   G+    +A+K ++  
Sbjct: 3   HTYEDPNQAVHE-FAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG 61
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V EYM NGSLD   F K+N G
Sbjct: 62  YTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD--TFLKKNDG 119
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G + G++YL    D+  +H D+   NIL++ N + KVSDFGL++   
Sbjct: 120 Q-FTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL- 174
Query: 301 KENDFVSISDTRG---TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            E+D  +   TRG    I + APE I+  F   +  SDV+ +G+V+ E+
Sbjct: 175 -EDDPEAAYTTRGGKIPIRWTAPEAIA--FRKFTSASDVWSYGIVMWEV 220

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAPAGAKFPIKWTAPESLAYN--KFS 192
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 193 IKSDVWAFGVLLWEIA 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 36/270 (13%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 83  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 137
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 194
Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 391
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER------PEGC 241
Query: 392 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 192
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 193 IKSDVWAFGVLLWEIA 208

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 92  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 146
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 203
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 204 IKSDVWAFGVLLWEIA 219

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 192
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 193 IKSDVWAFGVLLWEIA 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 31/203 (15%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------- 206
           EI   +     KLG G FG V+    +    +AVK M+    S E F+ E          
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 237
Query: 207 -LLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
            L+ L +   K    ++ E+M  GSL    F K ++G    L K  + +   A G+ ++ 
Sbjct: 238 KLVKLHAVVTKEPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
                  +H D++  NIL+  + + K++DFGLA+   K             I + APE I
Sbjct: 296 QR---NYIHRDLRAANILVSASLVCKIADFGLARVGAK-----------FPIKWTAPEAI 341
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             NFG+ + KSDV+ FG++L+E+
Sbjct: 342 --NFGSFTIKSDVWSFGILLMEI 362

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFK 216
           E+   T     +LG G  G V+ G  +    +AVK ++    S + F+ E   +     +
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 217 RA-------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           R              ++ EYM NGSL    F K   G    + K  ++A   A G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              +   +H D++  NIL+      K++DFGLA+   ++ +  +    +  I + APE I
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDAEXTAREGAKFPIKWTAPEAI 182
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
             N+GT + KSDV+ FG++L E+
Sbjct: 183 --NYGTFTIKSDVWSFGILLTEI 203

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +    + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTX-TAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   N L+  N + KV+DFGL++    +    + +  +  I + APE ++ N    S
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTX-TAHAGAKFPIKWTAPESLAYN--KFS 191
Query: 332 CKSDVYGFGMVLLEMA 347
            KSDV+ FG++L E+A
Sbjct: 192 IKSDVWAFGVLLWEIA 207

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 135/294 (45%), Gaps = 52/294 (17%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHT-GR---LIAVKMMEN--SKFSAEEFINE---- 206
           EI A        +G G FG V  G+L   G+    +A+K ++   +     +F++E    
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 207 ----------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
                     L G+ ++     ++ EYM NGSLD   F ++N G+ F + +   +  G  
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGR-FTVIQLVGMLRGIG 141
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG--- 313
            G++YL    D+  +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG   
Sbjct: 142 SGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKI 196
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQ 372
            I + APE I+  +   +  SDV+ +G+V+ E M+ G R              P W    
Sbjct: 197 PIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGER--------------PYWDMSN 240
Query: 373 LN--KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424
            +  K  +   R    ++  IA    M+  W  Q + +DRP   +++ ML+  I
Sbjct: 241 QDVIKAIEEGYRLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLDKLI 292

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 32/207 (15%)
Query: 169 LGQGGFGSVYKGQLH-TGR---LIAVKMMEN--SKFSAEEFINE--------------LL 208
           +G G FG V  G L   G+    +A+K +++  ++    +F++E              L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+ ++     ++ E+M NGSLD   F ++N GQ F + +   +  G A G++YL    D+
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADM 154
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG---TIGYLAPELISR 325
             +H D+   NIL++ N + KVSDFGL++F   +    + +   G    I + APE I  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 212
Query: 326 NFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            +   +  SDV+ +G+V+ E M+ G R
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMSYGER 239

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 135/294 (45%), Gaps = 52/294 (17%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHT-GR---LIAVKMMEN--SKFSAEEFINE---- 206
           EI A        +G G FG V  G+L   G+    +A+K ++   +     +F++E    
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 207 ----------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
                     L G+ ++     ++ EYM NGSLD   F ++N G+ F + +   +  G  
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGR-FTVIQLVGMLRGIG 126
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG--- 313
            G++YL    D+  +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG   
Sbjct: 127 SGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKI 181
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQ 372
            I + APE I+  +   +  SDV+ +G+V+ E M+ G R              P W    
Sbjct: 182 PIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGER--------------PYWDMSN 225
Query: 373 LN--KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424
            +  K  +   R    ++  IA    M+  W  Q + +DRP   +++ ML+  I
Sbjct: 226 QDVIKAIEEGYRLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLDKLI 277

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 112/235 (47%), Gaps = 35/235 (14%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME-- 194
           H Y    QTV      E+ A        +G G FG V  G+L         +A+K ++  
Sbjct: 24  HTYEDPTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 82
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V EYM NGSLD   F +++  
Sbjct: 83  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDA 140
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGL++   
Sbjct: 141 Q-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL- 195
Query: 301 KENDFVSISDTRG---TIGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            E+D  +   TRG    I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 196 -EDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 247

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 52/291 (17%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHT-GR---LIAVKMMENSKFSAE--EFINE---- 206
           EI A        +G G FG V  G+L   G+    +A+K ++      +  +F++E    
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 207 ----------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
                     L G+ ++     ++ EYM NGSLD   F ++N G+ F + +   +  G  
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGR-FTVIQLVGMLRGIG 120
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG--- 313
            G++YL    D+  +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG   
Sbjct: 121 SGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKI 175
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQ 372
            I + APE I+  +   +  SDV+ +G+V+ E M+ G R              P W    
Sbjct: 176 PIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGER--------------PYWDMSN 219
Query: 373 LN--KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
            +  K  +   R    ++  IA    M+  W  Q + +DRP   +++ ML+
Sbjct: 220 QDVIKAIEEGYRLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLD 268

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 112/235 (47%), Gaps = 35/235 (14%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME-- 194
           H Y    QTV      E+ A        +G G FG V  G+L         +A+K ++  
Sbjct: 26  HTYEDPTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V EYM NGSLD   F +++  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDA 142
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGL++   
Sbjct: 143 Q-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL- 197
Query: 301 KENDFVSISDTRG---TIGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            E+D  +   TRG    I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 198 -EDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 112/235 (47%), Gaps = 35/235 (14%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME-- 194
           H Y    QTV      E+ A        +G G FG V  G+L         +A+K ++  
Sbjct: 26  HTYEDPTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V EYM NGSLD   F +++  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDA 142
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGL++   
Sbjct: 143 Q-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL- 197
Query: 301 KENDFVSISDTRG---TIGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            E+D  +   TRG    I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 198 -EDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 113/236 (47%), Gaps = 37/236 (15%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME-- 194
           H +    QTV      E+ A        +G G FG V  G+L         +A+K ++  
Sbjct: 26  HTFEDPTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V EYM NGSLD   F +++  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDA 142
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGLA+   
Sbjct: 143 Q-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVL- 197
Query: 301 KENDFVSISDTRG---TIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            E+D  +   TRG    I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 198 -EDDPEAAYTTRGGKIPIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 249

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 44/274 (16%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 340
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H ++   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 397
Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----SWVYDQLNKGGDLELRNVTEI 387
            KSDV+ FG++L E+A               + +P    S VY+ L K   +E       
Sbjct: 398 IKSDVWAFGVLLWEIA-----------TYGMSPYPGIDLSQVYELLEKDYRMER------ 440
Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                 K+  +   C Q   +DRPS  ++ +  E
Sbjct: 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 32/207 (15%)
Query: 169 LGQGGFGSVYKGQLHT-GR---LIAVKMMEN--SKFSAEEFINE--------------LL 208
           +G G FG V +G+L   G+    +A+K ++   ++    EF++E              L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+ +      ++ E+M NG+LD   F + N GQ F + +   +  G A G+ YL    ++
Sbjct: 82  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEM 135
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG---TIGYLAPELISR 325
             +H D+   NIL++ N + KVSDFGL++F  + +   + + + G    I + APE I+ 
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA- 194
Query: 326 NFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            F   +  SD + +G+V+ E M+ G R
Sbjct: 195 -FRKFTSASDAWSYGIVMWEVMSFGER 220

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 44/274 (16%)
Query: 167 HKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LLGLC 211
           HKLG G +G VY+G      L +AVK ++      EEF+ E              LLG+C
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           +      ++ E+M  G+L  ++  +E   Q         +A   +  +EYL        +
Sbjct: 325 TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 379
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H ++   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 436
Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----SWVYDQLNKGGDLELRNVTEI 387
            KSDV+ FG++L E+A               + +P    S VY+ L K   +E       
Sbjct: 437 IKSDVWAFGVLLWEIA-----------TYGMSPYPGIDLSQVYELLEKDYRMER------ 479
Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                 K+  +   C Q   +DRPS  ++ +  E
Sbjct: 480 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 43/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   +  E P ++             
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK-EAPEDLYKDFLTLEHLICY 155
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V   D 
Sbjct: 156 SFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 213 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 245

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 113/236 (47%), Gaps = 37/236 (15%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME-- 194
           H +    QTV      E+ A        +G G FG V  G+L         +A+K ++  
Sbjct: 26  HTFEDPTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V EYM NGSLD   F +++  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDA 142
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGL++   
Sbjct: 143 Q-FTVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVL- 197
Query: 301 KENDFVSISDTRG---TIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            E+D  +   TRG    I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 198 -EDDPEAAYTTRGGKIPIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 249

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 32/207 (15%)
Query: 169 LGQGGFGSVYKGQLHT-GR---LIAVKMMEN--SKFSAEEFINE--------------LL 208
           +G G FG V +G+L   G+    +A+K ++   ++    EF++E              L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+ +      ++ E+M NG+LD   F + N GQ F + +   +  G A G+ YL    ++
Sbjct: 84  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEM 137
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISDTRGT--IGYLAPELISR 325
             +H D+   NIL++ N + KVSDFGL++F     +D    S   G   I + APE I+ 
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA- 196
Query: 326 NFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            F   +  SD + +G+V+ E M+ G R
Sbjct: 197 -FRKFTSASDAWSYGIVMWEVMSFGER 222

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 113/233 (48%), Gaps = 37/233 (15%)
Query: 144 RTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME--NSK 197
           R + QTV      E+ A        +G G FG V  G+L         +A+K ++   ++
Sbjct: 17  RGSTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 75
Query: 198 FSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF 243
               +F+ E              L G+ ++     +V EYM NGSLD   F +++  Q F
Sbjct: 76  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-F 132
Query: 244 GLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303
            + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+
Sbjct: 133 TVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--ED 187
Query: 304 DFVSISDTRG---TIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
           D  +   TRG    I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 188 DPEAAYTTRGGKIPIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 237

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 113/236 (47%), Gaps = 37/236 (15%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME-- 194
           H +    QTV      E+ A        +G G FG V  G+L         +A+K ++  
Sbjct: 26  HTFEDPTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V EYM NGSLD   F +++  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDA 142
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGL++   
Sbjct: 143 Q-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL- 197
Query: 301 KENDFVSISDTRG---TIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            E+D  +   TRG    I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 198 -EDDPEAAYTTRGGKIPIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 112/235 (47%), Gaps = 35/235 (14%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME-- 194
           H +    QTV      E+ A        +G G FG V  G+L         +A+K ++  
Sbjct: 26  HTFEDPTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V EYM NGSLD   F +++  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDA 142
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGL++   
Sbjct: 143 Q-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL- 197
Query: 301 KENDFVSISDTRG---TIGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            E+D  +   TRG    I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 198 -EDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFG--------LEKPHEIALGTA 256
            LLG C++ G    ++ E+   G+L  ++ SK N+   +         LE     +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           +G+E+L +   +   H D+   NILL    + K+ DFGLA+   K+ D+V   D R  + 
Sbjct: 155 KGMEFLASRKXI---HRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 WMAPETIFDRVYTI--QSDVWSFGVLLWEI 239

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 47/212 (22%)
Query: 169 LGQGGFGSVYKGQLHTGRLIAVKM------------MENSKFSAEEF-------INELLG 209
           +G GGFG VY+     G  +AVK             +EN +  A+ F       I  L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI----ALGTARGIEYLHNG 265
           +C +     LV E+   G L+R +  K           P +I    A+  ARG+ YLH+ 
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR---------IPPDILVNWAVQIARGMNYLHDE 124
Query: 266 CDVCILHFDIKPHNILLDH--------NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
             V I+H D+K  NIL+          N I K++DFGLA    +E    +     G   +
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAW 180
Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           +APE+I  +    S  SDV+ +G++L E+  G
Sbjct: 181 MAPEVIRASM--FSKGSDVWSYGVLLWELLTG 210

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 111/235 (47%), Gaps = 35/235 (14%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME-- 194
           H +    QTV      E+ A        +G G FG V  G+L         +A+K ++  
Sbjct: 26  HTFEDPTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V EYM NGSLD   F +++  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDA 142
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGL +   
Sbjct: 143 Q-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL- 197
Query: 301 KENDFVSISDTRG---TIGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            E+D  +   TRG    I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 198 -EDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 32/207 (15%)
Query: 169 LGQGGFGSVYKGQLH-TGR---LIAVKMMEN--SKFSAEEFINE--------------LL 208
           +G G FG V  G L   G+    +A+K +++  ++    +F++E              L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+ ++     ++ E+M NGSLD   F ++N GQ F + +   +  G A G++YL    D+
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADM 128
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG---TIGYLAPELISR 325
             +H  +   NIL++ N + KVSDFGL++F   +    + +   G    I + APE I  
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 186
Query: 326 NFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            +   +  SDV+ +G+V+ E M+ G R
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGER 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 153 ILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN--- 205
           +L+   IA T      +G+G FG V++G+   G  +AVK+     E S F   E      
Sbjct: 21  LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM 79
Query: 206 ----ELLGLCSEGFKR-------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG 254
                +LG  +   K         LV +Y  +GSL    F   N+  T  +E   ++AL 
Sbjct: 80  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALS 134
Query: 255 TARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309
           TA G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+
Sbjct: 135 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 194
Query: 310 DTR--GTIGYLAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 347
                GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 195 PNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 238

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 43/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   + +  P ++             
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV-APEDLYKDFLTLEHLICY 144
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V   D 
Sbjct: 145 SFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 202 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 43/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   + +  P ++             
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV-APEDLYKDFLTLEHLICY 153
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V   D 
Sbjct: 154 SFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 211 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 37/210 (17%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFG------LEKPHEI--ALGTA 256
            LLG C++ G    ++ E+   G+L  ++ SK N+   +       L   H I  +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           +G+E+L +   +   H D+   NILL    + K+ DFGLA+   K+ D+V   D R  + 
Sbjct: 155 KGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 WMAPETIFDRVYTI--QSDVWSFGVLLWEI 239

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 153 ILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN--- 205
           +L+   IA T      +G+G FG V++G+   G  +AVK+     E S F   E      
Sbjct: 34  LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM 92
Query: 206 ----ELLGLCSEGFKR-------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG 254
                +LG  +   K         LV +Y  +GSL    F   N+  T  +E   ++AL 
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALS 147
Query: 255 TARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309
           TA G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 310 DTR--GTIGYLAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 347
                GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 251

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 43/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   + +  P ++             
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV-APEDLYKDFLTLEHLICY 144
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V   D 
Sbjct: 145 SFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 202 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 129
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +F  + +     I + AP
Sbjct: 130 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 187 ESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 45/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   F   KP ++             
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE---FVPYKPEDLYKDFLTLEHLIXY 153
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L +   +   H D+   NILL    + K+ DFGLA+   K+ D V   D 
Sbjct: 154 SFQVAKGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 211 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 43/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   + +  P ++             
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV-APEDLYKDFLTLEHLICY 190
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V   D 
Sbjct: 191 SFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 248 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 280

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 36/220 (16%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME--NSKFSAEEFINE---- 206
           E+ A        +G G FG V  G+L         +A+K ++   ++    +F+ E    
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 207 ----------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
                     L G+ ++     +V EYM NGSLD   F +++  Q F + +   +  G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 128
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG--- 313
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 129 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 183
Query: 314 TIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 184 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 220

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 135/285 (47%), Gaps = 58/285 (20%)
Query: 169 LGQGGFGSVYKGQLH-TGR---LIAVKMME--NSKFSAEEFINE--------------LL 208
           +G G FG V  G+L   G+    +A+K ++   ++    +F+ E              L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+ + G    +V E+M NG+LD   F +++ GQ F + +   +  G A G+ YL    D+
Sbjct: 111 GVVTRGKPVMIVIEFMENGALD--AFLRKHDGQ-FTVIQLVGMLRGIAAGMRYL---ADM 164
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG---TIGYLAPELISR 325
             +H D+   NIL++ N + KVSDFGL++    E+D  ++  T G    + + APE I  
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRV--IEDDPEAVYTTTGGKIPVRWTAPEAI-- 220
Query: 326 NFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
            +   +  SDV+ +G+V+ E M+ G R              P W  D  N+  D+ ++ +
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGER--------------PYW--DMSNQ--DV-IKAI 261
Query: 385 TEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSI 424
            E   + A   C  GL      C Q + A+RP   +++ +L+  I
Sbjct: 262 EEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 111/235 (47%), Gaps = 35/235 (14%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME-- 194
           H Y    QTV      E+ A        +G G FG V  G+L         +A+K ++  
Sbjct: 26  HTYEDPTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V E M NGSLD   F +++  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHDA 142
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGL++   
Sbjct: 143 Q-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL- 197
Query: 301 KENDFVSISDTRG---TIGYLAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            E+D  +   TRG    I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 198 -EDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 37/208 (17%)
Query: 165 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENS------KFSAE---------EFI 204
           +  +LG+G FGSV   +      +TG L+AVK +++S       F  E         +FI
Sbjct: 14  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 73
Query: 205 NELLGLCSEGFKRA---LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT--ARGI 259
            +  G+ S G  R    LV EY+P+G L    F + ++ +   L+    +   +   +G+
Sbjct: 74  VKYRGV-SYGPGRQSLRLVMEYLPSGCL--RDFLQRHRAR---LDASRLLLYSSQICKGM 127
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYL 318
           EYL  G   C+ H D+   NIL++     K++DFGLAK  P + D+  + +  +  I + 
Sbjct: 128 EYL--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE +S N    S +SDV+ FG+VL E+
Sbjct: 185 APESLSDNI--FSRQSDVWSFGVVLYEL 210

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   + +  P ++             
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV-APEDLYKDFLTLEHLICY 153
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V   D 
Sbjct: 154 SFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 211 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 126/298 (42%), Gaps = 61/298 (20%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL---IAVKMMEN--SKFSAEEFINELLGLCSEGFK--- 216
           F   +G+G FG V K ++    L    A+K M+   SK    +F  EL  LC  G     
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 217 ---------RALVY---EYMPNGSL------------DRHIFSKENKGQTFGLEKPHEIA 252
                    R  +Y   EY P+G+L            D       +   T   ++    A
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312
              ARG++YL        +H D+   NIL+  N++ K++DFGL++    +  +V  +  R
Sbjct: 139 ADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 192
Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVY 370
             + ++A E  S N+   +  SDV+ +G++L E+   GG     M             +Y
Sbjct: 193 LPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LY 241
Query: 371 DQLNKGGDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
           ++L +G  LE  L    E+  ++ +        C + K  +RPS  ++L  L   +++
Sbjct: 242 EKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSFAQILVSLNRMLEE 291

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 37/208 (17%)
Query: 165 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENS------KFSAE---------EFI 204
           +  +LG+G FGSV   +      +TG L+AVK +++S       F  E         +FI
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 205 NELLGLCSEGFKRA---LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT--ARGI 259
            +  G+ S G  R    LV EY+P+G L    F + ++ +   L+    +   +   +G+
Sbjct: 87  VKYRGV-SYGPGRQSLRLVMEYLPSGCL--RDFLQRHRAR---LDASRLLLYSSQICKGM 140
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYL 318
           EYL  G   C+ H D+   NIL++     K++DFGLAK  P + D+  + +  +  I + 
Sbjct: 141 EYL--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE +S N    S +SDV+ FG+VL E+
Sbjct: 198 APESLSDNI--FSRQSDVWSFGVVLYEL 223

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 44/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   +  + P ++             
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY--KTPEDLYKDFLTLEHLICY 153
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V   D 
Sbjct: 154 SFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 211 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 37/208 (17%)
Query: 165 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENS------KFSAE---------EFI 204
           +  +LG+G FGSV   +      +TG L+AVK +++S       F  E         +FI
Sbjct: 15  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 74
Query: 205 NELLGLCSEGFKRA---LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT--ARGI 259
            +  G+ S G  R    LV EY+P+G L    F + ++ +   L+    +   +   +G+
Sbjct: 75  VKYRGV-SYGPGRQSLRLVMEYLPSGCL--RDFLQRHRAR---LDASRLLLYSSQICKGM 128
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYL 318
           EYL  G   C+ H D+   NIL++     K++DFGLAK  P + D+  + +  +  I + 
Sbjct: 129 EYL--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 185
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE +S N    S +SDV+ FG+VL E+
Sbjct: 186 APESLSDNI--FSRQSDVWSFGVVLYEL 211

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   + +  P ++             
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV-APEDLYKDFLTLEHLICY 144
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V   D 
Sbjct: 145 SFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 202 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   + +  P ++             
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV-APEDLYKDFLTLEHLICY 144
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V   D 
Sbjct: 145 SFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 202 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 58/236 (24%)
Query: 150 VDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--- 206
           +DN+ L E+I          G+G +G+VYKG L   R +AVK+   S  + + FINE   
Sbjct: 12  LDNLKLLELI----------GRGRYGAVYKGSLDE-RPVAVKVF--SFANRQNFINEKNI 58
Query: 207 --------------LLG---LCSEG-FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKP 248
                         ++G   + ++G  +  LV EY PNGSL +++        T      
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSS 113
Query: 249 HEIALGTARGIEYLHNGC------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK----- 297
             +A    RG+ YLH            I H D+   N+L+ ++    +SDFGL+      
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 298 --FHPKENDFVSISDTRGTIGYLAPELIS-----RNFGTVSCKSDVYGFGMVLLEM 346
               P E D  +IS+  GTI Y+APE++      R+  +   + D+Y  G++  E+
Sbjct: 174 RLVRPGEEDNAAISEV-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRA--------- 218
           +G G +G VYKG+ + TG+L A+K+M+ +    EE   E+  L      R          
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 219 ------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
                       LV E+   GS+   I  K  KG T   E    I     RG+ +LH   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPEL 322
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 150 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 200
Query: 323 ISRNF---GTVSCKSDVYGFGMVLLEMAGG 349
           I+ +     T   KSD++  G+  +EMA G
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 169 LGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAEEF-----------------IN 205
           LG+G FG V +       +  T R +AVKM++     +E                   + 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 206 ELLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI------------- 251
            LLG C++ G    ++ E+   G+L  ++ SK N+   + +  P ++             
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV-APEDLYKDFLTLEHLICY 153
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           +   A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V   D 
Sbjct: 154 SFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 211 RLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 126/298 (42%), Gaps = 61/298 (20%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL---IAVKMMEN--SKFSAEEFINELLGLCSEGFK--- 216
           F   +G+G FG V K ++    L    A+K M+   SK    +F  EL  LC  G     
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 217 ---------RALVY---EYMPNGSL------------DRHIFSKENKGQTFGLEKPHEIA 252
                    R  +Y   EY P+G+L            D       +   T   ++    A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312
              ARG++YL        +H D+   NIL+  N++ K++DFGL++    +  +V  +  R
Sbjct: 149 ADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 202
Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVY 370
             + ++A E  S N+   +  SDV+ +G++L E+   GG     M             +Y
Sbjct: 203 LPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LY 251
Query: 371 DQLNKGGDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
           ++L +G  LE  L    E+  ++ +        C + K  +RPS  ++L  L   +++
Sbjct: 252 EKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSFAQILVSLNRMLEE 301

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 35/208 (16%)
Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN-------ELLGLCSEGF-- 215
           +G+G +G V++G  H G  +AVK+     E S F   E  N        +LG  +     
Sbjct: 16  VGKGRYGEVWRGLWH-GESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTS 74
Query: 216 -----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-----NG 265
                +  L+  Y  +GSL   +     + QT        +A+  A G+ +LH       
Sbjct: 75  RNSSTQLWLITHYHEHGSLYDFL-----QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--GTIGYLAPELI 323
               I H D K  N+L+  N    ++D GLA  H + +D++ I +    GT  Y+APE++
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 324 SRNFGTVSCKS----DVYGFGMVLLEMA 347
                T   +S    D++ FG+VL E+A
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 112/236 (47%), Gaps = 37/236 (15%)
Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME-- 194
           H +    QTV      E+ A        +G G FG V  G+L         +A+K ++  
Sbjct: 26  HTFEDPTQTVHE-FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++    +F+ E              L G+ ++     +V E M NGSLD   F +++  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHDA 142
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           Q F + +   +  G A G++YL    D+  +H D+   NIL++ N + KVSDFGL++   
Sbjct: 143 Q-FTVIQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVL- 197
Query: 301 KENDFVSISDTRG---TIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            E+D  +   TRG    I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 198 -EDDPEAAYTTRGGKIPIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 249

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 159 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN-------EL 207
           IA T      +G+G FG V++G+   G  +AVK+     E S F   E           +
Sbjct: 2   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 60
Query: 208 LGLCSEGFKR-------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
           LG  +   K         LV +Y  +GSL    F   N+  T  +E   ++AL TA G+ 
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALSTASGLA 115
Query: 261 YLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--G 313
           +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+     G
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 175
Query: 314 TIGYLAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 347
           T  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 213

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 37/208 (17%)
Query: 165 FTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENS------KFSAE---------EFI 204
           +  +LG+G FGSV   +      +TG L+AVK +++S       F  E         +FI
Sbjct: 11  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 70
Query: 205 NELLGLCSEGFKRA---LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT--ARGI 259
            +  G+ S G  R    LV EY+P+G L    F + ++ +   L+    +   +   +G+
Sbjct: 71  VKYRGV-SYGPGRPELRLVMEYLPSGCL--RDFLQRHRAR---LDASRLLLYSSQICKGM 124
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYL 318
           EYL  G   C+ H D+   NIL++     K++DFGLAK  P + D   + +  +  I + 
Sbjct: 125 EYL--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY 181
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE +S N    S +SDV+ FG+VL E+
Sbjct: 182 APESLSDNI--FSRQSDVWSFGVVLYEL 207

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 39/212 (18%)
Query: 168 KLGQGGFGSVYKGQLHT------GRLIAVKMMENSKFSAEE---------------FINE 206
           +LG+G FG V+  + H         L+AVK ++ +  SA +                I  
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQ-----------TFGLEKPHEIALGT 255
             G+C+EG    +V+EYM +G L+R + S     +             GL +   +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 316 GYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 202 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 230

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 159 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN-------EL 207
           IA T      +G+G FG V++G+   G  +AVK+     E S F   E           +
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 208 LGLCSEGFKR-------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
           LG  +   K         LV +Y  +GSL    F   N+  T  +E   ++AL TA G+ 
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALSTASGLA 114
Query: 261 YLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--G 313
           +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+     G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 314 TIGYLAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 347
           T  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 159 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN-------EL 207
           IA T      +G+G FG V++G+   G  +AVK+     E S F   E           +
Sbjct: 7   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 65
Query: 208 LGLCSEGFKR-------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
           LG  +   K         LV +Y  +GSL    F   N+  T  +E   ++AL TA G+ 
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALSTASGLA 120
Query: 261 YLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--G 313
           +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+     G
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 180
Query: 314 TIGYLAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 347
           T  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 181 TKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 218

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 39/212 (18%)
Query: 168 KLGQGGFGSVYKGQLHT------GRLIAVKMMENSKFSAEE---------------FINE 206
           +LG+G FG V+  + H         L+AVK ++ +  SA +                I  
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQ-----------TFGLEKPHEIALGT 255
             G+C+EG    +V+EYM +G L+R + S     +             GL +   +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 316 GYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 196 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 224

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 159 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN-------EL 207
           IA T      +G+G FG V++G+   G  +AVK+     E S F   E           +
Sbjct: 4   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 62
Query: 208 LGLCSEGFKR-------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
           LG  +   K         LV +Y  +GSL    F   N+  T  +E   ++AL TA G+ 
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALSTASGLA 117
Query: 261 YLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--G 313
           +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+     G
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 177
Query: 314 TIGYLAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 347
           T  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 215

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 34/203 (16%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINEL--LGLCSEG--------- 214
            KLG+G +GSVYK     TG+++A+K +   +   +E I E+  +  C            
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 215 FKRA---LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           FK     +V EY   GS+   I    NK  T   ++   I   T +G+EYLH    +  +
Sbjct: 94  FKNTDLWIVMEYCGAGSVS-DIIRLRNK--TLTEDEIATILQSTLKGLEYLHF---MRKI 147
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELISRNF 327
           H DIK  NILL+     K++DFG+A        K N  +      GT  ++APE+I +  
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI------GTPFWMAPEVI-QEI 200
Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
           G  +C +D++  G+  +EMA G+
Sbjct: 201 G-YNCVADIWSLGITAIEMAEGK 222

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 86/200 (43%), Gaps = 33/200 (16%)
Query: 169 LGQGGFGSVYK-GQLHTGRLIAVKMMENS------------------KFSAEEFINELLG 209
           LG G FG V+     H GR  A+K+++                          FI  + G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  ++ +Y+  G L    FS   K Q F        A      +EYLH+     
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--- 126
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I++ D+KP NILLD N   K++DFG AK+ P     +      GT  Y+APE++S     
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYN 181
Query: 330 VSCKSDVYGFGMVLLEMAGG 349
            S   D + FG+++ EM  G
Sbjct: 182 KSI--DWWSFGILIYEMLAG 199

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 31/205 (15%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               G+C    +R   L+ EY+P GSL  ++   + +     L    +      +G+EYL
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL 129
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPE 321
             G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + APE
Sbjct: 130 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 322 LISRNFGTVSCKSDVYGFGMVLLEM 346
            ++ +    S  SDV+ FG+VL E+
Sbjct: 187 SLTES--KFSVASDVWSFGVVLYEL 209

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 129
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 130 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 187 ESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 39/212 (18%)
Query: 168 KLGQGGFGSVYKGQLHT------GRLIAVKMMENSKFSAEE---------------FINE 206
           +LG+G FG V+  + H         L+AVK ++ +  SA +                I  
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQ-----------TFGLEKPHEIALGT 255
             G+C+EG    +V+EYM +G L+R + S     +             GL +   +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 316 GYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 225 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 253

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 133
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 134 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 190
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 191 ESLTES--KFSVASDVWSFGVVLYEL 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 127
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 128 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 184
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 185 ESLTES--KFSVASDVWSFGVVLYEL 208

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 129
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 130 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 187 ESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 160
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 161 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 217
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 218 ESLTES--KFSVASDVWSFGVVLYEL 241

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 132
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 133 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 190 ESLTES--KFSVASDVWSFGVVLYEL 213

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 31/205 (15%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               G+C    +R   L+ EY+P GSL  ++ +   +     L    +      +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL---LQYTSQICKGMEYL 133
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPE 321
             G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + APE
Sbjct: 134 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 322 LISRNFGTVSCKSDVYGFGMVLLEM 346
            ++ +    S  SDV+ FG+VL E+
Sbjct: 191 SLTES--KFSVASDVWSFGVVLYEL 213

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 115/233 (49%), Gaps = 52/233 (22%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 36  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 93
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 94  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 151
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G++YL +   V   H D+   N +LD  F  KV+DFGLA+
Sbjct: 152 KDLIGFGLQ--------VAKGMKYLASKKFV---HRDLAARNCMLDEKFTVKVADFGLAR 200
Query: 298 FHPKENDFVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
               + ++ S+ +  G    + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 201 -DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 249

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 134
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 135 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 191
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 192 ESLTES--KFSVASDVWSFGVVLYEL 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 135
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 136 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 192
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 193 ESLTES--KFSVASDVWSFGVVLYEL 216

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 52/233 (22%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 17  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 132
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G++YL +      +H D+   N +LD  F  KV+DFGLA+
Sbjct: 133 KDLIGFGLQ--------VAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 298 FHPKENDFVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
               + ++ S+ +  G    + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 182 -DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 52/233 (22%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 9   VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 66
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 67  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 124
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G++YL +      +H D+   N +LD  F  KV+DFGLA+
Sbjct: 125 KDLIGFGLQ--------VAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 173
Query: 298 FHPKENDFVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
               + ++ S+ +  G    + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 174 -DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 222

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 52/233 (22%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 14  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 72  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 129
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G++YL +      +H D+   N +LD  F  KV+DFGLA+
Sbjct: 130 KDLIGFGLQ--------VAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 298 FHPKENDFVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
               + ++ S+ +  G    + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 179 -DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 227

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 136
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 137 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 193
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 194 ESLTES--KFSVASDVWSFGVVLYEL 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 147
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 148 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 205 ESLTES--KFSVASDVWSFGVVLYEL 228

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 36/220 (16%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL----IAVKMME--NSKFSAEEFINE---- 206
           E+ A        +G G FG V  G+L         +A+K ++   ++    +F+ E    
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 207 ----------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
                     L G+ ++     +V E M NGSLD   F +++  Q F + +   +  G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIA 128
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG--- 313
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 129 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 183
Query: 314 TIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 351
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 184 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 220

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 126/298 (42%), Gaps = 61/298 (20%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL---IAVKMMEN--SKFSAEEFINELLGLCSEGFK--- 216
           F   +G+G FG V K ++    L    A+K M+   SK    +F  EL  LC  G     
Sbjct: 26  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 217 ---------RALVY---EYMPNGSL------------DRHIFSKENKGQTFGLEKPHEIA 252
                    R  +Y   EY P+G+L            D       +   T   ++    A
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312
              ARG++YL        +H ++   NIL+  N++ K++DFGL++    +  +V  +  R
Sbjct: 146 ADVARGMDYLSQKQ---FIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 199
Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVY 370
             + ++A E  S N+   +  SDV+ +G++L E+   GG     M             +Y
Sbjct: 200 LPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LY 248
Query: 371 DQLNKGGDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
           ++L +G  LE  L    E+  ++ +        C + K  +RPS  ++L  L   +++
Sbjct: 249 EKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSFAQILVSLNRMLEE 298

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 130
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H ++   NIL+++    K+ DFGL K  P++ ++  + +     I + AP
Sbjct: 131 L--GTKRYI-HRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 187
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 188 ESLTES--KFSVASDVWSFGVVLYEL 211

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 114/233 (48%), Gaps = 52/233 (22%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 17  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 132
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G++YL        +H D+   N +LD  F  KV+DFGLA+
Sbjct: 133 KDLIGFGLQ--------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 298 FHPKENDFVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
               + ++ S+ +  G    + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 182 -DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 52/233 (22%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 16  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 74  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 131
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G++YL +      +H D+   N +LD  F  KV+DFGLA+
Sbjct: 132 KDLIGFGLQ--------VAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 180
Query: 298 FHPKENDFVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
               + ++ S+ +  G    + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 181 -DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 229

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 52/233 (22%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 35  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 92
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 93  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 150
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G++YL +      +H D+   N +LD  F  KV+DFGLA+
Sbjct: 151 KDLIGFGLQ--------VAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 199
Query: 298 FHPKENDFVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
               + ++ S+ +  G    + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 200 -DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 248

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ EY+P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEY 147
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 148 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 205 ESLTES--KFSVASDVWSFGVVLYEL 228

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 114/233 (48%), Gaps = 52/233 (22%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 15  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 73  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 130
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G++YL        +H D+   N +LD  F  KV+DFGLA+
Sbjct: 131 KDLIGFGLQ--------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179
Query: 298 FHPKENDFVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
               + ++ S+ +  G    + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 180 -DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 114/233 (48%), Gaps = 52/233 (22%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 12  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 70  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 127
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G++YL        +H D+   N +LD  F  KV+DFGLA+
Sbjct: 128 KDLIGFGLQ--------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 298 FHPKENDFVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
               + ++ S+ +  G    + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 177 -DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 225

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 119
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 49/226 (21%)
Query: 164 HFTHKLGQGGFGSVYKGQLH----TGRLI--AVKMMENSKFSAE---------------- 201
            F   LG G FG V     +    TG  I  AVKM++    S+E                
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 202 -EFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE---------- 250
            E I  LLG C+      L++EY   G L  ++ SK  K     +E  ++          
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 251 ---------IALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
                     A   A+G+E+L    C    +H D+   N+L+ H  + K+ DFGLA+   
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            ++++V   + R  + ++APE +    G  + KSDV+ +G++L E+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEI 267

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 50/232 (21%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 15  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 73  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 130
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G+++L        +H D+   N +LD  F  KV+DFGLA+
Sbjct: 131 KDLIGFGLQ--------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179
Query: 298 -FHPKENDFV-SISDTRGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
             + KE D V + +  +  + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 180 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 228

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 165 FTHKLGQGGFGSVYKG-----QLHTGRLIAVKMMENS------KFSAE-EFINELL---- 208
           F  +LG+G FGSV        Q +TG ++AVK +++S       F  E E +  L     
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 209 ----GLCSEGFKR--ALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEY 261
               G+C    +R   L+ E++P GSL  ++   KE       L+   +I     +G+EY
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQIC----KGMEY 132
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAP 320
           L  G    I H D+   NIL+++    K+ DFGL K  P++ +   + +     I + AP
Sbjct: 133 L--GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEM 346
           E ++ +    S  SDV+ FG+VL E+
Sbjct: 190 ESLTES--KFSVASDVWSFGVVLYEL 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 41/208 (19%)
Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMM--ENSKFSA---EEF----------INELLGLCS 212
           LG+G +G VY G+ L     IA+K +   +S++S    EE           I + LG  S
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG-----TARGIEYLHNGCD 267
           E     +  E +P GSL   + SK      +G  K +E  +G        G++YLH   D
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSK------WGPLKDNEQTIGFYTKQILEGLKYLH---D 140
Query: 268 VCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPEL 322
             I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+APE+
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT------GTLQYMAPEI 194
Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           I +        +D++  G  ++EMA G+
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 50/232 (21%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 76  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 191
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G+++L        +H D+   N +LD  F  KV+DFGLA+
Sbjct: 192 KDLIGFGLQ--------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
Query: 298 -FHPKENDFV-SISDTRGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
             + KE D V + +  +  + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 50/232 (21%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 17  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 132
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G+++L        +H D+   N +LD  F  KV+DFGLA+
Sbjct: 133 KDLIGFGLQ--------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 298 -FHPKENDFV-SISDTRGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
             + KE D V + +  +  + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 182 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 50/232 (21%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 16  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 74  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 131
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G++YL +      +H D+   N +LD  F  KV+DFGLA+
Sbjct: 132 KDLIGFGLQ--------VAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 180
Query: 298 -FHPKENDFV-SISDTRGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
             + KE   V + +  +  + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 181 DMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 229

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 50/232 (21%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 17  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 132
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G+++L        +H D+   N +LD  F  KV+DFGLA+
Sbjct: 133 KDLIGFGLQ--------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 298 -FHPKENDFV-SISDTRGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
             + KE D V + +  +  + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 182 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 50/232 (21%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 22  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 79
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 80  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 137
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G+++L        +H D+   N +LD  F  KV+DFGLA+
Sbjct: 138 KDLIGFGLQ--------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186
Query: 298 -FHPKENDFV-SISDTRGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
             + KE D V + +  +  + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 187 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 235

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 42/214 (19%)
Query: 168 KLGQGGFGSVYKGQLHT------GRLIAVKMMENSKFSAE---------------EFINE 206
           +LG+G FG V+  + +         L+AVK +++   +A                E I +
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFS-------------KENKGQTFGLEKPHEIAL 253
             G+C +G    +V+EYM +G L++ + +             ++ KG+  GL +   IA 
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-LGLSQMLHIAS 140
Query: 254 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
             A G+ YL        +H D+   N L+  N + K+ DFG+++     + +     T  
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 314 TIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
            I ++ PE ++ R F T   +SDV+ FG++L E+
Sbjct: 198 PIRWMPPESIMYRKFTT---ESDVWSFGVILWEI 228

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 50/232 (21%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 18  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 76  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 133
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G+++L        +H D+   N +LD  F  KV+DFGLA+
Sbjct: 134 KDLIGFGLQ--------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182
Query: 298 -FHPKENDFV-SISDTRGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
             + KE D V + +  +  + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 183 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 231

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 9   LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 117
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 175 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 119
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 35/215 (16%)
Query: 155 LPEIIAVTNH----FTHKLGQGGFGSVYKGQLHT-GRLIAVKMME-------NSKFSAEE 202
           +P+   V NH       ++G+G FG V+ G+L     L+AVK           +KF  E 
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEA 163
Query: 203 FINE---------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL 253
            I +         L+G+C++     +V E +  G     +     +G    ++   ++  
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVG 220
Query: 254 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD--- 310
             A G+EYL + C  CI H D+   N L+    + K+SDFG+++   +E D V  +    
Sbjct: 221 DAAAGMEYLESKC--CI-HRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGL 274
Query: 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLE 345
            +  + + APE +  N+G  S +SDV+ FG++L E
Sbjct: 275 RQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 119
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 114/233 (48%), Gaps = 52/233 (22%)
Query: 147 MQTVDNILL-PEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGRLI--AVKMM-------E 194
           +Q V ++++ P  + V  HF   +G+G FG VY G L  + G+ I  AVK +       E
Sbjct: 18  VQAVQHVVIGPSSLIV--HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 195 NSKFSAEEFINE---------LLGLC--SEGFKRALVYEYMPNGSLDRHIFSKENKGQT- 242
            S+F  E  I +         LLG+C  SEG    +V  YM +G L R+    E    T 
Sbjct: 76  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDL-RNFIRNETHNPTV 133
Query: 243 -----FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
                FGL+         A+G+++L        +H D+   N +LD  F  KV+DFGLA+
Sbjct: 134 KDLIGFGLQ--------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182
Query: 298 FHPKENDFVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
               + +F S+ +  G    + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 183 -DMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWEL 231

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 41/208 (19%)
Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMM--ENSKFSA---EEF----------INELLGLCS 212
           LG+G +G VY G+ L     IA+K +   +S++S    EE           I + LG  S
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG-----TARGIEYLHNGCD 267
           E     +  E +P GSL   + SK      +G  K +E  +G        G++YLH   D
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSK------WGPLKDNEQTIGFYTKQILEGLKYLH---D 126
Query: 268 VCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPEL 322
             I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+APE+
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT------GTLQYMAPEI 180
Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           I +        +D++  G  ++EMA G+
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 119
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 119
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 119
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 35/215 (16%)
Query: 155 LPEIIAVTNH----FTHKLGQGGFGSVYKGQLHT-GRLIAVKMME-------NSKFSAEE 202
           +P+   V NH       ++G+G FG V+ G+L     L+AVK           +KF  E 
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEA 163
Query: 203 FINE---------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL 253
            I +         L+G+C++     +V E +  G     +     +G    ++   ++  
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVG 220
Query: 254 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD--- 310
             A G+EYL + C  CI H D+   N L+    + K+SDFG+++   +E D V  +    
Sbjct: 221 DAAAGMEYLESKC--CI-HRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGL 274
Query: 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLE 345
            +  + + APE +  N+G  S +SDV+ FG++L E
Sbjct: 275 RQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 89/209 (42%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN +L     
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 119
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 119
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G +G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 44/230 (19%)
Query: 168 KLGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI-NELLGLCSE------------ 213
           K+G+G  G V    + HTG+ +AVK M+  K    E + NE++ +               
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 214 --GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V E++  G+L D    ++ N+      E+   + L   R + YLHN     +
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIATVCLSVLRALSYLHNQG---V 162
Query: 271 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISR- 325
           +H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR 
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV------GTPYWMAPEVISRL 216
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR----RNSNMNATRSSKAYFPSWVYD 371
            +GT   + D++  G++++EM  G         + A R  +   P  V D
Sbjct: 217 PYGT---EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKD 263

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 153 ILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN--- 205
           +L+   IA       ++G+G +G V+ G+   G  +AVK+     E S F   E      
Sbjct: 29  LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL 87
Query: 206 ----ELLGLCSEGFKRA-------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG 254
                +LG  +   K         L+ +Y  NGSL  ++     K  T   +   ++A  
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYS 142
Query: 255 TARGIEYLHNGC-----DVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSI 308
           +  G+ +LH           I H D+K  NIL+  N    ++D GLA KF    N+    
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 309 SDTR-GTIGYLAPEL----ISRNFGTVSCKSDVYGFGMVLLEMA 347
            +TR GT  Y+ PE+    ++RN       +D+Y FG++L E+A
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K + +    +AVKM+++     +  + I+E            
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------------EI 251
              LLG C++     ++ EY   G+L  ++ ++E  G  +     H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   ++ 
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 30/199 (15%)
Query: 169 LGQGGFGSVYKG-QLHTGR----LIAVKMM-ENSKFSAEE---------------FINEL 207
           LG G FG+VYKG  +  G      +A+K++ EN+   A +               +++ L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           LG+C     + LV + MP G L  H+  +EN+G+  G +      +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHV--RENRGR-LGSQDLLNWCMQIAKGMSYLE---D 137
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
           V ++H D+   N+L+      K++DFGLA+    +         +  I ++A E I R  
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR- 196
Query: 328 GTVSCKSDVYGFGMVLLEM 346
              + +SDV+ +G+ + E+
Sbjct: 197 -RFTHQSDVWSYGVTVWEL 214

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 41/204 (20%)
Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMME-NSKFSAEEFINE----------------LLGL 210
           LG+G F +VYK +  +T +++A+K ++   +  A++ IN                 ++GL
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 211 CSE-GFKR--ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIA--LGTARGIEYLHNG 265
               G K   +LV+++M     D  +  K+N   +  L   H  A  L T +G+EYLH  
Sbjct: 78  LDAFGHKSNISLVFDFM---ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI- 323
               ILH D+KP+N+LLD N + K++DFGLAK F      +     TR    Y APEL+ 
Sbjct: 132 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR---WYRAPELLF 185
Query: 324 -SRNFGTVSCKSDVYGFGMVLLEM 346
            +R +G      D++  G +L E+
Sbjct: 186 GARMYGV---GVDMWAVGCILAEL 206

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 164 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMMENSKFSAE---------------- 201
            F   LG G FG V +      G+      +AVKM++++  + E                
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 202 -EFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSK------ENKGQTFGLEKPHEIALG 254
            E I  LLG C+ G    ++ EY   G L   +  K      +  G+   L      +  
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++   + R  
Sbjct: 161 VAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 218 VKWMAPESIFDCVYTV--QSDVWSYGILLWEI 247

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 164 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMMENSKFSAE---------------- 201
            F   LG G FG V +      G+      +AVKM++++  + E                
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 202 -EFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
            E I  LLG C+ G    ++ EY   G L   +     K +    +    IA  TA   +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAFAIANSTASTRD 165
Query: 261 YLHNGCDVC----------ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310
            LH    V            +H D+   N+LL +  + K+ DFGLA+    +++++   +
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 259

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 32/201 (15%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NELLGLCSE----------- 213
            K+GQG  G+VY    + TG+ +A++ M   +   +E I NE+L +              
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 214 ---GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              G +  +V EY+  GSL D    +  ++GQ         +     + +E+LH+     
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHSNQ--- 136
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
           ++H DIK  NILL  +   K++DFG  A+  P+++     S+  GT  ++APE+++R   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SEMVGTPYWMAPEVVTRK-- 191
Query: 329 TVSCKSDVYGFGMVLLEMAGG 349
               K D++  G++ +EM  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 164 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMMENSKFSAE---------------- 201
            F   LG G FG V +      G+      +AVKM++++  + E                
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 202 -EFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSK------ENKGQTFGLEKPHEIALG 254
            E I  LLG C+ G    ++ EY   G L   +  K      +  G+   L      +  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++   + R  
Sbjct: 169 VAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 VKWMAPESIFDCVYTV--QSDVWSYGILLWEI 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 167 HKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINE------------ 206
            +LGQG FG VY+G             +AVK +  S    E  EF+NE            
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFS-----KENKGQTF-GLEKPHEIALGTARG 258
             LLG+ S+G    +V E M +G L  ++ S     + N G+    L++  ++A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           + YL+       +H D+   N ++ H+F  K+ DFG+ +   + +           + ++
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE  S   G  +  SD++ FG+VL E+
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 167 HKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINE------------ 206
            +LGQG FG VY+G             +AVK +  S    E  EF+NE            
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFS-----KENKGQTF-GLEKPHEIALGTARG 258
             LLG+ S+G    +V E M +G L  ++ S     + N G+    L++  ++A   A G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           + YL+       +H D+   N ++ H+F  K+ DFG+ +   + +           + ++
Sbjct: 140 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE  S   G  +  SD++ FG+VL E+
Sbjct: 197 APE--SLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 167 HKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINE------------ 206
            +LGQG FG VY+G             +AVK +  S    E  EF+NE            
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFS-----KENKGQTF-GLEKPHEIALGTARG 258
             LLG+ S+G    +V E M +G L  ++ S     + N G+    L++  ++A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           + YL+       +H D+   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE  S   G  +  SD++ FG+VL E+
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 167 HKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINE------------ 206
            +LGQG FG VY+G             +AVK +  S    E  EF+NE            
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFS-----KENKGQTF-GLEKPHEIALGTARG 258
             LLG+ S+G    +V E M +G L  ++ S     + N G+    L++  ++A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           + YL+       +H D+   N ++ H+F  K+ DFG+ +   + +           + ++
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE  S   G  +  SD++ FG+VL E+
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 56/93 (60%), Gaps = 7/93 (7%)
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            ARG+E+L +    CI H D+   NILL  N + K+ DFGLA+   K  D+V   DTR  
Sbjct: 208 VARGMEFLSS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 315 IGYLAPELISRNFGTV-SCKSDVYGFGMVLLEM 346
           + ++APE I   F  + S KSDV+ +G++L E+
Sbjct: 265 LKWMAPESI---FDKIYSTKSDVWSYGVLLWEI 294

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 39/223 (17%)
Query: 155 LPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGR-LIAVK------------MMEN-SKFSA 200
           LP +      +  ++G+GGFG V+KG+L   + ++A+K            M+E   +F  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 201 EEFIN---------ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI 251
           E FI          +L GL     +  +V E++P G L   +    +K           +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRL 127
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFV 306
            L  A GIEY+ N  +  I+H D++  NI L   D N     KV+DFGL+     +    
Sbjct: 128 MLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVH 181
Query: 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           S+S   G   ++APE I     + + K+D Y F M+L  +  G
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE-----------------FINELLG 209
           +LG+G +G V K + + +G+++AVK +  +  S E+                 F     G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                    +  E M + SLD+      +KGQT   +   +IA+   + +E+LH+   + 
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 174
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR--NF 327
           ++H D+KP N+L++     K+ DFG++ +     D V+ +   G   Y+APE I+   N 
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 328 GTVSCKSDVYGFGMVLLEMA 347
              S KSD++  G+ ++E+A
Sbjct: 232 KGYSVKSDIWSLGITMIELA 251

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 89/209 (42%), Gaps = 39/209 (18%)
Query: 165 FTHKLGQGGFGSVYKGQLHTGRL----IAVKMMENSK-------FSAEEFINELL----- 208
               LG+G  G V   QL   R+    +AVK+++  +          E  IN++L     
Sbjct: 10  LVQTLGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 209 ----GLCSEGFKRALVYEYMPNGSL-DR---HIFSKENKGQTFGLEKPHEIALGTARGIE 260
               G   EG  + L  EY   G L DR    I   E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF----HQLMAGVV---- 118
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 30/199 (15%)
Query: 169 LGQGGFGSVYKG-QLHTGRLIAV----KMMEN----SKFSA------------EEFINEL 207
           LG G FG+V+KG  +  G  I +    K++E+      F A               I  L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           LGLC  G    LV +Y+P GSL  H+  ++++G   G +      +  A+G+ YL    +
Sbjct: 81  LGLCP-GSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYLE---E 133
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             ++H ++   N+LL      +V+DFG+A   P ++  +  S+ +  I ++A E I  +F
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HF 191
Query: 328 GTVSCKSDVYGFGMVLLEM 346
           G  + +SDV+ +G+ + E+
Sbjct: 192 GKYTHQSDVWSYGVTVWEL 210

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 30/199 (15%)
Query: 169 LGQGGFGSVYKG-QLHTGRLIAV----KMMEN----SKFSA------------EEFINEL 207
           LG G FG+V+KG  +  G  I +    K++E+      F A               I  L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           LGLC  G    LV +Y+P GSL  H+  ++++G   G +      +  A+G+ YL    +
Sbjct: 99  LGLCP-GSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYLE---E 151
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             ++H ++   N+LL      +V+DFG+A   P ++  +  S+ +  I ++A E I  +F
Sbjct: 152 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HF 209
Query: 328 GTVSCKSDVYGFGMVLLEM 346
           G  + +SDV+ +G+ + E+
Sbjct: 210 GKYTHQSDVWSYGVTVWEL 228

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 164 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMMENSKFSAE---------------- 201
            F   LG G FG V +      G+      +AVKM++++  + E                
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 202 -EFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----------- 249
            E I  LLG C+ G    ++ EY   G L   +  K   G  +     H           
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 250 -EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 308
              +   A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++  
Sbjct: 169 LHFSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            + R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 GNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 261

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K + +    +AVKM+++     +  + I+E            
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------------EI 251
              LLG C++     ++ EY   G+L  ++ ++   G  F     H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     +     ++ 
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 32/201 (15%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NELLGLCSE----------- 213
            K+GQG  G+VY    + TG+ +A++ M   +   +E I NE+L +              
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 214 ---GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              G +  +V EY+  GSL D    +  ++GQ         +     + +E+LH+     
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHSNQ--- 136
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
           ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK-- 191
Query: 329 TVSCKSDVYGFGMVLLEMAGG 349
               K D++  G++ +EM  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 32/201 (15%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NELLGLCSE----------- 213
            K+GQG  G+VY    + TG+ +A++ M   +   +E I NE+L +              
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 214 ---GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              G +  +V EY+  GSL D    +  ++GQ         +     + +E+LH+     
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHSNQ--- 137
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
           ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R   
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRK-- 192
Query: 329 TVSCKSDVYGFGMVLLEMAGG 349
               K D++  G++ +EM  G
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEG 213

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 42/210 (20%)
Query: 170 GQGGFGSVYKGQLHTGRLIAVKM---MENSKFSAEEFINELLGLCSEGF-------KRA- 218
            +G FG V+K QL     +AVK+    +   +  E  +  L G+  E         KR  
Sbjct: 33  ARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 219 -------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-------N 264
                  L+  +   GSL   +     K       +   IA   ARG+ YLH       +
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIG---YLAP 320
           G    I H DIK  N+LL +N    ++DFGLA KF   +    S  DT G +G   Y+AP
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK----SAGDTHGQVGTRRYMAP 202
Query: 321 ELI--SRNFGTVS-CKSDVYGFGMVLLEMA 347
           E++  + NF   +  + D+Y  G+VL E+A
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 167 HKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINE------------ 206
            +LGQG FG VY+G             +AVK +  S    E  EF+NE            
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFS-----KENKGQTF-GLEKPHEIALGTARG 258
             LLG+ S+G    +V E M +G L  ++ S     + N G+    L++  ++A   A G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           + YL+       +H D+   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 142 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE  S   G  +  SD++ FG+VL E+
Sbjct: 199 APE--SLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 32/201 (15%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NELLGLCSE----------- 213
            K+GQG  G+VY    + TG+ +A++ M   +   +E I NE+L +              
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 214 ---GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              G +  +V EY+  GSL D    +  ++GQ         +     + +E+LH+     
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHSNQ--- 136
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
           ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRK-- 191
Query: 329 TVSCKSDVYGFGMVLLEMAGG 349
               K D++  G++ +EM  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + + + ++ 
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 31/194 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG-LCSE 213
           +G+G FG V  G  + G  +AVK ++N   +A+ F+ E              LLG +  E
Sbjct: 14  IGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL  ++ S+       G +   + +L     +EYL        +H 
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELISRNFGTVSC 332
           D+   N+L+  + + KVSDFGL K      +  S  DT +  + + APE +       S 
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREK--KFST 178
Query: 333 KSDVYGFGMVLLEM 346
           KSDV+ FG++L E+
Sbjct: 179 KSDVWSFGILLWEI 192

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 31/196 (15%)
Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG-LC 211
             +G+G FG V  G  + G  +AVK ++N   +A+ F+ E              LLG + 
Sbjct: 18  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
            E     +V EYM  GSL  ++ S+       G +   + +L     +EYL        +
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FV 130
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELISRNFGTV 330
           H D+   N+L+  + + KVSDFGL K      +  S  DT +  + + APE +       
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALRE--AAF 182
Query: 331 SCKSDVYGFGMVLLEM 346
           S KSDV+ FG++L E+
Sbjct: 183 STKSDVWSFGILLWEI 198

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
           GI++ H   D+ I+H DIKP NIL+D N   K+ DFG+AK    E      +   GT+ Y
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTNHVLGTVQY 178
Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            +PE  ++   T  C +D+Y  G+VL EM  G 
Sbjct: 179 FSPEQ-AKGEATDEC-TDIYSIGIVLYEMLVGE 209

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 167 HKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINE------------ 206
            +LGQG FG VY+G             +AVK +  S    E  EF+NE            
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFS-----KENKGQTF-GLEKPHEIALGTARG 258
             LLG+ S+G    +V E M +G L  ++ S     + N G+    L++  ++A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           + YL+       +H D+   N ++ H+F  K+ DFG+ +   +   +         + ++
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE  S   G  +  SD++ FG+VL E+
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K + +    +AVKM+++     +  + I+E            
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------------EI 251
              LLG C++     ++ EY   G+L  ++ ++   G  +     H              
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   ++ 
Sbjct: 145 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 202 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 234

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K + +    +AVKM+++     +  + I+E            
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------------EI 251
              LLG C++     ++ EY   G+L  ++ ++   G  +     H              
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   ++ 
Sbjct: 149 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 206 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 238

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 36/202 (17%)
Query: 168 KLGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI-NELLGL-------CSEGFKRA 218
           K+G+G  G V    + H+GR +AVKMM+  K    E + NE++ +         E +K  
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 219 LV-------YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           LV        E++  G+L   I S+    +    E+   +     + + YLH      ++
Sbjct: 112 LVGEELWVLMEFLQGGALT-DIVSQVRLNE----EQIATVCEAVLQALAYLHAQG---VI 163
Query: 272 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR+ 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV------GTPYWMAPEVISRSL 217
Query: 328 GTVSCKSDVYGFGMVLLEMAGG 349
              + + D++  G++++EM  G
Sbjct: 218 --YATEVDIWSLGIMVIEMVDG 237

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 26/200 (13%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE-----------------FINELLG 209
           +LG+G +G V K + + +G+++AVK +  +  S E+                 F     G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                    +  E M + SLD+      +KGQT   +   +IA+   + +E+LH+   + 
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR--NF 327
           ++H D+KP N+L++     K+ DFG++ +     D V+     G   Y+APE I+   N 
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 328 GTVSCKSDVYGFGMVLLEMA 347
              S KSD++  G+ ++E+A
Sbjct: 188 KGYSVKSDIWSLGITMIELA 207

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   ++ 
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 31/194 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG-LCSE 213
           +G+G FG V  G  + G  +AVK ++N   +A+ F+ E              LLG +  E
Sbjct: 201 IGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL  ++ S+       G +   + +L     +EYL        +H 
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELISRNFGTVSC 332
           D+   N+L+  + + KVSDFGL K      +  S  DT +  + + APE +       S 
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREK--KFST 365
Query: 333 KSDVYGFGMVLLEM 346
           KSDV+ FG++L E+
Sbjct: 366 KSDVWSFGILLWEI 379

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K + +    +AVKM+++     +  + I+E            
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------------EI 251
              LLG C++     ++ EY   G+L  ++ ++   G  +     H              
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   ++ 
Sbjct: 148 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 205 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 237

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   ++ 
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 31/194 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG-LCSE 213
           +G+G FG V  G  + G  +AVK ++N   +A+ F+ E              LLG +  E
Sbjct: 29  IGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                +V EYM  GSL  ++ S+       G +   + +L     +EYL        +H 
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 274 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELISRNFGTVSC 332
           D+   N+L+  + + KVSDFGL K      +  S  DT +  + + APE +       S 
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREK--KFST 193
Query: 333 KSDVYGFGMVLLEM 346
           KSDV+ FG++L E+
Sbjct: 194 KSDVWSFGILLWEI 207

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K + +    +AVKM+++     +  + I+E            
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------------EI 251
              LLG C++     ++ EY   G+L  ++ ++   G  +     H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   ++ 
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   ++ 
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 39/229 (17%)
Query: 169 LGQGGFGSVYKGQLHT----GRLIAVKMMENSKFSAEEFIN-----ELLGLCSEGFKRAL 219
           LGQG FG V+  +  T    G L A+K+++ +     + +      ++L   +  F   L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 220 VYEYMPNGSL--------DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
            Y +   G L           +F++ +K   F  E         A G+++LH+   + I+
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS---LGII 152
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISDTRGTIGYLAPELISRNF 327
           + D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+++R  
Sbjct: 153 YRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC------GTVEYMAPEVVNRQ- 205
Query: 328 GTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNATRSSKAYFPSWV 369
              S  +D + +G+++ EM        G  R   M     +K   P ++
Sbjct: 206 -GHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFL 253

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 35/249 (14%)
Query: 134 VFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKL-GQGGFGSVYK-GQLHTGRLIAVK 191
           VF  F+     T      N+ L   + + +   H++ G+GGFG VY   +  TG++ A+K
Sbjct: 160 VFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 219
Query: 192 MMENSKFSAEE----FINE--LLGLCSEGF---------------KRALVYEYMPNGSLD 230
            ++  +   ++     +NE  +L L S G                K + + + M  G L 
Sbjct: 220 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 279
Query: 231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV 290
            H+    ++   F        A     G+E++HN     +++ D+KP NILLD +   ++
Sbjct: 280 YHL----SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 332
Query: 291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           SD GLA    K+    S+    GT GY+APE++ +     S  +D +  G +L ++  G 
Sbjct: 333 SDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGH 387
Query: 351 RNSNMNATR 359
                + T+
Sbjct: 388 SPFRQHKTK 396

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 35/249 (14%)
Query: 134 VFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKL-GQGGFGSVYK-GQLHTGRLIAVK 191
           VF  F+     T      N+ L   + + +   H++ G+GGFG VY   +  TG++ A+K
Sbjct: 161 VFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 192 MMENSKFSAEE----FINE--LLGLCSEGF---------------KRALVYEYMPNGSLD 230
            ++  +   ++     +NE  +L L S G                K + + + M  G L 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV 290
            H+    ++   F        A     G+E++HN     +++ D+KP NILLD +   ++
Sbjct: 281 YHL----SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 333
Query: 291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           SD GLA    K+    S+    GT GY+APE++ +     S  +D +  G +L ++  G 
Sbjct: 334 SDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGH 388
Query: 351 RNSNMNATR 359
                + T+
Sbjct: 389 SPFRQHKTK 397

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 35/249 (14%)
Query: 134 VFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKL-GQGGFGSVYK-GQLHTGRLIAVK 191
           VF  F+     T      N+ L   + + +   H++ G+GGFG VY   +  TG++ A+K
Sbjct: 161 VFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 192 MMENSKFSAEE----FINE--LLGLCSEGF---------------KRALVYEYMPNGSLD 230
            ++  +   ++     +NE  +L L S G                K + + + M  G L 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV 290
            H+    ++   F        A     G+E++HN     +++ D+KP NILLD +   ++
Sbjct: 281 YHL----SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 333
Query: 291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           SD GLA    K+    S+    GT GY+APE++ +     S  +D +  G +L ++  G 
Sbjct: 334 SDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGH 388
Query: 351 RNSNMNATR 359
                + T+
Sbjct: 389 SPFRQHKTK 397

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   ++ 
Sbjct: 209 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 266 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 298

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 35/249 (14%)
Query: 134 VFLVFLIHKYRTTMQTVDNILLPEIIAVTNHFTHKL-GQGGFGSVYK-GQLHTGRLIAVK 191
           VF  F+     T      N+ L   + + +   H++ G+GGFG VY   +  TG++ A+K
Sbjct: 161 VFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 192 MMENSKFSAEE----FINE--LLGLCSEGF---------------KRALVYEYMPNGSLD 230
            ++  +   ++     +NE  +L L S G                K + + + M  G L 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV 290
            H+    ++   F        A     G+E++HN     +++ D+KP NILLD +   ++
Sbjct: 281 YHL----SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 333
Query: 291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           SD GLA    K+    S+    GT GY+APE++ +     S  +D +  G +L ++  G 
Sbjct: 334 SDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGH 388
Query: 351 RNSNMNATR 359
                + T+
Sbjct: 389 SPFRQHKTK 397

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINE----LLGLCSEGFKRALVYE 222
           ++G+G FG VYKG   HT  ++A+K+++  +   E    +    +L  C   +       
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 223 YMPNGSLDRHIFSKENKGQTFGLEKP---HEIALGTA-----RGIEYLHNGCDVCILHFD 274
           Y+ +  L   I      G    L KP    E  + T      +G++YLH+   +   H D
Sbjct: 86  YLKSTKL-WIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI---HRD 141
Query: 275 IKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           IK  N+LL      K++DFG+A        K N FV      GT  ++APE+I ++    
Sbjct: 142 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEVIKQS--AY 193
Query: 331 SCKSDVYGFGMVLLEMAGGR-RNSNMNATR 359
             K+D++  G+  +E+A G   NS+++  R
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDLHPMR 223

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K + +    +AVKM+++     +  + I+E            
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------------EI 251
              LLG C++     ++ EY   G+L  ++ ++   G  +     H              
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   ++ 
Sbjct: 141 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 198 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 230

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K + +    +AVKM+++     +  + I+E            
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------------EI 251
              LLG C++     ++ EY   G+L  ++ ++   G  +     H              
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   ++ 
Sbjct: 197 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 254 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 286

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 167 HKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINE------------ 206
            +LGQG FG VY+G             +AVK +  S    E  EF+NE            
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFS-----KENKGQTF-GLEKPHEIALGTARG 258
             LLG+ S+G    +V E M +G L  ++ S     + N G+    L++  ++A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           + YL+       +H ++   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 143 MAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE  S   G  +  SD++ FG+VL E+
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 167 HKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINE------------ 206
            +LGQG FG VY+G             +AVK +  S    E  EF+NE            
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFS-----KENKGQTF-GLEKPHEIALGTARG 258
             LLG+ S+G    +V E M +G L  ++ S     + N G+    L++  ++A   A G
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           + YL+       +H ++   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 144 MAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE  S   G  +  SD++ FG+VL E+
Sbjct: 201 APE--SLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 219 LVYEYMPNGSL---DRHIFSKENKGQTF-GLEKPHEIALGTARGIEYLHNGCDVCILHFD 274
           ++YEYM N S+   D + F  +     F  ++    I         Y+HN  ++C  H D
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC--HRD 177
Query: 275 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           +KP NIL+D N   K+SDFG +++   +     I  +RGT  ++ PE  S        K 
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKV 233
Query: 335 DVYGFGMVLLEM 346
           D++  G+ L  M
Sbjct: 234 DIWSLGICLYVM 245

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 164 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMMENSKFSAE---------------- 201
            F   LG G FG V +      G+      +AVKM++++  + E                
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 202 -EFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
            E I  LLG C+ G    ++ EY   G L   +     K +    +    IA  T    +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAFAIANSTLSTRD 165
Query: 261 YLHNGCDVC----------ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310
            LH    V            +H D+   N+LL +  + K+ DFGLA+    +++++   +
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 259

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     +     ++ 
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + +++DFGLA+     + +   ++ 
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K + +    +AVKM+++     +  + I+E            
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------------EI 251
              LLG C++     ++ EY   G+L  ++ ++   G  +     H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   ++ 
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 155 LPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGR-LIAVK------------MMEN-SKFSA 200
           LP +      +  ++G+GGFG V+KG+L   + ++A+K            M+E   +F  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 201 EEFIN---------ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI 251
           E FI          +L GL     +  +V E++P G L   +    +K           +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRL 127
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFV 306
            L  A GIEY+ N  +  I+H D++  NI L   D N     KV+DF L+     +    
Sbjct: 128 MLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVH 181
Query: 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           S+S   G   ++APE I     + + K+D Y F M+L  +  G
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA----------------EEFINELLG 209
            ++G+G FG V+KG    T +++A+K+++  +                     ++ +  G
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 210 LCSEGFKRALVYEYMPNGS-LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
              +G K  ++ EY+  GS LD       ++ Q   + K  EI     +G++YLH+   +
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK--EIL----KGLDYLHSEKKI 142
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELIS 324
              H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I 
Sbjct: 143 ---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIQ 193
Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATR 359
           ++      K+D++  G+  +E+A G   NS+M+  R
Sbjct: 194 QS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR 227

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   ++ 
Sbjct: 150 TYQLARGMEYL--ASQKCI-HRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 207 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 239

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 155 LPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGR-LIAVK------------MMEN-SKFSA 200
           LP +      +  ++G+GGFG V+KG+L   + ++A+K            M+E   +F  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 201 EEFIN---------ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI 251
           E FI          +L GL     +  +V E++P G L   +    +K           +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRL 127
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFV 306
            L  A GIEY+ N  +  I+H D++  NI L   D N     KV+DFG +     +    
Sbjct: 128 MLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVH 181
Query: 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           S+S   G   ++APE I     + + K+D Y F M+L  +  G
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 33/203 (16%)
Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN------------------ELLG 209
           LG+G F  VY+ + +HTG  +A+KM++         +                   EL  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +     LV E   NG ++R++   +N+ + F   +          G+ YLH+     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSHG--- 132
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISDTRGTIGYLAPELISRNF 327
           ILH D+   N+LL  N   K++DFGLA     P E  +       GT  Y++PE+ +R+ 
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEIATRS- 187
Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
                +SDV+  G +   +  GR
Sbjct: 188 -AHGLESDVWSLGCMFYTLLIGR 209

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 29/201 (14%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE----FINE--LLGLCSEGFKRALVY 221
           LG+GGFG V   Q+  TG++ A K +E  +    +     +NE  +L   +  F  +L Y
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 222 EY------------MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            Y            M  G L  HI+     G  F   +    A     G+E LH      
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLHR---ER 306
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I++ D+KP NILLD +   ++SD GLA   P+     +I    GT+GY+APE++     T
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYT 363
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
            S   D +  G +L EM  G+
Sbjct: 364 FS--PDWWALGCLLYEMIAGQ 382

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 7/106 (6%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
            ++YL N     I+H D+KP NILLD +    ++DF +A   P+E    +++   GT  Y
Sbjct: 127 ALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPY 180
Query: 318 LAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 362
           +APE+ S   G   S   D +  G+   E+  GRR  ++ ++ SSK
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   ++ 
Sbjct: 155 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 212 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G  +  +    P E          
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   ++ 
Sbjct: 152 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 209 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 241

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 41/207 (19%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENS------------------KFSAEEFIN--E 206
           ++G G +G+VYK +  H+G  +A+K +                     +  A E  N   
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 207 LLGLCSEG-----FKRALVYEYMPNGSLDRHIFSKENKGQTFGL--EKPHEIALGTARGI 259
           L+ +C+        K  LV+E+     +D+ + +  +K    GL  E   ++     RG+
Sbjct: 71  LMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVTLWYRA 179
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEM 346
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 169 LGQGGFGSVYKGQLHTG----RLIAVKMMENSKFSAEEFIN-----ELLGLCSEGFKRAL 219
           LGQG FG V+  +  +G    +L A+K+++ +     + +      ++L   +  F   L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 220 VYEYMPNGSL--------DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
            Y +   G L           +F++ +K   F  E         A  +++LH+   + I+
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGII 148
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISDTRGTIGYLAPELISRNF 327
           + D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+++R  
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEVVNRRG 202
Query: 328 GTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNATRSSKAYFPSWV 369
            T S  +D + FG+++ EM        G  R   M     +K   P ++
Sbjct: 203 HTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 32/201 (15%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NELLGLCSE----------- 213
            K+GQG  G+VY    + TG+ +A++ M   +   +E I NE+L +              
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 214 ---GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              G +  +V EY+  GSL D    +  ++GQ         +     + +E+LH+     
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHSNQ--- 137
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
           ++H +IK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R   
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK-- 192
Query: 329 TVSCKSDVYGFGMVLLEMAGG 349
               K D++  G++ +EM  G
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEG 213

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 29/201 (14%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE----FINE--LLGLCSEGFKRALVY 221
           LG+GGFG V   Q+  TG++ A K +E  +    +     +NE  +L   +  F  +L Y
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 222 EY------------MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            Y            M  G L  HI+     G  F   +    A     G+E LH      
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLHR---ER 306
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I++ D+KP NILLD +   ++SD GLA   P+     +I    GT+GY+APE++     T
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYT 363
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
            S   D +  G +L EM  G+
Sbjct: 364 FS--PDWWALGCLLYEMIAGQ 382

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 169 LGQGGFGSVYKGQLHTG----RLIAVKMMENSKFSAEEFIN-----ELLGLCSEGFKRAL 219
           LGQG FG V+  +  +G    +L A+K+++ +     + +      ++L   +  F   L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 220 VYEYMPNGSL--------DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
            Y +   G L           +F++ +K   F  E         A  +++LH+   + I+
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGII 148
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISDTRGTIGYLAPELISRNF 327
           + D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+++R  
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEVVNRRG 202
Query: 328 GTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNATRSSKAYFPSWV 369
            T S  +D + FG+++ EM        G  R   M     +K   P ++
Sbjct: 203 HTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 169 LGQGGFGSVYKGQLHTG----RLIAVKMMENSKFSAEEFIN-----ELLGLCSEGFKRAL 219
           LGQG FG V+  +  +G    +L A+K+++ +     + +      ++L   +  F   L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 220 VYEYMPNGSL--------DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
            Y +   G L           +F++ +K   F  E         A  +++LH+   + I+
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGII 149
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISDTRGTIGYLAPELISRNF 327
           + D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+++R  
Sbjct: 150 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEVVNRRG 203
Query: 328 GTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNATRSSKAYFPSWV 369
            T S  +D + FG+++ EM        G  R   M     +K   P ++
Sbjct: 204 HTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 250

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 72/146 (49%), Gaps = 24/146 (16%)
Query: 250 EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309
           +I L T + + +L    ++ I+H DIKP NILLD +   K+ DFG++    +  D ++ +
Sbjct: 129 KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKT 183
Query: 310 DTRGTIGYLAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 367
              G   Y+APE I  S +      +SDV+  G+ L E+A GR              +P 
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP------------YPK 231
Query: 368 W--VYDQLN---KGGDLELRNVTEIE 388
           W  V+DQL    KG   +L N  E E
Sbjct: 232 WNSVFDQLTQVVKGDPPQLSNSEERE 257

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 155 LPEIIAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFSA--EEFINE 206
           L EI      F  +LG+  FG VYKG L         + +A+K +++       EEF +E
Sbjct: 20  LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 79
Query: 207 --------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSK----------ENKGQT 242
                         LLG+ ++    ++++ Y  +G L   +  +          +++   
Sbjct: 80  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 139
Query: 243 FGLEKPHEIAL--GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
             LE P  + L    A G+EYL +     ++H D+   N+L+      K+SD GL +   
Sbjct: 140 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 196
Query: 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             + +  + ++   I ++APE I   +G  S  SD++ +G+VL E+
Sbjct: 197 AADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 240

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 203 FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           +I  ++G+C E     LV E    G L++++    +      +E  H++++G    ++YL
Sbjct: 73  YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYL 127
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPE 321
               +   +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE
Sbjct: 128 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 322 LISRNFGTVSCKSDVYGFGMVLLE 345
            I  N+   S KSDV+ FG+++ E
Sbjct: 185 CI--NYYKFSSKSDVWSFGVLMWE 206

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 41/207 (19%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENS------------------KFSAEEFIN--E 206
           ++G G +G+VYK +  H+G  +A+K +                     +  A E  N   
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 207 LLGLCSEG-----FKRALVYEYMPNGSLDRHIFSKENKGQTFGL--EKPHEIALGTARGI 259
           L+ +C+        K  LV+E+     +D+ + +  +K    GL  E   ++     RG+
Sbjct: 71  LMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   +++     T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVTLWYRA 179
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEM 346
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 155 LPEIIAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFSA--EEFINE 206
           L EI      F  +LG+  FG VYKG L         + +A+K +++       EEF +E
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 207 --------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSK----------ENKGQT 242
                         LLG+ ++    ++++ Y  +G L   +  +          +++   
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 243 FGLEKPHEIAL--GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
             LE P  + L    A G+EYL +     ++H D+   N+L+      K+SD GL +   
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             + +  + ++   I ++APE I   +G  S  SD++ +G+VL E+
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 223

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 40/216 (18%)
Query: 151 DNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL---IAVKMMEN--SKFSAEEFIN 205
           DN+L+ +I         +LG G FGSV +G     +    +A+K+++    K   EE + 
Sbjct: 9   DNLLIADI---------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 59
Query: 206 E--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGL-EKPHE 250
           E              L+G+C +     LV E    G L + +  K  +     + E  H+
Sbjct: 60  EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 251 IALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSIS 309
           +++G    ++YL    +   +H D+   N+LL +    K+SDFGL+K     ++ + + S
Sbjct: 119 VSMG----MKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171
Query: 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLE 345
             +  + + APE I  NF   S +SDV+ +G+ + E
Sbjct: 172 AGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWE 205

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 44/210 (20%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENS---------------------KFSAEEFIN 205
           ++G G +G+VYK +  H+G  +A+K +                        +  A E  N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 206 --ELLGLCSEG-----FKRALVYEYMPNGSLDRHIFSKENKGQTFGL--EKPHEIALGTA 256
              L+ +C+        K  LV+E+     +D+ + +  +K    GL  E   ++     
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG+++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ 
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLW 184
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           Y APE++ ++  T +   D++  G +  EM
Sbjct: 185 YRAPEVLLQS--TYATPVDMWSVGCIFAEM 212

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 74
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+ +VY     +Y+P     + RH +S+    QT  +          
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 131
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 186
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 187 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++  Y   G+L  ++ ++   G  +  +    P E          
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   ++ 
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 37/209 (17%)
Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN-------ELLGLCSEGF-- 215
           +G+G +G V++G    G  +AVK+     E S F   E  N        +LG  +     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 216 -----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-----NG 265
                +  L+  Y   GSL  ++     +  T        I L  A G+ +LH       
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--GTIGYLAPELI 323
               I H D+K  NIL+  N    ++D GLA  H +  + + + +    GT  Y+APE++
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 324 SRNFGTVSC-----KSDVYGFGMVLLEMA 347
                 V C     + D++ FG+VL E+A
Sbjct: 190 DETI-QVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 44/220 (20%)
Query: 165 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAEEF--------------- 203
           F   LG G FG V +   +          +AVKM++ S    E                 
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 204 --INELLGLCSEGFKRALVYEYMPNGSL--------DRHIFSKENKG------QTFGLEK 247
             I  LLG C+ G    ++ EY   G L        D  I SK +            LE 
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 248 PHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307
               +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++V 
Sbjct: 170 LLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARHIKNDSNYVV 226
Query: 308 ISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEM 346
             + R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 227 KGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 263

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQ--TFGLEK-PHE---------I 251
              LLG C++     ++ EY   G+L  ++ ++   G   ++ + + P E          
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     +     ++ 
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 37/209 (17%)
Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN-------ELLGLCSEGF-- 215
           +G+G +G V++G    G  +AVK+     E S F   E  N        +LG  +     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 216 -----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-----NG 265
                +  L+  Y   GSL  ++     +  T        I L  A G+ +LH       
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--GTIGYLAPELI 323
               I H D+K  NIL+  N    ++D GLA  H +  + + + +    GT  Y+APE++
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 324 SRNFGTVSC-----KSDVYGFGMVLLEMA 347
                 V C     + D++ FG+VL E+A
Sbjct: 190 DETI-QVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 32/202 (15%)
Query: 169 LGQGGFGSVYKGQL-----HTGRLIAVKMME---------NSKFSAE-------EFINEL 207
           LG+G FG V   +      +TG  +AVK ++         + K   E       E I + 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 208 LGLCSE--GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            G+C+E  G    L+ E++P+GSL  ++   +NK     L++  + A+   +G++YL + 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 133
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPELIS 324
             V   H D+   N+L++     K+ DFGL K    + +  ++ D R + + + APE + 
Sbjct: 134 QYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 325 RNFGTVSCKSDVYGFGMVLLEM 346
           ++   ++  SDV+ FG+ L E+
Sbjct: 191 QSKFYIA--SDVWSFGVTLHEL 210

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 47/220 (21%)
Query: 169 LGQGGFGSVYKGQLH--TGRL----IAVKMMEN-----------SKFSAEEFIN-----E 206
           LG+G FG V K       GR     +AVKM++            S+F+  + +N     +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF----------GLEKPHEIAL--- 253
           L G CS+     L+ EY   GSL   +      G  +           L+ P E AL   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 254 -------GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306
                    ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +E+ +V
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEI 245

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 32/202 (15%)
Query: 169 LGQGGFGSVYKGQL-----HTGRLIAVKMME---------NSKFSAE-------EFINEL 207
           LG+G FG V   +      +TG  +AVK ++         + K   E       E I + 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 208 LGLCSE--GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            G+C+E  G    L+ E++P+GSL  ++   +NK     L++  + A+   +G++YL + 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 145
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPELIS 324
             V   H D+   N+L++     K+ DFGL K    + +  ++ D R + + + APE + 
Sbjct: 146 QYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 325 RNFGTVSCKSDVYGFGMVLLEM 346
           ++   ++  SDV+ FG+ L E+
Sbjct: 203 QSKFYIA--SDVWSFGVTLHEL 222

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 112/261 (42%), Gaps = 51/261 (19%)
Query: 133 IVFLVFLIHKYRTTMQTVDNILL----PEIIAVTNHF--------------THKLGQGGF 174
           +V ++++ H+ R   +  + +L     PE  +  + +              + +LGQG F
Sbjct: 1   LVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSF 60
Query: 175 GSVYKG------QLHTGRLIAVKMMENSKFSAE--EFINE--------------LLGLCS 212
           G VY+G      +      +A+K +  +    E  EF+NE              LLG+ S
Sbjct: 61  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 120
Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTF------GLEKPHEIALGTARGIEYLHNGC 266
           +G    ++ E M  G L  ++ S   + +         L K  ++A   A G+ YL+   
Sbjct: 121 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN- 179
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
               +H D+   N ++  +F  K+ DFG+ +   + + +         + +++PE  S  
Sbjct: 180 --KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE--SLK 235
Query: 327 FGTVSCKSDVYGFGMVLLEMA 347
            G  +  SDV+ FG+VL E+A
Sbjct: 236 DGVFTTYSDVWSFGVVLWEIA 256

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 31/199 (15%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE--------------------FINEL 207
           +LG G FG+V KG     +++    ++  K  A +                    +I  +
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           +G+C E     LV E    G L++++    +      +E  H++++G    ++YL    +
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 145
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELISRN 326
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 203
Query: 327 FGTVSCKSDVYGFGMVLLE 345
           +   S KSDV+ FG+++ E
Sbjct: 204 YYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 31/199 (15%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE--------------------FINEL 207
           +LG G FG+V KG     +++    ++  K  A +                    +I  +
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           +G+C E     LV E    G L++++    +      +E  H++++G    ++YL    +
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 145
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELISRN 326
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 203
Query: 327 FGTVSCKSDVYGFGMVLLE 345
           +   S KSDV+ FG+++ E
Sbjct: 204 YYKFSSKSDVWSFGVLMWE 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 203 FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           +I  ++G+C E     LV E    G L++++    +      +E  H++++G    ++YL
Sbjct: 79  YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYL 133
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPE 321
               +   +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE
Sbjct: 134 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 322 LISRNFGTVSCKSDVYGFGMVLLE 345
            I  N+   S KSDV+ FG+++ E
Sbjct: 191 CI--NYYKFSSKSDVWSFGVLMWE 212

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 203 FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           +I  ++G+C E     LV E    G L++++    +      +E  H++++G    ++YL
Sbjct: 67  YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYL 121
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPE 321
               +   +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE
Sbjct: 122 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 322 LISRNFGTVSCKSDVYGFGMVLLE 345
            I  N+   S KSDV+ FG+++ E
Sbjct: 179 CI--NYYKFSSKSDVWSFGVLMWE 200

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 203 FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           +I  ++G+C E     LV E    G L++++    +      +E  H++++G    ++YL
Sbjct: 69  YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYL 123
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPE 321
               +   +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE
Sbjct: 124 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 322 LISRNFGTVSCKSDVYGFGMVLLE 345
            I  N+   S KSDV+ FG+++ E
Sbjct: 181 CI--NYYKFSSKSDVWSFGVLMWE 202

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 34/202 (16%)
Query: 169 LGQGGFGSVY-----KGQLHTGRLIAVKMME-------NSKFSAE---------EFINEL 207
           LG+G FG V           TG ++AVK ++        S +  E         E I + 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 208 LGLCSEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            G C +  +++L  V EY+P GSL  ++        + GL +    A     G+ YLH+ 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SDTRGTIGYLAPELIS 324
                +H ++   N+LLD++ + K+ DFGLAK  P+ +++  +  D    + + APE + 
Sbjct: 137 H---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 325 RNFGTVSCKSDVYGFGMVLLEM 346
                    SDV+ FG+ L E+
Sbjct: 194 EY--KFYYASDVWSFGVTLYEL 213

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 44/220 (20%)
Query: 165 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAEE---------------- 202
           F   LG G FG V +   +          +AVKM++ S    E                 
Sbjct: 43  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 102
Query: 203 -FINELLGLCSEGFKRALVYEYMPNGSL--------DRHIFSKENKG------QTFGLEK 247
             I  LLG C+ G    ++ EY   G L        D  I SK +            LE 
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 248 PHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307
               +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++V 
Sbjct: 163 LLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 219
Query: 308 ISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEM 346
             + R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 220 KGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 256

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 37/210 (17%)
Query: 168 KLGQGGFGSVYKGQLHT------GRLIAVKMMENSKFSAE---------------EFINE 206
           +LG+G FG V+  + +         L+AVK ++++  +A                E I +
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRH---------IFSKENKGQTFGLEKPHEIALGTAR 257
             G+C EG    +V+EYM +G L++          + ++ N        +   IA   A 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
           G+ YL        +H D+   N L+  N + K+ DFG+++     + +     T   I +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 318 LAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           + PE ++ R F T   +SDV+  G+VL E+
Sbjct: 197 MPPESIMYRKFTT---ESDVWSLGVVLWEI 223

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 36/232 (15%)
Query: 147 MQTVDNILLPEIIAVTNH---FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSK 197
           M +  ++ +P+   V       + +LGQG FG VY+G      +      +A+K +  + 
Sbjct: 1   MVSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 60
Query: 198 FSAE--EFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQ 241
              E  EF+NE              LLG+ S+G    ++ E M  G L  ++ S   + +
Sbjct: 61  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 242 TF------GLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295
                    L K  ++A   A G+ YL+       +H D+   N ++  +F  K+ DFG+
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
            +   + + +         + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 37/209 (17%)
Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMM----ENSKFSAEEFIN-------ELLGLCSEGF-- 215
           +G+G +G V++G    G  +AVK+     E S F   E  N        +LG  +     
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 103
Query: 216 -----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-----NG 265
                +  L+  Y   GSL  ++     +  T        I L  A G+ +LH       
Sbjct: 104 RHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--GTIGYLAPELI 323
               I H D+K  NIL+  N    ++D GLA  H +  + + + +    GT  Y+APE++
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 324 SRNFGTVSC-----KSDVYGFGMVLLEMA 347
                 V C     + D++ FG+VL E+A
Sbjct: 219 DETI-QVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 203 FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           +I  ++G+C E     LV E    G L++++    +      +E  H++++G    ++YL
Sbjct: 73  YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYL 127
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPE 321
               +   +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE
Sbjct: 128 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 322 LISRNFGTVSCKSDVYGFGMVLLE 345
            I  N+   S KSDV+ FG+++ E
Sbjct: 185 CI--NYYKFSSKSDVWSFGVLMWE 206

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 35/203 (17%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMME-NSKFSAEEFINEL--LGLCSEGF-------- 215
           +LG G FG VYK +   TG L A K++E  S+   E++I E+  L  C   +        
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 216 ----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
               K  ++ E+ P G++D  +   +      GL +P +I +   + +E L+      I+
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEP-QIQVVCRQMLEALNFLHSKRII 139
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELI---S 324
           H D+K  N+L+      +++DFG++    K   K + F+      GT  ++APE++   +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCET 193
Query: 325 RNFGTVSCKSDVYGFGMVLLEMA 347
                   K+D++  G+ L+EMA
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMA 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 35/203 (17%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMME-NSKFSAEEFINEL--LGLCSEGF-------- 215
           +LG G FG VYK +   TG L A K++E  S+   E++I E+  L  C   +        
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 216 ----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
               K  ++ E+ P G++D  +   +      GL +P +I +   + +E L+      I+
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEP-QIQVVCRQMLEALNFLHSKRII 131
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELI---S 324
           H D+K  N+L+      +++DFG++    K   K + F+      GT  ++APE++   +
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCET 185
Query: 325 RNFGTVSCKSDVYGFGMVLLEMA 347
                   K+D++  G+ L+EMA
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMA 208

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K+++     A++ +      N +L      F  AL Y
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 222 EYMPNGSLDRHIFSKE--NKGQTF-GLEKPHEIALGTAR--------GIEYLHNGCDVCI 270
            +  +   DR  F  E  N G+ F  L +    +   AR         ++YLH+  +V  
Sbjct: 216 SFQTH---DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV-- 270
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FGT 329
           ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  YLAPE++  N +G 
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGR 328
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
                D +G G+V+ EM  GR
Sbjct: 329 A---VDWWGLGVVMYEMMCGR 346

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 59/297 (19%)
Query: 169 LGQGGFGSVYKGQLH--------TGRLIAVKMME-------NSKFSAE---------EFI 204
           LG+G FG V    L+        TG ++AVK ++        S +  E         E I
Sbjct: 17  LGEGHFGKV---SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 205 NELLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
            +  G C +  +++  LV EY+P GSL  ++          GL +    A     G+ YL
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYL 128
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SDTRGTIGYLAPE 321
           H       +H  +   N+LLD++ + K+ DFGLAK  P+ +++  +  D    + + APE
Sbjct: 129 HAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 185
Query: 322 LISRNFGTVSCK----SDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377
            +        CK    SDV+ FG+ L E+      +  ++ +S    F   +     +  
Sbjct: 186 CLK------ECKFYYASDVWSFGVTLYELL-----TYCDSNQSPHTKFTELIGHTQGQMT 234
Query: 378 DLELRNVTEIESMIAR-KLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSIDDLQ 428
            L L  + E    + R   C   ++     C + +A+ RP+   ++ +L+ + +  Q
Sbjct: 235 VLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ 291

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 36/232 (15%)
Query: 147 MQTVDNILLPEIIAVTNH---FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSK 197
           M +  ++ +P+   V       + +LGQG FG VY+G      +      +A+K +  + 
Sbjct: 1   MVSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 60
Query: 198 FSAE--EFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQ 241
              E  EF+NE              LLG+ S+G    ++ E M  G L  ++ S   + +
Sbjct: 61  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 242 TF------GLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295
                    L K  ++A   A G+ YL+       +H D+   N ++  +F  K+ DFG+
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
            +   + + +         + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 203 FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           +I  ++G+C E     LV E    G L++++    +      +E  H++++G    ++YL
Sbjct: 87  YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYL 141
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPE 321
               +   +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE
Sbjct: 142 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 198
Query: 322 LISRNFGTVSCKSDVYGFGMVLLE 345
            I  N+   S KSDV+ FG+++ E
Sbjct: 199 CI--NYYKFSSKSDVWSFGVLMWE 220

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 41/207 (19%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENS------------------KFSAEEFIN--E 206
           ++G G +G+VYK +  H+G  +A+K +                     +  A E  N   
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 207 LLGLCSEG-----FKRALVYEYMPNGSLDRHIFSKENKGQTFGL--EKPHEIALGTARGI 259
           L+ +C+        K  LV+E+     +D+ + +  +K    GL  E   ++     RG+
Sbjct: 71  LMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   +++     T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALFPVVVTLWYRA 179
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEM 346
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 44/220 (20%)
Query: 165 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAEE---------------- 202
           F   LG G FG V +   +          +AVKM++ S    E                 
Sbjct: 45  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 104
Query: 203 -FINELLGLCSEGFKRALVYEYMPNGSL--------DRHIFSKENKG------QTFGLEK 247
             I  LLG C+ G    ++ EY   G L        D  I SK +            LE 
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 248 PHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307
               +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++V 
Sbjct: 165 LLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 221
Query: 308 ISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEM 346
             + R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 222 KGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 258

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K+++     A++ +      N +L      F  AL Y
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 222 EYMPNGSLDRHIFSKE--NKGQTF-GLEKPHEIALGTAR--------GIEYLHNGCDVCI 270
            +  +   DR  F  E  N G+ F  L +    +   AR         ++YLH+  +V  
Sbjct: 219 SFQTH---DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV-- 273
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FGT 329
           ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  YLAPE++  N +G 
Sbjct: 274 VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGR 331
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
                D +G G+V+ EM  GR
Sbjct: 332 A---VDWWGLGVVMYEMMCGR 349

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 47/225 (20%)
Query: 164 HFTHKLGQGGFGSVYKGQ------LHTGRLIAVKMME-------NSKFSAE-----EFIN 205
            +   +G+G FG V++ +           ++AVKM++        + F  E     EF N
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 206 ----ELLGLCSEGFKRALVYEYMPNGSLDRHI----------FSKENKGQTFGLEKPHE- 250
               +LLG+C+ G    L++EYM  G L+  +           S  +      +  P   
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 251 ---------IALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301
                    IA   A G+ YL    +   +H D+   N L+  N + K++DFGL++    
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            + + +  +    I ++ PE I  N  T   +SDV+ +G+VL E+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTT--ESDVWAYGVVLWEI 269

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 59/297 (19%)
Query: 169 LGQGGFGSVYKGQLH--------TGRLIAVKMME-------NSKFSAE---------EFI 204
           LG+G FG V    L+        TG ++AVK ++        S +  E         E I
Sbjct: 16  LGEGHFGKV---SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 205 NELLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
            +  G C +  +++  LV EY+P GSL  ++          GL +    A     G+ YL
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYL 127
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SDTRGTIGYLAPE 321
           H       +H  +   N+LLD++ + K+ DFGLAK  P+ +++  +  D    + + APE
Sbjct: 128 HAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 184
Query: 322 LISRNFGTVSCK----SDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377
            +        CK    SDV+ FG+ L E+      +  ++ +S    F   +     +  
Sbjct: 185 CLK------ECKFYYASDVWSFGVTLYELL-----TYCDSNQSPHTKFTELIGHTQGQMT 233
Query: 378 DLELRNVTEIESMIAR-KLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSIDDLQ 428
            L L  + E    + R   C   ++     C + +A+ RP+   ++ +L+ + +  Q
Sbjct: 234 VLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ 290

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 33/207 (15%)
Query: 169 LGQGGFGSVYKGQLH----TGRLIAVKMME---NSKFSAEEFINE--------------L 207
           LG+G FGSV +G L     T   +AVK M+   +S+   EEF++E              L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 208 LGLC----SEGFKRALV-YEYMPNGSLDRHI-FSKENKG-QTFGLEKPHEIALGTARGIE 260
           LG+C    S+G  + +V   +M  G L  ++ +S+   G +   L+   +  +  A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           YL N      LH D+   N +L  +    V+DFGL+K     + +      +  + ++A 
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMA 347
           E ++    T   KSDV+ FG+ + E+A
Sbjct: 219 ESLADRVYT--SKSDVWAFGVTMWEIA 243

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 44/283 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKR----------- 217
           +G+G FG V K +    + +A+K +E S+   + FI EL  L                  
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACLNP 74
Query: 218 -ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
             LV EY   GSL  ++         +         L  ++G+ YLH+     ++H D+K
Sbjct: 75  VCLVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 133
Query: 277 PHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD 335
           P N+LL     + K+ DFG A      +    +++ +G+  ++APE+   +    S K D
Sbjct: 134 PPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS--NYSEKCD 186
Query: 336 VYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE-IESMIARK 394
           V+ +G++L E+   R+  +        A+   W     N      ++N+ + IES++ R 
Sbjct: 187 VFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVH--NGTRPPLIKNLPKPIESLMTR- 240
Query: 395 LCMIGLWCIQVKAADRPSMTKVLEML-------EGSIDDLQMP 430
                  C     + RPSM ++++++        G+ + LQ P
Sbjct: 241 -------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 276

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 44/220 (20%)
Query: 165 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAEEF--------------- 203
           F   LG G FG V +   +          +AVKM++ S    E                 
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 204 --INELLGLCSEGFKRALVYEYMPNGSL--------DRHIFSKENKG------QTFGLEK 247
             I  LLG C+ G    ++ EY   G L        D  I SK +            LE 
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 248 PHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307
               +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++V 
Sbjct: 170 LLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 226
Query: 308 ISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEM 346
             + R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 227 KGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 263

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 44/220 (20%)
Query: 165 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAEE---------------- 202
           F   LG G FG V +   +          +AVKM++ S    E                 
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 203 -FINELLGLCSEGFKRALVYEYMPNGSL--------DRHIFSKENKG------QTFGLEK 247
             I  LLG C+ G    ++ EY   G L        D  I SK +            LE 
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 248 PHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307
               +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++V 
Sbjct: 147 LLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 308 ISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEM 346
             + R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 204 KGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 240

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 44/283 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKR----------- 217
           +G+G FG V K +    + +A+K +E S+   + FI EL  L                  
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 218 -ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
             LV EY   GSL  ++         +         L  ++G+ YLH+     ++H D+K
Sbjct: 74  VCLVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 277 PHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD 335
           P N+LL     + K+ DFG A      +    +++ +G+  ++APE+   +    S K D
Sbjct: 133 PPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS--NYSEKCD 185
Query: 336 VYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE-IESMIARK 394
           V+ +G++L E+   R+  +        A+   W     N      ++N+ + IES++ R 
Sbjct: 186 VFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVH--NGTRPPLIKNLPKPIESLMTR- 239
Query: 395 LCMIGLWCIQVKAADRPSMTKVLEML-------EGSIDDLQMP 430
                  C     + RPSM ++++++        G+ + LQ P
Sbjct: 240 -------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 33  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 93  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 148
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 149 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 206 K---SACKSSDLWALGCIIYQLVAG 227

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 169 LGQGGFGSVY--------KGQLHTGRLIAVKMMENSKFSAE--EFINE------------ 206
           LG+G FG V         K +      +AVKM+++     +  + ++E            
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE---KPHE---------I 251
              LLG C++     ++  Y   G+L  ++ ++   G  +  +    P E          
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   ++ 
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 312 RGTIGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 165 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAE--EFINE---------- 206
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE          
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF------GLEKPHEIALGTA 256
               LLG+ S+G    ++ E M  G L  ++ S   + +         L K  ++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 206 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 11  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 70
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 71  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 126
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 127 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 184 K---SACKSSDLWALGCIIYQLVAG 205

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 165 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAE--EFINE---------- 206
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE          
Sbjct: 14  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF------GLEKPHEIALGTA 256
               LLG+ S+G    ++ E M  G L  ++ S   + +         L K  ++A   A
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + +           + 
Sbjct: 134 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 191 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 219

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 165 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAE--EFINE---------- 206
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE          
Sbjct: 20  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 79
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF------GLEKPHEIALGTA 256
               LLG+ S+G    ++ E M  G L  ++ S   + +         L K  ++A   A
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 140 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 197 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 225

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 49/226 (21%)
Query: 164 HFTHKLGQGGFGSVYK------GQLHTGRLIAVKMMENSKFSAE---------------- 201
            F   LG G FG V +      G+      +AVKM++++  + E                
Sbjct: 34  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 93
Query: 202 -EFINELLGLCSEGFKRALVYEYMPNGSL--------------------DRHIFSKENKG 240
            E I  LLG C+ G    ++ EY   G L                    D     KE+ G
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED-G 152
Query: 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
           +   L      +   A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+   
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
            +++++   + R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 253

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 100/226 (44%), Gaps = 38/226 (16%)
Query: 147 MQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKG----QLHTGRLIAVKMMEN--SKFSA 200
           +  V ++L+P    VT H    +G+G FG VY G    Q       A+K +         
Sbjct: 8   LAEVKDVLIPHERVVT-HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV 66
Query: 201 EEFINE--------------LLG--LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFG 244
           E F+ E              L+G  L  EG    L+  YM +G L + I S +       
Sbjct: 67  EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKD 125
Query: 245 LEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304
           L       L  ARG+EYL    +   +H D+   N +LD +F  KV+DFGLA+    + +
Sbjct: 126 LIS---FGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR-DILDRE 178
Query: 305 FVSISDTRGT---IGYLAPE-LISRNFGTVSCKSDVYGFGMVLLEM 346
           + S+   R     + + A E L +  F T   KSDV+ FG++L E+
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYRFTT---KSDVWSFGVLLWEL 221

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 34/202 (16%)
Query: 169 LGQGGFGSVY-----KGQLHTGRLIAVKMME-------NSKFSAE---------EFINEL 207
           LG+G FG V           TG ++AVK ++        S +  E         E I + 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 208 LGLCSEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            G C +  +++L  V EY+P GSL  ++        + GL +    A     G+ YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SDTRGTIGYLAPELIS 324
                +H ++   N+LLD++ + K+ DFGLAK  P+ +++  +  D    + + APE + 
Sbjct: 137 H---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 325 RNFGTVSCKSDVYGFGMVLLEM 346
                    SDV+ FG+ L E+
Sbjct: 194 EY--KFYYASDVWSFGVTLYEL 213

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V   D R  
Sbjct: 207 VAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 264 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 293

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 18  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 77
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 78  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 133
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 134 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 191 K---SACKSSDLWALGCIIYQLVAG 212

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 14  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 73
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 74  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 129
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 130 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 187 K---SACKSSDLWALGCIIYQLVAG 208

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V   D R  
Sbjct: 202 VAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 259 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 288

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELL 208
           P +      +   LG+G FG V    +  TGR  A+K+++     A++ +      N +L
Sbjct: 5   PRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 64
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKE--NKGQTF-GLEKPHEIALGTAR-------- 257
                 F  AL Y +  +   DR  F  E  N G+ F  L +    +   AR        
Sbjct: 65  QNSRHPFLTALKYSFQTH---DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 121
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
            ++YLH+  +V  ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y
Sbjct: 122 ALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEY 177
Query: 318 LAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 350
           LAPE++  N +G      D +G G+V+ EM  GR
Sbjct: 178 LAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 208

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V   D R  
Sbjct: 200 VAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 257 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 286

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 47/220 (21%)
Query: 169 LGQGGFGSVYKGQLH--TGRL----IAVKMMEN-----------SKFSAEEFIN-----E 206
           LG+G FG V K       GR     +AVKM++            S+F+  + +N     +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF----------GLEKPHEIAL--- 253
           L G CS+     L+ EY   GSL   +      G  +           L+ P E AL   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 254 -------GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306
                    ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +E+  V
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEI 245

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 127
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 128 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 185 K---SACKSSDLWALGCIIYQLVAG 206

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 165 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAE--EFINE---------- 206
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE          
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF------GLEKPHEIALGTA 256
               LLG+ S+G    ++ E M  G L  ++ S   + +         L K  ++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 200 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V   D R  
Sbjct: 209 VAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 266 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 295

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 33  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 93  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 148
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 149 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 206 K---SACKSSDLWALGCIIYQLVAG 227

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 43/210 (20%)
Query: 170 GQGGFGSVYKGQLHTGRLIAVK---MMENSKFSAEEFINELLGLCSEGF-------KRA- 218
            +G FG V+K QL     +AVK   + +   + +E  I    G+  E         KR  
Sbjct: 24  ARGRFGCVWKAQL-MNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 219 -------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC-- 269
                  L+  +   GSL  ++     KG      +   +A   +RG+ YLH     C  
Sbjct: 83  NLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 270 ------ILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIG---YLA 319
                 I H D K  N+LL  +    ++DFGLA +F P +       DT G +G   Y+A
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPP----GDTHGQVGTRRYMA 193
Query: 320 PELI--SRNFGTVS-CKSDVYGFGMVLLEM 346
           PE++  + NF   +  + D+Y  G+VL E+
Sbjct: 194 PEVLEGAINFQRDAFLRIDMYAMGLVLWEL 223

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
              + S  SD++  G ++ ++  G
Sbjct: 209 K--SASKSSDLWALGCIIYQLVAG 230

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 45  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 102
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 159
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 160 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 214
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 215 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 152
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 153 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 210 K---SACKSSDLWALGCIIYQLVAG 231

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 165 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAE--EFINE---------- 206
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE          
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF------GLEKPHEIALGTA 256
               LLG+ S+G    ++ E M  G L  ++ S   + +         L K  ++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 193 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 25  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 82
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 139
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 140 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 194
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 195 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K+++     A++ +      N +L      F  AL Y
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 222 EYMPNGSLDRHIFSKE--NKGQTF-GLEKPHEIALGTAR--------GIEYLHNGCDVCI 270
            +  +   DR  F  E  N G+ F  L +    +   AR         ++YLH+  +V  
Sbjct: 77  SFQTH---DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV-- 131
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FGT 329
           ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  YLAPE++  N +G 
Sbjct: 132 VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEYLAPEVLEDNDYGR 189
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
                D +G G+V+ EM  GR
Sbjct: 190 A---VDWWGLGVVMYEMMCGR 207

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 28/201 (13%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE-----------------FINELLG 209
           +LG+G +G V K + + +G++ AVK +  +  S E+                 F     G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 210 -LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            L  EG     +   + + SLD+      +KGQT   +   +IA+   + +E+LH+   +
Sbjct: 101 ALFREG--DVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KL 156
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR--N 326
            ++H D+KP N+L++     K  DFG++ +     D V+     G   Y APE I+   N
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGISGYL---VDDVAKDIDAGCKPYXAPERINPELN 213
Query: 327 FGTVSCKSDVYGFGMVLLEMA 347
               S KSD++  G+  +E+A
Sbjct: 214 QKGYSVKSDIWSLGITXIELA 234

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 165 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAE--EFINE---------- 206
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE          
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF------GLEKPHEIALGTA 256
               LLG+ S+G    ++ E M  G L  ++ S   + +         L K  ++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + +           + 
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 200 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 13  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 72
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 73  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 128
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 129 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 186 K---SACKSSDLWALGCIIYQLVAG 207

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 36  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 93
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 150
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 151 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 205
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 206 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 149
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 149
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K+++     A++ +      N +L      F  AL Y
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 222 EYMPNGSLDRHIFSKE--NKGQTF-GLEKPHEIALGTAR--------GIEYLHNGCDVCI 270
            +  +   DR  F  E  N G+ F  L +    +   AR         ++YLH+  +V  
Sbjct: 76  SFQTH---DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV-- 130
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FGT 329
           ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  YLAPE++  N +G 
Sbjct: 131 VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEYLAPEVLEDNDYGR 188
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
                D +G G+V+ EM  GR
Sbjct: 189 A---VDWWGLGVVMYEMMCGR 206

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 30  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 87
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 144
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 145 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 199
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 200 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 51  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 108
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 165
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 220
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 221 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 22  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 79
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+  +       K +   L  
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQL-- 136
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 137 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 191
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 192 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 74
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 131
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 186
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 187 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 51  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 108
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 165
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 220
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 221 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 29  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 86
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 143
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 198
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 199 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGS-VYKGQLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F + V   +L T R  A+K++E      E                   F  
Sbjct: 34  FGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 149
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 18  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 75
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 132
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 133 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 187
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 188 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 74
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 131
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 186
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 187 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 149
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 29  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 86
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 143
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 198
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 199 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 41  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 100
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 101 KLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 156
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 157 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 214 K---SACKSSDLWALGCIIYQLVAG 235

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 74
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 131
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 186
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 187 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 203 FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           +I  ++G+C E     LV E    G L++++    +      +E  H++++G    ++YL
Sbjct: 431 YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYL 485
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPE 321
               +   +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE
Sbjct: 486 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 322 LISRNFGTVSCKSDVYGFGMVLLE 345
            I  N+   S KSDV+ FG+++ E
Sbjct: 543 CI--NYYKFSSKSDVWSFGVLMWE 564

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 203 FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           +I  ++G+C E     LV E    G L++++    +      +E  H++++G    ++YL
Sbjct: 432 YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYL 486
Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPE 321
               +   +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE
Sbjct: 487 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 322 LISRNFGTVSCKSDVYGFGMVLLE 345
            I  N+   S KSDV+ FG+++ E
Sbjct: 544 CI--NYYKFSSKSDVWSFGVLMWE 565

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 53  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 110
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 167
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 168 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 222
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 223 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 39  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 98
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 99  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 154
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 155 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 212 K---SACKSSDLWALGCIIYQLVAG 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 152
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 153 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 210 K---SACKSSDLWALGCIIYQLVAG 231

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 21  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 78
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 135
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 136 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 190
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 191 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 55  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 112
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 169
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 170 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 224
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 225 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 326 NFGTVSCK-SDVYGFGMVLLEMAGG 349
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 47/220 (21%)
Query: 169 LGQGGFGSVYKGQLH--TGRL----IAVKMMEN-----------SKFSAEEFIN-----E 206
           LG+G FG V K       GR     +AVKM++            S+F+  + +N     +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF----------GLEKPHEIAL--- 253
           L G CS+     L+ EY   GSL   +      G  +           L+ P E AL   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 254 -------GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306
                    ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +E+  V
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEI 245

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K ++++ +F   E  I   L  C 
Sbjct: 96  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 153
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 210
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 211 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 265
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 266 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 165 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAE--EFINE---------- 206
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE          
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF------GLEKPHEIALGTA 256
               LLG+ S+G    ++ E M  G L  ++ S   + +         L K  ++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G+ YL+       +H D+   N  +  +F  K+ DFG+ +   + + +         + 
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 193 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELL 208
           P++      +   LG+G FG V    +  TGR  A+K++      A++ +      + +L
Sbjct: 5   PKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 209 GLCSEGFKRALVY------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
                 F  AL Y            EY   G L  H+    ++ + F  E+         
Sbjct: 65  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIV 120
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
             +EYLH+     +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  
Sbjct: 121 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPE 175
Query: 317 YLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 350
           YLAPE++  N +G      D +G G+V+ EM  GR
Sbjct: 176 YLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 207

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 32/202 (15%)
Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K++      A++ +      + +L      F  AL Y
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 222 ------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                       EY   G L  H+    ++ + F  E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FG 328
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  YLAPE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 32/202 (15%)
Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K++      A++ +      + +L      F  AL Y
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 222 ------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                       EY   G L  H+    ++ + F  E+           +EYLH+     
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 128
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FG 328
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  YLAPE++  N +G
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 186
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
                 D +G G+V+ EM  GR
Sbjct: 187 RA---VDWWGLGVVMYEMMCGR 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 32/202 (15%)
Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K++      A++ +      + +L      F  AL Y
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 222 ------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                       EY   G L  H+    ++ + F  E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FG 328
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  YLAPE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 32/202 (15%)
Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K++      A++ +      + +L      F  AL Y
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 222 ------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                       EY   G L  H+    ++ + F  E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FG 328
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  YLAPE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 32/202 (15%)
Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K++      A++ +      + +L      F  AL Y
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 222 ------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                       EY   G L  H+    ++ + F  E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FG 328
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  YLAPE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 165 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAE--EFINE---------- 206
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE          
Sbjct: 19  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF------GLEKPHEIALGTA 256
               LLG+ S+G    ++ E M  G L  ++ S               L K  ++A   A
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 139 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 196 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 224

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 165 FTHKLGQGGFGSVYKG------QLHTGRLIAVKMMENSKFSAE--EFINE---------- 206
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE          
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTF------GLEKPHEIALGTA 256
               LLG+ S+G    ++ E M  G L  ++ S               L K  ++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + + +         + 
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 206 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 30/198 (15%)
Query: 169 LGQGGFGSVYKGQL--HTGRLI--AVKMMEN-------SKFSAEEFINE---------LL 208
           LG+G FG VY+G    H G  I  AVK  +         KF +E  I +         L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+  E     ++ E  P G L  ++   +N  +   L      +L   + + YL +   +
Sbjct: 76  GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVL---YSLQICKAMAYLES---I 128
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 185
Query: 329 TVSCKSDVYGFGMVLLEM 346
             +  SDV+ F + + E+
Sbjct: 186 RFTTASDVWMFAVCMWEI 203

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 32/202 (15%)
Query: 169 LGQGGFGSV-YKGQLHTGRLIAVKMMENSKFSAEEFI------NELLGLCSEGFKRALVY 221
           LG+G FG V    +  TGR  A+K++      A++ +      + +L      F  AL Y
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 222 ------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                       EY   G L  H+    ++ + F  E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN-FG 328
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  YLAPE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 34/202 (16%)
Query: 169 LGQGGFGSVY-----KGQLHTGRLIAVKMME-------NSKFSAE---------EFINEL 207
           LG+G FG V           TG ++AVK ++        S +  E         E I + 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 208 LGLCSEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            G C +    +L  V EY+P GSL  ++        + GL +    A     G+ YLH  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SDTRGTIGYLAPELIS 324
                +H D+   N+LLD++ + K+ DFGLAK  P+ ++   +  D    + + APE + 
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 325 RNFGTVSCKSDVYGFGMVLLEM 346
                    SDV+ FG+ L E+
Sbjct: 211 EY--KFYYASDVWSFGVTLYEL 230

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 30/198 (15%)
Query: 169 LGQGGFGSVYKGQL--HTGRLI--AVKMMEN-------SKFSAEEFINE---------LL 208
           LG+G FG VY+G    H G  I  AVK  +         KF +E  I +         L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+  E     ++ E  P G L  ++   +N  +   L      +L   + + YL +   +
Sbjct: 92  GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVL---YSLQICKAMAYLES---I 144
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 201
Query: 329 TVSCKSDVYGFGMVLLEM 346
             +  SDV+ F + + E+
Sbjct: 202 RFTTASDVWMFAVCMWEI 219

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 40/216 (18%)
Query: 151 DNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL---IAVKMMEN--SKFSAEEFIN 205
           DN+L+ +I         +LG G FGSV +G     +    +A+K+++    K   EE + 
Sbjct: 335 DNLLIADI---------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385
Query: 206 E--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGL-EKPHE 250
           E              L+G+C +     LV E    G L + +  K  +     + E  H+
Sbjct: 386 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444
Query: 251 IALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSIS 309
           +++G    ++YL    +   +H ++   N+LL +    K+SDFGL+K     ++ + + S
Sbjct: 445 VSMG----MKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497
Query: 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLE 345
             +  + + APE I  NF   S +SDV+ +G+ + E
Sbjct: 498 AGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWE 531

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 28/204 (13%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE------------------FIN 205
           F   LG+G F +V    +L T R  A+K++E      E                   F  
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
           +L     +  K      Y  NG L ++I    +  +T       EI       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
                S  SD++  G ++ ++  G
Sbjct: 209 KSAXKS--SDLWALGCIIYQLVAG 230

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 30/198 (15%)
Query: 169 LGQGGFGSVYKGQL--HTGRLI--AVKMMEN-------SKFSAEEFINE---------LL 208
           LG+G FG VY+G    H G  I  AVK  +         KF +E  I +         L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+  E     ++ E  P G L  ++   +N  +   L      +L   + + YL +   +
Sbjct: 80  GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVL---YSLQICKAMAYLES---I 132
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 189
Query: 329 TVSCKSDVYGFGMVLLEM 346
             +  SDV+ F + + E+
Sbjct: 190 RFTTASDVWMFAVCMWEI 207

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 40/204 (19%)
Query: 168 KLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFSAEEFI-NELLGLCSE------------ 213
           K+G+G  G V    + + G+L+AVK M+  K    E + NE++ +               
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 214 --GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V E++  G+L D    ++ N+ Q         + L   + +  LH      +
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG---V 146
Query: 271 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISR- 325
           +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR 
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRL 200
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +G    + D++  G++++EM  G
Sbjct: 201 PYGP---EVDIWSLGIMVIEMVDG 221

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 29/201 (14%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINE----LLGLCSEGFKRALVY 221
            K+G+G FG V+KG    T +++A+K+++  +   E    +    +L  C   +      
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 222 EYMPNGSLDRHIFSKENKGQTFGLEKP---HEIALGTA-----RGIEYLHNGCDVCILHF 273
            Y+ +  L   I      G    L +P    E  + T      +G++YLH+   +   H 
Sbjct: 73  SYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI---HR 128
Query: 274 DIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+I ++   
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIKQS--A 180
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K+D++  G+  +E+A G 
Sbjct: 181 YDSKADIWSLGITAIELARGE 201

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 29/201 (14%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINE----LLGLCSEGFKRALVY 221
            K+G+G FG V+KG    T +++A+K+++  +   E    +    +L  C   +      
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 222 EYMPNGSLDRHIFSKENKGQTFGLEKP---HEIALGTA-----RGIEYLHNGCDVCILHF 273
            Y+ +  L   I      G    L +P    E  + T      +G++YLH+   +   H 
Sbjct: 93  SYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI---HR 148
Query: 274 DIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+I ++   
Sbjct: 149 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIKQS--A 200
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K+D++  G+  +E+A G 
Sbjct: 201 YDSKADIWSLGITAIELARGE 221

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 40/204 (19%)
Query: 168 KLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFSAEEFI-NELLGLCSE------------ 213
           K+G+G  G V    + + G+L+AVK M+  K    E + NE++ +               
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 214 --GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V E++  G+L D    ++ N+ Q         + L   + +  LH      +
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG---V 137
Query: 271 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISR- 325
           +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR 
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRL 191
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +G    + D++  G++++EM  G
Sbjct: 192 PYGP---EVDIWSLGIMVIEMVDG 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 29/201 (14%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINE----LLGLCSEGFKRALVY 221
            K+G+G FG V+KG    T +++A+K+++  +   E    +    +L  C   +      
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 222 EYMPNGSLDRHIFSKENKGQTFGLEKP---HEIALGTA-----RGIEYLHNGCDVCILHF 273
            Y+ +  L   I      G    L +P    E  + T      +G++YLH+   +   H 
Sbjct: 73  SYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI---HR 128
Query: 274 DIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+I ++   
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEVIKQS--A 180
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K+D++  G+  +E+A G 
Sbjct: 181 YDSKADIWSLGITAIELARGE 201

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 40/204 (19%)
Query: 168 KLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFSAEEFI-NELLGLCSE------------ 213
           K+G+G  G V    + + G+L+AVK M+  K    E + NE++ +               
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 214 --GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V E++  G+L D    ++ N+ Q         + L   + +  LH      +
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG---V 148
Query: 271 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISR- 325
           +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR 
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRL 202
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +G    + D++  G++++EM  G
Sbjct: 203 PYGP---EVDIWSLGIMVIEMVDG 223

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 29/201 (14%)
Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINE----LLGLCSEGFKRALVY 221
            K+G+G FG V+KG    T +++A+K+++  +   E    +    +L  C   +      
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 222 EYMPNGSLDRHIFSKENKGQTFGLEKP---HEIALGTA-----RGIEYLHNGCDVCILHF 273
            Y+ +  L   I      G    L +P    E  + T      +G++YLH+   +   H 
Sbjct: 88  SYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI---HR 143
Query: 274 DIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+I ++   
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEVIKQS--A 195
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K+D++  G+  +E+A G 
Sbjct: 196 YDSKADIWSLGITAIELARGE 216

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLI--AVKMMENSKFSAEE----FINELLGLCSEGFKR-- 217
           KLG G FG V +G+    +G+ +  AVK ++    S  E    FI E+  + S   +   
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 218 -----------ALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
                       +V E  P GSL DR    ++++G  F L      A+  A G+ YL + 
Sbjct: 79  RLYGVVLTPPMKMVTELAPLGSLLDR---LRKHQGH-FLLGTLSRYAVQVAEGMGYLESK 134
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPE-LI 323
                +H D+   N+LL    + K+ DFGL +  P+ +D   + + R     + APE L 
Sbjct: 135 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
           +R F   S  SD + FG+ L EM
Sbjct: 192 TRTF---SHASDTWMFGVTLWEM 211

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 40/204 (19%)
Query: 168 KLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFSAEEFI-NELLGLCSE------------ 213
           K+G+G  G V    + + G+L+AVK M+  K    E + NE++ +               
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 214 --GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V E++  G+L D    ++ N+ Q         + L   + +  LH      +
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG---V 141
Query: 271 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISR- 325
           +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR 
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRL 195
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +G    + D++  G++++EM  G
Sbjct: 196 PYGP---EVDIWSLGIMVIEMVDG 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKP 277
           ++  E+M  GSLD+ +     + +    E   ++++   RG+ YL       I+H D+KP
Sbjct: 90  SICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKP 143
Query: 278 HNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGT-VSCKS 334
            NIL++     K+ DFG++        N FV      GT  Y+APE   R  GT  S +S
Sbjct: 144 SNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMAPE---RLQGTHYSVQS 194
Query: 335 DVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 371
           D++  G+ L+E+A GR        +  +A F   V D
Sbjct: 195 DIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVD 231

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           LV E +  G L    F +  K + F   +   I       + ++H   DV ++H D+KP 
Sbjct: 83  LVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPE 135
Query: 279 NILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD 335
           N+L    + N   K+ DFG A+  P +N    +     T+ Y APEL+++N    SC  D
Sbjct: 136 NLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESC--D 191
Query: 336 VYGFGMVLLEMAGGR 350
           ++  G++L  M  G+
Sbjct: 192 LWSLGVILYTMLSGQ 206

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +++   F   E  I   L  C 
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCN 74
Query: 212 ---------SEGFKRALVY-----EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR 257
                    S G K+  VY     +Y+P  ++ R         QT  +           R
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R    
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---Y 187
Query: 317 YLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
           Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 188 YRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +++   F   E  I   L  C 
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCN 74
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 131
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 186
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 187 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF-INELLGLC- 211
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +++   F   E  I   L  C 
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCN 74
Query: 212 ---------SEGFKRALVY-----EYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                    S G K+  VY     +Y+P     + RH +S+    QT  +          
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK--QTLPVIYVKLYMYQL 131
Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R  
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 186
Query: 315 IGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
             Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 187 -YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 39/207 (18%)
Query: 166 THKLGQGGFGSVYK-GQLHTGRLIAVKMMENSKFS-AEEFINEL----------LGLCSE 213
           T  LG G FG V+K  +  TG  +A K+++       EE  NE+          L    +
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 214 GFKR----ALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIAL--GTARGIEYLHNGC 266
            F+      LV EY+  G L DR I       +++ L +   I        GI ++H   
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII------DESYNLTELDTILFMKQICEGIRHMHQ-- 205
Query: 267 DVCILHFDIKPHNILL---DHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPEL 322
            + ILH D+KP NIL    D   I K+ DFGLA ++ P+E   V+     GT  +LAPE+
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF----GTPEFLAPEV 259
Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           ++ +F  VS  +D++  G++   +  G
Sbjct: 260 VNYDF--VSFPTDMWSVGVIAYMLLSG 284

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLI--AVKMMENSKFSAEE----FINELLGLCSEGFKR-- 217
           KLG G FG V +G+    +G+ +  AVK ++    S  E    FI E+  + S   +   
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 218 -----------ALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
                       +V E  P GSL DR    ++++G  F L      A+  A G+ YL + 
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDR---LRKHQGH-FLLGTLSRYAVQVAEGMGYLESK 130
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPE-LI 323
                +H D+   N+LL    + K+ DFGL +  P+ +D   + + R     + APE L 
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
           +R F   S  SD + FG+ L EM
Sbjct: 188 TRTF---SHASDTWMFGVTLWEM 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLI--AVKMMENSKFSAEE----FINELLGLCSEGFKR-- 217
           KLG G FG V +G+    +G+ +  AVK ++    S  E    FI E+  + S   +   
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 218 -----------ALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
                       +V E  P GSL DR    ++++G  F L      A+  A G+ YL + 
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDR---LRKHQGH-FLLGTLSRYAVQVAEGMGYLESK 130
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPE-LI 323
                +H D+   N+LL    + K+ DFGL +  P+ +D   + + R     + APE L 
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
           +R F   S  SD + FG+ L EM
Sbjct: 188 TRTF---SHASDTWMFGVTLWEM 207

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           +G G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EYMP G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     KV+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 41/204 (20%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           +G G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGC 266
                    +V EYMP G +  H+       +  G   +PH    A       EYLH+  
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS-- 159
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SR 325
            + +++ D+KP N+L+D     KV+DFG AK        +      GT  YLAPE+I S+
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +       D +  G+++ EMA G
Sbjct: 214 GYNKA---VDWWALGVLIYEMAAG 234

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 73/138 (52%), Gaps = 22/138 (15%)
Query: 218 ALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           ++  E+M  GSLD+ +  K  +   Q  G     ++++   +G+ YL       I+H D+
Sbjct: 83  SICMEHMDGGSLDQ-VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDV 134
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKE--NDFVSISDTRGTIGYLAPELISRNFGT-VSC 332
           KP NIL++     K+ DFG++     E  N+FV      GT  Y++PE   R  GT  S 
Sbjct: 135 KPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV------GTRSYMSPE---RLQGTHYSV 185
Query: 333 KSDVYGFGMVLLEMAGGR 350
           +SD++  G+ L+EMA GR
Sbjct: 186 QSDIWSMGLSLVEMAVGR 203

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 40/204 (19%)
Query: 168 KLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFSAEEFI-NELLGLCSE------------ 213
           K+G+G  G V    + + G+L+AVK M+  K    E + NE++ +               
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 214 --GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V E++  G+L D    ++ N+ Q         + L   + +  LH      +
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG---V 268
Query: 271 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISR- 325
           +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR 
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRL 322
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +G    + D++  G++++EM  G
Sbjct: 323 PYGP---EVDIWSLGIMVIEMVDG 343

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLI--AVKMMENSKFSAEE----FINELLGLCSEGFKR-- 217
           KLG G FG V +G+    +G+ +  AVK ++    S  E    FI E+  + S   +   
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 218 -----------ALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
                       +V E  P GSL DR    ++++G  F L      A+  A G+ YL + 
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDR---LRKHQGH-FLLGTLSRYAVQVAEGMGYLESK 130
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPE-LI 323
                +H D+   N+LL    + K+ DFGL +  P+ +D   + + R     + APE L 
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
           +R F   S  SD + FG+ L EM
Sbjct: 188 TRTF---SHASDTWMFGVTLWEM 207

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 22/138 (15%)
Query: 218 ALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           ++  E+M  GSLD+ +  K  +   Q  G     ++++   +G+ YL       I+H D+
Sbjct: 99  SICMEHMDGGSLDQ-VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDV 150
Query: 276 KPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGT-VSC 332
           KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  GT  S 
Sbjct: 151 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQGTHYSV 201
Query: 333 KSDVYGFGMVLLEMAGGR 350
           +SD++  G+ L+EMA GR
Sbjct: 202 QSDIWSMGLSLVEMAVGR 219

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 47/271 (17%)
Query: 169 LGQGGFGSVYKG----QLHTGRL-IAVKMME-------NSKFSAEEFIN---------EL 207
           LG G FG+VYKG    +  T ++ +A+K++        N +F  E  I           L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + LV + MP+G L  ++   K+N G    L    +IA    +G+ YL    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIA----KGMMYLE--- 134
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           +  ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  +
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--H 192
Query: 327 FGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
           +   + +SDV+ +G+ + E M  G +  +   TR         + D L KG  L    + 
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLPQPPIC 244
Query: 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKV 416
            I+      + M+ + C  + A  RP   ++
Sbjct: 245 TID------VYMVMVKCWMIDADSRPKFKEL 269

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLI--AVKMMENSKFSAEE----FINELLGLCSEGFKR-- 217
           KLG G FG V +G+    +G+ +  AVK ++    S  E    FI E+  + S   +   
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 218 -----------ALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
                       +V E  P GSL DR    ++++G  F L      A+  A G+ YL + 
Sbjct: 79  RLYGVVLTPPMKMVTELAPLGSLLDR---LRKHQGH-FLLGTLSRYAVQVAEGMGYLESK 134
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPE-LI 323
                +H D+   N+LL    + K+ DFGL +  P+ +D   + + R     + APE L 
Sbjct: 135 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
           +R F   S  SD + FG+ L EM
Sbjct: 192 TRTF---SHASDTWMFGVTLWEM 211

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 47/271 (17%)
Query: 169 LGQGGFGSVYKG----QLHTGRL-IAVKMME-------NSKFSAEEFIN---------EL 207
           LG G FG+VYKG    +  T ++ +A+K++        N +F  E  I           L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + LV + MP+G L  ++   K+N G    L    +IA    +G+ YL    
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIA----KGMMYLE--- 157
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           +  ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  +
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--H 215
Query: 327 FGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
           +   + +SDV+ +G+ + E M  G +  +   TR         + D L KG  L    + 
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLPQPPIC 267
Query: 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKV 416
            I+      + M+ + C  + A  RP   ++
Sbjct: 268 TID------VYMVMVKCWMIDADSRPKFKEL 292

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPN 226
           ++G G FG+VY  + +    ++A+K M  S   + E   +++        R L     PN
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV-----RFLQKLRHPN 76
Query: 227 GSLDRHIFSKENK---------GQTFGLEKPHEIAL----------GTARGIEYLHNGCD 267
               R  + +E+          G    L + H+  L          G  +G+ YLH+   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
             ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + +
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMD 187
Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNS-NMNA 357
            G    K DV+  G+  +E+A  +    NMNA
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 84/203 (41%), Gaps = 30/203 (14%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAV----------------KMMENSKFSA--EEFINELLG 209
           LG+GGFG V+  Q+  TG+L A                  M+E    +     FI  L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI--ALGTARGIEYLHNGCD 267
                    LV   M  G +  HI++ +      G ++P  I        G+E+LH    
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP--GFQEPRAIFYTAQIVSGLEHLHQ--- 307
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             I++ D+KP N+LLD +   ++SD GLA    K           GT G++APEL+    
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQ-TKTKGYAGTPGFMAPELLLGEE 365
Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
              S   D +  G+ L EM   R
Sbjct: 366 YDFSV--DYFALGVTLYEMIAAR 386

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLI--AVKMMENSKFSAEE----FINELLGLCSEGFKR-- 217
           KLG G FG V +G+    +G+ +  AVK ++    S  E    FI E+  + S   +   
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 218 -----------ALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
                       +V E  P GSL DR    ++++G  F L      A+  A G+ YL + 
Sbjct: 85  RLYGVVLTPPMKMVTELAPLGSLLDR---LRKHQGH-FLLGTLSRYAVQVAEGMGYLESK 140
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPE-LI 323
                +H D+   N+LL    + K+ DFGL +  P+ +D   + + R     + APE L 
Sbjct: 141 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
           +R F   S  SD + FG+ L EM
Sbjct: 198 TRTF---SHASDTWMFGVTLWEM 217

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPN 226
           ++G G FG+VY  + +    ++A+K M  S   + E   +++        R L     PN
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV-----RFLQKLRHPN 115
Query: 227 GSLDRHIFSKENK---------GQTFGLEKPHEIAL----------GTARGIEYLHNGCD 267
               R  + +E+          G    L + H+  L          G  +G+ YLH+   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN- 174
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
             ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + +
Sbjct: 175 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMD 226
Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNS-NMNA 357
            G    K DV+  G+  +E+A  +    NMNA
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 32/204 (15%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAV----------------KMMENSKFSA--EEFINELLG 209
           LG+GGFG V+  Q+  TG+L A                  M+E    +     FI  L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR---GIEYLHNGC 266
                    LV   M  G +  HI++ +      G ++P  I   TA+   G+E+LH   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP--GFQEPRAI-FYTAQIVSGLEHLHQ-- 307
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
              I++ D+KP N+LLD +   ++SD GLA    K           GT G++APEL+   
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQ-TKTKGYAGTPGFMAPELLLGE 364
Query: 327 FGTVSCKSDVYGFGMVLLEMAGGR 350
               S   D +  G+ L EM   R
Sbjct: 365 EYDFSV--DYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 32/204 (15%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAV----------------KMMENSKFSA--EEFINELLG 209
           LG+GGFG V+  Q+  TG+L A                  M+E    +     FI  L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR---GIEYLHNGC 266
                    LV   M  G +  HI++ +      G ++P  I   TA+   G+E+LH   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP--GFQEPRAI-FYTAQIVSGLEHLHQ-- 307
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
              I++ D+KP N+LLD +   ++SD GLA    K           GT G++APEL+   
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQ-TKTKGYAGTPGFMAPELLLGE 364
Query: 327 FGTVSCKSDVYGFGMVLLEMAGGR 350
               S   D +  G+ L EM   R
Sbjct: 365 EYDFSV--DYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 84/203 (41%), Gaps = 30/203 (14%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAV----------------KMMENSKFSA--EEFINELLG 209
           LG+GGFG V+  Q+  TG+L A                  M+E    +     FI  L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI--ALGTARGIEYLHNGCD 267
                    LV   M  G +  HI++ +      G ++P  I        G+E+LH    
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP--GFQEPRAIFYTAQIVSGLEHLHQ--- 307
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             I++ D+KP N+LLD +   ++SD GLA    K           GT G++APEL+    
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQ-TKTKGYAGTPGFMAPELLLGEE 365
Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
              S   D +  G+ L EM   R
Sbjct: 366 YDFSV--DYFALGVTLYEMIAAR 386

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 40/207 (19%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINELLGL----------CSEGF-- 215
           +G GGFG V+K +    G+   +K ++ +   AE  +  L  L          C +GF  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDY 78
Query: 216 ---------KRA------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                     R+      +  E+   G+L++ I  ++ +G+        E+     +G++
Sbjct: 79  DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITKGVD 136
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           Y+H+     +++ D+KP NI L      K+ DFGL      +ND      ++GT+ Y++P
Sbjct: 137 YIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKRXR-SKGTLRYMSP 190
Query: 321 ELI-SRNFGTVSCKSDVYGFGMVLLEM 346
           E I S+++G    + D+Y  G++L E+
Sbjct: 191 EQISSQDYGK---EVDLYALGLILAEL 214

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 22/138 (15%)
Query: 218 ALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           ++  E+M  GSLD+ +  K  +   Q  G     ++++   +G+ YL       I+H D+
Sbjct: 142 SICMEHMDGGSLDQ-VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDV 193
Query: 276 KPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGT-VSC 332
           KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  GT  S 
Sbjct: 194 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQGTHYSV 244
Query: 333 KSDVYGFGMVLLEMAGGR 350
           +SD++  G+ L+EMA GR
Sbjct: 245 QSDIWSMGLSLVEMAVGR 262

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 34/206 (16%)
Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMM-----ENSKFSAEEFINELLGLCSEGFKR---- 217
           KLG G + +VYKG    TG  +A+K +     E +  +A   I+ +  L  E   R    
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 218 -------ALVYEYMPNG---SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
                   LV+E+M N     +D        +G    L K  +  L   +G+ + H    
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQGLAFCHENK- 128
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI--S 324
             ILH D+KP N+L++     K+ DFGLA+ F    N F   S    T+ Y AP+++  S
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAPDVLMGS 183
Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGR 350
           R   T S   D++  G +L EM  G+
Sbjct: 184 R---TYSTSIDIWSCGCILAEMITGK 206

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 99/243 (40%), Gaps = 52/243 (21%)
Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVY------ 221
           LGQG FG V K +     R  A+K + +++      ++E++ L S   +  + Y      
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 222 ---------------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                                EY  NG+L   I S EN  Q    ++   +       + 
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQ--RDEYWRLFRQILEALS 130
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV------------SI 308
           Y+H+     I+H D+KP NI +D +   K+ DFGLAK   +  D +            ++
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMNATRSSKA 363
           +   GT  Y+A E++    G  + K D+Y  G++  EM      G  R + +   RS   
Sbjct: 188 TSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSI 246
Query: 364 YFP 366
            FP
Sbjct: 247 EFP 249

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLI--AVKMMENSKFSAEE----FINELLGLCSEGFKR-- 217
           KLG G FG V +G+    +G+ +  AVK ++    S  E    FI E+  + S   +   
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 218 -----------ALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
                       +V E  P GSL DR    ++++G  F L      A+  A G+ YL + 
Sbjct: 85  RLYGVVLTPPMKMVTELAPLGSLLDR---LRKHQGH-FLLGTLSRYAVQVAEGMGYLESK 140
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPE-LI 323
                +H D+   N+LL    + K+ DFGL +  P+ +D   + + R     + APE L 
Sbjct: 141 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 324 SRNFGTVSCKSDVYGFGMVLLEM 346
           +R F   S  SD + FG+ L EM
Sbjct: 198 TRTF---SHASDTWMFGVTLWEM 217

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 22/138 (15%)
Query: 218 ALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           ++  E+M  GSLD+ +  K  +   Q  G     ++++   +G+ YL       I+H D+
Sbjct: 107 SICMEHMDGGSLDQ-VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDV 158
Query: 276 KPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGT-VSC 332
           KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  GT  S 
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQGTHYSV 209
Query: 333 KSDVYGFGMVLLEMAGGR 350
           +SD++  G+ L+EMA GR
Sbjct: 210 QSDIWSMGLSLVEMAVGR 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 257 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 308
           R IE + + C          I+H D+KP NIL+      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           +   GT  YL+PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 22/138 (15%)
Query: 218 ALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           ++  E+M  GSLD+ +  K  +   Q  G     ++++   +G+ YL       I+H D+
Sbjct: 80  SICMEHMDGGSLDQ-VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDV 131
Query: 276 KPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGT-VSC 332
           KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  GT  S 
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQGTHYSV 182
Query: 333 KSDVYGFGMVLLEMAGGR 350
           +SD++  G+ L+EMA GR
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 40/204 (19%)
Query: 168 KLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFSAEEFI-NELLGLCSE------------ 213
           K+G+G  G V    + + G+L+AVK M+  K    E + NE++ +               
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 214 --GFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             G +  +V E++  G+L D    ++ N+ Q         + L   + +  LH      +
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG---V 191
Query: 271 LHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISR- 325
           +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELISR 
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRL 245
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +G    + D++  G++++EM  G
Sbjct: 246 PYGP---EVDIWSLGIMVIEMVDG 266

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 22/138 (15%)
Query: 218 ALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           ++  E+M  GSLD+ +  K  +   Q  G     ++++   +G+ YL       I+H D+
Sbjct: 80  SICMEHMDGGSLDQ-VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDV 131
Query: 276 KPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGT-VSC 332
           KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  GT  S 
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQGTHYSV 182
Query: 333 KSDVYGFGMVLLEMAGGR 350
           +SD++  G+ L+EMA GR
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 22/138 (15%)
Query: 218 ALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           ++  E+M  GSLD+ +  K  +   Q  G     ++++   +G+ YL       I+H D+
Sbjct: 80  SICMEHMDGGSLDQ-VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDV 131
Query: 276 KPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGT-VSC 332
           KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  GT  S 
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQGTHYSV 182
Query: 333 KSDVYGFGMVLLEMAGGR 350
           +SD++  G+ L+EMA GR
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 22/138 (15%)
Query: 218 ALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           ++  E+M  GSLD+ +  K  +   Q  G     ++++   +G+ YL       I+H D+
Sbjct: 80  SICMEHMDGGSLDQ-VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDV 131
Query: 276 KPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGT-VSC 332
           KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  GT  S 
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQGTHYSV 182
Query: 333 KSDVYGFGMVLLEMAGGR 350
           +SD++  G+ L+EMA GR
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 22/138 (15%)
Query: 218 ALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275
           ++  E+M  GSLD+ +  K  +   Q  G     ++++   +G+ YL       I+H D+
Sbjct: 80  SICMEHMDGGSLDQ-VLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDV 131
Query: 276 KPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISDTRGTIGYLAPELISRNFGT-VSC 332
           KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  GT  S 
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQGTHYSV 182
Query: 333 KSDVYGFGMVLLEMAGGR 350
           +SD++  G+ L+EMA GR
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+++D     KV+DFGLAK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 257 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 308
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           +   GT  YL+PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 42/208 (20%)
Query: 169 LGQGGFGSVYKGQ----LHTGRLIAVKMME------NSKFSA---------EE----FIN 205
           LG+GG+G V++ +     +TG++ A+K+++      N+K +A         EE    FI 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 206 ELLGLCSEGFKRALVYEYMPNG----SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
           +L+     G K  L+ EY+  G     L+R     E+    +  E    +ALG      +
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI--SMALG------H 136
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
           LH      I++ D+KP NI+L+H    K++DFGL K     +D        GTI Y+APE
Sbjct: 137 LHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPE 191
Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           ++ R+    +   D +  G ++ +M  G
Sbjct: 192 ILMRSGHNRAV--DWWSLGALMYDMLTG 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 257 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 308
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           +   GT  YL+PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 257 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 308
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           +   GT  YL+PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 42/208 (20%)
Query: 169 LGQGGFGSVYKGQ----LHTGRLIAVKMME------NSKFSA---------EE----FIN 205
           LG+GG+G V++ +     +TG++ A+K+++      N+K +A         EE    FI 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 206 ELLGLCSEGFKRALVYEYMPNG----SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
           +L+     G K  L+ EY+  G     L+R     E+    +  E    +ALG      +
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI--SMALG------H 136
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
           LH      I++ D+KP NI+L+H    K++DFGL K     +D        GTI Y+APE
Sbjct: 137 LHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPE 191
Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           ++ R+    +   D +  G ++ +M  G
Sbjct: 192 ILMRSGHNRAV--DWWSLGALMYDMLTG 217

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRL--IAVKMME----NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G    I V +ME     S  + +E ++E              L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 168
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 169 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 228
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 229 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 277
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 278 CTID------VYMIMVKCWMIDADSRPKFRELI 304

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 49/244 (20%)
Query: 159 IAVTNHFTHK-LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFI------NELLGL 210
           + + +   HK LG+G FG V+  +   T +  A+K ++      ++ +        +L L
Sbjct: 14  LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 211 -----------CSEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR 257
                      C+   K  L  V EY+  G L  HI S       F L +    A     
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIIL 129
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISDTRG 313
           G+++LH+     I++ D+K  NILLD +   K++DFG+ K +     K N F       G
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC------G 180
Query: 314 TIGYLAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYF 365
           T  Y+APE++    G     S D + FG++L EM  G+            ++ R    ++
Sbjct: 181 TPDYIAPEIL---LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY 237
Query: 366 PSWV 369
           P W+
Sbjct: 238 PRWL 241

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 257 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 308
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           +   GT  YL+PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 49/244 (20%)
Query: 159 IAVTNHFTHK-LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFI------NELLGL 210
           + + +   HK LG+G FG V+  +   T +  A+K ++      ++ +        +L L
Sbjct: 15  LKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 74
Query: 211 -----------CSEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR 257
                      C+   K  L  V EY+  G L  HI S       F L +    A     
Sbjct: 75  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIIL 130
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISDTRG 313
           G+++LH+     I++ D+K  NILLD +   K++DFG+ K +     K N+F       G
Sbjct: 131 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC------G 181
Query: 314 TIGYLAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYF 365
           T  Y+APE++    G     S D + FG++L EM  G+            ++ R    ++
Sbjct: 182 TPDYIAPEIL---LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY 238
Query: 366 PSWV 369
           P W+
Sbjct: 239 PRWL 242

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 38/234 (16%)
Query: 165 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE-------------------FI 204
           F   LG+G FG V   ++  TG L AVK+++      ++                   F+
Sbjct: 27  FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 205 NELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
            +L        +   V E++  G L  HI     K + F   +    A      + +LH 
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEIISALMFLH- 141
Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
             D  I++ D+K  N+LLDH    K++DFG+ K      + V+ +   GT  Y+APE++ 
Sbjct: 142 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQ 197
Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSWVYD 371
                 +   D +  G++L EM  G         +    A  + +  +P+W+++
Sbjct: 198 EMLYGPAV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 257 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 308
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           +   GT  YL+PE    +  +V  +SDVY  G VL E+  G
Sbjct: 194 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 232

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 61/120 (50%), Gaps = 18/120 (15%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+L++     K+ DFGLA+    E+D    +++   T 
Sbjct: 155 RGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLN 374
            Y APE++  + G      D++  G +L EM             S++  FP   Y DQLN
Sbjct: 212 WYRAPEIMLNSKGYTKS-IDIWSVGCILAEML------------SNRPIFPGKHYLDQLN 258

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 58/230 (25%)
Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVK------------------MMENSKFSAEEFIN 205
              KLG+G +G V+K     TG ++AVK                  +M  ++ S  E I 
Sbjct: 13  LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 206 ELLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEY 261
            LL +      R   LV++YM     D H   + N      LE  H+  +     + I+Y
Sbjct: 73  NLLNVLRADNDRDVYLVFDYM---ETDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKY 124
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-------------FHPKEN----- 303
           LH+G    +LH D+KP NILL+     KV+DFGL++                 EN     
Sbjct: 125 LHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 304 -DFVSISDTRGTIGYLAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
            D   ++D   T  Y APE++    G+       D++  G +L E+  G+
Sbjct: 182 DDQPILTDYVATRWYRAPEIL---LGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 219 LVYEYMPNGS-LD--RHIFSK-ENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFD 274
           LV + +  GS LD  +HI +K E+K           I      G+EYLH    +   H D
Sbjct: 85  LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI---HRD 141
Query: 275 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR---GTIGYLAPELISRNFGTVS 331
           +K  NILL  +   +++DFG++ F     D       +   GT  ++APE++ +  G   
Sbjct: 142 VKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YD 200
Query: 332 CKSDVYGFGMVLLEMAGG 349
            K+D++ FG+  +E+A G
Sbjct: 201 FKADIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 219 LVYEYMPNGS-LD--RHIFSK-ENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFD 274
           LV + +  GS LD  +HI +K E+K           I      G+EYLH    +   H D
Sbjct: 90  LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI---HRD 146
Query: 275 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR---GTIGYLAPELISRNFGTVS 331
           +K  NILL  +   +++DFG++ F     D       +   GT  ++APE++ +  G   
Sbjct: 147 VKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YD 205
Query: 332 CKSDVYGFGMVLLEMAGG 349
            K+D++ FG+  +E+A G
Sbjct: 206 FKADIWSFGITAIELATG 223

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 145
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK   K   +       GT  YLAPE+I S+ 
Sbjct: 146 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWTLC----GTPEYLAPEIILSKG 200
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 201 YNKA---VDWWALGVLIYEMAAG 220

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           +G G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     KV+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 51/274 (18%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 134
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 385 TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+  MI RK       C  + A  RP   +++
Sbjct: 244 CTIDVYMIMRK-------CWMIDADSRPKFRELI 270

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 165 FTHKLGQGGFGSV--YKGQLHTGRLIAVKMM--------ENSKFSAEEF-------INEL 207
           F  KLG+GGF  V   +G LH G   A+K +        E ++  A+         I  L
Sbjct: 33  FIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 208 LGLC--SEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           +  C    G K    L+  +   G+L   I   ++KG     ++   + LG  RG+E +H
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFG---LAKFHPK-ENDFVSISD---TRGTIG 316
                   H D+KP NILL     P + D G    A  H +     +++ D    R TI 
Sbjct: 152 AKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 317 YLAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM 355
           Y APEL S ++   +  ++DV+  G VL  M  G    +M
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 160
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK   K   +       GT  YLAPE+I S+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWTLC----GTPEYLAPEIILSKG 215
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 216 YNKA---VDWWALGVLIYEMAAG 235

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 51/274 (18%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 144
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 145 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 204
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 205 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 253
Query: 385 TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+  MI RK       C  + A  RP   +++
Sbjct: 254 CTIDVYMIMRK-------CWMIDADSRPKFRELI 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMM------------------ENSKFSAEEFINELLG 209
           LG G FG V  G+   TG  +AVK++                  +N K      I +L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           + S      +V EY+  G L    F    K      ++   +      G++Y H      
Sbjct: 84  VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--- 136
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXS--CGSPNYAAPEVISGRL-Y 192
Query: 330 VSCKSDVYGFGMVLLEMAGG 349
              + D++  G++L  +  G
Sbjct: 193 AGPEVDIWSSGVILYALLCG 212

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 51/274 (18%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 137
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 198 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 246
Query: 385 TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+  MI RK       C  + A  RP   +++
Sbjct: 247 CTIDVYMIMRK-------CWMIDADSRPKFRELI 273

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 160
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 215
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 216 YNKA---VDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 41/204 (20%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGC 266
                    +V EY P G +  H+       +  G   +PH    A       EYLH+  
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS-- 159
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SR 325
            + +++ D+KP N+++D     KV+DFG AK        +      GT  YLAPE+I S+
Sbjct: 160 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +       D +  G+++ EMA G
Sbjct: 214 GYNKA---VDWWALGVLIYEMAAG 234

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 135
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 196 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 244
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 245 CTID------VYMIMVKCWMIDADSRPKFRELI 271

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 96/234 (41%), Gaps = 52/234 (22%)
Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKM--MENSKFSAEEFINELLGL---------- 210
               +LG GGFG V +     TG  +A+K    E S  + E +  E+  +          
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 77
Query: 211 ---CSEGFKRA-------LVYEYMPNGSLDRHIFSKENKGQTFGL-EKPHEIALG-TARG 258
                +G ++        L  EY   G L +++   EN     GL E P    L   +  
Sbjct: 78  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSA 134
Query: 259 IEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSI-SDTRGT 314
           + YLH      I+H D+KP NI+L       I K+ D G AK    E D   + ++  GT
Sbjct: 135 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGT 187
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW 368
           + YLAPEL+ +   TV+   D + FG +  E   G R            + P+W
Sbjct: 188 LQYLAPELLEQKKYTVTV--DYWSFGTLAFECITGFR-----------PFLPNW 228

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+++D     +V+DFGLAK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 41/204 (20%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGC 266
                    +V EY P G +  H+       +  G   +PH    A       EYLH+  
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS-- 160
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SR 325
            + +++ D+KP N+++D     KV+DFG AK        +      GT  YLAPE+I S+
Sbjct: 161 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +       D +  G+++ EMA G
Sbjct: 215 GYNKA---VDWWALGVLIYEMAAG 235

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 135
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 196 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 244
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 245 CTID------VYMIMVKCWMIDADSRPKFRELI 271

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 41/204 (20%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGC 266
                    +V EY P G +  H+       +  G   +PH    A       EYLH+  
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS-- 160
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SR 325
            + +++ D+KP N+++D     KV+DFG AK        +      GT  YLAPE+I S+
Sbjct: 161 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +       D +  G+++ EMA G
Sbjct: 215 GYNKA---VDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFXEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 134
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 244 CTID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 96/234 (41%), Gaps = 52/234 (22%)
Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKM--MENSKFSAEEFINELLGL---------- 210
               +LG GGFG V +     TG  +A+K    E S  + E +  E+  +          
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 211 ---CSEGFKRA-------LVYEYMPNGSLDRHIFSKENKGQTFGL-EKPHEIALG-TARG 258
                +G ++        L  EY   G L +++   EN     GL E P    L   +  
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSA 133
Query: 259 IEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSI-SDTRGT 314
           + YLH      I+H D+KP NI+L       I K+ D G AK    E D   + ++  GT
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGT 186
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW 368
           + YLAPEL+ +   TV+   D + FG +  E   G R            + P+W
Sbjct: 187 LQYLAPELLEQKKYTVTV--DYWSFGTLAFECITGFR-----------PFLPNW 227

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 128
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 189 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 237
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 238 CTID------VYMIMVKCWMIDADSRPKFRELI 264

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 34/203 (16%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENS-------KFSAEEF----------INELLG 209
           K+G+G +G V+K +   TG+++A+K    S       K +  E           +  LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDV 268
           +     +  LV+EY  +  L  H   +  +G    L K   I   T + + + H + C  
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVK--SITWQTLQAVNFCHKHNC-- 123
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI--SRN 326
             +H D+KP NIL+  + + K+ DFG A+     +D+    D   T  Y +PEL+     
Sbjct: 124 --IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQ 179
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +G      DV+  G V  E+  G
Sbjct: 180 YGP---PVDVWAIGCVFAELLSG 199

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFXEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 35/204 (17%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVK--MMENSKFSAEEFINELLGLCSEGFKRA------ 218
           KLG+G + +VYKG+   T  L+A+K   +E+ + +    I E+  L  +  K A      
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLL--KDLKHANIVTLH 66
Query: 219 ----------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
                     LV+EY+ +  L +++   ++ G    +           RG+ Y H     
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHRQK-- 120
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
            +LH D+KP N+L++     K++DFGLA+   K     +  +   T+ Y  P+++    G
Sbjct: 121 -VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDIL---LG 174
Query: 329 TV--SCKSDVYGFGMVLLEMAGGR 350
           +   S + D++G G +  EMA GR
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 41/204 (20%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGC 266
                    +V EY P G +  H+       +  G   +PH    A       EYLH+  
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS-- 159
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SR 325
            + +++ D+KP N+++D     KV+DFG AK        +      GT  YLAPE+I S+
Sbjct: 160 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +       D +  G+++ EMA G
Sbjct: 214 GYNKA---VDWWALGVLIYEMAAG 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 41/204 (20%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGC 266
                    +V EY P G +  H+       +  G   +PH    A       EYLH+  
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS-- 160
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SR 325
            + +++ D+KP N+++D     KV+DFG AK        +      GT  YLAPE+I S+
Sbjct: 161 -LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +       D +  G+++ EMA G
Sbjct: 215 GYNKA---VDWWALGVLIYEMAAG 235

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 138
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 199 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 247
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 248 CTID------VYMIMVKCWMIDADSRPKFRELI 274

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFXEPHARFYAAQIVLTFEYLHS--- 160
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 215
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 216 YNKA---VDWWALGVLIYEMAAG 235

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 136
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 197 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 245
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 246 CTID------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 134
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 244 CTID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 137
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 198 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 246
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 247 CTID------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 135 RGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 192 WYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNR 225

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 134
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 244 CTID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPAFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 165 FTHKLGQGGFGSVYKGQLHTG---RLIAVKMMENSKFSAEEFINELLGLCS--------- 212
           F  KLG G FG V+  +  +    R+I     + S+   E+   E+  L S         
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 213 -EGFK----RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
            E F+      +V E    G L   I S + +G+        E+       + Y H+   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-- 143
Query: 268 VCILHFDIKPHNILLD----HNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPEL 322
             ++H D+KP NIL      H+ I K+ DFGLA+ F   E+     ++  GT  Y+APE+
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELFKSDEHS----TNAAGTALYMAPEV 197
Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGG 349
             R+   V+ K D++  G+V+  +  G
Sbjct: 198 FKRD---VTFKCDIWSAGVVMYFLLTG 221

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 31/201 (15%)
Query: 169 LGQGGFGSV-----YKGQLHTG-RLIAVKMMENS-------------KFSAEEFINELLG 209
           LG+G FG V     YK Q     + I+ ++++ S             K      I +L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           + +      +V EY   G L  +I  K+   +  G     +I       IEY H      
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA----IEYCHRHK--- 128
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I+H D+KP N+LLD N   K++DFGL+      N F+  S   G+  Y APE+I+     
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC--GSPNYAAPEVINGKL-Y 184
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              + DV+  G+VL  M  GR
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGR 205

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 42/205 (20%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL----QKLSRFDEQR-------TATYITELANALSYC 128
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELIS 324
               ++H DIKP N+LL  N   K++DFG +   P      S  DT  GT+ YL PE+I 
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPS-----SRRDTLCGTLDYLPPEMIE 183
Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGG 349
                   K D++  G++  E   G
Sbjct: 184 GRMH--DEKVDLWSLGVLCYEFLVG 206

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 137
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 198 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 246
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 247 CTID------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 135 RGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 192 WYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNR 225

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 98/220 (44%), Gaps = 53/220 (24%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINELLGL----------CSEGF-- 215
           +G GGFG V+K +    G+   ++ ++ +   AE  +  L  L          C +GF  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDY 79
Query: 216 ----------------------KRA------LVYEYMPNGSLDRHIFSKENKGQTFGLEK 247
                                  R+      +  E+   G+L++ I  ++ +G+      
Sbjct: 80  DPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVL 137
Query: 248 PHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307
             E+     +G++Y+H+     ++H D+KP NI L      K+ DFGL      +ND   
Sbjct: 138 ALELFEQITKGVDYIHSKK---LIHRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKR 192
Query: 308 ISDTRGTIGYLAPELI-SRNFGTVSCKSDVYGFGMVLLEM 346
            + ++GT+ Y++PE I S+++G    + D+Y  G++L E+
Sbjct: 193 -TRSKGTLRYMSPEQISSQDYGK---EVDLYALGLILAEL 228

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 159
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 160 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 219
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 220 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 268
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 269 CTID------VYMIMVKCWMIDADSRPKFRELI 295

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 135 RGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 192 WYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNR 225

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 137
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 198 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 246
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 247 CTID------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 140
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 141 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 200
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 201 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 249
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 250 CTID------VYMIMVKCWMIDADSRPKFRELI 276

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 136
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 197 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 245
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 246 CTID------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 128
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K++DFG +   P        +D  GT+ YL PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHD 184
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 196 WYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 196 WYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNR 229

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 129
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K++DFG +   P        +D  GT+ YL PE+I      
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHD 185
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 186 E--KVDLWSLGVLCYEFLVGK 204

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 141
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 202 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 250
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 251 CTID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 128
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K++DFG +   P        +D  GT+ YL PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHD 184
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 137 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 194 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 227

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 117/279 (41%), Gaps = 47/279 (16%)
Query: 169 LGQGGFGSVYKGQLHTG---RLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMP 225
           +G+G FG VY G+ H     RLI ++     +  A  F  E++       +  +++    
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKA--FKREVMAYRQTRHENVVLFMGAC 98
Query: 226 NGSLDRHIFSKENKGQTF-----------GLEKPHEIALGTARGIEYLHNGCDVCILHFD 274
                  I +   KG+T             + K  +IA    +G+ YLH      ILH D
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 275 IKPHNILLDHNFIPKVSDFGLAKFHP-----KENDFVSISDTRGTIGYLAPELISR---- 325
           +K  N+  D+  +  ++DFGL          +  D + I +  G + +LAPE+I +    
Sbjct: 156 LKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQN--GWLCHLAPEIIRQLSPD 212
Query: 326 ---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382
              +    S  SDV+  G +  E+     ++     ++  A    W   Q+  G    L 
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYEL-----HAREWPFKTQPAEAIIW---QMGTGMKPNLS 264
Query: 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
            +      + +++  I L+C   +  +RP+ TK+++MLE
Sbjct: 265 QIG-----MGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 135 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 192 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 137 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 194 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 227

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 196 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 155 RGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 212 WYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNR 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 133 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 190 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 223

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 133
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K++DFG +   P        +D  GT+ YL PE+I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHD 189
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 142 KYRTTMQTVDNILLPEIIAVTN-HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS 199
           K   T+   DN    + + +T+ +F   LG+G FG V   +   T  L AVK+++     
Sbjct: 321 KTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI 380
Query: 200 AEE-------------------FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240
            ++                   F+ +L        +   V EY+  G L  HI       
Sbjct: 381 QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI------Q 434
Query: 241 QTFGLEKPHEI--ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298
           Q    ++PH +  A   A G+ +L +     I++ D+K  N++LD     K++DFG+   
Sbjct: 435 QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC-- 489
Query: 299 HPKEN--DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
             KEN  D V+     GT  Y+APE+I+  +       D + FG++L EM  G+
Sbjct: 490 --KENIWDGVTTKXFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE-------------------F 203
           +F   LG+G FG V   +   T  L AVK+++      ++                   F
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 204 INELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI--ALGTARGIEY 261
           + +L        +   V EY+  G L  HI       Q    ++PH +  A   A G+ +
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI------QQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISDTRGTIGYLA 319
           L +     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  Y+A
Sbjct: 137 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENIWDGVTTKXFCGTPDYIA 189
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           PE+I+  +       D + FG++L EM  G+
Sbjct: 190 PEIIA--YQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 143 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 200 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 135 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 192 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 140 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 197 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 141 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 198 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 132 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 189 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 196 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 137 RGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 194 WYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNR 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 133 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 190 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 196 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 229

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V       TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V       TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 152
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 207
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 208 YNKA---VDWWALGVLIYEMAAG 227

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V       TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V       TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 45/210 (21%)
Query: 166 THKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSA--------------EEFINELLGL 210
             KLG G +G V   +   G    A+K+++ S+F                EE  NE+  L
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 211 CS----------EGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256
            S          + F+      LV E+   G L   I ++      F       I     
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQIL 156
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISDTRG 313
            GI YLH      I+H DIKP NILL++       K+ DFGL+ F  K+     + D  G
Sbjct: 157 SGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLG 210
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVL 343
           T  Y+APE++ + +     K DV+  G+++
Sbjct: 211 TAYYIAPEVLKKKYNE---KCDVWSCGVIM 237

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 83/211 (39%), Gaps = 48/211 (22%)
Query: 173 GFGSVYKGQLH--TGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRA------------ 218
           G  SV +  +H  TG   AVK+ME    +AE    E L    E  +R             
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIME---VTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 219 ---------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
                          LV++ M  G L    F    +      ++   I       + +LH
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPEL 322
                 I+H D+KP NILLD N   ++SDFG +    P E     + +  GT GYLAPE+
Sbjct: 218 ANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK----LRELCGTPGYLAPEI 270
Query: 323 ISRNFGTV----SCKSDVYGFGMVLLEMAGG 349
           +  +          + D++  G++L  +  G
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V       TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFXEPHARFYAAQIVLTFEYLHS--- 152
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 207
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 208 YNKA---VDWWALGVLIYEMAAG 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    +++   T 
Sbjct: 155 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 212 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 245

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 86/220 (39%), Gaps = 62/220 (28%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE------------------------ 202
           ++G G  G V+K +   TG +IAVK M  S    E                         
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 203 -FIN--------ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL 253
            FI         EL+G C+E  K+ +       G +   I  K              + +
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRM------QGPIPERILGK--------------MTV 131
Query: 254 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
              + + YL     V  +H D+KP NILLD     K+ DFG++    +  D  +   + G
Sbjct: 132 AIVKALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAG 186
Query: 314 TIGYLAPELISRNFGT---VSCKSDVYGFGMVLLEMAGGR 350
              Y+APE I     T      ++DV+  G+ L+E+A G+
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY P G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+++D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA     G+ YL    
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----EGMNYLE--- 131
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 132 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 191
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 192 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 240
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 241 CTID------VYMIMVKCWMIDADSRPKFRELI 267

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 117/281 (41%), Gaps = 48/281 (17%)
Query: 169 LGQGGFGSVYK-GQLHTGRLIAVK-MMENSKFSAEEFINEL--------------LGLCS 212
           LG+G FG   K     TG ++ +K ++   + +   F+ E+              +G+  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILH 272
           +  +   + EY+  G+L   I S +++   +   +    A   A G+ YLH+   + I+H
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 273 FDIKPHNILLDHNFIPKVSDFGLAKF------HP------KENDFVSISDTRGTIGYLAP 320
            D+  HN L+  N    V+DFGLA+        P      K+ D        G   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           E+I  N  +   K DV+ FG+VL E+  GR N++ +       Y P  +   LN  G L+
Sbjct: 192 EMI--NGRSYDEKVDVFSFGIVLCEII-GRVNADPD-------YLPRTMDFGLNVRGFLD 241
Query: 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                            I + C  +    RPS  K+   LE
Sbjct: 242 ----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 98/243 (40%), Gaps = 52/243 (21%)
Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVY------ 221
           LGQG FG V K +     R  A+K + +++      ++E++ L S   +  + Y      
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 222 ---------------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                                EY  N +L   I S EN  Q    ++   +       + 
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHS-ENLNQQ--RDEYWRLFRQILEALS 130
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV------------SI 308
           Y+H+     I+H D+KP NI +D +   K+ DFGLAK   +  D +            ++
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMNATRSSKA 363
           +   GT  Y+A E++    G  + K D+Y  G++  EM      G  R + +   RS   
Sbjct: 188 TSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSI 246
Query: 364 YFP 366
            FP
Sbjct: 247 EFP 249

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    + +   T 
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 196 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D    + +   T 
Sbjct: 140 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  + G      D++  G +L EM   R
Sbjct: 197 WYRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNR 230

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 40/204 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL----QKLSRFDEQR-------TATYITELANALSYC 128
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL  N   K++DFG +   P        +   GT+ YL PE+I  
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 184
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
                  K D++  G++  E   G
Sbjct: 185 RMH--DEKVDLWSLGVLCYEFLVG 206

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V       TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 160
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 215
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 216 YNKA---VDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V       TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 160
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 215
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 216 YNKA---VDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V       TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+P G +  H+       +     +PH    A       EYLH+   
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 160
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 215
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 216 YNKA---VDWWALGVLIYEMAAG 235

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 30/200 (15%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMM------------------ENSKFSAEEFINELLG 209
           LG G FG V  G+   TG  +AVK++                  +N K      I +L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           + S      +V EY+  G L  +I  K  + +     +  +  L     ++Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSA---VDYCHRHM--- 131
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H D+KP N+LLD +   K++DFGL+      +D   + D+ G+  Y APE+IS     
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRDSCGSPNYAAPEVISGRL-Y 187
Query: 330 VSCKSDVYGFGMVLLEMAGG 349
              + D++  G++L  +  G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V       TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY P G +  H+       +     +PH    A       EYLH+   
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 160
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+++D     KV+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 215
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 216 YNKA---VDWWALGVLIYEMAAG 235

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 29/200 (14%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMME-NSKFSAEEFINELLGLCS----------EGF 215
           +LG G FG VYK Q   T  L A K+++  S+   E+++ E+  L S          + F
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 216 ----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
                  ++ E+   G++D  +   E   +     +   +   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELI---SRNF 327
           H D+K  NIL   +   K++DFG++    K    +   D+  GT  ++APE++   +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS---AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 328 GTVSCKSDVYGFGMVLLEMA 347
                K+DV+  G+ L+EMA
Sbjct: 215 RPYDYKADVWSLGITLIEMA 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCDVCILHFDIK 276
           +V EY P G +  H+       +     +PH    A       EYLH+   + +++ D+K
Sbjct: 119 MVLEYAPGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLK 169
Query: 277 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKSD 335
           P N+L+D     KV+DFG AK        +      GT  YLAPE+I S+ +       D
Sbjct: 170 PENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VD 221
Query: 336 VYGFGMVLLEMAGG 349
            +  G+++ EMA G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 29/200 (14%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMME-NSKFSAEEFINELLGLCS----------EGF 215
           +LG G FG VYK Q   T  L A K+++  S+   E+++ E+  L S          + F
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 216 ----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
                  ++ E+   G++D  +   E   +     +   +   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELI---SRNF 327
           H D+K  NIL   +   K++DFG++    K    +   D+  GT  ++APE++   +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 328 GTVSCKSDVYGFGMVLLEMA 347
                K+DV+  G+ L+EMA
Sbjct: 215 RPYDYKADVWSLGITLIEMA 234

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 127
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P         D  GT+ YL PE+I  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLDYLPPEMIEG 183
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 184 RMH--DEKVDLWSLGVLCYEFLVGK 206

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENS------------------KFSAEEFINELLG 209
           +G+G +G V K +   TGR++A+K    S                  +   E  +N LL 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVN-LLE 91
Query: 210 LCSEGFKRALVYEYMPNGSLDR-HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           +C +  +  LV+E++ +  LD   +F     G  + + + +   +    G  + HN    
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---- 144
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
            I+H DIKP NIL+  + + K+ DFG A+      +     D   T  Y APEL+  +  
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAPELLVGDV- 200
Query: 329 TVSCKSDVYGFGMVLLEMAGG 349
                 DV+  G ++ EM  G
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMG 221

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRG 313
           G+ YLH      I HFD+KP NI+L    IP    K+ DFGLA  H  E D V   +  G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFG 180
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           T  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 181 TPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 150
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P         D  GT+ YL PE+I  
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLDYLPPEMIEG 206
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 207 RMHDE--KVDLWSLGVLCYEFLVGK 229

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 22/203 (10%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV--CILHFDIK 276
           +V EY   G L   I     + Q    E    +       ++  H   D    +LH D+K
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 277 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDV 336
           P N+ LD     K+ DFGLA+    + DF    +  GT  Y++PE ++R   + + KSD+
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNRM--SYNEKSDI 199
Query: 337 YGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-VYDQLNKGGDLELRNVTEIESMIARKL 395
           +  G +L E+                A  P +  + Q    G +       I    + +L
Sbjct: 200 WSLGCLLYELC---------------ALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 396 CMIGLWCIQVKAADRPSMTKVLE 418
             I    + +K   RPS+ ++LE
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILE 267

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 156 PEIIAVTNHFT-------HKLGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEFINEL 207
           P+I+  T HFT         LG+G FG+VY  +      I A+K++  S+   E   ++L
Sbjct: 13  PDIL--TRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQL 70
Query: 208 ---------------LGLCSEGFKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPH 249
                          L L +  + R  +Y   EY P G L    + +  K  TF  ++  
Sbjct: 71  RREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL----YKELQKSCTFDEQRTA 126
Query: 250 EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309
            I    A  + Y H      ++H DIKP N+LL      K++DFG +   P     +   
Sbjct: 127 TIMEELADALMYCHGKK---VIHRDIKPENLLLGLKGELKIADFGWSVHAPS----LRRK 179
Query: 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
              GT+ YL PE+I         K D++  G++  E+  G
Sbjct: 180 TMCGTLDYLPPEMIEGRMHNE--KVDLWCIGVLCYELLVG 217

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 116/274 (42%), Gaps = 51/274 (18%)
Query: 169 LGQGGFGSVYKG-QLHTGRL----IAVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G      +A+K +    S  + +E ++E              L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +I    A+G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----AKGMNYLE--- 136
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 197 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 245
Query: 385 TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+  MI RK       C  + A  RP   +++
Sbjct: 246 CTIDVYMIMRK-------CWMIDADSRPKFRELI 272

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 45/212 (21%)
Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRA--------- 218
           +G+G F  V +     TG+  AVK+++ +KF++        GL +E  KR          
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSP------GLSTEDLKREASICHMLKH 85
Query: 219 -----------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                            +V+E+M    L   I  + + G  +               + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 262 LHNGCDVCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
            H   D  I+H D+KP N+LL    N  P K+ DFG+A     E+  V+     GT  ++
Sbjct: 146 CH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVA-GGRVGTPHFM 200
Query: 319 APELISRN-FGTVSCKSDVYGFGMVLLEMAGG 349
           APE++ R  +G      DV+G G++L  +  G
Sbjct: 201 APEVVKREPYGK---PVDVWGCGVILFILLSG 229

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 90  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 142
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 197
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 198 DMWSIGVITYILLSG 212

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 84/202 (41%), Gaps = 34/202 (16%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 129
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELISRNFG 328
           ++H DIKP N+LL      K++DFG +   P      S  DT  GT+ YL PE+I     
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRDTLCGTLDYLPPEMIEGRMH 184
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
               K D++  G++  E   G+
Sbjct: 185 DE--KVDLWSLGVLCYEFLVGK 204

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 90  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 142
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 197
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 198 DMWSIGVITYILLSG 212

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRL----IAVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G      +A+K +    S  + +E ++E              L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +I    A+G+ YL    
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----AKGMNYLE--- 138
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 199 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 247
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 248 CTID------VYMIMVKCWMIDADSRPKFRELI 274

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 46/212 (21%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVK--MMENSK----------------FSAEEFINELL 208
           K+GQG FG V+K +   TG+ +A+K  +MEN K                   E  +N L+
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN-LI 83
Query: 209 GLC---SEGFKRA-----LVYEYMPN--GSLDRHIFSKENKGQTFGLEKPHEIALGTARG 258
            +C   +  + R      LV+++  +    L  ++  K      F L +   +      G
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNG 137
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTR-GTIG 316
           + Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T+ 
Sbjct: 138 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 317 YLAPELI--SRNFGTVSCKSDVYGFGMVLLEM 346
           Y  PEL+   R++G      D++G G ++ EM
Sbjct: 195 YRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 44/211 (20%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVK--MMENSK---------------FSAEEFINELLG 209
           K+GQG FG V+K +   TG+ +A+K  +MEN K                   E +  L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 210 LC---SEGFKRA-----LVYEYMPN--GSLDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
           +C   +  + R      LV+++  +    L  ++  K      F L +   +      G+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNGL 138
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTR-GTIGY 317
            Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T+ Y
Sbjct: 139 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 318 LAPELI--SRNFGTVSCKSDVYGFGMVLLEM 346
             PEL+   R++G      D++G G ++ EM
Sbjct: 196 RPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 41/204 (20%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V       TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGC 266
                    +V EY+P G +  H+       +  G   +PH    A       EYLH+  
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS-- 180
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SR 325
            + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+
Sbjct: 181 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 234
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            +       D +  G+++ EMA G
Sbjct: 235 GYNKA---VDWWALGVLIYEMAAG 255

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 24/156 (15%)
Query: 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR---GIEYLHNGCDVCILH 272
           K  L+ +Y+  G L  H+  +E   +       HE+ +        +E+LH    + I++
Sbjct: 133 KLHLILDYINGGELFTHLSQRERFTE-------HEVQIYVGEIVLALEHLHK---LGIIY 182
Query: 273 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-----GTIGYLAPELISRNF 327
            DIK  NILLD N    ++DFGL+K      +FV+    R     GTI Y+AP+++    
Sbjct: 183 RDIKLENILLDSNGHVVLTDFGLSK------EFVADETERAYDFCGTIEYMAPDIVRGGD 236
Query: 328 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA 363
                  D +  G+++ E+  G     ++  ++S+A
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 44/211 (20%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVK--MMENSK---------------FSAEEFINELLG 209
           K+GQG FG V+K +   TG+ +A+K  +MEN K                   E +  L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 210 LC---SEGFKRA-----LVYEYMPN--GSLDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
           +C   +  + R      LV+++  +    L  ++  K      F L +   +      G+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNGL 137
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTR-GTIGY 317
            Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T+ Y
Sbjct: 138 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 318 LAPELI--SRNFGTVSCKSDVYGFGMVLLEM 346
             PEL+   R++G      D++G G ++ EM
Sbjct: 195 RPPELLLGERDYGP---PIDLWGAGCIMAEM 222

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 116/274 (42%), Gaps = 51/274 (18%)
Query: 169 LGQGGFGSVYKG-QLHTGRL----IAVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G      +A+K +    S  + +E ++E              L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +I    A+G+ YL    
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----AKGMNYLE--- 136
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 197 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 245
Query: 385 TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+  MI RK       C  + A  RP   +++
Sbjct: 246 CTIDVYMIMRK-------CWMIDADSRPKFRELI 272

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 44/211 (20%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVK--MMENSK---------------FSAEEFINELLG 209
           K+GQG FG V+K +   TG+ +A+K  +MEN K                   E +  L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 210 LC---SEGFKRA-----LVYEYMPN--GSLDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
           +C   +  + R      LV+++  +    L  ++  K      F L +   +      G+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNGL 138
Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTR-GTIGY 317
            Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T+ Y
Sbjct: 139 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 318 LAPELI--SRNFGTVSCKSDVYGFGMVLLEM 346
             PEL+   R++G      D++G G ++ EM
Sbjct: 196 RPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMME-NSKFSAEEFINELLGLCS----------EGF 215
           +LG G FG VYK Q   T  L A K+++  S+   E+++ E+  L S          + F
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 216 ----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
                  ++ E+   G++D  +   E   +     +   +   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISDTRGTIGYLAPELI---S 324
           H D+K  NIL   +   K++DFG++    +   + + F+      GT  ++APE++   +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI------GTPYWMAPEVVMCET 211
Query: 325 RNFGTVSCKSDVYGFGMVLLEMA 347
                   K+DV+  G+ L+EMA
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMA 234

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 35/209 (16%)
Query: 164 HFTHKLGQGGFGSVY-KGQLHTGRLIAVKMMENSKFSAEE-------------------F 203
           +F   LG+G FG V    +  T  L A+K+++      ++                   F
Sbjct: 22  NFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPF 81
Query: 204 INELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI--ALGTARGIEY 261
           + +L        +   V EY+  G L  HI       Q    ++P  +  A   + G+ +
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHI------QQVGKFKEPQAVFYAAEISIGLFF 135
Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
           LH      I++ D+K  N++LD     K++DFG+ K H    D V+  +  GT  Y+APE
Sbjct: 136 LHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH--MMDGVTTREFCGTPDYIAPE 190
Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           +I+  +       D + +G++L EM  G+
Sbjct: 191 IIA--YQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRG 313
           G+ YLH      I HFD+KP NI+L    IP    K+ DFGLA  H  E D V   +  G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFG 180
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           T  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 181 TPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRG 313
           G+ YLH      I HFD+KP NI+L    IP    K+ DFGLA  H  E D V   +  G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFG 180
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           T  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 181 TPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRG 313
           G+ YLH      I HFD+KP NI+L    IP    K+ DFGLA  H  E D V   +  G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFG 180
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           T  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 181 TPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRG 313
           G+ YLH      I HFD+KP NI+L    IP    K+ DFGLA  H  E D V   +  G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFG 180
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 371
           T  ++APE++  N+  +  ++D++  G++   +  G      +  + + A   S  YD
Sbjct: 181 TPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 124
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P        ++  GT+ YL PE+I  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLDYLPPEMIEG 180
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 181 RMHDE--KVDLWSLGVLCYEFLVGK 203

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRG 313
           G+ YLH      I HFD+KP NI+L    IP    K+ DFGLA  H  E D V   +  G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFG 180
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           T  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 181 TPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 159 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVK-MMENSKFSAEEF-----------INE 206
           IA TN     +G G FG V++ +L     +A+K ++++ +F   E            ++ 
Sbjct: 40  IAYTN--CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDL 97
Query: 207 LLGLCSEGFKR-----ALVYEYMPNG--SLDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
                S G K+      LV EY+P       RH ++K  +     L K +   L   R +
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH-YAKLKQTMPMLLIKLYMYQL--LRSL 154
Query: 260 EYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
            Y+H+   + I H DIKP N+LLD  + + K+ DFG AK        VS   +R    Y 
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSR---YYR 208
Query: 319 APELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 350
           APELI   FG  +  +  D++  G V+ E+  G+
Sbjct: 209 APELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE    +   E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           L  G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 134
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 244 CTID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 14/92 (15%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS----ISDTR 312
           +GIEYLH      I+H DIKP N+L+  +   K++DFG++      N+F      +S+T 
Sbjct: 148 KGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS------NEFKGSDALLSNTV 198
Query: 313 GTIGYLAPELISRNFGTVSCKS-DVYGFGMVL 343
           GT  ++APE +S      S K+ DV+  G+ L
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           L  G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 141
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 202 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 250
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 251 CTID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 24/176 (13%)
Query: 169 LGQGGFGS-VYKGQLHTGRLIAVKMMENSKFS-----------AEEFINELLGLCSEGFK 216
           LG G  G+ VY+G +   R +AVK +    FS           ++E  N +   C+E   
Sbjct: 32  LGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK-D 89
Query: 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
           R   Y  +   +     + ++      GLE P  +   T  G+ +LH+   + I+H D+K
Sbjct: 90  RQFQYIAIELCAATLQEYVEQKDFAHLGLE-PITLLQQTTSGLAHLHS---LNIVHRDLK 145
Query: 277 PHNILLD----HNFIPK-VSDFGLA-KFHPKENDFVSISDTRGTIGYLAPELISRN 326
           PHNIL+     H  I   +SDFGL  K     + F   S   GT G++APE++S +
Sbjct: 146 PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRL----IAVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G      +A+K +    S  + +E ++E              L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +I    A+G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----AKGMNYLE--- 136
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 197 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 245
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 246 CTID------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 29/178 (16%)
Query: 189 AVKMMENSKFSAEEFINELL------------GLCSEGFKRALVYEYMPNGSLDRHIFSK 236
           AVK+++ SK    E I  LL             +  +G    LV E M  G L   I   
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILR- 114
Query: 237 ENKGQTFGLEKPHEIALGT-ARGIEYLHNGCDVCILHFDIKPHNIL-LDHNFIP---KVS 291
               Q F  E+     L T  + +EYLH+     ++H D+KP NIL +D +  P   ++ 
Sbjct: 115 ----QKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRIC 167
Query: 292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           DFG AK    EN  +       T  ++APE++ R      C  D++  G++L  M  G
Sbjct: 168 DFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGC--DIWSLGILLYTMLAG 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRL----IAVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G      +A+K +    S  + +E ++E              L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +I    A+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----AKGMNYLE--- 134
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 244 CTID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 29/178 (16%)
Query: 189 AVKMMENSKFSAEEFINELL------------GLCSEGFKRALVYEYMPNGSLDRHIFSK 236
           AVK+++ SK    E I  LL             +  +G    LV E M  G L   I   
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILR- 114
Query: 237 ENKGQTFGLEKPHEIALGT-ARGIEYLHNGCDVCILHFDIKPHNIL-LDHNFIP---KVS 291
               Q F  E+     L T  + +EYLH+     ++H D+KP NIL +D +  P   ++ 
Sbjct: 115 ----QKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRIC 167
Query: 292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           DFG AK    EN  +       T  ++APE++ R      C  D++  G++L  M  G
Sbjct: 168 DFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGC--DIWSLGILLYTMLAG 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRLI----AVKMME--NSKFSAEEFINE--------------L 207
           L  G FG+VYKG  +  G  +    A+K +    S  + +E ++E              L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +IA    +G+ YL    
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGMNYLE--- 141
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 202 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 250
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 251 CTID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 169 LGQGGFGSVY-KGQLHTGRLIAVKMMENSKF----SAEEFINELLGLCSEGF-------- 215
           LG G FG V     + TG   A+K+++  K       E  +NE   L +  F        
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCD 267
                    +V EY+  G +  H+       +     +PH    A       EYLH+   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRN 326
           + +++ D+KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKG 214
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           +       D +  G+++ EMA G
Sbjct: 215 YNKA---VDWWALGVLIYEMAAG 234

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 125
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +  H   +   ++S   GT+ YL PE+I  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLS---GTLDYLPPEMIEG 181
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 182 RMH--DEKVDLWSLGVLCYEFLVGK 204

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVK--------------MMEN---SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK              +ME    SKF+ +  + 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 105 -CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 263 HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   + + +         + ++ 
Sbjct: 164 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 221 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 260
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 261 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 312

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           L+ E +  G L   +  KE+  +    E+  E       G+ YLH+   + I HFD+KP 
Sbjct: 91  LIGELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHS---LQIAHFDLKPE 143
Query: 279 NILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKS 334
           NI+L    +P    K+ DFGLA      N+F +I    GT  ++APE++  N+  +  ++
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEA 198
Query: 335 DVYGFGMVLLEMAGG 349
           D++  G++   +  G
Sbjct: 199 DMWSIGVITYILLSG 213

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 169 LGQGGFGSVYKG-QLHTGRL----IAVKMME--NSKFSAEEFINE--------------L 207
           LG G FG+VYKG  +  G      +A+K +    S  + +E ++E              L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LG+C     + L+ + MP G L  ++   K+N G  + L    +I    A+G+ YL    
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----AKGMNYLE--- 141
Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 327 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 202 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 250
Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
             I+      + MI + C  + A  RP   +++
Sbjct: 251 CTID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 41/207 (19%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF--------------------INEL 207
           K+G+G +G VYK +   GR++A+K +   +  AE+                     I  L
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH-EIAL-GTARGIEYLHNG 265
           + +        LV+E+M     D      ENK    GL+    +I L    RG+ + H  
Sbjct: 85  IDVIHSERCLTLVFEFMEK---DLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-- 323
               ILH D+KP N+L++ +   K++DFGLA+         S +    T+ Y AP+++  
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           S+ + T     D++  G +  EM  G+
Sbjct: 194 SKKYST---SVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 41/207 (19%)
Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF--------------------INEL 207
           K+G+G +G VYK +   GR++A+K +   +  AE+                     I  L
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH-EIAL-GTARGIEYLHNG 265
           + +        LV+E+M     D      ENK    GL+    +I L    RG+ + H  
Sbjct: 85  IDVIHSERCLTLVFEFMEK---DLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-- 323
               ILH D+KP N+L++ +   K++DFGLA+         S +    T+ Y AP+++  
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           S+ + T     D++  G +  EM  G+
Sbjct: 194 SKKYST---SVDIWSIGCIFAEMITGK 217

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 131
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K++DFG +   P        +   GT+ YL PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 187
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 188 E--KVDLWSLGVLCYEFLVGK 206

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVK--------------MMEN---SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK              +ME    SKF+ +  + 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 99  -CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 263 HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   + + +         + ++ 
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 215 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 254
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 255 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 127
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P        +   GT+ YL PE+I  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 183
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 184 RMH--DEKVDLWSLGVLCYEFLVGK 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 75  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 123
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P        +   GT+ YL PE+I  
Sbjct: 124 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 179
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 180 RMH--DEKVDLWSLGVLCYEFLVGK 202

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVKMMEN-----------------SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK +                   SKF+ +  + 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 98  -CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 263 HNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   + + +         + ++ 
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 214 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 253
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 254 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVK--------------MMEN---SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK              +ME    SKF+ +  + 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 115 -CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 263 HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   + + +         + ++ 
Sbjct: 174 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 231 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 270
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 271 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 322

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G     ++ +  K   F  ++       TA  I  L N    C
Sbjct: 81  YFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQR-------TATYITELANALSYC 129
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P            GT+ YL PE+I  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPEMIEG 185
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 186 RMH--DEKVDLWSLGVLCYEFLVGK 208

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVKMMEN-----------------SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK +                   SKF+ +  + 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 113 -CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 263 HNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   + + +         + ++ 
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 229 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 268
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 269 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 66/130 (50%), Gaps = 17/130 (13%)
Query: 219 LVYEYMPNGSLDRHIFSK-ENKG-QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
           +V E +  G L    FS+ +++G Q F   +  EI       I+YLH+   + I H D+K
Sbjct: 90  IVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVK 142
Query: 277 PHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           P N+L      N I K++DFG AK     N   S+++   T  Y+APE++       SC 
Sbjct: 143 PENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTEPCYTPYYVAPEVLGPEKYDKSC- 198
Query: 334 SDVYGFGMVL 343
            D++  G+++
Sbjct: 199 -DMWSLGVIM 207

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 128
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K++DFG +   P        +   GT+ YL PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 184
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVK--------------MMEN---SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK              +ME    SKF+ +  + 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 125 -CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 263 HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   + + +         + ++ 
Sbjct: 184 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 241 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMPY-----PSKSNQE 280
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 281 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 332

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 124
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P            GT+ YL PE+I  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEG 180
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 181 RMH--DEKVDLWSLGVLCYEFLVGK 203

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVKMMEN-----------------SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK +                   SKF+ +  + 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 98  -CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 263 HNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   + + +         + ++ 
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 214 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 253
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 254 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVKMMEN-----------------SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK +                   SKF+ +  + 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 113 -CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 263 HNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   + + +         + ++ 
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 229 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 268
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 269 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 133
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K++DFG +   P        +   GT+ YL PE+I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 189
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVK--------------MMEN---SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK              +ME    SKF+ +  + 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 99  -CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 263 HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   + + +         + ++ 
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 215 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 254
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 255 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 73  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 121
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P        +   GT+ YL PE+I  
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 177
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 178 RMH--DEKVDLWSLGVLCYEFLVGK 200

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 124
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P        +   GT+ YL PE+I  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLDYLPPEMIEG 180
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 181 RMH--DEKVDLWSLGVLCYEFLVGK 203

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 95/226 (42%), Gaps = 42/226 (18%)
Query: 143 YRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSA 200
           +R ++Q  D   + E I V           G  SV K  +H  T    AVK+++ SK   
Sbjct: 14  HRNSIQFTDGYEVKEDIGV-----------GSYSVCKRCIHKATNMEFAVKIIDKSKRDP 62
Query: 201 EEFINELL------------GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKP 248
            E I  LL             +  +G    +V E M  G L   I       Q F  E+ 
Sbjct: 63  TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-----QKFFSERE 117
Query: 249 HEIALGT-ARGIEYLHNGCDVCILHFDIKPHNIL-LDHNFIP---KVSDFGLAKFHPKEN 303
               L T  + +EYLH      ++H D+KP NIL +D +  P   ++ DFG AK    EN
Sbjct: 118 ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
             +       T  ++APE++ R     +C  D++  G++L  M  G
Sbjct: 175 GLLMTPCY--TANFVAPEVLERQGYDAAC--DIWSLGVLLYTMLTG 216

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVKMMEN-----------------SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK +                   SKF+ +  + 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 90  -CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 263 HNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   + + +         + ++ 
Sbjct: 149 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 206 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 245
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 246 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 297

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 81/201 (40%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G     ++ +  K   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHSKR--- 133
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K++DFG +   P        +   GT+ YL PE+I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 189
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 130
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K++DFG +   P            GT+ YL PE+I      
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMHD 186
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 187 E--KVDLWSLGVLCYEFLVGK 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 128
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P        +   GT+ YL PE+I  
Sbjct: 129 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 184
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 185 RMH--DEKVDLWSLGVLCYEFLVGK 207

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 30/200 (15%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMM------------------ENSKFSAEEFINELLG 209
           LG G FG V  G+   TG  +AVK++                  +N K      I +L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           + S      +V EY+  G L  +I  K  + +     +  +  L     ++Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSA---VDYCHRHM--- 131
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC--GSPNYAAPEVISGRL-Y 187
Query: 330 VSCKSDVYGFGMVLLEMAGG 349
              + D++  G++L  +  G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 124
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P            GT+ YL PE+I  
Sbjct: 125 HSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEG 180
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 181 RMH--DEKVDLWSLGVLCYEFLVGK 203

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 31/206 (15%)
Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLI-AVKMMENS---KFSAEEFI----NELLGLCSEGF 215
           HF   +G+G FG V   +     +  AVK+++     K   E+ I    N LL      F
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 216 ------------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
                       K   V +Y+  G L  H+     + + F   +    A   A  + YLH
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLH 156
Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
           +   + I++ D+KP NILLD      ++DFGL K + + N   + S   GT  YLAPE++
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVL 211
Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGG 349
            +         D +  G VL EM  G
Sbjct: 212 HKQ--PYDRTVDWWCLGAVLYEMLYG 235

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 93  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 141
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P            GT+ YL PE+I  
Sbjct: 142 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEG 197
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 198 RMHDE--KVDLWSLGVLCYEFLVGK 220

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 110/292 (37%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVK--------------MMEN---SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK              +ME    SKF+ +  + 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 139 -CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 263 HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   +   +         + ++ 
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 255 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 294
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 295 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 102/230 (44%), Gaps = 41/230 (17%)
Query: 148 QTVDNILLPEIIAVTNHFT--HKLGQGGFGSVYKGQLHT--GRLI--AVKMMENSKFSA- 200
           + ++++L+PE       FT    LG+G FGSV + QL    G  +  AVKM++    ++ 
Sbjct: 13  EKLEDVLIPE-----QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS 67
Query: 201 --EEFINE--------------LLGLCSEGFKRA------LVYEYMPNGSLDRHIFSKEN 238
             EEF+ E              L+G+      +       ++  +M +G L   + +   
Sbjct: 68  DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 239 KGQTFGL--EKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296
               F L  +      +  A G+EYL +      +H D+   N +L  +    V+DFGL+
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS 184
Query: 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           +     + +     ++  + +LA E ++ N  TV   SDV+ FG+ + E+
Sbjct: 185 RKIYSGDYYRQGCASKLPVKWLALESLADNLYTV--HSDVWAFGVTMWEI 232

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 150
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P            GT+ YL PE+I  
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEG 206
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 207 RMHDE--KVDLWSLGVLCYEFLVGK 229

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 127
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P            GT+ YL PE+I  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEG 183
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 184 RMH--DEKVDLWSLGVLCYEFLVGK 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 127
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P            GT+ YL PE+I  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEG 183
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 184 RMHDE--KVDLWSLGVLCYEFLVGK 206

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 110/292 (37%), Gaps = 58/292 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVK--------------MMEN---SKFSAEEFIN 205
           LG G FG VY+GQ+       +   +AVK              +ME    SKF+ +  + 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 206 ELLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL
Sbjct: 116 -CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 263 HNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                   +H DI   N LL       + K+ DFG+A+   +   +         + ++ 
Sbjct: 175 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           PE      G  + K+D + FG++L E+              S  Y P       +K    
Sbjct: 232 PEAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQE 271
Query: 380 ELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
            L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 272 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 323

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 64/142 (45%), Gaps = 18/142 (12%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           LV+E M  GS+  HI    +K + F   +   +    A  +++LHN     I H D+KP 
Sbjct: 88  LVFEKMRGGSILSHI----HKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPE 140
Query: 279 NILLDH--NFIP-KVSDFGLAKFHPKENDFVSISDTR-----GTIGYLAPELI---SRNF 327
           NIL +H     P K+ DFGL        D   IS        G+  Y+APE++   S   
Sbjct: 141 NILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 328 GTVSCKSDVYGFGMVLLEMAGG 349
                + D++  G++L  +  G
Sbjct: 201 SIYDKRCDLWSLGVILYILLSG 222

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 12/89 (13%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRG 313
           G+ YLH+     I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    G
Sbjct: 120 GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---G 173
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMV 342
           T  ++APE++  N+  +  ++D++  G++
Sbjct: 174 TPEFVAPEIV--NYEPLGLEADMWSIGVI 200

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        ++     GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA-----GTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 12/96 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRG 313
           G+ YLH+     I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    G
Sbjct: 127 GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---G 180
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           T  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 181 TPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 124
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K++DFG +   P            GT+ YL PE+I  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEG 180
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 181 RMH--DEKVDLWSLGVLCYEFLVGK 203

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 12/89 (13%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRG 313
           G+ YLH+     I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    G
Sbjct: 141 GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---G 194
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMV 342
           T  ++APE++  N+  +  ++D++  G++
Sbjct: 195 TPEFVAPEIV--NYEPLGLEADMWSIGVI 221

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 33/201 (16%)
Query: 167 HKLGQGGFG-SVYKGQLHTGRLIAVKMMENSKFSA---EEFINELLGLCS---------- 212
            K+G+G FG ++       GR   +K +  S+ S+   EE   E+  L +          
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 213 EGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           E F+      +V +Y   G L + I ++  KG  F  ++  +  +     ++++H   D 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVH---DR 144
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG---YLAPELISR 325
            ILH DIK  NI L  +   ++ DFG+A+     N  V ++  R  IG   YL+PE+   
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELA--RACIGTPYYLSPEICEN 199
Query: 326 NFGTVSCKSDVYGFGMVLLEM 346
                + KSD++  G VL E+
Sbjct: 200 K--PYNNKSDIWALGCVLYEL 218

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 109/291 (37%), Gaps = 56/291 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVKMMEN--SKFSAEEFINELL------------ 208
           LG G FG VY+GQ+       +   +AVK +    S+    +F+ E L            
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 209 --GLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
             G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 264 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 216 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 255
Query: 381 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
           L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 256 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 17/130 (13%)
Query: 219 LVYEYMPNGSLDRHIFSK-ENKG-QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
           +V E +  G L    FS+ +++G Q F   +  EI       I+YLH+   + I H D+K
Sbjct: 136 IVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVK 188
Query: 277 PHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           P N+L      N I K++DFG AK     N   S++    T  Y+APE++       SC 
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC- 244
Query: 334 SDVYGFGMVL 343
            D++  G+++
Sbjct: 245 -DMWSLGVIM 253

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 17/130 (13%)
Query: 219 LVYEYMPNGSLDRHIFSK-ENKG-QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
           +V E +  G L    FS+ +++G Q F   +  EI       I+YLH+   + I H D+K
Sbjct: 142 IVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVK 194
Query: 277 PHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           P N+L      N I K++DFG AK     N   S++    T  Y+APE++       SC 
Sbjct: 195 PENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC- 250
Query: 334 SDVYGFGMVL 343
            D++  G+++
Sbjct: 251 -DMWSLGVIM 259

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 17/130 (13%)
Query: 219 LVYEYMPNGSLDRHIFSK-ENKG-QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
           +V E +  G L    FS+ +++G Q F   +  EI       I+YLH+   + I H D+K
Sbjct: 90  IVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVK 142
Query: 277 PHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           P N+L      N I K++DFG AK     N   S++    T  Y+APE++       SC 
Sbjct: 143 PENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC- 198
Query: 334 SDVYGFGMVL 343
            D++  G+++
Sbjct: 199 -DMWSLGVIM 207

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 13/128 (10%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           +V E +  G L   I  ++   Q F   +  EI       I+YLH+   + I H D+KP 
Sbjct: 96  IVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 150
Query: 279 NILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD 335
           N+L      N I K++DFG AK     N   S++    T  Y+APE++       SC  D
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--D 205
Query: 336 VYGFGMVL 343
           ++  G+++
Sbjct: 206 MWSLGVIM 213

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 17/130 (13%)
Query: 219 LVYEYMPNGSLDRHIFSK-ENKG-QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
           +V E +  G L    FS+ +++G Q F   +  EI       I+YLH+   + I H D+K
Sbjct: 92  IVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVK 144
Query: 277 PHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           P N+L      N I K++DFG AK     N   S++    T  Y+APE++       SC 
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC- 200
Query: 334 SDVYGFGMVL 343
            D++  G+++
Sbjct: 201 -DMWSLGVIM 209

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 60/116 (51%), Gaps = 13/116 (11%)
Query: 233 IFSK-ENKG-QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFI 287
           +FS+ +++G Q F   +  EI       I+YLH+   + I H D+KP N+L      N I
Sbjct: 107 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAI 163
Query: 288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVL 343
            K++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++
Sbjct: 164 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 214

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 13/128 (10%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           +V E +  G L   I  ++   Q F   +  EI       I+YLH+   + I H D+KP 
Sbjct: 91  IVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 145
Query: 279 NILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD 335
           N+L      N I K++DFG AK     N   S++    T  Y+APE++       SC  D
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--D 200
Query: 336 VYGFGMVL 343
           ++  G+++
Sbjct: 201 MWSLGVIM 208

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
           G+ YLH      I+H D+KP N+LL   + + + K+ DFGL+     +     + +  GT
Sbjct: 148 GVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGT 201
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
             Y+APE++ + +     K DV+  G++L  +  G
Sbjct: 202 AYYIAPEVLRKKYDE---KCDVWSIGVILFILLAG 233

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 13/128 (10%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           +V E +  G L   I  ++   Q F   +  EI       I+YLH+   + I H D+KP 
Sbjct: 106 IVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 160
Query: 279 NILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD 335
           N+L      N I K++DFG AK     N   S++    T  Y+APE++       SC  D
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--D 215
Query: 336 VYGFGMVL 343
           ++  G+++
Sbjct: 216 MWSLGVIM 223

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 109/291 (37%), Gaps = 56/291 (19%)
Query: 169 LGQGGFGSVYKGQLH------TGRLIAVKMMEN--SKFSAEEFINELL------------ 208
           LG G FG VY+GQ+       +   +AVK +    S+    +F+ E L            
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 209 --GLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
             G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 264 NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 230 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 269
Query: 381 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
           L  VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 270 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 17/130 (13%)
Query: 219 LVYEYMPNGSLDRHIFSK-ENKG-QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
           +V E +  G L    FS+ +++G Q F   +  EI       I+YLH+   + I H D+K
Sbjct: 92  IVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVK 144
Query: 277 PHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           P N+L      N I K++DFG AK     N   S++    T  Y+APE++       SC 
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC- 200
Query: 334 SDVYGFGMVL 343
            D++  G+++
Sbjct: 201 -DMWSLGVIM 209

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 13/128 (10%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           +V E +  G L   I  ++   Q F   +  EI       I+YLH+   + I H D+KP 
Sbjct: 98  IVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 152
Query: 279 NILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD 335
           N+L      N I K++DFG AK     N   S++    T  Y+APE++       SC  D
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--D 207
Query: 336 VYGFGMVL 343
           ++  G+++
Sbjct: 208 MWSLGVIM 215

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 42/208 (20%)
Query: 168 KLGQGGFGSVYKGQ--LHTGRLIAVKMM------ENSKFSA----------EEF----IN 205
           ++G+G +G V+K +   + GR +A+K +      E    S           E F    + 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 206 ELLGLCS-----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGL--EKPHEIALGTARG 258
            L  +C+        K  LV+E++     D+ + +  +K    G+  E   ++     RG
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-----DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           +++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYR 186
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 15/106 (14%)
Query: 251 IALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND------ 304
           I L  A  +E+LH+     ++H D+KP NI    + + KV DFGL     ++ +      
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 305 ----FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
               +   +   GT  Y++PE I  N  + S K D++  G++L E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL 223

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 104/239 (43%), Gaps = 47/239 (19%)
Query: 139 LIHKYRTTMQTVDNILLP----EIIAVTNHFTHKLGQGGFGSVYKGQL----HTGRLIAV 190
            + +Y+ T+  + ++ +     E++ V       +G+G FG V   QL     T ++ A+
Sbjct: 55  FLSRYKDTINKIRDLRMKAEDYEVVKV-------IGRGAFGEV---QLVRHKSTRKVYAM 104
Query: 191 KMME--------NSKFSAEE----------FINELLGLCSEGFKRALVYEYMPNGSLDRH 232
           K++         +S F  EE          ++ +L     +     +V EYMP G L  +
Sbjct: 105 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VN 163
Query: 233 IFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD 292
           + S  +  + +      E+ L     ++ +H+   +  +H D+KP N+LLD +   K++D
Sbjct: 164 LMSNYDVPEKWARFYTAEVVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 216
Query: 293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT--VSCKSDVYGFGMVLLEMAGG 349
           FG      KE   V      GT  Y++PE++    G      + D +  G+ L EM  G
Sbjct: 217 FGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 40/204 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEFINEL---------------LGLCS 212
           LG+G FG+VY  +    + I A+K++  S+   E   ++L               L + +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 213 EGFKRALVY---EYMPNGSL----DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
               R  +Y   E+ P G L     +H    E +  TF  E         A  + Y H  
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH-- 131
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
            +  ++H DIKP N+L+ +    K++DFG +   P     +      GT+ YL PE+I  
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEG 186
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
              T   K D++  G++  E   G
Sbjct: 187 K--THDEKVDLWCAGVLCYEFLVG 208

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 42/208 (20%)
Query: 168 KLGQGGFGSVYKGQ--LHTGRLIAVKMM------ENSKFSA----------EEF----IN 205
           ++G+G +G V+K +   + GR +A+K +      E    S           E F    + 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 206 ELLGLCS-----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGL--EKPHEIALGTARG 258
            L  +C+        K  LV+E++     D+ + +  +K    G+  E   ++     RG
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-----DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           +++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYR 186
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK   K   +       GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK-RVKGRTWX----LXGTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 104/239 (43%), Gaps = 47/239 (19%)
Query: 139 LIHKYRTTMQTVDNILLP----EIIAVTNHFTHKLGQGGFGSVYKGQL----HTGRLIAV 190
            + +Y+ T+  + ++ +     E++ V       +G+G FG V   QL     T ++ A+
Sbjct: 50  FLSRYKDTINKIRDLRMKAEDYEVVKV-------IGRGAFGEV---QLVRHKSTRKVYAM 99
Query: 191 KMME--------NSKFSAEE----------FINELLGLCSEGFKRALVYEYMPNGSLDRH 232
           K++         +S F  EE          ++ +L     +     +V EYMP G L  +
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VN 158
Query: 233 IFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD 292
           + S  +  + +      E+ L     ++ +H+   +  +H D+KP N+LLD +   K++D
Sbjct: 159 LMSNYDVPEKWARFYTAEVVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT--VSCKSDVYGFGMVLLEMAGG 349
           FG      KE   V      GT  Y++PE++    G      + D +  G+ L EM  G
Sbjct: 212 FGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 13/90 (14%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTR 312
            G+ YLH      I+H D+KP NILL  +  P    K+ DFG+++   K      + +  
Sbjct: 142 EGVYYLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSR---KIGHACELREIM 194
Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMV 342
           GT  YLAPE++  N+  ++  +D++  G++
Sbjct: 195 GTPEYLAPEIL--NYDPITTATDMWNIGII 222

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 119 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 168
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 220
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 221 DWWALGVLIYEMAAG 235

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 40/204 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEFINEL---------------LGLCS 212
           LG+G FG+VY  +    + I A+K++  S+   E   ++L               L + +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 213 EGFKRALVY---EYMPNGSL----DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
               R  +Y   E+ P G L     +H    E +  TF  E         A  + Y H  
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH-- 132
Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
            +  ++H DIKP N+L+ +    K++DFG +   P     +      GT+ YL PE+I  
Sbjct: 133 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEG 187
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
              T   K D++  G++  E   G
Sbjct: 188 K--THDEKVDLWCAGVLCYEFLVG 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV--CILHFDIK 276
           +V EY   G L   I     + Q    E    +       ++  H   D    +LH D+K
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 277 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDV 336
           P N+ LD     K+ DFGLA+    +  F       GT  Y++PE ++R   + + KSD+
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRM--SYNEKSDI 199
Query: 337 YGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-VYDQLNKGGDLELRNVTEIESMIARKL 395
           +  G +L E+                A  P +  + Q    G +       I    + +L
Sbjct: 200 WSLGCLLYELC---------------ALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 396 CMIGLWCIQVKAADRPSMTKVLE 418
             I    + +K   RPS+ ++LE
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILE 267

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 104/239 (43%), Gaps = 47/239 (19%)
Query: 139 LIHKYRTTMQTVDNILLP----EIIAVTNHFTHKLGQGGFGSVYKGQL----HTGRLIAV 190
            + +Y+ T+  + ++ +     E++ V       +G+G FG V   QL     T ++ A+
Sbjct: 55  FLSRYKDTINKIRDLRMKAEDYEVVKV-------IGRGAFGEV---QLVRHKSTRKVYAM 104
Query: 191 KMME--------NSKFSAEE----------FINELLGLCSEGFKRALVYEYMPNGSLDRH 232
           K++         +S F  EE          ++ +L     +     +V EYMP G L  +
Sbjct: 105 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VN 163
Query: 233 IFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD 292
           + S  +  + +      E+ L     ++ +H+   +  +H D+KP N+LLD +   K++D
Sbjct: 164 LMSNYDVPEKWARFYTAEVVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 216
Query: 293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT--VSCKSDVYGFGMVLLEMAGG 349
           FG      KE   V      GT  Y++PE++    G      + D +  G+ L EM  G
Sbjct: 217 FGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 42/208 (20%)
Query: 168 KLGQGGFGSVYKGQ--LHTGRLIAVKMM------ENSKFSA----------EEF----IN 205
           ++G+G +G V+K +   + GR +A+K +      E    S           E F    + 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 206 ELLGLCS-----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGL--EKPHEIALGTARG 258
            L  +C+        K  LV+E++     D+ + +  +K    G+  E   ++     RG
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-----DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           +++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYR 186
Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEM 346
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 40/205 (19%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++       TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 127
Query: 270 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               ++H DIKP N+LL      K+++FG +   P        +   GT+ YL PE+I  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 183
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR 350
                  K D++  G++  E   G+
Sbjct: 184 RMH--DEKVDLWSLGVLCYEFLVGK 206

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 130
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K+++FG +   P        +   GT+ YL PE+I      
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 186
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 187 E--KVDLWSLGVLCYEFLVGK 205

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCDVCILHFDIK 276
           +V EY+  G +  H+       +     +PH    A       EYLH+   + +++ D+K
Sbjct: 118 MVMEYVAGGEMFSHL------RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLK 168
Query: 277 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKSD 335
           P N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VD 220
Query: 336 VYGFGMVLLEMAGG 349
            +  G+++ EMA G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISDTRG 313
           RG++Y+H+     ++H D+KP N+L++ N   K+ DFG+A+     P E+ +  +++   
Sbjct: 170 RGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-MTEYVA 225
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
           T  Y APEL+  +    +   D++  G +  EM   R+
Sbjct: 226 TRWYRAPELML-SLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 8/79 (10%)
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFG-LAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
           ++H D+KP NI L      K+ DFG L +        V   D R    Y+APEL+  ++G
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR----YMAPELLQGSYG 233
Query: 329 TVSCKSDVYGFGMVLLEMA 347
           T    +DV+  G+ +LE+A
Sbjct: 234 TA---ADVFSLGLTILEVA 249

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISDTRG 313
           RG++Y+H+     ++H D+KP N+L++ N   K+ DFG+A+     P E+ +  +++   
Sbjct: 169 RGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-MTEYVA 224
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
           T  Y APEL+  +    +   D++  G +  EM   R+
Sbjct: 225 TRWYRAPELML-SLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 22/203 (10%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV--CILHFDIK 276
           +V EY   G L   I     + Q    E    +       ++  H   D    +LH D+K
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 277 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDV 336
           P N+ LD     K+ DFGLA+    +  F       GT  Y++PE ++R   + + KSD+
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRM--SYNEKSDI 199
Query: 337 YGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-VYDQLNKGGDLELRNVTEIESMIARKL 395
           +  G +L E+                A  P +  + Q    G +       I    + +L
Sbjct: 200 WSLGCLLYELC---------------ALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 396 CMIGLWCIQVKAADRPSMTKVLE 418
             I    + +K   RPS+ ++LE
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILE 267

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 45/201 (22%)
Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMEN----SKFSAEEFIN--------ELLGL---C 211
           +LG G FG V++  +  TGR+   K +       K++ +  I+        +L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV--- 268
            + ++  L+ E++  G L   I +++ K             +  A  I Y+   C+    
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYK-------------MSEAEVINYMRQACEGLKH 164
Query: 269 ----CILHFDIKPHNILLDHNFIP--KVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPE 321
                I+H DIKP NI+ +       K+ DFGLA K +P E     +  T  T  + APE
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPE 220
Query: 322 LISRNFGTVSCKSDVYGFGMV 342
           ++ R    V   +D++  G++
Sbjct: 221 IVDRE--PVGFYTDMWAIGVL 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFAEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 29/204 (14%)
Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINELLGLCSEGFKRALV 220
           H   K+G+G +G VYK Q + G   A+K +   K         I E+  +  E     +V
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI-SILKELKHSNIV 63
Query: 221 YEYMPNGSLDRHIFSKENKGQTF---------GLEK--PHEIALGTARGIEYLHNGCDVC 269
             Y    +  R +   E+  Q           GLE        L    GI Y H   D  
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELI--SR 325
           +LH D+KP N+L++     K++DFGLA+    P       I     T+ Y AP+++  S+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSK 176
Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
            + T     D++  G +  EM  G
Sbjct: 177 KYSTT---IDIWSVGCIFAEMVNG 197

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCDVCILHFDIK 276
           +V EY+  G +  H+       +     +PH    A       EYLH+   + +++ D+K
Sbjct: 113 MVMEYVAGGEMFSHL------RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLK 163
Query: 277 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKSD 335
           P N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       D
Sbjct: 164 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VD 215
Query: 336 VYGFGMVLLEMAGG 349
            +  G+++ EMA G
Sbjct: 216 WWALGVLIYEMAAG 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 27/203 (13%)
Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINELLGLCSEGFKRALV 220
           H   K+G+G +G VYK Q + G   A+K +   K         I E+  +  E     +V
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI-SILKELKHSNIV 63
Query: 221 YEYMPNGSLDRHIFSKENKGQTF---------GLEK--PHEIALGTARGIEYLHNGCDVC 269
             Y    +  R +   E+  Q           GLE        L    GI Y H   D  
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI--SRN 326
           +LH D+KP N+L++     K++DFGLA+ F      +   +    T+ Y AP+++  S+ 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---THEVVTLWYRAPDVLMGSKK 177
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           + T     D++  G +  EM  G
Sbjct: 178 YSTT---IDIWSVGCIFAEMVNG 197

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGTARGIEYLHNGCDVCILHFDIK 276
           +V EY+  G +  H+       +     +PH    A       EYLH+   + +++ D+K
Sbjct: 105 MVMEYVAGGEMFSHL------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLK 155
Query: 277 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKSD 335
           P N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       D
Sbjct: 156 PENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VD 207
Query: 336 VYGFGMVLLEMAGG 349
            +  G+++ EMA G
Sbjct: 208 WWALGVLIYEMAAG 221

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 27/203 (13%)
Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINELLGLCSEGFKRALV 220
           H   K+G+G +G VYK Q + G   A+K +   K         I E+  +  E     +V
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI-SILKELKHSNIV 63
Query: 221 YEYMPNGSLDRHIFSKENKGQTF---------GLEK--PHEIALGTARGIEYLHNGCDVC 269
             Y    +  R +   E+  Q           GLE        L    GI Y H   D  
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI--SRN 326
           +LH D+KP N+L++     K++DFGLA+ F      +   +    T+ Y AP+++  S+ 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---THEVVTLWYRAPDVLMGSKK 177
Query: 327 FGTVSCKSDVYGFGMVLLEMAGG 349
           + T     D++  G +  EM  G
Sbjct: 178 YSTT---IDIWSVGCIFAEMVNG 197

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 22/163 (13%)
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
           T +G++YLHN     ++H D+K  N+ L+ +   K+ DFGLA     E D     D  GT
Sbjct: 135 TIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGT 189
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374
             Y+APE++ +     S + D++  G +L  +  G+     +  + +        Y ++ 
Sbjct: 190 PNYIAPEVLCKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIK 239
Query: 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
           K      R++  + S + R++       +      RPS+ ++L
Sbjct: 240 KNEYSVPRHINPVASALIRRM-------LHADPTLRPSVAELL 275

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 11/88 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S   GT
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMV 342
            GY+APE++++     S   D +  G++
Sbjct: 182 PGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 139 MVMEYVAGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDL 188
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 240
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 241 DWWALGVLIYEMAAG 255

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 26/200 (13%)
Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMME-----NSKFSAE-----EFINEL--------L 208
           K+G+G F  VY+   L  G  +A+K ++     ++K  A+     + + +L         
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
               E  +  +V E    G L R I   + + +        +  +     +E++H+    
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
            ++H DIKP N+ +    + K+ D GL +F   +    +     GT  Y++PE I  N  
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHEN-- 211
Query: 329 TVSCKSDVYGFGMVLLEMAG 348
             + KSD++  G +L EMA 
Sbjct: 212 GYNFKSDIWSLGCLLYEMAA 231

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 11/88 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S   GT
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMV 342
            GY+APE++++     S   D +  G++
Sbjct: 182 PGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 84/202 (41%), Gaps = 34/202 (16%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEF-----------------INELLGL 210
           LG+G FG V K +   T +  AVK++  +    ++                  I +L  +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             +     +V E    G L    F +  K + F       I      GI Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 271 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
           +H D+KP NILL   + +   K+ DFGL+    +      + D  GT  Y+APE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLR--- 196
Query: 328 GTVSCKSDVYGFGMVLLEMAGG 349
           GT   K DV+  G++L  +  G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 34/199 (17%)
Query: 165 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF----------------INEL 207
           F   LG G F  V   +   T +L+A+K +       +E                 I  L
Sbjct: 22  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEK-PHEIALGTARGIEYLHNGC 266
             +   G    L+ + +  G L   I  K      F  E+    +       ++YLH   
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH--- 133
Query: 267 DVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
           D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S   GT GY+APE++
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 324 SRNFGTVSCKSDVYGFGMV 342
           ++     S   D +  G++
Sbjct: 191 AQK--PYSKAVDCWSIGVI 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 32/201 (15%)
Query: 169 LGQGGFGSVYKGQLHTGRLI-AVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG+VY  +    + I A+K++  ++                        I  L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR--- 133
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           ++H DIKP N+LL      K++DFG +   P        +   GT+ YL PE I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEXIEGRXHD 189
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
              K D++  G++  E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 84/202 (41%), Gaps = 34/202 (16%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEF-----------------INELLGL 210
           LG+G FG V K +   T +  AVK++  +    ++                  I +L  +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
             +     +V E    G L    F +  K + F       I      GI Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 271 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
           +H D+KP NILL   + +   K+ DFGL+    +      + D  GT  Y+APE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLR--- 196
Query: 328 GTVSCKSDVYGFGMVLLEMAGG 349
           GT   K DV+  G++L  +  G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 11/88 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
            ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S   GT
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMV 342
            GY+APE++++     S   D +  G++
Sbjct: 182 PGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 33/202 (16%)
Query: 169 LGQGGFGSVYKGQLHT--GRLIAVKMMENSKFSAEEF------------------INELL 208
           LG+G FG V K   HT  G+ +A+K++     +  +                   I +L 
Sbjct: 12  LGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 70
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            +     +  +V EY  N   D +I  ++   +    ++           +EY H     
Sbjct: 71  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSE----QEARRFFQQIISAVEYCHRHK-- 123
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
            I+H D+KP N+LLD +   K++DFGL+      N    +  + G+  Y APE+IS    
Sbjct: 124 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKL- 178
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
               + DV+  G++L  M   R
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRR 200

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 47/231 (20%)
Query: 148 QTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVK----------MMENSK 197
           Q++ N+++ E I         LG G  G+V       GR +AVK          +ME   
Sbjct: 11  QSLKNLVVSEKI---------LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 61
Query: 198 FS-AEEFINELLGLCSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEK---PHEIA 252
            + +++  N +   CSE   R L +   + N +L   + SK    +   L+K   P  + 
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLD-------------HNFIPKVSDFGL-AKF 298
              A G+ +LH+   + I+H D+KP NIL+               N    +SDFGL  K 
Sbjct: 122 RQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 299 HPKENDF-VSISDTRGTIGYLAPELI--SRNFGT---VSCKSDVYGFGMVL 343
              ++ F  ++++  GT G+ APEL+  S N  T   ++   D++  G V 
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 16/136 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           LV++ M  G L  ++  K     T   ++  +I       I  LH    + I+H D+KP 
Sbjct: 88  LVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPE 140
Query: 279 NILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPELI----SRNFGTVSCK 333
           NILLD +   K++DFG + +  P E     + +  GT  YLAPE+I    + N      +
Sbjct: 141 NILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKE 196
Query: 334 SDVYGFGMVLLEMAGG 349
            D++  G+++  +  G
Sbjct: 197 VDMWSTGVIMYTLLAG 212

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
           GI Y+H      I+H D+KP NILL   + +   K+ DFGL+    +      + D  GT
Sbjct: 133 GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGT 186
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
             Y+APE++    GT   K DV+  G++L  +  G
Sbjct: 187 AYYIAPEVLR---GTYDEKCDVWSAGVILYILLSG 218

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF   
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRF 192
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 193 TSASDVWMFGVCMWEI 208

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 22/163 (13%)
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
           T +G++YLHN     ++H D+K  N+ L+ +   K+ DFGLA     E D     D  GT
Sbjct: 151 TIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGT 205
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374
             Y+APE++ +     S + D++  G +L  +  G+     +  + +        Y ++ 
Sbjct: 206 PNYIAPEVLCKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIK 255
Query: 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
           K      R++  + S + R++       +      RPS+ ++L
Sbjct: 256 KNEYSVPRHINPVASALIRRM-------LHADPTLRPSVAELL 291

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF   
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRF 191
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 192 TSASDVWMFGVCMWEI 207

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 33/202 (16%)
Query: 169 LGQGGFGSVYKGQLHT--GRLIAVKMMENSKFSAEEF------------------INELL 208
           LG+G FG V K   HT  G+ +A+K++     +  +                   I +L 
Sbjct: 16  LGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 74
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            +     +  +V EY  N   D +I  ++   +    ++           +EY H     
Sbjct: 75  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSE----QEARRFFQQIISAVEYCHRHK-- 127
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
            I+H D+KP N+LLD +   K++DFGL+      N    +  + G+  Y APE+IS    
Sbjct: 128 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKL- 182
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
               + DV+  G++L  M   R
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRR 204

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 141 RGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 193 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 139 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 188
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK   K   +       GT  YLAPE+I S+ +       
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAK-RVKGATWTLC----GTPEYLAPEIILSKGYNKA---V 240
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 241 DWWALGVLIYEMAAG 255

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 63/129 (48%), Gaps = 17/129 (13%)
Query: 219 LVYEYMPNGSLDRHIFSK-ENKG-QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK 276
           +V E +  G L    FS+ +++G Q F   +  EI       I+YLH+   + I H D+K
Sbjct: 136 IVXECLDGGEL----FSRIQDRGDQAFTEREASEIXKSIGEAIQYLHS---INIAHRDVK 188
Query: 277 PHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCK 333
           P N+L      N I K++DFG AK     N   S++    T  Y+APE++       SC 
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC- 244
Query: 334 SDVYGFGMV 342
            D +  G++
Sbjct: 245 -DXWSLGVI 252

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 33/202 (16%)
Query: 169 LGQGGFGSVYKGQLHT--GRLIAVKMMENSKFSAEEF------------------INELL 208
           LG+G FG V K   HT  G+ +A+K++     +  +                   I +L 
Sbjct: 21  LGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 79
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            +     +  +V EY  N   D +I  ++   +    ++           +EY H     
Sbjct: 80  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSE----QEARRFFQQIISAVEYCHRHK-- 132
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
            I+H D+KP N+LLD +   K++DFGL+      N    +  + G+  Y APE+IS    
Sbjct: 133 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKL- 187
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
               + DV+  G++L  M   R
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRR 209

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 141 RGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 193 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 33/202 (16%)
Query: 169 LGQGGFGSVYKGQLHT--GRLIAVKMMENSKFSAEEF------------------INELL 208
           LG+G FG V K   HT  G+ +A+K++     +  +                   I +L 
Sbjct: 22  LGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 80
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            +     +  +V EY  N   D +I  ++   +    ++           +EY H     
Sbjct: 81  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSE----QEARRFFQQIISAVEYCHRHK-- 133
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
            I+H D+KP N+LLD +   K++DFGL+      N    +  + G+  Y APE+IS    
Sbjct: 134 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKL- 188
Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
               + DV+  G++L  M   R
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRR 210

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE-LISRNFGTVSCKS 334
           KP N+++D     +V+DFG AK        +      GT  YLAPE +IS+ +       
Sbjct: 168 KPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIISKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF   
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRF 194
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 195 TSASDVWMFGVCMWEI 210

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 16/136 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           LV++ M  G L    F    +  T   ++  +I       I  LH    + I+H D+KP 
Sbjct: 101 LVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPE 153
Query: 279 NILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPELI----SRNFGTVSCK 333
           NILLD +   K++DFG + +  P E     + +  GT  YLAPE+I    + N      +
Sbjct: 154 NILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKE 209
Query: 334 SDVYGFGMVLLEMAGG 349
            D++  G+++  +  G
Sbjct: 210 VDMWSTGVIMYTLLAG 225

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF   
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRF 217
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 218 TSASDVWMFGVCMWEI 233

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF   
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRF 186
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 187 TSASDVWMFGVCMWEI 202

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 45/212 (21%)
Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRA--------- 218
           +G+G F  V +     TG+  AVK+++ +KF++        GL +E  KR          
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP------GLSTEDLKREASICHMLKH 85
Query: 219 -----------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                            +V+E+M    L   I  + + G  +               + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 262 LHNGCDVCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
            H   D  I+H D+KPH +LL    N  P K+  FG+A     E+  V+     GT  ++
Sbjct: 146 CH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVA-GGRVGTPHFM 200
Query: 319 APELISRN-FGTVSCKSDVYGFGMVLLEMAGG 349
           APE++ R  +G      DV+G G++L  +  G
Sbjct: 201 APEVVKREPYGK---PVDVWGCGVILFILLSG 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 22/138 (15%)
Query: 239 KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298
           K Q    E    +     RG++Y+H+     I+H D+KP N+ ++ +   ++ DFGLA+ 
Sbjct: 124 KSQALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQ 180
Query: 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAT 358
             +E     ++    T  Y APE++  N+   +   D++  G ++ E+  G         
Sbjct: 181 ADEE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLQG--------- 225
Query: 359 RSSKAYFPSWVY-DQLNK 375
              KA FP   Y DQL +
Sbjct: 226 ---KALFPGSDYIDQLKR 240

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF   
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRF 189
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF   
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRF 189
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRW 194
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 195 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 51/106 (48%), Gaps = 15/106 (14%)
Query: 251 IALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND------ 304
           I +  A  +E+LH+     ++H D+KP NI    + + KV DFGL     ++ +      
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 305 ----FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
               + +     GT  Y++PE I  N    S K D++  G++L E+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFEL 269

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRW 194
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 195 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 147 MQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF-- 203
           ++ VD     E+   T+    +LG+G FG V++ +   TG   AVK +    F AEE   
Sbjct: 62  LKPVDYEYREEVHWATHQL--RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA 119
Query: 204 --------INELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT 255
                   I  L G   EG    +  E +  GSL + +     K Q    E      LG 
Sbjct: 120 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQGCLPEDRALYYLGQ 174
Query: 256 A-RGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PKVSDFGLAK-FHPK--ENDFVSISD 310
           A  G+EYLH+     ILH D+K  N+LL  +     + DFG A    P     D ++   
Sbjct: 175 ALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
             GT  ++APE++     +   K DV+    ++L M  G
Sbjct: 232 IPGTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHMLNG 268

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 147 RGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRW 198
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 199 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 39/211 (18%)
Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENS----------------KFSAEEFINELLGLC 211
           LG+G +  V     L  G+  AVK++E                  +    + I EL+   
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
            +  +  LV+E +  GS+  HI     K + F   +   +    A  +++LH      I 
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI----QKQKHFNEREASRVVRDVAAALDFLHTKG---IA 133
Query: 272 HFDIKPHNILLD--HNFIP-KVSDFGLAKFHPKENDFVSISDTR-----GTIGYLAPELI 323
           H D+KP NIL +      P K+ DF L       N    I+        G+  Y+APE++
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 324 -----SRNFGTVSCKSDVYGFGMVLLEMAGG 349
                   F    C  D++  G+VL  M  G
Sbjct: 194 EVFTDQATFYDKRC--DLWSLGVVLYIMLSG 222

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRW 194
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 195 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ +MA G
Sbjct: 220 DWWALGVLIYQMAAG 234

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 165 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 216
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE++  N+   +   D++  G ++ E+  GR
Sbjct: 217 YRAPEIM-LNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 45/212 (21%)
Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRA--------- 218
           +G+G F  V +     TG+  AVK+++ +KF++        GL +E  KR          
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP------GLSTEDLKREASICHMLKH 87
Query: 219 -----------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                            +V+E+M    L   I  + + G  +               + Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 262 LHNGCDVCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
            H   D  I+H D+KPH +LL    N  P K+  FG+A     E+  V+     GT  ++
Sbjct: 148 CH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVA-GGRVGTPHFM 202
Query: 319 APELISRN-FGTVSCKSDVYGFGMVLLEMAGG 349
           APE++ R  +G      DV+G G++L  +  G
Sbjct: 203 APEVVKREPYGK---PVDVWGCGVILFILLSG 231

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 37/199 (18%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSAEEF-----------------INELL 208
           +LG+G F SV +  +H  TG   A K++   K SA +F                 I  L 
Sbjct: 12  ELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCD 267
               E     LV++ +  G L   I ++E   +        +I       I Y H NG  
Sbjct: 71  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG-- 124
Query: 268 VCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
             I+H ++KP N+LL         K++DFGLA    + ND  +     GT GYL+PE++ 
Sbjct: 125 --IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLK 179
Query: 325 RNFGTVSCKSDVYGFGMVL 343
           ++    S   D++  G++L
Sbjct: 180 KD--PYSKPVDIWACGVIL 196

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 37/199 (18%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSAEEF-----------------INELL 208
           +LG+G F SV +  +H  TG   A K++   K SA +F                 I  L 
Sbjct: 13  ELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCD 267
               E     LV++ +  G L   I ++E   +        +I       I Y H NG  
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG-- 125
Query: 268 VCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
             I+H ++KP N+LL         K++DFGLA    + ND  +     GT GYL+PE++ 
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 325 RNFGTVSCKSDVYGFGMVL 343
           ++    S   D++  G++L
Sbjct: 181 KD--PYSKPVDIWACGVIL 197

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 41/206 (19%)
Query: 169 LGQGGFGSVY--KGQLHTGRLIAVKMMEN----SKFSAEEFINELLGLCS---------- 212
           LG+G FG V   K ++ TG+  AVK++       K   E  + E+  L            
Sbjct: 34  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 213 EGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           E F+      LV E    G L   I S++     F       I      GI Y+H     
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 269 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
            I+H D+KP N+LL     D N   ++ DFGL+           + D  GT  Y+APE++
Sbjct: 147 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 200
Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGG 349
               GT   K DV+  G++L  +  G
Sbjct: 201 ---HGTYDEKCDVWSTGVILYILLSG 223

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 138 RGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 190 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 141 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 193 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 135 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 186
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 187 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 194
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 195 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 142 RGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 194 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 22/120 (18%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   ++ DFGLA+   +E     ++    T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRW 193
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLNK 375
           Y APE++  N+   +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 194 YRAPEIM-LNWMHYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 240

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 18/142 (12%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           LV+E M  GS+  HI    +K + F   +   +    A  +++LHN     I H D+KP 
Sbjct: 88  LVFEKMRGGSILSHI----HKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPE 140
Query: 279 NILLDH--NFIP-KVSDFGLAKFHPKENDFVSISDTR-----GTIGYLAPELI---SRNF 327
           NIL +H     P K+ DF L        D   IS        G+  Y+APE++   S   
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 328 GTVSCKSDVYGFGMVLLEMAGG 349
                + D++  G++L  +  G
Sbjct: 201 SIYDKRCDLWSLGVILYILLSG 222

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF   
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRF 569
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 570 TSASDVWMFGVCMWEI 585

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 148 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 199
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 200 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 148 QTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVK----------MMENSK 197
           Q++ N+++ E I         LG G  G+V       GR +AVK          +ME   
Sbjct: 29  QSLKNLVVSEKI---------LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 79
Query: 198 FS-AEEFINELLGLCSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEK---PHEIA 252
            + +++  N +   CSE   R L +   + N +L   + SK    +   L+K   P  + 
Sbjct: 80  LTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLD-------------HNFIPKVSDFGL-AKF 298
              A G+ +LH+   + I+H D+KP NIL+               N    +SDFGL  K 
Sbjct: 140 RQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 299 HPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKS-DVYGFGMVL 343
              +  F  ++++  GT G+ APEL+  +      +S D++  G V 
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVF 243

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 146 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 197
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 198 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 148 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 199
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 200 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 148 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 199
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 200 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 22/120 (18%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   ++ DFGLA+   +E     ++    T  
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRW 185
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLNK 375
           Y APE++  N+   +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 186 YRAPEIML-NWMHYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 142 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 194 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 138 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 190 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 141 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 192
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 193 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 148 QTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVK----------MMENSK 197
           Q++ N+++ E I         LG G  G+V       GR +AVK          +ME   
Sbjct: 29  QSLKNLVVSEKI---------LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 79
Query: 198 FS-AEEFINELLGLCSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEK---PHEIA 252
            + +++  N +   CSE   R L +   + N +L   + SK    +   L+K   P  + 
Sbjct: 80  LTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLD-------------HNFIPKVSDFGL-AKF 298
              A G+ +LH+   + I+H D+KP NIL+               N    +SDFGL  K 
Sbjct: 140 RQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 299 HPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKS-DVYGFGMVL 343
              +  F  ++++  GT G+ APEL+  +      +S D++  G V 
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVF 243

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 37/199 (18%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSAEEF-----------------INELL 208
           +LG+G F SV +  +H  TG   A K++   K SA +F                 I  L 
Sbjct: 13  ELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCD 267
               E     LV++ +  G L   I ++E   +        +I       I Y H NG  
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG-- 125
Query: 268 VCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
             I+H ++KP N+LL         K++DFGLA    + ND  +     GT GYL+PE++ 
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 325 RNFGTVSCKSDVYGFGMVL 343
           ++    S   D++  G++L
Sbjct: 181 KD--PYSKPVDIWACGVIL 197

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 147 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 198
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 199 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 133 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 184
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 185 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 138 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 190 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 138 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 189
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 190 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 133 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 184
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 185 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 63/136 (46%), Gaps = 16/136 (11%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           LV++ M  G L    F    +  T   ++  +I       I  LH    + I+H D+KP 
Sbjct: 101 LVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPE 153
Query: 279 NILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPELI----SRNFGTVSCK 333
           NILLD +   K++DFG + +  P E     +    GT  YLAPE+I    + N      +
Sbjct: 154 NILLDDDMNIKLTDFGFSCQLDPGEK----LRSVCGTPSYLAPEIIECSMNDNHPGYGKE 209
Query: 334 SDVYGFGMVLLEMAGG 349
            D++  G+++  +  G
Sbjct: 210 VDMWSTGVIMYTLLAG 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 132 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 183
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 184 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 142 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 194 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 93/243 (38%), Gaps = 52/243 (21%)
Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVY------ 221
           LGQG FG V K +     R  A+K + +++      ++E+  L S   +  + Y      
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
Query: 222 ---------------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                                EY  N +L   I S EN  Q    ++   +       + 
Sbjct: 74  RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHS-ENLNQQ--RDEYWRLFRQILEALS 130
Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-------- 312
           Y+H+     I+H ++KP NI +D +   K+ DFGLAK   +  D + +            
Sbjct: 131 YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 313 ----GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMNATRSSKA 363
               GT  Y+A E++    G  + K D Y  G++  E       G  R + +   RS   
Sbjct: 188 TSAIGTAXYVATEVLD-GTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRSVSI 246
Query: 364 YFP 366
            FP
Sbjct: 247 EFP 249

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 134 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 185
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 186 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 132 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 183
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 184 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 155 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 206
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 207 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 156 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 207
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 208 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 159 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 210
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 211 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 132 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 183
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 184 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 155 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 206
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 207 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 156 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 207
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE++  N+   +   D++  G ++ E+  GR
Sbjct: 208 YRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 142 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 193
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 194 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 33/203 (16%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE----------------LLGL- 210
           +G+G +  V   +L  T R+ A+K+++    + +E I+                 L+GL 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 211 -CSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            C +   R   V EY+  G L  H+  +    +        EI+L     + YLH   + 
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ER 140
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNF 327
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  Y+APE++   ++
Sbjct: 141 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 198
Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
           G      D +  G+++ EM  GR
Sbjct: 199 G---FSVDWWALGVLMFEMMAGR 218

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 82/183 (44%), Gaps = 36/183 (19%)
Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF------SAEEF----------INELLGLC 211
           LGQG   +V++G+   TG L A+K+  N  F         EF          I +L  + 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 212 SEGFKR--ALVYEYMPNGSLDRHIFSKENKGQTFGL-EKPHEIAL-GTARGIEYLH-NGC 266
            E   R   L+ E+ P GSL   +   E     +GL E    I L     G+ +L  NG 
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 267 DVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
              I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT  YL P++
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHPDM 186
Query: 323 ISR 325
             R
Sbjct: 187 YER 189

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 63/133 (47%), Gaps = 11/133 (8%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           +V EYMP G L  ++ S  +  + +      E+ L     ++ +H+   + ++H D+KP 
Sbjct: 152 MVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLA----LDAIHS---MGLIHRDVKPD 203
Query: 279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT--VSCKSDV 336
           N+LLD +   K++DFG       E   V      GT  Y++PE++    G      + D 
Sbjct: 204 NMLLDKHGHLKLADFGTC-MKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 262
Query: 337 YGFGMVLLEMAGG 349
           +  G+ L EM  G
Sbjct: 263 WSVGVFLFEMLVG 275

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 33/203 (16%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE----------------LLGL- 210
           +G+G +  V   +L  T R+ A+K+++    + +E I+                 L+GL 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 211 -CSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            C +   R   V EY+  G L  H+  +    +        EI+L     + YLH   + 
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ER 125
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNF 327
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  Y+APE++   ++
Sbjct: 126 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 183
Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
           G      D +  G+++ EM  GR
Sbjct: 184 G---FSVDWWALGVLMFEMMAGR 203

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 47/231 (20%)
Query: 148 QTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVK----------MMENSK 197
           Q++ N+++ E I         LG G  G+V       GR +AVK          +ME   
Sbjct: 11  QSLKNLVVSEKI---------LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 61
Query: 198 FS-AEEFINELLGLCSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEK---PHEIA 252
            + +++  N +   CSE   R L +   + N +L   + SK    +   L+K   P  + 
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLD-------------HNFIPKVSDFGL-AKF 298
              A G+ +LH+   + I+H D+KP NIL+               N    +SDFGL  K 
Sbjct: 122 RQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 299 HPKENDF-VSISDTRGTIGYLAPELI--SRNFGT---VSCKSDVYGFGMVL 343
              +  F  ++++  GT G+ APEL+  S N  T   ++   D++  G V 
Sbjct: 179 DSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    +++      TR    
Sbjct: 132 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATR---W 183
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 184 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     +     T  
Sbjct: 156 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRW 207
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 208 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     +     T  
Sbjct: 159 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRW 210
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE++  N+   +   D++  G ++ E+  GR
Sbjct: 211 YRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 41/206 (19%)
Query: 169 LGQGGFGSVY--KGQLHTGRLIAVKMMEN----SKFSAEEFINELLGLCS---------- 212
           LG+G FG V   K ++ TG+  AVK++       K   E  + E+  L            
Sbjct: 40  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 213 EGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           E F+      LV E    G L   I S++     F       I      GI Y+H     
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKNK-- 152
Query: 269 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
            I+H D+KP N+LL     D N   ++ DFGL+           + D  GT  Y+APE++
Sbjct: 153 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 206
Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGG 349
               GT   K DV+  G++L  +  G
Sbjct: 207 H---GTYDEKCDVWSTGVILYILLSG 229

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT  YLAP +I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPAIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 33/203 (16%)
Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE----------------LLGL- 210
           +G+G +  V   +L  T R+ A+K+++    + +E I+                 L+GL 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 211 -CSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            C +   R   V EY+  G L  H+  +    +        EI+L     + YLH   + 
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ER 129
Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNF 327
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  Y+APE++   ++
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 187
Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
           G      D +  G+++ EM  GR
Sbjct: 188 G---FSVDWWALGVLMFEMMAGR 207

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 87/208 (41%), Gaps = 40/208 (19%)
Query: 165 FTHKLGQGGFG--SVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCS------EGFK 216
           F   +G G FG   + + +L T  L+AVK +E      E    E++   S        FK
Sbjct: 24  FVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 217 R--------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
                    A++ EY   G L   I    N G+ F  ++          G+ Y H+   +
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERIC---NAGR-FSEDEARFFFQQLLSGVSYCHS---M 135
Query: 269 CILHFDIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISDTRGTIGYLAPELI 323
            I H D+K  N LLD +  P  K+ DFG +K    H +    V      GT  Y+APE++
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVL 189
Query: 324 SRNF--GTVSCKSDVYGFGMVLLEMAGG 349
            R    G +   +DV+  G+ L  M  G
Sbjct: 190 LRQEYDGKI---ADVWSCGVTLYVMLVG 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 37/199 (18%)
Query: 168 KLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSAEEF-----------------INELL 208
           +LG+G F SV +  +H  TG   A K++   K SA +F                 I  L 
Sbjct: 36  ELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCD 267
               E     LV++ +  G L   I ++E   +        +I       I Y H NG  
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG-- 148
Query: 268 VCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
             I+H ++KP N+LL         K++DFGLA    + ND  +     GT GYL+PE++ 
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 325 RNFGTVSCKSDVYGFGMVL 343
           ++    S   D++  G++L
Sbjct: 204 KD--PYSKPVDIWACGVIL 220

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 41/206 (19%)
Query: 169 LGQGGFGSVY--KGQLHTGRLIAVKMMEN----SKFSAEEFINELLGLCS---------- 212
           LG+G FG V   K ++ TG+  AVK++       K   E  + E+  L            
Sbjct: 57  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 213 EGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           E F+      LV E    G L   I S++     F       I      GI Y+H     
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKNK-- 169
Query: 269 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
            I+H D+KP N+LL     D N   ++ DFGL+           + D  GT  Y+APE++
Sbjct: 170 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 223
Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGG 349
               GT   K DV+  G++L  +  G
Sbjct: 224 ---HGTYDEKCDVWSTGVILYILLSG 246

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 93/226 (41%), Gaps = 42/226 (18%)
Query: 143 YRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSA 200
           +R ++Q  D   + E I V           G  SV K  +H  T    AVK+++ SK   
Sbjct: 14  HRNSIQFTDGYEVKEDIGV-----------GSYSVCKRCIHKATNXEFAVKIIDKSKRDP 62
Query: 201 EEFINELL------------GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKP 248
            E I  LL             +  +G    +V E    G L   I       Q F  E+ 
Sbjct: 63  TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILR-----QKFFSERE 117
Query: 249 HEIALGT-ARGIEYLHNGCDVCILHFDIKPHNIL-LDHNFIP---KVSDFGLAKFHPKEN 303
               L T  + +EYLH      ++H D+KP NIL +D +  P   ++ DFG AK    EN
Sbjct: 118 ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
             +       T  ++APE++ R     +C  D++  G++L     G
Sbjct: 175 GLLXTPCY--TANFVAPEVLERQGYDAAC--DIWSLGVLLYTXLTG 216

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ D+GLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 43/76 (56%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+  N   K+ DFGL+++  +++     S  +  I ++APE I  NF   
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKWMAPESI--NFRRF 189
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 29/203 (14%)
Query: 166 THKLGQGGFGSVYKG-QLHTGRLIAVKMME---NSKFSAEEFINELLGLCSEGFKR--AL 219
           TH +G G +GSV       +G  +A+K +     S+  A+    ELL L     +    L
Sbjct: 30  TH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 220 VYEYMPNGSLDRHIFS------------KENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           +  + P  SL R+ +             ++  G  F  EK   +     +G++Y+H+   
Sbjct: 89  LDVFTPASSL-RNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG- 146
Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             ++H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE+I  ++
Sbjct: 147 --VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVI-LSW 198
Query: 328 GTVSCKSDVYGFGMVLLEMAGGR 350
              +   D++  G ++ EM  G+
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 39/78 (50%), Gaps = 3/78 (3%)
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+KP NIL+  +    + DFG+A     E     + +T GT+ Y APE  S +  T  
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYXAPERFSESHATY- 214
Query: 332 CKSDVYGFGMVLLEMAGG 349
            ++D+Y    VL E   G
Sbjct: 215 -RADIYALTCVLYECLTG 231

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 155 LPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMME---NSKFSAEEFINELLGL 210
           LP+      H    +G G +GSV       +G  +A+K +     S+  A+    ELL L
Sbjct: 40  LPKTYVSPTH----VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 95
Query: 211 CSEGFKR--ALVYEYMPNGSLDRHIFS------------KENKGQTFGLEKPHEIALGTA 256
                +    L+  + P  SL R+ +             ++  G  F  EK   +     
Sbjct: 96  KHMQHENVIGLLDVFTPASSL-RNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQML 154
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           +G++Y+H+     ++H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRW 206
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE+I  ++   +   D++  G ++ EM  G+
Sbjct: 207 YRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 41/206 (19%)
Query: 169 LGQGGFGSVY--KGQLHTGRLIAVKMMEN----SKFSAEEFINELLGLCS---------- 212
           LG+G FG V   K ++ TG+  AVK++       K   E  + E+  L            
Sbjct: 58  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 213 EGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           E F+      LV E    G L   I S++     F       I      GI Y+H     
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKNK-- 170
Query: 269 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
            I+H D+KP N+LL     D N   ++ DFGL+           + D  GT  Y+APE++
Sbjct: 171 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 224
Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGG 349
               GT   K DV+  G++L  +  G
Sbjct: 225 ---HGTYDEKCDVWSTGVILYILLSG 247

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 64/133 (48%), Gaps = 13/133 (9%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
            V EY+  G L  H+  +    +        EI+L     + YLH   +  I++ D+K  
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ERGIIYRDLKLD 182
Query: 279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKSDVY 337
           N+LLD     K++D+G+ K   +  D  + S   GT  Y+APE++   ++G      D +
Sbjct: 183 NVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYG---FSVDWW 237
Query: 338 GFGMVLLEMAGGR 350
             G+++ EM  GR
Sbjct: 238 ALGVLMFEMMAGR 250

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHN--FIPKVSDFGLAKFHPKEN--DFVSISDTRG 313
            + YLHN     I H DIKP N L   N  F  K+ DFGL+K   K N  ++  ++   G
Sbjct: 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVL 343
           T  ++APE+++    +   K D +  G++L
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N    +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 26/194 (13%)
Query: 165 FTHKLGQGGFGSVY-KGQLHTGRLIAVKMMENS-KFSAEEFINELLGLCSEGFKRALVYE 222
           F   LG G F  V+   Q  TG+L A+K ++ S  F      NE+  L     +  +  E
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 223 YMPNGSLDRHIFSK-ENKGQTF------GLEKPHEIALGTAR---GIEYLH-NGCDVCIL 271
            +   +   ++  +  + G+ F      G+    + +L   +    ++YLH NG    I+
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG----IV 128
Query: 272 HFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
           H D+KP N+L    + N    ++DFGL+K   ++N  +S +   GT GY+APE++++   
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTA--CGTPGYVAPEVLAQK-- 182
Query: 329 TVSCKSDVYGFGMV 342
             S   D +  G++
Sbjct: 183 PYSKAVDCWSIGVI 196

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 22/135 (16%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFG-LEKPHE--IALGTARGIEYLHNGCDVCILHFDI 275
           +V EY+  G +  H+       +  G   +PH    A       EYLH+   + +++ D+
Sbjct: 118 MVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167
Query: 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNFGTVSCKS 334
           KP N+L+D     +V+DFG AK        +      GT   LAPE+I S+ +       
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEALAPEIILSKGYNKA---V 219
Query: 335 DVYGFGMVLLEMAGG 349
           D +  G+++ EMA G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 27/201 (13%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 123
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILL-GXKY 180
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
            S   D++  G +  EM   R
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRR 201

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 38/200 (19%)
Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA--------EEFINELL---------- 208
           +LG+G F  V +  ++ TG+  A K++   K SA        E  I  LL          
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCD 267
            +  EGF   LV++ +  G L   I ++E   +        +I       + + H NG  
Sbjct: 71  SISEEGF-HYLVFDLVTGGELFEDIVAREYYSEADASHCIQQIL----ESVNHCHLNG-- 123
Query: 268 VCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
             I+H D+KP N+LL         K++DFGLA     + D  +     GT GYL+PE++ 
Sbjct: 124 --IVHRDLKPENLLLASKSKGAAVKLADFGLAI--EVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 325 RN-FGTVSCKSDVYGFGMVL 343
           ++ +G      D++  G++L
Sbjct: 180 KDPYGK---PVDMWACGVIL 196

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/76 (31%), Positives = 43/76 (56%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+      K+ DFGL+++  +++ +   S  +  I ++APE I  NF   
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRF 189
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGL +    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 38/200 (19%)
Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA--------EEFINELL---------- 208
           +LG+G F  V +  ++ TG+  A K++   K SA        E  I  LL          
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCD 267
            +  EGF   LV++ +  G L   I ++E   +        +I       + + H NG  
Sbjct: 71  SISEEGF-HYLVFDLVTGGELFEDIVAREYYSEADASHCIQQIL----ESVNHCHLNG-- 123
Query: 268 VCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
             I+H D+KP N+LL         K++DFGLA     + D  +     GT GYL+PE++ 
Sbjct: 124 --IVHRDLKPENLLLASKSKGAAVKLADFGLAI--EVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 325 RN-FGTVSCKSDVYGFGMVL 343
           ++ +G      D++  G++L
Sbjct: 180 KDPYGK---PVDMWACGVIL 196

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLSFCHSHR--- 123
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 330 VSCK-----SDVYGFGMVLLEMAGGR 350
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 147 MQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF-- 203
           ++ VD     E+   T+    +LG+G FG V++ +   TG   AVK +    F AEE   
Sbjct: 81  LKPVDYEYREEVHWATHQL--RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA 138
Query: 204 --------INELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT 255
                   I  L G   EG    +  E +  GSL + +     K Q    E      LG 
Sbjct: 139 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQGCLPEDRALYYLGQ 193
Query: 256 A-RGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PKVSDFGLAK-FHPK--ENDFVSISD 310
           A  G+EYLH+     ILH D+K  N+LL  +     + DFG A    P       ++   
Sbjct: 194 ALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
             GT  ++APE++     +   K DV+    ++L M  G
Sbjct: 251 IPGTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHMLNG 287

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
           T +G++YLHN     ++H D+K  N+ L+ +   K+ DFGLA     E D        GT
Sbjct: 151 TIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKTLCGT 205
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374
             Y+APE++ +     S + D++  G +L  +  G+     +  + +        Y ++ 
Sbjct: 206 PNYIAPEVLCKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIK 255
Query: 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
           K      R++  + S + R++       +      RPS+ ++L
Sbjct: 256 KNEYSVPRHINPVASALIRRM-------LHADPTLRPSVAELL 291

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
           T +G++YLHN     ++H D+K  N+ L+ +   K+ DFGLA     E D        GT
Sbjct: 151 TIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKXLCGT 205
Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374
             Y+APE++ +     S + D++  G +L  +  G+     +  + +        Y ++ 
Sbjct: 206 PNYIAPEVLCKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIK 255
Query: 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
           K      R++  + S + R++       +      RPS+ ++L
Sbjct: 256 KNEYSVPRHINPVASALIRRM-------LHADPTLRPSVAELL 291

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 122
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 174
Query: 330 VSCK-----SDVYGFGMVLLEMAGGR 350
           + CK      D++  G +  EM   R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 38/200 (19%)
Query: 168 KLGQGGFGSVYK------GQLHTGRLIAVKMM---ENSKFSAEEFINELL---------- 208
           +LG+G F  V +       Q +  ++I  K +   ++ K   E  I  LL          
Sbjct: 38  ELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 97
Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
            +  EGF   LV++ +  G L   I ++E   +       H+I       + ++H     
Sbjct: 98  SISEEGF-HYLVFDLVTGGELFEDIVAREYYSEADASHCIHQIL----ESVNHIHQHD-- 150
Query: 269 CILHFDIKPHNILLD---HNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPELIS 324
            I+H D+KP N+LL         K++DFGLA +   ++  +   +   GT GYL+PE++ 
Sbjct: 151 -IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA---GTPGYLSPEVLR 206
Query: 325 RN-FGTVSCKSDVYGFGMVL 343
           ++ +G      D++  G++L
Sbjct: 207 KDPYGK---PVDIWACGVIL 223

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 36/218 (16%)
Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKM--------MENSKFSAEEFINELLGLCS-- 212
           H   K+G G FGSV+K  +   G + A+K         ++      E + + +LG  S  
Sbjct: 10  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 69
Query: 213 --------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
                   E     +  EY   GSL   I         F   +  ++ L   RG+ Y+H+
Sbjct: 70  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 129
Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSISD------T 311
              + ++H DIKP NI +    IP  +       D+   K   K  D   ++        
Sbjct: 130 ---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 186
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
            G   +LA E++  N+ T   K+D++   + ++  AG 
Sbjct: 187 EGDSRFLANEVLQENY-THLPKADIFALALTVVXAAGA 223

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 9/112 (8%)
Query: 239 KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298
           K +  G ++   +     +G+ Y+H      I+H D+KP N+ ++ +   K+ DFGLA+ 
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
              E     +     T  Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 178 ADSEMXGXVV-----TRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 84/206 (40%), Gaps = 41/206 (19%)
Query: 169 LGQGGFGSVY--KGQLHTGRLIAVKMMEN----SKFSAEEFINELLGLCS---------- 212
           LG+G FG V   K ++ TG+  AVK++       K   E  + E+  L            
Sbjct: 34  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 213 EGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           E F+      LV E    G L   I S++     F       I      GI Y H     
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYXHKNK-- 146
Query: 269 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
            I+H D+KP N+LL     D N   ++ DFGL+             D  GT  Y+APE++
Sbjct: 147 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KXKDKIGTAYYIAPEVL 200
Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGG 349
               GT   K DV+  G++L  +  G
Sbjct: 201 ---HGTYDEKCDVWSTGVILYILLSG 223

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 123
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 330 VSCK-----SDVYGFGMVLLEMAGGR 350
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 122
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 174
Query: 330 VSCK-----SDVYGFGMVLLEMAGGR 350
           + CK      D++  G +  EM   R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 27/201 (13%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 77  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 130
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGXKY 187
Query: 330 VSCKSDVYGFGMVLLEMAGGR 350
            S   D++  G +  EM   R
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 124
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 176
Query: 330 VSCK-----SDVYGFGMVLLEMAGGR 350
           + CK      D++  G +  EM   R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 123
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 330 VSCK-----SDVYGFGMVLLEMAGGR 350
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/76 (31%), Positives = 43/76 (56%), Gaps = 3/76 (3%)
Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H DI   N+L+      K+ DFGL+++  +++ +   S  +  I ++APE I  NF   
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRF 569
Query: 331 SCKSDVYGFGMVLLEM 346
           +  SDV+ FG+ + E+
Sbjct: 570 TSASDVWMFGVCMWEI 585

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 74  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 127
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 179
Query: 330 VSCK-----SDVYGFGMVLLEMAGGR 350
           + CK      D++  G +  EM   R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 54/234 (23%)
Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMMEN---------SKFSAEEFIN 205
           ++++        LG+G FG V +   H   GR +AVK+++N         S+    E +N
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 206 -----------ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG 254
                      ++L          +V+E +   + D   F KEN    F L+   ++A  
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYD---FIKENGFLPFRLDHIRKMAYQ 126
Query: 255 TARGIEYLHNGCDVCILHFDIKPHNILLDHN-----FIPKVS--------------DFGL 295
             + + +LH+     + H D+KP NIL   +     + PK+               DFG 
Sbjct: 127 ICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           A +  + +     S    T  Y APE+I     +  C  DV+  G +L+E   G
Sbjct: 184 ATYDDEHH-----STLVSTRHYRAPEVILALGWSQPC--DVWSIGCILIEYYLG 230

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 77  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 130
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 182
Query: 330 VSCK-----SDVYGFGMVLLEMAGGR 350
           + CK      D++  G +  EM   R
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 122
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 174
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 175 --LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 123
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 123
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 123
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 126
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 125
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 125
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 14/128 (10%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           ++ E M  G L   I  +E   Q F   +  EI       I++LH+     I H D+KP 
Sbjct: 84  IIMECMEGGELFSRI--QERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPE 138
Query: 279 NILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD 335
           N+L    + + + K++DFG A    KE    ++     T  Y+APE++       SC  D
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPCYTPYYVAPEVLGPEKYDKSC--D 192
Query: 336 VYGFGMVL 343
           ++  G+++
Sbjct: 193 MWSLGVIM 200

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 14/128 (10%)
Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH 278
           ++ E M  G L   I  +E   Q F   +  EI       I++LH+     I H D+KP 
Sbjct: 103 IIMECMEGGELFSRI--QERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPE 157
Query: 279 NILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD 335
           N+L    + + + K++DFG A    KE    ++     T  Y+APE++       SC  D
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPCYTPYYVAPEVLGPEKYDKSC--D 211
Query: 336 VYGFGMVL 343
           ++  G+++
Sbjct: 212 MWSLGVIM 219

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 124
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 122
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 174
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 175 --LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 123
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++   S+D   F   +      L           +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 125
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++   S+D   F   +      L           +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ D GLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+  FGLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++   S+D   F   +      L           +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++   S+D   F   +      L           +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 48/218 (22%)
Query: 165 FTHKLGQGGFGSVYKG---------QLHTGRLI------AVKMMENSKFSAEEFINEL-- 207
           F   LGQG F  ++KG         QLH   ++      A +    S F A   +++L  
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 208 ------LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                  G+C  G +  LV E++  GSLD ++  K+NK     L K  E+A   A  + +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWK-LEVAKQLAAAMHF 128
Query: 262 LHNGCDVCILHFDIKPHNILL---------DHNFIPKVSDFGLA-KFHPKENDFVSISDT 311
           L       ++H ++   NILL         +  FI K+SD G++    PK+     I   
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGISITVLPKD-----ILQE 179
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           R  I ++ PE I  N   ++  +D + FG  L E+  G
Sbjct: 180 R--IPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 126
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ D GLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 125
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 124
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DF LA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 74  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 127
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 179
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 180 --LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 124
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 168 KLGQGGFGSVY-----KGQLHTGRLIAVKMMENSKFSA-----------EEFINELLGLC 211
           ++G GG   V+     K Q++  + + ++  +N    +           ++  ++++ L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
                   +Y  M  G++D + + K+ K        P E        +E +H      I+
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSID-----PWERKSYWKNMLEAVHTIHQHGIV 149
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPELI-----SR 325
           H D+KP N L+    + K+ DFG+A +  P     V  S   GT+ Y+ PE I     SR
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSR 207
Query: 326 NFG----TVSCKSDVYGFGMVLLEMAGGR 350
             G     +S KSDV+  G +L  M  G+
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 36/218 (16%)
Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKM--------MENSKFSAEEFINELLGLCS-- 212
           H   K+G G FGSV+K  +   G + A+K         ++      E + + +LG  S  
Sbjct: 12  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 71
Query: 213 --------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
                   E     +  EY   GSL   I         F   +  ++ L   RG+ Y+H+
Sbjct: 72  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 131
Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSISD------T 311
              + ++H DIKP NI +    IP  +       D+   K   K  D   ++        
Sbjct: 132 ---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 188
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
            G   +LA E++  N+ T   K+D++   + ++  AG 
Sbjct: 189 EGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGA 225

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 36/218 (16%)
Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKM--------MENSKFSAEEFINELLGLCS-- 212
           H   K+G G FGSV+K  +   G + A+K         ++      E + + +LG  S  
Sbjct: 12  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 71
Query: 213 --------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
                   E     +  EY   GSL   I         F   +  ++ L   RG+ Y+H+
Sbjct: 72  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 131
Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSISD------T 311
              + ++H DIKP NI +    IP  +       D+   K   K  D   ++        
Sbjct: 132 ---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 188
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
            G   +LA E++  N+ T   K+D++   + ++  AG 
Sbjct: 189 EGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGA 225

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 80/200 (40%), Gaps = 34/200 (17%)
Query: 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE--FINELLGLCSEGFKRA-- 218
            F   LG G F  V   +   TG+L AVK +       +E    NE+  L     +    
Sbjct: 25  EFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVA 84
Query: 219 ------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA-RGIEYLHNG 265
                       LV + +  G L   I  K      F  EK     +      + YLH  
Sbjct: 85  LEDIYESPNHLYLVMQLVSGGELFDRIVEK-----GFYTEKDASTLIRQVLDAVYYLHR- 138
Query: 266 CDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
             + I+H D+KP N+L    D      +SDFGL+K   K +    +S   GT GY+APE+
Sbjct: 139 --MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYVAPEV 193
Query: 323 ISRNFGTVSCKSDVYGFGMV 342
           +++     S   D +  G++
Sbjct: 194 LAQK--PYSKAVDCWSIGVI 211

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 47/210 (22%)
Query: 161 VTNHFT--HKLGQGGFGSVYK-GQLHTGRLIAVKMMENSKFSAEEFINELLGLCS----- 212
           V +H+    +LG G FG V++  +  TG   A K +     S +E + + +   S     
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 213 ----------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
                     +  +  ++YE+M  G L   +  + NK             +     +EY+
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-------------MSEDEAVEYM 261
Query: 263 HNGCD-VC------ILHFDIKPHNILL--DHNFIPKVSDFGL-AKFHPKENDFVSISDTR 312
              C  +C       +H D+KP NI+     +   K+ DFGL A   PK+    S+  T 
Sbjct: 262 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTT 317
Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMV 342
           GT  + APE+       V   +D++  G++
Sbjct: 318 GTAEFAAPEVAEGK--PVGYYTDMWSVGVL 345

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 168 KLGQGGFGSVY-----KGQLHTGRLIAVKMMENSKFSA-----------EEFINELLGLC 211
           ++G GG   V+     K Q++  + + ++  +N    +           ++  ++++ L 
Sbjct: 19  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
                   +Y  M  G++D + + K+ K        P E        +E +H      I+
Sbjct: 79  DYEITDQYIYMVMECGNIDLNSWLKKKKSID-----PWERKSYWKNMLEAVHTIHQHGIV 133
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPELI-----SR 325
           H D+KP N L+    + K+ DFG+A +  P     V  S   GT+ Y+ PE I     SR
Sbjct: 134 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSR 191
Query: 326 NFG----TVSCKSDVYGFGMVLLEMAGGR 350
             G     +S KSDV+  G +L  M  G+
Sbjct: 192 ENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 48/218 (22%)
Query: 165 FTHKLGQGGFGSVYKG---------QLHTGRLI------AVKMMENSKFSAEEFINEL-- 207
           F   LGQG F  ++KG         QLH   ++      A +    S F A   +++L  
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 208 ------LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                  G+C  G +  LV E++  GSLD ++  K+NK     L K  E+A   A  + +
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWK-LEVAKQLAWAMHF 128
Query: 262 LHNGCDVCILHFDIKPHNILL---------DHNFIPKVSDFGLA-KFHPKENDFVSISDT 311
           L       ++H ++   NILL         +  FI K+SD G++    PK+     I   
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGISITVLPKD-----ILQE 179
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
           R  I ++ PE I  N   ++  +D + FG  L E+  G
Sbjct: 180 R--IPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 36/198 (18%)
Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA--------EEFINELL----------G 209
           +G+G F  V +  +L TG   A K++   K SA        E  I  LL           
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +  EGF   LV++ +  G L   I ++E   +        +I       +E + +   + 
Sbjct: 72  ISEEGF-HYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI-------LEAVLHCHQMG 123
Query: 270 ILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           ++H D+KP N+LL         K++DFGLA     + D  +     GT GYL+PE++ + 
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAI--EVQGDQQAWFGFAGTPGYLSPEVLRKE 181
Query: 327 -FGTVSCKSDVYGFGMVL 343
            +G      D++  G++L
Sbjct: 182 AYGK---PVDIWACGVIL 196

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 168 KLGQGGFGSVY-----KGQLHTGRLIAVKMMENSKFSA-----------EEFINELLGLC 211
           ++G GG   V+     K Q++  + + ++  +N    +           ++  ++++ L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
                   +Y  M  G++D + + K+ K        P E        +E +H      I+
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSID-----PWERKSYWKNMLEAVHTIHQHGIV 177
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPELI-----SR 325
           H D+KP N L+    + K+ DFG+A +  P     V  S   GT+ Y+ PE I     SR
Sbjct: 178 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSR 235
Query: 326 NFG----TVSCKSDVYGFGMVLLEMAGGR 350
             G     +S KSDV+  G +L  M  G+
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 12/91 (13%)
Query: 258 GIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
            ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   ++    G
Sbjct: 126 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 178
Query: 314 TIGYLAPE-LISRNFGTVSCKSDVYGFGMVL 343
           T  YLAPE L+S      +   D +  G++L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 12/91 (13%)
Query: 258 GIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
            ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   ++    G
Sbjct: 125 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 177
Query: 314 TIGYLAPE-LISRNFGTVSCKSDVYGFGMVL 343
           T  YLAPE L+S      +   D +  G++L
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 208

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           RG++Y+H+     I+H D+KP N+ ++ +   K+ D GLA+    E     ++    T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRW 187
Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 188 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 12/91 (13%)
Query: 258 GIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
            ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   ++    G
Sbjct: 126 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 178
Query: 314 TIGYLAPE-LISRNFGTVSCKSDVYGFGMVL 343
           T  YLAPE L+S      +   D +  G++L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 12/91 (13%)
Query: 258 GIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
            ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   ++    G
Sbjct: 126 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---G 178
Query: 314 TIGYLAPE-LISRNFGTVSCKSDVYGFGMVL 343
           T  YLAPE L+S      +   D +  G++L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 47/210 (22%)
Query: 161 VTNHFT--HKLGQGGFGSVYK-GQLHTGRLIAVKMMENSKFSAEEFINELLGLCS----- 212
           V +H+    +LG G FG V++  +  TG   A K +     S +E + + +   S     
Sbjct: 49  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 108
Query: 213 ----------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
                     +  +  ++YE+M  G L   +  + NK             +     +EY+
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-------------MSEDEAVEYM 155
Query: 263 HNGCD-VC------ILHFDIKPHNILL--DHNFIPKVSDFGL-AKFHPKENDFVSISDTR 312
              C  +C       +H D+KP NI+     +   K+ DFGL A   PK+    S+  T 
Sbjct: 156 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTT 211
Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMV 342
           GT  + APE+       V   +D++  G++
Sbjct: 212 GTAEFAAPEVAEGK--PVGYYTDMWSVGVL 239

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 168 KLGQGGFGSVY-----KGQLHTGRLIAVKMMENSKFSA-----------EEFINELLGLC 211
           ++G GG   V+     K Q++  + + ++  +N    +           ++  ++++ L 
Sbjct: 15  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
                   +Y  M  G++D + + K+ K        P E        +E +H      I+
Sbjct: 75  DYEITDQYIYMVMECGNIDLNSWLKKKKSID-----PWERKSYWKNMLEAVHTIHQHGIV 129
Query: 272 HFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYLAPELI-----SR 325
           H D+KP N L+    + K+ DFG+A +  P     V  S   GT+ Y+ PE I     SR
Sbjct: 130 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSR 187
Query: 326 NFG----TVSCKSDVYGFGMVLLEMAGGR 350
             G     +S KSDV+  G +L  M  G+
Sbjct: 188 ENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 36/218 (16%)
Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKM--------MENSKFSAEEFINELLGLCS-- 212
           H   K+G G FGSV+K  +   G + A+K         ++      E + + +LG  S  
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 213 --------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
                   E     +  EY   GSL   I         F   +  ++ L   RG+ Y+H+
Sbjct: 74  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSISD------T 311
              + ++H DIKP NI +    IP  +       D+   K   K  D   ++        
Sbjct: 134 ---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 349
            G   +LA E++  N+ T   K+D++   + ++  AG 
Sbjct: 191 EGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGA 227

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMM------ENSKFSAEEFIN-----------ELLG 209
           K+G+G +G VYK +   TG ++A+K +      E    +A   I+           +LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++ +  L + + +    G    L K +   L   +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--- 126
Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLAPELISRNF 327
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 328 GTVSCK-----SDVYGFGMVLLEMAGGR 350
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 24/100 (24%)
Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
           GI++LH+     I+H D+KP NI++  +   K+ DFGLA+             T GT   
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------------TAGTSFM 181
Query: 318 LAPELISRNFGTVSC--------KSDVYGFGMVLLEMAGG 349
           + PE+++R +               D++  G ++ EM  G
Sbjct: 182 MTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	453
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-84
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-83
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-57
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-53
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-51
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-47
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-47
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-45
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-45
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-45
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-44
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-42
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-41
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-31
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-30
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-30
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-30
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-29
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-28
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-25
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-21
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-21
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-21
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-20
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-20
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-20
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-19
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-19
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-18
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-16
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-15
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-15
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-12
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-07
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  292 bits (749), Expect = 2e-96
 Identities = 102/295 (34%), Positives = 146/295 (49%), Gaps = 39/295 (13%)

Query: 157 EIIAVTNHF--THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAE--EFINE------ 206
           E+   +++F   + LG+GGFG VYKG+L  G L+AVK ++  +      +F  E      
Sbjct: 24  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83

Query: 207 --------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARG 258
                   L G C    +R LVY YM NGS+   +  +          K   IALG+ARG
Sbjct: 84  AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--GTIG 316
           + YLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V+   T   GTIG
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGTIG 200

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN-ATRSSKAYFPSWVYDQLNK 375
           ++APE +S   G  S K+DV+G+G++LLE+  G+R  ++             WV   L +
Sbjct: 201 HIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 376 GGDLEL--------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422
                L            E+E +I      + L C Q    +RP M++V+ MLEG
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQ-----VALLCTQSSPMERPKMSEVVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  261 bits (669), Expect = 1e-84
 Identities = 101/296 (34%), Positives = 144/296 (48%), Gaps = 36/296 (12%)

Query: 155 LPEIIAVTNHF--THKLGQGGFGSVYKGQLHTGRLIAVKMM-ENSKFSAEEFINE----- 206
           L ++   TN+F     +G G FG VYKG L  G  +A+K     S    EEF  E     
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90

Query: 207 ---------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR 257
                    L+G C E  +  L+Y+YM NG+L RH++  +    +   E+  EI +G AR
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISDTR--GT 314
           G+ YLH      I+H D+K  NILLD NF+PK++DFG++K   + +   +S   T   GT
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS---TVVKGT 204

Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374
           +GY+ PE   +   T   KSDVY FG+VL E+   R     +  R        W  +  N
Sbjct: 205 LGYIDPEYFIKGRLTE--KSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHN 261

Query: 375 KGG-----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425
            G      D  L +    ES+  RK     + C+ + + DRPSM  VL  LE ++ 
Sbjct: 262 NGQLEQIVDPNLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  258 bits (661), Expect = 2e-83
 Identities = 89/308 (28%), Positives = 133/308 (43%), Gaps = 65/308 (21%)

Query: 157 EIIAVTNHF--------THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA-----EEF 203
           E+  VTN+F         +K+G+GGFG VYKG ++    +AVK +            ++F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQF 77

Query: 204 INE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKP- 248
             E              LLG  S+G    LVY YMPNGSL   +   +          P 
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-------PPL 130

Query: 249 -----HEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303
                 +IA G A GI +LH       +H DIK  NILLD  F  K+SDFGLA+   K  
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 304 D-FVSISDTR--GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS 360
              ++   +R  GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G    + +    
Sbjct: 188 QTVMT---SRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEH---R 238

Query: 361 SKAYFPSWVYDQLNKGGDLE------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 414
                     +  ++   +E      + +           +  +   C+  K   RP + 
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS---VEAMYSVASQCLHEKKNKRPDIK 295

Query: 415 KVLEMLEG 422
           KV ++L+ 
Sbjct: 296 KVQQLLQE 303

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  190 bits (484), Expect = 4e-57
 Identities = 66/307 (21%), Positives = 102/307 (33%), Gaps = 48/307 (15%)

Query: 155 LPEIIAVTNHFT--HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE------ 206
              +   +          +G FG V+K QL     +AVK+       + +   E      
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPG 74

Query: 207 --------LLGLCSEGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG 254
                    +G    G        L+  +   GSL   +     K       +   IA  
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAET 129

Query: 255 TARGIEYLH-------NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307
            ARG+ YLH       +G    I H DIK  N+LL +N    ++DFGLA           
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 308 ISDTRGTIGYLAPELISRNFGT---VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 364
                GT  Y+APE++            + D+Y  G+VL E+A     ++          
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV-DEYMLP 248

Query: 365 FPSWVYDQ----------LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 414
           F   +             ++K     LR+  +  + +   LC     C    A  R S  
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGM-AMLCETIEECWDHDAEARLSAG 307

Query: 415 KVLEMLE 421
            V E + 
Sbjct: 308 CVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  180 bits (459), Expect = 1e-53
 Identities = 75/288 (26%), Positives = 133/288 (46%), Gaps = 44/288 (15%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE-------------- 206
           +   K+G G FG+V++ + H G  +AVK++    F A    EF+ E              
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
            +G  ++    ++V EY+  GSL R +     + +     +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHN-R 156

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           +  I+H ++K  N+L+D  +  KV DFGL++   K + F+S     GT  ++APE++   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
               + KSDVY FG++L E+A  ++   N+N  +         V     K   LE+    
Sbjct: 215 --PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--------VVAAVGFKCKRLEIPRNL 264

Query: 386 --EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP 431
             ++ ++I          C   +   RPS   ++++L   +    +PP
Sbjct: 265 NPQVAAIIEG--------CWTNEPWKRPSFATIMDLLR-PLIKSAVPP 303

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  174 bits (442), Expect = 8e-51
 Identities = 68/328 (20%), Positives = 115/328 (35%), Gaps = 61/328 (18%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE----------------L 207
                +G+G +G+VYKG L   R +AVK+   S  + + FINE                 
Sbjct: 16  KLLELIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARF 72

Query: 208 LGLCSEGFKRA-----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
           +               LV EY PNGSL +++        T        +A    RG+ YL
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYL 127

Query: 263 HN------GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISDTR 312
           H            I H D+   N+L+ ++    +SDFGL+                +   
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187

Query: 313 --GTIGYLAPELIS-----RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY- 364
             GTI Y+APE++      R+  +   + D+Y  G++  E+    R +++    S   Y 
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF--MRCTDLFPGESVPEYQ 245

Query: 365 --FPSWVYDQ----------LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS 412
             F + V +             +    +     +  S+  R L      C    A  R +
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305

Query: 413 MTKVLEMLEGSIDDLQMPPKPFFSSSRH 440
                E +   +   +       ++  H
Sbjct: 306 AQXAEERMAELMMIWERNKSVSPTAHHH 333

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  170 bits (433), Expect = 1e-49
 Identities = 66/302 (21%), Positives = 120/302 (39%), Gaps = 45/302 (14%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
                +G+G FG V K +    + +A+K +E+     + FI E              L G
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER-KAFIVELRQLSRVNHPNIVKLYG 68

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            C       LV EY   GSL   +   E     +         L  ++G+ YLH+     
Sbjct: 69  ACLNPV--CLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 270 ILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
           ++H D+KP N+LL     + K+ DFG A     +    +    +G+  ++APE+   +  
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTN---NKGSAAWMAPEVFEGS-- 178

Query: 329 TVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLEL-RNV-T 385
             S K DV+ +G++L E+   R+    +             +   ++ G    L +N+  
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGP-------AFRIMWAVHNGTRPPLIKNLPK 231

Query: 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHISGRE 445
            IES++ R        C     + RPSM ++++++   +       +P     +H     
Sbjct: 232 PIESLMTR--------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG 283

Query: 446 TE 447
            +
Sbjct: 284 ED 285

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  164 bits (416), Expect = 2e-47
 Identities = 61/288 (21%), Positives = 108/288 (37%), Gaps = 56/288 (19%)

Query: 165 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA--------EEFINE--------- 206
           +  ++G+GGFG V+KG+ +    ++A+K +               +EF  E         
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                L GL        +V E++P G L   +    +K           + L  A GIEY
Sbjct: 83  PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 262 LHNGCDVCILHFDIKPHNILLD-----HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
           + N  +  I+H D++  NI L           KV+DFGL++         S+S   G   
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQ 191

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNK 375
           ++APE I     + + K+D Y F M+L  +  G       +  +        ++     +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------IKFINMIREE 245

Query: 376 GGDLELRNVT--EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           G    +       + ++I          C       RP  + +++ L 
Sbjct: 246 GLRPTIPEDCPPRLRNVIEL--------CWSGDPKKRPHFSYIVKELS 285

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  163 bits (415), Expect = 2e-47
 Identities = 79/276 (28%), Positives = 138/276 (50%), Gaps = 42/276 (15%)

Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAE---EFINE--------------LLG 209
            ++G G FG+VYKG+ H G  +AVKM+  +  + +    F NE               +G
Sbjct: 30  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDV 268
             +   + A+V ++    SL  H+ + E K   F ++K  +IA  TARG++YLH      
Sbjct: 88  YSTAP-QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKS--- 140

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNF 327
            I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++ 
Sbjct: 141 -IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 328 GTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLELR-NVT 385
              S +SDVY FG+VL E+  G+   SN+N            + + + +G    L  +++
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIEMVGRGS---LSPDLS 248

Query: 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           ++ S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  157 bits (400), Expect = 3e-45
 Identities = 69/288 (23%), Positives = 109/288 (37%), Gaps = 58/288 (20%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMM-----ENSKFSAEEFINE------------ 206
                +G GGFG VY+     G  +AVK       E+   + E    E            
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
             L G+C +     LV E+   G L+R +      G+    +     A+  ARG+ YLH+
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHD 123

Query: 265 GCDVCILHFDIKPHNILLD--------HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
              V I+H D+K  NIL+          N I K++DFGLA+   +     +     G   
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYA 179

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNK 375
           ++APE+I  +    S  SDV+ +G++L E+  G      ++             Y     
Sbjct: 180 WMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--------VAYGVAMN 229

Query: 376 GGDLELRNVT--EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
              L + +        ++          C       RPS T +L+ L 
Sbjct: 230 KLALPIPSTCPEPFAKLMED--------CWNPDPHSRPSFTNILDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  157 bits (399), Expect = 4e-45
 Identities = 52/279 (18%), Positives = 102/279 (36%), Gaps = 46/279 (16%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE-------------- 206
           +F  KL +   G ++KG+   G  I VK+++   +S     +F  E              
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 207 LLGLCSE--GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
           +LG C         L+  +MP GSL   +   E         +  + AL  ARG+ +LH 
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI- 323
             +  I    +   ++++D +   ++S   +                     ++APE + 
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-------RMYAPAWVAPEALQ 181

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382
            +   T    +D++ F ++L E+       ++++                  +G    LR
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEG----LR 229

Query: 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
               I   I+  +  +   C+    A RP    ++ +LE
Sbjct: 230 --PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  155 bits (395), Expect = 4e-44
 Identities = 58/288 (20%), Positives = 108/288 (37%), Gaps = 55/288 (19%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE-------------- 206
                +G+G FG VY G+ H G  +A+++++  + +    + F  E              
Sbjct: 36  EIGELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
            +G C      A++       +L   +   +       + K  +IA    +G+ YLH   
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEIVKGMGYLHA-- 148

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-----RGTIGYLAPE 321
              ILH D+K  N+  D+  +  ++DFGL              +       G + +LAPE
Sbjct: 149 -KGILHKDLKSKNVFYDNGKV-VITDFGLFSI--SGVLQAGRREDKLRIQNGWLCHLAPE 204

Query: 322 LISRNFGTVSC-------KSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQL 373
           +I +               SDV+  G +  E+                       +  Q+
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---------AEAIIWQM 255

Query: 374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             G    L      +  + +++  I L+C   +  +RP+ TK+++MLE
Sbjct: 256 GTGMKPNL-----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  155 bits (393), Expect = 1e-43
 Identities = 63/311 (20%), Positives = 113/311 (36%), Gaps = 52/311 (16%)

Query: 152 NILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE----- 206
            +L+   IA       ++G+G +G V+ G+   G  +AVK+   ++     +  E     
Sbjct: 28  PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQ 84

Query: 207 -----------LLGLCSEGFKR----ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI 251
                       +    +G        L+ +Y  NGSL  ++     K  T   +   ++
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKL 139

Query: 252 ALGTARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306
           A  +  G+ +LH           I H D+K  NIL+  N    ++D GLA     + + V
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 307 SISDT--RGTIGYLAPELISRNFGTVSC----KSDVYGFGMVLLEMAGGRRNSNMNATRS 360
            I      GT  Y+ PE++  +           +D+Y FG++L E+A  RR  +      
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA--RRCVSGGIVEE 257

Query: 361 SKAYFPSWVYDQ----------LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR 410
            +  +   V               K       N    +    R++  +   C     A R
Sbjct: 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDE-CLRQMGKLMTECWAHNPASR 316

Query: 411 PSMTKVLEMLE 421
            +  +V + L 
Sbjct: 317 LTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  148 bits (375), Expect = 2e-41
 Identities = 58/297 (19%), Positives = 104/297 (35%), Gaps = 48/297 (16%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMM---ENSKFSAEEFINEL-----------LG 209
                +G+G +G V++G    G  +AVK+    +   +  E  +              + 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 210 LCSEGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-- 263
                   +    L+  Y   GSL  ++     +  T        I L  A G+ +LH  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 264 ---NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT--RGTIGYL 318
                    I H D+K  NIL+  N    ++D GLA  H +  + + + +    GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 319 APELI----SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ-- 372
           APE++      +      + D++ FG+VL E+A  RR  +       K  F   V +   
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 373 --------LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                           + N    +      L  +   C     + R +  ++ + L 
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDP-TLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  148 bits (375), Expect = 5e-41
 Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 48/309 (15%)

Query: 152 NILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMM---ENSKFSAE------- 201
            +L+   IA T      +G+G FG V++G+   G  +AVK+    E   +  E       
Sbjct: 33  PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV 91

Query: 202 ----EFINELLGLCSEGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL 253
               E I   +   ++         LV +Y  +GSL  ++        T  +E   ++AL
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLAL 146

Query: 254 GTARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 308
            TA G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206

Query: 309 SDT--RGTIGYLAPELISRNFGTVSC----KSDVYGFGMVLLEMAGGRRNSNMNATRSSK 362
           +     GT  Y+APE++  +          ++D+Y  G+V  E+A  RR S        +
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHEDYQ 264

Query: 363 AYFPSWVYDQ----------LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS 412
             +   V               +     + N  +    + R +  I   C     A R +
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL-RVMAKIMRECWYANGAARLT 323

Query: 413 MTKVLEMLE 421
             ++ + L 
Sbjct: 324 ALRIKKTLS 332

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  143 bits (362), Expect = 2e-39
 Identities = 67/300 (22%), Positives = 113/300 (37%), Gaps = 50/300 (16%)

Query: 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVK-MMENSKFSAEEFINE--------------L 207
                LG+G FG   K     TG ++ +K ++   + +   F+ E               
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           +G+  +  +   + EY+  G+L   I S +++   +   +    A   A G+ YLH    
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLH---S 126

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF------------HPKENDFVSISDTRGTI 315
           + I+H D+  HN L+  N    V+DFGLA+               K+ D        G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 375
            ++APE+I  N  +   K DV+ FG+VL E+ G                 P ++   ++ 
Sbjct: 187 YWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRVNA------------DPDYLPRTMDF 232

Query: 376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL--QMPPKP 433
           G ++                  I + C  +    RPS  K+   LE     L   +P  P
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  129 bits (326), Expect = 6e-33
 Identities = 69/275 (25%), Positives = 118/275 (42%), Gaps = 42/275 (15%)

Query: 165 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLG 209
             HKLG G +G VY+G        +AVK ++      EEF+ E              LLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +C+      ++ E+M  G+L    + +E   Q         +A   +  +EYL       
Sbjct: 284 VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
            +H ++   N L+  N + KV+DFGL++     + + + +  +  I + APE +   +  
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESL--AYNK 395

Query: 330 VSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-RNVTE 386
            S KSDV+ FG++L E+A  G      ++ ++         VY+ L K   +E      E
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEKDYRMERPEGCPE 446

Query: 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                  K+  +   C Q   +DRPS  ++ +  E
Sbjct: 447 -------KVYELMRACWQWNPSDRPSFAEIHQAFE 474

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  125 bits (315), Expect = 2e-31
 Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 42/274 (15%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
              KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  +
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
            SE     +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  
Sbjct: 331 VSEE-PIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE     +G  
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAA--LYGRF 441

Query: 331 SCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-RNVTEI 387
           + KSDV+ FG++L E+   G      M             V DQ+ +G  +       E 
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCPPECPE- 491

Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                  L  +   C + +  +RP+   +   LE
Sbjct: 492 ------SLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  123 bits (311), Expect = 3e-31
 Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 42/274 (15%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
              KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  +
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
            SE     +V EYM  GSL    F K   G+   L +  ++A   A G+ Y+     +  
Sbjct: 248 VSEE-PIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE     +G  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAA--LYGRF 358

Query: 331 SCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-RNVTEI 387
           + KSDV+ FG++L E+   G      M             V DQ+ +G  +       E 
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCPPECPE- 408

Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                  L  +   C + +  +RP+   +   LE
Sbjct: 409 ------SLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  119 bits (301), Expect = 6e-31
 Identities = 75/280 (26%), Positives = 118/280 (42%), Gaps = 50/280 (17%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRL-IAVKMMENSKFSAEEFINE--------------LL 208
              HKLG G +G VY+G      L +AVK ++      EEF+ E              LL
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL--HNGC 266
           G+C+      ++ E+M  G+L    + +E   Q         +A   +  +EYL   N  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
              I H D+   N L+  N + KV+DFGL++     + + + +  +  I + APE +   
Sbjct: 132 --FI-HRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESL--A 185

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----VYDQLNKGGDLEL- 381
           +   S KSDV+ FG++L E+          AT     Y P      VY+ L K   +E  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEI----------ATYGMSPY-PGIDLSQVYELLEKDYRMERP 234

Query: 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
               E       K+  +   C Q   +DRPS  ++ +  E
Sbjct: 235 EGCPE-------KVYELMRACWQWNPSDRPSFAEIHQAFE 267

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  119 bits (300), Expect = 6e-31
 Identities = 73/279 (26%), Positives = 120/279 (43%), Gaps = 50/279 (17%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
               +LG G FG V+ G  +    +AVK ++    S + F+ E              L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL--HNGCD 267
           + ++     ++ EYM NGSL    F K   G    + K  ++A   A G+ ++   N   
Sbjct: 76  VVTQE-PIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             I H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I  N+
Sbjct: 130 -YI-HRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI--NY 184

Query: 328 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----VYDQLNKGGDLEL-R 382
           GT + KSDV+ FG++L E+           T     Y P      V   L +G  +    
Sbjct: 185 GTFTIKSDVWSFGILLTEI----------VTHGRIPY-PGMTNPEVIQNLERGYRMVRPD 233

Query: 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           N  E       +L  +   C + +  DRP+   +  +LE
Sbjct: 234 NCPE-------ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  121 bits (305), Expect = 9e-31
 Identities = 59/283 (20%), Positives = 109/283 (38%), Gaps = 54/283 (19%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRL-IAVKMM--ENSKFSAEEFINE-------------- 206
               ++G+G FG V+ G+L      +AVK            +F+ E              
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           L+G+C++     +V E +  G     +     +G    ++   ++    A G+EYL    
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE--- 230

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT-IGYLAPELISR 325
             C +H D+   N L+    + K+SDFG+++    +  + +    R   + + APE +  
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEAL-- 287

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLNKGGDL 379
           N+G  S +SDV+ FG++L E               S    P          + + KGG L
Sbjct: 288 NYGRYSSESDVWSFGILLWETF-------------SLGASPYPNLSNQQTREFVEKGGRL 334

Query: 380 EL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                  +        +  +   C   +   RPS + + + L+
Sbjct: 335 PCPELCPD-------AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  122 bits (308), Expect = 1e-30
 Identities = 69/274 (25%), Positives = 122/274 (44%), Gaps = 42/274 (15%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
              KLG G FG V+    +    +AVK M+    S E F+ E              L  +
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
            ++     ++ E+M  GSL    F K ++G    L K  + +   A G+ ++        
Sbjct: 252 VTKE-PIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ 
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI--NFGSF 362

Query: 331 SCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-RNVTEI 387
           + KSDV+ FG++L+E+   G      M+            V   L +G  +    N  E 
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---------VIRALERGYRMPRPENCPE- 412

Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                 +L  I + C + +  +RP+   +  +L+
Sbjct: 413 ------ELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  118 bits (297), Expect = 2e-30
 Identities = 67/285 (23%), Positives = 116/285 (40%), Gaps = 62/285 (21%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
               +LG G FG V  G+      +AVKM++    S +EF  E                G
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL--HNGCD 267
           +CS+ +   +V EY+ NG L  ++    + G+     +  E+      G+ +L  H    
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--- 124

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             I H D+   N L+D +   KVSDFG+ ++   ++ +VS   T+  + + APE+   ++
Sbjct: 125 -FI-HRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVF--HY 179

Query: 328 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLNKGGDLEL 381
              S KSDV+ FG+++ E+              S    P        V  ++++G  L  
Sbjct: 180 FKYSSKSDVWAFGILMWEVF-------------SLGKMPYDLYTNSEVVLKVSQGHRLYR 226

Query: 382 -----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                  + +I  M           C       RP+  ++L  +E
Sbjct: 227 PHLASDTIYQI--M---------YSCWHELPEKRPTFQQLLSSIE 260

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  117 bits (296), Expect = 2e-30
 Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 60/284 (21%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
            F  ++G G FG V+ G       +A+K +     S E+FI E              L G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL--HNGCD 267
           +C E     LV E+M +G L    + +  +G  F  E    + L    G+ YL       
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSD--YLRTQRGL-FAAETLLGMCLDVCEGMAYLEEAC--- 124

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             I H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+   +F
Sbjct: 125 -VI-HRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVF--SF 179

Query: 328 GTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSW----VYDQLNKGGDLELR 382
              S KSDV+ FG+++ E  + G+              + +     V + ++ G  L   
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIP------------YENRSNSEVVEDISTGFRLY-- 225

Query: 383 NVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 421
                      +L       I   C + +  DRP+ +++L  L 
Sbjct: 226 ---------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  117 bits (296), Expect = 3e-30
 Identities = 65/290 (22%), Positives = 119/290 (41%), Gaps = 62/290 (21%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
            F  +LG G FG V  G+      +A+KM++    S +EFI E              L G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL--HNGCD 267
           +C++     ++ EYM NG L    + +E + + F  ++  E+       +EYL       
Sbjct: 87  VCTKQRPIFIITEYMANGCLLN--YLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ--- 140

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             + H D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +
Sbjct: 141 -FL-HRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVL--MY 195

Query: 328 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLNKGGDLEL 381
              S KSD++ FG+++ E+              S    P          + + +G  L  
Sbjct: 196 SKFSSKSDIWAFGVLMWEIY-------------SLGKMPYERFTNSETAEHIAQGLRLY- 241

Query: 382 RNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
                        L       I   C   KA +RP+   +L  +   +D+
Sbjct: 242 ----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  120 bits (302), Expect = 4e-30
 Identities = 63/279 (22%), Positives = 104/279 (37%), Gaps = 54/279 (19%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------------LLGLCS 212
            LG G  G++    +   R +AVK +    FS  +   E                     
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRYFCTEK 88

Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDVCIL 271
           +   + +  E     +L  ++   E K       +P  +   T  G+ +LH       I+
Sbjct: 89  DRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN----IV 140

Query: 272 HFDIKPHNILL-----DHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELISR 325
           H D+KPHNIL+            +SDFGL K      + F   S   GT G++APE++S 
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 326 NFGT-VSCKSDVYGFGMVLLEM-AGGR----RNSNMNATRSSKAYFPSWVYDQLNKGGDL 379
           +     +   D++  G V   + + G     ++    A             + L     L
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------------NILLGACSL 247

Query: 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
           +  +  + E +IAR+L  I    I +    RPS   VL+
Sbjct: 248 DCLHPEKHEDVIAREL--I-EKMIAMDPQKRPSAKHVLK 283

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  118 bits (297), Expect = 5e-30
 Identities = 65/280 (23%), Positives = 112/280 (40%), Gaps = 47/280 (16%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRL-----IAVKMM--ENSKFSAEEFINE----------- 206
               LG G FG+VYKG            +A+K +    S  + +E ++E           
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
              LLG+C       L+ + MP G L  ++  +E+K    G +      +  A+G+ YL 
Sbjct: 79  VCRLLGICLTS-TVQLITQLMPFGCLLDYV--REHKDN-IGSQYLLNWCVQIAKGMNYLE 134

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
                  + +SDV+ +G+ + E+   G +    + A+          +   L KG  L  
Sbjct: 192 --LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQ 240

Query: 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             +  I+      + MI   C  + A  RP   +++    
Sbjct: 241 PPICTID------VYMIMRKCWMIDADSRPKFRELIIEFS 274

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  116 bits (292), Expect = 9e-30
 Identities = 54/282 (19%), Positives = 106/282 (37%), Gaps = 59/282 (20%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSK------------------------FSAEE 202
            +G GGFG V+K +    G+   +K ++ +                         +   +
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77

Query: 203 FINELLGLCSEGFKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
           +  E     S   K   ++   E+   G+L++ I  ++ +G+        E+     +G+
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITKGV 135

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           +Y+H      +++ D+KP NI L      K+ DFGL      +        ++GT+ Y++
Sbjct: 136 DYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR---SKGTLRYMS 189

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378
           PE IS        + D+Y  G++L E+          +             +  L  G  
Sbjct: 190 PEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETSK-----------FFTDLRDG-- 234

Query: 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420
                   I  +  +K   +    +  K  DRP+ +++L  L
Sbjct: 235 -------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  116 bits (292), Expect = 2e-29
 Identities = 61/289 (21%), Positives = 111/289 (38%), Gaps = 45/289 (15%)

Query: 164 HFTHKLGQGGFGSVYKGQLH-----TGRLIAVKMM--ENSKFSAEEFINE---------- 206
                LG+G FG V   +       TG  +AVK +  E+      +   E          
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 207 ----LLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                 G+C+E       L+ E++P+GSL    +  +NK +   L++  + A+   +G++
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNK-INLKQQLKYAVQICKGMD 140

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-VSISDTRGTIGYLA 319
           YL        +H D+   N+L++     K+ DFGL K    + ++     D    + + A
Sbjct: 141 YLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSW------VYDQ 372
           PE +          SDV+ FG+ L E +     +S+  A                 + + 
Sbjct: 198 PECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255

Query: 373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           L +G  L        E      +  +   C + + ++R S   ++E  E
Sbjct: 256 LKEGKRLPCPPNCPDE------VYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  115 bits (289), Expect = 3e-29
 Identities = 68/300 (22%), Positives = 113/300 (37%), Gaps = 55/300 (18%)

Query: 165 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKMM-ENSKFSAEEFINE------------ 206
           F  +LG+G FGSV   +       TG ++AVK +  +++    +F  E            
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 207 --LLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               G+C    +R   L+ EY+P GSL    + +++K +     K  +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKER-IDHIKLLQYTSQICKGMEYL 130

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-VSISDTRGTIGYLAPE 321
                   +H D+   NIL+++    K+ DFGL K  P++ +F          I + APE
Sbjct: 131 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSW------VYDQL 373
            +       S  SDV+ FG+VL E+     +  S                     + + L
Sbjct: 188 SL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 374 NKGGDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ 428
              G L         +  I         M   W        RPS   +   ++   D++ 
Sbjct: 246 KNNGRLPRPDGCPDEIYMI---------MTECW--NNNVNQRPSFRDLALRVDQIRDNMA 294

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  113 bits (284), Expect = 2e-28
 Identities = 63/282 (22%), Positives = 119/282 (42%), Gaps = 49/282 (17%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRL-----IAVKMM--ENSKFSAEEFINE---------- 206
                LG G FG+V+KG            + +K++  ++ + S +   +           
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               LLGLC       LV +Y+P GSL  H+  ++++G   G +      +  A+G+ YL
Sbjct: 76  HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV--RQHRGA-LGPQLLLNWGVQIAKGMYYL 131

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
               +  ++H ++   N+LL      +V+DFG+A   P ++  +  S+ +  I ++A E 
Sbjct: 132 E---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           I  +FG  + +SDV+ +G+ + E+   G    + +             V D L KG  L 
Sbjct: 189 I--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---------VPDLLEKGERLA 237

Query: 381 L-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             +  T         + M+ + C  +    RP+  ++     
Sbjct: 238 QPQICTI-------DVYMVMVKCWMIDENIRPTFKELANEFT 272

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  112 bits (283), Expect = 4e-28
 Identities = 65/280 (23%), Positives = 113/280 (40%), Gaps = 47/280 (16%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGR-----LIAVKMM--ENSKFSAEEFINE----------- 206
               LG G FG+VYKG            +A+K +    S  + +E ++E           
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
              LLG+C       L+ + MP G L  ++  +E+K    G +      +  A+G+ YL 
Sbjct: 79  VCRLLGICLTS-TVQLITQLMPFGCLLDYV--REHKDN-IGSQYLLNWCVQIAKGMNYLE 134

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
                  + +SDV+ +G+ + E+   G +    + A+          +   L KG  L  
Sbjct: 192 --LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQ 240

Query: 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             +  I+      + MI + C  + A  RP   +++    
Sbjct: 241 PPICTID------VYMIMVKCWMIDADSRPKFRELIIEFS 274

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (282), Expect = 5e-28
 Identities = 52/212 (24%), Positives = 79/212 (37%), Gaps = 31/212 (14%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE----------FINELLGLCSEGF 215
            ++G+G FG V++ +   TG   AVK +    F  EE           I  L G   EG 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGP 123

Query: 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA---RGIEYLHNGCDVCILH 272
              +  E +  GSL + I       +  G                G+EYLH      ILH
Sbjct: 124 WVNIFMELLEGGSLGQLI-------KQMGCLPEDRALYYLGQALEGLEYLH---TRRILH 173

Query: 273 FDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISDT---RGTIGYLAPELISRNFG 328
            D+K  N+LL  +     + DFG A     +    S+       GT  ++APE++     
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-- 231

Query: 329 TVSCKSDVYGFGMVLLEMAGGRR-NSNMNATR 359
               K D++    ++L M  G    +      
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  112 bits (282), Expect = 6e-28
 Identities = 68/309 (22%), Positives = 121/309 (39%), Gaps = 54/309 (17%)

Query: 165 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKMM-ENSKFSAEEFINE------------ 206
           +  +LG+G FGSV   +       TG L+AVK +  +      +F  E            
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 207 --LLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               G+     +++  LV EY+P+G L    F + ++ +     +    +    +G+EYL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRAR-LDASRLLLYSSQICKGMEYL 143

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISDTRGTIGYLAPE 321
                   +H D+   NIL++     K++DFGLAK  P + D +V     +  I + APE
Sbjct: 144 G---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
            +  +    S +SDV+ FG+VL E+           T   K+  PS  + ++        
Sbjct: 201 SL--SDNIFSRQSDVWSFGVVLYEL----------FTYCDKSCSPSAEFLRMMGCERDVP 248

Query: 382 RNVTEIESMIAR-------KLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM 429
              + +  ++           C      +   C      DRPS + +   L+      + 
Sbjct: 249 AL-SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307

Query: 430 PPKPFFSSS 438
                F++ 
Sbjct: 308 CETHAFTAH 316

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  112 bits (281), Expect = 7e-28
 Identities = 66/293 (22%), Positives = 110/293 (37%), Gaps = 55/293 (18%)

Query: 165 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKMM-ENSKFSAEEFINE------------ 206
           F  +LG+G FGSV   +       TG ++AVK +  +++    +F  E            
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 207 --LLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               G+C    +R   L+ EY+P GSL    + +++K +     K  +      +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKER-IDHIKLLQYTSQICKGMEYL 161

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-VSISDTRGTIGYLAPE 321
                   +H D+   NIL+++    K+ DFGL K  P++ ++          I + APE
Sbjct: 162 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 218

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSW------VYDQL 373
            +       S  SDV+ FG+VL E+     +  S                     + + L
Sbjct: 219 SL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276

Query: 374 NKGGDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
              G L         +  I         M   W        RPS   +   ++
Sbjct: 277 KNNGRLPRPDGCPDEIYMI---------MTECW--NNNVNQRPSFRDLALRVD 318

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  113 bits (285), Expect = 1e-27
 Identities = 66/280 (23%), Positives = 111/280 (39%), Gaps = 58/280 (20%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMM-ENSKFSAEEFINE--------------LLG 209
               +G+G FG V  G    G  +AVK +  ++  +A+ F+ E              LLG
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 210 LCSEGFKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL--HN 264
           +  E   +  +Y   EYM  GSL    + +       G +   + +L     +EYL  +N
Sbjct: 254 VIVEE--KGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
                + H D+   N+L+  + + KVSDFGL K         +    +  + + APE + 
Sbjct: 310 ----FV-HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL- 358

Query: 325 RNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL- 381
                 S KSDV+ FG++L E+   G      +             V  ++ KG  ++  
Sbjct: 359 -REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYKMDAP 408

Query: 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                        +  +   C  + AA RP+  ++ E LE
Sbjct: 409 DGCPP-------AVYDVMKNCWHLDAATRPTFLQLREQLE 441

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  112 bits (281), Expect = 1e-27
 Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 49/274 (17%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE---FINELLGLCS----------E 213
           K+G+G FG     +    GR   +K +  S+ S++E      E+  L +          E
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 214 GFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
            F+      +V +Y   G L + I     KG  F  ++  +  +     ++++H   D  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELISRNFG 328
           ILH DIK  NI L  +   ++ DFG+A+      +         GT  YL+PE+      
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR---ACIGTPYYLSPEICENK-- 200

Query: 329 TVSCKSDVYGFGMVLLEMAGGRR---NSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
             + KSD++  G VL E+   +      +M             +  ++  G      +  
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----------LVLKIISG------SFP 243

Query: 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419
            +    +  L  +     +    DRPS+  +LE 
Sbjct: 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  110 bits (277), Expect = 1e-27
 Identities = 68/281 (24%), Positives = 111/281 (39%), Gaps = 58/281 (20%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMM-ENSKFSAEEFINE--------------LL 208
                +G+G FG V  G    G  +AVK +  ++  +A+ F+ E              LL
Sbjct: 24  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLL 80

Query: 209 GLCSEGFKRA-LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL--HNG 265
           G+  E      +V EYM  GSL    + +       G +   + +L     +EYL  +N 
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 137

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
               + H D+   N+L+  + + KVSDFGL K         +    +  + + APE +  
Sbjct: 138 ---FV-HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL-- 186

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----VYDQLNKGGDLEL 381
                S KSDV+ FG++L E+           +     Y P      V  ++ KG  ++ 
Sbjct: 187 REKKFSTKSDVWSFGILLWEI----------YSFGRVPY-PRIPLKDVVPRVEKGYKMDA 235

Query: 382 -RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                         +  +   C  + AA RPS  ++ E LE
Sbjct: 236 PDGCPP-------AVYEVMKNCWHLDAAMRPSFLQLREQLE 269

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  110 bits (276), Expect = 3e-27
 Identities = 66/293 (22%), Positives = 111/293 (37%), Gaps = 57/293 (19%)

Query: 165 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKMM--ENSKFSAEEFINE----------- 206
               LG+G FG V           TG ++AVK +  +        +  E           
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 207 ---LLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                G C +    +  LV EY+P GSL  ++        + GL +    A     G+ Y
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAY 149

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-VSISDTRGTIGYLAP 320
           LH       +H D+   N+LLD++ + K+ DFGLAK  P+ +++     D    + + AP
Sbjct: 150 LH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNATRSSKAYFPSW------VYDQL 373
           E +          SDV+ FG+ L E+      + +                    + + L
Sbjct: 207 ECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264

Query: 374 NKGGDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
            +G  L         V  +  M   K C    W  + +A+ RP+   ++ +L+
Sbjct: 265 ERGERLPRPDKCPAEVYHL--M---KNC----W--ETEASFRPTFENLIPILK 306

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  108 bits (273), Expect = 4e-27
 Identities = 58/280 (20%), Positives = 98/280 (35%), Gaps = 59/280 (21%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE---------------------FIN 205
           ++G+G F +VYKG    T   +A   +++ K +  E                     F +
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
                        LV E M +G+L  ++     + +   ++          +G+++LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 266 CDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
               I+H D+K  NI +       K+ D GLA                GT  ++APE+  
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE 203

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMNA--TRSSKAYFPSWVYDQLNKGGD 378
             +       DVY FGM +LEMA          N      R +    P       +K   
Sbjct: 204 EKYDE---SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----ASFDKVAI 256

Query: 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
            E++ + E               CI+    +R S+  +L 
Sbjct: 257 PEVKEIIE--------------GCIRQNKDERYSIKDLLN 282

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  109 bits (274), Expect = 8e-27
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 61/288 (21%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGR-----LIAVKMM--ENSKFSAEEFINE----------- 206
               +G G FG VYKG L T        +A+K +    ++    +F+ E           
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
              L G+ S+     ++ EYM NG+LD+  F +E  G+ F + +   +  G A G++YL 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGE-FSVLQLVGMLRGIAAGMKYLA 164

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT---IGYLAP 320
              ++  +H D+   NIL++ N + KVSDFGL++    E+D  +   T G    I + AP
Sbjct: 165 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAP 219

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLN 374
           E I  ++   +  SDV+ FG+V+ E+              +    P W      V   +N
Sbjct: 220 EAI--SYRKFTSASDVWSFGIVMWEVM-------------TYGERPYWELSNHEVMKAIN 264

Query: 375 KGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
            G  L    +           +  + + C Q + A RP    ++ +L+
Sbjct: 265 DGFRLPTPMDCPS-------AIYQLMMQCWQQERARRPKFADIVSILD 305

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  107 bits (270), Expect = 1e-26
 Identities = 60/291 (20%), Positives = 106/291 (36%), Gaps = 61/291 (20%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGR----LIAVKMM--ENSKFSAEEFINE------------ 206
               +G+G FG V++G   +       +A+K      S    E+F+ E            
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL-- 262
             L+G+ +E     ++ E    G L    F +  K     L      A   +  + YL  
Sbjct: 79  VKLIGVITEN-PVWIIMELCTLGELRS--FLQVRKYS-LDLASLILYAYQLSTALAYLES 134

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
                  + H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE 
Sbjct: 135 KR----FV-HRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPES 188

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLNKG 376
           I  NF   +  SDV+ FG+ + E+                   P        V  ++  G
Sbjct: 189 I--NFRRFTSASDVWMFGVCMWEIL-------------MHGVKPFQGVKNNDVIGRIENG 233

Query: 377 GDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
             L +  N           L  +   C     + RP  T++   L   +++
Sbjct: 234 ERLPMPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (271), Expect = 1e-26
 Identities = 65/289 (22%), Positives = 108/289 (37%), Gaps = 60/289 (20%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGR----LIAVKMM--ENSKFSAEEFINE----------- 206
           H    +G+G FG VY G+           A+K +         E F+ E           
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 207 ---LLGLCSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
              L+G+          +  YM +G L + I    +  +   ++      L  ARG+EYL
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 263 --HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGT---IGY 317
                    + H D+   N +LD +F  KV+DFGLA+    + ++ S+   R     + +
Sbjct: 141 AEQK----FV-HRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHRHARLPVKW 194

Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----VYDQL 373
            A E  S      + KSDV+ FG++L E+           TR +  Y        +   L
Sbjct: 195 TALE--SLQTYRFTTKSDVWSFGVLLWEL----------LTRGAPPY-RHIDPFDLTHFL 241

Query: 374 NKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
            +G  L       +        L  +   C +   A RP+   ++  +E
Sbjct: 242 AQGRRLPQPEYCPD-------SLYQVMQQCWEADPAVRPTFRVLVGEVE 283

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  108 bits (271), Expect = 1e-26
 Identities = 55/280 (19%), Positives = 93/280 (33%), Gaps = 66/280 (23%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE---FINE---LLGLCSE----GFK 216
           +LG G +G V+K +    GRL AVK   +     ++    + E      +         +
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 217 RA--------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           +A        L  E     SL +H    E  G +    +       T   + +LH     
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISDTRGTIGYLAPELISR 325
            ++H D+KP NI L      K+ DFGL                    G   Y+APEL+  
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE------GDPRYMAPELLQG 230

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMNATRSSKAY--FPSWVYDQLNKGGDL 379
           ++G     +DV+  G+ +LE+A               R       F + +          
Sbjct: 231 SYG---TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL---------- 277

Query: 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419
                    S   R + +     ++     R +   +L +
Sbjct: 278 ---------SSELRSVLV---MMLEPDPKLRATAEALLAL 305

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  108 bits (271), Expect = 2e-26
 Identities = 72/347 (20%), Positives = 123/347 (35%), Gaps = 74/347 (21%)

Query: 143 YRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGR------LIAVKMM--E 194
           Y    +T     L E+          LG G FG VY+GQ+           +AVK +   
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71

Query: 195 NSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLD---RHIFSKE 237
            S+    +F+ E               +G+  +   R ++ E M  G L    R    + 
Sbjct: 72  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131

Query: 238 NKGQTFGLEKPHEIALGTARGIEYL--HNGCDVCILHFDIKPHNILLD---HNFIPKVSD 292
           ++  +  +     +A   A G +YL  ++     I H DI   N LL       + K+ D
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENH----FI-HRDIAARNCLLTCPGPGRVAKIGD 186

Query: 293 FGLAKFHPKENDFVSISD--TRGTIGYL-----APELISRNFGTVSCKSDVYGFGMVLLE 345
           FG+A+        +  +    +G    L      PE  +   G  + K+D + FG++L E
Sbjct: 187 FGMAR-------DIYRASYYRKGGCAMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWE 237

Query: 346 MAGGRRNSNMNATRSSKAYFPSW----VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGL 400
           +           +     Y PS     V + +  GG ++  +N           +  I  
Sbjct: 238 I----------FSLGYMPY-PSKSNQEVLEFVTSGGRMDPPKNCPG-------PVYRIMT 279

Query: 401 WCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHISGRETE 447
            C Q +  DRP+   +LE +E    D  +           +   E +
Sbjct: 280 QCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK 326

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  107 bits (270), Expect = 2e-26
 Identities = 70/321 (21%), Positives = 115/321 (35%), Gaps = 64/321 (19%)

Query: 141 HKYRTTMQTVDNILLPEIIAVTNH---FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMME-N 195
           H +  +    +      ++ + N    F  KLG+GGF  V   + LH G   A+K +  +
Sbjct: 6   HHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH 65

Query: 196 SKFSAEEFINE-----------LLGLCSEGFKRA-------LVYEYMPNGSLDRHIFSKE 237
            +   EE   E           +L L +   +         L+  +   G+L   I   +
Sbjct: 66  EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK 125

Query: 238 NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297
           +KG     ++   + LG  RG+E +H        H D+KP NILL     P + D G   
Sbjct: 126 DKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182

Query: 298 FHPKENDFVSISDT-------RGTIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGG 349
                 +    + T       R TI Y APEL S ++   +  ++DV+  G VL  M  G
Sbjct: 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

Query: 350 R-----RNSNMNATR---SSKAYFPSW-VYDQLNKGGDLELRNVTEIESMIARKLCMIGL 400
                      ++      ++   P    +          L  +  + SM          
Sbjct: 243 EGPYDMVFQKGDSVALAVQNQLSIPQSPRHSS-------ALWQL--LNSM---------- 283

Query: 401 WCIQVKAADRPSMTKVLEMLE 421
             + V    RP +  +L  LE
Sbjct: 284 --MTVDPHQRPHIPLLLSQLE 302

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  106 bits (268), Expect = 2e-26
 Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 48/278 (17%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE---FINE--LLGLCS--------E 213
            +G G +G   K +    G+++  K ++    +  E    ++E  LL            +
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 214 GFKRA------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH--NG 265
                      +V EY   G L   I     + Q    E    +       ++  H  + 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELIS 324
               +LH D+KP N+ LD     K+ DFGLA+    +  F     T  GT  Y++PE ++
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK---TFVGTPYYMSPEQMN 189

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGRR---NSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
           R   + + KSD++  G +L E+          +              +  ++ +G     
Sbjct: 190 RM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----------LAGKIREG----- 231

Query: 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419
                I    + +L  I    + +K   RPS+ ++LE 
Sbjct: 232 -KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  107 bits (270), Expect = 2e-26
 Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 56/286 (19%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGR----LIAVKMM--ENSKFSAEEFINE----------- 206
           H    +G G  G V  G+L         +A+K +    ++    +F++E           
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
              L G+ + G    +V EYM NGSLD   F + + GQ F + +   +  G   G+ YL 
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQ-FTIMQLVGMLRGVGAGMRYLS 168

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD-TRGTIGYLAPEL 322
              D+  +H D+   N+L+D N + KVSDFGL++    + D    +   +  I + APE 
Sbjct: 169 ---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           I   F T S  SDV+ FG+V+ E+   G R   NM             V   + +G  L 
Sbjct: 226 I--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---------VISSVEEGYRLP 274

Query: 381 L-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                   + ++  M         L C     A RP  ++++ +L+
Sbjct: 275 APMGCPHALHQL--M---------LDCWHKDRAQRPRFSQIVSVLD 309

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  106 bits (267), Expect = 3e-26
 Identities = 68/287 (23%), Positives = 112/287 (39%), Gaps = 61/287 (21%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRL----IAVKMM--ENSKFSAEEFINE----------- 206
                LG+G FG VY+G     +     +AVK    + +  + E+F++E           
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL- 262
              L+G+  E     ++ E  P G L  ++  + NK     +      +L   + + YL 
Sbjct: 75  IVKLIGIIEEE-PTWIIMELYPYGELGHYL--ERNKNS-LKVLTLVLYSLQICKAMAYLE 130

Query: 263 -HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
             N    C+ H DI   NIL+      K+ DFGL+++  ++ D+   S TR  I +++PE
Sbjct: 131 SIN----CV-HRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPE 184

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLNK 375
            I  NF   +  SDV+ F + + E+              S    P +      V   L K
Sbjct: 185 SI--NFRRFTTASDVWMFAVCMWEIL-------------SFGKQPFFWLENKDVIGVLEK 229

Query: 376 GGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           G  L                L  +   C     +DRP  T+++  L 
Sbjct: 230 GDRLPKPDLCPP-------VLYTLMTRCWDYDPSDRPRFTELVCSLS 269

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  106 bits (267), Expect = 4e-26
 Identities = 66/301 (21%), Positives = 105/301 (34%), Gaps = 80/301 (26%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE--LLGLCS--------EGFK 216
            LGQG FG V K +     R  A+K + +++      ++E  LL   +          + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 217 RA-----------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR-- 257
                              +  EY  NG+L   I S+        L +  +      R  
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-------NLNQQRDEYWRLFRQI 125

Query: 258 --GIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-- 312
              + Y+H  G    I+H D+KP NI +D +   K+ DFGLAK   +  D + +      
Sbjct: 126 LEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 313 ----------GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA-----GGRRNSNMNA 357
                     GT  Y+A E++    G  + K D+Y  G++  EM      G  R + +  
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240

Query: 358 TRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
            RS    FP    D                +  + +K+       I      RP    +L
Sbjct: 241 LRSVSIEFPPDFDDN---------------KMKVEKKII---RLLIDHDPNKRPGARTLL 282

Query: 418 E 418
            
Sbjct: 283 N 283

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  106 bits (267), Expect = 4e-26
 Identities = 54/310 (17%), Positives = 100/310 (32%), Gaps = 65/310 (20%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKM--MENSKFSAEEFINELLGL-------------- 210
            LG+GGFG V++ +        A+K   + N + + E+ + E+  L              
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 211 ---------CSEGFKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEK-PHEIALGTAR 257
                          +  +Y   +     +L   +                  I L  A 
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLHIFLQIAE 129

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR----- 312
            +E+LH      ++H D+KP NI    + + KV DFGL     ++ +  ++         
Sbjct: 130 AVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186

Query: 313 -----GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 367
                GT  Y++PE I  N  + S K D++  G++L E+              S      
Sbjct: 187 HTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL----------LYPFSTQMERV 234

Query: 368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL 427
                +      +   +   +      +       +     +RP    ++E      +DL
Sbjct: 235 RTLTDVRNL---KFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAINIIEN--AVFEDL 286

Query: 428 QMPPKPFFSS 437
             P K     
Sbjct: 287 DFPGKTVLRQ 296

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  106 bits (267), Expect = 4e-26
 Identities = 72/304 (23%), Positives = 116/304 (38%), Gaps = 60/304 (19%)

Query: 155 LPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGR----LIAVKMM--ENSKFSAEEFINE-- 206
           +    ++  HF   +G+G FG VY G L          AVK +          +F+ E  
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78

Query: 207 ------------LLGLCSEGFKRAL-VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL 253
                       LLG+C       L V  YM +G L    F +        ++      L
Sbjct: 79  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHN-PTVKDLIGFGL 135

Query: 254 GTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
             A+G++YL         + H D+   N +LD  F  KV+DFGLA+    + ++ S+ + 
Sbjct: 136 QVAKGMKYLASKK----FV-HRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNK 189

Query: 312 RGT---IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW 368
            G    + ++A E  S      + KSDV+ FG++L E+           TR +  Y P  
Sbjct: 190 TGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWEL----------MTRGAPPY-PDV 236

Query: 369 ----VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423
               +   L +G  L       +        L  + L C   KA  RPS ++++  +   
Sbjct: 237 NTFDITVYLLQGRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

Query: 424 IDDL 427
               
Sbjct: 290 FSTF 293

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  107 bits (270), Expect = 4e-26
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 56/285 (19%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGR----LIAVKMM--ENSKFSAEEFINE------------ 206
               +G G FG V  G+L         +A+K +    ++    +F+ E            
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
             L G+ ++     +V EYM NGSLD   F +++  Q F + +   +  G A G++YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIASGMKYLS- 164

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD-TRGTIGYLAPELI 323
             D+  +H D+   NIL++ N + KVSDFGL +    + +    +   +  I + +PE I
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
              +   +  SDV+ +G+VL E+   G R    M+            V   +++G  L  
Sbjct: 223 --AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---------VIKAVDEGYRLP- 270

Query: 382 RNVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 421
                         C   L+     C Q    +RP   +++ +L+
Sbjct: 271 ----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  106 bits (266), Expect = 5e-26
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 31/204 (15%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMME-NSKFSAEEFINEL--------------LGLCS 212
           LG+G +G VY G  L     IA+K +       ++    E+              LG  S
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA---RGIEYLHNGCDVC 269
           E     +  E +P GSL   +    +K       +   I   T     G++YLH   D  
Sbjct: 90  ENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQT-IGFYTKQILEGLKYLH---DNQ 142

Query: 270 ILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELISRNF 327
           I+H DIK  N+L++ ++ + K+SDFG +K   +       ++T  GT+ Y+APE+I +  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 328 GTVSCKSDVYGFGMVLLEMAGGRR 351
                 +D++  G  ++EMA G+ 
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  106 bits (266), Expect = 5e-26
 Identities = 65/281 (23%), Positives = 109/281 (38%), Gaps = 56/281 (19%)

Query: 168 KLGQGGFGSVYKGQLHTGR---LIAVKMM--ENSKFSAEEFINE--------------LL 208
           +LG G FGSV +G     +    +A+K++     K   EE + E              L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+C       LV E    G L +  F    + +   +    E+    + G++YL    + 
Sbjct: 77  GVCQAE-ALMLVMEMAGGGPLHK--FLVGKREE-IPVSNVAELLHQVSMGMKYL---EEK 129

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISDTRGTIGYLAPELISRNF 327
             +H D+   N+LL +    K+SDFGL+K    ++  + + S  +  + + APE I  NF
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 187

Query: 328 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
              S +SDV+ +G+ + E    G +    M             V   + +G  +E     
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIEQGKRME----- 233

Query: 386 EIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 421
                     C   L+     C   K  DRP    V + + 
Sbjct: 234 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (265), Expect = 6e-26
 Identities = 53/292 (18%), Positives = 98/292 (33%), Gaps = 71/292 (24%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE---FINE---LLGLCS-------- 212
           K+G G FGSV+K      G + A+K  +     + +    + E      L          
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 213 ----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
               E     +  EY   GSL   I         F   +  ++ L   RG+ Y+H    +
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134

Query: 269 CILHFDIKPHNILLDHN-------------------FIPKVSDFGLAKFHPKENDFVSIS 309
            ++H DIKP NI +                       + K+ D G               
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--- 191

Query: 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNATRSSKAYFP 366
              G   +LA E++  N+     K+D++   + ++  AG     RN +            
Sbjct: 192 ---GDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ----------- 236

Query: 367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
              + ++ +G       +  I  +++++   +    I      RPS   +++
Sbjct: 237 ---WHEIRQG------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  106 bits (267), Expect = 1e-25
 Identities = 73/313 (23%), Positives = 121/313 (38%), Gaps = 61/313 (19%)

Query: 146 TMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGR----LIAVKMM--ENSKFS 199
            +Q V + ++    ++  HF   +G+G FG VY G L          AVK +        
Sbjct: 75  LVQAVQH-VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133

Query: 200 AEEFINE--------------LLGLCSEG-FKRALVYEYMPNGSLDRHIFSKENKGQTFG 244
             +F+ E              LLG+C        +V  YM +G L    F +        
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHN-PT 190

Query: 245 LEKPHEIALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302
           ++      L  A+G+++L         + H D+   N +LD  F  KV+DFGLA+    +
Sbjct: 191 VKDLIGFGLQVAKGMKFLASKK----FV-HRDLAARNCMLDEKFTVKVADFGLARD-MYD 244

Query: 303 NDFVSISDTRGT---IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR 359
            +F S+ +  G    + ++A E  S      + KSDV+ FG++L E+           TR
Sbjct: 245 KEFDSVHNKTGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWEL----------MTR 292

Query: 360 SSKAYFPSW----VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 414
            +  Y P      +   L +G  L       +        L  + L C   KA  RPS +
Sbjct: 293 GAPPY-PDVNTFDITVYLLQGRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFS 344

Query: 415 KVLEMLEGSIDDL 427
           +++  +       
Sbjct: 345 ELVSRISAIFSTF 357

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  105 bits (263), Expect = 2e-25
 Identities = 62/282 (21%), Positives = 103/282 (36%), Gaps = 57/282 (20%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA----EEFINE--LLGLCS------- 212
            K+G+G F  VY+   L  G  +A+K ++           + I E  LL   +       
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 213 -EGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
              F       +V E    G L R I   + + +        +  +     +E++H    
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
             ++H DIKP N+ +    + K+ D GL +F   +          GT  Y++PE I  N 
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHEN- 211

Query: 328 GTVSCKSDVYGFGMVLLEMAGGRR-----NSNMNA-----TRSSKAYFPSWVYDQLNKGG 377
              + KSD++  G +L EMA  +        N+ +      +      PS  Y +     
Sbjct: 212 -GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE----- 265

Query: 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419
             ELR +                 CI      RP +T V ++
Sbjct: 266 --ELRQLVN--------------MCINPDPEKRPDVTYVYDV 291

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  105 bits (263), Expect = 2e-25
 Identities = 73/300 (24%), Positives = 119/300 (39%), Gaps = 60/300 (20%)

Query: 164 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFSAEE---FINE---------- 206
                LG+G FGSV +G L     T   +AVK M+    S  E   F++E          
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 207 ----LLGLCSEGFKRA-----LVYEYMPNGSLDRHIFSK--ENKGQTFGLEKPHEIALGT 255
               LLG+C E   +      ++  +M  G L  ++     E   +   L+   +  +  
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 256 ARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
           A G+EYL   N     + H D+   N +L  +    V+DFGL+K     + +      + 
Sbjct: 157 ALGMEYLSNRN----FL-HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211

Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----V 369
            + ++A E  S      + KSDV+ FG+ + E+          ATR    Y P      +
Sbjct: 212 PVKWIAIE--SLADRVYTSKSDVWAFGVTMWEI----------ATRGMTPY-PGVQNHEM 258

Query: 370 YDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ 428
           YD L  G  L+   +  +       +L  I   C +    DRP+ + +   LE  ++ L 
Sbjct: 259 YDYLLHGHRLKQPEDCLD-------ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  104 bits (261), Expect = 2e-25
 Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 58/288 (20%)

Query: 164 HFTHKLGQGGFGSVYKGQLHT--GRLI--AVKMMENSKFS----AEEFINE--------- 206
               KLG G FG V +G+     G+ +  AVK ++    S     ++FI E         
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                L G+        +V E  P GSL   +  ++++G  F L      A+  A G+ Y
Sbjct: 81  RNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGY 136

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISDTRGTIGYLAP 320
           L        +H D+   N+LL    + K+ DFGL +  P+ +D +V     +    + AP
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378
           E +     T S  SD + FG+ L EM   G      +N ++         +  +++K G 
Sbjct: 194 ESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------ILHKIDKEG- 241

Query: 379 LELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 421
                    E +   + C      + + C   K  DRP+   + + L 
Sbjct: 242 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  105 bits (263), Expect = 2e-25
 Identities = 74/318 (23%), Positives = 124/318 (38%), Gaps = 63/318 (19%)

Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTG---RLIAVKMM-ENS 196
           H +       D  + P +      F   +G+G FG V K ++         A+K M E +
Sbjct: 5   HHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA 64

Query: 197 KFSA-EEFINE---------------LLGLCSEGFKRALVYEYMPNGSL----------- 229
                 +F  E               LLG C       L  EY P+G+L           
Sbjct: 65  SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124

Query: 230 -DRHIFSKENKGQTFGLEKPHEIALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNF 286
            D       +   T   ++    A   ARG++YL         I H D+   NIL+  N+
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ----FI-HRDLAARNILVGENY 179

Query: 287 IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
           + K++DFGL++    +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+
Sbjct: 180 VAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEI 234

Query: 347 A--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCI 403
              GG     M             +Y++L +G  LE   N  +       ++  +   C 
Sbjct: 235 VSLGGTPYCGMTCAE---------LYEKLPQGYRLEKPLNCDD-------EVYDLMRQCW 278

Query: 404 QVKAADRPSMTKVLEMLE 421
           + K  +RPS  ++L  L 
Sbjct: 279 REKPYERPSFAQILVSLN 296

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  105 bits (264), Expect = 2e-25
 Identities = 59/323 (18%), Positives = 108/323 (33%), Gaps = 61/323 (18%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCS------EGFKRA--- 218
            L QG F  +   +    +  A+K  E S    +    +            + FK     
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 219 -----------------------LVYEYMPNGSLDRHIFSK----ENKGQTFGLEKPHEI 251
                                  ++YEYM N S+ +         +N      ++    I
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
                    Y+HN  ++C  H D+KP NIL+D N   K+SDFG +++   +     I  +
Sbjct: 157 IKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGS 210

Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR----RNSNMNAT----RSSKA 363
           RGT  ++ PE  S        K D++  G+ L  M           ++       R+   
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270

Query: 364 YFPSWVYDQLNKGGDLELRNVTEIESMIARKL--CMIGLWCIQVKAADRPSMTKVLE--- 418
            +P      L    + +        S               ++   A+R +    L+   
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF-----LRKNPAERITSEDALKHEW 325

Query: 419 MLEGSIDDLQMPPKPFFSSSRHI 441
           + + +I+DL+   K  +   + +
Sbjct: 326 LADTNIEDLREFSKELYKKRKKL 348

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  104 bits (262), Expect = 3e-25
 Identities = 71/305 (23%), Positives = 118/305 (38%), Gaps = 74/305 (24%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKMM-ENSKFSA-EEFINE--------- 206
             + +LGQG FG VY+G             +A+K + E +      EF+NE         
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSLD------RHIFSKENKGQTFGLEKPHEIALGT 255
                LLG+ S+G    ++ E M  G L       R   +         L K  ++A   
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 256 ARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD--T 311
           A G+ YL  +      + H D+   N ++  +F  K+ DFG+ +        +  +D   
Sbjct: 148 ADGMAYLNANK----FV-HRDLAARNCMVAEDFTVKIGDFGMTR-------DIYETDYYR 195

Query: 312 RGTIGYL-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP 366
           +G  G L     +PE  S   G  +  SDV+ FG+VL E+          AT + + Y  
Sbjct: 196 KGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI----------ATLAEQPY-Q 242

Query: 367 SW----VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                 V   + +GG L+   N  +        L  +   C Q     RPS  +++  ++
Sbjct: 243 GLSNEQVLRFVMEGGLLDKPDNCPD-------MLFELMRMCWQYNPKMRPSFLEIISSIK 295

Query: 422 GSIDD 426
             ++ 
Sbjct: 296 EEMEP 300

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  104 bits (261), Expect = 6e-25
 Identities = 69/326 (21%), Positives = 117/326 (35%), Gaps = 74/326 (22%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKMM-ENSKFSAE-EFINE--------- 206
                LG G FG VY+GQ+           +AVK + E      E +F+ E         
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSLD---RHIFSKENKGQTFGLEKPHEIALGTARG 258
                 +G+  +   R ++ E M  G L    R    + ++  +  +     +A   A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 259 IEYL--HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISD--T 311
            +YL  ++     I H DI   N LL       + K+ DFG+A+        +  +    
Sbjct: 194 CQYLEENH----FI-HRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRAGYYR 241

Query: 312 RGTIGYL-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP 366
           +G    L      PE  +   G  + K+D + FG++L E+           +     Y P
Sbjct: 242 KGGCAMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEI----------FSLGYMPY-P 288

Query: 367 SW----VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           S     V + +  GG ++  +N           +  I   C Q +  DRP+   +LE +E
Sbjct: 289 SKSNQEVLEFVTSGGRMDPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERIE 341

Query: 422 GSIDDLQMPPKPFFSSSRHISGRETE 447
               D  +           +   E +
Sbjct: 342 YCTQDPDVINTALPIEYGPLVEEEEK 367

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  103 bits (258), Expect = 7e-25
 Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 62/284 (21%)

Query: 168 KLGQGGFGSVYKGQLHTGRL---IAVKMM---ENSKFSAEEFINE--------------L 207
           +LG G FG+V KG     ++   +AVK++    N     +E + E              +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL--HNG 265
           +G+C       LV E    G L++++     + +    +   E+    + G++YL   N 
Sbjct: 84  IGICEAE-SWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 137

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-VSISDTRGTIGYLAPELIS 324
               + H D+   N+LL      K+SDFGL+K    + ++  + +  +  + + APE I 
Sbjct: 138 ---FV-HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI- 192

Query: 325 RNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382
            N+   S KSDV+ FG+++ E    G +    M  +          V   L KG  +   
Sbjct: 193 -NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---------VTAMLEKGERMG-- 240

Query: 383 NVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 421
                        C   ++     C      +RP    V   L 
Sbjct: 241 ---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  106 bits (266), Expect = 9e-25
 Identities = 61/291 (20%), Positives = 107/291 (36%), Gaps = 56/291 (19%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGR----LIAVKMM--ENSKFSAEEFINE------------ 206
               +G+G FG V++G   +       +A+K      S    E+F+ E            
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL-- 262
             L+G+ +E     ++ E    G L    F +  K     L      A   +  + YL  
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRS--FLQVRKFS-LDLASLILYAYQLSTALAYLES 509

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
                  + H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE 
Sbjct: 510 KR----FV-HRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPES 563

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           I  NF   +  SDV+ FG+ + E+   G +    +             V  ++  G  L 
Sbjct: 564 I--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------VIGRIENGERLP 612

Query: 381 L-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMP 430
           +  N           L  +   C     + RP  T++   L      L+  
Sbjct: 613 MPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLS---TILEEE 653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  103 bits (258), Expect = 9e-25
 Identities = 66/300 (22%), Positives = 111/300 (37%), Gaps = 59/300 (19%)

Query: 164 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFS---AEEFINE---------- 206
                LG+G FGSV + QL     +   +AVKM++    +    EEF+ E          
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 207 ----LLGLCSEGFKRA------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPH--EIALG 254
               L+G+      +       ++  +M +G L   + +       F L         + 
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 255 TARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312
            A G+EYL   N     I H D+   N +L  +    V+DFGL++     + +     ++
Sbjct: 146 IACGMEYLSSRN----FI-HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200

Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF---PSWV 369
             + +LA E  S      +  SDV+ FG+ + E+           TR    Y     + +
Sbjct: 201 LPVKWLALE--SLADNLYTVHSDVWAFGVTMWEI----------MTRGQTPYAGIENAEI 248

Query: 370 YDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ 428
           Y+ L  G  L+      E       ++  +   C       RPS T +   LE  +  L 
Sbjct: 249 YNYLIGGNRLKQPPECME-------EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  105 bits (264), Expect = 1e-24
 Identities = 65/288 (22%), Positives = 110/288 (38%), Gaps = 56/288 (19%)

Query: 168 KLGQGGFGSVYKGQLHTGR---LIAVKMM--ENSKFSAEEFINE--------------LL 208
           +LG G FGSV +G     +    +A+K++     K   EE + E              L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+C       LV E    G L +  F    + +   +    E+    + G++YL    + 
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPLHK--FLVGKREE-IPVSNVAELLHQVSMGMKYL---EEK 455

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISDTRGTIGYLAPELISRNF 327
             +H ++   N+LL +    K+SDFGL+K    ++  + + S  +  + + APE I  NF
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 513

Query: 328 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
              S +SDV+ +G+ + E    G +    M             V   + +G  +E     
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIEQGKRME----- 559

Query: 386 EIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSIDDLQ 428
                     C   L+     C   K  DRP    V + +      L 
Sbjct: 560 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  102 bits (256), Expect = 2e-24
 Identities = 59/303 (19%), Positives = 107/303 (35%), Gaps = 64/303 (21%)

Query: 164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMM-ENSKFSA-EEFINE--------- 206
            F   LG G FG V +              +AVKM+   +     E  ++E         
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108

Query: 207 ------LLGLCSEGFKRALVYEYMPNGSL----------DRHIFSKENKGQTFGLEKPHE 250
                 LLG C+ G    ++ EY   G L               +      T        
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 251 IALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 308
            +   A+G+ +L   N    CI H D+   N+LL +  + K+ DFGLA+    +++++  
Sbjct: 169 FSSQVAQGMAFLASKN----CI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223

Query: 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--FP 366
            + R  + ++APE  S      + +SDV+ +G++L E+           +     Y    
Sbjct: 224 GNARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEI----------FSLGLNPYPGIL 271

Query: 367 SW--VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423
                Y  +  G  +       +        +  I   C  ++   RP+  ++   L+  
Sbjct: 272 VNSKFYKLVKDGYQMAQPAFAPK-------NIYSIMQACWALEPTHRPTFQQICSFLQEQ 324

Query: 424 IDD 426
             +
Sbjct: 325 AQE 327

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  101 bits (253), Expect = 3e-24
 Identities = 61/326 (18%), Positives = 107/326 (32%), Gaps = 76/326 (23%)

Query: 154 LLPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRL--------IAVKMM-ENSKFSAEEFI 204
           +  +I      F   LGQG F  ++KG               + +K++ +  +  +E F 
Sbjct: 1   VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF 60

Query: 205 NE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE 250
                             G+C  G +  LV E++  GSLD   + K+NK     +    E
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNC-INILWKLE 117

Query: 251 IALGTARGIEYL--HNGCDVCILHFDIKPHNILLD--------HNFIPKVSDFGLAKFHP 300
           +A   A  + +L  +      I H ++   NILL         +    K+SD G++    
Sbjct: 118 VAKQLAAAMHFLEENT----LI-HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--- 169

Query: 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS 360
                +     +  I ++ PE I  N   ++  +D + FG  L E+              
Sbjct: 170 ---TVLPKDILQERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEIC------------- 212

Query: 361 SKAYFPSW------VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 414
           S    P                  L      E+ ++I          C+  +   RPS  
Sbjct: 213 SGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLI--------NNCMDYEPDHRPSFR 264

Query: 415 KVLEMLEGSIDDLQMPPKPFFSSSRH 440
            ++  L        + P+       H
Sbjct: 265 AIIRDLNSLFTP-DLVPRGSHHHHHH 289

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  100 bits (251), Expect = 5e-24
 Identities = 64/317 (20%), Positives = 117/317 (36%), Gaps = 86/317 (27%)

Query: 164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMM-ENSKFSAEEFINE---------- 206
               +LG+G FG V+  + +         L+AVK + + +  + ++F  E          
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSL------------DRHIFSKENKGQTFGLEKPHE 250
                 G+C +G    +V+EYM +G L                          GL +   
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 251 IALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 308
           IA   A G+ YL   +     + H D+   N L+  N + K+ DFG+++        V  
Sbjct: 138 IASQIASGMVYLASQH----FV-HRDLATRNCLVGANLLVKIGDFGMSR-------DVYS 185

Query: 309 SD--TRGTIGYL-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 361
           +D    G    L      PE I   +   + +SDV+ FG++L E+              +
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIF-------------T 230

Query: 362 KAYFPSW------VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 414
               P +      V + + +G  LE  R   +       ++  + L C Q +   R ++ 
Sbjct: 231 YGKQPWFQLSNTEVIECITQGRVLERPRVCPK-------EVYDVMLGCWQREPQQRLNIK 283

Query: 415 KVLEMLEGSIDDLQMPP 431
           ++ ++L       +  P
Sbjct: 284 EIYKILH---ALGKATP 297

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  101 bits (253), Expect = 5e-24
 Identities = 67/306 (21%), Positives = 114/306 (37%), Gaps = 82/306 (26%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKMM-ENSKFSAEEFINE---------- 206
               +LG+G FG V+  + H         L+AVK + E S+ + ++F  E          
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSL-----------DRHIFSKENKGQTFGLEKPHEI 251
                 G+C+EG    +V+EYM +G L                 ++      GL +   +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 252 ALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309
           A   A G+ YL   +     + H D+   N L+    + K+ DFG+++        +  +
Sbjct: 164 ASQVAAGMVYLAGLH----FV-HRDLATRNCLVGQGLVVKIGDFGMSR-------DIYST 211

Query: 310 D--TRGTIGYL-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 362
           D    G    L      PE I   +   + +SDV+ FG+VL E+              + 
Sbjct: 212 DYYRVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFGVVLWEIF-------------TY 256

Query: 363 AYFPSW------VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTK 415
              P +        D + +G +LE  R           ++  I   C Q +   R S+  
Sbjct: 257 GKQPWYQLSNTEAIDCITQGRELERPRACPP-------EVYAIMRGCWQREPQQRHSIKD 309

Query: 416 VLEMLE 421
           V   L+
Sbjct: 310 VHARLQ 315

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  101 bits (254), Expect = 7e-24
 Identities = 65/334 (19%), Positives = 123/334 (36%), Gaps = 73/334 (21%)

Query: 164 HFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMM-ENSKFSA-EEFINE------- 206
                LG+G FG V   +              +AVKM+  ++      + I+E       
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 207 --------LLGLCSEGFKRALVYEYMPNGSL------------DRHIFSKENKGQTFGLE 246
                   LLG C++     ++ EY   G+L            +       N  +    +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 247 KPHEIALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304
                A   ARG+EYL        CI H D+   N+L+  + + K++DFGLA+     + 
Sbjct: 192 DLVSCAYQVARGMEYLASKK----CI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246

Query: 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 364
           +   ++ R  + ++APE  +      + +SDV+ FG++L E+              +   
Sbjct: 247 YKKTTNGRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIF-------------TLGG 291

Query: 365 FP------SWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417
            P        ++  L +G  ++   N T        +L M+   C     + RP+  +++
Sbjct: 292 SPYPGVPVEELFKLLKEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLV 344

Query: 418 EMLEGSIDDLQMPPKPFFSSSRHISGRETESASL 451
           E L+  +         ++    H       + +L
Sbjct: 345 EDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENL 378

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  103 bits (258), Expect = 1e-23
 Identities = 45/212 (21%), Positives = 78/212 (36%), Gaps = 52/212 (24%)

Query: 168 KLGQGGFGSVYKG---QLHTGRLIAVKMMENSK-------FSAE-EFINEL--------- 207
            +  GG G +Y      ++ GR + +K + +S          AE +F+ E+         
Sbjct: 87  CIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 208 -LGLCSEGFKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
                ++     + Y   EY+   SL R        GQ   + +     L     + YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLH 199

Query: 264 -NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR---GTIGYLA 319
             G    +++ D+KP NI+L    + K+ D G             I+      GT G+ A
Sbjct: 200 SIG----LVYNDLKPENIMLTEEQL-KLIDLGAVS---------RINSFGYLYGTPGFQA 245

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
           PE++       +  +D+Y  G  L  +     
Sbjct: 246 PEIVR---TGPTVATDIYTVGRTLAALTLDLP 274

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 42/211 (19%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM--ENSKFSAEEFINELLGLCSE----------G 214
           +LG+G +G V K + + +G+++AVK +    +    +  + +L                G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 215 --FKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             F+   V+   E M + SLD+      +KGQT   +   +IA+   + +E+LH+   + 
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFG--------LAKFHPKENDFVSISDTRGTIGYLAPE 321
           ++H D+KP N+L++     K+ DFG        +AK     +         G   Y+APE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-----DIDA------GCKPYMAPE 179

Query: 322 LI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            I    N    S KSD++  G+ ++E+A  R
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILR 210

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 46/221 (20%)

Query: 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS--AEEFINE-------------- 206
             +  LGQG   +V++G+   TG L A+K+  N  F    +  + E              
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 207 LLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR----GIE 260
           L  +  E   R   L+ E+ P GSL   +    N    +GL  P    L   R    G+ 
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGL--PESEFLIVLRDVVGGMN 126

Query: 261 YLH-NGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           +L  NG    I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT 
Sbjct: 127 HLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTE 179

Query: 316 GYLAPELISRNFGTV------SCKSDVYGFGMVLLEMAGGR 350
            YL P++  R               D++  G+     A G 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (250), Expect = 2e-23
 Identities = 63/301 (20%), Positives = 117/301 (38%), Gaps = 67/301 (22%)

Query: 164 HFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMM-ENSKFSA-EEFINE------- 206
                LG+G FG V   +              +AVKM+ +++      + ++E       
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143

Query: 207 --------LLGLCSEGFKRALVYEYMPNGSL------DRHIFSKENKGQTFGLEKP---- 248
                   LLG C++     ++ EY   G+L       R    + +       E+     
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 249 --HEIALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304
                    ARG+EYL        CI H D+   N+L+  N + K++DFGLA+     + 
Sbjct: 204 DLVSCTYQLARGMEYLASQK----CI-HRDLAARNVLVTENNVMKIADFGLARDINNIDY 258

Query: 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 364
           +   ++ R  + ++APE  +      + +SDV+ FG+++ E+           T     Y
Sbjct: 259 YKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEI----------FTLGGSPY 306

Query: 365 F---PSWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420
                  ++  L +G  ++   N T        +L M+   C     + RP+  +++E L
Sbjct: 307 PGIPVEELFKLLKEGHRMDKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDL 359

Query: 421 E 421
           +
Sbjct: 360 D 360

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =   99 bits (249), Expect = 2e-23
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 31/202 (15%)

Query: 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMM--ENSKFSAEEFINELLGLCSEG--------- 214
            +LG G  G V+K     +G ++A K++  E       + I EL  L             
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 215 --FKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             +    +    E+M  GSLD+ +     K      +   ++++   +G+ YL       
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE--KHK 152

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELISRNFG 328
           I+H D+KP NIL++     K+ DFG++          S++++  GT  Y++PE +     
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLIDSMANSFVGTRSYMSPERLQGT-- 205

Query: 329 TVSCKSDVYGFGMVLLEMAGGR 350
             S +SD++  G+ L+EMA GR
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGR 227

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 98.0 bits (245), Expect = 3e-23
 Identities = 61/310 (19%), Positives = 108/310 (34%), Gaps = 70/310 (22%)

Query: 155 LPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGR------LIAVKMM-ENSKFSA-EEFINE 206
           L EI      F  +LG+  FG VYKG L           +A+K + + ++    EEF +E
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62

Query: 207 --------------LLGLCSEGFKRALVYEYMPNGSLD------------RHIFSKENKG 240
                         LLG+ ++    ++++ Y  +G L                       
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 241 QTFGLEKPHEIALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298
                     +    A G+EYL  H+     + H D+   N+L+      K+SD GL + 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH----VV-HKDLATRNVLVYDKLNVKISDLGLFRE 177

Query: 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAT 358
               + +  + ++   I ++APE I   +G  S  SD++ +G+VL E+            
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVF----------- 224

Query: 359 RSSKAYFPSW------VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRP 411
             S    P        V + +     L    +           +  + + C     + RP
Sbjct: 225 --SYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPA-------WVYALMIECWNEFPSRRP 275

Query: 412 SMTKVLEMLE 421
               +   L 
Sbjct: 276 RFKDIHSRLR 285

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 63/301 (20%), Positives = 117/301 (38%), Gaps = 67/301 (22%)

Query: 164 HFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMM-ENSKFSA-EEFINE------- 206
                LG+G FG V   +              +AVKM+ +++      + ++E       
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 207 --------LLGLCSEGFKRALVYEYMPNGSL------DRHIFSKENKGQTFGLEKP---- 248
                   LLG C++     ++ EY   G+L       R    + +       E+     
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 249 --HEIALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304
                    ARG+EYL        CI H D+   N+L+  N + K++DFGLA+     + 
Sbjct: 158 DLVSCTYQLARGMEYLASQK----CI-HRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

Query: 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 364
           +   ++ R  + ++APE  +      + +SDV+ FG+++ E+           T     Y
Sbjct: 213 YKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEI----------FTLGGSPY 260

Query: 365 F---PSWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420
                  ++  L +G  ++   N T        +L M+   C     + RP+  +++E L
Sbjct: 261 PGIPVEELFKLLKEGHRMDKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDL 313

Query: 421 E 421
           +
Sbjct: 314 D 314

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 41/212 (19%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE-----FINELL---GL-------- 210
            LG GG   V+  + L   R +AVK++  +  + +      F  E      L        
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 211 ----CSEGFKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
                +E     L Y   EY+   +L   +    +       ++  E+     + + + H
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSH 133

Query: 264 -NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR---GTIGYLA 319
            NG    I+H D+KP NI++      KV DFG+A+     +   S++ T    GT  YL+
Sbjct: 134 QNG----IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYLS 187

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
           PE       +V  +SDVY  G VL E+  G  
Sbjct: 188 PEQARG--DSVDARSDVYSLGCVLYEVLTGEP 217

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 53/212 (25%), Positives = 78/212 (36%), Gaps = 47/212 (22%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKR-A------- 218
           KLG GG  +VY  +       +A+K +       EE +        + F+R         
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL--------KRFEREVHNSSQLS 69

Query: 219 ------------------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                             LV EY+   +L  +I           ++           GI+
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIK 125

Query: 261 YLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           + H       I+H DIKP NIL+D N   K+ DFG+AK    E      +   GT+ Y +
Sbjct: 126 HAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFS 180

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
           PE            +D+Y  G+VL EM  G  
Sbjct: 181 PEQAKG--EATDECTDIYSIGIVLYEMLVGEP 210

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 96.9 bits (242), Expect = 7e-23
 Identities = 51/231 (22%), Positives = 88/231 (38%), Gaps = 43/231 (18%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE------------------FINEL 207
             LG+G FG+VY  +   +  ++A+K++  ++                        I  L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGC 266
            G   +  +  L+ EY P G++    + +  K   F  ++        A  + Y H    
Sbjct: 75  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKR- 129

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELISR 325
              ++H DIKP N+LL      K++DFG +   P             GT+ YL PE+I  
Sbjct: 130 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTDLCGTLDYLPPEMIEG 181

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 369
                  K D++  G++  E   G+     +    T       +  FP +V
Sbjct: 182 R--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 67/310 (21%), Positives = 115/310 (37%), Gaps = 74/310 (23%)

Query: 164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMM-ENSKFSA-EEFINE--------- 206
            F   LG G FG V +   +          +AVKM+  ++  +  E  ++E         
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 207 ------LLGLCSEGFKRALVYEYMPNGSL------DRHIFSKENKGQTFGLEKPHE---- 250
                 LLG C+ G    ++ EY   G L       R  F           +        
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 251 ----IALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304
                +   A+G+ +L   N    CI H D+   NILL H  I K+ DFGLA+    +++
Sbjct: 146 DLLSFSYQVAKGMAFLASKN----CI-HRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 364
           +V   + R  + ++APE  S      + +SDV+ +G+ L E+              S   
Sbjct: 201 YVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELF-------------SLGS 245

Query: 365 FP-------SWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 416
            P       S  Y  + +G  +    +          ++  I   C       RP+  ++
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPA-------EMYDIMKTCWDADPLKRPTFKQI 298

Query: 417 LEMLEGSIDD 426
           ++++E  I +
Sbjct: 299 VQLIEKQISE 308

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 98.4 bits (245), Expect = 1e-22
 Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 46/221 (20%)

Query: 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS--AEEFINE-------------- 206
             +  LGQG   +V++G+   TG L A+K+  N  F    +  + E              
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 207 LLGLCSEGFKRA--LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR----GIE 260
           L  +  E   R   L+ E+ P GSL   +    N    +GL  P    L   R    G+ 
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGL--PESEFLIVLRDVVGGMN 126

Query: 261 YLH-NGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           +L  NG    I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT 
Sbjct: 127 HLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTE 179

Query: 316 GYLAPELISRNFGTV------SCKSDVYGFGMVLLEMAGGR 350
            YL P++  R               D++  G+     A G 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 67/300 (22%), Positives = 116/300 (38%), Gaps = 65/300 (21%)

Query: 164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMM-ENSKFSA-EEFINE--------- 206
                LG+G FG V +          T R +AVKM+ E +  S     ++E         
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 207 ------LLGLCS-EGFKRALVYEYMPNGSL------DRHIFSKENKGQTFGLEKP----- 248
                 LLG C+  G    ++ E+   G+L       R+ F           +       
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 249 -HEIALGTARGIEYL-HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306
               +   A+G+E+L    C    +H D+   NILL    + K+ DFGLA+   K+ D+V
Sbjct: 150 LICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-- 364
              D R  + ++APE  +      + +SDV+ FG++L E+           +  +  Y  
Sbjct: 206 RKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEI----------FSLGASPYPG 253

Query: 365 FPSW--VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                    +L +G  +      T        ++    L C   + + RP+ ++++E L 
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLG 306

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 33/207 (15%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM--ENSKFSAEEFINELLGLCSEG---------- 214
           ++G+G +GSV K     +G+++AVK +     +   ++ + +L  +              
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 215 --FKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPH--EIALGTARGIEYLHNGCD 267
             F+    +   E M + S D+  +          + +    +I L T + + +L    +
Sbjct: 89  ALFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--N 144

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--GTIGYLAPELI-- 323
           + I+H DIKP NILLD +   K+ DFG++          SI+ TR  G   Y+APE I  
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISG-----QLVDSIAKTRDAGCRPYMAPERIDP 199

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           S +      +SDV+  G+ L E+A GR
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 95.4 bits (238), Expect = 6e-22
 Identities = 70/313 (22%), Positives = 116/313 (37%), Gaps = 75/313 (23%)

Query: 164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMM-ENSKFSA-EEFINE--------- 206
            F   LG G FG V     +          +AVKM+ E +  S  E  ++E         
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107

Query: 207 ------LLGLCSEGFKRALVYEYMPNGSL-------------------DRHIFSKENKGQ 241
                 LLG C+      L++EY   G L                   ++    +E    
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 242 TFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301
               E     A   A+G+E+L      C+ H D+   N+L+ H  + K+ DFGLA+    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS--CV-HRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 361
           ++++V   + R  + ++APE  S   G  + KSDV+ +G++L E+              S
Sbjct: 225 DSNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIF-------------S 269

Query: 362 KAYFP-------SWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSM 413
               P       +  Y  +  G  ++     TE       ++ +I   C    +  RPS 
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATE-------EIYIIMQSCWAFDSRKRPSF 322

Query: 414 TKVLEMLEGSIDD 426
             +   L   + D
Sbjct: 323 PNLTSFLGCQLAD 335

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 43/221 (19%), Positives = 76/221 (34%), Gaps = 65/221 (29%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA-EEFINELLGLCSEGFKR------AL 219
            +G+GG G VY+ +     R++A+K+M +   S+   F            +R       L
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFR--------TRMQREARTAGRL 91

Query: 220 -------VY-------------EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
                  ++               +    L   +     +       +   I       +
Sbjct: 92  QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSAL 147

Query: 260 EYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR------ 312
           +  H  G      H D+KP NIL+  +    + DFG+A          + +D +      
Sbjct: 148 DAAHAAG----ATHRDVKPENILVSADDFAYLVDFGIAS---------ATTDEKLTQLGN 194

Query: 313 --GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
             GT+ Y+APE  S      + ++D+Y    VL E   G  
Sbjct: 195 TVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSP 233

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.8 bits (236), Expect = 9e-22
 Identities = 65/325 (20%), Positives = 109/325 (33%), Gaps = 65/325 (20%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMME-NSKFSAEEFINE---LLGLCS--------- 212
             L +GGF  VY+ Q + +GR  A+K +  N +      I E   +  L           
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 213 ----------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH--EIALGTARGIE 260
                      G    L+   +  G L   +   E++G    L      +I   T R ++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP---LSCDTVLKIFYQTCRAVQ 150

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-------- 312
           ++H      I+H D+K  N+LL +    K+ DFG A       D+   +  R        
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 313 --GTIGYLAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGR---RNSNMNATRSSKAYFP 366
              T  Y  PE+I       +  K D++  G +L  +   +    +       + K   P
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIP 269

Query: 367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
                             T   S+I           +QV   +R S+ +V+  L+     
Sbjct: 270 PH------------DTQYTVFHSLIR--------AMLQVNPEERLSIAEVVHQLQEIAAA 309

Query: 427 LQMPPK-PFFSSSRHISGRETESAS 450
             + PK P         G  + + S
Sbjct: 310 RNVNPKSPITELLEQNGGYGSATLS 334

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 47/226 (20%), Positives = 82/226 (36%), Gaps = 42/226 (18%)

Query: 157 EIIAVTN---HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINE---- 206
           E I+V         ++G GG   V++      ++ A+K +   +   +    + NE    
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 207 ------------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALG 254
                       L           +V E   N  L+  +     K ++    +       
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKN 116

Query: 255 TARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
               +  +H +G    I+H D+KP N L+    + K+ DFG+A     +   V      G
Sbjct: 117 MLEAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVG 171

Query: 314 TIGYLAPELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR 350
           T+ Y+ PE I     +         +S KSDV+  G +L  M  G+
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 42/219 (19%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMME-NSKFSAEEFINE--------------LLGLC 211
           +LG G FG VYK +   TG L A K++E  S+   E++I E              LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL---GTARGIEYLHNGCDV 268
               K  ++ E+ P G++D  +   +       L +P  I +        + +LH+    
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQ-IQVVCRQMLEALNFLHSKR-- 137

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELIS 324
            I+H D+K  N+L+      +++DFG      K   K + F+      GT  ++APE++ 
Sbjct: 138 -IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVM 190

Query: 325 RNFGTVS---CKSDVYGFGMVLLEMAGGRR-NSNMNATR 359
                 +    K+D++  G+ L+EMA     +  +N  R
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 47/226 (20%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE---LLGLCS---------- 212
             +G G +G VYKG+ + TG+L A+K+M+ +    EE   E   L               
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 213 --------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL---GTARGIEY 261
                      +  LV E+   GS+   I  K  KG T    K   IA       RG+ +
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTL---KEEWIAYICREILRGLSH 144

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGY 317
           LH      ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  +
Sbjct: 145 LHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYW 195

Query: 318 LAPELISRNFGTVS---CKSDVYGFGMVLLEMAGGR-RNSNMNATR 359
           +APE+I+ +    +    KSD++  G+  +EMA G     +M+  R
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 44/216 (20%), Positives = 78/216 (36%), Gaps = 39/216 (18%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINE-------------- 206
               ++G GG   V++      ++ A+K +   +   +    + NE              
Sbjct: 31  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH- 263
             L           +V E   N  L+  +     K ++    +           +  +H 
Sbjct: 91  IRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
           +G    I+H D+KP N L+    + K+ DFG+A     +   V      GT+ Y+ PE I
Sbjct: 146 HG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 324 SRNFGT---------VSCKSDVYGFGMVLLEMAGGR 350
                +         +S KSDV+  G +L  M  G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 40/204 (19%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFI-NELLGL--CS----------- 212
           K+G+G  G V   +  H+GR +AVKMM+  K    E + NE++ +               
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111

Query: 213 -EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH--EIALGTARGIEYLHNGCDVC 269
             G +  ++ E++  G+L   +   + +     L +     +     + + YLH      
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV--SQVR-----LNEEQIATVCEAVLQALAYLHAQG--- 161

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELISR 325
           ++H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISR 215

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGG 349
           +    + + D++  G++++EM  G
Sbjct: 216 S--LYATEVDIWSLGIMVIEMVDG 237

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 94.6 bits (235), Expect = 2e-21
 Identities = 45/257 (17%), Positives = 85/257 (33%), Gaps = 58/257 (22%)

Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFT--HKLGQG--GFGSVYKGQ-LHTGRLIAVKMM-- 193
           H      Q + + L          +     +G+G     +V   +   TG  + V+ +  
Sbjct: 8   HMENLYFQGMSSFLPEG-----GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL 62

Query: 194 -ENSKFSAEEFINE--LLGLCS------------EGFKRALVYEYMPNGSLDRHIFSKEN 238
              S         E  +  L +               +  +V  +M  GS  + +     
Sbjct: 63  EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHF 121

Query: 239 KGQTFGLEKPHEIAL---GTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFG 294
                G+ +   IA    G  + ++Y+H  G     +H  +K  +IL+  +    +S   
Sbjct: 122 MD---GMNELA-IAYILQGVLKALDYIHHMGY----VHRSVKASHILISVDGKVYLSGLR 173

Query: 295 LA-----------KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVL 343
                          H      V        + +L+PE++ +N      KSD+Y  G+  
Sbjct: 174 SNLSMISHGQRQRVVHDFPKYSV------KVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227

Query: 344 LEMAGGRR-NSNMNATR 359
            E+A G     +M AT+
Sbjct: 228 CELANGHVPFKDMPATQ 244

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 70/314 (22%), Positives = 121/314 (38%), Gaps = 74/314 (23%)

Query: 164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMM-ENSKFSA-EEFINE--------- 206
                LG+G FG V K              +AVKM+ EN+  S   + ++E         
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSL----------DRHIFSKENKGQTFGLEKPHEI 251
                L G CS+     L+ EY   GSL                      +  L+ P E 
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 252 ALGT----------ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301
           AL            ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 361
           E+ +V  S  R  + ++A E  S      + +SDV+ FG++L E+              +
Sbjct: 203 EDSYVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIV-------------T 247

Query: 362 KAYFPSW------VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 414
               P        +++ L  G  +E   N +E       ++  + L C + +   RP   
Sbjct: 248 LGGNPYPGIPPERLFNLLKTGHRMERPDNCSE-------EMYRLMLQCWKQEPDKRPVFA 300

Query: 415 KVLEMLEGSIDDLQ 428
            + + LE  +   +
Sbjct: 301 DISKDLEKMMVKRR 314

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 95.5 bits (237), Expect = 4e-21
 Identities = 54/220 (24%), Positives = 75/220 (34%), Gaps = 47/220 (21%)

Query: 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAE--------------------- 201
               +LG GGFG V +     TG  +A+K                               
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 202 --EFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR-- 257
             E  + L  L        L  EY   G L +++   EN     GL              
Sbjct: 77  AREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCC---GL--KEGPIRTLLSDI 130

Query: 258 --GIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISDTR 312
              + YLH   +  I+H D+KP NI+L       I K+ D G AK   +           
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--- 184

Query: 313 GTIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRR 351
           GT+ YLAPEL+  + +       D + FG +  E   G R
Sbjct: 185 GTLQYLAPELLEQKKYT---VTVDYWSFGTLAFECITGFR 221

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 93.7 bits (233), Expect = 4e-21
 Identities = 44/219 (20%), Positives = 76/219 (34%), Gaps = 45/219 (20%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINE-------------- 206
               ++G GG   V++      ++ A+K +   +   +    + NE              
Sbjct: 59  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT---ARGIEY 261
             L           +V E   N  L+  +       +      P E           +  
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWL-------KKKKSIDPWERKSYWKNMLEAVHT 170

Query: 262 LH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           +H +G    I+H D+KP N L+    + K+ DFG+A     +   V      G + Y+ P
Sbjct: 171 IHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

Query: 321 ELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR 350
           E I     +         +S KSDV+  G +L  M  G+
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 64/323 (19%), Positives = 108/323 (33%), Gaps = 92/323 (28%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGR------LIAVKMM-ENSKFSA-EEFINE--------- 206
            +   +G+G FG V++ +           ++AVKM+ E +      +F  E         
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSL--------------------DRHIFSKENKGQ 241
                LLG+C+ G    L++EYM  G L                                
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 242 TFGLEKPHEIALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299
                +   IA   A G+ YL         + H D+   N L+  N + K++DFGL++  
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK----FV-HRDLATRNCLVGENMVVKIADFGLSR-- 222

Query: 300 PKENDFVSISD--TRGTIGYL-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN 352
                 +  +D         +      PE  S  +   + +SDV+ +G+VL E+      
Sbjct: 223 -----NIYSADYYKADGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIF----- 270

Query: 353 SNMNATRSSKAYFPSW------VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQV 405
                   S    P +      V   +  G  L    N          +L  +   C   
Sbjct: 271 --------SYGLQPYYGMAHEEVIYYVRDGNILACPENCPL-------ELYNLMRLCWSK 315

Query: 406 KAADRPSMTKVLEMLEGSIDDLQ 428
             ADRPS   +  +L+   +  +
Sbjct: 316 LPADRPSFCSIHRILQRMCERAE 338

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.0 bits (229), Expect = 6e-21
 Identities = 48/212 (22%), Positives = 79/212 (37%), Gaps = 46/212 (21%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM--ENSKFSAEEFINELLGLCSEG---------- 214
           ++G G  G V+K +   TG +IAVK M    +K   +  + +L  +              
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 215 --FKRALVY---EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                  V+   E M   +       K+            ++ +   + + YL       
Sbjct: 92  TFITNTDVFIAMELMGTCAEKL----KKRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFG--------LAKFHPKENDFVSISDTRGTIGYLAPE 321
           ++H D+KP NILLD     K+ DFG         AK     +         G   Y+APE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-----DRSA------GCAAYMAPE 194

Query: 322 LISRNF---GTVSCKSDVYGFGMVLLEMAGGR 350
            I            ++DV+  G+ L+E+A G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 92.7 bits (230), Expect = 7e-21
 Identities = 40/239 (16%), Positives = 78/239 (32%), Gaps = 38/239 (15%)

Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQ------LHTGRLIAVKMME 194
            +++  +  +      ++ +   +  H LG+G F  VY+            +   +K+ +
Sbjct: 45  FEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104

Query: 195 NSK----FSAEEFINELLGLCSEGFKRA-----------LVYEYMPNGSLDRHI-FSKEN 238
            +     +   + +  L       F +            LV E    G+L   I   K  
Sbjct: 105 PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164

Query: 239 KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP---------- 288
             +          A+     IE +H   D  I+H DIKP N +L + F+           
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

Query: 289 -KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEM 346
             + D G +            +    T G+   E++S      + + D +G    +  M
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCM 278

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 91.6 bits (228), Expect = 7e-21
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 40/205 (19%)

Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMME-NSKFSAEEFINELLGL--CS---------- 212
            K+GQG  G+VY    + TG+ +A++ M    +   E  INE+L +              
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 213 --EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH--EIALGTARGIEYLHNGCDV 268
              G +  +V EY+  GSL   +   E       +++     +     + +E+LH+    
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETC-----MDEGQIAAVCRECLQALEFLHSNQ-- 136

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELIS 324
            ++H DIK  NILL  +   K++DFG    +     K +  V      GT  ++APE+++
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPEVVT 189

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGG 349
           R       K D++  G++ +EM  G
Sbjct: 190 RK--AYGPKVDIWSLGIMAIEMIEG 212

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 91.1 bits (227), Expect = 8e-21
 Identities = 52/231 (22%), Positives = 90/231 (38%), Gaps = 47/231 (20%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE------------------FINELLG 209
           LG+G FG+VY  +      ++A+K++  S+   E                    I  +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
              +  +  L+ E+ P G L    + +  K   F  ++        A  + Y H      
Sbjct: 82  YFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCHE---RK 134

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR----GTIGYLAPELISR 325
           ++H DIKP N+L+ +    K++DFG +   P        S  R    GT+ YL PE+I  
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAP--------SLRRRTMCGTLDYLPPEMIEG 186

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 369
              T   K D++  G++  E   G     + +   T     +    FP ++
Sbjct: 187 K--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 44/215 (20%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMM--ENSKFSAEEFINE--LLGLCS---------- 212
            +G G    V           +A+K +  E  + S +E + E   +  C           
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 213 --EGFKRALVYEYMPNGSLDRHIFSKENKGQTFG--LEKPHEIAL---GTARGIEYLH-N 264
                +  LV + +  GS+   I     KG+     L++   IA        G+EYLH N
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVLEGLEYLHKN 140

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---------HPKENDFVSISDTRGTI 315
           G     +H D+K  NILL  +   +++DFG++ F         +     FV      GT 
Sbjct: 141 G----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV------GTP 190

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            ++APE++ +  G    K+D++ FG+  +E+A G 
Sbjct: 191 CWMAPEVMEQVRG-YDFKADIWSFGITAIELATGA 224

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 23/229 (10%), Positives = 52/229 (22%), Gaps = 55/229 (24%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINEL-------------------- 207
           L  G    V+    +      A+K+      ++   +  L                    
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 208 ---------------------LGLCSEGFKRALVYEYMP-----NGSLDRHIFSKENKGQ 241
                                L    + +  A     MP        L   +        
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 242 TFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301
             G+   H +     R    L       ++H    P N+ +  +    + D         
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
                    +   + Y   E ++ +  T +   + +  G+ +  +    
Sbjct: 247 -----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 41/216 (18%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINEL--------------LGLC 211
            KLG+G +GSVYK     TG+++A+K +       +E I E+               G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSY 93

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL---GTARGIEYLHNGCDV 268
            +     +V EY   GS+   I  +        L +   IA     T +G+EYLH     
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDIIRLRNKT-----LTEDE-IATILQSTLKGLEYLHFMR-- 145

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPELIS 324
             +H DIK  NILL+     K++DFG    L     K N  +      GT  ++APE+I 
Sbjct: 146 -KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEVIQ 198

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATR 359
                 +C +D++  G+  +EMA G+   ++++  R
Sbjct: 199 E--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 49/217 (22%), Positives = 77/217 (35%), Gaps = 44/217 (20%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------------LLGLCS 212
            LG G  G+V       GR +AVK M       +  + E                    +
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTESDDHPNVIRYYCSET 79

Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGL---EKPHEIALGTARGIEYLHNGCDVC 269
                 +  E   N +L   + SK    +   L     P  +    A G+ +LH    + 
Sbjct: 80  TDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLK 135

Query: 270 ILHFDIKPHNILLDH-------------NFIPKVSDFGLAK-FHPKENDFVSISDTR-GT 314
           I+H D+KP NIL+               N    +SDFGL K     ++ F +  +   GT
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195

Query: 315 IGYLAPELISRNFGTV-----SCKSDVYGFGMVLLEM 346
            G+ APEL+  +         +   D++  G V   +
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 39/308 (12%), Positives = 82/308 (26%), Gaps = 87/308 (28%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINEL-------------------- 207
           LGQ    +  +     TG    V +   ++      I ++                    
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 208 ----------------------LGLCSEGFKRALVYEYMP-----NGSLDRHIFSKENKG 240
                                 + L          +   P       +    + S  +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 241 QTFGLEKPHEIALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299
           ++       ++ L   R +  LH  G    ++H  ++P +I+LD      ++ F      
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 300 PKENDFVSISDTRGTIGYLAPELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR 350
            ++        +  + G+  PEL +R             ++   D +  G+V+  +    
Sbjct: 255 -RDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA- 309

Query: 351 RNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR 410
                          P    D    G +   R+   I     R L       ++    DR
Sbjct: 310 -------------DLP-ITKDAALGGSEWIFRSCKNI-PQPVRALLE---GFLRYPKEDR 351

Query: 411 PSMTKVLE 418
               + +E
Sbjct: 352 LLPLQAME 359

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 44/218 (20%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMM--ENSKFSAEEFINE--LLGLCS--------- 212
            K+G+G FG V+KG    T +++A+K++  E ++   E+   E  +L  C          
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 213 ---EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL---GTARGIEYLHNGC 266
              +  K  ++ EY+  GS    +           L++   IA       +G++YLH+  
Sbjct: 88  SYLKDTKLWIIMEYLGGGSA-LDLLEPG------PLDETQ-IATILREILKGLDYLHSEK 139

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISDTRGTIGYLAPEL 322
               +H DIK  N+LL  +   K++DFG    L     K N FV      GT  ++APE+
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 190

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATR 359
           I +       K+D++  G+  +E+A G   +S ++  +
Sbjct: 191 IKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMK 226

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 90.1 bits (223), Expect = 8e-20
 Identities = 26/233 (11%), Positives = 57/233 (24%), Gaps = 55/233 (23%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINEL-------------------- 207
           LGQ    +  +     TG    V +   ++      I ++                    
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 208 ----------------------LGLCSEGFKRALVYEYMP--NGSLDRHIFSKENKGQTF 243
                                 + L          +   P    +L        +   T 
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 244 GLEKPHE---IALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300
                H    + L   R +  LH      ++H  ++P +I+LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-RD 261

Query: 301 KENDFVSISDTRGTIGYLAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGR 350
             +    I          A  ++     +   ++   D +  G+ +  +    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 42/188 (22%), Positives = 74/188 (39%), Gaps = 33/188 (17%)

Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFIN------------------ 205
               +G+G F  V +     TG+  AVK+++ +KF++   ++                  
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 206 --ELLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
             ELL   S      +V+E+M    L    I  + + G  +               + Y 
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 263 H-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           H N     I+H D+KPH +LL   +++   K+  FG+A    +           GT  ++
Sbjct: 147 HDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFM 200

Query: 319 APELISRN 326
           APE++ R 
Sbjct: 201 APEVVKRE 208

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 40/217 (18%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINEL------------------ 207
            ++G G FG+VY  + +    ++A+K M  S   + E   ++                  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIAL---GTARGIEYLHN 264
            G         LV EY    + D     + +K     L++   IA    G  +G+ YLH+
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASD---LLEVHKK---PLQEVE-IAAVTHGALQGLAYLHS 172

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
                ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I 
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVIL 223

Query: 325 RNF-GTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATR 359
               G    K DV+  G+  +E+A  +    NMNA  
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 38/228 (16%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINEL---------------LGL-- 210
           LG+G F  VY+ + +HTG  +A+KM++         +  +               L L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 211 CSEGFKRA-LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
             E      LV E   NG ++R++   +N+ + F   +          G+ YLH+     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHS---HG 132

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELISRNFG 328
           ILH D+   N+LL  N   K++DFGLA      ++      T  GT  Y++PE+ +R+  
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRS-- 187

Query: 329 TVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 369
               +SDV+  G +   +  GR       +  T      +    PS++
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL 235

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 36/206 (17%)

Query: 169 LGQGGFGSVYKGQLH-TGRLIAVKMME----NSKFSAEEFINE--LLGLCSEGF------ 215
           LG+GGFG V+  Q+  TG+L A K +       +   +  + E  +L      F      
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARGIEYLHNG 265
                    LV   M  G +  HI++ +     F   +      +I  G    +E+LH  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQ- 307

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELIS 324
               I++ D+KP N+LLD +   ++SD GLA                 GT G++APEL+ 
Sbjct: 308 --RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPELLL 362

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGR 350
                 S   D +  G+ L EM   R
Sbjct: 363 GEEYDFSV--DYFALGVTLYEMIAAR 386

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 61/304 (20%), Positives = 110/304 (36%), Gaps = 78/304 (25%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS----AEEFINELLGLCS----------E 213
           LG+GGF   ++     T  + A K++  S        E+   E+    S           
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 214 GFKRA----LVYEYMPNGSLDRHIFSK----ENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            F+      +V E     SL      +    E + + +      +I      G +YLH  
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY----LRQIV----LGCQYLHRN 160

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELIS 324
               ++H D+K  N+ L+ +   K+ DFGLA     + +         GT  Y+APE++S
Sbjct: 161 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLS 214

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWVYDQLNKGG 377
           +     S + DV+  G ++  +  G+     S +  T    + ++   P  +        
Sbjct: 215 KK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI-------- 264

Query: 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE---MLEGSIDD------LQ 428
                      + +A  L  I    +Q     RP++ ++L       G I        L 
Sbjct: 265 -----------NPVAASL--IQ-KMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLT 310

Query: 429 MPPK 432
           +PP+
Sbjct: 311 IPPR 314

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 41/245 (16%), Positives = 80/245 (32%), Gaps = 44/245 (17%)

Query: 192 MMENSKFSAEEFINELLGLCSEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKP- 248
            ++  +       N +  L     K  L    +     +L   +                
Sbjct: 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVC 166

Query: 249 ----HEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304
                +IA      +E+LH      ++H D+KP NI    + + KV DFGL     ++ +
Sbjct: 167 LHIFIQIAEA----VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219

Query: 305 FVSISDTR----------GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN 354
             ++              GT  Y++PE I  N    S K D++  G++L E+        
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFS--- 274

Query: 355 MNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 414
              T+  +      +   +             + +    +  M+    +     +RP  T
Sbjct: 275 ---TQMERVR----IITDVRNL------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321

Query: 415 KVLEM 419
            ++E 
Sbjct: 322 DIIEN 326

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 61/304 (20%), Positives = 109/304 (35%), Gaps = 78/304 (25%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS----AEEFINELLGLCS----------E 213
           LG+GGF   ++     T  + A K++  S        E+   E+    S           
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 214 GFKRA----LVYEYMPNGSLDRHIFSK----ENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            F+      +V E     SL      +    E + + +      +I      G +YLH  
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY----LRQIV----LGCQYLHRN 134

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPELIS 324
               ++H D+K  N+ L+ +   K+ DFGLA     + +         GT  Y+APE++S
Sbjct: 135 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLS 188

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWVYDQLNKGG 377
           +     S + DV+  G ++  +  G+     S +  T    + ++   P  +        
Sbjct: 189 KK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI-------- 238

Query: 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE---MLEGSIDD------LQ 428
                      S+I + L        Q     RP++ ++L       G I        L 
Sbjct: 239 ------NPVAASLIQKML--------QTDPTARPTINELLNDEFFTSGYIPARLPITCLT 284

Query: 429 MPPK 432
           +PP+
Sbjct: 285 IPPR 288

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.4 bits (219), Expect = 8e-19
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 48/211 (22%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---------AEEFINELLGLCSEGF--- 215
           +G+GGFG VY  +   TG++ A+K ++  +            E  +  L+      F   
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 216 ---------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARGIEYL 262
                    K + + + M  G L  H+    ++   F          EI LG    +E++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG----LEHM 308

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE--NDFVSISDTRGTIGYLAP 320
           HN     +++ D+KP NILLD +   ++SD GLA    K+  +  V      GT GY+AP
Sbjct: 309 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAP 359

Query: 321 ELISRNFG-TVSCKSDVYGFGMVLLEMAGGR 350
           E++ +      S   D +  G +L ++  G 
Sbjct: 360 EVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 58/232 (25%), Positives = 90/232 (38%), Gaps = 45/232 (19%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE------------------FINELLG 209
           LG+G F +V   +   T R  A+K++E      E                   F  +L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARGIEYLH-N 264
              +  K      Y  NG L ++I     K  +F          EI       +EYLH  
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA----LEYLHGK 149

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
           G    I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 369
                 S  SD++  G ++ ++  G    R  N           +  FP   
Sbjct: 206 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF 255

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 46/267 (17%), Positives = 85/267 (31%), Gaps = 68/267 (25%)

Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSK 197
           H + ++ +         ++ +   +     +GQG +G V    +  T  + A+K+M  +K
Sbjct: 4   HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63

Query: 198 FSAE--------------------EFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKE 237
                                     I  L  +  +     LV E    G L   +    
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123

Query: 238 NKGQTFGLEKPHEIALGTAR------------------------------------GIEY 261
           +           +  +                                         + Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183

Query: 262 LH-NGCDVCILHFDIKPHNILL--DHNFIPKVSDFGLAKFHP--KENDFVSISDTRGTIG 316
           LH  G    I H DIKP N L   + +F  K+ DFGL+K        ++  ++   GT  
Sbjct: 184 LHNQG----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239

Query: 317 YLAPELISRNFGTVSCKSDVYGFGMVL 343
           ++APE+++    +   K D +  G++L
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLL 266

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 42/216 (19%)

Query: 163 NHFT-HK-LGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--LLGLCSE 213
           +HF   + +G+G FG V   Q   T ++ A+K M   K            E  ++     
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 214 GF------------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTAR 257
            F               +V + +  G L  H+     +   F  E       E+ +    
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMA--- 127

Query: 258 GIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            ++YL        I+H D+KP NILLD +    ++DF +A   P+E    +++   GT  
Sbjct: 128 -LDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKP 179

Query: 317 YLAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGRR 351
           Y+APE+ S   G     + D +  G+   E+  GRR
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 49/203 (24%), Positives = 76/203 (37%), Gaps = 38/203 (18%)

Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE---FINE------------- 206
               KLG G +G V       T    A+K++  +  S       + E             
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 207 -LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH- 263
            L     +     LV E    G L D  I  +      F       I      G+ YLH 
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDE-IIHRMK----FNEVDAAVIIKQVLSGVTYLHK 154

Query: 264 NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           +     I+H D+KP N+LL   + + + K+ DFGL+     +          GT  Y+AP
Sbjct: 155 HN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAP 207

Query: 321 ELISRNFGTVSCKSDVYGFGMVL 343
           E++ + +     K DV+  G++L
Sbjct: 208 EVLRKKYDE---KCDVWSIGVIL 227

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 85.5 bits (212), Expect = 5e-18
 Identities = 51/204 (25%), Positives = 76/204 (37%), Gaps = 39/204 (19%)

Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE----FINE------------ 206
                LG+G FG V       TG+  AVK++   +   +      + E            
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 207 --LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
             L     +     LV E    G L D  I S++     F       I      GI Y+H
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDE-IISRKR----FSEVDAARIIRQVLSGITYMH 143

Query: 264 -NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
            N     I+H D+KP N+LL     +   ++ DFGL+                GT  Y+A
Sbjct: 144 KNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIA 196

Query: 320 PELISRNFGTVSCKSDVYGFGMVL 343
           PE++   +     K DV+  G++L
Sbjct: 197 PEVLHGTYDE---KCDVWSTGVIL 217

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 47/202 (23%), Positives = 80/202 (39%), Gaps = 33/202 (16%)

Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA--EEFINE-------------- 206
            F  KLG G FG V+   +  +G    +K +   +     E+   E              
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 207 LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-N 264
           +  +  +     +V E    G L +R I S + +G+        E+       + Y H  
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLER-IVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143

Query: 265 GCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
                ++H D+KP NIL      +   K+ DFGLA+    +      ++  GT  Y+APE
Sbjct: 144 H----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPE 196

Query: 322 LISRNFGTVSCKSDVYGFGMVL 343
           +  R+      K D++  G+V+
Sbjct: 197 VFKRDVTF---KCDIWSAGVVM 215

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 47/183 (25%), Positives = 72/183 (39%), Gaps = 35/183 (19%)

Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEF-----------------INELL 208
            +LG+G F  V +     TG   A K++   K SA +F                 I  L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 209 GLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGC 266
               E     LV++ +  G L +  I ++E     +               I Y H NG 
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFED-IVAREF----YSEADASHCIQQILESIAYCHSNG- 125

Query: 267 DVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              I+H ++KP N+LL         K++DFGLA        +       GT GYL+PE++
Sbjct: 126 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVL 179

Query: 324 SRN 326
            ++
Sbjct: 180 KKD 182

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 50/203 (24%), Positives = 80/203 (39%), Gaps = 38/203 (18%)

Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE---FINE------------- 206
           +    LG+G FG V K     T +  AVK++  +    ++    + E             
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 207 -LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH- 263
            L  +  +     +V E    G L D  I  ++     F       I      GI Y+H 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDE-IIKRKR----FSEHDAARIIKQVFSGITYMHK 139

Query: 264 NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           +     I+H D+KP NILL   + +   K+ DFGL+    +           GT  Y+AP
Sbjct: 140 HN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAP 192

Query: 321 ELISRNFGTVSCKSDVYGFGMVL 343
           E++   +     K DV+  G++L
Sbjct: 193 EVLRGTYDE---KCDVWSAGVIL 212

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 32/204 (15%)

Query: 144 RTTMQTVDNILLPEIIAVTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA 200
              + ++   L    I  T+ +     +G G +    +     T    AVK+++ SK   
Sbjct: 3   TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP 62

Query: 201 EEFIN------------ELLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEK 247
            E I              L  +  +G    +V E M  G L D+ I  ++     F   +
Sbjct: 63  TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDK-ILRQKF----FSERE 117

Query: 248 PHEIALGTARGIEYLH-NGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKE 302
              +     + +EYLH  G    ++H D+KP NIL      +    ++ DFG AK    E
Sbjct: 118 ASAVLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 303 NDFVSISDTRGTIGYLAPELISRN 326
           N    +     T  ++APE++ R 
Sbjct: 174 NGL--LMTPCYTANFVAPEVLERQ 195

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 47/182 (25%), Positives = 72/182 (39%), Gaps = 35/182 (19%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEF-----------------INELLG 209
           +LG+G F  V +     TG   A K++   K SA +F                 I  L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 210 LCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCD 267
              E     LV++ +  G L +  I ++E     +               I Y H NG  
Sbjct: 96  SIQEESFHYLVFDLVTGGELFED-IVAREF----YSEADASHCIQQILESIAYCHSNG-- 148

Query: 268 VCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
             I+H ++KP N+LL         K++DFGLA        +       GT GYL+PE++ 
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLK 203

Query: 325 RN 326
           ++
Sbjct: 204 KD 205

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 66/241 (27%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKM--MENSKFSAEEF------------------INE 206
            LG+G F +VYK +  +T +++A+K   + +   + +                    I  
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI---ALGTARGIEYLH 263
           LL         +LV+++M    L+  I   ++         P  I    L T +G+EYLH
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLT---PSHIKAYMLMTLQGLEYLH 129

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDF----VSISDTRGTIGYL 318
                 ILH D+KP+N+LLD N + K++DFGLAK F      +    V       T  Y 
Sbjct: 130 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-------TRWYR 179

Query: 319 APELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLN 374
           APEL+  +R +G  V    D++  G +L E+                 + P     DQL 
Sbjct: 180 APELLFGARMYGVGV----DMWAVGCILAELLLR------------VPFLPGDSDLDQLT 223

Query: 375 K 375
           +
Sbjct: 224 R 224

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 80.7 bits (200), Expect = 4e-17
 Identities = 51/202 (25%), Positives = 80/202 (39%), Gaps = 38/202 (18%)

Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEF-----------------INE 206
               LG+G FG V K     T +  AVK++  +    ++                  I +
Sbjct: 26  IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 207 LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-N 264
           L  +  +     +V E    G L D  I  ++     F       I      GI Y+H +
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDE-IIKRKR----FSEHDAARIIKQVFSGITYMHKH 140

Query: 265 GCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
                I+H D+KP NILL   + +   K+ DFGL+    +        D  GT  Y+APE
Sbjct: 141 N----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPE 193

Query: 322 LISRNFGTVSCKSDVYGFGMVL 343
           ++   +     K DV+  G++L
Sbjct: 194 VLRGTYDE---KCDVWSAGVIL 212

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 44/188 (23%), Positives = 68/188 (36%), Gaps = 40/188 (21%)

Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA----------EEFINE--------- 206
             LG+G    V +     T +  AVK+++ +   +          E  + E         
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 207 ------LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGI 259
                 L           LV++ M  G L D  +  K         ++  +I       I
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDY-LTEKVT----LSEKETRKIMRALLEVI 137

Query: 260 EYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
             LH       I+H D+KP NILLD +   K++DFG +             +  GT  YL
Sbjct: 138 CALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYL 190

Query: 319 APELISRN 326
           APE+I  +
Sbjct: 191 APEIIECS 198

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 61/208 (29%), Positives = 85/208 (40%), Gaps = 43/208 (20%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMME----NSKFSAEEFINE--LLGLCSEGF------ 215
           LG+GGFG V   Q+  TG++ A K +E      +      +NE  +L   +  F      
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 216 ------KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------EIALGTARGIEYLH 263
                    LV   M  G L  HI          G  +        EI  G    +E LH
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHI----YHMGQAGFPEARAVFYAAEICCG----LEDLH 303

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPEL 322
                 I++ D+KP NILLD +   ++SD GLA               R GT+GY+APE+
Sbjct: 304 ---RERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPEV 356

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           +     T S   D +  G +L EM  G+
Sbjct: 357 VKNERYTFSP--DWWALGCLLYEMIAGQ 382

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 37/207 (17%)

Query: 168 KLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF----------INELLG-LCSEG 214
            +G G FG VY+ +L  +G L+A+K ++++ +F   E           I  L     S G
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 120

Query: 215 FKRA-----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT---ARGIEYLHNGC 266
            K+      LV +Y+P  ++ R         QT  +     + L      R + Y+H+  
Sbjct: 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVI---YVKLYMYQLFRSLAYIHS-- 174

Query: 267 DVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
              I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R    Y APELI  
Sbjct: 175 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI-- 228

Query: 326 NFGTV--SCKSDVYGFGMVLLEMAGGR 350
            FG    +   DV+  G VL E+  G+
Sbjct: 229 -FGATDYTSSIDVWSAGCVLAELLLGQ 254

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 41/201 (20%), Positives = 66/201 (32%), Gaps = 36/201 (17%)

Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE-FINE--------------L 207
              + +G+G +G V    Q  T    A K +        + F  E              L
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 208 LGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NG 265
                +     LV E    G L +R +  K      F       I       + Y H   
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFER-VVHKRV----FRESDAARIMKDVLSAVAYCHKLN 126

Query: 266 CDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
               + H D+KP N L      +   K+ DFGLA                GT  Y++P++
Sbjct: 127 ----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQV 179

Query: 323 ISRNFGTVSCKSDVYGFGMVL 343
           +   +G    + D +  G+++
Sbjct: 180 LEGLYGP---ECDEWSAGVMM 197

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 33/208 (15%)

Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFT---HKLGQGGFGSVYKG-QLHTGRLIAVKMMENS 196
           H + + ++ +     P+  AVT+ +      LG G  G V +     TG+  A+K++ +S
Sbjct: 6   HHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS 65

Query: 197 KFSAEEF-----------INELLGLCSEGFKRA----LVYEYMPNGSLDRHIFSKENKGQ 241
             + +E            I  +L +            ++ E M  G L   I  + ++  
Sbjct: 66  PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF 125

Query: 242 TFGLEKP-HEIALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAK 297
           T   E+   EI       I++LH      I H D+KP N+L    + + + K++DFG AK
Sbjct: 126 T---EREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

Query: 298 FHPKENDFVSISDTRGTIGYLAPELISR 325
              +     ++     T  Y+APE++  
Sbjct: 180 ETTQN----ALQTPCYTPYYVAPEVLGP 203

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 49/214 (22%)

Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA--------------EEFINE-- 206
               KLG G +G V    + +     A+K+++ S+F                EE  NE  
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 207 ------------LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIAL 253
                       L  +  +     LV E+   G L ++ I ++      F       I  
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ-IINRHK----FDECDAANIMK 153

Query: 254 GTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSIS 309
               GI YLH +     I+H DIKP NILL   +     K+ DFGL+ F  K+       
Sbjct: 154 QILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209

Query: 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVL 343
              GT  Y+APE++ + +     K DV+  G+++
Sbjct: 210 ---GTAYYIAPEVLKKKYNE---KCDVWSCGVIM 237

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 41/185 (22%), Positives = 72/185 (38%), Gaps = 34/185 (18%)

Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEF-----------------INE 206
              +LG+G F  V +  ++  G+  A  ++   K SA +                  I  
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 207 LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-N 264
           L    SE     L+++ +  G L +  I ++E     +               + + H  
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFED-IVAREY----YSEADASHCIQQILEAVLHCHQM 129

Query: 265 GCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
           G    ++H ++KP N+LL         K++DFGLA     E          GT GYL+PE
Sbjct: 130 G----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPE 183

Query: 322 LISRN 326
           ++ ++
Sbjct: 184 VLRKD 188

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 46/227 (20%), Positives = 86/227 (37%), Gaps = 47/227 (20%)

Query: 141 HKYRTTMQTVDNILLPEIIAVTNHFT---HKLGQGGFGSVYKG-QLHTGRLIAVKMMENS 196
           H         +N+    +    N +     +LG+G F  V +     TG+  A K ++  
Sbjct: 6   HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKR 65

Query: 197 KFSA---EEFINE---------------LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKE 237
           +       E ++E               L  +     +  L+ EY   G +       + 
Sbjct: 66  RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL-CLPEL 124

Query: 238 NKGQTFGLEKPHEIALGTAR----GIEYLH-NGCDVCILHFDIKPHNILLDHNFIP---K 289
            +  +   E      +   +    G+ YLH N     I+H D+KP NILL   +     K
Sbjct: 125 AEMVS---EN---DVIRLIKQILEGVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIK 174

Query: 290 VSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDV 336
           + DFG+++      +     +  GT  YLAPE+++ +   ++  +D+
Sbjct: 175 IVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDP--ITTATDM 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 54/233 (23%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKM--MENSK----FSA-----------EEFINELLGL 210
           K+G+G +G VYK Q + G   A+K   +E        +               I +L  +
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
                +  LV+E++    L + +   +               L    GI Y H   D  +
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDF----VSISDTRGTIGYLAPELI-- 323
           LH D+KP N+L++     K++DFGLA+ F      +    V       T+ Y AP+++  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-------TLWYRAPDVLMG 174

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 375
           S+ + T     D++  G +  EM  G               FP     DQL +
Sbjct: 175 SKKYST---TIDIWSVGCIFAEMVNGT------------PLFPGVSEADQLMR 212

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 77.2 bits (191), Expect = 6e-16
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 34/183 (18%)

Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NE--------------LL 208
           F   LG G F  V+   Q  TG+L A+K ++ S    +  + NE              L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 209 GLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGC 266
            +        LV + +  G L DR I  +      +  +    +       ++YLH NG 
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDR-ILERGV----YTEKDASLVIQQVLSAVKYLHENG- 126

Query: 267 DVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              I+H D+KP N+L    + N    ++DFGL+K          +S   GT GY+APE++
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVL 179

Query: 324 SRN 326
           ++ 
Sbjct: 180 AQK 182

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 46/183 (25%), Positives = 69/183 (37%), Gaps = 34/183 (18%)

Query: 169 LGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEF----------------INELLGLC 211
           LG+G    V     L T +  AVK++E                         + EL+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDVCI 270
            E  +  LV+E M  GS+  HI  + +    F   +   +    A  +++LH  G    I
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHNKG----I 132

Query: 271 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTR-----GTIGYLAPEL 322
            H D+KP NIL    +     K+ DF L        D   IS        G+  Y+APE+
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192

Query: 323 ISR 325
           +  
Sbjct: 193 VEA 195

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 26/176 (14%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE-------------FINELLGLCSE 213
            LG+G F    K     + +  AVK++     +  +              I +L  +  +
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD 77

Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHF 273
                LV E +  G L   I  K++    F   +   I       + ++H   DV ++H 
Sbjct: 78  QLHTFLVMELLNGGELFERIKKKKH----FSETEASYIMRKLVSAVSHMH---DVGVVHR 130

Query: 274 DIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           D+KP N+L    + N   K+ DFG A+  P +N    +     T+ Y APEL+++N
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQN 184

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.5 bits (189), Expect = 7e-16
 Identities = 59/236 (25%), Positives = 87/236 (36%), Gaps = 51/236 (21%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF----------------INELLGLC 211
           LG+G +G V       T   +AVK+++  +                      + +  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR--------GIEYLH 263
            EG  + L  EY   G L   I                +     A+        G+ YLH
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-----AQRFFHQLMAGVVYLH 122

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPEL 322
               + I H DIKP N+LLD     K+SDFGLA    + N+   + +   GT+ Y+APEL
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPEL 178

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMNATR---SSKAYFPSWVY 370
           + R     +   DV+  G+VL  M  G       + +          K Y   W  
Sbjct: 179 LKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 54/233 (23%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKM--MENSK----FSA-----------EEFINELLGL 210
           K+G+G +G VYK +   GR++A+K   ++        +A              I  L+ +
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
                   LV+E+M    L + +   +         +         RG+ + H      I
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDF----VSISDTRGTIGYLAPELI-- 323
           LH D+KP N+L++ +   K++DFGLA+ F      +    V       T+ Y AP+++  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-------TLWYRAPDVLMG 193

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 375
           S+ + T     D++  G +  EM  G            K  FP     DQL K
Sbjct: 194 SKKYST---SVDIWSIGCIFAEMITG------------KPLFPGVTDDDQLPK 231

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 47/187 (25%), Positives = 69/187 (36%), Gaps = 39/187 (20%)

Query: 167 HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA---------EEFINE---------- 206
             +G+G    V +     TG   AVK+ME +             E    E          
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                L+          LV++ M  G L D  +  K         ++   I       + 
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDY-LTEK----VALSEKETRSIMRSLLEAVS 214

Query: 261 YLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
           +LH N     I+H D+KP NILLD N   ++SDFG +             +  GT GYLA
Sbjct: 215 FLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL---RELCGTPGYLA 267

Query: 320 PELISRN 326
           PE++  +
Sbjct: 268 PEILKCS 274

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 57/219 (26%), Positives = 83/219 (37%), Gaps = 62/219 (28%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVK------------------------------MMENSK 197
            +G G FG V++ +L     +A+K                                 N  
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGD 106

Query: 198 FSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT-- 255
              E F+N             LV EY+P  ++ R         QT  +     I L    
Sbjct: 107 KKDEVFLN-------------LVLEYVPE-TVYRASRHYAKLKQTMPML---LIKLYMYQ 149

Query: 256 -ARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
             R + Y+H+   + I H DIKP N+LLD  + + K+ DFG AK        VS   +R 
Sbjct: 150 LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR- 205

Query: 314 TIGYLAPELISRNFGTV--SCKSDVYGFGMVLLEMAGGR 350
              Y APELI   FG    +   D++  G V+ E+  G+
Sbjct: 206 --YYRAPELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 39/213 (18%)

Query: 166 THKLGQGGFGSVYKGQL-HTGRLIAVK-MMENSKFSAEEF--INELLGL----------- 210
               GQG FG+V  G+   TG  +A+K ++++ +F   E   + +L  L           
Sbjct: 28  ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSY 87

Query: 211 -CSEGFKR------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT---ARGIE 260
             + G +        +V EY+P+ +L R   +   +           I +      R I 
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVA--PPPIL-IKVFLFQLIRSIG 143

Query: 261 YLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
            LH    V + H DIKPHN+L++  +   K+ DFG AK        V+   +R    Y A
Sbjct: 144 CLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR---YYRA 199

Query: 320 PELISRNFGTV--SCKSDVYGFGMVLLEMAGGR 350
           PELI   FG    +   D++  G +  EM  G 
Sbjct: 200 PELI---FGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 45/236 (19%), Positives = 74/236 (31%), Gaps = 73/236 (30%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRA--------- 218
           +G+G +G V      +     A+K++   K   +                          
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 219 ----------------------------------LVYEYMPNGSLDRHIFSKENKGQTFG 244
                                             +V+E +  G +               
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK---- 132

Query: 245 LEKPHEIALGTAR--------GIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295
                E     AR        GIEYLH       I+H DIKP N+L+  +   K++DFG+
Sbjct: 133 --PLSE---DQARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGR 350
           +      +    +S+T GT  ++APE +S      S    DV+  G+ L     G+
Sbjct: 184 SNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 65/239 (27%), Positives = 98/239 (41%), Gaps = 61/239 (25%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN-------------------EL 207
           KLG G + +VYKG    TG  +A+K +   K  +EE                       L
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH--EIALGTARGIEYLHNG 265
             +     K  LV+E+M N  L +++ S+       GLE            +G+ + H  
Sbjct: 69  YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDF----VSISDTRGTIGYLAP 320
               ILH D+KP N+L++     K+ DFGLA+ F    N F    V       T+ Y AP
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-------TLWYRAP 177

Query: 321 ELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 375
           +++  SR + T +    D++  G +L EM  G            K  FP +   +QL  
Sbjct: 178 DVLMGSRTYSTSI----DIWSCGCILAEMITG------------KPLFPGTNDEEQLKL 220

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 75.6 bits (187), Expect = 2e-15
 Identities = 52/234 (22%), Positives = 96/234 (41%), Gaps = 54/234 (23%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKM--MENSK----FSA-----------EEFINELLG 209
           K+G+G +G+V+K +   T  ++A+K   +++       SA            + I  L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E+     L ++    ++       E          +G+ + H      
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDF----VSISDTRGTIGYLAPELIS 324
           +LH D+KP N+L++ N   K+++FGLA+ F      +    V       T+ Y  P+++ 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-------TLWYRPPDVL- 173

Query: 325 RNFGTV--SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 375
             FG    S   D++  G +  E+A              +  FP + V DQL +
Sbjct: 174 --FGAKLYSTSIDMWSAGCIFAELANAG-----------RPLFPGNDVDDQLKR 214

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 57/196 (29%), Positives = 81/196 (41%), Gaps = 43/196 (21%)

Query: 166 THKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFS-AEEFINE--------------LLG 209
           T  LG G FG V+K  +  TG  +A K+++       EE  NE              L  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153

Query: 210 LCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTAR----GIEYLH- 263
                    LV EY+  G L DR I    ++      E      +   +    GI ++H 
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII----DESYNLT-EL---DTILFMKQICEGIRHMHQ 205

Query: 264 NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
                 ILH D+KP NIL    D   I K+ DFGLA+ +             GT  +LAP
Sbjct: 206 MY----ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKL---KVNFGTPEFLAP 257

Query: 321 ELISRNFGTVSCKSDV 336
           E+++ +F  VS  +D+
Sbjct: 258 EVVNYDF--VSFPTDM 271

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 35/198 (17%), Positives = 71/198 (35%), Gaps = 36/198 (18%)

Query: 161 VTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINE----------- 206
           +   +     LG+G FG V++  +  + +    K ++           E           
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN 62

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
              L        +  +++E++    + +R I +           +           +++L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFER-INTS---AFELNEREIVSYVHQVCEALQFL 118

Query: 263 H-NGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           H +     I HFDI+P NI+      + I K+ +FG A+     ++F           Y 
Sbjct: 119 HSHN----IGHFDIRPENIIYQTRRSSTI-KIIEFGQARQLKPGDNF---RLLFTAPEYY 170

Query: 319 APELISRNFGTVSCKSDV 336
           APE+   +   VS  +D+
Sbjct: 171 APEVHQHDV--VSTATDM 186

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 51/197 (25%), Positives = 77/197 (39%), Gaps = 42/197 (21%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA-------EEFINE------------- 206
           +LG G F  V K  +  TG   A K ++  +  A       EE   E             
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 207 -LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH- 263
            L  +        L+ E +  G L D  +  KE+       E+          G+ YLH 
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDF-LAQKES----LSEEEATSFIKQILDGVNYLHT 133

Query: 264 NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                 I HFD+KP NI+L    IP    K+ DFGLA       +F    +  GT  ++A
Sbjct: 134 KK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVA 186

Query: 320 PELISRNFGTVSCKSDV 336
           PE+++     +  ++D+
Sbjct: 187 PEIVNYEP--LGLEADM 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 51/197 (25%), Positives = 77/197 (39%), Gaps = 42/197 (21%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA-------EEFINE------------- 206
           +LG G F  V K  +  TG   A K ++  +  A       EE   E             
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 207 -LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH- 263
            L  +        L+ E +  G L D  +  KE+       E+          G+ YLH 
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDF-LAQKES----LSEEEATSFIKQILDGVNYLHT 133

Query: 264 NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                 I HFD+KP NI+L    IP    K+ DFGLA       +F    +  GT  ++A
Sbjct: 134 KK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVA 186

Query: 320 PELISRNFGTVSCKSDV 336
           PE+++     +  ++D+
Sbjct: 187 PEIVNYEP--LGLEADM 201

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 59/236 (25%), Positives = 87/236 (36%), Gaps = 51/236 (21%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF----------------INELLGLC 211
           LG+G +G V       T   +AVK+++  +                      + +  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR--------GIEYLH 263
            EG  + L  EY   G L   I                +     A+        G+ YLH
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-----AQRFFHQLMAGVVYLH 122

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPEL 322
               + I H DIKP N+LLD     K+SDFGLA    + N+   + +   GT+ Y+APEL
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPEL 178

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMNATR---SSKAYFPSWVY 370
           + R     +   DV+  G+VL  M  G       + +          K Y   W  
Sbjct: 179 LKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 51/234 (21%), Positives = 90/234 (38%), Gaps = 55/234 (23%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN-------------------EL 207
           K+G+G +G V+K +   TG+++A+K    S+   +  I                     L
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESED--DPVIKKIALREIRMLKQLKHPNLVNL 67

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGC 266
           L +     +  LV+EY  + ++   +   +   +         I   T + + + H +  
Sbjct: 68  LEVFRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHKHN- 122

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI-- 323
               +H D+KP NIL+  + + K+ DFG A+      + +    D   T  Y +PEL+  
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY---DDEVATRWYRSPELLVG 176

Query: 324 SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 375
              +G  V    DV+  G V  E+  G               +P     DQL  
Sbjct: 177 DTQYGPPV----DVWAIGCVFAELLSGV------------PLWPGKSDVDQLYL 214

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 45/182 (24%), Positives = 71/182 (39%), Gaps = 31/182 (17%)

Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE-----------FINELLGLCS 212
            +  LG G  G V +     T    A+KM+++   +  E            I  ++ +  
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYE 125

Query: 213 EGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKP-HEIALGTARGIEYLH-NGC 266
             +       +V E +  G L   I  + ++  T   E+   EI       I+YLH    
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT---EREASEIMKSIGEAIQYLHSIN- 181

Query: 267 DVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
              I H D+KP N+L      N I K++DFG AK     N     +    T  Y+APE++
Sbjct: 182 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVL 235

Query: 324 SR 325
             
Sbjct: 236 GP 237

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 40/213 (18%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKM--MENSK----FSA-----------EEFINELLG 209
           K+GQG FG V+K +   TG+ +A+K   MEN K     +A            E +  L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83

Query: 210 LCSEGFKRA--------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
           +C               LV+++  +  L   +    N    F L +   +      G+ Y
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYY 139

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG--TIGYLA 319
           +H      ILH D+K  N+L+  + + K++DFGLA+      +      T    T+ Y  
Sbjct: 140 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196

Query: 320 PELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           PEL+   R++G      D++G G ++ EM    
Sbjct: 197 PELLLGERDYGP---PIDLWGAGCIMAEMWTRS 226

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 61/241 (25%), Positives = 93/241 (38%), Gaps = 64/241 (26%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVK----------------MMENSKFSAEE--FINELLG 209
           LG+G FG V   +   TGR  A+K                + EN         F+  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 210 -------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARG 258
                  LC        V EY   G L  H+ S+E     F  ++      EI       
Sbjct: 216 SFQTHDRLC-------FVMEYANGGELFFHL-SRERV---FSEDRARFYGAEIVSA---- 260

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR---GTI 315
           ++YLH+  +  +++ D+K  N++LD +   K++DFGL K   K+         +   GT 
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-----TMKTFCGTP 313

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSW 368
            YLAPE++  N    +   D +G G+V+ EM  GR                  +  FP  
Sbjct: 314 EYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT 371

Query: 369 V 369
           +
Sbjct: 372 L 372

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 66/242 (27%), Positives = 98/242 (40%), Gaps = 65/242 (26%)

Query: 169 LGQGGFGSVY----KGQLHTGRLIAVK---------------MMENSKFSAEE--FINEL 207
           LGQG FG V+           +L A+K                ME          FI +L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 208 LGLCSEGF----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARGI 259
               +  F    K  L+ +++  G L   + SKE     F  E       E+AL     +
Sbjct: 92  H--YA--FQTEGKLYLILDFLRGGDLFTRL-SKEVM---FTEEDVKFYLAELALA----L 139

Query: 260 EYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR---GT 314
           ++LH  G    I++ D+KP NILLD    I K++DFGL+K                  GT
Sbjct: 140 DHLHSLG----IIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKK-----AYSFCGT 189

Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPS 367
           + Y+APE+++R   T S   D + FG+++ EM  G        R   M     +K   P 
Sbjct: 190 VEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ 247

Query: 368 WV 369
           ++
Sbjct: 248 FL 249

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 60/236 (25%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKM--MENSK---FSA-----------EEFINELLGL 210
           KLG+G + +VYKG    T  L+A+K   +E+ +    +A              I  L  +
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA---RGIEYLHNGCD 267
                   LV+EY+    L +++   ++ G        H + L      RG+ Y H    
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYL---DDCGNII---NMHNVKLFLFQLLRGLAYCH---R 118

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDF----VSISDTRGTIGYLAPEL 322
             +LH D+KP N+L++     K++DFGLA+        +    V       T+ Y  P++
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-------TLWYRPPDI 171

Query: 323 I--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 375
           +  S ++ T   + D++G G +  EMA GR              FP S V +QL+ 
Sbjct: 172 LLGSTDYST---QIDMWGVGCIFYEMATGR------------PLFPGSTVEEQLHF 212

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 63/243 (25%), Positives = 91/243 (37%), Gaps = 69/243 (28%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVK----------------MMENSKFSAEE--FINELLG 209
           LG+G FG V   +   TGR  A+K                + E+         F+  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 210 -------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARG 258
                  LC        V EY   G L  H+ S+E     F  E+      EI       
Sbjct: 73  AFQTHDRLC-------FVMEYANGGELFFHL-SRERV---FTEERARFYGAEIVSA---- 117

Query: 259 IEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR---G 313
           +EYLH       +++ DIK  N++LD +  I K++DFGL K    +         +   G
Sbjct: 118 LEYLHSRD----VVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGAT-----MKTFCG 167

Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFP 366
           T  YLAPE++  N    +   D +G G+V+ EM  GR                  +  FP
Sbjct: 168 TPEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225

Query: 367 SWV 369
             +
Sbjct: 226 RTL 228

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 73.8 bits (182), Expect = 7e-15
 Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 44/206 (21%)

Query: 161 VTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA-------EEFINE---- 206
           V +H+    +LG G F  V K  Q  TG+  A K ++  + S+       EE   E    
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 207 ----------LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGT 255
                     L  +        L+ E +  G L D  +  KE+       ++  +     
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDF-LAEKES----LTEDEATQFLKQI 117

Query: 256 ARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISD 310
             G+ YLH       I HFD+KP NI+L    +P    K+ DFG+A      N+F    +
Sbjct: 118 LDGVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KN 170

Query: 311 TRGTIGYLAPELISRNFGTVSCKSDV 336
             GT  ++APE+++     +  ++D+
Sbjct: 171 IFGTPEFVAPEIVNYEP--LGLEADM 194

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 75.2 bits (185), Expect = 8e-15
 Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 45/212 (21%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMM---------ENSKFSAE---------EFINELLG 209
           +G+G FG V   +L +  ++ A+K++         E + F  E         ++I  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------EIALGTARGIEYLH 263
              +     LV +Y   G L   +   E++     L +        E+ +     I+ +H
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-----LPEEMARFYLAEMVIA----IDSVH 192

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
               +  +H DIKP NIL+D N   +++DFG      ++    S     GT  Y++PE++
Sbjct: 193 Q---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEIL 248

Query: 324 SRNFG-----TVSCKSDVYGFGMVLLEMAGGR 350
               G        C  D +  G+ + EM  G 
Sbjct: 249 QAMEGGKGRYGPEC--DWWSLGVCMYEMLYGE 278

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 44/198 (22%), Positives = 76/198 (38%), Gaps = 35/198 (17%)

Query: 161 VTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFS-AEEFINE---------- 206
           V +++    +LG G FG V++  +  TGR+   K +            NE          
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
               L     + ++  L+ E++  G L DR       +       +          G+++
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKH 164

Query: 262 LH-NGCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           +H +     I+H DIKP NI+ +       K+ DFGLA     +        T  T  + 
Sbjct: 165 MHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFA 217

Query: 319 APELISRNFGTVSCKSDV 336
           APE++ R    V   +D+
Sbjct: 218 APEIVDREP--VGFYTDM 233

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 38/193 (19%), Positives = 69/193 (35%), Gaps = 44/193 (22%)

Query: 164 HFTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINELLGLCSEGFKR----- 217
             +  LG G  G V    +  T + +A++++   KF+            +   +      
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADP---ALNVETEIEIL 194

Query: 218 --------------------ALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTA 256
                                +V E M  G L D+ +       +               
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDK-VVGN----KRLKEATCKLYFYQML 249

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRG 313
             ++YLH   +  I+H D+KP N+LL   + + + K++DFG +K   + +         G
Sbjct: 250 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCG 303

Query: 314 TIGYLAPELISRN 326
           T  YLAPE++   
Sbjct: 304 TPTYLAPEVLVSV 316

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 57/232 (24%), Positives = 92/232 (39%), Gaps = 51/232 (21%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM------ENSKFSA-----------EEFINELLG 209
            +G+G +G V K +   TGR++A+K        +  K  A            E +  LL 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDV 268
           +C +  +  LV+E++ + ++   +   E        +   +       GI + H +    
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTIGYLAPELI--SR 325
            I+H DIKP NIL+  + + K+ DFG A+        +    D   T  Y APEL+    
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---DDEVATRWYRAPELLVGDV 200

Query: 326 NFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 375
            +G  V    DV+  G ++ EM  G               FP     DQL  
Sbjct: 201 KYGKAV----DVWAIGCLVTEMFMGE------------PLFPGDSDIDQLYH 236

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 46/211 (21%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMM--------ENSKFSAEE----------FINELLG 209
           +G+G FG V   +   T ++ A+K++         +S F  EE          ++ +L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------EIALGTARGIEYLH 263
              +     +V EYMP G L   +         + + +        E+ L     ++ +H
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLM-------SNYDVPEKWARFYTAEVVLA----LDAIH 185

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
           +   +  +H D+KP N+LLD +   K++DFG      KE      +   GT  Y++PE++
Sbjct: 186 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVL 241

Query: 324 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 350
               G       C  D +  G+ L EM  G 
Sbjct: 242 KSQGGDGYYGREC--DWWSVGVFLYEMLVGD 270

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 47/214 (21%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMM---------ENSKFSAE---------EFINELLG 209
           +G+G F  V   ++  TG++ A+K+M         E S F  E          +I +L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127

Query: 210 LCSEGFKRA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARGIEY 261
             +  F+      LV EY   G L   +      G+    E       EI +     I+ 
Sbjct: 128 -FA--FQDENYLYLVMEYYVGGDLLTLL---SKFGERIPAEMARFYLAEIVMA----IDS 177

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
           +H    +  +H DIKP NILLD     +++DFG       +    S+    GT  YL+PE
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPE 233

Query: 322 LISRNFGTVSCKS-----DVYGFGMVLLEMAGGR 350
           ++    G     S     D +  G+   EM  G+
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 39/200 (19%)

Query: 161 VTNHFT--HKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFI-NE---------- 206
           V +H+    +LG G FG V++  +  TG   A K +     S +E +  E          
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
               L     +  +  ++YE+M  G L ++      ++      ++  E      +G+ +
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCH 270

Query: 262 LH-NGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLA-KFHPKENDFVSISDTRGTIG 316
           +H N      +H D+KP NI+      N + K+ DFGL     PK++    +  T GT  
Sbjct: 271 MHENN----YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQS----VKVTTGTAE 321

Query: 317 YLAPELISRNFGTVSCKSDV 336
           + APE+       V   +D+
Sbjct: 322 FAAPEVA--EGKPVGYYTDM 339

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 58/244 (23%), Positives = 101/244 (41%), Gaps = 67/244 (27%)

Query: 169 LGQGGFGSVY----KGQLHTGRLIAVK-----------------MMENSKFSAEE--FIN 205
           LG+GG+G V+        +TG++ A+K                   E +     +  FI 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 206 ELLGLCSEGF----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTAR 257
           +L+   +  F    K  L+ EY+  G L   +  +E     F  +       EI++    
Sbjct: 85  DLI--YA--FQTGGKLYLILEYLSGGELFMQL-EREGI---FMEDTACFYLAEISMA--- 133

Query: 258 GIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR--- 312
            + +LH  G    I++ D+KP NI+L+H   + K++DFGL K    +        T    
Sbjct: 134 -LGHLHQKG----IIYRDLKPENIMLNHQGHV-KLTDFGLCKESIHDGTV-----THTFC 182

Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYF 365
           GTI Y+APE++ R+    +   D +  G ++ +M  G        R   ++     K   
Sbjct: 183 GTIEYMAPEILMRSGHNRAV--DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240

Query: 366 PSWV 369
           P ++
Sbjct: 241 PPYL 244

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 50/197 (25%), Positives = 79/197 (40%), Gaps = 42/197 (21%)

Query: 168 KLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSA-------EEFINE------------- 206
           +LG G F  V K  +  TG   A K ++  +  +       E+   E             
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 207 -LLGLCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH- 263
            L  +        L+ E +  G L D  +  KE+       E+  E       G+ YLH 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDF-LAEKES----LTEEEATEFLKQILNGVYYLHS 132

Query: 264 NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319
                 I HFD+KP NI+L    +P    K+ DFGLA      N+F    +  GT  ++A
Sbjct: 133 LQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVA 185

Query: 320 PELISRNFGTVSCKSDV 336
           PE+++     +  ++D+
Sbjct: 186 PEIVNYEP--LGLEADM 200

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 71.8 bits (177), Expect = 4e-14
 Identities = 55/243 (22%), Positives = 91/243 (37%), Gaps = 63/243 (25%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKM--MENSKFSAEEF-------INELLGL------- 210
           ++G G +G+VYK +  H+G  +A+K   + N               +  L  L       
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 211 ------------CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARG 258
                            K  LV+E++     D   +  +        E   ++     RG
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF----VSISDTRGT 314
           +++LH     CI+H D+KP NIL+      K++DFGLA+ +  +       V       T
Sbjct: 133 LDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-------T 182

Query: 315 IGYLAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQ 372
           + Y APE++      T +   D++  G +  EM               K  F  +   DQ
Sbjct: 183 LWYRAPEVL---LQSTYATPVDMWSVGCIFAEMFRR------------KPLFCGNSEADQ 227

Query: 373 LNK 375
           L K
Sbjct: 228 LGK 230

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 43/213 (20%), Positives = 76/213 (35%), Gaps = 46/213 (21%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN---------------------- 205
           LG+G +G V +     T    AVK+++  K                              
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR-------- 257
           ++L    +  K  +V EY   G  +  +     + +        +     A         
Sbjct: 73  DVLYNEEKQ-KMYMVMEYCVCGMQE--MLDSVPEKRF----PVCQ-----AHGYFCQLID 120

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317
           G+EYLH+     I+H DIKP N+LL      K+S  G+A+         +   ++G+  +
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
             PE+ +        K D++  G+ L  +  G 
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 63/218 (28%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVK----------------MMENSKFSAEE---FINELL 208
           LG+G FG V+  +   T +  A+K                M+E    S      F+  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 209 G-------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEK----PHEIALGTAR 257
                   L         V EY+  G L  HI    +K   F L +      EI LG   
Sbjct: 85  CTFQTKENLF-------FVMEYLNGGDLMYHI-QSCHK---FDLSRATFYAAEIILG--- 130

Query: 258 GIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR--- 312
            +++LH  G    I++ D+K  NILLD +  I K++DFG+ K +   +       T    
Sbjct: 131 -LQFLHSKG----IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAK-----TNTFC 179

Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           GT  Y+APE++       S   D + FG++L EM  G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSV--DWWSFGVLLYEMLIGQ 215

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 59/241 (24%), Positives = 85/241 (35%), Gaps = 64/241 (26%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVK----------------MMENSKFSAEE---FINELL 208
           +G+G FG V   +        AVK                M E +         F+  L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 209 GLCSEGF----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARGIE 260
              S  F    K   V +Y+  G L  H+  +E     F   +      EIA      + 
Sbjct: 106 --FS--FQTADKLYFVLDYINGGELFYHL-QRERC---FLEPRARFYAAEIASA----LG 153

Query: 261 YLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR---GTI 315
           YLH       I++ D+KP NILLD    I  ++DFGL K + + N       T    GT 
Sbjct: 154 YLHSLN----IVYRDLKPENILLDSQGHI-VLTDFGLCKENIEHNST-----TSTFCGTP 203

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSW 368
            YLAPE++ +     +   D +  G VL EM  G             +   +        
Sbjct: 204 EYLAPEVLHKQPYDRTV--DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 261

Query: 369 V 369
           +
Sbjct: 262 I 262

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 41/201 (20%), Positives = 73/201 (36%), Gaps = 44/201 (21%)

Query: 154 LLPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINELLGLCS 212
           + P+ +      +  LG G  G V    +  T + +A+K++   KF+            +
Sbjct: 3   VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP---A 59

Query: 213 EGFKR-------------------------ALVYEYMPNGSL-DRHIFSKENKGQTFGLE 246
              +                           +V E M  G L D+ +       +     
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDK-VVGN----KRLKEA 114

Query: 247 KPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKEN 303
                       ++YLH   +  I+H D+KP N+LL   + + + K++DFG +K    E 
Sbjct: 115 TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170

Query: 304 DFVSISDTRGTIGYLAPELIS 324
               +    GT  YLAPE++ 
Sbjct: 171 SL--MRTLCGTPTYLAPEVLV 189

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 48/182 (26%), Positives = 68/182 (37%), Gaps = 43/182 (23%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAE----EFIN----------ELLGLCSE 213
           +G G FG     +   T  L+AVK +E      E    E IN              +   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR--------GIEYLHNG 265
               A++ EY   G L   I +        G     E     AR        G+ Y H+ 
Sbjct: 88  PTHLAIIMEYASGGELYERICNA-------GRFSEDE-----ARFFFQQLLSGVSYCHS- 134

Query: 266 CDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
             + I H D+K  N LLD +  P  K+ DFG +K     +     +   GT  Y+APE++
Sbjct: 135 --MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV--GTPAYIAPEVL 189

Query: 324 SR 325
            R
Sbjct: 190 LR 191

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 66/316 (20%), Positives = 107/316 (33%), Gaps = 98/316 (31%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN---------ELLGLCSEGFKRA 218
           LG+GGFG+V+ G  L     +A+K++  ++      ++          LL     G    
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 219 ----------------LVYEYMPNGSLDRHIFSK-ENKGQTFGLEKPHEIALGTAR---- 257
                           LV E        + +F     KG         E   G +R    
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKG------PLGE---GPSRCFFG 146

Query: 258 ----GIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPKEN--DFVSIS 309
                I++ H      ++H DIK  NIL+D       K+ DFG       E   DF    
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA-KLIDFGSGALLHDEPYTDFD--- 199

Query: 310 DTRGTIGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 367
              GT  Y  PE ISR+         + V+  G++L +M  G                P 
Sbjct: 200 ---GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCG--------------DIP- 238

Query: 368 WVYDQLNK--GGDLELRNV--TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE---ML 420
             +++  +    +L        +  ++I          C+  K + RPS+ ++L    M 
Sbjct: 239 --FERDQEILEAELHFPAHVSPDCCALIR--------RCLAPKPSSRPSLEEILLDPWMQ 288

Query: 421 EGSIDDLQMPPKPFFS 436
             + D    P K   +
Sbjct: 289 TPAEDVPLNPSKGGPA 304

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 59/237 (24%), Positives = 91/237 (38%), Gaps = 56/237 (23%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVK----------------MMENSKFSAEE---FINELL 208
           LG+G FG V   ++  TG L AVK                M E    S      F+ +L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEK----PHEIALGTARGIEYLH- 263
                  +   V E++  G L  HI  K  +   F   +      EI       + +LH 
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRR---FDEARARFYAAEIISA----LMFLHD 142

Query: 264 NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR---GTIGYLA 319
            G    I++ D+K  N+LLDH     K++DFG+ K             T    GT  Y+A
Sbjct: 143 KG----IIYRDLKLDNVLLDHEGHC-KLADFGMCKEGICNGVT-----TATFCGTPDYIA 192

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSWV 369
           PE++       +   D +  G++L EM  G         +    A  + +  +P+W+
Sbjct: 193 PEILQEMLYGPAV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 247

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 59/244 (24%), Positives = 93/244 (38%), Gaps = 70/244 (28%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVK----------------MMENSKFSAEE---FINELL 208
           LG+G FG V   +   T  L AVK                M+E    +      F+ +L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 209 G-------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTAR 257
                   L         V EY+  G L  HI  +  +   F          EIA+G   
Sbjct: 88  SCFQTMDRLY-------FVMEYVNGGDLMYHI-QQVGR---FKEPHAVFYAAEIAIG--- 133

Query: 258 GIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR--- 312
            + +L   G    I++ D+K  N++LD    I K++DFG+ K +  +        T+   
Sbjct: 134 -LFFLQSKG----IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVT-----TKTFC 182

Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYF 365
           GT  Y+APE+I+      S   D + FG++L EM  G+        +    +       +
Sbjct: 183 GTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240

Query: 366 PSWV 369
           P  +
Sbjct: 241 PKSM 244

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 58/243 (23%), Positives = 92/243 (37%), Gaps = 68/243 (27%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVK----------------MMENSKFSAEE---FINELL 208
           LG+G FG V   +   T  L AVK                M+E    +      F+ +L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 209 G-------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTAR 257
                   L         V EY+  G L  HI  +  +   F          EIA+G   
Sbjct: 409 SCFQTMDRLY-------FVMEYVNGGDLMYHI-QQVGR---FKEPHAVFYAAEIAIG--- 454

Query: 258 GIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR---G 313
            + +L       I++ D+K  N++LD    I K++DFG+ K +  +        T+   G
Sbjct: 455 -LFFLQ---SKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVT-----TKTFCG 504

Query: 314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFP 366
           T  Y+APE+I+      S   D + FG++L EM  G+        +    +       +P
Sbjct: 505 TPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 562

Query: 367 SWV 369
             +
Sbjct: 563 KSM 565

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 41/215 (19%)

Query: 168 KLGQGGFGSVYKGQ---LHTGRLIAVKMMENSKFSAE-------------EFINELLGLC 211
           K+G+G +G VYK +       +  A+K +E +  S                 +  L  + 
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87

Query: 212 SEGFKRA--LVYEYMPN---GSLDRHIFSKENKGQTFGLEKPH--EIALGTARGIEYLH- 263
                R   L+++Y  +     +  H  SK NK +   L +     +      GI YLH 
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANK-KPVQLPRGMVKSLLYQILDGIHYLHA 146

Query: 264 NGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLA-KFHPKENDFVSISDTRGTIGYL 318
           N     +LH D+KP NIL+          K++D G A  F+        +     T  Y 
Sbjct: 147 NW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202

Query: 319 APELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGR 350
           APEL+  +R++   +    D++  G +  E+    
Sbjct: 203 APELLLGARHYTKAI----DIWAIGCIFAELLTSE 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 56/242 (23%), Positives = 90/242 (37%), Gaps = 67/242 (27%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKM--MENSK----FSA-----------EEFINELLG 209
           KLG+G +G VYK     T   +A+K   +E+ +     +A              I EL  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100

Query: 210 LCSEGFKRALVYEYMPN---GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           +     +  L++EY  N     +D++        ++F  +           G+ + H   
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ--------LINGVNFCH--- 149

Query: 267 DVCILHFDIKPHNILLDHNFIP-----KVSDFGLAK-FHPKENDF----VSISDTRGTIG 316
               LH D+KP N+LL  +        K+ DFGLA+ F      F    +       T+ 
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-------TLW 202

Query: 317 YLAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQL 373
           Y  PE++  SR++ T     D++    +  EM                  FP     DQL
Sbjct: 203 YRPPEILLGSRHYST---SVDIWSIACIWAEMLMK------------TPLFPGDSEIDQL 247

Query: 374 NK 375
            K
Sbjct: 248 FK 249

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 58/234 (24%), Positives = 88/234 (37%), Gaps = 54/234 (23%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMM----------------ENSKFSAEE--FINELLG 209
           LG G FG V   +   +G   A+K++                E     A    F+ +L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------EIALGTARGIEYLH 263
              +     +V EY+  G +    FS   +   F   +PH      +I L      EYLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEM----FSHLRRIGRF--SEPHARFYAAQIVLT----FEYLH 158

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP-KENDFVSISDTRGTIGYLAPEL 322
               + +++ D+KP N+L+D     +V+DFG AK    +           GT   LAPE+
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC------GTPEALAPEI 209

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 369
           I       +   D +  G+++ EMA G                 S K  FPS  
Sbjct: 210 ILSKGYNKAV--DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 27/220 (12%)

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
           S+    +   E      ++     ++       LE     +   A+G+E+L      CI 
Sbjct: 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI- 215

Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H D+   NILL    + K+ DFGLA+   K+ D+V   D R  + ++APE I     T+ 
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI- 274

Query: 332 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY----FPSWVYDQLNKGGDLEL-RNVTE 386
            +SDV+ FG++L E+           +  +  Y           +L +G  +      T 
Sbjct: 275 -QSDVWSFGVLLWEI----------FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 323

Query: 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
                  ++    L C   + + RP+ ++++E L   +  
Sbjct: 324 -------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 64/222 (28%)

Query: 169 LGQGGFGSVY----KGQLHTGRLIAVK-----------------MMENSKFSAEE---FI 204
           LG G +G V+         TG+L A+K                   E           F+
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 205 NELLG-------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIAL 253
             L         L        L+ +Y+  G L  H+ S+  +   F   +      EI L
Sbjct: 122 VTLHYAFQTETKLH-------LILDYINGGELFTHL-SQRER---FTEHEVQIYVGEIVL 170

Query: 254 GTARGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDT 311
                +E+LH  G    I++ DIK  NILLD N  +  ++DFGL+    KE         
Sbjct: 171 A----LEHLHKLG----IIYRDIKLENILLDSNGHV-VLTDFGLS----KEFVADETERA 217

Query: 312 R---GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
               GTI Y+AP+++           D +  G+++ E+  G 
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 68.0 bits (167), Expect = 6e-13
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 54/213 (25%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN---------------------E 206
           LG G FG V  G+   TG  +AVK++   K  + + +                      +
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR--------G 258
           ++   ++ F   +V EY+  G L  +I          G  +  E     AR         
Sbjct: 79  VISTPTDFF---MVMEYVSGGELFDYICKH-------GRVEEME-----ARRLFQQILSA 123

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGY 317
           ++Y H      ++H D+KP N+LLD +   K++DFGL+     + +F+    T  G+  Y
Sbjct: 124 VDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFL---RTSCGSPNY 176

Query: 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            APE+IS        + D++  G++L  +  G 
Sbjct: 177 AAPEVISGR-LYAGPEVDIWSCGVILYALLCGT 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 45/181 (24%), Positives = 72/181 (39%), Gaps = 33/181 (18%)

Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
              +LG+G    VY+  Q  T +  A+K+++ +    +    E              L  
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 210 LCSEGFKRALVYEYMPNGSL-DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCD 267
           +     + +LV E +  G L DR I  K      +      +        + YLH NG  
Sbjct: 116 IFETPTEISLVLELVTGGELFDR-IVEKGY----YSERDAADAVKQILEAVAYLHENG-- 168

Query: 268 VCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
             I+H D+KP N+L      +   K++DFGL+K    +          GT GY APE++ 
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILR 223

Query: 325 R 325
            
Sbjct: 224 G 224

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 46/215 (21%), Positives = 88/215 (40%), Gaps = 48/215 (22%)

Query: 168 KLGQGGFGSVYKGQ--LHTGRLIAVKM--MENSK----FSAEEFINELLGL--------- 210
           ++G+G +G V+K +   + GR +A+K   ++  +     S    +  L  L         
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 211 ----------CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
                          K  LV+E++    L  ++      G      K  ++     RG++
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 134

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF----VSISDTRGTIG 316
           +LH      ++H D+KP NIL+  +   K++DFGLA+ +  +       V       T+ 
Sbjct: 135 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-------TLW 184

Query: 317 YLAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGR 350
           Y APE++      + +   D++  G +  EM   +
Sbjct: 185 YRAPEVL---LQSSYATPVDLWSVGCIFAEMFRRK 216

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 44/188 (23%), Positives = 68/188 (36%), Gaps = 45/188 (23%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN---------------------- 205
           LG G FG V+        + + VK ++  K   + +I                       
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 206 -ELLGLCSEGFKRALVYEYMPNGS-----LDRHIFSKENKGQTFGLEKPHEIALGTARGI 259
            ++L +        LV E   +G      +DRH    E            ++       +
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF----RQLV----SAV 143

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYL 318
            YL       I+H DIK  NI++  +F  K+ DFG A +  +   F     T  GTI Y 
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF----YTFCGTIEYC 196

Query: 319 APELISRN 326
           APE++  N
Sbjct: 197 APEVLMGN 204

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 45/209 (21%), Positives = 79/209 (37%), Gaps = 47/209 (22%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF-----------------INELLGL 210
           +G+G F  V   + + TGR +A+K+++ ++ +                     I +L  +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR--------GIEYL 262
                   L+ EY   G +  ++ +        G  K  E     AR         ++Y 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAH-------GRMKEKE-----ARSKFRQIVSAVQYC 130

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAPE 321
           H      I+H D+K  N+LLD +   K++DFG +         +       G   Y APE
Sbjct: 131 HQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLD---AFCGAPPYAAPE 183

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           L          + DV+  G++L  +  G 
Sbjct: 184 LFQGK-KYDGPEVDVWSLGVILYTLVSGS 211

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.0 bits (167), Expect = 9e-13
 Identities = 56/220 (25%), Positives = 86/220 (39%), Gaps = 67/220 (30%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVK----------------MMENSKFSAEE---FINELL 208
           +G+G +  V   +L  T R+ A+K                  E   F       F+  L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 209 G-------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------EIALGT 255
                   L         V EY+  G L  H+  ++ K     L + H      EI+L  
Sbjct: 77  SCFQTESRLF-------FVIEYVNGGDLMFHM-QRQRK-----LPEEHARFYSAEISLA- 122

Query: 256 ARGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR- 312
              + YLH  G    I++ D+K  N+LLD    I K++D+G+ K   +  D      T  
Sbjct: 123 ---LNYLHERG----IIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDT-----TST 169

Query: 313 --GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
             GT  Y+APE++       S   D +  G+++ EM  GR
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 207

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 68.1 bits (167), Expect = 9e-13
 Identities = 49/231 (21%), Positives = 92/231 (39%), Gaps = 53/231 (22%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELLGLC--------------- 211
           KLG+G +  V++   +     + VK+++      ++   E+  L                
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIV 100

Query: 212 --SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                   ALV+E++ N    +         QT              + ++Y H+     
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG--- 150

Query: 270 ILHFDIKPHNILLDH-NFIPKVSDFGLAKF-HPKE--NDFVSISDTRGTIGYLAPELISR 325
           I+H D+KPHN+++DH +   ++ D+GLA+F HP +  N  V+   +R    +  PEL+  
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA---SR---YFKGPELLV- 203

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 375
           ++       D++  G +L  M   +             +F     YDQL +
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKE-----------PFFHGHDNYDQLVR 243

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 64/209 (30%), Positives = 91/209 (43%), Gaps = 49/209 (23%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVKMM----------------ENSKFSAEE--FINELLG 209
           LG G FG V+  +  H GR  A+K++                E    S     FI  + G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH----EIALGTARGIEYLHNG 265
              +  +  ++ +Y+  G L    FS   K Q F          E+ L     +EYLH+ 
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLA----LEYLHS- 124

Query: 266 CDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR---GTIGYLAPE 321
            D  I++ D+KP NILLD N  I K++DFG AK      D      T    GT  Y+APE
Sbjct: 125 KD--IIYRDLKPENILLDKNGHI-KITDFGFAK---YVPD-----VTYTLCGTPDYIAPE 173

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           ++S      S   D + FG+++ EM  G 
Sbjct: 174 VVSTKPYNKSI--DWWSFGILIYEMLAGY 200

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 44/217 (20%), Positives = 84/217 (38%), Gaps = 44/217 (20%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE--LLGLCSEGFKRALVYEYM 224
           KLG G F +V+  + +     +A+K++   K   E   +E  LL   ++           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 225 PN-----------GSLDRHI-------------FSKENKGQTFGLEKPHEIALGTARGIE 260
            +           G    H+               K+ + +   L    +I+     G++
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 145

Query: 261 YLHNGCDVCILHFDIKPHNILLDH------NFIPKVSDFGLAKFHPKENDFVSISDTRGT 314
           Y+H  C   I+H DIKP N+L++           K++D G A +   +  + +   TR  
Sbjct: 146 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSIQTR-- 199

Query: 315 IGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGR 350
             Y +PE++    G    C +D++    ++ E+  G 
Sbjct: 200 -EYRSPEVL---LGAPWGCGADIWSTACLIFELITGD 232

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 36/138 (26%), Positives = 66/138 (47%), Gaps = 19/138 (13%)

Query: 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT---ARGIEYLHNGCDVCILHFDI 275
           ++ EY+P+ +L + + S    G++  +     I++      R + ++H+   + I H DI
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRS--IPMNL-ISIYIYQLFRAVGFIHS---LGICHRDI 167

Query: 276 KPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV--SC 332
           KP N+L++  +   K+ DFG AK        V+   +R    Y APEL+    G    + 
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR---FYRAPELM---LGATEYTP 221

Query: 333 KSDVYGFGMVLLEMAGGR 350
             D++  G V  E+  G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 66/290 (22%), Positives = 101/290 (34%), Gaps = 87/290 (30%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN---------ELLGLCSEGF--- 215
           LG GGFGSVY G  +     +A+K +E  + S    +           LL   S GF   
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 216 -----------KRALVYEY-MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR------ 257
                         L+ E   P   L   I  +       G  +        AR      
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER-------GALQEEL-----ARSFFWQV 158

Query: 258 --GIEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISDTRGT 314
              + + HN     +LH DIK  NIL+D N    K+ DFG              +D  GT
Sbjct: 159 LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGT 211

Query: 315 IGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 372
             Y  PE I  +   G     + V+  G++L +M  G                P   ++ 
Sbjct: 212 RVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCG--------------DIP---FEH 251

Query: 373 LNK--GGDLELRNV--TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
             +   G +  R    +E + +I         WC+ ++ +DRP+  ++  
Sbjct: 252 DEEIIRGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEIQN 293

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 55/220 (25%), Positives = 86/220 (39%), Gaps = 67/220 (30%)

Query: 169 LGQGGFGSVYKGQL-HTGRLIAVK----------------MMENSKFSAEE---FINELL 208
           +G+G +  V   +L  T R+ A++                  E   F       F+  L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 209 G-------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH------EIALGT 255
                   L         V EY+  G L  H+  ++ K     L + H      EI+L  
Sbjct: 120 SCFQTESRLF-------FVIEYVNGGDLMFHM-QRQRK-----LPEEHARFYSAEISLA- 165

Query: 256 ARGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTR- 312
              + YLH  G    I++ D+K  N+LLD    I K++D+G+ K   +  D      T  
Sbjct: 166 ---LNYLHERG----IIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDT-----TST 212

Query: 313 --GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
             GT  Y+APE++       S   D +  G+++ EM  GR
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 250

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 53/188 (28%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN---------------------E 206
           LG G FG V  G+   TG  +AVK++   K  + + +                      +
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR--------G 258
           ++   S+ F   +V EY+  G L  +I          G     E     +R        G
Sbjct: 84  VISTPSDIF---MVMEYVSGGELFDYICKN-------GRLDEKE-----SRRLFQQILSG 128

Query: 259 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGY 317
           ++Y H      ++H D+KP N+LLD +   K++DFGL+     + +F+    T  G+  Y
Sbjct: 129 VDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFL---RTSCGSPNY 181

Query: 318 LAPELISR 325
            APE+IS 
Sbjct: 182 AAPEVISG 189

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 22/207 (10%), Positives = 48/207 (23%), Gaps = 67/207 (32%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINELL-------GLCSEGFKR-- 217
             G       ++       R +A+  ++      ++ + E L        +   G  R  
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 218 ---------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE---IALGTARGIEYLH-N 264
                     +V E++  GSL     +            P          A   +  H  
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADT--------SPS-PVGAIRAMQSLAAAADAAHRA 148

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
           G    +      P  + +  +    ++                          +      
Sbjct: 149 G----VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPD---- 178

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGRR 351
                 + + D+ G G  L  +   R 
Sbjct: 179 -----ANPQDDIRGIGASLYALLVNRW 200

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 62.3 bits (152), Expect = 8e-11
 Identities = 55/209 (26%), Positives = 81/209 (38%), Gaps = 47/209 (22%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF------------------INELLG 209
           LG+G FG V       T + +A+K +        +                   I +L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR--------GIEY 261
           + +      +V EY   G L  +I  K             E      R         IEY
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEK-------KRMTEDE-----GRRFFQQIICAIEY 123

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
            H      I+H D+KP N+LLD N   K++DFGL+     + +F+  S   G+  Y APE
Sbjct: 124 CHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTS--CGSPNYAAPE 177

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           +I+        + DV+  G+VL  M  GR
Sbjct: 178 VINGK-LYAGPEVDVWSCGIVLYVMLVGR 205

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 56/215 (26%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAE---------EFINE-----------L 207
           +G+G FG V K       + +A+KM+ N K             E + +           +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164

Query: 208 LG-------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIE 260
           L        +C       + +E +   S++ +   K+NK Q F L    + A    + ++
Sbjct: 165 LENFTFRNHIC-------MTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214

Query: 261 YLHNGCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVS--ISDTRGTIG 316
            LH      I+H D+KP NILL        KV DFG + +   E+  V   I  +R    
Sbjct: 215 ALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTYIQ-SR---F 264

Query: 317 YLAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGR 350
           Y APE+I    G       D++  G +L E+  G 
Sbjct: 265 YRAPEVI---LGARYGMPIDMWSLGCILAELLTGY 296

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 45/228 (19%), Positives = 75/228 (32%), Gaps = 54/228 (23%)

Query: 161 VTNHFT--HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---FINELLGL----- 210
           + + +T    +  G +G+V  G    G  +A+K + N+           +  L       
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 211 ----------------------CSEGFKRA-LVYEYMPNGSLDRHIFSKENKGQTFGLEK 247
                                       +  LV E M    L + I  +        +  
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIV-----ISP 133

Query: 248 PHE--IALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN-- 303
            H          G+  LH      ++H D+ P NILL  N    + DF LA+    +   
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190

Query: 304 -DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
             +V+    R    Y APEL+   F   +   D++  G V+ EM   +
Sbjct: 191 THYVT---HR---WYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRK 231

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 40/155 (25%), Positives = 62/155 (40%), Gaps = 30/155 (19%)

Query: 165 FTHKLGQGGFGSVYKG-QLHTGRLIAVKMMENSKFSAEE-----------FINELLGLCS 212
            +  LG G  G V +     T    A+KM+++   +  E            I  ++ +  
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYE 81

Query: 213 EGFKRA----LVYEYMPNGSL-DRHIFSKENKGQTFGLEKP-HEIALGTARGIEYLH-NG 265
             +       +V E +  G L  R I  + ++  T   E+   EI       I+YLH   
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSR-IQDRGDQAFT---EREASEIMKSIGEAIQYLHSIN 137

Query: 266 CDVCILHFDIKPHNILL---DHNFIPKVSDFGLAK 297
               I H D+KP N+L      N I K++DFG AK
Sbjct: 138 ----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 48/227 (21%), Positives = 82/227 (36%), Gaps = 54/227 (23%)

Query: 157 EIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAE---------EFINE 206
           E           +G+G FG V K         +A+K+++N K             E +N+
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK 109

Query: 207 -----------LLG-------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKP 248
                      L         LC       LV+E +   S + +   +    +   L   
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLC-------LVFEML---SYNLYDLLRNTNFRGVSLNLT 159

Query: 249 HEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFV 306
            + A      + +L    ++ I+H D+KP NILL +      K+ DFG +         +
Sbjct: 160 RKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRI 215

Query: 307 S--ISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGR 350
              I  +R    Y +PE++    G       D++  G +L+EM  G 
Sbjct: 216 YQYIQ-SR---FYRSPEVL---LGMPYDLAIDMWSLGCILVEMHTGE 255

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 11/95 (11%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTI 315
           +G+ Y+H      I+H D+KP N+ ++ +   K+ DFGLA+    +   +V    TR   
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV---TR--- 189

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 190 WYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 27/95 (28%), Positives = 52/95 (54%), Gaps = 11/95 (11%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTI 315
           +G++Y+H+     ++H D+KP N+ ++ +   K+ DFGLA+    +   +V    TR   
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---TR--- 187

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE+I  ++   +   D++  G ++ EM  G+
Sbjct: 188 WYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 5/95 (5%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTI 315
           RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+   P  +    +++   T 
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  N    +   D++  G +L EM   R
Sbjct: 196 WYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 42/163 (25%), Positives = 67/163 (41%), Gaps = 32/163 (19%)

Query: 157 EIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENS--------------KFS 199
           E+  V N +    K+G G FG +Y G  +  G  +A+K+                     
Sbjct: 4   ELR-VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62

Query: 200 AEEFINELLGLCSEGFKRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPHEIALGTARG 258
               I  +    +EG    +V E +  G SL+  +F+     + F L+    +A      
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELL--GPSLE-DLFNF--CSRKFSLKTVLLLADQMISR 117

Query: 259 IEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK 297
           IEY+H+      +H D+KP N L+      N +  + DFGLAK
Sbjct: 118 IEYIHS---KNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 36/168 (21%)

Query: 155 LPEIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE----- 206
           +  ++ V  +F    K+G G FG +  G+ L+T   +A+K +E  K  A +   E     
Sbjct: 2   MGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYK 59

Query: 207 ----------LLGLCSEGFKRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPHEIALGT 255
                     +      G   A+V E +  G SL+  +F      +TF L+    IA+  
Sbjct: 60  QLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLE-DLFDL--CDRTFSLKTVLMIAIQL 114

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILL------DHNFIPKVSDFGLAK 297
              +EY+H+     +++ D+KP N L+          I  + DF LAK
Sbjct: 115 ISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 36/174 (20%), Positives = 66/174 (37%), Gaps = 38/174 (21%)

Query: 147 MQTVDNILLPEIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGRLIAVKMM-ENSK----- 197
           M   +N+       V  H+    ++G+G FG +++G  L   + +A+K     S      
Sbjct: 1   MSGQNNV-------VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR 53

Query: 198 --------FSAEEFINELLGLCSEGFKRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKP 248
                    +    I  +     EG    LV + +  G SL+  +   +  G+ F ++  
Sbjct: 54  DEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLE-DLL--DLCGRKFSVKTV 108

Query: 249 HEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK-----VSDFGLAK 297
              A      ++ +H      +++ DIKP N L+            V DFG+ K
Sbjct: 109 AMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 34/121 (28%), Positives = 52/121 (42%), Gaps = 23/121 (19%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            GI++LH+     I+H D+KP NI++  +   K+ DFGLA           ++    T  
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 191

Query: 317 YLAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLN 374
           Y APE+I    +       D++  G ++ EM  G               FP   + DQ N
Sbjct: 192 YRAPEVILGMGYKE---NVDIWSVGCIMGEMIKG------------GVLFPGTDHIDQWN 236

Query: 375 K 375
           K
Sbjct: 237 K 237

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 43/226 (19%), Positives = 80/226 (35%), Gaps = 48/226 (21%)

Query: 161 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMM-----------------------E 194
           + + +     LG GG G V+        + +A+K +                       +
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHD 68

Query: 195 N-----SKFSAEEFINELLGLCSEGFKRA-LVYEYMPNGSLDRHIFSKENKGQTFGLEKP 248
           N                             +V EYM     D     ++       L + 
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---DLANVLEQGP-----LLEE 120

Query: 249 HE--IALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAK-FHPKEND 304
           H         RG++Y+H+     +LH D+KP N+ ++  + + K+ DFGLA+   P  + 
Sbjct: 121 HARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

Query: 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
              +S+   T  Y +P L+  +    +   D++  G +  EM  G+
Sbjct: 178 KGHLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 11/95 (11%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISDTRGTI 315
           RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    +   +V+   TR   
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA---TR--- 193

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
            Y APE++  N+   +   D++  G ++ E+  GR
Sbjct: 194 WYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 10/95 (10%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            GI++LH+     I+H D+KP NI++  +   K+ DFGLA+          ++    T  
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRY 228

Query: 317 YLAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
           Y APE+I    +       D++  G ++ EM   +
Sbjct: 229 YRAPEVILGMGYKE---NVDIWSVGCIMGEMVRHK 260

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 45/164 (27%), Positives = 69/164 (42%), Gaps = 34/164 (20%)

Query: 157 EIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE------- 206
           E   V N F    K+G G FG +Y G  + T   +A+K +EN K    + + E       
Sbjct: 2   EPR-VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKIYRIL 59

Query: 207 --------LLGLCSEGFKRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPHEIALGTAR 257
                   +     EG    LV + +  G SL+  +F+     +   L+    +A     
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLE-DLFNF--CSRKLSLKTVLMLADQMIN 114

Query: 258 GIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK 297
            +E++H+      LH DIKP N L+      N +  + DFGLAK
Sbjct: 115 RVEFVHS---KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAK 154

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 30/102 (29%), Positives = 46/102 (45%), Gaps = 12/102 (11%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG--- 313
           R ++ LH      ++H D+KP N+L++ N   KV DFGLA+   +     S    +    
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 314 -----TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
                T  Y APE++       S   DV+  G +L E+   R
Sbjct: 180 VEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRR 220

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 46/262 (17%), Positives = 85/262 (32%), Gaps = 90/262 (34%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINEL--LGLCSEGFKRALVYEY 223
            KLG G F +V+    +   + +A+K++++++   E  ++E+  L             E 
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 224 M-----------PNGSLDRHI-------------FSKENKGQTFGLEKPHEIALGTARGI 259
           +            NG    HI             +  ++  Q   L    +I     +G+
Sbjct: 103 VVQLLDDFKISGVNG---THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159

Query: 260 EYLHNGCDVCILHFDIKPHNILL------------------------------------- 282
           +YLH  C +   H DIKP NILL                                     
Sbjct: 160 DYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217

Query: 283 ------------DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT- 329
                             K++D G A +  K       ++   T  Y + E++    G+ 
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVL---IGSG 269

Query: 330 VSCKSDVYGFGMVLLEMAGGRR 351
            +  +D++    +  E+A G  
Sbjct: 270 YNTPADIWSTACMAFELATGDY 291

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 56/234 (23%)

Query: 161 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMMEN------------------SKFS 199
           V   +    KLG+G +G V+K     TG ++AVK + +                  ++ S
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66

Query: 200 AEEFINELLGLC-SEGFKRA-LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IALGT 255
             E I  LL +  ++  +   LV++YM     D H   + N      LE  H+  +    
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMET---DLHAVIRANI-----LEPVHKQYVVYQL 118

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
            + I+YLH+G    +LH D+KP NILL+     KV+DFGL++         +        
Sbjct: 119 IKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 316 G-------------------YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350
                               Y APE++       +   D++  G +L E+  G+
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEILCGK 228

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 34/164 (20%), Positives = 62/164 (37%), Gaps = 39/164 (23%)

Query: 161 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF-------------- 203
           + + +   H +G G +G V +       R++A+K +    F                   
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRL 109

Query: 204 ----INELLGLC----SEGFKRA-LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHE--IA 252
               + ++L +      E F    +V E   +    +   +         L + H   + 
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY------LTELHIKTLL 162

Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296
                G++Y+H+     ILH D+KP N L++ +   KV DFGLA
Sbjct: 163 YNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 33/130 (25%), Positives = 51/130 (39%), Gaps = 25/130 (19%)

Query: 257 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIG 316
            G  ++H      I+H D+KP N LL+ +   KV DFGLA+    E D   ++D      
Sbjct: 140 LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 317 --------------------YLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN 356
                               Y APELI       +   D++  G +  E+    + S++N
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELIL-LQENYTKSIDIWSTGCIFAELLNMLQ-SHIN 254

Query: 357 ATRSSKAYFP 366
              +    FP
Sbjct: 255 DPTNRFPLFP 264

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 55/246 (22%), Positives = 80/246 (32%), Gaps = 96/246 (39%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAE---------EFIN------------ 205
           K+G G FG V   Q +   +  AVK++ N K             + I             
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101

Query: 206 --------------ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEI 251
                         E LG          +YE +             N    F +E     
Sbjct: 102 HGKFMYYDHMCLIFEPLGPS--------LYEII-----------TRNNYNGFHIEDIKLY 142

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP----------------------- 288
            +   + + YL     + + H D+KP NILLD  +                         
Sbjct: 143 CIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 289 --KVSDFGLAKFHPKENDFVS--ISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVL 343
             K+ DFG A F   ++D+    I+ TR    Y APE+I           SD++ FG VL
Sbjct: 200 GIKLIDFGCATF---KSDYHGSIIN-TR---QYRAPEVI---LNLGWDVSSDMWSFGCVL 249

Query: 344 LEMAGG 349
            E+  G
Sbjct: 250 AELYTG 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 34/167 (20%), Positives = 57/167 (34%), Gaps = 46/167 (27%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM--ENSK----FSAEEFINELLGLCS-------- 212
           K+G GGFG +Y     +     A  ++  E  +    FS  +F   +             
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 213 -------------------EGFKRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPHEIA 252
                                  R +V E +  G  L   I     +  TF      ++ 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ-KIS---GQNGTFKKSTVLQLG 157

Query: 253 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV--SDFGLAK 297
           +     +EY+H       +H DIK  N+LL +    +V  +D+GL+ 
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 33/170 (19%), Positives = 57/170 (33%), Gaps = 47/170 (27%)

Query: 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE---------FINEL---------- 207
             +GQGGFG +Y   +++   +        K    +         F              
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 208 -------LGLCS----------EGFKRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPH 249
                  LG+                R ++ +    G  L   I+    K   F  +   
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQ-KIYEANAK--RFSRKTVL 155

Query: 250 EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV--SDFGLAK 297
           +++L     +EY+H       +H DIK  N+LL++    +V   D+GLA 
Sbjct: 156 QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 50/242 (20%), Positives = 81/242 (33%), Gaps = 92/242 (38%)

Query: 168 KLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSAE---------EFIN----------- 205
            LG+G FG V +   H      +A+K++ N     E         + I            
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85

Query: 206 ----------------ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH 249
                           ELLG           +E++           KEN  Q + L    
Sbjct: 86  LMSDWFNFHGHMCIAFELLGKN--------TFEFL-----------KENNFQPYPLPHVR 126

Query: 250 EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP-------------------KV 290
            +A      + +LH   +  + H D+KP NIL  ++                      +V
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 291 SDFGLAKFHPKENDFVS--ISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMA 347
           +DFG A F   +++  +  ++ TR    Y  PE+I        +   DV+  G +L E  
Sbjct: 184 ADFGSATF---DHEHHTTIVA-TR---HYRPPEVI---LELGWAQPCDVWSIGCILFEYY 233

Query: 348 GG 349
            G
Sbjct: 234 RG 235

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 33/229 (14%), Positives = 68/229 (29%), Gaps = 58/229 (25%)

Query: 168 KLGQGGFGSVYKGQLHTGRLI---------AVKM-MENSKFSAE-------------EFI 204
              +   G +Y+    +             ++K+  ++ +   E                
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 205 NELLGL------------CSEGFKRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPHEI 251
            +L                 +   R LV   +  G SL        +           ++
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQ-SAL-DVSPKHVLSERSVLQV 164

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV--SDFGLAKFHPKENDFVSIS 309
           A      +E+LH       +H ++   NI +D     +V  + +G A  +      V+  
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221

Query: 310 DTR-----GTIGYLAPELISRN--FG-TVSCKSDVYGFGMVLLEMAGGR 350
           +       G + +     IS +   G   S +SD+   G  +L+   G 
Sbjct: 222 EGSRSPHEGDLEF-----ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 59/242 (24%), Positives = 87/242 (35%), Gaps = 92/242 (38%)

Query: 168 KLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSAE---------EFIN----------- 205
            LG+G FG V +   H   GR +AVK+++N     E         E +N           
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80

Query: 206 ----------------ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH 249
                           ELLGL          Y+++           KEN    F L+   
Sbjct: 81  QMLEWFEHHGHICIVFELLGLS--------TYDFI-----------KENGFLPFRLDHIR 121

Query: 250 EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP-------------------KV 290
           ++A    + + +LH      + H D+KP NIL   +                      KV
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 291 SDFGLAKFHPKENDFVS--ISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMA 347
            DFG A +   +++  S  +S TR    Y APE+I        S   DV+  G +L+E  
Sbjct: 179 VDFGSATY---DDEHHSTLVS-TR---HYRAPEVI---LALGWSQPCDVWSIGCILIEYY 228

Query: 348 GG 349
            G
Sbjct: 229 LG 230

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 2e-04
 Identities = 64/450 (14%), Positives = 123/450 (27%), Gaps = 128/450 (28%)

Query: 58  DTNDAISDLPESCVFISKV--PVVLNRSVDNPSYEDLRKLLDSG------F-------DF 102
           D  D + D+P+S +   +    +++++   + +      LL         F       ++
Sbjct: 34  DCKD-VQDMPKS-ILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY 91

Query: 103 TWFEECSSYHPITNWIPIDVLIIGRFIL--APIVFLVFLIHKYRTT-MQTVDNI--LLPE 157
            +             +   + I  R  L     VF      KY  + +Q    +   L E
Sbjct: 92  KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA-----KYNVSRLQPYLKLRQALLE 146

Query: 158 IIAVTNHFTHKLGQGGFG-SVYKGQLHTGRLIA--------VKMMENSKF--------SA 200
           +    N      G  G G +          +             M+   F        S 
Sbjct: 147 LRPAKNVLID--GVLGSGKTW---------VALDVCLSYKVQCKMDFKIFWLNLKNCNSP 195

Query: 201 EEFINELLGLCSEGFKRALVYEYMPNG--------SLDRHIFSKENKGQTFGLEKPHEIA 252
           E  +  L  L          Y+  PN         ++   I S + + +     KP+E  
Sbjct: 196 ETVLEMLQKLL---------YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246

Query: 253 L------GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-- 304
           L        A+     +  C + +     +  + L          D       P E    
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306

Query: 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 364
            +   D R     L  E+++ N   +S         ++           +  AT      
Sbjct: 307 LLKYLDCR--PQDLPREVLTTNPRRLS---------II------AESIRDGLATWD---N 346

Query: 365 FPSWVYDQLNKGGDLELRNVTEIE--------------SMIARK-LCMIGLWCIQVKAAD 409
           +     D+L    +  L  +   E              + I    L +  +W   V  +D
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL--IWF-DVIKSD 403

Query: 410 RPSMTKVLE---MLEG-------SIDDLQM 429
              +   L    ++E        SI  + +
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIPSIYL 433

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 42.2 bits (98), Expect = 2e-04
 Identities = 42/303 (13%), Positives = 81/303 (26%), Gaps = 90/303 (29%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMM---------ENSKFSAEEFINELL---------- 208
           K+G+G FG V++        +A+K++          + + + EE + E++          
Sbjct: 27  KIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 209 -------------------GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH 249
                              G       +A  +     GS +      ++      LE   
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 250 -------------------EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV 290
                               I       +            H D+   N+LL    + K+
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKL 203

Query: 291 SDFGLAK--------FHPKENDF-VSISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFG 340
                 K              D+ +S  +  G + +    +    F G    + D+Y   
Sbjct: 204 HYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIY--- 260

Query: 341 MVLLEMAGGRRNSNMNATRSSKAYFPS----WVY---DQLNKGGDLELRNVTEIESMIAR 393
                     R            Y P     W++   D++ K    + +  T     I R
Sbjct: 261 ----------RLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKR 310

Query: 394 KLC 396
           K+ 
Sbjct: 311 KIQ 313

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	453
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.92
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.86
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.69
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.58
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.9
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.75
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.73
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.71
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.69
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.58
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.48
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.18
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.86
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.75
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.69
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.65
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.33
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.29
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.16
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.03
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.02
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.9
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.16
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	94.05
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.55
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.78
3mes_A	424	Choline kinase; malaria, structural genomics, stru	89.06
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	84.88

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.1e-53  Score=412.22  Aligned_cols=248  Identities=23%  Similarity=0.363  Sum_probs=201.4

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCC--CCHHHHHHH--------------HhcccccC
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEG  214 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~  214 (453)
                      ++...+.+|.++||+|+||+||+|++.      +++.||||+++...  ...++|.+|              ++|+|.+.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            444556778899999999999999863      57899999997632  345667766              68899999


Q ss_pred             cceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL  282 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl  282 (453)
                      ...+||||||++|+|.++|.....            ....++|.+++.|+.|||+||+|||+.   +||||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            999999999999999999965321            124699999999999999999999998   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccc
Q 048517          283 DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSS  361 (453)
Q Consensus       283 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~  361 (453)
                      ++++.+||+|||+|+...........+...||+.|||||++.+.  .++.++|||||||+||||+| |+.||.....   
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---  253 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---  253 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCH---
Confidence            99999999999999876544333334566899999999999864  89999999999999999998 8999865432   


Q ss_pred             cccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          362 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       362 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                           ..+...+..+...+..      ...+..+.+++.+||+.||++||||+||++.|+..
T Consensus       254 -----~~~~~~i~~~~~~~~p------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          254 -----QDVVEMIRNRQVLPCP------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -----HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----HHHHHHHHcCCCCCCc------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                 2244555555544332      22345688999999999999999999999999863

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.3e-52  Score=408.69  Aligned_cols=243  Identities=27%  Similarity=0.433  Sum_probs=189.6

Q ss_pred             hhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .+.++||+|+||+||+|+++      +++.||||+++.... ..++|.+|              ++|+|.+....+||||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            45689999999999999864      478999999986433 34567666              6889999999999999


Q ss_pred             ecCCCChhhhhhhccC-----------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517          223 YMPNGSLDRHIFSKEN-----------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  291 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  291 (453)
                      ||++|+|.+++.....           ....++|.+++.|+.|||+||+|||+.   +|+||||||+||||++++.+||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence            9999999999965321           235699999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517          292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  370 (453)
                      |||+|+...........+...||+.|||||++.+.  .++.++|||||||+||||+| |+.||.....        ..+.
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~  270 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEAI  270 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHHH
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            99999976554443344556799999999999864  79999999999999999999 8999965432        2244


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ..+.++...+..      ..++..+.+++.+||+.||++||||+||+++|+.+.+
T Consensus       271 ~~i~~g~~~~~p------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          271 DCITQGRELERP------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHTCCCCCC------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCc------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            555555544332      2234678899999999999999999999999997654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.8e-52  Score=406.70  Aligned_cols=244  Identities=24%  Similarity=0.397  Sum_probs=197.4

Q ss_pred             hhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      .+.+.++||+|+||+||+|++.      +++.||||+++.... ..++|.+|              ++|+|.++...+||
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV   93 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   93 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            4456789999999999999863      478899999986433 34566666              68899999999999


Q ss_pred             EEecCCCChhhhhhhcc---------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517          221 YEYMPNGSLDRHIFSKE---------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  291 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  291 (453)
                      ||||++|+|.++|....         .....++|.+++.|+.|||+||+|||++   +|+||||||+|||++.++.+||+
T Consensus        94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~  170 (299)
T 4asz_A           94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG  170 (299)
T ss_dssp             EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence            99999999999996532         2345799999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517          292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  370 (453)
                      |||+|+...............||+.|||||++.+.  .++.|+|||||||+||||+| |+.||.....        ..+.
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~  240 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVI  240 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHH
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            99999876554443333445699999999999864  89999999999999999999 8999975432        2245


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      ..+.++......      ...+..+.+++.+||+.||++||||++|+++|+...
T Consensus       241 ~~i~~~~~~~~p------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          241 ECITQGRVLQRP------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCC------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            555555543322      223457889999999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=402.96  Aligned_cols=247  Identities=26%  Similarity=0.445  Sum_probs=187.4

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      ...+.++||+|+||+||+|++++  .||||+++.....   .++|.+|              ++|+|.+ ...+||||||
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~  113 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC  113 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence            34567899999999999998763  5999999764433   3456666              6777765 4589999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++|+|.++|...   ...++|.++..|+.|||+||+|||++   +||||||||+||||++++.+||+|||+|+.......
T Consensus       114 ~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          114 EGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             SSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999543   35699999999999999999999998   999999999999999999999999999987654433


Q ss_pred             ceeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          305 FVSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      ........||+.|||||++... .+.++.|+|||||||+||||+||+.||......       ..+...+..+.....  
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~~~~p~--  258 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRGYASPD--  258 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTTCCCCC--
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCCCC--
Confidence            3334566899999999999653 346899999999999999999999999643321       123333333322111  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ....+..++..+.+++.+||+.||++||||.||++.|+.+...
T Consensus       259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            1112233456788999999999999999999999998865444

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4e-50  Score=392.95  Aligned_cols=257  Identities=23%  Similarity=0.273  Sum_probs=187.2

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCc----ceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGF----KRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~----~~~lv~E~  223 (453)
                      ++.+.++||+|+||+||+|+++ |+.||||++.........+..|              ++|+|.+..    ..+|||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            3456789999999999999985 8999999997643322222223              456665432    57899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC-----CCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG-----CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      |++|+|.++|..     ..++|+.+.+++.|+++||+|||++     +.++|+||||||+||||+.++.+||+|||+|+.
T Consensus        83 ~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999953     3589999999999999999999986     246899999999999999999999999999987


Q ss_pred             cCCCCCce--eecccCCCCCccChhhhcccC----CCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccc
Q 048517          299 HPKENDFV--SISDTRGTIGYLAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYF  365 (453)
Q Consensus       299 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~  365 (453)
                      ........  ......||+.|||||++.+..    +.++.|+|||||||+||||+||+.|+.........       ...
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            65443321  123457999999999997531    24678999999999999999999887543321100       001


Q ss_pred             hHHHHHHh-hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          366 PSWVYDQL-NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       366 ~~~~~~~l-~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      .......+ .++.+..+.... ...+..+.+.+++.+||+.||++||||.||+++|+.+.+
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            11122222 222222222211 223455678999999999999999999999999987543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.2e-50  Score=399.15  Aligned_cols=248  Identities=27%  Similarity=0.426  Sum_probs=200.1

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH---------------Hhccccc-Cc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSE-GF  215 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~-~~  215 (453)
                      ...+.+.++||+|+||+||+|+..      .++.||||++......  .++|++|               ++|+|.+ +.
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            445677899999999999999854      2468999999864432  2345555               5677755 45


Q ss_pred             ceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517          216 KRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD  283 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~  283 (453)
                      ..++|||||++|+|.++|.....            ....++|.++..++.|||+||+|||++   +||||||||+|||++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence            68999999999999999965432            135689999999999999999999998   999999999999999


Q ss_pred             CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccc
Q 048517          284 HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSK  362 (453)
Q Consensus       284 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~  362 (453)
                      +++.+||+|||+|+....+......+...||+.|||||++.+.  .++.++|||||||+||||+| |+.||.....    
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~----  293 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----  293 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCH----
Confidence            9999999999999987666555555667899999999999874  89999999999999999998 8999965332    


Q ss_pred             ccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                         ...+...+.++.......      ..+..+.+++.+||+.||++|||++||++.|+..++
T Consensus       294 ---~~~~~~~i~~g~~~~~p~------~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          294 ---DEEFCRRLKEGTRMRAPD------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             ---SHHHHHHHHHTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHcCCCCCCCc------cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence               223555666665544322      234568899999999999999999999999987553

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.6e-49  Score=389.29  Aligned_cols=254  Identities=22%  Similarity=0.240  Sum_probs=198.1

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHH----------HHHHHhcccccCcceEEEEEecCCCChhh
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE----------FINELLGLCSEGFKRALVYEYMPNGSLDR  231 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~----------~i~el~g~~~~~~~~~lv~E~~~~gsL~~  231 (453)
                      +.+.++||+|+||.||+|+. .+|+.||||+++......++          ++.++++++.++...+||||||++|+|.+
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~  139 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ  139 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence            34557899999999999995 47999999999875544332          22337788888889999999999999999


Q ss_pred             hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccCCCCCc---ee
Q 048517          232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDF---VS  307 (453)
Q Consensus       232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~~~---~~  307 (453)
                      +|...    ..+++..+..++.||+.||+|||++   +|+||||||+||||+.++ .+||+|||+|+....+...   ..
T Consensus       140 ~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          140 LIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             HHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             HHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence            99532    4699999999999999999999998   999999999999999987 6999999999976543221   11


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      .....||+.|||||++.+.  .++.++||||+||++|||++|+.||.......        +...+...... .   ...
T Consensus       213 ~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~~-~---~~~  278 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--------LCLKIASEPPP-I---REI  278 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--------CHHHHHHSCCG-G---GGS
T ss_pred             CCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHHcCCCC-c---hhc
Confidence            2335799999999999874  78999999999999999999999997543221        11222222211 1   112


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCCCCC
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSS  437 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~~~~  437 (453)
                      +..++..+.+++.+||+.||++|||+.|+++.|...+.++..-..|++..
T Consensus       279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~  328 (336)
T 4g3f_A          279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE  328 (336)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence            23455678899999999999999999999999988877776667777643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.9e-48  Score=380.52  Aligned_cols=233  Identities=25%  Similarity=0.312  Sum_probs=187.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .|.+.++||+|+||+||+|+.. +|+.||||++..... ..+.+.+|              +++++......+||||||+
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  154 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  154 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            3566789999999999999964 799999999975332 23333333              6777888889999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++..     ..+++.++..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+....... 
T Consensus       155 gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          155 GGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            9999998842     3589999999999999999999998   999999999999999999999999999997754432 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                       ......||+.|||||++.+.  .++.++||||+||++|||++|+.||......        .+...+.......+.   
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~~~~~---  291 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNLPPRLK---  291 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSSCCCCS---
T ss_pred             -cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCCCCCCC---
Confidence             23556899999999999764  7899999999999999999999999653321        133344433222221   


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       ....++..+.+++.+||+.||++|||+.|+++
T Consensus       292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             12234567889999999999999999999976

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9e-48  Score=372.73  Aligned_cols=231  Identities=24%  Similarity=0.360  Sum_probs=179.2

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------Hhccccc----CcceEEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSE----GFKRALVY  221 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~----~~~~~lv~  221 (453)
                      .|.++||+|+||+||+|... +++.||||++......   .++|.+|              +++++..    ....+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999954 7899999999764333   3445555              4454432    34578999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHP  300 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~  300 (453)
                      |||++|+|.+++...    ..+++..+..++.||+.||+|||++ .++|+||||||+||||+. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999532    5689999999999999999999997 123999999999999984 7999999999998654


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ...    .....||+.|||||++.+   .++.++|||||||++|||+||+.||.....       ...+...+..+....
T Consensus       184 ~~~----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i~~~~~~~  249 (290)
T 3fpq_A          184 ASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPA  249 (290)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCCG
T ss_pred             CCc----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHHHcCCCCC
Confidence            332    245679999999999864   689999999999999999999999964321       112344444432211


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       250 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 112223356889999999999999999999976

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.5e-48  Score=381.23  Aligned_cols=234  Identities=24%  Similarity=0.321  Sum_probs=182.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      .|.+.++||+|+||+||+|+. .+|+.||||++.......   +++.+|              +++++.+....+|||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            466778999999999999995 579999999998754432   345555              56777888889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      |++|+|.++|...  ....+++.+++.|+.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+......
T Consensus       105 ~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          105 CEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999998543  335678899999999999999999998   99999999999999999999999999998764322


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  ..+...||+.|||||++.+.  .++.++||||+||+||||++|+.||......        .+...+..+.....  
T Consensus       180 ~--~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~~~~--  245 (350)
T 4b9d_A          180 E--LARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMK--------NLVLKIISGSFPPV--  245 (350)
T ss_dssp             H--HHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCCC--
T ss_pred             c--cccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCCCCCC--
Confidence            1  12345799999999999874  7899999999999999999999999754321        13333333332221  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          +..++..+.+++.+||+.||++|||+.|+++
T Consensus       246 ----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 ----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                1224567889999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.8e-47  Score=371.61  Aligned_cols=232  Identities=23%  Similarity=0.316  Sum_probs=188.8

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||+||+|+. .+|+.||||++.+.    ....+.+.+|              +++++.+....++|||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            367889999999999999995 57999999999752    2234445555              5667778888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus       113 y~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          113 YAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             cCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999998532    5699999999999999999999998   9999999999999999999999999999987654


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..........||+.|||||++.+.  .++.++||||+||++|||++|+.||...+..        .+...+.++.. .. 
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~-~~-  253 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEG--------LIFAKIIKLEY-DF-  253 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCC-CC-
T ss_pred             CCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC-CC-
Confidence            433344567899999999999875  7899999999999999999999999754321        13334433322 11 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  417 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl  417 (453)
                           +..++..+.+++.+||+.||++|||++|++
T Consensus       254 -----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 -----PEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                 122446688999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=381.28  Aligned_cols=232  Identities=25%  Similarity=0.325  Sum_probs=187.3

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      |.+.++||+|+||.||+|+.. +|+.||||++..... ..+.+.+|              +++++......+||||||++
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            566789999999999999954 799999999976433 23334444              57778888899999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++..     ..+++.++..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.......  
T Consensus       233 G~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          233 GALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             EEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             CcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            999998842     3589999999999999999999998   999999999999999999999999999997654432  


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|||||++.+.  .++.++||||+||++|||++|+.||......        .+...+.......+..   
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~~~~~~---  369 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNLPPRLKN---  369 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCCSC---
T ss_pred             cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCCCCCCcc---
Confidence            23456799999999999764  7899999999999999999999999653321        1333444332222211   


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       ...++..+.+++.+||+.||++|||+.|+++
T Consensus       370 -~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1224467889999999999999999999976

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3e-46  Score=359.15  Aligned_cols=234  Identities=23%  Similarity=0.348  Sum_probs=174.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.++||+|+||+||+|+. .+|+.||||++.+...    ..+.+.+|              +++++......++|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            577889999999999999994 5799999999976432    23345555              5667778888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+ +|+|.+++..    ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        94 y~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           94 YA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             CC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             CC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            99 7899998843    25699999999999999999999998   9999999999999999999999999999876443


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .   ......||+.|||||++.+. +..+.++||||+||++|||++|+.||.....        ..+.+.+..+... + 
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~~~~-~-  231 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNGVYT-L-  231 (275)
T ss_dssp             ------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCC-C-
T ss_pred             C---ccCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCC-C-
Confidence            3   22456799999999999864 2346899999999999999999999965321        1133344443221 1 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  422 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~  422 (453)
                           +..++..+.+++.+||+.||++|||++|+++  .++.
T Consensus       232 -----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          232 -----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                 1224466889999999999999999999987  4543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.5e-46  Score=363.54  Aligned_cols=231  Identities=23%  Similarity=0.282  Sum_probs=179.9

Q ss_pred             hhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      .|++.++||+|+||+||+|+..    +++.||||+++....   ...++.+|              +++++.+....++|
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv  104 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI  104 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            5788899999999999999852    578999999875321   12233333              67778888899999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++...    ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus       105 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          105 LDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             ECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999998532    4699999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ....  ......||+.|||||++.+.  .++.++||||+||++|||++|+.||......        .+...+.++... 
T Consensus       178 ~~~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~~-  244 (304)
T 3ubd_A          178 DHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--------ETMTMILKAKLG-  244 (304)
T ss_dssp             ---C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC-
T ss_pred             CCCc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHH--------HHHHHHHcCCCC-
Confidence            3322  22456799999999999864  7899999999999999999999999754321        133333333221 


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~  418 (453)
                      .      +..++..+.+++.+||+.||++|||+     +|+++
T Consensus       245 ~------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 M------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            1      12245678899999999999999984     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.8e-45  Score=353.72  Aligned_cols=248  Identities=21%  Similarity=0.280  Sum_probs=167.0

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccC-----------
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEG-----------  214 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~-----------  214 (453)
                      |++.+.||+|+||+||+|+. .+|+.||||++.....  ..+.+.+|              +++.+.+.           
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            56678999999999999995 4799999999876432  23455555              23333221           


Q ss_pred             -cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEec
Q 048517          215 -FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  293 (453)
Q Consensus       215 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF  293 (453)
                       ...++||||+++|+|.+++.... ......+..++.|+.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence             23689999999999999985432 223456677889999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCCCce----------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc
Q 048517          294 GLAKFHPKENDFV----------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA  363 (453)
Q Consensus       294 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~  363 (453)
                      |+|+.........          ..+...||+.|||||++.+.  .++.++|||||||++|||++   ||....+.    
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~~----  233 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQMER----  233 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHHH----
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccHH----
Confidence            9998765432211          12345699999999999864  78999999999999999996   66422110    


Q ss_pred             cchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCC
Q 048517          364 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPF  434 (453)
Q Consensus       364 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~  434 (453)
                         ......+.....      ............+++.+||+.||++|||+.|+++.  .-+++++.|.++.
T Consensus       234 ---~~~~~~~~~~~~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h--~~~~~~~~p~~~~  293 (299)
T 4g31_A          234 ---VRTLTDVRNLKF------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN--AVFEDLDFPGKTV  293 (299)
T ss_dssp             ---HHHHHHHHTTCC------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGCCC-------
T ss_pred             ---HHHHHHHhcCCC------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhCCCCCCCchH
Confidence               001112222111      11223334556789999999999999999999872  1223445554443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=351.78  Aligned_cols=244  Identities=20%  Similarity=0.241  Sum_probs=178.7

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH---HHHHHH--------------Hhcccc------cCcce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCS------EGFKR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~------~~~~~  217 (453)
                      .|.+.++||+|+||+||+|+. .+|+.||||++.......   +.+++|              +++++.      +....
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            467788999999999999995 479999999997654332   334445              333332      34568


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      +||||||+ |+|.+++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus       135 ~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence            99999995 78988884    346799999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCC--ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh--
Q 048517          298 FHPKEND--FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL--  373 (453)
Q Consensus       298 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l--  373 (453)
                      .......  ........||+.|||||++.+. ..++.++||||+||++|||++|+.||........    -..+....  
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~----l~~I~~~~g~  281 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ----LQLIMMVLGT  281 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH----HHHHHHHHCC
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH----HHHHHHhcCC
Confidence            6643211  1123456899999999998764 3578999999999999999999999975432110    00011100  


Q ss_pred             ------------------hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          374 ------------------NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       374 ------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                        ..................+..+.+++.+||+.||++|||+.|+++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                              000000000000011123456889999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.9e-42  Score=346.30  Aligned_cols=185  Identities=21%  Similarity=0.321  Sum_probs=149.1

Q ss_pred             HhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCCHHHHHHH---------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFSAEEFINE---------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~~~~~~lv~  221 (453)
                      ..|.+.++||+|+||+||+|+.+    +++.||||++..... ..+..+|               ++.++......++||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            35777899999999999999843    578999999876432 2333333               445566777889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCccccC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHP  300 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~  300 (453)
                      ||+++|+|.+++       ..+++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus       100 E~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A          100 PYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             ECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             eCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            999999999988       3589999999999999999999998   99999999999999877 799999999998654


Q ss_pred             CCCC--------------------------ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 048517          301 KEND--------------------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  354 (453)
Q Consensus       301 ~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~  354 (453)
                      ....                          ....+...||+.|||||++.+. ..++.++||||+||+++||++|+.||.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            3211                          0112345699999999999764 358899999999999999999999996


Q ss_pred             CCc
Q 048517          355 MNA  357 (453)
Q Consensus       355 ~~~  357 (453)
                      ...
T Consensus       249 ~~~  251 (361)
T 4f9c_A          249 KAS  251 (361)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-41  Score=334.01  Aligned_cols=258  Identities=35%  Similarity=0.601  Sum_probs=201.2

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .|.+.+.||+|+||.||+|+.++|+.||||++...... .+++.+|              +++++......++||||+++
T Consensus        40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  119 (321)
T 2qkw_B           40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN  119 (321)
T ss_dssp             CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred             ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence            34556789999999999999888999999998764433 3455555              56677778889999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++.........++|.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  196 (321)
T 2qkw_B          120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH  196 (321)
T ss_dssp             CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred             CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            999999865544445799999999999999999999998   99999999999999999999999999998654332222


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc---cc
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL---RN  383 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~---~~  383 (453)
                      ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||....... ......|.......+.....   ..
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  273 (321)
T 2qkw_B          197 LSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQLEQIVDPNL  273 (321)
T ss_dssp             CBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred             cccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhccccccHHHhcChhh
Confidence            22345689999999999764  78999999999999999999999997554332 22233343333322221111   11


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ...........+.+++.+||+.||++|||+.++++.|+..+.
T Consensus       274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            112345677889999999999999999999999999997654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.9e-42  Score=337.33  Aligned_cols=267  Identities=37%  Similarity=0.622  Sum_probs=204.9

Q ss_pred             cchhHHHHHhh--hhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccC
Q 048517          153 ILLPEIIAVTN--HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEG  214 (453)
Q Consensus       153 ~~~~~~~~~~~--~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~  214 (453)
                      +...++...+.  .+.+.||+|+||.||+|+..+|+.||||++.....  ...++..|              +++++...
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   99 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP   99 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence            44455555544  44578999999999999988899999999876432  12234444              56777788


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...++||||+++|+|.+++.........++|..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  179 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG  179 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred             CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence            88899999999999999997655555679999999999999999999999877799999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccc-cccccchHHHHHHh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR-SSKAYFPSWVYDQL  373 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~l  373 (453)
                      +++........ ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...... ........|+...+
T Consensus       180 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          180 LAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             SCEECCSSSSC-EECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cccccCccccc-ccccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            99876544332 23455699999999999764  6899999999999999999999999643211 12233333433333


Q ss_pred             hhCCCcccc---chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          374 NKGGDLELR---NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       374 ~~~~~~~~~---~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      .........   ............+.+++.+||+.||++|||+++|+++|++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            222211111   1112345667889999999999999999999999999997

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2e-41  Score=358.44  Aligned_cols=232  Identities=24%  Similarity=0.323  Sum_probs=180.4

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHH-----------------HHhcccccCcceEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFIN-----------------ELLGLCSEGFKRALV  220 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~-----------------el~g~~~~~~~~~lv  220 (453)
                      |.+.+.||+|+||.||+|+.. +|+.||||++.+.    .........                 .+++.+.+....++|
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV  270 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI  270 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence            445678999999999999954 7999999999752    111111111                 145566778889999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||++||+|.++|...    ..+++..+..++.||+.||+|||++   +||||||||+||||+.++++||+|||+|+...
T Consensus       271 mEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          271 LDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             ECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999532    5699999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ...    .....||+.|||||++.+. ..++.++||||+||++|||++|+.||........     ..+......... .
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~~~~~-~  412 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMAV-E  412 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHHHCCC-C
T ss_pred             CCC----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhcCCCC-C
Confidence            443    2456899999999999642 3689999999999999999999999975432210     112222222221 1


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                            .+..++..+.+++.+||+.||++|++     ++||.+
T Consensus       413 ------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          413 ------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                  12234567889999999999999998     677764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4e-41  Score=331.55  Aligned_cols=257  Identities=25%  Similarity=0.288  Sum_probs=189.9

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccC----cceEEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEG----FKRALVYE  222 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~----~~~~lv~E  222 (453)
                      ..+.+.++||+|+||+||+|+.. ++.||||++.........+..|              +++++...    ...++|||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            35567789999999999999876 8999999997654444444444              34444432    23689999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC-------CCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG-------CDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      |+++|+|.+++..     ..++|..++.++.|++.||+|||+.       +..+|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          103 FHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            9999999999843     3489999999999999999999985       234899999999999999999999999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccC---CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc---------
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA---------  363 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~---------  363 (453)
                      ++...............||+.|+|||++.+..   ..++.++|||||||++|||++|+.||..........         
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            98766544333334567999999999987521   245678999999999999999999997644322111         


Q ss_pred             cchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          364 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       364 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      ....+............+.... ........+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          258 SLEDMQEVVVHKKKRPVLRDYW-QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhhhhhhhhcccCCCCccccc-cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111111111111222111111 22234567999999999999999999999999998643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.3e-41  Score=357.99  Aligned_cols=235  Identities=20%  Similarity=0.271  Sum_probs=187.2

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH-HHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA-EEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~-~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .|.+.++||+|+||.||+|+. .+|+.||||++....... +.+.+|              +++++.+....++|||||+
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~  237 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  237 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence            567889999999999999995 479999999997654332 333333              5667778888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC--CceEEEecCCccccCCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN--FIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~--~~~kl~DFGla~~~~~~~  303 (453)
                      +|+|.++|..   ....+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+......
T Consensus       238 gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          238 GGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            9999998842   235699999999999999999999998   99999999999999854  899999999999875543


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   .....||+.|||||++.+.  .++.++||||+||++|||++|+.||......        .....+...... .  
T Consensus       312 ~---~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~i~~~~~~-~--  375 (573)
T 3uto_A          312 S---VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDWN-M--  375 (573)
T ss_dssp             E---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCCC-C--
T ss_pred             c---eeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHhCCCC-C--
Confidence            2   3456799999999999875  7899999999999999999999999754321        123333332211 1  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .......++..+.+|+.+||+.||++|||+.|+++
T Consensus       376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01122234567889999999999999999999987

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1e-40  Score=335.27  Aligned_cols=246  Identities=23%  Similarity=0.397  Sum_probs=193.0

Q ss_pred             HhhhhhcccCccCceEEEEEEEc--------CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCc
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGF  215 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~--------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~  215 (453)
                      ..+.+.+.||+|+||.||+|+..        ++..||||+++.....  .+++..|               +++++....
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            45667789999999999999852        4568999999764321  2334444               456677788


Q ss_pred             ceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517          216 KRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD  283 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~  283 (453)
                      ..++||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+.   +|+||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence            89999999999999999865432            124589999999999999999999998   999999999999999


Q ss_pred             CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccc
Q 048517          284 HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSK  362 (453)
Q Consensus       284 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~  362 (453)
                      .++.+||+|||+++...............+|+.|+|||++.+.  .++.++|||||||++|||++ |+.||......   
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---  312 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  312 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            9999999999999876554433333455678999999999764  78999999999999999999 99998654321   


Q ss_pred             ccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                           .+...+..+......      ..++..+.+++.+||+.+|++|||+.|+++.|+.++.
T Consensus       313 -----~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          313 -----ELFKLLKEGHRMDKP------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             -----GHHHHHHTTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 133344444332221      1234568899999999999999999999999997653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-40  Score=327.13  Aligned_cols=249  Identities=29%  Similarity=0.475  Sum_probs=182.5

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      ...+.+.++||+|+||+||+|+. +|+.||||++.......   +++.+|              +++++......++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            34566778999999999999987 48899999997754433   234444              5667777888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc--eeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.+||+|||+++...
T Consensus       115 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          115 YLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             CCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             cCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            999999999985321 123489999999999999999999998   7  9999999999999999999999999998654


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh-hCCCc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN-KGGDL  379 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~-~~~~~  379 (453)
                      ....  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......        .....+. .....
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~~~~  258 (309)
T 3p86_A          191 STFL--SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPA--------QVVAAVGFKCKRL  258 (309)
T ss_dssp             -------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHHHSCCCC
T ss_pred             cccc--ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCCCC
Confidence            3321  22456799999999999864  6899999999999999999999999654321        1122221 22222


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP  431 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~  431 (453)
                      ..      +..++..+.+++.+||+.+|++|||+.++++.|+..++....||
T Consensus       259 ~~------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          259 EI------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             CC------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence            21      12234568899999999999999999999999999888755444

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.3e-40  Score=316.68  Aligned_cols=244  Identities=26%  Similarity=0.436  Sum_probs=196.8

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ...+.+.++||+|+||.||+|+.++++.||||++.......+++.+|              +++++......++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            34567788999999999999999988899999998877666766665              5667777888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        87 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           87 NGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            99999998543   24689999999999999999999998   9999999999999999999999999999876554322


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                       ......+|+.|+|||.+.+.  .++.++||||+|++++||++ |+.||......        .....+..+......  
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--  227 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHRLYRP--  227 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCC--
T ss_pred             -cccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCCCCCC--
Confidence             23455678889999999764  68899999999999999999 99998654321        122233333222211  


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                          ...+..+.+++.+||+.+|++|||+.++++.|+...+.
T Consensus       228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                11235688999999999999999999999999986553

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.2e-40  Score=318.19  Aligned_cols=248  Identities=22%  Similarity=0.288  Sum_probs=182.2

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH----------------Hhcccc----cCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE----------------LLGLCS----EGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e----------------l~g~~~----~~~~~~lv  220 (453)
                      ..+.+.++||+|+||+||+|+. +|+.||||++.....  ..+..|                +++++.    .....++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv   84 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI   84 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH--HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc--hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence            3566778999999999999987 589999999876432  222222                223221    23457899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhH--------cCCCCceeecccCCcceEEcCCCceEEEe
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH--------NGCDVCILHFDIKPHNILLDHNFIPKVSD  292 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dikp~NILl~~~~~~kl~D  292 (453)
                      |||+++|+|.+++.     ...+++..++.++.|++.||+|||        +.   +|+||||||+|||++.++.+||+|
T Consensus        85 ~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           85 THYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             ECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred             hhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence            99999999999983     246999999999999999999999        66   999999999999999999999999


Q ss_pred             cCCccccCCCCCcee--ecccCCCCCccChhhhcccCC----CCCccchHHHHHHHHHHHHcC----------CCCCCCC
Q 048517          293 FGLAKFHPKENDFVS--ISDTRGTIGYLAPELISRNFG----TVSCKSDVYGFGMVLLEMAGG----------RRNSNMN  356 (453)
Q Consensus       293 FGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~----~~s~k~DV~S~Gvvl~elltg----------~~p~~~~  356 (453)
                      ||+++..........  .....||+.|+|||.+.+...    .++.++||||||+++|||++|          +.||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            999986654332211  233479999999999975311    345799999999999999999          7777543


Q ss_pred             ccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          357 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       357 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      ....  ..................... ..........+.+++.+||+.||++|||+.++++.|++
T Consensus       237 ~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          237 VPND--PSFEDMRKVVCVDQQRPNIPN-RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             SCSS--CCHHHHHHHHTTSCCCCCCCG-GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCC--cchhhhhHHHhccCCCCCCCh-hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            2211  111111111111222222211 11344567789999999999999999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-40  Score=317.04  Aligned_cols=241  Identities=28%  Similarity=0.492  Sum_probs=194.6

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      .+.+.++||+|+||.||+|+..+++.||||++.......+++.+|              +++++.+....++||||+++|
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   90 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             hceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence            466778999999999999998889999999999877777777666              466777778899999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.+++..   ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus        91 ~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  163 (269)
T 4hcu_A           91 CLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  163 (269)
T ss_dssp             BHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred             cHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc-cc
Confidence            99999843   235689999999999999999999998   999999999999999999999999999986644321 12


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      .....+|+.|+|||.+...  .++.++||||+|++++||++ |+.||......        .....+..+......    
T Consensus       164 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----  229 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKP----  229 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCCCC----
T ss_pred             ccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhcCccCCCC----
Confidence            2345678889999999764  78999999999999999999 89998653321        133333333222211    


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                        ...+..+.+++.+||+.+|++|||++++++.|+...+
T Consensus       230 --~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          230 --RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence              1124568899999999999999999999999987543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.1e-40  Score=318.78  Aligned_cols=261  Identities=34%  Similarity=0.549  Sum_probs=200.9

Q ss_pred             cccchhHHHHHhhhhh--------cccCccCceEEEEEEEcCCcEEEEEEecCCC-----CCHHHHHHH-----------
Q 048517          151 DNILLPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGRLIAVKMMENSK-----FSAEEFINE-----------  206 (453)
Q Consensus       151 ~~~~~~~~~~~~~~~~--------~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~-----~~~~~~i~e-----------  206 (453)
                      ..+...++..++.+|.        ++||+|+||.||+|+. +++.||||++....     ...+.+.+|           
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            4567778999998887        4599999999999986 58899999987532     112344444           


Q ss_pred             ---HhcccccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517          207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD  283 (453)
Q Consensus       207 ---l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~  283 (453)
                         +++++......++||||+++|+|.+++.... ....++|..++.++.|++.||+|||+.   +|+|+||||+||+++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence               5667777888999999999999999885432 235699999999999999999999998   999999999999999


Q ss_pred             CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc
Q 048517          284 HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA  363 (453)
Q Consensus       284 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~  363 (453)
                      .++.+||+|||+++...............||+.|+|||.+.+   .++.++||||||+++|||++|+.||.......   
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---  241 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ---  241 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS---
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchH---
Confidence            999999999999987655433333345579999999998864   57889999999999999999999997654322   


Q ss_pred             cchHHHHHHhhhCCC-cc---ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          364 YFPSWVYDQLNKGGD-LE---LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       364 ~~~~~~~~~l~~~~~-~~---~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      .+..+ .+.+..... ..   ..............+.+++.+||+.+|++|||+.+++++|+.+
T Consensus       242 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          242 LLLDI-KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             BTTHH-HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHH-HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11121 122211110 00   0001112345667899999999999999999999999999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.8e-40  Score=343.68  Aligned_cols=248  Identities=28%  Similarity=0.432  Sum_probs=201.1

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEE
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ++....+.+.++||+|+||.||+|+.. +++.||||+++......+++.+|              ++++|......++||
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            334455677789999999999999976 48899999998877677777776              577888888899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       296 E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          296 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            999999999998542  235689999999999999999999998   999999999999999999999999999997654


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      .. ........+|+.|+|||++...  .++.++||||||+++|||++ |+.|+......        .+.+.+..+....
T Consensus       371 ~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  439 (495)
T 1opk_A          371 DT-YTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDYRME  439 (495)
T ss_dssp             CC-EECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTTCCCC
T ss_pred             Cc-eeecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            32 2222345578899999999764  78999999999999999999 88888654321        1344444443332


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ..      ..++..+.+++.+||+.||++|||+.+++++|+....+
T Consensus       440 ~~------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          440 RP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CC------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            21      22345688999999999999999999999999987654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.4e-41  Score=344.58  Aligned_cols=248  Identities=26%  Similarity=0.410  Sum_probs=197.8

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      ++....+.+.++||+|+||.||+|..++++.||||+++......+++++|              +++++. ....++|||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            33445567778999999999999999889999999998877777788777              455554 456899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       263 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             CCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             ecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            999999999985332  23688999999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      .. .......+|+.|+|||++...  .++.++||||||+++|||++ |+.||.....        ..+...+..+.....
T Consensus       338 ~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~  406 (454)
T 1qcf_A          338 EY-TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERGYRMPR  406 (454)
T ss_dssp             HH-HTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHHTCCCCC
T ss_pred             ce-eccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence            21 112334578899999999753  78999999999999999999 9999864332        123344444433222


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCC
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  427 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~  427 (453)
                      .      ...+..+.+++.+||+.||++|||+++|+++|+......
T Consensus       407 ~------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          407 P------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             C------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             C------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            1      223457889999999999999999999999999876643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=326.69  Aligned_cols=248  Identities=29%  Similarity=0.439  Sum_probs=191.7

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcce
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKR  217 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~  217 (453)
                      +....+.+.+.||+|+||.||+|+..    .+..||||++.....  ..+++..|              +++++..+...
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            34456677889999999999999964    455699999986432  23345555              56677778888


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       126 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            999999999999999843   235699999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhh
Q 048517          298 FHPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       298 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      ........ .......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .+...+..
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~  269 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVISSVEE  269 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHT
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHc
Confidence            77543322 122344578899999999764  78999999999999999999 99998654321        13333443


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCC
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  427 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~  427 (453)
                      +......      ..++..+.+++.+||+.||++|||+.+++++|+..+...
T Consensus       270 ~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          270 GYRLPAP------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             TCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             CCCCCCC------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            3322211      123457889999999999999999999999999876653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=332.62  Aligned_cols=260  Identities=23%  Similarity=0.376  Sum_probs=199.9

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc--------CCcEEEEEEecCCCCC--HHHHHHH---------------Hhccc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLC  211 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~--------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~  211 (453)
                      ++....+.+.++||+|+||+||+|+..        +++.||||++......  .+++.+|               +++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            334456777899999999999999852        3468999999764322  2334343               46677


Q ss_pred             ccCcceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcc
Q 048517          212 SEGFKRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHN  279 (453)
Q Consensus       212 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N  279 (453)
                      ......++||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+.   +|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            788889999999999999999965432            124689999999999999999999998   99999999999


Q ss_pred             eEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcc
Q 048517          280 ILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAT  358 (453)
Q Consensus       280 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~  358 (453)
                      ||++.++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||++++||++ |+.|+.....
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999876554433334556788999999999764  78999999999999999999 9999864332


Q ss_pred             ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCCC
Q 048517          359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFF  435 (453)
Q Consensus       359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~~  435 (453)
                              ..+.+.+..+......      ...+..+.+++.+||+.+|++|||+.++++.|+.++......+.+..
T Consensus       300 --------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~  362 (382)
T 3tt0_A          300 --------EELFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY  362 (382)
T ss_dssp             --------HHHHHHHHTTCCCCCC------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred             --------HHHHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence                    1233444444332221      12345688999999999999999999999999988766554444443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.8e-40  Score=342.25  Aligned_cols=248  Identities=28%  Similarity=0.415  Sum_probs=193.2

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +....+.+.++||+|+||.||+|..+++..||||+++......+++.+|              +++++.+ ...++||||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            3445566778999999999999999888899999998876667777776              4566655 568999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...  .+..+++.+++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            9999999998532  224589999999999999999999998   99999999999999999999999999998765432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      . .......+|+.|+|||.+...  .++.++||||||+++|||++ |+.||.....        ..+.+.+..+......
T Consensus       335 ~-~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~  403 (452)
T 1fmk_A          335 Y-TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCP  403 (452)
T ss_dssp             ---------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC
T ss_pred             e-ecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence            2 122345578899999999764  78999999999999999999 8999864332        1234444444333221


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                            ..++..+.+++.+||+.||++|||+++++++|+.......
T Consensus       404 ------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          404 ------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence                  2234578899999999999999999999999998776544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=318.61  Aligned_cols=233  Identities=24%  Similarity=0.292  Sum_probs=182.9

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHH---HHHHH---------------HhcccccCcce
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAE---EFINE---------------LLGLCSEGFKR  217 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~---~~i~e---------------l~g~~~~~~~~  217 (453)
                      ++....+.+.++||+|+||+||+|+.. +|+.||||++........   +++.|               +++++.++...
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            555667788899999999999999965 799999999876443332   22222               56677788889


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||+ +++|.+++...   ...++|..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             EEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeee
Confidence            9999999 77998888543   35699999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ......   ......||++|+|||++.+   .++.++||||||+++|||++|+.++....           ....+..+.
T Consensus       206 ~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~~~~~  268 (311)
T 3p1a_A          206 ELGTAG---AGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQLRQGY  268 (311)
T ss_dssp             ECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHHHTTTC
T ss_pred             ecccCC---CCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHhccC
Confidence            764432   2244569999999998864   68899999999999999999977664321           122232221


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..     ......++..+.+++.+||+.||++|||+.|+++
T Consensus       269 ~~-----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          269 LP-----PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CC-----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11     1123345577999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.8e-40  Score=316.45  Aligned_cols=243  Identities=26%  Similarity=0.435  Sum_probs=193.0

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ...+.+.++||+|+||.||+|+..+++.||||++.......+++.+|              +++++......++||||++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            34566778999999999999999989999999999877777777666              4667777888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++...   ...+++.+++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       103 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          103 NGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             TCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            99999998542   24699999999999999999999998   999999999999999999999999999986644321 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                      .......+|+.|+|||.+...  .++.++||||+|+++|||++ |+.||......        .....+.++......  
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--  243 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLYRP--  243 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCC--
T ss_pred             ccccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhcccCCCCC--
Confidence            122345578889999999864  78999999999999999998 99998654321        133334433222211  


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                          ...+..+.+++.+||+.+|++|||+.++++.|+..++
T Consensus       244 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          244 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence                1123568899999999999999999999999987543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-39  Score=316.33  Aligned_cols=260  Identities=17%  Similarity=0.249  Sum_probs=194.1

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHH---H---------HhcccccCcceEEEEEecC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFIN---E---------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~---e---------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ..|.+.+.||+|+||.||+|+. .+|+.||||++.....  ...+.+.   .         +++++......++||||+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            3566778999999999999995 5799999999865322  1111111   1         345566777889999999 


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc-----eEEEecCCccccC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-----PKVSDFGLAKFHP  300 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~-----~kl~DFGla~~~~  300 (453)
                      +++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||+++...
T Consensus        89 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           89 GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99999998543   34699999999999999999999998   9999999999999987765     9999999998765


Q ss_pred             CCCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          301 KENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       301 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      .....     .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.........     .....+..
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~  235 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYERIGE  235 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHHHHHH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-----HHHHHHHh
Confidence            43221     122455799999999998764  6899999999999999999999999764322211     11111111


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCCCC
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFS  436 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~~~  436 (453)
                      .....  ........++..+.+++.+||+.||++|||++++++.|+..++.+.......++
T Consensus       236 ~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~d  294 (298)
T 1csn_A          236 KKQST--PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD  294 (298)
T ss_dssp             HHHHS--CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred             hccCc--cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccc
Confidence            10000  001111234567899999999999999999999999999988776655444443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.1e-40  Score=319.10  Aligned_cols=233  Identities=26%  Similarity=0.360  Sum_probs=184.3

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .|.+.++||+|+||+||+|.. .+|+.||||++..... ..+.+.+|              +++++..+...++||||++
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  100 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence            466778999999999999994 5799999999876433 34444444              4666777788999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       101 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A          101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             TCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            9999998843     3589999999999999999999998   999999999999999999999999999987654432 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                       ......||+.|+|||.+.+.  .++.++||||+|+++|||++|+.||......       .......... .....   
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~-~~~~~---  237 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNG-TPELQ---  237 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHC-SCCCS---
T ss_pred             -ccCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-CCCCC---
Confidence             22456799999999999764  7899999999999999999999999654321       1111111111 11111   


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       .+..++..+.+++.+||+.||++|||+.|+++
T Consensus       238 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 -NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             12234566889999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.4e-40  Score=332.29  Aligned_cols=241  Identities=24%  Similarity=0.414  Sum_probs=188.8

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..+.+.++||+|+||.||+|+.. +++.||||++......  .+++..|              +++++......++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            45567789999999999999976 7999999998754211  1123333              57788888889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...   +..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       194 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          194 VQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999998543   24689999999999999999999998   99999999999999999999999999998654332


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .........+|+.|+|||.+...  .++.++||||||+++|||++ |+.|+.....        ..+.+.+..+......
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  337 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKGGRLPCP  337 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTTCCCCCC
T ss_pred             eeecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence            11111223457789999999753  78999999999999999998 9998865432        1234444444433322


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      .      ..+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       338 ~------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          338 E------LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             T------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            1      2345688999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.2e-39  Score=317.16  Aligned_cols=231  Identities=24%  Similarity=0.333  Sum_probs=184.1

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      .+.++||+|+||.||+|+.. +|+.||||++..... ..+.+.+|              +++++......++||||+++|
T Consensus        48 ~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  127 (321)
T 2c30_A           48 DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG  127 (321)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred             hccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCC
Confidence            34568999999999999976 799999999976433 34555555              456667777889999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.+++.     ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus       128 ~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  197 (321)
T 2c30_A          128 ALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  197 (321)
T ss_dssp             BHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence            9999873     24689999999999999999999998   999999999999999999999999999987654322  2


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....        ......+.........    .
T Consensus       198 ~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~----~  263 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMKRLRDSPPPKLK----N  263 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSSCCCCT----T
T ss_pred             cccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCCCCcC----c
Confidence            2456799999999999764  789999999999999999999999965432        1123333333222211    1


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...++..+.+++.+||+.||++|||+.++++
T Consensus       264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          264 SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1223456889999999999999999999987

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9e-40  Score=323.60  Aligned_cols=249  Identities=26%  Similarity=0.409  Sum_probs=192.2

Q ss_pred             HhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ..+.+.+.||+|+||.||+|+..      +++.||||++......  .+++.+|              +++++......+
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            34566789999999999999964      3589999999764322  2344444              567777888899


Q ss_pred             EEEEecCCCChhhhhhhccCC--------------------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCc
Q 048517          219 LVYEYMPNGSLDRHIFSKENK--------------------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH  278 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~  278 (453)
                      +||||+++|+|.+++......                    ...+++.+++.++.|+++||.|||+.   +|+||||||+
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~  203 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR  203 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcc
Confidence            999999999999998653211                    25789999999999999999999998   9999999999


Q ss_pred             ceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCc
Q 048517          279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNA  357 (453)
Q Consensus       279 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~  357 (453)
                      |||++.++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||....
T Consensus       204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            999999999999999999876443322233455689999999998764  78999999999999999999 999986433


Q ss_pred             cccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          358 TRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       358 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      .        ..+...+.++......      ..++..+.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus       282 ~--------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          282 H--------EEVIYYVRDGNILACP------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             H--------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             h--------HHHHHHHhCCCcCCCC------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            2        1233344443332221      1234578899999999999999999999999998776543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=315.64  Aligned_cols=245  Identities=26%  Similarity=0.352  Sum_probs=187.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC-CCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK-FSAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .+.+.++||+|+||+||+|+.. +++.||+|++.... ...+.+..|              +++++..+...++||||++
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   90 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK   90 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence            4566789999999999999964 69999999886532 233445555              5667777788899999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++...   ...+++.++..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus        91 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           91 GGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            99999998542   35699999999999999999999998   9999999999999999999999999999876443221


Q ss_pred             e------------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh
Q 048517          306 V------------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       306 ~------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      .            ......||+.|+|||.+.+.  .++.++||||||+++|||++|..|+............  .....+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--~~~~~~  240 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--NVRGFL  240 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--CHHHHH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--hhhccc
Confidence            1            01145699999999999764  7899999999999999999999988654332211111  011111


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ....          +..++..+.+++.+||+.||++|||+.++++.|+.....
T Consensus       241 ~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          241 DRYC----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             HHTC----------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccC----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1110          112234688899999999999999999999999876543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.9e-40  Score=323.71  Aligned_cols=262  Identities=22%  Similarity=0.267  Sum_probs=185.3

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------Hhc-----ccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG-----LCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g-----~~~~~~~~~lv~  221 (453)
                      ..+.+.++||+|+||.||+|+. +++.||||++............+              +++     .+......++||
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   91 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM   91 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence            3566778999999999999986 58999999997543222111222              121     112233567999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC------CCceeecccCCcceEEcCCCceEEEecCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC------DVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      ||+++|+|.+++..     ...++..+..++.|+++||+|||+.+      .++|+||||||+|||++.++.+||+|||+
T Consensus        92 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           92 EYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             CCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence            99999999999843     23589999999999999999999863      23899999999999999999999999999


Q ss_pred             ccccCCCCCc------eeecccCCCCCccChhhhcccC-----CCCCccchHHHHHHHHHHHHcCCCCCCCCccccc-cc
Q 048517          296 AKFHPKENDF------VSISDTRGTIGYLAPELISRNF-----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-KA  363 (453)
Q Consensus       296 a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~-----~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~-~~  363 (453)
                      ++........      .......||+.|+|||++.+..     ..++.++|||||||++|||++|+.|+........ ..
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            9876433211      1123456999999999987521     2466799999999999999999877644332111 11


Q ss_pred             c----------chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          364 Y----------FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       364 ~----------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      .          +..+.......................+..+.+++.+||+.||++|||++|+++.|+.+++..+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            1          1111111111112222222222233456789999999999999999999999999998877654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-39  Score=315.82  Aligned_cols=249  Identities=24%  Similarity=0.333  Sum_probs=188.4

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceEEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ...|.+.++||+|+||.||+|+. .+++.||||++.......    +.+.+|              +++++......++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            34567789999999999999995 478999999986543322    234444              46667777888999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            9999999999998533    4689999999999999999999998   99999999999999999999999999998764


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ..... ......||+.|+|||.+.+.  .++.++||||+|+++|||++|+.||......       ......+..... .
T Consensus       163 ~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~-~  231 (294)
T 4eqm_A          163 ETSLT-QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDSVP-N  231 (294)
T ss_dssp             -------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSCCC-C
T ss_pred             ccccc-ccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhccCC-C
Confidence            33221 22345699999999999864  6789999999999999999999999754321       112222222111 1


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhCCCCCCC
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~Le~~~~~~~  428 (453)
                      .  .......++..+.+++.+||+.||++|| +++++.+.|+..+.+-.
T Consensus       232 ~--~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          232 V--TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             H--HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             c--chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            0  1112233456789999999999999999 99999999998776644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8e-40  Score=323.14  Aligned_cols=253  Identities=17%  Similarity=0.201  Sum_probs=187.8

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH-----HHHHHH---------HhcccccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA-----EEFINE---------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~-----~~~i~e---------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .|.+.+.||+|+||.||+|+. .+|+.||||++.......     -+.+..         +++++..+...++||||+ +
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~   88 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G   88 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence            456778999999999999995 579999999987532211     112222         355666777889999999 9


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc-----eEEEecCCccccCC
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-----PKVSDFGLAKFHPK  301 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~-----~kl~DFGla~~~~~  301 (453)
                      ++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||+++....
T Consensus        89 ~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           89 PSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            9999988543   35799999999999999999999998   9999999999999998887     99999999987644


Q ss_pred             CCCce-----eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          302 ENDFV-----SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       302 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      .....     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||........     ......+...
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-----~~~~~~i~~~  235 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-----KERYQKIGDT  235 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-----HHHHHHHHHH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccH-----HHHHHHHHhh
Confidence            32211     12356799999999999864  789999999999999999999999976432211     1111111111


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCC
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP  431 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~  431 (453)
                      .....  ........+ .+.+++.+||+.+|.+||++.++++.|+...+....+.
T Consensus       236 ~~~~~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~  287 (330)
T 2izr_A          236 KRATP--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF  287 (330)
T ss_dssp             HHHSC--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             hccCC--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCC
Confidence            00000  000111123 78999999999999999999999999987665544433

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-39  Score=318.40  Aligned_cols=260  Identities=22%  Similarity=0.279  Sum_probs=186.5

Q ss_pred             hHHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccC----cce
Q 048517          156 PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEG----FKR  217 (453)
Q Consensus       156 ~~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~----~~~  217 (453)
                      .+.....|.+.++||+|+||.||+|+.. |+.||||++............+              +++++...    ...
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            3555667888899999999999999976 8999999986543222111222              33444444    567


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC-----CCceeecccCCcceEEcCCCceEEEe
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC-----DVCILHFDIKPHNILLDHNFIPKVSD  292 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dikp~NILl~~~~~~kl~D  292 (453)
                      ++||||+++|+|.+++..     ..+++..++.++.|++.||+|||+.+     ..+|+||||||+|||++.++.+||+|
T Consensus       111 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            899999999999999843     35899999999999999999999852     34899999999999999999999999


Q ss_pred             cCCccccCCCCCce--eecccCCCCCccChhhhcccCCCCCc------cchHHHHHHHHHHHHcC----------CCCCC
Q 048517          293 FGLAKFHPKENDFV--SISDTRGTIGYLAPELISRNFGTVSC------KSDVYGFGMVLLEMAGG----------RRNSN  354 (453)
Q Consensus       293 FGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~------k~DV~S~Gvvl~elltg----------~~p~~  354 (453)
                      ||+++.........  ......||+.|+|||.+.+.  ..+.      ++|||||||++|||++|          +.|+.
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99998765433221  11245799999999999764  3333      49999999999999999          44443


Q ss_pred             CCccccccccchHHHHHHhhhCC-CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCC
Q 048517          355 MNATRSSKAYFPSWVYDQLNKGG-DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  427 (453)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~  427 (453)
                      ......  ..... ......... ..... ...........+.+++.+||+.||++|||+.++++.|+...+..
T Consensus       264 ~~~~~~--~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          264 DLVPSD--PSYED-MREIVCIKKLRPSFP-NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTSCSS--CCHHH-HHHHHTTSCCCCCCC-GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhcCCC--Cchhh-hHHHHhhhccCcccc-ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            322111  11111 112221111 11111 11123456778999999999999999999999999999876653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.7e-40  Score=322.71  Aligned_cols=243  Identities=25%  Similarity=0.409  Sum_probs=182.8

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcE----EEEEEecCC--CCCHHHHHHH--------------HhcccccCcceE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRL----IAVKMMENS--KFSAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~----VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ...|.+.++||+|+||+||+|+.. +|+.    ||+|.+...  ....+++.+|              ++++|..+ ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence            345667789999999999999954 4543    688887653  2344555555              45556554 478


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +|+||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            999999999999998543   35689999999999999999999998   999999999999999999999999999997


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ..............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        +...+..+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~  236 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGE  236 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTC
T ss_pred             ccCCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------HHHHHHcCC
Confidence            7654443333455678899999999864  78999999999999999999 999997543221        334444433


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      .....      ......+..++.+||+.+|++|||+.++++.|+....
T Consensus       237 ~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 RLPQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCCC------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCCC------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            32221      1133568889999999999999999999999987654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.8e-40  Score=331.09  Aligned_cols=269  Identities=16%  Similarity=0.160  Sum_probs=192.4

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEcC------CcEEEEEEecCCCCCH---HH---------HHHH-------------
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLHT------GRLIAVKMMENSKFSA---EE---------FINE-------------  206 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~------g~~VAVK~l~~~~~~~---~~---------~i~e-------------  206 (453)
                      +....|.+.++||+|+||.||+|+..+      ++.||||++.......   .+         ++.+             
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            334467788999999999999998754      4789999987643211   11         1111             


Q ss_pred             -HhcccccC----cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceE
Q 048517          207 -LLGLCSEG----FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNIL  281 (453)
Q Consensus       207 -l~g~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIL  281 (453)
                       +++++...    ...++||||+ +++|.+++..   ....+++..++.|+.|++.||+|||+.   +|+||||||+|||
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nil  184 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLL  184 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEE
Confidence             23333332    3478999999 9999998854   235799999999999999999999998   9999999999999


Q ss_pred             Ec--CCCceEEEecCCccccCCCCCce-----eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 048517          282 LD--HNFIPKVSDFGLAKFHPKENDFV-----SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  354 (453)
Q Consensus       282 l~--~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~  354 (453)
                      ++  .++.+||+|||+++.........     ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            99  88999999999998764332111     11234599999999999764  68999999999999999999999997


Q ss_pred             CCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCC
Q 048517          355 MNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPF  434 (453)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~  434 (453)
                      ......   .+........... ........-.....+..+..++.+||+.+|++||++.+++++|+..++....+....
T Consensus       263 ~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~  338 (364)
T 3op5_A          263 DNLKDP---KYVRDSKIRYREN-IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK  338 (364)
T ss_dssp             GGTTCH---HHHHHHHHHHHHC-HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             ccccCH---HHHHHHHHHhhhh-HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence            432211   1111111111100 000000000001224678899999999999999999999999999888887777766


Q ss_pred             CCCCC
Q 048517          435 FSSSR  439 (453)
Q Consensus       435 ~~~~~  439 (453)
                      +++..
T Consensus       339 ~dw~~  343 (364)
T 3op5_A          339 LDLSV  343 (364)
T ss_dssp             CCC--
T ss_pred             cceEe
Confidence            66654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.1e-40  Score=326.17  Aligned_cols=247  Identities=27%  Similarity=0.417  Sum_probs=190.3

Q ss_pred             HHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccC-c
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEG-F  215 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~-~  215 (453)
                      ...+.+.++||+|+||.||+|+.      .+++.||||++......  .+.+.+|               +++++... .
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~  100 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  100 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence            34566778999999999999973      24689999999764332  2334444               34455443 4


Q ss_pred             ceEEEEEecCCCChhhhhhhccCC--------------------------------------------------------
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENK--------------------------------------------------------  239 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  239 (453)
                      ..++||||+++|+|.+++......                                                        
T Consensus       101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3vhe_A          101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  180 (359)
T ss_dssp             CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred             ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence            489999999999999998654321                                                        


Q ss_pred             ------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCC
Q 048517          240 ------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRG  313 (453)
Q Consensus       240 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  313 (453)
                            ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...............|
T Consensus       181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             cccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence                  12289999999999999999999998   999999999999999999999999999987655544444456678


Q ss_pred             CCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHH
Q 048517          314 TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIA  392 (453)
Q Consensus       314 t~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  392 (453)
                      |+.|+|||++.+.  .++.++||||||+++|||++ |+.||......       ......+..+......      ...+
T Consensus       258 t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~------~~~~  322 (359)
T 3vhe_A          258 PLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAP------DYTT  322 (359)
T ss_dssp             CGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HHHHHHHHHTCCCCCC------TTCC
T ss_pred             CceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------HHHHHHHHcCCCCCCC------CCCC
Confidence            9999999999764  78999999999999999998 99998654321       1233344443332222      1233


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          393 RKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       393 ~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      ..+.+++.+||+.||++|||+.+++++|+..+
T Consensus       323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            56889999999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-40  Score=328.86  Aligned_cols=251  Identities=23%  Similarity=0.370  Sum_probs=192.8

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCc
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGF  215 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~  215 (453)
                      +....+.+.++||+|+||.||+|+..      +++.||||++.....  ...++..|              +++++....
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            33445677889999999999999843      467899999975322  22334444              567777788


Q ss_pred             ceEEEEEecCCCChhhhhhhccC---CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC---ceE
Q 048517          216 KRALVYEYMPNGSLDRHIFSKEN---KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPK  289 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~---~~k  289 (453)
                      ..++||||+++|+|.+++.....   ....+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence            88999999999999999965432   234689999999999999999999998   999999999999998544   599


Q ss_pred             EEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHH
Q 048517          290 VSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSW  368 (453)
Q Consensus       290 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  368 (453)
                      |+|||+++...............||+.|+|||.+.+.  .++.++|||||||++|||++ |+.||.....        ..
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~  294 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QE  294 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence            9999999854322222222445689999999999764  78999999999999999998 9999865432        12


Q ss_pred             HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCC
Q 048517          369 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  427 (453)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~  427 (453)
                      +.+.+..+......      ...+..+.+++.+||+.+|++|||+.++++.|+......
T Consensus       295 ~~~~i~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          295 VLEFVTSGGRMDPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            33444444332221      123356889999999999999999999999998765543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-39  Score=320.57  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=191.6

Q ss_pred             HHHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCC--CCHHHHHHH---------------HhcccccCc
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSK--FSAEEFINE---------------LLGLCSEGF  215 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~--~~~~~~i~e---------------l~g~~~~~~  215 (453)
                      ....+.+.+.||+|+||.||+|+.      .+++.||||++....  ...+.+..|               +++++....
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            344567778999999999999985      246789999997532  223344443               456677778


Q ss_pred             ceEEEEEecCCCChhhhhhhccCC-------------------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccC
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENK-------------------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIK  276 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik  276 (453)
                      ..++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||+.   +|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            899999999999999998653221                   13489999999999999999999998   99999999


Q ss_pred             CcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCC
Q 048517          277 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNM  355 (453)
Q Consensus       277 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~  355 (453)
                      |+|||++.++.+||+|||+++...............||+.|+|||.+.+.  .++.++||||||+++|||++ |+.||..
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999876554444444556788999999998764  78999999999999999998 9999865


Q ss_pred             CccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCC
Q 048517          356 NATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  427 (453)
Q Consensus       356 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~  427 (453)
                      ....       ......+..+......      ...+..+..++.+||+.||++|||+.++++.|+..+...
T Consensus       278 ~~~~-------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          278 IPVD-------ANFYKLIQNGFKMDQP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCCS-------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCcH-------HHHHHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            4321       1233334333222211      123456889999999999999999999999999876654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.9e-39  Score=315.82  Aligned_cols=246  Identities=24%  Similarity=0.381  Sum_probs=193.3

Q ss_pred             HhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ..+.+.+.||+|+||.||+|+.      .+++.||||++.....  ..+++..|              +++++......+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            4566778999999999999985      2458899999976432  12344444              466777788899


Q ss_pred             EEEEecCCCChhhhhhhccC--------------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCc
Q 048517          219 LVYEYMPNGSLDRHIFSKEN--------------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH  278 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~  278 (453)
                      +||||+++|+|.+++.....                    ....+++.+++.++.|+++||.|||+.   +|+||||||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~  179 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAAR  179 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchh
Confidence            99999999999999865432                    123589999999999999999999998   9999999999


Q ss_pred             ceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCc
Q 048517          279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNA  357 (453)
Q Consensus       279 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~  357 (453)
                      |||++.++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||+|+++|||++ |+.||....
T Consensus       180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999877655444334455688999999999764  68999999999999999999 999986543


Q ss_pred             cccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          358 TRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       358 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ..        .....+..+......      ..++..+.+++.+||+.||++|||+.++++.|++++.
T Consensus       258 ~~--------~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          258 PE--------RLFNLLKTGHRMERP------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GG--------GHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH--------HHHHHhhcCCcCCCC------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            21        133344443322211      2234678899999999999999999999999987654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.8e-39  Score=312.36  Aligned_cols=259  Identities=19%  Similarity=0.251  Sum_probs=193.0

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH------H---------hcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE------L---------LGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e------l---------~g~~~~~~~~~lv~E~~~  225 (453)
                      .|.+.+.||+|+||.||+|+. .+|+.||||++...... +++..|      +         ..+...+...++||||+ 
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            456778999999999999995 68999999998764332 223222      1         12224556678999999 


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE---cCCCceEEEecCCccccCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~~~~  302 (453)
                      +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           88 GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999988532   34699999999999999999999998   99999999999999   48899999999999876543


Q ss_pred             CCce-----eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          303 NDFV-----SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       303 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ....     ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...........+.......... .
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~  238 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-P  238 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-C
T ss_pred             ccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-c
Confidence            3211     12345799999999999864  68999999999999999999999997644322222111111111111 0


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSS  437 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~~~~  437 (453)
                            .......++..+.+++.+||+.||++|||++++++.|+........+..-.+++
T Consensus       239 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw  292 (296)
T 3uzp_A          239 ------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW  292 (296)
T ss_dssp             ------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred             ------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence                  001112345678999999999999999999999999998877766554444443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.6e-39  Score=313.26  Aligned_cols=257  Identities=18%  Similarity=0.245  Sum_probs=189.0

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC--HH---HHHHH---------HhcccccCcceEEEEEec
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS--AE---EFINE---------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~---~~i~e---------l~g~~~~~~~~~lv~E~~  224 (453)
                      ...|.+.+.||+|+||.||+|+. .+++.||||++......  ..   +.+..         +..+.......++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            34577789999999999999995 57999999987653221  11   11111         122334566778999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE---cCCCceEEEecCCccccCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~~~  301 (453)
                       +++|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++....
T Consensus        88 -~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           88 -GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             -CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence             99999988532   34699999999999999999999998   99999999999999   7889999999999987654


Q ss_pred             CCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          302 ENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       302 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      ....     .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...........+...........
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            3321     112345799999999999864  789999999999999999999999976543322222111111111110


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCC
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPK  432 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~  432 (453)
                             .......++..+.+++.+||+.+|++|||++++++.|+..++....+..
T Consensus       239 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~  287 (296)
T 4hgt_A          239 -------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD  287 (296)
T ss_dssp             -------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTT
T ss_pred             -------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCcc
Confidence                   0001122346789999999999999999999999999988776654443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-39  Score=321.19  Aligned_cols=242  Identities=26%  Similarity=0.407  Sum_probs=183.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcE----EEEEEecCCCC--CHHHH--------------HHHHhcccccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRL----IAVKMMENSKF--SAEEF--------------INELLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~----VAVK~l~~~~~--~~~~~--------------i~el~g~~~~~~~~~lv  220 (453)
                      .+.+.+.||+|+||+||+|+.. +++.    ||+|.+.....  ...++              +.++++++. +...++|
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v   92 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV   92 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence            4566789999999999999954 4554    88888754221  11111              112566665 4568899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      +||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999998532   35799999999999999999999998   99999999999999999999999999999876


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ............||++|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .+.+.+..+...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~  236 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--------EVPDLLEKGERL  236 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--------HHHHHHHTTCBC
T ss_pred             cccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCCC
Confidence            55443334556788899999999764  78999999999999999999 99999754322        133344443332


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ....      ..+..+..++.+||+.||++|||+.++++.|+.....
T Consensus       237 ~~~~------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          237 AQPQ------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CCCT------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCC------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            2211      1234577899999999999999999999999876543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.3e-39  Score=317.66  Aligned_cols=231  Identities=18%  Similarity=0.319  Sum_probs=184.3

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      .|.+.+.||+|+||.||+|+. .+|+.||||++.......   +++.+|              +++++......++||||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            456778999999999999996 589999999997654332   233333              56677778889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        96 ~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           96 ASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             CTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999998543    4589999999999999999999998   99999999999999999999999999998765443


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   .....||+.|+|||.+.+. ...+.++||||+||++|||++|+.||......        ...+.+..+....   
T Consensus       169 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~~~---  233 (328)
T 3fe3_A          169 K---LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--------ELRERVLRGKYRI---  233 (328)
T ss_dssp             G---GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCC---
T ss_pred             c---cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCC---
Confidence            2   3456799999999999864 23357999999999999999999999754321        1233333332211   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          +...+..+.+++.+||+.||.+|||++|+++
T Consensus       234 ----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          234 ----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                1123456788999999999999999999987

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.6e-40  Score=328.97  Aligned_cols=245  Identities=27%  Similarity=0.432  Sum_probs=179.0

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      ...+.+.+.||+|+||.||+|+..    +++.||||+++....  ..+++.+|              +++++......++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            345667789999999999999864    577899999976432  23445555              5677778888999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||+++|+|.+++..   ....+++.+++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999853   235699999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          300 PKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       300 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ....... ......+|+.|+|||++...  .++.++||||||+++|||++ |+.||......        .+...+..+.
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------~~~~~i~~~~  267 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------DVIKAVDEGY  267 (373)
T ss_dssp             ----------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------HHHHHHHTTE
T ss_pred             ccCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCC
Confidence            5432211 11223467889999999764  78999999999999999998 99998643321        1233333332


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ....      +...+..+.+++.+||+.+|++|||+.+|+++|+..+..
T Consensus       268 ~~~~------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 RLPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ECCC------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCC------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            2111      112345688999999999999999999999999876543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-39  Score=314.59  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=185.6

Q ss_pred             HHHhhhhhcccCccCceEEEEEEE-----cCCcEEEEEEecCCCCC-HHHHHHH--------------Hhccccc--Ccc
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSE--GFK  216 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~-----~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~--~~~  216 (453)
                      ....+.+.++||+|+||+||+|++     .+++.||||++...... .+++.+|              +++++..  ...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            345667789999999999999984     36899999999764322 2344444              3444432  234


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             eEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            78999999999999998543   24589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccc--------cccccchH
Q 048517          297 KFHPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR--------SSKAYFPS  367 (453)
Q Consensus       297 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~--------~~~~~~~~  367 (453)
                      +........ .......+|..|+|||.+.+.  .++.++||||||+++|||++|..|+......        ........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            876544322 122344577889999999864  7899999999999999999999988643211        00001111


Q ss_pred             HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCC
Q 048517          368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  427 (453)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~  427 (453)
                      ...+.+..+.....      +..++..+.+++.+||+.||++|||+.+++++|+.+.+.+
T Consensus       240 ~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          240 HLIELLKNNGRLPR------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHhccCcCCC------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            22233333322221      1223467889999999999999999999999999766543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-39  Score=319.61  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=175.4

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCc---EEEEEEecCCCC---CHHHHHHH--------------HhcccccCcce-
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGR---LIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKR-  217 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~---~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~-  217 (453)
                      ...|.+.+.||+|+||.||+|+.. +++   .||||++.....   ..+++.+|              +++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            345677889999999999999854 333   899999976422   23445555              34444444333 


Q ss_pred             -----EEEEEecCCCChhhhhhhccC--CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517          218 -----ALVYEYMPNGSLDRHIFSKEN--KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  290 (453)
Q Consensus       218 -----~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  290 (453)
                           ++||||+++|+|.+++.....  ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence                 899999999999999865432  223689999999999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHH
Q 048517          291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  369 (453)
Q Consensus       291 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  369 (453)
                      +|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        .
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~  248 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------I  248 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------H
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChHH--------H
Confidence            999999876554433333455678899999999764  78999999999999999999 899986543221        3


Q ss_pred             HHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      ...+..+......      ...+..+.+++.+||+.||++|||+.++++.|+.++....
T Consensus       249 ~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          249 YNYLIGGNRLKQP------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             HHHHHTTCCCCCC------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHhcCCCCCCC------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            3333333322211      1234568899999999999999999999999998777644

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.3e-39  Score=315.85  Aligned_cols=238  Identities=25%  Similarity=0.307  Sum_probs=182.4

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .|.+.++||+|+||+||+|+.. +++.||||++......  .+.+.+|              +++++..+...++||||+
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   87 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence            4567789999999999999965 7999999998653221  1222222              567778888899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        88 ~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           88 SGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             TTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999999883    335699999999999999999999998   999999999999999999999999999987643332


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                      ........||+.|+|||++.+. ...+.++||||||+++|||++|+.||.......  .     ............ .  
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~-----~~~~~~~~~~~~-~--  229 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--Q-----EYSDWKEKKTYL-N--  229 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--H-----HHHHHHTTCTTS-T--
T ss_pred             ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--H-----HHHHHhcccccC-C--
Confidence            2233456799999999999764 234779999999999999999999997543321  0     111111111110 0  


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                        ....++..+.+++.+||+.||++|||+.|+++.
T Consensus       230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              112234567889999999999999999999873

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-38  Score=328.45  Aligned_cols=235  Identities=29%  Similarity=0.449  Sum_probs=186.5

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCc-ceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGF-KRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~-~~~lv~E~~~~  226 (453)
                      .+.+.++||+|+||.||+|... |+.||||+++... ..+++..|              +++++.... ..++||||+++
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~  271 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK  271 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred             HeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence            4456688999999999999986 7899999998754 44556665              456654443 68999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++...  ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......   
T Consensus       272 g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---  343 (450)
T 1k9a_A          272 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  343 (450)
T ss_dssp             CBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence            9999999643  224579999999999999999999998   99999999999999999999999999998543321   


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                        ....+|+.|+|||.+...  .++.++||||||+++|||++ |+.||.......        +...+.++......   
T Consensus       344 --~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~p---  408 (450)
T 1k9a_A          344 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAP---  408 (450)
T ss_dssp             -----CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHTTCCCCCC---
T ss_pred             --cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCC---
Confidence              233578899999999764  78999999999999999998 999987543221        33444444333222   


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                         ..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       409 ---~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          409 ---DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               223467889999999999999999999999998643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.8e-39  Score=310.05  Aligned_cols=245  Identities=26%  Similarity=0.420  Sum_probs=193.1

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .++.+.+.||+|+||.||+|+.++++.||||.+.......+.+..|              +++++. ....++||||+++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   91 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN   91 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCC
Confidence            4567788999999999999998888899999998776666666665              344444 3457899999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      ++|.+++...  ....+++..++.++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++....... .
T Consensus        92 ~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  165 (279)
T 1qpc_A           92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (279)
T ss_dssp             CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence            9999998432  123689999999999999999999998   999999999999999999999999999987654332 2


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      ......+|+.|+|||.+...  .++.++||||||++++||++ |+.||......        .....+..+.....    
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~----  231 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNLERGYRMVR----  231 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCC----
T ss_pred             cccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHHhcccCCCC----
Confidence            22345678899999999753  78899999999999999999 88888643221        12333333322211    


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                        +..++..+.+++.+||+.+|++|||+.++++.|+.......
T Consensus       232 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             --cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence              11234578899999999999999999999999998765543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.4e-39  Score=315.14  Aligned_cols=249  Identities=26%  Similarity=0.429  Sum_probs=194.6

Q ss_pred             HHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFK  216 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~  216 (453)
                      ...+.+.+.||+|+||.||+|+.      .+++.||||++......  .+.+.+|               +++++.....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            44667788999999999999985      35789999999864332  2334444               4566777788


Q ss_pred             eEEEEEecCCCChhhhhhhccC--------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE
Q 048517          217 RALVYEYMPNGSLDRHIFSKEN--------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL  282 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl  282 (453)
                      .++||||+++|+|.+++.....              ....+++..++.++.|+++||.|||+.   +|+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            8999999999999999865432              123589999999999999999999998   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccc
Q 048517          283 DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSS  361 (453)
Q Consensus       283 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~  361 (453)
                      +.++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||++++||++ |+.||......  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--  254 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--  254 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccch--
Confidence            99999999999999877665544444556688999999998764  78999999999999999999 99998654321  


Q ss_pred             cccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          362 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       362 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                           ......+........      +...+..+.+++.+||+.||++|||+.+++++|++.+.+
T Consensus       255 -----~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          255 -----SKFYKMIKEGFRMLS------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             -----HHHHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----hHHHHHhccCCCCCC------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                 112333333322211      112345688999999999999999999999999976553

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=314.99  Aligned_cols=237  Identities=22%  Similarity=0.262  Sum_probs=186.5

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-------CHHHHHHH--------------HhcccccCcc
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-------SAEEFINE--------------LLGLCSEGFK  216 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-------~~~~~i~e--------------l~g~~~~~~~  216 (453)
                      ....|.+.+.||+|+||.||+++.. +|+.||||++.....       ..+++.+|              +++++.....
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3456778899999999999999965 799999999876322       23445454              4666777888


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC----ceEEEe
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSD  292 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~----~~kl~D  292 (453)
                      .++||||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++    .+||+|
T Consensus        89 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           89 VILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             EEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            999999999999999884    235689999999999999999999998   999999999999998877    899999


Q ss_pred             cCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517          293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  372 (453)
Q Consensus       293 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  372 (453)
                      ||+++.......   .....||+.|+|||++...  .++.++||||||+++|||++|+.||......        .....
T Consensus       162 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~  228 (326)
T 2y0a_A          162 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLAN  228 (326)
T ss_dssp             CTTCEECCTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH
T ss_pred             CCCCeECCCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHH
Confidence            999987654332   2345799999999999754  7899999999999999999999999653321        12222


Q ss_pred             hhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       373 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +.......   ........+..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          229 VSAVNYEF---EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHTCCCC---CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCc---CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22221110   11122234567889999999999999999999987

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-39  Score=318.55  Aligned_cols=239  Identities=16%  Similarity=0.205  Sum_probs=188.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||+|.+.......+.+.+|              +++++......++||||+++
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g   85 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence            4667789999999999999965 68999999997654444444444              46667777889999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC--CCceEEEecCCccccCCCCC
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~~  304 (453)
                      |+|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.  ++.+||+|||+++.......
T Consensus        86 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           86 LDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            999998842   234689999999999999999999998   9999999999999987  78999999999987755432


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                         .....||+.|+|||++.+.  .++.++||||+|+++|||++|+.||......        .....+..+....   .
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~---~  223 (321)
T 1tki_A          160 ---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYTF---D  223 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCC---C
T ss_pred             ---cccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHcCCCCC---C
Confidence               2345699999999999764  6789999999999999999999999654321        1223333322111   1


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  422 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~  422 (453)
                      ......++..+.+++.+||+.||++|||+.|+++  .+..
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence            1122334567899999999999999999999998  4444

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-39  Score=342.96  Aligned_cols=248  Identities=28%  Similarity=0.425  Sum_probs=198.4

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +....+.+.++||+|+||.||+|+.+++..||||+++......++|++|              +++++.+ ...++||||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            4445566778999999999999999888899999998876667777776              4566655 568999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++....  ...+++.+++.|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       343 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          343 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             hcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            99999999995322  24589999999999999999999998   99999999999999999999999999998664321


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                       ........+|..|+|||.+...  .++.++||||||+++|||++ |+.||.....        ..+.+.+..+......
T Consensus       418 -~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~  486 (535)
T 2h8h_A          418 -YTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCP  486 (535)
T ss_dssp             -HHTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC
T ss_pred             -eecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence             1112334578899999999764  78999999999999999999 8999864322        1234445444333221


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                            ..++..+.+++.+||+.||++|||+.+++++|+.......
T Consensus       487 ------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          487 ------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             ------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence                  1234568899999999999999999999999998776544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-39  Score=308.04  Aligned_cols=240  Identities=28%  Similarity=0.480  Sum_probs=192.9

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      .+.+.+.||+|+||.||+|+..+++.||||++.......+++.+|              +++++......++||||++++
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG   88 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred             heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence            456778999999999999998889999999998876666666666              456677778889999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +|.+++...   ...+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus        89 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  161 (267)
T 3t9t_A           89 CLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  161 (267)
T ss_dssp             BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred             cHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-cc
Confidence            999998543   34689999999999999999999998   999999999999999999999999999986643211 12


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      .....+|+.|+|||.+...  .++.++||||+|+++|||++ |+.||......        .....+..+......    
T Consensus       162 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~i~~~~~~~~~----  227 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKP----  227 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCCCC----
T ss_pred             cccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCHH--------HHHHHHhcCCcCCCC----
Confidence            2345678899999999764  78899999999999999999 88888643321        123333333222111    


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                        ...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       228 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          228 --RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              123456889999999999999999999999998654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=312.25  Aligned_cols=254  Identities=19%  Similarity=0.259  Sum_probs=191.1

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCc--ceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGF--KRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~--~~~lv~E  222 (453)
                      .|.+.++||+|+||+||+|+.. +|+.||||++....  ...+.+..|              +++++....  ..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence            4667789999999999999965 69999999997632  233444444              344444333  6789999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE----cCCCceEEEecCCccc
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKF  298 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~~  298 (453)
                      |+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             CCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             CCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            999999999985432 223499999999999999999999998   99999999999999    7888999999999987


Q ss_pred             cCCCCCceeecccCCCCCccChhhhccc------CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRN------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  372 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  372 (453)
                      ......   .....||+.|+|||++...      ...++.++|||||||++|||++|+.||........   ........
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~  239 (319)
T 4euu_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR---NKEVMYKI  239 (319)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG---CHHHHHHH
T ss_pred             cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch---hHHHHHHH
Confidence            755432   2345699999999998631      24788999999999999999999999964332211   11222222


Q ss_pred             hhhCCCc-----------------cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          373 LNKGGDL-----------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       373 l~~~~~~-----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      +......                 ...........+...+.+++.+||+.||++|||++|+++.......
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            2221100                 1111112446677889999999999999999999999999875433

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-38  Score=319.17  Aligned_cols=234  Identities=21%  Similarity=0.277  Sum_probs=185.5

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-------CHHHHHHH--------------HhcccccCcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-------SAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-------~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++.....       ..+.+.+|              +++++......++
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   92 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL   92 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence            4667889999999999999965 799999999976432       23445554              4566777788999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC----ceEEEecCC
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSDFGL  295 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFGl  295 (453)
                      ||||+++|+|.+++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||+
T Consensus        93 v~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           93 ILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999983    235799999999999999999999998   999999999999998776    799999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      ++.......   .....||+.|+|||++.+.  .++.++||||+|+++|||++|+.||......        .....+..
T Consensus       166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i~~  232 (361)
T 2yab_A          166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITA  232 (361)
T ss_dssp             CEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHT
T ss_pred             ceEcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh
Confidence            987654332   2456799999999999764  7899999999999999999999999654321        12233333


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +... .  .......++..+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~-~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          233 VSYD-F--DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TCCC-C--CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCC-C--CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2211 1  11122334567889999999999999999999885

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.2e-39  Score=317.27  Aligned_cols=249  Identities=22%  Similarity=0.389  Sum_probs=192.4

Q ss_pred             HHHhhhhhcccCccCceEEEEEEE--------cCCcEEEEEEecCCCCC--HHHHHHH---------------Hhccccc
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQL--------HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSE  213 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~--------~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~  213 (453)
                      ....+.+.+.||+|+||.||+|+.        .+++.||||++......  .+++..|               +++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            345667778999999999999986        35778999999764321  2233333               4566777


Q ss_pred             CcceEEEEEecCCCChhhhhhhccCC------------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceE
Q 048517          214 GFKRALVYEYMPNGSLDRHIFSKENK------------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNIL  281 (453)
Q Consensus       214 ~~~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIL  281 (453)
                      ....++||||+++|+|.+++......            ...+++..++.++.|++.||+|||+.   +|+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence            78889999999999999998654321            23589999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccc
Q 048517          282 LDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRS  360 (453)
Q Consensus       282 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~  360 (453)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.....  
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--  265 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  265 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence            999999999999999877655443334455678999999998764  68899999999999999999 9999864321  


Q ss_pred             ccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          361 SKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       361 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                            ......+..+......      ..++..+.+++.+||+.+|++|||+.++++.|+.++..
T Consensus       266 ------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          266 ------EELFKLLKEGHRMDKP------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             ------HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHHHHhcCCCCCCC------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                  1133334443322221      12345688999999999999999999999999987653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.1e-38  Score=308.63  Aligned_cols=244  Identities=21%  Similarity=0.272  Sum_probs=181.2

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..|.+.++||+|+||+||+|+..+|+.||||++......   .+.+.+|              +++++......++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            456677899999999999999888999999999764322   2334444              56677778889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      ++ |+|.+.+..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       101 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          101 ME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            97 578777743   235689999999999999999999998   99999999999999999999999999998765332


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc---
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE---  380 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~---  380 (453)
                      .  ......||+.|+|||.+.+. ..++.++||||+|++++||++|+.||........    ...+...+.......   
T Consensus       174 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          174 R--SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ----LPKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH----HHHHHHHHCCCCTTTSGG
T ss_pred             c--cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHHCCCChHHhhh
Confidence            2  22445789999999998753 3689999999999999999999999975443211    111111111110000   


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 ----------------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ----------------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                      ..........++..+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                            00000111223457889999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.8e-39  Score=319.70  Aligned_cols=241  Identities=22%  Similarity=0.305  Sum_probs=188.6

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC------CCCHHHHHHH--------------HhcccccCcce
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS------KFSAEEFINE--------------LLGLCSEGFKR  217 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~------~~~~~~~i~e--------------l~g~~~~~~~~  217 (453)
                      ....|.+.+.||+|+||+||+|+.. +|+.||||++...      ....+++.+|              +++++......
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3456788899999999999999854 7999999998642      1234455554              46667777889


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc---eEEEecC
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDFG  294 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DFG  294 (453)
                      ++||||+++|+|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            999999999999988865544456789999999999999999999998   9999999999999976554   9999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      +++.......  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||.....         .....+.
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~  245 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGII  245 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHH
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHH
Confidence            9987654332  22456799999999999764  689999999999999999999999975321         1223333


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+.....   ......++..+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          246 KGKYKMN---PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HTCCCCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCCCCC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            3221110   1112234567889999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.3e-39  Score=317.17  Aligned_cols=247  Identities=21%  Similarity=0.289  Sum_probs=176.4

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCc----c
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGF----K  216 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~----~  216 (453)
                      ...|.+.+.||+|+||.||+++. .+++.||||++.......    ..+.+|              +++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            34677789999999999999995 579999999998754332    234444              233333322    2


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++||||+++|+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            38999999999999998533    4689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          297 KFHPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       297 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      +........ .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......       .........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~  234 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVRE  234 (311)
T ss_dssp             ------------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcC
Confidence            876443221 122345689999999999764  7899999999999999999999999654321       112222222


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHhCCCCC
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL-EMLEGSIDD  426 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl-~~Le~~~~~  426 (453)
                      ....    .......++..+.+++.+||+.||++||+..+++ +.|......
T Consensus       235 ~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          235 DPIP----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             CCCC----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             CCCC----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            1111    1111223456788999999999999999665544 455554433

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-38  Score=315.27  Aligned_cols=231  Identities=25%  Similarity=0.334  Sum_probs=182.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .+.+.+.||+|+||.||+++.. +|+.||||++...    ....+.+..|              +++.+......++|||
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E   85 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence            4566789999999999999965 7999999999752    2233344444              4566677788999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           86 YANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             CCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999988532    4689999999999999999999998   9999999999999999999999999999864332


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......||+.|+|||++.+.  .++.++||||+|+++|||++|+.||......        ...+.+..... .. 
T Consensus       159 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~-~~-  224 (337)
T 1o6l_A          159 GA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEEI-RF-  224 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC-CC-
T ss_pred             CC--cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCC-CC-
Confidence            22  22456799999999999764  7899999999999999999999999653321        12233322221 11 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                           +..++..+.+++.+||+.||++||     +++|+++
T Consensus       225 -----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          225 -----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                 112345788999999999999999     8999976

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.4e-38  Score=304.56  Aligned_cols=236  Identities=29%  Similarity=0.429  Sum_probs=173.5

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC-----CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF-----SAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~-----~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .+.+.+.||+|+||.||+|+.. |+.||||++.....     ..+.+..|              +++++......++|||
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            4567789999999999999976 89999999876322     12334333              5677777888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC--------CCceEEEecC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--------NFIPKVSDFG  294 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~--------~~~~kl~DFG  294 (453)
                      |+++++|.+++.     ...+++..++.++.|++.||+|||+....+|+||||||+|||++.        ++.+||+|||
T Consensus        87 ~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           87 FARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             CCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             cCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999998883     346899999999999999999999982223999999999999986        7789999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      +++.......    ....||+.|+|||.+.+.  .++.++||||||++++||++|+.||.......       .......
T Consensus       162 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~  228 (271)
T 3dtc_A          162 LAREWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-------VAYGVAM  228 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-------HHHHHHT
T ss_pred             cccccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHhhhc
Confidence            9986544322    345699999999999764  78999999999999999999999996543211       1111121


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      .......      +...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       229 ~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          229 NKLALPI------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             SCCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCCCCC------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            2111111      12234568899999999999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-38  Score=308.37  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=183.3

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG  227 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g  227 (453)
                      .+.+.+.||+|+||.||+|+.. ++.||||++.... ..+.+..|              +++++.  ...++||||+++|
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~   84 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGG   84 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT-HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTC
T ss_pred             HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh-HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCC
Confidence            4566789999999999999976 7899999997532 34455555              344444  3478999999999


Q ss_pred             ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc-eEEEecCCccccCCCCCce
Q 048517          228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~-~kl~DFGla~~~~~~~~~~  306 (453)
                      +|.+++.... ....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....    
T Consensus        85 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----  159 (307)
T 2eva_A           85 SLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----  159 (307)
T ss_dssp             BHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence            9999985432 2235788999999999999999999943348999999999999988876 799999999755432    


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                       .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......      .-+......+......    
T Consensus       160 -~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~----  226 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAVHNGTRPPLI----  226 (307)
T ss_dssp             ------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH------HHHHHHHHTTCCCCCB----
T ss_pred             -cccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccH------HHHHHHHhcCCCCCcc----
Confidence             1334699999999999764  78999999999999999999999996432211      0011122222222111    


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCCC
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFF  435 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~~  435 (453)
                        ..++..+.+++.+||+.||++|||+.+++++|+.....++-+..|..
T Consensus       227 --~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~  273 (307)
T 2eva_A          227 --KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ  273 (307)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred             --cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence              12345688999999999999999999999999987766655555543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.3e-39  Score=311.84  Aligned_cols=251  Identities=30%  Similarity=0.486  Sum_probs=179.9

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEE
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      |+....+.+.++||+|+||+||+|+.+  ..||||++.......   +.+.+|              +++++ .....++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            566667888899999999999999855  359999998654432   334444              33433 3455789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        97 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence            9999999999998843   235689999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCceeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      .............||+.|+|||.+... ...++.++||||||+++|||++|+.||......       ....+.+..+..
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~  243 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMVGRGSL  243 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHHHHTSC
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHhccccc
Confidence            443322233455799999999998621 246788999999999999999999999654321       123333333322


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ...  .......++..+.+++.+||+.+|++|||+.+++++|+.+.+
T Consensus       244 ~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 SPD--LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCC--TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             Ccc--hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            111  011122344678999999999999999999999999998765

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=320.44  Aligned_cols=232  Identities=23%  Similarity=0.298  Sum_probs=178.7

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv  220 (453)
                      ..+.+.+.||+|+||+||+|+.. +|+.||||++....    ...+....|               +++++......++|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            35667789999999999999965 68999999987531    122222222               45566677889999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       103 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999988543    4689999999999999999999998   99999999999999999999999999998543


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ....  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        .+...+..+....
T Consensus       176 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~  243 (353)
T 3txo_A          176 CNGV--TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDEVVY  243 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCC
T ss_pred             cCCc--cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            3222  23456799999999999865  6889999999999999999999999754321        1333333332211


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM------TKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~------~evl~  418 (453)
                             +..++..+.+++.+||+.||++||++      .++++
T Consensus       244 -------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          244 -------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                   11234568889999999999999998      67765

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.2e-39  Score=310.98  Aligned_cols=245  Identities=28%  Similarity=0.418  Sum_probs=196.5

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ....+.+.++||+|+||.||+|... +++.||||++.......+++..|              +++++......++||||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            3445667789999999999999966 58899999998766666666555              56677778889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...  ....+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++......
T Consensus        91 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           91 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             CCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999999998542  335689999999999999999999998   99999999999999999999999999998765443


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      . .......+|+.|+|||.+.+.  .++.++||||+|++++||++ |+.|+......        ...+.+.........
T Consensus       166 ~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~  234 (288)
T 3kfa_A          166 Y-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDYRMERP  234 (288)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTTCCCCCC
T ss_pred             c-ccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHhccCCCCCC
Confidence            2 233445678899999999764  78999999999999999999 88888654322        133333333222211


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                            ..++..+.+++.+||+.||++|||+.++++.|+....
T Consensus       235 ------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          235 ------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                  1234578899999999999999999999999987544

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.6e-39  Score=315.31  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=192.7

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcc
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFK  216 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~  216 (453)
                      ....|.+.+.||+|+||.||+|+..      +++.||||++......  ..++.+|              +++++.....
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            3446677899999999999999854      4788999999764332  2344454              4566777788


Q ss_pred             eEEEEEecCCCChhhhhhhccC------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517          217 RALVYEYMPNGSLDRHIFSKEN------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  290 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  290 (453)
                      .++||||+++|+|.+++.....      ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEE
Confidence            8999999999999999854321      124578999999999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHH
Q 048517          291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  369 (453)
Q Consensus       291 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  369 (453)
                      +|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+......        ..
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~  249 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------QV  249 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--------HH
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCHH--------HH
Confidence            999999865443332223344578899999998764  78999999999999999999 88888643221        12


Q ss_pred             HHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ...+..+......      ...+..+.+++.+||+.||++|||+.++++.|+..++.
T Consensus       250 ~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          250 LRFVMEGGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHHcCCcCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            3333333322211      12345688999999999999999999999999987664

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.4e-38  Score=303.26  Aligned_cols=243  Identities=26%  Similarity=0.415  Sum_probs=184.2

Q ss_pred             hHHHHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH--------HHHHHH--------------Hhcccc
Q 048517          156 PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA--------EEFINE--------------LLGLCS  212 (453)
Q Consensus       156 ~~~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~--------~~~i~e--------------l~g~~~  212 (453)
                      |.+....+.+.+.||+|+||+||+|+. .+++.||||++.......        +++.+|              +++++.
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            334445677789999999999999996 479999999987533221        344444              334443


Q ss_pred             cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc--eeecccCCcceEEcCCCc---
Q 048517          213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFI---  287 (453)
Q Consensus       213 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dikp~NILl~~~~~---  287 (453)
                      ..  .++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.   
T Consensus        94 ~~--~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           94 NP--PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             TT--TEEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             CC--CeEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCc
Confidence            33  3799999999999988853   335799999999999999999999998   7  999999999999987776   


Q ss_pred             --eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc
Q 048517          288 --PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF  365 (453)
Q Consensus       288 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~  365 (453)
                        +||+|||+++.....     .....||+.|+|||.+......++.++||||+|+++|||++|+.||.......     
T Consensus       166 ~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----  235 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----  235 (287)
T ss_dssp             CCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----
T ss_pred             eeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----
Confidence              999999999854332     24567999999999985443467899999999999999999999997543221     


Q ss_pred             hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          366 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       366 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      ................      +..++..+.+++.+||+.||++|||++++++.|+.
T Consensus       236 ~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          236 IKFINMIREEGLRPTI------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHHHHHHSCCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHhccCCCCCC------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            0111111122211111      12234678899999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=313.67  Aligned_cols=243  Identities=25%  Similarity=0.410  Sum_probs=180.4

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcE----EEEEEecCC--CCCHHHHHHH--------------HhcccccCcceEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRL----IAVKMMENS--KFSAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~----VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      ..|.+.++||+|+||.||+|+.. +++.    ||+|.+...  ....+++.+|              +++++... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence            34667789999999999999954 5554    577777542  3345556555              34455443 4789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ++||+.+|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        94 v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999998543   35689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      .............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        ....+..+..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  237 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGER  237 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             cCccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            544433333445678899999999864  78999999999999999999 999997543221        3334444333


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ....      ...+..+.+++.+||+.||++|||+.|+++.|+.....
T Consensus       238 ~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 LPQP------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            2221      11335688999999999999999999999999987654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-38  Score=320.77  Aligned_cols=234  Identities=20%  Similarity=0.311  Sum_probs=179.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH---------------HhcccccCcceEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE---------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e---------------l~g~~~~~~~~~lv~  221 (453)
                      .+.+.+.||+|+||.||+++.. +++.||||++++.....    +.+..|               +++++......++||
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~  132 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI  132 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence            4566789999999999999965 68899999997632211    111111               456677788899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|..++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       133 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          133 EYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999988533    4689999999999999999999998   999999999999999999999999999986433


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc-cccchHHHHHHhhhCCCcc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-KAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~l~~~~~~~  380 (453)
                      ...  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||........ .........+.+...... 
T Consensus       206 ~~~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-  280 (396)
T 4dc2_A          206 PGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-  280 (396)
T ss_dssp             TTC--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-
T ss_pred             CCC--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-
Confidence            222  23456799999999999864  789999999999999999999999965432211 111222334444333221 


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM  413 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  413 (453)
                            .+..++..+.+++.+||+.||++||++
T Consensus       281 ------~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          281 ------IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                  112234568899999999999999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.8e-38  Score=312.78  Aligned_cols=258  Identities=24%  Similarity=0.316  Sum_probs=189.7

Q ss_pred             hhHHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH----------------HhcccccCc---
Q 048517          155 LPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE----------------LLGLCSEGF---  215 (453)
Q Consensus       155 ~~~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e----------------l~g~~~~~~---  215 (453)
                      ..+.....+.+.+.||+|+||.||+|+.. |+.||||++....  ...+..|                +++++....   
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            34556677888899999999999999975 8999999997532  2233222                334444443   


Q ss_pred             -ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhH--------cCCCCceeecccCCcceEEcCCC
Q 048517          216 -KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH--------NGCDVCILHFDIKPHNILLDHNF  286 (453)
Q Consensus       216 -~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dikp~NILl~~~~  286 (453)
                       ..++||||+++|+|.+++..     ..+++..++.++.|++.||+|||        +.   +|+||||||+|||++.++
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred             ceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence             67999999999999999843     35899999999999999999999        65   999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCce--eecccCCCCCccChhhhcccCC----CCCccchHHHHHHHHHHHHcC----------C
Q 048517          287 IPKVSDFGLAKFHPKENDFV--SISDTRGTIGYLAPELISRNFG----TVSCKSDVYGFGMVLLEMAGG----------R  350 (453)
Q Consensus       287 ~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~s~k~DV~S~Gvvl~elltg----------~  350 (453)
                      .+||+|||+++.........  ......||+.|+|||.+.+...    .++.++||||||+++|||++|          +
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            99999999998765443221  1234579999999999875311    233689999999999999999          5


Q ss_pred             CCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          351 RNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       351 ~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      .||......  ......+............+.... ........+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus       265 ~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          265 LPYYDLVPS--DPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CTTTTTSCS--SCCHHHHHHHHTTSCCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCccccCcC--cccHHHHHHHHHHHHhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            666443221  111122222222222222221111 2234567899999999999999999999999999976544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-38  Score=314.49  Aligned_cols=242  Identities=21%  Similarity=0.281  Sum_probs=182.7

Q ss_pred             HHHHHhhhhh-cccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH---------------HhcccccCcc
Q 048517          157 EIIAVTNHFT-HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE---------------LLGLCSEGFK  216 (453)
Q Consensus       157 ~~~~~~~~~~-~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e---------------l~g~~~~~~~  216 (453)
                      +.....|.+. ++||+|+||.||+|+.. +|+.||||++.....   ...++..|               +++++.....
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            4555566665 78999999999999965 699999999876322   23444444               4556667778


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEec
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDF  293 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DF  293 (453)
                      .++||||+++|+|.+++..  .....+++..++.++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            8999999999999998843  2346799999999999999999999998   9999999999999987   789999999


Q ss_pred             CCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh
Q 048517          294 GLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       294 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      |+++.......   .....||+.|+|||.+...  .++.++||||||+++|||++|+.||......        .....+
T Consensus       179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i  245 (327)
T 3lm5_A          179 GMSRKIGHACE---LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--------ETYLNI  245 (327)
T ss_dssp             GGCEEC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred             ccccccCCccc---cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch--------HHHHHH
Confidence            99987654332   2345799999999999754  7899999999999999999999999654321        122222


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ........   ......++..+.+++.+||+.||++|||++++++.
T Consensus       246 ~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 SQVNVDYS---EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHTCCCCC---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HhcccccC---chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            22211110   11112344668899999999999999999999873

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=307.38  Aligned_cols=234  Identities=21%  Similarity=0.288  Sum_probs=175.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---------------------------HHHHHHH-------
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---------------------------AEEFINE-------  206 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---------------------------~~~~i~e-------  206 (453)
                      .|.+.+.||+|+||.||+|+. .+|+.||||++......                           .+++.+|       
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            466778999999999999995 47899999998764311                           1233444       


Q ss_pred             -------Hhccccc--CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCC
Q 048517          207 -------LLGLCSE--GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKP  277 (453)
Q Consensus       207 -------l~g~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp  277 (453)
                             +++++..  ....++||||+++|+|.+++     ....+++..+..++.|++.||+|||+.   +|+||||||
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  165 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP  165 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence                   3455544  55789999999999998764     235699999999999999999999998   999999999


Q ss_pred             cceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCC-CCCccchHHHHHHHHHHHHcCCCCCCCC
Q 048517          278 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGRRNSNMN  356 (453)
Q Consensus       278 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~k~DV~S~Gvvl~elltg~~p~~~~  356 (453)
                      +|||++.++.+||+|||+++.......  ......||+.|+|||.+.+... ..+.++||||||+++|||++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999987654332  2345679999999999875421 1477899999999999999999999643


Q ss_pred             ccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          357 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       357 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...        .....+..... ....    ...++..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~--------~~~~~~~~~~~-~~~~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RIM--------CLHSKIKSQAL-EFPD----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SHH--------HHHHHHHHCCC-CCCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cHH--------HHHHHHhcccC-CCCC----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            211        12222222211 1111    1123456889999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.6e-38  Score=315.72  Aligned_cols=239  Identities=19%  Similarity=0.162  Sum_probs=182.8

Q ss_pred             HhhhhhcccCccCceEEEEEE------EcCCcEEEEEEecCCCCCHHHHHHH-----------------HhcccccCcce
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQ------LHTGRLIAVKMMENSKFSAEEFINE-----------------LLGLCSEGFKR  217 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~------~~~g~~VAVK~l~~~~~~~~~~i~e-----------------l~g~~~~~~~~  217 (453)
                      ..|.+.++||+|+||+||+|.      ..+++.||||++....  ..++..|                 +++.+......
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            356677899999999999993      4578999999997643  2233222                 34555667788


Q ss_pred             EEEEEecCCCChhhhhhhccC-CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-----------C
Q 048517          218 ALVYEYMPNGSLDRHIFSKEN-KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----------N  285 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-----------~  285 (453)
                      ++||||+++|+|.+++..... ....++|..++.|+.|+++||+|||+.   +|+||||||+|||++.           +
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence            999999999999999965332 346799999999999999999999998   9999999999999988           8


Q ss_pred             CceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc
Q 048517          286 FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF  365 (453)
Q Consensus       286 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~  365 (453)
                      +.+||+|||+++...............||++|+|||++.+.  .++.++|||||||++|||++|+.||.........   
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---  294 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---  294 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCcee---
Confidence            99999999999765432222344567899999999999864  6899999999999999999999998543321100   


Q ss_pred             hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhCCCC
Q 048517          366 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR-PSMTKVLEMLEGSID  425 (453)
Q Consensus       366 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Ps~~evl~~Le~~~~  425 (453)
                             +.  ....  ..     .....+.+++..|++.+|.+| |+++++.+.|+..++
T Consensus       295 -------~~--~~~~--~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          295 -------PE--GLFR--RL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             -------EC--SCCT--TC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -------ec--hhcc--cc-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                   00  0000  00     013456778999999999999 578888888886554

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.4e-39  Score=308.76  Aligned_cols=242  Identities=22%  Similarity=0.350  Sum_probs=176.6

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      ...|.+.+.||+|+||.||+|...    .+..||||++.....  ..+.+..|              +++++. ....++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            446777899999999999999864    256799999876432  23344444              345543 456789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence            99999999999998532   34689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ...... ......+|+.|+|||.+...  .++.++||||||+++|||++ |+.||.......        ....+..+..
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~~~~  235 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGER  235 (281)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             Cccccc-ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHcCCC
Confidence            543321 12344578899999999764  78999999999999999997 889986543221        2333433332


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ....      ..++..+.+++.+||+.||++|||+.++++.|+.+++
T Consensus       236 ~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          236 LPMP------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             CCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            2221      2234568899999999999999999999999987543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.2e-38  Score=312.23  Aligned_cols=254  Identities=27%  Similarity=0.378  Sum_probs=189.0

Q ss_pred             HhhhhhcccCccCceEEEEEEE-----cCCcEEEEEEecCCCCC-HHHHHHH--------------Hhcccc--cCcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCS--EGFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-----~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~--~~~~~~  218 (453)
                      ..+.+.++||+|+||.||+|++     .+++.||||++...... .+.+.+|              +++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4566778999999999999984     36889999999765332 2334444              334433  455678


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence            9999999999999985432   4589999999999999999999998   999999999999999999999999999997


Q ss_pred             cCCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccc-------ccccchHHHH
Q 048517          299 HPKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS-------SKAYFPSWVY  370 (453)
Q Consensus       299 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~-------~~~~~~~~~~  370 (453)
                      ........ ......||+.|+|||.+.+.  .++.++||||||++++||++|+.|+.......       ..........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            75544322 22345688899999999764  67899999999999999999999986432210       0000111122


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      +.+..+.....      +..++..+.+++.+||+.||++|||+.++++.|+.......
T Consensus       255 ~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          255 ELLEEGQRLPA------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             HHhhcccCCCC------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            23333322221      12234678899999999999999999999999998776544

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-38  Score=309.67  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=190.9

Q ss_pred             HHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCCC--HHHHHHH---------------Hhccccc-Cc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSE-GF  215 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~-~~  215 (453)
                      ...+.+.+.||+|+||.||+|+.      .+++.||||++......  .+.+..|               +++++.. +.
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            34567778999999999999984      35689999999764332  2234343               3344443 34


Q ss_pred             ceEEEEEecCCCChhhhhhhccCC------------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENK------------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD  283 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~  283 (453)
                      ..++||||+++|+|.+++......            ...+++..++.++.|++.||.|||+.   +|+||||||+|||++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~  182 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  182 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC
Confidence            589999999999999998654321            12388999999999999999999998   999999999999999


Q ss_pred             CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccc
Q 048517          284 HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSK  362 (453)
Q Consensus       284 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~  362 (453)
                      .++.+||+|||+++...............||+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......   
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---  257 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---  257 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccchh---
Confidence            9999999999999876555444444556789999999999764  78999999999999999998 99998653321   


Q ss_pred             ccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                          ......+..+......      ...+..+.+++.+||+.||++|||+.++++.|+..++
T Consensus       258 ----~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          258 ----EEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             ----HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHHhccCccCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                1233344443332221      1134568899999999999999999999999987653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-38  Score=305.11  Aligned_cols=239  Identities=23%  Similarity=0.317  Sum_probs=182.0

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCcceEEEE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ....|.+.++||+|+||.||+++.. +++.||+|++....  ...+.+..|              +++++......++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3456788899999999999999964 78999999987643  234555444              566777788889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE---cCCCceEEEecCCccc
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKF  298 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~  298 (453)
                      ||+++|+|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999999999866544456799999999999999999999998   99999999999999   4568899999999986


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ......   .....||+.|+|||.+.+   .++.++||||||++++||++|+.||......        ...........
T Consensus       177 ~~~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--------~~~~~~~~~~~  242 (285)
T 3is5_A          177 FKSDEH---STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--------EVQQKATYKEP  242 (285)
T ss_dssp             -------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC
T ss_pred             cCCccc---CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHH--------HHHhhhccCCc
Confidence            644322   244569999999999863   6889999999999999999999999654321        11222222111


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ....    ....++..+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 NYAV----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccc----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1100    01113456789999999999999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.8e-38  Score=310.70  Aligned_cols=248  Identities=29%  Similarity=0.409  Sum_probs=178.3

Q ss_pred             HhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCc----
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGF----  215 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~----  215 (453)
                      ..+.+.+.||+|+||.||+|...    +++.||||++.......   +++..|              +++++....    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            45566788999999999999854    35589999997654332   334444              344444333    


Q ss_pred             -ceEEEEEecCCCChhhhhhhcc--CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEe
Q 048517          216 -KRALVYEYMPNGSLDRHIFSKE--NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  292 (453)
Q Consensus       216 -~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~D  292 (453)
                       ..++||||+++|+|.+++....  .....+++..++.++.|+++||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence             3489999999999999985432  2346799999999999999999999998   999999999999999999999999


Q ss_pred             cCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHH
Q 048517          293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYD  371 (453)
Q Consensus       293 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  371 (453)
                      ||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.......        ..+
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~  260 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--------MYD  260 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHH
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHH
Confidence            9999876544333333445678899999999764  78999999999999999999 888886543221        233


Q ss_pred             HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCC
Q 048517          372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  427 (453)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~  427 (453)
                      .+..+......      ..++..+.+++.+||+.+|++|||+.++++.|+..++.+
T Consensus       261 ~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          261 YLLHGHRLKQP------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHHTTCCCCCB------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHcCCCCCCC------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            33333222211      123456889999999999999999999999999876543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=319.52  Aligned_cols=244  Identities=27%  Similarity=0.405  Sum_probs=177.0

Q ss_pred             hhhhcccCccCceEEEEEEEc--CC--cEEEEEEecCCCC--CHHHHHHH--------------Hhcccc-cCcceEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH--TG--RLIAVKMMENSKF--SAEEFINE--------------LLGLCS-EGFKRALVY  221 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~--~g--~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~-~~~~~~lv~  221 (453)
                      +.+.+.||+|+||+||+|+..  ++  ..||||.++....  ..+++.+|              ++++|. .....++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            456689999999999999853  22  4689999876332  23556666              455543 345778999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|.+++..   ....+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       171 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          171 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             ECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence            99999999999843   335688999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCc--eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          302 ENDF--VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       302 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ....  .......+|+.|+|||.+.+.  .++.++||||||+++|||++ |.+||.......        ....+.++..
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------~~~~~~~~~~  314 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR  314 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------HHHHHHTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------HHHHHHcCCC
Confidence            3211  112344678899999999764  78999999999999999999 566665433221        2223333332


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      ....      ...+..+.+++.+||+.+|++|||+.++++.|+.++..+.
T Consensus       315 ~~~p------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          315 LLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             CCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            2211      1234568899999999999999999999999998776544

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-37  Score=297.25  Aligned_cols=239  Identities=21%  Similarity=0.326  Sum_probs=185.2

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccC--cceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEG--FKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~--~~~~lv~  221 (453)
                      ..+.+.++||+|+||.||+|+.+ |+.||||++......   .+++.+|              +++++...  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            35667789999999999999986 899999999875433   2345555              45555554  6779999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc--eeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||+++|+|.+++...  ....+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.++|+|||++...
T Consensus        89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999998532  234689999999999999999999997   7  999999999999999999999999887643


Q ss_pred             CCCCCceeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ..       ....||+.|+|||.+.+. ....+.++||||||+++|||++|+.||......       .........+..
T Consensus       164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~  229 (271)
T 3kmu_A          164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALEGLR  229 (271)
T ss_dssp             SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHSCCC
T ss_pred             cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhcCCC
Confidence            22       335689999999998753 123445899999999999999999999644321       112222222222


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ...      +..++..+.+++.+||+.||++|||++++++.|+...+
T Consensus       230 ~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 PTI------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            221      12234568899999999999999999999999987543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.6e-38  Score=305.83  Aligned_cols=252  Identities=22%  Similarity=0.370  Sum_probs=187.5

Q ss_pred             HHHhhhhhcccCccCceEEEEEEE-----cCCcEEEEEEecCCC--CCHHHHHHH--------------HhcccccC--c
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEG--F  215 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~-----~~g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~--~  215 (453)
                      ....+.+.++||+|+||.||+|++     .+++.||||++....  ...+.+..|              +++++...  .
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            344566778999999999999984     368999999997532  233445444              34455444  5


Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      ..++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             eEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence            578999999999999998543   24689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccc-------cccccchH
Q 048517          296 AKFHPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR-------SSKAYFPS  367 (453)
Q Consensus       296 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~-------~~~~~~~~  367 (453)
                      ++........ .......||..|+|||.+.+.  .++.++||||+|+++|||++|+.|+......       ........
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence            9877654432 223445688899999999764  7889999999999999999999875432110       00000111


Q ss_pred             HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      .....+..+.....      +..++..+.+++.+||+.||++|||+.+++++|+..+
T Consensus       251 ~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          251 RLVNTLKEGKRLPC------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhccCCCCC------CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            12222333322221      1223467889999999999999999999999998654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.1e-38  Score=305.61  Aligned_cols=243  Identities=21%  Similarity=0.274  Sum_probs=178.5

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .|.+.++||+|+||+||+|+..+|+.||||++.....   ..+.+.+|              +++++......++||||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            3567789999999999999988899999999876432   22445555              456667777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++ +|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           83 DQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             SE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             CC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            75 888887432   35689999999999999999999998   999999999999999999999999999987643221


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc-----
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL-----  379 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~-----  379 (453)
                        ......||+.|+|||.+.+. ..++.++||||+|+++|||++|+.||........    ...+...+......     
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ----LMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTG
T ss_pred             --ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHHCCCChhhchhh
Confidence              22345689999999998753 3689999999999999999999999975432110    00011111100000     


Q ss_pred             --------cc-----cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          380 --------EL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       380 --------~~-----~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                              ..     .........++..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                    00     0000011224567889999999999999999999976

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.9e-38  Score=307.76  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=171.9

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .|.+.++||+|+||.||+|.. .+|+.||||++....  ...+.+.+|              +++++......++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   85 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM   85 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence            466778999999999999995 479999999987532  223445444              566777788899999999


Q ss_pred             CCCChhhhhhhcc--CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          225 PNGSLDRHIFSKE--NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       225 ~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      + |+|.+++....  .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            7 69999886432  2234689999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC----
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD----  378 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~----  378 (453)
                      ..  ......||+.|+|||.+.+. ..++.++|||||||++|||++|+.||.......    ....+.+.+.....    
T Consensus       162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          162 VN--TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE----QLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             CC--CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCTTTCG
T ss_pred             cc--cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhHhh
Confidence            22  12345789999999998753 368999999999999999999999997543211    00111111110000    


Q ss_pred             -----------ccc---cch-----hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 -----------LEL---RNV-----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 -----------~~~---~~~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                 ...   ...     ......++..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                       000   000     0001123457899999999999999999999876

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-38  Score=312.07  Aligned_cols=237  Identities=21%  Similarity=0.288  Sum_probs=174.6

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---HHHHHH----------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE----------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~~~i~e----------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.++||+|+||.||++...+++.||||++.......   +.+.+|                +++++......++|||
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e   89 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME   89 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence            466778999999999999998889999999997654332   233333                3455667778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                       +.+|+|.+++..    ...+++.++..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||+++.....
T Consensus        90 -~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           90 -CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             -CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             -CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence             568999999853    25689999999999999999999998   999999999999997 578999999999876554


Q ss_pred             CCceeecccCCCCCccChhhhccc---------CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh
Q 048517          303 NDFVSISDTRGTIGYLAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      ..........||+.|+|||++.+.         .+.++.++|||||||++|||++|+.||......      .......+
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~  234 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAII  234 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHH
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------HHHHHHHh
Confidence            433233456799999999998641         146889999999999999999999999643211      01112222


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ..........      ..+..+.+++.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 DPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CTTSCCCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCcccCCcc------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            2222222111      112467899999999999999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-38  Score=316.23  Aligned_cols=231  Identities=23%  Similarity=0.328  Sum_probs=181.3

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH---------------HhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE---------------LLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e---------------l~g~~~~~~~~~lv  220 (453)
                      ..+.+.+.||+|+||.||+|+.. +|+.||||+++..    ....+....|               +++.+......++|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            34566789999999999999965 6899999999753    2222222222               45566777889999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            9999999999998542    4689999999999999999999998   99999999999999999999999999998643


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ....  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        .+...+...... 
T Consensus       170 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~-  236 (345)
T 1xjd_A          170 LGDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNPF-  236 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC-
T ss_pred             cCCC--cccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCCCC-
Confidence            3222  23456799999999999764  7899999999999999999999999754321        133333333211 


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT-KVL  417 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl  417 (453)
                      .      +..++..+.+++.+||+.||++||++. ++.
T Consensus       237 ~------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 Y------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             C------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             C------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            1      112345688999999999999999997 664

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-37  Score=320.95  Aligned_cols=246  Identities=23%  Similarity=0.374  Sum_probs=191.7

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++....    ...+.+.+|              +++++......++|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4667789999999999999965 79999999997532    223344444              4666777788999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        97 ~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           97 YVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             CCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999884    235699999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..   .....||+.|+|||++.+. ...+.++||||+||++|||++|+.||......        .....+..+....  
T Consensus       170 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~--  235 (476)
T 2y94_A          170 EF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKICDGIFYT--  235 (476)
T ss_dssp             CC---BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHHTTCCCC--
T ss_pred             cc---ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCcCC--
Confidence            32   2456799999999999764 23478999999999999999999999754321        1233333332111  


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCCCCCCCCCCCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSIDDLQMPPKP  433 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~~~~~~~p~~p  433 (453)
                           +..++..+.+++.+||+.||++|||+.++++  .+.........|+.+
T Consensus       236 -----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~  283 (476)
T 2y94_A          236 -----PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDP  283 (476)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSS
T ss_pred             -----CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCc
Confidence                 1123356889999999999999999999998  666655444444443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-38  Score=309.21  Aligned_cols=228  Identities=25%  Similarity=0.353  Sum_probs=181.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .+.+.+.||+|+||.||+++.. +|+.||||++...    ....+.+..|              +++.+.+....++|||
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e   86 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   86 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence            4567789999999999999965 7999999998753    1223333333              5666777888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           87 YIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            9999999999853    24689999999999999999999998   9999999999999999999999999999875432


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                           .....||+.|+|||++.+.  .++.++||||+|+++|||++|+.||......        .....+..... .. 
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~-~~-  222 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAEL-RF-  222 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCCC-CC-
T ss_pred             -----cccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-CC-
Confidence                 2345799999999999764  7899999999999999999999999654321        12233333221 11 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                           +..++..+.+++.+||+.||++||     +++++++
T Consensus       223 -----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          223 -----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                 112345688999999999999999     8999884

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.1e-38  Score=314.35  Aligned_cols=247  Identities=25%  Similarity=0.288  Sum_probs=179.3

Q ss_pred             HHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH-------------------HhcccccCcceE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE-------------------LLGLCSEGFKRA  218 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e-------------------l~g~~~~~~~~~  218 (453)
                      ....|.+.++||+|+||+||+|+. .+++.||||++.......+.+..|                   +++++......+
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~  112 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC  112 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence            344667779999999999999996 578999999997543322222222                   344555667789


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC--------------
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--------------  284 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~--------------  284 (453)
                      +||||+ +++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.              
T Consensus       113 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          113 LIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             EEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             EEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccc
Confidence            999999 99999988543  234589999999999999999999998   9999999999999975              


Q ss_pred             -----------CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCC
Q 048517          285 -----------NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  353 (453)
Q Consensus       285 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~  353 (453)
                                 ++.+||+|||+++......     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCC
Confidence                       7899999999998654322     345789999999999864  7899999999999999999999999


Q ss_pred             CCCcccccc-------ccchHHHHHHhhhCC--------Ccc--ccchh--------------hhHHHHHHHHHHHHHHh
Q 048517          354 NMNATRSSK-------AYFPSWVYDQLNKGG--------DLE--LRNVT--------------EIESMIARKLCMIGLWC  402 (453)
Q Consensus       354 ~~~~~~~~~-------~~~~~~~~~~l~~~~--------~~~--~~~~~--------------~~~~~~~~~l~~l~~~C  402 (453)
                      .........       ...+...........        ...  .....              .........+.+++.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            754321100       000111110000000        000  00000              00111125678999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 048517          403 IQVKAADRPSMTKVLE  418 (453)
Q Consensus       403 l~~~p~~RPs~~evl~  418 (453)
                      |+.||++|||++|+++
T Consensus       340 L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          340 LQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCSSGGGSCCHHHHTT
T ss_pred             hcCChhhCCCHHHHhc
Confidence            9999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.6e-38  Score=328.08  Aligned_cols=247  Identities=19%  Similarity=0.263  Sum_probs=186.1

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .|.+.++||+|+||.||+|+. .+++.||||++....... ++..|               +..++......++||||+ 
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            466778999999999999995 579999999887533211 12221               223445566778999999 


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE---cCCCceEEEecCCccccCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~~~~  302 (453)
                      +++|.+++...   ...+++..++.|+.||+.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        86 g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           86 GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99999988532   35699999999999999999999998   99999999999999   68899999999999876544


Q ss_pred             CCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          303 NDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       303 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ...     .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||...........+.......+..  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~--  235 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT--  235 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS--
T ss_pred             ccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc--
Confidence            321     112356799999999999864  78999999999999999999999997644322111111111111100  


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                           ........++..+.+++.+||+.+|++||++.+|+++|+..+.
T Consensus       236 -----~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          236 -----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             -----CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -----cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                 0011222345678999999999999999999999999987643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-38  Score=313.43  Aligned_cols=235  Identities=21%  Similarity=0.294  Sum_probs=163.1

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH---------------HhcccccCcceEEEEEecCCCChh
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE---------------LLGLCSEGFKRALVYEYMPNGSLD  230 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~gsL~  230 (453)
                      +.||+|+||.||+|+.. +|+.||||++....  ...+..|               +++++.+....++||||+++|+|.
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChhh--hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            67999999999999965 78999999997532  2222222               566677788899999999999999


Q ss_pred             hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC---ceEEEecCCccccCCCCCcee
Q 048517          231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +++..    ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.++   .+||+|||+++.......  .
T Consensus        95 ~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~  165 (325)
T 3kn6_A           95 ERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P  165 (325)
T ss_dssp             HHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence            99853    25699999999999999999999998   999999999999997655   899999999987654332  2


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      .....||+.|+|||.+.+.  .++.++||||+|+++|||++|+.||......... .....+...+..+...   ...+.
T Consensus       166 ~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~~~~~~---~~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIKKGDFS---FEGEA  239 (325)
T ss_dssp             ------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHTTTCCC---CCSHH
T ss_pred             ccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHHcCCCC---CCccc
Confidence            2456789999999999764  7899999999999999999999999764432111 1122233444433221   11122


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...++..+.+++.+||+.||++|||++++++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            3345677899999999999999999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.3e-38  Score=307.05  Aligned_cols=235  Identities=20%  Similarity=0.271  Sum_probs=174.7

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccC----------
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEG----------  214 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~----------  214 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++.....  ..+.+.+|              +++++.+.          
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~   86 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD   86 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence            4667789999999999999975 899999999875332  33455555              23333221          


Q ss_pred             -----------------------------------------------cceEEEEEecCCCChhhhhhhccCCCCCCCchh
Q 048517          215 -----------------------------------------------FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEK  247 (453)
Q Consensus       215 -----------------------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~  247 (453)
                                                                     ...++||||+++|+|.+++.... .....++..
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~  165 (332)
T 3qd2_B           87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGV  165 (332)
T ss_dssp             C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHH
T ss_pred             hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHH
Confidence                                                           13789999999999999985432 234456777


Q ss_pred             HHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc----------eeecccCCCCCc
Q 048517          248 PHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF----------VSISDTRGTIGY  317 (453)
Q Consensus       248 ~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y  317 (453)
                      ++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........          .......||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            899999999999999998   9999999999999999999999999999876544211          112345699999


Q ss_pred             cChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHH
Q 048517          318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCM  397 (453)
Q Consensus       318 ~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~  397 (453)
                      +|||.+.+.  .++.++||||||+++|||++|..|+...          ............      ..........+.+
T Consensus       243 ~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~~~~~~------~~~~~~~~~~~~~  304 (332)
T 3qd2_B          243 MSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDVRNLKF------PLLFTQKYPQEHM  304 (332)
T ss_dssp             SCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHHHTTCC------CHHHHHHCHHHHH
T ss_pred             cChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHhhccCC------CcccccCChhHHH
Confidence            999999864  7899999999999999999987653210          011112222111      1123344566789


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 048517          398 IGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       398 l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ++.+||+.||++|||+.|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.5e-38  Score=318.72  Aligned_cols=235  Identities=23%  Similarity=0.277  Sum_probs=170.8

Q ss_pred             cccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHH--HH---------Hhccccc----CcceEEEEEecCCCChh
Q 048517          167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFI--NE---------LLGLCSE----GFKRALVYEYMPNGSLD  230 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i--~e---------l~g~~~~----~~~~~lv~E~~~~gsL~  230 (453)
                      +.||+|+||+||+++.. +|+.||||++........+..  .+         +++++..    ....++||||+++|+|.
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~  147 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF  147 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHH
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHH
Confidence            67999999999999965 789999999975432222211  11         3333332    45678999999999999


Q ss_pred             hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEecCCccccCCCCCcee
Q 048517          231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      +++...  ....+++..+..|+.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++......   .
T Consensus       148 ~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~  219 (400)
T 1nxk_A          148 SRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---S  219 (400)
T ss_dssp             HHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC---c
Confidence            998532  234699999999999999999999998   9999999999999987   7899999999998764432   2


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||..........    .....+..+.....   ...
T Consensus       220 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~~~~i~~~~~~~~---~~~  290 (400)
T 1nxk_A          220 LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMKTRIRMGQYEFP---NPE  290 (400)
T ss_dssp             -------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC----SHHHHHHHTCCCCC---TTT
T ss_pred             cccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH----HHHHHHHcCcccCC---Ccc
Confidence            2456789999999998753  78999999999999999999999997654322111    12222222221110   001


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...++..+.+++.+||+.||++|||+.++++
T Consensus       291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1234567889999999999999999999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7e-38  Score=304.11  Aligned_cols=245  Identities=27%  Similarity=0.403  Sum_probs=182.7

Q ss_pred             hhhhhcccCccCceEEEEEEEcC----CcEEEEEEecCCCC--CHHHHHHH--------------Hhccc-ccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMMENSKF--SAEEFINE--------------LLGLC-SEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~----g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~-~~~~~~~lv  220 (453)
                      ++.+.++||+|+||+||+|+..+    +..||||.+.....  ..+++.+|              +++++ ......++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            45667899999999999998542    23689999876332  22344444              44553 345577899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       106 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          106 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999999843   335689999999999999999999998   99999999999999999999999999998664


Q ss_pred             CCCCc--eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC-CCCCCCccccccccchHHHHHHhhhCC
Q 048517          301 KENDF--VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       301 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      .....  .......+|+.|+|||.+.+.  .++.++||||+|++++||++|+ +|+.......        ....+..+.
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--------~~~~~~~~~  249 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGR  249 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--------HHHHHHTTC
T ss_pred             ccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhcCC
Confidence            33211  122345678899999999764  7899999999999999999955 4554332211        222233322


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      .....      ...+..+.+++.+||+.+|++|||+++++++|+..+..+.
T Consensus       250 ~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          250 RLLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             CCCCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            22111      1123568899999999999999999999999998776543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.2e-38  Score=315.07  Aligned_cols=240  Identities=22%  Similarity=0.296  Sum_probs=185.0

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHH---HHHH---------HhcccccCcceEEEEEecCC
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE---FINE---------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~---~i~e---------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ...|.+.+.||+|+||.||+++.. +|+.||||++........+   .+.+         +++++.++...++||||+++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g  100 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG  100 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence            345677789999999999999965 7899999999875433222   1222         56677788889999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC----CceEEEecCCccccCCC
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN----FIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~----~~~kl~DFGla~~~~~~  302 (453)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||+..+    +.+||+|||+++.....
T Consensus       101 g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A          101 GELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            999998843    35689999999999999999999998   99999999999998432    35999999999876543


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......     ....+...+..+..... 
T Consensus       174 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i~~~~~~~~-  243 (342)
T 2qr7_A          174 NG--LLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDD-----TPEEILARIGSGKFSLS-  243 (342)
T ss_dssp             TC--CBCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-----CHHHHHHHHHHCCCCCC-
T ss_pred             CC--ceeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-----CHHHHHHHHccCCcccC-
Confidence            32  22456789999999999764  5788999999999999999999999753221     12223344444332111 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        ......++..+.+++.+||+.||++|||+.++++
T Consensus       244 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 --GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              1112234567889999999999999999999987

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.4e-38  Score=314.17  Aligned_cols=232  Identities=24%  Similarity=0.293  Sum_probs=181.2

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH---------------HhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE---------------LLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e---------------l~g~~~~~~~~~lv  220 (453)
                      ..+.+.+.||+|+||.||+|+.. +|+.||||++...    ....+.+..|               +++++......++|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            34667789999999999999965 5889999998753    2233333333               34555667788999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       100 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999998532    4689999999999999999999998   99999999999999999999999999998643


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ....  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .+...+...... 
T Consensus       173 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~-  239 (353)
T 2i0e_A          173 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNVA-  239 (353)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC-
T ss_pred             cCCc--ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhCCCC-
Confidence            3222  23456799999999999764  7899999999999999999999999754321        133333332211 


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                      .      +..++..+.+++.+||+.||++||+     +.++++
T Consensus       240 ~------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          240 Y------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             C------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             C------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1      1224467889999999999999995     467664

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.8e-38  Score=306.97  Aligned_cols=236  Identities=22%  Similarity=0.272  Sum_probs=186.1

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-------CHHHHHHH--------------HhcccccCcce
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-------SAEEFINE--------------LLGLCSEGFKR  217 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-------~~~~~i~e--------------l~g~~~~~~~~  217 (453)
                      ...|.+.+.||+|+||.||+|+.. +|+.||||++.....       ..+++.+|              +++++......
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456778899999999999999965 799999999876322       23445454              45667777889


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC----ceEEEec
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSDF  293 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DF  293 (453)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999843    35689999999999999999999998   999999999999999887    7999999


Q ss_pred             CCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh
Q 048517          294 GLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       294 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      |+++.......   .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......        .....+
T Consensus       164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i  230 (321)
T 2a2a_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANI  230 (321)
T ss_dssp             TTCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHH
T ss_pred             ccceecCcccc---ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHH
Confidence            99987654332   2445699999999999754  7899999999999999999999999653321        122222


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...... .  ........+..+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~-~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          231 TSVSYD-F--DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HTTCCC-C--CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Hhcccc-c--ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            222111 1  11122334567889999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-38  Score=306.04  Aligned_cols=239  Identities=22%  Similarity=0.321  Sum_probs=182.3

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CC-------cEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TG-------RLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFK  216 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g-------~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~  216 (453)
                      ...+.+.++||+|+||+||+|+.. ++       +.||+|++..... ..+.+.+|              +++++.....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            345677889999999999999854 34       5799999976433 34445554              5677777888


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc--------e
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--------P  288 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~--------~  288 (453)
                      .++||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence            89999999999999998543   24589999999999999999999998   9999999999999998877        9


Q ss_pred             EEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHH
Q 048517          289 KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW  368 (453)
Q Consensus       289 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  368 (453)
                      ||+|||+++.....      ....||+.|+|||.+.+. ..++.++||||||+++|||++|+.|+.......       .
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-------~  226 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-------R  226 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------H
T ss_pred             eeccCcccccccCc------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchH-------H
Confidence            99999999754322      234578999999999762 368999999999999999999665543322110       1


Q ss_pred             HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          369 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      .............        ..+..+.+++.+||+.||++|||+.++++.|+..+.+
T Consensus       227 ~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          227 KLQFYEDRHQLPA--------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHHHHTTCCCCC--------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HHHHhhccCCCCC--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            1112222111111        1124578899999999999999999999999987664

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-38  Score=335.26  Aligned_cols=236  Identities=25%  Similarity=0.413  Sum_probs=183.9

Q ss_pred             ccCccCceEEEEEEEc---CCcEEEEEEecCC--CCCHHHHHHH--------------HhcccccCcceEEEEEecCCCC
Q 048517          168 KLGQGGFGSVYKGQLH---TGRLIAVKMMENS--KFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGS  228 (453)
Q Consensus       168 ~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gs  228 (453)
                      +||+|+||.||+|...   ++..||||+++..  ....+++.+|              ++++|.. ...++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   5678999999864  2345666666              4566655 45899999999999


Q ss_pred             hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc-ee
Q 048517          229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-VS  307 (453)
Q Consensus       229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~  307 (453)
                      |.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus       422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9999843   235699999999999999999999998   9999999999999999999999999999876543321 11


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      .....+|+.|+|||++...  .++.++|||||||++|||++ |+.||......        .+...+..+......    
T Consensus       496 ~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p----  561 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMECP----  561 (613)
T ss_dssp             ------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHHHHHTTCCCCCC----
T ss_pred             ccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCCCC----
Confidence            2234567899999999764  78999999999999999998 99999754321        244555555443322    


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                        ..++..+.+++.+||+.+|++|||+.++++.|+.....
T Consensus       562 --~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          562 --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             --TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence              22346788999999999999999999999999875443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.2e-38  Score=314.16  Aligned_cols=238  Identities=23%  Similarity=0.309  Sum_probs=186.3

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ....|.+.+.||+|+||.||+|... +|+.||||++.......   +.+.+|              +++++.+....++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3456778899999999999999965 79999999998754433   233333              46677778889999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---CceEEEecCCcc
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAK  297 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~  297 (453)
                      |||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.+   +.+||+|||+++
T Consensus       107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999998843    35689999999999999999999998   99999999999999764   459999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      .......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .....+..+.
T Consensus       180 ~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~~i~~~~  246 (362)
T 2bdw_A          180 EVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAGA  246 (362)
T ss_dssp             CCTTCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC
T ss_pred             EecCCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCC
Confidence            7654332   2346799999999999764  7899999999999999999999999654321        1333333332


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ....   ......++..+.+++.+||+.||++|||+.++++.
T Consensus       247 ~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 YDYP---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCCC---TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCC---cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            2111   11112345678899999999999999999998763

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=314.86  Aligned_cols=246  Identities=29%  Similarity=0.436  Sum_probs=183.2

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcC-----CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHT-----GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~-----g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ...+.+.+.||+|+||.||+|+...     +..||||++......  ..++..|              +++++......+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3345566889999999999998542     246999999764322  2334444              466777778899


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999998532   35689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhC
Q 048517          299 HPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       299 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      ....... .......+|+.|+|||.+...  .++.++||||||+++|||++ |+.||.....        ..+...+..+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~  266 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDG  266 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT
T ss_pred             hccccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCC
Confidence            6543221 112234568899999999754  78999999999999999999 9999864322        1233344443


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCC
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  427 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~  427 (453)
                      ......      ...+..+.+++.+||+.+|++|||+.+++++|+..+...
T Consensus       267 ~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          267 FRLPTP------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             CCCCCC------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CcCCCc------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            322211      123456889999999999999999999999998766543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=317.11  Aligned_cols=265  Identities=15%  Similarity=0.126  Sum_probs=190.7

Q ss_pred             HhhhhhcccCccCceEEEEEEEc---------CCcEEEEEEecCCCCCHHH--H--------HHH---------------
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH---------TGRLIAVKMMENSKFSAEE--F--------INE---------------  206 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~---------~g~~VAVK~l~~~~~~~~~--~--------i~e---------------  206 (453)
                      ..|.+.+.||+|+||.||+|+..         +++.||||++........+  .        +.+               
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~  121 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT  121 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence            46677899999999999999965         3889999999765322211  1        111               


Q ss_pred             Hhccccc-CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC
Q 048517          207 LLGLCSE-GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN  285 (453)
Q Consensus       207 l~g~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~  285 (453)
                      +++++.. +...++||||+ +++|.+++...  ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus       122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             CCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETT
T ss_pred             hhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCC
Confidence            1223333 56789999999 99999999543  235799999999999999999999998   99999999999999999


Q ss_pred             C--ceEEEecCCccccCCCCCce-----eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcc
Q 048517          286 F--IPKVSDFGLAKFHPKENDFV-----SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAT  358 (453)
Q Consensus       286 ~--~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~  358 (453)
                      +  .+||+|||+++.........     ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.....
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            8  99999999998764322111     11334799999999999764  789999999999999999999999975431


Q ss_pred             ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCCCCC
Q 048517          359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSS  437 (453)
Q Consensus       359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~~~~  437 (453)
                      ..  ..+.... ..+.... ............++..+.+++.+||+.||++|||+++++++|+.+++.....+...++.
T Consensus       274 ~~--~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw  348 (352)
T 2jii_A          274 NT--EDIMKQK-QKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGL  348 (352)
T ss_dssp             CH--HHHHHHH-HHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCC
T ss_pred             CH--HHHHHHH-HhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccC
Confidence            11  0011111 1111111 11110000011234678899999999999999999999999999888776555444443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-38  Score=312.86  Aligned_cols=247  Identities=24%  Similarity=0.419  Sum_probs=189.4

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CC-----cEEEEEEecCCCC--CHHHHHHH---------------HhcccccCcc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TG-----RLIAVKMMENSKF--SAEEFINE---------------LLGLCSEGFK  216 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g-----~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~~~~~  216 (453)
                      ...+.+.+.||+|+||.||+|... ++     +.||||++.....  ..+.+..|               +++++.....
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            344566789999999999999864 23     4899999976432  12334333               4566777788


Q ss_pred             eEEEEEecCCCChhhhhhhccC----------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC
Q 048517          217 RALVYEYMPNGSLDRHIFSKEN----------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  286 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~  286 (453)
                      .++||||+++|+|.+++.....          ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence            9999999999999999864321          134689999999999999999999998   999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccc
Q 048517          287 IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYF  365 (453)
Q Consensus       287 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~  365 (453)
                      .+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......      
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------  273 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------  273 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS------
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchh------
Confidence            9999999999866544433334455678899999998764  78999999999999999998 88888653321      


Q ss_pred             hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          366 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       366 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                       ......+..+......      ...+..+.+++.+||+.||.+|||+.++++.|+...
T Consensus       274 -~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          274 -SKFYKLVKDGYQMAQP------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             -HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHHhcCCCCCCC------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence             1123333333222111      112356889999999999999999999999998643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-37  Score=310.58  Aligned_cols=239  Identities=20%  Similarity=0.310  Sum_probs=181.5

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH---------------HhcccccCcceEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE---------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e---------------l~g~~~~~~~~~lv~  221 (453)
                      .+.+.+.||+|+||.||+++.. +|+.||||++.......    +.+..|               +++++......++||
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            4566789999999999999965 68999999998643221    112222               455666778889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        90 e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           90 EYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999988532    4689999999999999999999998   999999999999999999999999999986433


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc-cccchHHHHHHhhhCCCcc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-KAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~l~~~~~~~  380 (453)
                      ...  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||........ ...........+..... .
T Consensus       163 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~  237 (345)
T 3a8x_A          163 PGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R  237 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-C
T ss_pred             CCC--cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-C
Confidence            222  23456799999999999864  789999999999999999999999965322111 11112223333333322 1


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM------TKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~------~evl~  418 (453)
                      .      +..++..+.+++.+||+.||++||++      .++++
T Consensus       238 ~------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          238 I------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             C------CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             C------CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            1      12234568899999999999999995      56654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.8e-38  Score=310.60  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=192.6

Q ss_pred             cchhHHHHHhhhhhcccCccCceEEEEEEE-cCCcEE--EEEEecCC--CCCHHHHHHH---------------Hhcccc
Q 048517          153 ILLPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLI--AVKMMENS--KFSAEEFINE---------------LLGLCS  212 (453)
Q Consensus       153 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~V--AVK~l~~~--~~~~~~~i~e---------------l~g~~~  212 (453)
                      ..+|.+....+.+.+.||+|+||.||+|+. .+|+.+  |||.+...  ....+++..|               +++++.
T Consensus        17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   96 (327)
T 1fvr_A           17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   96 (327)
T ss_dssp             CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             cccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence            345555566778889999999999999995 466654  99988752  2222334333               455666


Q ss_pred             cCcceEEEEEecCCCChhhhhhhcc------------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcce
Q 048517          213 EGFKRALVYEYMPNGSLDRHIFSKE------------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNI  280 (453)
Q Consensus       213 ~~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI  280 (453)
                      .....++||||+++|+|.+++....            .....+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NI  173 (327)
T 1fvr_A           97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI  173 (327)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceE
Confidence            7778899999999999999986432            2335799999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccc
Q 048517          281 LLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATR  359 (453)
Q Consensus       281 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~  359 (453)
                      |++.++.+||+|||+++......   ......+|+.|+|||.+...  .++.++||||||+++|||++ |+.||..... 
T Consensus       174 l~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~-  247 (327)
T 1fvr_A          174 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-  247 (327)
T ss_dssp             EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred             EEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcH-
Confidence            99999999999999997432211   12334578899999999764  67899999999999999998 9999865432 


Q ss_pred             cccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCC
Q 048517          360 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM  429 (453)
Q Consensus       360 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~  429 (453)
                             ......+..+......      ..++..+.+++.+||+.+|++|||+.++++.|+..+++...
T Consensus       248 -------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          248 -------AELYEKLPQGYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             -------HHHHHHGGGTCCCCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             -------HHHHHHhhcCCCCCCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence                   1133344443222211      12345688999999999999999999999999987776543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-38  Score=304.55  Aligned_cols=243  Identities=25%  Similarity=0.400  Sum_probs=189.0

Q ss_pred             hhhhc-ccCccCceEEEEEEEc---CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          163 NHFTH-KLGQGGFGSVYKGQLH---TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       163 ~~~~~-~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      +.+.+ .||+|+||.||+|...   +++.||||++.....  ..+++.+|              +++++ .....++|||
T Consensus        11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e   89 (287)
T 1u59_A           11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME   89 (287)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred             hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence            34444 8999999999999853   688899999987432  23344444              34555 4456899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++++|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           90 MAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             CCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             eCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999998843   335699999999999999999999998   9999999999999999999999999999877544


Q ss_pred             CCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          303 NDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       303 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      .... ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .....+..+....
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~i~~~~~~~  233 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRME  233 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCCCC
T ss_pred             cceeeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHhcCCcCC
Confidence            3321 12334578999999999754  68899999999999999998 99998654321        1333444443322


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      ..      ..++..+.+++.+||+.+|++|||+.++++.|+..+.+..
T Consensus       234 ~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          234 CP------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             CC------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CC------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            21      2234678899999999999999999999999998766544

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=323.11  Aligned_cols=237  Identities=20%  Similarity=0.278  Sum_probs=185.3

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ...|.+.++||+|+||.||+|.. .+|+.||+|++.......   +.+.+|              +++++.+....++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            44677789999999999999985 479999999998754332   233333              567777888899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc---CCCceEEEecCCccc
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKF  298 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGla~~  298 (453)
                      ||+++|+|.+.+...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||+++.
T Consensus        90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999988543    4689999999999999999999998   999999999999998   467899999999987


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ......  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        .....+..+..
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~  230 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQH--------RLYQQIKAGAY  230 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCC
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhCCC
Confidence            654332  22456799999999999764  7899999999999999999999999654321        13334433322


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ....   .....++..+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          231 DFPS---PEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCCT---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCc---cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1111   111233467889999999999999999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=314.63  Aligned_cols=253  Identities=17%  Similarity=0.178  Sum_probs=178.4

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCCH------------HHHHHH--------------
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFSA------------EEFINE--------------  206 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~~------------~~~i~e--------------  206 (453)
                      ++....|.+.++||+|+||.||+|+..    +++.||||++.......            +.++.|              
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            444556778899999999999999965    57889999987653211            112222              


Q ss_pred             Hhccccc----CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE
Q 048517          207 LLGLCSE----GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL  282 (453)
Q Consensus       207 l~g~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl  282 (453)
                      +++++..    ....++||||+ +++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  184 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL  184 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence            3344444    66789999999 99999988432    3799999999999999999999998   99999999999999


Q ss_pred             cCCC--ceEEEecCCccccCCCCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 048517          283 DHNF--IPKVSDFGLAKFHPKENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  355 (453)
Q Consensus       283 ~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~  355 (453)
                      +.++  .+||+|||+++........     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            9877  9999999999876432211     111345799999999999864  789999999999999999999999964


Q ss_pred             CccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          356 NATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       356 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      .....  ... ................. ......++..+.+++.+||+.||++|||+.++++.|+..
T Consensus       263 ~~~~~--~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          263 NLKDP--VAV-QTAKTNLLDELPQSVLK-WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             GTTCH--HHH-HHHHHHHHHTTTHHHHH-HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             ccccc--HHH-HHHHHhhcccccHHHHh-hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            22111  000 00111111100000000 000003445799999999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-38  Score=303.18  Aligned_cols=245  Identities=25%  Similarity=0.358  Sum_probs=184.7

Q ss_pred             hhhhcccCccCceEEEEEEEc-CC---cEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcc-eEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TG---RLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFK-RALVY  221 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g---~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~-~~lv~  221 (453)
                      +...++||+|+||+||+|+.. ++   ..||+|++.....  ..+.+.+|              +++++..... .++++
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            344588999999999999853 33   3799999976433  22344444              4555554444 48999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+.+|+|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       103 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          103 PYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             ecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999999843   335689999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCc--eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          302 ENDF--VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       302 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ....  .......+|+.|+|||.+.+.  .++.++||||||+++|||++|+.|+.......       .....+..+...
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-------~~~~~~~~~~~~  247 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-------DLTHFLAQGRRL  247 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-------GHHHHHHTTCCC
T ss_pred             CcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHH-------HHHHHhhcCCCC
Confidence            3211  122345688999999999764  78999999999999999999666654322211       133333333322


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      ...      ...+..+.+++.+||+.||++|||+.+++++|+..+..+.
T Consensus       248 ~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          248 PQP------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCC------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            211      1233568899999999999999999999999998766543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=314.43  Aligned_cols=234  Identities=19%  Similarity=0.272  Sum_probs=171.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .|.+.++||+|+||.||+|+.. +++.||||++.... ..+.+..|              +++++......++||||+++
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            4667789999999999999965 68899999997642 12222222              56777788889999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEecCCccccCCCC
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~~~~~~~  303 (453)
                      |+|.+++..    ...+++.++..++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++......
T Consensus       133 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          133 GELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            999998842    35689999999999999999999998   9999999999999975   8899999999998664432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                         ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       ......+........  
T Consensus       206 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~~~~--  271 (349)
T 2w4o_A          206 ---LMKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEYYFI--  271 (349)
T ss_dssp             ----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCCCCC--
T ss_pred             ---ccccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCCccC--
Confidence               12345699999999999764  7899999999999999999999999644321       112333333222111  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       ......++..+.+++.+||+.||++|||+.++++
T Consensus       272 -~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 -SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             1111234567889999999999999999999987

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.8e-38  Score=304.78  Aligned_cols=244  Identities=19%  Similarity=0.266  Sum_probs=179.1

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      .|.+.++||+|+||+||+|+.. +|+.||||++......   .+.+.+|              +++++..+...++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            3566789999999999999965 7899999999764332   2344444              45667777888999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++ +|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           83 CDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             CCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            975 55555532   235699999999999999999999998   99999999999999999999999999998765432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc---
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE---  380 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~---  380 (453)
                      .  ......||+.|+|||.+.+. ..++.++||||+|++++||++|+.|+........   ....+.+.+.......   
T Consensus       156 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~---~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          156 R--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH---HHHHHHHHHCCCCTTTCTT
T ss_pred             c--cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhhhhh
Confidence            2  22456789999999998764 3479999999999999999999888643322110   0011111111100000   


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 ---------------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ---------------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                     ..........++..+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                           00000111234567889999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.4e-38  Score=305.36  Aligned_cols=247  Identities=23%  Similarity=0.346  Sum_probs=178.1

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC------CHHHHHHH-----------------Hhcccc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF------SAEEFINE-----------------LLGLCS  212 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~------~~~~~i~e-----------------l~g~~~  212 (453)
                      ++....|.+.++||+|+||+||+|+. .+|+.||||++.....      ....+..|                 +++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            44556778889999999999999995 5799999999864221      11122222                 334443


Q ss_pred             cCc-----ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517          213 EGF-----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  287 (453)
Q Consensus       213 ~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~  287 (453)
                      ...     ..++||||+. |+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            332     4689999996 6999988533  234599999999999999999999998   9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchH
Q 048517          288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS  367 (453)
Q Consensus       288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  367 (453)
                      +||+|||+++.......   .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.......    ...
T Consensus       159 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~  229 (308)
T 3g33_A          159 VKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLG  229 (308)
T ss_dssp             EEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH----HHH
T ss_pred             EEEeeCccccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHH
Confidence            99999999987654332   2456789999999999764  78999999999999999999999997543211    011


Q ss_pred             HHHHHhhhCCCcc----------------ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          368 WVYDQLNKGGDLE----------------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       368 ~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+.+.+.......                ..........++..+.+++.+||+.||++|||+.|+++
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1111111100000                00001111234567889999999999999999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.8e-38  Score=307.20  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=180.9

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++......    .+++.+|              +++++......++|||
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  112 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE  112 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence            567788999999999999995 57999999999763221    2334444              4566677778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++.........+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++.....
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            9999999999865444456789999999999999999999998   9999999999999999999999999999866443


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......      .......+.........
T Consensus       190 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~  259 (310)
T 2wqm_A          190 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPPLP  259 (310)
T ss_dssp             -----------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHHHTTCSCCCC
T ss_pred             Cc--cccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHhhcccCCCCc
Confidence            22  12345689999999998764  7899999999999999999999998643211      11122233332221111


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP  431 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~  431 (453)
                           ...++..+.+++.+||+.||++|||+.++++.|+.+......||
T Consensus       260 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          260 -----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             -----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             -----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence                 11234568899999999999999999999999998655544333

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-38  Score=315.49  Aligned_cols=237  Identities=24%  Similarity=0.293  Sum_probs=173.9

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ..|.+.++||+|+||+||+++.. +|+.||||++.......+.+.+|              +++++......++||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            35777899999999999999965 79999999998765555555444              5667777888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc--eEEEecCCccccCCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--PKVSDFGLAKFHPKEN  303 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~--~kl~DFGla~~~~~~~  303 (453)
                      +|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+++......
T Consensus       100 ~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A          100 GGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             SCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            99999988532    4689999999999999999999998   9999999999999987765  9999999998543222


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCc-cchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSC-KSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                         ......||+.|+|||++.+.  .++. ++||||+||++|||++|+.||.......   .+.......+.......  
T Consensus       173 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~--  242 (361)
T 3uc3_A          173 ---QPKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR---DYRKTIQRILSVKYSIP--  242 (361)
T ss_dssp             -----------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CC---CHHHHHHHHHTTCCCCC--
T ss_pred             ---CCCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH---HHHHHHHHHhcCCCCCC--
Confidence               12345699999999999764  4544 4999999999999999999997543221   11121222222111111  


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .    ...++..+.+++.+||+.||++|||+.|+++
T Consensus       243 ~----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          243 D----DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             T----TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             C----cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            1    1113356889999999999999999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.6e-38  Score=311.76  Aligned_cols=252  Identities=23%  Similarity=0.228  Sum_probs=184.5

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC------CCCHHHHHHH--------------HhcccccCcceE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS------KFSAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~------~~~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ...|.+.++||+|+||.||+|+. .+++.||||++...      ....+.+..|              +++++.+....+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            44677789999999999999996 47889999998653      2223444444              567778888899


Q ss_pred             EEEEecCCCChhhhhhhccC------------------------------------CCCCCCchhHHHHHHHHHHHHHHh
Q 048517          219 LVYEYMPNGSLDRHIFSKEN------------------------------------KGQTFGLEKPHEIALGTARGIEYL  262 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~ia~gL~yL  262 (453)
                      +||||+++|+|.+++.....                                    ....+++..++.++.|++.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998842110                                    122345677889999999999999


Q ss_pred             HcCCCCceeecccCCcceEEcCCC--ceEEEecCCccccCCCC--CceeecccCCCCCccChhhhcccCCCCCccchHHH
Q 048517          263 HNGCDVCILHFDIKPHNILLDHNF--IPKVSDFGLAKFHPKEN--DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYG  338 (453)
Q Consensus       263 H~~~~~~ivH~Dikp~NILl~~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S  338 (453)
                      |+.   +|+||||||+|||++.++  .+||+|||+++......  .........||+.|+|||.+.+....++.++||||
T Consensus       185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            998   999999999999998766  89999999998653221  11123456799999999999754457899999999


Q ss_pred             HHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          339 FGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       339 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ||+++|||++|+.||......       ......+........    .....++..+.+++.+||+.||++|||+.++++
T Consensus       262 lG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCFEN----PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCTTS----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcccccCC----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999654321       112222222221111    111224567889999999999999999999988


Q ss_pred             --HHhCCCC
Q 048517          419 --MLEGSID  425 (453)
Q Consensus       419 --~Le~~~~  425 (453)
                        .+++..+
T Consensus       331 hp~~~~~~~  339 (345)
T 3hko_A          331 HPWISQFSD  339 (345)
T ss_dssp             SHHHHTTSS
T ss_pred             ChhhccChH
Confidence              4554433

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.4e-37  Score=314.70  Aligned_cols=236  Identities=21%  Similarity=0.295  Sum_probs=175.1

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---HHHHHH----------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE----------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~~~i~e----------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.++||+|+||.||++...+++.||||++.......   +.+.+|                +++++......++|||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            366778999999999999998889999999997654332   333333                3445566677899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                       +.+++|.+++...    ..+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++.....
T Consensus       137 -~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          137 -CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             -CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             -cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence             5789999988532    4688999999999999999999998   999999999999996 578999999999876544


Q ss_pred             CCceeecccCCCCCccChhhhccc---------CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh
Q 048517          303 NDFVSISDTRGTIGYLAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      ..........||+.|+|||++.+.         ...++.++|||||||++|||++|+.||......      .......+
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~~~~  281 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAII  281 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHH
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HHHHHHHh
Confidence            332233456799999999998641         136889999999999999999999999643211      11122222


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...........      .+..+.+++.+||+.||++|||+.|+++
T Consensus       282 ~~~~~~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          282 DPNHEIEFPDI------PEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CTTSCCCCCCC------SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccccCCCCcc------chHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            22222211111      1346889999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.1e-38  Score=323.34  Aligned_cols=231  Identities=23%  Similarity=0.324  Sum_probs=178.1

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .+.+.++||+|+||.||+|+. .+|+.||||++...    ......+..|              +++++......++|||
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  228 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME  228 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence            456678999999999999995 47999999998752    1122233333              5667777788999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++....
T Consensus       229 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          229 YANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             CCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             eCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999988532    468999999999999999999998 7   999999999999999999999999999986433


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .....+...... .
T Consensus       302 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~-~  368 (446)
T 4ejn_A          302 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEEIR-F  368 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC-C
T ss_pred             CCc--ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCCCC-C
Confidence            322  23456799999999999764  7899999999999999999999999654321        122222222211 1


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                            +..++..+.+++.+||+.||++||     |++|+++
T Consensus       369 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          369 ------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  112345688999999999999999     9999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.5e-38  Score=315.19  Aligned_cols=230  Identities=27%  Similarity=0.317  Sum_probs=177.5

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH---------------HhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE---------------LLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e---------------l~g~~~~~~~~~lv  220 (453)
                      ..+.+.+.||+|+||.||+++.. +++.||||++.+...    ..+.++.|               +++.+......++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            35667789999999999999965 688999999976332    12222222               45566777888999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       118 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          118 LDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999988532    4688999999999999999999998   99999999999999999999999999998643


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ....  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        ...+.+..... .
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~-~  257 (373)
T 2r5t_A          191 EHNS--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKPL-Q  257 (373)
T ss_dssp             CCCC--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--------HHHHHHHHSCC-C
T ss_pred             cCCC--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhccc-C
Confidence            3222  23456799999999999864  7899999999999999999999999654321        12333333221 1


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV  416 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev  416 (453)
                      .      +..++..+.+++.+||+.||++||++.+.
T Consensus       258 ~------~~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          258 L------KPNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             C------CSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             C------CCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence            1      11234568899999999999999998543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.8e-38  Score=315.13  Aligned_cols=230  Identities=27%  Similarity=0.306  Sum_probs=176.6

Q ss_pred             hcccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517          166 THKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      .+.||+|+||.||+|+. .+|+.||||++..... ..+++.+|              +++++......++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            35799999999999995 4799999999986442 33445444              56677788889999999999999


Q ss_pred             hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE--cCCCceEEEecCCccccCCCCCcee
Q 048517          230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL--DHNFIPKVSDFGLAKFHPKENDFVS  307 (453)
Q Consensus       230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~  307 (453)
                      .+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            9988532   24689999999999999999999998   99999999999999  5678999999999997754432   


Q ss_pred             ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC-Cccccchhh
Q 048517          308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-DLELRNVTE  386 (453)
Q Consensus       308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~  386 (453)
                      .....||+.|+|||++...  .++.++|||||||++|||++|+.||......       . ....+.... ....    .
T Consensus       245 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~-~~~~i~~~~~~~~~----~  310 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------E-TLNNILACRWDLED----E  310 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHHTCCCSCS----G
T ss_pred             cccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhccCCCCh----h
Confidence            2345699999999998753  7889999999999999999999999654321       1 222222221 1111    1


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ....++..+.+++.+||+.||++|||+.|+++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11234567889999999999999999999987

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.9e-38  Score=311.28  Aligned_cols=228  Identities=25%  Similarity=0.303  Sum_probs=182.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .+.+.+.||+|+||.||+++.. +|+.||||++...    ....+.+.+|              +++.+......++|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            4566789999999999999965 7999999998653    2233444444              4556667778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       122 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          122 YVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             CCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999998543    4589999999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.....        ....+.+..+.. .. 
T Consensus       195 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~-~~-  257 (350)
T 1rdq_E          195 T-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKV-RF-  257 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC-CC-
T ss_pred             c-----ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcCCC-CC-
Confidence            1     345699999999999764  789999999999999999999999965432        113333433322 11 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                           +..++..+.+++.+||+.||++||+     ++++++
T Consensus       258 -----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          258 -----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                 1123456889999999999999998     888875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.3e-37  Score=299.06  Aligned_cols=235  Identities=19%  Similarity=0.202  Sum_probs=186.0

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC-CCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS-KFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ...|.+.++||+|+||.||+|... +++.||+|++... ....+.+.+|              +++++......++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            345677889999999999999965 5789999998763 3344555554              46677778888999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE---cCCCceEEEecCCccccC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~~  300 (453)
                      +++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+|+||||+|||+   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999988543    4589999999999999999999998   99999999999999   788999999999998765


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ....   .....||+.|+|||.+.+   .++.++||||+|++++||++|+.||......        .....+..+....
T Consensus       161 ~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~  226 (277)
T 3f3z_A          161 PGKM---MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGTFTF  226 (277)
T ss_dssp             TTSC---BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCC
T ss_pred             Cccc---hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCC
Confidence            4432   244579999999999864   5889999999999999999999999654321        1233333332211


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .   ......++..+.+++.+||+.||++|||+.++++
T Consensus       227 ~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          227 P---EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             C---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             C---chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1   1111234567899999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-38  Score=317.29  Aligned_cols=236  Identities=21%  Similarity=0.275  Sum_probs=183.7

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .|.+.++||+|+||.||+|... +|+.||+|++..... ....+.+|              +++++......++||||++
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  131 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  131 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence            5677789999999999999965 789999999876432 22334444              4666777888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC--CCceEEEecCCccccCCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~  303 (453)
                      +|+|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.  ++.+||+|||+++......
T Consensus       132 gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          132 GGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            9999998842   234689999999999999999999998   9999999999999974  5789999999998775543


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......        .....+........  
T Consensus       206 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~i~~~~~~~~--  270 (387)
T 1kob_A          206 I---VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCDWEFD--  270 (387)
T ss_dssp             C---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCCCCCC--
T ss_pred             c---eeeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCC--
Confidence            2   2345799999999999764  7899999999999999999999999754321        12222222211100  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                       ......++..+.+++.+||+.||++|||+.++++.
T Consensus       271 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          271 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             01112344678899999999999999999999873

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=313.52  Aligned_cols=236  Identities=24%  Similarity=0.339  Sum_probs=184.3

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ..|.+.+.||+|+||.||+++.. +|+.||||++...    ....+.+..|              +++++......++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            34667789999999999999955 6899999998652    2233444444              466677788899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+.+|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999998842    35699999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCceeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ..   ......||+.|+|||++... ...++.++|||||||++|||++|+.||........     ......+...... 
T Consensus       168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~-  238 (384)
T 4fr4_A          168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----KEIVHTFETTVVT-  238 (384)
T ss_dssp             TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----HHHHHHHHHCCCC-
T ss_pred             CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----HHHHHHHhhcccC-
Confidence            43   23456799999999998753 23588999999999999999999999975433221     1122222222111 


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPS-MTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~  418 (453)
                            .+..++..+..++.+||+.||++||+ ++++.+
T Consensus       239 ------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          239 ------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                  11223467889999999999999998 777764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.7e-37  Score=298.65  Aligned_cols=232  Identities=22%  Similarity=0.350  Sum_probs=181.2

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH---------------HhcccccCcceEEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE---------------LLGLCSEGFKRALV  220 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e---------------l~g~~~~~~~~~lv  220 (453)
                      ...|.+.++||+|+||+||+|+.. +++.||||++.....   ...+++.|               +++++......++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            455677789999999999999965 799999999886422   22334443               45566677788999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC----------------
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----------------  284 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~----------------  284 (453)
                      |||+++|+|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+|||++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999965443346789999999999999999999998   9999999999999984                


Q ss_pred             ---CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc
Q 048517          285 ---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS  361 (453)
Q Consensus       285 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~  361 (453)
                         +..+||+|||++.......      ...||+.|+|||.+.+. ..++.++||||||++++||++|++++....    
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  235 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGD----  235 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence               4479999999998765432      24589999999999753 356789999999999999999987754221    


Q ss_pred             cccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          362 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       362 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                             ....+.++......      ..++..+.+++.+||+.||++|||+.++++
T Consensus       236 -------~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 -------QWHEIRQGRLPRIP------QVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -------HHHHHHTTCCCCCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHHcCCCCCCC------cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                   12233333222221      123456889999999999999999999976

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.1e-38  Score=308.71  Aligned_cols=249  Identities=26%  Similarity=0.411  Sum_probs=186.8

Q ss_pred             hhhcccCccCceEEEEEEEc-----CCcEEEEEEecCCCCC--HHHHHHH--------------Hhccccc--CcceEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSE--GFKRALV  220 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~--~~~~~lv  220 (453)
                      .+.++||+|+||+||++.+.     +|+.||||++......  .+.+.+|              +++++..  ....++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            67789999999999998643     6889999999865321  2334444              3455544  3567899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++..     ..+++..++.++.|++.||+|||+.   +|+|+||||+|||++.++.+||+|||+++...
T Consensus       114 ~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             ECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999998842     3489999999999999999999998   99999999999999999999999999999876


Q ss_pred             CCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc------cccc-hHHHHHH
Q 048517          301 KENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS------KAYF-PSWVYDQ  372 (453)
Q Consensus       301 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~------~~~~-~~~~~~~  372 (453)
                      ...... ......+|+.|+|||.+.+.  .++.++||||||++++||++|+.|+........      .... .....+.
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            543321 22345688899999999764  688999999999999999999999864321100      0000 0011222


Q ss_pred             hhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       373 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      +..+.....      +..++..+.+++.+||+.||++|||+.++++.|+...+.++
T Consensus       264 ~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          264 LERGERLPR------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HhcccCCCC------CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            222222211      12234678999999999999999999999999998766554

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.4e-38  Score=310.90  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=190.3

Q ss_pred             hhHHHHHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCC--CHHHHHHH--------------Hhcccc
Q 048517          155 LPEIIAVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCS  212 (453)
Q Consensus       155 ~~~~~~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~  212 (453)
                      ++++....|.+.+.||+|+||.||+|+.      .+++.||||++.....  ...++..|              +++++.
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            3455666788889999999999999983      3578999999975322  22344444              466777


Q ss_pred             cCcceEEEEEecCCCChhhhhhhccC---CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CC
Q 048517          213 EGFKRALVYEYMPNGSLDRHIFSKEN---KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NF  286 (453)
Q Consensus       213 ~~~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~  286 (453)
                      .....++||||+++|+|.+++.....   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.   +.
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence            77788999999999999999965432   124589999999999999999999998   9999999999999984   55


Q ss_pred             ceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccc
Q 048517          287 IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYF  365 (453)
Q Consensus       287 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~  365 (453)
                      .+||+|||+++...............||+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....       
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------  251 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------  251 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------
Confidence            6999999999865433332233445689999999999764  78999999999999999998 8888864322       


Q ss_pred             hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCC
Q 048517          366 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  427 (453)
Q Consensus       366 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~  427 (453)
                       ....+.+..+......      ..++..+.+++.+||+.||++|||+.++++.|+......
T Consensus       252 -~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          252 -QEVLEFVTSGGRMDPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             -HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -HHHHHHHhcCCCCCCC------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence             1133334333322221      123456889999999999999999999999998765543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-37  Score=314.36  Aligned_cols=253  Identities=16%  Similarity=0.152  Sum_probs=182.5

Q ss_pred             hhhhhcccCcc--CceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEE
Q 048517          162 TNHFTHKLGQG--GFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G--~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      .|.+.++||+|  +||+||+|+.. +|+.||||++.......   +.+.+|              +++++......++||
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  105 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT  105 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence            56778999999  99999999965 79999999997654332   222223              566777888899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       106 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          106 SFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             ECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999998543  235689999999999999999999998   999999999999999999999999999865422


Q ss_pred             CCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          302 ENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       302 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      ....     .......||+.|+|||++.+....++.++|||||||++|||++|+.||...................+...
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            1110     01123468999999999986434789999999999999999999999965432211000000000000000


Q ss_pred             C----------------------------Cc---cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          377 G----------------------------DL---ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       377 ~----------------------------~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      .                            ..   ...........++..+.+++.+||+.||++|||+.|+++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0                            00   0000001223345678999999999999999999999863

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.7e-37  Score=298.92  Aligned_cols=237  Identities=22%  Similarity=0.299  Sum_probs=183.3

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-------CHHHHHHH--------------HhcccccCcc
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-------SAEEFINE--------------LLGLCSEGFK  216 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-------~~~~~i~e--------------l~g~~~~~~~  216 (453)
                      ....|.+.+.||+|+||.||+++.. +|+.||||++.....       ..+++.+|              +++++.....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            3456778899999999999999965 799999999876322       24445444              4566777788


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC----ceEEEe
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSD  292 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~----~~kl~D  292 (453)
                      .++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++    .+||+|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEe
Confidence            89999999999999998532    4689999999999999999999998   999999999999998876    899999


Q ss_pred             cCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517          293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  372 (453)
Q Consensus       293 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  372 (453)
                      ||+++.......   .....||+.|+|||.+...  .++.++||||||++++||++|+.||......        .....
T Consensus       156 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~  222 (283)
T 3bhy_A          156 FGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTN  222 (283)
T ss_dssp             CTTCEECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred             cccceeccCCCc---ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHH
Confidence            999987654332   2345699999999998754  7899999999999999999999999654321        12222


Q ss_pred             hhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       373 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +.......   ........+..+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          223 ISAVNYDF---DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHTTCCCC---CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hHhcccCC---cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            22221110   11122334567889999999999999999999997

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.5e-38  Score=316.42  Aligned_cols=255  Identities=19%  Similarity=0.258  Sum_probs=191.5

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCc--ceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGF--KRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~--~~~lv~E  222 (453)
                      .|.+.++||+|+||+||+|+.. +|+.||||++....  ...+.+.+|              +++++....  ..++|||
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e   89 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence            4667789999999999999965 69999999997632  233444444              344554433  6799999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE----cCCCceEEEecCCccc
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKF  298 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~~  298 (453)
                      |+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        90 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             cCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            999999999985432 223499999999999999999999998   99999999999999    7888899999999987


Q ss_pred             cCCCCCceeecccCCCCCccChhhhccc------CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRN------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  372 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  372 (453)
                      ......   .....||+.|+|||++.+.      ...++.++|||||||++|||++|+.||........   ........
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~---~~~~~~~~  239 (396)
T 4eut_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR---NKEVMYKI  239 (396)
T ss_dssp             CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT---CHHHHHHH
T ss_pred             ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc---hHHHHHHH
Confidence            654332   2345799999999998641      12567899999999999999999999964332111   11222222


Q ss_pred             hhhCCCc-----------------cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          373 LNKGGDL-----------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       373 l~~~~~~-----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      +......                 ...........+...+..++.+||+.||++|||+.++++.++.+++.
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            2211100                 01111123466778899999999999999999999999999887664

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.3e-38  Score=321.98  Aligned_cols=238  Identities=19%  Similarity=0.243  Sum_probs=180.7

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.+.++||+|+||+||+|+.. +++.||||++.+.    ....+.+..|              +++++.+....++||||
T Consensus        76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey  155 (437)
T 4aw2_A           76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY  155 (437)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence            445588999999999999966 5889999998641    1111112111              56778888889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       156 ~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          156 YVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            9999999998532   35699999999999999999999998   99999999999999999999999999998765443


Q ss_pred             CceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh-CCCc
Q 048517          304 DFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDL  379 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~  379 (453)
                      .. ......||+.|+|||++...   .+.++.++|||||||++|||++|+.||.......        ....+.. ....
T Consensus       230 ~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~  300 (437)
T 4aw2_A          230 TV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKERF  300 (437)
T ss_dssp             CE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHHHHC
T ss_pred             Cc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--------HHHhhhhccccc
Confidence            32 23446799999999998731   2468999999999999999999999997543211        1222211 1111


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLE  418 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~  418 (453)
                      ....   ....++..+.+++.+||+.+|++  ||+++|+++
T Consensus       301 ~~p~---~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          301 QFPT---QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCCS---SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cCCc---ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1110   00113456888999999888888  999999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.5e-37  Score=304.38  Aligned_cols=246  Identities=23%  Similarity=0.287  Sum_probs=177.8

Q ss_pred             hhhh-cccCccCceEEEEEE-EcCCcEEEEEEecCCCC-CHHHHHHH---------------HhcccccCcceEEEEEec
Q 048517          163 NHFT-HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF-SAEEFINE---------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~-~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~-~~~~~i~e---------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+. +.||+|+||+||+|+ ..+|+.||||++..... ..+.+.+|               +++++......++||||+
T Consensus        14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   93 (316)
T 2ac3_A           14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM   93 (316)
T ss_dssp             CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence            4443 679999999999999 45799999999976433 34444444               345666777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc---eEEEecCCccccCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDFGLAKFHPK  301 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DFGla~~~~~  301 (453)
                      ++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.   +||+|||+++....
T Consensus        94 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           94 RGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             CCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999998543    4689999999999999999999998   9999999999999988765   99999999986543


Q ss_pred             CCCc-----eeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc----c---h
Q 048517          302 ENDF-----VSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY----F---P  366 (453)
Q Consensus       302 ~~~~-----~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~----~---~  366 (453)
                      ....     .......||+.|+|||.+...   ...++.++||||||+++|||++|+.||...........    .   .
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            2211     112234599999999998641   12578899999999999999999999976543211000    0   1


Q ss_pred             HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ....+.+..+... .  .......++..+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~i~~~~~~-~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKYE-F--PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCCC-C--CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCcc-c--CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            1122333332211 1  11111234567899999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.9e-37  Score=300.44  Aligned_cols=240  Identities=25%  Similarity=0.405  Sum_probs=184.1

Q ss_pred             hhhhhc-ccCccCceEEEEEEE---cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEE
Q 048517          162 TNHFTH-KLGQGGFGSVYKGQL---HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~-~LG~G~fG~Vy~g~~---~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      .+.+.+ .||+|+||.||+|..   .+++.||||++......   .+++..|              +++++ .....++|
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv   95 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV   95 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence            455556 899999999999964   35789999999764322   3445444              45555 45567899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++++|.+++..    ...+++..++.++.|++.||+|||+.   +|+|+||||+|||++.++.+||+|||+++...
T Consensus        96 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           96 MEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            999999999999853    24589999999999999999999998   99999999999999999999999999998775


Q ss_pred             CCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          301 KENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       301 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ...... ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .+...+..+..
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~  238 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGER  238 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC
T ss_pred             cCCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            544322 12334577899999999764  68899999999999999999 99998654321        13334444333


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ...      +..++..+.+++.+||+.||++|||+.++++.|+....
T Consensus       239 ~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          239 MGC------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            222      12234678899999999999999999999999987544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-37  Score=297.72  Aligned_cols=244  Identities=22%  Similarity=0.353  Sum_probs=186.3

Q ss_pred             hHHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHH---HH--------Hhcccc-----------
Q 048517          156 PEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFI---NE--------LLGLCS-----------  212 (453)
Q Consensus       156 ~~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i---~e--------l~g~~~-----------  212 (453)
                      .+.....|.+.+.||+|+||.||+|+.. +|+.||||++........+.+   ..        +++++.           
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            3445566778899999999999999975 799999999976543222211   11        333332           


Q ss_pred             -----cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517          213 -----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  287 (453)
Q Consensus       213 -----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~  287 (453)
                           .....++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+.   +|+|+||||+|||++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence                 1344789999999999999985432  35689999999999999999999998   9999999999999999999


Q ss_pred             eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchH
Q 048517          288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS  367 (453)
Q Consensus       288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  367 (453)
                      +||+|||+++.......   .....||+.|+|||.+.+.  .++.++||||||+++|||++|..|+....          
T Consensus       161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~----------  225 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETS----------  225 (284)
T ss_dssp             EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------
T ss_pred             EEECcchhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhHH----------
Confidence            99999999987654432   2345699999999999764  78999999999999999999987753210          


Q ss_pred             HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      .....+......         ..++..+.+++.+||+.||++|||+.|+++.|+......+
T Consensus       226 ~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          226 KFFTDLRDGIIS---------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHHHHTTCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHHHHhhccccc---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            112222222111         1123457889999999999999999999999987665544

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-37  Score=309.21  Aligned_cols=233  Identities=25%  Similarity=0.346  Sum_probs=180.6

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ..+...++||+|+||+||+|+. .+|+.||||++.......    +++.+|              +++++......++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3456678899999999999995 579999999997643322    234444              466777778889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+. |+|.+.+...   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 6887777432   35689999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      .      ....||+.|+|||++.. ..+.++.++||||||+++|||++|+.||......       .... .+.......
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~-~~~~~~~~~  272 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALY-HIAQNESPA  272 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHH-HHHHSCCCC
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHH-HHHhcCCCC
Confidence            2      34569999999999853 1247899999999999999999999998644321       1122 222222211


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ..     ....+..+.+++.+||+.||++|||+.++++.
T Consensus       273 ~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          273 LQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CC-----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11     11234568899999999999999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.4e-37  Score=296.58  Aligned_cols=238  Identities=26%  Similarity=0.320  Sum_probs=182.9

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..|.+.+.||+|+||.||+|+.. +|+.||||++.....  ..+.+.+|              +++++..+...++|+||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            35667789999999999999965 799999999875332  22334443              45666777788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++.......
T Consensus        87 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           87 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999883    235689999999999999999999998   99999999999999999999999999998664333


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .........||+.|+|||.+.+. ...+.++||||||++++||++|+.||.......  .     ........... .. 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~-----~~~~~~~~~~~-~~-  229 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--Q-----EYSDWKEKKTY-LN-  229 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--H-----HHHHHHTTCTT-ST-
T ss_pred             chhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--H-----HHHHhhhcccc-cC-
Confidence            22223456799999999998753 234779999999999999999999997543221  0     11122221111 00 


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         ....++..+.+++.+||+.||++|||+.++++
T Consensus       230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               11223456889999999999999999999976

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-37  Score=317.02  Aligned_cols=243  Identities=22%  Similarity=0.314  Sum_probs=177.8

Q ss_pred             hhHHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---------HHHHHHH--------------Hhcc
Q 048517          155 LPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---------AEEFINE--------------LLGL  210 (453)
Q Consensus       155 ~~~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---------~~~~i~e--------------l~g~  210 (453)
                      .|+.....|.+.++||+|+||+||+|... +++.||||++......         ...+.+|              ++++
T Consensus       129 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  208 (419)
T 3i6u_A          129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF  208 (419)
T ss_dssp             SCHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             cchhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            45666677888899999999999999854 6899999998753211         0112222              4555


Q ss_pred             cccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---Cc
Q 048517          211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FI  287 (453)
Q Consensus       211 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~  287 (453)
                      +. ....++||||+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.+   ..
T Consensus       209 ~~-~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~  280 (419)
T 3i6u_A          209 FD-AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL  280 (419)
T ss_dssp             EE-SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCC
T ss_pred             Ee-cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcce
Confidence            54 345789999999999998884    335699999999999999999999998   99999999999999654   45


Q ss_pred             eEEEecCCccccCCCCCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch
Q 048517          288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP  366 (453)
Q Consensus       288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  366 (453)
                      +||+|||+++......   ......||+.|+|||++.. ....++.++||||||+++|||++|+.||........     
T Consensus       281 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-----  352 (419)
T 3i6u_A          281 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-----  352 (419)
T ss_dssp             EEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-----
T ss_pred             EEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-----
Confidence            9999999998765432   2244679999999999853 224678899999999999999999999975432211     


Q ss_pred             HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                        ..+.+..+.....   ......++..+.+++.+||+.||++|||+.|+++
T Consensus       353 --~~~~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 --LKDQITSGKYNFI---PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             --HHHHHHTTCCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHHHhcCCCCCC---chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              2233333322111   1122334567899999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.4e-38  Score=335.83  Aligned_cols=234  Identities=26%  Similarity=0.417  Sum_probs=181.8

Q ss_pred             cccCccCceEEEEEEEc---CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH---TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ++||+|+||.||+|.+.   +++.||||+++....   ..+++..|              ++++|.. ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            37999999999999753   568899999986432   23556555              5666654 457899999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc-
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-  305 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~-  305 (453)
                      |+|.+++..    ...+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999843    35689999999999999999999998   9999999999999999999999999999877544322 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                      .......+|+.|+|||++...  .++.++|||||||++|||++ |+.||.....        ..+...+..+......  
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~~~~~p--  594 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCP--  594 (635)
T ss_dssp             --------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC--
T ss_pred             ccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC--
Confidence            222344578899999999764  78999999999999999998 9999965432        1244455555443322  


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                          ..++..+.+++.+||+.||++|||+.+|+++|+...
T Consensus       595 ----~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          595 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                123467889999999999999999999999998643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-38  Score=314.08  Aligned_cols=234  Identities=24%  Similarity=0.303  Sum_probs=181.7

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||.||+|+. .+|+.||||++...    ......+.+|              +++++......++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            466778999999999999995 57999999998642    1222334333              5667777888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+ +|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           90 YA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             CC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            99 78998888543    4689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..   .....||+.|+|||.+.+. ...+.++||||+|+++|||++|+.||..........        .+.... ..  
T Consensus       162 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------~i~~~~-~~--  226 (336)
T 3h4j_B          162 NF---LKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------KVNSCV-YV--  226 (336)
T ss_dssp             BT---TCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------CCCSSC-CC--
T ss_pred             cc---cccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------HHHcCC-CC--
Confidence            32   2445799999999999764 223789999999999999999999996543221100        011110 00  


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  422 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~  422 (453)
                          .+..++..+.+++.+||+.||.+|||++|+++  .+..
T Consensus       227 ----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          227 ----MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             ----CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             ----CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                11223456889999999999999999999987  4444

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.8e-38  Score=320.09  Aligned_cols=186  Identities=26%  Similarity=0.326  Sum_probs=152.1

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------------HhcccccCcce
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------------LLGLCSEGFKR  217 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------------l~g~~~~~~~~  217 (453)
                      ...+|.+.++||+|+||.||+|... +++.||||++.......+++..|                    +++.+......
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            3445777899999999999999854 68999999998654333333332                    23445556778


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc--eEEEecCC
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--PKVSDFGL  295 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~--~kl~DFGl  295 (453)
                      ++||||+. ++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            99999995 6898888543  234589999999999999999999998   9999999999999999887  99999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  357 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~  357 (453)
                      ++.....     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||....
T Consensus       249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          249 SCYEHQR-----VYTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ceecCCc-----ccccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9765432     2345789999999999864  78999999999999999999999997543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.9e-37  Score=296.54  Aligned_cols=239  Identities=26%  Similarity=0.379  Sum_probs=181.9

Q ss_pred             HhhhhhcccCccCceEEEEEEEcC----CcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~----g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ..+.+.+.||+|+||.||+|+..+    +..||||++.....  ..+++.+|              +++++.+ ...++|
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence            345667899999999999998542    34699999976432  23344444              3455543 456899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+||+|||+++...
T Consensus        91 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           91 MELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            9999999999998543   24689999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ..... ......+|+.|+|||.+...  .++.++||||||+++|||++ |+.||.......        ....+..+...
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~~~~  233 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKGDRL  233 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHTCCC
T ss_pred             ccccc-ccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcCCCC
Confidence            43321 22345678899999999754  78999999999999999998 999986543221        23334333322


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      ...      ...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       234 ~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          234 PKP------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            221      12345688999999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.8e-37  Score=308.72  Aligned_cols=237  Identities=23%  Similarity=0.282  Sum_probs=183.0

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---------HHHHHHH---------------HhcccccCc
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---------AEEFINE---------------LLGLCSEGF  215 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---------~~~~i~e---------------l~g~~~~~~  215 (453)
                      ..|.+.+.||+|+||.||+|+.. +|+.||||++......         .+.+..|               +++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            34566689999999999999975 7999999998764321         1122222               345566777


Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      ..++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+||+|||+
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCc
Confidence            889999999999999988532    4689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhccc----CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  371 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  371 (453)
                      +........   .....||+.|+|||++.+.    ...++.++||||||+++|||++|+.||......        ....
T Consensus       247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--------~~~~  315 (365)
T 2y7j_A          247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--------LMLR  315 (365)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred             ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--------HHHH
Confidence            987654432   2456799999999998642    235788999999999999999999999653211        1222


Q ss_pred             HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+..+....   ........+..+.+++.+||+.||++|||+.++++
T Consensus       316 ~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 MIMEGQYQF---SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHTCCCC---CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhCCCCC---CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            232222111   01111223456889999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-38  Score=313.13  Aligned_cols=240  Identities=22%  Similarity=0.285  Sum_probs=181.6

Q ss_pred             hhhhhcccCccCceEEEEEEE----cCCcEEEEEEecCCC-----------CCHHHHHHH---------HhcccccCcce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMMENSK-----------FSAEEFINE---------LLGLCSEGFKR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~-----------~~~~~~i~e---------l~g~~~~~~~~  217 (453)
                      .|.+.++||+|+||.||+++.    .+|+.||||+++...           ....+.+..         +++++......
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  134 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  134 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence            566778999999999999996    378999999986421           112223332         34556677788


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       135 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          135 HLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999998543    4689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ........ ......||+.|+|||++.+....++.++|||||||++|||++|+.||........    ...+...+....
T Consensus       208 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~  282 (355)
T 1vzo_A          208 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKSE  282 (355)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHCC
T ss_pred             ecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhccC
Confidence            66433221 1234579999999999975434678999999999999999999999975432211    111222222221


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEML  420 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~L  420 (453)
                      ..       .+..++..+.+++.+||+.||++||     |+.++++..
T Consensus       283 ~~-------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 PP-------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CC-------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             CC-------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            11       1122345688999999999999999     999998744

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.8e-37  Score=304.91  Aligned_cols=233  Identities=24%  Similarity=0.327  Sum_probs=176.1

Q ss_pred             HHhhhhhcccCccCceEEEEEEE----cCCcEEEEEEecCCCC-----CHHHHHHH--------------HhcccccCcc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF-----SAEEFINE--------------LLGLCSEGFK  216 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~-----~~~~~i~e--------------l~g~~~~~~~  216 (453)
                      ...|.+.+.||+|+||.||+++.    .+|+.||||++.....     ....+..|              +++++.....
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            34567788999999999999986    4799999999876321     11122222              5667777888


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            99999999999999988532    4688999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      +.......  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......        .....+...
T Consensus       169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~  236 (327)
T 3a62_A          169 KESIHDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRK--------KTIDKILKC  236 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHT
T ss_pred             cccccCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhC
Confidence            86433322  22445799999999999764  6899999999999999999999999754321        122223222


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                      .. ..      +..++..+.+++.+||+.||++||     ++.++++
T Consensus       237 ~~-~~------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 KL-NL------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CC-CC------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CC-CC------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            21 11      112345688999999999999999     7778876

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.9e-38  Score=321.48  Aligned_cols=237  Identities=21%  Similarity=0.284  Sum_probs=181.4

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHH--------------HHhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFIN--------------ELLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~--------------el~g~~~~~~~~~lv~E  222 (453)
                      .+.+.++||+|+||+||+|+.. +++.||||++.+.    ....+.+..              ++++++.+....++|||
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E  149 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  149 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4456688999999999999965 6899999998641    111111111              15677888888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       150 ~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          150 YMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             CCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            9999999998843     3589999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCceeecccCCCCCccChhhhcccCC--CCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC-Cc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFG--TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-DL  379 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~--~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~-~~  379 (453)
                      .. .......||+.|+|||++.+..+  .++.++|||||||++|||++|+.||.......        ....+.... ..
T Consensus       222 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~  292 (410)
T 3v8s_A          222 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMNHKNSL  292 (410)
T ss_dssp             SE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHHHHC
T ss_pred             Cc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--------HHHHHHhccccc
Confidence            32 22345679999999999976421  27889999999999999999999997543211        222222110 11


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  419 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~  419 (453)
                      ...    ....++..+.+++.+||+.+|.+  ||+++|+++.
T Consensus       293 ~~p----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 TFP----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CCC----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cCC----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            111    11123456889999999999988  9999999973

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3e-37  Score=332.76  Aligned_cols=231  Identities=24%  Similarity=0.295  Sum_probs=182.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH---------------HhcccccCcceEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE---------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e---------------l~g~~~~~~~~~lv~  221 (453)
                      .+.+.+.||+|+||.||+|+.. +++.||||+++..    ....+.++.|               +++++......++||
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~  421 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  421 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence            4566789999999999999955 6899999998752    2223333333               344566777889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++....
T Consensus       422 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          422 EYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             eCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999998543    4689999999999999999999998   999999999999999999999999999986443


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ...  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......        .+...+......  
T Consensus       495 ~~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~--  560 (674)
T 3pfq_A          495 DGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNVA--  560 (674)
T ss_dssp             TTC--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHSSCCC--
T ss_pred             CCc--ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhCCCC--
Confidence            322  23456799999999999764  7899999999999999999999999754321        133334333221  


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~  418 (453)
                           .+..++..+.+++.+||+.||++||++     +||++
T Consensus       561 -----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          561 -----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                 112345678899999999999999998     67764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-37  Score=299.12  Aligned_cols=234  Identities=23%  Similarity=0.316  Sum_probs=182.9

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      .|.+.++||+|+||.||+|... +|+.||+|++.......   +.+.+|              +++++......++||||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   86 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   86 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence            4567789999999999999964 68999999997654332   223333              56677778888999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc---eEEEecCCccccC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDFGLAKFHP  300 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DFGla~~~~  300 (453)
                      +++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||++....
T Consensus        87 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           87 VTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999888543    4689999999999999999999998   9999999999999976554   9999999998765


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ....   .....||+.|+|||.+.+.  .++.++||||+|++++||++|+.||......        .....+..+....
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~  226 (284)
T 3kk8_A          160 DSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAGAYDY  226 (284)
T ss_dssp             SSCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCC
T ss_pred             cCcc---ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchh--------HHHHHHHhccccC
Confidence            4332   2346799999999999764  7899999999999999999999999654321        1223333322111


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .   ......++..+.+++.+||+.||++|||+.|+++
T Consensus       227 ~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 P---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             C---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C---chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1   0111223456889999999999999999999987

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.6e-38  Score=305.03  Aligned_cols=246  Identities=22%  Similarity=0.317  Sum_probs=177.1

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      .|.+.++||+|+||+||+|+.. +|+.||||++.......   +.+..|              +++++......++||||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY   83 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence            4567789999999999999965 69999999987654332   233333              56677777888999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           84 CDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             CCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999988763    235689999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc--------cchHHHHHHhhh
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--------YFPSWVYDQLNK  375 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~~l~~  375 (453)
                      ..  .....||+.|+|||.+.+. ..++.++||||+|++++||++|+.||..........        ..+.+. .....
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  232 (311)
T 4agu_A          157 DY--YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ-QVFST  232 (311)
T ss_dssp             -----------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH-HHHHT
T ss_pred             cc--cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc-ccccc
Confidence            21  2345789999999998753 467999999999999999999999997544321100        000000 00000


Q ss_pred             -----CCCc-cccc---hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 -----GGDL-ELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 -----~~~~-~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           +... ....   .......++..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                 0000 0000   00011234566889999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.9e-38  Score=302.14  Aligned_cols=240  Identities=22%  Similarity=0.300  Sum_probs=185.0

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------Hhccc--ccCcceEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLC--SEGFKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~--~~~~~~~lv~  221 (453)
                      .|.+.+.||+|+||.||+++.. +|+.||+|++.......   +.+..|              +++++  ......++||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   86 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   86 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence            4567789999999999999965 79999999997654332   334444              34444  3356789999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc-----eeecccCCcceEEcCCCceEEEecCCc
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC-----ILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      ||+++|+|.+++.........+++..++.++.|++.||+|||+.   +     |+|+||||+|||++.++.+||+|||++
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            99999999999976544456699999999999999999999997   6     999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      +........  .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.....        ..+...+..+
T Consensus       164 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~  231 (279)
T 2w5a_A          164 RILNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREG  231 (279)
T ss_dssp             HHC---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT
T ss_pred             eeecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHhhc
Confidence            876543221  1234689999999999764  788999999999999999999999875432        1133344443


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      ....+.      ..++..+.+++.+||+.||++|||+.++++.+..
T Consensus       232 ~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          232 KFRRIP------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             CCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ccccCC------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            332221      1234678899999999999999999999986653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4e-37  Score=303.18  Aligned_cols=246  Identities=25%  Similarity=0.315  Sum_probs=180.4

Q ss_pred             HHhhhhhcccCccCceEEEEEEE--cCCcEEEEEEecCCCCCHHHHHHH--------------------HhcccccCcce
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL--HTGRLIAVKMMENSKFSAEEFINE--------------------LLGLCSEGFKR  217 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~--~~g~~VAVK~l~~~~~~~~~~i~e--------------------l~g~~~~~~~~  217 (453)
                      ...|.+.++||+|+||.||+|..  .+|+.||||++.......+.+..|                    +++++......
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            44677889999999999999986  368999999997643333333332                    23445566788


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-------------
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-------------  284 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-------------  284 (453)
                      ++||||+ +++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.             
T Consensus        93 ~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence            9999999 89999988543  234689999999999999999999998   9999999999999987             


Q ss_pred             ------CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcc
Q 048517          285 ------NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAT  358 (453)
Q Consensus       285 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~  358 (453)
                            ++.+||+|||+++......     ....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                  6789999999998654322     345789999999999764  789999999999999999999999975432


Q ss_pred             ccccc-------cchHHHHHHhhhC-----CCc-----------------cccchhhhHHHHHHHHHHHHHHhcccCCCC
Q 048517          359 RSSKA-------YFPSWVYDQLNKG-----GDL-----------------ELRNVTEIESMIARKLCMIGLWCIQVKAAD  409 (453)
Q Consensus       359 ~~~~~-------~~~~~~~~~l~~~-----~~~-----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~  409 (453)
                      .....       .++..........     ...                 ............+..+.+++.+||+.||++
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            21000       0000000000000     000                 000000012234567899999999999999


Q ss_pred             CCCHHHHHH
Q 048517          410 RPSMTKVLE  418 (453)
Q Consensus       410 RPs~~evl~  418 (453)
                      |||+.|+++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.1e-38  Score=306.04  Aligned_cols=246  Identities=18%  Similarity=0.256  Sum_probs=180.9

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ..|.+.+.||+|+||.||+|+.. +++.||||++.......    +.+..|              +++++......++|+
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            35677889999999999999965 78999999997643322    334444              456667777889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+|+||||+|||++.++.+||+|||++.....
T Consensus       114 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          114 RLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             ECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999998532    4689999999999999999999998   999999999999999999999999999986644


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ... .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......        .....+......  
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~--  253 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAIPR--  253 (309)
T ss_dssp             -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCCCC--
T ss_pred             ccc-ccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCCCC--
Confidence            321 122345699999999998764  7889999999999999999999999653311        122222222111  


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhCCCCCCC
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~Le~~~~~~~  428 (453)
                        .......++..+.+++.+||+.||++|| |++++++.|+..+....
T Consensus       254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence              1112223445788999999999999999 99999999998877654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.8e-38  Score=301.83  Aligned_cols=240  Identities=24%  Similarity=0.340  Sum_probs=171.1

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHH--HHHHH---------------HhcccccCcceEEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAE--EFINE---------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~--~~i~e---------------l~g~~~~~~~~~lv~E  222 (453)
                      ..+.+.++||+|+||+||+|+. .+|+.||||++.......+  +...+               +++++......++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            4566778999999999999995 5799999999976433221  22222               4666777888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |++ |+|.+++.........+++..+..++.|++.||+|||++  .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD  163 (290)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred             hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence            997 588888765444557899999999999999999999984  28999999999999999999999999999876443


Q ss_pred             CCceeecccCCCCCccChhhhcc--cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          303 NDFVSISDTRGTIGYLAPELISR--NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ..   .....||+.|+|||.+..  ....++.++||||+|++++||++|+.||......      ........... ...
T Consensus       164 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~~  233 (290)
T 3fme_A          164 VA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------FQQLKQVVEEP-SPQ  233 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------HHHHHHHHHSC-CCC
T ss_pred             cc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------HHHHHHHhccC-CCC
Confidence            22   233469999999999732  1246889999999999999999999999643211      01111222221 111


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..     ...++..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          234 LP-----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CC-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cc-----cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            11     1123456889999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.6e-37  Score=296.28  Aligned_cols=235  Identities=29%  Similarity=0.446  Sum_probs=177.1

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------Hhcccc-cCcceEEEEEecC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCS-EGFKRALVYEYMP  225 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~-~~~~~~lv~E~~~  225 (453)
                      ..+.+.+.||+|+||+||+|+.. |+.||||++.... ..+.+.+|              +++++. .....++||||++
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            35667789999999999999875 8999999997643 34445444              344433 3346799999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++....  ...+++..++.++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++......  
T Consensus        99 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           99 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             TEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            999999985432  23488999999999999999999998   99999999999999999999999999998654322  


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                         ....+|+.|+|||.+.+.  .++.++||||||++++||++ |+.|+.......        ....+..+......  
T Consensus       172 ---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~--  236 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAP--  236 (278)
T ss_dssp             -------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCCCC--
T ss_pred             ---cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCCCc--
Confidence               234578899999999764  78999999999999999998 999986543211        23334333222211  


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                          ...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       237 ----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          237 ----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence                22345788999999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-37  Score=312.69  Aligned_cols=238  Identities=11%  Similarity=0.032  Sum_probs=172.2

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH------Hh-----------c------ccccC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE------LL-----------G------LCSEG  214 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e------l~-----------g------~~~~~  214 (453)
                      +.+.++||+|+||.||+|+.. +|+.||||++.......    +.+..|      |.           .      .+...
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            566789999999999999954 79999999998754321    112221      11           1      11000


Q ss_pred             -----------------cceEEEEEecCCCChhhhhhhccCCCCCCCchhH------HHHHHHHHHHHHHhHcCCCCcee
Q 048517          215 -----------------FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKP------HEIALGTARGIEYLHNGCDVCIL  271 (453)
Q Consensus       215 -----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv  271 (453)
                                       ...++||||++ |+|.+++....   ..+.+..+      ..++.|++.||+|||+.   +|+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv  216 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV  216 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence                             33699999998 99999996532   34577777      78889999999999998   999


Q ss_pred             ecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCC
Q 048517          272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR  351 (453)
Q Consensus       272 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~  351 (453)
                      ||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+....++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999866432     12456779999999997522378999999999999999999999


Q ss_pred             CCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          352 NSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       352 p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ||..........+. ..   ...........  ......++..+.+++.+||+.||++|||+.++++
T Consensus       292 Pf~~~~~~~~~~~~-~~---~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWK-RP---SLRVPGTDSLA--FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCC-BC---CTTSCCCCSCC--CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchh-hh---hhhhccccccc--hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99765332111100 00   00000000000  0011234567889999999999999999999975

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.1e-37  Score=296.88  Aligned_cols=229  Identities=24%  Similarity=0.391  Sum_probs=177.8

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||.||+|+.. +++.||||++....    ...+.+..|              +++++......++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   89 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence            4566789999999999999855 67899999986521    122334333              5667777888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.+||+|||++......
T Consensus        90 ~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           90 YAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999988543    4589999999999999999999998   9999999999999999999999999998654433


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .    .....||+.|+|||.+.+.  .++.++||||+|++++||++|+.||......        .....+.......  
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~--  226 (279)
T 3fdn_A          163 R----RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVEFTF--  226 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCC--
T ss_pred             c----ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHHHHhCCCCC--
Confidence            2    2345789999999999764  7788999999999999999999999643321        1223333222111  


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           +...+..+.+++.+||+.||++|||+.|+++
T Consensus       227 -----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          227 -----PDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             -----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -----CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 1123456789999999999999999999997

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5e-37  Score=314.71  Aligned_cols=184  Identities=25%  Similarity=0.322  Sum_probs=143.9

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccC-----cceE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEG-----FKRA  218 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~-----~~~~  218 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++......   .+++.+|              +++++...     ...+
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            5677889999999999999954 6899999999764332   2344444              34444433     5689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+. |+|.+++.    ....+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            9999986 69998884    235699999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCc--------------------eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 048517          299 HPKENDF--------------------VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  354 (453)
Q Consensus       299 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~  354 (453)
                      .......                    ...+...||+.|+|||++... ..++.++||||+||+++||++|..|+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence            6543211                    123556799999999987543 468999999999999999998665553

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-37  Score=311.09  Aligned_cols=252  Identities=25%  Similarity=0.316  Sum_probs=168.9

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH---------------Hhcccc--cCcc
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE---------------LLGLCS--EGFK  216 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e---------------l~g~~~--~~~~  216 (453)
                      .....|.+.++||+|+||.||+|.. .+|+.||||++......   ..+...|               +++++.  ....
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3445677789999999999999985 47999999998654322   2223333               334443  2336


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++||||++ |+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            799999997 689888743     3689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCC-------------------CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517          297 KFHPKEN-------------------DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  357 (453)
Q Consensus       297 ~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~  357 (453)
                      +......                   .....+...||+.|+|||++.+. ..++.++||||+||+++||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8653211                   01122345799999999999753 478999999999999999999999997543


Q ss_pred             ccccc-------------------ccchHHHHHHhhhCC---Cccccchhhh----------HHHHHHHHHHHHHHhccc
Q 048517          358 TRSSK-------------------AYFPSWVYDQLNKGG---DLELRNVTEI----------ESMIARKLCMIGLWCIQV  405 (453)
Q Consensus       358 ~~~~~-------------------~~~~~~~~~~l~~~~---~~~~~~~~~~----------~~~~~~~l~~l~~~Cl~~  405 (453)
                      ....-                   ..+.....+.+....   ..........          ....+..+.+++.+||+.
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            21100                   000000000000000   0000000000          002245788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 048517          406 KAADRPSMTKVLEM  419 (453)
Q Consensus       406 ~p~~RPs~~evl~~  419 (453)
                      ||++|||++|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=305.39  Aligned_cols=252  Identities=21%  Similarity=0.315  Sum_probs=179.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH--------HH--------HHHHHhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA--------EE--------FINELLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~--------~~--------~i~el~g~~~~~~~~~lv~E~~  224 (453)
                      +|.+.++||+|+||+||+|+.. +++.||||++.......        -+        .+..+++++......++||||+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   82 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence            3567789999999999999965 79999999986532111        11        1222677777888899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      + |+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           83 D-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             S-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             c-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            7 6888887532   35689999999999999999999998   999999999999999999999999999986543322


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc---
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL---  381 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~---  381 (453)
                        ......||+.|+|||.+.+. ..++.++||||+|+++|||++|+.||.......    ....+...+........   
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             ---------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTG
T ss_pred             --ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhchhh
Confidence              22345689999999998753 368999999999999999999999997543211    01111111111000000   


Q ss_pred             ----------------cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCCCCCC
Q 048517          382 ----------------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSIDDL  427 (453)
Q Consensus       382 ----------------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~~~~~  427 (453)
                                      .........++..+.+++.+||+.||++|||++|+++  .+.+..+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence                            0000111224467889999999999999999999988  555544443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-37  Score=295.70  Aligned_cols=232  Identities=26%  Similarity=0.402  Sum_probs=161.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||.||+|+. .+|+.||||++....    ...+.+..|              +++++......++|||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            356678999999999999996 579999999986531    122344444              4566777788899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++++|.+++..   ....+++..++.++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++......
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           92 MCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             CCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             cCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999998853   235689999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......||+.|+|||.+.+.  .++.++||||||++++||++|+.||........        ........ ..  
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~-~~--  230 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNKVVLAD-YE--  230 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSC-CC--
T ss_pred             CC--cceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHHHhhcc-cC--
Confidence            22  12345689999999998764  678899999999999999999999975432210        01111100 01  


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          .+..++..+.+++.+||+.||++|||+.++++
T Consensus       231 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 ----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                11223456889999999999999999999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.2e-37  Score=324.66  Aligned_cols=237  Identities=23%  Similarity=0.299  Sum_probs=183.5

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .+.+.||+|+||.||+++.. +|+.||||++...    ....+.+..|              +++.+......++||||+
T Consensus       188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~  267 (543)
T 3c4z_A          188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM  267 (543)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence            34467999999999999965 7999999999653    1223334443              456667778899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++|+|.+++.........+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            99999999865544456799999999999999999999998   999999999999999999999999999987654432


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||........    ...+...+..... .    
T Consensus       345 --~~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~~~~-~----  411 (543)
T 3c4z_A          345 --KTKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLEQAV-T----  411 (543)
T ss_dssp             --CBCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHHCCC-C----
T ss_pred             --ccccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhhccc-C----
Confidence              12345799999999999864  789999999999999999999999976432211    1112233322211 1    


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE  418 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~  418 (453)
                        .+..++..+.+++.+||+.||++||++     .++++
T Consensus       412 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          412 --YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             --CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             --CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence              112234678899999999999999975     56654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=307.75  Aligned_cols=228  Identities=21%  Similarity=0.242  Sum_probs=179.9

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH--------------H-H--------HHHHHhcccccCc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA--------------E-E--------FINELLGLCSEGF  215 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~--------------~-~--------~i~el~g~~~~~~  215 (453)
                      ...|.+.+.||+|+||.||+|+. .+|+.||||++.......              + +        ++.++++++....
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            34567778999999999999995 579999999987643211              1 1        1122677788888


Q ss_pred             ceEEEEEecCCC-ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          216 KRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       216 ~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ..++||||+.+| +|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            899999999777 99888842    34699999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      +++.......   .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||.......             .
T Consensus       176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------~  238 (335)
T 3dls_A          176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------E  238 (335)
T ss_dssp             TCEECCTTCC---BCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------T
T ss_pred             cceECCCCCc---eeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------h
Confidence            9987655432   2345699999999999764 233889999999999999999999996432110             0


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      .  ...      .+..++..+.+++.+||+.||++|||+.++++.
T Consensus       239 ~--~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 A--AIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             T--CCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             h--ccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0  000      011134568899999999999999999999984

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.2e-37  Score=302.82  Aligned_cols=237  Identities=21%  Similarity=0.303  Sum_probs=185.4

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ..|.+.+.||+|+||.||+++.. +++.||+|++.....    ..+.+..|              +++++......++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            35667789999999999999965 688999999876432    12333333              566777788899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++++|.+++...    ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       121 e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          121 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             CCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999987432    4689999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ...  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......       . ....+..... ..
T Consensus       194 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~-~~~~~~~~~~-~~  260 (335)
T 2owb_A          194 DGE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------E-TYLRIKKNEY-SI  260 (335)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHHTCC-CC
T ss_pred             Ccc--cccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------H-HHHHHhcCCC-CC
Confidence            332  12445799999999999764  6889999999999999999999999654321       1 1222222221 11


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCC
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS  423 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~  423 (453)
                            +..+...+.+++.+||+.||++|||+.++++  .+...
T Consensus       261 ------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          261 ------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             ------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence                  1123356788999999999999999999997  45543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-37  Score=302.74  Aligned_cols=251  Identities=26%  Similarity=0.409  Sum_probs=186.8

Q ss_pred             HhhhhhcccCccCceEEEEEEE-----cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccC--cceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEG--FKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-----~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~--~~~~  218 (453)
                      ..+.+.++||+|+||.||+++.     .+|+.||||++...... .+++.+|              +++++...  ...+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            3456778999999999999984     36899999999764332 3344444              33444332  3678


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+++|+|.+++...   ...+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       121 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            999999999999998543   24689999999999999999999998   999999999999999999999999999998


Q ss_pred             cCCCCCcee-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccc--------cccccchHHH
Q 048517          299 HPKENDFVS-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR--------SSKAYFPSWV  369 (453)
Q Consensus       299 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~--------~~~~~~~~~~  369 (453)
                      ......... .....+|..|+|||.+.+.  .++.++||||||++++||++|+.|+......        .........+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            765443222 2334578889999999764  6889999999999999999999887532110        0000011112


Q ss_pred             HHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      .+.+..+.....      +..++..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       273 ~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          273 IELLKNNGRLPR------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHTTCCCCC------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCCC------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            223333322221      12234678899999999999999999999999987543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.8e-37  Score=310.41  Aligned_cols=186  Identities=23%  Similarity=0.270  Sum_probs=149.1

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------------HhcccccCcceEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------------LLGLCSEGFKRAL  219 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------------l~g~~~~~~~~~l  219 (453)
                      ..|.+.++||+|+||+||+|+.. +++.||||++........++..|                    +.+.+......++
T Consensus        54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  133 (382)
T 2vx3_A           54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL  133 (382)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred             eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence            35667789999999999999955 78999999997643322222222                    2234455677899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc--CCCceEEEecCCcc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAK  297 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~--~~~~~kl~DFGla~  297 (453)
                      ||||++ |+|.+++....  ...+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||+++
T Consensus       134 v~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          134 VFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            999995 59999885432  24589999999999999999999952 34899999999999994  57889999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  357 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~  357 (453)
                      .....     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||....
T Consensus       210 ~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          210 QLGQR-----IYQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecccc-----cccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            76432     2346789999999999864  78999999999999999999999997543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=306.62  Aligned_cols=255  Identities=21%  Similarity=0.243  Sum_probs=171.5

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH---------------Hhccc--------ccC
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE---------------LLGLC--------SEG  214 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e---------------l~g~~--------~~~  214 (453)
                      ...+.+.++||+|+||.||+|+. .+|+.||||++...... .+.+..|               +++++        ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            34667789999999999999995 47999999988654322 2333333               22333        334


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc--eeecccCCcceEEcCCCceEEEe
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSD  292 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dikp~NILl~~~~~~kl~D  292 (453)
                      ...++++||+. |+|.+++.... ....+++..++.++.|++.||.|||+.   +  |+||||||+|||++.++.+||+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            45789999995 89988885432 235699999999999999999999997   7  99999999999999999999999


Q ss_pred             cCCccccCCCCCce----------eecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc
Q 048517          293 FGLAKFHPKENDFV----------SISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS  361 (453)
Q Consensus       293 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~  361 (453)
                      ||+++.........          ......||+.|+|||.+.. ....++.++||||||+++|||++|+.||....... 
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-  260 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-  260 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence            99998765432211          1113458999999999842 12467899999999999999999999986432211 


Q ss_pred             cccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCCCC
Q 048517          362 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFS  436 (453)
Q Consensus       362 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~~~  436 (453)
                                .+.........      ......+.+++.+||+.||++|||+.|+++.|+........++++...
T Consensus       261 ----------~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~  319 (337)
T 3ll6_A          261 ----------IVNGKYSIPPH------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT  319 (337)
T ss_dssp             ---------------CCCCTT------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCH
T ss_pred             ----------hhcCcccCCcc------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHH
Confidence                      11111111110      111234778999999999999999999999999877666655555443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.5e-37  Score=310.64  Aligned_cols=249  Identities=22%  Similarity=0.304  Sum_probs=180.1

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH------H----------------hcccc--
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE------L----------------LGLCS--  212 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e------l----------------~g~~~--  212 (453)
                      +....|.+.++||+|+||+||+|+. .+++.||||++.......+.+.+|      +                ++.+.  
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            3345677889999999999999985 578999999997654333444333      1                22222  


Q ss_pred             --cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC----
Q 048517          213 --EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----  286 (453)
Q Consensus       213 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~----  286 (453)
                        .+...++||||+ +++|.+++...  ....+++..+..++.|++.||+|||+++  +|+||||||+|||++.++    
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence              445678999999 66776666432  2356999999999999999999999852  899999999999998775    


Q ss_pred             ---------------------------------------------ceEEEecCCccccCCCCCceeecccCCCCCccChh
Q 048517          287 ---------------------------------------------IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE  321 (453)
Q Consensus       287 ---------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  321 (453)
                                                                   .+||+|||+++.....     .....||+.|+|||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE  263 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence                                                         7999999999876433     23457899999999


Q ss_pred             hhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc--hHHHHHHhhh--------CCC-----------cc
Q 048517          322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF--PSWVYDQLNK--------GGD-----------LE  380 (453)
Q Consensus       322 ~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~--~~~~~~~l~~--------~~~-----------~~  380 (453)
                      ++.+.  .++.++|||||||++|||++|+.||............  ...+.+.+..        +..           ..
T Consensus       264 ~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          264 VLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             hhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            99864  6899999999999999999999999764432211000  0001111000        000           00


Q ss_pred             cc------------chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LR------------NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~------------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..            .........+..+.+++.+||+.||++|||+.|+++
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00            000123456678999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-37  Score=313.55  Aligned_cols=228  Identities=16%  Similarity=0.132  Sum_probs=167.6

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC----CCHHHHHHH-----------------Hh-------cccc
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK----FSAEEFINE-----------------LL-------GLCS  212 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~----~~~~~~i~e-----------------l~-------g~~~  212 (453)
                      .+.+.+.||+|+||.||+|+. .+|+.||||++....    ...+.+.+|                 ++       +++.
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            455678999999999999994 679999999986421    122333333                 33       2222


Q ss_pred             cCc-----------------ceEEEEEecCCCChhhhhhhccC---CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceee
Q 048517          213 EGF-----------------KRALVYEYMPNGSLDRHIFSKEN---KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILH  272 (453)
Q Consensus       213 ~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  272 (453)
                      ...                 ..++||||+ +|+|.+++.....   ....+++..++.|+.|++.||+|||+.   +|+|
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  229 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  229 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            221                 278999999 6899999864321   123455688899999999999999998   9999


Q ss_pred             cccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhccc---------CCCCCccchHHHHHHHH
Q 048517          273 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN---------FGTVSCKSDVYGFGMVL  343 (453)
Q Consensus       273 ~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DV~S~Gvvl  343 (453)
                      |||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.         ...++.++|||||||++
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            99999999999999999999999986432     2244567 999999998753         01588999999999999


Q ss_pred             HHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          344 LEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       344 ~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      |||++|+.||..........        .+...           ...++..+.+++.+||+.||++|||+.++++
T Consensus       304 ~elltg~~Pf~~~~~~~~~~--------~~~~~-----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSE--------WIFRS-----------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHSSCCC------CCSG--------GGGSS-----------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHCCCCCcccccccchh--------hhhhh-----------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999996543221100        01000           0112356888999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.5e-37  Score=320.46  Aligned_cols=238  Identities=25%  Similarity=0.322  Sum_probs=186.9

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecC---CCCCHHHHHHH--------------HhcccccCcceE
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMEN---SKFSAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      .-....|.+.++||+|+||+||+|+.. +|+.||||++..   .......+.+|              +++++......+
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            345567888999999999999999965 799999999864   22334444444              566777888899


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc---CCCceEEEecCC
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGL  295 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGl  295 (453)
                      +||||+++|+|.+.+...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            999999999999988543    4689999999999999999999998   999999999999995   456899999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      ++......   ......||+.|+|||++.+   .++.++||||+||++|||++|+.||......        .+...+..
T Consensus       171 a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~  236 (486)
T 3mwu_A          171 STCFQQNT---KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVET  236 (486)
T ss_dssp             TTTBCCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH
T ss_pred             CeECCCCC---ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh
Confidence            98765433   2245679999999999874   6889999999999999999999999654321        12333333


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +.....   ......++..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          237 GKYAFD---LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             TCCCSC---SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCC---CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            322111   1122234567889999999999999999999998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.2e-37  Score=302.07  Aligned_cols=250  Identities=26%  Similarity=0.315  Sum_probs=184.2

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------Hhcccc----cCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCS----EGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~----~~~~~~lv  220 (453)
                      ..|.+.+.||+|+||.||+++. .+|+.||||++..... ..+.+.+|              +++++.    .....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            4567789999999999999996 5799999998865332 23334444              344443    33467899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      +||+++|+|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999999999876544567799999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCCCc-------eeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517          301 KENDF-------VSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  372 (453)
Q Consensus       301 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  372 (453)
                      .....       .......||+.|+|||.+... ...++.++||||||+++|||++|+.||........  .    ....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~----~~~~  259 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--S----VALA  259 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--C----HHHH
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--h----hhHH
Confidence            21100       001233579999999998643 12368899999999999999999999853211110  0    1111


Q ss_pred             hhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       373 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ........      ....++..+.+++.+||+.||++|||+.++++.|+....
T Consensus       260 ~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          260 VQNQLSIP------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HHCC--CC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hhccCCCC------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            11111111      111234578899999999999999999999999997543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.8e-37  Score=316.95  Aligned_cols=179  Identities=23%  Similarity=0.317  Sum_probs=131.9

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------Hhccc-----ccCcceE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLC-----SEGFKRA  218 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~-----~~~~~~~  218 (453)
                      .|.+.+.||+|+||+||+|+.. +|+.||||++......   .+++.+|              +++++     ......+
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            5677899999999999999854 7999999999764332   2334444              34554     2335689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+ +|+|.+++.    ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       134 lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          134 VVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence            999998 578988873    235699999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCc-------------------------eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcC
Q 048517          299 HPKENDF-------------------------VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG  349 (453)
Q Consensus       299 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg  349 (453)
                      .......                         ...+...||+.|+|||++... ..++.++|||||||++|||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHh
Confidence            6432110                         122445789999999987543 4689999999999999999994

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1e-36  Score=296.81  Aligned_cols=232  Identities=24%  Similarity=0.338  Sum_probs=182.9

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      .+...++||+|+||.||+|+. .+++.||||++....  ...+.+..|              +++++......++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  102 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL  102 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence            355678899999999999985 479999999997643  233445444              456666777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++.     ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++........
T Consensus       103 ~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          103 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             TTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            9999999883     24689999999999999999999998   999999999999999999999999999987644321


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                        ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.|+......        .....+.........  
T Consensus       175 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--  240 (303)
T 3a7i_A          175 --KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIPKNNPPTLE--  240 (303)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCCC--
T ss_pred             --ccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHH--------HHHHHhhcCCCCCCc--
Confidence              22445799999999999764  7889999999999999999999998643221        122223332222111  


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                          ..++..+.+++.+||+.||++|||+.++++.
T Consensus       241 ----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          241 ----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ----cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                1233568899999999999999999999873

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.9e-37  Score=300.49  Aligned_cols=242  Identities=22%  Similarity=0.310  Sum_probs=181.3

Q ss_pred             hHHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---------HHHHHHH--------------Hhccc
Q 048517          156 PEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---------AEEFINE--------------LLGLC  211 (453)
Q Consensus       156 ~~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---------~~~~i~e--------------l~g~~  211 (453)
                      +......|.+.+.||+|+||.||+|+.. +++.||||++......         ...+..|              +++++
T Consensus         5 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A            5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             CHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            4556677888899999999999999964 6899999998753211         1122223              34555


Q ss_pred             ccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC---ce
Q 048517          212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IP  288 (453)
Q Consensus       212 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~---~~  288 (453)
                      ..+ ..++||||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++   .+
T Consensus        85 ~~~-~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           85 DAE-DYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             ESS-SEEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCE
T ss_pred             cCC-ceEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeE
Confidence            444 4799999999999999884    335789999999999999999999998   999999999999998755   49


Q ss_pred             EEEecCCccccCCCCCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchH
Q 048517          289 KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS  367 (453)
Q Consensus       289 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  367 (453)
                      ||+|||+++......   ......||+.|+|||++.. ....++.++||||||+++|||++|+.||.......   .   
T Consensus       157 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---  227 (322)
T 2ycf_A          157 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---S---  227 (322)
T ss_dssp             EECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---C---
T ss_pred             EEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---H---
Confidence            999999998764432   1234468999999999853 12468899999999999999999999997543221   1   


Q ss_pred             HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       ....+..+.....   ......++..+.+++.+||+.||++|||+.++++
T Consensus       228 -~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 -LKDQITSGKYNFI---PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -HHHHHHHTCCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHhCccccC---chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             2223333222111   1122334567899999999999999999999874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6e-37  Score=320.18  Aligned_cols=239  Identities=26%  Similarity=0.349  Sum_probs=185.6

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--------------CHHHHHHH--------------Hhcc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--------------SAEEFINE--------------LLGL  210 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--------------~~~~~i~e--------------l~g~  210 (453)
                      ...|.+.++||+|+||+||+|+.. +++.||||++.....              ..+++.+|              ++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            345677899999999999999965 689999999876432              23344444              5677


Q ss_pred             cccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC---c
Q 048517          211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---I  287 (453)
Q Consensus       211 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~---~  287 (453)
                      +......++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            77888899999999999999988543    4689999999999999999999998   999999999999998765   6


Q ss_pred             eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchH
Q 048517          288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS  367 (453)
Q Consensus       288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  367 (453)
                      +||+|||+++.......   .....||+.|+|||++.+   .++.++||||+||++|+|++|+.||......        
T Consensus       188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------  253 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------  253 (504)
T ss_dssp             EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred             EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------
Confidence            99999999987755432   245679999999999864   6889999999999999999999999754321        


Q ss_pred             HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhC
Q 048517          368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  422 (453)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~  422 (453)
                      .+...+..+....   .......++..+.+++.+||+.||.+|||+.|+++  .+.+
T Consensus       254 ~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          254 DIIKKVEKGKYYF---DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             HHHHHHHHCCCCC---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             HHHHHHHcCCCCC---CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence            1333444432211   11122334567899999999999999999999987  3444

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.6e-37  Score=297.34  Aligned_cols=230  Identities=24%  Similarity=0.362  Sum_probs=176.6

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH---HHHHHH--------------Hhcccc----cCcceEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCS----EGFKRALV  220 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~----~~~~~~lv  220 (453)
                      +.+.++||+|+||+||+|.. .+++.||+|++.......   +.+..|              +++++.    .....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            45667899999999999985 478899999987644332   234444              233332    24557899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc--eeecccCCcceEEc-CCCceEEEecCCcc
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC--ILHFDIKPHNILLD-HNFIPKVSDFGLAK  297 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dikp~NILl~-~~~~~kl~DFGla~  297 (453)
                      |||+++|+|.+++...    ..+++..++.++.|++.||.|||+.   +  |+|+||||+|||++ .++.+||+|||++.
T Consensus       108 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            9999999999998532    4689999999999999999999997   6  99999999999997 78999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ......    .....||+.|+|||.+.+   .++.++||||+|++++||++|+.||......       ......+..+.
T Consensus       181 ~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~  246 (290)
T 1t4h_A          181 LKRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGV  246 (290)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTC
T ss_pred             cccccc----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhccC
Confidence            654432    234569999999998864   6889999999999999999999999643221       11223333322


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...     ..+......+.+++.+||+.||++|||+.++++
T Consensus       247 ~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          247 KPA-----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCG-----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Ccc-----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            211     112222356889999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=302.72  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=180.2

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC---HH--------------HHHHHHhcccccCcceEEEEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---AE--------------EFINELLGLCSEGFKRALVYE  222 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---~~--------------~~i~el~g~~~~~~~~~lv~E  222 (453)
                      ...+.+.+.||+|+||.||+|+.++  .||||++......   .+              ..+.++++++......++|+|
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            3456677899999999999998764  4999998753211   11              122236777778888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++++|.+++..   ....+++..++.++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+++.....
T Consensus       110 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          110 LCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             CCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             cccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999998843   235699999999999999999999998   999999999999998 679999999998765321


Q ss_pred             C---CceeecccCCCCCccChhhhccc-------CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517          303 N---DFVSISDTRGTIGYLAPELISRN-------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  372 (453)
Q Consensus       303 ~---~~~~~~~~~gt~~y~aPE~~~~~-------~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  372 (453)
                      .   .........||+.|+|||.+...       ...++.++||||||+++|||++|+.||......        .....
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~  254 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--------AIIWQ  254 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--------HHHHH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence            1   11122344689999999998742       135788999999999999999999998653321        12233


Q ss_pred             hhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCC
Q 048517          373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPF  434 (453)
Q Consensus       373 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~  434 (453)
                      +..+.......     ..++..+.+++.+||+.||++|||+.+++++|+...+.......|.
T Consensus       255 ~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~  311 (319)
T 2y4i_B          255 MGTGMKPNLSQ-----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG  311 (319)
T ss_dssp             HHTTCCCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------
T ss_pred             hccCCCCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence            33332222111     1123458899999999999999999999999999887765444443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-36  Score=320.35  Aligned_cols=235  Identities=28%  Similarity=0.355  Sum_probs=184.1

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.+.+.||+|+||.||+|+.. +|+.||||++...    ......+..|              +++.+......++||||
T Consensus       186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy  265 (576)
T 2acx_A          186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL  265 (576)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence            455678999999999999965 7999999998652    2223334333              45667778889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...  ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       266 ~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          266 MNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             CCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999988543  234589999999999999999999998   99999999999999999999999999998765443


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......    ....+...+..... .   
T Consensus       341 ~---~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~i~~~i~~~~~-~---  407 (576)
T 2acx_A          341 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEVPE-E---  407 (576)
T ss_dssp             C---EECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHHHHHHHHHCCC-C---
T ss_pred             c---ccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHHHHHHhhcccc-c---
Confidence            2   2445799999999999764  68999999999999999999999997643221    11223333332221 1   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                         .+..++..+.+++.+||+.||++||     ++.|+++
T Consensus       408 ---~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 ---YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ---CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence               1122346788999999999999999     7888875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.8e-37  Score=319.50  Aligned_cols=236  Identities=24%  Similarity=0.342  Sum_probs=182.6

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccCcceEEE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ....|.+.++||+|+||+||+|+.. +++.||||++....   ...+.+.+|              +++++......++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3456778899999999999999965 78999999987632   233444444              56777788889999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEecCCcc
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAK  297 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~  297 (453)
                      |||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++
T Consensus       115 ~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            9999999999888543    4689999999999999999999998   9999999999999976   4569999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ......   ......||+.|+|||++.+   .++.++||||+||++|||++|+.||......        .+...+..+.
T Consensus       188 ~~~~~~---~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~  253 (494)
T 3lij_A          188 VFENQK---KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEKGK  253 (494)
T ss_dssp             ECBTTB---CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC
T ss_pred             ECCCCc---cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC
Confidence            765433   2245679999999999863   6889999999999999999999999754321        1333343332


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ....   ......++..+.+++.+||+.+|++|||+.++++
T Consensus       254 ~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          254 YTFD---SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCCC---SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCC---chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            2111   1112234567889999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.4e-36  Score=292.18  Aligned_cols=241  Identities=22%  Similarity=0.263  Sum_probs=182.3

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC-----CCHHHHHHH--------------Hhccc--ccCcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK-----FSAEEFINE--------------LLGLC--SEGFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~-----~~~~~~i~e--------------l~g~~--~~~~~~~l  219 (453)
                      .|.+.+.||+|+||.||++.. .+++.||||++....     ...+.+.+|              +++++  .+....++
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            467788999999999999995 478999999987532     223445454              34544  34557899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||++++ |.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus        86 v~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            99999877 66666432  245789999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      .............||+.|+|||.+.+.....+.++||||||+++|||++|+.||.....        ....+.+..+...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~~~~  231 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKLFENIGKGSYA  231 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCCC
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHHHHhcCCCC
Confidence            54333233345679999999999875423457899999999999999999999975321        1123333333221


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS  423 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~  423 (453)
                       .      +......+.+++.+||+.||++|||+.++++  .+.+.
T Consensus       232 -~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          232 -I------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             -C------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             -C------CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence             1      1123356788999999999999999999997  45543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=316.99  Aligned_cols=238  Identities=21%  Similarity=0.245  Sum_probs=179.7

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHH--------------HHhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFIN--------------ELLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~--------------el~g~~~~~~~~~lv~E  222 (453)
                      .+.+.+.||+|+||.||+++.. +|+.||||++.+...    ..+.+..              .+++.+.+....++|||
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE  141 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME  141 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence            3455688999999999999965 799999999864211    1111111              15666778888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...   +..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       142 ~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          142 YYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             CCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            99999999998543   24689999999999999999999998   9999999999999999999999999999876554


Q ss_pred             CCceeecccCCCCCccChhhhccc-----CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-
Q 048517          303 NDFVSISDTRGTIGYLAPELISRN-----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-  376 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-  376 (453)
                      ... ......||+.|+|||++...     .+.++.++|||||||++|||++|+.||.......        .+..+... 
T Consensus       216 ~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~  286 (412)
T 2vd5_A          216 GTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--------TYGKIVHYK  286 (412)
T ss_dssp             SCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHH
T ss_pred             Ccc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcc
Confidence            332 22346799999999998731     2368899999999999999999999997543211        22222111 


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADR---PSMTKVLE  418 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~evl~  418 (453)
                      ......   .....++..+.+++.+||+ +|++|   |+++|+++
T Consensus       287 ~~~~~p---~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          287 EHLSLP---LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cCcCCC---ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            001110   0122345678899999999 99998   58999886

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-36  Score=292.63  Aligned_cols=233  Identities=21%  Similarity=0.309  Sum_probs=183.4

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||.||+|+.. +++.||||++...    ....+.+..|              +++++......++|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            4566789999999999999965 6889999998642    2223344444              4566777788899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++......
T Consensus        95 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           95 FAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             eCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999988543    3589999999999999999999998   9999999999999999999999999999765432


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .    .....||+.|+|||.+.+.  .++.++||||||++++||++|+.||......        .....+..... .. 
T Consensus       168 ~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~-~~-  231 (284)
T 2vgo_A          168 R----RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRRIVNVDL-KF-  231 (284)
T ss_dssp             C----BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCC-CC-
T ss_pred             c----cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHHHhcccc-CC-
Confidence            2    2345689999999999764  6889999999999999999999999654321        11222222211 11 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  422 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~  422 (453)
                           +..++..+.+++.+||+.||++|||+.++++  .+..
T Consensus       232 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~  268 (284)
T 2vgo_A          232 -----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA  268 (284)
T ss_dssp             -----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred             -----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence                 1123456889999999999999999999987  5554

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.7e-37  Score=319.98  Aligned_cols=237  Identities=26%  Similarity=0.307  Sum_probs=188.9

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceE
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      +....|.+.+.||+|+||.||+|+.. +|+.||||++...    ....+.+.+|              +++++......+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            44567888899999999999999965 7999999998653    2334555555              566777788899


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE---cCCCceEEEecCC
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGL  295 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGl  295 (453)
                      +||||+.+|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||+
T Consensus       103 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             EEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            99999999999998843    35689999999999999999999998   99999999999999   5678999999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      ++.......   .....||+.|+|||++.+   .++.++||||+||++|||++|+.||......        .+...+..
T Consensus       176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~  241 (484)
T 3nyv_A          176 STHFEASKK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVEK  241 (484)
T ss_dssp             HHHBCCCCS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH
T ss_pred             eEEcccccc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHc
Confidence            987654432   244579999999999864   6889999999999999999999999754321        13333443


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +.....   ......++..+.+++.+||+.+|++|||+.++++
T Consensus       242 ~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          242 GKYTFE---LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCCCC---SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            322111   1122234567889999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-36  Score=298.01  Aligned_cols=242  Identities=19%  Similarity=0.270  Sum_probs=178.0

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------Hhccccc--CcceEEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLCSE--GFKRALVYE  222 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~--~~~~~lv~E  222 (453)
                      ..|.+.++||+|+||+||+|+. .+++.||||++....  .+.+..|               +++++..  ....++|||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            3566778999999999999985 579999999997533  3333333               2334444  556789999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPK  301 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~  301 (453)
                      |+++++|.+++       ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|||+++....
T Consensus       114 ~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          114 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999998887       3488999999999999999999998   999999999999999766 899999999987654


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc------chHHHHHHhhh
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY------FPSWVYDQLNK  375 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~------~~~~~~~~l~~  375 (453)
                      ...   .....||+.|+|||.+.+. ..++.++||||+|++++||++|+.||...........      -.....+.+.+
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCc---cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            432   2445789999999998753 4689999999999999999999999954332110000      00001111111


Q ss_pred             CCC---------------ccccc--hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 GGD---------------LELRN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ~~~---------------~~~~~--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...               .....  .......++..+.+++.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            100               00000  00112224567899999999999999999999987

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.4e-36  Score=292.87  Aligned_cols=232  Identities=22%  Similarity=0.300  Sum_probs=182.8

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      ..|.+.+.||+|+||.||+++.. +++.||+|++......    .+.+..|              +++++......++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            35667789999999999999965 6889999998764321    2333333              567777788889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++++|.+++...    ..+++.++..++.|+++||+|||+.   +|+|+||||+|||++.++.+||+|||+++....
T Consensus        95 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           95 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             ECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999987432    4689999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ...  ......||+.|+|||.+.+.  .++.++||||+|++++||++|+.||......       . ....+..... ..
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~-~~  234 (294)
T 2rku_A          168 DGE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------E-TYLRIKKNEY-SI  234 (294)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHTTCC-CC
T ss_pred             Ccc--ccccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhhccC-CC
Confidence            322  12345799999999999764  6889999999999999999999999654321       1 1222222211 11


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                            +..++..+.+++.+||+.||++|||+.++++
T Consensus       235 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          235 ------PKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ------ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                  1123356888999999999999999999997

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-36  Score=302.44  Aligned_cols=246  Identities=26%  Similarity=0.339  Sum_probs=177.7

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC------HHHHHHH--------------HhcccccCcceE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS------AEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~------~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ...|.+.+.||+|+||.||+|+.. +|+.||||++......      .+.+.+|              +++++......+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            345677789999999999999954 6999999998753221      1233333              456677778899


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+++ +|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        89 lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999975 88887742   335689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ......  ......||+.|+|||.+.+. ..++.++|||||||++|||++|++|+.......   .+ ..+.+.......
T Consensus       162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~-~~i~~~~~~~~~  234 (346)
T 1ua2_A          162 FGSPNR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QL-TRIFETLGTPTE  234 (346)
T ss_dssp             TTSCCC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-HHHHHHHCCCCT
T ss_pred             ccCCcc--cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HH-HHHHHHcCCCCh
Confidence            644322  22456789999999998653 357899999999999999999999986543211   00 001111110000


Q ss_pred             cc------------ccc-----hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          379 LE------------LRN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       379 ~~------------~~~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                      ..            ...     ........+..+.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00            000     000112334678999999999999999999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.9e-37  Score=302.52  Aligned_cols=247  Identities=22%  Similarity=0.281  Sum_probs=177.4

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CC-cEEEEEEecCCCCCHHHHHHH--------------------HhcccccCcc
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TG-RLIAVKMMENSKFSAEEFINE--------------------LLGLCSEGFK  216 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g-~~VAVK~l~~~~~~~~~~i~e--------------------l~g~~~~~~~  216 (453)
                      ....|.+.+.||+|+||+||+|... ++ +.||||++.......+.+..|                    +.+++.....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            3456778899999999999999964 44 789999997643333333332                    1233445667


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE--------------
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL--------------  282 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl--------------  282 (453)
                      .++||||+ +++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||+              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence            89999999 67777776432  234689999999999999999999998   99999999999999              


Q ss_pred             -----cCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517          283 -----DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  357 (453)
Q Consensus       283 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~  357 (453)
                           +.++.+||+|||+++......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||....
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                 668899999999998654332     345799999999999764  78999999999999999999999997543


Q ss_pred             cccccc-------cchHHHHHHhhhCC-------Cc---------------cccchhhhHHHHHHHHHHHHHHhcccCCC
Q 048517          358 TRSSKA-------YFPSWVYDQLNKGG-------DL---------------ELRNVTEIESMIARKLCMIGLWCIQVKAA  408 (453)
Q Consensus       358 ~~~~~~-------~~~~~~~~~l~~~~-------~~---------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~  408 (453)
                      ......       ..+...........       ..               ...............+.+++.+||+.||+
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            221000       00000000000000       00               00000001123355788999999999999


Q ss_pred             CCCCHHHHHH
Q 048517          409 DRPSMTKVLE  418 (453)
Q Consensus       409 ~RPs~~evl~  418 (453)
                      +|||+.|+++
T Consensus       324 ~Rpt~~e~l~  333 (355)
T 2eu9_A          324 QRITLAEALL  333 (355)
T ss_dssp             TSCCHHHHTT
T ss_pred             hCcCHHHHhc
Confidence            9999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.2e-37  Score=299.84  Aligned_cols=240  Identities=23%  Similarity=0.351  Sum_probs=185.2

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      ....|.+.+.||+|+||.||+++.. +|+.||||++..... ..+.+.+|              +++++......++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3456778899999999999999965 799999999976432 22333333              4566777888899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE---cCCCceEEEecCCcccc
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~  299 (453)
                      |+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+|+||||+||++   +.++.+||+|||+++..
T Consensus        87 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           87 LVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             cCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999988543    4689999999999999999999998   99999999999999   78899999999999765


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ....    .....||+.|+|||.+.+.  .++.++||||+|+++|||++|+.||......        ...+.+.++...
T Consensus       160 ~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~  225 (304)
T 2jam_A          160 QNGI----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETES--------KLFEKIKEGYYE  225 (304)
T ss_dssp             CCBT----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHCCCC
T ss_pred             CCCc----cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            4321    1334689999999998764  7899999999999999999999998654321        123333333211


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  422 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~  422 (453)
                      ..   ......++..+.+++.+||+.||++|||+.++++  .+++
T Consensus       226 ~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          226 FE---SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             CC---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             CC---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence            10   0111234467889999999999999999999987  4554

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-36  Score=291.86  Aligned_cols=235  Identities=23%  Similarity=0.372  Sum_probs=176.0

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++....    ...+.+..|              +++++......++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME   91 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4667789999999999999965 79999999986521    223344443              4566777788899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++......
T Consensus        92 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           92 YVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             CCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             ccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999998543    4589999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..   .....||+.|+|||.+.+. ...+.++||||||++++||++|+.||.....        ....+.+..+... . 
T Consensus       165 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~-~-  230 (276)
T 2h6d_A          165 EF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLFKKIRGGVFY-I-  230 (276)
T ss_dssp             ---------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCC-C-
T ss_pred             cc---eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHHhhcCccc-C-
Confidence            21   2345689999999998764 2346899999999999999999999864321        1123333332211 1 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEG  422 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~  422 (453)
                           +..++..+.+++.+||+.||++|||+.++++.  +..
T Consensus       231 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          231 -----PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             -----chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence                 11233568899999999999999999999983  554

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.7e-37  Score=315.32  Aligned_cols=242  Identities=22%  Similarity=0.208  Sum_probs=170.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccC------cce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEG------FKR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~------~~~  217 (453)
                      .|.+.++||+|+||+||+|+. .+|+.||||++......   .+++.+|              +++++...      ...
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  142 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV  142 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence            466678999999999999985 47999999999764222   2333343              34444322      456


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||++++ |.+.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       143 ~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          143 YLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             EEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            9999999765 555552      2489999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc---------------
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK---------------  362 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~---------------  362 (453)
                      ......   ..+...||+.|+|||++.+.  .++.++||||+||+++||++|+.||........-               
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          213 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             ----CC---CC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCc---ccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            764432   23456799999999999874  7899999999999999999999999754321100               


Q ss_pred             ccchHHHHHHhhhCCC---cc---------ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          363 AYFPSWVYDQLNKGGD---LE---------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       363 ~~~~~~~~~~l~~~~~---~~---------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..+.......+.....   ..         ...........+..+.+++.+||+.||++|||++|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000111111000   00         00011122334677899999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.8e-37  Score=307.42  Aligned_cols=243  Identities=21%  Similarity=0.292  Sum_probs=158.9

Q ss_pred             hhhhh-cccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH-----------Hhccccc----CcceEEEEEec
Q 048517          162 TNHFT-HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE-----------LLGLCSE----GFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~-~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e-----------l~g~~~~----~~~~~lv~E~~  224 (453)
                      .|.+. +.||+|+||+||+|+.. +|+.||||++........+...+           +++++..    +...++||||+
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~  108 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM  108 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence            45553 46999999999999965 79999999997654333333222           3344433    34478999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEecCCccccCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~~~~~  301 (453)
                      ++|+|.+++...  ....+++.+++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++....
T Consensus       109 ~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          109 EGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             TTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            999999998532  235799999999999999999999998   9999999999999976   45699999999986543


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ..    .....||+.|+|||++...  .++.++||||||+++|||++|+.||...........    ....+..... ..
T Consensus       184 ~~----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~-~~  252 (336)
T 3fhr_A          184 NA----LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----MKRRIRLGQY-GF  252 (336)
T ss_dssp             ------------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC--------------------------CC
T ss_pred             cc----cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----HHHhhhcccc-cc
Confidence            32    2345689999999998653  788899999999999999999999965433211000    0111111110 00


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhC
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  422 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~  422 (453)
                        .......++..+.+++.+||+.||++|||+.++++  .+..
T Consensus       253 --~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          253 --PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             --CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             --CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence              00111234567889999999999999999999998  5543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-36  Score=302.72  Aligned_cols=246  Identities=22%  Similarity=0.269  Sum_probs=176.6

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------Hhccccc--------C
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSE--------G  214 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~--------~  214 (453)
                      ..|.+.++||+|+||.||+|+. .+|+.||||++.....   ....+.+|              +++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            3567778999999999999996 5799999999865322   22344444              3344433        3


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...++||||+++ +|.+.+..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            457899999974 77776642   234699999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCC--ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517          295 LAKFHPKEND--FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  372 (453)
Q Consensus       295 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  372 (453)
                      +++.......  ........||+.|+|||++.+. ..++.++||||||++++||++|+.||........    ...+...
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~  244 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ----LALISQL  244 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHH
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHH
Confidence            9987643221  1122455789999999998753 3678999999999999999999999975432110    0001111


Q ss_pred             hhhCCC--------------ccc--cchhhhHH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          373 LNKGGD--------------LEL--RNVTEIES-----MIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       373 l~~~~~--------------~~~--~~~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ......              ...  ........     ..+..+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            000000              000  00000111     12356889999999999999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.2e-37  Score=309.52  Aligned_cols=246  Identities=19%  Similarity=0.194  Sum_probs=176.8

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH--HHHHH---------HHhccc-----------------
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA--EEFIN---------ELLGLC-----------------  211 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~--~~~i~---------el~g~~-----------------  211 (453)
                      ..|.+.+.||+|+||.||+|+. .+|+.||||++.......  +-.+.         ++++++                 
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~   86 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH   86 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence            3567779999999999999985 579999999987643222  11111         134444                 


Q ss_pred             ---------------------ccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCce
Q 048517          212 ---------------------SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI  270 (453)
Q Consensus       212 ---------------------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  270 (453)
                                           ......++||||++ |+|.+.+.........+++..+..++.|+++||+|||+.   +|
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi  162 (383)
T 3eb0_A           87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GI  162 (383)
T ss_dssp             -----------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TE
T ss_pred             ccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cC
Confidence                                 22334789999997 688887765444557899999999999999999999998   99


Q ss_pred             eecccCCcceEEc-CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcC
Q 048517          271 LHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG  349 (453)
Q Consensus       271 vH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg  349 (453)
                      +||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||.+.+. ..++.++||||+||+++||++|
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g  238 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELILG  238 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHHhC
Confidence            9999999999998 688999999999987654432   2345689999999998753 3589999999999999999999


Q ss_pred             CCCCCCCccccccccchHHHHHHhhh------------CCCccccc------hhhhHHHHHHHHHHHHHHhcccCCCCCC
Q 048517          350 RRNSNMNATRSSKAYFPSWVYDQLNK------------GGDLELRN------VTEIESMIARKLCMIGLWCIQVKAADRP  411 (453)
Q Consensus       350 ~~p~~~~~~~~~~~~~~~~~~~~l~~------------~~~~~~~~------~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  411 (453)
                      +.||........   +.. +...+..            ........      ....+...+..+.+++.+||+.||++||
T Consensus       239 ~~pf~~~~~~~~---~~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          239 KPLFSGETSIDQ---LVR-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             SCSSCCSSHHHH---HHH-HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             CCCCCCCChHHH---HHH-HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            999975432110   000 0000000            00000000      0001122445689999999999999999


Q ss_pred             CHHHHHH
Q 048517          412 SMTKVLE  418 (453)
Q Consensus       412 s~~evl~  418 (453)
                      |+.|+++
T Consensus       315 t~~e~l~  321 (383)
T 3eb0_A          315 NPYEAMA  321 (383)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.9e-36  Score=301.79  Aligned_cols=252  Identities=20%  Similarity=0.297  Sum_probs=178.2

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH-------------------------Hhccccc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE-------------------------LLGLCSE  213 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e-------------------------l~g~~~~  213 (453)
                      ...|.+.++||+|+||+||+|+. .+|+.||||++.......+.+..|                         +++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            34677889999999999999995 579999999997643333333222                         2233332


Q ss_pred             C----cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc------
Q 048517          214 G----FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD------  283 (453)
Q Consensus       214 ~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~------  283 (453)
                      .    ...+++|||+ +++|.+++...  ....+++..+..++.|++.||+|||++  .+|+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCc
Confidence            2    2678999999 99999988543  234589999999999999999999984  2899999999999994      


Q ss_pred             CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc
Q 048517          284 HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA  363 (453)
Q Consensus       284 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~  363 (453)
                      .++.+||+|||+++.....     .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..........
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence            4458999999999876442     2345789999999999864  68999999999999999999999997544221110


Q ss_pred             cch--HHHHHHhhh--------C----------C------Ccccc-------chhhhHHHHHHHHHHHHHHhcccCCCCC
Q 048517          364 YFP--SWVYDQLNK--------G----------G------DLELR-------NVTEIESMIARKLCMIGLWCIQVKAADR  410 (453)
Q Consensus       364 ~~~--~~~~~~l~~--------~----------~------~~~~~-------~~~~~~~~~~~~l~~l~~~Cl~~~p~~R  410 (453)
                      ...  ..+.+.+..        +          .      .....       .....+...+..+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence            000  000000000        0          0      00000       0001234567789999999999999999


Q ss_pred             CCHHHHHH--HHhCC
Q 048517          411 PSMTKVLE--MLEGS  423 (453)
Q Consensus       411 Ps~~evl~--~Le~~  423 (453)
                      ||+.|+++  .+.+.
T Consensus       326 pt~~ell~hp~f~~~  340 (373)
T 1q8y_A          326 ADAGGLVNHPWLKDT  340 (373)
T ss_dssp             BCHHHHHTCGGGTTC
T ss_pred             CCHHHHhhChhhhcc
Confidence            99999998  55543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=298.93  Aligned_cols=237  Identities=27%  Similarity=0.359  Sum_probs=174.4

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------Hhccccc------CcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLCSE------GFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~------~~~~~l  219 (453)
                      .|.+.+.||+|+||.||+|+. .+|+.||||++.......+++..|               +++++..      ....++
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l  104 (326)
T 2x7f_A           25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL  104 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence            456678999999999999996 479999999998765555555444               2333333      456799


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+||+|||++...
T Consensus       105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          105 VMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             EEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            99999999999998543  235689999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      .....  ......||+.|+|||.+...   ...++.++||||||+++|||++|+.||.......        ....+...
T Consensus       180 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~  249 (326)
T 2x7f_A          180 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPRN  249 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHS
T ss_pred             CcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--------HHHHhhcC
Confidence            43221  12345689999999998631   2468899999999999999999999986433211        11122222


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ......     ...++..+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          250 PAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CCCCCS-----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccCC-----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111111     1123456889999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=294.45  Aligned_cols=239  Identities=26%  Similarity=0.352  Sum_probs=179.9

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEE
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      +.....+.+.+.||+|+||.||+|... +|+.||||++..... .+++..|              +++++......++||
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            444556777889999999999999965 699999999976432 3444444              456666777889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+++|+|.+++...   ...+++..+..++.+++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.....
T Consensus       104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            999999999988532   35689999999999999999999998   999999999999999999999999999986643


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ...  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......        ....+........
T Consensus       178 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  245 (314)
T 3com_A          178 TMA--KRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMR--------AIFMIPTNPPPTF  245 (314)
T ss_dssp             TBS--CBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCC
T ss_pred             hcc--ccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhcCCCccc
Confidence            321  22345789999999999764  78899999999999999999999986433210        1112222221111


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .    .+..++..+.+++.+||+.||++|||+.++++
T Consensus       246 ~----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 R----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             S----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C----CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1    12223457889999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-36  Score=303.72  Aligned_cols=252  Identities=23%  Similarity=0.194  Sum_probs=167.2

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCc-------c
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGF-------K  216 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~-------~  216 (453)
                      ....|.+.+.||+|+||.||+|+.. +|+.||||++.........++.+              +++++....       .
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            3345667789999999999999964 79999999987644333333222              333442211       2


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhH--cCCCCceeecccCCcceEEcC-CCceEEEec
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH--NGCDVCILHFDIKPHNILLDH-NFIPKVSDF  293 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dikp~NILl~~-~~~~kl~DF  293 (453)
                      .++||||+++ +|.+.+.........+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.+||+||
T Consensus       101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Df  176 (360)
T 3e3p_A          101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDF  176 (360)
T ss_dssp             EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred             EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeC
Confidence            6799999975 555554433344567899999999999999999999  66   9999999999999997 899999999


Q ss_pred             CCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------h
Q 048517          294 GLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------P  366 (453)
Q Consensus       294 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~  366 (453)
                      |+++.......   .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||............       +
T Consensus       177 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          177 GSAKKLSPSEP---NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             TTCBCCCTTSC---CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCceecCCCCC---cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            99987654432   2345689999999998653 35899999999999999999999999754322100000       0


Q ss_pred             HHHHHHhhhC-CCccccc--hh-------hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          367 SWVYDQLNKG-GDLELRN--VT-------EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       367 ~~~~~~l~~~-~~~~~~~--~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ......+... .......  ..       ......+..+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000011000 0000000  00       001113567899999999999999999999987

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-36  Score=295.42  Aligned_cols=236  Identities=22%  Similarity=0.231  Sum_probs=182.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---C-------HHHHHHH---------------HhcccccCc
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---S-------AEEFINE---------------LLGLCSEGF  215 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~-------~~~~i~e---------------l~g~~~~~~  215 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++.....   .       .+.+..|               +++++....
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   97 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence            4556788999999999999965 789999999976431   1       1222233               355666777


Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      ..++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+
T Consensus        98 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           98 FFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccc
Confidence            889999999999999998542    4689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcc----cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISR----NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  371 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  371 (453)
                      +........   .....||+.|+|||.+..    ....++.++||||||++++||++|+.||......        ....
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~  239 (298)
T 1phk_A          171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------LMLR  239 (298)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred             hhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--------HHHH
Confidence            987654332   244578999999999853    1246788999999999999999999998643321        1222


Q ss_pred             HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+..+.....   ......++..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MIMSGNYQFG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHTCCCCC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhcCCcccC---cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            2332221111   1111234567899999999999999999999976

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.3e-37  Score=304.54  Aligned_cols=242  Identities=20%  Similarity=0.285  Sum_probs=171.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      .|.+.++||+|+||+||+|+. .+|+.||||++......   .+.+.+|              +++++..+...++||||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY  114 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence            566778999999999999985 47999999999754322   1223333              56667778888999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE-----cCCCceEEEecCCccc
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL-----DHNFIPKVSDFGLAKF  298 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl-----~~~~~~kl~DFGla~~  298 (453)
                      ++ |+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||+     +.++.+||+|||+++.
T Consensus       115 ~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          115 AE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             CS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             CC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            97 5999988432    4589999999999999999999998   99999999999999     4556699999999987


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ......  ......||+.|+|||++.+. ..++.++|||||||+++||++|+.||........   + ..+.+.+.....
T Consensus       187 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~-~~~~~~~~~~~~  259 (329)
T 3gbz_A          187 FGIPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---L-FKIFEVLGLPDD  259 (329)
T ss_dssp             HC-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-HHHHHHHCCCCT
T ss_pred             cCCccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---H-HHHHHHhCCCch
Confidence            643322  22445689999999999763 3589999999999999999999999975432110   0 001111100000


Q ss_pred             c----------------cccc---hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 L----------------ELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 ~----------------~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .                ....   .......++..+.+++.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0                0000   00011224467889999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.3e-37  Score=302.04  Aligned_cols=247  Identities=23%  Similarity=0.341  Sum_probs=177.2

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++.......   +.+..|              +++++......++||||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  105 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF  105 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence            4566789999999999999965 69999999987644332   223333              56677778888999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       106 ~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          106 VDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             CCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            99999987753    234689999999999999999999998   99999999999999999999999999998654432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc-------chHHHHHHhhh-
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQLNK-  375 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-------~~~~~~~~l~~-  375 (453)
                      .  ......||+.|+|||.+.+. ..++.++||||+|+++|||++|+.||...........       ........... 
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  22445799999999998753 3678999999999999999999999975442210000       00000000000 


Q ss_pred             ----CCC-ccccc---hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 ----GGD-LELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ----~~~-~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          +.. .....   .......++..+.+++.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                000 00000   00111234567999999999999999999999876

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-36  Score=293.55  Aligned_cols=242  Identities=26%  Similarity=0.415  Sum_probs=174.9

Q ss_pred             HhhhhhcccCccCceEEEEEEEc--CCc--EEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH--TGR--LIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~--~g~--~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ..+.+.++||+|+||+||+|+..  +++  .||||++.....    ..+++..|              +++++... ..+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-Cce
Confidence            45677789999999999999853  333  699999876422    22344444              34444443 378


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +|+||+++|+|.+++....   ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++.
T Consensus        97 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence            9999999999999985432   4689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhC
Q 048517          299 HPKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       299 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      ........ ......+|..|+|||.+...  .++.++||||||++++||++ |+.||......        .....+...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~  240 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKE  240 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTS
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--------HHHHHHHcc
Confidence            75543322 22344678899999999764  67899999999999999999 99998654321        122223222


Q ss_pred             C-CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          377 G-DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       377 ~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      . ...      .+..++..+.+++.+||+.||++|||+.++++.|+....
T Consensus       241 ~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          241 GERLP------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCCCC------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            1 111      112234678899999999999999999999999987543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.1e-37  Score=297.09  Aligned_cols=246  Identities=22%  Similarity=0.290  Sum_probs=170.4

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..|.+.+.||+|+||.||+|+. .+++.||||++....  ...+++..|              +++++......++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            3566778999999999999984 578999999886532  223344444              45666777788999999


Q ss_pred             cCCCChhhhhhhcc----CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          224 MPNGSLDRHIFSKE----NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       224 ~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      +++|+|.+++....    .....+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++..
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            99999999885321    1245689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCc---eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          300 PKENDF---VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       300 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      ......   .......||+.|+|||.+.+. ..++.++||||||+++|||++|+.||.......       .....+...
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~  243 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQND  243 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHTSS
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-------HHHHHhccC
Confidence            443211   112345699999999998652 257899999999999999999999997543211       111111111


Q ss_pred             CCccccch---hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 GDLELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       .......   ......++..+.+++.+||+.||++|||+.++++
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 -PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             -CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             1110000   0011123456889999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.4e-37  Score=306.35  Aligned_cols=242  Identities=22%  Similarity=0.305  Sum_probs=180.1

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      ...|.+.++||+|+||.||+++.. +|+.||+|++.....  ..+.+..|              +++++......++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            345667789999999999999965 799999999976432  22344454              4566667778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...    ..+++..+..++.+++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999998543    4689999999999999999999983  17999999999999999999999999999754322


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-----------------
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-----------------  365 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-----------------  365 (453)
                      .    .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...........+                 
T Consensus       186 ~----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          186 M----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             C--------CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             c----ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            1    2345799999999999764  7899999999999999999999999654321100000                 


Q ss_pred             -----------------hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          366 -----------------PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       366 -----------------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                       .....+.+........     ....++..+.+++.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL-----PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCC-----CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCC-----CcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                             0000011111111100     01123456889999999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-36  Score=301.75  Aligned_cols=247  Identities=21%  Similarity=0.279  Sum_probs=173.6

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccC------cce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEG------FKR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~------~~~  217 (453)
                      .|.+.+.||+|+||.||+|+. .+|+.||||++......   .+++.+|              +++++...      ...
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            466778999999999999996 57999999999664332   2333444              34444433      345


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||+ +++|.+++..     ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          106 YLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             EEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            9999999 8899988843     3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-------cchHH--
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------YFPSW--  368 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~--  368 (453)
                      .....     .....+|+.|+|||++.+. ..++.++||||+||+++||++|+.||........-.       ..+..  
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            75432     2445789999999998763 478999999999999999999999997543211000       00000  


Q ss_pred             -------HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCC
Q 048517          369 -------VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS  423 (453)
Q Consensus       369 -------~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~  423 (453)
                             ....+..................+..+.+++.+||+.||++|||+.++++  .++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                   00000000000000001111223467889999999999999999999998  45543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2e-36  Score=300.32  Aligned_cols=241  Identities=22%  Similarity=0.310  Sum_probs=183.6

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH------------------HHHHHH--------------Hhc
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA------------------EEFINE--------------LLG  209 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~------------------~~~i~e--------------l~g  209 (453)
                      .|.+.+.||+|+||.||+|+. +|+.||||++.......                  +.+.+|              +++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            566778999999999999998 89999999987521110                  555555              466


Q ss_pred             ccccCcceEEEEEecCCCChhhhhh----hccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcC
Q 048517          210 LCSEGFKRALVYEYMPNGSLDRHIF----SKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDH  284 (453)
Q Consensus       210 ~~~~~~~~~lv~E~~~~gsL~~~l~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~  284 (453)
                      ++......++||||+++|+|.+++.    ........+++..++.++.|++.||.|||+ .   +|+|+||||+|||++.
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK  187 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence            6777788999999999999999832    112224679999999999999999999998 7   9999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCc-cchHHHHHHHHHHHHcCCCCCCCCccccccc
Q 048517          285 NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSC-KSDVYGFGMVLLEMAGGRRNSNMNATRSSKA  363 (453)
Q Consensus       285 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~  363 (453)
                      ++.+||+|||+++.....    ......||+.|+|||.+.+. ..++. ++||||||++++||++|+.||......    
T Consensus       188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            999999999999876443    23556799999999998753 24555 999999999999999999999754321    


Q ss_pred             cchHHHHHHhhhCCCccccc------------hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          364 YFPSWVYDQLNKGGDLELRN------------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       364 ~~~~~~~~~l~~~~~~~~~~------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         ......+..+.......            .......++..+.+++.+||+.||++|||+.|+++
T Consensus       259 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 ---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               11222332221110000            00011334567899999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.7e-36  Score=288.52  Aligned_cols=234  Identities=25%  Similarity=0.314  Sum_probs=176.5

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCCCChh
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLD  230 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~  230 (453)
                      ..||+|+||.||+|+. .+++.||||.+..... ..+.+..|              +++++......++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            3799999999999995 5789999999876433 23444444              456677777889999999999999


Q ss_pred             hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCCCceeec
Q 048517          231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSIS  309 (453)
Q Consensus       231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~  309 (453)
                      +++.... ....+++..+..++.|++.||+|||+.   +|+|+||||+||+++. ++.+||+|||+++.......  ...
T Consensus       108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~  181 (295)
T 2clq_A          108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTE  181 (295)
T ss_dssp             HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred             HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--ccc
Confidence            9985432 234567888999999999999999998   9999999999999987 89999999999987654322  123


Q ss_pred             ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517          310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  389 (453)
Q Consensus       310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (453)
                      ...||+.|+|||.+.+....++.++||||||+++|||++|+.||.......      ..............      .+.
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~------~~~  249 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGMFKVHPE------IPE  249 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHHHCCCCC------CCT
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhcccccccc------ccc
Confidence            457999999999997642347899999999999999999999986432111      00111111111111      112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          390 MIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .++..+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            23456889999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-36  Score=294.38  Aligned_cols=238  Identities=23%  Similarity=0.301  Sum_probs=171.2

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH--------------Hhcccc-------------
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE--------------LLGLCS-------------  212 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~-------------  212 (453)
                      ..|.+.+.||+|+||.||+|+. .+|+.||||++.......+.+.+|              +++++.             
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            3566778999999999999996 479999999997644334455555              222221             


Q ss_pred             cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEe
Q 048517          213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  292 (453)
Q Consensus       213 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~D  292 (453)
                      .....++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+|+||||+|||++.++.+||+|
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence            245678999999999999998542   35678899999999999999999998   999999999999999999999999


Q ss_pred             cCCccccCCCCC------------ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccc
Q 048517          293 FGLAKFHPKEND------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS  360 (453)
Q Consensus       293 FGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~  360 (453)
                      ||+++.......            ........||+.|+|||.+.+. +.++.++||||||+++|||++   |+.....  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~--  233 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME--  233 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence            999986643211            1112345689999999998753 468899999999999999998   4432111  


Q ss_pred             ccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          361 SKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       361 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           .......+...... ..  ..........+.+++.+||+.||++|||+.++++
T Consensus       234 -----~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 -----RVNILKKLRSVSIE-FP--PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -----HHHHHHHHHSTTCC-CC--TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----HHHHHHhccccccc-cC--ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                 01122222222111 11  1122233456789999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3e-36  Score=299.62  Aligned_cols=247  Identities=22%  Similarity=0.253  Sum_probs=175.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------Hhccccc-----CcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSE-----GFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~-----~~~~~l  219 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++......  ..++.+|              +++++..     ....++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   91 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI   91 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence            4566789999999999999965 7999999999753321  2233344              3343333     256799


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||+. |+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        92 v~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           92 IQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            999996 689888743     3689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCce--------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc--------
Q 048517          300 PKENDFV--------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--------  363 (453)
Q Consensus       300 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~--------  363 (453)
                      .......        ......||+.|+|||++... ..++.++||||||+++|||++|+.||..........        
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            5322110        11234689999999988653 478999999999999999999999997543211000        


Q ss_pred             --------cc-hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          364 --------YF-PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       364 --------~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                              .. .....+.+.................++..+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                    00 00000001000000000001111234567889999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8e-36  Score=299.61  Aligned_cols=242  Identities=20%  Similarity=0.265  Sum_probs=173.0

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcce------
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKR------  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~------  217 (453)
                      +|.+.+.||+|+||.||+|+.. +|+.||||++.......   +++..|              +++++......      
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            5566788999999999999854 79999999998643332   333343              44555544433      


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||+. ++|.+.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       123 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             EEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             EEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            99999997 68877661      3489999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc------------
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF------------  365 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~------------  365 (453)
                      .....     .....||+.|+|||.+.+. ..++.++||||||++++||++|+.||............            
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccC-----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            65432     2445789999999998762 47899999999999999999999999754321100000            


Q ss_pred             ----hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          366 ----PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       366 ----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                          ..........................+..+.+++.+||+.||++|||+.|+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                000000000000000000111112335678999999999999999999999873

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.9e-36  Score=300.24  Aligned_cols=243  Identities=19%  Similarity=0.230  Sum_probs=177.4

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccC-----cceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEG-----FKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~-----~~~~l  219 (453)
                      +|.+.+.||+|+||.||+|+.. +++.||||++......  .+.+..|              +++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            5667789999999999999954 7889999999753322  2344444              23333322     35789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      |+||+. |+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          108 VQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            999996 689888743     3589999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh---
Q 048517          300 PKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK---  375 (453)
Q Consensus       300 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~---  375 (453)
                      ....... ......||+.|+|||++.+. ..++.++||||+|+++|||++|+.||........    ...+...+..   
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~  253 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ----LNHILGILGSPSQ  253 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH----HHHHHHHHCSCCH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH----HHHHHHHhCCCCH
Confidence            5432211 12345799999999987653 3589999999999999999999999975442211    0001100000   


Q ss_pred             -----------------CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 -----------------GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 -----------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                       ................+..+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                             0000000000111223467889999999999999999999997

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.6e-36  Score=300.42  Aligned_cols=246  Identities=20%  Similarity=0.205  Sum_probs=170.4

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC------------HHHHHHH--------------Hhccc----
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS------------AEEFINE--------------LLGLC----  211 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~------------~~~~i~e--------------l~g~~----  211 (453)
                      .|.+.+.||+|+||.||+|...+|+.||||++......            .+.+.+|              +++++    
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE  102 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred             ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence            45566899999999999999888999999998653221            1344444              34444    


Q ss_pred             -ccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517          212 -SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  290 (453)
Q Consensus       212 -~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  290 (453)
                       ......++||||++ |+|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       103 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl  175 (362)
T 3pg1_A          103 EPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITI  175 (362)
T ss_dssp             TTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             CCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEE
Confidence             23345789999997 688887752   335799999999999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc------
Q 048517          291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY------  364 (453)
Q Consensus       291 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~------  364 (453)
                      +|||+++.......   .....||+.|+|||.+.+. ..++.++||||+|+++|||++|+.||...........      
T Consensus       176 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (362)
T 3pg1_A          176 CDFNLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG  251 (362)
T ss_dssp             CCTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EecCcccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999985443322   2345689999999998763 4689999999999999999999999975432110000      


Q ss_pred             ---chH-------HHHHHhhhCC-CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          365 ---FPS-------WVYDQLNKGG-DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       365 ---~~~-------~~~~~l~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         ...       ...+.+.... ..............+..+.+++.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence               000       0000010100 00000011112233466889999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.2e-36  Score=308.91  Aligned_cols=245  Identities=22%  Similarity=0.273  Sum_probs=174.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHH-HHHH--------Hhcccc------cCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEE-FINE--------LLGLCS------EGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~-~i~e--------l~g~~~------~~~~~~lv~E~  223 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++......  .+- .+..        +++++.      .....++||||
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~  134 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  134 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence            4667789999999999999975 6999999998764332  221 2221        333332      12235689999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCccccCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~~~  302 (453)
                      +++ +|.+.+.........+++..+..++.|+++||+|||+.   +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus       135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            975 66665543333456799999999999999999999998   99999999999999965 67899999999876543


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH--------hh
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ--------LN  374 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--------l~  374 (453)
                      ..   .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.......   .+.. +.+.        +.
T Consensus       211 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~-i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          211 EP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVE-IIKVLGTPTREQIR  282 (420)
T ss_dssp             CC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-HHHHHCSCCHHHHH
T ss_pred             CC---ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-HHHHhCCCCHHHHH
Confidence            32   2345789999999998753 368999999999999999999999997543211   0100 1110        00


Q ss_pred             hC----CCccccch--hh----hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KG----GDLELRNV--TE----IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~----~~~~~~~~--~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..    ........  ..    .....+..+.+++.+||+.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            00    00000000  00    11123467899999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-36  Score=295.93  Aligned_cols=238  Identities=24%  Similarity=0.333  Sum_probs=178.1

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC-CCHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK-FSAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      ..|.+.+.||+|+||.||+|+.. +|+.||+|++.... ...+++..|              +++++......++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            35667789999999999999965 68999999987643 334555555              456667777889999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++++|.+++...   ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++....... 
T Consensus        99 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           99 PGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            999999988542   25689999999999999999999998   99999999999999999999999999976432110 


Q ss_pred             ceeecccCCCCCccChhhhcc---cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          305 FVSISDTRGTIGYLAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                       .......||+.|+|||.+..   ....++.++||||||+++|||++|+.|+......       . ....+........
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~  242 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------R-VLLKIAKSDPPTL  242 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------H-HHHHHHHSCCCCC
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------H-HHHHHhccCCccc
Confidence             01133468999999999842   1246889999999999999999999998654321       1 1222222221111


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .    .+..++..+.+++.+||+.||++|||+.++++
T Consensus       243 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 L----TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             S----SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             C----CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1    12223457889999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4e-36  Score=290.51  Aligned_cols=238  Identities=25%  Similarity=0.321  Sum_probs=185.8

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC---CCCHHHHHHH--------------HhcccccCcceE
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS---KFSAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ......|.+.++||+|+||.||+|+.. +++.||||++...   ....+.+.+|              +++++......+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            455567788899999999999999965 7999999998653   2234455554              456677778889


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---CceEEEecCC
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGL  295 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGl  295 (453)
                      +|+||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.+   +.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            999999999999888543    4689999999999999999999998   99999999999999754   4799999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      ++.......   .....||+.|+|||.+.+   .++.++||||||++++||++|+.||......        .....+..
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~  236 (287)
T 2wei_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVET  236 (287)
T ss_dssp             GGTBCCCSS---CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH
T ss_pred             ceeecCCCc---cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHc
Confidence            987654332   233458899999999864   5889999999999999999999998654321        12333333


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +.....   ......++..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          237 GKYAFD---LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCCCC---SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCC---chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            321110   1111234567889999999999999999999987

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-35  Score=297.95  Aligned_cols=246  Identities=21%  Similarity=0.202  Sum_probs=170.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCc------ce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGF------KR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~------~~  217 (453)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++.......   +++.+|              +++++....      ..
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  105 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  105 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence            4667789999999999999854 78999999997643322   233343              344443332      67


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||++ |+|.+.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          106 YIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             EEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            99999996 57877773      3488999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc--------ccc-----
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--------KAY-----  364 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~--------~~~-----  364 (453)
                      ......   ......||+.|+|||++.+.  .++.++||||+||+++||++|+.||........        ...     
T Consensus       176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          176 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -----------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             cccccc---ccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            654332   12345799999999999864  789999999999999999999999975432110        000     


Q ss_pred             --chHHHHHHhhhCCCc------------cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhC
Q 048517          365 --FPSWVYDQLNKGGDL------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  422 (453)
Q Consensus       365 --~~~~~~~~l~~~~~~------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~  422 (453)
                        +..............            ............+..+.+++.+||+.||++|||++|+++  .+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence              000001111110000            000011123345678999999999999999999999998  4543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.5e-36  Score=323.57  Aligned_cols=243  Identities=22%  Similarity=0.339  Sum_probs=185.0

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceE
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ....+.+.+.||+|+||.||+|...    .+..||||++......  .+.+..|              +++++. ....+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            3445667788999999999999864    2567999998764322  2445554              456664 34689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       467 lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence            999999999999998532   34689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ....... ......+|+.|+|||.+...  .++.++||||||+++|||++ |+.||......        .+...+..+.
T Consensus       541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~~~~~i~~~~  609 (656)
T 2j0j_A          541 MEDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGE  609 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHHTC
T ss_pred             cCCCcce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcCC
Confidence            6543322 22344578899999999764  78999999999999999997 88898643321        1333444443


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      .....      ..++..+.+++.+||+.||++|||+.++++.|+.+++
T Consensus       610 ~~~~~------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          610 RLPMP------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCC------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            33221      1234578899999999999999999999999987543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-35  Score=291.15  Aligned_cols=237  Identities=21%  Similarity=0.291  Sum_probs=173.2

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---HHHHHH----------------HhcccccCcceEEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE----------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~~~i~e----------------l~g~~~~~~~~~lv~  221 (453)
                      ..|.+.+.||+|+||.||+++..+++.||||++.......   +.+.+|                +++++......++||
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  107 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  107 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence            3466778999999999999998889999999997644332   233333                344556677789999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      | +.+++|.+++...    ..+++..+..++.|+++||.|||+.   +|+||||||+|||+++ +.+||+|||+++....
T Consensus       108 e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          108 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             C-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             e-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            9 6689999998532    4689999999999999999999998   9999999999999975 8999999999987654


Q ss_pred             CCCceeecccCCCCCccChhhhccc---------CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  372 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  372 (453)
                      ...........||+.|+|||.+...         ...++.++||||||+++|||++|+.||......      .......
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~  252 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAI  252 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHH
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------HHHHHHH
Confidence            4332223445799999999998641         136788999999999999999999999643221      1112222


Q ss_pred             hhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       373 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +..........      ..+..+.+++.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          253 IDPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HCTTSCCCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhcccccCCcc------cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            22222221111      11356889999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.9e-36  Score=293.59  Aligned_cols=242  Identities=21%  Similarity=0.332  Sum_probs=177.3

Q ss_pred             hhhhhcccCccCceEEEEEEE--cCCcEEEEEEecCCCCC---HHHH------HHH-----------Hhcccc-----cC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL--HTGRLIAVKMMENSKFS---AEEF------INE-----------LLGLCS-----EG  214 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~--~~g~~VAVK~l~~~~~~---~~~~------i~e-----------l~g~~~-----~~  214 (453)
                      .|.+.+.||+|+||.||+|+.  .+|+.||||++......   ...+      +..           +++++.     ..
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            466778999999999999997  46899999998642211   1111      111           344443     45


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...++||||++ |+|.+++...  ....+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+||+|||
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence            66789999997 6999988543  234589999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      +++......   ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......    ....+.+.+.
T Consensus       166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~  236 (326)
T 1blx_A          166 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDVIG  236 (326)
T ss_dssp             SCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHC
T ss_pred             ccccccCCC---CccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHHcC
Confidence            998654322   22445789999999999764  78999999999999999999999997543211    0011111111


Q ss_pred             hCCCc----------------cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KGGDL----------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~~~~----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .....                ...........++..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000                000001112234567889999999999999999999995

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=301.72  Aligned_cols=247  Identities=20%  Similarity=0.271  Sum_probs=161.5

Q ss_pred             hcccCccCceEEEEEEEc---CCcEEEEEEecCCCCCHHHHHHH--------------Hhccc--ccCcceEEEEEecCC
Q 048517          166 THKLGQGGFGSVYKGQLH---TGRLIAVKMMENSKFSAEEFINE--------------LLGLC--SEGFKRALVYEYMPN  226 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~--~~~~~~~lv~E~~~~  226 (453)
                      .++||+|+||+||+|+..   +++.||||++...... +.+.+|              +++++  ......++||||++ 
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence            357999999999999965   5789999999865433 233333              34555  34667899999996 


Q ss_pred             CChhhhhhhcc-----CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE----cCCCceEEEecCCcc
Q 048517          227 GSLDRHIFSKE-----NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK  297 (453)
Q Consensus       227 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~  297 (453)
                      |+|.+++....     .....+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus       104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence            57877764322     1223589999999999999999999998   99999999999999    778999999999998


Q ss_pred             ccCCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccc--ccccchHHHH---H
Q 048517          298 FHPKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS--SKAYFPSWVY---D  371 (453)
Q Consensus       298 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~---~  371 (453)
                      ....... ........||+.|+|||++.+. ..++.++|||||||++|||++|+.||.......  ........+.   +
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             ----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             ecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            7653221 1122445799999999999763 358999999999999999999999996543321  0111111111   1


Q ss_pred             HhhhCCCccccch--------------------hhhHH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          372 QLNKGGDLELRNV--------------------TEIES-------MIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       372 ~l~~~~~~~~~~~--------------------~~~~~-------~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+...........                    .....       ..+..+.+++.+||+.||++|||++|+++
T Consensus       260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1110000000000                    00000       01346789999999999999999999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.2e-36  Score=304.25  Aligned_cols=248  Identities=22%  Similarity=0.221  Sum_probs=176.3

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC--HHHHHHH---------Hhccccc------CcceEEEEE
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS--AEEFINE---------LLGLCSE------GFKRALVYE  222 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~--~~~~i~e---------l~g~~~~------~~~~~lv~E  222 (453)
                      ..+|.+.+.||+|+||+||+|+...+..||+|++......  .+..+.+         +++++..      ....++|||
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            3457778999999999999999877777999987653322  2222221         4444422      223779999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-CCCceEEEecCCccccCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~~~~  301 (453)
                      |++++.+ +.+.........+++..+..++.|+++||+|||+.   +|+||||||+|||++ .++.+||+|||+++....
T Consensus       119 ~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          119 YVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             CCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            9976544 33332223346799999999999999999999998   999999999999999 799999999999987644


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh-------
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN-------  374 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~-------  374 (453)
                      ...   .....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||........   +.. +.+.+.       
T Consensus       195 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~-i~~~~g~p~~~~~  266 (394)
T 4e7w_A          195 GEP---NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVE-IIKVLGTPSREQI  266 (394)
T ss_dssp             TCC---CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH-HHHHHCCCCHHHH
T ss_pred             CCC---CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-HHHHhCCCCHHHH
Confidence            432   2345789999999998753 3689999999999999999999999975432110   000 011000       


Q ss_pred             --------hCCCccccc---hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          375 --------KGGDLELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       375 --------~~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                              .........   ........+..+.+++.+||+.||++|||+.|+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                    000000000   000111244678999999999999999999999873

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-35  Score=304.54  Aligned_cols=237  Identities=23%  Similarity=0.249  Sum_probs=165.9

Q ss_pred             hcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH---------------HhcccccCcceEEEEEecCCCChh
Q 048517          166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE---------------LLGLCSEGFKRALVYEYMPNGSLD  230 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~gsL~  230 (453)
                      .+.||+|+||+||.+...+|+.||||++....  .+.+..|               +++.+......++||||+. |+|.
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            46799999999987777789999999986532  1222222               4555667778899999995 7999


Q ss_pred             hhhhhccCCCCC---CCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-------------CCceEEEecC
Q 048517          231 RHIFSKENKGQT---FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-------------NFIPKVSDFG  294 (453)
Q Consensus       231 ~~l~~~~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-------------~~~~kl~DFG  294 (453)
                      +++.........   .++..++.++.|++.||+|||+.   +|+||||||+|||++.             ++.+||+|||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            998654322221   24556789999999999999998   9999999999999965             4589999999


Q ss_pred             CccccCCCCCce--eecccCCCCCccChhhhccc-----CCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccch
Q 048517          295 LAKFHPKENDFV--SISDTRGTIGYLAPELISRN-----FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFP  366 (453)
Q Consensus       295 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  366 (453)
                      +++.........  ......||++|+|||++.+.     ...++.++|||||||++|||++ |+.||.......      
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------  247 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------  247 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------
Confidence            999775443211  12345799999999999651     2468999999999999999999 899986432211      


Q ss_pred             HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         ...+......... .......++..+.+++.+||+.||++|||+.++++
T Consensus       248 ---~~i~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ---SNIIRGIFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ---HHHHHTCCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHhcCCCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence               1111111111100 11123446678899999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.1e-36  Score=293.03  Aligned_cols=226  Identities=24%  Similarity=0.359  Sum_probs=177.1

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-------------HHHHHHH----------HhcccccCc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-------------AEEFINE----------LLGLCSEGF  215 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-------------~~~~i~e----------l~g~~~~~~  215 (453)
                      ...|.+.+.||+|+||.||+|+. .+|+.||||++......             +.+.+.+          +++++....
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            44577789999999999999985 57899999998753211             1122222          455666777


Q ss_pred             ceEEEEEecCC-CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-CCCceEEEec
Q 048517          216 KRALVYEYMPN-GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDF  293 (453)
Q Consensus       216 ~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DF  293 (453)
                      ..++|+|++.+ ++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++ .++.+||+||
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             cEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            88999999976 8999988542    4689999999999999999999998   999999999999999 7899999999


Q ss_pred             CCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh
Q 048517          294 GLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  373 (453)
Q Consensus       294 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l  373 (453)
                      |+++......    .....||+.|+|||.+... ...+.++||||||+++|||++|+.||.....              .
T Consensus       195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------------~  255 (320)
T 3a99_A          195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------I  255 (320)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------H
T ss_pred             cccccccccc----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh--------------h
Confidence            9998765432    2345699999999998764 2347889999999999999999999864321              1


Q ss_pred             hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...... .      ...++..+.+++.+||+.||++|||++++++
T Consensus       256 ~~~~~~-~------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 IRGQVF-F------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHCCCC-C------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hccccc-c------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111 0      1112356889999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.2e-36  Score=298.95  Aligned_cols=239  Identities=21%  Similarity=0.248  Sum_probs=160.2

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------Hhccccc------Ccc
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSE------GFK  216 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~------~~~  216 (453)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++......   .+++.+|              +++++..      ...
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            3566778999999999999984 57999999999764332   2333343              3444432      245


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  296 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  296 (453)
                      .++++|++ +++|.+++..     ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             EEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            78999999 7899888732     4689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh---
Q 048517          297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL---  373 (453)
Q Consensus       297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l---  373 (453)
                      +.....     .....||+.|+|||.+.+. ..++.++||||+||+++||++|+.||........    ...+.+.+   
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----l~~i~~~~g~p  249 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ----LKLILRLVGTP  249 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSC
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCC
Confidence            865432     2345799999999998753 4789999999999999999999999975432110    00011110   


Q ss_pred             -----------------hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          374 -----------------NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       374 -----------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                       ..-...............+..+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                             000000000000011123456889999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=291.01  Aligned_cols=229  Identities=25%  Similarity=0.366  Sum_probs=172.1

Q ss_pred             HHHHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH-------------HHHHHH------------Hhcc
Q 048517          157 EIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA-------------EEFINE------------LLGL  210 (453)
Q Consensus       157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~-------------~~~i~e------------l~g~  210 (453)
                      +.....|.+.+.||+|+||.||+|+. .+|+.||||++.......             .+.+.+            ++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            44556678889999999999999985 578999999996542211             111222            3455


Q ss_pred             cccCcceEEEEEe-cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-CCCce
Q 048517          211 CSEGFKRALVYEY-MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIP  288 (453)
Q Consensus       211 ~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~-~~~~~  288 (453)
                      +......++|+|| +.+++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++ .++.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            6667778999999 7899999998542    4589999999999999999999998   999999999999999 88999


Q ss_pred             EEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHH
Q 048517          289 KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW  368 (453)
Q Consensus       289 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  368 (453)
                      ||+|||+++......    .....||+.|+|||.+.+. ...+.++||||||+++|||++|+.||.....          
T Consensus       180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------  244 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE----------  244 (312)
T ss_dssp             EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred             EEEEcchhhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH----------
Confidence            999999998765432    2445699999999998764 2335689999999999999999999864211          


Q ss_pred             HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          369 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         .... .. ..      +..++..+.+++.+||+.||++|||+.|+++
T Consensus       245 ---~~~~-~~-~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ---ILEA-EL-HF------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---HHHT-CC-CC------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---Hhhh-cc-CC------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               1111 11 11      1123456889999999999999999999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=290.76  Aligned_cols=240  Identities=21%  Similarity=0.257  Sum_probs=169.5

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------Hhccc--------------
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLC--------------  211 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~--------------  211 (453)
                      .|.+.+.||+|+||.||+|... +|+.||||++..... ..+++.+|              +++++              
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   91 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL   91 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence            4566789999999999999965 599999999876432 23344444              22222              


Q ss_pred             ccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-CCCceEE
Q 048517          212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKV  290 (453)
Q Consensus       212 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~-~~~~~kl  290 (453)
                      ......++||||++ |+|.+++.     ...+++..+..++.|++.||+|||+.   +|+||||||+|||++ .++.+||
T Consensus        92 ~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           92 TELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence            34467789999997 69998883     24689999999999999999999998   999999999999997 5779999


Q ss_pred             EecCCccccCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHH
Q 048517          291 SDFGLAKFHPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV  369 (453)
Q Consensus       291 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  369 (453)
                      +|||+++........ .......+|..|+|||.+.+. ..++.++||||||+++|||++|+.||........       .
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-------~  234 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-------M  234 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-------H
Confidence            999999876432211 112344679999999988653 4789999999999999999999999975432110       0


Q ss_pred             HHHhhhCCC----------------------ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          370 YDQLNKGGD----------------------LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       370 ~~~l~~~~~----------------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...+.....                      ............++..+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            000000000                      0000001111234567899999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.5e-35  Score=292.58  Aligned_cols=237  Identities=21%  Similarity=0.288  Sum_probs=171.7

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCc------ce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGF------KR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~------~~  217 (453)
                      +|.+.+.||+|+||.||+|+.. +|+.||||++.......   +++.+|              +++++....      ..
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  104 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  104 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence            4667789999999999999964 79999999997643332   333343              344444433      24


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||++ |+|.+++.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          105 YLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             EEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            89999997 68877662      3489999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH------
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD------  371 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------  371 (453)
                      .....     .....||+.|+|||.+.+. ..++.++||||||++++||++|+.||........   + ..+..      
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~-~~i~~~~~~~~  244 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---L-TQILKVTGVPG  244 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---H-HHHHHHHCBCC
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H-HHHHHHhCCCC
Confidence            65432     2345689999999998752 4688999999999999999999999975432110   0 00000      


Q ss_pred             --------------HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          372 --------------QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       372 --------------~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                                    .+..................+..+.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                          00000000000001111234567899999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-36  Score=304.37  Aligned_cols=225  Identities=15%  Similarity=0.133  Sum_probs=162.6

Q ss_pred             hhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC----HHHHHHHHhc--cc-------------------------
Q 048517          164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS----AEEFINELLG--LC-------------------------  211 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~----~~~~i~el~g--~~-------------------------  211 (453)
                      ...+.||+|+||.||+|+ ..+|+.||||++......    .+.+.+|...  ..                         
T Consensus        81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  160 (413)
T 3dzo_A           81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  160 (413)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred             EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence            345789999999999999 457999999998843221    2333333110  00                         


Q ss_pred             ---------cc-----CcceEEEEEecCCCChhhhhhh---ccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecc
Q 048517          212 ---------SE-----GFKRALVYEYMPNGSLDRHIFS---KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFD  274 (453)
Q Consensus       212 ---------~~-----~~~~~lv~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D  274 (453)
                               ..     ....+++|+++ +++|.+++..   .......+++..++.++.|+++||+|||+.   +|+|||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrD  236 (413)
T 3dzo_A          161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY  236 (413)
T ss_dssp             C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence                     00     11235566654 7899888732   123345688999999999999999999998   999999


Q ss_pred             cCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhccc--------CCCCCccchHHHHHHHHHHH
Q 048517          275 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN--------FGTVSCKSDVYGFGMVLLEM  346 (453)
Q Consensus       275 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~s~k~DV~S~Gvvl~el  346 (453)
                      |||+|||++.++.+||+|||+++.....     .....| +.|+|||++...        ...++.++|||||||++|||
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            9999999999999999999999865432     344567 999999998421        13578899999999999999


Q ss_pred             HcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517          347 AGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  417 (453)
Q Consensus       347 ltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl  417 (453)
                      ++|+.||..........        .+....           ..++..+.+++.+||+.||++|||+.+++
T Consensus       311 ltg~~Pf~~~~~~~~~~--------~~~~~~-----------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSE--------WIFRSC-----------KNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHSSCCCCTTGGGSCSG--------GGGSSC-----------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHCCCCCCCcchhhhHH--------HHHhhc-----------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999997543221100        010000           01235688999999999999999965553

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.7e-35  Score=285.31  Aligned_cols=236  Identities=22%  Similarity=0.308  Sum_probs=161.0

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH--HHHHHH---------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA--EEFINE---------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~--~~~i~e---------------l~g~~~~~~~~~lv~E~  223 (453)
                      .+.+.+.||+|+||.||+|+.. +|+.||||++.......  .+.+.+               +++++......++||||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~  105 (318)
T 2dyl_A           26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL  105 (318)
T ss_dssp             GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence            4556688999999999999965 79999999997653322  122222               45667777888999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      + ++.+.... ..  ....+++..+..++.|++.||.|||+ .   +|+|+||||+|||++.++.+||+|||+++.....
T Consensus       106 ~-~~~~~~l~-~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          106 M-GTCAEKLK-KR--MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             C-SEEHHHHH-HH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             c-CCcHHHHH-HH--hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9 44444433 22  13568999999999999999999998 4   8999999999999999999999999999765443


Q ss_pred             CCceeecccCCCCCccChhhhcc---cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          303 NDFVSISDTRGTIGYLAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ..   .....||+.|+|||.+..   ....++.++||||||+++|||++|+.||......       ......+......
T Consensus       179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~  248 (318)
T 2dyl_A          179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVLQEEPP  248 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHHSCCC
T ss_pred             cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHhccCCC
Confidence            21   234569999999999853   1246788999999999999999999999643211       1122222222222


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .....    ..++..+.+++.+||+.||++|||+.++++
T Consensus       249 ~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 LLPGH----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCcc----CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11111    123456889999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-35  Score=292.07  Aligned_cols=242  Identities=25%  Similarity=0.324  Sum_probs=159.5

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~lv~E~  223 (453)
                      .+.+.+.||+|+||.||+|... +|+.||||++......  ..++..|               +++++......++||||
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~  102 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL  102 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence            4556788999999999999964 7999999999764322  2233333               45666777788999999


Q ss_pred             cCCCChhhhhhhc-cCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          224 MPNGSLDRHIFSK-ENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       224 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      +++ +|.+++... ......+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            975 777776431 12246789999999999999999999984  38999999999999999999999999999866443


Q ss_pred             CCceeecccCCCCCccChhhhcc--cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          303 NDFVSISDTRGTIGYLAPELISR--NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ..   .....||+.|+|||.+..  ....++.++||||||+++|||++|+.||........       ....+..+....
T Consensus       180 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~  249 (327)
T 3aln_A          180 IA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVVKGDPPQ  249 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCC
T ss_pred             cc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------HHHHHhcCCCCC
Confidence            21   233469999999999842  123688999999999999999999999965322100       000111111111


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +..  .....++..+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          250 LSN--SEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            110  011223457889999999999999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-35  Score=299.22  Aligned_cols=238  Identities=24%  Similarity=0.281  Sum_probs=167.7

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC----HHHHHHH---------HhcccccCcceEEEEEecCCCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS----AEEFINE---------LLGLCSEGFKRALVYEYMPNGS  228 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~----~~~~i~e---------l~g~~~~~~~~~lv~E~~~~gs  228 (453)
                      .+...+.||+|+||+||.....+|+.||||++......    +.+.+.+         +++.+......++||||+. |+
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~  103 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT  103 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence            34556889999999976655667999999998753221    1122222         4566677778899999995 69


Q ss_pred             hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-----CCceEEEecCCccccCCCC
Q 048517          229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-----~~~~kl~DFGla~~~~~~~  303 (453)
                      |.+++...   ...+.+..+..++.|++.||+|||+.   +|+||||||+|||++.     ...+||+|||+++......
T Consensus       104 L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          104 LQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             HHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             HHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            99988532   23466677889999999999999998   9999999999999943     3468899999998765432


Q ss_pred             C-ceeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          304 D-FVSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       304 ~-~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      . ........||++|+|||++.+. ...++.++|||||||+++||++ |+.||......         ....+.......
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~~~~~~~~~  248 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANILLGACSLD  248 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHHHTTCCCCT
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHHHhccCCcc
Confidence            1 1223456799999999998742 2467889999999999999999 88888533211         111111111111


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..   .........+.+++.+||+.||++|||+.++++
T Consensus       249 ~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          249 CL---HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TS---CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc---CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            10   011233456788999999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-33  Score=305.48  Aligned_cols=226  Identities=20%  Similarity=0.259  Sum_probs=173.1

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEc--CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcc----
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFK----  216 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~--~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~----  216 (453)
                      ....|.+.++||+|+||.||+|+..  +|+.||||++.....  ..+.+..|              +++++.....    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3456778899999999999999965  689999999875432  22344444              4555554443    


Q ss_pred             -eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          217 -RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       217 -~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                       .++||||+++++|.+++.      ..++|.+++.++.||+.||.|||+.   +|+||||||+|||++.+ .+||+|||+
T Consensus       158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence             699999999999988662      2689999999999999999999998   99999999999999986 899999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      ++.....      ....||++|+|||++.+   ..+.++||||||++++||++|..|+.......    ++         
T Consensus       228 a~~~~~~------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----~~---------  285 (681)
T 2pzi_A          228 VSRINSF------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----LP---------  285 (681)
T ss_dssp             CEETTCC------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS----CC---------
T ss_pred             chhcccC------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccccc----cc---------
Confidence            9876443      34569999999999875   34889999999999999999988875322110    00         


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhCCC
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSI  424 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~Le~~~  424 (453)
                             . ..........+..++.+||+.||++|| +++++.+.|.+.+
T Consensus       286 -------~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 -------E-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -------T-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------c-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                   0 001122345788999999999999999 5666766666543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.3e-34  Score=276.53  Aligned_cols=222  Identities=21%  Similarity=0.235  Sum_probs=161.0

Q ss_pred             hhhh-cccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHH--HHH---------Hhccccc----CcceEEEEEecC
Q 048517          163 NHFT-HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEF--INE---------LLGLCSE----GFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~-~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~--i~e---------l~g~~~~----~~~~~lv~E~~~  225 (453)
                      |.+. +.||+|+||.||++.. .+|+.||||++.......++.  +..         +++++..    ....++||||++
T Consensus        19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~   98 (299)
T 3m2w_A           19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   98 (299)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence            4444 6799999999999996 579999999997543222221  111         3444443    566889999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEecCCccccCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~~~~~~  302 (453)
                      +|+|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||++..... 
T Consensus        99 ~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-  172 (299)
T 3m2w_A           99 GGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-  172 (299)
T ss_dssp             SCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT-
T ss_pred             CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccccccc-
Confidence            99999998543  234699999999999999999999998   9999999999999998   78999999999864321 


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                                               ..++.++||||+|+++|||++|+.||............       ..........
T Consensus       173 -------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-------~~~~~~~~~~  220 (299)
T 3m2w_A          173 -------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRIRMGQYE  220 (299)
T ss_dssp             -------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-------CCSSCTTCCS
T ss_pred             -------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-------HHHHhhcccc
Confidence                                     24677999999999999999999999654322100000       0000000111


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  422 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~  422 (453)
                      ........++..+.+++.+||+.||++|||+.|+++  .+.+
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence            111122335677899999999999999999999997  4444

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.5e-34  Score=276.24  Aligned_cols=220  Identities=13%  Similarity=0.079  Sum_probs=165.7

Q ss_pred             HHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceE
Q 048517          158 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      +....|.+.+.||+|+||.||+|+.. +|+.||||++.......    +++..|              +++++......+
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44456788899999999999999965 59999999998754432    344444              456666777889


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+++++|.+++..      .....++..|+.|++.||+|||+.   +|+||||||+|||++.++.+||+++|    
T Consensus       108 lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred             EEEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----
Confidence            99999999999998831      135557889999999999999998   99999999999999999999997432    


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                                        |++         .++.++||||||+++|||++|+.||............        .+...
T Consensus       175 ------------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~  219 (286)
T 3uqc_A          175 ------------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTA  219 (286)
T ss_dssp             ------------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTT
T ss_pred             ------------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhc
Confidence                              333         3678999999999999999999999765432210000        00000


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ............++..+.+++.+||+.||++| |+.|+++.|+.....
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            00111111223345678999999999999999 999999999875543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.6e-33  Score=277.08  Aligned_cols=228  Identities=16%  Similarity=0.124  Sum_probs=169.1

Q ss_pred             HHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC---------CHHHHHHH-----------------------
Q 048517          159 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---------SAEEFINE-----------------------  206 (453)
Q Consensus       159 ~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---------~~~~~i~e-----------------------  206 (453)
                      ....|.+.++||+|+||+||+|+. +|+.||||++.....         ..+.+.+|                       
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            345678889999999999999997 689999999876421         11333222                       


Q ss_pred             -----------------Hhccccc-------------CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHH
Q 048517          207 -----------------LLGLCSE-------------GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA  256 (453)
Q Consensus       207 -----------------l~g~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia  256 (453)
                                       +++++..             ....++||||+++|++.+.+..     ..+++..+..++.|++
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence                             2222222             6788999999999987776622     4689999999999999


Q ss_pred             HHHHHhH-cCCCCceeecccCCcceEEcCCC--------------------ceEEEecCCccccCCCCCceeecccCCCC
Q 048517          257 RGIEYLH-NGCDVCILHFDIKPHNILLDHNF--------------------IPKVSDFGLAKFHPKENDFVSISDTRGTI  315 (453)
Q Consensus       257 ~gL~yLH-~~~~~~ivH~Dikp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~  315 (453)
                      .||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....       ...||+
T Consensus       172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~  241 (336)
T 2vuw_A          172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred             HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence            9999999 87   999999999999999886                    8999999999866432       236999


Q ss_pred             CccChhhhcccCCCCCccchHHHHHHH-HHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHH
Q 048517          316 GYLAPELISRNFGTVSCKSDVYGFGMV-LLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARK  394 (453)
Q Consensus       316 ~y~aPE~~~~~~~~~s~k~DV~S~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  394 (453)
                      .|+|||++.+.   .+.++||||+|++ .+++++|..||....       ......+.+.................++..
T Consensus       242 ~y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          242 VSMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNVL-------WLHYLTDKMLKQMTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             CTTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHHH-------HHHHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred             cccChhhhcCC---CccceehhhhhCCCCcccccccCCCcchh-------hhhHHHHhhhhhhccCcccchhhhhhcCHH
Confidence            99999999864   3889999998777 777888888873210       001122222222222212222345667889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHH
Q 048517          395 LCMIGLWCIQVKAADRPSMTKVL  417 (453)
Q Consensus       395 l~~l~~~Cl~~~p~~RPs~~evl  417 (453)
                      +.+++.+||+.|     |+.|++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            999999999976     898887

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.2e-34  Score=305.21  Aligned_cols=247  Identities=23%  Similarity=0.277  Sum_probs=174.0

Q ss_pred             HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------Hhccccc------Ccc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSE------GFK  216 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~------~~~  216 (453)
                      ...|.+.++||+|+||+||+|.. .+|+.||||++.....  ..+.+..|              +++++..      +..
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            35678889999999999999995 4799999999876422  22334444              2344333      667


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc---eEEEec
Q 048517          217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDF  293 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DF  293 (453)
                      .++||||+++|+|.+++.... ....+++..++.++.+++.||+|||+.   +|+||||||+|||++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            789999999999999985432 234699999999999999999999998   9999999999999986654   999999


Q ss_pred             CCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc-cccchHHHHHH
Q 048517          294 GLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-KAYFPSWVYDQ  372 (453)
Q Consensus       294 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~  372 (453)
                      |+++.......   .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||........ ...........
T Consensus       169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH  243 (676)
T ss_dssp             CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred             ccccccccccc---cccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence            99987654432   2446799999999998754  789999999999999999999999965321100 00000000000


Q ss_pred             hh--h--CCCc----cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 048517          373 LN--K--GGDL----ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTK  415 (453)
Q Consensus       373 l~--~--~~~~----~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  415 (453)
                      ..  .  ....    ...........++..+.+++.+||+.||++|||+.+
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            00  0  0000    001111123346678999999999999999999976

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.92  E-value=4.4e-27  Score=248.53  Aligned_cols=171  Identities=17%  Similarity=0.157  Sum_probs=112.1

Q ss_pred             cccCccCceEEEEEE-EcCCcEEEEEEecCCCC-----------CHHHHHHH---------------HhcccccCcceEE
Q 048517          167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF-----------SAEEFINE---------------LLGLCSEGFKRAL  219 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~-----------~~~~~i~e---------------l~g~~~~~~~~~l  219 (453)
                      ..++.|++|.+..++ .-.|+.+|||.+.....           +.++|.+|               ++.++.++...||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            346778888777665 44688999999876321           12344444               5677788889999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||++|++|.+.|..    ...++.   .+|+.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+..
T Consensus       320 VMEyv~G~~L~d~i~~----~~~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAA----GEEIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EEECCCSEEHHHHHHT----TCCCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EEecCCCCcHHHHHHh----CCCCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            9999999999999943    234543   36899999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCC
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN  352 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p  352 (453)
                      ..+..  ......||++|||||++.+   .+..++|+||+|++++++.++..+
T Consensus       390 ~~~~~--~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          390 PQDCS--WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             C---C--CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred             CCCCc--cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence            54432  2345679999999999975   567789999999998887665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.88  E-value=6.5e-24  Score=223.03  Aligned_cols=170  Identities=16%  Similarity=0.156  Sum_probs=126.6

Q ss_pred             hcccCccCceEEEEEEEcCCcEEEEEEecCCCCC---------HHHHHHHH--------------hcccccCcceEEEEE
Q 048517          166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---------AEEFINEL--------------LGLCSEGFKRALVYE  222 (453)
Q Consensus       166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---------~~~~i~el--------------~g~~~~~~~~~lv~E  222 (453)
                      .+.||+|+||.||+|.. .++.+|+|+.......         .+++.+|+              ..++......++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            35799999999999954 4788999987553322         12234441              334445566799999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++..            +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||+++.....
T Consensus       420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999998832            568999999999999998   9999999999999998  9999999999987543


Q ss_pred             CCce-----eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCC
Q 048517          303 NDFV-----SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  353 (453)
Q Consensus       303 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~  353 (453)
                      ....     ......||+.|||||++......++.+.|+||..+-.++-+.++.++
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2211     11245799999999999863346788899999999999988776554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=1.7e-21  Score=188.05  Aligned_cols=130  Identities=18%  Similarity=0.122  Sum_probs=101.2

Q ss_pred             hhcccCccCceEEEEEEEcCCcEEEEEEecCCCC-------------------CHHHHHHH-----------HhcccccC
Q 048517          165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF-------------------SAEEFINE-----------LLGLCSEG  214 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~-------------------~~~~~i~e-----------l~g~~~~~  214 (453)
                      +.+.||+|+||.||+|...+|+.||||++.....                   ....+.+|           +.+++ +.
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~-~~  172 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY-AW  172 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE-EE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEE-ec
Confidence            4488999999999999998899999999965321                   12233333           12222 23


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...++||||+++|+|.+ +          .......++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||
T Consensus       173 ~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          173 EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            45689999999999987 4          1234567999999999999998   999999999999999 9999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcc
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISR  325 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  325 (453)
                      +++.               +..++|||++.+
T Consensus       238 ~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          238 QSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             TCEE---------------TTSTTHHHHHHH
T ss_pred             CCeE---------------CCCCCHHHHHHH
Confidence            9863               335789998864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=7.5e-18  Score=160.22  Aligned_cols=124  Identities=16%  Similarity=0.090  Sum_probs=90.5

Q ss_pred             hhhcccCccCceEEEEEEE-cCCcE--EEEEEecCCCCCH-------------------------HHHHHH------Hhc
Q 048517          164 HFTHKLGQGGFGSVYKGQL-HTGRL--IAVKMMENSKFSA-------------------------EEFINE------LLG  209 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~-~~g~~--VAVK~l~~~~~~~-------------------------~~~i~e------l~g  209 (453)
                      .+.+.||+|+||.||+|.. .+|+.  ||||++.......                         ..+..|      +..
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            4567899999999999997 68999  9999875431110                         122233      221


Q ss_pred             c--cc----cCcceEEEEEecCC-C----ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhH-cCCCCceeecccCC
Q 048517          210 L--CS----EGFKRALVYEYMPN-G----SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDVCILHFDIKP  277 (453)
Q Consensus       210 ~--~~----~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dikp  277 (453)
                      .  ..    .....+|||||+.+ |    +|.+...       ..++..+..++.|++.||.||| +.   +|+||||||
T Consensus       130 ~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp  199 (258)
T 1zth_A          130 AGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEA---ELVHADLSE  199 (258)
T ss_dssp             TTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCST
T ss_pred             CCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence            1  10    11245799999942 4    5555431       1346678899999999999999 87   999999999


Q ss_pred             cceEEcCCCceEEEecCCcccc
Q 048517          278 HNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       278 ~NILl~~~~~~kl~DFGla~~~  299 (453)
                      .|||++.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=2.3e-16  Score=157.25  Aligned_cols=123  Identities=15%  Similarity=0.149  Sum_probs=91.4

Q ss_pred             hhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC---------------CH--------------HHHHHHHhccccc
Q 048517          163 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---------------SA--------------EEFINELLGLCSE  213 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---------------~~--------------~~~i~el~g~~~~  213 (453)
                      |.+.++||+|+||.||+|...+|+.||||+++....               ..              .+++..+......
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            556789999999999999988999999998754210               00              1223334322211


Q ss_pred             C------cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-
Q 048517          214 G------FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-  286 (453)
Q Consensus       214 ~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-  286 (453)
                      .      ...+|||||+++++|.+..          ..+....++.|++.+|.|||+.   +||||||||.|||+++++ 
T Consensus       177 vp~p~~~~~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          177 VPEPIAQSRHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CCCEEEEETTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEEC
T ss_pred             CCeeeeccCceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCC
Confidence            1      1236999999998886543          2234567899999999999998   999999999999998766 


Q ss_pred             ---------ceEEEecCCccc
Q 048517          287 ---------IPKVSDFGLAKF  298 (453)
Q Consensus       287 ---------~~kl~DFGla~~  298 (453)
                               .+.|+||+-+..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                     389999987753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.92  E-value=1.8e-09  Score=101.87  Aligned_cols=125  Identities=15%  Similarity=0.110  Sum_probs=89.3

Q ss_pred             hhhhcccCccCceEEEEEEEcCCcEEEEEEecCC----CCCH--H-HHHHH---------HhcccccCcceEEEEEecCC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENS----KFSA--E-EFINE---------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~----~~~~--~-~~i~e---------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      +.+...+|.|+.+.||+.... |+.+++|+....    ....  | +.+..         +++++......++||||++|
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   94 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG   94 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred             ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence            445667888889999999855 688999998641    1111  1 11221         33444555667899999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC-----------------------------------------
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG-----------------------------------------  265 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------------  265 (453)
                      .+|.+.+         .+......++.+++++|..||+.                                         
T Consensus        95 ~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           95 VLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             EEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             eehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            9987653         12234457889999999999981                                         


Q ss_pred             ---------------CCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          266 ---------------CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       266 ---------------~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                                     ....++|+|++|.|||++++..+.|.||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                           01459999999999999876667799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.86  E-value=7e-09  Score=97.14  Aligned_cols=118  Identities=18%  Similarity=0.132  Sum_probs=81.0

Q ss_pred             ccC-ccCceEEEEEEEcCCcEEEEEEecCCCCC---HH-HHHHH----------HhcccccCcceEEEEEecCCCChhhh
Q 048517          168 KLG-QGGFGSVYKGQLHTGRLIAVKMMENSKFS---AE-EFINE----------LLGLCSEGFKRALVYEYMPNGSLDRH  232 (453)
Q Consensus       168 ~LG-~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---~~-~~i~e----------l~g~~~~~~~~~lv~E~~~~gsL~~~  232 (453)
                      .++ .|..+.||+....+|+.+++|+.......   .+ +.+..          ++++...+...++||||+++.+|.  
T Consensus        26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             ecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            354 55569999998777888999997654211   11 12222          223334445578999999998884  


Q ss_pred             hhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC----------------------------------------------
Q 048517          233 IFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC----------------------------------------------  266 (453)
Q Consensus       233 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------  266 (453)
                      ..       .   .....++.++++.|..||+..                                              
T Consensus       104 ~~-------~---~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 SS-------H---LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             TS-------C---CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cC-------c---CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            21       0   122367778888888888742                                              


Q ss_pred             ---------CCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          267 ---------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       267 ---------~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                               ...++|+|++|.|||++.+..++|.|||.+.
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                     1239999999999999887667899999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.69  E-value=3.5e-08  Score=97.56  Aligned_cols=126  Identities=17%  Similarity=0.172  Sum_probs=88.2

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEec--CCC--CCHHHH------HHH----------HhcccccC---cceEEEEEe
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMME--NSK--FSAEEF------INE----------LLGLCSEG---FKRALVYEY  223 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~--~~~--~~~~~~------i~e----------l~g~~~~~---~~~~lv~E~  223 (453)
                      +.|+.|.++.||+....+ +.+++|+..  ...  ...+.+      +..          ++.++...   ...++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            568999999999988764 678888876  322  111122      222          23344443   347899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC-------------------------------------
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC-------------------------------------  266 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  266 (453)
                      +++.++.+..      ...++..++..++.++++.|..||+..                                     
T Consensus       123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9998875422      134677888999999999999999731                                     


Q ss_pred             ------------------CCceeecccCCcceEEcCCCc--eEEEecCCcccc
Q 048517          267 ------------------DVCILHFDIKPHNILLDHNFI--PKVSDFGLAKFH  299 (453)
Q Consensus       267 ------------------~~~ivH~Dikp~NILl~~~~~--~kl~DFGla~~~  299 (453)
                                        ...++|+|+++.|||++.++.  +.|.||+.+...
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              257999999999999987653  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.58  E-value=3.9e-08  Score=95.01  Aligned_cols=173  Identities=20%  Similarity=0.251  Sum_probs=105.3

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH------Hh-----------cccccCc---ceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE------LL-----------GLCSEGF---KRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e------l~-----------g~~~~~~---~~~lv~E~~~~  226 (453)
                      +.++.|....||+..    +.+++|+.... .....+..|      +.           .......   ..++|||+++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458899999999863    56888986543 112222222      21           1111111   24789999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC-----------------------------------------
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG-----------------------------------------  265 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------------  265 (453)
                      .+|.....      ..++..++..++.++++.|..||+.                                         
T Consensus       101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            88865432      2356677778888888888888851                                         


Q ss_pred             --------------CCCceeecccCCcceEEcC--CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhc---cc
Q 048517          266 --------------CDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS---RN  326 (453)
Q Consensus       266 --------------~~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~  326 (453)
                                    ....++|+|++|.||+++.  +..+.|.||+.+.......+.......  . .-..|+...   ..
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~--~-~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED--D-EEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT--T-TSCCHHHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh--c-cccCHHHHHHHHHH
Confidence                          1246899999999999998  556789999998764332111000000  0 002232211   11


Q ss_pred             CCC---------CCccchHHHHHHHHHHHHcCCCCC
Q 048517          327 FGT---------VSCKSDVYGFGMVLLEMAGGRRNS  353 (453)
Q Consensus       327 ~~~---------~s~k~DV~S~Gvvl~elltg~~p~  353 (453)
                      ++.         .....+.|++|.+++++.+|..++
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111         122368999999999999997543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.75  E-value=8.4e-05  Score=71.58  Aligned_cols=122  Identities=17%  Similarity=0.140  Sum_probs=73.6

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH------Hh-----------ccc-ccCcceEEEEEecCCCC
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE------LL-----------GLC-SEGFKRALVYEYMPNGS  228 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e------l~-----------g~~-~~~~~~~lv~E~~~~gs  228 (453)
                      +.++.|....||+.    |+.+++|+-... .....+..|      |-           .++ ......++||||++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~-~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKSQ-QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESSH-HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCCc-hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            35788888899987    567888885321 112222222      21           112 12334679999999988


Q ss_pred             hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC-------------------------------------------
Q 048517          229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG-------------------------------------------  265 (453)
Q Consensus       229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------  265 (453)
                      +.+...      ..++..+...++.++++.|..||+.                                           
T Consensus       100 l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A          100 LGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             Cchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            865321      1123333444444444444444432                                           


Q ss_pred             --------------CCCceeecccCCcceEEcC---CCc-eEEEecCCcccc
Q 048517          266 --------------CDVCILHFDIKPHNILLDH---NFI-PKVSDFGLAKFH  299 (453)
Q Consensus       266 --------------~~~~ivH~Dikp~NILl~~---~~~-~kl~DFGla~~~  299 (453)
                                    ....++|+|++|.|||++.   ++. ..|.||+.+...
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          2346799999999999987   344 589999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.69  E-value=9.2e-05  Score=69.48  Aligned_cols=120  Identities=17%  Similarity=0.119  Sum_probs=76.7

Q ss_pred             cCccCce-EEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH---------------HhcccccCcceEEEEEecCCCChhh
Q 048517          169 LGQGGFG-SVYKGQLH-TGRLIAVKMMENSKFSAEEFINE---------------LLGLCSEGFKRALVYEYMPNGSLDR  231 (453)
Q Consensus       169 LG~G~fG-~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~gsL~~  231 (453)
                      +..|.-| .||+-... +++.+.+|+-....  ..++..|               ++.++......++|||++++.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            3334444 68987744 56789999865431  2222222               4556666777899999999988765


Q ss_pred             hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC----------------------------------------------
Q 048517          232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG----------------------------------------------  265 (453)
Q Consensus       232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------  265 (453)
                      ....        .......+..++++.|.-||+.                                              
T Consensus       110 ~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          110 VLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            4311        1122334445555555555531                                              


Q ss_pred             ---------CCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          266 ---------CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       266 ---------~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                               ....++|+|+.+.|||++.+..+-|.||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     112389999999999999887778999988753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.58  E-value=0.00016  Score=70.89  Aligned_cols=32  Identities=19%  Similarity=0.199  Sum_probs=26.8

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ...++|+|+.+.|||++++..+.|.||+.+..
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            35799999999999999655578999998763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.48  E-value=0.00052  Score=66.40  Aligned_cols=31  Identities=26%  Similarity=0.154  Sum_probs=27.6

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ...++|+|+++.|||++.+..+.|.||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            3589999999999999888889999998775

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.18  E-value=0.0017  Score=64.61  Aligned_cols=31  Identities=23%  Similarity=0.278  Sum_probs=26.6

Q ss_pred             CceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ..++|+|+.+.|||++.+ .+++.||..+...
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G  257 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG  257 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence            489999999999999876 4899999887644

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.86  E-value=0.0058  Score=61.25  Aligned_cols=81  Identities=10%  Similarity=0.078  Sum_probs=46.7

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCC-CCCccchHHHHHHHHHH
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG-TVSCKSDVYGFGMVLLE  345 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~k~DV~S~Gvvl~e  345 (453)
                      ...++|+|++|.|||++.+. ++|.||+.+.......+....- ..-...|.+|+......+ .-....++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            35899999999999998876 9999999987543211110000 001123555554431100 11123445577777777


Q ss_pred             HHcC
Q 048517          346 MAGG  349 (453)
Q Consensus       346 lltg  349 (453)
                      ...+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.75  E-value=0.0058  Score=58.86  Aligned_cols=124  Identities=17%  Similarity=0.088  Sum_probs=72.7

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH------H-----------hcccccCcceEEEEEecCCCCh
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE------L-----------LGLCSEGFKRALVYEYMPNGSL  229 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e------l-----------~g~~~~~~~~~lv~E~~~~gsL  229 (453)
                      +.|+.|....+|+.... ++.+++|+.....  ...+..|      |           +.++......++||||+++..+
T Consensus        42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~--~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDE-VQTVFVKINERSY--RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEESS-SCEEEEEEEEGGG--HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEEC-CCeEEEEeCCccc--HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            46899999999998864 6778899876432  2223222      2           2333444567899999998875


Q ss_pred             hh-----------hhhhccC-CCC-----------------CCCchhHH---HHH----------------HHHH-HHHH
Q 048517          230 DR-----------HIFSKEN-KGQ-----------------TFGLEKPH---EIA----------------LGTA-RGIE  260 (453)
Q Consensus       230 ~~-----------~l~~~~~-~~~-----------------~l~~~~~~---~i~----------------~~ia-~gL~  260 (453)
                      ..           .||.... ..-                 .-+|....   ++.                ..+. ....
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            31           1232211 000                 11343221   011                0111 1123


Q ss_pred             HhHc-CCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          261 YLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       261 yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      .|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3432 2346899999999999999887 8888873

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.69  E-value=0.0048  Score=58.40  Aligned_cols=64  Identities=19%  Similarity=0.163  Sum_probs=41.2

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCCCCC-HHHHHHH------Hhcccc-------cCcceEEEEEecCCCChh
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS-AEEFINE------LLGLCS-------EGFKRALVYEYMPNGSLD  230 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~-~~~~i~e------l~g~~~-------~~~~~~lv~E~~~~gsL~  230 (453)
                      +.+|.|..+.||+.++.||+.|.||+-...... ...|..|      |-....       .....++||||++.+...
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~~~~~~   98 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVDERPPT   98 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCCCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeecccCCC
Confidence            568999999999999999999999987653322 1222222      211110       012246899999877643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.65  E-value=0.005  Score=55.72  Aligned_cols=100  Identities=10%  Similarity=-0.005  Sum_probs=64.4

Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      -||.+.|..   .+.+++.+++|.++.|.+.+|.-+-.+.. + ..+=+.|..|++..+|.+...+ +.+.         
T Consensus        33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence            367787744   34789999999999999999877622101 1 1233457899999999888764 1110         


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcC
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG  349 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg  349 (453)
                           .....+.|||...   ...+.+.=|||+|+++|.-+-=
T Consensus        98 -----~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             --------------CCSS---SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             -----ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhc
Confidence                 1122456887653   2567889999999999998853

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.33  E-value=0.018  Score=55.54  Aligned_cols=35  Identities=29%  Similarity=0.324  Sum_probs=29.3

Q ss_pred             CCceeecccCCcceEEcCC----CceEEEecCCccccCC
Q 048517          267 DVCILHFDIKPHNILLDHN----FIPKVSDFGLAKFHPK  301 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~----~~~kl~DFGla~~~~~  301 (453)
                      ...++|+|+.+.|||++.+    ..+.|.||+.+.....
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence            4589999999999999874    6789999999875543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.29  E-value=0.013  Score=57.99  Aligned_cols=127  Identities=17%  Similarity=0.198  Sum_probs=69.4

Q ss_pred             cccCccCceEEEEEEEc--------CCcEEEEEEecCCCCCHHHHHHH---------------HhcccccCcceEEEEEe
Q 048517          167 HKLGQGGFGSVYKGQLH--------TGRLIAVKMMENSKFSAEEFINE---------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~--------~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.|..|-...+|+....        +++.+.+|+........+....|               +++++..    .+|+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            45666777889998864        35789999864432234443333               3333332    289999


Q ss_pred             cCCCChhhh-----------------hhhccC-CCCCCC--chhHHHHHHHHHH-------------------HHHH---
Q 048517          224 MPNGSLDRH-----------------IFSKEN-KGQTFG--LEKPHEIALGTAR-------------------GIEY---  261 (453)
Q Consensus       224 ~~~gsL~~~-----------------l~~~~~-~~~~l~--~~~~~~i~~~ia~-------------------gL~y---  261 (453)
                      ++|.+|...                 ||.... ......  |.++.++..++..                   .+..   
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998665421                 111111 011122  3444444433211                   1222   


Q ss_pred             -hHc-CCCCceeecccCCcceEEcCC----CceEEEecCCcc
Q 048517          262 -LHN-GCDVCILHFDIKPHNILLDHN----FIPKVSDFGLAK  297 (453)
Q Consensus       262 -LH~-~~~~~ivH~Dikp~NILl~~~----~~~kl~DFGla~  297 (453)
                       |.. .....++|+|+.+.|||++.+    +.+.+.||..+.
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence             322 223579999999999999876    688999998775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.16  E-value=0.015  Score=58.46  Aligned_cols=58  Identities=19%  Similarity=0.340  Sum_probs=36.7

Q ss_pred             cccCccCceEEEEEEEcC--------CcEEEEEEecCCCCCHHHHHHH---------------HhcccccCcceEEEEEe
Q 048517          167 HKLGQGGFGSVYKGQLHT--------GRLIAVKMMENSKFSAEEFINE---------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~--------g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~~~~~~lv~E~  223 (453)
                      +.|+.|....+|+....+        ++.+.+|+.... ...+.++.|               +++.+..    .+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            467888889999998763        578999988442 111344444               1222221    379999


Q ss_pred             cCCCCh
Q 048517          224 MPNGSL  229 (453)
Q Consensus       224 ~~~gsL  229 (453)
                      +++.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986454

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.03  E-value=0.029  Score=53.75  Aligned_cols=31  Identities=32%  Similarity=0.266  Sum_probs=26.3

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ...++|+|+++.|||++ + .+.|.||+.+...
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            35789999999999999 4 8899999887643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.02  E-value=0.027  Score=53.77  Aligned_cols=130  Identities=15%  Similarity=0.198  Sum_probs=69.0

Q ss_pred             cccCccCceEEEEEEEcCCcEEEEEEecCC-CCCHHH----HHHHHh--cc-c-------------ccCcceEEEEEecC
Q 048517          167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENS-KFSAEE----FINELL--GL-C-------------SEGFKRALVYEYMP  225 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~-~~~~~~----~i~el~--g~-~-------------~~~~~~~lv~E~~~  225 (453)
                      +.|+.|....+|+....+| .+++|+.... ....-+    .+..|.  |+ +             ......+++++|++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            3467788899999987766 5778988762 111111    111111  11 0             01234578999998


Q ss_pred             CCChhh--------------hhhhccCC---C-----CCCCchhHHH------------HHHHHHHHHHHhHcC----CC
Q 048517          226 NGSLDR--------------HIFSKENK---G-----QTFGLEKPHE------------IALGTARGIEYLHNG----CD  267 (453)
Q Consensus       226 ~gsL~~--------------~l~~~~~~---~-----~~l~~~~~~~------------i~~~ia~gL~yLH~~----~~  267 (453)
                      |..+..              .+|.....   .     ....|.....            +...+.+.++.|++.    ..
T Consensus       107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~  186 (322)
T 2ppq_A          107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  186 (322)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence            865421              12211100   0     0012322110            111234455555531    23


Q ss_pred             CceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          268 VCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ..++|+|+.+.|||++.+..+.|.||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            579999999999999987666899998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.90  E-value=0.01  Score=56.53  Aligned_cols=32  Identities=19%  Similarity=0.164  Sum_probs=26.4

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ...++|+|+.+.||+ ..++.+.+.||..+...
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            346999999999999 55667899999988654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.16  E-value=0.24  Score=47.79  Aligned_cols=34  Identities=21%  Similarity=0.307  Sum_probs=29.1

Q ss_pred             CCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      ...++|+|+.+.||+++.++.+.|.||+.+....
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            3579999999999999988889999998876543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=94.05  E-value=0.27  Score=49.74  Aligned_cols=29  Identities=7%  Similarity=-0.002  Sum_probs=21.4

Q ss_pred             cccCccCceEEEEEEEcC-CcEEEEEEecC
Q 048517          167 HKLGQGGFGSVYKGQLHT-GRLIAVKMMEN  195 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~~-g~~VAVK~l~~  195 (453)
                      +.|+.|-...+|+....+ ++.+++|+...
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~  143 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGP  143 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCC
Confidence            468888889999998775 57888998754

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.78  E-value=0.2  Score=49.72  Aligned_cols=30  Identities=27%  Similarity=0.356  Sum_probs=24.6

Q ss_pred             ceeecccCCcceEE------cCCCceEEEecCCccc
Q 048517          269 CILHFDIKPHNILL------DHNFIPKVSDFGLAKF  298 (453)
Q Consensus       269 ~ivH~Dikp~NILl------~~~~~~kl~DFGla~~  298 (453)
                      .++|+|+.+.|||+      +++..+++.||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      3456789999988753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=89.06  E-value=0.99  Score=45.07  Aligned_cols=30  Identities=17%  Similarity=0.344  Sum_probs=26.4

Q ss_pred             CceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ..++|+|+.+.||+ +.+..+.+.||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            46999999999999 7888999999988763

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=84.88  E-value=0.73  Score=44.74  Aligned_cols=29  Identities=21%  Similarity=0.407  Sum_probs=24.5

Q ss_pred             CceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          268 VCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ..++|+|+++.|||++.+. +.|.||..+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            4699999999999998655 8999998775

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	453
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-50
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-47
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-45
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-43
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-43
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-43
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-42
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-42
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-42
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-41
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-40
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-39
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-39
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-37
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-36
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-33
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-33
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-33
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-28
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-26
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-23
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-18
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-14

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 4e-58
 Identities = 75/277 (27%), Positives = 130/277 (46%), Gaps = 38/277 (13%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE-------------- 206
               ++G G FG+VYKG+ H    +AVKM+  +  +    + F NE              
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
            +G  +     A+V ++    SL  H+   E K   F + K  +IA  TA+G++YLH   
Sbjct: 69  FMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS 124

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SR 325
              I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
           +    S +SDVY FG+VL E+  G+   SN+N            +   + +G      ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRG--YLSPDL 231

Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           +++ S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-52
 Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 47/289 (16%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
               +LG G FG V+ G  +    +AVK ++    S + F+ E              L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           + ++     ++ EYM NGSL   +  K   G    + K  ++A   A G+ ++       
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---N 129

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
            +H D++  NIL+      K++DFGLA+    +N++ +    +  I + APE I  N+GT
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI--NYGT 186

Query: 330 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389
            + KSDV+ FG++L E+    R      T          V   L +G  +          
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRM------VRPD 233

Query: 390 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSS 438
               +L  +   C + +  DRP+   +  +LE            FF+++
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE-----------DFFTAT 271

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-52
 Identities = 70/284 (24%), Positives = 117/284 (41%), Gaps = 36/284 (12%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
               KLGQG FG V+ G  +    +A+K ++    S E F+ E              L  
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           + SE     +V EYM  GSL   +  +   G+   L +  ++A   A G+ Y+     + 
Sbjct: 80  VVSEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MN 133

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
            +H D++  NIL+  N + KV+DFGLA+    +N++ +    +  I + APE      G 
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY--GR 190

Query: 330 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389
            + KSDV+ FG++L E+    R                 V DQ+ +G  +          
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRM------PCPP 237

Query: 390 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKP 433
                L  +   C + +  +RP+   +   LE      +   +P
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 1e-51
 Identities = 63/272 (23%), Positives = 120/272 (44%), Gaps = 36/272 (13%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
            F  +LG G FG V  G+      +A+KM++    S +EFI E              L G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +C++     ++ EYM NG L  ++    ++   F  ++  E+       +EYL +     
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESK---Q 120

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
            LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++      
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY--SK 177

Query: 330 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389
            S KSD++ FG+++ E+    +          + +  S   + + +G  L          
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK-------MPYERFTNSETAEHIAQGLRL------YRPH 224

Query: 390 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           + + K+  I   C   KA +RP+   +L  + 
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 6e-51
 Identities = 66/271 (24%), Positives = 117/271 (43%), Gaps = 36/271 (13%)

Query: 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGL 210
           F  ++G G FG V+ G       +A+K +     S E+FI E              L G+
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
           C E     LV+E+M +G L  ++ ++      F  E    + L    G   +    + C+
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEG---MAYLEEACV 122

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           +H D+   N L+  N + KVSDFG+ +F   +    S   T+  + + +PE+   +F   
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVF--SFSRY 179

Query: 331 SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM 390
           S KSDV+ FG+++ E+    +    N +        S V + ++ G  L          +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRL------YKPRL 226

Query: 391 IARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
            +  +  I   C + +  DRP+ +++L  L 
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 3e-50
 Identities = 61/291 (20%), Positives = 110/291 (37%), Gaps = 44/291 (15%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE 213
            +G+G FG V++G+   G  +AVK+  + +  +     E               +   ++
Sbjct: 10  SIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 214 GF----KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
                 +  LV +Y  +GSL  ++        T  +E   ++AL TA G+ +LH      
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 270 -----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR--GTIGYLAPEL 322
                I H D+K  NIL+  N    ++D GLA  H    D + I+     GT  Y+APE+
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 323 ISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS--------SKAYFPSWVY 370
           +  +          ++D+Y  G+V  E+A       ++            S         
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
               +     + N  +    + R +  I   C     A R +  ++ + L 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEAL-RVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-47
 Identities = 69/273 (25%), Positives = 110/273 (40%), Gaps = 42/273 (15%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLG 209
                +G+G FG V  G  + G  +AVK ++N   +A+ F+ E              LLG
Sbjct: 10  KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLG 67

Query: 210 LCSEGFKR-ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           +  E      +V EYM  GSL  ++ S+       G +   + +L     +EYL      
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GN 122

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
             +H D+   N+L+  + + KVSDFGL K      D       +  + + APE +     
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE--K 175

Query: 329 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 388
             S KSDV+ FG++L E+    R                 V  ++ KG  +      +  
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKM------DAP 222

Query: 389 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                 +  +   C  + AA RPS  ++ E LE
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  162 bits (411), Expect = 2e-47
 Identities = 69/273 (25%), Positives = 112/273 (41%), Gaps = 36/273 (13%)

Query: 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LL 208
              HKLG G +G VY+G        +AVK ++      EEF+ E              LL
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+C+      ++ E+M  G+L  ++   E   Q         +A   +  +EYL      
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KK 134

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
             +H D+   N L+  N + KV+DFGL++    +      +  +  I + APE ++    
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAY--N 191

Query: 329 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 388
             S KSDV+ FG++L E+A    +              S VY+ L K   +      E  
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRM------ERP 238

Query: 389 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                K+  +   C Q   +DRPS  ++ +  E
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 3e-47
 Identities = 65/300 (21%), Positives = 114/300 (38%), Gaps = 54/300 (18%)

Query: 164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSA--EEFINE--------- 206
            F   LG G FG V +   +          +AVKM++ S      E  ++E         
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 207 ------LLGLCSEGFKRALVYEYMPNGSLDRHIFSK--------------ENKGQTFGLE 246
                 LLG C+ G    ++ EY   G L   +  K              E+      LE
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 247 KPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306
                +   A+G+ +L +      +H D+   NILL H  I K+ DFGLA+    ++++V
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP 366
              + R  + ++APE I       + +SDV+ +G+ L E+     +              
Sbjct: 203 VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------D 254

Query: 367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
           S  Y  + +G  +              ++  I   C       RP+  ++++++E  I +
Sbjct: 255 SKFYKMIKEGFRM------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (410), Expect = 5e-47
 Identities = 63/300 (21%), Positives = 108/300 (36%), Gaps = 60/300 (20%)

Query: 164 HFTHKLGQGGFGSVYKGQL------HTGRLIAVKMM--ENSKFSAEEFINEL-------- 207
            +   +G+G FG V++ +           ++AVKM+  E S     +F  E         
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75

Query: 208 ------LGLCSEGFKRALVYEYMPNGSLDRHIFSK--------------------ENKGQ 241
                 LG+C+ G    L++EYM  G L+  + S                          
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 242 TFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301
                +   IA   A G+ YL        +H D+   N L+  N + K++DFGL++    
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192

Query: 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 361
            + + +  +    I ++ PE I  N    + +SDV+ +G+VL E+               
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMA--- 247

Query: 362 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                  V   +  G      N+         +L  +   C     ADRPS   +  +L+
Sbjct: 248 ----HEEVIYYVRDG------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (401), Expect = 1e-45
 Identities = 62/271 (22%), Positives = 98/271 (36%), Gaps = 46/271 (16%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE----FINE--------------LL 208
           ++G G FG+VY  + +    ++A+K M  S   + E     I E                
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G         LV EY    + D     K    +     +   +  G  +G+ YLH     
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SH 134

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI-SRNF 327
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDE 188

Query: 328 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387
           G    K DV+  G+  +E+A  +              F       L      E   +   
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKP-----------PLFNMNAMSALYHIAQNESPAL--Q 235

Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
               +         C+Q    DRP+   +L+
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-45
 Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 52/296 (17%)

Query: 168 KLGQGGFGSVYKGQLH---TGRLIAVKMM--ENSKFSAEEFINE--------------LL 208
           +LG G FGSV +G          +A+K++     K   EE + E              L+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G+C +     LV E    G L + +  K  +     +    E+    + G++YL      
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEE---K 128

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELISRNF 327
             +H D+   N+LL +    K+SDFGL+K    ++ + +     +  + + APE I  NF
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 186

Query: 328 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387
              S +SDV+ +G+ + E     +       +  K      V   + +G  +      E 
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQ-------KPYKKMKGPEVMAFIEQGKRM------EC 233

Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHISG 443
                 +L  +   C   K  DRP    V + +             ++S +  + G
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR----------ACYYSLASKVEG 279

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 5e-45
 Identities = 58/277 (20%), Positives = 102/277 (36%), Gaps = 47/277 (16%)

Query: 165 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE-------------- 206
           F  ++G+G F +VYKG    T   +A   +++ K +    + F  E              
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 207 LLGLCSEGFKR----ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
                    K      LV E M +G+L  ++     + +   ++          +G+++L
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128

Query: 263 HNGCDVCILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
           H      I+H D+K  NI +       K+ D GLA                GT  ++APE
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPE 183

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
           +    +       DVY FGM +LEMA             S+    + +Y ++  G     
Sbjct: 184 MYEEKYDE---SVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPA- 232

Query: 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
                 + +   ++  I   CI+    +R S+  +L 
Sbjct: 233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 7e-45
 Identities = 56/277 (20%), Positives = 102/277 (36%), Gaps = 40/277 (14%)

Query: 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE---FINE------------- 206
              + +G G +G   K +    G+++  K ++    +  E    ++E             
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 207 -LLGLCSEGFKRAL--VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
                  +     L  V EY   G L   I     + Q    E    +       ++  H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 264 --NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
             +     +LH D+KP N+ LD     K+ DFGLA+    +  F       GT  Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPE 184

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
            ++R   + + KSD++  G +L E+                A+    +  ++ +G     
Sbjct: 185 QMNR--MSYNEKSDIWSLGCLLYELCALMPPFT--------AFSQKELAGKIREG----- 229

Query: 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
                I    + +L  I    + +K   RPS+ ++LE
Sbjct: 230 -KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  153 bits (387), Expect = 9e-44
 Identities = 64/289 (22%), Positives = 115/289 (39%), Gaps = 44/289 (15%)

Query: 156 PEIIAVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMM--ENSKFSAEEFINE--- 206
            EI          +G G FG V  G L         +A+K +    ++    +F++E   
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80

Query: 207 -----------LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGT 255
                      L G+ ++     ++ E+M NGSLD  +   + +   F + +   +  G 
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ---FTVIQLVGMLRGI 137

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND---FVSISDTR 312
           A G++YL +   +  +H D+   NIL++ N + KVSDFGL++F   +     + S    +
Sbjct: 138 AAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 372
             I + APE I   +   +  SDV+ +G+V+ E+            R         V + 
Sbjct: 195 IPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGE-------RPYWDMTNQDVINA 245

Query: 373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
           + +   L               L  + L C Q     RP   +++  L+
Sbjct: 246 IEQDYRL------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-43
 Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 44/281 (15%)

Query: 164 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFS----AEEFINE--------- 206
               KLG G FG V +G+          +AVK ++    S     ++FI E         
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                L G+      + +V E  P GSL   +   +     F L      A+  A G+ Y
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGY 126

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAP 320
           L +      +H D+   N+LL    + K+ DFGL +  P+ +D   + + R     + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           E +     T S  SD + FG+ L EM    +   +           S +  +++K G+  
Sbjct: 184 ESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGE-- 232

Query: 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                       + +  + + C   K  DRP+   + + L 
Sbjct: 233 ---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-43
 Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 44/275 (16%)

Query: 168 KLGQGGFGSVYKGQLH---TGRLIAVKMMENSKFSA---EEFINE--------------L 207
           +LG G FG+V KG        + +AVK+++N        +E + E              +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           +G+C       LV E    G L++++     + +    +   E+    + G++YL     
Sbjct: 74  IGICEAE-SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN- 127

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELISRN 326
              +H D+   N+LL      K+SDFGL+K    + ++       +  + + APE I+  
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY- 184

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386
               S KSDV+ FG+++ E     +               S V   L KG  +       
Sbjct: 185 -YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERM------G 230

Query: 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
             +   R++  +   C      +RP    V   L 
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 9e-43
 Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 59/299 (19%)

Query: 165 FTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINE---------- 206
           F   LG G FG V     +          +AVKM++    S+E    ++E          
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENK-------------------GQT 242
                LLG C+      L++EY   G L  ++ SK  K                      
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 243 FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302
              E     A   A+G+E+L        +H D+   N+L+ H  + K+ DFGLA+    +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 362
           +++V   + R  + ++APE +    G  + KSDV+ +G++L E+     N          
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--- 272

Query: 363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
               +  Y  +  G  +      +       ++ +I   C    +  RPS   +   L 
Sbjct: 273 ---DANFYKLIQNGFKM------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-42
 Identities = 66/298 (22%), Positives = 112/298 (37%), Gaps = 45/298 (15%)

Query: 147 MQTVDNILLPEIIAVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMM--ENSKFSA 200
           +Q V ++++    ++  HF   +G+G FG VY G L          AVK +         
Sbjct: 14  VQAVQHVVIGPS-SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 72

Query: 201 EEFINE--------------LLGLCSEG-FKRALVYEYMPNGSLDRHIFSKENKGQTFGL 245
            +F+ E              LLG+C        +V  YM +G L   I    N+     +
Sbjct: 73  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTV 129

Query: 246 EKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305
           +      L  A+G   +        +H D+   N +LD  F  KV+DFGLA+    +   
Sbjct: 130 KDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186

Query: 306 VSISDT--RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA 363
              + T  +  + ++A E +       + KSDV+ FG++L E+         +       
Sbjct: 187 SVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----- 239

Query: 364 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
                +   L +G  L               L  + L C   KA  RPS ++++  + 
Sbjct: 240 --TFDITVYLLQGRRL------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-42
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 31/209 (14%)

Query: 162 TNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMM--ENSKFSAEEFINE---------- 206
            + F    +LG G  G V+K     +G ++A K++  E       + I E          
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
                 G      + ++  E+M  GSLD+ +     K      +   ++++   +G+ YL
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
                  I+H D+KP NIL++     K+ DFG++            +   GT  Y++PE 
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPER 174

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
           +       S +SD++  G+ L+EMA GR 
Sbjct: 175 LQG--THYSVQSDIWSMGLSLVEMAVGRY 201

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (376), Expect = 2e-42
 Identities = 55/294 (18%), Positives = 106/294 (36%), Gaps = 60/294 (20%)

Query: 164 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE------------ 206
                LG+G FG+VY  +   +  ++A+K++  ++        +   E            
Sbjct: 9   EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 207 --LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
             L G   +  +  L+ EY P G++ R +     K   F  ++        A  + Y H+
Sbjct: 69  LRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS 124

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
                ++H DIKP N+LL      K++DFG +   P            GT+ YL PE+I 
Sbjct: 125 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 177

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384
                   K D++  G++  E   G+             +  +   +   +   +E    
Sbjct: 178 G--RMHDEKVDLWSLGVLCYEFLVGKP-----------PFEANTYQETYKRISRVEF--- 221

Query: 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSS 438
                 +      +    ++   + RP + +VLE              P+ +++
Sbjct: 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH-------------PWITAN 261

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-42
 Identities = 65/294 (22%), Positives = 114/294 (38%), Gaps = 53/294 (18%)

Query: 164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINELLGL----- 210
                LG+G FG V +          T R +AVKM++     +E    ++EL  L     
Sbjct: 16  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75

Query: 211 -----------CSEGFKRALVYEYMPNGSLDRHIFSKENK------------GQTFGLEK 247
                         G    ++ E+   G+L  ++ SK N+                 LE 
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 248 PHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307
               +   A+G+E+L +      +H D+   NILL    + K+ DFGLA+   K+ D+V 
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 367
             D R  + ++APE I       + +SDV+ FG++L E+     +               
Sbjct: 193 KGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDE 244

Query: 368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
               +L +G  +              ++    L C   + + RP+ ++++E L 
Sbjct: 245 EFCRRLKEGTRM------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 6e-42
 Identities = 58/270 (21%), Positives = 105/270 (38%), Gaps = 39/270 (14%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMME-NSKFSAEEFINE--------------LLGLC 211
           +LG G FG VYK Q   T  L A K+++  S+   E+++ E              LL   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
                  ++ E+   G++D  +       +     +   +   T   + YLH   D  I+
Sbjct: 79  YYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKII 132

Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI---SRNFG 328
           H D+K  NIL   +   K++DFG++  + +           GT  ++APE++   +    
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 329 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 388
               K+DV+  G+ L+EMA                  P  V  ++ K     L   +   
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE--------PPHHELNPMRVLLKIAKSEPPTLAQPSRW- 241

Query: 389 SMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
           S   +        C++     R + +++L+
Sbjct: 242 SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-41
 Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 43/276 (15%)

Query: 169 LGQGGFGSVYKGQLHTG-----RLIAVKMMENSKFSAE--EFINEL-------------- 207
           +G G FG VYKG L T        +A+K ++      +  +F+ E               
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
            G+ S+     ++ EYM NG+LD+ +  K+ +   F + +   +  G A G++YL N   
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLAN--- 128

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISDTRGTIGYLAPELISRN 326
           +  +H D+   NIL++ N + KVSDFGL++    + +   + S  +  I + APE IS  
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY- 187

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386
               +  SDV+ FG+V+ E+           +          V   +N G  L       
Sbjct: 188 -RKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDGFRL------P 233

Query: 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422
                   +  + + C Q + A RP    ++ +L+ 
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 5e-41
 Identities = 66/297 (22%), Positives = 118/297 (39%), Gaps = 53/297 (17%)

Query: 164 HFTHKLGQGGFGSVYKGQLHTG---RLIAVKMM--ENSKFSAEEFINE------------ 206
            F   +G+G FG V K ++         A+K M    SK    +F  E            
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSK------------ENKGQTFGLEKPHEI 251
              LLG C       L  EY P+G+L   +                +   T   ++    
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311
           A   ARG++YL        +H D+   NIL+  N++ K++DFGL++       +V  +  
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMG 186

Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 371
           R  + ++A E +  N+   +  SDV+ +G++L E+           T        + +Y+
Sbjct: 187 RLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE 237

Query: 372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ 428
           +L +G  L      E       ++  +   C + K  +RPS  ++L  L   +++ +
Sbjct: 238 KLPQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 6e-41
 Identities = 63/272 (23%), Positives = 91/272 (33%), Gaps = 37/272 (13%)

Query: 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMM--ENSKFSAEEFINE-------------- 206
                LG+G +G V       T   +AVK++  + +    E    E              
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
             G   EG  + L  EY   G L   I                        G+ YLH   
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
            + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ R 
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386
               +   DV+  G+VL  M  G    +            S       K     L    +
Sbjct: 181 -EFHAEPVDVWSCGIVLTAMLAGELPWDQP--------SDSCQEYSDWKEKKTYLNPWKK 231

Query: 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
           I       L       +    + R ++  + +
Sbjct: 232 I-DSAPLALLH---KILVENPSARITIPDIKK 259

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-40
 Identities = 63/301 (20%), Positives = 115/301 (38%), Gaps = 53/301 (17%)

Query: 164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSAE--EFINEL-------- 207
             + +LGQG FG VY+G             +A+K +  +    E  EF+NE         
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 208 ------LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKP------HEIALGT 255
                 LG+ S+G    ++ E M  G L  ++ S         +  P       ++A   
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315
           A G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + + +         +
Sbjct: 143 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 375
            +++PE +    G  +  SDV+ FG+VL E+A           +  +      V   + +
Sbjct: 200 RWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAE-------QPYQGLSNEQVLRFVME 250

Query: 376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFF 435
           GG L      +        L  +   C Q     RPS  +++  ++  ++       P F
Sbjct: 251 GGLL------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME-------PGF 297

Query: 436 S 436
            
Sbjct: 298 R 298

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 59/294 (20%), Positives = 118/294 (40%), Gaps = 55/294 (18%)

Query: 165 FTHKLGQGGFGSVYKGQL--------HTGRLIAVKMM--ENSKFSAEEFINEL------- 207
               LG+G FG V   +         +    +AVKM+  + ++    + I+E+       
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 208 --------LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPH---------- 249
                   LG C++     ++ EY   G+L  ++ ++   G  +     H          
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 250 --EIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307
               A   ARG+EYL        +H D+   N+L+  + + K++DFGLA+     + +  
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 367
            ++ R  + ++APE +       + +SDV+ FG++L E+     +               
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------VE 244

Query: 368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
            ++  L +G  +      +  S    +L M+   C     + RP+  +++E L+
Sbjct: 245 ELFKLLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-39
 Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 43/296 (14%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRL----IAVKMM--ENSKFSAEEFINE-------------- 206
            LG G FG+VYKG  +  G      +A+K +    S  + +E ++E              
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LLG+C       L+ + MP G L  ++          G +      +  A+G+ YL +  
Sbjct: 76  LLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
              ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 132 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH- 187

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386
               + +SDV+ +G+ + E+            +       S +   L KG  L       
Sbjct: 188 -RIYTHQSDVWSYGVTVWELMTFGS-------KPYDGIPASEISSILEKGERL------P 233

Query: 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSSSRHIS 442
              +    + MI + C  + A  RP   +++        D Q           H+ 
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 5e-39
 Identities = 56/283 (19%), Positives = 104/283 (36%), Gaps = 43/283 (15%)

Query: 164 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFSA--EEFINE----------- 206
                +G+G FG V++G           +A+K  +N    +  E+F+ E           
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
              L+G+ +E     ++ E    G L   +  ++       L      A   +  + YL 
Sbjct: 70  IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLE 125

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
                  +H DI   N+L+  N   K+ DFGL+++      + + S  +  I ++APE I
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESI 181

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383
             NF   +  SDV+ FG+ + E+                    + V  ++  G  L    
Sbjct: 182 --NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERL---- 228

Query: 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426
              +       L  +   C     + RP  T++   L   +++
Sbjct: 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-38
 Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 42/268 (15%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE-FINE--------------LLGLC 211
           K+GQG  G+VY    + TG+ +A++ M   +   +E  INE               L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 212 SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271
             G +  +V EY+  GSL   +             +   +     + +E+LH      ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLH---SNQVI 138

Query: 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVS 331
           H DIK  NILL  +   K++DFG       E      S   GT  ++APE+++R      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTR--KAYG 194

Query: 332 CKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM 390
            K D++  G++ +EM  G     N N         P      +   G  EL+N  ++ S 
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNEN---------PLRALYLIATNGTPELQNPEKL-SA 244

Query: 391 IARKLCMIGLWCIQVKAADRPSMTKVLE 418
           I R        C+ +    R S  ++L+
Sbjct: 245 IFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-37
 Identities = 59/300 (19%), Positives = 100/300 (33%), Gaps = 64/300 (21%)

Query: 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE------------------FI 204
            F   LG+G F +V   + L T R  A+K++E      E                   F 
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 205 NELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
            +L     +  K      Y  NG L ++I          G          TA  +  L  
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-------IGSFDETCTRFYTAEIVSALEY 123

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
                I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQLNKGG 377
               +    SD++  G ++ ++  G                   +  FP   +       
Sbjct: 184 E--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP------ 235

Query: 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSS 437
                   +   ++ +         + + A  R    ++     G          PFF S
Sbjct: 236 --------KARDLVEK--------LLVLDATKRLGCEEME----GYGPLKAH---PFFES 272

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  135 bits (340), Expect = 2e-36
 Identities = 58/306 (18%), Positives = 103/306 (33%), Gaps = 47/306 (15%)

Query: 161 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS-AEEFINE---------- 206
           V +H+    +LG G FG V++     TG   A K +     S  E    E          
Sbjct: 24  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               L     +  +  ++YE+M  G L   +  + NK      ++  E      +G+ ++
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHM 140

Query: 263 HNGCDVCILHFDIKPHNILL--DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           H   +   +H D+KP NI+     +   K+ DFGL       +   S+  T GT  + AP
Sbjct: 141 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAP 194

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           E+       V   +D++  G++   +  G              +      + L      +
Sbjct: 195 EVAEG--KPVGYYTDMWSVGVLSYILLSGLS-----------PFGGENDDETLRNVKSCD 241

Query: 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE-----MLEGSIDDLQMPPKPFF 435
                   S I+          +      R ++ + LE            D Q+P   + 
Sbjct: 242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYT 301

Query: 436 SSSRHI 441
                I
Sbjct: 302 KIRDSI 307

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  132 bits (332), Expect = 4e-36
 Identities = 51/281 (18%), Positives = 96/281 (34%), Gaps = 51/281 (18%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA----------EEFINE---------- 206
            LG+G    V +     T +  AVK+++ +   +          E  + E          
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                L           LV++ M  G L  ++     +  T   ++  +I       I  
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICA 125

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
           LH    + I+H D+KP NILLD +   K++DFG +           + +  GT  YLAPE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPE 179

Query: 322 LIS----RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377
           +I      N      + D++  G+++  +  G              ++       L    
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP-----------PFWHRKQMLMLRMIM 228

Query: 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
               +  +      +  +  +    + V+   R +  + L 
Sbjct: 229 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 4e-33
 Identities = 40/268 (14%), Positives = 84/268 (31%), Gaps = 39/268 (14%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCS 212
            LG+G FG V++     + +    K ++           E              L     
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILH 272
              +  +++E++    +   I             +           +++LH      I H
Sbjct: 72  SMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH---SHNIGH 125

Query: 273 FDIKPHNILLDH--NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           FDI+P NI+     +   K+ +FG A+     ++F           Y APE+       V
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQH--DVV 180

Query: 331 SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM 390
           S  +D++  G ++  +  G              +        +    + E     E    
Sbjct: 181 STATDMWSLGTLVYVLLSGIN-----------PFLAETNQQIIENIMNAEYTFDEEAFKE 229

Query: 391 IARKLCMIGLWCIQVKAADRPSMTKVLE 418
           I+ +        +  +   R + ++ L+
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQ 257

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  125 bits (316), Expect = 4e-33
 Identities = 56/314 (17%), Positives = 111/314 (35%), Gaps = 46/314 (14%)

Query: 161 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSK-FSAEEFINE---------- 206
           V +++    +LG G FG V++     TGR+   K +            NE          
Sbjct: 27  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 86

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               L     + ++  L+ E++  G L   I     +       +          G++++
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHM 143

Query: 263 HNGCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320
           H   +  I+H DIKP NI+ +       K+ DFGLA     +        T  T  + AP
Sbjct: 144 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAP 197

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           E++ R    V   +D++  G++   +  G              +      + L      +
Sbjct: 198 EIVDR--EPVGFYTDMWAIGVLGYVLLSGLS-----------PFAGEDDLETLQNVKRCD 244

Query: 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSIDDL--QMPPKPFFS 436
                +  S ++ +        +Q +   R ++   LE   L+G   +L  ++P   +  
Sbjct: 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNK 304

Query: 437 SSRHISGRETESAS 450
             + I  +  +  +
Sbjct: 305 IRQKIKEKYADWPA 318

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  125 bits (314), Expect = 9e-33
 Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 54/292 (18%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE---------------------FIN 205
            +G+GGFG VY  +   TG++ A+K ++  +   ++                     FI 
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 206 ELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            +        K + + + M  G L  H+    ++   F        A     G+E++H  
Sbjct: 71  CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMH-- 124

Query: 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISR 325
            +  +++ D+KP NILLD +   ++SD GLA    K+        + GT GY+APE++ +
Sbjct: 125 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQK 179

Query: 326 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385
                   +D +  G +L ++  G               F        ++   + L    
Sbjct: 180 GVA-YDSSADWFSLGCMLFKLLRGHS------------PFRQHKTKDKHEIDRMTLTMAV 226

Query: 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFSS 437
           E+    + +L  +    +Q     R         L     +++    PFF S
Sbjct: 227 ELPDSFSPELRSLLEGLLQRDVNRRLG------CLGRGAQEVKE--SPFFRS 270

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  123 bits (311), Expect = 9e-33
 Identities = 49/271 (18%), Positives = 88/271 (32%), Gaps = 37/271 (13%)

Query: 165 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE--FINE--------------L 207
           F   LG G F  V   +   T +L+A+K +       +E    NE              L
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
             +   G    L+ + +  G L   I  K      +       +       ++YLH+   
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNF 327
           V             LD +    +SDFGL+K    E+    +S   GT GY+APE++++  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ-- 183

Query: 328 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387
              S   D +  G++   +  G              ++         +    E    +  
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYP-----------PFYDENDAKLFEQILKAEYEFDSPY 232

Query: 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
              I+          ++     R +  + L+
Sbjct: 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  123 bits (310), Expect = 1e-32
 Identities = 51/287 (17%), Positives = 95/287 (33%), Gaps = 43/287 (14%)

Query: 161 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE----------- 206
           V N +    K+G G FG +Y G  +  G  +A+K+    K    +   E           
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGGV 63

Query: 207 ----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL 262
               +    +EG    +V E +     D          + F L+    +A      IEY+
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYI 119

Query: 263 HNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSI-----SDTRGT 314
           H       +H D+KP N L        +  + DFGLAK +        I      +  GT
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 315 IGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374
             Y +           S + D+   G VL+    G          + +  +      +++
Sbjct: 177 ARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234

Query: 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421
              ++  +           +      +C  ++  D+P  + + ++  
Sbjct: 235 TPIEVLCKGYPS-------EFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 5e-32
 Identities = 57/269 (21%), Positives = 102/269 (37%), Gaps = 36/269 (13%)

Query: 169 LGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE-----------FINELLGLCSEGFK 216
           LG G  G V +     T    A+KM+++   +  E            I  ++ +    + 
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 79

Query: 217 RA----LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILH 272
                 +V E +  G L   I  ++   Q F   +  EI       I+YLH    + I H
Sbjct: 80  GRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAH 134

Query: 273 FDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
            D+KP N+L      N I K++DFG AK     N   +   T     Y+APE++      
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP---YYVAPEVLGP--EK 189

Query: 330 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389
                D++  G+++  +  G        +    A  P        + G  E  N     S
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMK--TRIRMGQYEFPN--PEWS 242

Query: 390 MIARKLCMIGLWCIQVKAADRPSMTKVLE 418
            ++ ++ M+    ++ +   R ++T+ + 
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  120 bits (302), Expect = 1e-31
 Identities = 44/301 (14%), Positives = 97/301 (32%), Gaps = 45/301 (14%)

Query: 158 IIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE---------- 206
           ++ V      ++G+G FG +++G  L   + +A+K     +  A +  +E          
Sbjct: 2   VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAGC 60

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                +     EG    LV + +     D      +  G+ F ++     A      ++ 
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQS 116

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIP-----KVSDFGLAKFHPKEND-----FVSISDT 311
           +H   +  +++ DIKP N L+            V DFG+ KF+          +    + 
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173

Query: 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 371
            GT  Y++           S + D+   G V +    G                 +    
Sbjct: 174 SGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQ--------GLKAATNKQ 223

Query: 372 QLNKGGDLELRN-VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMP 430
           +  + G+ +    + E+ +    +      +   +     P    +  +    ++ L   
Sbjct: 224 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283

Query: 431 P 431
            
Sbjct: 284 E 284

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 5e-31
 Identities = 51/236 (21%), Positives = 91/236 (38%), Gaps = 38/236 (16%)

Query: 165 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE-------------------FI 204
               LG+G FG V+  +   T +  A+K ++      ++                   F+
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 205 NELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
             +            V EY+  G L  HI         F L +    A     G+++L  
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFL-- 119

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
                I++ D+K  NILLD +   K++DFG+ K +   +     +   GT  Y+APE++ 
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILL 176

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQL 373
                 +   D + FG++L EM  G+            ++ R    ++P W+  + 
Sbjct: 177 G--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 230

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  117 bits (293), Expect = 1e-30
 Identities = 52/282 (18%), Positives = 94/282 (33%), Gaps = 45/282 (15%)

Query: 165 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS----AEEFINE------------- 206
               LG GG   V+  + L   R +AVK++             F  E             
Sbjct: 11  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 207 -LLGLC----SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
            +          G    +V EY+   +L   +    +       ++  E+     + + +
Sbjct: 71  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNF 126

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR-GTIGYLAP 320
                   I+H D+KP NI++      KV DFG+A+      + V+ +    GT  YL+P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           E       +V  +SDVY  G VL E+  G              +          +    +
Sbjct: 184 EQARG--DSVDARSDVYSLGCVLYEVLTGEP-----------PFTGDSPVSVAYQHVRED 230

Query: 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLE 421
               +     ++  L  + L  +     +R  +  ++   L 
Sbjct: 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 6e-30
 Identities = 51/287 (17%), Positives = 110/287 (38%), Gaps = 44/287 (15%)

Query: 168 KLGQGGFGSVYKGQ--LHTGRLIAVKMMENSKFS---AEEFINE---------------- 206
           ++G+G +G V+K +   + GR +A+K +             I E                
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 207 -LLGLCSEGFKRALVYEYMPNGSLDRHIFS--KENKGQTFGLEKPHEIALGTARGIEYLH 263
            L  +C+           +    +D+ + +   +        E   ++     RG+++LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
                 ++H D+KP NIL+  +   K++DFGLA+ +   +  ++++    T+ Y APE++
Sbjct: 134 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVL 187

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMN--------ATRSSKAYFPSWVYD 371
            +   + +   D++  G +  EM   +     +S+++             +  +P  V  
Sbjct: 188 LQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
                     + + +  + I      + L C+    A R S    L 
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 8e-30
 Identities = 62/286 (21%), Positives = 101/286 (35%), Gaps = 44/286 (15%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE--------------------FINE 206
            LG+G F +VYK +  +T +++A+K ++    S  +                     I  
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC 266
           LL         +LV+++M             +              L T +G+EYLH   
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
              ILH D+KP+N+LLD N + K++DFGLAK     N   + +    T  Y APEL+   
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELL-FG 174

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGR-------------RNSNMNATRSSKAYFPSWVYDQL 373
                   D++  G +L E+                 R      T + + +         
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419
                     +  I S     L  +           R + T+ L+M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 1e-29
 Identities = 57/335 (17%), Positives = 112/335 (33%), Gaps = 47/335 (14%)

Query: 161 VTNHFT--HKLGQGGFGSVYKGQ-LHTGRLIAVKMM--ENSKFSAEEFINE--------- 206
           V   +T    +G+G +G V           +A+K +     +   +  + E         
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65

Query: 207 -----LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
                +  +        +   Y+    +   ++ K  K Q    +          RG++Y
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISDTRGTIGYLAP 320
           +H      +LH D+KP N+LL+     K+ DFGLA+   P  +    +++   T  Y AP
Sbjct: 125 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMNATRSSKAYFPSWVYDQLNKG 376
           E++  + G  +   D++  G +L EM   R        ++          S   + LN  
Sbjct: 182 EIMLNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 377 GDLELRNV------------TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL------E 418
            +L+ RN               +      K   +    +      R  + + L      +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

Query: 419 MLEGSIDDLQMPPKPFFSSSRHISGRETESASLTE 453
             + S + +   P  F      +   + +     E
Sbjct: 301 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEE 335

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 4e-29
 Identities = 56/277 (20%), Positives = 87/277 (31%), Gaps = 59/277 (21%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS-------AEEFINE------------- 206
            LG GGFGSVY G  +     +A+K +E  + S             E             
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 207 ---LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
              LL          L+ E            ++         E            + +  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC- 126

Query: 264 NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322
              +  +LH DIK  NIL+D N    K+ DFG              +D  GT  Y  PE 
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEW 180

Query: 323 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
           I R        + V+  G++L +M  G     +       + +F   V            
Sbjct: 181 I-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV------------ 227

Query: 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
                  S   + L     WC+ ++ +DRP+  ++  
Sbjct: 228 -------SSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 3e-28
 Identities = 55/277 (19%), Positives = 96/277 (34%), Gaps = 49/277 (17%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM-------ENSKFSAEEFINE------------- 206
           +LG G F  V K +   TG   A K +            S E+   E             
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 207 -LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG 265
            L  +        L+ E +  G L   +  KE+  +    E   +I  G       ++  
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG-------VYYL 129

Query: 266 CDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPE 321
             + I HFD+KP NI+L    +P    K+ DFGLA      N+F    +  GT  ++APE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186

Query: 322 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381
           ++  N+  +  ++D++  G++   +  G              +      + L     +  
Sbjct: 187 IV--NYEPLGLEADMWSIGVITYILLSGASP-----------FLGDTKQETLANVSAVNY 233

Query: 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
               E  S  +          +      R ++   L+
Sbjct: 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  109 bits (274), Expect = 7e-28
 Identities = 48/282 (17%), Positives = 91/282 (32%), Gaps = 41/282 (14%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---AEEFINE--------------LLGL 210
           K+G+G +G VYK Q + G   A+K +   K         I E              L  +
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI 270
                +  LV+E++           +       G  +         + +  +    D  +
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 271 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV 330
           LH D+KP N+L++     K++DFGLA+           +    T+ Y AP+++       
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVL-MGSKKY 178

Query: 331 SCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383
           S   D++  G +  EM  G            +           S  +  + +    +   
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 384 VTEIESMIARKLCMIG-------LWCIQVKAADRPSMTKVLE 418
                      L  +           +++    R +  + LE
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (275), Expect = 9e-28
 Identities = 51/232 (21%), Positives = 87/232 (37%), Gaps = 40/232 (17%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS----AEEFINE--------------LL 208
            LG G FG V+  +  H GR  A+K+++          E   +E              + 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
           G   +  +  ++ +Y+  G L   +   +                  A     L      
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-------PNPVAKFYAAEVCLALEYLHSK 123

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
            I++ D+KP NILLD N   K++DFG AK+ P            GT  Y+APE++S    
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVST--K 176

Query: 329 TVSCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQL 373
             +   D + FG+++ EM  G                 +++  FP +  + +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 9e-28
 Identities = 55/286 (19%), Positives = 94/286 (32%), Gaps = 47/286 (16%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---AEEFINE--------------LLG 209
           K+G+G +G VYK +   TG ++A+K +     +       I E              LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E++         F   +      L           +G+ +        
Sbjct: 69  VIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++     K++DFGLA+           +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGC-KY 179

Query: 330 VSCKSDVYGFGMVLLEMAGGRR----NSNMNA--------TRSSKAYFPSWVYD-----Q 372
            S   D++  G +  EM   R     +S ++             +  +P           
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
             K    +   V        R L       +      R S    L 
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALA 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 1e-26
 Identities = 67/322 (20%), Positives = 110/322 (34%), Gaps = 54/322 (16%)

Query: 168 KLGQGGFGSVYKGQLH-TGRLIAVKMMENSK--FSAE---------EFINELLGLCSEGF 215
            +G G FG VY+ +L  +G L+A+K +   K   + E           I  L        
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 86

Query: 216 KR------ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           ++       LV +Y+P     R         QT  +           R + Y+H      
Sbjct: 87  EKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFG 142

Query: 270 ILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
           I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R    Y APELI     
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATD 199

Query: 329 TVSCKSDVYGFGMVLLEMAGGRR-------------------NSNMNATRSSKAYFPSWV 369
             +   DV+  G VL E+  G+                           R     +  + 
Sbjct: 200 -YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258

Query: 370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE---MLEGSIDD 426
           + Q+      ++          A  LC      ++     R +  +        E    +
Sbjct: 259 FPQIKAHPWTKVFR--PRTPPEAIALCS---RLLEYTPTARLTPLEACAHSFFDELRDPN 313

Query: 427 LQMPPKPFFSSSRHISGRETES 448
           +++P      +  + + +E  S
Sbjct: 314 VKLPNGRDTPALFNFTTQELSS 335

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-26
 Identities = 54/296 (18%), Positives = 95/296 (32%), Gaps = 53/296 (17%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---AEEFINE--------------LLG 209
           K+GQG FG V+K +   TG+ +A+K +             + E              L+ 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 210 LCSEGFKRA--------LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261
           +C               LV+++  +                       EI       +  
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL-------SEIKRVMQMLLNG 129

Query: 262 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISDTRGTIGYLA 319
           L+      ILH D+K  N+L+  + + K++DFGLA+     K +     ++   T+ Y  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMNATRSSKAYFPSWVYDQLNK 375
           PEL+           D++G G ++ EM         N+  +          S   +    
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 376 GGDLELRNVTEIESMIARKLCMIGL-------------WCIQVKAADRPSMTKVLE 418
             + EL    E+     RK+                    + +  A R      L 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 2e-26
 Identities = 50/287 (17%), Positives = 99/287 (34%), Gaps = 49/287 (17%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM---ENSKFSAEEFINEL--------------LG 209
           K+G+G +G+V+K +   T  ++A+K +   ++ +      + E+                
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           +     K  LV+E+                    G   P  +     + ++ L       
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           +LH D+KP N+L++ N   K+++FGLA+           S    T+ Y  P+++      
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGA-KL 178

Query: 330 VSCKSDVYGFGMVLLEMAGGRR--------NSNMNATRSSKAYFPSWVYDQLNKGGDLE- 380
            S   D++  G +  E+A   R        +  +              +  + K  D + 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 381 ---------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
                    L NV    +   R L       ++     R S  + L+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEALQ 282

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 6e-26
 Identities = 49/207 (23%), Positives = 79/207 (38%), Gaps = 30/207 (14%)

Query: 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE------------------FI 204
            +   LG+G FG V   +   TGR  A+K++      A++                  F+
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 205 NELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN 264
             L        +   V EY   G L  H+  +        +          A  +  L  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRER-------VFTEERARFYGAEIVSALEY 120

Query: 265 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELIS 324
                +++ DIK  N++LD +   K++DFGL K    +    ++    GT  YLAPE++ 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLE 178

Query: 325 RNFGTVSCKSDVYGFGMVLLEMAGGRR 351
                     D +G G+V+ EM  GR 
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRL 203

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  103 bits (257), Expect = 4e-25
 Identities = 51/295 (17%), Positives = 107/295 (36%), Gaps = 54/295 (18%)

Query: 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSK-------------FSAEEFINELLG 209
               KLG+G +  V++   +     + VK+++  K                   I  L  
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLAD 97

Query: 210 LCSEGFKR--ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           +  +   R  ALV+E++ N    +         QT              + ++Y H    
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH---S 147

Query: 268 VCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326
           + I+H D+KPHN+++DH +   ++ D+GLA+F+    ++   +    +  +  PEL+  +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELL-VD 203

Query: 327 FGTVSCKSDVYGFGMVLLEMAGGR------RNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380
           +       D++  G +L  M   +       ++     R +K      +YD ++K     
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 381 LRNVTEIESMIARKLCMIGL-----------------WCIQVKAADRPSMTKVLE 418
                +I    +RK     +                   ++     R +  + +E
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (251), Expect = 3e-24
 Identities = 48/203 (23%), Positives = 79/203 (38%), Gaps = 33/203 (16%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE------------------FINELL 208
            LG G FG V   +   +G   A+K+++  K    +                  F+ +L 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 209 GLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDV 268
               +     +V EY+  G +  H+     +   F        A       EYLH    +
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLH---SL 160

Query: 269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG 328
            +++ D+KP N+L+D     +V+DFG AK        +      GT   LAPE+I     
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEIILS--K 213

Query: 329 TVSCKSDVYGFGMVLLEMAGGRR 351
             +   D +  G+++ EMA G  
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYP 236

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 3e-23
 Identities = 52/285 (18%), Positives = 102/285 (35%), Gaps = 43/285 (15%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMM---ENSKFSAEEFINE--------------LLG 209
            +G G +G+V       TG  +A+K +     S+  A+    E              LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           + +         ++            K  K +  G ++   +     +G+ Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE+I  N+  
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVI-LNWMR 195

Query: 330 VSCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQLNKGG----- 377
            +   D++  G ++ EM  G+           +          P+    +L         
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 378 ----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
               +LE ++   I +  +     +    + + A  R +  + L 
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 4e-23
 Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 37/236 (15%)

Query: 141 HKYRTTMQTVDNILLPEIIAVTN-HFTHKLGQGGFGSVYKGQL----HTGRLIAVKMMEN 195
           H+ RT   T       E + + N      LG G +G V+  +      TG+L A+K+++ 
Sbjct: 7   HELRTANLTGH----AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK 62

Query: 196 SKFSAEE--------------------FINELLGLCSEGFKRALVYEYMPNGSLDRHIFS 235
           +    +                     F+  L        K  L+ +Y+  G L  H+  
Sbjct: 63  ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 122

Query: 236 KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295
           +E           HE+ +     +  L +   + I++ DIK  NILLD N    ++DFGL
Sbjct: 123 RERF-------TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 175

Query: 296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 351
           +K    +    +  D  GTI Y+AP+++           D +  G+++ E+  G  
Sbjct: 176 SKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 89.7 bits (221), Expect = 3e-20
 Identities = 47/342 (13%), Positives = 108/342 (31%), Gaps = 69/342 (20%)

Query: 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE------------------- 206
            KLG G F +V+  + +     +A+K++   K   E   +E                   
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 207 ------LLGLCSEGFKRALVYEYMPNGSLDRHI-FSKENKGQTFGLEKPHEIALGTARGI 259
                 LL   +      +    +     +  +   K+ + +   L    +I+     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 260 EYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318
           +Y+H  C   I+H DIKP N+L++       +    +A            +++  T  Y 
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 319 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRR--------------------------- 351
           +PE++        C +D++    ++ E+  G                             
Sbjct: 197 SPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 352 --NSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGL----WCIQV 405
                 N   +   +    +   ++K     L +V   +   ++             +Q+
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 406 KAADRPSMTKVLEM----LEGSIDDLQMPPKPFFSSSRHISG 443
               R     ++          ++++++P +  + S   I G
Sbjct: 315 DPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPG 356

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.8 bits (206), Expect = 3e-18
 Identities = 44/207 (21%), Positives = 71/207 (34%), Gaps = 39/207 (18%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---AEEFINE--------------LLG 209
            +G G  G V         R +A+K +     +   A+    E              LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 210 LCS------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH 263
           + +      E     LV E M                     E+   +      GI++LH
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH 136

Query: 264 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELI 323
           +     I+H D+KP NI++  +   K+ DFGLA+           +    T  Y APE+I
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVI 190

Query: 324 SRNFGTVSCKSDVYGFGMVLLEMAGGR 350
                      D++  G ++ EM   +
Sbjct: 191 LGM--GYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (202), Expect = 7e-18
 Identities = 53/288 (18%), Positives = 99/288 (34%), Gaps = 49/288 (17%)

Query: 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---AEEFINE--------------LLG 209
            +G G +GSV       TG  +AVK +     S   A+    E              LL 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 210 LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC 269
           + +         +      L     +   K Q    +    +     RG++Y+H      
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141

Query: 270 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGT 329
           I+H D+KP N+ ++ +   K+ DFGLA+    E      +    T  Y APE++  N+  
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIM-LNWMH 195

Query: 330 VSCKSDVYGFGMVLLEMAGGRR----NSNMNA---------------TRSSKAYFPSWVY 370
            +   D++  G ++ E+  GR       +++                 +   +       
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418
             L +   +   NV    + +A  L       + + +  R +  + L 
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQALA 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 69.8 bits (170), Expect = 1e-14
 Identities = 27/157 (17%), Positives = 50/157 (31%), Gaps = 26/157 (16%)

Query: 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFIN----------ELLGLCSEGFKR 217
            +G+G   +V+           VK  +    S ++              L    +    R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 218 ALV----------YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD 267
           AL           Y +  N  L   I +KE       +E P E+       +   ++   
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELIDAKELY--RVRVENPDEVLDMILEEVAKFYH--- 121

Query: 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304
             I+H D+  +N+L+       + DF  +    +E  
Sbjct: 122 RGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGW 157

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	453
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.7
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.33
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.44
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.43
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.7
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	91.31

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=379.10  Aligned_cols=240  Identities=28%  Similarity=0.482  Sum_probs=186.5

Q ss_pred             hhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCCC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGS  228 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gs  228 (453)
                      +++.++||+|+||+||+|++.+++.||||+++......++|.+|              ++|+|......++||||+++|+
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~   86 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   86 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence            45778999999999999999889999999999877778888777              6888888889999999999999


Q ss_pred             hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceee
Q 048517          229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  308 (453)
Q Consensus       229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  308 (453)
                      |.+++..   ....++|..++.|+.|+|+||+|||+.   +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus        87 L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~  159 (263)
T d1sm2a_          87 LSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS  159 (263)
T ss_dssp             HHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             HHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce-ee
Confidence            9998853   335689999999999999999999998   9999999999999999999999999999876544322 22


Q ss_pred             cccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhH
Q 048517          309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  388 (453)
Q Consensus       309 ~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  388 (453)
                      ....||+.|+|||++.+.  .++.|+|||||||++|||+|++.|+.....       ...+.+.+..+......      
T Consensus       160 ~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~~~~p------  224 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRLYKP------  224 (263)
T ss_dssp             -----CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHHHHTCCCCCC------
T ss_pred             cceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHhcCCCCCc------
Confidence            345789999999999864  789999999999999999996555432221       11133444444333221      


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          389 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       389 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      ...+..+.+++.+||+.||++||||+||+++|+++.
T Consensus       225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            122356889999999999999999999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=379.67  Aligned_cols=240  Identities=27%  Similarity=0.432  Sum_probs=194.9

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ..+++.++||+|+||+||+|++++++.||||+++......++|.+|              ++|++.+ ...++||||+++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~   91 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence            4567788999999999999999989999999998877777888777              5676654 457899999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++....  ...++|..++.|+.||++||.|||++   +|+||||||+|||+++++.+||+|||+|+....... .
T Consensus        92 g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~  165 (272)
T d1qpca_          92 GSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (272)
T ss_dssp             CBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc-c
Confidence            99999874332  24699999999999999999999998   999999999999999999999999999998754432 2


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE  386 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  386 (453)
                      ......||+.|+|||++...  .++.++|||||||++|||+||+.|+.....       ...+...+..+......    
T Consensus       166 ~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~~~~~~~~p----  232 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRP----  232 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCC----
T ss_pred             cccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCCc----
Confidence            23456799999999999764  789999999999999999997666543221       11234455554433322    


Q ss_pred             hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                        ..++..+.+++.+||+.||++||||++|+++|+.
T Consensus       233 --~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         233 --DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence              1234568899999999999999999999999985

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=381.24  Aligned_cols=248  Identities=29%  Similarity=0.448  Sum_probs=186.8

Q ss_pred             HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..+.+.++||+|+||+||+|+++  ..||||+++....   ..++|.+|              +++++.+ ...++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            34567789999999999999865  3599999976432   33556666              5666654 457899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...   ...++|.++..|+.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        85 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          85 CEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             CCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999998543   35699999999999999999999998   99999999999999999999999999998775544


Q ss_pred             CceeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .........||+.|||||++... .+.++.++|||||||++|||+||+.||......       ..+...+.++..... 
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~~p~-  230 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGYLSPD-  230 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTSCCCC-
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCCCc-
Confidence            33344566899999999998643 246899999999999999999999999653321       123333333322111 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                       ........++.+.+++.+||+.||++|||++++++.|+.+.+.
T Consensus       231 -~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         231 -LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence             1112233456788999999999999999999999999876543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-48  Score=376.74  Aligned_cols=246  Identities=28%  Similarity=0.417  Sum_probs=201.7

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      ...+.+.++||+|+||+||+|+.. +|+.||||+++.+....+++.+|              ++++|.++...++||||+
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            345667789999999999999965 68999999998877777888777              678888888999999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++|+|.+++...  ....++|..+..|+.|+++||+|||++   +|+||||||+|||++.++.+||+|||+|+....+..
T Consensus        96 ~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          96 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             TTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            999999998543  346799999999999999999999998   999999999999999999999999999997655433


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                      . ......||+.|+|||++.+.  .++.|+|||||||++|||++|+.|+......       .-+.+.+..+...+..  
T Consensus       171 ~-~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-------~~~~~~i~~~~~~~~~--  238 (287)
T d1opja_         171 T-AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKDYRMERP--  238 (287)
T ss_dssp             E-EETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCCC--
T ss_pred             e-eeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchH-------HHHHHHHhcCCCCCCC--
Confidence            2 33455689999999999864  7899999999999999999987776433221       1234445444333322  


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                          ...+..+.+++.+||+.||++||||+||++.|+...++
T Consensus       239 ----~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         239 ----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             ----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                22345788999999999999999999999999986654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=363.98  Aligned_cols=237  Identities=27%  Similarity=0.438  Sum_probs=199.1

Q ss_pred             hhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCCC
Q 048517          163 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGS  228 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gs  228 (453)
                      +.|.++||+|+||+||+|+.++++.||||+++.+....++|++|              ++|+|.+....++||||+++|+
T Consensus         6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~   85 (258)
T d1k2pa_           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC   85 (258)
T ss_dssp             CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence            45778999999999999999989999999999888888888887              6888888889999999999999


Q ss_pred             hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceee
Q 048517          229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  308 (453)
Q Consensus       229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  308 (453)
                      |..++...   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus        86 l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~  158 (258)
T d1k2pa_          86 LLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS  158 (258)
T ss_dssp             HHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CC
T ss_pred             HHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-ee
Confidence            99987543   35689999999999999999999998   9999999999999999999999999999866544322 23


Q ss_pred             cccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517          309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  387 (453)
Q Consensus       309 ~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  387 (453)
                      ....||+.|+|||.+...  .++.|+|||||||++|||+| |+.||......        .+...+.++.......    
T Consensus       159 ~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~~~~p~----  224 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLYRPH----  224 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCCCCCCT----
T ss_pred             cccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHhCCCCCCcc----
Confidence            456799999999999864  78999999999999999998 78888654321        2444555554433322    


Q ss_pred             HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                        ..++.+.+++.+||+.||++|||++++++.|..
T Consensus       225 --~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         225 --LASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             --TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             --cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence              233578899999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-48  Score=370.64  Aligned_cols=247  Identities=27%  Similarity=0.410  Sum_probs=193.9

Q ss_pred             HHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ...+++.++||+|+||.||+|++++++.||||+++......++|.+|              ++|+|.+ ...++||||++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            34677889999999999999999988899999998877777888877              5677754 45789999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|..++....  ...++|.+++.|+.||+.||+|||+.   +|+||||||+|||+|.++.+||+|||+++....... 
T Consensus        95 ~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          95 KGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            999998886532  24699999999999999999999998   999999999999999999999999999987654332 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      .......||+.|+|||++...  .++.++||||||+++|||++|+.|+......       ..+...+..+...+..   
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~~~i~~~~~~~~~---  236 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPCP---  236 (285)
T ss_dssp             -------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCC---
T ss_pred             eeeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCC---
Confidence            223456799999999999864  8899999999999999999977766543221       1234444444333322   


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                         ...++.+.+++.+||+.||++||||++|+++|+......+
T Consensus       237 ---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         237 ---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ---cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence               2234578899999999999999999999999998766543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-47  Score=372.88  Aligned_cols=239  Identities=27%  Similarity=0.441  Sum_probs=178.9

Q ss_pred             hhcccCccCceEEEEEEEc-CC---cEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          165 FTHKLGQGGFGSVYKGQLH-TG---RLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       165 ~~~~LG~G~fG~Vy~g~~~-~g---~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      +.+.||+|+||+||+|+.. +|   ..||||.+.....  ..++|++|              ++|+|......++||||+
T Consensus        30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~  109 (299)
T d1jpaa_          30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM  109 (299)
T ss_dssp             EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence            3467999999999999964 33   3689999876433  23466666              678888888999999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++|+|.+++..   ....++|.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       110 ~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         110 ENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             TTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             CCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            99999998743   235699999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ce---eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          305 FV---SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       305 ~~---~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ..   ......||+.|||||.+.+.  .++.++|||||||++|||+| |+.||......        .+...+.++....
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~~~  253 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--------DVINAIEQDYRLP  253 (299)
T ss_dssp             ------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCC
T ss_pred             cceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            21   12234589999999999764  88999999999999999998 89998643321        2344454444333


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      ..      ...+..+.+++.+||+.||++||||.||++.|+.++.
T Consensus       254 ~~------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         254 PP------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CC------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            22      1234568899999999999999999999999987654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=373.95  Aligned_cols=244  Identities=25%  Similarity=0.401  Sum_probs=190.9

Q ss_pred             HhhhhhcccCccCceEEEEEEEcC-C-----cEEEEEEecCCC--CCHHHHHHH---------------HhcccccCcce
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHT-G-----RLIAVKMMENSK--FSAEEFINE---------------LLGLCSEGFKR  217 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~-g-----~~VAVK~l~~~~--~~~~~~i~e---------------l~g~~~~~~~~  217 (453)
                      ..+.+.++||+|+||+||+|+... +     ..||||++....  .....+++|               +++++......
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            456677899999999999998542 2     369999986532  223344444               56778888889


Q ss_pred             EEEEEecCCCChhhhhhhccC-------------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCc
Q 048517          218 ALVYEYMPNGSLDRHIFSKEN-------------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH  278 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~  278 (453)
                      ++||||+++|+|.++|.....                   ....++|..++.++.||++||+|||++   +|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            999999999999999965432                   124689999999999999999999998   9999999999


Q ss_pred             ceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCc
Q 048517          279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNA  357 (453)
Q Consensus       279 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~  357 (453)
                      |||++.++.+||+|||+|+...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999877665554444566789999999999864  78999999999999999998 899986533


Q ss_pred             cccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          358 TRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       358 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      ..       ..+.+.+..+...+..      ...+..+.+++.+||+.||++|||++||+++|..
T Consensus       272 ~~-------~~~~~~~~~~~~~~~p------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         272 VD-------ANFYKLIQNGFKMDQP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CS-------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH-------HHHHHHHhcCCCCCCC------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            21       1133444444333322      2234578899999999999999999999999963

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=363.68  Aligned_cols=236  Identities=25%  Similarity=0.304  Sum_probs=183.1

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      |.+.++||+|+||+||+|+. .+|+.||||++.....  ..+++.+|              +++++.+....++||||++
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~   86 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence            56778999999999999996 4799999999876432  22334444              5677778888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++.    ....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+|+........
T Consensus        87 gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          87 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             CCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999883    335799999999999999999999998   9999999999999999999999999999976544333


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                      .......||+.|||||++.+. ...+.++||||+||++|||++|+.||.......       ..............    
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~~~~~~~~~~~----  227 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKTYLN----  227 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-------HHHHHHHTTCTTST----
T ss_pred             ccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-------HHHHHHhcCCCCCC----
Confidence            334556899999999999764 234678999999999999999999997543221       01112222111110    


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       ....++..+.+++.+||+.||++|||++|+++
T Consensus       228 -~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 -PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             11223456788999999999999999999854

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=362.25  Aligned_cols=236  Identities=25%  Similarity=0.413  Sum_probs=188.7

Q ss_pred             hhc-ccCccCceEEEEEEEc---CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          165 FTH-KLGQGGFGSVYKGQLH---TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       165 ~~~-~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      +.+ +||+|+||+||+|.++   ++..||||+++....  ..++|++|              ++|+|.. ...++||||+
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~   90 (285)
T d1u59a_          12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA   90 (285)
T ss_dssp             EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence            345 5999999999999754   456899999976432  23566666              5777754 4578999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      ++|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        91 ~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          91 GGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             TTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            99999998743   335799999999999999999999998   999999999999999999999999999998765433


Q ss_pred             ce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          305 FV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       305 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .. ......||+.|+|||++...  .++.++|||||||++|||+| |+.||......        -+...+.++...+..
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p  234 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMECP  234 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCCCCCC
T ss_pred             ccccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence            22 22345689999999999764  78999999999999999998 89999754321        244555555554432


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                      .      .++..+.+++.+||+.||++||||.+|++.|+..
T Consensus       235 ~------~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         235 P------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             T------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C------cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2      2345788999999999999999999999999854

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=361.55  Aligned_cols=232  Identities=26%  Similarity=0.423  Sum_probs=183.3

Q ss_pred             cccCccCceEEEEEEEc---CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          167 HKLGQGGFGSVYKGQLH---TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      ++||+|+||+||+|.++   .++.||||+++....   ..+++++|              ++|+|.. ...++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999864   356899999976332   23456666              5677754 457899999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++..    ...++|..++.++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999998853    35699999999999999999999998   99999999999999999999999999999775544332


Q ss_pred             -eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          307 -SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       307 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                       ......||+.|+|||.+.+.  .++.++|||||||++|||+| |+.||.....        ..+...+.++...+... 
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~~~~~~p~-  233 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCPA-  233 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCT-
T ss_pred             ccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCc-
Confidence             22345799999999999764  78999999999999999998 8999865332        12445555555443322 


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                           .++..+.+++.+||+.||++|||+++|+++|+.
T Consensus       234 -----~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         234 -----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             -----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                 234578899999999999999999999998874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=369.89  Aligned_cols=246  Identities=27%  Similarity=0.411  Sum_probs=182.5

Q ss_pred             HhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH---------------Hhcccc-cCcc
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCS-EGFK  216 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~-~~~~  216 (453)
                      ..+.+.++||+|+||.||+|+..      +++.||||+++.....  .++++.|               +++++. .+..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            45677899999999999999853      3578999999764322  2334333               233333 3456


Q ss_pred             eEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC
Q 048517          217 RALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  284 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~  284 (453)
                      .++||||+++|+|.+++.....            ....++|.++..++.||++||+|||++   +|+||||||+|||++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence            7899999999999999965432            134689999999999999999999998   9999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC-CCCCCCccccccc
Q 048517          285 NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATRSSKA  363 (453)
Q Consensus       285 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~-~p~~~~~~~~~~~  363 (453)
                      ++.+||+|||+|+...............||+.|+|||.+.+.  .++.++|||||||++|||++|. .||.....     
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-----  242 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----  242 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-----
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCH-----
Confidence            999999999999877655444444566799999999999864  7899999999999999999975 46643321     


Q ss_pred             cchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          364 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       364 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                        ...+...+.++.......      ..+..+.+++.+||+.||++|||++|++++|+.++
T Consensus       243 --~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         243 --DEEFCRRLKEGTRMRAPD------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             --SHHHHHHHHHTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHHHhcCCCCCCCc------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              123445555555443322      23456889999999999999999999999998754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=367.78  Aligned_cols=243  Identities=29%  Similarity=0.438  Sum_probs=184.0

Q ss_pred             hhhhhcccCccCceEEEEEEEcCC-----cEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTG-----RLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g-----~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      .+.+.+.||+|+||+||+|.+++.     ..||||++......  ..+|++|              ++|+|.+....++|
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v   87 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII   87 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence            345668899999999999986532     47999999764332  3456666              67888888899999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+.+|++.+.+...   ...++|.+++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        88 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          88 TEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999998877432   35799999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          301 KENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       301 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ..... .......||+.|||||++.+.  .++.++|||||||++|||++|+.|+......       .-+.+.+.++...
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~~  232 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRL  232 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC
T ss_pred             CCCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhccCCC
Confidence            43221 122345689999999999764  8899999999999999999977665432211       1244455555443


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      +...      ..+..+.+++.+||+.||++||||+||+++|+++++
T Consensus       233 ~~~~------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         233 PTPM------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             CCCT------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCch------hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            3221      234568899999999999999999999999987654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=365.02  Aligned_cols=239  Identities=21%  Similarity=0.301  Sum_probs=176.7

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH---HHHHHH--------------Hhccccc--CcceEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSE--GFKRALVY  221 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~--~~~~~lv~  221 (453)
                      .|++.+.||+|+||+||+|+. .+|+.||||++.......   +.+.+|              +++++.+  ....++||
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence            356778999999999999985 579999999998754433   345555              4555533  45578999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC--CCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||+++|+|.+++.........+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            999999999998654444568999999999999999999999852  135999999999999999999999999999987


Q ss_pred             CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      .....  ......||+.|||||++.+.  .++.++|||||||++|||++|+.||.....        ..+...+..+...
T Consensus       165 ~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~~~~  232 (269)
T d2java1         165 NHDTS--FAKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGKFR  232 (269)
T ss_dssp             -------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCC
T ss_pred             ccCCC--ccccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            54432  22456799999999999764  789999999999999999999999964322        1234444444332


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+.      ..+++.+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~------~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 RIP------YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            221      224457889999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=357.79  Aligned_cols=228  Identities=24%  Similarity=0.390  Sum_probs=185.7

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |.+.+.||+|+||+||+|+.. +|+.||||++...    ....+.+.+|              +++++.++...++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            567789999999999999964 7899999998642    2234445444              67778888889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...    ..+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        88 ~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          88 APLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             cCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            9999999998532    4689999999999999999999998   99999999999999999999999999998665432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                          .....||+.|||||++.+.  .++.++|||||||++|||++|+.||.....        ......+.+.... .  
T Consensus       161 ----~~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~-~--  223 (263)
T d2j4za1         161 ----RTTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVEFT-F--  223 (263)
T ss_dssp             ----CEETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCCC-C--
T ss_pred             ----ccccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCC-C--
Confidence                2346799999999999874  689999999999999999999999965432        1133333333221 1  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          +..+++.+.+++.+||+.||++|||++|+++
T Consensus       224 ----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 ----PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                1224467889999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-46  Score=360.72  Aligned_cols=233  Identities=26%  Similarity=0.358  Sum_probs=186.3

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .|.+.++||+|+||+||+|+. .+|+.||||++..... ..+.+.+|              +++++......++||||++
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            467778999999999999994 5799999999876433 34455555              5677778888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++..     ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....... 
T Consensus       101 gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            9999987632     3589999999999999999999998   999999999999999999999999999997654432 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                       ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......       .......... ...+.   
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~-~~~~~---  237 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNG-TPELQ---  237 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHC-SCCCS---
T ss_pred             -cccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCC-CCCCC---
Confidence             22456799999999999864  7899999999999999999999999643321       1122222222 11111   


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       .+..++..+.+++.+||+.||++|||+.|+++
T Consensus       238 -~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             22334567889999999999999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-46  Score=365.02  Aligned_cols=245  Identities=26%  Similarity=0.403  Sum_probs=192.3

Q ss_pred             hhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      .+++.++||+|+||+||+|+.+      +++.||||+++.....  .++|.+|              ++++|......++
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~   93 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL   93 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence            3556789999999999999864      4578999999764332  3456665              5677788888999


Q ss_pred             EEEecCCCChhhhhhhccC--------------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcc
Q 048517          220 VYEYMPNGSLDRHIFSKEN--------------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHN  279 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N  279 (453)
                      +|||+++|+|.+++.....                    ....++|..++.|+.|++.||+|||+.   +|+||||||+|
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N  170 (301)
T d1lufa_          94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN  170 (301)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence            9999999999999864321                    123589999999999999999999998   99999999999


Q ss_pred             eEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC-CCCCCCcc
Q 048517          280 ILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNAT  358 (453)
Q Consensus       280 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~-~p~~~~~~  358 (453)
                      ||+|.++.+||+|||+|+...........+...||+.|+|||.+.+.  .++.|+|||||||++|||++|. +|+.....
T Consensus       171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999876554443344556789999999999874  7999999999999999999986 45543322


Q ss_pred             ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      .        -+...+.++......      ..++..+.+++.+||+.+|++||||.||+++|+++.+
T Consensus       249 ~--------e~~~~v~~~~~~~~p------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         249 E--------EVIYYVRDGNILACP------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             H--------HHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             H--------HHHHHHHcCCCCCCC------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1        133445554443322      2233568899999999999999999999999998754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-46  Score=355.20  Aligned_cols=231  Identities=24%  Similarity=0.360  Sum_probs=178.6

Q ss_pred             hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------Hhccccc----CcceEEEE
Q 048517          164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSE----GFKRALVY  221 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~----~~~~~lv~  221 (453)
                      +|.++||+|+||+||+|+.. +++.||||++......   .+++.+|              +++++..    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56778999999999999964 7899999998764433   2345555              3444432    34578999


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-CCCceEEEecCCccccC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~~~  300 (453)
                      ||+++|+|.+++...    ..+++..+..++.||++||+|||++ .++|+||||||+|||++ .++.+||+|||+|+...
T Consensus        92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            999999999998533    4689999999999999999999997 12399999999999996 57899999999998654


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ...    .....||+.|||||++.+   .++.++|||||||++|||++|+.||.....       ...+...+..+....
T Consensus       167 ~~~----~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~i~~~~~~~  232 (270)
T d1t4ha_         167 ASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPA  232 (270)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCCG
T ss_pred             CCc----cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHHHHHcCCCCc
Confidence            432    234679999999999864   689999999999999999999999964321       112344444432211


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           ..+...++.+.+++.+||+.||++|||++|+++
T Consensus       233 -----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 112223456889999999999999999999976

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-46  Score=359.35  Aligned_cols=237  Identities=23%  Similarity=0.310  Sum_probs=185.8

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC-CCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK-FSAEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~-~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .|++.++||+|+||+||+|+. .+|+.||||++.... ...+++.+|              +++++......++||||++
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            356678999999999999995 479999999997643 223344444              6777788888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      +|+|.+++...   ...+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+....... 
T Consensus        93 ~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          93 GGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             TEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            99999987543   35699999999999999999999998   999999999999999999999999999975432211 


Q ss_pred             eeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          306 VSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                       ......||+.|+|||++...   ...++.++|||||||++|||++|+.||.......        +...+..+....+.
T Consensus       166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i~~~~~~~~~  236 (288)
T d2jfla1         166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKSEPPTLA  236 (288)
T ss_dssp             -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHHHHSCCCCCS
T ss_pred             -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCCCC
Confidence             22456799999999998532   2367899999999999999999999996543221        22333333322211


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                          .+..++..+.+++.+||+.||++|||++|+++
T Consensus       237 ----~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 ----QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                12234567889999999999999999999865

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=356.63  Aligned_cols=256  Identities=23%  Similarity=0.268  Sum_probs=186.5

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCc----ceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGF----KRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~----~~~lv~E~  223 (453)
                      ++.+.++||+|+||.||+|+++ |+.||||++.........+..|              ++++|....    ..++||||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            4456789999999999999975 8999999997643322222223              455554332    57899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC-----CCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG-----CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      |++|+|.+++..     ..++|..++.++.|+|.||+|||+.     .+++|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999953     3589999999999999999999974     235999999999999999999999999999997


Q ss_pred             cCCCCCce--eecccCCCCCccChhhhcccC----CCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccc
Q 048517          299 HPKENDFV--SISDTRGTIGYLAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYF  365 (453)
Q Consensus       299 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~  365 (453)
                      ........  ......||++|+|||++....    ..++.|+|||||||+||||+||..|+.........       ...
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            75543322  223467999999999987531    13677999999999999999999887543322110       111


Q ss_pred             hHHHHHHhhh-CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          366 PSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       366 ~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      .....+.+.. ..+..+... ....+....+.+++.+||+.||++|||+.||+++|+.+.
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGG-GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcc-cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1222222222 222222221 123345567899999999999999999999999998643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-46  Score=357.88  Aligned_cols=233  Identities=23%  Similarity=0.313  Sum_probs=183.6

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|.+.+.||+|+||+||+|+. .+|+.||||++...    ....+.+.+|              +++++.+....++|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            467889999999999999996 57999999998642    2233445444              5667778888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        89 y~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          89 YAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999987533    4699999999999999999999998   9999999999999999999999999999987554


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..........||+.|+|||++.+.  .++.++||||+||++|||++|+.||.....        ..+...+.++.. .. 
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~-~~-  229 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLEY-DF-  229 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTCC-CC-
T ss_pred             CcccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcCCC-CC-
Confidence            433334556799999999999864  789999999999999999999999975432        123334433321 11 


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           +..++..+.+++.+||+.||++|||++|+++
T Consensus       230 -----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 -----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                 1224466889999999999999999998743

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-45  Score=358.57  Aligned_cols=231  Identities=24%  Similarity=0.318  Sum_probs=183.6

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|...++||+|+||+||+|+. .+|+.||||++.......    +++.+|              +++++......++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            456678999999999999995 579999999998754433    234555              5677777888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|..++..    ...+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        96 ~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          96 YCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             CCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            9999999766532    35799999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCceeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                            ....||+.|||||++.+. .+.++.++|||||||++|||++|+.||......        .....+..+....+
T Consensus       169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~  234 (309)
T d1u5ra_         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPAL  234 (309)
T ss_dssp             ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCC
T ss_pred             ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCCC
Confidence                  345799999999998642 346899999999999999999999999643221        12222333322222


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..     ..+++.+.+++.+||+.||++|||++|+++
T Consensus       235 ~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 QS-----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             SC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC-----CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            11     123457889999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=359.30  Aligned_cols=239  Identities=25%  Similarity=0.416  Sum_probs=185.5

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCc----EEEEEEecCC--CCCHHHHHHH--------------HhcccccCcceEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGR----LIAVKMMENS--KFSAEEFINE--------------LLGLCSEGFKRALVY  221 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~----~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~~~~~lv~  221 (453)
                      |++.++||+|+||+||+|+.. +|+    +||||.++..  ....+++.+|              ++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            567789999999999999854 454    6899988753  3345667666              56777654 567889


Q ss_pred             EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517          222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  301 (453)
                      ||+.+|+|.+++...   ...+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        90 e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          90 QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             ECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            999999999887543   46799999999999999999999998   999999999999999999999999999998765


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ...........||+.|+|||++.+.  .++.++|||||||++|||+| |+.||.......        +...+.++....
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~~  233 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERLP  233 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------HHHHHHHTCCCC
T ss_pred             ccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCC
Confidence            5544334456799999999999864  78999999999999999998 788876543221        445555555443


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                      ..      ...+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus       234 ~p------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         234 QP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             CC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            22      123456889999999999999999999999987653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-46  Score=364.82  Aligned_cols=245  Identities=22%  Similarity=0.312  Sum_probs=182.0

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..|.+.++||+|+||+||+|+. .+|+.||||+++....  ..+++.+|              +++++.+....++||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3466678999999999999995 4799999999976432  24556666              56777788889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...    ..+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+|+......
T Consensus        86 ~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          86 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             CTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             CCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            9999999998543    4689999999999999999999963  179999999999999999999999999998654322


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH-------------
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-------------  370 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------------  370 (453)
                          .....||+.|+|||++.+.  .++.++||||+||+++||++|+.||........+........             
T Consensus       160 ----~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         160 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             ----C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             ----cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence                2345799999999999874  799999999999999999999999975433211000000000             


Q ss_pred             -HHhhh---CCCccccchhh-------------hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          371 -DQLNK---GGDLELRNVTE-------------IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       371 -~~l~~---~~~~~~~~~~~-------------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                       .....   ...... ...+             .....+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------CCC-CHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccch-hHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence             00000   000000 0000             00112456889999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=357.99  Aligned_cols=246  Identities=26%  Similarity=0.400  Sum_probs=190.6

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCc--EEEEEEecCC--CCCHHHHHHH---------------HhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGR--LIAVKMMENS--KFSAEEFINE---------------LLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~--~VAVK~l~~~--~~~~~~~i~e---------------l~g~~~~~~~~~lv  220 (453)
                      ..+++.++||+|+||+||+|+++ +|.  .||||++...  ....+++.+|               ++|+|.++...++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            34566789999999999999965 454  4788887642  2233456565               56777778889999


Q ss_pred             EEecCCCChhhhhhhc------------cCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCce
Q 048517          221 YEYMPNGSLDRHIFSK------------ENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP  288 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~  288 (453)
                      |||+++|+|.++|+..            ......++|..+..++.||++||.|||+.   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999998643            12356799999999999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCC-CCCCCccccccccchH
Q 048517          289 KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPS  367 (453)
Q Consensus       289 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~-p~~~~~~~~~~~~~~~  367 (453)
                      ||+|||+++.......   .....||..|+|||.+...  .++.++|||||||++|||++|.. |+....        ..
T Consensus       167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~  233 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CA  233 (309)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HH
T ss_pred             EEcccccccccccccc---ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCC--------HH
Confidence            9999999986543221   2345689999999999764  78999999999999999999765 454322        12


Q ss_pred             HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517          368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  428 (453)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~  428 (453)
                      .+.+.+.++...+..      ..++..+.+++.+||+.||++||||+||++.|++++++.+
T Consensus       234 ~~~~~i~~~~~~~~~------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         234 ELYEKLPQGYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             HHHHHGGGTCCCCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHHHHHHhcCCCCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            244555555443322      2234578899999999999999999999999998876544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-45  Score=354.15  Aligned_cols=245  Identities=24%  Similarity=0.393  Sum_probs=190.4

Q ss_pred             HhhhhhcccCccCceEEEEEEEcC--------CcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCc
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLHT--------GRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGF  215 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~~--------g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~  215 (453)
                      ..+.+.++||+|+||.||+|+...        +..||||+++.....  ..++..|               ++++|.+..
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            356677899999999999998532        347999999764432  2344444               577888888


Q ss_pred             ceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517          216 KRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD  283 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~  283 (453)
                      ..++||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+.   +|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence            89999999999999999965432            235689999999999999999999998   999999999999999


Q ss_pred             CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccc
Q 048517          284 HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSK  362 (453)
Q Consensus       284 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~  362 (453)
                      .++.+||+|||+++...............||+.|+|||.+.+.  .++.|+||||||+++|||++ |+.||.....    
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----  243 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----  243 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence            9999999999999977655444444556799999999999864  89999999999999999998 6777753322    


Q ss_pred             ccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517          363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  424 (453)
Q Consensus       363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~  424 (453)
                          ..+.+.+..+.......      ..+..+.+++.+||+.||++|||+.||+++|++++
T Consensus       244 ----~~~~~~i~~~~~~~~p~------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 ----EELFKLLKEGHRMDKPS------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ----HHHHHHHHTTCCCCCCS------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHHHHcCCCCCCCc------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                22445555554443322      23456889999999999999999999999998753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-45  Score=358.06  Aligned_cols=235  Identities=22%  Similarity=0.294  Sum_probs=172.5

Q ss_pred             HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      ..|++.+.||+|+||+||+|+.. +|+.||||++......  ...+.+|              +++++.++...++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45778899999999999999964 7999999998763321  2223333              57777888889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc---CCCceEEEecCCccccC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGla~~~~  300 (453)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||+.   +++.+||+|||+|+...
T Consensus        89 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          89 VSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             cCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999843    35799999999999999999999998   999999999999994   57899999999998764


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ....   .....||+.|||||++.+.  .++.++||||+||++|||++|+.||......        .....+..+....
T Consensus       162 ~~~~---~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~~~  228 (307)
T d1a06a_         162 PGSV---LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAEYEF  228 (307)
T ss_dssp             --------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTCCCC
T ss_pred             CCCe---eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccCCCC
Confidence            4332   2446799999999999864  7899999999999999999999999653321        1233333322211


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .   ......++..+.+++.+||+.||++|||++|+++
T Consensus       229 ~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 D---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             C---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C---CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1   1122234567889999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=357.54  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=196.1

Q ss_pred             HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCCH--HHHHHH--------------HhcccccCcce
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSA--EEFINE--------------LLGLCSEGFKR  217 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~~--~~~i~e--------------l~g~~~~~~~~  217 (453)
                      ...+++.++||+|+||+||+|.++      +++.||||+++......  ..+.+|              ++++|......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            345567789999999999999863      36789999997643322  345566              57778888889


Q ss_pred             EEEEEecCCCChhhhhhhcc------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517          218 ALVYEYMPNGSLDRHIFSKE------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  291 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  291 (453)
                      ++||||+++|+|.+++....      .....++|..+..++.|+++||.|||++   +|+||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence            99999999999999986432      1224578999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC-CCCCCCccccccccchHHHH
Q 048517          292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATRSSKAYFPSWVY  370 (453)
Q Consensus       292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~  370 (453)
                      |||+++...............||+.|+|||.+.+.  .++.++||||||+++|||+||+ .|+.....        ..+.
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------~~~~  245 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVL  245 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence            99999876554443334455689999999999874  7889999999999999999986 55543221        1134


Q ss_pred             HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ..+.++...+...      ..+..+.+++.+||+.+|++||||++|+++|++.+++
T Consensus       246 ~~i~~~~~~~~p~------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         246 RFVMEGGLLDKPD------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             HHHHTTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHhCCCCCCcc------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            4455554433322      2345799999999999999999999999999987664

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=358.46  Aligned_cols=249  Identities=26%  Similarity=0.415  Sum_probs=196.5

Q ss_pred             HHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcc
Q 048517          160 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFK  216 (453)
Q Consensus       160 ~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~  216 (453)
                      ...+.+.++||+|+||.||+|++      .+++.||||+++.....  ..++++|               ++++|.....
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            34667889999999999999985      24678999999864432  2345444               5778888888


Q ss_pred             eEEEEEecCCCChhhhhhhccC--------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE
Q 048517          217 RALVYEYMPNGSLDRHIFSKEN--------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL  282 (453)
Q Consensus       217 ~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl  282 (453)
                      .++||||+++|+|.+++.....              ....+++..+..++.||++||+|||++   +|+||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence            9999999999999999865432              234689999999999999999999998   99999999999999


Q ss_pred             cCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc
Q 048517          283 DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK  362 (453)
Q Consensus       283 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~  362 (453)
                      +.++.+|++|||+++...............||+.|+|||.+.+.  .++.++|||||||++|||+|++.|+......   
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~---  253 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPV---  253 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCCCH---
Confidence            99999999999999987766555555667899999999999764  7899999999999999999955554322211   


Q ss_pred             ccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                         ...+.+.+..+......      ...+..+.+++.+||+.||++||||++|+++|++.+.
T Consensus       254 ---~~~~~~~i~~~~~~~~~------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         254 ---DSKFYKMIKEGFRMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             ---SHHHHHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHhcCCCCCCc------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence               11133344444433322      1234568999999999999999999999999987544

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-45  Score=348.04  Aligned_cols=234  Identities=29%  Similarity=0.444  Sum_probs=180.3

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------Hhccccc-CcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSE-GFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~-~~~~~lv~E~~~~  226 (453)
                      .+.+.++||+|+||.||+|+++ |+.||||+++.+. ..+++.+|              ++|+|.+ ....++||||+++
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~   85 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   85 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence            3457789999999999999986 7899999997653 34556665              5777744 4567999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  306 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  306 (453)
                      |+|.+++....  ...++|..++.|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        86 g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          86 GSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             EEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence            99999996432  24589999999999999999999998   99999999999999999999999999998654322   


Q ss_pred             eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517          307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT  385 (453)
Q Consensus       307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  385 (453)
                        ....+|+.|+|||++.+.  .++.++||||||+++|||+| |+.|+......        .+...+..+...+...  
T Consensus       158 --~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--------~~~~~i~~~~~~~~~~--  223 (262)
T d1byga_         158 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMDAPD--  223 (262)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------GHHHHHTTTCCCCCCT--
T ss_pred             --ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCCCCc--
Confidence              345689999999999864  78999999999999999998 67766543222        1444455544433322  


Q ss_pred             hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517          386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  423 (453)
Q Consensus       386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~  423 (453)
                          ..+..+.+++.+||+.||++||||.+++++|+.+
T Consensus       224 ----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         224 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                2335688999999999999999999999999853

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-45  Score=356.94  Aligned_cols=244  Identities=26%  Similarity=0.390  Sum_probs=188.0

Q ss_pred             hhhhhcccCccCceEEEEEEEcCC----cEEEEEEecCCCC--CHHHHHHH--------------Hhccccc-CcceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTG----RLIAVKMMENSKF--SAEEFINE--------------LLGLCSE-GFKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g----~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~-~~~~~lv  220 (453)
                      +.+|.++||+|+||+||+|++.++    ..||||+++....  ..++|.+|              ++|+|.+ +...++|
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            335677899999999999996532    3699999975322  23556666              5677654 4578999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++..   ....+++..++.++.|+++||.|||+.   +|+||||||+|||+++++.+||+|||+++...
T Consensus       108 ~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            999999999998853   335678889999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCce--eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517          301 KENDFV--SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  378 (453)
Q Consensus       301 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~  378 (453)
                      ......  ......||+.|+|||.+...  .++.++||||||+++|||++|+.|+.......   .    +...+..+..
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~----~~~~i~~g~~  252 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---D----ITVYLLQGRR  252 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCC
T ss_pred             ccccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---H----HHHHHHcCCC
Confidence            433221  22345789999999998864  78999999999999999999888876433211   1    2233344433


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                      ....      ...+..+.+++.+||+.||++||||.||++.|++++..
T Consensus       253 ~~~p------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 LLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCc------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            3221      12335688999999999999999999999999987665

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=353.10  Aligned_cols=241  Identities=23%  Similarity=0.352  Sum_probs=180.1

Q ss_pred             HhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALV  220 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv  220 (453)
                      ..+++.+.||+|+||.||+|+..    .+..||||.++.....  .+.+.+|              +++++.+ ...++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence            45677899999999999999864    2457999998764332  3445555              5677754 568999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++...   ...+++..++.++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+|+...
T Consensus        86 ~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          86 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999887432   35789999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  379 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~  379 (453)
                      ..... ......||+.|+|||.+.+.  .++.++|||||||++|||++ |++|+......        .+...+..+...
T Consensus       160 ~~~~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~i~~~~~~  228 (273)
T d1mp8a_         160 DSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGERL  228 (273)
T ss_dssp             ------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCCC
T ss_pred             CCcce-eccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            43322 23455689999999999864  78999999999999999998 78888654332        144455555443


Q ss_pred             cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517          380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  425 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~  425 (453)
                      +..      ..++..+.+++.+||+.||++|||+.||++.|+.+++
T Consensus       229 ~~~------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         229 PMP------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            322      2234678899999999999999999999999987543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.3e-44  Score=358.06  Aligned_cols=236  Identities=20%  Similarity=0.261  Sum_probs=187.3

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .|.+.++||+|+||.||+|+. .+|+.||||++...... .+.+.+|              +++++.+....++|||||+
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            577889999999999999995 57999999999765433 2333344              5677788889999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc--CCCceEEEecCCccccCCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~--~~~~~kl~DFGla~~~~~~~  303 (453)
                      +|+|.+++..   ....+++..+..|+.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+|+......
T Consensus       107 gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         107 GGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             SCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999998843   235699999999999999999999998   999999999999995  46789999999999775543


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   .....||+.|||||++.+.  .++.++||||+||++|||++|+.||......        .....+........  
T Consensus       181 ~---~~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~--  245 (350)
T d1koaa2         181 S---VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDWNMD--  245 (350)
T ss_dssp             C---EEEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCSC--
T ss_pred             c---cceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCC--
Confidence            2   2446799999999999864  7889999999999999999999999644321        12333333221111  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                       ......+++.+.+++.+||+.||++|||++|+++.
T Consensus       246 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 -DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             11222345678899999999999999999999883

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-44  Score=347.71  Aligned_cols=235  Identities=23%  Similarity=0.264  Sum_probs=187.8

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC-------CHHHHHHH--------------HhcccccCcceE
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-------SAEEFINE--------------LLGLCSEGFKRA  218 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-------~~~~~i~e--------------l~g~~~~~~~~~  218 (453)
                      ..|++.++||+|+||+||+|+. .+|+.||||++.....       ..+.+.+|              +++++.+....+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3577889999999999999996 5799999999865321       23455555              577788888999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC----ceEEEecC
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSDFG  294 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFG  294 (453)
                      +||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++    .+|++|||
T Consensus        90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            999999999999998543    4699999999999999999999998   999999999999998766    59999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      +|+.......   .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        .....+.
T Consensus       163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~  229 (293)
T d1jksa_         163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVS  229 (293)
T ss_dssp             TCEECTTSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred             hhhhcCCCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHHHHH
Confidence            9987654432   2456799999999999864  7899999999999999999999999754321        1233333


Q ss_pred             hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .....   ........++..+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         230 AVNYE---FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TTCCC---CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hcCCC---CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            32211   111223345567889999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.8e-44  Score=356.00  Aligned_cols=240  Identities=21%  Similarity=0.281  Sum_probs=189.4

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      .|++.++||+|+||+||+|+. .+|+.||||++...... .+.+.+|              +++++.++...++||||++
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  109 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  109 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            467789999999999999995 57999999998764432 2334444              5677778888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc--CCCceEEEecCCccccCCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~--~~~~~kl~DFGla~~~~~~~  303 (453)
                      +|+|.+++.   .....+++.++..|+.||+.||+|||+.   +|+||||||+|||++  .++.+||+|||+|+......
T Consensus       110 gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         110 GGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            999988763   2335699999999999999999999998   999999999999998  57899999999999876544


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .   .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        .....+..+.....  
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~~~--  248 (352)
T d1koba_         184 I---VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCDWEFD--  248 (352)
T ss_dssp             C---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCCCCCC--
T ss_pred             c---eeeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCC--
Confidence            2   2446799999999999864  7899999999999999999999999654321        12333333321111  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhCC
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGS  423 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~~  423 (453)
                       ......++..+.+++.+||+.||++|||+.|+++.  +++.
T Consensus       249 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence             11122345678899999999999999999999873  5543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-44  Score=343.10  Aligned_cols=238  Identities=26%  Similarity=0.416  Sum_probs=176.5

Q ss_pred             hhhhhcccCccCceEEEEEEEc--CC--cEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH--TG--RLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRAL  219 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~--~g--~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~l  219 (453)
                      .+++.++||+|+||.||+|+++  ++  ..||||+++....    ..++|.+|              ++|+|.+ ...++
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l   87 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM   87 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence            3567789999999999999854  23  3789999876322    23456665              5677755 46789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ||||+++|++.+++....   ..+++..++.++.|+++||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence            999999999998875432   4699999999999999999999998   9999999999999999999999999999987


Q ss_pred             CCCCCcee-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh-hhC
Q 048517          300 PKENDFVS-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL-NKG  376 (453)
Q Consensus       300 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l-~~~  376 (453)
                      ........ .....||..|+|||.+.+.  .++.++||||||+++|||+| |+.||......       . +...+ ..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-------~-~~~~i~~~~  231 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------Q-ILHKIDKEG  231 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H-HHHHHHTSC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------H-HHHHHHhCC
Confidence            65543322 2344678899999999874  78999999999999999998 89998643321       1 22233 333


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  422 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~  422 (453)
                      ...+..      ..++..+.+++.+||+.||++||||.+|+++|+.
T Consensus       232 ~~~~~~------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         232 ERLPRP------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             CCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCc------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            232221      2234568899999999999999999999999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-44  Score=351.15  Aligned_cols=240  Identities=22%  Similarity=0.268  Sum_probs=181.0

Q ss_pred             hhhhhc-ccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHH--HH---------Hhccccc----CcceEEEEEec
Q 048517          162 TNHFTH-KLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFI--NE---------LLGLCSE----GFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~-~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i--~e---------l~g~~~~----~~~~~lv~E~~  224 (453)
                      .|.+.+ .||+|+||+||+|+. .+|+.||||+++.......+..  ..         +++++..    +...++|||||
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~   91 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   91 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence            355544 599999999999995 5799999999976543333321  11         3444432    45679999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEecCCccccCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPK  301 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~~~~~  301 (453)
                      ++|+|.+++...  ....+++.++..|+.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||+|+....
T Consensus        92 ~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          92 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             CSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence            999999998532  235799999999999999999999998   9999999999999975   56799999999987655


Q ss_pred             CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517          302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  381 (453)
Q Consensus       302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  381 (453)
                      ...   .....||+.|||||++.+.  .++.++||||+||++|||+||+.||.........    ..+...+..   ...
T Consensus       167 ~~~---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~----~~~~~~i~~---~~~  234 (335)
T d2ozaa1         167 HNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRM---GQY  234 (335)
T ss_dssp             CCC---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCS---CSS
T ss_pred             CCc---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH----HHHHHHHhc---CCC
Confidence            432   2456799999999999864  7899999999999999999999999654322110    001111111   111


Q ss_pred             cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .........+++.+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1112233456678999999999999999999999988

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=346.84  Aligned_cols=230  Identities=25%  Similarity=0.334  Sum_probs=185.6

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |.+.+.||+|+||.||+|+. .+|+.||||++.+.    ....+.+++|              +++.+.+....++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            56778999999999999995 58999999999752    2334555555              56677788889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        87 ~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          87 ANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             CTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             cCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            9999999988543    4688999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                      .  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        .+...+..+.. ..  
T Consensus       160 ~--~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--------~~~~~i~~~~~-~~--  224 (337)
T d1o6la_         160 A--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEEI-RF--  224 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC-CC--
T ss_pred             c--ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCHH--------HHHHHHhcCCC-CC--
Confidence            2  23456799999999999874  7899999999999999999999999754421        13333333322 11  


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                          +..++..+.+++.+||+.||++||+     ++|+++
T Consensus       225 ----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                1224456888999999999999995     788876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-43  Score=353.03  Aligned_cols=232  Identities=24%  Similarity=0.337  Sum_probs=180.0

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH-----------------HhcccccCcceEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE-----------------LLGLCSEGFKRALV  220 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e-----------------l~g~~~~~~~~~lv  220 (453)
                      |.+.+.||+|+||.||+|+.. +|+.||||++....    .....+..|                 +++++......++|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            566789999999999999954 79999999986421    122222221                 45566777889999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        86 mE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             ECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999998533    4688999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517          301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  380 (453)
Q Consensus       301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~  380 (453)
                      ...    .....||+.|+|||++... ..++.++||||+||++|||++|+.||........     ..+...... ....
T Consensus       159 ~~~----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~~~-~~~~  227 (364)
T d1omwa3         159 KKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLT-MAVE  227 (364)
T ss_dssp             SSC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHHSSS-CCCC
T ss_pred             CCc----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhccc-CCCC
Confidence            443    2456799999999999643 3688999999999999999999999976433210     111111111 1111


Q ss_pred             ccchhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                            .+..++..+.+++.+||+.||++|||     ++|+++
T Consensus       228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         228 ------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                  11223456889999999999999999     688875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.5e-43  Score=339.63  Aligned_cols=236  Identities=22%  Similarity=0.227  Sum_probs=186.3

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---H-------HHHHHH---------------HhcccccCc
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---A-------EEFINE---------------LLGLCSEGF  215 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~-------~~~i~e---------------l~g~~~~~~  215 (453)
                      .|.+.++||+|+||+||+|+. .+|+.||||++......   .       +.+.+|               +++++.++.
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            356778999999999999995 57999999999764321   1       123333               456677888


Q ss_pred             ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517          216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  295 (453)
Q Consensus       216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  295 (453)
                      ..++||||+++|+|.+++...    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            899999999999999999532    4699999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhccc----CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  371 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  371 (453)
                      ++.......   .....||+.|+|||.+.+.    ...++.++||||+||+++||++|+.||.....        .....
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~  225 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLR  225 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH
T ss_pred             eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHH
Confidence            997755332   2456799999999998642    23568899999999999999999999975432        22333


Q ss_pred             HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .+..+.....   ......+++.+.+++.+||+.||++|||+.|+++
T Consensus       226 ~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         226 MIMSGNYQFG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHTCCCCC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhCCCCCC---CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            4433322111   1122235567899999999999999999999865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4e-43  Score=342.81  Aligned_cols=227  Identities=26%  Similarity=0.352  Sum_probs=183.2

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      |++.++||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|              +++++......++||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            56778999999999999996 57999999998642    2234445444              56677788889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +++|+|...+..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        86 ~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_          86 IEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             CCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             cCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence            999999888743    35678899999999999999999998   99999999999999999999999999999765432


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN  383 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  383 (453)
                           ....||+.|||||++.+.  .++.++||||+||++|||++|+.||......        .+...+..+....   
T Consensus       159 -----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~~~~---  220 (316)
T d1fota_         159 -----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAELRF---  220 (316)
T ss_dssp             -----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCCCCC---
T ss_pred             -----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCHH--------HHHHHHHcCCCCC---
Confidence                 356799999999999764  7899999999999999999999999754321        1333333332211   


Q ss_pred             hhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          384 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                          +..++..+.+++.+||+.||.+||     |++++++
T Consensus       221 ----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         221 ----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                112345688999999999999996     8999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.9e-44  Score=342.59  Aligned_cols=243  Identities=21%  Similarity=0.293  Sum_probs=179.6

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccC----cce
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEG----FKR  217 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~----~~~  217 (453)
                      ..|.+.+.||+|+||+||+|+. .+|+.||||+++.....    .+++.+|              +++++...    ...
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            3577889999999999999995 57999999999864432    2345555              23333222    236


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||+++|+|.+++...    ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++..+++|||.++
T Consensus        87 ~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            8999999999999887433    4699999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517          298 FHPKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  376 (453)
Q Consensus       298 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~  376 (453)
                      ....... ........||+.|+|||++.+.  .++.++||||+||++|||+||+.||......       ......+...
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~  230 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVRED  230 (277)
T ss_dssp             ECC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcC
Confidence            6543322 1223456799999999999764  7899999999999999999999999643321       1223333332


Q ss_pred             CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhCC
Q 048517          377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGS  423 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~Le~~  423 (453)
                      ....    ......++..+.+++.+||+.||++|| |++++++.|.+.
T Consensus       231 ~~~~----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         231 PIPP----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             CCCG----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCC----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            2211    112223456788999999999999999 899999988753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=346.56  Aligned_cols=230  Identities=23%  Similarity=0.334  Sum_probs=184.6

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCC----CCCHHHHHHH---------------HhcccccCcceEEEEE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENS----KFSAEEFINE---------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~----~~~~~~~i~e---------------l~g~~~~~~~~~lv~E  222 (453)
                      |.+.++||+|+||+||+|+.. +|+.||||++.+.    ....+.++.|               +++.+.++...++|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            567899999999999999954 7999999999642    2233333333               5667778888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+++|+|.+++...    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 y~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          84 YLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             ecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999998533    4688999999999999999999998   9999999999999999999999999999865443


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      ..  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        .+...+..+...   
T Consensus       157 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~~---  221 (320)
T d1xjda_         157 DA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNPF---  221 (320)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC---
T ss_pred             cc--cccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCC---
Confidence            32  23456799999999999864  7899999999999999999999999754321        233444433221   


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMT-KVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl~  418 (453)
                          .+..++..+.+++.+||+.||++|||+. ++++
T Consensus       222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                1122346688999999999999999995 6753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-43  Score=343.77  Aligned_cols=241  Identities=17%  Similarity=0.209  Sum_probs=190.4

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN  226 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~  226 (453)
                      .|.+.++||+|+||+||+|... +|+.||||+++........+.+|              +++++.+....++||||+++
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence            4677889999999999999964 78999999998765444444444              56677788889999999999


Q ss_pred             CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC--CCceEEEecCCccccCCCCC
Q 048517          227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~~  304 (453)
                      |+|.+++..   .+..+++.++..++.||+.||+|||+.   +|+||||||+|||++.  +..+||+|||+++.......
T Consensus        86 g~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          86 LDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            999998842   234699999999999999999999998   9999999999999985  45899999999987654432


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV  384 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  384 (453)
                         .....+|+.|+|||.+.+.  .++.++||||+||++|||++|+.||......        .+...+..+....   .
T Consensus       160 ---~~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~~~~~---~  223 (321)
T d1tkia_         160 ---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYTF---D  223 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCC---C
T ss_pred             ---ccccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCC---C
Confidence               2445789999999998764  7899999999999999999999999754321        1333343332211   1


Q ss_pred             hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCCC
Q 048517          385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSI  424 (453)
Q Consensus       385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~~  424 (453)
                      ......++..+.+++.+||+.||++|||+.|+++  .+.+..
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence            1122234567889999999999999999999998  354433

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=340.69  Aligned_cols=238  Identities=25%  Similarity=0.324  Sum_probs=175.8

Q ss_pred             cccCccCceEEEEEEE-cCCcEEEEEEecCCCCC------HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517          167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS------AEEFINE--------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~------~~~~i~e--------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      +.||+|+||+||+|+. .+|+.||||+++.....      .+.+.+|              +++++..+...++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            5799999999999995 57999999998753321      1233344              5677888888999999999


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  305 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  305 (453)
                      ++++....    .....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....... 
T Consensus        84 ~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          84 TDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             EEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             chHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            88776554    3346799999999999999999999998   999999999999999999999999999987654432 


Q ss_pred             eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC-------
Q 048517          306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD-------  378 (453)
Q Consensus       306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~-------  378 (453)
                       ......||+.|+|||++... ..++.++||||+||++|||++|+.||.......    .-..+.+.+.....       
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTTTSSSTT
T ss_pred             -cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH----HHHHHHHhcCCCChhhccchh
Confidence             22445799999999998653 367999999999999999999999986543211    00001111100000       


Q ss_pred             -----cccc-----chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          379 -----LELR-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       379 -----~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                           ....     .........++.+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                 0000     000011223467899999999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-42  Score=341.35  Aligned_cols=228  Identities=25%  Similarity=0.290  Sum_probs=184.4

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC----CCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS----KFSAEEFINE--------------LLGLCSEGFKRALVYE  222 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~----~~~~~~~i~e--------------l~g~~~~~~~~~lv~E  222 (453)
                      .|++.++||+|+||.||+|+. .+|+.||||++...    ....+.+++|              +++.+......++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            466778999999999999996 47999999998642    2334455555              4566677778899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517          223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  302 (453)
                      |+.+|+|..++...    ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus       122 ~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         122 YVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             CCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999988543    4689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR  382 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  382 (453)
                      .     ....||+.|||||++.+.  .++.++||||+||++|||++|+.||.....        ......+..+....  
T Consensus       195 ~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~~--  257 (350)
T d1rdqe_         195 T-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVRF--  257 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCC--
T ss_pred             c-----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCCCCC--
Confidence            2     345799999999999864  789999999999999999999999964321        12334444433211  


Q ss_pred             chhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517          383 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  418 (453)
Q Consensus       383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~  418 (453)
                           +..++..+.+++.+||+.||.+|+     |++++++
T Consensus       258 -----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 -----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 122345688999999999999994     8999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-42  Score=332.66  Aligned_cols=244  Identities=20%  Similarity=0.281  Sum_probs=179.8

Q ss_pred             hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      |.+.++||+|+||+||+|+. .+|+.||||+++....   ..+++++|              +++++..+...++||||+
T Consensus         4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~   83 (298)
T d1gz8a_           4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   83 (298)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence            45668999999999999995 5799999999976432   24455555              567777888899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      .++.+ .++..  .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        84 ~~~~~-~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          84 HQDLK-KFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             SEEHH-HHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             CCchh-hhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            75544 44422  2346799999999999999999999998   999999999999999999999999999987654432


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC------
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD------  378 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~------  378 (453)
                        ......||+.|+|||.+... ...+.++||||+||++|||++|+.||...+...   .+.. +.........      
T Consensus       158 --~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~-i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         158 --TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFR-IFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             --CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH-HHHHHCCCCTTTSTTG
T ss_pred             --cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHH-HHHhcCCCchhhcccc
Confidence              23455799999999988764 456889999999999999999999997543211   0000 0000000000      


Q ss_pred             ------------ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          379 ------------LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       379 ------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                                  ............++..+.+++.+||+.||++|||++|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                        00000011112334678899999999999999999999873

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-42  Score=333.03  Aligned_cols=248  Identities=19%  Similarity=0.265  Sum_probs=180.3

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------HhcccccCcceEEEEEecC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      +|.+.++||+|+||+||+|+. .+|+.||||++...... +++..|               +..+..++...++||||+ 
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            477889999999999999995 57999999998764322 112222               223345566778999999 


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc---CCCceEEEecCCccccCCC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGla~~~~~~  302 (453)
                      +|+|.+.+..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+|+.....
T Consensus        86 ~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          86 GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            5666665532   335799999999999999999999998   999999999999985   4567999999999976543


Q ss_pred             CCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          303 NDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       303 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ...     .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||..............+....+..  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--  235 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--  235 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--
Confidence            321     122345799999999999864  68999999999999999999999997544322111111111111100  


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  426 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~  426 (453)
                        .   .......++..+.+++.+||+.+|++||+++++.+.|+.....
T Consensus       236 --~---~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         236 --P---IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             --C---HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --C---hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence              0   0111223446788999999999999999999999988865443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=326.01  Aligned_cols=224  Identities=24%  Similarity=0.360  Sum_probs=174.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC------------CHH-HHHH----------HHhcccccCcce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF------------SAE-EFIN----------ELLGLCSEGFKR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~------------~~~-~~i~----------el~g~~~~~~~~  217 (453)
                      .|.+.+.||+|+||+||+|+. .+|+.||||++.....            ..| +.+.          ++++++......
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            567789999999999999995 5799999999864211            111 1222          255667778889


Q ss_pred             EEEEEecCC-CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCC
Q 048517          218 ALVYEYMPN-GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGL  295 (453)
Q Consensus       218 ~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGl  295 (453)
                      ++||||+.+ +++.+++..    ...+++.++..++.|++.||+|||+.   +|+||||||+|||++. ++.+||+|||+
T Consensus        85 ~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence            999999976 577676633    25689999999999999999999998   9999999999999985 47999999999


Q ss_pred             ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      |+......    .+...||+.|+|||++.+. ..++.++||||+||++|||++|+.||....              .+.+
T Consensus       158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~  218 (273)
T d1xwsa_         158 GALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIR  218 (273)
T ss_dssp             CEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHH
T ss_pred             ceeccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCch--------------HHhh
Confidence            98764432    2456799999999999764 234678999999999999999999996421              1111


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +... .      +..++..+.+++.+||+.||++|||++|+++
T Consensus       219 ~~~~-~------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         219 GQVF-F------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCCC-C------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccC-C------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111 1      1123456889999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-41  Score=328.10  Aligned_cols=260  Identities=17%  Similarity=0.259  Sum_probs=191.0

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH------------HhcccccCcceEEEEEecC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE------------LLGLCSEGFKRALVYEYMP  225 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e------------l~g~~~~~~~~~lv~E~~~  225 (453)
                      ..|.+.++||+|+||+||+|+. .+|+.||||++.....  ...+.+.+            +++++..+...++||||+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            3567889999999999999995 4799999999865322  22222222            445556677789999998 


Q ss_pred             CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-----CCceEEEecCCccccC
Q 048517          226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFHP  300 (453)
Q Consensus       226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-----~~~~kl~DFGla~~~~  300 (453)
                      +|+|.+++..   .+..+++.++..++.|++.||+|||+.   +|+||||||+|||++.     ++.+||+|||+|+...
T Consensus        84 ~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          84 GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            7899888743   235689999999999999999999998   9999999999999974     5689999999998764


Q ss_pred             CCCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517          301 KENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  375 (453)
Q Consensus       301 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~  375 (453)
                      .....     .......||+.|||||.+.+.  .++.++||||||+++|||++|+.||.........     .....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-----~~~~~i~~  230 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYERIGE  230 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHHHHHH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-----HHHHHHHh
Confidence            33211     122345799999999999864  7899999999999999999999999754332211     11111111


Q ss_pred             CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCCCCC
Q 048517          376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKPFFS  436 (453)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p~~~  436 (453)
                      ....  ....+....+++.+.+++..|++.+|++||+++.+.+.|+..++.......-.++
T Consensus       231 ~~~~--~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~D  289 (293)
T d1csna_         231 KKQS--TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD  289 (293)
T ss_dssp             HHHH--SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred             ccCC--CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            1000  0011111224467889999999999999999999999998877666544443333

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.7e-41  Score=326.78  Aligned_cols=243  Identities=21%  Similarity=0.257  Sum_probs=180.1

Q ss_pred             hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM  224 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~  224 (453)
                      +|+..++||+|+||+||+|+.++|+.||||++.....   ..+++.+|              +++.+......++++||+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            3566789999999999999999999999999976432   24566666              566677788899999999


Q ss_pred             CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517          225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  304 (453)
Q Consensus       225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  304 (453)
                      .++.+..+.    .....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||++........
T Consensus        83 ~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          83 DQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             SEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             hhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            887776654    2346799999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC--------
Q 048517          305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG--------  376 (453)
Q Consensus       305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~--------  376 (453)
                        ......||+.|+|||.+.+. ..++.++||||+||+++||++|+.||........   + .-+...+...        
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~-~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---L-MRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-HHHHHHHCCCCTTTSTTG
T ss_pred             --ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---H-HHHHHhhCCCChhhccch
Confidence              22345689999999998764 4678999999999999999999999975432110   0 0001100000        


Q ss_pred             ---C----C---ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 ---G----D---LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ---~----~---~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                         .    .   .............+..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0    0   0000001112234467889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=327.87  Aligned_cols=242  Identities=22%  Similarity=0.335  Sum_probs=174.2

Q ss_pred             hhhhhcccCccCceEEEEEEE-cC-CcEEEEEEecCCCC------CH--H-HHHHH-----------Hhcccc-----cC
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HT-GRLIAVKMMENSKF------SA--E-EFINE-----------LLGLCS-----EG  214 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~-g~~VAVK~l~~~~~------~~--~-~~i~e-----------l~g~~~-----~~  214 (453)
                      .|++.++||+|+||+||+|+. .+ ++.||||++.....      ..  + +.++.           +++++.     ..
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence            466778999999999999996 44 67899999864211      11  1 11111           233332     23


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...++++||+.+|++.....   .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        88 ~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence            46789999998887754432   3346789999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  374 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~  374 (453)
                      +++......   ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||........   +. .+...+.
T Consensus       162 ~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~-~i~~~~~  232 (305)
T d1blxa_         162 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LG-KILDVIG  232 (305)
T ss_dssp             SCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH-HHHHHHC
T ss_pred             hhhhhcccc---cCCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HH-HHHHhhC
Confidence            998654332   23556799999999999764  789999999999999999999999975432110   00 0111110


Q ss_pred             hCC----------------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KGG----------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~~----------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ...                ..............++.+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000                00000001112234456888999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-40  Score=326.88  Aligned_cols=249  Identities=21%  Similarity=0.272  Sum_probs=173.4

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCc------ce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGF------KR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~------~~  217 (453)
                      +|.+.++||+|+||+||+|+. .+|+.||||++.......   +.+++|              +++++....      ..
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence            566678999999999999995 579999999998644332   334444              344443332      46


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      ++||||+ +++|...+.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||+|+
T Consensus        99 ~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          99 YLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             EEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence            8999999 566766552     24699999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHH--
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSW--  368 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~--  368 (453)
                      .....     .+...||+.|+|||.+.+. ..++.++||||+||+++||++|+.||.........       ...+..  
T Consensus       170 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         170 QADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccCCc-----cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            76443     2456799999999998753 36789999999999999999999999754321100       000000  


Q ss_pred             -------HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhCCCC
Q 048517          369 -------VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSID  425 (453)
Q Consensus       369 -------~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~~~~  425 (453)
                             .......................+..+.+++.+||+.||++|||++|+++.  |+...+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence                   000000000000000111112234567889999999999999999999984  665443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-40  Score=326.88  Aligned_cols=249  Identities=22%  Similarity=0.246  Sum_probs=175.6

Q ss_pred             hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH--H-HHHHH--------Hhcccc------cCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA--E-EFINE--------LLGLCS------EGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~--~-~~i~e--------l~g~~~------~~~~~~lv~E~  223 (453)
                      +|+..++||+|+||+||+|+.. +|+.||||++.......  | +.+.+        +++++.      .....++||||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            5666788999999999999964 79999999997744322  2 22232        334432      23346899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKE  302 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~  302 (453)
                      +++|.+ +.+.........+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++.....
T Consensus       101 ~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_         101 VPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             CSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred             cCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence            986644 33332223456799999999999999999999998   999999999999999765 8999999999876544


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc--------ccchHHHHHHhh
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK--------AYFPSWVYDQLN  374 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~l~  374 (453)
                      ..   .....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||........-        .....+......
T Consensus       177 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         177 EP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             SC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             cc---cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            32   2345799999999988753 46899999999999999999999999754321100        000011111100


Q ss_pred             hCCCccccc------hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          375 KGGDLELRN------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       375 ~~~~~~~~~------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      .........      ........+..+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000000      00011224456889999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=318.15  Aligned_cols=245  Identities=21%  Similarity=0.250  Sum_probs=172.3

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------Hhcccc--------cC
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCS--------EG  214 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~--------~~  214 (453)
                      ..|++.++||+|+||+||+|+. .+|+.||||++.....   ..+++++|              +++.+.        ..
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            3567778999999999999995 5899999999865322   23445555              222221        23


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...++||||++++.+....    .....++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            4578999999888775443    3345788899999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCc--eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517          295 LAKFHPKENDF--VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  372 (453)
Q Consensus       295 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  372 (453)
                      +++........  .......||+.|+|||.+... ..++.++||||+||+++||++|+.||........    ...+.+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~----~~~i~~~  237 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ----LALISQL  237 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHH
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH----HHHHHHh
Confidence            99876533221  112335699999999998753 3688999999999999999999999965332110    0001111


Q ss_pred             hhh--------------------CCCccccchhh--hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          373 LNK--------------------GGDLELRNVTE--IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       373 l~~--------------------~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      +..                    ..... .....  ........+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQK-RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCC-BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCChhhccccchhhhhhhhccccccc-ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            100                    00000 00000  01112346778999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-40  Score=324.91  Aligned_cols=249  Identities=18%  Similarity=0.210  Sum_probs=173.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccC----cceEEE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEG----FKRALV  220 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~----~~~~lv  220 (453)
                      +|++.++||+|+||+||+|+. .+|+.||||++......  .+++++|              +++.+...    ...+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            356678999999999999985 58999999999764322  3345555              23333322    123456


Q ss_pred             EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517          221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  300 (453)
Q Consensus       221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  300 (453)
                      ++|+.+|+|.+++..     ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          89 VTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            677789999999842     3589999999999999999999998   99999999999999999999999999998764


Q ss_pred             CCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc------chHH-----
Q 048517          301 KENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY------FPSW-----  368 (453)
Q Consensus       301 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~------~~~~-----  368 (453)
                      ..... .......||+.|+|||.+... ..++.++||||+||+++||++|+.||...........      .+..     
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            43221 122445799999999998654 4678899999999999999999999975432110000      0000     


Q ss_pred             -----HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517          369 -----VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  419 (453)
Q Consensus       369 -----~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~  419 (453)
                           .......................+..+.+++.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 000000000000000000111234568899999999999999999999974

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=318.39  Aligned_cols=238  Identities=21%  Similarity=0.279  Sum_probs=179.5

Q ss_pred             hhhhhcccCccCceEEEEEEE----cCCcEEEEEEecCCC-----C------CHHHHHHH---------HhcccccCcce
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMMENSK-----F------SAEEFINE---------LLGLCSEGFKR  217 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~-----~------~~~~~i~e---------l~g~~~~~~~~  217 (453)
                      .|.+.++||+|+||+||+|+.    .+|+.||||+++...     .      .+-+.+.+         +++.+......
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence            477789999999999999984    258999999986421     1      11122222         45566677788


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      +++|||+.+|+|.+++...    ..++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999988543    3567888999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517          298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  377 (453)
Q Consensus       298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~  377 (453)
                      ........ ......||+.|+|||.+......++.++||||+||+||||++|+.||.......    ....+........
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~~~~~  252 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRILKSE  252 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHHHCC
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcccCC
Confidence            76543322 124567999999999997654467889999999999999999999997654322    1111222221211


Q ss_pred             CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517          378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  418 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~  418 (453)
                      . .      .+..++..+.+++.+||+.||++|||     ++|+++
T Consensus       253 ~-~------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 P-P------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             C-C------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             C-C------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1 1      12234567889999999999999995     788886

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.2e-39  Score=315.93  Aligned_cols=241  Identities=19%  Similarity=0.263  Sum_probs=176.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------Hhcccc--cCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLCS--EGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~--~~~~~~lv~E~  223 (453)
                      .|.+.++||+|+||+||+|+. .+|+.||||+++...  .+++.+|               +++++.  .....++||||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~  113 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  113 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence            466778999999999999995 579999999997643  3334333               233333  33457899999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCccccCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKE  302 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~~~  302 (453)
                      +.+|+|....       ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.+ ..+||+|||+|+.....
T Consensus       114 ~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         114 VNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             CCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             cCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999997654       4689999999999999999999998   99999999999999865 46999999999876544


Q ss_pred             CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc------hHHHHHHhhhC
Q 048517          303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF------PSWVYDQLNKG  376 (453)
Q Consensus       303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~------~~~~~~~l~~~  376 (453)
                      ..   .....+|+.|+|||.+.+. ..++.++||||+||+++||++|+.||............      .....+.....
T Consensus       184 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         184 QE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             Cc---ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            32   2456799999999998764 35789999999999999999999999654432110000      00000011000


Q ss_pred             CC---------------cccc--chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          377 GD---------------LELR--NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       377 ~~---------------~~~~--~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ..               ....  ........++..+.+++.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00               0000  001122334567889999999999999999999976

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-39  Score=311.42  Aligned_cols=244  Identities=18%  Similarity=0.247  Sum_probs=181.5

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEY  223 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~  223 (453)
                      +|++.++||+|+||+||+|+. .+|+.||||+++.....   .+++.+|              +++.+......++++|+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            356678999999999999995 58999999999764322   3445555              45667777888999999


Q ss_pred             cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517          224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  303 (453)
Q Consensus       224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  303 (453)
                      +.+++|..++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.++......
T Consensus        83 ~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          83 CDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99999877663    335788999999999999999999998   99999999999999999999999999999876544


Q ss_pred             CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh--------
Q 048517          304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK--------  375 (453)
Q Consensus       304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~--------  375 (453)
                      ..  .....+++.|+|||.+... ..++.++||||+||+++||++|+.|+.........  + ..+......        
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         156 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--L-KRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--H-HHHHHHHCCCCTTTCTT
T ss_pred             cc--ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--H-HHHHhhcCCCChhhhhh
Confidence            32  2345678899999998764 35789999999999999999999997543321100  0 000000000        


Q ss_pred             ------CCCc----cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          376 ------GGDL----ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       376 ------~~~~----~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                            ....    ............+..+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0000    000011122234456889999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-38  Score=312.56  Aligned_cols=247  Identities=19%  Similarity=0.240  Sum_probs=174.0

Q ss_pred             hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH---HHHHHH--------------Hhcccc-----cCcceE
Q 048517          162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCS-----EGFKRA  218 (453)
Q Consensus       162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~-----~~~~~~  218 (453)
                      +|...++||+|+||+||+|+. .+|+.||||++.......   +++.+|              +++++.     +....+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            466778999999999999995 579999999998754432   234444              223332     223346


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      ++++|+.+|+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++..
T Consensus        99 ~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             EEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             EEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence            77888899999998832     4699999999999999999999998   999999999999999999999999999975


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc-------ch-----
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FP-----  366 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-------~~-----  366 (453)
                      ....     .....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||...........       ..     
T Consensus       171 ~~~~-----~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         171 TDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CTGG-----GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cCcc-----cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            5332     2456789999999987754 3578899999999999999999999975432110000       00     


Q ss_pred             ----HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhC
Q 048517          367 ----SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  422 (453)
Q Consensus       367 ----~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~  422 (453)
                          .........................+..+.+++.+||+.||++|||++|+++  .+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                0000000000000000000011123456889999999999999999999997  4543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-38  Score=309.55  Aligned_cols=241  Identities=21%  Similarity=0.192  Sum_probs=166.5

Q ss_pred             hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHH---HHHHH--------------Hhcccc------cCcceE
Q 048517          163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAE---EFINE--------------LLGLCS------EGFKRA  218 (453)
Q Consensus       163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~---~~i~e--------------l~g~~~------~~~~~~  218 (453)
                      |++.++||+|+||+||+|+.. +|+.||||++........   ++.+|              +++.+.      .....+
T Consensus        19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~   98 (355)
T d2b1pa1          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY   98 (355)
T ss_dssp             EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence            556689999999999999954 799999999986544322   33344              333332      335779


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517          219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      +||||+.++.+ +.+.      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|++|||+++.
T Consensus        99 iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          99 LVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence            99999976555 4442      4589999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc--------c-------
Q 048517          299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK--------A-------  363 (453)
Q Consensus       299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~--------~-------  363 (453)
                      .....   ......+|+.|+|||++.+.  .++.++||||+||+++||++|+.||.........        .       
T Consensus       169 ~~~~~---~~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         169 AGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             ---------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccc---ccccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            65433   22455799999999999864  7899999999999999999999999644311000        0       


Q ss_pred             cchHHHHHHhhhCCCc------------cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517          364 YFPSWVYDQLNKGGDL------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  418 (453)
Q Consensus       364 ~~~~~~~~~l~~~~~~------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~  418 (453)
                      ................            ............+..+.+++.+||++||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000011111111000            000111233456778999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-36  Score=299.54  Aligned_cols=273  Identities=19%  Similarity=0.281  Sum_probs=185.7

Q ss_pred             HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH------H-------------------hccccc-
Q 048517          161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE------L-------------------LGLCSE-  213 (453)
Q Consensus       161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e------l-------------------~g~~~~-  213 (453)
                      .+|.+.++||+|+||+||+|+. .+|+.||||+++......+.+.+|      +                   ++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            3578889999999999999995 579999999998754333333222      1                   222221 


Q ss_pred             -CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC------
Q 048517          214 -GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF------  286 (453)
Q Consensus       214 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~------  286 (453)
                       .....++++++..+....... .......+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccc
Confidence             233456777766554433322 223446788899999999999999999983  2899999999999997654      


Q ss_pred             ceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch
Q 048517          287 IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP  366 (453)
Q Consensus       287 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  366 (453)
                      .+|++|||.+.......     ....||+.|+|||.+...  .++.++||||+||+++||++|+.||.............
T Consensus       170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             eeeEeeccccccccccc-----ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence            48999999998654322     445799999999998864  78999999999999999999999987543221111000


Q ss_pred             HHH--HHH--------hhhC----------------CCccccc-------hhhhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517          367 SWV--YDQ--------LNKG----------------GDLELRN-------VTEIESMIARKLCMIGLWCIQVKAADRPSM  413 (453)
Q Consensus       367 ~~~--~~~--------l~~~----------------~~~~~~~-------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  413 (453)
                      ...  ...        ....                .......       ........+..+.+++.+||+.||++|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            000  000        0000                0000000       001224566789999999999999999999


Q ss_pred             HHHHHH--HhC--CCCCCCCCCCCCCCCCCCCCC
Q 048517          414 TKVLEM--LEG--SIDDLQMPPKPFFSSSRHISG  443 (453)
Q Consensus       414 ~evl~~--Le~--~~~~~~~p~~p~~~~~~~~~~  443 (453)
                      +|+++.  ++.  ..++.+.|+++...+...+|.
T Consensus       323 ~e~L~Hp~f~~~~~~~~~~~p~~~~~~~~~~~~~  356 (362)
T d1q8ya_         323 GGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPG  356 (362)
T ss_dssp             HHHHTCGGGTTCTTCTTCCCTTSCTTCBSTTSTT
T ss_pred             HHHhcCcccCCCCCcccCCCCCcccCCCCCCCCc
Confidence            999984  653  356688888888876655553

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=1.2e-22  Score=182.43  Aligned_cols=153  Identities=19%  Similarity=0.139  Sum_probs=105.8

Q ss_pred             hhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC------H-------------------HHHHHHHhcccccC----
Q 048517          164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS------A-------------------EEFINELLGLCSEG----  214 (453)
Q Consensus       164 ~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~------~-------------------~~~i~el~g~~~~~----  214 (453)
                      .+.++||+|+||+||+|+..+|+.||||+++.+...      .                   .+.+..+.+.+...    
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            356899999999999999889999999987642111      0                   01122233332211    


Q ss_pred             cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517          215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  294 (453)
Q Consensus       215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  294 (453)
                      ...+++|||++++.+.           .++......++.|++++|+|||+.   +|+||||||+|||++++ .++|+|||
T Consensus        83 ~~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          83 EGNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             ETTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             cCCEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECC
Confidence            2346999999876542           255667788999999999999998   99999999999999965 58999999


Q ss_pred             CccccCCCCCceeecccCCCCCccC------hhhhcccCCCCCccchHHHHHHHHH
Q 048517          295 LAKFHPKENDFVSISDTRGTIGYLA------PELISRNFGTVSCKSDVYGFGMVLL  344 (453)
Q Consensus       295 la~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~s~k~DV~S~Gvvl~  344 (453)
                      +|........          ..|..      .|.+.+   .++.++|+||..--++
T Consensus       148 ~a~~~~~~~~----------~~~l~rd~~~~~~~f~r---~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         148 QSVEVGEEGW----------REILERDVRNIITYFSR---TYRTEKDINSAIDRIL  190 (191)
T ss_dssp             TCEETTSTTH----------HHHHHHHHHHHHHHHHH---HHCCCCCHHHHHHHHH
T ss_pred             CcccCCCCCc----------HHHHHHHHHHHHHHHcC---CCCCcccHHHHHHHHh
Confidence            9975532221          01111      122322   5678899999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.70  E-value=9.3e-05  Score=66.81  Aligned_cols=116  Identities=16%  Similarity=0.097  Sum_probs=70.8

Q ss_pred             cCceEEEEEEEcCCcEEEEEEecCCC-CCH-----H-HHHHH---------HhcccccCcceEEEEEecCCCChhhhhhh
Q 048517          172 GGFGSVYKGQLHTGRLIAVKMMENSK-FSA-----E-EFINE---------LLGLCSEGFKRALVYEYMPNGSLDRHIFS  235 (453)
Q Consensus       172 G~fG~Vy~g~~~~g~~VAVK~l~~~~-~~~-----~-~~i~e---------l~g~~~~~~~~~lv~E~~~~gsL~~~l~~  235 (453)
                      ++.+.||+.... ++.+.||+..... ...     + ..+..         ++.+.......++||+++++.++.+... 
T Consensus        25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~-  102 (263)
T d1j7la_          25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-  102 (263)
T ss_dssp             CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT-
T ss_pred             CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc-
Confidence            344689988654 5567788875421 111     1 11111         3344445666789999999888754331 


Q ss_pred             ccCCCCCCCchhHHHHHHHHHHHHHHhHcCC-------------------------------------------------
Q 048517          236 KENKGQTFGLEKPHEIALGTARGIEYLHNGC-------------------------------------------------  266 (453)
Q Consensus       236 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------------  266 (453)
                              +......++.++++.+..||+..                                                 
T Consensus       103 --------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         103 --------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             --------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             --------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence                    11122334444555555555321                                                 


Q ss_pred             -------CCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          267 -------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       267 -------~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                             ...++|+|+.|.|||++++..+-|.||+.+.
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                   1238999999999999987777799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.33  E-value=0.00035  Score=62.52  Aligned_cols=129  Identities=18%  Similarity=0.181  Sum_probs=71.4

Q ss_pred             cCccC-ceEEEEEEEcCCcEEEEEEecCCCCCH---H-HHHHH----------HhcccccCcceEEEEEecCCCChhhh-
Q 048517          169 LGQGG-FGSVYKGQLHTGRLIAVKMMENSKFSA---E-EFINE----------LLGLCSEGFKRALVYEYMPNGSLDRH-  232 (453)
Q Consensus       169 LG~G~-fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~-~~i~e----------l~g~~~~~~~~~lv~E~~~~gsL~~~-  232 (453)
                      +..|. -+.||+...+++..+.+|.-.......   + ..+..          ++..+.+....++||+++++.++.+. 
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~   97 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH   97 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc
Confidence            44444 368999988888889999876543321   1 11111          34445566678899999988665331 


Q ss_pred             ----------------hhhccCCCCCCCchhHHHH----------------------HHHHHHHHHHhHcC----CCCce
Q 048517          233 ----------------IFSKENKGQTFGLEKPHEI----------------------ALGTARGIEYLHNG----CDVCI  270 (453)
Q Consensus       233 ----------------l~~~~~~~~~l~~~~~~~i----------------------~~~ia~gL~yLH~~----~~~~i  270 (453)
                                      |+........+.+.....+                      .......+..+...    ....+
T Consensus        98 ~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l  177 (255)
T d1nd4a_          98 LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVV  177 (255)
T ss_dssp             CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEE
T ss_pred             ccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceE
Confidence                            1110000001111000000                      00011222233222    12348


Q ss_pred             eecccCCcceEEcCCCceEEEecCCcc
Q 048517          271 LHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       271 vH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      +|+|+.|.|||++++..+-|.||+.+.
T Consensus       178 iHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         178 THGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             ECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EeCCCCCcceEEeCCceEEEEEchhcc
Confidence            999999999999987777899998775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.44  E-value=0.0057  Score=58.45  Aligned_cols=31  Identities=23%  Similarity=0.265  Sum_probs=26.6

Q ss_pred             CceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517          268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  299 (453)
Q Consensus       268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  299 (453)
                      ..++|+|+.|.|||++++. ++|.||..+...
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G  253 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  253 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence            3699999999999998765 899999888654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.43  E-value=0.0068  Score=56.25  Aligned_cols=122  Identities=21%  Similarity=0.224  Sum_probs=68.7

Q ss_pred             eEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH------Hhc---------------ccccCcceEEEEEecCCCChhh--
Q 048517          175 GSVYKGQLHTGRLIAVKMMENSKFSAEEFINE------LLG---------------LCSEGFKRALVYEYMPNGSLDR--  231 (453)
Q Consensus       175 G~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e------l~g---------------~~~~~~~~~lv~E~~~~gsL~~--  231 (453)
                      -.||+.+.++|+.+++|+........++...|      |..               ....+...+.++++++|..+..  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            58999999999999999987765555544433      211               1123345678999987644321  


Q ss_pred             --h----------hhhc----c-CCCCCCCc-------------------hhHHHHHHHHHHHHHHhH----cCCCCcee
Q 048517          232 --H----------IFSK----E-NKGQTFGL-------------------EKPHEIALGTARGIEYLH----NGCDVCIL  271 (453)
Q Consensus       232 --~----------l~~~----~-~~~~~l~~-------------------~~~~~i~~~ia~gL~yLH----~~~~~~iv  271 (453)
                        .          ++..    . .....+++                   .....+...+.+.++.+.    +....+++
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li  195 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  195 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence              0          1110    0 00011111                   111122222223333332    23345799


Q ss_pred             ecccCCcceEEcCCCceEEEecCCccc
Q 048517          272 HFDIKPHNILLDHNFIPKVSDFGLAKF  298 (453)
Q Consensus       272 H~Dikp~NILl~~~~~~kl~DFGla~~  298 (453)
                      |+|+.+.|||++++  ..+.||+-+..
T Consensus       196 HgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         196 HGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             cCCCCcccEEEeCC--ceEEechhccc
Confidence            99999999999754  45889988764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.70  E-value=0.07  Score=50.42  Aligned_cols=73  Identities=18%  Similarity=0.162  Sum_probs=30.3

Q ss_pred             ceeecccCCcceEEcCCCceEEEecCCccccC-CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH
Q 048517          269 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHP-KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA  347 (453)
Q Consensus       269 ~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell  347 (453)
                      .++|+|+.+.||++.+....++.+-..+.... .+..........+....++.|+..-+       -=.|-+|..+.|..
T Consensus       219 v~CHnDL~~~NiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lID~EYa~~n-------~~~fDian~f~E~~  291 (395)
T d1nw1a_         219 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASYN-------YRAFDFANHFIEWT  291 (395)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEEE-------EHHHHHHHHHHHTT
T ss_pred             eEEecCCCcccEeeccccccccccccccccccccccccccccCCCCcEEEEeecccCCC-------cchhhHHHHHHHHh
Confidence            36799999999999765544443322211100 00000011122234456677755322       11466777777776


Q ss_pred             c
Q 048517          348 G  348 (453)
Q Consensus       348 t  348 (453)
                      .
T Consensus       292 ~  292 (395)
T d1nw1a_         292 I  292 (395)
T ss_dssp             E
T ss_pred             c
Confidence            4

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=91.31  E-value=0.068  Score=48.60  Aligned_cols=32  Identities=19%  Similarity=0.263  Sum_probs=27.9

Q ss_pred             CCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517          266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  297 (453)
Q Consensus       266 ~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  297 (453)
                      .+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccceeEecccccc
Confidence            34589999999999999998777899999874